<SEC-DOCUMENT>0001104659-23-105297.txt : 20230929
<SEC-HEADER>0001104659-23-105297.hdr.sgml : 20230929
<ACCEPTANCE-DATETIME>20230929160143
ACCESSION NUMBER:		0001104659-23-105297
CONFORMED SUBMISSION TYPE:	424B4
PUBLIC DOCUMENT COUNT:		30
FILED AS OF DATE:		20230929
DATE AS OF CHANGE:		20230929

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adlai Nortye Ltd.
		CENTRAL INDEX KEY:			0001944552
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B4
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-273465
		FILM NUMBER:		231295353

	BUSINESS ADDRESS:	
		STREET 1:		685 U.S. HIGHWAY ONE, 2ND FLOOR
		CITY:			NORTH BRUNSWICK
		STATE:			NJ
		ZIP:			08902
		BUSINESS PHONE:		848-230-7430

	MAIL ADDRESS:	
		STREET 1:		685 U.S. HIGHWAY ONE, 2ND FLOOR
		CITY:			NORTH BRUNSWICK
		STATE:			NJ
		ZIP:			08902
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B4
<SEQUENCE>1
<FILENAME>tm2225088-43_424b4.htm
<DESCRIPTION>424B4
<TEXT>
<html>
  <head>
    <title>tm2225088-43_424b4 - none - 42.2290339s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:27pt;width:541.31pt;">
        <div style="text-align:right; width:541.31pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">&#8202; Filed pursuant to Rule 424(b)(4)</font>
          <br >
          <font style="letter-spacing:-0.17pt;">&#8202;Registration No. 333-273465</font>&#8203;</div>
        <div style="margin-top:5.8pt; text-align:center; width:541.31pt; line-height:13pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">2,500,000 American Depositary Shares</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
        </div>
        <div style="position:relative;margin-top:5.6pt; text-align:center; width:541.31pt;">
          <img src="lg_adlainortye-4c.jpg" alt="[MISSING IMAGE: lg_adlainortye-4c.jpg]" height="56" width="373" >
        </div>
        <div style="margin-top:8.4pt; text-align:center; width:541.31pt; line-height:17pt;font-weight:bold;font-size:16pt;">
          <font style="letter-spacing:-0.32pt;">Adlai Nortye Ltd.</font><font style="font-weight:normal;letter-spacing:0.32pt;"> </font>
        </div>
        <div style="margin-top:5pt; text-align:center; width:541.31pt; line-height:13pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">Representing 7,500,000 Class A Ordinary Shares</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.17pt;">This is an initial public offering of American depositary shares, or ADSs, representing Class A ordinary shares of Adlai Nortye Ltd. We are offering a total of 2,500,000 ADSs. Each ADS represents three of our Class A ordinary shares, par value US$0.0001 per share. The underwriters may also purchase up to 375,000 additional ADSs within 30&#160;days from the date of this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.17pt;">Prior to this offering, there has been no public market for the ADSs or our Class A ordinary shares. We have been approved to list the ADSs on the Nasdaq Global Market under the symbol &#8220;ANL.&#8221;</font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.17pt;">Immediately prior to the completion of this offering, our issued and outstanding share capital will consist of Class A ordinary shares and Class B ordinary shares. Holders of Class A ordinary shares and Class B ordinary shares have the same rights except for voting and conversion rights. Each Class A ordinary share will be entitled to one vote, and each Class B ordinary share shall be entitled to 15 votes on all matters subject to a vote at general meetings of our company. Each Class B ordinary share shall be convertible into Class A ordinary share at any time at the option of the holder thereof. Class A ordinary shares shall not be convertible into Class B ordinary shares under any circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.17pt;">Additionally, upon the completion of this offering and the concurrent private placement, we will be a &#8220;controlled company&#8221; as defined under corporate governance rules of Nasdaq Stock Market, because Mr. Yang Lu will beneficially own 100% of our then-issued and outstanding Class B ordinary shares and will be able to exercise 79.5% of the total voting power of our issued and outstanding ordinary shares immediately after the consummation of this offering and the concurrent private placement, assuming the underwriters do not exercise its option to purchase additional ADSs. For further information, see &#8220;Principal Shareholders&#8221; and &#8220;Risk Factors &#8201;&#8212;&#8201; Risks related to the ADSs&#8201;&#8212;&#8201;We will be a &#8220;controlled company&#8221; within the meaning of the Nasdaq Stock Market listing rules and, as a result, may rely on exemptions from certain corporate governance requirements that provide protection to shareholders of other companies.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.17pt;">Concurrently with, and subject to, the completion of this offering, Nippon Kayaku Co., Ltd., or Nippon Kayaku, a chemical company headquartered in Japan, which undertakes the development, manufacturing and sale of functional chemicals, pharmaceuticals, safety systems and agrochemicals, has agreed to purchase US$40.0 million in Class A ordinary shares from us. This concurrent private placement is at a price per Class A ordinary share equal to the initial public offering price adjusted to reflect the ADS-to-Class A ordinary share ratio. We will issue and sell a total of 5,217,391 Class A ordinary shares in this concurrent private placement. Our proposed issuance and sale of Class A ordinary shares to Nippon Kayaku is being made through private placement pursuant to an exemption from registration with the SEC under Regulation S of the Securities Act. Pursuant to the subscription agreement executed with Nippon Kayaku on July&#160;27, 2023, the closing of this concurrent private placement is subject to the completion of this offering and satisfaction of customary closing conditions. If this offering is completed, the closing of this concurrent private placement is expected to occur concurrently. Nippon Kayaku has agreed with the underwriters not to, directly or indirectly, sell, transfer or dispose of any Class A ordinary shares for a period of 180 days after the date of the underwriting agreement, subject to certain exceptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.17pt;">In addition, an investor has subscribed for, and has been allocated by the underwriters, an aggregate of 2,173,913 ADSs at the initial public offering price and on the same terms as the other ADSs being offered, representing approximately 87.0% of the total ADSs in this offering, assuming the underwriters do not exercise their option to purchase additional ADSs. The underwriters will receive the same underwriting discounts and commissions on any ADSs purchased by this investor as they will on any other ADSs sold to the public in this offering. See &#8220;Underwriting.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.17pt;">Adlai Nortye Ltd. is not a Chinese operating company, but is a Cayman Islands holding company. Our daily operations are conducted primarily through our operating subsidiaries in the United States and mainland China. Investors purchasing the ADSs in this initial public offering are purchasing equity securities of our Cayman Islands holding company and are not purchasing equity securities of our operating subsidiaries. As a holding company, we may rely on dividends from our subsidiaries for our cash requirements, including any payment of dividends to our shareholders. The ability of our subsidiaries to pay dividends to us, however, may be restricted by the debt they incur on their own behalf and/or laws and regulations applicable to them. Unless otherwise indicated or the context otherwise requires, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our company,&#8221; and &#8220;our&#8221; refer to Adlai Nortye&#160;Ltd., our Cayman Islands holding company and its subsidiaries, which include those in the U.S. and mainland China that conduct daily operations.</font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.17pt;">If needed, cash can be transferred between our Cayman Islands holding company and subsidiaries incorporated in the United States, mainland China and Hong Kong through equity investments and intercompany loans. Currently, there are no restrictions of transferring funds between our Cayman Islands holding company and subsidiaries in the United States and Hong Kong; however, currency exchange control measures imposed by the PRC government may restrict the ability of our subsidiaries in the PRC to transfer their cash to our Cayman Islands holding company and other subsidiaries incorporated outside the PRC through loans, advances or cash dividends. See Note&#160;27 to our consolidated financial statements for a detailed discussion. We may also make loans and additional capital contribution to our subsidiaries or branches, subject to certain restrictions under the applicable local laws, including the laws of China. We have no plans to declare cash dividends in the near term, but as a holding company, we may depend on receipt of funds from one or more of our subsidiaries if we determine to pay cash dividends to holders of our ordinary shares and ADSs in the future. We do not have a regular dividend policy, and our Board of Directors has discretion as to whether to distribute dividends, subject to certain requirements of Cayman Islands law. As of the date of this prospectus, our Cayman Islands holding company has not declared or paid any dividends or distributions on equity to its shareholders. See &#8220;Prospectus Summary&#8201;&#8212;&#8201;Cash transfers and dividend distributions&#8221; for the summary of our cash transfers and dividend distributions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.17pt;">Pursuant to the Holding Foreign Companies Accountable Act, or the HFCAA, the Public Company Accounting Oversight Board, or the PCAOB, issued a Determination Report in December&#160;2021 which found that the PCAOB is unable to inspect or investigate completely registered public accounting firms headquartered in mainland China and Hong Kong because of positions taken by the authorities in those jurisdictions. Our auditor, which is based in New York, is currently subject to inspection by the PCAOB at least every two&#160;years. However, our auditor&#8217;s China affiliate is located in, and organized under the laws of, the PRC. On August&#160;26, 2022, the PCAOB entered into a Statement of Protocol with the China Securities Regulatory Commission and the Ministry of Finance of the PRC and, as summarized in the &#8220;Statement on Agreement Governing Inspections and Investigations of Audit Firms Based in China and Hong Kong&#8221; published on the U.S. Securities and Exchange Commission&#8217;s official website, the parties agreed to the following: (i)&#160;in accordance with the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, the PCAOB shall have independent discretion to select any issuer audits for </font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:27pt;width:541.31pt;">
        <div style="text-align:justify; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.17pt;">inspection or investigation; (ii)&#160;the PCAOB shall have direct access to interview or take testimony from all personnel of the audit firms whose issuer engagements are being inspected or investigated; (iii)&#160;the PCAOB shall have the unfettered ability to transfer information to the SEC, in accordance with the Sarbanes-Oxley Act; and (iv)&#160;the PCAOB inspectors shall have access to complete audit work papers without any redactions, with view-only procedures for certain targeted pieces of information such as personally identifiable information. On December&#160;15, 2022, the PCAOB issued a report that vacated its December&#160;16, 2021 determination and removed mainland China and Hong Kong from the list of jurisdictions where it is unable to inspect or investigate completely registered public accounting firms. On December 29, 2022, legislation entitled &#8220;Consolidated Appropriations Act, 2023&#8221; &#8203;(the &#8220;Consolidated Appropriations Act&#8221;), was signed into law by President Joseph Biden of the United States. The Consolidated Appropriations Act contained, among other things, an identical provision to Accelerating Holding Foreign Companies Accountable Act, which reduces the number of consecutive non-inspection years required for triggering the prohibitions under the HFCAA from three years to two. Each year, the PCAOB will determine whether it can inspect and investigate completely audit firms in mainland China and Hong Kong, among other jurisdictions. We cannot assure you that we will not be identified by the SEC under the HFCAA as an issuer that has retained an auditor that has a branch or office located in a foreign jurisdiction that the PCAOB determines it is unable to inspect or investigate completely because of a position taken by an authority in that foreign jurisdiction. In addition, there can be no assurance that, if we have a &#8220;non-inspection&#8221; year, we will be able to take any remedial measures. If any such event were to occur, trading in our securities could in the future be prohibited under the HFCAA and, as a result, we cannot assure you that we will be able to maintain the listing of the ADSs on the Nasdaq Stock Market or that you will be allowed to trade the ADSs in the United States on the &#8220;over-the-counter&#8221; markets or otherwise. Should the ADSs become not listed or tradeable in the United States, the value of the ADSs could be materially affected. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks relating to our operation in the People&#8217;s Republic of China&#8221; for a detailed discussion.</font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">We are an &#8220;emerging growth company&#8221; under the applicable U.S. federal securities laws and are eligible for reduced public company reporting requirements. See &#8220;Risk Factors&#8221; beginning on page <a href="#tRIFA">20</a> for factors you should consider before buying the ADSs.</font><font style="font-weight:normal;letter-spacing:0.17pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font><font style="font-weight:normal;letter-spacing:0.17pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:4.5pt; text-align:justify; width:541.31pt; line-height:9.5pt;">
          <font style="letter-spacing:0.17pt;">We face various legal and operational risks and uncertainties relating to our operation in China. We have substantial business operations located in mainland China and are subject to evolving PRC laws and regulations. Recently, the PRC government has indicated an intent to exert more oversight and control over offerings that are conducted overseas and/or involve foreign investment in China-based issuers, and initiated a series of regulatory actions and made a number of public statements, some of which are published with little advance notice, including stringent enforcement against illegal activities in the securities market, enhancing supervision over China-based companies listed overseas, adopting new measures to extend the scope of cybersecurity reviews, and expanding efforts in anti-monopoly enforcement. We may be subject to the approval, filing or other requirements of the China Securities Regulatory Commission, or the CSRC, or other PRC governmental authorities in connection with this Offering under current PRC laws, regulations and rules. However, we do not believe that approval of the cybersecurity review of the Cyberspace Administration of China, or the CAC is required in connection with this Offering under current PRC laws, regulations and rules at this stage, as&#160;we have not processed, and do not anticipate to process in the foreseeable future, personal information of more than one million users or persons and the data we handle in our business operations, either by its nature or in scale, does not normally trigger significant concerns over PRC national security. However, we cannot affirm that PRC regulators share the same interpretation. Because these statements and regulatory actions are new and subject to change, it is highly uncertain as to how quickly the legislative or administrative regulation making bodies in China will respond to companies, or what existing or new laws or regulations will be amended or promulgated, if any, or the potential impact such amended or new legislation will have on our daily business operations or our ability to accept foreign investments and list on a U.S. stock exchange. For risks relating to approval of the CSRC, the oversight of the CAC, and other PRC government authorities, please refer to &#8220;Risk Factors&#8201;&#8212;&#8201;Risks relating to our operation in the People&#8217;s Republic of China.&#8221; Uncertainties in the PRC legal system and the interpretation and enforcement of PRC laws and regulations could limit the legal protections available to you and us, hinder our ability to offer or continue to offer the ADSs, result in a material adverse effect on our business operations, and damage our reputation, which might further cause the ADSs to significantly decline in value or become worthless. </font>
        </div>
        <div style="margin-top:6.633pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.8pt; text-align:center; width:541.31pt; line-height:10pt;font-weight:bold;font-size:9pt;">
          <font style="letter-spacing:-0.18pt;">PRICE US$23.00 PER ADS</font><font style="font-weight:normal;letter-spacing:0.18pt;"> </font>
        </div>
        <div style="margin-top:6.5pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <table style="width:541.31pt;height:53.5pt;margin-top:-0.200000000000045pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:411.69pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Per ADS </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:411.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Initial public offering price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">23.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">57,500,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:411.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Underwriting discounts and commissions</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8199;1.15 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">&#8199;2,875,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:411.69pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Proceeds, before expenses, to us </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">21.85</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">54,625,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.5pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:9pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">See &#8220;Underwriting&#8221; for additional information regarding total underwriter compensation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:4.5pt; text-align:justify; width:521.31pt; line-height:9.5pt;font-style:italic;">
          <font style="letter-spacing:0.17pt;">The underwriters expect to deliver the ADSs to purchasers on or about October&#160;3, 2023.</font><font style="font-style:normal;letter-spacing:0.17pt;"> </font>
        </div>
        <div style="margin-top:13.133pt; text-align:center; width:541.31pt;">
          <div style="margin-left: 40.024%; margin-right: 40.024%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <table style="width:541.31pt;margin-top:5.29999999999995pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:16pt;">
          <tr style="line-height:16pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:16pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.32pt;">Cantor</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13pt; text-align:center; width:541.31pt; line-height:10pt;font-weight:bold;font-size:9pt;">
          <font style="letter-spacing:-0.18pt;">Prospectus Dated September&#160;29, 2023.</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:370pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRSU"><font style="letter-spacing:0.2pt;">Prospectus Summary </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPRSU">1</a></font> <a href="#tPRSU"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRIFA"><font style="letter-spacing:0.2pt;">Risk Factors </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRIFA">20</a></font> <a href="#tRIFA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSNRF"><font style="letter-spacing:0.2pt;">Special Note Regarding Forward-Looking Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSNRF">85</a></font> <a href="#tSNRF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUOP"><font style="letter-spacing:0.2pt;">Use of Proceeds </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUOP">87</a></font> <a href="#tUOP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDIPO"><font style="letter-spacing:0.2pt;">Dividend Policy </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDIPO">88</a></font> <a href="#tDIPO"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCAP"><font style="letter-spacing:0.2pt;">Capitalization </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCAP">89</a></font> <a href="#tCAP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDIL"><font style="letter-spacing:0.2pt;">Dilution </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDIL">91</a></font> <a href="#tDIL"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCHAS"><font style="letter-spacing:0.2pt;">Corporate History and Structure </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCHAS">93</a></font> <a href="#tCHAS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMDAA"><font style="letter-spacing:0.2pt;">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMDAA">94</a></font> <a href="#tMDAA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tBUS"><font style="letter-spacing:0.2pt;">Business </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tBUS">107</a></font> <a href="#tBUS"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tREG"><font style="letter-spacing:0.2pt;">Regulation </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tREG">151</a></font> <a href="#tREG"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tMAN"><font style="letter-spacing:0.2pt;">Management </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMAN">169</a></font> <a href="#tMAN"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRSH"><font style="letter-spacing:0.2pt;">Principal Shareholders </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPRSH">177</a></font> <a href="#tPRSH"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRPT"><font style="letter-spacing:0.2pt;">Related Party Transactions </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tRPT">180</a></font> <a href="#tRPT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOSC"><font style="letter-spacing:0.2pt;">Description of Share Capital </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOSC">181</a></font> <a href="#tDOSC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOAD"><font style="letter-spacing:0.2pt;">Description of American Depositary Shares </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDOAD">191</a></font> <a href="#tDOAD"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSEFF"><font style="letter-spacing:0.2pt;">Shares Eligible for Future Sale </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSEFF">199</a></font> <a href="#tSEFF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tTAX"><font style="letter-spacing:0.2pt;">Taxation </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tTAX">200</a></font> <a href="#tTAX"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUND"><font style="letter-spacing:0.2pt;">Underwriting </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tUND">208</a></font> <a href="#tUND"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tERTT"><font style="letter-spacing:0.2pt;">Expenses Related to this Offering </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tERTT">219</a></font> <a href="#tERTT"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tLEMA"><font style="letter-spacing:0.2pt;">Legal Matters </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tLEMA">220</a></font> <a href="#tLEMA"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXP"><font style="letter-spacing:0.2pt;">Experts </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEXP">221</a></font> <a href="#tEXP"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEOCL"><font style="letter-spacing:0.2pt;">Enforceability of Civil Liabilities </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tEOCL">222</a></font> <a href="#tEOCL"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tWYCF"><font style="letter-spacing:0.2pt;">Where You Can Find Additional Information </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWYCF">224</a></font> <a href="#tWYCF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:429pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tISFS"><font style="letter-spacing:0.2pt;">Index to Consolidated Financial Statements </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tISFS">F-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Through and including October&#160;24, 2023 (the 25th day after the date of this prospectus), all dealers that effect transactions in these ADSs, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#8217; obligation to deliver a prospectus when acting as an underwriter and with respect to their unsold allotments or subscriptions.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You should rely only on the information contained in this prospectus or in any free writing prospectus that we authorize to be distributed to you. We and the underwriters have not authorized anyone to provide you with any information other than that contained in this prospectus or in any free writing prospectus prepared by or on behalf of us or to which we have referred you, and neither we, nor the underwriters, take responsibility for any other information others may give you. We are offering to sell, and seeking offers to buy the ADSs, only in jurisdictions where such offers and sales are permitted. The information in this prospectus or any free writing prospectus is accurate only as of its date, regardless of its time of delivery or the time of any sale of the ADSs. Our business, financial condition, results of operations, and prospects may have changed since that date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Neither we nor any of the underwriters has taken any action to permit a public offering of the ADSs outside the United States or to permit the possession or distribution of this prospectus or any filed free writing prospectus outside the United States. Persons outside the United States who come into possession of this prospectus or any filed free writing prospectus must inform themselves about and observe any restrictions relating to the offering of the ADSs and the distribution of the prospectus or any filed free writing prospectus outside the United States.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRSU">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">PROSPECTUS SUMMARY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">The following summary is qualified in its entirety by, and should be read in conjunction with, the more detailed information and financial statements appearing elsewhere in this prospectus. In addition to this summary, we urge you to read the entire prospectus carefully, especially the risks of investing in the ADSs discussed under &#8220;Risk Factors&#8221; before deciding whether to invest in the ADSs.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We are a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types. Our mission is to transform deadly cancer into a chronic and eventually curable disease. We are now developing multiple innovative antitumor drug candidates by leveraging our deep knowledge in cancer biology, as well as significant global R&amp;D and clinical execution capabilities. These drug candidates are currently undergoing clinical trials, and in many cases, in collaboration with multinational pharmaceutical companies to fully realize their commercialization potential on a global scale. Our combination therapy strategy is directed towards systematically activating the immune system through a combination of multiple drugs, aiming to enhance the clinical benefit by achieving superior efficacy and safety while overcoming drug resistance. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We have identified and developed a robust pipeline of six drug candidates. Currently, our pipeline includes three clinical-stage drug candidates, buparlisib (AN2025), palupiprant (AN0025), and AN4005, as well as three preclinical candidates. Our most advanced program is our lead product AN2025, a pan-phosphoinositide 3-kinase (&#8220;PI3K&#8221;) inhibitor that is designed to act against solid tumors. AN2025 is currently undergoing a Phase&#160;III, multi-regional, randomized, open-label clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas (&#8220;HNSCC&#8221;) after anti-programmed death-1 (&#8220;PD-1&#8221;) or its ligand (&#8220;PD-L1&#8221;) treatment in more than 180 sites in 18 jurisdictions covering North America, Europe, Asia, and South America. We believe that AN2025, if approved, has the potential to be first-to-market, and is currently the only drug candidate in active Phase&#160;III clinical trial targeting recurrent or metastatic HNSCC patients after progression on prior anti-PD-1/PD-L1 therapy, potentially addressing a global unmet medical need. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We are collaborating with MSD International GmbH, or MSD, to evaluate AN0025, a small molecule prostaglandin E receptor 4 (&#8220;EP4&#8221;) antagonist. It is currently being developed to modulate the tumor microenvironment in combination with Keytruda or pembrolizumab, in a Phase&#160;Ib clinical trial for the treatment of recurrent non-small cell lung cancer (&#8220;NSCLC&#8221;) and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer (&#8220;TNBC&#8221;), microsatellite stable colorectal cancer (&#8220;MSS CRC&#8221;) and cervical cancer after standard of care treatments in the U.S. and France. In addition, a Phase&#160;I clinical trial has been initiated for a combination therapy consisting of AN2025, AN0025, and Tecentriq or atezolizumab targeting a variety of PIK3CA mutant solid tumors. The atezolizumab used in this clinical trial is supplied by F.&#160;Hoffman La Roche Ltd or Roche. This triple combination is expected to target the PI3K mediated tumorigenesis while inhibiting the immunosuppressive tumor microenvironment through multiple non-overlapping mechanisms, leading to synergistic action for tumor regression. AN4005, which is currently being studied in a Phase&#160;I clinical trial in the U.S. and China, is an internally discovered oral small molecule PD-L1 inhibitor in development to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Additionally, we continue to advance three in-house preclinical programs which we believe have high global commercial viability. Our preclinical candidates include: AN8025, a multifunctional antibody as T cell and antigen-presenting cell (&#8220;APC&#8221;) modulator; AN1025, an oral small molecule degrader of &beta;-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. We anticipate submitting the IND for AN8025 in the second half of 2024. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We believe the next frontier in cancer immunotherapy lies in the category of combination therapies. Our drug candidates combine an immune checkpoint inhibitor with two or more additional cancer therapies in effort to elicit synergistic anti-cancer effects and improved tolerability relative to monotherapies. As we endeavor to engender complementary and synergistic results across our portfolio, our primary consideration is the potential interaction with our other pipeline candidates and/or currently available treatments. We strive to develop innovative antitumor candidates focusing on druggability as well as combinational strength to be leveraged in the next wave of immuno-oncology treatments, ultimately helping to shape the next-generation of cancer therapy. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Through our multi-national R&amp;D centers established in New Jersey and Hangzhou, we execute on our global vision for drug development innovation. The geographic span of our R&amp;D footprint empowers us to more effectively identify and develop novel early-stage programs, as well as recruit top R&amp;D talent from the U.S. and China. We have assembled a management team and a scientific advisory board with industry leaders and influential scientists, who provide international and strategic guidance to our R&amp;D, business development, and operational teams. In addition to building our own R&amp;D capabilities, we continue to seek and secure partnerships with leading multi-national pharmaceutical companies such as Eisai Co., Ltd. or Eisai and Novartis Pharma AG or Novartis, to fully realize the potential of our pipeline programs. We believe our partnerships validate our clinical expertise and reflect belief in our ability to deliver on our development and commercialization capabilities across a versatile pipeline. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our pipeline</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We are advancing a robust pipeline of innovative drug candidates in various stages of development. The following chart provides an overview of the status of our drug candidates: </font>
          </div>
          <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
            <img src="tm2225088d1-tbl_pipelin4c.jpg" alt="[MISSING IMAGE: tm2225088d1-tbl_pipelin4c.jpg]" height="271" width="603" >
          </div>
          <div style="margin-top:16.61pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">AN2025: a pan-PI3K inhibitor aimed at becoming the vanguard for recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our lead product AN2025, the most clinically advanced drug candidate in our pipeline, is a pan-PI3K inhibitor currently undergoing a global Phase&#160;III trial. In-licensed from Novartis, we have the exclusive global rights to develop and commercialize AN2025. It is currently the only drug candidate we are aware of in active registrational clinical trial for the treatment of recurrent or metastatic HNSCC after disease progression with anti-PD-1/PD-L1 therapy. Although anti-PD-1/PD-L1 therapy is becoming first line treatment in patients with recurrent or metastatic HNSCC since its U.S. Food and Drug Administration (&#8220;FDA&#8221;) approval in 2019, the current treatments are unable to meet the needs of HNSCC patients progressed on prior anti-PD-1/PD-L1 treatment. We believe that AN2025, if approved, has the potential to be the first product globally with such label to address this unmet medical need and capture the sizable addressable market. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">AN2025 is a widely studied molecule with Novartis alone having sponsored 40 clinical trials on over 4,200 patients across a variety of cancers. These studies include a Phase&#160;II trial that demonstrated that the combination of AN2025 with paclitaxel achieved a superior median overall survival (&#8220;mOS&#8221;), and significant improvements in median progression-free survival (&#8220;mPFS&#8221;) and overall response rate (&#8220;ORR&#8221;) compared to the control group in recurrent or metastatic HNSCC after disease progression with platinum based chemotherapy. In July 2016, AN2025 was granted Fast Track designation by the FDA for the treatment of recurrent or metastatic HNSCC with disease progression on or after platinum-based therapy. For the Phase&#160;III trial, we expect to enroll 483 patients in more than 180 sites around the world, spanning over 18 markets in North America, Europe, Asia, and South America. Leveraging the benefit of using ORR data from the planned Phase&#160;III interim analysis, we expect to submit the NDA to the FDA seeking a potential accelerated </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">approval in the second half of 2024, followed by further marketing approval applications to National Medical Products Administration of People&#8217;s Republic of China (&#8220;NMPA&#8221;), European Medicines Agency (&#8220;EMA&#8221;), Pharmaceuticals and Medical Devices Agency of Japan (&#8220;PMDA&#8221;), and other authorities. </font>
          </div>
          <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">AN0025: a tumor microenvironment modulator</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">AN0025, in-licensed from Eisai, is a small molecule EP4 antagonist designed to modulate the tumor microenvironment. It is designed to block the prostaglandin E2 (&#8220;PGE2&#8221;)-EP4 signaling pathway to inhibit PGE2-mediated immunosuppression in cancer patients. In the CT26 murine colon cancer model, for those which are not responsive to anti-PD-1/PD-L1 therapy, AN0025 combined with an anti-PD-1 antibody treatment demonstrated stronger antitumor activity compared to each standalone compound. In June&#160;2020, we initiated a Phase&#160;Ib clinical trial to evaluate the combination of AN0025 and pembrolizumab for the treatment of recurrent NSCLC and urothelial cancer after anti-PD-1/PD-L1 treatments, as well as recurrent TNBC, MSS CRC, and cervical cancer after standard of care treatments. As of June&#160;30, 2023, we were in the dose expansion stage having enrolled 63 patients in the U.S. and France, and expect to obtain top-line results in the second half of 2023. We aim to identify specific cancer types sensitive to this combination based on the results and will proactively communicate with the regulatory authorities for the design of Phase&#160;II/III registrational trials. </font>
          </div>
          <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Triple combination of AN2025, AN0025, and atezolizumab: an example of our combination therapy strategy</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">To fully explore the potential of AN2025 and AN0025, we initiated a study of the triple combination of AN2025, AN0025, and atezolizumab, an anti-PD-L1 antibody. This study exemplifies our combination therapy strategy to achieve synergistic effects from both targeted therapy and immunotherapy perspectives. AN2025 targets not only PI3K mediated tumorigenesis (e.g., via inhibition of PI3K&alpha; / PIK3CA mutants) but also the immunosuppression of the tumor microenvironment (e.g., via inhibition of PI3K&#948; and PI3K&#947;). Leveraging the complementary and synergistic antitumor effects of our drug candidates in combination therapies, AN2025 is designed to mechanistically complement and synergize with the combination of anti-PD-1/PD-L1 and AN0025 to form an improved treatment regimen for patients with multiple advanced solid tumors. In different tumor-bearing mouse models, we have consistently observed significantly stronger antitumor activity in the triple combination of AN2025, AN0025, and atezolizumab compared with doublet combinations. In July&#160;2021, we initiated a Phase&#160;I clinical trial to evaluate the triple combination of AN2025, AN0025, and atezolizumab, for a variety of PIK3CA mutant solid tumors. In September&#160;2022, subsequent to the doublet arm dose-ranging studies, we initiated a dose-ranging study for the triple combination, and we expect to identify the recommended Phase&#160;II dose (&#8220;RP2D&#8221;) in the second half of 2023. </font>
          </div>
          <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">AN4005: a backbone of our future oral combination therapies</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">AN4005, a drug candidate discovered in-house, is an oral small-molecule PD-L1 inhibitor designed to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Compared to the crowded development of anti-PD-1/PD-L1 antibodies, with multiple brands already available to patients and many potential candidates in clinical trials, small-molecule PD-L1 inhibitors are underdeveloped and do not have a drug approved in any jurisdiction globally, despite advantages such as shorter half-life that may allow for dose titration and schedule modifications to minimize immune-related adverse events (&#8220;AEs&#8221;) and lower production costs. In our preclinical studies, AN4005 was well tolerated and exhibited excellent tumor growth inhibition (&#8220;TGI&#8221;) to an extent comparable to an approved anti-PD-L1 antibody, and promoted an adaptive immune response for antitumor activities. We received allowance to proceed under INDs from the FDA and NMPA for the treatment of advanced tumors in June&#160;2021 and December 2021, respectively, dosed the first patient in January&#160;2022, and expect to identify the RP2D from the Phase&#160;I clinical trial in the second half of 2023. </font>
          </div>
          <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;">
            <font style="letter-spacing:0.2pt;">Our preclinical programs</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We continue actively advancing three in-house preclinical programs which we believe have high global commercial viability. Our preclinical candidates include: AN8025, a multifunctional antibody as T cell and APC modulator; AN1025, an oral small molecule degrader of &beta;-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. We anticipate submitting the IND for AN8025 in the second half of 2024. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our company history and team</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We rebranded in 2016 as Adlai Nortye Biopharma and began development activities focusing on the discovery and development of innovative cancer therapies, after originally incorporating in 2004. We have assembled an experienced management team consisting of successful entrepreneurs and industry veterans. Largely, our success stems from management&#8217;s leadership and industry expertise, covering the full spectrum of the cancer therapy development process, from design and execution of preclinical and clinical studies through the regulatory process and commercialization. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Our management team has more than 100 cumulative&#160;years of industry experience and a proven track record of innovative drug R&amp;D, clinical development, and commercialization. Our founder, chief executive officer, and chairman of our board of directors, Mr.&#160;Yang Lu is a successful entrepreneur who brings expertise across the domains of business development, operations, and management. Our president, chief medical officer, and chief executive officer of our U.S. subsidiary, Dr.&#160;Lars Erik Birgerson, has extensive experience as a senior leader with numerous well-known companies in the biopharmaceutical industry, including Roche Pharmaceuticals, Genentech, and Bristol-Myers Squibb (&#8220;BMS&#8221;). Our senior vice president and global head of clinical operations, Dr.&#160;Kaiyang Tang, has deep experience in global clinical operations and regulatory affairs in the pharmaceutical industry, and has served as a clinical leader in a number of companies, including Generon (Shanghai) Corporation Ltd. and Hutchison MediPharma Ltd, a company triple listed on the Nasdaq, Hong Kong Stock Exchange, and Alternative Investment Market. Our senior vice president and global head of regulatory affairs, Dr.&#160;Victoria Elizabeth Demby, has over 20&#160;years of industry experience and has served in various senior positions for several multinational pharmaceutical companies such as GSK, MSD, and BMS. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Since our inception, we have received strong support from our shareholders, including financial investors as well as several industry-leading strategic investors. This investor base is, and we expect will continue to be, aligned with our vision and strategy going forward. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our strengths</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We believe our competitive advantage is underpinned by the following competitive strengths: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Multi-modality pipeline with several innovative drug candidates targeting a range of tumor indications.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We plan to continue to leverage our expertise in drug discovery and our proficiency in executing promising collaborations and partnerships to bring innovative drugs to patients across the cancer type spectrum. Our candidates utilize a multitude of different mechanisms of action, enabling us to employ our assets on a standalone basis or in combination across tumor types and treatment combinations. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Robust Phase&#160;II data laying a concrete foundation for potential registration.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp; In a Phase II clinical trial of our lead asset, AN2025, for the treatment of recurrent or metastatic HNSCC on or after disease progression with platinum-based chemotherapy, the clinical data showed that the combination of AN2025 with paclitaxel achieved an mOS of over 10&#160;months (vs. 6.5&#160;months in the placebo plus paclitaxel group), an mPFS of 4.6&#160;months (vs. 3.5&#160;months in the placebo plus paclitaxel group), and a 39.2% ORR (vs. 13.9% in the placebo plus paclitaxel group). These data also showed that when AN2025 was combined with paclitaxel, grade 3-4 AEs (82% in the AN2025 plus paclitaxel group vs. 72% in the placebo group), serious adverse events (&#8220;SAEs&#8221;) (57% in the AN2025 plus paclitaxel group vs. 47% in the placebo group) or on-treatment deaths (20% in the AN2025 plus paclitaxel group vs. 22% in the placebo group) is comparable to paclitaxel alone. The most frequent SAEs for AN2025 plus paclitaxel combination were pneumonia (7.89% vs. 7.69% in the placebo group), and diarrhea (5.26% vs. 0.00% in the placebo group). The most frequent SAEs for AN2025 plus paclitaxel combination that occurred less in the placebo group were diarrhea (5.26% vs. 0.00%), hyperglycaemia (3.95% vs. 0.00%), and general physical health deterioration (3.95% vs. 0.00%). See &#8220;Business &#8212; Our differentiated oncology portfolio &#8212; Buparlisib (AN2025): a pan-PI3K inhibitor aimed at becoming the vanguard for recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy&#8221; for a complete list of SAEs of AN2025 plus paclitaxel combination. In addition, the Phase&#160;II clinical trial was designed to be a thoroughly placebo-controlled double-arm study, which provides us with further confidence in the success of the ongoing Phase&#160;III clinical trial. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Targeting unmet medical need with large total addressable markets.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;AN2025 is designed to address globally urgent unmet medical demands for effective treatments in HNSCC after anti-PD-1/PD-L1 treatment. In seven major markets (the U.S., the U.K., Germany, France, Italy, Spain, and Japan), it is estimated that by 2028 there can be more than 50,000 recurrent or metastatic HNSCC patients experiencing progression after anti-PD-1/PD-L1 therapy. As the only drug candidate currently in Phase&#160;III clinical trial for the treatment of recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy of which we are aware, we believe that AN2025, if approved, has potential to be the first product globally to address this unmet need and capture the sizable addressable market. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Strong R&amp;D capabilities</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Spanning the full spectrum from target identification to clinical development, our in-house drug discovery platforms deploy a suite of powerful and specialized techniques. They consist of two platforms, PAINT-2D</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> and ANEAT-Id</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">. PAINT-2D</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> provides us with a &#8220;one-stop&#8221; function for early-stage development of immuno-oncology therapies. ANEAT-Id</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> is a highly efficient and robust yeast display system dedicated to therapeutic antibody discovery and development. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Sustainable patent portfolio in our key jurisdictions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As of June 30, 2023, we owned or had exclusive license rights to (i)&#160;165 granted patents and 101 pending patent applications in jurisdictions such as the U.S., European Patent Office (&#8220;EPO&#8221;), mainland China, Japan, South Korea, Canada, Australia, Taiwan, Mexico and Brazil, and (ii)&#160;12 patent applications under the Patent Cooperation Treaty, or PCT, that have not been nationalized. Granted patents and pending patent applications cover the key inventions for our pipeline candidates in clinical trials under IND, as well as our key technologies. Protections over potential approved use of core matters of AN2025 and AN0025 can expire in 2032 and 2036, respectively, both taking into account of the possible 5-year patent term extensions in jurisdictions where patent term extension is available, including but not limited to the U.S., Europe, China and Japan. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Seasoned industry veterans and strong shareholder support</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We believe our team, with a proven track record of innovative drug R&amp;D, clinical development, and commercialization knowledge, as well as rich expertise in business development and operational execution, can successfully drive our drug candidates to approval and clinical use on a global scale. Additionally, we are supported by the strategic guidance of a visionary scientific advisory board with members from both academia and the pharmaceutical industry. We have also received continued support from our shareholders including financial investors and several industry-leading strategic investors. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Our vision &amp; strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We strive to become a global leader in the next wave of immuno-oncology therapies employing a combination therapy strategy. Our mission is to transform deadly cancer into a chronic and eventually curable disease. We intend to execute the following strategies to achieve this goal: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Advance the development of and pursue regulatory approval for our lead drug candidate AN2025.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp; We have advanced AN2025, in combination with paclitaxel for the treatment of recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy into a Phase&#160;III clinical trial. We expect to enroll 483 patients across 180 sites in North America, Europe, Asia, and South America, and to submit an NDA to the FDA for a potential accelerated approval in the second half of 2024 leveraging the ORR data from the Phase&#160;III interim analysis, followed by further marketing approval applications to the NMPA, EMA, PMDA and other authorities. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Continue advancing pipeline products through in-house development and strategic partnerships to maximize value.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As we evaluate assets, we place a strong emphasis on first-in-class potential, combinational synergies with our current pipeline or other available therapies, as well as global development and commercialization rights. We intend to continue to develop our novel drug candidates by leveraging our proprietary R&amp;D platforms, our strong early and clinical stage drug discovery expertise, as well as through the support of our various global collaborators. We intend to continue building upon our existing partnership success, exploring new opportunities through strategic collaborations and potentially co-development arrangements, ultimately maximizing the clinical and commercial value of our drug candidates. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Utilize manufacturing partnerships to maximize economies of scale.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We currently work with qualified contract manufacturing organizations, or CMOs, to manufacture drug candidates for preclinical and clinical supply. In the near future, we plan to continue outsourcing the manufacturing of our drug candidates, including commercial-scale manufacturing of our approved drugs, to industry-leading, highly reputable, and qualified CMOs/contract development and manufacturing organizations, or CDMOs, globally. We have historically adopted and plan to continue to implement robust procedures to ensure that production qualifications, facilities, and processes of our CMOs/CDMOs comply with applicable regulatory requirements as well as our own internal guidelines and quality standards. We may also engage additional qualified CMOs/CDMOs in the future to ensure sufficient supply of drug candidates for our clinical trials as well as for commercial sale of our approved drugs. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Assemble a world-class marketing team to accelerate the adoption of emerging next-wave immuno-oncology treatments.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We aim to capture market share in the U.S. and gradually enter other significant markets including Europe, China, and Japan. To ensure maximum commercial value of our late-stage drug candidates globally, we intend to form our core in-house commercial leadership team by recruiting senior-level sales and marketing personnel to support commercialization of our drug candidates in the U.S. We may also consider strategic collaboration opportunities for the commercialization of our drug candidates in other countries in Europe and Asia. In particular, we may selectively out-license, establish joint ventures or consider other forms of commercialization partnerships with leading biopharmaceutical companies. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Seek and nurture top talent to fuel our innovation and ingenuity.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We place a high priority on selecting and retaining top talent. Our R&amp;D centers in New Jersey and Hangzhou provide access to a global talent pool of highly skilled scientists and physicians. To support our continued growth, we plan to continue investing in recruiting and retaining top talent for our various operations around the world, including drug discovery, chemistry, manufacturing and controls (&#8220;CMC&#8221;), clinical development, regulatory affairs, and sales and marketing. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Summary of significant risk factors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We face various legal and operational risks and uncertainties as we have substantial operations in China. The PRC government has significant authority to exert influence on the ability of a China-based company, like us, to conduct its business, accept foreign investments or list on a U.S. stock exchange. For example, we face risks associated with regulatory approvals of offshore offerings, anti-monopoly regulatory actions, cybersecurity and data privacy, as well as the lack of inspection from the PCAOB. The PRC government may also intervene with or influence our operations as the government deems appropriate to further regulatory, political and societal goals. Any such action, once taken by the PRC government, could cause the value of our securities to significantly decline or in extreme cases, become worthless. The operational risks associated with being based in and having operations in China also apply to operations in Hong Kong and Macau. With respect to the legal risks associated with being based in and having operations in China, the laws, regulations and discretion of the governmental authorities in China discussed in this prospectus are expected to apply to entities and businesses in mainland China, rather than to entities or businesses in Hong Kong and Macau which operate under different sets of laws from those of mainland China. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Investing in the ADSs involves significant risks. You should carefully consider all of the information set forth in this prospectus before making an investment in the ADSs. Below please find a summary of the principal risks and uncertainties we face, organized under relevant headings. These risks are discussed more fully in the section titled &#8220;Risk factors.&#8221; </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks relating to our operation in the People&#8217;s Republic of China</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Having the majority of our operations in China poses risks to investors. We face risks arising from the legal system in China, including risks and uncertainties regarding the enforcement of laws and that rules and regulations in China can change quickly with little advance notice: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We have the majority of our operations in China and are subject to evolving PRC laws and regulations. Recently, the PRC government has indicated an intent to exert more oversight and control over offerings that are conducted overseas and/or foreign investment in China-based issuers, and initiated a </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:30pt; text-align:justify; width:426pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">series of regulatory actions and made a number of public statements, some of which are published with little advance notice. We may be subject to the approval, filing or other requirements of the CSRC or other PRC governmental authorities in connection with this Offering under current PRC laws, regulations and rules. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks relating to our operation in the People&#8217;s Republic of China&#8201;&#8212;&#8201;The approval, filing, or other procedures of the CSRC or other PRC regulatory authorities may be required in connection with this offering under PRC laws, regulations, and rules.&#8221; </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">The CAC has recently increased oversight over data security, particularly for companies seeking to list on a foreign exchange. We believe the impact of the CAC&#8217;s increasing oversight on our business is immaterial. However, there remains uncertainty as to how the CAC&#8217;s regulations will be interpreted or implemented and whether CAC may adopt new regulations which may adversely affect us. See &#8220; Risk Factors&#8201;&#8212;&#8201;Risks relating to our operation in the People&#8217;s Republic of China&#8201;&#8212;&#8201;The impact of the CAC&#8217;s increasing oversight over data security remains highly uncertain, particularly for China-based companies seeking to list on a foreign stock exchange.&#8221; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Our substantial operations are located in mainland China. Accordingly, we may be influenced to a significant degree by political, economic and social conditions in China generally. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks relating to our operation in the People&#8217;s Republic of China&#8201;&#8212;&#8201;We may be influenced by changes in the political and economic policies of the PRC government.&#8221; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Our operations in mainland China are governed by PRC laws and regulations. The uncertainties with respect to the PRC legal system could materially and adversely affect us. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks relating to our operation in the People&#8217;s Republic of China&#8201;&#8212;&#8201;Uncertainties with respect to the enforcement of laws, and changes in laws and regulations in China with little advance notice could materially and adversely affect us.&#8221; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">The Chinese government may intervene or influence our operations at any time, or may exert more control over offerings conducted overseas and/or foreign investment in China-based issuers, which could result in a material change in our operations and/or the value of our securities. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks Relating to our operation in the People&#8217;s Republic of China&#8201;&#8212;&#8201;The PRC government has significant authority to exert influence on our operations in mainland China.&#8221; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Recent negative publicity surrounding China-based companies listed in the United States may negatively impact the trading price of the ADSs.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We are also subject to other risks and uncertainties in relation to PCAOB inspection. We cannot assure you that we will not be identified by the SEC under the HFCAA, as an issuer that has retained an auditor that has a branch or office located in a foreign jurisdiction that the PCAOB determines it is unable to inspect or investigate completely because of a position taken by an authority in that foreign jurisdiction. In addition, there can be no assurance that, if we have a &#8220;non-inspection&#8221; year, we will be able to take any remedial measures. If any such event were to occur, trading in our securities could in the future be prohibited under the HFCAA and, as a result, we cannot assure you that we will be able to maintain the listing of the ADSs on the Nasdaq Stock Market or that you will be allowed to trade the ADSs in the United States on the &#8220;over-the-counter&#8221; markets or otherwise. Should the ADSs become not listed or tradeable in the United States, the value of the ADSs could be materially affected. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks Relating to our operation in the People&#8217;s Republic of China&#8201;&#8212;&#8201;the ADSs may be delisted under the HFCAA if the PCAOB is unable to inspect auditors or their affiliates that are located in mainland China. The delisting of the ADSs, or the threat of such delisting, may materially and adversely affect the value of your investment. Additionally, the inability of the PCAOB to conduct inspections deprives our investors of the benefits of such inspections.&#8221; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.5pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:4.5pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We face uncertainties in the PRC with respect to indirect transfer of equity interests in our PRC subsidiaries. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:11.12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks relating to our business</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We have a limited operating history, have incurred net losses and anticipate that we will continue to incur net losses for the foreseeable future. We may not be able to generate sufficient revenue to achieve or maintain profitability </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Our business depends substantially on the success of our preclinical and clinical drug candidates. If we are unable to successfully develop drug candidates or experience significant delays in doing so, our business will be materially harmed. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We have relied and will continue to rely on third parties to manufacture our drug candidates in the foreseeable future. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We may seek and form strategic alliance, collaboration, or licensing arrangements for the development of drug candidates in the future, which may not achieve the anticipated benefits to or even negatively impact our business. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We may rely on certain third-party collaborators for some of our clinical development activities, which could delay or limit the future development or regulatory approval of our drug candidates. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Our success depends upon our and our business partners&#8217; ability to obtain and maintain intellectual property protection for our drug candidates and technologies. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We may face competition from generic or biosimilar manufacturers after the patent protection is no longer valid. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We are exposed to risks of conducting our business and operations in international markets. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We may face force majeure risks, including the recent COVID-19 outbreak. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Risks relating to the ADSs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">An active trading market for our ordinary shares or the ADSs may not develop and the trading price of the ADSs may be volatile regardless of our operating performance, which could result in substantial losses to you. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">ADS holders do not have the same rights as our shareholders. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">Owners or holders of the ADSs have limited recourse if we or the depositary fail to meet our respective obligations under the deposit agreement. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">As an exempted company incorporated in the Cayman Islands, we are permitted to adopt certain home country practices for corporate governance matters that differ significantly from the Nasdaq corporate governance listing standards; these practices may afford less protection to shareholders than they would enjoy if we complied fully with the corporate governance listing standards. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We are a foreign private issuer within the meaning of the rules under the Exchange Act, and as such we are exempt from certain provisions applicable to U.S. domestic public companies. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We are an emerging growth company within the meaning of the Securities Act and may take advantage of certain reduced reporting requirements.</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">We will be a &#8220;controlled company&#8221; within the meaning of the Nasdaq Stock Market listing rules and, as a result, may rely on exemptions from certain corporate governance requirements that provide protection to shareholders of other companies. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Recent PRC regulatory developments</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On July&#160;6, 2021, the relevant PRC government authorities issued the Opinions on Strictly Scrutinizing on Illegal Securities Activities in Accordance with the Law. These opinions call for strengthened regulation over illegal securities activities, supervision of overseas securities offerings and listings by China-based companies, and propose to take effective measures, such as promoting the development of relevant regulatory systems, to deal with perceived risks or incidents faced by China-based overseas-listed companies. As of the date of this prospectus, no official guidance and implementation rules have been issued in relation to these recently issued opinions. Therefore, the interpretation and implementation of these opinions remain unclear at this stage. We cannot assure you we will not be required to obtain the pre-approval of the China Securities Regulatory Commission, or the CSRC, and potentially other regulatory authorities to pursue this offering. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">On February&#160;17, 2023, the China Securities Regulatory Commission, or the CSRC, released the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies, or the Trial </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Measures, and five supporting guidelines, which took effect on March&#160;31, 2023. Pursuant to the Trial Measures, domestic companies that seek to list overseas, both directly and indirectly, should fulfill the filing procedure and report relevant information to the CSRC. If a domestic company fails to complete the filing procedure or conceals any material fact or falsifies any major content in its filing documents, such domestic company may be subject to administrative penalties, such as order to rectify, warnings, fines, and its controlling shareholders, actual controllers, the person directly in charge and other directly liable persons may also be subject to administrative penalties, such as warnings and fines. See &#8220;Regulations&#8201;&#8212;&#8201;Regulations on M&amp;A Rules and Overseas Listings.&#8221; However, since the Trial Measures were newly promulgated, the interpretation, application and enforcement of Trial Measures remain unclear. If the filing procedure with the CSRC under the Trial Measures is required for any future offerings or any other capital raising activities, it is uncertain whether it would be possible for us to complete the filing, or how long it will take us to do so. For further details, see &#8216;&#8216;Risk Factors&#8201;&#8212;&#8201;Risks relating to our operation in the People&#8217;s Republic of China&#8201;&#8212;&#8201;The approval, filing, or other procedures of the CSRC or other PRC regulatory authorities may be required in connection with this offering under PRC laws, regulations, and rules.&#8217;&#8217;</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We submitted initial filing documents to the CSRC on April 20, 2023, and the CSRC published the notification on our completion of the required filing procedures on August 7, 2023 for this offering.</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The revised Measures of Cybersecurity Review as promulgated by a total of thirteen governmental departments of the PRC, including the Cyberspace Administration of China, or the CAC, came into effect on February&#160;15, 2022. The revised Measures of Cybersecurity Review stipulated that, in addition to network products and services acquired by critical information infrastructure operators, online platform operators are also subject to cybersecurity review if they carry out data processing activities that affect or may affect national security. Moreover, online platform operators listing in a foreign country with more than one million users&#8217; personal information data must apply for a cybersecurity review with the Cybersecurity Review Office. The revised Measures of Cybersecurity Review further elaborated the factors to be considered when assessing the national security risks of the relevant activities. On July&#160;7, 2022, the CAC promulgated the Measures on Security Assessment of Cross-border Data Transfer, or the Data Export Measures, which became effective on September&#160;1, 2022. The Data Export Measures requires that any data processor who processes or exports personal information exceeding a certain volume threshold shall apply for a security assessment by the CAC before transferring any personal information abroad. The security assessment requirement also applies to any transfer of important data outside of China. Since our business operation is not an operator of a network platform with personal information of over one million users, we should not be required to undergo the cybersecurity review for this offering and the listing of the ADSs under the revised Measures of Cybersecurity Review. However, as the aforementioned measures were issued recently, there are uncertainties regarding how they would be interpreted and enforced, and to what extent they may affect us. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On February&#160;24, 2023, the CSRC, jointly with other relevant governmental authorities, promulgated the Provisions on Strengthening Confidentiality and Archives Management of Overseas Securities Issuance and Listing by Domestic Enterprises, or the Confidentiality and Archives Management Provisions, which took effect on March&#160;31, 2023. The Confidentiality and Archives Management Provisions outline obligations of issuers listed in overseas markets with operations in mainland China when they provide information involving state secrets or sensitive information to their securities service providers (such as auditors) and overseas regulators. In addition, under the Confidentiality and Archives Management Provisions, such issuers will also be required to obtain approval from the CSRC and other authorities in mainland China before accepting any investigation or inspection by overseas regulators. As the Confidentiality and Archives Management Provisions were recently promulgated, there are uncertainties with respect to their interpretation and implementation. For further details, see &#8220;Regulation&#8201;&#8212;&#8201;Regulations relating to information security and data privacy.&#8221; </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Industry and market data</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We include statements and information in this prospectus concerning our industry ranking and the markets in which we operate, including our general expectations and market opportunity. We obtained the industry, market, and similar data set forth in this prospectus from our internal estimates and research and from academic and industry research, publications, surveys, and studies conducted by third parties, including governmental agencies. In some cases, we do not expressly refer to the sources from which this data is derived. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="text-align:justify; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances that are assumed in this information. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">Projections, assumptions and estimates of the future performance of the industry in which we operate and our future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in &#8220;Risk Factors&#8221; and &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; in this prospectus. These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Corporate history and structure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">We commenced our business in mainland China in 2004 through Adlai Nortye Biopharma Co., Ltd., which we refer to as our operating subsidiary in the PRC. We initially focused primarily on generic pharmaceuticals and polypeptide intermediate, until 2016 when our founders Mr.&#160;Yang Lu and Mr.&#160;Donghui Yang led our strategic transition to become a R&amp;D-driven pharmaceutical company, focusing on the discovery and development of innovative cancer therapies. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">Our ultimate holding company was incorporated in the Cayman Islands in May&#160;2018 to facilitate offshore financing activities, and our daily operations are conducted primarily through our operating subsidiaries in the United States and mainland China. Between January&#160;2018 and June&#160;2022, Alpine Bioscience Ltd, Adlai Nortye Pte. Ltd., Adlai Nortye (HK) Limited, and Adlai Nortye (Switzerland) AG were incorporated in the British Virgin Islands, Singapore, Hong Kong, and Switzerland as our intermediary holding entities. In March&#160;2019, Adlai Nortye (HK) Limited acquired entire equity interests in the Adlai Nortye Biopharma Co., Ltd. from its then shareholders and Adlai Nortye Biopharma Co., Ltd. became a wholly owned subsidiary of our ultimate holding company. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">In order to conduct clinical trials in the U.S., Adlai Nortye USA INC was incorporated under the laws of the State of Delaware in the U.S. in January&#160;2018. In June&#160;2022, as a part of a reorganization, Adlai Nortye (Switzerland) AG acquired all its shares and Adlai Nortye USA INC become a wholly owned subsidiary of our ultimate holding company. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11pt;">
            <font style="letter-spacing:0.2pt;">The chart below sets forth our corporate structure and identifies our subsidiaries and their subsidiaries, as of the date of this prospectus: </font>
          </div>
          <div style="position:relative;margin-top:9.41pt; text-align:center; width:456pt;">
            <img src="fc_ourcorporate-bw.jpg" alt="[MISSING IMAGE: fc_ourcorporate-bw.jpg]" height="303" width="536" >
          </div>
          <div style="margin-top:15.8pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Cash transfers and dividend distributions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Adlai Nortye Ltd. is not a Chinese operating company, but is a Cayman Islands holding company. We maintain our bank accounts and balances primarily in licensed banks in the United States, mainland China </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:7.05999999999995pt; margin-left:12pt;width:456pt;">
          <div style="text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">and Hong Kong. If needed, cash can be transferred between our Cayman Islands holding company and subsidiaries incorporated in the United States, mainland China and Hong Kong through equity investments, dividends and intercompany loans, and there are currently no restrictions of transferring funds between our Cayman Islands holding company and subsidiaries in the United States and Hong Kong. We may also make loans and additional capital contribution to our mainland China, subject to certain restrictions under the applicable local laws. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Adlai Nortye Ltd., our Cayman Islands holding company, has not declared or made any dividends or other distributions to its shareholders since its inception. U.S. investors will not be subject to Cayman Islands taxation on dividend distributions, and no withholding will be required on the payment of dividends or distributions to them while they may be subject to U.S. federal income tax. Adlai Nortye Ltd. may be classified as a &#8220;resident enterprise&#8221; of China. This classification could result in unfavorable tax consequences to us and our non-PRC shareholders and dividends paid by us may be subject to PRC withholding tax. See &#8220;Taxation&#8201;&#8212;&#8201;United States federal income tax considerations&#8201;&#8212;&#8201;Dividends.&#8221; </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We have no plans to declare cash dividends in the near term, but as a holding company, we may depend on receipt of funds from one or more of our subsidiaries if we determine to pay cash dividends to holders of our ordinary shares in the future. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Our subsidiaries incorporated in the United States and Hong Kong are permitted, under the respective laws, to provide funding to Adlai Nortye Ltd. through dividend distributions without restrictions on the amount of the funds. The ability of our PRC subsidiaries to distribute dividends to us will be limited by foreign exchange restrictions under PRC law. The restrictions on currency exchanges in the PRC may limit our ability to freely convert RMB to fund any future business activities outside the PRC or other payments in U.S. dollars, and capital control measures imposed by the Chinese government may limit our ability to use capital from our PRC subsidiaries for business purposes outside of the PRC. Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments and trade and service-related foreign exchange transactions, cannot be made in currencies other than RMB without complying with certain procedural requirements of State Administration of Foreign Exchange, or SAFE. Specifically, approval from or registration with appropriate government authorities is required where RMB is to be converted into another currency and remitted out of China to pay capital expenses, such as the repayment of loans denominated in currencies other than RMB. As a result, we may need to obtain SAFE approval to use cash generated from the operations of our PRC subsidiaries in the future to pay off its debt in a currency other than RMB owed to entities outside the PRC, or to make other capital expenditure payments outside the PRC in a currency other than RMB. Additionally, the PRC Enterprise Tax and its implementation rules provide that a withholding tax rate of up to 10% will be applicable to dividends payable by Chinese companies to non-PRC-resident enterprises unless otherwise exempted or reduced according to treaties or arrangements between the PRC central government and governments of other countries or regions where the non-PRC-resident enterprises are incorporated. The following table sets forth the amount of the cash transfers for the periods presented. Further details are contained in Note 27 of our consolidated financial statements included elsewhere in this prospectus. </font>
          </div>
          <table style="width:456pt;height:157pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt; width:0pt;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">For the Year </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Ended December&#160;31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt; width:0pt;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">For the Six Months </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Ended June 30,</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2021 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2023</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:1.75pt 0pt 0.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:1.75pt 0pt 0.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:1.75pt 0pt 0.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:1.75pt 0pt 0.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:310.65pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:1.75pt 0pt 0.5pt 0pt; width:0pt;text-align:center;" colspan="22">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(in thousands) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.75pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Capital Contribution</font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Capital contributions from Adlai Nortye Ltd. (Cayman) to Adlai Nortye </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Pte Ltd.(Singapore) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">17</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">30</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Capital contributions from Adlai Nortye Ltd. (Cayman) to Adlai Nortye </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">(Switzerland) AG (Swiss) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">113</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">105</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">29</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Capital contributions from Adlai Nortye Ltd. (Cayman) to Adlai Nortye </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">USA Inc.(United States) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">18,670</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">24,035</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">14,201</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">17,069</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Capital contributions from Adlai Nortye (HK) Limited (Hong Kong) to </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">its mainland China subsidiaries </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">33,960</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">19,394</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,500</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">863</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:37pt; margin-left:12pt;width:456pt;">
          <table style="width:456pt;height:625pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt; width:0pt;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">For the Year </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Ended December&#160;31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt; width:0pt;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">For the Six Months </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Ended June 30,</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2021 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2023</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:310.65pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:1.75pt 0pt 1pt 0pt; width:0pt;text-align:center;" colspan="22">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(in thousands) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.417pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Capital contributions from Adlai Nortye (HK) Limited (Hong Kong) to </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">its non-mainland China subsidiaries </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.417pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.417pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.417pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.417pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.417pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.417pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.417pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.417pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Intercompany Loan</font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans from Adlai Nortye Ltd. (Cayman) to Adlai Nortye (HK) Limited (Hong Kong) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">46,794</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,900</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,850</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">50</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans from Adlai Nortye (HK) Limited (Hong Kong) to its mainland China subsidiaries </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans from Adlai Nortye (HK) Limited (Hong Kong) to its non-mainland China subsidiaries </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans from Adlai Nortye (HK) Limited (Hong Kong) to Adlai Nortye Pte Ltd.(Singapore) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">750</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans from Adlai Nortye Ltd. (Cayman) to our mainland China subsidiaries </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">257</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans from Adlai Nortye Ltd. (Cayman) to Adlai Nortye USA Inc.(United States) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">84</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans from Adlai Nortye Ltd. (Cayman) to our non- mainland China subsidiaries </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans from Adlai Nortye Pte Ltd.(Singapore) to Adlai Nortye Ltd. (Cayman)</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">740</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans from our mainland China subsidiaries to Adlai Nortye USA Inc.(United States) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">150</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans from Adlai Nortye Biopharma Co., Ltd to Shanghai </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Adlai Nortye Biopharma Co., Ltd </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,640</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,891</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,094</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans repaid by Shanghai Adlai Nortye Biopharma Co., Ltd to Adlai Nortye Biopharma Co., Ltd</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">860</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans repaid by Adlai Nortye (HK) Limited (Hong Kong) </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">to Adlai Nortye Ltd. (Cayman) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">355</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans repaid by our mainland China subsidiaries to Adlai </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Nortye (HK) Limited (Hong Kong) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">18</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">2</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans repaid by our non-mainland China subsidiaries to Adlai Nortye (HK) Limited (Hong Kong) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans repaid by our mainland China subsidiaries to Adlai </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Nortye Ltd. (Cayman) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans repaid by our non-mainland China subsidiaries to Adlai Nortye Ltd. (Cayman) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans repaid by Adlai Nortye USA Inc.(United States) to our mainland China subsidiaries </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Intercompany loans repaid by Adlai Nortye USA Inc.(United States) to Adlai Nortye Ltd. (Cayman)</font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">654</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Dividend Distribution</font>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Dividend distribution from our mainland China subsidiaries to Adlai Nortye (HK) Limited (Hong Kong) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Dividend distribution from our non-mainland-China subsidiaries to Adlai Nortye (HK) Limited (Hong Kong) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Dividend distribution from Adlai Nortye (HK) Limited (Hong Kong) to </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Adlai Nortye Ltd. (Cayman) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:0.667pt 0pt 0.5pt 0pt; width:310.65pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Dividend distribution from Adlai Nortye USA Inc.(United States) to Adlai Nortye Ltd. (Cayman) </font>
                </div>
              </td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:1.755pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt; width:3pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0.875pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Implication of being an emerging growth company and a foreign private issuer</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">As a company with less than US$1.235&#160;billion in revenue for our last fiscal year, we qualify as an &#8220;emerging growth company&#8221; pursuant to the Jumpstart Our Business Startups Act of 2012, as amended, or the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other requirements compared to those that are otherwise applicable generally to public companies. These provisions include exemption from the auditor attestation requirement under Section&#160;404 of the Sarbanes-Oxley Act of 2002 in the assessment of the emerging growth company&#8217;s internal control over financial reporting. The JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. Pursuant to the JOBS Act, we have elected to take advantage of the benefits of this extended transition period for complying with new or revised accounting standards. As a result, our operating results and financial statements may not be comparable to the operating results and financial statements of other companies who have adopted the new or revised accounting standards. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We will remain an emerging growth company until the earliest of (a)&#160;the last day of the fiscal year during which we have total annual gross revenues of at least US$1.235&#160;billion; (b)&#160;the last day of our fiscal year following the fifth anniversary of the completion of this offering; (c)&#160;the date on which we have, during the preceding three-year period, issued more than US$1.0&#160;billion in non-convertible debt; or (d)&#160;the date on which we are deemed to be a &#8220;large accelerated filer&#8221; under the Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur if the market value of the ADSs that are held by non-affiliates exceeds US$700&#160;million as of the last business day of our most recently completed second fiscal quarter. Once we cease to be an emerging growth company, we will not be entitled to the exemptions provided in the JOBS Act discussed above. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Upon consummation of this offering, we will report under the Exchange Act as a non-U.S. company with foreign private issuer status. Even after we no longer qualify as an emerging growth company, as long as we qualify as a foreign private issuer under the Exchange Act, we will be exempt from certain provisions in the Exchange Act that are applicable to U.S. domestic public companies, including: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the sections of the Exchange Act regulating the solicitation of proxies, consents, or authorizations in respect of a security registered under the Exchange Act; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the sections of the Exchange Act requiring insiders to file public reports of their share ownership and trading activities and liability for insiders who profit from trades made in a short period of time; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information, or current reports on Form 8-K, upon the occurrence of specified significant events. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">Both foreign private issuers and emerging growth companies are also exempt from certain more stringent executive compensation disclosure rules. Thus, even if we no longer qualify as an emerging growth company, but remain a foreign private issuer, we will continue to be exempt from the more stringent compensation disclosures required of companies that are neither an emerging growth company nor a foreign private issuer. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Implication of being a controlled company</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We will be a &#8220;controlled company&#8221; as defined under the Nasdaq Stock Market Listing Rules because Mr.&#160;Yang Lu, our founder, chairman and the chief executive officer, will hold 35.3% of our total issued and outstanding ordinary shares and will be able to exercise 79.5% of the total voting power of our issued and outstanding share capital upon the completion of this offering and the concurrent private placement, assuming that the underwriters do not exercise their option to purchase additional ADSs, or 35.0% of our total issued and outstanding ordinary shares and 79.2% of the total voting power of our issued and outstanding share capital upon the completion of this offering and the concurrent private placement, assuming that the underwriters exercise their option to purchase additional ADSs in full. As a result, Mr. Yang Lu will have the ability to control or significantly influence the outcome of matters requiring approval by shareholders. As long as we remain as a &#8220;controlled company,&#8221; we are permitted to elect not to comply with certain corporate governance requirements, including an exemption from the rule that a majority of our board of directors must be independent directors. We may also rely on the exemption available for foreign private issuers to </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:20pt; margin-left:12pt;width:456pt;">
          <div style="text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">follow our home country governance practices. As a result, you will not have the same protection afforded to shareholders of companies that are subject to these corporate governance requirements. For details, see &#8220;Risk Factors &#8212; Risks Related to the ADSs &#8212; We will be a &#8220;controlled company&#8221; within the meaning of the Nasdaq Stock Market listing rules and, as a result, may rely on exemptions from certain corporate governance requirements that provide protection to shareholders of other companies.&#8221;</font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Corporate information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Adlai Nortye Ltd. was incorporated in the Cayman Islands on May&#160;9, 2018 as an exempted company with limited liability. The address of our registered office in Cayman Islands and our principal executive office is at c/o&#160;PO Box 309, Ugland House, Grand Cayman KY1-1104, Cayman Islands. Our telephone number is +1 848-230-7430. The United States and China are two important markets and locations for our operations. In addition to our principal executive office in the Cayman Islands, we also have two regional headquarters at (i)&#160;New Jersey Biotechnology Development Center, 685 US Hwy 1, 2nd floor, North Brunswick Township, NJ 08902, the United States and (ii)&#160;Building 6 &amp; 8, 1008 Xiangwang Street, Yuhang District, Hangzhou, Zhejiang, People&#8217;s Republic of China. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Investor inquiries should be directed to us at the address and telephone number of our principal executive offices set forth above. Our website address is </font><font style="font-style:italic;letter-spacing:0.2pt;">https://www.adlainortye.com</font><font style="letter-spacing:0.2pt;">. Our website and the information contained on our website do not constitute a part of this prospectus. Our agent for service of process in the United States is Cogency Global Inc., with the address at 122 East 42nd Street, 18th Floor, New York, NY 10168. </font>
          </div>
          <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Conventions that apply to this prospectus</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Unless otherwise indicated or the context otherwise requires, references in this prospectus to: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;ADRs&#8221; are to the American depositary receipts that may evidence the ADSs; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;ADSs&#8221; are to the American depositary shares, each of which represents our Class A ordinary shares; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;BVI&#8221; are to the British Virgin Islands; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;CAGR&#8221; are to the compound annual growth rate; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;China&#8221; or the &#8220;PRC&#8221; or &#8216;&#8216;mainland China&#8221;, unless otherwise specified herein, are to the People&#8217;s Republic of China; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;Class A ordinary shares&#8221; are to our Class A ordinary shares, par value US$0.0001 per share; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;Class&#160;B ordinary shares&#8221; are to our Class&#160;B ordinary shares, par value US$0.0001 per share;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;Hangzhou Adlai&#8221; is to Adlai Nortye Biopharma Co., Ltd., our wholly foreign-owned enterprise incorporated in the PRC; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;Hong Kong&#8221; is to Hong Kong Special Administrative Region of China;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;Macau&#8221; is to Macau Special Administrative Region of China;</font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;RMB&#8221; or &#8220;Renminbi&#8221; are to the legal currency of China; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;shares&#8221; or &#8220;ordinary shares&#8221; are to prior to the completion of this offering and the concurrent private placement, our pre-offering ordinary shares, and upon and after the completion of this offering, are to our Class A ordinary shares and Class B ordinary shares; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;US$,&#8221; &#8220;U.S. dollars,&#8221; &#8220;$,&#8221; and &#8220;dollars&#8221; are to the legal currency of the United States; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our company,&#8221; and &#8220;our&#8221; are to Adlai Nortye Ltd., our Cayman Islands holding company and its subsidiaries, which include those in the U.S. and mainland China that conduct daily operations. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Unless the context indicates otherwise, all information in this prospectus assumes no exercise by the underwriters of their option to purchase additional ADSs from us. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-bottom:0.0199999999999818pt; margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The offering</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Offering price </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">US$23.00 per ADS. </font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">ADSs offered by us </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">2,500,000 ADSs (or 2,875,000 ADSs if the underwriters exercise their option to purchase additional ADSs in full). </font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">ADSs outstanding immediately after this offering </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">2,500,000 ADSs (or 2,875,000 ADSs if the underwriters exercise their option to purchase additional ADSs in full). </font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:11.5pt;">
              <font style="letter-spacing:0.2pt;">Ordinary shares issued and outstanding immediately after this offering </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">93,710,805 Class A&#8199;ordinary shares (or 94,835,805 Class A ordinary shares if the underwriters exercise their option to purchase additional ADSs) and 16,990,000 Class B ordinary shares, including 5,217,391 Class A ordinary shares that we will issue and sell in the concurrent private placement, calculated based on the initial offering price of US$23.00 per ADS. </font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Concurrent Private Placement </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Concurrently with, and subject to, the completion of this offering, Nippon Kayaku Co., Ltd., or Nippon Kayaku, a chemical company headquartered in Japan, which undertakes the development, manufacturing and sale of functional chemicals, pharmaceuticals, safety systems and agrochemicals, has agreed to purchase US$40.0 million in Class A ordinary shares from us. This concurrent private placement is at a price per Class A ordinary share equal to the initial public offering price adjusted to reflect the ADS-to-Class A ordinary share ratio. We will issue and sell a total of 5,217,391 Class A ordinary shares in this concurrent private placement. Our proposed issuance and sale of Class A ordinary shares to Nippon Kayaku is being made through private placement pursuant to an exemption from registration with the SEC under Regulation S of the Securities Act. Pursuant to the subscription agreement executed with Nippon Kayaku on July&#160;27, 2023, the closing of this concurrent private placement is subject to the completion of this offering and satisfaction of customary closing conditions. If this offering is completed, the closing of this concurrent private placement is expected to occur concurrently. Nippon Kayaku has agreed with the underwriters not to, directly or indirectly, sell, transfer or dispose of any Class&#160;A ordinary shares for a period of 180 days after the date of the underwriting agreement, subject to certain exceptions. </font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Indication of Interest </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">An investor has subscribed for, and has been allocated by the underwriters, an aggregate of 2,173,913 ADSs at the initial public offering price and on the same terms as the other ADSs being offered, representing approximately 87.0% of the total ADSs in this offering, assuming the underwriters do not exercise their option to purchase additional ADSs. The underwriters will receive the same underwriting discounts and commissions on any ADSs purchased by this investor as they will on any other ADSs sold to the public in this offering. See &#8220;Underwriting&#8221;. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;margin-left:12pt;width:456pt;">
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">The ADSs </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">Each ADS represents three Class A ordinary shares, par value US$0.0001 per share. </font>
          </div>
          <div style="margin-left:216pt; margin-top:8pt; text-align:justify; width:240pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">The depositary will hold in custody Class A ordinary shares underlying your ADSs. You will have rights as provided in the deposit agreement among us, the depositary and owners and holders of ADSs from time to time. </font>
          </div>
          <div style="margin-left:216pt; margin-top:8pt; text-align:justify; width:240pt; line-height:11.5pt;">
            <font style="letter-spacing:0.2pt;">We do not expect to pay dividends in the foreseeable future. If, however, we declare dividends on our ordinary shares, the depositary will pay you the cash dividends and other distributions it receives on our Class A ordinary shares after deducting its fees and expenses in accordance with the terms set forth in the deposit agreement. </font>
          </div>
          <div style="margin-left:216pt; margin-top:8pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">You may surrender your ADSs to the depositary for cancellation to receive the underlying Class A ordinary shares. The depositary will charge you fees for any cancellation. </font>
          </div>
          <div style="margin-left:216pt; margin-top:8pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We may amend or terminate the deposit agreement without your consent. If you continue to hold your ADSs after an amendment to the deposit agreement, you agree to be bound by the deposit agreement as amended. </font>
          </div>
          <div style="margin-left:216pt; margin-top:8pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">To better understand the terms of the ADSs, you should carefully read the &#8220;Description of American Depositary Shares&#8221; section of this prospectus. You should also read the deposit agreement, which is filed as an exhibit to the registration statement that includes this prospectus. </font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Option to purchase additional ADSs </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We have granted to the underwriters an option, exercisable within 30&#160;days from the date of this prospectus, to purchase up to an aggregate of 375,000 additional ADSs. </font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Use of proceeds </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We expect that we will receive net proceeds of approximately US$54.2&#160;million from this offering, after deducting underwriting discounts and commissions and estimated offering expenses payable by us, as well as net proceeds of US$35.7&#160;million from the concurrent private placement.</font>
          </div>
          <div style="margin-left:216pt; margin-top:8pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We intend to use approximately US$46.7 million to fund the ongoing registrational trial for AN2025 (buparlisib) and the milestone payments in connection with development of AN2025 and the commercial launch, if approved, of AN2025; approximately US$29.7 million to fund the development of our pipeline programs; and approximately US$13.5&#160;million for our general working capital and general corporate purposes. See &#8220;Use of Proceeds&#8221; for more information. </font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Lock-up </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We and each of our officers, directors who beneficially own our shares, holders of share-based awards, approximately 69.4% of our existing shareholders (representing over 85.7% of our total outstanding and issued shares on an as-converted basis prior to this offering) and Nippon Kayaku have agreed with the </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="margin-left:216pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">underwriters, subject to certain exceptions, not to sell, transfer or otherwise dispose of any ADSs, ordinary shares or similar securities for a period of 180&#160;days after the date of the underwriting agreement. See &#8220;Shares Eligible for Future Sale&#8221; and &#8220;Underwriting&#8221; for more information. </font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Listing </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We have been approved to list the ADSs on the Nasdaq Global Market under the symbol &#8220;ANL.&#8221; The ADSs and our Class A ordinary shares will not be listed on any other stock exchange or traded on any automated quotation system.</font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Payment and settlement </font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The underwriters expect to deliver the ADSs against payment therefor through the facilities of the Depository Trust Company on October 3, 2023. </font>
          </div>
          <div style="width:192pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Depositary</font>
            </div>
          </div>
          <div style="margin-left:216pt; margin-top:-12pt; text-align:justify; width:240pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The Bank of New York Mellon.</font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The number of ordinary shares that will be outstanding immediately after this offering and the concurrent private placement: </font>
          </div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">97,983,414 ordinary shares issued and outstanding on an as-converted basis as of the date of this prospectus, assuming (1)&#160;the re-designation of 16,990,000 shares beneficially owned by Archer Future Limited into Class&#160;B ordinary shares on a one-for-one basis immediately prior to the completion of this offering; (2)&#160;the re-designation of all of our remaining issued and outstanding 80,993,414 ordinary shares into Class&#160;A ordinary shares on a one-for-one basis immediately prior to the completion of this offering; </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">7,500,000 Class&#160;A ordinary shares in the form of ADSs that we will issue and sell in this offering, assuming the underwriters do not exercise their option to purchase additional ADSs; and </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
          <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
            <font style="letter-spacing:0.2pt;">&#8226;</font>
            <br >
          </div>
          <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
            <!--blacklining:none;-->
            <font style="letter-spacing:0.2pt;">5,217,391 Class A ordinary shares to be issued in the concurrent private placement. </font>
          </div>
          <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        </div>
        <div style="clear:both;font-size:0pt;">&#8203;</div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Summary Consolidated Financial and Operating Data</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The following summary consolidated statements of operations and comprehensive loss data for the years ended December&#160;31, 2021 and 2022, summary consolidated balance sheets data as of December&#160;31, 2021 and 2022, and summary consolidated statements of cash flows data for the years ended December&#160;31, 2021 and 2022 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. The following summary consolidated statements of operations and comprehensive loss data for the six months ended June&#160;30, 2022 and 2023, summary consolidated balance sheet data as of June&#160;30, 2023, and summary consolidated statements of cash flows data for the six months ended June&#160;30, 2022 and 2023 have been derived from our unaudited condensed consolidated financial statements included elsewhere in this prospectus. Our consolidated financial statements are prepared and presented in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB. None of our consolidated financial statements were prepared in accordance with U.S. GAAP. Our historical results are not necessarily indicative of results expected for future periods. You should read this Summary Consolidated Financial Data section together with our consolidated financial statements and the related notes and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included elsewhere in this prospectus. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The following table sets forth a summary of our consolidated statements of operations and comprehensive loss for the years/periods indicated. </font>
          </div>
          <table style="width:456pt;height:328.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:283.85pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">For the Year </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Ended December&#160;31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">For the Six Months </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Ended June 30,</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:283.85pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2021 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2023</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:283.85pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:283.85pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(in thousands) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:1.917pt 0pt 0.833pt 0pt; width:283.85pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:-0.2pt;">Selected consolidated statements of operations and comprehensive loss:</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Revenue </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">45,726</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Other operating income, net </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">183</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">259</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">137</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">349</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Administrative expenses </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,450<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(13,039<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(7,039<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(5,231<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Research and development expenses </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(42,105<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(54,490<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(21,913<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(27,243<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Total operating loss</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,646<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(67,270<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,815<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(32,125<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Other income and gains</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">213</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,079</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">447</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">269</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Other expenses </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(70<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,395<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(822<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(488<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Investment income </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">32</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">550</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">81</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">63</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Fair value gain on financial assets at FVTPL </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">40</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">484</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">644</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Fair value (loss)/gain on financial liabilities at FVTPL </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(46,910<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">7,195</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">14,167</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(45,894<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Finance costs </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,337<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(433<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(262<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(243<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Loss before tax</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Income tax expense </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:283.85pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Loss for the year/period</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
                <font style="letter-spacing:0.2pt;">Attributable to: </font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 3.25pt 0pt; width:283.85pt;text-align:left;">
                <div style="margin-left:10pt;">
                  <font style="letter-spacing:0.2pt;">Ordinary equity holders of the parent </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
          <div style="text-indent:20pt; margin-top:14.19pt; text-align:justify; width:456pt; line-height:12.5pt;">
            <font style="letter-spacing:0.2pt;">The following table sets forth a selected consolidated statements of financial position as of the years/</font>&#8203;<font style="letter-spacing:0.2pt;">periods indicated. </font></div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:17.5pt;min-height:660pt;margin-left:12pt;width:456pt;">
          <table style="width:456pt;height:379.5pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">As of </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">June 30, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2021 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2023</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:311.89pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:311.89pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="16">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(in thousands) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Selected consolidated statements of financial position:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="6">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">ASSETS</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="6">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Current assets:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="6">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">64,131</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,758</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">60,028</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Financial assets at FVTPL </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">53,809</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">21,287</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Prepayments, other receivables and other assets </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">6,604</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">2,258</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,492</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Total current assets</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">124,544</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">66,303</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">61,527</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Total non-current assets</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">7,141</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">6,291</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">4,969</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Total assets</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">131,685</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">72,594</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">66,496</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.75pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">LIABILITIES</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="6">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <font style="letter-spacing:-0.2pt;">Current liabilities:</font>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td colspan="6">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Trade payables </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2,981</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13,098</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">16,871</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Other payables and accruals </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">3,224</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,877</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">9,738</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Interest-bearing bank borrowings </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10,457</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4,307</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">19,495</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Lease liabilities </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">834</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,001</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,001</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">290,368</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">336,262</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Total current liabilities</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">17,496</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">312,651</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">383,367</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Total non-current liabilities</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">299,617</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,236</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">664</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Total liabilities</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">317,113</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">313,887</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">384,031</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 2.5pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Total shareholders&#8217; deficit</font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(185,428<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(241,293<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(317,535<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:311.89pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Total liabilities and shareholders&#8217; equity </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">131,685</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">72,594</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">66,496</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
          <div style="text-indent:20pt; margin-top:13pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The following table sets forth a consolidated statements of cash flows for the years/periods indicated. </font>
          </div>
          <table style="width:456pt;height:194pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:246.06pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">For the Year Ended December&#160;31, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
                <div style="text-align:center;">
                  <font style="letter-spacing:-0.16pt;">For the </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Six Months </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">Ended </font>
                  <br >
                  <font style="letter-spacing:-0.16pt;">June 30, </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:246.06pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2021 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2022 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">2023 </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:246.06pt;text-align:left;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">US$ </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
              <td style="padding:0pt 0pt 0.5pt 0pt; width:246.06pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
                <div style="white-space:nowrap; text-align:center;">
                  <font style="letter-spacing:-0.16pt;">(in thousands) </font>
                </div>
              </td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:246.06pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Net cash used in operating activities </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(3,034<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(43,223<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(23,265<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(18,323<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.5pt 0pt 1.5pt 0pt; width:246.06pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Net cash (used in)/generated from investing activities </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(54,857<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">28,376</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">5,930</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">21,367</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:246.06pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Net cash from/(used in) financing activities </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">97,200</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(6,780<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(5,725<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">14,963</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 1.5pt 0pt; width:246.06pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Net increase/(decrease) in cash and cash equivalents </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">39,309</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(21,627<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(23,060<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">18,007</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:2.167pt 0pt 0.833pt 0pt; width:246.06pt;white-space:normal;text-align:left;">
                <div style="margin-left:10pt; text-indent:-10pt;">
                  <font style="letter-spacing:0.2pt;">Cash and cash equivalents at the beginning of the year/period </font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">24,261</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">64,131</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">64,131</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">42,758</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:246.06pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:0.2pt;">Effect of foreign exchange rate changes, net </font>
                </div>
              </td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">561</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">254</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">638</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(737<font style="position:absolute;">)</font></td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
              <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            </tr>
            <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
              <td style="padding:3.25pt 0pt 3.25pt 0pt; width:246.06pt;text-align:left;">
                <div style="white-space:nowrap;">
                  <font style="letter-spacing:-0.2pt;">Cash and cash equivalents at the end of the year/period</font>
                </div>
              </td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">64,131</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">42,758</td>
              <td style="padding:0pt;padding-left:9.445pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">41,709</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt; width:6pt;">&#8203;</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
              <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">60,028</td>
              <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
              <td style="padding:0pt; width:0pt;">&#8203;</td>
            </tr>
          </table>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRIFA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Investing in the ADSs involves a high degree of risk. You should carefully consider the following risks and uncertainties and all other information contained in this prospectus before investing in the ADSs. Our business, financial condition, results of operations, or prospects could also be harmed by risks and uncertainties not currently known to us or that we currently do not believe are material. If any of the risks actually occur, our business, financial condition, results of operations, and prospects could be adversely affected. In that event, the market price of the ADSs could decline, and you could lose part or all of your investment. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of a number of factors, including the risks described below. See the section titled &#8220;Special Note Regarding Forward-Looking Statements.&#8221;</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks related to our business</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our business depends substantially on the success of our preclinical and clinical drug candidates. If we are unable to successfully develop drug candidates or experience significant delays in doing so, our business will be materially harmed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our business will depend on the successful development, regulatory approvals, and commercialization of our drug candidates. Our drug candidates are still in preclinical and clinical development. We cannot guarantee that we will be able to obtain regulatory approvals for our drug candidates in a timely manner, or at all. None of our drug candidates has been approved for marketing in the U.S., Europe, China, or any other jurisdiction. Each of our drug candidates will require additional clinical development, regulatory approvals, development of manufacturing supply and capacity, substantial investment, and significant marketing efforts before we generate any revenue from product sales. Further, we are not in control of any clinical trials conducted by our licensors or sublicensors for obtaining regulatory clearance and they may be driven by strategical goals or concerns that do not align with ours. If our licensors or sublicensors fail to obtain regulatory approvals for those drug candidates in jurisdictions where they reserve their rights, if any, it would be more difficult for us to obtain regulatory approvals from the regulatory authorities in other jurisdictions where we have exclusive rights for to develop the drug candidates for regulatory approvals. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The success of our drug candidates will depend on several factors, including but not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">completion of preclinical studies as well as completion of clinical trials, including successful enrollment of patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">favorable safety and efficacy data from our clinical trials and other studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtaining sufficient supplies of any drug products that are used in combination with our drug candidates, competitor drugs or comparison drugs that may be necessary for use in clinical trials for evaluation of our drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">receipt of regulatory allowances or approvals from applicable regulatory authorities for planned clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishing sufficient commercial manufacturing capabilities by making arrangements with third-party manufacturers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the performance by CROs or other third parties we may retain to conduct clinical trials, of their duties to us in a manner that complies with our protocols and applicable laws and that protects the integrity of the resulting data; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtaining, maintaining, and enforcing patent, trademark, trade secret, and other intellectual property protection and regulatory exclusivity for our drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">ensuring we do not infringe, misappropriate or otherwise violate the patents, trademarks, trade secrets or other intellectual property rights of third parties, and successfully defend against any claims by third parties that we have infringed, misappropriated or otherwise violated any intellectual property of any such third party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">receipt of marketing approvals from applicable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successfully launching commercial sales of our drug candidates, if and when approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtaining and maintaining favorable reimbursement from third-party payors for drugs, if and when approved; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">competition with other drug candidates and drugs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">continued acceptable safety profiles of our drug candidates following regulatory approvals. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we do not achieve one or more of these in a timely manner or at all, we could experience significant delays in our ability to obtain approval for our drug candidates, which would materially harm our business and may prevent us from generating sufficient revenues and cash flows to continue our operations. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The clinical trial results of our drug candidates may fail to satisfy regulatory authorities or might not produce positive results.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We must conduct extensive clinical trials to demonstrate the safety and efficacy of our drug candidates in humans to obtain regulatory approvals for the sale of our drug candidates. Clinical and preclinical development is expensive and can take many&#160;years to complete, and its outcome is inherently uncertain. We cannot guarantee that any clinical trials or preclinical studies will be conducted as planned or completed on schedule, if at all, and failure can occur at any time during the trial or study process. Despite promising preclinical or clinical results, any drug candidate can unexpectedly fail at any stage of clinical development. The historical failure rate for drug candidates in our industry is high, particularly in the earlier stages of development. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The results from preclinical studies or clinical trials of a drug candidate or a competitor&#8217;s candidate in the same class may not predict the results of later clinical trials of our drug candidate, and interim, top-line, or preliminary results of a clinical trial are not necessarily indicative of final results. Drug candidates in later stages of clinical trials may fail to show the desired safety and efficacy characteristics despite having progressed through preclinical studies and initial clinical trials. It is not uncommon to observe results in clinical trials that are unexpected based on earlier clinical trials and preclinical studies, many candidates fail in clinical trials despite very promising early results, and a number of companies in the biopharmaceutical and biotechnology industries have suffered significant setbacks in clinical development even after achieving promising results in earlier studies. Based upon negative or inconclusive results, we or any future collaborator may decide, or regulators may require us, to conduct additional preclinical studies or clinical trials, which would cause us to incur additional operating expenses. As a result, we cannot be certain that our ongoing and planned clinical trials and preclinical studies will be successful. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may also experience numerous unexpected events during, or as a result of, clinical trials that could delay or prevent our ability to obtain regulatory approvals or commercialize our drug candidates, including but not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may be unable to generate sufficient preclinical, toxicology, or other </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> or </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> data to support the initiation or continuation of clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulators, institutional review boards, or IRBs, or ethics committees not authorizing us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.31pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulators may disagree as to the design or implementation of our clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">manufacturing issues relating to our third-party CMOs, including problems with manufacturing, supply quality, compliance with good manufacturing practice, or GMP, or obtaining from third parties sufficient quantities of a drug candidate for use in a clinical trial; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.21pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.21pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">clinical trials of our drug candidates producing negative or inconclusive results, and additional clinical trials or abandoning drug development programs being required; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of patients required for clinical trials of our drug candidates being larger than we anticipate, enrollment being insufficient or slower than we anticipate, or patients dropping out at a higher rate than we anticipate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">clinical sites may deviate from trial protocols or drop out of trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.2pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">selection of clinical endpoints that require prolonged periods of clinical observation or extended analysis of the resulting data; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our third-party contractors failing to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our having to suspend or terminate clinical trials of our drug candidates for various reasons, including a finding of a lack of clinical response or other unexpected characteristics or a finding that participants are being exposed to unacceptable health risks; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the cost of clinical trials of our drug candidates being greater than we anticipate; and the supply or quality of our drug candidates, companion diagnostics or other materials necessary to conduct clinical trials of our drug candidates being insufficient or inadequate. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Clinical trials are expensive and difficult to design and implement and can take many&#160;years to complete, and their outcomes are inherently uncertain. Our research and development expenses amounted to US$42.1&#160;million, US$54.5 million, and US$27.2 million, for the years ended December&#160;31, 2021, 2022 and six months ended June 30, 2023, respectively. With our further exploration of potential new drug candidates and indication expansion of our current drug candidates, we may need more capital to support our R&amp;D activities. If we are unable to obtain sufficient capital resources in a timely manner, our clinical process may be adversely impacted. We could also face difficulties due to any number of reasons including, but not limited to, regulatory delay, complexities of analytical testing technology, shortage of clinical trial material supply, and health epidemics, such as the recent COVID-19 pandemic. For a detailed discussion about the impact from COVID-19 on our clinical development, see &#8220;&#8212; We may face force majeure risks, including the recent COVID-19 outbreak.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Clinical trials must be conducted in accordance with applicable regulatory authorities&#8217; legal requirements, regulations or guidelines, and are subject to oversight by these governmental agencies and ethics committees or IRBs at the medical institutions where the clinical trials are conducted. We could also encounter delays if a clinical trial is suspended or terminated by us, by the IRBs of the institutions in which such trials are being conducted, by a Data Safety Monitoring Board for such trial or by applicable regulatory authorities. Such authorities may impose such a suspension or termination due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by applicable regulatory authorities foreign regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug, changes in governmental regulations or administrative actions or lack of adequate funding to continue the clinical trial. In addition, changes in regulatory requirements and policies may occur, and we may need to amend clinical trial protocols to comply with these changes. Amendments may require us to resubmit our clinical trial protocols to IRBs for reexamination, which may impact the costs, timing or successful completion of a clinical trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, conducting clinical trials in foreign countries presents additional risks that may delay completion of our clinical trials. These risks include the failure of enrolled subjects in foreign countries to adhere to clinical protocols as a result of differences in healthcare services or cultural customs, managing additional administrative burdens associated with foreign regulatory schemes, and political and economic risks, including war, relevant to such foreign countries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA or comparable foreign regulatory authorities. The FDA or comparable foreign regulatory authority may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the study. The FDA or comparable foreign regulatory authority may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications by the FDA or comparable foreign regulatory authority, as the case may be, and may ultimately lead to the denial of marketing approval of one or more of our drug candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we are required to conduct additional clinical trials or other testing of our drug candidates beyond those that we currently contemplate, or if we are unable to successfully complete clinical trials of our drug candidates or other testing, or if the results of these trials or tests are not positive or are only modestly positive </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or if they raise safety concerns, we may (i)&#160;be delayed in obtaining regulatory approvals for our drug candidates; (ii)&#160;not obtain regulatory approvals at all; (iii)&#160;obtain approval for indications that are not as broad as intended; (iv)&#160;have the drugs removed from the market after obtaining regulatory approvals; (v)&#160;be subject to additional post-marketing testing requirements; (vi)&#160;be subject to restrictions on how the drugs are distributed or used; or (vii)&#160;be unable to obtain reimbursement for the use of the drugs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Significant clinical trial delays may also increase our development costs, shorten the commercialization periods enjoyed by our drug candidates, or allow our competitors to bring drugs to market before we do. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may seek and form strategic alliance, collaboration, or licensing arrangements for the development of drug candidates in the future, which may not achieve the anticipated benefits to or even negatively impact our business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have in the past formed and may in the future continue to seek and form strategic alliances, collaboration, and/or licensing arrangements with third parties that we believe will complement or augment our development and commercialization efforts with respect to our current and future drug candidates. Any of these relationships may require us to increase our near and long-term expenditures, issue securities that dilute our existing shareholders or disrupt our management and business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our strategic collaboration with partners involves various risks. If and when we collaborate with a third party for development and commercialization of a drug candidate, we may have to relinquish some or all of the control over the future success of that drug candidate to the third party. We may not achieve the revenue and cost synergies expected from the transaction. These synergies are inherently uncertain, and are subject to significant business, economic, and competitive uncertainties and contingencies, many of which are difficult to predict and are beyond our control. Even if we achieve the expected benefits, they may not be achieved within the anticipated time frame. Also, the synergies from our collaboration with partners may be offset by other costs incurred in the collaboration, increases in other expenses, operating losses, or problems in the business unrelated to our collaboration. As a result, there can be no assurance that we will be able to achieve our expected benefits and synergies from these collaborations, if at all. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may rely on certain third parties for some of our clinical development activities, which could delay or limit the future development or regulatory approval of our drug candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We collaborate with third parties for clinical development activities from time to time. For example, we reached a supply agreement with MSD to evaluate the combination of AN0025 and pembrolizumab in patients with solid tumors in a Phase&#160;Ib clinical trial, and also a supply agreement with Roche to evaluate the triple combination of AN2025, AN0025, and atezolizumab for a variety of PIK3CA mutant solid tumors in a Phase&#160;I clinical trial. We cannot guarantee that MSD, Roche, or other third parties will not diminish the amount of supply of the relevant compounds, or terminate the agreements altogether. Disputes arising between us and these third parties may cause delay or termination of the research, development, or commercialization of our drug candidates, or may result in costly litigation or arbitration that diverts management attention and resources. In such cases, we may need to reevaluate our approaches with respect to these combination trials, and potentially find other compounds with combination potential with our drug candidates. We cannot guarantee that we will be able to find such alternative combination trial opportunities, or that we will not incur significant costs and efforts in doing so. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our rights to develop and commercialize some of our drug candidates are subject to the terms and conditions of licenses granted to us by third parties.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have relied on and plan to continue to rely on licenses to certain patent rights and other intellectual property from third parties that are important or necessary to the development, manufacture, or commercialization of some of our drug candidates. Pursuant to these license agreements, our licensors may also provide us with clinical data required for NDA filings in our licensed territories, besides many other types of support. However, some of the licenses may not provide exclusive rights to use such intellectual property in all relevant fields of use and in all territories where we may wish to develop or commercialize our drug candidates and the underlying patents may fail to provide the intended exclusivity. As a result, we may not be able to develop, export, or sell our drug candidates outside of the territories stipulated by the license agreements or prevent competitors from developing and commercializing competitive drug candidates in the markets that we hope to address. In addition, our licenses may not include rights to all intellectual property </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">relevant to these drug candidates, and as a result, we may need to obtain additional licenses from our existing licensors, which may not be available on an exclusive basis or commercially reasonable terms. Otherwise, we will need to spend significant time and resources to redesign our drug candidates or the methods for manufacturing them. Moreover, we do not own the background intellectual property rights related to these drug candidates invented prior to the licenses. If our licensors breach our license agreements, we may lack bargaining power to enforce such agreements or obtain adequate remedies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Over time, we may seek additional rights to intellectual property from our licensors and, in connection with the related negotiations, we may agree to amend our existing licenses in a manner that may be more favorable to the licensors, including by agreeing to terms that could enable third parties (potentially including our competitors) to receive licenses to a portion of the intellectual property that is subject to our existing licenses. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may not have the rights to handle patent management related to the in-licensed drug candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may not have the right to control the preparation, filing, prosecution, maintenance, enforcement, and defense of patents and patent applications covering the drug candidates that we in-license from third parties. We also have not had and do not have primary control over these activities for certain of our patents or patent applications and other intellectual property rights that we jointly own with certain of our licensors. Therefore, we cannot be certain that these patents and patent applications will be prepared, filed, prosecuted, maintained, enforced, and defended in a manner consistent with the best interests of our business. If our current or future licensors or collaboration partners fail to prosecute, maintain (including by failing to pay the relevant fees), enforce, and defend patents licensed to us that are material to our business, the exclusivity associated with the relevant drug candidate may be reduced or eliminated, and as a result, our ability to prevent competitors from developing or commercializing the same drug candidates could be adversely affected. In addition, even if we have the right to control patent prosecution and maintenance of patents and patent applications licensed to us, we may still be adversely affected or prejudiced by actions or inactions of our licensors, the inventors, third-party collaborators, and their respective counsel that took place either before or after the date upon which we assumed that control. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the terms of our license agreements, the licensors may have the right to control enforcement of our in-licensed patents or defense of any claims asserting the invalidity or unenforceability of these patents. Even if we are permitted to enforce or defend these patents, this will require the cooperation of our licensors and any other relevant patent owners, and we cannot be certain that such cooperation will be provided to us. We also cannot be certain that our licensors will allocate sufficient resources or prioritize their enforcement of such patents or defense of such claims to protect our interests. An adverse outcome in any of these matters, regardless of whether we are a party or otherwise participating, could significantly harm our business if we are relying on the patents for exclusivity or material technology or we are subject to damages or other restrictions on our business activities. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The in-licensed patent rights may be encumbered.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our licensors may have relied on third party consultants or collaborators or on funds, resources, or expertise from third parties such that our licensors are not the sole and exclusive owners of the patents we in-license. If other third parties have ownership rights to our in-licensed patents, they may be able to license such patents to our competitors, and our competitors could market equivalent or substantially equivalent drug candidates and technologies. In addition, if our licensors have not obtained adequate rights and licenses from these third parties, we may need to obtain additional rights from these third parties or we could be prevented from developing and commercializing the related drug candidates or face competition. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we fail to comply with our obligations in the licensing agreements or experience disruptions to our business relationships with our licensors, we could lose license rights or be required to pay monetary damages.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are required to make various payments to our licensors in exchange for in-licensing of certain drug candidates, including upfront payments, milestone payments, tiered royalties based on commercial sales and other payments. Our license and intellectual property-related agreements also require us to comply with other obligations, such as to use commercially reasonable efforts in developing and commercializing the drug candidates, provide certain information regarding our activities and maintain the confidentiality of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">information we receive from our licensors. In certain of our license agreements, we also are required to achieve certain developmental and commercial milestones by specific deadlines. We cannot be certain that we will be able to fulfill all such obligations. In particular, some of the milestone payments that we are obligated to pay under these agreements are payable upon our drug candidates reaching development milestones before we have commercialized or received any revenue from sales of such drug candidate, and we cannot guarantee that we will have sufficient resources to make such milestone payments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, drug development is an uncertain process and even if we have such resources, we cannot be certain that such milestones will be met within the timeline required by our license agreements. If we fail to comply with our obligations under our current or future license agreements, our counterparties may have the right to terminate these agreements and, upon the effective date of such termination, may have the right to terminate our exclusive rights or all of our rights and acquire rights to certain of our intellectual property. If any of our licensors terminate any license we rely upon, we might not be able to develop, manufacture, or market any drug candidate related to the intellectual property licensed under these agreements and we may face other additional penalties. In such case, we may have to negotiate new agreements or terms with less favorable terms to us, if we are able to do so at all. We may also face claims for monetary damages or other penalties. While we would expect to exercise all rights and remedies available to us, including seeking to cure any breach we commit if permitted, and otherwise seek to preserve our rights under the intellectual property rights licensed and sublicensed to us, we may not be able to do so in a timely manner, at an acceptable cost or at all. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disputes may arise from the license agreements between us and our collaborating parties, which may have negative impacts on the scope of our rights.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The license agreements under which we in-license intellectual property or technology from third parties are complex, and disputes may arise regarding these agreements, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the scope of rights granted under the license agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which the conduct of our business, including any relevant technology and processes, infringe, misappropriate, or otherwise violate intellectual property of the licensor that is not subject to the license agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the sublicensing of patent and other rights under the license agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our diligence obligations under the license agreement and what activities satisfy those diligence obligations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by us, our partners, and our licensors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.5pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the priority right of the patents or patent applications of inventions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The resolution of any dispute could narrow what we understand to be the scope of our rights to the relevant intellectual property or technology, or increase what we understand to be our financial or other obligations under the relevant license agreement. Moreover, if disputes over intellectual property that we have in-licensed prevent or impair our ability to use the intellectual property or otherwise maintain our current licensing arrangements on commercially acceptable terms, we may not be able to successfully develop and commercialize the affected drug candidates. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may face significant competition and fail to establish a partnership with a third party.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may face significant competition from other pharmaceutical or biotechnology companies, even ones with greater resources or capabilities than us, in seeking appropriate strategic partners. Moreover, we may fail to establish a strategic partnership or other alternative arrangements with a third party especially when the drug candidate is in the early developmental stage, due to the fact that the third party may believe our drug candidates lacking potentials to commercial viability. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may lose our relationships with CROs and they may not successfully carry out their contractual duties.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have relied on and plan to continue to rely on third-party CROs to generate, monitor, and manage data for certain of our ongoing clinical programs. We also expect to rely on third parties to assist in conducting </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">certain preclinical studies that we may carry out in the future. Our CROs have the right to terminate their agreements with us in the event of an unrectified material breach. If any of our relationships with our third-party CROs is terminated, we may not be able to enter into arrangements with alternative qualified CROs or do so on commercially reasonable terms; or meet our desired clinical development timelines. There is a natural transition period when a new CRO commences work, and the new CRO may not provide the same type or level of services as the original provider, and as a result, we cannot assure you that data from our clinical trials may not be compromised. There is also a need for relevant technology to be transferred to the new CRO, which may take time and further delay our development timelines. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, except for remedies available to us under our agreements with our CROs, we cannot control whether or not our CROs devote sufficient time and resources to our ongoing clinical, nonclinical, and preclinical programs. If our CROs fail to successfully carry out their contractual duties or obligations or meet expected deadlines, or if the accuracy of the clinical data obtained by CROs is compromised due to their failure to adhere to our clinical protocols, regulatory requirements, or for other reasons, our clinical trials may be extended, delayed, or terminated and we may not be able to obtain regulatory approvals for or successfully commercialize our drug candidates. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If CROs fail to comply with applicable protocol, laws, regulations, or scientific standards, our clinical development plan can be delayed.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As we rely on CROs for the execution of certain of our clinical trials, we control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of the studies sponsored by us is conducted in accordance with the applicable protocol, legal, and regulatory requirements and scientific standards, and our reliance on the CROs does not relieve us of our regulatory responsibilities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We, our CROs for our clinical programs and our clinical investigators are required to comply with good clinical practice, or GCP, and other regulatory regulations and guidelines enforced by the FDA and other comparable regulatory authorities for all of our drug candidates in clinical development. Regulatory authorities enforce these GCP or other regulatory requirements through periodic inspections of trial sponsors, investigators, and trial sites. If we or any of our CROs or clinical investigators fail to comply with applicable GCP or other regulatory requirements, the relevant clinical data generated in our clinical trials may be deemed unreliable and the FDA and other comparable regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. There can be no assurance that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials complies with GCP requirements. In addition, our clinical trials must be conducted with drug candidates produced under GMP requirements. Our failure to comply with these regulations may require us to repeat clinical trials, which would delay the regulatory approval process. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">There may be information disclosure risks associated with using CROs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The use of CROs requires us to disclose proprietary information to these third parties, which could increase the risk that such information will be misappropriated or disclosed. We currently have a small number of employees, which limits our ability to identify and monitor the activities of CROs. To the extent we are unable to identify and successfully manage the performance of CROs in the future, our business may be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our success depends upon our and our business partners&#8217; ability to obtain and maintain intellectual property protection for our drug candidates and technologies.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have and will apply for our own patents with claims covering our technologies, processes, and drug candidates. Additionally, we have also licensed patent rights from third parties for some of our pipeline products, including AN2025 from Novartis and AN0025 from Eisai. There can be no assurance that each patent eligible subject matter has been or will be applied for patent protection, the claims of any existing or future patent application that we or our partners file will be issued as a patent, or that the protection scope of a patent will be broad enough to exclude others from making, using, or selling our existing or future drug candidates or drugs similar or identical to those drug candidates. There is also no guarantee that the patent protection scope of a subject matter will be the same in all jurisdictions where patent applications have been filed. We also rely on trade secrets to protect aspects of our business, especially where we or our partners do </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">not believe patent protection is appropriate or feasible. However, trade secrets are difficult to protect and even with trade secret protection, companies may be able to independently develop equivalent knowledge, methods, and know-how. As a result, in countries where we or our partners have not sought and do not seek patent protection, third parties may be able to manufacture and sell products we commercialize in the future without our permission, and we may not be able to stop them from doing so, even if our products are protected by trade secrets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The patent portfolio to which we have rights may not provide us with sufficient rights to exclude others from commercializing drug candidates similar or identical to ours. With respect to issued patents in certain jurisdictions, we or our partners may be entitled to obtain a patent term extension to extend the patent expiration date provided we or our partners meet the applicable requirements for obtaining such patent term extensions. For example, patents protecting core matters of AN2025 and AN0025 will expire in 2027 and 2031 respectively. Our partners may be entitled to extend the term of those patents in jurisdictions where patent term extension is adopted, including U.S., EU, China, and Japan. However, the applicable authorities may not agree with our assessment of whether such extensions are available, and may refuse to grant extensions to our patents, or may grant more limited extensions than we request. In addition, we or our partners may not be granted an extension because of, for example, failing to apply within applicable deadlines, failing to apply prior to the expiration of relevant patents or otherwise failing to satisfy applicable requirements. If this occurs, any period during which we have the right to exclusively market our drug candidates will be shorter than we would otherwise expect. As such, the patent terms of AN2025 and AN0025 may not be successfully extended to 2032 and 2036 respectively, or at all. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may face competition from generic or biosimilar manufacturers after the patent protection is no longer valid. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if patent protection for our approved drug candidates is successfully obtained, we may face competition from generic or biosimilar medications once the patent has expired. Manufacturers of generic or biosimilar drugs may also challenge the scope, validity, or enforceability of the patents to which we have right in court or before a patent office, and we may not be successful in enforcing or defending those intellectual property rights and, as a result, may not be able to develop or market the relevant product exclusively. The applied and issued patents of our licensing partners for our drug candidates are expected to expire on various dates as described in paragraphs headed &#8220;Business&#8201;&#8212;&#8201;Intellectual Property&#8221; in this prospectus. Upon the expiration or invalidation of these and our future applied and issued patents, we will not be able to assert such patent rights against potential competitors. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may face risks related to compulsory licensing</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many jurisdictions have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many jurisdictions limit the enforceability of patents against government agencies or government contractors. In these jurisdictions, the patent owner may have limited remedies, which could materially diminish the value of such patents. If we or any of our licensors, licensees or collaborators are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be materially impaired. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our owned and in-licensed patents and patent applications may be subject to priority disputes, inventorship disputes, and similar proceedings.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While we are not currently aware of any pending challenges, we or our licensing partners may be subject to claims brought by former employees, collaborators, or other third parties who have an interest in our owned or in-licensed patents or other intellectual property or become involved in opposition, revocation, post-grant, and </font><font style="font-style:italic;letter-spacing:0.2pt;">inter partes</font><font style="letter-spacing:0.2pt;"> review, or interference proceedings challenging our patent rights or the patent rights of others. If we or our licensing partners are unsuccessful in any interference proceedings or other priority or validity disputes to which our owned or the in-licensed intellectual properties are subject, we may lose valuable intellectual property rights through the loss of one or more patents or our patent claims may be narrowed, invalidated, or held unenforceable. Particularly, if we or our licensing partners are unsuccessful in any inventorship disputes to which we or they are subject, we may lose valuable intellectual property rights, such as exclusive ownership. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any such event may require us to obtain and maintain licenses from third parties, including parties involved in such proceedings or disputes. Those licenses may not be available to us on commercially reasonable terms or at all, or may be non-exclusive. If we are unable to obtain and maintain such licenses, we may need to cease the development, manufacture, and commercialization of one or more of our drug candidates. The loss of exclusivity or the narrowing of our or our licensing partners&#8217; patent claims could limit our ability to stop others from using or commercializing similar or identical drug products. Even if we are successful in an interference proceeding or other similar priority or inventorship disputes, it could result in substantial costs and be a distraction to our management and other employees. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may face future patent claims or alike against our drug candidates or the exploitation of our products.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our commercial success depends in significant part upon our ability to develop, manufacture, market, and sell our drug candidates without infringing, misappropriating, or otherwise violating the intellectual property rights of third parties. There is no assurance that our drug candidates or the sale or use of our future products do not and will not in the future infringe third-party patents or other intellectual property rights. Numerous issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing drug candidates. The risk increases as patent offices issue more patents to third parties or accept and examine more patent applications filed by them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Third parties may also allege that we misappropriated their trade secrets, or that we are otherwise violating their intellectual property rights, whether with respect to the manner in which we have conducted our research or development, or with respect to the sale, use or manufacture of the compounds we have developed, in-licensed, or are developing. Such third parties might resort to litigation against us or our licensors or other parties we have agreed to indemnify based on either existing intellectual property or intellectual property that arises in the future. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may fail to identify potential intellectual property related risks and take precautions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">It may be possible that we or our licensors failed to identify, or may in the future fail to identify, relevant patents or patent applications held by third parties with claims to materials, formulations, methods of manufacture or methods for treatment related to the use or manufacture of our drug candidates. Because patent applications can take many&#160;years to issue, there may be pending patent applications that we are not aware of and which may later result in issued patents that our drug candidates may infringe. In addition, third parties may obtain patents in the future and claim that development or commercialization of our drug candidates infringes upon these patents. We or our licensors also may incorrectly conclude that third party patents are invalid or that our activities do not infringe, misappropriate, or otherwise violate a third party&#8217;s intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If a competent court holds that our drug candidates, their manufacturing process, or any intermediate products during the manufacturing process falls into the protection scope of a patent owned by a third party, the patent holder may be able to prevent us from manufacturing such drug candidate unless we obtain a license under the applicable patents, design around the patent, or until such patents expire or they are held invalid or unenforceable. Similarly, if a competent court holds that our formulations, processes for manufacture or methods of use, including combination therapy or patient selection methods fall within the protection scope of a patent owned by a third party, the patent holder may be able to block the development and commercialization of the applicable drug candidate unless we obtain a license, limit our uses, design around the patent, or until such patent expires or is held invalid or unenforceable. In either case, such a license may not be available on commercially reasonable terms or at all. Even if we were able to obtain a license, the rights may be nonexclusive, which could result in our competitors gaining access to the same intellectual property. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we were found liable for intellectual property infringement or misappropriation, we may be obligated to pay substantial damages.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of a successful claim of infringement or misappropriation against us, we may have to pay substantial damages, including, in the U.S., triple damages, and attorneys&#8217; fees in the case of willful infringement, obtain one or more licenses from third parties, pay royalties or redesign our infringing drug candidates, which may be impossible or require substantial time and monetary expenditure. Third parties who </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">bring successful claims against us for infringement of their intellectual property rights may obtain injunctive or other equitable relief, which could prevent us from developing and commercializing one or more of our drug candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Defending against claims of patent infringement, misappropriation of trade secrets or other violations of intellectual property rights, regardless of merit, would involve substantial expense and be time-consuming, regardless of the outcome, and our adversaries may have the ability to dedicate substantially greater resources to prosecuting these legal actions than we can. Thus, even if we were to ultimately prevail, or to settle at an early stage, such litigation could burden us with substantial unanticipated adverse impacts on our business. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace. Claims that we misappropriated the confidential information or trade secrets of third parties could have a similar material adverse effect. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may face legal proceedings or disputes before regulatory authorities related to our patents and other intellectual property, which can be unpredictable, expensive and time-consuming.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding measures we or our licensors may take, now or in the future, to obtain and maintain patent and other intellectual property rights with respect to drug candidates we plan to develop, our intellectual property rights could be challenged or invalidated in courts or before regulatory authorities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable. An adverse result in any litigation proceeding could put one or more of our patents at risk of being invalidated or otherwise interpreted narrowly. Such proceedings could result in revocation of or amendment to our patents in such a way that they no longer adequately cover and protect our drug candidates. Even if a defendant does not prevail on a legal assertion of invalidity and/or unenforceability, our patent claims may be construed in a manner that would limit our or our licensor&#8217;s ability to enforce such claims against the defendant and others. Additionally, during an intellectual property litigation, there will be substantial amount of discovery required in connection with the litigation. As a result, there is a risk that some of our confidential information could be compromised by disclosure. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Litigation and other proceedings in connection with any of the foregoing claims can be expensive and time-consuming and, even if resolved in our favor, may cause us to incur significant expenses and could distract management and our scientific and technical personnel from their normal responsibilities. Many of our current and potential competitors have the ability to dedicate substantially greater resources to enforce and defend their intellectual property rights than we can. Thus, we or our licensors may not have sufficient funds to defend against any such claims or may otherwise decide not to defend them for commercial or other reasons. Moreover, the damages or other remedies awarded, if any, may not be commercially meaningful. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if we obtain patent protection, a competent court may nevertheless find that a potentially infringing technology does not fall within protection scope of our patent protection scope.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if we or our licensors obtain patent protections, a competent court may still find that an alleged infringing technology does not fall within the protection scope of our or our licensor&#8217;s patent protection scope. The scope of a patent can be reinterpreted after its issuance and changes pursuant to either the patent laws or interpretation of the patent laws in the U.S. and other applicable jurisdictions. If the protection scope is interpreted narrowly, it may diminish the value of the patents we hold or in-license. Issuance is not conclusive as to its scope and any patents that we hold or in-license rights may be challenged by third parties in the courts or patent offices in the U.S., China, or other applicable jurisdictions. We cannot predict whether the claims of any issued patents will provide sufficient protection from competitors or other third parties. If a court determines that the actual protection scope of our or our licensor&#8217;s patent is narrower than the scope based on its literal meaning, the court will hold that the alleged infringer does not infringe the patent at issue and will refuse to stop the alleged infringer from using the technology at issue on the grounds that our patents do not cover the technology in question. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our current or any future patent applications may not be successfully granted into patents, or if granted, the protection scope may not be broad enough to cover our technology.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The patent positions of biotechnology and pharmaceutical companies, including our patent position, involve complex legal and factual questions. Therefore, the issuance of any patent applicants to which we have </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">rights or may obtain rights cannot be predicted with certainty. Our pending and future patent applications may not result in the issuance of patents at all. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the U.S. and other applicable jurisdictions are typically not published until 18&#160;months after filing or in some cases, as in the U.S., until they are issued as a patent. Therefore, we cannot be certain that we or our current or future licensors, licensees, or collaborators were the first to make or file on the inventions claimed in our owned or licensed patents or pending patent applications. There is also no assurance that all of the potentially relevant prior art relating to the patents and patent applications covering our drug candidates has been identified and disclosed to the relevant patent office, during the prosecution of the related patent application, and such prior art could be used by a third party to prevent a patent from being issued from a pending patent application. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Even if our current or future licensors&#8217;, licensees&#8217;, or collaborators&#8217; patent applications are issued as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors, or other third parties from competing with us, or otherwise provide us with any competitive advantage. The coverage claimed in a patent application can be significantly reduced before the patent is issued. We cannot predict whether the patent applications we are currently pursuing and may pursue in the future will successfully result in the issuance of any patents sufficiently covering our technology in any particular jurisdiction. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual property litigation may lead to unfavorable publicity which may harm our reputation.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the course of any intellectual property litigation, there could be public announcements of the results of hearings, rulings on motions, and other interim proceedings in the litigation. If securities analysts or investors regard any such announcements as negative, the perceived value of our drug candidates, future drugs, programs, or intellectual property could be diminished. Accordingly, the market price of the ADSs may decline. Such announcements could also harm our reputation or the market for our drug candidates, which could have a material adverse effect on our business. In addition, the uncertainties associated with litigation could have a material adverse effect on our ability to raise the funds necessary to conduct our clinical trials, in-license needed technology, or enter into strategic partnerships that would help us bring our drug candidates to market. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our patent protection could be reduced or eliminated if we or our licensors do not comply with patent administration authorities&#8217; relevant requirements.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In several stages over the lifetime of a patent and patent application, periodic maintenance fees, renewal fees, annuity fees and various other governmental fees are due to be paid to the United States Patent and Trademark Office, or the USPTO, the China National Intellectual Property Administration, or the CNIPA, and other patent offices and agencies. The USPTO, the CNIPA and various comparable governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application and maintenance process. In certain circumstances, we may be required to rely on our licensors to take the necessary action to comply with these requirements with respect to patents or other intellectual property they have licensed to us. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance, which could include failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents, can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes in patent law of the U.S., China, or other jurisdictions could diminish the value of our patents in general. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Changes in either the patent laws or their interpretation in the U.S., China, or other applicable jurisdictions may increase the uncertainties and costs surrounding the prosecution of our patents, diminish our ability to protect our inventions, obtain, maintain, defend, and enforce our intellectual property rights, and more generally, affect the value of our intellectual property or narrow the scope of our patent rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain recently enacted U.S. laws have changed the procedures through which patents may be obtained and by which the validity of patents may be challenged. For example, the Leahy-Smith America Invents Act, or the Leahy-Smith Act, includes a number of significant changes to U.S. patent law. Particularly, in March&#160;2013, the U.S. changed from first to invent to first to file rule, meaning the applicant who files a patent </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">application first is entitled to the patent regardless of whether a third party was the first to invent the claimed invention. As such, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of patent applications in the U.S. and the enforcement or defense of patents issued to us or our licensors. Recent U.S. Supreme Court rulings have also changed the law surrounding patent eligibility and narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. Furthermore, depending on decisions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. Similar changes in the laws could happen in other applicable jurisdictions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In China, intellectual property laws are constantly evolving and efforts have been made to improve intellectual property protection. For example, on October&#160;17, 2020, the Standing Committee of the National People&#8217;s Congress of PRC promulgated the amended Patent Law of the PRC (2020 Revision), which took effect since June&#160;1, 2021. It regulates a patent linkage for pharmaceutical patents and approves the patent term extension for eligible innovative pharmaceutical patents. However, it lacks an implementing rule for how to obtain and how to calculate patent term extension, and thus we may not be able to successfully secure sufficient patent term extensions or at all for our patents or patents we in-licensed. Also, if a third party obtains patent term extension for its patent and our drug candidates fall within the protection scope, we are required to delay commercialization for an extended period of time. Therefore, we cannot guarantee that these changes or any future changes to PRC intellectual property laws would not have a negative impact on our intellectual property protection. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be unable to protect our trade secrets.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition to patent rights, we currently rely on and plan to continue to rely on trade secrets and confidential information, including unpatented know-how, technology, and other proprietary information, to maintain our competitive position and to protect our drug candidates. We seek to protect trade secrets and confidential information, in part, by entering into non-disclosure and confidentiality agreements with parties that have access to them, such as our employees, our collaborators, sponsored researchers, contract manufacturers, consultants, advisers, and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. However, we may not be able to prevent the unauthorized disclosure or use of our trade secrets and confidential information by the parties to these agreements. Monitoring unauthorized uses and disclosures is difficult and we do not know whether the steps we have taken to protect our proprietary technologies will be effective. Any of the parties with whom we enter into confidentiality agreements may breach or violate the terms of any such agreements and may disclose our proprietary information, and we may not be able to obtain adequate remedies for any such breach or violation. As a result, we could lose our trade secrets and third parties could use our trade secrets to compete with our drug candidates and technology. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, we cannot guarantee that we have entered into such agreements with each party that may have or has had access to our trade secrets or proprietary technology and processes. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive, and time-consuming, and the outcome is likely to be unpredictable. In addition, if any trade secrets that we rely on were to be lawfully obtained or independently developed by a competitor or other third party, we may have no right to prevent them from using that technology or information to compete with us and our competitive position would be harmed. In addition, while we typically require our employees, consultants, and contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own. Furthermore, the assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, each of which may result in claims by or against us related to the ownership of such intellectual property. Our partners who have granted rights to trade secrets or other confidential information also may not take all such precautions or may be exposed to other risk that could result in the loss of trade secrets or rights in confidential information that we rely upon. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be subject to claims that we have wrongfully used or disclosed alleged trade secrets of others or claims asserting ownership of what we regard as our own or our partners&#8217; intellectual property.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Some of our employees, consultants, and advisers, including our senior management, were previously employed at other biotechnology or pharmaceutical companies, including our competitors or potential </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">competitors. Some of these employees, consultants, and advisers, including members of our senior management, may have executed proprietary rights, non-disclosure, and non-competition agreements in connection with such previous employment. Although we try to ensure that they do not use the proprietary information or know-how of others in their work for us, we cannot be certain that we or our partners take enough precautions, and we may be subject to claims that we, our partners or these individuals have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#8217;s current or former employer. We are not aware of any such disclosures, or threatened or pending claims related to these matters or concerning the agreements with our senior management, but in the future, there can be litigation where we need to defend against such claims. If we fail in defending any such claims, in addition to possibly paying monetary damages, we may lose valuable intellectual property rights, or be required to obtain licenses to such intellectual property rights, which may not be available on commercially reasonable terms or at all. In addition, we may lose personnel or even important ones as a result of such claims, and any such litigation or the threat thereof may adversely affect our ability to hire employees or contract with independent contractors. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, individuals executing agreements with us may have pre-existing or competing obligations to a third party, such as an academic institution, and thus an agreement with us may be ineffective in perfecting ownership of inventions developed by that individual. If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights. Even if we are successful in prosecuting or defending any of the foregoing claims, litigation could result in substantial costs and be a distraction to our management and scientific personnel. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may not be able to enjoy additional protection over drug-related patents in the U.S.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the U.S., the Federal Food Drug and Cosmetic Act, as amended by the law generally referred to as &#8220;Hatch-Waxman&#8221;, provides the opportunity for limited patent term extension, which can compensate for patent term lost due to FDA&#8217;s regulatory review. However, a patent term extension cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of drug approval; only one patent may be extended and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. The application for the extension must be submitted prior to the expiration of the patent for which extension is sought. A patent that covers multiple products for which approval is sought can only be extended in connection with one of the approvals. Even then, we may not be granted an extension because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents, or otherwise failing to satisfy applicable requirements. Moreover, the applicable period or the scope of patent protection afforded could be less than we request. In addition, to the extent we wish to pursue patent term extension based on a patent that we in-license from a third party, we would need the cooperation of that third party. If we fail to obtain patent term extensions or if the term of any such extension is less than we request, our competitors may obtain approval of competing products following our patent expiration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Hatch-Waxman also has a process for patent linkage, pursuant to which the FDA will stay approval of certain follow-on applications during the pendency of litigation between the follow-on applicant and the patent holder or licensee, generally for a period of 30&#160;months. Moreover, Hatch-Waxman provides for statutory exclusivities that can prevent submission or approval of certain follow-on marketing applications. For example, federal law provides a five-year period of exclusivity within the U.S. to the first applicant to obtain approval of a new chemical entity and three&#160;years of exclusivity protecting certain innovations to previously approved active ingredients where the applicant was required to conduct new clinical investigations to obtain approval for the modification. Similarly, the U.S. Orphan Drug Act provides seven&#160;years of market exclusivity for certain drugs to treat rare diseases, where the FDA designates the drug candidate as an orphan drug and the drug is approved for the designated orphan indication. However, we may not be able to enjoy those benefits if we fail to apply for them according to the FDA&#8217;s relevant requirements. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our drugs may not share the same level of protection in China as in the U.S.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Patent Law of the PRC (2020 Revision) provides a patent linkage system, pursuant to which the patent holder or a party of interest can resolve potential patent infringement disputes before a follow-on drug </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">receives marketing approval. Depending on the outcome of the disputes, NMPA will decide whether to delay approval of such follow-on applications. There are certain implementation rules and interpretations for the patent linkage system, such as Measures for the Implementation of Early Resolution Mechanisms for Drug Patent Disputes (Trial) published by NMPA and the CNIPA and took effect from July&#160;4, 2021, and Provisions on Several Issues Concerning the Application of Law in the Trial of Patent Civil Cases Involving Drug Marketing Review and Approval of Patent (Draft for Solicitation of Comments) published by Supreme People&#8217;s Court on October&#160;29, 2020. Currently, the patent linkage system has been established in China. However, the enforcement of laws and regulations to some extent remain uncertain in China. In addition, there is no currently effective law or regulation providing data exclusivity in China (referred to as regulatory data protection). Although Implementation Rules for Drug Regulatory Data Protection (Trial) (Draft for Solicitation of Comments was published by NMPA on April&#160;25, 2018), no updates or progress have been reported on this legislation. In view of the uncertainty of the newly established patent linkage system and the lack of data protection, a lower-cost generic drug can emerge onto the market much more quickly than in the U.S. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The registered and unregistered trademarks or trade names that we own or in-license are valuable assets and may be challenged, infringed, circumvented, declared generic, lapsed, or determined to infringe on or dilutive of other marks. We may not be able to protect and maintain our rights to these trademarks and trade names, which may be necessary to build name recognition among potential collaborators or customers in our markets of interest. Sometimes, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. As of June 30, 2023, we had trademarks in the progress of registration and are subject to the risk of limited trademark protection. If we delay or fail to complete the registration of our trademarks, if third parties succeed in registering or developing common law rights in trademarks similar or identical to our trademarks and if we are not successful in challenging such rights, we may not be able to use these trademarks to develop brand recognition of our products. In addition, there could be potential trade name or trademark infringement claims brought by owners of other trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names against us. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may license our trademarks and trade names to third parties, such as distributors. Though these license agreements may provide guidelines for how our trademarks and trade names may be used, a breach of these agreements or misuse of our trademarks and tradenames by our licensees may jeopardize our rights in or diminish the goodwill associated with our trademarks and trade names. Our efforts to enforce or protect our proprietary rights related to trademarks, trade names, trade secrets, domain names, copyrights, or other intellectual property may be ineffective, incur substantial costs and divert our resources. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">FIRRMA may restrict our ability to acquire technologies and assets in the U.S. that are material to our commercial success.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Legislation that the U.S. Congress has passed is likely to expand the jurisdiction and powers of the Committee on Foreign Investment in the U.S., or the CFIUS, the U.S. interagency committee that conducts national security reviews of foreign investment. President Trump signed the Foreign Investment Risk Review Modernization Act or FIRRMA in August&#160;2018. Pursuant to the FIRRMA, investments in companies that deal in &#8220;critical technology&#8221; are subject to filing requirements and, in some instances, review and approval by the CFIUS. The term &#8220;critical technology&#8221; includes, among others, technology subject to U.S. export controls and certain &#8220;emerging and foundational technology,&#8221; a term that is still being defined but is expected to include a range of U.S. biotechnology. If an investment by a foreign entity in a U.S. business dealing in &#8220;critical technology&#8221; meets certain thresholds, a filing with the CFIUS is mandatory. While the FIRRMA currently grants CFIUS jurisdiction on only controlling and certain non-controlling investments made by foreign persons in U.S. businesses in research and development in biotechnology, the CFIUS&#8217;s jurisdiction may be further expanded in the future, which may place additional limitations on strategic collaborations with our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">current or future U.S. partners, which could detrimentally affect our capacity to acquire foreign assets in the U.S. that may be material to our commercial success. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual property rights do not necessarily address all potential threats.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. Thus, the degree of future protection afforded by our intellectual property rights is uncertain. The following examples are illustrative: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">others may be able to make products that are similar to any drug candidates we may develop or utilize similar technology that are not covered by the claims of the patents that we own or in-license now or in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we or any of our licensors might not have been the first to make the inventions covered by the issued patents or pending patent applications that we own or exclusively in-license, which could result in the patents applied for not being issued or being invalidated after issuing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we or any of our licensors might not have been the first to file patent applications covering certain of our or their inventions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">pending patent applications may not lead to issued patents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may obtain or in-license patents for certain compounds many&#160;years before we receive NDA approval for drugs containing such compounds, and because patents have a limited life, which may begin to run prior to the commercial sale of the related drugs, the commercial value of our patents may be limited; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing, misappropriating, or otherwise violating our intellectual property rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">patents that may be issued from our pending patent applications may be held invalid or unenforceable, including as a result of legal challenges by our competitors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our competitors might conduct research and development activities in countries where we do not have rights to patents and then use the information learned from such activities to develop competitive products for commercialization in our major markets; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may fail to develop or acquire rights to additional proprietary technologies that are patentable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may fail to apply for or obtain adequate intellectual property protection in all the jurisdictions in which we operate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">third parties may gain unauthorized access to our intellectual property due to potential lapses in our information systems; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the patents of others may materially and adversely affect our business, for example by preventing us from commercializing one or more of our drug candidates for one or more indications; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may choose not to file a patent for certain trade secrets or know-how, and a third party may subsequently file a patent covering such intellectual property. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Should any of these events occur, they could have a material adverse effect on our business, financial condition, results of operations, and prospects. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may allocate our limited resources to pursue a particular drug candidate or indication and fail to capitalize on drug candidates or indications that may later prove to be more profitable, or for which there is a greater likelihood of success.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As there are many potential drug candidates to choose from, our research programs to identify drug candidates that we may wish to in-license require substantial technical, financial, and human resources. We may focus our efforts and resources on research programs or drug candidates that ultimately prove to be unsuccessful. Moreover, because we have limited financial and managerial resources, we focus on clinical development programs and drug candidates for specific indications. As a result, we may forego or delay pursuit </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of opportunities with other drug candidates or for other indications that later prove to have greater commercial potential or a greater likelihood of success. Our resource allocation decisions may result in failure to capitalize on viable commercial products or profitable market opportunities, which could materially and adversely affect our future growth and prospects. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may not be able to identify, discover, or in-license new drug candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although a substantial amount of our effort will focus on the continued clinical testing, potential approval, and commercialization of our existing drug candidates, the success of our business depends in part upon our ability to identify, license in, discover, develop, or commercialize additional drug candidates. Our research programs or licensing efforts may fail to identify, discover or in-license new drug candidates for clinical development and commercialization for a number of reasons, including, without limitation, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our research or business development methodology or search criteria and process may be unsuccessful in identifying potential drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our potential drug candidates may be shown to have harmful side effects or may have other characteristics that may make the drug candidates unmarketable or unlikely to receive marketing approval; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">it may take greater human and financial resources to identify additional therapeutic opportunities for our drug candidates or to develop suitable potential drug candidates through internal research programs, thereby limiting our ability to diversify and expand our product portfolio. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certain of our drug candidates may be limited to those patients who are ineligible for or have failed prior treatments and the relevant market may be relatively small.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain of our drug candidates are mainly targeted for treatment of patients who are ineligible for or have failed prior treatments. Our lead product buparlisib or AN2025 is used for treatment of recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy. Also, our product AN0025 is developed in combination with Keytruda or pembrolizumab for the treatment of NSCLC and bladder cancer after anti-PD-1/PD-L1 treatments and TNBC, MSS CRC, and cervical cancer after standard of care treatments. As such drug candidates are targeting late-line patients, the relevant market may be relatively small. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may encounter difficulties enrolling patients in our clinical trials.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of patients in the clinical trials. We may fail or experience significant delays to initiate or continue clinical trials for our drug candidates if we are unable to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA, NMPA, EMA, or similar regulatory authorities, or the patient enrollment is delayed. Even if we are able to enroll a sufficient number of patients in our clinical trials, delays in patient enrollment may result in increased costs or may affect the timing or outcome of the planned clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Patient enrollment for our clinical trials may be affected by many factors. For example, some of our competitors have ongoing clinical trials for drug candidates that treat the same indications as our drug candidates, and patients who would otherwise be eligible for our clinical trials may instead enroll in the clinical trials of our competitors&#8217; drug candidates. Other factors include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">severity of the disease under investigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">total size and nature of the relevant patient population; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">design and eligibility criteria for the clinical trial in question; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">perceived risks and benefits of the drug candidate under study; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our resources to facilitate timely enrollment in clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the ability to obtain and maintain informed consents; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the risk that enrolled patients will not complete a clinical trial; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">clinicians&#8217; and patients&#8217; perceptions as to the potential advantages and risks of the candidate being studied in relation to other available therapies, including any new products that may be approved for the indications we are investigating as well as any candidates under development; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">patient referral practices of physicians; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our investigators&#8217; or clinical trial sites&#8217; efforts to screen and recruit eligible patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">proximity and availability of clinical trial sites for prospective patients; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">epidemics. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The outbreak of epidemics and the resulting government actions may adversely impact our planned and ongoing clinical trials. Clinical site initiation, including difficulties in recruiting clinical site investigators and clinical site staff, and patient enrollment may be delayed due to the prioritization of hospital resources towards combating the COVID-19 pandemic. For further details, see &#8220;Risk Factors&#8201;&#8212;&#8201;Risks related to our business&#8201;&#8212;&#8201;We may face force majeure risks, including the recent COVID-19 outbreak.&#8221; </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AEs or undesirable side effects caused by our drug candidates could interrupt, delay, or halt clinical trials, delay or prevent regulatory approvals, limit the commercial profile of an approved label, or result in significant negative consequences following any regulatory approvals.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As is the case with biopharmaceuticals generally, it is likely that there may be adverse side effects associated with pipeline products or our future drug candidates&#8217; use. Results of our clinical trials could reveal a high and unacceptable severity and prevalence of expected or unexpected side effects or unexpected characteristics. Undesirable side effects caused by our drug candidates when used alone or in combination with approved or investigational drugs could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label, or lead to the delay or denial of regulatory approval by the FDA or comparable foreign regulatory authorities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Drug-related AEs and SAEs have been reported in our clinical trials. See &#8220;Business&#8201;&#8212;&#8201;Our differentiated oncology portfolio.&#8221; Undesirable AEs caused by our drug candidates, or caused by our drug candidates when used in combination with other drugs, could potentially cause significant negative consequences, including but not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulatory authorities could interrupt, delay or halt pending clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may suspend, delay or alter development or marketing of our drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulatory authorities may order us to cease further development of, or deny approval of, our drug candidates for any or all targeted indications if results of our trials reveal a high and unacceptable severity or prevalence of certain AEs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulatory authorities may delay or deny approval of our drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulatory authorities may withdraw approvals or revoke licenses of an approved drug candidate, or we may determine to do so even if not required; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulatory authorities may require additional warnings on the label of an approved drug candidate or impose other limitations on an approved drug candidate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may be required to develop a risk evaluation mitigation strategy for the drug candidate, or, if one is already in place, to incorporate additional requirements under the risk evaluation mitigation strategy, or to develop a similar strategy as required by a comparable regulatory authority; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may be required to conduct post-market studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we could be subject to litigation proceedings and held liable for harm caused to patients exposed to or taking our drug candidates may suffer from AEs related to the treatment and patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the patient enrollment may be insufficient or slower than we anticipate or patients may drop out or fail to return for post-treatment follow-up at a higher rate than anticipated; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs of clinical trials of our drug candidates may be substantially higher than anticipated. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, some of our drug candidates are still considered as emerging and relatively novel therapeutics for treating cancer. Their mechanisms of action are yet to be thoroughly understood, and side effects have been observed in clinical studies and reported by medical practitioners in connection with their usage in patients. For example, the FDA, NMPA, EMA, or other comparable authorities could order us to suspend or terminate our studies or to cease further development of or deny approval of our drug candidates. Any drug-related side effects could affect patient recruitment or the ability of enrolled patients to complete trials or may result in potential product liability claims, which could prevent us from obtaining regulatory approvals or achieving or maintaining market acceptance of a particular drug candidate. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interim, &#8220;top-line&#8221; or preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From time to time, we may publicly disclose top-line or preliminary data from our preclinical studies and clinical trials, which is based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the top-line or preliminary results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Top-line or preliminary data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, top-line or preliminary data should be viewed with caution until the final data are available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From time to time, we may also disclose interim data from our preclinical studies and clinical trials. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available or as patients from our clinical trials continue other treatments for their disease. Adverse differences between preliminary or interim data and final data could significantly harm our business prospects. Disclosure of interim data by us or by our competitors could also result in volatility in the price of the ADSs after this offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimations, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular drug candidate or product and our stock. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive information, and investors or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure. If the interim, top-line, or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our drug candidates may be harmed, which could harm our business, operating results, prospects or financial condition. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">In conducting drug discovery, development, and commercialization, we face potential liabilities, in particular, product liability claims or lawsuits that could cause us to incur substantial liabilities.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We face an inherent risk of product liability as a result of the clinical trials and any future commercialization of our drug candidates worldwide. For example, we may be sued if our drug candidates cause or are perceived to cause injury or are found to be otherwise unsuitable during clinical trials, manufacturing, marketing, or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the drug, negligence, strict liability, or a breach of warranties. Claims could also be asserted under applicable consumer protection laws. If we cannot successfully defend ourselves against or obtain indemnification from our collaborators for product liability claims, we may incur substantial liabilities or be required to limit commercialization of our drug </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">candidates. Even successful defense would require significant financial and management resources. Regardless of the merits or eventual outcome, liability claims may result in significant negative consequences, including but not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">decreased demand for our drug candidates; injury to our reputation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">withdrawal of clinical trial participants and inability to continue clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">initiation of investigations by regulators; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">costs to defend the related litigation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a diversion of management&#8217;s time and our resources; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">substantial monetary awards to trial participants or patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">product recalls, withdrawals, or labeling, marketing, or promotional restrictions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">loss of revenue; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">exhaustion of any available insurance and our capital resources; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the inability to commercialize any approved drug candidate. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To cover such liability claims arising from clinical studies, we have purchased clinical trial insurance in the conduct of our clinical trials. However, it is possible that our liabilities could exceed our insurance coverage or that our insurance will not cover all situations in which a claim against us could be made. We may not be able to maintain insurance coverage at a reasonable cost or obtain insurance coverage that will be adequate to satisfy any liability that may arise. If a successful product liability claim or series of claims are brought against us for uninsured liabilities or in excess of insured liabilities, our assets may not be sufficient to cover such claims and our business operations could be impaired. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If a product fails to demonstrate safety and efficacy in one clinical trial, we may have to execute additional clinical trials or even terminate clinical trials of such drug candidate.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During clinical trials, there can be numerous unexpected events that could cause one or more of our drug candidates to fail to demonstrate safety and efficacy in humans in accordance with our current clinical development plans, including but not limited to: clinical trials of our drug candidates may produce negative or inconclusive results, and additional clinical trials may be required. Examples include lack of clinical response or other unexpected characteristics, participants are being exposed to unacceptable health risks, and the cost of clinical trials of our drug candidates is greater than we anticipate. If any of these events occurs and a product fails a clinical trial, we cannot guarantee that we would be able to effectively develop alternative clinical plans in time or at all and we may have to terminate clinical trials of the drug candidate. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may in the future conduct additional clinical trials for our drug candidates outside the United States and/or China, and FDA, NMPA and similar foreign regulatory authorities may not accept data from such trials.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have conducted clinical trials for our drug candidates in France and China, and may in the future conduct clinical trials for our drug candidates outside the U.S., including in Europe, Australia, China or other foreign jurisdictions. The acceptance of trial data from clinical trials conducted outside the U.S. by the FDA may be subject to certain conditions. In cases where data from clinical trials conducted outside the U.S. are intended to serve as the sole basis for marketing approval in the U.S., the FDA will generally not approve the application on the basis of foreign data alone unless (i)&#160;the data are applicable to the U.S. population and U.S. medical practice; (ii)&#160;the trials were performed by clinical investigators of recognized competence; and (iii)&#160;the data may be considered valid without the need for an on-site inspection by the FDA or, if the FDA considers such an inspection to be necessary, the FDA is able to validate the data through an on-site inspection or other appropriate means. Otherwise, for studies that are conducted at sites outside of the U.S. and not subject to an IND and which are intended to support a marketing application (but which are not intended to serve as the sole basis for marketing approval), the FDA requires the clinical trial to have been conducted in accordance with GCP requirements and the FDA must be able to validate the data from the clinical trial through an onsite inspection if it deems such inspection necessary. Additionally, the FDA&#8217;s clinical trial requirements, including sufficient size of patient populations and statistical powering, must be met. Many regulatory bodies, such as </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">NMPA, have similar approval requirements. In addition, such foreign trials would be subject to the applicable local laws of the foreign jurisdictions where the trials are conducted. There can be no assurance that the FDA, NMPA, or any similar foreign regulatory authority will accept data from trials conducted outside of the U.S. or the applicable jurisdiction. If the FDA, NMPA or any similar foreign regulatory authority does not accept such data, it would result in the need for additional trials, which would be costly and time-consuming and delay aspects of our business plan, and which may result in our drug candidates not receiving approval or clearance for commercialization in the applicable jurisdiction. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have relied and will continue to rely on third parties to manufacture our drug candidates in the foreseeable future.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently work with qualified CMOs to manufacture drug candidates for preclinical and clinical supply. In the near future, we plan to continue outsourcing the manufacturing of our drug candidates, including commercial-scale manufacturing of our approved drugs, to CMOs/CDMOs globally and in China. The facilities used by third-party manufacturers to manufacture our drug candidates must be approved for such manufacture by the FDA and any comparable foreign regulatory authority pursuant to inspections that will be conducted after we submit an NDA to the FDA or any comparable submission to a foreign regulatory authority. We do not control the manufacturing process of, and are completely dependent on, third-party manufacturers for compliance with GMP requirements for manufacture of products. If these third-party manufacturers cannot successfully manufacture material that conforms to our specifications and the strict regulatory requirements of the FDA or any comparable foreign regulatory authority, they will not be able to secure and/or maintain regulatory approval for their manufacturing facilities. In addition, we have no control over the ability of third-party manufacturers to maintain adequate quality control, quality assurance (&#8220;QA&#8221;) and qualified personnel. If the FDA or any comparable foreign regulatory authority does not approve these facilities for the manufacture of our drug candidates or if it withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for such drug candidates, if approved. Our failure, or the failure of our third-party manufacturers, to comply with applicable regulations could result in sanctions being imposed on us, including clinical holds, fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, seizures or recalls of products, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our products. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our reliance on third-party CMOs exposes us to certain additional risks, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">due to the limited number of qualified CMOs, we may not be able to locate a sufficient number of qualified CMOs at all times and on acceptable terms; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">substantial training is required for CMOs to manufacture a new drug candidate. We cannot ensure that the CMOs can acquire the technology and know-how in the manufacturing of our drug candidates in a timely manner, if at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the CMOs may not always be able to fully perform our obligations, including timely manufacture and deliver our drug candidates in quantity and quality to meet our clinical and commercial needs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the CMOs are subject to ongoing periodic unannounced inspections by NMPA and other comparable regulatory authorities to ensure strict compliance with GMP and other government regulations and requirements. We have limited control over these matters for our CMOs and thus cannot assure you that our CMOs will comply with these regulations and requirements at all times; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the CMOs fail to properly obtain, protect, maintain, defend, or enforce our or our licensors&#8217; intellectual property rights, or otherwise use our or our licensors&#8217; intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability, our business may be materially harmed; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we may not own, or may have to share, the intellectual property rights to any improvements made by the third-party manufacturers in the manufacturing process for our drug candidates; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">products and components from our or our licensors&#8217; overseas third-party manufacturers may be subject to additional customs and import charges, which may cause us to incur delays or additional costs as a result. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the CMOs were to encounter any of these difficulties or fail to comply with their contractual obligations, our ability to supply our drug candidates in clinical trials and to deliver drugs for commercial sales in the future would be jeopardized. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may encounter problems in manufacturing our drug candidates or our future drug products through CMOs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The manufacturing of biopharmaceutical products is highly complex. We currently work with qualified CMOs to manufacture drug candidates for preclinical and clinical supply. In the near future, we plan to continue outsourcing the manufacturing of our drug candidates, including commercial-scale manufacturing of our approved drugs, to CMOs/CDMOs globally and in China. Problems may arise during the course of manufacturing for a variety of reasons, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">equipment malfunction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure to follow specific protocols and procedures; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in product specification; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">low quality or insufficient supply of raw materials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">delays in the construction of new facilities or the expansion of existing manufacturing facilities of third-party manufacturers as a result of changes in manufacturing production sites and limits to manufacturing capacity due to regulatory requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in the types of products produced; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">advances in manufacturing techniques; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">physical limitations that could inhibit continuous supply; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">man-made or natural disasters and other environmental factors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Products with quality issues may have to be discarded, resulting in product shortages or additional expenses. This could cause, among other things, increased costs, lost revenue, damage to customer relationships, time and expense spent investigating the cause and, depending on the cause, similar losses with respect to other batches or products. If problems are not discovered before the product is released to the market, recall and product liability costs may also be incurred. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may experience delay in clinical trials or commercialization due to manufacturing problems.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Manufacturing methods and formulation are sometimes altered through the development of drug candidates from clinical trials to approval, and further to commercialization, in an effort to optimize manufacturing processes and results. Such alterations carry the risk that they will not achieve these intended objectives. Any of these alterations could cause the drug candidates to perform differently and affect the results of planned clinical trials or other future clinical trials conducted with the altered materials. This could delay the commercialization of drug candidates and require bridging studies or the repetition of one or more clinical trials, which may result in increases in clinical trial costs, delays in drug approvals and jeopardize our ability to commence product sales and generate revenue. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may also encounter problems with achieving adequate or clinical-grade products that meet the FDA, NMPA, EMA, or other comparable regulatory authority standards or specifications, and maintaining consistent and acceptable production costs. In such events, we may be required to locate alternative suitable CMOs, and we cannot guarantee that we will be able to secure temporary, alternative manufacturers for our drug candidates with the terms, quality, and costs acceptable to us, or at all. It could delay our clinical trials and/or the availability of our future drug products for commercial sale. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CMOs that we collaborate with now or in the future may fail to exercise effective quality control and quality assurance.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The quality of our future drug products, including drug candidates manufactured for research and development purposes and, in the future, drugs manufactured for commercial use, depends in significant part on the effectiveness of the quality control and quality assurance, which in turn depends on factors such as the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">production processes used in the manufacturing facilities, the quality and reliability of equipment used, the quality of the staff and related training programs of our cooperative CMOs. However, we cannot assure you that the employees of CMOs will always adhere to the quality control and QA protocol, and that such quality control and QA procedures will be effective in consistently preventing and resolving deviations from pre-agreed quality standards. Any significant failure or deterioration of the quality control and QA protocol could render our future drug products unsuitable for use, or not in compliance with the relevant requirements of the GMP and/or harm our market reputation and relationship with business partners. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be unable to meet the increasing demand for our existing drug candidates and future drug products due to insufficient manufacturing or shipping capabilities.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Manufacturers of pharmaceutical products often encounter difficulties in production, particularly in scaling up or out, validating the production process, and assuring high reliability of the manufacturing process, including the elimination of contamination. These problems include problems in logistics and shipping, difficulties in managing production costs and increasing yields, and potential issues related to quality control, including stability of the product, product testing, operator error, availability of qualified personnel and compliance with strictly-enforced regulations. For example, if contaminants are discovered in our supply of our drug candidates or in the manufacturing facilities of our contract manufacturers, such manufacturing facilities may need to be closed for an extended period of time to investigate and remedy the contamination. If our contract manufacturers encounter unanticipated delays and expenses as a result of any of these difficulties, we may not be able to manufacture sufficient quantities of our drug candidates in the time frame we expect or at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To produce our drug candidates in the quantities that we understand to be required to meet anticipated market demand for our drug candidates, if approved, our contract manufacturers will need to significantly increase, or &#8220;scale up,&#8221; the production process over the initial level of production. If our contract manufacturers are unable to meet the quantity requirements, or if we cannot find a sufficient number of quality third-party suppliers, we may not be able to produce our approved drug candidates in a sufficient quantity to meet future demand. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our suppliers may fail to provide us with sufficient quantities of the raw materials or fail to do so at acceptable quality levels or prices.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We currently rely on and expect to continue to rely on third parties to supply raw materials for us to manufacture the approved drugs in the future. However, raw materials and components used in the manufacturing process, particularly those for which we have no other source or supplier, may not be available or may not be suitable or acceptable for use due to material defects or prices. Such risks could delay or prevent R&amp;D activities, result in higher costs, or adversely impact commercialization of our future approved drug candidates. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our drug candidates may fail to achieve the degree of market acceptance by physicians, patients, third-party payors, and others in the medical community.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our future approved drug candidates, if any, may fail to gain sufficient market acceptance by physicians, patients, third-party payors, and others in the medical community, who may prefer other drugs to ours. If our future approved drug candidates do not achieve an adequate level of acceptance, we may not generate significant revenue from sales of such drug candidates and may not become profitable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The degree of market acceptance of our future approved drug candidates, if and when they are approved for commercial sale, will depend on a number of factors, including but not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">product labeling or package insert requirements of the FDA, NMPA, EMA or other comparable regulatory authorities, including the clinical indications for which our drug candidates are approved and limitations or warnings contained in the labeling; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">physicians, hospitals, cancer treatment and patients considering our drug candidates to be safe and effective; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">whether our drug candidates have achieved first-in-class or best-in-class status and the potential and perceived advantages of our drug candidates over alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the prevalence and severity of any side effects; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">timing of the launch of our drug candidates as well as competitive drugs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">cost of treatment in relation to alternative treatments; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">availability of adequate coverage and reimbursement under the National Reimbursement Drug List (the &#8220;NRDL&#8221;) and provincial reimbursement drug lists in China, or from third-party payors and government authorities in other applicable jurisdictions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">willingness of patients to pay any out-of-pocket expenses in the absence of coverage and reimbursement by third-party payors and government authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.89pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.89pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">relative convenience and ease of administration, including as compared with alternative treatments and competitive therapies; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the effectiveness of our sales and marketing efforts. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Even if our future approved drug candidates achieve market acceptance, we may not be able to maintain that market acceptance over time if new products or technologies are introduced that are more favorably received than our drug candidates and render our drug candidates obsolete. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We face intense competition and rapid technological change and the possibility that our competitors may develop therapies that are similar, more advanced, or more effective than ours.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The biotechnology and pharmaceutical industries are subject to intense competition and rapid and significant technological change. We face competition with respect to our current drug candidates, and we will face competition with respect to any drug candidates that we may seek to develop or commercialize in the future. Our competitors include major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide. We are developing our drug candidates in competition with a number of large biopharmaceutical companies that currently market and sell drugs or are pursuing the development of drugs for the same target indications as ours. Some of these competitive drugs and therapies are based on scientific approaches that are the same as or similar to our approach, and others are based on entirely different approaches. Potential competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection, and establish collaborative arrangements for research, development, manufacturing, and commercialization. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Many of our competitors have substantially greater financial, technical, and other resources, such as larger research and development staff and experienced marketing and manufacturing organizations. Additional mergers and acquisitions in the biotechnology and pharmaceutical industries may result in even more resources being concentrated in our competitors. As a result, these companies may obtain regulatory approvals from the FDA, NMPA, EMA or other comparable regulatory authorities more rapidly than we are able to and may be more effective in selling and marketing their products as well. For example, recently NMPA has accelerated market approval of drugs for diseases with high unmet medical needs, and may review and approve drugs that have gained regulatory market approval in the U.S., the European Union or Japan within the previous ten&#160;years without requiring further clinical trials in China. This may lead to increased competition from drugs which have already obtained approval in other jurisdictions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large, established companies. Competition may increase further as a result of advances in the commercial applicability of technologies and greater availability of capital for investment in these industries. Our competitors may succeed in developing, acquiring, or licensing products that are more effective or less costly than any future drug product that we may develop, or achieve earlier patent protection, regulatory approvals, product commercialization, and market penetration than we do. Additionally, technologies developed by our competitors may render our future drug products uneconomical or obsolete, and we may not be successful in marketing our future drug products against competitors. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have no experience in launching and marketing drug candidates. We may not be able to effectively build and manage our sales network, or benefit from third-party collaborators&#8217; sales network.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently have no sales, marketing or commercial product distribution capabilities and have no experience in marketing drugs. We intend to develop an in-house marketing organization and sales force, which will require significant capital expenditures, management resources and time. We will have to compete with other biopharmaceutical companies to recruit, hire, train and retain marketing and sales personnel. If we are unable or decide not to establish internal sales, marketing and commercial distribution capabilities for any or all of the drugs we develop, we will likely pursue collaborative arrangements regarding the sales and marketing of our drugs. However, there can be no assurance that we will be able to establish or maintain such collaborative arrangements, or, if we are able to do so, that they will have effective sales forces. Any revenue we receive will depend on the efforts of such third parties, which may not be successful. We may have little or no control over the marketing and sales efforts of such third parties, and our revenue from product sales may be lower than if we had commercialized our drug candidates ourselves. We will also face competition in our search for third parties to assist us with the sales and marketing efforts of our drug candidates. There can be no assurance that we will be able to develop in-house sales and commercial distribution capabilities or establish or maintain relationships with third-party collaborators to successfully commercialize any product, and as a result, we may not be able to generate product sales revenue. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our future approved drug candidates may not receive reimbursement in the U.S., Europe, China, or other countries, and we may be subject to unfavorable pricing regulations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The regulations governing regulatory approvals, pricing and reimbursement for new therapeutic products vary widely from country to country. Some countries require approval of the sale price of a drug before it can be marketed. In many countries, the pricing review period begins after marketing or licensing approval is granted. In some non-U.S. markets, prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain regulatory approvals for a drug in a particular country, but then be subject to price regulations that delay our commercial launch of the drug and reduce the revenues we are able to generate from the sale of the drug in that country. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our ability to successfully commercialize any future approved drug candidates will depend in part on the extent to which reimbursement for such drug candidates and related treatments will be available from government health administration authorities, private health insurers and other organizations. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide the medications they will pay for and establish reimbursement levels. If our future approved drug candidates failed to be included in the reimbursement programs or did not receive a favorable reimbursement level, our drug candidates may lose advantages in pricing compared to the competitor drugs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Obtaining reimbursement for our future approved drug candidates may be particularly difficult because of the higher prices often associated with drugs administered under the supervision of a physician. If reimbursement is not available or is available only to limited levels, we may not be able to successfully commercialize any drug candidate that we in-license or successfully develop. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reimbursement of our future approved drug candidates may not be immediately available or may be limited in the U.S., Europe, China, or other countries.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There may be significant delays in obtaining reimbursement for our future approved drug candidates, and coverage may be more limited than the approved indications. Inability to promptly obtain coverage and profitable payment rates from both government-funded and private payors for any future approved drug candidates could have a material adverse effect on our business, operating results, and financial condition. Moreover, eligibility for reimbursement does not imply that any drug will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale and distribution. Interim payments for new drugs, if applicable, may also not be sufficient to cover our costs and may not be made permanent. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our revenue may be negatively affected whether our future approved drug candidates are included in reimbursement programs or not.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A primary trend in the global healthcare industry is cost containment. In recent&#160;years, government authorities and third-party payors, such as private health insurers and health maintenance organizations have </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. As a result, our revenue may be negatively affected whether our future approved drug candidates are included in reimbursement programs or not. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For example, if the Ministry of Human Resources and Social Security of the People&#8217;s Republic of China or any of its local counterparts accepted our application for the inclusion of our future approved drug candidates in the NRDL or the Provincial Reimbursement Drug List (the &#8220;PRDL&#8221;), our potential revenue from the sales of such drug candidates could decrease as a result of the significantly lowered prices we may be required to charge for the products to be included in the NRDL or the PRDL. If we failed in our efforts to have our future drug products included in the NRDL or the PRDL but were able to successfully launch commercial sales of our future approved drug candidates, our revenue from commercial sales would be highly dependent on patient self-payment, which can make our future approved drug candidates less competitive. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Illegal and/or parallel imports and counterfeit biopharmaceutical products may reduce demand for our future approved drug candidates and could have a negative impact on our reputation and business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The illegal importation of competing products from countries where government price controls or other market dynamics result in lower prices may adversely affect the demand for our future approved drug candidates, which may adversely affect our sales and profitability in the U.S., China, and other applicable jurisdictions where we commercialize our future approved drug candidates. Unapproved foreign imports of prescription drugs are illegal under the current laws of the U.S., China, and other applicable jurisdictions. However, illegal imports occur and may continue to occur or even increase as the ability of patients and other customers to obtain these lower priced imports continues to grow. Furthermore, cross-border imports from lower-priced markets, known as parallel imports, into higher-priced markets could harm sales of our future drug products and exert commercial pressure on pricing within one or more markets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Certain products distributed or sold in the pharmaceutical market may be manufactured without proper licenses or approvals, or be fraudulently mislabeled with respect to their content or manufacturers. These products are generally referred to as counterfeit pharmaceutical products. The counterfeit pharmaceutical product control and enforcement system, particularly in developing markets such as China, may be inadequate to discourage or eliminate the manufacturing and sale of counterfeit pharmaceutical products imitating our future drug products. Since counterfeit pharmaceutical products in many cases are very similar in appearance to the authentic pharmaceutical products but are generally sold at lower prices, counterfeits of our products could quickly erode the demand for our future approved drug candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, counterfeit pharmaceutical products are unlikely to meet our or our collaborators&#8217; rigorous manufacturing and testing standards. A patient who receives a counterfeit pharmaceutical product may be at risk for a number of dangerous health consequences. Our reputation and business could suffer as a result of counterfeit pharmaceutical products sold under our or our collaborators&#8217; brand name(s). In addition, thefts of improperly stored inventory at warehouses or plants or while in transit which are sold through unauthorized channels could also adversely impact patient safety, our reputation, and our business. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">All material aspects of the research, development, manufacturing, and commercialization of our drug candidates are heavily regulated.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All jurisdictions in which we intend to conduct our pharmaceutical-industry activities regulate these activities in great depth and detail. We intend to conduct our activities spanning over 18 significant markets in North America, Europe, and Asia. These jurisdictions strictly regulate the pharmaceutical industry, and in doing so they employ broadly similar regulatory strategies, including regulation of product development and approval, manufacturing, and marketing, sales, and distribution of products. However, there are differences in the regulatory regimes that make for a more complex and costly regulatory compliance burden for a company like ours that plans to operate in these regions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The process of obtaining regulatory approvals and compliance with appropriate laws and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable requirements at any time during the product development process and approval process, or after approval, may subject an applicant to administrative or judicial sanctions. These sanctions could include refusal to approve pending applications, withdrawal of an approval, revocation of a license, a hold on clinical trials, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">voluntary or mandatory recalls of products, the seizure of products, total or partial suspension of production, or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement of profits, or other civil or criminal penalties. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We are subject to stringent privacy laws, information security policies, and contractual obligations related to data privacy and security.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We routinely receive, collect, generate, store, process, transmit, and maintain medical data treatment records and other personal details of subjects enrolled in our clinical trials, along with other personal or sensitive information. As such, we are subject to the relevant local, state, national, and international data protection and privacy laws, directives, regulations, and standards that apply to the collection, use, retention, protection, disclosure, transfer, and other processing of personal data in the various jurisdictions in which we operate and conduct our clinical trials, as well as contractual obligations. These data protection and privacy law regimes continue to evolve and may result in ever-increasing public scrutiny and escalating levels of enforcement and sanctions and increased costs of compliance. Failure to comply with any of these laws could result in enforcement action against us, including fines, imprisonment of company officials and public censure, claims for damages by customers, and other affected individuals, damage to our reputation and loss of goodwill. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Such data protection and privacy laws and regulations generally require clinical trial sponsors and operators and their personnel to protect the privacy of their enrolled subjects and prohibit unauthorized disclosure of personal information. If such institutions or personnel divulge the patients&#8217; private or medical records without their consent, they will be held liable for damage caused thereby. We have taken measures to maintain the confidentiality of the medical records and personal data of patients enrolled in our clinical trials we collected, including encrypting such information in our information technology system so that it cannot be viewed without proper authorization, and setting internal rules requiring our employees to maintain the confidentiality of our patients&#8217; medical records. However, these measures may not be always effective. For example, our information technology systems could be breached through hacking activities, and personal information could be leaked due to theft or misuse of personal information arising from misconduct or negligence. In addition, our clinical trials frequently also involve professionals from third party institutions working on-site with our staff and enrolled subjects. We cannot ensure that such persons will always comply with our data privacy measures. Furthermore, any change in such laws and regulations could affect our ability to use medical data and subject us to liability for the use of such data for previously permitted purposes. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The regulatory approval processes of the FDA and other comparable regulatory authorities are uncertain and time-consuming and may evolve over time.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The time required to obtain the approval from the FDA, NMPA, EMA, and other comparable regulatory authorities is inherently uncertain and depends on numerous factors, including the substantial discretion of the regulatory authorities. Generally, such approvals take many&#160;years to obtain following the commencement of preclinical studies and clinical trials. In addition, approval policies, regulations, or the type and amount of clinical data necessary to gain approval may change during the course of a drug candidate&#8217;s clinical development and may vary among jurisdictions. We cannot guarantee that we will be able to obtain regulatory approvals for our existing drug candidates or any drug candidates we may discover, in-license, or acquire and seek to develop in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our drug candidates could fail to receive the regulatory approvals from the FDA, NMPA, EMA, or a comparable regulatory authority for many reasons, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">disagreement with the design or implementation of our clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure to demonstrate that a drug candidate is safe and effective for its proposed indication; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure of our clinical trial results to meet the level of statistical significance required for approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure of our clinical trial process to pass relevant GCP and inspections; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure to demonstrate that a drug candidate&#8217;s clinical and other benefits outweigh its safety risks; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">disagreement with our interpretation of data from preclinical studies or clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">insufficient data collected from the clinical trials of our drug candidates to support the submission and filing of a NDA, or other submissions or to obtain regulatory approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure of our drug candidates to pass current GMP inspections during the regulatory review process or across the production cycle of our drug; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure of our clinical sites to pass audits carried by out by the FDA, NMPA, EMA, or comparable regulatory authorities, resulting in a potential invalidation of our research data; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">findings by the FDA, NMPA, EMA, or comparable regulatory authorities of deficiencies related to the manufacturing processes or the facilities of third-party manufacturers with whom we contract for clinical and commercial supplies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in approval policies or regulations that render our preclinical and clinical data insufficient for approval; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure of our clinical trial process to keep up with any scientific or technological advancements required by approval policies or regulations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA, NMPA, EMA, or a comparable regulatory authority may require more information, including additional preclinical, clinical, or chemistry, manufacturing, and control data, to support approval, which may delay or prevent approval and our commercialization plans. Based on the feedback we received from the FDA, we are able to submit ORR data from the Phase&#160;III interim analysis for the potential accelerated approval of AN2025 in combination with paclitaxel for the treatment of recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy. However, if the FDA believes that ORR is not good enough to support approval, we will need to wait to obtain and submit OS, which may at least cause delays in receiving the marketing approval. Even if we were to obtain approval, regulatory authorities may approve any of our drug candidates for fewer or more limited indications than we request, grant approval contingent on the performance of costly post-marketing clinical trials, or approve a drug candidate with an indication that is not desirable for the successful commercialization of that drug candidate. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disruptions at the FDA and other government agencies caused by funding shortages or global health concerns could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified drugs from being developed, approved or commercialized in a timely manner or at all.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels. Statutory, regulatory, and policy changes, the FDA&#8217;s ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise affect the FDA&#8217;s ability to perform routine functions. Average review times at the FDA have fluctuated in recent&#160;years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable. Disruptions at the FDA and other agencies may also slow the time necessary for new biologics or modifications to licensed biologics to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several&#160;years, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Separately, in response to the Covid-19 pandemic, in March, 2020, the FDA postponed most inspections of foreign and domestic manufacturing facilities. Subsequently, on July&#160;10, 2020, the FDA resumed certain on-site inspections of domestic manufacturing facilities subject to a risk-based prioritization system. The FDA utilized this risk-based assessment system to identify the categories of regulatory activity that can occur within a given geographic area, ranging from mission critical inspections to resumption of all regulatory activities. In July&#160;2021, the FDA resumed standard inspectional operations of domestic facilities. Since that time, the FDA has continued to monitor and implement changes to its inspectional activities to ensure the safety of its employees and those of the firms it regulates as it adapts to the evolving COVID-19 pandemic. Regulatory authorities outside the U.S. may adopt similar restrictions or other policy measures in response to the Covid-19 pandemic. If a prolonged government shutdown occurs, or if global health concerns continue to prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may attempt to secure approval from the FDA or comparable foreign regulatory authorities through the use of accelerated approval pathways. If we are unable to obtain such approval, we may be required to conduct additional preclinical studies or clinical trials beyond those that we contemplate, which could increase the expense of obtaining, and delay the receipt of, necessary marketing approvals. Even if we receive accelerated approval from the FDA, if our confirmatory trials do not verify clinical benefit, or if we do not comply with rigorous post-marketing requirements, the FDA may seek to withdraw accelerated approval.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may in the future seek an accelerated approval for AN2025 in combination with paclitaxel for the treatment of recurrent or metastatic head and neck squamous cell carcinomas (&#8220;HNSCC&#8221;) after anti-PD1/PD-L1 therapy. Under the accelerated approval program, the FDA may grant accelerated approval to a drug candidate designed to treat a serious or life-threatening condition that provides meaningful therapeutic benefit over available therapies upon a determination that the drug candidate has an effect on a surrogate endpoint or intermediate clinical endpoint that is reasonably likely to predict clinical benefit. The FDA considers a clinical benefit to be a positive therapeutic effect that is clinically meaningful in the context of a given disease, such as irreversible morbidity or mortality. For the purposes of accelerated approval, a surrogate endpoint is a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure that is thought to predict clinical benefit, but is not itself a measure of clinical benefit. An intermediate clinical endpoint is a clinical endpoint that can be measured earlier than an effect on irreversible morbidity or mortality that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit. The accelerated approval pathway may be used in cases in which the advantage of a new drug over available therapy may not be a direct therapeutic advantage, but is a clinically important improvement from a patient and public health perspective. If granted, accelerated approval is usually contingent on the sponsor&#8217;s agreement to conduct, in a diligent manner, additional post-approval confirmatory studies to verity and describe the drug&#8217;s clinical benefit. If such post-approval studies fail to confirm the drug&#8217;s clinical benefit, the FDA may withdraw its approval of the drug. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to seeking accelerated approval for any of our drug candidates, we intend to seek feedback from the FDA and will otherwise evaluate our ability to seek and receive accelerated approval. There can be no assurance that after our evaluation of the feedback and other factors we will decide to pursue or submit an IND or BLA for accelerated approval or any other form of expedited development, review or approval. Similarly, there can be no assurance that after subsequent FDA feedback we will continue to pursue or apply for accelerated approval or any other form of expedited development, review or approval, even if we initially decide to do so. Furthermore, if we decide to submit an application for accelerated approval or receive an expedited regulatory designation (e.g., breakthrough therapy designation) for our drug candidates, there can be no assurance that such submission or application will be accepted or that any expedited development, review or approval will be granted on a timely basis, or at all. The FDA or other comparable foreign regulatory authorities could also require us to conduct further studies prior to considering our application or granting approval of any type. A failure to obtain accelerated approval or any other form of expedited development, review or approval for our drug candidate would result in a longer time period to commercialization of such drug candidate, could increase the cost of development of such drug candidate and could harm our competitive position in the marketplace. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">A fast track designation by the FDA, even if granted for any of our drug candidates, may not lead to a faster development or regulatory review or approval process, and does not increase the likelihood that our drug candidates will receive marketing approval.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have received fast track designation for AN2025 the treatment of recurrent or metastatic HNSCC with disease progression on or after platinum-based therapy. We may seek additional designation for some or all of our other drug candidates. If a drug or biologic is intended for the treatment of a serious condition and demonstrates the potential to address unmet medical needs for this condition, the sponsor may apply for FDA fast track designation. The sponsor of a fast track drug candidate has opportunities for more frequent interactions with the applicable FDA review team during product development and, once a BLA or NDA is submitted, the application may be eligible for priority review. A fast track drug candidate may also be eligible for rolling review, where the FDA may consider for review sections of the BLA or NDA on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the BLA or NDA, the FDA agrees to accept sections of the BLA or NDA and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">BLA or NDA. The FDA has broad discretion on whether or not to grant this designation. Even if we believe a particular drug candidate is eligible for this designation, we cannot assure you that the FDA would decide to grant it. Even if we do receive fast track designation, we may not experience a faster development process, review or approval compared to conventional FDA procedures. The FDA may withdraw fast track designation if it believes that statutory criteria for granting such designation are no longer met. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we are unable to obtain NMPA approval for our drug candidates to be eligible for an expedited registration pathway as innovative drug candidates, the time and cost we incur to obtain regulatory approvals may increase.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">NMPA has mechanisms in place for expedited review and approval for drug candidates that are innovative drug applications, provided such drug or drug candidate has a new and clearly defined structure, pharmacological property, and apparent clinical value and has not been marketed anywhere in the world. However, there is no assurance that an innovative drug designation will be granted by NMPA for any of our drug candidates. Moreover, an innovative drug designation, which is typically granted only towards the end of a drug&#8217;s developmental stage, does not increase the likelihood that our drug candidates will receive regulatory approvals on a fast-track basis, or at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, there have been recent regulatory initiatives in China regarding clinical trial approvals, the evaluation and approval of certain drugs and medical devices and the simplification and acceleration of the clinical trial process. For further details, see &#8220;Regulation&#8201;&#8212;&#8201;PRC laws and regulations&#8201;&#8212;&#8201;PRC drug regulatory regime&#8221; in this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The regulatory environment in China has substantially changed in recent&#160;years and may change further in the future in unpredictable ways. Any future policies, or changes to current policies, that NMPA approves might require us to change our planned clinical study design or otherwise spend additional resources and effort to obtain approval of our drug candidates. In addition, policy changes may contain significant limitations related to use restrictions for certain age groups, warnings, precautions, or contraindications, or may be subject to burdensome post-approval study or risk management requirements. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Even if we receive regulatory approvals for our drug candidates, we will be subject to ongoing regulatory obligations and continued regulatory review.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the FDA, NMPA, EMA, or a comparable regulatory authority approves any of our drug candidates, the manufacturing processes, labeling, packaging, distribution, AE reporting, storage, advertising, promotion, and recordkeeping for the drug will be subject to extensive and ongoing regulatory requirements on pharmacovigilance. These requirements include submissions of safety and other post-marketing information and reports, registration, random quality control testing, adherence to any chemistry, manufacturing, and controls, specifications, continued compliance with current GMPs, and GCPs and potential post-approval studies for the purposes of license renewal. Any regulatory approvals that we receive for our drug candidates may also be subject to limitations on the approved indicated uses for which the drug may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing studies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, once a drug is approved by the FDA, NMPA, EMA, or a comparable regulatory authority for marketing, it is possible that there could be a subsequent discovery of previously unknown problems with the drug, including problems with third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements. If any of the foregoing occurs with respect to our drug products, it may result in, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions on the marketing or manufacturing of the drug, withdrawal of the drug from the market, or voluntary or mandatory drug recalls; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">fines, warning letters, or holds on our clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">refusal by the FDA, NMPA, EMA, or comparable regulatory authorities to approve pending applications or supplements to approved applications filed by us; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">suspension or revocation of existing drug license approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">refusal by the FDA, NMPA, EMA, or comparable regulatory authorities to accept any of our other IND approvals or NDAs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">drug seizure or detention, or refusal to permit the import or export of drugs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">injunctions or the imposition of civil, administrative, or criminal penalties. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any government investigation of alleged violations of law could require us to spend significant time and resources and could generate negative publicity. Moreover, regulatory policies may change or additional government regulations may be enacted that could prevent, limit, or delay regulatory approvals of our drug candidates. If we are not able to maintain regulatory compliance, we may lose the regulatory approvals that we have already obtained and may not achieve or sustain profitability. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Failure by us or other parties to obtain or renew certain approvals, licenses, permits, and certificates required for our business, or any failure to comply with applicable regulations and industry standards may materially and adversely affect our reputation, business, financial condition, and results of operations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the relevant laws, regulations, and relevant regulatory practice by governmental authority, we and/or other parties related to our operations, such as landlords or managers of premises on or local science parks in which we operate, are required to obtain and maintain various approvals, licenses, permits, and certificates (e.g., drainage permits) from relevant authorities to operate our business. Some of these approvals, permits, licenses and certificates are subject to periodic renewal and/or reassessment by the relevant authorities, and the standards of such renewal and/or reassessment may change from time to time. Any failure to obtain or renew any approvals, licenses, permits, and certificates necessary for our operations may result in enforcement actions thereunder, including orders issued by the relevant regulatory authorities causing operations to cease, and may include corrective measures requiring capital expenditure or remedial actions. There is also no assurance that the relevant authorities would not take any enforcement action against us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, if the interpretation or implementation of existing laws and regulations changes, or new regulations come into effect requiring us and/or other such related parties to obtain any additional approvals, permits, licenses, or certificates that were previously not required to operate our existing businesses, we cannot assure you that we and/or other such related parties will successfully obtain such approvals, permits, licenses, or certificates. Our or these parties&#8217; failure to obtain the additional approvals, permits, licenses, or certificates may restrict the conduct of our business, decrease our revenues and/or increase our costs. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The FDA and other regulatory agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If any of our drug candidates are approved and we are found to have improperly promoted off-label uses of those products, we may become subject to significant liability. The FDA, NMPA, EMA and other regulatory agencies strictly regulate the promotional claims that may be made about prescription products, such as our drug candidates, if approved. In particular, a product may not be promoted for uses that are not approved by the FDA or such other regulatory agencies as reflected in the product&#8217;s approved labeling. If we receive marketing approval for any of our drug candidates, physicians may nevertheless prescribe it to their patients in a manner that is inconsistent with the approved label. If we are found to have promoted such off-label uses, we may become subject to significant liability. The U.S. federal government has levied large civil and criminal fines against companies for alleged improper promotion of off-label use and has enjoined several companies from engaging in off-label promotion. The FDA has also requested that companies enter into consent decrees or permanent injunctions under which specified promotional conduct is changed or curtailed. If we cannot successfully manage the promotion of any of our drug candidates, if approved, we could become subject to significant liability, which would materially adversely affect our business and financial condition. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Adverse drug reactions and negative results from off-label use of our products could materially and adversely affect our business reputation, product brand name, and financial condition and expose us to liability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Products distributed or sold in the pharmaceutical market may be subject to off-label drug use. Off-label drug use is prescribing a product for an indication, dosage or in a dosage form that is not in accordance with regulatory approved usage and labeling. Even though the FDA, NMPA, EMA, and other comparable regulatory authorities actively enforce the laws and regulations prohibiting the promotion of off-label use, there remains the risk that our product is subject to off-label drug use and is prescribed in a patient population, dosage or dosage form that has not been approved by competent authorities. This occurrence may render our </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">products less effective or entirely ineffective and may cause adverse drug reactions. These occurrences may also expose us to liability and cause, or lead to, a delay in the progress of our clinical trials and may also ultimately result in failure to obtain regulatory approvals for our drug candidates. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If safety, efficacy, or other issues arise with any drug or medical product used in combination with or to facilitate the use of our drug candidates, we may be unable to market such drug candidate or may experience significant regulatory delays.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our strategy to develop combination therapies depends on the safety and efficacy of each component drug within each combination therapy. If the FDA, NMPA, EMA, or another comparable regulatory agency revokes or denies its approval of one component drug, in either the clinical design, clinical administration, therapy approval or commercialization stage, we will be forced to terminate or redesign the clinical trials for the combination therapy, and experience significant regulatory delays or stop our commercialization efforts. In addition, we may fail our commercialization effort because products that facilitate the use of our drug candidates incur safety, efficacy, or availability issues. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be restricted from transferring our scientific data abroad.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2018, the General Office of the State Council promulgated the Measures for the Management of Scientific Data , which provide a broad definition of scientific data and relevant rules for the management of scientific data. According to this new regulation, enterprises in China must seek governmental approval before any scientific data involving a state secret may be transferred abroad or to foreign parties. Further, any researcher conducting research funded at least in part by the Chinese government is required to submit relevant scientific data for management by the entity to which such researcher is affiliated before such data may be published in any foreign academic journal. If and to the extent our research and development of drug candidates will be subject to this new rule and any relevant laws as required by the relevant government authorities, we cannot guarantee that we can always obtain relevant approvals for sending scientific data (such as the results of our preclinical studies or clinical trials conducted within China) abroad. If we are unable to obtain necessary approvals in a timely manner, or at all, our research and development of drug candidates may be hindered. If the relevant government authorities consider the transmission of our scientific data to be in violation of the requirements under this new regulation, we may be subject to fines and other administrative penalties imposed by those government authorities. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have a limited operating history, have incurred net losses and anticipate that we will continue to incur net losses for the foreseeable future. We may not be able to generate sufficient revenue to achieve or maintain profitability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Investment in the development of biopharmaceutical products is highly speculative as it entails substantial upfront capital expenditures and significant risks that a drug candidate may fail to demonstrate sufficient efficacy or safety to gain regulatory or marketing approvals or become commercially viable. Previously, we have financed our activities primarily through proceeds from private equity and debt financings. We have not generated any revenue from commercial product sales, and continue to incur significant upfront licensing fees, milestone payments, and other fees under existing in-license agreements, as well as research and development expenses and other expenses related to our ongoing operations. In addition, we issued a series of preferred shares to investors and recorded these financial instruments as financial liabilities at FVTPL. As a result, we are not profitable currently and have incurred net losses. Our net loss was US$56.7&#160;million, US$58.8&#160;million, and US$78.4 million for the years ended December&#160;31, 2021, 2022 and six&#160;months ended June 30, 2023, respectively. Substantially all of our net losses have resulted from costs incurred in connection with our research and development programs, financial liabilities at FVTPL, and from general and administrative costs associated with our operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We expect to continue to incur significant expenses and losses for the foreseeable future, and that these expenses and losses will increase as we carry out certain activities relating to our development, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">acquiring or in-licensing other intellectual property, drug candidates, and technologies and payment of milestones and other fees under existing in-license agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">conducting preclinical studies and clinical trials of our existing and new drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">manufacturing clinical trial materials and commercial supplies through contract manufacturing organizations in and out of China; seeking regulatory approvals for our drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">commercializing those of our drug candidates for which we have obtained marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">hiring additional clinical, operational, financial, quality control, and scientific personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">granting equity-settled awards to our employees under our share incentive schemes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtaining, maintaining, expanding, and protecting our intellectual property portfolio; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">creating additional infrastructure to support our operations as a public company and our product development and planned future commercialization efforts. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We expect that it could take multiple&#160;years to develop a new drug from discovery, clinical development to commercialization. During the process, we may encounter unforeseen expenses, difficulties, complications, delays, and other unknown factors that may adversely affect our business. The size of our future net losses will depend partially on the rate of the future growth of our expenses, our ability to generate revenues, and the timing and amount of milestone payments and other payments that we make to third parties. If any of our drug candidates fails during clinical trials or does not gain regulatory approvals, or, even if approved, fails to achieve market acceptance, our business may not become profitable. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may need to obtain additional financing to fund our drug development programs and commercialization efforts, which may not be available to us on acceptable terms, or at all.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our operations have consumed substantial amounts of cash. We recorded net cash outflow from operating activities of US$3.0&#160;million, US$43.2&#160;million and US$18.3&#160;million, for the years ended December&#160;31, 2021, 2022, and six&#160;months ended June 30, 2023, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe our available financial resources, including cash and cash equivalents and the estimated net proceeds from this offering and the concurrent private placement will be sufficient to meet our anticipated cash needs for the next 12&#160;months from the date of this prospectus. We may, however, from time to time experience net cash outflows from our operating activities for the foreseeable future, and require additional cash resources to meet our continued operating cash requirements in the future. We expect our expenses to increase in connection with our ongoing activities, particularly as we advance the clinical development of our drug candidates, initiate additional clinical trials of these and other future drug candidates, and seek regulatory approvals for them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, if we obtain regulatory approvals for any of our drug candidates, we expect to incur significant commercialization expenses relating to product manufacturing, marketing, sales and distribution and post-approval commitments to continue monitoring the efficacy and safety data of those products we may have on the market. In particular, costs that may be required for the manufacture of any drug candidate that has received regulatory approvals may be substantial as we mainly rely on third party contract manufacturing organizations and/or our partners to manufacture such drug candidates. We may also incur expenses as we create additional infrastructure to support our operations as a public company. Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations through public or private equity offerings, debt financing, collaborations or licensing arrangements or other sources. If we are unable to raise capital when needed or on acceptable terms, we could be forced to delay, limit, reduce or terminate our research and development programs or any future commercialization efforts. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We had a working capital deficiency as of December 31, 2022 and June 30, 2023 as well as accumulated deficits as of December 31, 2021, 2022 and June 30, 2023.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We cannot assure you that we will not experience working capital deficiencies or accumulated deficits in the future, which could expose us to liquidity risks. We had net current liabilities of US$246.3 million as of December&#160;31, 2022 and US$321.8 million as of June 30, 2023. In addition, we had net liabilities of US$185.4&#160;million, US$241.3 million and US$317.5 million, as of December&#160;31, 2021, 2022 and June&#160;30, 2023, respectively. Our net current liabilities position and deficit position were in part due to the accounting treatment of our preferred shares, which were classified as financial liabilities in accordance with IFRSs. Such preferred shares will automatically convert into shares upon completion of this offering, at which time we </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">expect to reclassify them from liabilities to equity and, accordingly, turn into net current asset position and net asset position. However, there can be no assurance that we will not experience liquidity problems in the future. If we fail to maintain sufficient cash and financing, we may not have sufficient cash flows to fund our business, operations and capital expenditure and our business and financial position will be adversely affected. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to our Amended and Restated Shareholders Agreement, our Series B investors, Series&#160;C investors and Series D investors shall be entitled to require us to redeem all or a portion of the outstanding preferred shares held by them if we fails to complete a qualified IPO at the earlier of (a) September 7, 2023; and (b) two years after the date of closing of the series D preferred shares. Given that these deadlines have lapsed, if the holders of these shares require us to do so and we do not have sufficient funds to redeem some or all of the preferred shares for cash, we could be forced to liquidate or declare bankruptcy. In any such event, the Series&#160;B, C and D preferred shares have a liquidation preference, such that any remaining assets would be transferred to the holders of the Series B, C and D preferred shares and ordinary stockholders and any remaining preferred holders could receive no consideration for their shares. In addition, the accounting rules to which we are subject may require us to treat the Series B, C and D preferred shares as a debt security, in light of the redemption feature. This could have a materially negative effect on our financial statements, financial condition and future operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because all redemption rights related to our Series B, C and D preferred shares terminate upon the completion of this initial public offering, and all preferred shares automatically convert to class A ordinary shares immediately prior to the completion of the initial public offering, any and all risks to our Company related to such redemption rights also terminate upon the initial public offering&#8217;s completion. As of the date of this registration statement, we have not received any redemption requests from the holders of Series B, C or D preferred shares. Further, as of September 27, 2023, all holders of Series B, C and D preferred shares confirmed to us that they do not intend to declare or exercise their redemption rights regarding the Group&#8217;s preferred shares before the completion of the initial public offering.</font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our results of operations, financial conditions, and prospects may be adversely affected by fair value changes and credit risk associated with our financial assets at FVTPL.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021 and 2022 and June 30, 2023, we recorded financial assets at FVTPL of US$53.8&#160;million, US$21.3 million and US$7.0 thousand, respectively. Our financial assets at FVTPL represented wealth management products purchased from commercial banks in the PRC and Hong Kong. As these wealth management products were not traded in active markets, their fair values were determined based on the expected rate of return on our investment. The valuation involves the exercise of professional judgment and the use of certain bases, assumptions and unobservable inputs. As a result, such treatment of carrying amounts of our financial assets measured at FVTPL may cause significant volatility in or materially and adversely affect our financial condition and results of operations. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Share-based payment may cause shareholding dilution to our existing shareholders and potentially have a material and adverse effect on our financial performance.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We adopted employee incentive plans for the benefit of our employees as remuneration for their services provided to us to incentivize and reward the eligible persons who have contributed to the success of our company. For the&#160;years ended December&#160;31, 2021, 2022, and six months ended June 30, 2023, we incurred share-based payment expenses of US$3.4 million, US$6.1 million, and US$2.4 million, respectively. To further incentivize our employees to contribute to us, we may grant additional share-based compensation in the future. Issuance of additional Shares with respect to such share-based payment may dilute the shareholding percentage of our existing shareholders. Expenses incurred with respect to such share-based payment may also increase our operating expenses and therefore have a material and adverse effect on our financial performance. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Disruptions in the financial markets and economic conditions could affect our ability to raise capital.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Global economies could suffer dramatic downturns as the result of a deterioration in the credit markets and related financial crisis as well as a variety of other factors including, extreme volatility in security prices, severely diminished liquidity and credit availability, ratings downgrades of certain investments and declining valuations of others. In the past, governments have taken unprecedented actions in an attempt to address and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">rectify these extreme market and economic conditions by providing liquidity and stability to the financial markets. If these actions are not successful, the return of adverse economic conditions may cause a significant impact on our ability to raise capital, if needed, on a timely basis and on acceptable terms or at all. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, there is considerable uncertainty over the long-term effects of the expansionary monetary and fiscal policies adopted by the central banks and financial authorities of some of the world&#8217;s leading economies, including the U.S. and China. There have been concerns over unrest and terrorist threats in the Middle East, Europe and Africa and over the conflicts involving Ukraine, Syria and North Korea. There have also been concerns on the relationship among China and other Asian countries, which may result in or intensify potential conflicts in relation to territorial disputes or the trade related disputes between the U.S. and China. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we fail to implement and maintain an effective system of internal controls to remediate our material weaknesses over financial reporting, we may be unable to accurately report our results of operations, meet our reporting obligations or prevent fraud, and investor confidence in our company and the market price of the ADSs may be materially and adversely affected.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to this offering, we have been a private company with limited reporting and accounting personnel and other resources with which to address our internal control over financial reporting. In connection with the audits of our consolidated financial statements included in this prospectus, we and our independent registered public accounting firm identified material weaknesses in our internal control over financial reporting. As defined in the standards established by the U.S. Public Company Accounting Oversight Board, or PCAOB, a &#8220;material weakness&#8221; is a deficiency, or combination of deficiencies in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. For details of these material weaknesses, see &#8220;Financial Information&#8201;&#8212;&#8201;Internal control over financial reporting&#8221;. We are in the process of implementing a number of measures to address the material weaknesses and deficiencies that have been identified. See &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; However, we cannot assure you that these measures will fully address the material weaknesses and deficiencies in our internal control over financial reporting or that we may conclude that they have been fully remediated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon completion of this offering, we will become subject to the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act. Section&#160;404 of such Act will require that we include a report from management on the effectiveness of our internal control over financial reporting in our annual report on Form&#160;20-F beginning with our second annual report on Form 20-F after becoming a public company. In addition, once we cease to be an &#8220;emerging growth company&#8221; as such term is defined in the JOBS Act, our independent registered public accounting firm must attest to and report on the effectiveness of our internal control over financial reporting. Moreover, even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm, after conducting its own independent testing, may issue an adverse opinion on the effectiveness of internal control over financial reporting because of the existence of a material weakness if it is not satisfied with our internal controls or the level at which our controls are documented, designed, operated or reviewed, or if it interprets the relevant requirements differently from us. In addition, after we become a public company, our reporting obligations may place a significant strain on our management, operational and financial resources and systems for the foreseeable future. We may be unable to timely complete our evaluation testing and any required remediation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the course of documenting and testing our internal control procedures, in order to satisfy the requirements of Section&#160;404, we may identify other weaknesses and deficiencies in our internal control over financial reporting. If we fail to maintain the adequacy of our internal control over financial reporting, as these standards are modified, supplemented or amended from time to time, we may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section&#160;404. Generally speaking, if we fail to achieve and maintain an effective internal control environment, it could result in material misstatements in our financial statements and could also impair our ability to comply with applicable financial reporting requirements and related regulatory filings on a timely basis. As a result, our business, financial condition, results of operations and prospects, as well as the trading price of the ADSs, may be materially and adversely affected. Additionally, ineffective internal control over financial reporting could expose us to increased risk of fraud or misuse of corporate assets and subject us to potential delisting from the stock exchange on which we list, regulatory investigations and civil or criminal sanctions. We may also be required to restate our financial statements from prior periods. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be contractually obligated to make significant payments for in-licensed drug candidates which may eventually not be approved for sale or which we find that we are unable to commercialize successfully.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our research and development engine runs on both in-house discovery and external licensing of highly innovative products. Leveraging our global clinical development capability, deep understanding of relevant molecules, and proficiency in clinical trial designs, we are able to identify and secure suitable and promising compounds ahead of our competitors. We are developing two clinical-stage drug candidates which were secured from in-licensing agreements with third parties. Pursuant to the license agreements, we are required to make various payments to the licensors, including an upfront payment at the time when the relevant license agreement is signed, milestone payments for the achievements of specified clinical, regulatory and commercial milestones, and royalties calculated as a specified&#160;percentage of the annual net sales of the products covered by the license. Royalties are often structured so that the&#160;percentage increases in tiers as net sales increase. Please refer to the paragraphs headed &#8220;Business&#8201;&#8212;&#8201;License and collaboration agreements&#8221; in this prospectus for more details. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">When we negotiate our license agreements, we must estimate the probability of success for the drug&#8217;s development and the potential size of the eventual market for the drug product. We may have to make significant upfront payments to secure the rights to attractive drug candidates, and there is no guarantee that we will ever be able to recoup those expenses. Milestone or other non-royalty payments also become due on a drug candidate before we can obtain regulatory approvals for it or commercialize it, and we may not have sufficient funds available to make these payments when they come due. If and when we obtain regulatory approvals to market a drug, our profits from any sales will be reduced by the royalties that we agreed to pay under the license agreement. If we make significant payments under our license agreements for drug candidates that never reach market, or if we misjudge the potential size of the market for our drug candidates and overpay for the rights that we license, our financial condition and financial performance may be materially and adversely affected. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Raising additional capital may cause dilution to the interests of our shareholders, restrict our operations, or require us to relinquish rights to our technologies or drug candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may seek additional funding through a combination of equity offerings, debt financings, collaborations, and licensing arrangements. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the value of your ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect your rights as a holder of the ADSs. Incurring additional indebtedness or the issuance of certain equity securities could result in increased fixed payment obligations and also result in certain additional restrictive covenants, such as limitations on our ability to incur additional debt or issue additional equity, limitations on our ability to acquire or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. In addition, the issuance of additional equity securities, or the possibility of such issuance, may cause the market price of the ADSs to decline. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event we enter into collaborations or licensing arrangements in order to raise capital, we may be required to accept unfavorable terms, including relinquishing or licensing to a third party our rights to technologies or drug candidates on unfavorable terms, which we would have otherwise sought to develop or commercialize ourselves or reserve for future potential arrangements when we are more likely to achieve more favorable terms. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We are exposed to risks of conducting our business and operations in international markets.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Global markets are a crucial component of our growth strategy. If we fail to obtain licenses or enter into collaboration arrangements with third parties in such markets, or if third-party collaborators are not successful, our revenue-generating growth potential will be adversely affected. Risks associated with global operation include, but are not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in a specific country or region&#8217;s political and cultural climate or economic condition; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">differing regulatory requirements for drug approvals and marketing internationally; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">difficulty of effective enforcement of contractual provisions in local jurisdictions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">potentially reduced protection for intellectual property rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">potential third-party patent rights; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">unexpected changes in tariffs, trade barriers and regulatory requirements, as well as trade-protection measures, import or export licensing requirements and fines, penalties or suspension or revocation of export privileges; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">unexpected detention of cargos by customs, including raw material, equipment, reagents, and drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">economic weakness, including inflation or political instability; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance with tax, employment, immigration and labor laws for employees traveling abroad; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incidental to doing business in another country; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">workforce uncertainty and labor unrest; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">failure of our employees and contracted third parties to comply with Office of Foreign Assets Control rules and regulations and the Foreign Corrupt Practices Act of the U.S., and other applicable rules and regulations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">business interruptions resulting from geo-political actions, including war and terrorism, or natural disasters, including earthquakes, volcanoes, typhoons, floods, hurricanes, and fires. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;12, 2022, the President of the United States issued an &#8220;Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy&#8221;, launching a national biotechnology and biomanufacturing initiative in the United States. This initiative will be comprised of various efforts by the U.S. government, including investments, programs and partnerships to advance research and development in biotechnology, and biomanufacturing, as well as efforts to secure and protect the U.S. bioeconomy. This executive order may lead to potential changes to U.S. policies affecting the biotechnology and biomanufacturing industries, however, it is unknown at this time whether and what specific policies and actions will be adopted by the U.S. government. Our business and operations in the U.S. primarily involve conducting research and development. We therefore expect that this executive order will have no immediate impact on our activities in the United States. Nevertheless, if the U.S. government were to adopt any policies that adversely impact transnational companies with business operating in China conducting research and development activities in the United States, our business and results of operations could be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our international operations may require us to comply with various trade restrictions, such as economic sanctions and export controls.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our international operations may be subject to various trade restrictions, including economic sanctions and export controls, imposed by governments around the world with jurisdiction over our operations. Such trade restrictions may prohibit or restrict transactions involving certain persons and certain designated countries or territories. Our failure to successfully comply with applicable trade restrictions may expose us to legal, business or reputational harm. Investigations of alleged violations can be expensive and disruptive. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For example, the United States continues to expand economic sanctions targeting Russian financial institutions in response to Russia&#8217;s military action against Ukraine. Such sanctions on Russian financial institutions may interfere with our ability to make payment to Russian CROs in US dollars and may force us to choose another settlement currency, limit or stop our collaboration with Russian CROs. We are currently engaging a Russian CRO for conducting one clinical trial in Russia. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We endeavor to conduct our activities in compliance with applicable trade restrictions. However, we cannot guarantee that our existing compliance policies and procedures will be effective in preventing violations, which could adversely affect our business, reputation, financial condition and results of operations. Further, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">we cannot predict the nature, scope or effect of future regulatory requirements, including changes that may impose additional restrictions on our international operations. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may face force majeure risks, including the recent COVID-19 outbreak.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our operations may be under threat of numerous natural disasters such as floods, earthquakes, sandstorms, snowstorms, fire, or drought, the outbreak of a widespread health epidemic, such as swine flu, avian influenza, severe acute respiratory syndrome, or SARS, Ebola, Zika, COVID-19, or other events, such as power, water or fuel shortages, failures, malfunction, and breakdown of information management systems, unexpected maintenance, or technical problems, or are susceptible to unforeseen catastrophic events such as potential wars or terrorist attacks. Serious natural disasters may result in loss of lives, injury, destruction of assets, and disruption of our business and operations. Acts of war or terrorism may also injure our employees, cause loss of lives, disrupt our business network, and destroy our markets. For example, our business could be adversely impacted by the ongoing geopolitical tensions related to Russia&#8217;s actions in Ukraine, resulting sanctions imposed by the United States and other countries and retaliatory actions taken by Russia in response to such sanctions; or other catastrophic events. Any of these factors and other factors beyond our control could have an adverse effect on the overall business sentiment and environment, cause uncertainties in the regions where we conduct business, cause our business to suffer in ways that we cannot predict and materially and adversely impact our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The occurrence of a disaster or a prolonged outbreak of an epidemic illness or other adverse public health developments in the areas where we operate could materially disrupt our business and operations. These factors could cause delay of clinical trials, regulatory submissions, and required approvals of our drug candidates, and could cause us to incur additional costs. For example, since the end of December&#160;2019, the outbreak of COVID-19 has affected many people globally, caused temporary suspension of productions and shortage of labor and raw materials in affected regions, and disrupted local and international travel and economy. The exacerbation, continuance or reoccurrence of COVID-19 has already caused and may continue to cause an adverse and prolonged impact on the economic, geopolitical, and social conditions in relevant countries. The existing clinical trials and the commencement of new clinical trials could be substantially delayed or prevented by any delay or failure in patient recruitment or enrollment in our or our collaborators&#8217; trials as a result of elevated public health safety measures. If our employees or employees of our business partners are suspected of being infected with an epidemic disease, our operations may be disrupted if we or our business partners must quarantine some or all of the affected employees or disinfect the operating facilities. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The market opportunities for our drug candidates can be smaller than we estimate or the approvals that we obtain may be based on a narrower definition of the patient population.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We make estimates regarding the incidence and prevalence of target patient populations for particular diseases based on various third-party sources and internally generated analysis and use such estimates in making decisions regarding our drug development strategy, including acquiring or in-licensing drug candidates and determining indications on which to focus in preclinical or clinical trials. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These estimates may be inaccurate or based on imprecise data. For example, the total addressable market opportunity will depend on, among other things, acceptance by the medical community, patient access, drug pricing and reimbursement. The number of patients in the addressable markets may turn out to be lower than expected, patients may not be otherwise amenable to treatment with our drugs, or new patients may become increasingly difficult to identify or gain access to, all of which may significantly harm our business, financial condition, results of operations, and prospects. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our future success depends on our ability to retain key executives and to attract, train, retain, and motivate qualified and highly skilled personnel especially R&amp;D and clinical related staff.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are heavily dependent on the expertise of our senior management and other key employees and consultants, as well as our scientific teams. Although we have formal employment agreements with each of our executive officers, these agreements do not prevent our executives from terminating their employment with us at any time. In addition, we do not maintain key-person insurance for any of our executives or other key personnel. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Recruiting and retaining qualified management, scientific, technical, clinical, manufacturing, and sales and marketing personnel in the future will also be critical to our success. The loss of the services of our executive officers or other key employees and consultants could impede the achievement of our research, development and commercialization objectives and seriously harm our ability to successfully implement our business strategy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, replacing executive officers, key employees, experienced R&amp;D staff, or consultants may be difficult and take an extended period of time due to the limited number of individuals in our industry with the breadth of skills and experience required to successfully develop, obtain regulatory approvals of and commercialize drugs. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain, or motivate these key personnel on acceptable terms given the competition among numerous pharmaceutical and biopharmaceutical companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. To compete effectively, we may need to offer higher compensation and other benefits. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we or our suppliers, CROs or CMOs fail to comply with environmental, health, and safety laws and regulations, we could become subject to fines or penalties or incur costs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are subject to various environmental, health and safety laws and regulations, including but not limited to the treatment and discharge of pollutants into the environment and the use of toxic and hazardous chemicals in the process of our business operations. In addition, our construction projects can only be put into operation after the relevant administrative authorities in charge of environmental protection and health and safety have examined and approved the relevant facilities in certain jurisdictions. We cannot guarantee that we will be able to obtain all the regulatory approvals or complete all the required procedure for our construction projects in a timely manner, or at all. Delays or failures in obtaining all the requisite regulatory approvals or completing all the required procedure for our construction projects may affect our business operation. Furthermore, we may be required to incur substantial costs to comply with current or future environmental, health and safety laws and regulations. These current or future laws and regulations may impair our research, development, or production efforts. Failure to comply with these laws and regulations also may result in substantial fines, penalties, or other sanctions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">While we attempt to comply with such laws and regulations, we cannot fully eliminate the risk of accidental contamination, biological or chemical hazards or personal injury at our or third-parties&#8217; facilities during the process of discovery, testing, development and manufacturing of biopharmaceuticals. In the event of such accident, we could be held liable for damages and clean-up costs which, to the extent not covered by existing insurance or indemnification. Other adverse effects could result from such liability, including reputational damage. We or our collaborators may also be forced to close or suspend operations at certain of the affected facilities temporarily, or permanently due to any accidental contamination, biological or chemical hazards or personal injury. We do not maintain insurance for environmental liability or toxic tort claims that may be asserted against us. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our employees, management, service providers, independent contractors, principal investigators, consultants, commercial partners, vendors, CROs, and CMOs may engage in misconduct or other improper activities.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are exposed to the risk of fraud, misconduct or other illegal activities by our employees, management, service providers, independent contractors, principal investigators, consultants, commercial partners, vendors, CROs and CMOs. Misconduct by these parties could include intentional, reckless and/or negligent conduct that fails to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">comply with the laws of the FDA, NMPA, EMA, and other comparable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide true, complete and accurate information to the FDA, NMPA, EMA, and other comparable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">comply with manufacturing standards that we have established in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">comply with laws in the U.S., Europe, China, and similar fraudulent misconduct laws in other applicable jurisdictions; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">report financial information or data accurately or to disclose unauthorized activities to us. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">If we obtain approval of any of our drug candidates and begin commercializing those drugs in the U.S., Europe, China, or other applicable jurisdictions, our potential exposure under the laws of such jurisdictions will increase considerably and our costs associated with compliance with such laws are also likely to increase. These laws may impact, among other things, our current activities with principal investigators and research patients, as well as future sales, marketing, and educational programs. In particular, the promotion, sales and marketing of healthcare items and services, as well as certain business arrangements in the healthcare industry, are subject to extensive laws and regulations designed to prevent fraud, kickbacks, self-dealing, and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing, and promotion, structuring and commissions, certain customer incentive programs, and other business arrangements generally. Misconduct by these parties could also involve individually identifiable information, including, without limitation, the improper use of information obtained in the course of clinical trials, or illegal misappropriation of drug product, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct by employees and other parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, including the imposition of civil, criminal, and administrative penalties, damages, monetary fines, possible exclusion from the NRDL, contractual damages, reputational harm, diminished profits, and future earnings and curtailment of our operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, our employees, management, directors, independent contractors, commercial partners, and vendors may be subject to legal, regulatory, and administrative proceedings. The existence of legal, regulatory, and administrative proceedings against any of our employees, management, directors, independent contractors, commercial partners, and vendors, even if they do not involve our company, may harm our reputation, and adversely affect our business and operations. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be involved in lawsuits, claims, administrative proceedings, or other legal proceedings against us, which could adversely affect our business, financial condition, results of operations, and reputation.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From time to time, we may be involved in lawsuits, claims, administrative proceedings, or other legal proceedings arising in the ordinary course of business or pursuant to governmental or regulatory enforcement activity. In addition, as we are under the progress of inspection and acceptance of one of our completed construction projects, we are subject to risks of administrative penalty if we delay or fail to obtain relevant approvals. Litigation and governmental proceedings can be expensive, lengthy, and disruptive to normal business operations, and can require extensive management attention and resources, regardless of their merit. Furthermore, any litigation, legal disputes, claims, or administrative proceedings which are initially not of material importance may escalate and become important to us due to a variety of factors, such as the facts and circumstances of the cases, the likelihood of loss, the monetary amount at stake, and the parties involved. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, our insurance might not cover claims brought against us, provide sufficient payments to cover all of the costs to resolve one or more such claims, or continue to be available on terms acceptable to us. In particular, any claim could result in unanticipated liability to us if the claim is outside the scope of the indemnification arrangement we have with third parties, they do not abide by the indemnification arrangement as required, or the liability exceeds the amount of any applicable indemnification limits or available insurance coverage. While we intend to defend the aforementioned matters vigorously, we cannot predict the results of complex legal proceedings and an unfavorable resolution of a lawsuit or proceeding could materially adversely affect our business, results of operations, financial condition, and reputation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Mr. Yang Lu, our co-founder, chairman and the chief executive officer, may face a divorce lawsuit against him. If a case is brought to a court, and the court rules in favor of Mr. Lu&#8217;s spouse, it could be detrimental to our business and reputation. For example, the litigation proceedings could divert a significant amount of Mr. Lu&#8217;s attention and other resources from our business and operations, which could harm our results of operations. Also, the publicity of the divorce lawsuit could damage our brand or have material adverse effect on our business, results of operations and financial condition. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our reputation is key to our business success. Negative publicity may adversely affect our reputation, business, and growth prospects.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our reputation and business prospects could be adversely affected by any negative publicity concerning us, our affiliates, our employees, or any entity that shares the &#8220;Adlai Nortye&#8221; name, even if untrue. Therefore, we cannot assure you that negative publicity about us or any of our affiliates or any entity that shares the &#8220;Adlai Nortye&#8221; name would not damage our brand image or have a material adverse effect on our business, results of operations and financial condition. In addition, referrals and word of mouth have significantly contributed to our ability to establishing new partnerships. As a result, any negative publicity about us or any of our affiliates or any entity that shares the &#8220;Adlai Nortye&#8221; name could adversely affect our ability to maintain our existing collaboration arrangements or attract new partners. A recent example of negative publicity relates to a blog published in August&#160;2021, alleging us paying RMB2.87&#160;million bribes for our Series&#160;C financing purposes. Although the local police concluded that the bribery allegation had no factual basis and issued a Notice of Dismissal of Accusation, and the blog post was removed after we issued a warning letter to the blogger for potential defamation, we still suffered reputational damages associated with this blog post. We cannot assure you that similar events or negative publicity will not repeat in the future. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our business operations and current or future relationships with healthcare professionals, principal investigators, consultants, customers and third-party payors in the United States and elsewhere may be subject, directly or indirectly, to applicable anti-kickback, fraud and abuse, false claims, physician payment transparency and other healthcare laws and regulations.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Healthcare providers, physicians, and others play a primary role in recommending and prescribing any products for which we obtain regulatory approvals. If we obtain the FDA, NMPA, EMA, PMDA, or other comparable regulatory authorities&#8217; approval for any of our drug candidates and begin commercializing those drug products in the U.S., China, Europe, Japan or other applicable jurisdictions, our operations may be subject to various fraud and abuse laws of such jurisdictions, including, without limitation, the PRC Anti-Unfair Competition Law, the PRC Criminal Law, the Federal Anti-Kickback Statute, the Federal False Claims Act, and transparency laws and regulations with respect to drug pricing and transfers of value made to physicians and other licensed healthcare professionals. These laws may impact, among other things, our proposed sales, marketing, and education programs. In the U.S., such laws include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the federal Anti-Kickback Statute, which prohibits, among other things, persons or entities from knowingly and willfully soliciting, offering, receiving or providing any remuneration (including any kickback, bribe or certain rebates), directly or indirectly, overtly or covertly, in cash or in kind, in return for, either the referral of an individual or the purchase, lease, or order, or arranging for or recommending the purchase, lease, or order of any good, facility, item or service, for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it in order to have committed a violation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the federal false claims laws, including the civil False Claims Act, and civil monetary penalties laws, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, to the federal government, claims for payment or approval that are false or fraudulent, knowingly making, using or causing to be made or used, a false record or statement material to a false or fraudulent claim, or from knowingly making or causing to be made a false statement to avoid, decrease or conceal an obligation to pay money to the federal government. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the federal Health Insurance Portability and Accountability Act of 1996, which imposes criminal and civil liability for, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement, in connection with the delivery of, or payment for, healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the federal Physician Payments Sunshine Act, which requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program (with certain exceptions) to report annually to the Centers for Medicare &amp; Medicaid Services, information related to payments and other &#8220;transfers of value&#8221; made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain non-physician practitioners (physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists, anesthesiology assistants and certified nurse-midwives), and teaching hospitals and other healthcare providers, as well as ownership and investment interests held by such healthcare professionals and their immediate family members; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third-party payors, including private insurers; some state laws require biotechnology companies to comply with the biotechnology industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government and may require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; some state laws that require biotechnology companies to report information on the pricing of certain drug products; and some state and local laws that require the registration or pharmaceutical sales representatives; and state medical privacy laws. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Efforts to ensure that our current and future business arrangements with third parties will comply with applicable healthcare and privacy laws and regulations will involve ongoing substantial costs. It is possible that governmental authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of these laws or any other governmental regulations that may apply to us, we may be subject to significant penalties, including civil, criminal and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government-funded healthcare programs, such as Medicare and Medicaid, integrity oversight and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings and the curtailment or restructuring of our operations. Defending against any such actions can be costly and time-consuming and may require significant financial and personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired. Further, if any of the physicians or other healthcare providers or entities with whom we expect to do business are found not to be in compliance with applicable laws or regulations, they may be subject to significant criminal, civil or administrative sanctions, including exclusions from government-funded healthcare programs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If any of the physicians or other providers or entities with whom we expect to do business are found to be not in compliance with applicable laws, they may be subject to criminal, civil, or administrative sanctions, including exclusions from government-funded healthcare programs. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If we fail to comply with applicable anti-bribery laws, our reputation may be harmed and we could be subject to penalties and significant expenses.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are subject to anti-bribery laws in China that generally prohibit companies and their intermediaries from making payments to government officials for the purpose of obtaining or retaining business or securing any other improper advantage. In addition, although currently our primary operating business is in China, we are subject to the Foreign Corrupt Practices Act or the FCPA. The FCPA generally prohibits us from making improper payments to non-U.S. officials for the purpose of obtaining or retaining business. Although we have policies and procedures designed to ensure that we, our employees, and our agents comply with anti-bribery laws, there is no assurance that such policies or procedures will prevent our agents, employees, and intermediaries from engaging in bribery activities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Failure to comply with anti-bribery laws could disrupt our business and lead to severe criminal and civil penalties, including imprisonment, criminal and civil fines, loss of our export licenses, suspension of our ability to do business with the government, denial of government reimbursement for our products and/or exclusion from participation in government healthcare programs. Other remedial measures could include further changes or enhancements to our procedures, policies, and controls and potential personnel changes </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and/or disciplinary actions, any of which could have a material adverse effect on our business, financial condition, results of operations, and liquidity. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recently enacted and future legislation in the United States and other countries may affect the prices we may obtain for our drug candidates and increase the difficulty and cost for us to obtain marketing approval of and commercialize our drug candidates.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the U.S. and many other countries, rising healthcare costs have been a concern for governments, patients and the health insurance sector, which resulted a number of changes to laws and regulations, and may result in further legislative and regulatory action regarding the healthcare and health insurance systems that could affect our ability to profitably sell any drug candidates for which we obtain marketing approval. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For example, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, was enacted in the U.S. in March&#160;2010 with the stated goals of containing healthcare costs, improving quality and expanding access to healthcare, and includes measures to change health care delivery, increase the number of individuals with insurance, ensure access to certain basic health care services, and contain the rising cost of care. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, other federal health reform measures have been proposed and adopted in the U.S. For example, as a result of the Budget Control Act of 2011, providers are subject to Medicare payment reductions through 2031, unless additional Congressional action is taken. Further, the American Taxpayer Relief Act of 2012 reduced Medicare payments to several providers and increased the statute of limitations period for the government to recover overpayments from providers from three to five&#160;years. The Medicare Access and CHIP Reauthorization Act of 2015 also introduced a quality payment program under which certain individual Medicare providers will be subject to certain incentives or penalties based on new program quality standards. Payment adjustments for the Medicare quality payment program began in 2019. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Further, there has been heightened governmental scrutiny in the U.S. of pharmaceutical pricing practices in light of the rising cost of prescription drugs. Such scrutiny has resulted in several recent congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient assistance programs, and reform government program reimbursement methodologies for products. Most recently, the Inflation Reduction Act of 2022, or IRA, included a number of significant drug pricing reforms, which include the establishment of a drug price negotiation program within the U.S. Department of Health and Human Services, or HHS (beginning in 2026) that requires manufacturers to charge a negotiated &#8220;maximum fair price&#8221; for certain selected drugs or pay an excise tax for noncompliance, the establishment of rebate payment requirements on manufacturers under Medicare Parts B and D to penalize price increases that outpace inflation (first due in 2023), and a redesign of the Part&#160;D benefit, as part of which manufacturers are required to provide discounts on Part&#160;D drugs (beginning in 2025). The IRA permits the HHS Secretary to implement many of these provisions through guidance, as opposed to regulation, for the initial&#160;years. Additional drug pricing proposals could appear in future legislation. Further, it is possible that additional governmental action is taken in response to the COVID-19 pandemic. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. Legally mandated price controls on payment amounts by third-party payors or other restrictions could harm our business, results of operations, financial condition and prospects. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. This could reduce the ultimate demand for our product candidates, if approved, or put pressure on our product pricing, which could negatively affect our business, results of operations, financial condition and prospects. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These new laws and other healthcare reform measures that may be adopted in the future may result in additional reductions in Medicare and other healthcare funding, more rigorous coverage criteria, new payment </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">methodologies and additional downward pressure on the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our drug candidates, if approved. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We have limited insurance coverage, and any claims beyond our insurance coverage may result in our incurring substantial costs and a diversion of resources.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We maintain insurance policies that are required under PRC laws and regulations as well as insurance based on our assessment of our operational needs and industry practice. Our principal insurance policies cover losses arising from liabilities in our human clinical trials for the development of our clinical-stage drug candidates in the United States, United Kingdom, Poland, and France. We have elected not to maintain certain types of insurances, such as business interruption insurance or key-man insurance. Our insurance coverage may be insufficient to cover any claim for product liability, damage to our fixed assets or employee injuries. Any liability or damage to, or caused by, our facilities or our personnel beyond our insurance coverage may result in our incurring substantial costs and a diversion of resources and may negatively impact our drug development and overall operations. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our internal computer systems, or those used by our CROs or other contractors or consultants, may fail or suffer security breaches.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the implementation of security measures, our internal computer systems, and those of our partners and other contractors and consultants may be vulnerable to damage from computer viruses and unauthorized access. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the ordinary course of our business, we collect and store sensitive data, and manage and maintain our applications and data utilizing on-site systems and outsourced vendors. These applications and data encompass a wide variety of business-critical information including research and development information, commercial information, and business and financial information. Shutdowns, or service disruptions at us or vendors that provide information systems, networks, or other services to us could have an adverse impact on us and our business, including loss of data and damage to equipment and data. In addition, system redundancy may be ineffective or inadequate, and our disaster recovery planning may not be sufficient to cover all eventualities. Significant events could result in a disruption of our operations, damage to our reputation or a loss of revenues. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we could be subject to risks caused by misappropriation, misuse, leakage, falsification, or intentional or accidental release or loss of information maintained in the information systems and networks of us and our vendors. Moreover, outside parties may attempt to penetrate our systems or those of our vendors or fraudulently induce our personnel or the personnel of our vendors to disclose sensitive information in order to gain access to our data and/or systems. Like other companies, we may experience threats to our data and systems, including malicious codes and viruses, phishing, and other cyberattacks. If a material breach of our information technology systems or those of our vendors occurs, the market perception of the effectiveness of our security measures could be harmed, our reputation and credibility could be damaged, and significant amounts of money and other resources could be required to expend on the repair or replacement of information systems or networks. In addition, we could be subject to regulatory actions and/or claims made by individuals and groups in private litigation involving privacy issues related to data collection and use practices, and other data privacy laws and regulations. The development and maintenance of systems and controls for preventing, identifying, and mitigating threats are costly and requires ongoing monitoring and updating. Moreover, despite our efforts, the possibility of these events occurring cannot be eliminated entirely. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cyber-security incidents, including data security breaches or computer viruses, could harm our business by disrupting our delivery of services, damaging our reputation or exposing us to liability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We receive, process, store and transmit, often electronically, the data of our clinical trial and others, much of which is confidential. Unauthorized access to our computer systems or stored data could result in the theft, including cyber-theft, or improper disclosure of confidential information, and the deletion or modification of records could cause interruptions in our operations. These cyber-security risks increase when we transmit </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">information from one location to another, including over the internet or other electronic networks. Despite the security measures we have implemented, our facilities, systems and procedures, and those of our third-party service providers, may be vulnerable to security breaches, acts of vandalism, software viruses, misplaced or lost data, programming or human errors or other similar events which may disrupt our operations. Any security breach involving the misappropriation, loss or other unauthorized disclosure or use of confidential information, whether by us or a third party, could (i) subject us to civil and criminal penalties, (ii) have a negative impact on our reputation, or (iii) expose us to liability to third parties or government authorities. We are not aware of such breaches to date. Any of these developments could have a material adverse effect on our business, financial condition and results of operations.</font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We are subject to changing law and regulations regarding regulatory matters, corporate governance, and public disclosure that have increased both our costs and the risk of non-compliance.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The oncology drug market is subject to influence of relevant regulations. Recently, there is a trend of enhanced regulations. On November&#160;19, 2021, the Center for Drug Evaluation issue the Clinical Value-Oriented Anti-tumor Drug Clinical Research and Development Guidelines with the purpose to better address the needs of patients and to promote the clinical value-oriented R&amp;D of anti-tumor drugs. Such regulations expose our R&amp;D of oncology drugs to higher requirements. According to the Guidelines, when clinical trials of innovative drugs are designed to choose controlled drugs, the best supportive treatment should be preferred over placebo. Also, if an indication already has the current best drug recommendation in the treatment guidelines, the new drug should be compared with the existing drug. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Guidelines aim to select more high-quality first-in-class drugs. As AN2025 has the potential to be the first treatment globally for recurrent or metastatic HNSCC patients after disease progression with anti-PD-1/PD-L1 therapy, this new focus of regulatory policies promoting value-oriented research and development activities in China is in line with our development strategies and may further facilitate our clinical trials and studies. To the best of our knowledge, we are currently in compliance with the relevant requirements in the Guidelines. However, we cannot assure you that there will be no adverse regulatory changes in the implementation of Guidelines in the PRC, or other regulatory changes in the PRC that will have a negative impact on our business going forward. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, because these laws, regulations, and standards are subject to disparate interpretations, their application in practice may evolve over time as new guidance becomes available. This evolution may result in continuing uncertainty regarding compliance matters and additional costs necessitated by ongoing revisions to our disclosure and governance practices. If we fail to address and comply with these regulations and any subsequent changes, we may be subject to penalties and our business may be harmed. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Changes in U.S. and international policies, particularly with regard to China, may adversely impact our business and operating results.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any tensions and political concerns between China and the relevant foreign countries or regions may adversely affect our business, financial condition, results of operations, cash flows, and prospects. The U.S. government has recently made statements and taken certain actions that may lead to potential changes to the U.S. and international policies with regard to China. It is unknown whether and to what extent other new laws or regulations will be adopted, or the effect that any such actions would have on us or our industry. While we have not started commercialization of drug candidates, any unfavorable international government policies, such as capital controls or tariffs, may affect the demand for our future approved drug products, the competitive position of our future approved drug products, the hiring of scientists and other research and development personnel, the use and transfer of clinical data, and import or export of raw materials in relation to drug development, or prevent us from selling our future approved drug products in certain countries. If any new legislation and/or regulations are implemented, or in particular, if the U.S. government takes retaliatory actions due to the recent U.S.-China tension, such changes could have an adverse effect on our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">It also remains unclear what actions, if any, the U.S. government will take with respect to other existing international trade agreements. If the U.S. were to withdraw from or materially modify certain international trade agreements to which it is a party, especially with respect to intellectual properties transfer, our business, financial condition, and results of operations could be negatively impacted. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our business benefits from certain financial incentives and discretionary policies granted by local governments. Expiration of, or changes to, these incentives or policies would have an adverse effect on our results of operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the past, local governments in mainland China granted certain financial incentives from time to time to our PRC subsidiaries as part of their efforts to encourage the development of local business. We recorded government grants of US$2,000, US$2.1&#160;million and US$0.2&#160;million for the&#160;years ended December&#160;31, 2021, 2022, and six&#160;months ended June 30, 2023. The local governments have discretion in deciding the timing, amount, and criteria of government financial incentives and thus we cannot predict with certainty whether or how much financial incentive will be granted to us even if we apply for such funding. We generally do not have the ability to influence local governments in making these decisions. Government authorities may also decide to reduce or eliminate incentives or may amend or terminate the relevant financial incentive policies at any time. In addition, some of the government financial incentives are granted to us on a project basis and subject to the satisfaction of certain conditions, including compliance with the applicable financial incentive agreements and completion of the specific projects therein. We cannot guarantee that we will satisfy all relevant conditions, and if we fail to satisfy any such conditions, we may be deprived of the relevant incentives. We cannot assure you of the continued availability of the government incentives currently enjoyed by us. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks relating to our operation in the People&#8217;s Republic of China</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The operational risks associated with being based in and having operations in China also apply to operations in Hong Kong and Macau. With respect to the legal risks associated with being based in and having operations in China, the laws, regulations and discretion of the governmental authorities in China discussed in this prospectus are expected to apply to entities and businesses in mainland China, rather than to entities or businesses in Hong Kong and Macau which operate under different sets of laws from those of mainland China. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The approval, filing, or other procedures of the CSRC or other PRC regulatory authorities may be required in connection with this offering under PRC laws, regulations, and rules.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;6, 2021, the General Office of the State Council, together with another regulatory authority, jointly promulgated the Opinions on Strictly Combating Illegal Securities Activities in Accordance with the Law, which calls for, among others, enhanced administration and supervision of overseas-listed China-based companies, proposes to revise the relevant regulation governing the overseas issuance and listing of shares by such companies, and clarifies the responsibilities of competent domestic industry regulators and government authorities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On February 17, 2023, the China Securities Regulatory Commission, or the CSRC, released the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies, or the Trial Measures, and five supporting guidelines, which took effect on March 31, 2023. Pursuant to the Trial Measures, domestic companies that seek to list overseas, both directly and indirectly, should fulfill the filing procedure and report relevant information to the CSRC. Where a domestic company seeks to conduct indirect overseas offerings and listings, the issuer shall designate a major domestic operating entity. This entity shall act as the domestic responsible entity and be responsible for filing with the CSRC. If a domestic company fails to complete the filing procedure or conceals any material fact or falsifies any major content in its filing documents, such domestic company may be subject to administrative penalties, such as order to rectify, warnings, fines, and its controlling shareholders, actual controllers, the person directly in charge, and other directly liable persons may also be subject to administrative penalties, such as warnings and fines. See &#8220;Regulations&#8201;&#8212;&#8201;Regulations on M&amp;A Rules and Overseas Listings.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As advised by our PRC legal counsel, according to the relevant PRC laws and regulations as of the date of this registration statement, our offering will be deemed as an indirect overseas listing by a domestic company by the CSRC. We shall fulfill the filing procedure with the CSRC in accordance with the Trial Measures. We submitted initial filing documents to the CSRC on April 20, 2023, and the CSRC published the notification on our completion of the required filing procedures on August&#160;7, 2023 for this offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the filing procedure with the CSRC under the Trial Measures is required for any future offerings or any other capital raising activities, it is uncertain whether it would be possible for us to complete the filing, or how long it will take us to do so. Failure to complete the required filing may result in an investigation by the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">relevant authorities, as well as fines or penalties, and could lead to an order prohibiting us from conducting an offering. These risks have the potential to cause a material adverse change in our operations and the value of our ordinary shares. Moreover, they could significantly limit or completely hinder our ability to offer or continue to offer securities to investors, or cause such securities to significantly decline in value or become worthless. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;24, 2023, the CSRC jointly with other relevant governmental authorities, promulgated the Confidentiality and Archives Management Provisions, which took effect on March&#160;31, 2023. According to the Confidentiality and Archives Management Provisions, domestic companies, whether offering and listing securities overseas directly or indirectly, must strictly abide the applicable laws and regulations when providing or publicly disclosing, either directly or through their overseas listed entities, documents and materials to securities services providers such as securities companies and accounting firms or overseas regulators in the process of their overseas offering and listing. If such documents or materials contain any state secrets or government authorities work secrets, domestic companies must obtain the approval from competent governmental authorities according to the applicable laws, and file with the secrecy administrative department at the same level with the approving governmental authority. Furthermore, the Confidentiality and Archives Management Provisions provide that securities companies and securities service providers shall fulfill the applicable legal procedures when providing overseas regulatory institutions and other relevant institutions and individuals with documents or materials containing any state secrets or government authorities work secrets or other documents or materials that, if divulged, will jeopardize national security or public interest. Since the Confidentiality and Archives Management Provisions were promulgated recently, substantial uncertainties still exist with respect to the interpretation and implementation of such provisions and how they will affect us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If it is determined that we are subject to the approval of the CSRC for this Offering, we may fail to obtain such approval, filing or meet such requirements in a timely manner or at all, or completion could be rescinded. Any failure to obtain or delay in obtaining such approval, filing or completing such procedures for this Offering, or a rescission of any such approval or filing obtained by us, would subject us to sanctions by the CSRC or other PRC regulatory authorities. These regulatory authorities may impose fines and penalties on our operations in China, limit our ability to pay dividends outside of China, limit our operating privileges in China, delay or restrict the repatriation of the Offering or future capital raising activities into China, or take other actions that could materially and adversely affect our business, financial condition, results of operations and prospects, as well as this offering and the listing of the ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The CSRC or other PRC regulatory authorities may also take actions requiring us, or making it advisable for us, to halt this Offering or future capital raising activities before settlement and delivery of the ADS we are offering hereby. Consequently, if you engage in market trading or other activities in anticipation of and prior to settlement and delivery, you do so at the risk that settlement and delivery may not occur. In addition, if the CSRC or other regulatory authorities later promulgate new rules or explanations requiring that we obtain their approvals or accomplish the required filing or other regulatory procedures for this Offering or future capital raising activities, we may be unable to obtain a waiver of such approval requirements, if and when procedures are established to obtain such a waiver. Such procedures for obtaining the waiver remain unclear. Any uncertainties or negative publicity regarding such approval, filing or other requirements could materially and adversely affect our business, prospects, financial condition, reputation, and this offering and the listing of the ADSs. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The impact of the CAC&#8217;s increasing oversight over data security remains highly uncertain, particularly for companies with substantial China operations seeking to list on a foreign stock exchange.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2022, the CAC amended Measures of Cybersecurity Review, or the Revised CAC Measures, which came into effect on February&#160;15, 2022. Pursuant to the Revised CAC Measures, critical information infrastructure operators procuring network products and services, and online platform operators (as opposed to &#8220;data processors&#8221; in the Draft Management Regulation) carrying out data processing activities which affect or may affect national security, shall conduct a cybersecurity review pursuant to the provisions therein. In addition, online platform operators possessing personal information of more than one million users seeking to be listed in foreign country must apply for a cybersecurity review. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, we have not received any notice from any PRC regulatory authority identifying us as a &#8220;critical information infrastructure operator,&#8221; &#8220;online platform operator&#8221; or &#8220;data processor,&#8221; or requiring us to go through the cybersecurity review procedures pursuant to the Revised CAC Measures and the Draft Management Regulations. According to the Revised CAC Measures, we do not expect ourselves to become subject to cybersecurity review by the CAC for this offering, given that: (i)&#160;the data we handle in our business operations, either by its nature or in scale, do not normally trigger significant concerns over PRC national security and (ii)&#160;we have not processed, and do not anticipate to process in the foreseeable future, personal information of more than one million users or persons. Based on the above and the information currently available, we believe the impact of the CAC&#8217;s increasing oversight over data security on our business is immaterial as of the date of this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, there remains uncertainty as to how the Revised CAC Measures will be interpreted or implemented and whether the PRC regulatory authorities may adopt new laws, regulations, rules, or detailed implementation and interpretation in relation, or in addition to the Revised CAC Measures. While we intend to closely monitor the evolving laws and regulations in this area and take all reasonable measures to mitigate compliance risks, we cannot guarantee that our business and operations will not be adversely affected by the potential impact of the Revised CAC Measures or other laws and regulations related to privacy, data protection and information security. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be influenced by changes in the political and economic policies of the PRC government.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A very substantial portion of our assets and operations are currently located in mainland China. Accordingly, we may be influenced to a significant degree by political and social conditions in China generally. The Chinese economy differs from the economies of most developed countries in many respects, including the level of government involvement, level of development, growth rate, control of foreign exchange and allocation of resources. Although the Chinese government has implemented measures emphasizing the utilization of market forces for economic reform, the reduction of state ownership of productive assets, and the establishment of improved corporate governance in business enterprises, a substantial portion of productive assets in China is still owned by the government. In addition, the Chinese government continues to play a significant role in regulating industry development by imposing industrial policies. The Chinese government also exercises significant control over China&#8217;s economic growth by allocating resources, controlling payment of foreign currency-denominated obligations, setting monetary policy, and providing preferential treatment to companies in particular industries or regions. While the Chinese economy has experienced significant growth over past decades, growth has been uneven, both geographically and among various sectors of the economy. Any adverse changes in economic conditions in China, in the policies of the Chinese government or in the laws and regulations in China could have a material adverse effect on the overall economic growth of China. Such developments could adversely affect our business and results of operations, lead to a reduction in demand for our future products and adversely affect our competitive position. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Uncertainties with respect to the enforcement of laws, and changes in laws and regulations in China with little advance notice, could materially and adversely affect us.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our operations in mainland China are governed by PRC laws and regulations. Our operating subsidiary in the PRC, Hangzhou Adlai, is a foreign-invested enterprise, or FIE, and is subject to laws and regulations applicable to foreign investment in China and, in particular, laws applicable to FIEs. The PRC legal system is a civil law system based on written statutes. Unlike the common law system, prior court decisions may be cited for reference but do not have binding authority. There are substantial uncertainties regarding the interpretation and application of PRC laws and regulations including, but not limited to, the laws and regulations governing our business and the enforcement and performance of our business arrangements in certain circumstances. The laws and regulations are sometimes vague and may be subject to future changes, and their official interpretation and enforcement could be unpredictable, with little advance notice. The effectiveness and interpretation of newly enacted laws or regulations, including amendments to existing laws and regulations, may be delayed, and our business may be affected if we rely on laws and regulations which are subsequently adopted or interpreted in a manner different from our current understanding of these laws and regulations. New laws and regulations that affect existing and proposed future businesses may also be applied retroactively. We cannot predict what effect the interpretation of existing or new PRC laws or regulations may have on our business. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since late 1970s, the PRC government has been developing a comprehensive system of laws and regulations governing economic matters in general. The overall effect of legislation over the past several decades has significantly enhanced the protections afforded to various forms of foreign investments in China. However, China has not developed a fully integrated legal system, and recently enacted laws and regulations may not sufficiently cover all aspects of economic activities in China. In particular, because these laws and regulations are relatively new, and because of the limited volume of published decisions and their nonbinding nature, the interpretation and enforcement of these laws and regulations involve uncertainties. In addition, the PRC legal system is based in part on government policies and internal rules, some of which may not be published on a timely basis or at all, and some of which may have a retroactive effect. As a result, we may not be aware of our violation of these policies and rules until sometime after the violation. Any administrative and court proceedings in China may be protracted, resulting in substantial costs and diversion of resources and management attention. However, since PRC administrative and court authorities have significant discretion in interpreting and implementing statutory and contractual terms, it may be more difficult to evaluate the outcome of administrative and court proceedings and the level of legal protection we enjoy than in more developed legal systems. These uncertainties may also impede our ability to enforce the contracts we have entered into. As a result, these uncertainties could materially and adversely affect our business and results of operations. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The PRC government has significant authority to exert influence on our operations in mainland China.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The PRC government has significant authority to exert influence on our operations in mainland China. Therefore, uncertainties in the PRC legal system and the interpretation and enforcement of PRC laws and regulations could limit the legal protection available to you and us, hinder our ability to offer or continue to offer the ADSs, result in a material adverse effect on our business operations, and damage our reputation, which might further cause the ADSs to significantly decline in value or become worthless. Changes in China&#8217;s economic, political or social conditions, or government policies could materially and adversely affect our business, financial condition, and results of operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The economic, political and social conditions in the PRC differ from those in more developed countries in many respects, including structure, government involvement, level of development, growth rate, control of foreign exchange, capital reinvestment, allocation of resources, rate of inflation and trade balance position. Before the adoption of its reform and opening up policies in 1978, the PRC was primarily a planned economy. In recent years, the PRC government has been reforming the PRC economic system and government structure. For example, the PRC government has implemented economic reform and measures emphasizing the utilization of market forces in the development of the PRC economy in the past three decades. These reforms have resulted in significant economic growth and social prospects. Economic reform measures, however, may be adjusted, modified or applied inconsistently from industry to industry or across different regions of the country. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We cannot predict whether the resulting changes will have any adverse effect on our current or future business, financial condition or results of operations. Despite these economic reforms and measures, the PRC government continues to play a significant role in regulating industrial development, allocation of natural and other resources, production, pricing and management of currency, and there can be no assurance that the PRC government will continue to pursue a policy of economic reform or that the direction of reform will continue to be market friendly. Our ability to successfully expand business operations in the PRC depends on a number of factors, including macro-economic and other market conditions. Demand for our future products in the Chinese market and our business, financial condition and results of operations may be materially and adversely affected by the following factors: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in political or social conditions of the PRC; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in laws, regulations, and administrative directives or the interpretation thereof; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">measures which may be introduced to control inflation or deflation; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in the rate or method of taxation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These factors are affected by a number of variables which are beyond our control. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recent negative publicity surrounding China-based companies listed in the United States may negatively impact the trading price of the ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe that recent negative publicity surrounding companies with operations in China that are listed in the United States have negatively impacted the stock prices of these companies. Certain politicians in the United States have publicly warned investors to shun China-based companies listed in the United States. The SEC and the PCAOB, also issued a joint statement on April&#160;21, 2020, reiterating the disclosure, financial reporting and other risks involved in the investments in companies that are based in emerging markets as well as the limited remedies available to investors who might take legal action against such companies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, various equity-based research organizations have recently published reports on China-based companies after examining their corporate governance practices, related party transactions, sales practices and financial statements, and these reports have led to special investigations and listing suspensions on U.S. national exchanges. Any similar scrutiny on us, regardless of its lack of merit, could cause the market price of the ADSs to fall, divert management resources and energy, cause us to incur expenses in defending ourselves against rumors, and increase the premiums we pay for director and officer insurance. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The ADSs may be delisted under the HFCAA if the PCAOB is unable to inspect auditors or their affiliates that are located in mainland China. The delisting of the ADSs, or the threat of such delisting, may materially and adversely affect the value of your investment. Additionally, the inability of the PCAOB to conduct inspections deprives our investors of the benefits of such inspections.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The HFCAA was enacted on December&#160;18, 2020. The HFCAA states if the SEC determines that we have filed audit reports issued by a registered public accounting firm that has not been subject to inspection by the PCAOB for three consecutive&#160;years beginning in 2021, the SEC shall prohibit our shares or ADSs from being traded on a national securities exchange or in the over the counter trading market in the U.S. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our auditor, the independent registered public accounting firm that issued the audit report in the prospectus, as auditor of companies that are traded publicly in the United States and as a firm registered with the PCAOB is subject to laws in the United States pursuant to which the PCAOB conducts regular inspections to assess its compliance with the applicable professional standards. Our auditor, which is based in New York, is currently subject to inspection by the PCAOB at least every two&#160;years. However, our auditor&#8217;s China affiliate is located in, and organized under the laws of, the PRC, which is a jurisdiction where the PCAOB has been unable to conduct inspections without the approval of the Chinese authorities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On March&#160;18, 2021, the SEC adopted on an interim basis rules disclosure requirements for companies with PCAOB member auditors whom the PCAOB has determined that it cannot inspect their operations within a foreign jurisdiction, or the Covered Issuers. Covered Issuers are required to disclose in their annual reports on Form 20-F: (i)&#160;that, during the period covered by the form, the registered public accounting firm has prepared an audit report for the issuer; (ii)&#160;the&#160;percentage of the shares of the issuer owned by governmental entities in the foreign jurisdiction in which the issuer is incorporated or otherwise organized; (iii)&#160;whether governmental entities in the applicable foreign jurisdiction with respect to that registered public accounting firm have a controlling financial interest with respect to the issuer; (iv)&#160;the name of each official of the Chinese Communist Party who is a member of the board of directors of the issuer or the operating entity with respect to the issuer; and (v)&#160;whether the articles of incorporation of the issuer (or equivalent organizing document) contains any charter of the Chinese Communist Party, including the text of any such charter. Furthermore, on June&#160;22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act, or the AHFCAA, which would amend the HFCAA and require the SEC to prohibit an issuer&#8217;s securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive&#160;years instead of three. On September&#160;22, 2021, the PCAOB adopted rules governing its procedures for making determinations as to its inability to inspect or investigate registered firms headquartered in a particular foreign jurisdiction or which has an office in a foreign jurisdiction, or a PCAOB-Identified Firm. Promptly after the effective date of this rule, the PCAOB will make determinations under the HFCAA to the extent such determinations are appropriate. Thereafter, the PCAOB will consider, at least annually, whether changes in facts and circumstances support any additional determinations. The PCAOB will make additional determinations as and when appropriate, to allow the SEC on a timely basis to identify covered issuers pursuant to the SEC rules. The rule became effective when the SEC approved the rule on November&#160;4, 2021. On December&#160;2, 2021, the SEC finalized its rules regarding disclosure by Covered Issuers. In addition, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">the release discussed the procedures the SEC will follow in implementing trading prohibitions for Covered Issuers. A foreign company would have to be designated a Covered Issuer three&#160;years in a row to be subject to a trading prohibition on that basis. The trading suspension would prohibit trading of the Covered Issuer&#8217;s securities on any exchange or in the over-the-counter markets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The trading prohibition will be terminated if the Covered Issuer certifies to the SEC that the issuer has retained a registered public accounting firm that the PCAOB has inspected to the satisfaction of the SEC and files financial statements that include an audit report signed by the non-PCAOB-Identified Firm. The SEC is not required to engage in rulemaking to implement the trading prohibition provisions of the HFCAA. Neither the Act nor the SEC&#8217;s release create an obligation for an exchange to delist the Covered Issuer, but the SEC noted that under existing listing rules of the exchanges, a trading prohibition would be grounds for delisting. On December&#160;16, 2021, the PCAOB issued a report on its determinations that it is unable to inspect or investigate completely PCAOB-registered public accounting firms headquartered in mainland China and in Hong Kong because of positions taken by PRC authorities in those jurisdictions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On August&#160;26, 2022, the PCAOB entered into a Statement of Protocol with the China Securities Regulatory Commission and the Ministry of Finance of the PRC and, as summarized in the &#8220;Statement on Agreement Governing Inspections and Investigations of Audit Firms Based in China and Hong Kong&#8221; published on the U.S. Securities and Exchange Commission&#8217;s official website, the parties agreed to the following: (i)&#160;in accordance with the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, the PCAOB shall have independent discretion to select any issuer audits for inspection or investigation; (ii)&#160;the PCAOB shall have direct access to interview or take testimony from all personnel of the audit firms whose issuer engagements are being inspected or investigated; (iii)&#160;the PCAOB shall have the unfettered ability to transfer information to the SEC, in accordance with the Sarbanes-Oxley Act; and (iv)&#160;the PCAOB inspectors shall have access to complete audit work papers without any redactions, with view-only procedures for certain targeted pieces of information such as personally identifiable information. On December&#160;15, 2022, the PCAOB issued a report that vacated its December&#160;16, 2021 determination and removed mainland China and Hong Kong from the list of jurisdictions where it is unable to inspect or investigate completely registered public accounting firms. On December 29, 2022, legislation entitled &#8220;Consolidated Appropriations Act, 2023&#8221; &#8203;(the &#8220;Consolidated Appropriations Act&#8221;), was signed into law by President Joseph Biden of the United Sates. The Consolidated Appropriations Act contained, among other things, an identical provision to the AHFCAA, which reduces the number of consecutive non-inspection years required for triggering the prohibitions under the HFCAA from three years to two. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The auditor of our PRC-based subsidiaries is located in mainland China and the auditor is an affiliate of our New York based auditor that signs our audit report. Given the current question as to how &#8220;retain&#8221; should be understood for purposes of the HFCA Act, we cannot assure you that we will not be identified by the SEC as an issuer that has retained an auditor that has a branch or office that is located in a foreign jurisdiction that the PCAOB determines it is unable to inspect or investigate completely because of a position taken by an authority in that foreign jurisdiction as a result of the fact that the auditor of our China affiliates is located in, and organized under the laws of, the PRC. In addition, there can be no assurance that, if we have a &#8220;non-inspection&#8221; year, we will be able to take remedial measures in response thereto. If any such event were to occur, trading in our securities could in the future be prohibited under the HFCAA, so we cannot assure you that we will be able to maintain the listing of the ADSs on the Nasdaq or that you will be allowed to trade the ADSs in the United States on the &#8220;over-the-counter&#8221; markets or otherwise. Should the ADSs not be listed or tradeable in the United States, the value of the ADSs could be materially affected. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This lack of PCAOB inspections in China prevents the PCAOB from fully evaluating audits and quality control procedures of our independent registered public accounting firm. As a result, we and investors in the ADSs are deprived of the benefits of such PCAOB inspections. The inability of the PCAOB to conduct inspections of auditors in China makes it more difficult to evaluate the effectiveness of our independent registered public accounting firm&#8217;s China affiliate&#8217;s audit procedures or quality control procedures as compared to auditor outside of China that are subject to PCAOB inspections, which could cause investors and potential investors in the ADSs to lose confidence in our audit procedures, reported financial information and the quality of our financial statements. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRC regulation of loans to, and direct investments in, PRC entities by offshore holding companies may delay or prevent us from making loans or additional capital contributions to our PRC subsidiaries and thereby prevent us from funding our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As an offshore holding company with PRC subsidiaries, we may transfer funds to our PRC subsidiaries by means of loans or capital contributions. Any loans to our operating subsidiary in the PRC, Hangzhou Adlai, which is a foreign-invested enterprise, cannot exceed statutory limits based on the difference between the amount of our investments and registered capital in such subsidiary, and shall be registered with SAFE, the PRC State Administration of Foreign Exchange, or its local counterparts. Furthermore, at this stage, any capital increase contributions we make to Hangzhou Adlai, which is a foreign-invested enterprise, shall be registered with the SAMR or its local counterparts, and reported to the Ministry of Commerce or its local counterparts. In addition, the PRC government also restricts the convertibility of foreign currencies into RMB and use of the proceeds. Furthermore, SAFE promulgated a series of rules and regulations, including Notice on Reforming the Management Method for the Settlement of Foreign Exchange Capital of Foreign-invested Enterprises, the Circular on Reforming and Regulating Policies on the Management of Foreign Exchange Settlement of Capital Accounts, and the Circular to Further Facilitating Cross-border Trade and Investment, to further regulate the all foreign-invested companies to use RMB converted from foreign currency-denominated capital for equity investments in China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In light of the various requirements imposed by PRC regulations on loans to, and direct investment in, PRC entities by offshore holding companies, we may not be able to obtain these government registrations or approvals on a timely basis, if at all, with respect to future loans to our PRC subsidiaries or future capital contributions by us to our PRC subsidiaries. If we fail to receive such registrations or approvals, our ability to provide loans or capital to increase contributions to our PRC subsidiaries may be negatively affected, which could adversely affect their liquidity and our ability to fund and expand their business. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our business may be negatively affected by the potential obligations to make additional social insurance and housing fund contributions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are required by PRC labor laws and regulations to make registrations for social insurance and housing funds, and to pay various statutory employee benefits, including pensions insurance, medical insurance, work-related injury insurance, unemployment insurance, maternity insurance, and housing funds, to designated government agencies for the benefit of our employees. The relevant government agencies may examine whether we are in compliance with the relevant labor laws and regulations. Failure to make full payment of the requisite statutory employee benefits and any potential non-compliance may subject us to late payment fees, fines, and/or other penalties. If the relevant PRC authorities determine that we shall make supplemental social insurance and housing fund contributions or that we are subject to fines and legal sanctions in relation to our failure to make social insurance and housing fund contributions in full for our employees, our business, financial condition, and results of operations may be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">It may be difficult for overseas regulators to conduct investigations or collect evidence within the PRC.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Shareholder claims or regulatory investigation that are common in the United States generally are difficult to pursue as a matter of law or practicality in China. For example, in China, there are significant legal and other obstacles to providing information needed for regulatory investigations or litigation initiated outside China. Although the authorities in China may establish a regulatory cooperation mechanism with the securities regulatory authorities of another country or region to implement cross-border supervision and administration, such cooperation with the securities regulatory authorities in the Unities States may not be efficient in the absence of a mutual and practical cooperation mechanism. Furthermore, according to Article&#160;177 of the PRC Securities Law, which became effective in March&#160;2020, no overseas securities regulator is allowed to directly conduct investigation or evidence collection activities within the territory of the PRC; no organization or individual is allowed to provide documents and information related to securities business activities to overseas securities regulators without the consent of the securities regulatory authority under the State Council and the relevant competent department under the State Council; and according to the Data Security Law, no organization or individual within the territory of the PRC may provide foreign judicial or law enforcement authorities with data stored within the territory of the PRC without the approval of the competent authorities of the PRC. While detailed interpretation of or implementation rules under these </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">regulations have yet to be promulgated, the inability of an overseas securities regulator to directly conduct investigation or evidence collection activities within China may further increase difficulties faced by you in protecting your interests. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may rely on dividends and other distributions on equity paid by our PRC subsidiaries to fund any cash and financing requirements we may have, and any limitation on the ability of our PRC subsidiaries to make payments to us could have a material and adverse effect on our ability to conduct our business.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are a holding company, and we may rely principally on dividends and other distributions on equity paid by our PRC subsidiaries for our cash and financing requirements, including the funds necessary to pay dividends and other cash distributions to our shareholders and service any debt we may incur. If our PRC subsidiaries incur debt on their own behalf in the future, the instruments governing the debt may restrict their ability to pay dividends or make other distributions to us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under PRC laws and regulations, our operating subsidiary in the PRC, Hangzhou Adlai, as a wholly foreign-owned enterprise in the PRC, may pay dividends only out of their accumulated profits as determined in accordance with PRC accounting standards and regulations. In addition, a wholly foreign-owned enterprise, such as Hangzhou Adlai, is required to set aside at least 10% of its accumulated after-tax profits after making up the previous year&#8217;s accumulated losses each year, if any, to fund statutory reserve funds, until the aggregate amount of such fund reaches 50% of its registered capital. It may allocate a portion of its after-tax profits based on PRC accounting standards to discretionary reserve funds according to its shareholder&#8217;s decision. These statutory reserve funds and discretionary reserve funds are not distributable as cash dividends. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, the PRC Enterprise Income Tax Law, and its implementation rules provide that withholding tax rate of 10% will be applicable to dividends payable by PRC companies to non-PRC-resident enterprises unless otherwise exempted or reduced according to treaties or arrangements between the PRC central government and governments of other countries or regions where the non-PRC-resident enterprises are incorporated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any limitation on the ability of our PRC subsidiaries to pay dividends or make other distributions to us could materially and adversely limit our ability to grow, make investments or acquisitions that could be beneficial to our business, pay dividends, or otherwise fund and conduct our business. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be deemed to be a PRC resident enterprise under the Enterprise Income Tax Law, and be subject to the PRC taxation on our worldwide income, which may significantly increase our income tax expenses and materially decrease our profitability.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the PRC Enterprise Income Tax Law, enterprises established outside of China whose &#8220;de facto management bodies&#8221; are located in China are considered to be &#8220;resident enterprises&#8221; and will generally be subject to a uniform 25% corporate income tax on their global income (excluding dividends received from &#8220;resident enterprises&#8221;). In addition, a circular issued by State Administration of Taxation, or the SAT, on April&#160;22, 2009 and amended on January&#160;29, 2014 sets out certain standards for determining whether the &#8220;de facto management body&#8221; of an offshore enterprise funded by Chinese enterprises as controlling shareholders is located in China. Although this circular applies only to offshore enterprises funded by Chinese enterprises as controlling shareholders, rather than those funded by Chinese or foreign individuals or foreign enterprises as controlling shareholders, the determining criteria set forth in the circular may reflect SAT&#8217;s general position on how the &#8220;de facto management body&#8221; test should be applied in determining the tax resident status of offshore enterprises, regardless of how they are funded. Although our company is not funded by Chinese enterprises as controlling shareholders, substantial uncertainties remain as to whether our company or any of our other non-PRC entities will be deemed a PRC resident enterprise for the Enterprise Income Tax purposes. If we or any of our subsidiaries registered outside the PRC are to be deemed a &#8220;resident enterprise&#8221; under the PRC Enterprise Income Tax Law, our income tax expenses may increase significantly, and our profitability could decrease materially. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We face uncertainties in the PRC with respect to indirect transfer of equity interests in our PRC subsidiaries.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The indirect transfer of equity interest in PRC enterprises by a non-resident enterprise, is potentially subject to income tax in China at a rate of 10% on the gain if such transfer is considered not to have a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">commercial purpose and is carried out for tax avoidance. We also face uncertainties as to the reporting and other implications of certain past and future transactions where PRC taxable assets are involved, such as offshore restructuring, sale of the shares in our offshore subsidiaries or investments. Our company may be subject to filing obligations or taxed if our company is transferor in such transactions, and may be subject to withholding obligations if our company is transferee in such transaction. For transfer of shares in our company by investors that are non-PRC resident enterprises, our PRC subsidiaries may be requested to assist in investors&#8217; tax filing in China. As a result, we may be required to expend valuable resources to comply with SAT Circular 7 and SAT Circular 37 or to request the relevant transferors from whom we purchase taxable assets to comply with these publications, or to establish that our company should not be taxed under these publications, which may have a material adverse effect on our financial condition and results of operations. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Failure to comply with PRC regulations regarding the registration requirements for employee stock ownership plans or share option plans may subject the PRC plan participants or us to fines and other legal or administrative sanctions.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Under the applicable regulations and SAFE rules, PRC citizens who participate in an employee stock ownership plan or a stock option plan in an overseas publicly listed company are required to register with SAFE and complete certain other procedures. Pursuant to the rules related to stock options by SAFE, if a PRC resident participates in any stock incentive plan of an overseas publicly listed company, a qualified PRC domestic agent must, among other things, file on behalf of such participant an application with SAFE to conduct the SAFE registration with respect to such stock incentive plan and obtain approval for an annual allowance with respect to the purchase of foreign exchange in connection with the exercise or sale of stock options or stock such participant holds. Such participating PRC residents&#8217; foreign exchange income received from the sale of stock and dividends distributed by the overseas publicly listed company must be fully remitted into a PRC collective foreign currency account opened and managed by the PRC agent before distribution to such participants. We and our PRC resident employees who have been granted stock options or other share-based incentives of ours will be subject to these rules when our company becomes an overseas listed company upon the completion of this offering. If we or our PRC resident participants fail to comply with these regulations, we and/or our PRC resident participants may be subject to fines and legal sanctions. In addition, SAT has issued certain circulars concerning employee share options and restricted shares. Under these circulars, our employees working in China who exercise share options and/or are granted restricted shares in the future will be subject to PRC individual income tax. Our PRC subsidiaries have obligations to file documents related to employee share options and/or restricted shares with tax authorities and to withhold individual income taxes of those employees who exercise their share options. If our employees fail to pay or we fail to withhold their income taxes according to laws and regulations, we may face sanctions imposed by the tax authorities or other PRC government authorities. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conversion of RMB to and from other currency may be subject to governmental control in China</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Currently, the RMB cannot be freely converted into any foreign currency. The PRC government imposes controls on the convertibility of RMB into foreign currencies and, in certain cases, the remittance of currency out of China. Shortages in the availability of foreign currency may restrict the ability of our PRC subsidiaries to remit sufficient foreign currency to pay dividends or other payments to us, or otherwise satisfy their foreign currency dominated obligations. Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments, and expenditures from trade-related transactions, can be made in foreign currencies without prior approval from SAFE by complying with certain procedural requirements. However, for most capital account items, approval from or registration with appropriate government authorities is required where RMB is to be converted into foreign currency and remitted out of China to pay capital expenses such as the repayment of bank loans denominated in foreign currencies. The PRC government may also at its discretion restrict access in the future to foreign currencies for current account transactions. If the foreign exchange control system prevents us from obtaining sufficient foreign currency to satisfy our currency demands, we may not be able to pay dividends in foreign currencies to our shareholders, including holders of the ADSs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Risks relating to the ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">An active trading market for our ordinary shares or the ADSs may not develop and the trading price of the ADSs may be volatile regardless of our operating performance, which could result in substantial losses to you.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Prior to this initial public offering, there has been no public market for our ordinary shares or the ADSs. We have been approved to list the ADSs on the Nasdaq Global Market under the symbol &#8220;ANL.&#8221; Our ordinary shares will not be listed on any exchange or quoted for trading on any over-the-counter trading system. If an active trading market for the ADSs does not develop after this offering, the market price and liquidity of the ADSs will be materially and adversely affected. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The trading price of the ADSs may be volatile and could fluctuate widely due to factors beyond our control. This may happen because of broad market and industry factors, including the performance and fluctuation of the market prices of other companies with business operations located mainly in China that have listed their securities in the United States. The securities of some of these companies have experienced significant volatility since their initial public offerings, including, in some cases, substantial trading price declines. In addition, any negative news or perceptions about inadequate corporate governance practices or fraudulent accounting, corporate structure or matters of other companies with substantial operations in China may also negatively affect the attitudes of investors towards similar companies in general, including us, regardless of whether we have conducted any inappropriate activities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An investor has subscribed for, and has been allocated by the underwriters, an aggregate of 2,173,913 ADSs at the initial public offering price and on the same terms as the other ADSs being offered, representing approximately 87.0% of the total ADSs in this offering, assuming the underwriters do not exercise their option to purchase additional ADSs. Such purchase could reduce the level of trading activities and the liquidity of the ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to market and industry factors, the price and trading volume for the ADSs may be volatile for factors specific to our own operations, including the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the commencement, enrollment or results of our planned and future clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">positive or negative results from, or delays in, testing and clinical trials by us, collaborators or competitors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the loss of any of our key scientific or management personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulatory or legal developments in the United States, China, and other countries; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the success of competitive products or technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">adverse actions taken by regulatory agencies with respect to our clinical trials or manufacturers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in the structure of healthcare payment systems; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes to our relationships with collaborators, manufacturers or suppliers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">announcements concerning our competitors or the pharmaceutical industry in general; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in financial estimates or recommendations by securities analysts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">potential acquisitions, financing, collaborations or other corporate transactions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the trading volume of the ADSs on the Nasdaq; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sales of the ADSs or ordinary shares by us, members of our senior management and directors or our shareholders or the anticipation that such sales may occur in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">general economic, political, and market conditions and overall fluctuations in the financial markets in the United States or China; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">stock market price and volume fluctuations of comparable companies and, in particular, those that operate in the biopharmaceutical industry. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">In addition, the share price of a number of companies involved in initial public offerings, particularly among companies with relatively smaller public floats, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Such rapid and substantial price volatility, including any share price run-up, may be unrelated to our actual or expected operating performance and financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of the ADSs. This volatility may prevent you from being able to sell your securities at or above the price you paid for your securities. If the market price of the ADSs after this offering does not exceed the initial public offering price, you may not realize any return on your investment in us and may lose some or all of your investment.</font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our dual-class share structure with different voting rights will limit your ability to influence corporate matters and could discourage others from pursuing any change of control transactions that holders of our Class A ordinary shares and ADSs may view as beneficial.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">We expect to have a dual-class share structure after the completion of this offering such that our ordinary shares will consist of Class A ordinary shares and Class B ordinary shares. In respect of matters requiring the votes of shareholders, holders of Class A ordinary shares will be entitled to one vote per share, while holders of Class B ordinary shares will be entitled to 15 votes per share based on our proposed dual-class share structure. We will sell Class A ordinary shares represented by the ADSs in this offering. Each Class B ordinary share is convertible into one Class A ordinary share at any time by the holder thereof, while Class A ordinary shares are not convertible into Class B ordinary shares under any circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon the completion of this offering, our founder, Mr. Yang Lu will beneficially own all of our issued Class B ordinary shares. These Class B ordinary shares will constitute approximately 15.3% of our total issued and outstanding share capital immediately after the completion of this offering and 73.1% of the aggregate voting power of our total issued and outstanding share capital due to the disparate voting powers associated with our dual-class share structure, assuming the underwriters do not exercise their over-allotment option. As a result of the dual-class share structure and the concentration of ownership, the holder of our Class B ordinary shares will have considerable influence over matters such as decisions regarding mergers, consolidations and the sale of all or substantially all of our assets, election of directors and other significant corporate actions. They may take actions that are not in the best interest of us or our other shareholders. This concentration of ownership may discourage, delay or prevent a change in control of our company, which could have the effect of depriving our other shareholders of the opportunity to receive a premium for their shares as part of a sale of our company and may reduce the price of the ADSs. This concentrated control will limit your ability to influence corporate matters and could discourage others from pursuing any potential merger, takeover or other change of control transactions that holders of Class A ordinary shares and ADSs may view as beneficial.</font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our dual-class voting structure may render the ADSs representing our Class A ordinary shares ineligible for inclusion in certain stock market indices, and thus adversely affect the trading price and liquidity of the ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We cannot predict whether our dual-class share structure with different voting rights will result in a lower or more volatile market price of the ADSs, adverse publicity, or other adverse consequences. Certain index providers have announced restrictions on including companies with multi-class share structures in certain of their indices. For example, S&amp;P Dow Jones and FTSE Russell have changed their eligibility criteria for inclusion of shares of public companies on certain indices, including the S&amp;P 500, to exclude companies with multiple classes of shares and companies whose public shareholders hold no more than 5% of total voting power from being added to such indices. As a result, our dual-class voting structure may prevent the inclusion of the ADSs representing our Class A ordinary shares in such indices, which could adversely affect the trading price and liquidity of the ADSs representing our Class A ordinary shares. In addition, several shareholder advisory firms have announced their opposition to the use of multiple class structure and our dual-class structure may cause shareholder advisory firms to publish negative commentary about our corporate governance, in which case the market price and liquidity of the ADSs could be adversely affected. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Because we do not have a regular dividend policy yet, you may need to rely on price appreciation of the ADSs for return on your investment.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently intend to retain most, if not all, of our available funds and any future earnings after this offering to fund the development and growth of our business. As a result, we do not expect to pay any cash </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">dividends in the foreseeable future. Therefore, you should not rely on an investment in the ADSs as a source for any future dividend income. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors has complete discretion as to whether to distribute dividends, subject to certain restrictions under Cayman Islands law, namely that our company may only pay dividends out of profits or share premium account, and provided always that in no circumstances may a dividend be paid out of share premium if this would result in our company being unable to pay its debts as they fall due in the ordinary course of business. In addition, our shareholders may by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended by our board of directors. Even if our board of directors decides to declare and pay dividends, the timing, amount, and form of future dividends, if any, will depend on our future results of operations and cash flow, our capital requirements and surplus, the amount of distributions, if any, received by us from our subsidiaries, our financial condition, contractual restrictions, and other factors deemed relevant by our board of directors. Accordingly, the return on your investment in the ADSs will likely depend entirely upon any future price appreciation of the ADSs. There is no guarantee that the ADSs will appreciate in value after this offering or even maintain the price at which you purchased the ADSs. You may not realize a return on your investment in the ADSs and you may even lose your entire investment in the ADSs. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Because our initial public offering price is substantially higher than our net tangible book value per share, you will experience immediate and substantial dilution.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If you purchase ADSs in this offering, you will pay more for your ADSs than the amount paid by existing shareholders for their Class A ordinary shares on a per ADS basis. As a result, you will experience immediate and substantial dilution of US$20.06 per ADS, representing the difference between (i)&#160;our pro&#160;forma as adjusted net tangible book value per ADS as of December&#160;31, 2021, after giving effect to this offering and the concurrent private placement, and (ii)&#160;the initial public offering price per share of US$23.00 per ADS. In addition, you may experience further dilution to the extent that our Class A ordinary shares are issued upon the exercise of share options. Substantially all of the Class A ordinary shares issuable upon the exercise of currently outstanding share options will be issued at a purchase price on a per ADS basis that is less than the initial public offering price per ADS in this offering. See &#8220;Dilution&#8221; for a more complete description of how the value of your investment in the ADSs will be diluted upon the completion of this offering and the concurrent private placement. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If securities or industry analysts do not publish research or reports about our business, or if they adversely change their recommendations regarding the ADSs, the market price for the ADSs and trading volume could decline.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The trading market for the ADSs will be influenced by research or reports that industry or securities analysts publish about our business. If one or more analysts who cover us downgrade the ADSs, the market price for the ADSs would likely decline. If one or more of these analysts cease to cover us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which, in turn, could cause the market price or trading volume for the ADSs to decline. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our post-offering memorandum and articles of association contain anti-takeover provisions that could have a material adverse effect on the rights of holders of our ordinary shares and ADSs.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will adopt an amended and restated memorandum and articles of association that will become effective immediately prior to completion of this offering. Our new memorandum and articles of association contain provisions that may discourage, delay or prevent a change of control of our company, including a provision that entitles each Class B ordinary share to 15 votes in respect of all matters subject to a shareholders&#8217; vote and a provision that authorizes our board of directors to issue additional ordinary shares from time to time as our board of directors may determine, to the extent of available authorized but unissued shares. These provisions could have the effect of depriving our shareholders of an opportunity to sell their shares at a premium over prevailing market prices by discouraging third parties form seeking to obtain control of our company in a tender offer or similar transaction.</font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Techniques employed by short sellers may drive down the market price of the ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Short selling is the practice of selling securities that the seller does not own but rather has borrowed from a third party with the intention of buying identical securities back at a later date to return to the lender. The </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">short seller hopes to profit from a decline in the value of the securities between the sale of the borrowed securities and the purchase of the replacement shares, as the short seller expects to pay less in that purchase than it received in the sale. As it is in the short seller&#8217;s best interests for the price of the stock to decline, many short sellers publish, or arrange for the publication of, negative opinions regarding the relevant issuer and its business prospects in order to create negative market momentum and generate profits for themselves after selling a stock short. These short attacks have, in the past, led to selling of shares in the market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Public companies, including those having a substantial portion of their operations in China have been the subject of short selling. Much of the scrutiny and negative publicity has centered on allegations of a lack of effective internal control over financial reporting resulting in financial and accounting irregularities and mistakes, inadequate corporate governance policies or a lack of adherence thereto and, in many cases, allegations of fraud. As a result, many of these companies are now conducting internal and external investigations into the allegations and, in the interim, are subject to shareholder lawsuits and/or SEC enforcement actions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">It is not clear what effect such negative publicity could have on us. If we were to become the subject of any unfavorable allegations, whether such allegations are proven to be true or untrue, we could have to expend significant amount of resources to investigate such allegations and/or defend ourselves. While we would strongly defend against any such short seller attacks, we may be constrained in the manner in which it can proceed against the relevant short seller by principles of freedom of speech, applicable state law or issues of commercial confidentiality. Such a situation could be costly and time-consuming, and could distract our management from growing our business. Even if such allegations are ultimately proven to be groundless, allegations against us could severely impact our business operations and stockholders&#8217; equity, and any investment in the ADSs could be greatly reduced or rendered worthless. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The sale or availability for sale, or perceived sale or availability for sale, of substantial amounts of the ADSs could adversely affect their market price.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sales of substantial amounts of the ADSs in the public market after the completion of this offering, or the perception that these sales could occur, could adversely affect the market price of the ADSs and could materially impair our ability to raise capital through equity offerings in the future. The ADSs sold in this offering will be freely tradable without restriction or further registration under the Securities Act of 1933, as amended, or the Securities Act, and shares held by our existing shareholders may also be sold in the public market in the future subject to the restrictions in Rule&#160;144 and Rule&#160;701 under the Securities Act and the applicable lock-up agreements. There will be 2,500,000 ADSs (equivalent to 7,500,000 Class A ordinary shares) outstanding immediately after this offering, we and each of our officers, directors who beneficially own our shares, holders of share-based awards, approximately 69.4% of our existing shareholders (representing over 85.7% of our total outstanding and issued shares on an as-converted basis prior to this offering) and Nippon Kayaku have agreed not to sell any of our ordinary shares or the ADSs or similar securities for 180&#160;days after the date of the underwriting agreement without the prior written consent of the representatives of the underwriters, subject to certain exceptions. However, the underwriters may release these securities from these restrictions at any time, subject to applicable regulations of the Financial Industry Regulatory Authority, or FINRA. We cannot predict what effect, if any, market sales of securities held by our significant shareholders or any other shareholder or the availability of these securities for future sale will have on the market price of the ADSs. See &#8220;Underwriting&#8221; and &#8220;Shares Eligible for Future Sale&#8221; for a more detailed description of the restrictions on selling our securities after this offering. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADS holders do not have the same rights as our shareholders.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ADS holders do not have the same rights as our shareholders. For example, ADS holders may not attend shareholders&#8217; meetings or directly exercise the voting rights attaching to the Class A ordinary shares underlying their ADSs. ADS holders may vote only by instructing the depositary to vote on their behalf. If we request the depositary to solicit your voting instructions (and we are not required to do so), the depositary will notify you of a shareholders&#8217; meeting and send or make voting materials available to you. Those materials will describe the matters to be voted on and explain how ADS holders may instruct the depositary how to vote. For instructions to be valid, they must reach the depositary by a date set by the depositary. The depositary will try, as far as practical, subject to the laws of the Cayman Islands and the provisions of our articles of association </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or similar documents, to vote or to have its agents vote the deposited common shares as instructed by ADS holders. If we do not request the depositary to solicit your voting instructions, you can still send voting instructions, and, in that case, the depositary may try to vote as you instruct, but it is not required to do so. Except by instructing the depositary as described above, you will not be able to exercise voting rights unless you surrender the ADSs and withdraw the Class A ordinary shares. However, you may not know about the meeting enough in advance to withdraw the Class A ordinary shares. We cannot assure you that you will receive the voting materials in time to ensure that you can instruct the depositary to vote your Class A ordinary shares. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. This means that you may not be able to exercise voting rights and there may be nothing you can do if your Class A ordinary shares are not voted as you requested. In addition, ADS holders have no right to call a shareholders&#8217; meeting.</font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Owners or holders of the ADSs have limited recourse if we or the depositary fail to meet our respective obligations under the deposit agreement.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement expressly limits the obligations and liability of us and the depositary. For example, the depositary is not liable if any of us or our respective controlling persons or agents is prevented or forbidden from, or subjected to any civil or criminal penalty or restraint on account of, or delayed in, doing or performing any act or thing required by the terms of the deposit agreement and any ADS, by reason of any provision of any present or future law or regulation of the United States or any state thereof, the Cayman Islands or any other country, or of any other governmental authority or regulatory authority or stock exchange, or on account of the possible criminal or civil penalties or restraint, or by reason of any provision, present or future, of our memorandum and articles of association or any provision of or governing any deposited securities, or by reason of any act of God or war or other circumstances beyond its control (including, without limitation, nationalization, expropriation, currency restrictions, work stoppage, strikes, civil unrest, revolutions, rebellions, explosions, and computer failure). See &#8220;Description of American Depositary Shares&#8221; for more information. In addition, the depositary and any of its agents also disclaim any liability for (i)&#160;any failure to carry out any instructions to vote, the manner in which any vote is cast or the effect of any vote or failure to determine that any distribution or action may be lawful or reasonably practicable or for allowing any rights to lapse in accordance with the provisions of the deposit agreement, (ii)&#160;the failure or timeliness of any notice from us, the content of any information submitted to it by us for distribution to you or for any inaccuracy of any translation thereof, (iii)&#160;any investment risk associated with the acquisition of an interest in the deposited securities, the validity or worth of the deposited securities or the credit-worthiness of any third party, (iv)&#160;any tax consequences that may result from ownership of ADSs, ordinary shares or deposited securities, or (v)&#160;any acts or omissions made by a successor depositary whether in connection with a previous act or omission of the depositary or in connection with any matter arising wholly after the removal or resignation of the depositary, provided that in connection with the issue out of which such potential liability arises the depositary performed its obligations without gross negligence or willful misconduct while it acted as depositary. These provisions of the deposit agreement will limit the ability of owners or holders of the ADSs to obtain recourse if we or the depositary fail to meet our respective obligations under the deposit agreement. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">You must rely on the judgment of our management as to the use of the net proceeds from this offering and the concurrent private placement, and such use may not produce income or increase the price of our ordinary shares and/or ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our management will have considerable discretion in the application of the net proceeds received by us. You will not have the opportunity, as part of your investment decision, to assess whether proceeds are being used appropriately. The net proceeds may be used for corporate purposes that do not improve our efforts to achieve or maintain profitability or increase the ADS price. The net proceeds from this offering and the concurrent private placement may be placed in investments that do not produce income or that lose value. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">You may experience dilution of your holdings due to the inability to participate in rights offerings.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may from time to time distribute rights to our shareholders, including rights to acquire our securities. However, we cannot make rights available to you in the United States unless we register both the rights and the securities to which the rights relate under the Securities Act or an exemption from the registration requirements is available. Under the deposit agreement, the depositary will not make rights available to you unless both the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">rights and the underlying securities to be distributed to ADS holders are either registered under the Securities Act or exempt from registration under the Securities Act. We are under no obligation to file a registration statement with respect to any such rights or securities or to endeavor to cause such a registration statement to be declared effective and we may not be able to establish a necessary exemption from registration under the Securities Act. Accordingly, you may be unable to participate in our rights offerings and may experience dilution in your holdings. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As a holder of ADSs, you may not receive distributions on the Class A ordinary shares represented by the ADSs or any value for them if it is illegal or impractical to make them available to holders of ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of the deposit agreement, the Depositary has agreed to pay to you the cash dividends or other distributions it or the custodian receives on the Class A ordinary shares or other deposited securities after deducting its fees and expenses and any taxes or other governmental charges. However, in accordance with the limitations set forth in the deposit agreement, it may be unlawful or impractical to make a distribution other than cash available to holders of ADSs. We have no obligation to take any other action to permit the distribution of the ADSs, Class A ordinary shares, rights or anything else to holders of the ADSs. This means that, as a holder of ADSs, you may not receive the distributions we make on the Class A ordinary shares or any value from them if it is unlawful or impractical to make them available to you. These restrictions may have a material adverse effect on the value of your ADSs. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">You may be subject to limitations on transfer of your ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Your ADSs are transferable on the books of the depositary. However, the depositary may close its books at any time or from time to time when it deems it expedient in connection with the performance of its duties. The depositary may also close its books in emergencies, and on weekends and public holidays. The depositary may refuse to deliver, transfer or register transfers of the ADSs generally when our share register or the books of the depositary are closed, or at any time if we or the depositary thinks it is advisable to do so because of any requirement of law or of any government or governmental body, or under any provision of the deposit agreement, or for any other reason. In addition, ADS holders may not be able to cancel their ADSs and withdraw the underlying Class A ordinary shares when they owe money for fees, taxes and similar charges. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">You may experience difficulties in effecting service of legal process, enforcing foreign judgments, or bringing actions in China against us or our management named in the prospectus based on foreign laws.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are a company incorporated under the laws of the Cayman Islands and, to date, conduct the majority of our operations in China and a substantial portion of our assets are located in mainland China. In addition, many of our directors and executive officers reside within China for a significant portion of the time. As a result, it may be difficult for you to effect service of process upon us or those persons inside China. It may also be difficult for you to enforce in U.S. courts judgments obtained in U.S. courts based on the civil liability provisions of the U.S. federal securities laws against us and our officers and directors residing in China. In addition, there is uncertainty as to whether the courts of the Cayman Islands or the PRC would recognize or enforce judgments of U.S. courts against us or such persons predicated upon the civil liability provisions of the securities laws of the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The recognition and enforcement of foreign judgments are provided for under the PRC Civil Procedures Law. PRC courts may recognize and enforce foreign judgments in accordance with the requirements of the PRC Civil Procedures Law based either on treaties between China and the country or region where the judgment is made or on principles of reciprocity between jurisdictions. China does not have any treaties or other forms of written arrangement with the United States that provide for the reciprocal recognition and enforcement of foreign judgments. In addition, according to the PRC Civil Procedures Law, the PRC courts will not enforce a foreign judgment against us or our directors and officers if they decide that the judgment violates the basic principles of PRC laws or national sovereignty, security, or the public interest. As a result, it is uncertain whether and on what basis a PRC court would enforce a judgment rendered by a court in the United States. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">You may face difficulties in protecting your interests, and your ability to protect your rights through U.S. courts may be limited, because we are incorporated under Cayman Islands law.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are an exempted company incorporated under the laws of the Cayman Islands. Our corporate affairs are governed by, among other things, our memorandum and articles of association, the Companies Act (As </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Revised) of the Cayman Islands, or the Companies Act, and the common law of the Cayman Islands. The rights of shareholders to take action against our directors, actions by our minority shareholders and the fiduciary duties of our directors to us under the Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands as well as from the common law of England, the decisions of whose courts are of persuasive authority, but are not binding, on a court in the Cayman Islands. The rights of our shareholders and the fiduciary duties of our directors under Cayman Islands law are not as clearly established as they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a less developed body of securities laws than the United States. Some U.S. states, such as Delaware, have more fully developed and judicially interpreted bodies of corporate law than the Cayman Islands. In addition, the Cayman Islands companies may not have the standing to initiate a shareholder derivative action in a federal court of the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Shareholders of Cayman Islands companies like us have no general rights under the Cayman Islands law to inspect corporate records, or to obtain copies of lists of shareholders of these companies. Our directors have discretion under our post-offering memorandum and articles of association to determine whether or not, and under what conditions, our corporate records may be inspected by our shareholders, but are not obliged to make them available to our shareholders. This may make it more difficult for you to obtain the information needed to establish any facts necessary for a shareholder motion or to solicit proxies from other shareholders in connection with a proxy contest. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain corporate governance practices in the Cayman Islands, which is our home country, differ significantly from requirements for companies incorporated in other jurisdictions such as the United States. We may in the future rely on home country practice with respect to our corporate governance after we complete this offering. If we choose to follow home country practice in the future, our shareholders may be afforded less protection than they otherwise would under rules and regulations applicable to U.S. domestic issuers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a result of all of the above, public shareholders may have more difficulty in protecting their interests in the face of actions taken by our management, members of our board of directors or our controlling shareholders than they would as public shareholders of a company incorporated in the United States. For a discussion of significant differences between the provisions of the Companies Act and the laws applicable to companies incorporated in the United States and their shareholders, see &#8220;Description of Share Capital&#8201;&#8212;&#8201;Differences in corporate law.&#8221; </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We are a foreign private issuer within the meaning of the rules under the Exchange Act, and as such we are exempt from certain provisions applicable to U.S. domestic public companies.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because we qualify as a foreign private issuer under the Exchange Act, we are exempt from certain provisions of the securities rules and regulations in the United States that are applicable to U.S. domestic issuers, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q or current reports on Form 8-K; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the sections of the Exchange Act regulating the solicitation of proxies, consents, or authorizations in respect of a security registered under the Exchange Act; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the sections of the Exchange Act requiring insiders to file public reports of their stock ownership and trading activities and liability for insiders who profit from trades made in a short period of time; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the selective disclosure rules by issuers of material nonpublic information under Regulation&#160;FD; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">certain audit committee independence requirements in Rule&#160;10A-3 of the Exchange Act. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will be required to file an annual report on Form 20-F within four&#160;months of the end of each fiscal year. In addition, we intend to publish our results on a quarterly basis as press releases, distributed pursuant to the rules and regulations of the Nasdaq Stock Market. Press releases relating to financial results and material events will also be furnished to the SEC on Form 6-K. However, the information we are required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">U.S. domestic issuers. As a result, you may not be afforded the same protections or information that would be made available to you were you investing in a U.S. domestic issuer. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As a foreign private issuer, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from the Nasdaq corporate governance listing standards. These practices may afford less protection to shareholders than they would enjoy if we complied fully with the Nasdaq corporate governance listing standards.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Nasdaq permits a foreign private issuer like us to follow the corporate governance practices of its home country. Certain corporate governance practices in the Cayman Islands, which is our home country, may differ significantly from the Nasdaq corporate governance listing standards. For instance, we are not required to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">have a majority of the board be independent (although all of the members of the audit committee must be independent under the Exchange Act); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">have a compensation committee or a nominations or corporate governance committee consisting entirely of independent directors; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">have regularly scheduled executive sessions with only independent directors each year. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We may rely on home country practice with respect to our corporate governance after we complete this offering. If we choose to follow home country practice in the future, our shareholders may be afforded less protection than they otherwise would enjoy under the Nasdaq corporate governance listing standards applicable to U.S. domestic issuers. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We are an emerging growth company within the meaning of the Securities Act and may take advantage of certain reduced reporting requirements.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a company with less than US$1.235&#160;billion in revenues for our last fiscal year, we qualify as an &#8220;emerging growth company&#8221; pursuant to the JOBS Act. Therefore, we have elected to take advantage of specified reduced reporting and other requirements that are otherwise applicable generally to public companies and acknowledge such election is irrevocable pursuant to Section&#160;107 of the JOBS Act. These provisions include exemption from the auditor attestation requirement under Section&#160;404 of the Sarbanes-Oxley Act of 2002, or Section&#160;404, in the assessment of the emerging growth company&#8217;s internal control over financial reporting and permission to delay adopting new or revised accounting standards until such time as those standards apply to private companies. As a result, if we elect not to comply with such reporting and other requirements, in particular the auditor attestation requirements, our investors may not have access to certain information they may deem important. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The JOBS Act also provides that an emerging growth company does not need to comply with any new or revised financial accounting standards until such date that a private company is otherwise required to comply with such new or revised accounting standards. We have elected to take advantage of the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies. As a result, our results of operations and financial statements may not be comparable to the results of operations and financial statements of other companies that have adopted the new or revised accounting standards. If we cease to be an emerging growth company, we will no longer be able to take advantage of these exemptions or the extended transition period for complying with new or revised accounting standards. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The deposit agreement provides that the United States District Court for the Southern District of New York (or, if the United States District Court for the Southern District of New York lacks subject matter jurisdiction over a particular dispute, the state courts in New York County, New York) shall have exclusive jurisdiction over any suit, action or proceeding arising out of or relating in any way to the ADSs or the deposit agreement, which could limit the ability of owners and holders of the ADSs or other securities to obtain a favorable judicial forum for disputes with us, our directors and officers, the depositary, and potentially others.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement provides that the United States District Court for the Southern District of New York (or, if the United States District Court for the Southern District of New York lacks subject matter </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">jurisdiction over a particular dispute, the state courts in New York County, New York) shall have exclusive jurisdiction over any suit, action or proceeding against or involving us or the depositary, arising out of or relating in any way to the deposit agreement or the transactions contemplated thereby or by virtue of owning the ADSs. The enforceability of similar federal court choice of forum provisions has been challenged in legal proceedings in the United States, and it is possible that a court could find this type of provision to be inapplicable or unenforceable. If a court were to find the federal choice of forum provision contained in the deposit agreement to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions. If upheld, the forum selection provision in the deposit agreement may limit a security-holder&#8217;s ability to bring a claim against us, our directors and officers, the depositary, and potentially others in his or her preferred judicial forum, and this limitation may result in increased costs for investors to bring lawsuits and discourage such lawsuits. Owners and holders of the ADSs will not be deemed to have waived our compliance with the federal securities laws and the regulations promulgated thereunder pursuant to the exclusive forum provision in the deposit agreement. In addition, the forum selection provision of the deposit agreement does not affect the right of an ADS holder or the depositary to require any claim against us, including a federal securities law claim, to be submitted to arbitration or to commence an action in any court in aid of that arbitration provision, or to enter judgment upon or enforce any arbitration award. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADSs holders may not be entitled to a jury trial with respect to claims arising under the deposit agreement, which could result in less favorable outcomes to the plaintiff(s) in any such action.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement governing the ADSs representing our Class A ordinary shares provides that, to the fullest extent permitted by law, ADS holders waive the right to a jury trial of any claim that they may have against us or the depositary arising out of or relating to our Class A ordinary shares, the ADSs or the deposit agreement, including any claim under the U.S. federal securities laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable based on the facts and circumstances of that case in accordance with the applicable state and federal law. To our knowledge, the enforceability of a contractual pre-dispute jury trial waiver in connection with claims arising under the federal securities laws has not been finally adjudicated by the United States Supreme Court. However, we believe that a contractual pre-dispute jury trial waiver provision is generally enforceable, including under the laws of the State of New York, which govern the deposit agreement, by a federal or state court in the City of New York, which has nonexclusive jurisdiction over matters arising under the deposit agreement. In determining whether to enforce a contractual pre-dispute jury trial waiver provision, courts will generally consider whether a party knowingly, intelligently, and voluntarily waives the right to a jury trial. We believe that this is the case with respect to the deposit agreement and the ADSs. It is advisable that you consult legal counsel regarding the jury waiver provision before entering into the deposit agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you or any other owners or holders of ADSs bring a claim against us or the depositary in connection with matters arising under the deposit agreement or the ADSs, including claims under federal securities laws, you or such other holder or beneficial owner may not be entitled to a jury trial with respect to such claims, which may have the effect of limiting and discouraging lawsuits against us or the depositary. If a lawsuit is brought against us or the depositary under the deposit agreement, it may be heard only by a judge or justice of the applicable trial court, which would be conducted according to different civil procedures and may result in different outcomes than a trial by jury would have had, including results that could be less favorable to the plaintiff(s) in any such action. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Nevertheless, if this jury trial waiver provision is not permitted by applicable law, an action could proceed under the terms of the deposit agreement with a jury trial. The deposit agreement also provides that ADSs holders and the depositary have the right to elect to have any claim against us arising out of or relating to our Class A ordinary shares, ADSs, ADRs or the deposit agreement settled by arbitration in New York, New York rather than in a court of law, and to have any judgment rendered by the arbitrators entered in any court having jurisdiction. The arbitral tribunal in any such arbitration would not have the authority to award any consequential, special, or punitive damages or other damages not measured by the prevailing party&#8217;s actual damages and may not make any ruling, finding or award that does not conform to the provisions of the deposit agreement. The deposit agreement does not give us the right to require that any claim, whether brought </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">by us or against us, be arbitrated. The optional arbitration provision does not apply to claims under federal securities laws or claims other than in connection with this offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No condition, stipulation, or provision of the deposit agreement or ADSs serves as a waiver by any holder or beneficial owner of ADSs or by us or the depositary of compliance with any substantive provision of the U.S. federal securities laws and the rules and regulations promulgated thereunder. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The deposit agreement may be amended or terminated without your consent.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We and the depositary may amend or terminate the deposit agreement without your consent. Such amendment or termination may be done in favor of our company. Holders of the ADSs, subject to the terms of the deposit agreement, will receive notice in the event of an amendment that prejudices a substantial existing right or a termination. If you continue to hold your ADSs after an amendment to the deposit agreement, you agree to be bound by the deposit agreement as amended. The deposit agreement may be terminated at any time upon a prior written notice. Upon the termination of the deposit agreement, our company will be discharged from all obligations under the deposit agreement, except for our obligations to the depositary thereunder. See &#8220;Description of American Depositary Shares&#8221; for more information. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our post-offering memorandum and articles of association contain anti-takeover provisions that could have a material adverse effect on the rights of holders of our ordinary shares and ADSs.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our memorandum and articles of association contain certain provisions that could limit the ability of others to acquire control of our company and a provision that grants authority to our board of directors to establish from time to time one or more series of preferred shares without action by our shareholders and to determine, with respect to any series of preferred shares, the terms and rights of that series. These provisions could have the effect of depriving our shareholders of the opportunity to sell their shares at a premium over the prevailing market price by discouraging third parties from seeking to obtain control of our company in a tender offer or similar transactions. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We will be a &#8220;controlled company&#8221; within the meaning of the Nasdaq Stock Market listing rules and, as a result, may rely on exemptions from certain corporate governance requirements that provide protection to shareholders of other companies.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will be a &#8220;controlled company&#8221; as defined under the Nasdaq Stock Market listing rules because Mr.&#160;Yang Lu, our founder, will continue to control more than 50% of our total voting power immediately after the completion of this offering and the concurrent private placement. Pursuant to our post-offering memorandum and articles of association, an ordinary resolution to be passed at a shareholders&#8217; meeting requires the affirmative vote of a simple majority of the votes attaching to the ordinary shares cast at a meeting, while a special resolution requires the affirmative vote of no less than two-thirds of the votes cast attaching to the outstanding and issued ordinary shares cast at a meeting. A special resolution will be required for important matters such as making changes to our post-offering memorandum and articles of association. As a result, Mr. Yang Lu will have the ability to control or significantly influence the outcome of matters requiring approval by shareholders. In addition, for so long as we remain a controlled company under that definition, we are permitted to elect to rely on, and may rely on, certain exemptions from corporate governance rules, including an exemption from the rule that a majority of our board of directors must be independent directors. We may also rely on the exemption available for foreign private issuers to follow our home country governance practices. See &#8220;&#8212; Risks Related to the ADSs &#8212; As a foreign private issuer, we are permitted to adopt certain home country practices in relation to corporate governance matters that differ significantly from the Nasdaq corporate governance listing standards. These practices may afford less protection to shareholders than they would enjoy if we complied fully with the Nasdaq corporate governance listing standards&#8221; As a result, you will not have the same protection afforded to shareholders of companies that are subject to these corporate governance requirements.</font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We may be classified as a passive foreign investment company, which could result in adverse U.S. federal income tax consequences to U.S. investors in ADSs or ordinary shares.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based on current estimates of our gross income and the value of our gross assets (including goodwill) and the manner in which we conduct our business, we do not expect to be a passive foreign investment company </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(&#8220;PFIC&#8221;) for U.S. federal income tax purposes for the taxable year ending December 31, 2023. However, because PFIC status depends on the composition of a company&#8217;s income and assets and the market value of its assets from time to time, there can be no assurance that we will not be a PFIC for any taxable year.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A non-U.S. corporation is a PFIC for U.S. federal income tax purposes for any taxable year in which (after taking into account the income and assets of subsidiaries in which it owns at least a 25% interest by value), (i)&#160;at least 75% of its gross income is &#8220;passive&#8221; income, such as interest and income from financial investments (the &#8220;income test&#8221;) or (ii)&#160;at least 50% of the average value of its assets (generally determined on a quarterly basis) consists of assets that produce or are held to produce passive income (the &#8220;asset test&#8221;). For purposes of the asset test, any cash, and cash equivalents (such as bank deposits) will count as passive assets, and goodwill should be treated as an active asset to the extent associated with activities that produce or intended to produce active income. In determining the average&#160;percentage value of our gross assets, the aggregate value of our assets will generally be deemed to be equal to our market capitalization (determined by the sum of the aggregate value of our outstanding equity) plus our liabilities. With certain exceptions, we do not currently generate any income from our primary business, and our gross income is currently comprised primarily of interest and other investment income (which is passive) and governmental grants and the option grant fee from Nippon Kayaku (the &#8220;Option Grant Fee&#8221;) (which are both likely to be active income). Therefore, our PFIC status under the income test for any taxable year in which we do not generate significant income from our primary business, including the current taxable year, will likely depend on the relative amounts of government grants and the Option Grant Fee against the amounts of interest and other passive income we earn. The receipt of governmental grants is subject to various conditions and there can be no assurance that we will continue to receive governmental grants in future taxable years or as to the amount of governmental grants that we will receive in any taxable year. Additionally, the Option Grant Fee is not a reoccurring payment in future taxable years and is subject to repayment if certain conditions under the Nippon Kayaku Agreement are not satisfied. We cannot assure you that such conditions under the Nippon Kayaku Agreement will be satisfied and that the option grant fee will not be subject to repayment to Nippon Kayaku. Further, we will hold a substantial amount of cash and cash equivalents following the offering and while we continue to do so, our PFIC status for any taxable year will depend on the value of our goodwill. The value of our goodwill may be determined, in large part, by reference to the market price of our ADSs, which is likely to be volatile given the nature of our business and the current market conditions. Therefore, we could be a PFIC for any future taxable year if our market capitalization were to decrease significantly while we hold substantial cash and cash equivalents, or if the gross income that we and our subsidiaries earn from investing the portion of cash raised in this offering and the concurrent private placement is substantial in comparison with the gross income from our business operation. Accordingly, we cannot assure you that we will not become a PFIC for the current or any future taxable year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we were treated as a PFIC for any taxable year, then U.S. investors could be subject to adverse U.S. federal income tax consequences (regardless of whether we continue to be a PFIC), including increased tax liability on disposition gains and certain &#8220;excess distributions&#8221; and additional reporting requirements. See &#8220;Taxation&#8201;&#8212;&#8201;United States federal income tax considerations&#8201;&#8212;&#8201;Passive foreign investment company&#8221; for further information. U.S. investors should consult their tax advisers regarding our PFIC status for any taxable year and the potential application of the PFIC rules to an investment in ADSs or ordinary shares including the availability and the advisability of making certain elections under the PFIC rules. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">We expect to incur increased costs as a result of being a public company, and will incur further increased costs after we cease to qualify as an &#8220;emerging growth company.&#8221;</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will become a public company after this offering, and expect to incur significant legal, accounting, and other expenses that we would not incur as a private company. The Sarbanes-Oxley Act of 2002, as well as rules subsequently implemented by the SEC and the Nasdaq Stock Market, impose various requirements on the corporate governance practices of public companies. We expect these rules and regulations to increase our legal and financial compliance costs and to make some corporate activities more time-consuming and costly. Especially after we are no longer an emerging growth company, we expect to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002 and the other rules and regulations of the SEC. For example, as a result of becoming a public company, we need to increase the number of independent directors and adopt policies regarding internal controls and disclosure controls and procedures. We also expect that operating as a public </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:452pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">company will make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits and coverage or incur substantially higher costs to obtain the same or similar coverage. In addition, we will incur additional costs associated with our public company reporting requirements. It may also be more difficult for us to find qualified persons to serve on our board of directors or as executive officers. We are currently evaluating and monitoring developments with respect to these rules and regulations, and we cannot predict or estimate with any degree of certainty the amount of additional costs we may incur or the timing of such costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the past, shareholders of a public company often brought securities class action suits against the company following periods of instability in the market price of that company&#8217;s securities. If we were involved in a class action suit, it could divert a significant amount of our management&#8217;s attention and other resources from our business and operations, which could harm our results of operations and require us to incur significant expenses to defend the suit. Any such class action suit, whether or not successful, could harm our reputation and restrict our ability to raise capital in the future. In addition, if a claim is successfully made against us, we may be required to pay significant damages.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">84</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSNRF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus contains forward-looking statements that reflect our current expectations and views of future events. The forward-looking statements are contained principally in the sections entitled &#8220;Prospectus Summary,&#8221; &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Business.&#8221; Known and unknown risks, uncertainties, and other factors, including those listed under &#8220;Risk Factors,&#8221; may cause our actual results, performance, or achievements to be materially different from those expressed or implied by the forward-looking statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You can identify some of these forward-looking statements by words or phrases, such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;aim,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;is/are likely to,&#8221; &#8220;potential,&#8221; &#8220;continue&#8221; or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events that we believe may affect our financial condition, results of operations, business strategy, and financial needs. These forward-looking statements include statements relating to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our business strategies and plans to achieve these strategies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing, progress, and results of preclinical studies, and clinical trials for drug candidates we may develop; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the possibility to obtain the relevant requisite regulatory approvals of our drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the feasibility to successfully commercialize our drug candidates in a timely manner; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes in competitive conditions and the feasibility to compete under these conditions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the size of the market opportunity for our drug candidates, including our estimates of the number of patients who suffer from the diseases we are targeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the likelihood to maintain the collaboration with licensors, and establish or maintain future collaborations or strategic relationships; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the feasibility to obtain, and negotiate favorable terms of, any collaboration, licensing or other arrangements that may be necessary or desirable to develop, manufacture or commercialize our drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">changes to the political and regulatory environment in the industry and markets in which we operate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">effects of the global financial markets and economic crisis; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">change or volatility in interest rates, foreign exchange rates, equity prices, volumes, operations, margins, risk management, and overall market trends; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our expectations regarding the period during which we will qualify as an emerging growth company under the JOBS Act; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our anticipated use of our existing resources and the proceeds from this offering and the concurrent private placement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These forward-looking statements involve various risks and uncertainties. Although we believe that our expectations expressed in these forward-looking statements are reasonable, our expectations may later be found to be incorrect. Our actual results could be materially different from our expectations. Important risks and factors that could cause our actual results to be materially different from our expectations are generally set forth in &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; &#8220;Business,&#8221; &#8220;Regulation,&#8221; and other sections in this prospectus. You should read thoroughly this prospectus and the documents that we refer to with the understanding that our actual future results may be materially different from and worse than what we expect. We qualify all of our forward-looking statements by these cautionary statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus contains certain data and information that we obtained from various government and private publications. Statistical data in these publications also include projections based on a number of assumptions. Our industry may not grow at the rate projected by market data, or at all. Failure of this market to grow at the projected rate may have a material and adverse effect on our business and the market price of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">85</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:476pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the ADSs. In addition, the rapidly evolving nature of this industry results in significant uncertainties for any projections or estimates relating to the growth prospects or future condition of our market. Furthermore, if any one or more of the assumptions underlying the market data are later found to be incorrect, actual results may differ from the projections based on these assumptions. You should not place undue reliance on these forward-looking statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The forward-looking statements made in this prospectus relate only to events or information as of the date on which the statements are made in this prospectus. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this prospectus and the documents that we refer to in this prospectus and have filed as exhibits to the registration statement, of which this prospectus is a part, completely and with the understanding that our actual future results may be materially different from what we expect. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">86</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUOP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:160pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">USE OF PROCEEDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We estimate that we will receive net proceeds from this offering of approximately US$54.2 million, or approximately US$62.3 million if the underwriters exercise their option to purchase additional ADSs, after deducting underwriting discounts and commissions and the estimated offering expenses payable by us, as well as net proceeds of US$35.7 million from the concurrent private placement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The primary purposes of this offering are to create a public market for our Class A ordinary shares for the benefit of all shareholders, retain talented employees by providing them with equity incentives, and obtain additional capital. We plan to use the net proceeds of this offering and the concurrent private placement as follows: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approximately US$46.7 million to fund the ongoing registrational trial for AN2025 (buparlisib) and the milestone payments in connection with development of AN2025 and the commercial launch, if approved, of AN2025;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approximately US$29.7 million to fund the development of our pipeline programs; and</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approximately US$13.5 million for our general working capital and general corporate purposes.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:6pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on our current operating plan, we believe that the net proceeds from this offering, together with our existing cash and cash equivalents, will enable us to fund our planned operating expenses and capital expenditures through the next 12 months. The foregoing represents our current intentions based upon our present plans and business conditions to use and allocate the net proceeds of this offering and the concurrent private placement. Our management, however, will have broad discretion in the application of our net proceeds from this offering and the concurrent private placement, and investors will be relying on the judgment of our management regarding the application of these proceeds. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks relating to the ADSs&#8201;&#8212;&#8201;You must rely on the judgment of our management as to the use of the net proceeds from this offering and the concurrent private placement, and such use may not produce income or increase the price of our ordinary shares and/or ADSs.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We intend to invest the net proceeds in short- and intermediate-term interest-bearing obligations, investment-grade instruments, certificates of deposit or guaranteed obligations of the U.S. government, pending their use as described above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:6pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In using the proceeds of this offering and the concurrent private placement, we are permitted under PRC laws and regulations as an offshore holding company to provide funding to our PRC subsidiaries only through loans or capital contributions, subject to satisfaction of applicable government registration and approval requirements. We cannot assure you that we will be able to obtain these government registrations or approvals on a timely basis, or at all. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks relating to our operation in the People&#8217;s Republic of China&#8201;&#8212;&#8201;PRC regulation of loans to, and direct investments in, PRC entities by offshore holding companies may delay or prevent us from making loans or additional capital contributions to our PRC operating subsidiaries and thereby prevent us from funding our business.&#8221; </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">87</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDIPO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:352pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DIVIDEND POLICY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have not set any regular dividend policy yet, and our board of directors has discretion as to whether and when to distribute dividends, subject to certain requirements of Cayman Islands law. In addition, our shareholders may by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended by our directors. Under Cayman Islands law, a Cayman Islands exempted company may pay a dividend out of either profit, retained earnings or share premium, provided that in no circumstances may a dividend be paid if that would result in the company being unable to pay its debts as they fall due in the ordinary course of business. Even if our Board decides to pay dividends, the form, frequency, and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions, and other factors that the Board may deem relevant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a holding company incorporated in the Cayman Islands. For our cash requirements, including any payment of dividends to our shareholders, we rely upon payments from our operating entities. PRC regulations may restrict the ability of our PRC subsidiaries to pay dividends to us. See &#8220;Regulation&#8201;&#8212;&#8201;PRC laws and regulations&#8201;&#8212;&#8201;Regulations relating to foreign exchange control&#8221; and &#8220;Regulation&#8201;&#8212;&#8201;PRC laws and regulations&#8201;&#8212;&#8201;Regulations relating to dividend distribution.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If we pay any dividends on our ordinary shares, we will pay those dividends which are payable in respect of the Class A ordinary shares underlying the ADSs to the depositary, as the registered holder of such Class A ordinary shares, and the depositary then will pay such amounts to the ADS holders in proportion to the Class A ordinary shares underlying the ADSs held by such ADS holders, subject to the terms of the deposit agreement, including the fees and expenses payable thereunder. See &#8220;Description of American Depositary Shares.&#8221; Cash dividends on our ordinary shares, if any, will be paid in U.S. Dollars. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">88</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCAP">&#8203;</a><a name="GoBack">&#8203;</a><a name="footnotePr1_0_0_1">&#8203;</a><a name="endnotePr1_3_0_1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAPITALIZATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth our capitalization as of June 30, 2023: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.41pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">on an actual basis; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">on a pro forma basis to reflect (i) the automatic conversion and the re-designation of all of the issued and outstanding preferred shares on a one-for-one basis into ordinary shares immediately prior to the completion of this offering; (ii) the re-designation of 16,990,000 ordinary shares into Class B ordinary shares on a one-for one basis immediately prior to the completion of this offering; and (iii) the re-designation of all of the remaining ordinary shares into Class A ordinary shares on a one-for-one basis immediately prior to the completion of this offering; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.4pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">on a pro&#160;forma as adjusted basis to reflect (i)&#160;the automatic conversion and the re-designation of all of the issued and outstanding preferred shares on a one-for-one basis into ordinary shares immediately prior to the completion of this offering; (ii) the re-designation of 16,990,000 ordinary shares into Class B ordinary shares on a one-for-one basis immediately prior to the completion of this offering; and (iii) the re-designation of all of the remaining ordinary shares into Class A ordinary shares on a one-for-one basis immediately prior to the completion of this offering; and (iv)&#160;the issuance and sale of Class A ordinary shares in the form of ADSs by us in this offering and the issuance and sale of Class A ordinary shares by us in the concurrent private placement at the initial public offering price of US$23.00 per ADS, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You should read this table together with our consolidated financial statements and the related notes included elsewhere in this prospectus and the information under &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; </font>
        </div>
        <table style="width:456pt;margin-bottom:4.99999999999989pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:275.61pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of June 30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Actual </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pro Forma </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pro&#160;forma As</font>
                <br >
                <font style="letter-spacing:-0.16pt;">adjusted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:275.61pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands, except for shares and par value data) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Preferred shares liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;B convertible redeemable preferred shares (par value of</font>
                <br >
                <font style="letter-spacing:0.2pt;">US$0.0001 per share; 13,607,896 shares authorized, issued and</font>
                <br >
                <font style="letter-spacing:0.2pt;">outstanding on an actual basis; and nil outstanding on a </font>
                <br >
                <font style="letter-spacing:0.2pt;">pro&#160;forma and pro&#160;forma as adjusted basis as of June 30, </font>
                <br >
                <font style="letter-spacing:0.2pt;">2023) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">105,823</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;C convertible redeemable preferred shares (par value of</font>
                <br >
                <font style="letter-spacing:0.2pt;">US$0.0001 per share; 14,653,013 shares authorized, issued and</font>
                <br >
                <font style="letter-spacing:0.2pt;">outstanding on an actual basis; and nil outstanding on a </font>
                <br >
                <font style="letter-spacing:0.2pt;">pro&#160;forma and pro&#160;forma as adjusted basis as of June 30, </font>
                <br >
                <font style="letter-spacing:0.2pt;">2023) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">113,810</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt; line-height:12.0000000000001pt; margin-bottom:-0.500000000000019pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;D convertible redeemable preferred shares (par value of</font>
                <br >
                <font style="letter-spacing:0.2pt;">US$0.0001 per share; 14,722,505 shares authorized, issued and</font>
                <br >
                <font style="letter-spacing:0.2pt;">outstanding on an actual basis; and nil outstanding on a </font>
                <br >
                <font style="letter-spacing:0.2pt;">pro&#160;forma and pro&#160;forma as adjusted basis as of June 30, </font>
                <br >
                <font style="letter-spacing:0.2pt;">2023) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">116,629</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.333pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:275.61pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total preferred shares liabilities</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Ordinary shares (par value of $0.0001 per share; 442,456,586 </font>
                <br >
                <font style="letter-spacing:0.2pt;">shares authorized; 40,440,000 shares issued and outstanding </font>
                <br >
                <font style="letter-spacing:0.2pt;">on an actual basis, and nil outstanding on a pro&#160;forma basis or </font>
                <br >
                <font style="letter-spacing:0.2pt;">pro&#160;forma as adjusted basis as of June 30, 2023) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Class A Ordinary shares (par value of $0.0001 per share; nil </font>
                <br >
                <font style="letter-spacing:0.2pt;">outstanding at an actual basis, 80,993,414 shares at pro forma </font>
                <br >
                <font style="letter-spacing:0.2pt;">basis, 93,710,805 at pro forma as adjusted basis, respectively, </font>
                <br >
                <font style="letter-spacing:0.2pt;">as of June 30, 2023) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">8</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">9</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">89</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:408.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:192.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:275.61pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of June 30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Actual </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pro Forma </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Pro&#160;forma As</font>
                <br >
                <font style="letter-spacing:-0.16pt;">adjusted </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:275.61pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:0pt;text-align:center;" colspan="16">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands, except for shares and par value data) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.917pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Class B Ordinary shares (par value of $0.0001 per share; nil </font>
                <br >
                <font style="letter-spacing:0.2pt;">outstanding at an actual basis, 16,990,000 shares at pro forma </font>
                <br >
                <font style="letter-spacing:0.2pt;">basis or pro forma as adjusted basis, respectively, as of June </font>
                <br >
                <font style="letter-spacing:0.2pt;">30, 2023) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.917pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">6,415</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">353,651</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">443,531</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;A convertible preferred shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Share option reserve </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">16,080</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">16,080</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">16,080</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange fluctuation reserve </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(4,375<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(4,375<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(4,375<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accumulated loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(346,639<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(346,639<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(346,639<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:275.61pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total shareholders&#8217; (deficit) equity</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">(317,535<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">18,727</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">108,608</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:275.61pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total capitalization</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">18,727</td>
            <td style="padding:0pt;padding-left:4.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">18,727</td>
            <td style="padding:0pt;padding-left:4.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">108,608</td>
            <td style="padding:0pt;padding-left:8.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="height:5pt;line-height:5pt;">
            <td style="padding:0pt;font-size:0pt;line-height:0pt;" colspan="20">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The pro&#160;forma as adjusted information discussed above is illustrative only. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">90</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDIL">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:91.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DILUTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you invest in the ADSs, your interest will be diluted to the extent of the difference between the initial public offering price per ADS and our net tangible book value per ADS after this offering. Dilution results from the fact that the initial public offering price per ordinary share is substantially in excess of the book value per ordinary share attributable to the existing shareholders for our presently outstanding ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11pt;">
          <font style="letter-spacing:0.2pt;">Our net tangible book value as of June 30, 2023 was approximately US$(317.6) million, representing US$(7.85) per ordinary share on a pro&#160;forma basis and US$(23.55) per ADS. Net tangible book value represents the amount of our total consolidated tangible assets less total consolidated liabilities. Dilution is determined by subtracting net tangible book value per ordinary share after giving effect to the additional proceeds we will receive from this offering and the concurrent private placement, from the initial public offering price of US$7.67 per ordinary share, adjusted to reflect the ADS-to-ordinary share ratio, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. Because the Class A ordinary shares and Class B ordinary shares have the same dividend and other rights, except for voting and conversion rights, the dilution is presented based on all issued and outstanding ordinary shares, including Class A ordinary shares and Class B ordinary shares.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Without taking into account any other changes in pro&#160;forma net tangible book value after June&#160;30, 2023, other than to give effect to our sale of the ADSs offered in this offering and our sale of Class&#160;A ordinary shares in the concurrent private placement at the initial public offering price of US$23.00 per ADS, after deduction of the underwriting discounts and commissions and estimated offering expenses payable by us, our pro&#160;forma as adjusted net tangible book value as of June&#160;30, 2023 would have been US$108.5 million, or US$0.98 per ordinary share and US$2.94 per ADS. This represents an immediate increase in net tangible book value of US$0.79 per ordinary share and US$2.37 per ADS to the existing shareholders and an immediate dilution in net tangible book value of US$6.69 per ordinary share and US$20.06 per ADS to investors purchasing ADSs in this offering. The following table illustrates such dilution: </font>
        </div>
        <table style="width:456pt;height:140.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:329.57pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:8.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:44.32pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Per Ordinary </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:8.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:48.11pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Per ADS </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:329.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Initial public offering price </font>
              </div>
            </td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:44.32pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$7.67 </font>
              </div>
            </td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:48.11pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$23.00 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net tangible book value as of June 30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:44.32pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$(7.85) </font>
              </div>
            </td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:48.11pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$(23.55) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:329.57pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Pro&#160;forma net tangible book value after giving effect to the conversion of our preferred shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:44.32pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$0.19 </font>
              </div>
            </td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48.11pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$0.57 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:329.57pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Pro&#160;forma as adjusted net tangible book value after giving effect to the conversion of our preferred shares and this offering and the concurrent private placement </font>
              </div>
            </td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:44.32pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$0.98 </font>
              </div>
            </td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48.11pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$2.94 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:329.57pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Amount of dilution in net tangible book value to new investors in this offering </font>
              </div>
            </td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:44.32pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$6.69 </font>
              </div>
            </td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:0pt; width:8.5pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:48.11pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$20.06</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes, on a pro&#160;forma as adjusted basis as of June 30, 2023, the differences between existing shareholders and the new investors with respect to the number of ordinary shares (in the form of ADSs or shares) purchased from us, the total consideration paid and the average price per ordinary share and per ADS paid before deducting the underwriting discounts and commissions and estimated offering expenses payable by us. The total number of ordinary shares does not include Class A ordinary shares underlying the ADSs issuable upon the exercise of the over-allot option granted to the underwriters. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">91</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:485.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:115.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;height:18.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:125.04pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary shares </font>
                <br >
                <font style="letter-spacing:-0.16pt;">purchased </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="7">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total consideration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:44.62pt;" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Average price </font>
                <br >
                <font style="letter-spacing:-0.16pt;">per ordinary </font>
                <br >
                <font style="letter-spacing:-0.16pt;">share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:44.62pt;" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Average price </font>
                <br >
                <font style="letter-spacing:-0.16pt;">per ADS </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:125.04pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:69.16pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:125.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Existing shareholders </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">97,983,414</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">88<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:69.16pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$224,311,236 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">70<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:44.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$2.29</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:44.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$6.87</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:125.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">New investors </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:38.25pt; text-align:right; white-space:nowrap;">7,500,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">7<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:69.16pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$57,500,000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">18<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:44.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$7.67</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:44.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$23.00</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:125.04pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Concurrent private placement </font>
                <br >
                <font style="letter-spacing:0.2pt;">investor </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">5,217,391</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">5<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.167pt 0pt 1.833pt 0pt; width:69.16pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$40,000,000</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">12<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.167pt 0pt 1.833pt 0pt; width:44.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$7.67</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.167pt 0pt 1.833pt 0pt; width:44.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$23.00</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:125.04pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:38.25pt; text-align:right; white-space:nowrap;">110,700,805</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:3pt double #000000;padding:3.25pt 0pt 2.5pt 0pt; width:69.16pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$321,811,236 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:5.035pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:3pt double #000000;padding:3.25pt 0pt 2.5pt 0pt; width:44.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$2.91</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="border-bottom:3pt double #000000;padding:3.25pt 0pt 2.5pt 0pt; width:44.62pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">US$8.73</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The pro&#160;forma as adjusted information discussed above is illustrative only. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">92</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCHAS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:24.02pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CORPORATE HISTORY AND STRUCTURE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our corporate history</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We commenced our business in mainland China in 2004 through Adlai Nortye Biopharma Co.,&#160;Ltd., which we refer to as our operating subsidiary in the PRC. We initially focused primarily on generic pharmaceuticals and polypeptide intermediate, until 2016 when our founders, Mr.&#160;Yang Lu and Mr.&#160;Donghui Yang, led our strategic transition to become a R&amp;D-driven pharmaceutical company, focusing on the discovery and development of innovative cancer therapies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our ultimate holding company was incorporated in the Cayman Islands in May&#160;2018 to facilitate offshore financing activities, and our daily operations are conducted primarily through our operating subsidiaries in the United States and mainland China. Between January&#160;2018 and June&#160;2022, Alpine Bioscience Ltd, Adlai Nortye Pte. Ltd., Adlai Nortye (HK) Limited, and Adlai Nortye (Switzerland) AG were incorporated in the British Virgin Islands, Singapore, Hong Kong, and Switzerland as our intermediary holding entities. In March&#160;2019, Adlai Nortye (HK) Limited acquired entire equity interests in the Adlai Nortye Biopharma Co., Ltd. from its then shareholders and Adlai Nortye Biopharma Co., Ltd. became a wholly owned subsidiary of our ultimate holding company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to conduct clinical trials in the U.S., Adlai Nortye USA INC was incorporated under the laws of the State of Delaware in the U.S. in January&#160;2018. In June&#160;2022, as a part of a reorganization, Adlai Nortye (Switzerland) AG acquired all its shares and Adlai Nortye USA INC become a wholly owned subsidiary of our ultimate holding company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our corporate structure</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The&#160;chart below sets forth our corporate structure and identifies our subsidiaries and their subsidiaries, as of the date of this prospectus:</font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="fc_ourcorporate-bw.jpg" alt="[MISSING IMAGE: fc_ourcorporate-bw.jpg]" height="303" width="536" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">93</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMDAA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL </font>
          <br >
          <font style="letter-spacing:-0.2pt;">CONDITION AND RESULTS OF OPERATIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">You should read the following discussion and analysis of our financial condition and results of operations together with &#8220;Summary Consolidated Financial and Operating Data,&#8221; and our financial statements and the related notes appearing elsewhere in this prospectus. Some of the information contained in this discussion and analysis or set forth elsewhere in this prospectus, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. You should read the &#8220;Risk factors&#8221; and &#8220;Cautionary note regarding forward-looking statements&#8221; sections of this prospectus for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types. Our mission is to transform deadly cancer into a chronic and eventually curable disease. We are now developing multiple innovative antitumor drug candidates by leveraging our deep knowledge in cancer biology, as well as significant global R&amp;D and clinical execution capabilities. These drug candidates are currently undergoing clinical trials, and in many cases, in collaboration with multinational pharmaceutical companies, to fully realize their commercialization potential on a global scale. Our combination therapy strategy is directed towards systematically activating the immune system through a combination of multiple drugs, aiming to enhance the clinical benefit by achieving superior efficacy and safety while overcoming drug resistance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have identified and developed a robust pipeline of six drug candidates. Currently, our pipeline includes three clinical-stage drug candidates, buparlisib (AN2025), palupiprant (AN0025), and AN4005, as well as three preclinical candidates. Our most advanced program is AN2025, a pan-phosphoinositide 3-kinase (&#8220;PI3K&#8221;) inhibitor that is designed to act against solid tumors. We believe that AN2025, if approved, has the potential to be first-to-market, and is currently the only drug candidate in active Phase&#160;III clinical trial targeting recurrent or metastatic HNSCC patients after progression on prior anti-PD-1/PD-L1 therapy, potentially addressing a global unmet medical need. We are also collaborating with MSD International GmbH, or MSD, to evaluate AN0025, a small molecule prostaglandin E receptor 4 (&#8220;EP4&#8221;) antagonist, in combination with Keytruda or pembrolizumab, in a Phase&#160;Ib clinical trial for five different types of advanced solid tumors after progression with anti-PD-1/PD-L1 therapy or standard of care treatment. In addition, a Phase&#160;I clinical trial has been initiated for a combination therapy consisting of AN2025, AN0025, and Tecentriq or atezolizumab targeting a variety of PIK3CA mutant solid tumors. AN4005, which is currently being studied in a Phase&#160;I clinical trial, is an internally discovered, oral small molecule PD-L1 inhibitor in development to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have assembled a management team and a scientific advisory board with industry leaders and influential scientists, who provide international and strategic guidance to our R&amp;D, business development, and operational teams. In addition to building our own R&amp;D capabilities, we continue to seek and secure partnerships with leading multi-national pharmaceutical companies such as Eisai and Novartis to fully realize the potential of our pipeline programs. We believe our partnerships validate our clinical expertise and reflect belief in our ability to deliver on our development and commercialization capabilities across a versatile pipeline. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since our inception, our operations have focused on organizing and staffing our company, business planning, raising capital, establishing our intellectual property portfolio and conducting preclinical studies and clinical trials. We do not have any drug candidates approved for sale and have not generated any revenue from product sales. We have financed operations through a combination of equity financings and payments from our collaborators. We use the capital we have raised to fund operations and investing activities across research for technology creation, drug discovery and clinical development programs, infrastructure, creation of our portfolio of intellectual property, and administrative support. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since our founding, we have incurred significant operating losses. Our net losses were US$56.7&#160;million, US$58.8 million, and US$78.4 million for the&#160;years ended December&#160;31, 2021, 2022, and six months ended June&#160;30, 2023, respectively. We expect to continue to incur significant expenses and operating losses for the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">94</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">foreseeable future. In addition, we anticipate that our expenses will increase significantly in connection with our ongoing activities as we: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">continue or expand our research or development of our programs in preclinical development; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">continue or expand the scope of our clinical trials for our drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">initiate additional preclinical studies or clinical or other trials for our drug candidates, including under our collaboration agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">continue to invest in our R&amp;D platforms to conduct research to identify novel technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">add additional infrastructure to our quality control, quality assurance, legal, compliance and other groups to support our operations as we progress our drug candidates toward commercialization; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">attract and retain skilled personnel; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">create additional infrastructure to support our operations as a public company and our product development and planned future commercialization efforts, including expansion of sites in the United States and Europe; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">seek marketing approvals and reimbursement for our drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establish a sales, marketing and distribution infrastructure to commercialize any products for which we may obtain marketing approval; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">seek to identify and validate additional drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">acquire or in-license other drug candidates and technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">make milestone or other payments under any in-license agreements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">maintain, protect, defend, enforce and expand our intellectual property portfolio; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">experience any delays or encounter issues with any of the above. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We do not expect to generate revenue from the sale of our drug candidates unless and until we successfully complete clinical development and obtain regulatory approval for such drug candidates. If we seek to obtain regulatory approval for any of our drug candidates, we expect to incur significant commercialization expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a result, we will need substantial additional funding to support our continued operations and pursue our growth strategy. Until we can generate significant revenue from product sales, if ever, we expect to finance our operations through a combination of public or private equity offerings and debt financings, government funding arrangements, collaborations and marketing, or distribution and licensing arrangements. We may be unable to raise additional funds or enter into such other arrangements on favorable terms, or at all. If we fail to raise capital or enter into such arrangements as and when needed, we may have to significantly delay, scale back or discontinue the development and commercialization of one or more of our programs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because of the numerous risks and uncertainties associated with pharmaceutical development, we are unable to predict the timing or amount of increased expenses or when or if we will be able to achieve or maintain profitability. Even if we are able to generate revenues from the sale of our products, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be unable to continue our operations at planned levels and may be forced to reduce our operations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Key components of our results of operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To date, we have not generated any revenue from product sales. In 2021, our revenue of US$45.7&#160;million consisted of the revenue from the sale of intellectual property pursuant to the collaboration agreement with Biotime. Revenue was recognized when we sold the rights to the intellectual property and after there was no future performance obligation to be performed. For more details, see &#8220;Business&#8201;&#8212;&#8201;License and collaboration agreements&#8201;&#8212;&#8201;Collaboration with Biotime.&#8221; Our ability to generate product revenue and to become profitable will depend upon our ability to successfully develop, obtain regulatory approval and commercialize our drug </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">95</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">candidates. Because of the numerous risks and uncertainties associated with product development and regulatory approval, we are unable to predict the amount, timing or ability to obtain product revenue. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Administrative expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Administrative expenses primarily include payroll, share-based compensation expenses, and other related expenses for employees involved in general corporate functions including finance, legal and human resources, rental and depreciation expenses related to facilities and equipment used by these functions, professional service expenses and other general corporate related expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We expect our administrative expenses to increase in the future to support our continued research and development activities and, if any of our drug candidates receive marketing approval, commercialization activities. We also anticipate increased expenses related to professional fees, including audit, legal, regulatory and tax-related services, associated with maintaining compliance with Nasdaq listing and SEC requirements, director and officer insurance premiums, and investor relations costs associated with operating as a public company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and development expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development expenses consist primarily of costs incurred in connection with our research activities and include: (i)&#160;cost of personnel engaged in research and development activities, including salaries, benefits and share-based compensation expenses, if any; (ii)&#160;costs of funding research performed by third parties including laboratory, CRO, and other investigator and vendor expenses related to the execution of preclinical and clinical trials; (iii)&#160;costs related to production of preclinical and clinical materials; (iv)&#160;licensing fees for maintaining licenses under our third-party licensing agreements; (v)&#160;facility costs including rent, depreciation and maintenance expense; and (vi)&#160;expenses related to regulatory activities, including filing fees paid to regulatory agencies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development costs are expensed as incurred. Costs for certain activities, such as manufacturing and preclinical studies and clinical trials, are generally recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by our vendors and investigators. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Research and development activities are central to our business model. Drug candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to the increased size and duration of later-stage clinical trials. We expect our research and development expenses to increase over the next several&#160;years as our existing clinical programs progress and as we seek to initiate clinical trials of additional drug candidates. We also expect to incur increased research and development expenses as we selectively identify and develop additional drug candidates. However, it is difficult to determine with certainty the duration and completion costs of our current or future preclinical programs and clinical trials of our drug candidates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The duration, costs and timing of clinical trials and development of our drug candidates will depend on a variety of factors that include, but are not limited to, the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">successful enrollment in and completion of clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishing an appropriate safety profile; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">establishing commercial manufacturing capabilities or making arrangements with third-party manufacturers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">receipt of marketing approvals from applicable regulatory authorities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">commercializing the drug candidates, if approved, whether alone or in collaboration with others; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtaining and maintaining patent and trade secret protection and regulatory exclusivity for our drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">continued acceptable safety profiles of products following approval; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">retention of key research and development personnel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">96</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A change in the outcome of any of these variables with respect to the development of any of our drug candidates would significantly change the costs, timing and viability associated with the development of that drug candidate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other income and gains</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Other income and gains primarily consist of government subsidies that we receive from local government in the PRC.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair value changes on financial liabilities at FVTPL</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Fair value changes on financial liabilities at FVTPL consists primarily of the non-cash items incurred in connection with changes in the fair value of our preferred share liabilities that we issued to certain investors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Taxation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cayman Islands and British Virgin Islands</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the current laws of the Cayman Islands and the British Virgin Islands, the Company and its subsidiaries are not subject to tax on income or capital gains. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The United States</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the current laws of the United States of America, the subsidiary which operates in the United States America is subject to federal tax at a rate of 21% and New Jersey state tax at a rate of 6.5% with net taxable income of $50,000 or less; 7.5% with net taxable income greater than US$50,000 and less than or equal to US$100,000; and 9% with net taxable income greater than US$100,000. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Hong Kong</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary incorporated in Hong Kong is subject to Hong Kong profits tax at the rate of 16.5% on any estimated assessable profits arising in Hong Kong during the period presented. The first HKD2,000 thousands of assessable profits of this subsidiary are taxed at 8.25% and the remaining assessable profits are taxed at&#160;16.5%. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Mainland China</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The provision for corporate income tax in Mainland China is based on a statutory rate of 25% of the assessable profits as determined in accordance with the PRC Corporate Income Tax Law which was approved and became effective on January&#160;1, 2008. Certain other subsidiaries qualified as &#8220;High and New Technology Enterprise&#8221; and &#8220;Small and Medium-sized Technological Enterprises&#8221;, for details of their preferential tax treatments, see Note 6 to our consolidated financial statements for a detailed discussion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Singapore</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The prevailing corporate income tax rate in Singapore is 17.0%, with 75% of up to the first SGD10,000 and 50% of up to the next SGD190,000 of a company&#8217;s chargeable income (otherwise subject to normal taxation) being exempt from corporate tax (the &#8220;Partial Tax Exemption&#8221;). The remaining chargeable income that exceeds SGD200,000 will be fully taxable at the prevailing corporate tax rate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, subject to certain conditions and exceptions, newly established companies in Singapore will also be eligible for tax exemption on 75% of up to the first SGD100,000 and 50% of up to the next SGD100,000 of a company&#8217;s annual normal chargeable income for each of the company&#8217;s first three years of assessment from year of assessment 2020 onwards (the &#8220;Start-up Exemption&#8221;). The remaining chargeable income (after the tax exemption) will be taxed at the applicable corporate tax rate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event a company claims the Start-up Exemption for its first three years of assessment, it will not be able to claim the Partial Tax Exemption. From the fourth year of assessment onwards, the company can enjoy the Partial Tax Exemption. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">97</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Switzerland</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary incorporated in Switzerland is subject to a total corporate income tax rate of 11.9%, including 8.5% federal, and Zug cantonal and communal tax, during the period presented on the estimated assessable profits of the Swiss subsidiary. If the main business is operated in other cantons, the total corporate income tax, including federal, cantonal, and communal tax, could be up to 21.6%.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Results of operations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes key components of our results of operations for the&#160;years/periods indicated: </font>
        </div>
        <table style="width:456pt;height:328.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:283.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">For the Year </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">For Six Months </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ended June 30,</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:283.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:283.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:283.85pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:283.85pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.2pt;">Selected consolidated statements of operations and comprehensive loss:</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Revenue </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">45,726</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other operating income, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">183</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">259</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">137</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">349</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Administrative expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(12,450<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(13,039<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(7,039<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(5,231<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(42,105<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(54,490<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(21,913<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(27,243<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total operating loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(8,646<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(67,270<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(28,815<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(32,125<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other income and gains</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">213</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,079</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">447</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">269</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(70<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,395<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(822<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(488<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Investment income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">32</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">550</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">81</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">63</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value gain on financial assets at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">484</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">644</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value (loss)/gain on financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(46,910<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">7,195</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">14,167</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(45,894<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Finance costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,337<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(433<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(262<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(243<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Loss before tax</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income tax expense </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:283.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Loss for the year/period</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:283.85pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Attributable to: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:283.85pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Ordinary equity holders of the parent </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.5pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of six&#160;months ended June 30, 2023 and 2022</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Administrative expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our administrative expenses decreased by 25.7%, from US$7.0&#160;million for the six&#160;months ended June 30, 2022 to US$5.2&#160;million for the six&#160;months ended June 30, 2023, primarily attributable to a decrease in share-based compensation expenses resulting from the vesting schedule of certain stock options in 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and development expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Our research and development expenses increased by 24.3%, from US$21.9&#160;million for the six&#160;months ended June 30, 2022 to US$27.2&#160;million for the six&#160;months ended June 30, 2023. This increase was primarily due to (i) an increase in CRO service fees as we advanced some of our existing drug candidates into more advanced clinical development stages; and (ii) an increase in payroll and other related costs of personnel, primarily due to increased share-based compensation and expansion of the R&amp;D staff. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">98</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other income and gains</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our other income and gains decreased by 39.8% from US$0.4 million for the six&#160;months ended June 30, 2022 to US$0.3 million for the six&#160;months ended June 30, 2023, primarily due to foreign exchange losses as result of fluctuations in the exchange rate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair value changes on financial liabilities at FVTPL</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We had fair value gain on financial liabilities at FVTPL of US$14.2 million for the six months ended June&#160;30, 2022 and fair value loss on financial liabilities at FVTPL of US$45.9 million for the six months ended June&#160;30, 2023. This change was primarily due to the increased likelihood of the shares being listed publicly, which reduced the liquidation value. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Loss for the period</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the reasons described above, our loss for the period increased significantly from US$14.6&#160;million for the six&#160;months ended June 30, 2022 to US$78.4&#160;million for the six&#160;months ended June 30, 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of twelve&#160;months ended December&#160;31, 2022 and 2021</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Revenue</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We did not generate any revenue in 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Administrative expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our administrative expenses increased by 4.7%, from US$12.5&#160;million in 2021 to US$13.0&#160;million in 2022, primarily attributable to (i) an increase in employee compensation due to an increase in the number of employees and (ii) an increase in share-based compensation expenses from additional options granted to new employees in 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and development expenses</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our research and development expenses increased by 29.4%, from US$42.1&#160;million in 2021 to US$54.5&#160;million in 2022. This increase was primarily due to (i) an increase in payroll and other related costs of personnel, primarily due to increased share-based compensation and expansion of the R&amp;D staff; (ii) an increase in the CRO service fees as we advanced some of our existing drug candidates into more advanced clinical development stages; and (iii) an increase in the cost of materials and consumables used for our discovery projects and preclinical studies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other income and gains</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our other income and gains increased significantly, from US$0.2&#160;million in 2021 to US$2.1&#160;million in 2022, primarily due to additional government grants received in 2022.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair value changes on financial liabilities at FVTPL</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We had fair value loss on financial liabilities at FVTPL of US$46.9&#160;million in 2021 and fair value gain on financial liabilities at FVTPL of US$7.2&#160;million in 2022. This change was primarily due to the increased likelihood of the shares being listed publicly, which reduced the liquidation value. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Finance costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our finance costs decreased by 67.6% from US$1.3&#160;million in 2021 to US$0.4&#160;million in 2022, primarily due to a decrease of private financing related expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Loss for the year</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the reasons described above, our loss for the year increased by 3.7%, from US$56.7&#160;million in 2021 to US$58.8&#160;million in 2022. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">99</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity and capital resources</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since inception, we have incurred net losses and negative cash flows from our operations. Substantially all of our losses have resulted from funding our research and development activities and administrative costs associated with our operations. We incurred net loss of US$56.7&#160;million, US$58.8 million, and US$78.4&#160;million for the years ended December 31, 2021, 2022, and six months ended June 30, 2023. We used US$3.0&#160;million, US$43.2 million, and US$18.3 million in cash for our operating activities for the years ended December 31, 2021, 2022 and six months ended June 30, 2023, respectively. Historically, we have financed our operations primarily through proceeds from the issuance and sale of preferred shares, warrants in private placement transactions, and bank borrowings. For more information of our equity financing, see &#8220;Description of Share Capital&#8201;&#8212;&#8201;History of share capital.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Currently, our primary source of liquidity are cash and cash equivalents. As of June 30, 2023, we had US$60.0 million in cash and cash equivalents. Our cash and cash equivalents consist primarily of bank deposits. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Based on our current operating plan, we believe that our current cash and cash equivalents and proceeds from this offering and the concurrent private placement will be sufficient to meet our current and anticipated working capital requirements and capital expenditures for at least the next 12&#160;months. In that time, we expect that our expenses will increase substantially as we fund new and ongoing research and development activities and working capital needs. The assumptions on which our estimates are based may prove to be wrong, and we may use our available capital resources sooner than we currently expect. Because of the numerous risks and uncertainties associated with the development and commercialization of our drug candidates, we are unable to estimate the amounts of increased capital outlays and operating expenditures necessary to complete the development and commercialization of our drug candidates. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of our cash flows for the&#160;years/periods presented: </font>
        </div>
        <table style="width:456pt;height:164pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:271.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">For the Year Ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">For the Six Months </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ended June 30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:271.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:271.85pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">US$ </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:271.85pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="25">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:271.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash used in operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(3,034<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(43,223<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(23,265<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(18,323<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:271.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash (used in)/generated from investing activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(54,857<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">28,376</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">5,930</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">21,367</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:271.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash from/(used in) financing activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">97,200</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(6,780<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(5,725<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">14,963</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:271.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net increase/(decrease) in cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">39,309</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(21,627<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(23,060<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">18,007</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:271.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents at the beginning of the year/period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">24,261</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">64,131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">64,131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">42,758</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:271.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effect of foreign exchange rate changes, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">561</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">254</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">638</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(737<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:271.85pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Cash and cash equivalents at the end of the year/period</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">64,131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">42,758</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">41,709</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">60,028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="3">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.19pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Operating activities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the six months ended June 30, 2023, we had US$18.3 million net cash used in operating activities. The difference with US$78.4 million of loss before tax on accrual basis was mainly the result of adding back non-cash items such as (i)&#160;US$45.9 million of fair value loss on financial liabilities at FVTPL and (ii)&#160;US$2.4 million of equity-settled share-based payment expenses. For the six months ended June 30, 2023, US$10.4 million was released from operating assets and liabilities, mainly due to (i) our other payables and accruals increasing by US$5.8 million and (ii) our trade payables increasing by US$3.8 million, which was attributable to the progress of R&amp;D activities.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In 2022, we had US$43.2 million net cash used in operating activities. The difference with US$58.8 million of loss before tax on accrual basis was mainly the result of adding back non-cash items such as US$6.1 million of equity-settled share-based payment expenses and US$1.1 million of depreciation of right-of-use assets. In 2022, US$15.2 million of cash was released from operating assets and liabilities, mainly due to (i) our trade </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">100</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">payables increasing by US$10.1 million as a result of certain drug candidates entered into more advanced clinical development stage and (ii) our prepayments, other receivables and other assets decreasing by US$4.3 million.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 2021, we had US$3.0&#160;million net cash used in operating activities. The difference with US$56.7&#160;million of loss before tax on accrual basis was mainly the result of adding back non-cash items such as US$46.9&#160;million of fair value loss on financial liabilities at FVTPL and US$3.4&#160;million of equity-settled share-based payment expenses. In 2021, US$0.3&#160;million of cash was released from operating assets and liabilities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Investing activities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the six&#160;months ended June 30, 2023, our net cash provided from investing activities was US$21.4&#160;million, primarily as a result of disposal of financial assets at FVTPL. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 2022, our net cash generated from investing activities was US$28.3 million, primarily as a result of disposal of financial assets at FVTPL.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 2021, our net cash used in investing activities was US$54.9&#160;million, primarily as a result of purchase of financial assets at FVTPL of US$81.2&#160;million, partially offset by disposal of financial assets at FVTPL of US$27.5&#160;million. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Financing activities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the six&#160;months ended June 30, 2023, our net cash from financing activities was US$15.0&#160;million, primarily as a result of addition of bank and other borrowings of US$20.0 million, which was partially offset by repayment of bank and other borrowings of US$4.3 million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 2022, our net cash used in financing activities was US$6.8 million, primarily due to repayment of bank and other borrowings of US$13.3 million, partially offset by the addition of bank and other borrowings of US$7.9 million.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 2021, our net cash generated from financing activities was US$97.2&#160;million, primarily due to (i)&#160;US$97.4&#160;million of proceeds from issuance of financial instruments and (ii)&#160;US$12.4&#160;million of addition of bank and other borrowings, partially offset by US$10.4&#160;million repayment of bank and other borrowings. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Operating capital requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We do not expect to generate any revenue from product sales unless and until we successfully complete development and obtain regulatory approval for one or more of our drug candidates, which we expect will take a number of&#160;years. As a result, until such time, if ever, as we can generate substantial product revenue, we expect to finance our cash needs through equity offerings, debt financings or other capital sources, including potential collaborations, licenses and other similar arrangements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, we may be unable to raise additional funds or enter into such other arrangements when needed on favorable terms or at all. If we do raise additional capital through public or private equity offerings, the ownership interest of our existing shareholders, including investors in this offering, will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect our shareholders&#8217; rights. If we raise additional capital through debt financing, we may be subject to covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise funds through additional collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or drug candidates or to grant licenses on terms that may not be favorable to us. Any failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies. If we are unable to raise capital, we will need to delay, reduce or terminate planned activities to reduce costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because of the numerous risks and uncertainties associated with research, development and commercialization of pharmaceutical products, we are unable to estimate the exact amount of our operating capital requirements. Our future funding requirements will depend on many factors, including, but not limited to: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">101</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing, receipt and amount of sales of any future approved or cleared products, if any; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the scope, progress, results and costs of researching and developing our existing drug candidates or any future drug candidates, and conducting preclinical studies and clinical trials; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the timing of, and the costs involved in, obtaining regulatory approvals or clearances for our existing drug candidates or any future drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the time and costs involved in obtaining regulatory approval for our drug candidates and any delays we may encounter as a result of evolving regulatory requirements or adverse results with respect to any of these drug candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number and characteristics of any additional drug candidates we develop or acquire; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.5pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.5pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the cost of manufacturing our drug candidates and any products we successfully commercialize, including costs associated with developing our manufacturing capabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property rights and defending intellectual property-related claims; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the extent to which we acquire or in-license other drug candidates or technologies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">our ability to establish and maintain strategic collaborations, licensing or other arrangements and the financial terms of any such agreements that we may enter into; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the expenses needed to attract and retain skilled personnel and senior management; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:4.51pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:4.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the costs associated with being a public company. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, our operating plans may change, and we may need additional funds to meet operational needs and capital requirements for clinical trials and other research and development activities. Because of the numerous risks and uncertainties associated with the development and commercialization of our drug candidates, we are unable to estimate the amounts of increased capital outlays and operating expenditures associated with our current and anticipated product development programs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Capital expenditures</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We made capital expenditures of US$1.1&#160;million, US$1.2 million, and US$85,178 in 2021, 2022, and six&#160;months ended June 30, 2023 respectively. Our capital expenditures were primarily for the purchase of property, plant and equipment and the purchase of intangible assets. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Contractual obligations and commitments</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth material cash requirements from our contractual obligations as of June&#160;30, 2023: </font>
        </div>
        <table style="width:416pt;height:46pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:285.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Less than</font>
                <br >
                <font style="letter-spacing:-0.16pt;">1 year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">1 to 3</font>
                <br >
                <font style="letter-spacing:-0.16pt;">years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">3 to 5</font>
                <br >
                <font style="letter-spacing:-0.16pt;">years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:285.97pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">(in thousands) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:285.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,001</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">664</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.33pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,665</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.5pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Off-balance sheet commitments and arrangements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have not entered into any financial guarantees or other commitments to guarantee the payment obligations of any unconsolidated third parties. In addition, we have not entered into any derivative contracts that are indexed to our shares and classified as shareholders&#8217; equity or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity, or market risk support to such entity. Moreover, we do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or product development services with us. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Quantitative and qualitative disclosures about market risk</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Market risk is the risk that the fair value of, or future cash flows from, a financial instrument will vary due to changes in market prices. The type of market risk that primarily impacts us is foreign currency risk. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">102</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Foreign currency risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are subject to currency risk as our income and expenditures are denominated in U.S. dollar and Renminbi. As such, we are exposed to exchange rate fluctuations between these currencies. We currently plan to utilize our financial resources denominated in Renminbi to fund our expenditure in China, and we do not hedge this exposure. If we increase our operation in China, especially if we roll out additional clinical trials in China, we expect to have significant increases in expenses denominated in Renminbi, while we would expect our near-term revenue, after the commercialization of our product candidates, and the proceeds from our financial activities to remain denominated in U.S. dollars. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We prepare and publish our consolidated financial statements in U.S. dollars. Revenue and expenses incurred in Renminbi will be translated into U.S. dollars when they are reported in our consolidated financial statements. As a result, any substantial future appreciation or decline of the Renminbi against U.S. dollar could have a material effect on our financial performance. Assuming Renminbi weakens by 10% against U.S.&#160;dollar, our cash and cash equivalents as of June&#160;30, 2023 would decrease by US$4.4&#160;million, or&#160;7.4%. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We monitor and maintain a level of cash and cash equivalents deemed adequate by the management to finance the operations and mitigate the effects of fluctuations in cash flows. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Internal control over financial reporting</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prior to this offering, we have been a private company with limited reporting and accounting personnel and other resources with which to address our internal control over financial reporting. In connection with the audits of our consolidated financial statements included in this prospectus, we and our independent registered public accounting firm identified material weaknesses. As defined in the standards established by the PCAOB, a &#8220;material weakness&#8221; is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our internal control over financial reporting was not effective due to (i) inadequate segregation of duties and effective risk assessment; (ii) lack of personnel adequately trained in IFRS including income taxes (for the year ended December 31, 2021); and (iii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both IFRS and SEC guidelines for reporting and compliance. During the audit for the year ended December 31, 2021, we revised accounting records after initial accounting records were received and provided multiple versions of trial balances and financial statements. These inefficiencies created rework and required incremental and unplanned audit time. As we continued to implement a number of measures to address the material weakness, we recognized significant improvement during the audit for the year ended December 31, 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will continue to implement the following measures to address the material weaknesses and deficiencies that have been identified including: (i)&#160;hiring additional accounting and financial reporting personnel with IFRS and SEC reporting experience, (ii)&#160;expanding the capabilities of existing accounting and financial reporting personnel through continuous training and education in the accounting and reporting requirements under IFRS, and SEC rules and regulations, (iii)&#160;developing, communicating and implementing an accounting policy manual for our accounting and financial reporting personnel for recurring transactions and period-end closing processes, and (iv)&#160;establishing effective monitoring and oversight controls for non-recurring and complex transactions to ensure the accuracy and completeness of our company&#8217;s consolidated financial statements and related disclosures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The process of designing and implementing an effective financial reporting system is a continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments and to devote significant resources to maintain a financial reporting system that is adequate to satisfy our reporting obligation. However, we cannot assure you that all these measures will be sufficient to remediate our material weakness in a timely manner, or at all. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks related to our business&#8201;&#8212;&#8201;If we fail to implement and maintain an effective system of internal controls to remediate our material weaknesses over financial reporting, we may be unable to accurately report our results of operations, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">103</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">meet our reporting obligations or prevent fraud, and investor confidence in our company and the market price of the ADSs may be materially and adversely affected.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Change in auditor</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We engaged Ernst &amp; Young, or E&amp;Y, in December&#160;2018 to audit our consolidated financial statements for the two&#160;years ended December&#160;31, 2019 and 2020 and the five&#160;months ended May&#160;31, 2020 and 2021, to facilitate our previous attempt to access the Hong Kong capital market. We dismissed E&amp;Y in June&#160;2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As part of our new plan to seek an initial public offering in the United States, in August&#160;2022, we engaged Mazars USA LLP, or Mazars, which is located in the United States and can be subject to inspection by the PCAOB, as our independent auditor to audit our consolidated financial statements for the three&#160;years ended December&#160;31, 2020, 2021, and 2022. The change of independent auditor was approved by our board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We and E&amp;Y agreed on a draft report relating to the financial statements for the two&#160;years ended December&#160;31, 2019 and 2020 and the five&#160;months ended May&#160;31, 2020 and 2021, which does not contain an adverse opinion or a disclaimer of opinion, and is not qualified or modified as to uncertainty, audit scope, or accounting principles. This report however was not ultimately signed or delivered as we suspended our plan for the Hong Kong IPO. During E&amp;Y&#8217;s engagement and up to the interim period before E&amp;Y&#8217;s dismissal, there had been no disagreements between E&amp;Y and us on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, and there had been no &#8220;reportable events&#8221; as defined under Item&#160;16F(a)(1)(v) of Form 20-F that would require disclosure. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We provided a copy of this disclosure to E&amp;Y, and requested it to furnish us with a letter addressed to the SEC stating whether it agrees with the above statements, and if not, stating the respects in which it does not agree. Although we sent the draft disclosure to E&amp;Y, and requested E&amp;Y to submit a letter addressed to the SEC confirming the above statement, as of the date of this submission, E&amp;Y has neither prepared nor submitted a letter confirming or denying the above statement, and has not otherwise confirmed or denied the above statement.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During 2020, 2021, and 2022, and any subsequent interim period prior to the engagement of Mazars in August&#160;2022, neither we nor any person on our behalf consulted with Mazars regarding either (i)&#160;the application of accounting principles to a specific completed or contemplated transaction, or the type of audit opinion that might be rendered on our financial statements and no written or oral advice provided by Mazars was an important factor considered by us in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii)&#160;any matter that was the subject of a disagreement or reportable event as defined in the Form 20-F. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Critical accounting policies, judgments and estimates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our consolidated financial statements are prepared in accordance with IFRS as issued by the IASB. The preparation of our consolidated financial statements requires us to make estimates, assumptions and judgments that affect the reported amounts of assets, liabilities, costs and expenses. We base our estimates and assumptions on historical experience and other factors that we believe to be reasonable under the circumstances. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates. Our most critical accounting policies are summarized below. See note 2.4 to our consolidated financial statements beginning on page F-1 of this prospectus for a description of our other significant accounting policies. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and development costs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All research costs are charged to expense as incurred. Expenditure incurred on projects to develop new products is capitalized and deferred only when we can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale, our intention to complete and our ability to use or sell the asset, how the asset will generate future economic benefits, the availability of resources to complete the project and our ability to measure reliably the expenditure during the development. Product development expenditure which does not meet these criteria is expensed when incurred. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">104</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Share-based payments</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We operate a share option scheme for the purpose of providing incentives and rewards to eligible participants who contribute to the success of our operations. Employees (including directors) receive remuneration in the form of share-based payments, whereby employees render services as consideration for equity instruments, or equity settled transactions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The cost of equity-settled transactions with employees for grants is measured by reference to the fair value at the date at which they are granted. The fair value is determined by an external valuer using a binomial model, further details of which are given in note 19 of our consolidated financial statements included elsewhere in this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The cost of equity-settled transactions is recognized in employee benefit expense, together with a corresponding increase in equity, over the period in which the performance and/or service conditions are fulfilled. The cumulative expense recognized for equity-settled transactions at the end of each of the relevant periods until the vesting date reflects the extent to which the vesting period has expired and our best estimate of the number of equity instruments that will ultimately vest. The charge or credit to the statement of profit or loss and other comprehensive income for a period represents the movement in the cumulative expense recognized as at the beginning and end of that period. Service and non-market performance conditions are not considered when determining the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of our best estimate of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair value of financial liabilities measured at FVTPL</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the financial liabilities, including convertible redeemable preferred shares, convertible loans, forwards and warrants, are measured at FVTPL and determined using the valuation techniques, including the discounted cash flow method and the back-solve method. Such valuation requires us to make estimates of the key assumptions including the risk-free interest rate, discount for lack of marketability and volatility, which are subject to uncertainty and might materially differ from the actual results. Further details are included in note 15 of our consolidated financial statements included elsewhere in this prospectus. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fair value of share-based payment</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the awarded shares is determined at the grant dates by the binomial option-pricing model. Significant estimates on assumptions, including the underlying equity value, discount rate, expected volatility, and dividend yield, are made by management. Further details are included in note 19 of our consolidated financial statements included elsewhere in this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preparation of the consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reporting amounts of assets and liabilities, and disclosure of contingent assets and liabilities, as of the date of the consolidated financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the valuation and accounting for financial liabilities at FVTPL and equity awards.</font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Impairment of non-financial assets (other than goodwill)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We assess whether there are any indicators of impairment for all non-financial assets (including the right-of-use assets) at the end of each of the relevant periods. Other non-financial assets are tested for impairment when there are indicators that the carrying amounts may not be recoverable. An impairment exists when the carrying value of an asset or a cash-generating unit exceeds its recoverable amount, which is the higher of its fair value less costs of disposal and its value in use. The calculation of the fair value less costs of disposal is based on available data from binding sales transactions in an arm&#8217;s length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. When value in use calculations are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">105</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:316pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">undertaken, management must estimate the expected future cash flows from the asset or cash-generating unit and choose a suitable discount rate in order to calculate the present value of those cash flows. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Deferred tax assets</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets are recognized for unused tax losses to the extent that it is probable that taxable profit will be available against which the losses can be utilized. Significant management judgement is required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and level of future taxable profits together with future tax planning strategies. Further details are contained in note 6 of our consolidated financial statements included elsewhere in this prospectus. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Leases&#8201;&#8212;&#8201;estimating the incremental borrowing rate</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group cannot readily determine the interest rate implicit in a lease; therefore, it uses an incremental borrowing rate, or IBR, to measure lease liabilities. The IBR is the rate of interest that we would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment. The IBR therefore reflects what the Group &#8220;would have to pay&#8221;, which requires estimation when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when it needs to be adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary&#8217;s functional currency). The Group estimates the IBR using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates (such as the subsidiary&#8217;s stand-alone credit rating). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recent accounting pronouncements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A list of recently issued accounting pronouncements that are relevant to us is included in note 2.2 of our consolidated financial statements included elsewhere in this prospectus.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">106</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tBUS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">BUSINESS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Overview</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are a global clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types. Our mission is to transform deadly cancer into a chronic and eventually curable disease. We are now developing multiple innovative antitumor drug candidates by leveraging our deep knowledge in cancer biology, as well as significant global R&amp;D and clinical execution capabilities. These drug candidates are currently undergoing clinical trials, and in many cases, in collaboration with multinational pharmaceutical companies to fully realize their commercialization potential on a global scale. Our combination therapy strategy is directed towards systematically activating the immune system through a combination of multiple drugs, aiming to enhance the clinical benefit by achieving superior efficacy and safety while overcoming drug resistance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have identified and developed a robust pipeline of six drug candidates. Currently, our pipeline includes three clinical-stage drug candidates, buparlisib (AN2025), palupiprant (AN0025), and AN4005, as well as three preclinical candidates. Our most advanced program is our lead product AN2025, a pan-phosphoinositide 3-kinase (&#8220;PI3K&#8221;) inhibitor that is designed to act against solid tumors. AN2025 is currently undergoing a Phase&#160;III, multi-regional, randomized, open-label clinical trial for the treatment of recurrent or metastatic HNSCC after anti-programmed death-1 (&#8220;PD-1&#8221;) or its ligand (&#8220;PD-L1&#8221;) treatment in more than 180 sites in 18 jurisdictions covering North America, Europe, Asia, and South America. We believe that AN2025, if approved, has the potential to be first-to-market, and is currently the only drug candidate in active Phase&#160;III clinical trial targeting recurrent or metastatic HNSCC patients after progression on prior anti-PD-1/PD-L1 therapy, potentially addressing a global unmet medical need. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are collaborating with MSD International GmbH, or MSD, to evaluate AN0025, a small molecule prostaglandin E receptor 4 (&#8220;EP4&#8221;) antagonist. It is currently being developed to modulate the tumor microenvironment in combination with Keytruda or pembrolizumab, in a Phase&#160;Ib clinical trial for the treatment of recurrent non-small cell lung cancer (&#8220;NSCLC&#8221;) and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer (&#8220;TNBC&#8221;), microsatellite stable colorectal cancer (&#8220;MSS CRC&#8221;) and cervical cancer after standard of care treatments in the U.S. and France. In addition, a Phase&#160;I clinical trial has been initiated for a combination therapy consisting of AN2025, AN0025, and Tecentriq or atezolizumab targeting a variety of PIK3CA mutant solid tumors. This triple combination is expected to target the PI3K mediated tumorigenesis while inhibiting the immunosuppressive tumor microenvironment through multiple non-overlapping mechanisms, leading to synergistic action for tumor regression. AN4005, which is currently being studied in a Phase&#160;I clinical trial in the U.S. and China, is an internally discovered oral small molecule PD-L1 inhibitor in development to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Additionally, we continue to advance three in-house preclinical programs which we believe have high global commercial viability. Our preclinical candidates include: AN8025, a multifunctional antibody as T cell and antigen-presenting cell (&#8220;APC&#8221;) modulator; AN1025, an oral small molecule degrader of &beta;-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. We anticipate submitting the IND for AN8025 in the second half of 2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We believe the next frontier in cancer immunotherapy lies in the category of combination therapies. Our drug candidates combine an immune checkpoint inhibitor with two or more additional cancer therapies in effort to elicit synergistic anti-cancer effects and improved tolerability relative to monotherapies. As we endeavor to engender complementary and synergistic results across our portfolio, our primary consideration is the potential interaction with our other pipeline candidates and/or currently available treatments. We strive to develop innovative antitumor candidates focusing on druggability as well as combinational strength to be leveraged in the next wave of immuno-oncology treatments, ultimately helping to shape the next-generation of cancer therapy. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Through our multi-national R&amp;D centers established in New Jersey and Hangzhou, we execute on our global vision for drug development innovation. The geographic span of our R&amp;D footprint empowers us to more effectively identify and develop novel early-stage programs, as well as recruit top R&amp;D talent from the U.S. and China. We have assembled a management team and a scientific advisory board with industry leaders </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">107</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">and influential scientists, who provide international and strategic guidance to our R&amp;D, business development and operational teams. In addition to building our own R&amp;D capabilities, we continue to seek and secure partnerships with leading multi-national pharmaceutical companies such as Eisai Co.,&#160;Ltd. or Eisai and Novartis Pharma AG or Novartis, to fully realize the potential of our pipeline programs. We believe our partnerships validate our clinical expertise and reflect belief in our ability to deliver on our development and commercialization capabilities across a versatile pipeline. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our pipeline</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are advancing a robust pipeline of innovative drug candidates in various stages of development. The following chart provides an overview of the status of our drug candidates: </font>
        </div>
        <div style="position:relative;margin-top:10.2pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-tbl_pipelin4c.jpg" alt="[MISSING IMAGE: tm2225088d1-tbl_pipelin4c.jpg]" height="271" width="603" >
        </div>
        <div style="margin-top:17.4pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AN2025: a pan-PI3K inhibitor aimed at becoming the vanguard for recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our lead product AN2025, the most clinically advanced drug candidate in our pipeline, is a pan-PI3K inhibitor currently undergoing a global Phase&#160;III trial. In-licensed from Novartis, we have the exclusive global rights to develop and commercialize AN2025. It is currently the only drug candidate we are aware of in active registrational clinical trial for the treatment of recurrent or metastatic HNSCC after disease progression with anti-PD-1/PD-L1 therapy. Although anti-PD-1/PD-L1 therapy is becoming first line treatment in patients with recurrent or metastatic HNSCC since its U.S. Food and Drug Administration (&#8220;FDA&#8221;) approval in 2019, the current treatments are unable to meet the needs of HNSCC patients progressed on prior anti-PD-1/PD-L1 treatment. We believe that AN2025, if approved, has potential to be the first product globally with such label to address this unmet medical need and capture the sizable addressable market. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">AN2025 is a widely studied molecule with Novartis alone having sponsored 40 clinical trials on over 4,200&#160;patients across a variety of cancers. These studies include a Phase&#160;II trial that demonstrated that the combination of AN2025 with paclitaxel achieved a superior median overall survival (&#8220;mOS&#8221;), and significant improvements in median progression-free survival (&#8220;mPFS&#8221;) and overall response rate (&#8220;ORR&#8221;) compared to the control group in recurrent or metastatic HNSCC after disease progression with platinum based chemotherapy. In July 2016, AN2025 was granted Fast Track designation by the FDA for the treatment of recurrent or metastatic HNSCC with disease progression on or after platinum-based therapy. For the Phase&#160;III trial, we expect to enroll 483 patients in more than 180 sites around the world, spanning over 18 markets in North America, Europe, Asia, and South America. Leveraging the benefit of using ORR data from the planned Phase&#160;III interim analysis, we expect to submit the NDA to the FDA seeking a potential accelerated approval in the second half of 2024, followed by further marketing approval applications to National Medical Products Administration (&#8220;NMPA&#8221;), European Medicines Agency (&#8220;EMA&#8221;), Pharmaceuticals and Medical Devices Agency (&#8220;PMDA&#8221;) and other authorities. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">108</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AN0025: a tumor microenvironment modulator</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">AN0025, in-licensed from Eisai, is a small molecule EP4 antagonist designed to modulate the tumor microenvironment. It is designed to block the prostaglandin E2 (&#8220;PGE2&#8221;)-EP4 signaling pathway to inhibit PGE2-mediated immunosuppression in cancer patients. In the CT26 murine colon cancer model, for those which are not responsive to anti-PD-1/PD-L1 therapy, AN0025 combined with an anti-PD-1 antibody treatment demonstrated stronger antitumor activity compared to each standalone compound. In June&#160;2020, we initiated a Phase&#160;Ib clinical trial to evaluate the combination of AN0025 and pembrolizumab for the treatment of recurrent NSCLC and urothelial cancer after anti-PD-1/PD-L1 treatments, as well as recurrent TNBC, MSS CRC and cervical cancer after standard of care treatments. As of June&#160;30, 2023, we were in the dose expansion stage having enrolled 63 patients in the U.S. and France, and expect to obtain top-line results in the second half of 2023. We aim to identify specific cancer types sensitive to this combination based on the results and will proactively communicate with the regulatory authorities for the design of Phase&#160;II/III registrational trials. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Triple combination of AN2025, AN0025 and atezolizumab: an example of our combination therapy strategy</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To fully explore the potential of AN2025 and AN0025, we initiated a study of the triple combination of AN2025, AN0025 and atezolizumab, an anti-PD-L1 antibody. This study exemplifies our combination therapy strategy to achieve synergistic effects from both targeted therapy and immunotherapy perspectives. AN2025 targets not only PI3K mediated tumorigenesis (e.g., via inhibition of PI3K&alpha; / PIK3CA mutants) but also the immunosuppression of the tumor microenvironment (e.g., via inhibition of PI3K&#948; and PI3K&#947;). Leveraging the complementary and synergistic antitumor effects of our drug candidates in combination therapies, AN2025 is designed to mechanistically complement and synergize with the combination of anti-PD-1/PD-L1 antibody and AN0025 to form an improved treatment regimen for patients with multiple advanced solid tumors. In different tumor-bearing mouse models, we have consistently observed significantly stronger antitumor activity in the triple combination of AN2025, AN0025 and atezolizumab compared with the doublet combinations. In July&#160;2021, we initiated a Phase&#160;I clinical trial to evaluate the triple combination of AN2025, AN0025, and atezolizumab, for a variety of PIK3CA mutant solid tumors. In September&#160;2022, subsequent to the doublet arm dose-ranging studies, we initiated a dose-ranging study for the triple combination, and we expect to identify the recommended Phase&#160;II dose (&#8220;RP2D&#8221;) in the second half of 2023. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AN4005: a backbone of our future oral combination therapies</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">AN4005, a drug candidate discovered in-house, is an oral small-molecule PD-L1 inhibitor designed to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Compared to the crowded development of anti-PD-1/PD-L1 antibodies, with multiple brands already available to patients and many potential candidates in clinical trials, small-molecule PD-L1 inhibitors are underdeveloped and do not have a drug approved in any jurisdiction globally, despite advantages such as shorter half-life that may allow for dose titration and schedule modifications to minimize immune-related AEs and lower production costs. In our preclinical studies, AN4005 was well tolerated and exhibited excellent tumor growth inhibition (&#8220;TGI&#8221;) to an extent comparable to an approved anti-PD-L1 antibody, and promoted an adaptive immune response for antitumor activities. We received allowance to proceed under INDs from the FDA and NMPA for the treatment of advanced tumors in June&#160;2021 and December 2021, respectively, dosed the first patient in January&#160;2022, and expect to identify the RP2D from the Phase&#160;I clinical trial in the second half of 2023. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our preclinical programs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We continue actively advancing three in-house preclinical programs which we believe have high global commercial viability. Our preclinical candidates include: AN8025, a multifunctional antibody as T cell and APC modulator; AN1025, an oral small molecule degrader of &beta;-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. We anticipate submitting the IND for AN8025 in the second half of 2024. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our company history and team</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We rebranded in 2016 as Adlai Nortye Biopharma and began development activities focusing on the discovery and development of innovative cancer therapies, after originally incorporating in 2004. We have </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">109</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">assembled an experienced management team consisting of successful entrepreneurs and industry veterans. Largely, our success stems from management&#8217;s leadership and industry expertise, covering the full spectrum of the cancer therapy development process, from design and execution of preclinical and clinical studies through the regulatory process and commercialization. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our management team has more than 100 cumulative&#160;years of industry experience and a proven track record of innovative drug R&amp;D, clinical development and commercialization. Our founder, chief executive officer, and chairman of our board of directors, Mr.&#160;Yang Lu is a successful entrepreneur who brings expertise across the domains of business development, operations, and management. Our president, chief medical officer and chief executive officer of our U.S. subsidiary, Dr.&#160;Lars Erik Birgerson, has extensive experience as a senior leader with numerous well-known companies in the biopharmaceutical industry, including Roche Pharmaceuticals, Genentech, and Bristol-Myers Squibb (&#8220;BMS&#8221;). Our senior vice president and global head of clinical operations, Dr.&#160;Kaiyang Tang, has deep experience in global clinical operations and regulatory affairs in the pharmaceutical industry, and has served as a clinical leader in a number of companies, including Generon (Shanghai) Corporation Ltd. and Hutchison MediPharma Ltd, a company triple listed on the Nasdaq, Hong Kong Stock Exchange, and Alternative Investment Market. Our senior vice president and global head of regulatory affairs, Dr.&#160;Victoria Elizabeth Demby has over 20&#160;years of industry experience and has served in various senior positions for several multinational pharmaceutical companies such as GSK, MSD, and BMS. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Since our inception, we have received strong support from our shareholders, including financial investors as well as several industry-leading strategic investors. This investor base is, and we expect will continue to be, aligned with our vision and strategy going forward. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our strengths</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe our competitive advantage is underpinned by the following competitive strengths: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Multi-modality pipeline with several innovative drug candidates targeting a range of tumor indications.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We plan to continue to leverage our expertise in drug discovery and our proficiency in executing promising collaborations and partnerships to bring innovative drugs to patients across the cancer type spectrum. Our candidates utilize a multitude of different mechanisms of action, enabling us to employ our assets on a standalone basis or in combination across tumor types and treatment combinations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Robust Phase&#160;II data laying a concrete foundation for potential registration.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp; In a Phase II clinical trial of our lead asset, AN2025, for the treatment of recurrent or metastatic HNSCC on or after disease progression with platinum-based chemotherapy, the clinical data showed that the combination of AN2025 with paclitaxel achieved an mOS of over 10&#160;months (vs. 6.5&#160;months in the placebo plus paclitaxel group), an mPFS of 4.6&#160;months (vs. 3.5&#160;months in the placebo plus paclitaxel group), and a 39.2% ORR (vs. 13.9% in the placebo plus paclitaxel group). These data also showed that when AN2025 was combined with paclitaxel, grade 3-4 adverse events (&#8220;AEs&#8221;) (82% in the AN2025 plus paclitaxel group vs. 72% in the placebo group), serious adverse events (&#8220;SAEs&#8221;) (57% in the AN2025 plus paclitaxel group vs. 47% in the placebo group) or on-treatment deaths (20% in the AN2025 plus paclitaxel group vs. 22% in the placebo group) is comparable to paclitaxel alone. The most frequent SAEs for AN2025 plus paclitaxel combination were pneumonia (7.89% vs. 7.69% in the placebo group), and diarrhea (5.26% vs. 0.00% in the placebo group). The most frequent SAEs for AN2025 plus paclitaxel combination that occurred less in the placebo group were diarrhea (5.26% vs. 0.00%), hyperglycaemia (3.95% vs. 0.00%), and general physical health deterioration (3.95% vs. 0.00%). See &#8220;Business &#8212; Our differentiated oncology portfolio &#8212; Buparlisib (AN2025): a pan-PI3K inhibitor aimed at becoming the vanguard for recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy&#8221; for a complete list of SAEs of AN2025 plus paclitaxel combination. In addition, the Phase&#160;II clinical trial was designed to be a thoroughly placebo-controlled double-arm study, which provides us with further confidence in the success of the ongoing Phase&#160;III clinical trial. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Targeting unmet medical need with large total addressable markets.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;AN2025 is designed to address globally urgent unmet medical demands for effective treatments of HNSCC after anti-PD-1/PD-L1 treatment. In seven major markets (the U.S., the U.K., Germany, France, Italy, Spain, and Japan), it is </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">110</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; text-align:justify; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">estimated that by 2028 there can be more than 50,000 recurrent or metastatic HNSCC patients experiencing progression after anti-PD-1/PD-L1 therapy. As the only drug candidate currently in Phase&#160;III clinical trial for the treatment of recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy of which we are aware, we believe that AN2025, if approved, has potential to be the first product globally to address this unmet need and capture the sizable addressable market. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Strong R&amp;D capabilities</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Spanning the full spectrum from target identification to clinical development, our in-house drug discovery platforms deploy a suite of powerful and specialized techniques. They consist of two platforms, PAINT-2D</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> and ANEAT-Id</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;">. PAINT-2D</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> provides us with a &#8220;one-stop&#8221; function for early-stage development of immuno-oncology therapies. ANEAT-Id</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> is a highly efficient and robust yeast display system dedicated to therapeutic antibody discovery and development. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Sustainable patent portfolio in our key jurisdictions.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As of June&#160;30, 2023, we owned or had the exclusive rights to (i)&#160;165 granted patents and 101 pending patent applications in jurisdictions such as the U.S., European Patent Office (&#8220;EPO&#8221;), mainland China, Japan, South Korea, Canada, Australia, Taiwan, Mexico and Brazil, and (ii)&#160;12 patent applications under the Patent Cooperation Treaty, or PCT, that have not been nationalized. Granted patents and pending patent applications cover the key inventions for our pipeline candidates in clinical trials under IND, as well as our key technologies. Protection over potential approved use of core matters of AN2025 and AN0025 can expire in 2032 and 2036, respectively, both taking into account of the possible 5-year patent term extensions in jurisdictions where patent term extension is available, including but not limited to the U.S., Europe, China and Japan. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Seasoned industry veterans and strong shareholder support</font><font style="font-weight:bold;letter-spacing:-0.2pt;">.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We believe our team, with a proven track record of innovative drug R&amp;D, clinical development, and commercialization knowledge, as well as rich expertise in business development and operational execution, can successfully drive our drug candidates to approval and clinical use on a global scale. Additionally, we are supported by the strategic guidance of a visionary scientific advisory board with members from both academia and the pharmaceutical industry. We have also received continued support from our shareholders including financial investors and several industry-leading strategic investors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our vision &amp; strategy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We strive to become a global leader in the next wave of immuno-oncology therapies employing a combination therapy strategy. Our mission is to transform deadly cancer into a chronic and eventually curable disease. We intend to execute the following strategies to achieve this goal: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Advance the development of and pursue regulatory approval for our lead drug candidate AN2025.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We have advanced AN2025, in combination with paclitaxel for the treatment of recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy into a Phase&#160;III clinical trial. We expect to enroll 483 patients across 180 sites in North America, Europe, Asia, and South America, and to submit an NDA to the FDA for a potential accelerated approval in the second half of 2024 leveraging the ORR data from the Phase&#160;III interim analysis, followed by further marketing approval applications to the NMPA, EMA, PMDA and other authorities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Continue advancing pipeline products through in-house development and strategic partnerships to maximize value.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As we evaluate assets, we place a strong emphasis on first-in-class potential, combinational synergies with our current pipeline or other available therapies, as well as global development and commercialization rights. We intend to continue to develop our novel drug candidates by leveraging our proprietary R&amp;D platforms, our strong early and clinical stage drug discovery expertise, as well as through the support of our various global collaborators. We intend to continue building upon our existing partnership success, exploring new opportunities through strategic collaborations and potentially co-development arrangements, ultimately maximizing the clinical and commercial value of our drug candidates. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Utilize manufacturing partnerships to maximize economies of scale.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We currently work with qualified contract manufacturing organizations, or CMOs, to manufacture drug candidates for preclinical and clinical supply. In the near future, we plan to continue outsourcing the manufacturing of our drug </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">111</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; text-align:justify; width:426pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">candidates, including commercial-scale manufacturing of our approved drugs, to industry-leading, highly reputable, and qualified CMOs/contract development and manufacturing organizations, or CDMOs globally. We have historically adopted and planned to continue to implement robust procedures to ensure that production qualifications, facilities, and processes of our CMOs/CDMOs comply with applicable regulatory requirements as well as our own internal guidelines and quality standards. We may also engage additional qualified CMOs/CDMOs in the future to ensure sufficient supply of drug candidates for our clinical trials as well as for commercial sale of our approved drugs. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Assemble a world-class marketing team to accelerate the adoption of emerging next-wave immuno-oncology treatments.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We aim to capture market share in the U.S. and gradually enter other significant markets including Europe, China, and Japan. To ensure maximum commercial value of our late-stage drug candidates globally, we intend to form our core in-house commercial leadership team by recruiting senior-level sales and marketing personnel to support commercialization of our drug candidates in the U.S. We may also consider strategic collaboration opportunities for the commercialization of our drug candidates in other countries in Europe and Asia. In particular, we may selectively out-license, establish joint ventures, or consider other forms of commercialization partnerships with leading biopharmaceutical companies. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Seek and nurture top talent to fuel our innovation and ingenuity.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We place a high priority on selecting and retaining top talent. Our R&amp;D centers in New Jersey and Hangzhou provide access to a global talent pool of highly skilled scientists and physicians. To support our continued growth, we plan to continue investing in recruiting and retaining top talent for our various operations around the world, including drug discovery, chemistry, manufacturing and controls (&#8220;CMC&#8221;), clinical development, regulatory affairs, and sales and marketing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Scientific background&#8201;&#8212;&#8201;cancer therapies: immunotherapy, combination therapy, and others.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cancer is a disease in which some of the body&#8217;s cells grow uncontrollable and potentially spread to other parts of the body. As the understanding of the human body&#8217;s functioning has evolved, it has become clear that cancer is caused by genetic abnormalities that lead to changes in cells&#8217; function, primarily how they grow and divide. Three types of genetic changes principally contribute to cancer: the upregulation of genes that promote cancer; the downregulation of genes that suppress cancer; and the dysfunction of genes that repair DNA damage. Conventional cancer treatments commonly used include radiation therapy, chemotherapy, and surgery. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although still a first-line treatment for some types of cancer, often chemotherapy cannot effectively control progression of advanced cancer and causes side effects significantly affecting the quality of patients&#8217; lives, which necessitates research and development of new therapies for cancer treatments. After a long process of historical development, the field of cancer treatment has advanced rapidly in recent decades, leading to more advanced treatment options represented by targeted therapies, and more recently, immunotherapies. These therapies aim to improve patient outcomes while mitigating systemic adverse effects. Targeted therapy and immunotherapy, through targeting specific oncogenic pathways and leveraging patients&#8217; immune systems respectively, can benefit patients in terms of improved efficacy, reduced symptoms, or better quality of life. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Targeted therapy is a form of cancer treatment that encompasses chemical drugs and biological products, and targets proteins that regulate cancer cells&#8217; growth, division, and spread. As small molecules, chemical drugs can enter cells easily and are usually designed to target tumor-specific proteins inside cancer cells. Biological products, especially antibodies, identify targets on the surface of cancer cells and consequently are designed to directly identify and fight cancer cells, carry anti-tumor chemical toxins to the cancer cells, or mark cancer cells to facilitate easy targeting and destruction by the immune system. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Immunotherapy is a type of cancer treatment that helps the immune system fight cancer. The human immune system can recognize and attack foreign substances and protect its own cells from those attacks. However, cancer cells escape attack in various ways. For example, cancer cell may &#8220;pretend&#8221; to be healthy cells by completing a &#8220;handshake&#8221; with immune cells called T cells. Another way is through building a tumor microenvironment that silences the immune system. Immune checkpoint inhibitors, mostly biological products such as anti-PD-1/PD-L1 antibodies, can block the &#8220;handshake&#8221; between cancer cells and T cells, thereby enabling T cells to recognize and attack cancer cells as foreign objects. Drugs that target tumor </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">112</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">microenvironments are designed to reverse the tumor-associated immunosuppressive state. The tumor microenvironment is a complex ecosystem, which includes immune cells, the extracellular matrix, blood vessels, and other cells such as fibroblasts. Therefore, drugs targeting tumor microenvironments are designed to function in different ways, such as reducing immunosuppressive cells surrounding a tumor or suppressing generation of blood vessels. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cancer development and progression is a complex process that can involve multiple levels of cell functional disorders. Combination therapy that addresses disorders through different mechanisms is considered a promising next generation cancer treatment. Many studies have shown that immunotherapeutic combinations can significantly boost response rates in cancer patients as compared to monotherapies. An increasing number of studies are testing combinations with previously failed monotherapy drug candidates or shelved drugs. Moreover, scientists believe that targeted therapy can be potentiated by combination with immunotherapy, because the combination will make cancer cells more susceptible to the immune system and thus potentially yield both higher response rates and longer treatment benefit. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Despite the promising future of combination therapy, there are challenges to overcome, especially escalated safety issues observed in many previously failed combinations. Therefore, deep understanding of cancer biology and strong R&amp;D and preclinical and clinical design and execution capabilities are needed to develop the right paring, sequencing, timing, and dosage of therapies. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our differentiated oncology portfolio</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Buparlisib (AN2025): a pan-PI3K inhibitor aimed at becoming the vanguard for recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our lead drug candidate, buparlisib, or AN2025, is a global registrational trial-stage pan-PI3K inhibitor, which specifically targets the PI3K signaling pathway and reverses the immunosuppressive tumor microenvironment through inhibition of class I PI3Ks. We have the exclusive global rights to develop and commercialize AN2025 through in-licensing agreement with Novartis. For more details, see &#8220;&#8212; License and collaboration agreements&#8201;&#8212;&#8201;Collaboration with Novartis&#8221;. Novartis has conducted 40 clinical trials on over 4,200 patients across a variety of tumor types and a multi-center Phase&#160;II clinical trial of AN2025 demonstrated strong antitumor activity and a manageable safety profile in combination with paclitaxel in the treatment of recurrent or metastatic HNSCC on or after disease progression with platinum based chemotherapy. In July 2016, AN2025 was granted Fast Track designation by the FDA for the treatment of recurrent or metastatic HNSCC with disease progression on or after platinum-based therapy. We are now advancing AN2025 in combination with paclitaxel for the treatment of recurrent or metastatic HNSCC after anti-PD-1/PD-L1 therapy in a Phase&#160;III clinical trial, in which we expect to enroll a total of 483 patients in more than 180 sites around the world, spanning over 18 significant markets in North America, Europe, Asia, and South America. We expect to complete the patient enrollment in the fourth quarter of 2023, and submit an NDA to the FDA for the potential accelerated approval using the ORR readout in the second half of 2024, followed by further marketing approval applications to the NMPA, EMA, PMDA, and other authorities. To the best of our knowledge, AN2025 is currently the only drug candidate in Phase&#160;III clinical development for the treatment of recurrent or metastatic HNSCC after disease progression with anti-PD-1/PD-L1 therapy. We believe that AN2025, if approved, has the potential to be the first drug product with such label globally to address this unmet medical need and capture the sizable addressable market. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Background on HNSCC</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Head and neck cancers are defined as any cancer that begins in cells of the oral cavity, pharynx, nose, sinuses, or salivary glands. The overwhelming majority (&gt;90%) of head and neck cancers are squamous cell carcinomas (&#8220;HNSCC&#8221;). HNSCC is one of the most morbid, mortal, and genetically diverse malignancies. Studies show that HNSCC can be caused by various risk factors including tobacco consumption, alcohol abuse, viral infections (e.g., HPV or Epstein-Barr virus), and other carcinogens such as radiation exposures and occupational exposures to wood dust, nickel dust, or formaldehyde. Most patients present with locally advanced disease with a high risk of recurrence, and approximately 10% of HNSCC patients present with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">113</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">metastatic disease. Platinum-based chemotherapy was the standard regimen that dominated the treatment of first-line recurrent or metastatic HNSCC for 30&#160;years with a mOS of less than 9&#160;months. Despite initial responses to chemotherapy, many patients experience recurrence, which can later progress into advanced stages of these diseases with debilitating symptoms impacting their quality of life. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">An illustration of head and neck cancer regions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.81pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-pht_head4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-pht_head4clr.jpg]" height="255" width="303" >
        </div>
        <div style="margin-top:5.1pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5.8pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Source: National Institutes of Health </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Targeted therapy was the first major alternative treatment for first-line recurrent or metastatic HNSCC. In 2011, cetuximab, a chimeric monoclonal antibody that targets EGFR, in combination with platinum-based therapy plus fluorouracil was approved as a first-line treatment for HNSCC by the FDA. Compared to chemotherapy alone, this treatment regimen has an improved efficacy with a higher response rate of about 36% and extends mOS to 10.1&#160;months. In the next few&#160;years, immunotherapy became the most popular area of cancer research and was accepted by medical authorities for its durable response and long-term survival, which largely changed the therapeutic landscape of cancer. Currently, there are two anti-PD-1 antibodies, i.e., pembrolizumab (Keytruda) and nivolumab (Opdivo) approved by the FDA for the treatment of recurrent or metastatic HNSCC. Pembrolizumab was the first immune checkpoint inhibitor approved for the treatment of HNSCC. It was first approved in the U.S. and Europe for second-line treatment of recurrent or metastatic HNSCC in 2016, and later approved for first-line treatment in 2019. Pembrolizumab alone or in combination with chemotherapy significantly prolonged mOS to around 14&#160;months, tripled the five-year survival rate compared to cetuximab in combination with chemotherapy, and also exhibited a favorable safety profile. As a result, it became the mainstream drug for first-line treatment of HNSCC in major developed countries in the U.S., Europe, and Japan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, it is observed that most recurrent or metastatic HNSCC patients do not respond to immunotherapy (manifested by a response rate of ~23%) and about 85% patients experience disease progression after immunotherapy. At present, these patients can only use chemotherapies, cetuximab, or combined chemotherapy drugs that were marketed in this therapeutic field before the advent of immunotherapy, notwithstanding that these treatment options have never been verified by registrational clinical trials on efficacy in progressed HNSCC patients. Presently, there is an unmet medical need for more effective therapies for recurrent or metastatic HNSCC patients after anti-PD-1/PD-L1 treatment approved by medical authorities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Mechanism of action</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">PI3K regulates many physiologic cellular functions, including protein synthesis and glucose metabolism, cell survival growth, proliferation, cell migration, and angiogenesis. It is a family of phospholipid kinase, which is categorized into three classes based on structure, function, and substrate specificity. Class&#160;I PI3Ks are widely implicated in cancer. They function as heterodimers consisting of one catalytic subunit selecting from </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">114</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">p110&alpha;, p110&#223;, p110&#948;, and p110&#947;, and one regulatory subunit selecting from p85&alpha; (or its splice variants p55&alpha; and p50&alpha;), p85&#223;, p55&#947;, p101, and p84. Between the two subunits, the catalytic subunit plays the central role of performing the action of PI3K, which is to convert PIP2 to PIP3, and the regulatory subunit regulates the catalytic subunit&#8217;s activation in response to the absence or presence of upstream stimulation by growth factors. Depending on the catalytic subunit, class I PI3K is categorized into four isoforms PI3K&alpha;, PI3K&#223;, PI3K&#948;, and PI3K&#947;. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon activation (e.g., by growth factor stimulation) of the PI3K signaling pathway, PI3K converts PIP2 to PIP3, a lipid second messenger that binds to the pleckstrin homology domain of target proteins and recruits them to the inner surface of the plasma membrane. The best understood PI3K target is AKT/PKB, a serine/</font>&#8203;<font style="letter-spacing:0.2pt;">threonine kinase, which functions as a &#8220;molecular hub&#8221; to regulate diverse cellular functions such as cell proliferation, growth, metabolism, survival, and angiogenesis. PI3K signaling can be negatively regulated by action of dual specificity protein phosphatases, also known as 3-PI phosphatases. The prototype member of this family of phosphatases is the tumor suppressor phosphatase and tensin homologue (&#8220;PTEN&#8221;), which has the potential to attenuate the downstream signaling of multiple PI3K complexes. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Evidence suggests that constitutive PI3K activation is a critical step in mediating the transforming potential and growth stimulating activity of various oncogenes and tumor suppressors, which contribute to the onset and growth of many solid tumors as well as tumors of the hematopoietic system. Activation of the PI3K signaling pathway will lead to the subsequent activation of downstream pathways, including the PI3K/</font>&#8203;<font style="letter-spacing:0.2pt;">AKT/mTOR signaling pathway. The PI3K/AKT/mTOR pathway is an important intracellular signaling network that regulates cellular metabolism, proliferation, and survival. Abnormal activation of the PI3K/</font>&#8203;<font style="letter-spacing:0.2pt;">AKT/mTOR pathway has been identified as an important step in the initiation and maintenance of tumors and a key regulator of angiogenesis and upregulated metabolic activities in tumor cells. Activation of the PI3K pathway frequently occurs in HNSCC, through a number of mechanisms including PIK3CA or PTEN molecular alterations, overexpression of EGFR, or in association with HPV infection. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our lead product AN2025 is designed to specifically inhibit PI3K&alpha; isoform (and PI3K&#223; to a lesser extent) in the PI3K/AKT signaling pathway in an adenosine triphosphate (ATP)-competitive manner, inhibiting the production of the PIP3 and the subsequent activation of the PI3K signaling pathway, including the PI3K/</font>&#8203;<font style="letter-spacing:0.2pt;">AKT/mTOR signaling pathway. As a pan-PI3K inhibitor, it also targets PI3K&#948; and PI3K&#947;, which play important roles in the immune system, empowering it to be a partner for combination therapies. For details, see &#8220;&#8212; Triple combination of AN2025, AN0025, and Tecentriq, or atezolizumab&#8221;. </font></div>
        <div style="position:relative;margin-top:10.1pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-pht_action4c.jpg" alt="[MISSING IMAGE: tm2225088d1-pht_action4c.jpg]" height="275" width="333" >
        </div>
        <div style="margin-top:17.2pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Summary of preclinical results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In a study conducted on mice transfected with FaDu cells, an HNSCC cell line, AN2025 (previously known as BKM120) showed down regulation of AKT in tumor in the animals treated with doses equivalent to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">115</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">patient&#8217;s maximum tolerated dose (&#8220;MTD&#8221;), to an extent more significant than BEZ235 (also known as dactolisib, another PI3K inhibitor developed by Novartis). </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-tbl_summary4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-tbl_summary4clr.jpg]" height="215" width="384" >
        </div>
        <div style="margin-top:5.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5.9pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Source: https://doi.org/10.1158/0008-5472.CAN-11-2263 </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In an animal study we conducted before the initiation of our Phase&#160;III clinical trial, AN2025 showed an encouraging outcome for the treatment of anti-PD-1 antibody refractory tumors. In anti-PD-1 antibody refractory tumor bearing mice, single agent treatment with AN2025 significantly inhibited tumor growth in a dose range consistent with doses equivalent to patient&#8217;s MTD. This animal model result suggests AN2025 could potentially address anti-PD-1 antibody refractory tumors. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Activity of AN2025 in anti-PD-1 antibody refractory CT26 mice model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_activity4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_activity4clr.jpg]" height="208" width="357" >
        </div>
        <div style="margin-top:16.8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Summary of clinical trial results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Phase&#160;Ia trial in patients with advanced solid tumors by Novartis</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial design</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This trial was a Phase&#160;Ia, multi-center, open-label dose escalation study of AN2025 in patients with advanced solid tumors. A total of 83 patients enrolled in five clinical sites in the U.S., Canada, Spain, and Netherlands. The study was designed to consist of two stages. One was the dose escalation phase, during which patients were assigned to cohorts over six dose levels: 12.5 mg/day, 25 mg/day, 50 mg/day, 80&#160;mg/day, 100 mg/day, and 150 mg/day. At the end of the dose escalation phase where the MTD was declared, the next stage, an MTD expansion phase, was initiated enrolling additional patients with advanced solid tumors. The primary objective of this study was to determine the MTD of AN2025 as a monotherapy. The secondary objectives included assess the safety, tolerability, pharmacokinetic (&#8220;PK&#8221;) portfolio, pharmacodynamics (&#8220;PD&#8221;), and preliminary evidence of efficacy of AN2025. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial status</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This trial was completed in August&#160;2012. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">116</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Safety data</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All patients reported at least one AE, with the most commonly reported (&ge; 30%) AEs being nausea (45.8%), decreased appetite (42.2%), asthenia (37.3%), diarrhea (36.1%), hyperglycemia (33.7%), rash (31.3%), and constipation (30.1%). The AE profile of patients treated at the determined MTD (100&#160;mg/day) was similar to the overall AE profile, with the most commonly reported AEs being nausea (27&#160;patients, 49.1%), asthenia (26 patients, 47.3%), diarrhea (25 patients, 45.5%), decreased appetite (22&#160;patients, 40.0%), hyperglycemia (19 patients, 34.5%), rash (18 patients, 32.7%), and constipation (18&#160;patients, 32.7%). Overall, 68.7% of patients experienced at least one grade 3&#8211;4 AE. In patients treated at MTD of 100mg/day, the incidence of grade 3&#8211;4 AE was 65.5%. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Of all patients treated with AN2025, 36 (43.4%) experienced SAE, including four patients in the 50 mg/day dose group (80%), four patients in the 80 mg/day group (36.4%) and 23 patients in the 100 mg/day group (41.8%), four patients in the 150 mg/day group (100%) and 1 patient in the TEC 100mg/day group (20%). Eleven patients experienced SAEs suspected to be drug-related including one patient in the 80 mg/day dose group (9.1%), and seven patients in the 100 mg/day group (12.7%), and three patients in the 150 mg/day group (75.0%). The most frequent SAEs suspected to be treatment-related were hyperglycemia, diarrhea and fatigue. 29 (34.9%) patients died during the study, with 13 (15.7%) deaths occurring on treatment or up to 28&#160;days after end of treatment. None of the deaths were considered by the investigator to be related to the study treatment.</font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Summary of deaths and AEs of patients being treated with AN2025</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:203.18pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:153.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Category </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:26.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">12.5 mg </font>
                <br >
                <font style="letter-spacing:-0.16pt;">N=1</font>
                <br >
                <font style="letter-spacing:-0.16pt;">n (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">25 mg </font>
                <br >
                <font style="letter-spacing:-0.16pt;">N=2</font>
                <br >
                <font style="letter-spacing:-0.16pt;">n (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">50 mg </font>
                <br >
                <font style="letter-spacing:-0.16pt;">N=5</font>
                <br >
                <font style="letter-spacing:-0.16pt;">n (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:30.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">80 mg </font>
                <br >
                <font style="letter-spacing:-0.16pt;">N=11</font>
                <br >
                <font style="letter-spacing:-0.16pt;">n (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:33.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">100 mg </font>
                <br >
                <font style="letter-spacing:-0.16pt;">N=55</font>
                <br >
                <font style="letter-spacing:-0.16pt;">n (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">150 mg </font>
                <br >
                <font style="letter-spacing:-0.16pt;">N=4</font>
                <br >
                <font style="letter-spacing:-0.16pt;">n (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">TEC </font>
                <br >
                <font style="letter-spacing:-0.16pt;">100 mg</font>
                <br >
                <font style="letter-spacing:-0.16pt;">N=5</font>
                <br >
                <font style="letter-spacing:-0.16pt;">n (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:33.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">All </font>
                <br >
                <font style="letter-spacing:-0.16pt;">patients</font>
                <br >
                <font style="letter-spacing:-0.16pt;">N=83</font>
                <br >
                <font style="letter-spacing:-0.16pt;">n (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:2.77pt 0pt 1.29pt 0pt; width:153.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">All deaths </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.77pt 0pt 1.29pt 0pt; width:26.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.77pt 0pt 1.29pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.77pt 0pt 1.29pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">3 (60.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.77pt 0pt 1.29pt 0pt; width:30.74pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">3 (27.3) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.77pt 0pt 1.29pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">21 (38.2) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.77pt 0pt 1.29pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (25.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.77pt 0pt 1.29pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (20.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.77pt 0pt 1.29pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">29 (34.9) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:153.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">AEs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:26.34pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">2 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">5 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:30.74pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">11 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">55 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">4 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">5 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">83 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:153.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">AEs suspected to be drug- related </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:26.34pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">2 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">4 (80.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:30.74pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">9 (81.8) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">54 (98.2) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">4 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">3 (60.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.03pt 0pt 1.28pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">77 (92.8) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:153.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Grade 3-4 AEs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:26.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (50.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">4 (80.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:30.74pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">8 (72.7) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">36 (65.5) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">4 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">4 (80.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">57 (68.7) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:153.87pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Suspected to be drug- related G3-4 </font>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:26.34pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:28.68pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:28.68pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:30.74pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:33.18pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:28.68pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:28.68pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:33.18pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:153.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">AEs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:26.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (50.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:30.74pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">3 (27.3) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">25 (45.5) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">3 (75.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (20.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.04pt 0pt 1.27pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">33 (39.8)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:153.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">SAEs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:26.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">4 (80.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:30.74pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">4 (36.4) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">23 (41.8) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">4 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (20.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">36 (43.4) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:153.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Suspected to be drug- related SAEs </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:26.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:30.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (9.1) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">7 (12.7) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">3 (75.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.05pt 0pt 1.26pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">11 (13.3) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.96999999999997pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.06pt 0pt 1.25pt 0pt; width:153.87pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">AEs leading to discontinuation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.06pt 0pt 1.25pt 0pt; width:26.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.06pt 0pt 1.25pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.06pt 0pt 1.25pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (20.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.06pt 0pt 1.25pt 0pt; width:30.74pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">2 (18.2) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.06pt 0pt 1.25pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">13 (23.6) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.06pt 0pt 1.25pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (25.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.06pt 0pt 1.25pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">3 (60.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:3.06pt 0pt 1.25pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">20 (24.1) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:153.87pt;white-space:normal;text-align:left;">
              <div style="line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">AEs, suspected to be drug-related, leading to discontinuation </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:26.34pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:28.68pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">0 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:30.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (9.1) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">11 (20.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (25.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (20.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">14 (16.9) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.77pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:153.87pt;white-space:normal;text-align:left;">
              <div style="line-height:10.78pt;">
                <font style="letter-spacing:0.18pt;">AEs requiring dose interruption and/or reduction </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:26.34pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (100) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (50.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">3 (60.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:30.74pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">7 (63.6) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">42 (76.4) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">2 (50.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:28.68pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">1 (20.0) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:1.86pt 0pt 0.66pt 0pt; width:33.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.18pt;">57 (68.7)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.61pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5.8pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Abbreviation: TEC=terminal elimination half-life assessment cohort. </font>
        </div>
        <div style="margin-top:2pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Source: Novartis Clinical Trial Results Website </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Efficacy data</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Among 83 patients treated with AN2025, there was one confirmed partial response (&#8220;PR&#8221;), and 33 patients (39.8%) had a best overall response of stable disease (&#8220;SD&#8221;). The disease control rate (&#8220;DCR&#8221;) for patients in the MTD/RP2D cohort was 41.8%. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conclusion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;AN2025, at the MTD of 100 mg/day, was well tolerated with preliminary antitumor activity. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Phase&#160;II trial in patients with recurrent or metastatic HNSCC by Novartis</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial design</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The trial was a multi-center, randomized, double-blind, placebo-controlled Phase&#160;II study assessing patients with histologically or cytologically-confirmed recurrent or metastatic HNSCC after disease progression on or after one previous platinum-based chemotherapy regimen in the metastatic setting. A total of 158 eligible patients were enrolled from 58 centers across 18 jurisdictions and randomly assigned (1:1) to receive second-line oral AN2025 (n=79, 76 treated with 100 mg once daily) or placebo (n=79, 78 treated with 80 mg/m</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;"> on days 1, 8, 15 and 22) plus intravenous paclitaxel in 28-day treatment cycles. The primary endpoint </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">117</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:4pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">of this study was PFS for the patients. Secondary endpoints included safety and PK profile and other efficacy measurements such as OS, ORR, time to response (&#8220;TTR&#8221;), DCR, duration of response (&#8220;DoR&#8221;), and health related quality of life (&#8220;HRQoL&#8221;). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial status</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This trial was completed in March&#160;2017. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Demographic and baseline characteristics.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The following table sets forth the age, demographic, and ECOG for the 158 randomized patients. </font>
        </div>
        <table style="width:416pt;height:62.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:291.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:50.2pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">AN2025 arm</font>
                <br >
                <font style="letter-spacing:-0.16pt;">N=79 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:50.2pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Placebo arm</font>
                <br >
                <font style="letter-spacing:-0.16pt;">N=79 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:291.61pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Median age in&#160;years (25</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">&#8201;&#8211;&#8201;75</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> percentile) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:50.2pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">59.0 (53-65) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:50.2pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">58.0 (53-65) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.61pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Distribution male/female </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:50.2pt;">
              <font style="letter-spacing:0.2pt;">65/14 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:50.2pt;">
              <font style="letter-spacing:0.2pt;">68/11 </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:291.61pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Distribution ECOG at baseline 0/1/2/missing </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:50.2pt;">
              <font style="letter-spacing:0.2pt;">31/48/0/0 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:50.2pt;">
              <font style="letter-spacing:0.2pt;">25/53/0/1</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.69pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.19pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Abbreviation: ECOG=Eastern Cooperative Oncology Group </font>
        </div>
        <div style="margin-top:2pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Source: http://doi.org/10.1016/S1470-2045(17)30064-5</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Efficacy data</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This trial met the primary endpoint of PFS based on the protocol pre-specified criteria. Median PFS in this trial was 4.6&#160;months in the AN2025 in combination with paclitaxel treatment arm and 3.5&#160;months in the placebo in combination with paclitaxel treatment arm. The study also met the key secondary endpoint of OS based on the protocol pre-specified criteria. The median OS showed a 3.9-month difference in favor of the AN2025 arm. The clinical result suggested that adding AN2025 to paclitaxel for the treatment of recurrent or metastatic HNSCC improved the median OS to over 10&#160;months (i.e., 10.4&#160;months compared to 6.5&#160;months in the placebo plus paclitaxel group), a superior outcome in the treatment of recurrent or metastatic HNSCC on or after disease progression with platinum-based chemotherapy. The study also demonstrated a clinically meaningful improvement of an approximately three-fold increase in ORR by local investigator assessment (39.2% vs 13.9%) favoring AN2025 arm. In addition, TTR (~1.0 month) and DCR (~56%) were similar in both study arms; median time to deterioration was 5.6&#160;months in AN2025 arm and 4.2&#160;months in the placebo arm while DoR was 3.06 (2.1&#8211;9.6) months in AN2025 arm compared with 4.17 (2.7&#8211;5.6) months in the placebo arm. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Progression free and overall survival data</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_survival4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_survival4clr.jpg]" height="272" width="424" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">118</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_data4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_data4clr.jpg]" height="277" width="423" >
        </div>
        <div style="margin-top:5.1pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5.9pt; width:456pt; line-height:10pt;">
          <font style="letter-spacing:0.16pt;">Source: http://doi.org/10.1016/S1470-2045(17)30064-5</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Safety data</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Grade 3-4 AEs were reported in 62 (82%) of 76 patients in the AN2025 in combination with paclitaxel treatment arm and 56 (72%) of 78 patients in the placebo in combination with paclitaxel treatment arm. The most common grade 3-4 AEs with AN2025 treatment in combination with paclitaxel were hyperglycemia (22%), anemia (18%), neutropenia (17%), and fatigue (8%). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">SAEs (regardless of relation to study treatment) were reported in 43 (57%) of 76 patients in the AN2025 in combination with paclitaxel treatment arm and in 37 (47%) of 78 patients in the placebo in combination with paclitaxel treatment arm. The most frequent SAEs for AN2025 plus paclitaxel combination were pneumonia (7.89% vs. 7.69% in the placebo group), and diarrhea (5.26% vs. 0.00% in the placebo group). The most frequent SAEs for AN2025 plus paclitaxel combination that occurred less in the placebo group were diarrhea (5.26% vs. 0.00%), hyperglycaemia (3.95% vs. 0.00%), and general physical health deterioration (3.95%&#160;vs. 0.00%). A summary of SAEs of AN2025 plus paclitaxel combination and placebo plus paclitaxel combination is set out below. </font>
        </div>
        <table style="width:456pt;height:251.76pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:76.8pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Buparlisib + Paclitaxel </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:139.56pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Buparlisib Matching Placebo + Paclitaxel </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt; width:76.8pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Affected / at Risk (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt; width:139.56pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Affected / at Risk (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.263pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">43/76 (56.58)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">37/78 (47.44)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.513pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Blood and lymphatic system disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Anaemia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">3/76 (3.95)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">3/78 (3.85)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Febrile neutropenia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Leukopenia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Neutropenia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/76 (2.63)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Thrombocytopenia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.493pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Cardiac disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.493pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Cardiac arrest</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.493pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Sinus bradycardia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.493pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Endocrine disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.493pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Hypercalcaemia of malignancy</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.483pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Eye disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.483pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Blindness</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28)% </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.483pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Gastrointestinal disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.483pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Abdominal pain</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/76 (2.63%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.483pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Aorto-oesophageal fistula</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.473pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Diarrhoea</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">4/76 (5.26%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.473pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Dysphagia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/76 (2.63%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">3/78 (3.85%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.473pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Gastrointestinal haemorrhage</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 0.5pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 0.5pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">119</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;min-height:645.76pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt; width:215.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt; width:76.8pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Buparlisib + Paclitaxel </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt; width:139.56pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Buparlisib Matching Placebo + Paclitaxel </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt; width:215.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt; width:76.8pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Affected / at Risk (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt; width:139.56pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Affected / at Risk (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Mouth haemorrhage</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Nausea</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Oesophageal obstruction</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Oesophagitis</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Oral cavity fistula</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Stomatitis</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Upper gastrointestinal haemorrhage</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Vomiting</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/76 (2.63%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">General disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Asthenia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/76 (2.63%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Face oedema</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Fatigue</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">4/78 (5.13%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">General physical health deterioration</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">3/76 (3.95%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Non-cardiac chest pain</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Pain</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Pyrexia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Systemic inflammatory response syndrome</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Hepatobiliary disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Hepatic failure</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Jaundice</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Infections and infestations</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Anal abscess</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/76 (2.63%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Bronchitis</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Candida sepsis</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Chest wall abscess</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Clostridium difficile colitis</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Erysipelas</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Herpes zoster</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Lower respiratory tract infection</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Lung abscess</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Lung infection</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/76 (2.63%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Pneumonia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">6/76 (7.89%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">6/78 (7.69%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Post procedural infection</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Pulmonary tuberculosis</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Respiratory tract infection</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Sepsis</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Septic shock</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">3/76 (3.95%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Urinary tract infection</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Wound infection</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/76 (2.63%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Injury, poisoning and procedural complications</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Femur fracture</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Post procedural discharge</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Post procedural fistula</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Post procedural haemorrhage</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Spinal compression fracture</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Investigations</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Blood creatinine increased</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Neutrophil count decreased</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Metabolism and nutrition disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Cachexia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">3/78 (3.85%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Decreased appetite</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">3/76 (3.95%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Dehydration</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/76 (2.63%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Hypercalcaemia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Hyperglycaemia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">3/76 (3.95%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">120</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:573.62pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:76.8pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Buparlisib + Paclitaxel </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:139.56pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Buparlisib Matching Placebo + Paclitaxel </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:215.64pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt; width:76.8pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Affected / at Risk (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt; width:139.56pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Affected / at Risk (%) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.263pt 0pt 1.097pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Hypocalcaemia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.263pt 0pt 1.097pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.513pt 0pt 1.097pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Hypoglycaemia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 1.097pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.513pt 0pt 1.097pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Hypokalaemia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Hypomagnesaemia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Musculoskeletal and connective tissue disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Spinal pain</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8.98pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:1.837pt 0pt 0.773pt 0pt; width:215.64pt;white-space:normal;text-align:left;">
              <div style="margin-left:8pt; text-indent:-8pt;">
                <font style="letter-spacing:-0.16pt;">Neoplasms benign, malignant and unspecified (incl cysts and polyps)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.11pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.11pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Cancer pain</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Malignant neoplasm progression</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.503pt 0pt 1.107pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Tumour haemorrhage</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">3/76 (3.95%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">5/78 (6.41%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Tumour invasion</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Nervous system disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Dizziness</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Hypoaesthesia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.493pt 0pt 1.117pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Intracranial pressure increased</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Ischaemic cerebral infarction</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Neuralgia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Paraplegia</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Somnolence</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.483pt 0pt 1.127pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999999pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.473pt 0pt 1.137pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Spinal cord compression</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 1.137pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 1.137pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.473pt 0pt 1.137pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Syncope</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 1.137pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 1.137pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.473pt 0pt 1.137pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Product Issues</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.473pt 0pt 1.137pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Device connection issue</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 1.137pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.473pt 0pt 1.137pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.473pt 0pt 1.137pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Psychiatric disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Acute psychosis</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Aggression</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Completed suicide</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Mental status changes</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Renal and urinary disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Renal failure</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.463pt 0pt 1.147pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Respiratory, thoracic and mediastinal disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Acute respiratory failure</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/76 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Dyspnoea</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/76 (2.63%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Haemoptysis</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Pneumonia aspiration</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.453pt 0pt 1.157pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Pneumonitis</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Pneumothorax</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Pulmonary embolism</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Respiratory arrest</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Respiratory failure</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.443pt 0pt 1.167pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">2/78 (2.56%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.433pt 0pt 1.177pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Upper airway obstruction</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.433pt 0pt 1.177pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.433pt 0pt 1.177pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.97999999999996pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.433pt 0pt 1.177pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Skin and subcutaneous tissue disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.433pt 0pt 1.177pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Erythema</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.433pt 0pt 1.177pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.433pt 0pt 1.177pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.433pt 0pt 1.177pt 0pt; width:215.64pt;text-align:left;">
              <font style="letter-spacing:-0.16pt;">Vascular disorders</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:76.8pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:139.56pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.433pt 0pt 1.177pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Arterial rupture</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.433pt 0pt 1.177pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.433pt 0pt 1.177pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.423pt 0pt 1.187pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Hypotension</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.423pt 0pt 1.187pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.423pt 0pt 1.187pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/78 (1.28%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.98000000000002pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:2.423pt 0pt 1.187pt 0pt; width:215.64pt;text-align:left;">
              <div style="margin-left:8pt;">
                <font style="letter-spacing:0.16pt;">Phlebitis</font><font style=" position:relative; bottom:3.25pt;font-size:5pt;letter-spacing:0.12pt;">&#8224;1</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.423pt 0pt 1.187pt 0pt; width:76.8pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">1/76 (1.32%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.423pt 0pt 1.187pt 0pt; width:139.56pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">0/78 (0.00%)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.31pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.19pt; width:456pt; line-height:10pt;">
          <font style="letter-spacing:0.16pt;">Notes: </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:5.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">1</font>
          <br >
        </div>
        <div style=" margin-top:5.19pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Term from vocabulary, MedDRA (19.1) </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:5.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">&#8224;</font>
          <br >
        </div>
        <div style=" margin-top:5.19pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Indicates events were collected by systematic assessment </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:4pt; width:456pt; line-height:10pt;">
          <font style="letter-spacing:0.16pt;">Source: clinicaltrials. gov </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">121</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The frequency of hyperglycemia was higher with AN2025 versus placebo, suggesting effective PI3K on-target inhibition. Known AEs associated with AN2025, including hyperglycemia and gastrointestinal AEs (e.g., stomatitis, diarrhea, nausea, and vomiting) were managed with established strategies of dose reduction and treatment of symptoms with appropriate concomitant medications. The proportions of patients discontinuing treatment because of AEs were similar in AN2025 and placebo groups, suggesting that AN2025 did not substantially increase paclitaxel toxicity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There were a total of 110 deaths reported among patients in the safety set with 32 being on-treatment deaths. Among the 32 on-treatment deaths, 15 (20%) patients were in the AN2025 plus paclitaxel group, and 17 patients (22%) were in the placebo plus paclitaxel group. In the AN2025 plus paclitaxel group, nine deaths were due to study indication and six deaths were due to AEs. No on-treatment deaths were suspected by the investigator to be study treatment related.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conclusion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The results of this trial warranted further development of AN2025 in combination with paclitaxel in patients with platinum-pretreated recurrent or metastatic HNSCC. In July 2016, the FDA concluded that AN2025 met the criteria for the &#8220;Fast Track&#8221; designation and designated the investigation of AN2025 for recurrent or metastatic HNSCC with disease progression on or after platinum-based therapy as a Fast Track development program. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Phase&#160;III multi-center clinical trial of AN2025 in combination with paclitaxel for the treatment of patients with recurrent or metastatic HNSCC after anti-PD-1/PD-L1 treatment</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The evolving therapeutic landscape of first-line HNSCC led us to pivot treatment background from platinum pre-treated to anti-PD-1/PD-L1 based therapy pre-treated patients for the clinical design of Phase&#160;III trial to capture the sizable addressable market. Based on the strong preclinical evidence and encouraging Phase&#160;II clinical results, we are currently conducting a global Phase&#160;III multi-center clinical trial of AN2025 in combination with paclitaxel for the treatment of patients with recurrent or metastatic HNSCC after anti-PD-1/PD-L1 treatment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial design</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The study is a randomized, open-label Phase&#160;III study to assess the treatment effect of AN2025 in combination with paclitaxel in patients with recurrent and metastatic HNSCC that have progressed after anti-PD-1/PD-L1 treatment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A total of 483 patients are expected to be enrolled in approximately 180 clinical trial sites in the U.S., Canada, the U.K., Spain, Italy, Germany, France, Poland, Hungary, Belgium, Russia, mainland China, Hong Kong, Taiwan, Japan, South Korea, Australia, and Argentina. Enrolled patients will be randomized in a 2:1&#160;ratio to receive either daily AN2025 (100 mg) in combination with weekly paclitaxel (80 mg/m</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">2</font><font style="letter-spacing:0.2pt;">) or weekly paclitaxel alone in a 21-day treatment cycle. The primary endpoint of this study is OS for the entire (intent-to-treat) population of patients. The interim endpoint of the study is ORR on a subset of patients with at least six-month follow-up at the time the last patient is enrolled. Secondary endpoints include safety profile and other efficacy measurements such as PFS, ORR, DoR, and HRQoL. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial status and future plan</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In 2020, we communicated with the FDA regarding the updated Phase&#160;III clinical protocol. Based on the FDA&#8217;s feedback, we are currently focusing on recruiting patients with recurrent or metastatic HNSCC after anti-PD-1/PD-L1 treatment instead of patients progressing after platinum-based chemotherapy. The first patient was dosed in April&#160;2021 in this Phase&#160;III trial. We expect to complete the patient enrollment in the fourth quarter of 2023, and submit an NDA to the FDA for the potential accelerated approval using the ORR readout in the second half of 2024, followed by further marketing approval applications to the NMPA, EMA, PMDA and other authorities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Market opportunities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to Datamonitor Healthcare, the annual incidence of HNSCC is expected to reach 71,267 and 183,193 new cases in the U.S. and in seven major markets (including the U.S., the U.K., Germany, France, Italy, Spain, and Japan) in 2028, respectively. Most patients present with locally advanced disease are of a high risk of recurrence. Around 50&#8211;60% of HNSCC patients develop recurrence or metastasis, with a projected incidence of approximately 32,000 in the U.S. and 89,000 in seven major markets, among which approximately 22,000 patients in the U.S. and around 68,000 patients in these seven major markets are expected to be treated </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">122</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">by anti-PD-1/PD-L1 therapy in 2028. Although anti-PD-1/PD-L1 based therapy has become a mainstream drug for first-line treatment of HNSCC in these seven major markets, about 85% of patients would progress after anti-PD-1/PD-L1 treatment. As such, in 2028, recurrent or metastatic HNSCC patients progressing after anti-PD-1/PD-L1 treatment can be more than 50,000 in the seven major markets. Considering the lack of effective therapies validated by registrational clinical studies and the popularization of anti-PD-1/PD-L1 treatment around the world, the market opportunity for HNSCC patient population after anti-PD-1/PD-L1 based treatment should be significant. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Competitive landscape</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Among the investigational drugs targeting the recurrent or metastatic HNSCC patients progressing after anti-PD-1/PD-L1 based therapy, we believe AN2025 is currently the most advanced candidate globally, being the only drug under active development in the Phase&#160;III clinical trial. Monalizumab, an anti-NKG2A antibody developed by Innate Pharma S.A./AstraZeneca PLC, in combination with cetuximab, failed to meet the pre-defined efficacy threshold in a predefined futility interim analysis as compared with cetuximab, and thus was terminated in August&#160;2022. Based on our knowledge, current potential competitive candidates in Phase&#160;I/II trial include: (1)&#160;Duvelisib, a selective PI3K&#948;/&#947; inhibitor, developed by Secura Bio, Inc., entered an investigator-initiated Phase&#160;II study in combination with docetaxel in September&#160;2021; (2)&#160;Ficlatuzumab, an anti-HGF antibody developed by Aveo Pharmaceuticals Inc. (&#8220;Aveo&#8221;), in combination with cetuximab demonstrated ORR of 38% and mPFS of 4.1&#160;months in an interim analysis based on HPV 16- patients. Aveo may initiate the registrational study in the first half of 2023; (3)&#160;Tisotumab vedotin, an antibody-drug conjugate developed by Genmab A/S, entered into a Phase II study on locally advanced or metastatic disease in solid tumors including HNSCC with prior platinum and/or anti-PD-1/PD-L1 treatment, and demonstrated ORR of 16% and mOS of 9.4&#160;months in an interim analysis based on 31 patients; (4)&#160;Tipifarnib, a farnesyltransferase inhibitor developed by Kura Oncology Inc., is designed for patients with HRAS mutations, which account for only about 4% of HNSCC patients; (5)&#160;Lenvatinib, a multi-tyrosine kinase inhibitor developed by MSD and Eisai, is currently being evaluated in a phase II study in combination with pembrolizumab against standard chemotherapy; the study will also assess the efficacy of lenvatinib monotherapy, (6)&#160;Cabozantinib, another multi-tyrosine kinase inhibitor developed by Exelixis, Inc., has just entered a Phase&#160;II study in combination with nivolumab in August&#160;2022, and (7)&#160;Cue-101, a targeted interleukin 2-based immunotherapy developed by Cue Biopharma Inc., demonstrated one PR and six with SD for &ge; 12 weeks based on 14 HPV16+ patients in a Phase I dose escalating trial. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Palupiprant (AN0025): a tumor microenvironment modulator</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Palupiprant, or AN0025, is an oral EP4 antagonist with high potency and selectivity. It is designed to block the PGE2-EP4 signaling pathway by preventing the binding of prostaglandin E2 to its EP4 receptor, thereby inhibiting PGE2-mediated immunosuppression in the tumor microenvironment. In-licensed from Eisai in January&#160;2018, we have exclusive rights and license to develop and commercialize AN0025 globally, excluding Japan, Korea, Singapore, Taiwan, India, Thailand, Philippines, Indonesia, Malaysia, Vietnam, Myanmar, Laos, and Cambodia. For more details, see &#8220;&#8212;&#160;&#8201;License and collaboration agreements&#8201;&#8212;&#8201;Collaboration with Eisai&#8221;. The mechanism of action and preliminary safety profile of AN0025 have been demonstrated in early clinical trials. Based on its mechanism of action, we believe that AN0025 has the potential to be used in combination with multiple therapies including immune checkpoint inhibitors to treat solid tumors. Currently, we are in collaboration with MSD to evaluate the combination of AN0025 and MSD&#8217;s pembrolizumab for the treatment of solid tumors as a second or third-line therapy in a Phase&#160;Ib study. For more details, see &#8220;&#8212; License and Collaboration Agreements&#8201;&#8212;&#8201;Supply agreement with MSD&#8221;. As of June&#160;30, 2023, we have enrolled 63 patients in this trial in the U.S. and France and expect to obtain proof of concept clinical results in the second half of 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Mechanism of action</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A permissive tumor microenvironment is critical for tumor progression and metastasis. The development of a tumor-favoring microenvironment is a hallmark of cancer progression. As recent studies begin to reveal the mechanisms of how a tumor can successfully embed itself within a network supporting normal cells and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">123</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">reprogram it into an immunosuppressive tumor microenvironment, targeting alternatively activated tumor associated M2 macrophage, myeloid-derived suppressor cells (&#8220;MDSC&#8221;) and regulatory T cells (&#8220;Tregs&#8221;) represents a promising strategy for developing novel cancer immunotherapy. Tackling immunosuppression in tumor microenvironments, EP4 is considered a promising target for developing novel immune-targeting anti-cancer therapies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Prostaglandins play a key role in mediating inflammatory responses, and their effects on the differentiation of monocytic cells and suppression of T-cell activation are exploited by tumors to maintain an immunosuppressive tumor microenvironment. A key signaling pathway related to the re-shaping of tumor-promoting immunosuppressive microenvironments is the PGE2-mediated pathway. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon binding of PGE2 to its receptors, e.g., EP4, PGE2/EP4 signaling pathway produces cAMP and subsequently activates the cAMP/PKA signaling cascade, which has long been regarded as a pathway that negatively regulates T cell and NK cell functions. In addition, this pathway has been well recognized as an essential mediator that not only enhances the differentiation of immunosuppressive cells, such as M2 macrophage (&#8220;M2M&#8221;) and MDSC, which inhibit the antitumor activity of T cells like CD8</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">+</font><font style="letter-spacing:0.2pt;">, but also compromises the maturation of dendritic cells, a type of APC, in the tumor microenvironment. Early studies have shown that the presence or accumulation of M2M and MDSC in tumors is associated with a poorer prognosis in many types of solid tumors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our AN0025, a small molecule EP4 antagonist, is designed to prevent the binding of PGE2 to its EP4 receptor to change the immunosuppressive character of the tumor microenvironment. By blocking the downstream signaling of PGE2/EP4 pathway, AN0025 is designed to inhibit the differentiation and accumulation of MDSC and M2M, promote the maturation of dendritic cells (&#8220;DC&#8221;) and antitumor M1 type macrophage, thereby increasing the activity of CD8</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">+</font><font style="letter-spacing:0.2pt;"> cells and the T-cell immune responses against tumors. </font>
        </div>
        <div style="position:relative;margin-top:9.4pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-pht_mechani4c.jpg" alt="[MISSING IMAGE: tm2225088d1-pht_mechani4c.jpg]" height="374" width="403" >
        </div>
        <div style="margin-top:16.01pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Summary of preclinical results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Animal studies supported the combination of AN0025 with PD-1 inhibitor for treating tumors that are not responsive to anti-PD-1 therapy. In the CT26 murine colon cancer model, a portion of non-responders after anti-PD-1 treatment were selected, re-grouped and re-treated by combining AN0025 with an anti-PD-1 antibody. As shown in the figure below, AN0025 combined with anti-PD-1 antibody treatment demonstrated stronger antitumor activity, compared with each compound alone. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">124</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Antitumor Activity of AN0025 in combination with anti-PD-1 treatment in CT26 Murine Colon Cancer Syngeneic Model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.8pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_summary4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_summary4clr.jpg]" height="290" width="451" >
        </div>
        <div style="text-indent:20pt; margin-top:12.6pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In another preclinical study, the combination of AN0025 and radiotherapy (&#8220;RT&#8221;) demonstrated improved antitumor activity, and antitumor memory T-cell response in mice compared with RT treatment alone. As shown in the figure below, in a CT26 murine colon cancer model, treatment of AN0025 plus a single 9 Gy of RT rendered nine of the 12 animals tumor free, which was significantly better than RT alone. None of the tumor free animals regrew tumors over a subsequent 2-month period that followed the cessation of treatment, and all the nine mice completely rejected tumor rechallenge. These results suggested an antitumor memory response in those nine animals cured by the combination of AN0025 and RT. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Antitumor activity of AN0025 in combination with RT in CT26 murine colon cancer isograft model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:9.9pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_antitum4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_antitum4clr.jpg]" height="256" width="588" >
        </div>
        <div style="margin-top:16.8pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Summary of clinical trial results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Phase&#160;I study for AN0025 monotherapy in solid tumors by Eisai</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial design</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This trial was a multi-center, open-label, dose escalation study in patients with selected advanced malignancies with high myeloid infiltrate. This trial was conducted in the U.S. and France. A total of 30 patients were enrolled and received study treatment, of which 80% had received at least three lines of prior </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">125</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">treatment. Most common tumor types were colorectal cancer (43%), pancreatic cancer (20%), and HNSCC (13%). The patients were randomized into four cohorts and administered 125 mg to 750 mg AN0025 orally, once daily (&#8220;QD&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Primary objectives of this trial were to assess the safety and tolerability of AN0025 and determine the MTD and/or the RP2D of AN0025. Secondary objectives included studying of PK, ORR, and DCR. Exploratory objectives included PD assessments on immune cells infiltrated into tumors and in peripheral blood and metabolic response. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial status</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This trial was completed on February&#160;27, 2018. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Efficacy data</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Seven out of 30 patients (23%) achieved SD, including four patients who achieved SD of more than 18 weeks, and three patients had metabolic responses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Safety data</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;No dose limiting toxicities (&#8220;DLTs&#8221;) were observed and the MTD was not reached. The most common treatment-related adverse events (&#8220;TRAEs&#8221;) (&ge;10%) were fatigue (36.7%), diarrhea (33.3%), nausea (30.0%), anemia (23.3%), decreased appetite (23.3%), vomiting (20.0%), abdominal pain (16.7%), and dyspnea (16.7%). Grade 3 or above TRAE occurred in three patients. Two patients discontinued treatment due to TRAEs. There were no treatment-related deaths. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">PK/PD profile</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;AN0025 exposure was dose proportional up to 500 mg, QD with no incremental increase in exposure at 750 mg, QD. AN0025 was extensively metabolized. Elimination half-life was approximately 12 hours and accumulation on multiple dosing was around 2 to 3-fold. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conclusion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In this trial, single-agent AN0025 was well tolerated up to 750 mg, QD with no MTD reached in heavily pretreated patients with myeloid-rich tumors. </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Phase&#160;Ib study for AN0025 in combination with Keytruda, or pembrolizumab, in solid tumors</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial design</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;This trial is an open-label, multicenter, Phase&#160;Ib study to evaluate the safety and preliminary efficacy of AN0025 in combination with pembrolizumab in patients with locally advanced/</font>&#8203;<font style="letter-spacing:0.2pt;">advanced solid tumors in the U.S. and France. The study will include a DLT observation phase followed by an expansion phase. The pembrolizumab dose will remain constant at 200 mg every 3 weeks for each dose level of AN0025 and in each cohort. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The DLT observation period will employ a dosing de-escalation scheme. If the results of DLT observation phase yield an acceptable number of DLTs, then the expansion Phase&#160;Ib will start. Approximately 10-12&#160;patients will be enrolled in each of the expansion cohorts, including urothelial cancer, NSCLC, TNBC, cervical cancer, and MSS CRC cohorts. For urothelial cancer and NSCLC, patients who received previous treatment of anti-PD-1/PD-L1 therapy will be enrolled. For the other three cancer types, patients who did not receive anti-PD-1/PD-L1 treatment but progressed on standard of care will be enrolled. The trial is primarily designed to evaluate the safety and tolerability and determine the DLT of this combination therapy. Secondary objectives include ORR, PFS, DoR, and OS. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial status and future plan.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;As of June&#160;30, 2023, we were in the dose expansion stage with 63&#160;patients enrolled in the U.S. and France. We expect to obtain results of this trial in the second half of 2023, in which we aim to identify specific cancer types sensitive to this combination based on the results. We will then proactively communicate with the regulatory authorities for the design of Phase&#160;II/III registrational trials. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Market opportunities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although anti-PD-1/PD-L1 therapy has been primarily used to treat patients with NSCLC and urothelial cancer, current treatments are still unable to meet the needs of patients who have progressed on anti-PD-1/PD-L1 therapy. According to Datamonitor Healthcare, incidences of NSCLC treated with anti-PD-1/PD-L1 therapy in 2021 reached approximately 84,000 in the U.S., and approximately 201,590 in seven major markets of the U.S., the U.K., Germany, France, Italy, Spain, and Japan. Around 70&#8201;&#8211;&#8201;80% of NSCLC patients would progress after anti-PD-1/PD-L1 treatment, with approximately 59,000 patients in the U.S. and 141,000 patients in seven major markets. Incidences of urothelial cancer treated with anti-PD-1/PD-L1 therapy in 2021 reached approximately 18,000 in the U.S., and approximately 27,517 in seven major markets. Around </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">126</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">80&#8201;&#8211;&#8201;90% of urothelial cancer patients would progress after anti-PD-1/PD-L1 treatment, with approximately 14,000 patients in the U.S. and 22,000 patients in seven major markets. Furthermore, current treatments are limited for MSS CRC, TNBC, and cervical cancer after standard of care treatment. According to Datamonitor Healthcare, in 2021, the incidences of MSS CRC, TNBC and cervical cancer after standard of care treatment reached approximately 30,000, 4,074, and 5,800, respectively, in the U.S., and 113,000, 15,747, and 15,600, respectively, in the aforementioned seven major markets. Effective treatments are therefore urgently needed to address these unmet medical demands. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Competitive landscape</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Phase&#160;Ib study for AN0025 in combination with pembrolizumab is in dose expansion stage to evaluate preliminary efficacy in patients with the progression after standard of care treatment. Based on our knowledge, there are several programs also in early clinical development targeting EP4, including those run by Ono Pharmaceutical Co., Ltd./BMS (ONO-4578/BMS-986310), Ikena Oncology Inc. (Grapiprant (IK-007)), Rottapharm Biotech S.r.l. (CR6086), Tempest Therapeutics Inc. (TPST-1495), Shenzhen Ionova Life Science Co., Ltd. (INV-1120), Shanghai Yuyao Biotech Ltd. (YY001), and Keythera (Suzhou) Pharmaceutical Co., Ltd. (KF-0210). </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Triple combination of AN2025, AN0025, and Tecentriq, or atezolizumab: an example of our combination therapy strategy</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To fully explore the potential of AN2025 and AN0025, we initiated a study of the triple combination of AN2025, AN0025, and an anti-PD-1/PD-L1 antibody for the treatment of solid tumors. This study exemplifies our combination therapy strategy to achieve synergistic effects of targeted therapy and immunotherapy. In different tumor-hearing mouse models, we have consistently observed significantly stronger antitumor activity in the triple combination of AN2025, AN0025, and an anti-PD-1 antibody compared with the doublet combinations. We initiated a Phase&#160;I clinical trial to evaluate the triple combination of AN2025, AN0025, and atezolizumab, for a variety of PIK3CA mutant solid tumors. For more details, see &#8220;&#8212; License and collaboration agreements&#8201;&#8212;&#8201;Supply agreement with Roche&#8221;. In September&#160;2022, subsequent to the doublet arm dose-ranging studies, we initiated a dose-ranging study for the triple combination, and we expect to identify RP2D from this Phase&#160;I clinical trial in the second half of 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Rationale of triple combination design</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Immune checkpoint inhibitors, such as anti-CTLA-4 and anti-PD-1/PD-L1 antibodies, have revolutionized cancer treatment. However, there are still a significant number of cancer patients who do not respond to immune checkpoint inhibitors. One hypothesis explaining this phenomenon is that the tumor immunosuppressive microenvironment can cause resistance to immune checkpoint blockade. It is now increasingly accepted that the tumor microenvironment contributes to cancer cells&#8217; escape from immunosurveillance. Although immune checkpoint inhibitors can block the interaction between cancer cell and T cells to enable T cells recognize and kill cancer cells, T cells may not be able to reach the targets through the microenvironment that harbors the tumor (for example extravasate from tumor blood vessels and infiltrate barriers such as stromal tissue) to reach the cancer cells, which necessitates an improved combination therapy regimen that could further exploit the immune system for cancer treatment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a pan-PI3K inhibitor, AN2025 targets not only PI3K mediated tumorigenesis (e.g., via inhibition of PI3K&alpha;/PIK3CA mutants) but also the immunosuppression of the tumor microenvironment (e.g., via inhibition of PI3K&#948; and PI3K&#947;). PI3K&#948; is well established to control the function and integrity of Tregs, whereas both PI3K&#948; and PI3K&#947; help recruit suppressive myeloid cells (including tumor-associated macrophages (TAMs) and MDSCs) into the tumor microenvironment and also strengthen their inhibitory effects on antitumor T cell immune responses. As Tregs and suppressive myeloid cells are key contributors to immunosuppression within the tumor microenvironment, targeting PI3K&#948; and PI3K&#947; provides an excellent opportunity to improve the antitumor immune response. As targeting the tumor-promoting microenvironment, especially those suppressive immune cells inside become an attractive way to promote </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">127</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:147.61pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">antitumor immune response, agents like PI3K&#948; and PI3K&#947; inhibitors (such as AN2025) could serve as great combination partners for the checkpoint inhibitors in the field of cancer immunotherapy. </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-pht_ration4c.jpg" alt="[MISSING IMAGE: tm2225088d1-pht_ration4c.jpg]" height="337" width="426" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Leveraging the complementary and synergistic antitumor effects of our drug candidates in combination therapies, AN2025 is expected to mechanistically complement and synergize with the combination of anti-PD-1/PD-L1 antibody and AN0025 to form an improved treatment regimen for patients with multiple advanced solid tumors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Summary of preclinical results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">By targeting Tregs as well as tumor-promoting myeloid cells in the tumor microenvironment, AN2025 is designed to mechanistically synergize with the combination of anti-PD-1/PD-L1 antibody and AN0025 to improve the treatment of advanced solid tumors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We conducted preclinical studies of the triple combination of AN2025, AN0025, and an anti-PD-1 antibody, and observed encouraging antitumor activity in the following studies. As illustrated by the figures below, the triple combination showed significantly stronger TGI compared with doublet combinations in syngeneic mice models: </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">128</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Triple combination of AN2025, AN0025, and anti-PD-1 antibody in syngeneic mice models</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.99pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_triple4c.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_triple4c.jpg]" height="263" width="608" >
        </div>
        <div style="text-indent:20pt; margin-top:13.6pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In another humanized mice model, the triple combination also demonstrated superior anti-tumor activities to the doublet combinations. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Triple combination of AN2025, AN0025, and an anti-PD-1 antibody in humanized mouse models</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10.99pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_combinat4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_combinat4clr.jpg]" height="319" width="339" >
        </div>
        <div style="margin-top:17.7pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Summary of clinical trial results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Phase&#160;Ia clinical trial of AN2025, AN0025, and atezolizumab, in patients with advanced solid tumors</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial design</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The trial is a Phase&#160;Ia, multi-center, open-label clinical trial study in patients with locally advanced or metastatic cancer that were previously treated with one to four lines of therapy. This trial is conducted in the U.S. It consists of three DLT observations I, II, and III. Observations I (AN2025 + atezolizumab) and II (AN0025 + atezolizumab) are double combination treatments, which will be conducted in parallel, whereas observation III (AN2025 + AN0025 + atezolizumab) will be initiated only after a thorough review of the safety data from observations I and II. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">129</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Primary objectives of this trial are to evaluate the safety and tolerability of the double combinations (observations I and II) and triple combination (observation III) in patients with advanced solid tumors. Secondary objectives include studying of ORR, PFS, DoR, OS, and efficacy by PI3KCA mutation in observations I and III. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial status and future plan</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In September&#160;2022, subsequent to the doublet arm dose-ranging studies, we initiated a dose-ranging study for the triple combination, and we expect to identify RP2D from this Phase&#160;I clinical trial in the second half of 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Market opportunities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Mutations in PIK3CA are associated with high rates of mutations in important cancer-associated pathways such as the tyrosine kinase receptors/K-Ras/BRAF/MAPK and the Wnt/</font>&#8203;<font style="letter-spacing:0.2pt;">&beta;-catenin pathway. PIK3CA mutations are found in approximately 13% of all solid tumors globally, including 25% to 40% of cervical cancer, 30% to 40% of breast cancer, 30% to 35% of endometrial cancer, 30% of ovarian cancer, 24% of urothelial cancer, 20% of colorectal cancer, and 10% to 20% of HNSCC globally, indicating a large addressable market and significant commercial potential. To date, only Novartis&#8217; Piqray</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#174;</font><font style="letter-spacing:0.2pt;"> has been approved for the treatment of breast cancer with a PIK3CA mutation (in combination with hormonal therapy fulvestrant), and thus treatment options for patients with PIK3CA mutant solid tumors around the world are limited. </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Competitive landscape</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To our knowledge, we believe that we are the first to explore the combination of PI3K inhibitor, EP4&#160;antagonist and checkpoint inhibitor for the treatment of advanced solid tumors in a clinical trial. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">AN4005: a backbone for our future oral combination therapies</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:11.62pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Overview</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">AN4005 is an in-house developed, oral small-molecule PD-L1 inhibitor. In our preclinical studies, AN4005 was well tolerated and exhibited excellent TGI when compared to an approved anti-PD-L1 antibody and promoted an adaptive immune response for antitumor activity. In view of the encouraging preclinical data, we entered into a collaboration agreement assigning the related patent rights to develop, manufacture, and commercialize AN4005 in China to Xiamen Biotime Biotechnology Co., Ltd., reserving the exclusive rights to explore AN4005 in the rest of the world. For more details, see &#8220;&#8212; License and collaboration agreements&#8201;&#8212;&#8201;Collaboration with Biotime&#8221;. We received IND clearance from the FDA and NMPA for AN4005 for the treatment of advanced tumors in June 2021 and December 2021, respectively, and dosed the first patient in January&#160;2022. We expect to identify the RP2D in the second half of 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Mechanism of action</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The immune system defends the human body against foreign objects. To function properly, it needs to be able to differentiate between normal cells in the body and those considered &#8220;abnormal&#8221; or &#8220;foreign&#8221; &#8203;(such as cancer cells). Part of how the immune system does this is through &#8220;checkpoint&#8221; proteins on the surface of immune cells. Checkpoints act like switches that need to be turned on or off to start an immune response. However, cancer cells sometimes manage to escape attacks by the immune system through certain interactions with these checkpoints. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">T cells play a key role in the human immune system and fight cancer. The ultimate function of T cells relies on the balance between the activating and suppressing pathways. PD-1 is a checkpoint protein found on the surface of T cells. It interacts with its ligand, PD-L1, a protein usually found on the surface of normal cells. The interaction between PD-1 and PD-L1 will activate the downstream signals of PD-1 and suppress T cell activation. Therefore, PD-1 usually acts as an &#8220;off switch&#8221; that prevents T cells from attacking normal cells of human body. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, like normal cells, a wide range of cancer cells also express PD-L1 protein on the cell surface and sometimes in a vast amount. As a result, cancer cells can pretend to be normal cells by interacting with PD-1 on the T cells through their cell surface PD-L1 and thus avoid being attacked by the T cells. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">130</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:64.0599999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">AN4005 is a small-molecule PD-L1 inhibitor, which is designed to induce and stabilize PD-L1 dimerization to disrupt the protein-protein interactions between PD-1 and PD-L1. </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-pht_mechan4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-pht_mechan4clr.jpg]" height="205" width="287" >
        </div>
        <div style="margin-top:18.69pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Summary of preclinical results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In our preclinical studies, AN4005 demonstrated excellent antitumor activity in the MC38-hPD-L1 syngeneic mouse model. AN4005 (50 mg/kg, QD) showed significant TGI compared with the vehicle control. Furthermore, AN4005 (50 mg/kg, QD) showed a comparable effect in antitumor activity as durvalumab, an FDA-approved anti-PD-L1 antibody developed by Medimmune/AstraZeneca, as both agents inhibited the tumor growth to a similar extent. </font>
        </div>
        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_model4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_model4clr.jpg]" height="268" width="331" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The anti-tumor activities of AN4005 were convincingly demonstrated to be stringently dependent on the immune system, as depletion of the T cells (both CD4</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">+</font><font style="letter-spacing:0.2pt;"> and CD8</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">+</font><font style="letter-spacing:0.2pt;"> T cells) in mice abolished AN4005&#8217;s antitumor activity, a phenomenon that was similarly observed in anti-PD-L1 antibody treated subjects as well. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">131</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_treat4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_treat4clr.jpg]" height="323" width="343" >
        </div>
        <div style="margin-top:15.21pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Summary of clinical trial results</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9.63pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Phase&#160;I study for AN4005 monotherapy in advanced tumors</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial design</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The trial is a Phase&#160;I, multi-center, open-label clinical trial study in patients with advanced solid tumors. This study is designed to determine a RP2D/MTD. The study is conducted in the U.S. and China in approximately 31&#8211;36 patients, and the actual enrollment number will depend upon the identified safe dose. Once RP2D/MTD dose level has been determined, we will recruit additional patients in China to confirm the RP2D/MTD in the Chinese population as required by local regulatory authorities. Dosing will begin with dose level 0 (50 mg BID) and proceed to escalated dose levels of 100 mg BID, 200 mg BID, 400 mg BID, and 600 mg BID, successively. Dose escalation is conditioned upon the finding that the current dose is well tolerated at the completion of the cohort. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Primary objectives of this trial are to evaluate the safety and tolerability of AN4005. Secondary objectives include studying of PK/PD, ORR, PFS, DoR, complete remission rate (&#8220;CRR&#8221;), and OS. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Trial status and future plan</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The first U.S. patient was dosed in January&#160;2022 and the first Chinese patient was dosed in July&#160;2022. We expect to identify RP2D from the Phase&#160;I clinical trial in the second half of 2023. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Market opportunities</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Immunotherapies blocking the immune checkpoint PD-1/PD-L1 have achieved a significant success in treating various types of cancers. In the past few&#160;years, several monoclonal antibodies (&#8220;mAbs&#8221;) targeting PD-1 or PD-L1 have been approved for clinical use by the FDA, which exhibit significant benefits with durable clinical responses and acceptable treatment-related toxicities in several types of solid tumors. Although these mAbs have transformed cancer immunotherapy, they still have several disadvantages such as low permeability to tumors, immunogenicity, complex production process, high manufacturing and treatment costs and immune-related AEs due to very long half-life. Therefore, developing small-molecule inhibitors as an alternative to antibodies to interrupt the PD-1/PD-L1 pathway has emerged as an important area of research in cancer immunotherapy. The small molecule PD-L1 inhibitors are expected to bring a number of benefits over antibodies, such as amenability for oral administration, lower production costs, improved tumor penetration, and lack of immunogenicity. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Competitive landscape</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Phase&#160;I study for AN4005 monotherapy in advanced tumors is in the dose escalation stage. Based on our knowledge, there are several oral small-molecule PD-L1 candidates also in early development stage, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">132</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">including those developed by Incyte, Corp., Chemocentryx Inc. (acquired by Amgen Inc. in August&#160;2022), Maxinovel Pharmaceuticals Co., Ltd., Abbisko Cayman Ltd., Ascletis Pharma Inc., Betta Pharmaceuticals Co., Ltd., and Chase Sun Pharmaceutical Co., Ltd. INCB086550, developed by Incyte, is the globally first small-molecule PD-L1 inhibitor to enter the clinical trial. Although the clinical development of this molecule has been terminated due to likely compound-specific peripheral neuropathy, preliminary efficacy of this molecule in tumor types known to be responsible to anti-PD-1/PD-L1 antibody is encouraging and warrants further investigation to develop small-molecule PD-1/PD-L1 inhibitors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our preclinical programs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">AN8025: a T cell and APC modulator</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">AN8025 is an in-house developed multifunctional antibody, which serves as a T cell and APC modulator. We are currently in the lead optimization stage and expect to submit the IND in the second half of 2024. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">To confirm the ability of AN8025 to stimulate T cell activation, we conducted an enzyme-linked immunosorbent assay (&#8220;ELISA&#8221;) to measure cytokine concentrations </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;">. The results demonstrated that AN8025 provides almost eight times cytokine concentration induced by an anti-PD-L1 mAb. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of T-cell activation by AN8025 and anti-PD-L1 mAb</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_activate4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_activate4clr.jpg]" height="177" width="292" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We also tested the T cell co-stimulation and relevant cytokines/chemokines to determine and compare AN8025&#8217;s ability to fully induce immune response </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;">. Compared to an anti-PD-L1 mAb, where almost no co-simulation signals were detected, AN8025 showed significantly stronger co-stimulation signals, which represented enhanced interactions between T cells and APC. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of immune response induction by AN8025 and anti-PD-L1 mAb</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_immunec4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_immunec4clr.jpg]" height="165" width="563" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Furthermore, the micrograph result revealed that AN8025 induced the maturation of more primary DC than an anti-PD-L1 mAb. The results showed that AN8025 improved the quantity and quality of antigen presenting cells. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">133</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:101.68pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Comparison of dendritic cell maturation by AN8025 and anti-PD-L1 mAb</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-pht_dendrit4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-pht_dendrit4clr.jpg]" height="167" width="408" >
        </div>
        <div style="margin-top:18.69pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">AN1025: a &beta;-catenin degrader</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">AN1025 is an in-house developed, oral small molecule degrader of &beta;-catenin, which is currently in the lead optimization phase. Wnt/</font>&#8203;<font style="letter-spacing:0.2pt;">&beta;-catenin pathway is one of the key tumor-promoting signaling cascades that regulate cell cycle progression, epithelial-mesenchymal transition, angiogenesis, stemness, and tumor immune microenvironment. Aberrant activation of Wnt signaling as a result of genetic mutation has been linked to different cancers. Therefore, this pathway represents a promising target for therapeutic intervention. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In our preclinical studies, we demonstrated that AN1025 efficiently inhibited Wnt signaling with a low nanomolar IC</font><font style=" position:relative; bottom:-2.25pt;font-size:7.5pt;letter-spacing:0.15pt;">50</font><font style="letter-spacing:0.2pt;">. AN1025 treatment led to the reduction of &beta;-catenin (a key component in Wnt signaling pathway) level in tumor cells. In addition, human cancer cell lines with high &beta;-catenin expression were more sensitive to AN1025, when compared with those having low &beta;-catenin expression, suggesting that &beta;-catenin could serve as a biomarker of sensitivity to AN1025. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">&beta;-catenin expression is sensitive to AN1025&#8217;s anti-tumor effects</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_sensitve4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_sensitve4clr.jpg]" height="161" width="487" >
        </div>
        <div style="text-indent:20pt; margin-top:14.69pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, we also demonstrated that AN1025 showed dose-dependent anti-tumor activities in colo205 xenograft mice models. As shown below, after a 14-day treatment, the tumor volume in subjects administered with AN1025 (1.5 mg/kg, QO) was around 62% less than the tumor volume in the control group. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">134</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Antitumor effects of AN1025 in colo205 xenograft mice model</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-lc_effects4clr.jpg" alt="[MISSING IMAGE: tm2225088d1-lc_effects4clr.jpg]" height="268" width="447" >
        </div>
        <div style="margin-top:18.69pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">AN9025: a Pan-KRAS inhibitor</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">AN9025 is an in-house developed, oral small molecule pan-KRAS inhibitor to address a broad range of Kirsten rat sarcoma viral oncogene homologue (&#8220;KRAS&#8221;) mutations in multiple tumor types. It is currently in the lead optimization phase. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As the most frequently mutated oncogene, KRAS has attracted substantial attention. However, it has been deemed a challenging therapeutic target, and efforts to directly inhibit its function have been continuing for decades. The most successful of these has been the development of covalent allele-specific inhibitors that trap KRAS G12C in its inactive conformation and suppress tumor growth in patients. Therefore, AN9025, as a pan-KRAS inhibitor, represents an urgent unmet medical need to target KRAS mutations other than KRAS&#160;G12C in KRAS-driven cancers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In our </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> studies, we demonstrated that AN9025 efficiently inhibited cancer types with KRAS mutations including pancreas adenocarcinoma, lung adenocarcinoma, and colorectal adenocarcinoma with low nanomolar IC</font><font style=" position:relative; bottom:-2.25pt;font-size:7.5pt;letter-spacing:0.15pt;">50</font><font style="letter-spacing:0.2pt;"> values.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, in our </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> studies, we also demonstrated that deep, sustained, and durable anti-tumor efficacy of AN9025 in KRAS-driven xenograft mice models.</font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Antitumor effects of AN9025 in KRAS-driven xenograft mice models</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:11.19pt; text-align:center; width:456pt;">
          <img src="lc_antitumor-4clr.jpg" alt="[MISSING IMAGE: lc_antitumor-4clr.jpg]" height="215" width="544" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">135</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other programs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">AN1004</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pelareorep, or AN1004, is an intravenously delivered oncolytic virus. We own the exclusive rights to AN1004 in China, Singapore, and South Korea through an in-licensing agreement with Oncolytics Biotech, Inc. Ongoing Phase Ib clinical trial of AN1004 in combination with atezolizumab and gemcitabine/nab-paclitaxel demonstrated encouraging results as first-line treatment in advanced or metastatic pancreatic ductal adenocarcinoma cancer (&#8220;PDAC&#8217;&#8217;), demonstrating ORR of 69% that is substantially higher than historical response rate (ORR~25%) reported for PDAC patients treated with gemcitabine/nab-paclitaxel. In addition, a Phase&#160;II clinical trial of AN1004 in combination with paclitaxel in patients with HR+/HER2- metastatic breast cancer (&#8220;mBC&#8221;) showed that adding AN1004 to paclitaxel has significantly increased the median OS from 10.8&#160;months in the paclitaxel group to 21&#160;months in the combination group. AN1004 has been administered to &ge;1100 patients, and was well tolerated with most AEs of grade 1 or 2. We are conducting a bridging trial in China to assess the safety and tolerability of AN1004 in combination with paclitaxel for the Chinese patient population with HR+/HER2- mBC and obtained the safety and efficacy data of this bridging trial in December 2022. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">AN0025 in combination with RT/CRT for the treatment of rectal cancer</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to evaluating the combination of AN0025 and pembrolizumab for the treatment of advanced solid tumors, we also completed a Phase&#160;Ib study to evaluate AN0025 in combination with RT/CRT for the treatment of preoperative rectal cancer where primary resection without chemoradiotherapy is unlikely to achieve clear margins. We presented encouraging interim results of this trial cut off on August&#160;8, 2019 at the European Society for Medical Oncology (&#8220;ESMO&#8221;) in October&#160;2019. In particular, the combination therapy with AN0025 and RT/CRT reported an exceptionally high clinical complete response (&#8220;cCR&#8221;) of 20%, indicating surgery is no longer required for these patients, as well as a high pathologic complete response (&#8220;pCR&#8221;) of 16%, indicating no residual tumors were found in these patients after the surgery. The promising results from the Phase&#160;Ib study warrants further development. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">AN3025</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">AN3025 is an in-house developed anti-TNFR2 mAb. Its discovery was published in Frontiers in Immunology, a leading journal publishing rigorously peer-reviewed research across basic, translational, and clinical immunology. In the preclinical studies, AN3025 demonstrated promising antitumor activity in MC38-hTNFR2 syngeneic mouse model. As another mechanism of immune checkpoint inhibitor besides PD-1/PD-L1 pathway, AN3025 showed comparable TGI compared to the mouse anti-PD-1 antibody. In view of the promising preclinical data, we have entered into a collaboration agreement assigning the related patent rights to develop, manufacture, and commercialize AN3025 in China to Xiamen Biotime Biotechnology Co., Ltd. For more details, see &#8220;&#8212; License and collaboration agreements &#8212; Collaboration with Biotime&#8221;. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and development</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We believe that R&amp;D is key to driving our therapeutic strategy and maintaining our competitiveness in the biopharmaceutical industry. Our in-house research and development function had 90 members with extensive drug discovery and development experience as of June 30, 2023. Around 83% of our research and development team members have master or doctorate degrees in biology or chemistry related majors. Leveraging our strong research and development capabilities, we have developed a pipeline with significant potential. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Drug discovery platforms</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Spanning the full spectrum from target identification to clinical development, our in-house drug discovery platforms deploy a suite of powerful and specialized techniques and know-how. They consist of the following two platforms: PAINT-2D</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> platform (i.e., the Platform for AN&#8217;s Immune Therapeutics Discovery and Development) and ANEAT-Id</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> platform (i.e., AN&#8217;s high-Efficiency Antibody Technology for Identification/</font>&#8203;<font style="letter-spacing:0.2pt;">Development). </font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">136</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:1.71000000000004pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">PAINT-2D</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> platform (the platform for AN&#8217;s immune therapeutics discovery and development)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">PAINT-2D</font><font style=" position:relative; bottom:4.25pt;font-weight:bold;font-size:7.5pt;letter-spacing:-0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> platform is our proprietary platform equipped with &#8220;one-stop&#8221; functionalities for the early-stage development of immuno-oncology therapies, and enables us to study the functions of immuno-oncology therapies and their effects on immune cells in an efficient manner, as well as to evaluate the combination potential of different immuno-oncology therapies and the toxicity and AEs for different combination regimens. The following flowchart illustrates the functions of the PAINT-2D</font><font style=" position:relative; bottom:4.25pt;font-weight:bold;font-size:7.5pt;letter-spacing:-0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> platform: </font>
        </div>
        <div style="position:relative;margin-top:11.2pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-fc_platform4c.jpg" alt="[MISSING IMAGE: tm2225088d1-fc_platform4c.jpg]" height="286" width="578" >
        </div>
        <div style="text-indent:20pt; margin-top:14.68pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The platform begins with chemical compounds or biological agents first being tested </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> in immune cell lines and/or primary immune cells to assess the preliminary activity as well as cytotoxicity. The effects of activity and cytotoxicity of potential candidate molecules are further tested in more physiologically relevant immune cells, which are tumor infiltrating lymphocytes (&#8220;TIL&#8221;) collected from tumors </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;">. Data from those tests are evaluated using established algorithms, which are generated through comprehensive data analyses of clinical immune related drugs (either approved or unapproved) after being tested in similar assays. If compounds show favorable efficacy/cytotoxicity profiles (or benefit/risk ratios) similar to those of approved drugs, they might be considered to move on for extensive preclinical evaluation before going into clinical trials. Otherwise, they will be sent back and further optimized until they pass the evaluation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">By utilizing immune cell lines, primary immune cells, and </font><font style="font-style:italic;letter-spacing:0.2pt;">ex vivo</font><font style="letter-spacing:0.2pt;"> tumor/tumor-infiltrating lymphocyte (TIL), our PAINT-2D</font><font style=" position:relative; bottom:4.25pt;font-weight:bold;font-size:7.5pt;letter-spacing:-0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> platform can perform a series of assays to comprehensively assess (i)&#160;the effects of immuno-oncology drugs on the functioning of immune cells, including T-cells, B-cells, dendritic cells, monocytes, and macrophages, and (ii)&#160;the combination potential and off-target effects for different immuno-oncology drugs. This allows us to (i)&#160;thoroughly optimize the efficacy and undesired AEs of drug candidates to maximize their efficacy in immuno-oncology, (ii)&#160;fully assess the combinational synergies between different drugs in preclinical stages, and (iii)&#160;potentially correlate preclinical output with clinical performance using data generated internally. This platform is expected to lead to optimal candidate molecules and combination regimens to potentially reduce the risks associated with subsequent clinical trials. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">ANEAT-Id</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> platform (AN&#8217;s high-efficiency antibody technology for identification / development)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">ANEAT-Id</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">TM</font><font style="letter-spacing:0.2pt;"> platform is a highly efficient and robust yeast display system that is dedicated to therapeutic antibody discovery and development. The following flowchart illustrates the functions of our ANEAT-Id technology: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">137</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;margin-top:8pt; text-align:center; width:456pt;">
          <img src="tm2225088d1-pht_tech4c.jpg" alt="[MISSING IMAGE: tm2225088d1-pht_tech4c.jpg]" height="254" width="546" >
        </div>
        <div style="text-indent:20pt; margin-top:13.4pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The platform operation begins with the antigen of interest first being incubated with an antibody library displayed on the surface of yeasts. Preliminary binders are selected and enriched via flow cytometry-based sorting. After several rounds of selection and enrichment, strong binders are subjected to early assessment to identify functional candidates, which are further sequenced to obtain detailed information of the preliminarily selected antibodies. The candidates are then expressed and purified for extensive characterization </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;">, where those with good </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vivo</font><font style="letter-spacing:0.2pt;"> activities are moved to further preclinical evaluation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This yeast display technique-based antibody platform in combination with flow cytometry allows for high-throughput, and high-speed detection and selection of appropriate antibody candidates. It features by (i)&#160;a super-sized library of over 50&#160;billion human antibodies, (ii)&#160;high display efficiency to successfully express antibodies on yeast surface, (iii)&#160;a display/secretion switchable design to allow flexibility in small-scale antibody purification and subsequent functional test, and (iv)&#160;various developability assessment tools to minimize risks in late-stage development. We are utilizing our ANEAT-Id technology to facilitate and speed therapeutic antibody R&amp;D. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Research and development for in-licensed drug candidates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We promptly commence research and development activities after in-licensing drug candidates from our licensing partners. We have devoted a considerable amount of time and resources to the R&amp;D of in-licensed drug candidates, and such efforts include but are not limited to: (i)&#160;the design of the clinical trials to be implemented in our licensed territories and proactive communication with relevant regulatory authorities to obtain approval, and (ii)&#160;the preparation of clinical trials. We also engage third-party service providers, such as CROs to manage the day-to-day execution of clinical trials under the close supervision and management of our research and development team and clinical development team. We set up standards of project management and clinical operations, and give detailed instructions and guidance to such third parties. Additionally, we invite leading experts in relevant areas to share their expertise in R&amp;D of drug candidates, and arrange training sessions for potential investigators in preparation for the clinical trials. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Competition</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The pharmaceutical and biopharmaceutical industries are highly competitive and subject to rapid and significant change. While we believe that our pipeline of innovative drug candidates in clinical and preclinical trials, strong R&amp;D capability, integrated platform and cohesive leadership team provide us with competitive advantages, we face potential competition from many different sources working to develop therapies targeting the same indications against which we develop our drug candidates, in particular in the immuno-oncology field. These include major pharmaceutical companies as well as specialty pharmaceutical and biotechnology companies, academic institutions, government agencies, and research institutions. Any drug candidates that we successfully develop and commercialize will compete with existing drugs and with any new drugs that may become available in the future. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">138</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">License and collaboration agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Collaboration with Novartis</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;22, 2017, we entered into a license agreement (as amended, the &#8220;Novartis Agreement&#8221;) with Novartis, a global pharmaceutical company regarding the worldwide development and commercialization of products containing AN2025 as an active ingredient (the &#8220;Novartis Licensed Product(s)&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Novartis Agreement, Novartis granted us (a)&#160;an exclusive, royalty-bearing, sublicensable, assignable worldwide license under Novartis&#8217; certain know-how and patent rights related to AN2025 (the &#8220;Product-Specific Patents&#8221;), and (b)&#160;a non-exclusive, royalty-bearing, sublicensable, assignable license under Novartis&#8217; certain platform patents (the &#8220;Platform Patents&#8221;), in each case of (a)&#160;and (b), to develop and commercialize the Novartis Licensed Products for therapeutic, prophylactic and/or diagnostic uses in humans (the &#8220;Novartis Licensed Field&#8221;) worldwide and to manufacture and have manufactured AN2025 for use in Novartis Licensed Products in the Novartis Licensed Field worldwide. Novartis and its affiliates retain or share full and unencumbered rights under all relevant patents and know-how for AN2025 worldwide outside the Novartis Licensed Field. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are solely responsible for and have final decision-making authority with respect to the development, commercialization, and manufacturing of the Novartis Licensed Products in the Novartis Licensed Field worldwide. We are obligated to develop a clinical development plan for the Novartis Licensed Products that is consistent with certain clinical trials to which we have agreed with Novartis. We have shared the clinical development plan with Novartis. We are obligated to use commercially reasonable efforts to develop, manufacture, and commercialize the Novartis Licensed Products and to use commercially reasonable efforts to obtain regulatory approval for as many indications as possible, as included in the development plan. We are required to bear 100% of all costs and expenses associated with the development, commercialization, and manufacturing of the Novartis Licensed Products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In accordance with the terms of the Novartis Agreement, Novartis is eligible to receive a series of payments from us, comprising an upfront payment, milestone payments, royalty payments, and, if any, sublicense payments. The upfront payment amounted to US$9.5 million and was paid in full in 2018. In&#160;addition we are obliged to pay to Novartis (i)&#160;regulatory milestone payments with an aggregate amount up to US$74&#160;million upon the achievement of regulatory milestones, including dosing of the first patients in the first registrational study for Novartis Licensed Products, submission of certain applications to regulatory authorities and receipt of certain approvals from regulatory authorities for different indications; and (ii)&#160;sales-based payments ranging from US$10&#160;million to US$100&#160;million upon achievement of certain annual net sales targets for Novartis Licensed Products. As of June&#160;30, 2022, we had made regulatory milestone payments of US$4&#160;million for achievement of dosing of the first patient in the first registrational study for a Novartis Licensed Product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, under the Novartis Agreement, unless otherwise provided, during the applicable royalty term, we shall also pay royalties based on annual net sales of Novartis Licensed Products worldwide at progressive rates ranging from the mid-teens to the mid-twenties. Currently, we do not owe royalty payments to Novartis under the Novartis Agreement. The royalty term continues on a country-by-country and product-by-product basis with each such royalty term commencing on the first commercial sale in such country until the latest of (i)&#160;the expiration of the last-to-expire valid claim of any licensed patent covering such Novartis Licensed Product in such country; (ii)&#160;the expiration of regulatory-based exclusivity for such licensed product in such country; or (iii)&#160;the tenth anniversary of the date of first commercial sale of such Novartis Licensed Product in such country. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, under the Novartis Agreement, in further consideration for the sublicensing rights granted to us, we shall pay to Novartis up to 50% of net profit from any payments or other consideration received by us or our affiliates in connection with the grant of any sublicense depending on the development stage of the Novartis Licensed Products at the time of occurrence of sublicense event. Currently, we do not owe any sublicense fees payable to Novartis under the Novartis Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Novartis Agreement may be terminated (i)&#160;by either us or Novartis for the other party&#8217;s uncured material breach, (ii)&#160;by us at our sole discretion with at least 90&#160;days&#8217; prior written notice to Novartis for any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">139</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">reason, or (iii)&#160;by Novartis in case of our insolvency. In the event of a termination for any reason, all rights and licenses granted to us under the Novartis Agreement shall terminate, we are obligated to cease any and all development, manufacture, and commercialization activities with respect to all Novartis Licensed Products, and all rights and licenses granted by Novartis to us shall revert to Novartis. Unless terminated earlier, the Novartis Agreement will expire, on a product-by-product and country-by-country basis, on the date of the expiration of all applicable royalty terms with respect to such Novartis Licensed Product in such country, and, in its entirety, expire upon the expiration of all applicable royalty terms with respect to all Novartis Licensed Products in all countries globally. Following expiration of the royalty term for a Novartis Licensed Product in a given country, the license granted to us with respect to the Novartis Licensed Product in such country will automatically become fully paid-up, perpetual, irrevocable, and royalty-free. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Collaboration with Eisai</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2018, we entered into a license agreement (the &#8220;Eisai Agreement&#8221;) with Eisai Co, Ltd. (&#8220;Eisai&#8221;), concerning the products containing the compound formerly referred to as E7046 (renamed as AN0025), an EP4 antagonist, including its therapeutically-active metabolites and prodrugs (the &#8220;Eisai Licensed Products&#8221;). Pursuant to the Eisai Agreement, we obtained exclusive, sub-licensable rights and license to research, develop, manufacture, and commercialize the Eisai Licensed Products in any and all preventative, therapeutic, and/or diagnostic uses in human (the &#8220;Eisai Licensed Field&#8221;), worldwide excluding Japan, Korea, Taiwan, Thailand, India, Philippines, Indonesia, Singapore, Malaysia, Vietnam, Myanmar, Laos, and Cambodia (the &#8220;Eisai Licensed Territory&#8221;). In addition, Eisai obtained exclusive, sub-licensable rights and license under our technology invented or created under this agreement to research, develop, manufacture, and commercialize the Eisai Licensed Products outside the Eisai Licensed Territory. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Eisai Agreement, we will be solely responsible for the development of Eisai Licensed Products in the Eisai Licensed Field in the Eisai Licensed Territory, and shall use commercially reasonable efforts to complete the Development Plan (as defined below) and submit for regulatory approval in specified major countries. We have formulated a high-level development plan for AN0025 towards regulatory approval (the &#8220;Development Plan&#8221;) which was included as part of the Eisai Agreement. According to the Development Plan, (i)&#160;after analysis of available clinical data from the Phase&#160;I study (monotherapy and combination with chemo-radiotherapy), we can move to multiple, small scale Phase&#160;I/II studies in the U.S. to evaluate new combination therapies in ICI sensitive tumor types; (ii)&#160;we can also conduct novel study design to combine the molecule with anti-PD-1 in both PD-1 na&#239;ve and PD-1 failed patient populations; (iii)&#160;we can have early interaction with health authorities to help future registration study design and work closely with experienced KOLs to identify potential registration opportunities. Our recent development plan of AN0025 was in line with the Development Plan under the Eisai Agreement. We will bear all the costs and expenses associated with the development of the Eisai Licensed Products. In addition, we are solely responsible for sourcing the manufacturing and supplying of, and all commercialization activities for the Eisai Licensed Products in the Eisai Licensed Territory. Eisai is obliged to provide reasonable assistance to facilitate the transfer of development, manufacturing, and commercialization responsibilities to us as we request. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Eisai Agreement, Eisai and we have established a joint development committee (the &#8220;JDC&#8221;) to implement and oversee the development activities in the Eisai Licensed Field in the Eisai Licensed Territory and to serve as a forum for exchanging data, information and strategy regarding the Eisai Licensed Products. The JDC has equal representation from each party with a chairperson designated by us, and it shall take actions by simple majority vote with each representative having one vote. If the JDC cannot reach agreement on a matter within a specified period, such matter should be elevated to C-level executive officers of both parties; if such matter is still unresolved within a specified period after the elevation, the chairperson designated by us shall have the controlling vote unless such matter involves an amendment of the Development Plan. In accordance with the Eisai Agreement, neither us nor Eisai is allowed to directly or indirectly make, market, promote, sell, offer for sale, import, export, or commercialize any competitive product in the Eisai Licensed Field, or in-license or otherwise acquire any competitive product in the Eisai Licensed Field in the Eisai Licensed Territory. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the period of time commencing with enrollment of the first five patients in a Phase&#160;III clinical trial for the Eisai Licensed Products pursuant to the Development Plan and ending 90&#160;days following the completing of such Phase&#160;III clinical trial, Eisai has the option, by written notice, to notify us that it is </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">140</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">interested in re-acquiring the rights to develop, manufacture, and commercialize the Eisai Licensed Products in the Eisai Licensed Territory. Upon receipt of the notice, we will negotiate with Eisai on an exclusive basis for up to 90&#160;days in good faith with regard to the terms of Eisai&#8217;s exercising of its option at a fair market value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In accordance with the terms of the Eisai Agreement, Eisai would be eligible to receive a series of payments from us, comprising an upfront payment, milestone payments, royalty payments, and, if any, sublicense remuneration payments. In terms of the upfront payment, we shall pay to Eisai an amount up to US$6.0&#160;million, and such amount has been paid by us in May and June&#160;2018. Moreover, under the Eisai Agreement, we are obliged to pay to Eisai milestone payments up to an aggregate amount of approximately US$367&#160;million upon (i)&#160;the first achievement of the net sales target of Eisai Licensed Products in a rolling 12-month period; and (ii)&#160;the achievement of development milestones, including dosing of the first patient in various clinical trial stages for Eisai Licensed Products, submission of NDA or marketing authorization applications and receipt of regulatory approval for various indications. As of August&#160;31, 2022, we had made milestone payments of US$4.0&#160;million. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Eisai Agreement, during the applicable royalty term, we will also pay royalties based on annual net sales of Eisai Licensed Products in the Eisai Licensed Territory at progressive rates ranging from low-teens to high-teens. Currently, we do not owe any royalty payments to Eisai. The royalty term continues on a country-by-country and product-by-product basis with each such royalty term commencing on the first commercial sale in such country until the latest of (i)&#160;expiration of the last-to-expire licensed patent that contains a valid claim in such country, (ii)&#160;the tenth anniversary of the date of first commercial sale of such Eisai Licensed Product in such country, or (iii)&#160;expiration of regulatory exclusivity for such Eisai Licensed Product in such country, provided that with respect to an Eisai Licensed Product being commercialized in certain major countries, the royalty term shall continue in all these countries until expiration of the last-to-expire licensed patent that contains a valid claim in these countries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, under the Eisai Agreement, if we sublicense our rights and license to a third party, we shall pay to Eisai sublicense remuneration payments at remuneration rates ranging from low-teens to mid-twenties depending on the sublicense conclusion dates. Currently, we do not owe any sublicense remuneration payments to Eisai. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless terminated earlier, the Eisai Agreement will continue in full force and effect on a product-by-product and country-by-country basis until (i)&#160;the expiration of the royalty term in a country if a product is commercialized within 15&#160;years of the date of the Eisai Agreement, or (ii)&#160;the 15</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> anniversary of this Eisai Agreement if there has not been a first commercial sale of a product in a country within 15&#160;years of the date of the Eisai Agreement. After expiration of the Eisai Agreement, on a product-by-product, country-by-country basis, the rights and licenses granted to us or Eisai thereunder will become irrevocable, non-exclusive, royalty-free, fully paid-up, and non-terminable. The Eisai Agreement can be early terminated by either party because of the other party&#8217;s uncured material breach, bankruptcy-related events, or proceedings, or patent challenge. We may terminate this agreement if competent regulatory authority in certain major countries decides to preclude clinical use of the Eisai Licensed Products on grounds of safety. This agreement may also be terminated by Eisai if we do not use commercially reasonable efforts to perform our obligations as per the Development Plan and achieve regulatory and commercial milestones under the Eisai Agreement and the JDC fails to resolve such issue. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Supply agreement with Roche</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In November&#160;2020, we entered into a master clinical supply agreement (the &#8220;Roche Agreement&#8221;) with F.&#160;Hoffmann-La Roche Ltd (&#8220;Roche&#8221;) for supply of atezolizumab for clinical trials to evaluate the triple combination of our AN2025 and AN0025 and atezolizumab (the &#8220;Study&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the Roche Agreement, Roche will supply its atezolizumab for use in the Study at no cost unless otherwise provided in the clinical supply agreement supplement (the &#8220;CSA Supplement&#8221;), which specifies the quantities and timelines for supply of atezolizumab. As of the date of this prospectus, we had not entered into a CSA Supplement that requires us to pay for the supplied atezolizumab. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We, as the sponsor of the Study, are required to prepare a protocol of the Study (which Roche is required to review), conduct the Study, provide written updates regarding the status of the Study, and summarize the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">141</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">findings of the Study in a final study report, all in accordance with applicable regulatory authority rules, regulations, guidance, our protocol, and the Roche Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All clinical data generated in the performance of the Study in accordance with the Roche Agreement belong to us as the sponsor of the Study. Roche and its affiliates are granted certain use rights in relation to such data. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless terminated earlier, the Roche Agreement will continue in force for five&#160;years. Either party may terminate the Roche Agreement upon 60-day prior written notice to the other party. CSA Supplements continue in effect unless separately terminated. We may terminate CSA Supplements on 60 days&#8217; notice for any reason. Roche is only entitled to terminate CSA supplements (and therefore supply) for certain limited reasons, including patient safety issues, supply constraints and material breaches by us.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Supply agreement with MSD</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In January&#160;2019, we entered into a clinical trial collaboration and supply agreement with MSD (the &#8220;MSD Agreement&#8221;) to collaborate for a clinical trial to evaluate the safety and preliminary efficacy of the combination of MSD&#8217;s pembrolizumab, a PD-1 monoclonal antibody (the &#8220;MSD Compound&#8221;), and our AN0025, in subjects with locally advanced or metastatic solid tumor cancers which may include but not be limited to NSCLC, MSS CRC, bladder cancer, cervical cancer, and TNBC in the territory where we have exclusive license to AN0025 (&#8220;MSD Collaborative Study&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each party will manufacture and supply its respective compound for use in the MSD Collaborative Study and conduct its sample testing at its own costs and expenses, and we will bear all other costs associated with the conduct of the MSD Collaborative Study. We will act as the sponsor of the MSD Collaborative Study, and the parties have formed a joint development committee with equal representation from each party to coordinate all regulatory and other activities under the agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All clinical data shall be jointly owned by us and MSD. Each party retains the exclusive ownership of all rights to inventions relating solely to, or covering its compound and any improvements related thereto. The parties jointly own all rights to all inventions relating to, or covering the combined use of both parties&#8217; compounds that are not either party&#8217;s inventions. The parties must consult and reasonably cooperate with one another in the preparation, filing, prosecution, and maintenance of each joint patent application and equally share the expenses associated therewith. In the event that one party wishes to file a joint patent application in respect of a jointly owned invention and the other party does not want to file, or that one party wishes to discontinue the prosecution and maintenance of a joint patent application or joint patent, the non-filing/</font>&#8203;<font style="letter-spacing:0.2pt;">opting-out party shall assign such jointly owned invention, joint patent application, or joint patent to the filing/continuing party, and the filing/continuing party shall thereafter solely own the jointly owned invention, joint patent application, or joint patent so assigned. </font></div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless terminated earlier, the term of the MSD Agreement will continue in full force and effect until delivery to MSD of the final study report for the MSD Collaborative Study. In addition to each party&#8217;s certain customary termination rights such as the right to terminate for the other party&#8217;s uncured material breach, MSD may terminate the agreement if it in good faith believes that the MSD Compound is being used in the MSD Collaborative Study in an unsafe manner and we fail to promptly incorporate changes into the protocol requested by MSD to address such issue or to otherwise address such issue reasonably and in good faith. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Collaboration with Biotime</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On November&#160;15, 2021, we entered into a collaboration agreement with Xiamen Biotime Biotechnology Co. Ltd (&#8220;Biotime&#8221;), a biotechnology company established in 2008, focusing on the R&amp;D, manufacturing, and commercialization of </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> diagnostic devices and reagents, with respect to five products, namely our drug candidates AN4005 and AN3025, and three other early-stage programs not included in our pipeline. Under this agreement, we assigned to Biotime a list of patents and related research material, know-how, and research results generated through studies of the five products to engage in preclinical and clinical development, registration, manufacturing, and commercialization of (a)&#160;AN4005 and AN3025 in China, and (b)&#160;three early-stage programs globally. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">142</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under this agreement, Biotime is obligated to pay an aggregated down payment of up to RMB295.0&#160;million (approximately US$46.0 million, based on the conversion rate of RMB6.4508 to US$1.00, which was the average daily exchange rate for the year ended December 31, 2021) in relation to the patents, patent applications, know-how, data, and information of the five products. Biotime also agreed to make milestone payments in the aggregate amount of RMB835.0&#160;million (approximately US$129.0 million, based on the conversion&#160;rate of RMB6.4508 to US$1.00, which was the average daily exchange rate for the year ended December 31, 2021) conditioned upon the achievement of certain development and sales targets. Additionally, Biotime also agrees to make payments at remuneration rates ranging from mid-single digits to mid-teens depending on the net sales of the products. As of June&#160;30, 2022, Biotime has made down payments totaling RMB295.0&#160;million (approximately US$46.0 million) to us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless terminated earlier, the term of the agreement will continue in full force and effect. Each party enjoys customary termination rights such as the right to terminate for the other party&#39;s material breach. Specifically, Biotime is entitled to suspend performance of the agreement or terminate the agreement if we make any materially false or misleading statement that causes Biotime to not be able to perform its obligations under the agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Option agreement with Nippon Kayaku</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In April&#160;2023, we entered into an option agreement (the &#8220;Nippon Kayaku Agreement&#8221;) with Nippon Kayaku Co., Ltd. (&#8220;Nippon Kayaku&#8221;) to grant Nippon Kayaku an exclusive option (&#8220;Option&#8221;) to enter into a license agreement to further develop and commercialize products containing AN2025 in all therapeutic, prophylactic and/or diagnostic uses in humans in Japan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the Nippon Kayaku Agreement, we shall immediately notify Nippon Kayaku if the AN2025 NDA is accepted by the FDA, and provide all documents included in the NDA submission to Nippon Kayaku. Nippon Kayaku has already paid us the agreed one-time option grant fee of US$5&#160;million in full before the agreed due date, May 20, 2023. If the AN2025 NDA is accepted by the FDA without refusal or amendments (the &#8220;NDA Acceptance&#8221;), Nippon Kayaku may then exercise the Option provided that (1)&#160;Nippon Kayaku has already invested an agreed amount in us according to the terms and conditions of a separate commitment agreement, which provides that a concurrent private placement or a private equity investment agreement shall be entered into by Nippon Kayaku and us, and (2)&#160;Nippon Kayaku has notified us of its intention to exercise this Option. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon exercise of the Option by Nippon Kayaku, the parties will enter into a license agreement granting Nippon Kayaku exclusive rights to further develop and commercialize products containing AN2025 in all therapeutic, prophylactic and/or diagnostic uses in humans in Japan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the form license agreement (the &#8220;License Agreement&#8221;), which is included as an exhibit to the Nippon Kayaku Agreement, once executed, we will grant to Nippon Kayaku an exclusive, royalty-bearing, sublicensable, assignable license under the licensed patents and know-how agreed upon between the parties under the License Agreement, to commercialize, develop, and manufacture the products containing AN2025 (&#8220;Licensed Products&#8221;) for all therapeutic, prophylactic and/or diagnostic use in humans (the &#8220;Field&#8221;) in Japan. We will also grant to Nippon Kayaku an exclusive, sublicensable, assignable, perpetual, irrevocable, royalty-free, and fully paid-up license for trademarks to commercialize, develop, and manufacture the Licensed Products in the Field in Japan. We will reserve the right to exercise full and unencumbered rights to exploit the Licensed Products outside the Field in Japan and in any field outside Japan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the License Agreement, once executed, Nippon Kayaku will be solely responsible for the development, commercialization, and manufacturing (unless in bulk) of Licensed Products in the Field in Japan. For an invention solely made by one party, the party will solely own the invention. If an invention is jointly made by both parties, the invention will be jointly owned by the parties, unless otherwise agreed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the License Agreement, once executed, we would be eligible to receive a series of payments from Nippon Kayaku, comprising milestone payments, royalty payments, and, if any, sublicense remuneration payments. Under the License Agreement, once executed, Nippon Kayaku will be obligated to pay us milestone payments up to an aggregate amount of approximately US$800&#160;million upon (i)&#160;the achievement of regulatory </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">143</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">milestones, including submission of an NDA and receipt of certain approvals from the PMDA for different indications, and (ii)&#160;the achievement of sales-based milestones based on annual sales for all Licensed Products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the License Agreement, once executed, Nippon Kayaku will also pay royalties based on annual net sales during the royalty payment period, with royalty rate percentages ranging from mid-twenties to mid-thirties, subject to customary royalty rate reductions. The royalty term starts from the first commercial sale of the Licensed Products in Japan and shall continue until the latest of (a)&#160;the expiration of the last to expire valid claim of any licensed patent covering such Licensed Products in Japan; (b)&#160;the expiration of regulatory-based exclusivity for such Licensed Products in Japan; and (c)&#160;the ten (10) year anniversary of the date of the first commercial sale of such Licensed Product in Japan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, under the License Agreement, once executed, if Nippon Kayaku sublicenses its rights and license to a third party, Nippon Kayaku shall pay us sublicense remuneration payments with a percentage rate in the low-teen or mid-double digits of all net profits from any payments or other considerations attributable to such sublicenses, depending on the timing of the sublicense agreements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless terminated earlier, the License Agreement shall remain in full force and effect. Either party may terminate this License Agreement for the other party&#8217;s uncured material breach. In addition, Nippon Kayaku may terminate at its sole discretion without consequence upon providing at least 180&#160;days&#8217; prior written notice to us. We may terminate the agreement by giving written notice upon an insolvency event of Nippon Kayaku. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, Nippon Kayaku has not exercised the Option to enter into the License Agreement with us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Nippon Kayaku Agreement can be terminated at any time prior to Nippon Kayaku&#8217;s exercise of the Option by the mutual written consent of the parties. In addition, each party has certain customary termination rights such as the right to terminate for the other party&#8217;s uncured material breach of the Nippon Kayaku Agreement, or for either party&#8217;s insolvency. We are entitled to terminate the Nippon Kayaku Agreement if Nippon Kayaku fails to complete the investment in us in accordance with the terms and conditions of the commitment agreement unless such failure is because we have prevented such investment solely through our actions. Nippon Kayaku may terminate the agreement if the NDA Acceptance does not occurred before an agreed due date. In addition, Nippon Kayaku may demand in writing that we repay US$5.0 million, only when both of the following conditions are met by the agreed due date: (a) Nippon Kayaku has not acquired shares in us fully pursuant to the commitment agreement due to our actions preventing them from doing so; and (b) the NDA Acceptance is not satisfied.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Intellectual property</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Intellectual property, including patents, trade secrets, trademarks, and copyrights, is critical to our business. Our future commercial success depends, in part, on our ability to obtain and maintain patent and other intellectual property and proprietary protections for commercially important technologies, inventions, and know-how related to our business; defend and enforce our patents; preserve the confidentiality of our trade secrets; and operate without infringing, misappropriating, or otherwise violating the valid, enforceable intellectual property rights of third parties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have a global portfolio of patents to protect our drug candidates and technologies. As of June 30, 2023, we owned or had exclusive license rights to (i)&#160;165 granted patents and 101&#160;pending patent applications in jurisdictions such as the U.S., EPO, mainland China, Japan, South Korea, Canada, Australia, Taiwan, Mexico, and Brazil, and (ii)&#160;12 patent applications under the PCT that has not been nationalized. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The patent portfolios for our clinical stage lead product and other products as of June&#160;30, 2023 are summarized below: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">AN2025</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;As of June 30, 2023, we in-licensed 86 granted patents, including seven in the U.S., six in EPO, five in China, and 68 in other jurisdictions, including Canada and Japan, and 18 pending patent applications directed to AN2025. The expected expiration date of granted patents directed to the potential approved use of the compound is 2032, taking into account of the possible 5-year patent term extension in jurisdictions where patent term extension is available, including but not limited to U.S., Europe, and China. The term of patent extension in each jurisdiction is estimated based on the </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">144</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:396.85pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; text-align:justify; width:426pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">patent filing date, the patent grant date, the IND enabling date, the estimated NDA date, and FDA/</font>&#8203;<font style="letter-spacing:0.2pt;">EMA/NMPA approval date according to relevant regulations in each jurisdiction. In addition to the in-licensed patents, we filed two more PCT applications claiming use of AN2025 in combination therapy, which have not been nationalized yet. Even if these patents can provide us with adequate protection, after patent term expires, we may face competition from generic manufacturers. For further details, see &#8220;Risk Factors&#8201;&#8212;&#8201; Risk related to our business&#8201;&#8212;&#8201;We may face competition from generic or biosimilar manufacturers after the patent protection is no longer valid.&#8221; </font></div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.2pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">AN0025</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;As of June 30, 2023, we in-licensed 22 granted patents, including two in the U.S., one in EPO, two in China, and 16 in other jurisdictions, including Canada and Australia, and five pending patent applications directed to AN0025. The expected expiration date of granted patents directed to the potential approved use of the compound is 2036, taking into account of the possible 5-year patent term extensions in jurisdictions where patent term extension is available, including but not limited to the U.S., Europe, and China. Similar to AN2025, the term of patent extension in each jurisdiction is estimated based on the patent filing date, the patent grant date, the IND enabling date, the estimated NDA date, and FDA/EMA/NMPA approval date according to relevant regulations in each jurisdiction. Further to the in-licensed patents, we also filed two provisional patent applications directed to a new formulation of AN0025 and a series of biomarkers to predict patients&#8217; responsiveness to the treatment with AN0025. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">145</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the details of the material patents or patent applications in-licensed/</font>&#8203;<font style="letter-spacing:0.2pt;">owned by us in connection with our clinical drug candidates: </font></div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.417pt 0pt; width:60pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Product </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.417pt 0pt; width:60pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Scope of patent </font>
                <br >
                <font style="letter-spacing:-0.16pt;">protection </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.417pt 0pt; width:84pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Jurisdiction </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.417pt 0pt; width:36pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Status </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.417pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Applicant </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.417pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Patent </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Expiration</font><font style=" position:relative; bottom:3.25pt;line-height:5pt;font-size:5pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.417pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Our Rights </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7.25pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:60pt;text-align:left;">
              <div style="line-height:12pt;">
                <font style="letter-spacing:0.2pt;">AN2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;" rowspan="6">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:60pt;white-space:normal;" rowspan="6">
              <div style="text-align:center; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Directed to combination therapy </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="6">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">PCT </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:36pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Pending </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Our Group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Ownership </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">United States</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2034-05-09 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">EPO </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2034-05-06 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mainland China </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Novartis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2034-05-06 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Exclusive </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Japan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2034-05-06 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Others</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2034-05-06 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:60pt;white-space:normal;" rowspan="2">
              <div style="text-align:center; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Directed to formulation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:36pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Novartis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">2034-03-04 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Exclusive </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">EPO </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2034-03-04 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mainland China </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Novartis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2034-03-04 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Exclusive </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Japan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2034-03-04 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Others</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2034-03-04 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:60pt;white-space:normal;" rowspan="2">
              <div style="text-align:center; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Directed to process </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">2033-10-21 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">EPO </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2033-10-21 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mainland China </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2033-10-21 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Japan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2033-10-21 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Others</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2033-10-21 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:60pt;white-space:normal;" rowspan="2">
              <div style="text-align:center; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Directed to compound </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:36pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Novartis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">2027-12-05 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Exclusive </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">EPO </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2027-01-22 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mainland China </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2027-01-22 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Japan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2027-01-22 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Others</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2027-01-22 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">AN0025 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:60pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Directed to Biomarkers </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mainland China </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Pending </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Our Group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Ownership </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:60pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Directed to formulation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mainland China </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Pending </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Our Group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Ownership </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;" rowspan="5">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:60pt;white-space:normal;" rowspan="5">
              <div style="text-align:center; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Directed to combination therapy </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="5">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:36pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Pending </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Novartis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Exclusive </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">EPO </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mainland China </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2035-05-21 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Australia </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Others</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(6)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Pending </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:7pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;" rowspan="5">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:60pt;white-space:normal;" rowspan="5">
              <div style="text-align:center; line-height:12pt; padding-bottom:0pt;">
                <font style="letter-spacing:0.2pt;">Directed to compound </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;" rowspan="5">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">United States </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:36pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Eisai </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">2031-09-12 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Exclusive </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">EPO </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2031-09-12 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Mainland China </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2031-09-12 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Australia </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2031-09-12 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Others</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(7)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2031-09-12 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">AN4005 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:60pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Directed to compound </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:84pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">PCT </font>
                <br >
                <font style="letter-spacing:0.2pt;">United States, EPO,</font>
                <br >
                <font style="letter-spacing:0.2pt;">Mainland China, Japan,</font>
                <br >
                <font style="letter-spacing:0.2pt;">Taiwan</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Pending </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">Our Group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:48pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Ownership </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:18.25pt;white-space:nowrap;text-align:center;vertical-align:top;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:60pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:84pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:48pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Abbreviation: PCT = Patent Cooperation Treaty </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">146</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Notes: </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:3.8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Patent expiration date is estimated based on current filing status, without taking into account any possible patent term adjustments or extensions and assuming payment of all appropriate maintenance, renewal, annuity, and other government fees. Patent term extension is available in certain jurisdictions, such as in the U.S., Europe, and China. The patent term restored under patent term extension is estimated based on various factors in different jurisdictions, and subject to limitations. For example, in the U.S., the maximum extension that can be obtained for a patent is limited to five&#160;years, and the total remaining patent term (with PTE) is limited to fourteen&#160;years from the date of product approval by the FDA. The patent expiration date in the table is obtained from the commercial database of Patsnap. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Four countries, which are Canada, Australia, South Korea, and Russia. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">16 countries and/or territories, including Canada, Australia, New Zealand, South Korea, and Singapore. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Seven countries, including Canada, Australia, South Korea, and Russia. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">22 countries and/or territories, including Canada, Australia, New Zealand, South Korea, and Singapore. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:3.8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Israel and Russia. Except for the U.S. and EPO, patent applications of combination therapy are pending in Canada and Mexico. In addition to the combination therapy patent granted in mainland China, there is another patent application directed to the combination therapy pending before the China National Intellectual Property Administration. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:3.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:3.8pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Nine countries and/or territories, including Canada, New Zealand, and Hong Kong. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes the details of the material patent applications owned by us in connection with our platforms: </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Platform </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:84pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Title of Patent </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Application </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:48pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Jurisdiction </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Status </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Applicant </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Patent </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Expiration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:45pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Our Rights </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:72pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.2pt;">PAINT-2D</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;TM</font><font style="letter-spacing:0.2pt;"> platform </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:84pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.2pt;">System and method for screening and evaluating tumor immunotherapy drugs </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:48pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">U.S., EPO, Mainland China, and Hong Kong </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Pending </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Our</font>
                <br >
                <font style="letter-spacing:0.2pt;">Group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Ownership </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:72pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">ANEAT-Id</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;TM</font><font style="letter-spacing:0.2pt;"> </font>
              <br >
              <font style="letter-spacing:0.2pt;">platform </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:84pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.2pt;">Design and</font>
              <br >
              <font style="letter-spacing:0.2pt;">construction of fully human antibody yeast display technology </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:48pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">U.S., EPO, and Mainland China </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Pending </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:45pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Our</font>
              </div>
              <div style="margin-top:6pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">&#8212;</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:8.167pt 0pt 0.5pt 0pt; width:45pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Ownership</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.9pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The term of individual patents may vary based on the jurisdictions in which they are granted. In most jurisdictions in which we file patent applications, including the U.S. and China, the term of an issued patent is generally 20&#160;years from the filing date of the earliest non-provisional patent application to which the patent claims priority. In the United States and China, a patent&#8217;s term may be extended or adjusted to account for administrative delays during prosecution by the patent offices, in excess of a patent applicant&#8217;s own delays during the prosecution process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, with respect to any issued patents in the U.S., Europe, and China, we may be entitled to an extension of the patent term for up to five&#160;years, provided we meet the applicable requirements for obtaining such patent term extensions. For example, in the U.S., we may apply for a patent term extension of up to five&#160;years as compensation for the patent term lost during clinical trials and the FDA regulatory review process under the Hatch-Waxman Amendments. The exact duration of the extension depends on the time we spend in clinical studies, as well as getting an NDA or BLA approval from the FDA. However, a patent term extension cannot extend the remaining term of a patent beyond a total of 14&#160;years from the date of product approval. In addition, a patent may only be extended once, and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. Furthermore, a new chemical entity is granted five&#160;years of data exclusivity and a reference biological product is granted 12&#160;years of data exclusivity from the time of first licensure of the product, and the FDA will not accept an application for a biosimilar or interchangeable product based on the reference biological product until four&#160;years after the date of first licensure of the reference product. In certain other foreign jurisdictions, similar extensions as compensation for regulatory delays are also available. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We conduct our business under the brand name &#8220;Adlai Nortye&#8221; or &#8220;</font><font style="font-family:MSungHK-Light;">&#38463;</font><font style="font-family:MSungHKS-Light;">&#35582;</font><font style="font-family:MSungHK-Light;">&#21307;&#33647;</font><font style="letter-spacing:0.2pt;">&#8221;. As of June 30, 2023, we had registered 70 trademarks in total. Among them, we registered 19 &#8220;Adlai Nortye&#8221; or &#8220;</font><font style="font-family:MSungHK-Light;">&#38463;</font><font style="font-family:MSungHKS-Light;">&#35582;</font><font style="font-family:MSungHK-Light;">&#21307;&#33647;</font><font style="letter-spacing:0.2pt;">&#8221; </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">147</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">trademarks in mainland China, five in Hong Kong, one in Macau, one in Taiwan, and applied for trademark registration of &#8220;Adlai Nortye&#8221; in other twelve jurisdictions including the U.S., Canada, Europe, U.K., Australia, Japan, and South Korea and have successfully obtained registrations in the U.S., Europe, U.K., Australia, Japan, and other four jurisdictions. In addition, there are nine trademark applications of &#8220;Adlai Nortye&#8221; or &#8220;</font><font style="font-family:MSungHK-Light;">&#38463;</font><font style="font-family:MSungHKS-Light;">&#35582;</font><font style="font-family:MSungHK-Light;">&#21307;&#33647;</font><font style="letter-spacing:0.2pt;">&#8221; pending potential registration in the U.S., Canada, South Korea, mainland China, and South Africa. As of June 30, 2023, we were also the registered owner of one domain name.</font><font style="font-family:MSungHK-Light;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the license and collaboration agreements we entered into with our collaborators, we were granted certain exclusive licenses to develop and commercialize our drug candidates, including AN2025 and AN0025. For more details, please see the paragraphs headed &#8220;&#8212; License and collaboration agreements&#8221; in this section. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of June 30, 2023, we had not been involved in any proceedings in respect of, and we had not received notice of any claims of infringement, misappropriation, or other violations of third-party intellectual property and we are not involved in any proceedings in respect of any intellectual property rights that may be threatened or pending and that may have an influence on its research and development for any drug candidates in which we may be a claimant or a respondent. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employees</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of June 30, 2023, we had a total of 130 employees. The following table sets forth the number of our employees categorized by function as of June 30, 2023. </font>
        </div>
        <table style="width:416pt;height:53.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:329.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Function </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">% of Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:329.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and Development </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">90</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">69</td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.32pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Management, Finance, Administrative and Others </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">40</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">31</td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.32pt;text-align:left;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">130</td>
            <td style="padding:0pt;padding-left:5.96pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:0pt;padding-left:10.38pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8.3pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Among our 130 employees, 105 are stationed in China, and 25 are based in the U.S. We have not established a labor union in our New Jersey office. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We enter into individual employment contracts with our employees covering matters such as salaries, bonuses, employee benefits, workplace safety, confidentiality obligations, work product assignment clause, and grounds for termination. We also enter into separate confidentiality and non-competition agreements with our senior management and certain key members of our R&amp;D team and other employees who have access to trade secrets or confidential information about our business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To maintain the quality, knowledge, and skill levels of our workforce, we provide continuing education and training programs, including internal and external training, for our employees to improve their technical, professional, or management skills. We also provide training programs to our employees from time to time to ensure their awareness and compliance with our policies and procedures in various aspects. Furthermore, we provide various incentives and benefits to our employees, including competitive salaries, bonuses, and share-based compensation to our employees, particularly our key employees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have complied with the PRC law in respect of making contributions to statutory employee benefit plans (including pension insurance, medical insurance, work-related injury insurance, unemployment insurance, maternity insurance, and housing funds) at a certain&#160;percentage of our employees&#8217; salaries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We consider our relations with our employees to be good, and we have not experienced any strikes or labor disputes which had a material effect on our business. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Facilities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We do not own any property but instead lease certain properties in the United States and China in connection with our business operations. As of June 30, 2023, we rent a total of 623 sq.m. of combined office and laboratory space in New Jersey, the United States. We also leased two properties in Hangzhou and one property in Shanghai, China, with an aggregate gross floor area of 5,053 sq.m. We believe our current facilities </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">148</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">are sufficient to meet our near-term needs, and additional space can be obtained on commercially reasonable terms to meet our future needs. We do not anticipate undue difficulty in renewing our leases upon their expiration. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth a summary of the properties leased by us in 2023: </font>
        </div>
        <table style="width:456pt;height:233.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;min-height:18.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:78.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Location </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:78.91pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Usage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:132pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Address </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:78.91pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Lease Term </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:39.25pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Gross Floor </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Area (sq.m) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:53.25pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.833pt 0pt; width:78.92pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">United States </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.833pt 0pt; width:78.91pt;">
              <font style="letter-spacing:0.2pt;">Office and laboratory </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.833pt 0pt; width:132pt;">
              <font style="letter-spacing:0.2pt;">New Jersey Biotechnology Development Center, 685 US Hwy 1, North Brunswick Township, NJ 08902 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.833pt 0pt; width:78.91pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">July&#160;15, 2021 to July&#160;14, 2024* </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.833pt 0pt; width:39.25pt;white-space:nowrap;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">623.20 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:55pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:78.92pt;">
              <font style="letter-spacing:0.2pt;">China </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:78.91pt;">
              <font style="letter-spacing:0.2pt;">Office </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:132pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Building 6, No. 1008, Xiangwang Street, Yuhang District, Hangzhou, Zhejiang Province </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:78.91pt;white-space:normal;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;1, 2020 to September&#160;30, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:39.25pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2,236.26</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:55pt;white-space:normal;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:78.92pt;white-space:nowrap;">
              <font style="letter-spacing:0.2pt;">China </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:78.91pt;">
              <font style="letter-spacing:0.2pt;">Office and laboratory </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:132pt;">
              <font style="letter-spacing:0.2pt;">Building 8, No. 1008, Xiangwang Street, Yuhang District, Hangzhou, Zhejiang Province </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:78.91pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;1, 2020 to September&#160;30, 2025 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:39.25pt;white-space:nowrap;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2,303.9 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:57pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:78.92pt;">
              <font style="letter-spacing:0.2pt;">China </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:78.91pt;">
              <font style="letter-spacing:0.2pt;">Office </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:132pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">New Bund Oriental Plaza I, Room 1702, No. 512 Haiyang West Road, Pudong New District, Shanghai </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:78.91pt;white-space:normal;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">January&#160;1, 2022 to December&#160;31, 2024 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:39.25pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">512.71</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5.81pt; text-align:justify; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Note: </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Such lease commenced in July&#160;2018. We renewed the lease agreement for another three&#160;years in July&#160;2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Manufacturing and supply</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our CMC capability includes the following functions: (i)&#160;chemical process: our chemical process team focuses on developing and synthesizing active pharmaceutical ingredient (&#8220;API&#8221;), expediting scale up of compound for early developmental activities in drug safety and pharmaceutical sciences, and fulfilling in a timely and efficient manner the requests for drug substance supply to support preclinical and clinical studies; (ii)&#160;formulation development: our formulation development team focuses on developing dosage forms of toxicology evaluations and preclinical and clinical trials, evaluating the physicochemical properties and bioavailability of compounds; (iii)&#160;analytical sciences: our analytical science team implements a science-driven, clinical and commercial production oriented approach to the development and application of both classic and state-of-the-art analytical techniques and tools throughout the life cycle of each of our drug candidates, including but not limited to development and validation of analytical methods for API and drug product, technical transfer of process and analytical methods, establishment of specifications, testing and releasing of each batch of API and drug products to be used in preclinical and clinical studies; and (iv)&#160;quality control and assurance: with well-documented and comprehensive quality system, the quality control and assurance team is responsible for testing and verifying the product quality with predefined standards in effort to assure the quality of all the batches, manufactured at every stage of manufacturing/processing API and drug products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Manufacturing</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We currently work with qualified CMOs to manufacture and test drug candidates for preclinical and clinical supply. In the near future, we plan to continue outsourcing the manufacturing of our drug candidates, including commercial-scale manufacturing of any approved drugs, to industry-leading, highly reputable, and qualified CMOs/CDMOs globally and in China. We have adopted, and plan to continue to implement, robust procedures in effort to ensure that the production qualifications, facilities, and processes of our CMOs/</font>&#8203;<font style="letter-spacing:0.2pt;">CDMOs comply with the applicable regulatory requirements and our internal guidelines and quality standards. </font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">149</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:304pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may also engage additional qualified CMOs/CDMOs in the future to help ensure that we will have sufficient supply of drug candidates for our clinical trials as well as for the commercial sales of our approved drugs. When selecting CMOs/CDMOs, we plan to focus on their qualifications, relevant expertise, production capacity, reputation, track record, product quality, and production cost. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Raw materials and suppliers</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We procure raw materials and equipment for the development of our drug candidates from qualified suppliers. We also work with qualified CROs and CMOs to manage and conduct preclinical and clinical studies and of our pipeline candidates, as well as the manufacturing activities, in China and the United States. Our purchases mainly include licensor, third-party contracting services for research and development of our drug candidates, and manufacturing of certain drug substances for clinical supply, as well as raw materials, consumables, machines, and equipment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, we believe that adequate alternative sources for such supplies exist and we have developed alternative sourcing strategies for these supplies. We intend to establish necessary relationships with alternative sources based on supply continuity risk assessment. Other than the agreements with certain CROs, we order supplies and services on a purchase order basis and do not enter into long-term dedicated capacity or minimum supply arrangements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Legal proceedings</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may be subject to legal proceedings, investigations, and claims arising from the ordinary course of our business from time to time, and we may also initiate legal proceedings in order to protect our intellectual property and other rights. Currently, we are not a party to any actual or threatened legal or administrative proceedings which would have a material and adverse impact on our business, financial condition, or results of operations. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources, and other factors.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">150</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tREG">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REGULATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are subject to a variety of U.S. and PRC laws, rules, and regulations across a number of aspects of our business. This section sets forth a summary of the most significant laws and regulations that are applicable to our current business activities within the territory of U.S. and PRC that affect the dividends payment to our shareholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. laws and regulations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act, or FDCA, and its implementing regulations, and biologics under the FDCA and the Public Health Service Act, or PHSA, and its implementing regulations. FDA approval is required before any new unapproved drug or dosage form, including a new use of a previously approved drug, can be marketed in the United States. Drugs and biologics are also subject to other federal, state, and local statutes and regulations. The FDA generally requires the following before drug candidates may be marketed in the United States: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">completion of extensive preclinical laboratory tests and preclinical animal studies, all performed in accordance with Good Laboratory Practices, or GLP, regulations, where applicable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">submission to the FDA of an IND, which must become effective before human clinical studies may begin; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approval by an independent institutional review board, or IRB or ethics committee representing each clinical site before each clinical study may be initiated; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">performance of adequate and well-controlled human clinical studies in accordance with GCP, requirements to establish the safety and efficacy, or with respect to biologics, the safety, purity and potency of the drug candidate for each proposed indication; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">preparation of and submission to the FDA of a NDA, or biologics license application, or BLA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">potential review of the product application by an FDA advisory committee, where appropriate and if applicable; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a determination by the FDA within 60&#160;days of the initial submission of an NDA or BLA to accept the application for formal review; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">satisfactory completion of an FDA pre-approval inspection of the manufacturing facilities where the proposed product drug substance is produced to assess compliance with current Good Manufacturing Practices, or cGMP, and audits of selected clinical trial sites to ensure compliance with GCP; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">FDA review and approval of an NDA or BLA prior to any commercial marketing or sale of the drug in the United States. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An IND is a request for authorization from the FDA to administer an investigational drug product to humans. The central focus of an IND submission is on the general investigational plan and the protocol or protocols for preclinical studies and clinical trials. The IND also includes results of animal and </font><font style="font-style:italic;letter-spacing:0.2pt;">in vitro</font><font style="letter-spacing:0.2pt;"> studies assessing the toxicology, PK, pharmacology and pharmacodynamic characteristics of the product, chemistry, manufacturing and controls, information, and any available human data or literature to support the use of the investigational product. An IND must become effective before human clinical trials may begin. Upon the date of submission of the initial IND, the sponsor must wait 30&#160;days to allow for FDA review and comment (e.g., protocol design, proposed starting dose) before dosing the first patient under the IND. If the FDA accepts the sponsor&#8217;s response to all queries, the sponsor is given agency approval via an &#8220;OK to proceed letter&#8221; for the clinical trial. If questions are not answered appropriately or the FDA has concerns, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding concerns or questions before the clinical trial can begin. Submission of an IND therefore may or may not result in FDA authorization to begin a clinical trial. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Clinical trials involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with GCP, which includes the requirement that all research subjects provide their informed consent for their participation in any clinical study. Clinical trials are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">151</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">monitoring safety and the effectiveness criteria to be evaluated. An amendment to the existing IND or initiation of a new, separate IND must be made for each successive clinical trial or amendment to the information contained in the IND for the existing clinical trial. Furthermore, an independent IRB for each site proposing to conduct the clinical trial must review and approve the plan for any clinical trial and its informed consent form before the clinical trial begins at that site, and must monitor the study until completed. Regulatory authorities, the IRB or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. Some studies also include oversight by an independent group of qualified experts organized by the clinical study sponsor, known as a data safety monitoring board, which provides authorization for whether or not a study may move forward at designated check points based on access to certain data from the study and may halt the clinical trial if it determines that there is an unacceptable safety risk for subjects or other grounds, such as no demonstration of efficacy. There are also requirements governing the reporting of ongoing preclinical studies and clinical trials and clinical study results to public registries. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The clinical investigation of a drug is generally divided into three phases. Although the phases are usually conducted sequentially, they may overlap or be combined. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Phase&#160;1</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The investigational product is initially introduced into healthy human subjects or patients with the target disease or condition. These studies are designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans, the side effects associated with increasing doses, and, if possible. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Phase&#160;2</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The investigational product is administered to a limited patient population with a specified disease or condition to evaluate the preliminary efficacy, optimal dosages, and dosing schedule and to identify possible adverse side effects and safety risks. Multiple Phase&#160;2 clinical trials may be conducted to obtain information prior to beginning larger Phase&#160;3 clinical trials. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Phase&#160;3.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The investigational product is administered to an expanded patient population to further evaluate potential dose regimen(s), to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit ratio of the investigational product and to provide an adequate basis for product approval. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A clinical investigation may fail at any phase. In some cases, the FDA may conditionally approve an NDA or BLA for a drug candidate on the sponsor&#8217;s agreement to conduct additional clinical studies after approval, called a post-marketing requirement, or PMR or a post-marketing commitment, or PMC. The stipulations of the PMR and/or PMCs are outlined in the FDA approval letter. Concurrent with clinical trials, companies may complete additional animal studies and develop additional information about the biological characteristics of the drug candidate, and must finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the drug candidate and, among other things, must develop methods for testing the identity, strength, quality, and purity of the final product, or for biologics, the safety, purity and potency. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NDA and BLA review process</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product development, nonclinical studies and clinical trials are submitted to the FDA as part of an NDA or BLA requesting approval to market the product for an indication. The NDA or BLA must include all relevant data available from pertinent preclinical studies and pivotal and supporting clinical trials, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#8217;s chemistry, manufacturing and controls and proposed labeling. Data can come from company-sponsored clinical studies intended to test the safety and effectiveness of the product, or from a number of alternative sources, including studies initiated and sponsored by investigators. The initial indication submission of an NDA or BLA requires payment per US regulatory under the Prescription Drug User Fee Act, or the PDUFA. Subsequent submissions for additional indications, called supplements, do not have a fee associated with the Agency review. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, under the Pediatric Research Equity Act, or PREA, a NDA or BLA or supplement to an NDA or BLA must contain data to assess the safety and effectiveness of the biological drug candidate for the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">152</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA Safety and Innovation Act requires that a sponsor who is planning to submit a marketing application for a drug or biological product that includes a new active ingredient, new indication, new dosage form, new dosing regimen or new route of administration submit an initial pediatric study plan within sixty days after an end-of-Phase&#160;2 meeting or as may be agreed between the sponsor and FDA. Unless otherwise required by regulation, PREA does not apply to any drug or biological product for an indication for which orphan designation has been granted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Within 60&#160;days following submission of the application, the FDA will determine if the application is substantially complete before the agency accepts it for filing. The FDA may refuse to file any NDA or BLA that it deems incomplete or not properly reviewable at the time of submission and may request additional information. In this event, the NDA or BLA must be resubmitted with the additional information. Once an NDA or BLA has been accepted for filing, the FDA&#8217;s goal is to review standard applications within ten&#160;months after the filing date, or, if the application qualifies for priority review, six&#160;months after the FDA accepts the application for filing. In both standard and priority reviews, the review process may also be extended by FDA requests for additional information or clarification. The FDA reviews an NDA to determine, among other things, whether a product is safe and effective for its intended use and whether its manufacturing is sufficient to assure and preserve the product&#8217;s identity, strength, quality, and purity. Ninety (90) days after submission, the FDA generally requires the Sponsor provide a safety update report which updates more recent safety information from the patients being evaluated in the NDA or BLA. The FDA reviews a BLA to determine, among other things, whether a product is safe, pure, and potent and the facility in which it is manufactured, processed, packed, or held meets standards designed to assure the product&#8217;s continued safety, purity, and potency. When reviewing an NDA or BLA, the FDA may convene an advisory committee to provide clinical insight on application review questions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before approving an NDA or BLA, the FDA will typically inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA or BLA, the FDA will typically inspect one or more clinical sites to assure compliance with GCP. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">After the FDA evaluates the NDA or BLA and conducts inspections of manufacturing facilities where the investigational product and/or its drug substance will be produced, the FDA may issue an approval letter or a Complete Response Letter, or CRL. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A CRL will describe deficiencies that the FDA identified in the NDA or BLA, except that where the FDA determines that the data supporting the application are inadequate to support approval, the FDA may issue the CRL without first conducting required inspections, testing submitted product lots and/or reviewing proposed labeling. In issuing the CRL, the FDA may recommend actions that the applicant might take to place the NDA or BLA in condition for approval, including requests for additional information or clarification. The FDA may delay or refuse approval of an NDA or BLA if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post-marketing testing and surveillance to monitor safety or efficacy of a product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If regulatory approval of a product is granted, such approval will be granted for the indication supported by the data included in the NDA or BLA and may entail limitations on the indicated uses for which such product may be marketed. For example, the FDA may approve the NDA or BLA with a Risk Evaluation and Mitigation Strategy, or REMS, to ensure the benefits of the product outweigh its risks. A REMS is a safety strategy to manage a known or potential serious risk associated with a product and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling or the development of adequate controls and specifications. Once approved, the FDA may withdraw the product approval if compliance with pre- and post-marketing requirements is not maintained or if problems occur after the product reaches the marketplace. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">153</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Expedited development and review programs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The FDA offers a number of expedited development and review programs for qualifying drug candidates. For example, the fast track program is intended to expedite or facilitate the process for reviewing new products that meet certain criteria. Specifically, drug candidates are eligible for fast track designation if they are intended to treat a serious or life-threatening disease or condition and demonstrate the potential to address unmet medical needs for the disease or condition. Fast track designation applies to the combination of the drug candidate and the specific indication for which it is being studied. The sponsor of a fast track drug candidate has opportunities for more frequent interactions with the review team during product development and, once an NDA or BLA is submitted, the application may be eligible for priority review. A fast track drug candidate is eligible for rolling review, where the FDA may consider for review sections of the NDA or BLA on a rolling basis, with the NDA or BLA being considered complete upon submission of the final module(s). The sponsor pays any required user fees upon submission of the first section of the NDA or BLA. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A drug candidate intended to treat a serious or life-threatening disease or condition may also be eligible for breakthrough therapy designation to expedite its development and review. A product can receive breakthrough therapy designation if preliminary clinical evidence indicates that the product, alone or in combination with one or more other drugs or biologics, may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. The designation includes all of the fast track program features, as well as more intensive FDA interaction and guidance beginning as early as Phase&#160;1 and an organizational commitment to expedite the development and review of the drug candidate, including involvement of senior managers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any marketing application for a drug or biologic submitted to the FDA for approval, including a drug candidate with a fast track designation and/or breakthrough therapy designation, may be eligible for other types of FDA programs intended to expedite the FDA review and approval process, such as priority review and accelerated approval. A drug candidate is eligible for priority review if it has the potential to provide a significant improvement in the treatment, diagnosis or prevention of a serious disease or condition. For new-molecular-entity NDAs and original BLAs, priority review designation means the FDA&#8217;s goal is to take action on the marketing application within six&#160;months of the 60-day filing date (as compared to ten&#160;months under standard review). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Additionally, drug candidates studied for their safety and effectiveness in treating serious or life-threatening diseases or conditions may receive accelerated approval upon a determination that the drug candidate has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. As a condition of accelerated approval, the FDA will generally require the sponsor to perform adequate and well-controlled post-marketing clinical studies to verify and describe the anticipated effect on irreversible morbidity or mortality or other clinical benefit. Products receiving accelerated approval may be subject to expedited withdrawal procedures if the sponsor fails to conduct the required post-marketing studies or if such studies fail to verify the predicted clinical benefit. In addition, the FDA currently requires as a condition for accelerated approval pre-approval of promotional materials, which could adversely impact the timing of the commercial launch of the product. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Fast track designation, breakthrough therapy designation, priority review, and accelerated approval do not change the standards for approval but may expedite the development or approval process. Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Currently, the FDA granted fast track designation to AN2025 for the treatment of recurrent or metastatic HNSCC with disease progression on or after platinum-based therapy. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Post-approval requirements</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any products manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to record-keeping, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">154</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">reporting of adverse experiences, periodic reporting, product sampling and distribution, and advertising and promotion of the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing user fee requirements, under which the FDA assesses an annual program fee for each product identified in an approved NDA or BLA. Drug and biologic manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMPs, which impose certain procedural and documentation requirements upon us and our third-party manufacturers. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMPs and impose reporting requirements upon us and any third-party manufacturers that we may decide to use. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain compliance with cGMPs and other aspects of regulatory compliance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including AEs of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical studies to assess new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">restrictions on the marketing or manufacturing of a product, complete withdrawal of the product from the market or product recalls; fines, warning letters or holds on post-approval clinical studies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of existing product approvals; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">product seizure or detention, or refusal of the FDA to permit the import or export of products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">mandated modification of promotional materials and labeling and the issuance of corrective information; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the issuance of safety alerts, Dear Healthcare Provider letters, press releases and other communications containing warnings or other safety information about the product; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">injunctions or the imposition of civil or criminal penalties. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDA closely regulates the marketing, labeling, advertising and promotion of drug products and biologics. A company can make only those claims relating to safety and efficacy, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses. Failure to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising, and potential civil and criminal penalties. Physicians may prescribe legally available products for uses that are not described in the product&#8217;s labeling and that differ from those tested by us and approved by the FDA. Such off-label uses are common across medical specialties. Physicians may believe that such off-label uses are the best treatment for many patients in varied circumstances. The FDA does not regulate the behavior of physicians in their choice of treatments. The FDA does, however, restrict manufacturer&#8217;s communications on the subject of off-label use of their products. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Drug product marketing exclusivity</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Market exclusivity provisions authorized under the FDCA can delay the submission or the approval of certain marketing applications. For example, the FDCA provides a five-year period of non-patent data exclusivity within the United States to the first applicant to obtain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not previously approved any other new drug containing </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">155</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not approve or even accept for review an abbreviated new drug application, or ANDA, or an NDA submitted under Section&#160;505(b)(2), or 505(b)(2) NDA, submitted by another company for another drug based on the same active moiety, regardless of whether the drug is intended for the same indication as the original innovative drug or for another indication, where the applicant does not own or have a legal right of reference to all the data required for approval. However, an application may be submitted after four&#160;years if it contains a certification of patent invalidity or non-infringement to one of the patents listed with the FDA by the innovator NDA holder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The FDCA alternatively provides three&#160;years of marketing exclusivity for an NDA, or supplement to an existing NDA if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application, for example new indications, dosages or strengths of an existing drug. This three-year exclusivity covers only the modification for which the drug received approval on the basis of the new clinical investigations and does not prohibit the FDA from approving ANDAs or 505(b)(2) NDAs for drugs containing the active agent for the original indication or condition of use. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to any preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pediatric exclusivity is another type of marketing exclusivity available in the United States. Pediatric exclusivity provides for an additional six&#160;months of marketing exclusivity attached to another period of exclusivity if a sponsor conducts clinical trials in children in response to a written request from the FDA. The issuance of a written request does not require the sponsor to undertake the described clinical trials. In addition, orphan drug exclusivity, as described above, may offer a seven-year period of marketing exclusivity, except in certain circumstances. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other U.S. healthcare laws</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pharmaceutical and medical device manufacturers are subject to additional healthcare regulation and enforcement by the federal government and by authorities in the states and foreign jurisdictions in which they conduct their business. Such laws include, without limitation, federal and state anti-kickback, fraud and abuse, false claims, pricing reporting, and transparency laws and regulations, as well as similar foreign laws in the jurisdictions outside the United States, including but not limited to those discussed below: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The federal Anti-Kickback Statute prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, paying, receiving or providing any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made, in whole or in part, under a federal healthcare program. A person or entity need not have actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it in order to have committed a violation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The federal civil monetary penalties and false claims laws, including the civil False Claims Act, or FCA, prohibit individuals or entities from, among other things: knowingly presenting, or causing to be presented, to the federal government, claims for payment or approval that are false, fictitious or fraudulent; knowingly making, using, or causing to be made or used, a false statement or record material to a false or fraudulent claim or obligation to pay or transmit money or property to the federal government; or knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay money to the federal government. Manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#8220;cause&#8221; the submission of false or fraudulent claims. The FCA also permits a private individual acting as a &#8220;whistleblower&#8221; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery. In addition, the government may assert that a claim that includes items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The federal civil monetary penalties laws impose civil fines for, among other things, the offering or transfer or remuneration to a Medicare or state healthcare program beneficiary, if the person knows or should know it </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">156</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner, or supplier of services reimbursable by Medicare or a state health care program, unless an exception applies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Health Insurance Portability and Accountability Act of 1996, or HIPAA, imposes criminal and civil liability for knowingly and willfully executing a scheme, or attempting to execute a scheme, to defraud any healthcare benefit program, including private payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, or falsifying, concealing or covering up a material fact or making any materially false statements in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity need not have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Physician Payments Sunshine Act imposes annual reporting requirements for certain manufacturers of drugs, devices, biologics, and medical supplies for which payment is available under Medicare, Medicaid, or the Children&#8217;s Health Insurance Program, for certain payments and &#8220;transfers of value&#8221; provided to physicians (currently defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain non-physician providers including physician assistants and nurse practitioners, and teaching hospitals, as well as ownership and investment interests held by such physicians and their immediate family members. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Moreover, analogous state and foreign laws and regulations may be broader in scope than the provisions described above and may apply regardless of payor. Some state laws require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and relevant federal government compliance guidance; require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers, many of which differ from each other in significant ways, are often not pre-empted, thus further complicating compliance efforts; and restrict marketing practices or require disclosure of marketing expenditures and pricing information. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Violation of any of such laws or any other governmental regulations that apply may result in penalties, including, without limitation, significant administrative, civil and criminal penalties, damages, fines, additional reporting obligations and oversight if a manufacturer becomes subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, the curtailment or restructuring of operations, exclusion from participation in governmental healthcare programs and imprisonment. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. coverage and reimbursement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Sales of any product depend, in part, on the extent to which such product will be covered by third-party payors, such as federal, state, and foreign government healthcare programs, commercial insurance and managed healthcare organizations, and the level of reimbursement for such product by third-party payors. Decisions regarding the extent of coverage and amount of reimbursement to be provided are made on a plan-by-plan basis. These third-party payors are increasingly reducing reimbursements for medical products, drugs and services. In addition, the U.S. government, state legislatures and foreign governments have continued implementing cost-containment programs, including price controls, restrictions on coverage and reimbursement and requirements for substitution of generic products. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit sales of any product. Decreases in third-party reimbursement for any product or a decision by a third-party payor not to cover a product could reduce physician usage and patient demand for the product and also have a material adverse effect on sales. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. healthcare reform</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, each as amended, collectively known as the ACA, was enacted, which substantially changed the way healthcare is financed by both governmental and private insurers, and significantly affected the pharmaceutical industry. The ACA contains a number of provisions, including those governing enrollment in federal healthcare programs, reimbursement adjustments and changes to fraud and abuse laws. By way of example, the ACA: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">increased the minimum level of Medicaid rebates payable by manufacturers of brand name drugs from 15.1% to 23.1% of the average manufacturer price; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">157</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">required collection of rebates for drugs paid by Medicaid managed care organizations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">required manufacturers to participate in a coverage gap discount program, under which they must agree to offer 70&#160;percent point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#8217;s outpatient drugs to be covered under Medicare Part&#160;D; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">imposed a non-deductible annual fee on pharmaceutical manufacturers or importers who sell &#8220;branded prescription drugs&#8221; to specified federal government programs. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. On March&#160;11, 2021, the American Rescue Plan&#160;Act of 2021 was signed into law, which eliminates the statutory Medicaid drug rebate cap, currently set at 100% of a drug&#8217;s average manufacturer price, or AMP, beginning January&#160;1, 2024. Most recently, on August&#160;16, 2022, the Inflation Reduction Act of 2022, or IRA, was signed into law. Among other things, the IRA requires manufacturers of certain drugs to engage in price negotiations with Medicare (beginning in 2026), with prices that can be negotiated subject to a cap; imposes rebates under Medicare Part&#160;B and Medicare Part&#160;D to penalize price increases that outpace inflation (first due in 2023); and replaces the Part&#160;D coverage gap discount program with a new discounting program (beginning in 2025). The IRA permits the Secretary of the Department of Health and Human Services (HHS) to implement many of these provisions through guidance, as opposed to regulation, for the initial&#160;years. For that and other reasons, it is currently unclear how the IRA will be effectuated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Moreover, there has recently been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries, proposed and enacted legislation and executive orders issued by the President designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products. It is also possible that additional governmental action is taken in response to the COVID-19 pandemic. Individual states in the United States have also become increasingly active in implementing regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRC laws and regulations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRC drug regulatory regime</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">China heavily regulates the development, approval, manufacturing, and distribution of drugs, including biologics. The specific regulatory requirements applicable depend on whether the drug is made and finished in China, which is referred to as a domestically manufactured drug, or made abroad and imported into China in a finished form, which is referred to as an imported drug, as well as the approval or &#8220;registration&#8221; category of the drug. For both imported and domestically manufactured drugs, China typically requires regulatory approval for a clinical trial application to conduct clinical trials in China and submit China clinical trial data, prior to submitting an application for marketing approval. For a domestically manufactured drug, there is also a requirement to have a drug manufacturing license for a facility in China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In 2017, the drug regulatory system entered a new and significant period of reform. The General Office of the State Council and the General Office of the Central Committee of the Communist Party of China jointly issued an Opinions on Deepening the Reform of the Evaluation and Approval Systems and Encouraging Innovation on Drugs and Medical Devices, or the Innovation Opinions, in October&#160;2017. The expedited programs, the record-filing system, the prioritized review mechanism, the acceptance of foreign clinical data under the Innovation Opinions and other recent reforms encourage drug manufacturers to seek marketing approval in China first to develop drugs in highly prioritized therapeutical areas, such as oncology. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To implement the regulatory reform introduced by Innovation Opinions, the National People&#8217;s Congress, the National Medical Products Administration, or NMPA, a newly formed government authority as well as other authorities, has been revising the fundamental laws, regulations and rules regulating pharmaceutical products and the industry, which include the framework law known as the PRC Drug Administration Law. In </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">158</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">addition, the State Council issued the Regulations for Implementation of the Drug Administration Law of the PRC, which was promulgated in 2002 and latest amended in 2019, to further implement the PRC Drug Administration Law. NMPA also has its own set of regulations for the PRC Drug Administration Law, and the primary one governing clinical trial applications, marketing approval, and post-approval amendment and renewal is known as the Drug Registration Regulation, which was latest amended by NMPA in 2020. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulatory authorities</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the PRC, NMPA is the primary regulatory agency for pharmaceutical products and businesses. The agency was formed from the prior China Food and Drug Administration, in 2018 as part of a government reorganization. NMPA is responsible for drawing up the laws and regulations related to pharmaceuticals and medical devices, making policy planning, formulating departmental regulations, organizing the development and issuance of pharmaceutical and medical device standards, classification, and management systems, such as national formulary, and supervising the implementation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Center for Drug Evaluation is the technical evaluation unit for drug registration with NMPA. It is mainly responsible for conducting technical evaluation on the drugs applying for registration and verifying the relevant drug registrations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The National Health Commission (formerly known as the National Health and Family Planning Commission), is primary national regulator for public health and family planning management. It is primarily responsible for drafting national health policies, supervising and regulating public health, healthcare services, and health emergency systems, coordinating the reform of medical and health system, organizing the formulation of national drug policies and national essential medicine system, launching an early warning mechanism for the monitoring of the use and clinical comprehensive evaluation of medicine as well as the drug shortage, giving suggestions on the pricing policy of national essential medicine, and regulating the operation of medical institutions and practicing of medical personnel. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Non-clinical research</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">NMPA requires preclinical data to support registration applications for imported and domestic drugs. According to the Drug Registration Regulation, nonclinical safety studies must comply with the Administrative Measures for Good Laboratories Practice of Non-clinical Laboratory. In 2003, NMPA promulgated the Administrative Measures for Good Laboratories Practice of Non-clinical Laboratory to improve the quality of non-clinical research and began to conduct the Good Laboratories Practice. Pursuant to the Circular on Administrative Measures for Certification of Good Laboratory Practice for Non-clinical Laboratory issued by NMPA in 2007, NMPA is responsible for the certification of non-clinical research institutions nationwide and local provincial medical products administrative authorities is in charge of the daily supervision of non-clinical research institution. NMPA decides whether an institution is qualified for undertaking pharmaceutical non-clinical research by evaluating such institution&#8217;s organizational administration, its research personnel, its equipment and facilities, and its operation and management of non-clinical pharmaceutical projects. A Good Laboratory Practice Certification will be issued by NMPA if all the relevant requirements are satisfied, which will also be published on NMPA&#8217;s website. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Clinical trial application</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the Administrative Measures for Drug Registration, which was promulgated in January&#160;2020 and took effect in July&#160;2020, the Center for Drug Evaluation under NMPA is responsible for the application of conducting new drug clinical trials. According to the Administrative Measures for Drug Registration, drug clinical trials shall be divided into Phase&#160;I clinical trial, Phase&#160;II clinical trial, Phase&#160;III clinical trial, Phase&#160;IV clinical trial, and bioequivalence trial. In accordance with the Circular on Adjusting Evaluation and Approval Procedures for Clinical Trials for Drugs issued in 2018, if a clinical trial applicant does not receive any negative or questioned opinions from the Center for Drug Evaluation within 60 business days after the date when the trial application is accepted and the fees are paid, the applicant can proceed with the clinical trial in accordance with the trial protocol submitted to the Center for Drug Evaluation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After obtaining the clinical trial authorization from NMPA, the applicant must register the clinical trial at the Drug Clinical Trial Information Platform for public disclosure in accordance with the Announcement </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">159</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">on Drug Clinical Trial Information Platform. The applicant shall complete the initial registration within one month after obtaining the clinical trial authorization and complete follow-up registrations before the first subject&#8217;s enrollment in the trial. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conducting clinical trial and the communication with Center for Drug Evaluation</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">NMPA promulgated the Administration of Quality of Drug Clinical Practice in August&#160;2003. Pursuant to the Administration of Quality of Drug Clinical Practice, clinical trial means systematical investigation of drugs conducted on human subjects (patients or healthy volunteers) to prove or reveal the function, adverse reactions and/or absorption, distribution, metabolism, and excretion of the drug being investigated, of which the purpose is to determine the therapeutic efficacy and safety of the drug. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The conduct of clinical trials must adhere to GCP and the protocols approved by the ethics committees of each study site. The sponsor of clinical trials should provide insurance to the human subjects participating in the clinical trial and bear the cost of the treatment and the corresponding financial compensation for the human subjects who suffer harm or death related to the trial. To ensure authenticity and reliability of the clinical data, NMPA mandates applicants of the pending drug registration submissions to conduct self-inspection and verification of their clinical trial data. Based on the submitted self-inspection results, NMPA also regularly launches onsite clinical trial audits over selected applications and rejects those found with data forgery. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the Administrative Measures for Drug Registration, a clinical trial consists of Phases I, II, III and IV as well as the bioequivalence trial. Phase&#160;I refers to the initial clinical pharmacology and safety evaluation studies in humans. Phase&#160;II refers to the preliminary evaluation of a drug candidate&#8217;s therapeutic effectiveness and safety for indications in patients, to provide evidence and support for the design of Phase&#160;III clinical trials and to settle the administrative dose regimen. Phase&#160;III refers to clinical trials undertaken to confirm the therapeutic effectiveness and safety on patients with target indications, to evaluate the overall benefit-risk relationships of the drug, and ultimately to provide sufficient evidence for the review of drug registration application. Phase&#160;IV refers to a new drug&#8217;s post-marketing study to assess therapeutic effectiveness and adverse reactions when the drug is widely used, to evaluate the overall benefit-risk relationships of the drug when used among the general population or specific groups and to adjust the administration dose. Based on the characteristics of drugs and research objective, the research contents shall include clinical pharmacology research, exploratory clinical trial, confirmatory clinical trial, and post-marketing research. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the Technical Guiding Principles for Clinical Trials of Anti-tumor Drugs issued by the State FDA in May&#160;2012, the clinical study staging of anti-tumor drugs is not a fixed developmental sequence. The rapid development of anti-tumor drug research theories and technologies is likely to have an impact on future anti-cancer drug development models. Therefore, applicants can actively explore more scientific and rational research methods and promptly seek advice from the drug registration department under the State Food and Drug Administration. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Human genetic resources filing</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Interim Administrative Measures on Human Genetic Resources, promulgated by the Ministry of Science and Technology and the Ministry of Health in 1998, aimed at protecting and fair utilizing human genetic resources in the PRC. In July&#160;2015, the Ministry of Science and Technology issued the Service Guide for Administrative Licensing Items concerning Examination and Approval of Sampling, Collecting, Trading or Exporting Human Genetic Resources, or Taking Such Resources out of the PRC, or the Service Guide, which provides that the sampling, collection, or research activities of human genetic resources by a foreign-invested sponsor fall within the scope of international cooperation, and the cooperating organization of China shall apply for approval of the China Human Genetic Resources Management Office through the online system. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Regulations of the PRC on the Administration of Human Genetic Resources, promulgated by the State Council in 2019, which repealed the Interim Administrative Measures on Human Genetic Resources, and the Implementing Rules for the Regulations of the PRC on the Administration of Human Genetic Resources promulgated by the Ministry of Science and Technology in May 2023, further stipulate that, in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">160</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">order to obtain marketing authorization for relevant drugs and medical devices in China, no approval is required in international clinical trial cooperation using China&#8217;s human genetic resources at clinical medical and health institutions without exporting human genetic resource materials. This is provided that either of the following conditions is met: (1) relevant collection, testing, and analysis of human genetic resources, and the handling of the remaining materials of human genetic resources, among others, are conducted at clinical medical and health institutions; or (2) the collection of relevant human genetic resources is conducted at clinical medical and health institutions, while the testing and analysis of the human genetic resources and the handling of the remaining samples are conducted by the domestic entity as designated under the clinical trial protocol for the marketing authorization for relevant drugs and medical devices. Before commencing clinical trials, the two cooperating parties shall file the type, quantity, and usage of the human genetic resource to be used with the administrative department of science and technology under the State Council. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Currently, we have obtained the human generic resources approvals for AN0025, AN1004, AN2025 and AN4005. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Acceptance of overseas clinical trial data</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">NMPA may reduce requirements for clinical trials and data, depending on the drug and the existing data. NMPA issued the Technical Guiding Principles for the Acceptance of Overseas Clinical Trial Data of Drugs, or the Overseas Data Guiding Principles, in July&#160;2018, as one of the implementing rules for the Innovation Opinions, which provides that overseas clinical trial data can be submitted for clinical evaluation information in the process of drug marketing registration applications in China. According to the Overseas Data Guiding Principles, the overseas clinical trial data shall include, amongst others, the clinical trial data obtained overseas by the sponsor in its simultaneous R&amp;D at home and abroad of innovative drugs, and sponsors must ensure the authenticity, integrity, accuracy and traceability of the overseas clinical trial data and such data must be obtained consistent with the relevant requirements under the Good Clinical Trial Practice of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. Moreover, sponsors shall ensure the scientific design of overseas clinical trials, the compliance of clinical trial quality management system requirements, and the accuracy and integrity of statistical analysis of data. To ensure that the clinical trial design and statistical analysis of the data are scientific and reasonable, for the drugs with simultaneous R&amp;D at home and abroad and forthcoming clinical trials in China, the sponsors may, prior to implementing pivotal clinical trials, contact the Center for Drug Evaluation to ensure the compliance of pivotal clinical trials&#8217; design with the essential technical requirements for drug registration in China. Sponsors must also comply with other relevant sections of the Registration Measures when applying for drug marketing registrations in China using foreign clinical trial data. Currently, we have conducted some multi-center clinical trials overseas, and may apply for drug registrations in China by using overseas clinical trial data in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">International multi-center clinical trials regulations</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the Notice on Issuing the International Multi-Center Clinical Trial Guidelines (for Trial Implementation), or the Multi-Center Clinical Trial Guidelines, promulgated by NMPA in January&#160;2015, international multi-center clinical trial applicants may simultaneously perform clinical trials in different centers using the same clinical trial protocol. Where the applicants plan to implement the international multi-center clinical trials in the PRC, the applicants shall comply with relevant laws and regulations, such as the PRC Drug Administration Law, the Implementing Regulations of the PRC Drug Administration Law and the Administrative Measures for Drug Registration, execute the GCP, make reference to universal international principles such as the ICH-GCP, and comply with the laws and regulations of the countries involved in the international multi-center clinical trials. Where the applicants plan to use the data derived from the international multi-center clinical trials for approval of a drug registration in the PRC, it shall involve at least two countries, including China, and shall satisfy the requirements for clinical trials set forth in the Multi-Center Clinical Trial Guidelines and Administrative Measures for Drug Registration and other related laws and regulations. Currently, we have conducted certain multi-center clinical trials overseas for AN2025, AN0025 and AN4005. If we plan to implement the international multi-center clinical trials in the PRC, we shall comply with relevant laws and regulations accordingly. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">161</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">New drug application</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the Administrative Measures for Drug Registration, the applicant may apply for drug marketing registration to Center for Drug Evaluation upon completion of relevant research on pharmacy, pharmacology, toxicology and drug clinical trials, determination the quality standards of the drug, validation of commercial-scale production processes and preparation for acceptance of verification and inspection conducted by professional technical institution designated by competent NMPA. The Center for Drug Evaluation will organize pharmaceutical, medical, and other technicians to conduct comprehensive review of the safety, efficacy, and quality controllability, among others, of the drug according to the application materials submitted by the applicant, the results of the verification and inspection conducted by professional technical institution, etc. If the comprehensive review conclusion is affirmative, the drug shall be approved for marketing and a drug registration certificate will be issued containing the information of the drug approval number, the marketing authorization holders, and the manufacturer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In March&#160;2016, the China Food and Drug Administration issued the Reform Plan for Registration Category of Chemical Medicine, which aims to reclass the registration application of chemical drugs stipulated by the Administrative Measures for Drug Registration promulgated in 2007. According to the Reform Plan for Registration Category of Chemical Medicine, Category 1 drugs refer to innovative chemical drugs that have not been marketed anywhere in the world. Improved new chemical drugs that are not marketed anywhere in the world fall into Category 2 drugs. Generic chemical drugs, that have equivalent quality and efficacy to the originator&#8217;s drugs have been marketed abroad but not yet in China, can be classified as Category 3 drugs. Generic drugs, that have equivalent quality and efficacy to the originator&#8217;s drugs and have been marketed in China, fall into Category 4 drugs. Category 5 drugs are drugs which have already been marketed abroad but are not yet approved in China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As a support policy and implementing rule of the Administrative Measures for Drug Registration newly amended in 2020, NMPA issued the Chemical Drug Registration Classification and Application Data Requirements in June&#160;2020, effective in July&#160;2020, which reaffirmed the principles of the classification of chemical drugs set forth by the Reform Plan for Registration Category of Chemical Medicine and made minor adjustments to the subclassifications of Category 5. According to such regulation, Category 5.1 are innovative chemical drugs and improved new chemical drugs while Category 5.2 are generic chemical drugs, all of which shall have been already marketed abroad but not yet approved in China. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Special examination and fast track approval</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">NMPA has adopted several expedited review and approval mechanisms since 2009 and created additional expedited programs in recent&#160;years that are intended to encourage innovation. Applications for these expedited programs can be submitted together with the registration package or after the registration submission is admitted for review by the Center for Drug Evaluation. The Opinions on Encouraging the Prioritized Evaluation and Approval for Drug Innovation promulgated by NMPA on December&#160;21, 2017, clarified that fast track clinical trial applications or drug registration pathways will be available to the innovative drugs. It was further replaced by the Announcement on the Release of Three Documents including the Procedures for the Evaluation of Breakthrough Therapeutic Drugs (Trial) issued by the NMPA on July&#160;7, 2020, the three documents are namely the Procedures for the Evaluation of Breakthrough Therapeutic Drugs (Trial), Procedures for the Evaluation and Approval of the Listing Application for Conditional Approval of Drugs (Trial) and Procedures for Prioritized Evaluation and Approval for Drug Marketing (Trial), among others, which allow the applicant to apply for the breakthrough therapy drug procedure during the Phase&#160;I and II clinical trials and normally no later than the commencement of Phase&#160;III clinical trials for the innovative or improved drugs which are used for the prevention and treatment of diseases that seriously endanger life or seriously affect quality of life and there is no effective means of prevention and treatment or there is sufficient evidence to show a significant clinical advantage over the existing treatments. In addition, when applying for the marketing licenses for the drugs with obvious clinical value, the applicant can apply for the prioritized evaluation and approval procedure. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If admitted to one of these expedited programs, an applicant will be entitled to more frequent and timely communication with reviewers at the Center for Drug Evaluation, expedited review and approval, and more agency resources throughout the review approval process. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">162</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">NMPA also permits conditional approval of certain medicines based on early phase China clinical trial data or only on foreign approval clinical data. Post-approval the applicant may need to conduct one or more post-market studies. The agency has done this for drugs that meet unmet clinical needs for life-threatening illnesses and also for drugs that treat orphan indications. In 2018, NMPA established a conditional approval program for drugs designated by the Center for Drug Evaluation that have been approved in the US, EU and Japan within the last 10&#160;years and that meet one of three criteria (1)&#160;orphan indications, (2)&#160;drugs that treat life threatening illnesses for which there are not effective treatment or preventive methods, and (3)&#160;drugs that treat life threatening illnesses and that have a clear clinical advantage over other approved therapies. In the future, we anticipate that we may seek expedited review and approval for certain of our drug candidates. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Drug manufacturing permit</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the PRC Drug Administration Law and the Implement Measures of the PRC Drug Administration Law, a drug manufacturer must obtain a Drug Manufacturing Permit from the provincial Medical Products Administration before it starts to manufacture drug products. Prior to granting such a permit, the relevant government authority will inspect the applicant&#8217;s production facilities and decide whether the sanitary conditions, QA system, management structure and equipment within the facilities have met the required standards. Each Drug Manufacturing Permit will be valid for a period of five&#160;years and the manufacturer is required to apply for renewal of the permit within six&#160;months prior to its expiration date and will be subject to reassessment by the authority in accordance with then prevailing legal and regulatory requirements for the purposes of such renewal. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Coverage and reimbursement</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">China&#8217;s national medical insurance program was adopted pursuant to the Decision of the State Council on the Establishment of the Urban Employee Basic Medical Insurance Program issued by the State Council in 1998, under which all employers in urban cities are required to enroll their employees in the basic medical insurance program. The insurance premium is jointly contributed by the employers and employees. In 2007, the State Council promulgated Guiding Opinions of the State Council about the Pilot Urban Resident Basic Medical Insurance, under which urban residents of the pilot district, rather than urban employees, may voluntarily join Urban Resident Basic Medical Insurance. Participants of the national medical insurance program and their employers, if any, are required to contribute to the payment of insurance premiums on a monthly basis. Program participants are eligible for full or partial reimbursement of the cost of medicines included in the National Reimbursed Drugs List. A pharmaceutical product listed in the National Reimbursed Drugs List must be clinically needed, safe, effective, reasonably priced, easy to use, and available in sufficient quantity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Factors that affect the inclusion of a pharmaceutical product in the National Reimbursed Drugs List include whether the product is consumed in large volumes and commonly prescribed for clinical use in the PRC and whether it is considered to be important in meeting the basic healthcare needs of the general public. Since 2016, special consideration has been given to, among others, innovative drugs with high clinical value and drugs for serious diseases. In addition, the PRC Ministry of Human Resources and Social Security has also been negotiating with manufacturers of expensive drugs with high clinical demands and proven effectiveness for price cuts in exchange for inclusion into the National Reimbursed Drugs List. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRC laws and regulation in relation to Company Law and Foreign Investment</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The establishment, operation, and management of corporate entities in China are governed by the Company Law of the PRC, or the Company Law. Pursuant to the Company Law, companies are classified into categories, namely limited liability companies and limited companies by shares. The Company Law shall also apply to foreign-invested limited liability companies and companies limited by shares. According to the Company Law, the provisions otherwise prescribed by the laws on foreign investment shall prevail. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On March&#160;15, 2019, the National People&#8217;s Congress promulgated the Foreign Investment Law of the PRC, which came into force on January&#160;1, 2020 and repealed simultaneously the Law of PRC on Sino-foreign Equity Joint Ventures, the Wholly Foreign-owned Enterprise Law of the PRC, and the Law of the PRC on Sino-foreign Cooperative Joint Ventures. Subject to the Foreign Investment Law of the PRC, foreign-invested enterprises incorporated before the enforcement of the Foreign Investment Law of the PRC may keep their </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">163</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">original organizational forms for five&#160;years after the enforcement of the Foreign Investment Law of the PRC. And the Implementation Regulations for the Foreign Investment Law of the PRC was promulgated by the State Council on December&#160;26, 2019 and took effect on January&#160;1, 2020. According to the Foreign Investment Law of the PRC, the State adopts the management system of pre-establishment national treatment and negative list for foreign investment. The negative list refers to special administrative measures for access of foreign investment in specific fields as stipulated by the State. The State will give national treatment to foreign investments outside the negative list. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Provisions on Guiding Foreign Investment Direction, which was promulgated by the State Council on February&#160;11, 2002, and came into effect on April&#160;1, 2002, classify all foreign investment projects into four categories: (i)&#160;encouraged projects, (ii)&#160;permitted projects, (iii)&#160;restricted projects, and (iv)&#160;prohibited projects. Investment activities in the PRC by foreign investors were principally governed by the Catalogue of Industries for Guiding Foreign Investment, which was promulgated by the Ministry of Commerce and the National Development and Reform Commission and was abolished by the Special Administrative Measures (Negative List) for Access of Foreign Investment (2021 version), or the Negative List and Catalogue of Industries for Encouraging Foreign Investment (2022 version), or the &#8220;Encouraging List&#8221;. The Negative List, which came into effect on January&#160;1, 2022, sets out special administrative measures in respect of the access of foreign investments in a centralized manner, and the Encouraging List, which will come into effect on January&#160;1, 2023, sets out the encouraged industries for foreign investment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Interim Administrative for the Record-filling of the Establishment and Modification of Foreign-invested Enterprises, or the Interim Measures, promulgated by the Ministry of Commerce on October&#160;8, 2016, establishment and modifications of foreign investment enterprises that are not subject to the approval under the special entry management measures shall be filed with the delegated commercial authorities. The Measures on Reporting of Foreign Investment Information was issued by the Ministry of Commerce and State Administration for Market Regulation on December&#160;30, 2019. Since January&#160;1, 2020, for foreign investors carrying out investment activities directly or indirectly in China, the foreign investors or foreign-invested enterprises shall submit investment information to the commerce authorities pursuant to such measures. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRC laws and regulations in relation to intellectual property rights</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Patents</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the Patent Law of the PRC promulgated by the National People&#8217;s Congress of China, or the SCNPC, and the Implementation Rules of the Patent Law of the PRC, promulgated by the State Council, there are three types of patents in the PRC: invention patents, utility model patents and design patents. The protection period is 20&#160;years for an invention patent, 10&#160;years for a utility model patent and 15&#160;years for a design patent, commencing from their respective application dates. Any individual or entity that utilizes a patent or conducts any other activity in infringement of a patent without prior authorization of the patent holder shall pay compensation to the patent holder and is subject to a fine imposed by relevant administrative authorities and, if constituting a crime, shall be held criminally liable in accordance with the law. According to the Patent Law of the PRC, for public health purposes, the State Intellectual Property Office of the PRC may grant a compulsory license for manufacturing patented drugs and exporting them to countries or regions covered under relevant international treaties to which PRC has acceded. In addition, according to the Patent Law of the PRC, any organization or individual that applies for a patent in a foreign country for an invention or utility model patent established in China is required to report to the State Intellectual Property Office for confidentiality examination. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the purpose of compensating for the time taken to evaluate and approve a new drug to be put on market, the patent administrative department under the State Council shall grant compensation for duration of patent rights for invention of a new drug approved to be put on market in China upon request of the patentee. The compensation period shall not exceed five&#160;years, and the total validity period of patent rights for a new drug approved to be put on market shall not exceed 14&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Trade secrets</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the PRC Anti-Unfair Competition Law, promulgated by the SCNPC in September&#160;1993, as amended in 2017 and 2019 respectively, the term &#8220;trade secrets&#8221; refers to technical, operational, or other </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">164</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">business information that is unknown to the public, has utility, may create business interests or profits for its legal owners or holders, and is maintained as a secret by its legal owners or holders. Under the PRC Anti-Unfair Competition Law, business persons are prohibited from infringing others&#8217; trade secrets by: (1)&#160;obtaining the trade secrets from the legal owners or holders by any unfair methods such as theft, bribery, fraud, coercion, electronic intrusion, or any other illicit means; (2)&#160;disclosing, using or permitting others to use the trade secrets obtained illegally under item (1)&#160;above; (3)&#160;disclosing, using or permitting others to use the trade secrets, in violation of any confidentiality obligations or any requirements of the legal owners or holders to keep such trade secrets in confidence; or (4)&#160;instigate, entice or help others to obtain, disclose, use or permit others to use the trade secrets in violation of any confidentiality obligations or any requirements of the legal owners or holders to keep such trade secrets in confidence. If a third party knows or should have known of the above-mentioned illegal conduct but nevertheless obtains, uses, or discloses trade secrets of others, the third party may be deemed to have committed an infringement of the others&#8217; trade secrets. The parties whose trade secrets are being infringed may petition for administrative corrections, and regulatory authorities may stop any illegal activities and fine infringing parties. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Trademarks</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the Trademark Law of the PRC, promulgated by the SCNPC, the period of validity for a registered trademark is 10&#160;years, commencing from the date of registration. Upon expiry of the period of validity, the registrant shall go through the formalities for renewal within twelve&#160;months prior to the date of expiry, if intending to continue to use the trademark. Where the registrant fails to do so, a grace period of six&#160;months may be granted. The period of validity for each renewal of registration is 10&#160;years, commencing from the day immediately after the expiry of the preceding period of validity for the trademark. In the absence of renewal upon expiry, the registered trademark shall be canceled. Industrial and commercial administrative authorities have the authority to investigate any behavior in infringement of the exclusive right under a registered trademark in accordance with the law. In case of a suspected criminal offense, the case shall be timely referred to a judicial authority and decided according to law. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Product liability</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Product Quality Law of the PRC promulgated by the SCNPC, is the principal governing law relating to the supervision and administration of product quality, which clarified liabilities of the manufacturers and sellers. Manufacturers shall not be liable when they are able to prove that: (1)&#160;the product has never been circulated; (2)&#160;the defects causing injuries or damage did not exist at the time when the product was circulated; or (3)&#160;the science and technology at the time when the product was circulated were at a level incapable of detecting the defects. A seller shall pay compensation if it can neither indicate the manufacturer nor the supplier of the defective product. A person who is injured or whose property is damaged by the defects in the product may claim compensation from the manufacturer or the seller. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the Civil Code of the PRC, promulgated by the National People&#8217;s Congress on May&#160;28, 2020 and effective on January&#160;1, 2021, manufacturers shall assume tort liability where the defects in relevant products cause damage to others. The aggrieved party may claim compensation from the manufacturer or the seller of the relevant product in which the defects have caused damage. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulations relating to foreign exchange control</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The principal regulations governing foreign currency exchange in China are the Foreign Exchange Administration Regulations of the PRC and the Regulations on the Administration of Foreign Exchange Settlement, Sale and Payment. Pursuant to these regulations and other PRC rules and regulations on currency conversion, Renminbi is freely convertible for payments of current account items, such as trade and service-related foreign exchange transactions and dividend payments, but not freely convertible for capital account items, such as direct investment, loan, or investment in securities outside China unless prior approval of the State Administration of Foreign Exchange or its local counterpart is obtained. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Foreign-invested enterprises are permitted to convert their after-tax dividends into foreign exchange and to remit such foreign exchange out of their foreign exchange bank accounts in the PRC. However, foreign exchange transactions involving overseas direct investment or investment and exchange in securities, derivative </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">165</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">products abroad are subject to registration with SAFE, and approval from or filing with the relevant PRC government authorities (if necessary). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulations relating to dividend distribution</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the PRC Company Law, Foreign Investment Law of the PRC and Regulation for Implementing the Foreign Investment Law of the PRC, foreign-invested enterprises in the PRC may pay dividends only out of their accumulated profits as determined in accordance with PRC accounting standards and regulations. An enterprise is required to set aside at least 10% of its respective accumulated profits to its statutory common reserve where it distributes its after-tax profits of the current year, until the accumulative amount of such reserve reaches 50% of its registered capital. If the aggregate balance of the enterprise&#8217;s statutory common reserve is not enough to make up for the losses of the enterprise of the previous year, the current year&#8217;s profits shall first be used for making up the losses before the statutory common reserve is drawn. After the enterprise has drawn statutory common reserve from the after-tax profits, it may, upon a resolution made by the shareholders&#8217; meeting, draw a discretionary common reserve from the after-tax profits. After the losses have been made up and common reserves have been drawn, the remaining profits shall be distributed to shareholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulations relating to employee stock incentive plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;15, 2012, SAFE promulgated the Notices on Issues Concerning the Foreign Exchange Administration for Domestic Individuals Participating in Stock Incentive Plans of Overseas Publicly Listed Companies, which prescribed that PRC citizens or non-PRC citizens residing in China for a continuous period of no less than one year (except for foreign diplomatic personnel in China and representatives of international organizations in China) who participate in any stock incentive plan of an overseas publicly listed company shall, through the domestic company to which the said company is affiliated, collectively entrust a domestic agency (which may be the Chinese affiliate of the overseas publicly listed company that participates in a stock incentive plan, or other domestic institutions qualified for asset trust business lawfully designated by such company) to handle foreign exchange registration, and entrust an overseas institution to handle issues like exercise of options, purchase and sale of corresponding stocks or equity, and transfer of corresponding funds. In addition, the domestic agency is required to amend the SAFE registration with respect to the stock incentive plan if there is any material change to the stock incentive plan. Moreover, the SAFE Circular 37 provides that PRC residents who participate in a share incentive plan of an overseas unlisted special purpose company may register with local branches of SAFE before exercising rights. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulations on M&amp;A rules and Overseas Listings</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the Regulations on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors, or the M&amp;A Rules, the merger and acquisition of domestic companies by foreign investors means that the foreign investors purchase or subscribe for the equity or shares of a non-foreign invested PRC company or that the foreign investors establish a foreign-invested PRC company to acquire or operate the assets of a non-foreign-invested PRC company by agreement. The M&amp;A Rules require that an application be made to Ministry of Commerce for examination and approval in relation to the acquisition of any company inside China affiliated with a domestic company, enterprise, or natural person, which is made in the name of an overseas company lawfully established or controlled by such domestic company, enterprise, or natural person. The M&amp;A Rules also provide that the overseas listing of a special purpose company controlled directly or indirectly by PRC companies or individuals on an overseas stock market must be approved by the China Securities Regulatory Committee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The M&amp;A Rules, and other recently adopted regulations and rules concerning mergers and acquisitions established additional procedures and requirements that could make merger and acquisition activities by foreign investors more time-consuming and complex. For example, the M&amp;A Rules require that Ministry of Commerce be notified in advance of any change-of-control transaction in which a foreign investor takes control of a PRC domestic enterprise, if (i)&#160;any important industry is concerned, (ii)&#160;such transaction involves factors that impact or may impact national economic security, or (iii)&#160;such transaction will lead to a change in control of a domestic enterprise which holds a famous trademark or PRC time-honored brand. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">166</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;6, 2021, the General Office of the State Council, together with another regulatory authority, jointly promulgated the Opinions on Lawfully and Strictly Cracking Down Illegal Securities Activities, among which, it emphasizes the need to strengthen the administration over illegal securities activities and the supervision on overseas listings by China-based companies, and proposed to take effective measures, such as promoting the construction of relevant regulatory systems to deal with the risks and incidents faced by China-based overseas-listed companies, and provided that the special provisions of the State Council on overseas offering and listing by those companies limited by shares will be revised and therefore the duties of domestic industry competent authorities and regulatory authorities will be clarified. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;17, 2023, with the approval of the State Council, the CSRC released the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies, or the Trial Measures, and five supporting guidelines, which took effect on March&#160;31, 2023. According to the Trial Measures, (1)&#160;domestic companies that seek to offer or list securities overseas, both directly and indirectly, should fulfill the filing procedure and report relevant information to the CSRC; if a domestic company fails to complete the filing procedure or conceals any material fact or falsifies any major content in its filing documents, such domestic company may be subject to administrative penalties, such as order to rectify, warnings, fines, and its controlling shareholders, actual controllers, the person directly in charge and other directly liable persons may also be subject to administrative penalties, such as warnings and fines; (2)&#160;if the issuer meets both of the following conditions, the overseas offering and listing shall be determined as an indirect overseas offering and listing by a domestic company: (i)&#160;any of the total assets, net assets, revenues or profits of the domestic operating entities of the issuer in the most recent accounting year accounts for more than 50% of the corresponding figure in the issuer&#8217;s audited consolidated financial statements for the same period; (ii)&#160;its major operational activities are carried out in China or its main places of business are located in China, or the senior managers in charge of operation and management of the issuer are mostly Chinese citizens or are domiciled in China; and (3)&#160;where a domestic company seeks to indirectly offer and list securities in an overseas market, the issuer shall designate a major domestic operating entity responsible for all filing procedures with the CSRC, and where an issuer makes an application for listing in an overseas market, the issuer shall submit filings with the CSRC within three business days after such application is submitted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On the same day, the CSRC also held a press conference for the release of the Trial Measures and issued the Notice on Administration for the Filing of Overseas Offering and Listing by Domestic Companies, which, among others, clarifies that (1)&#160;on or prior to the effective date of the Trial Measures, domestic companies that have already submitted valid applications for overseas offering and listing but have not obtained approval from overseas regulatory authorities or stock exchanges may reasonably arrange the timing for submitting their filing applications with the CSRC, and must complete the filing before the completion of their overseas offering and listing; and (2)&#160;a six-month transition period will be granted to domestic companies which, prior to the effective date of the Trial Measures, have already obtained the approval from overseas regulatory authorities or stock exchanges (such as the completion of hearing in the market of Hong Kong or the completion of registration in the market of the United States), but have not completed the indirect overseas listing; if domestic companies fail to complete the overseas listing within such six-month transition period, they shall file with the CSRC according to the requirements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Regulations relating to information security and data privacy</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On June&#160;10, 2021, the SCNPC promulgated the PRC Data Security Law, which became effective from September&#160;1, 2021. According to the PRC Data Security Law, a data classification protection system shall be established to protect data by classification. Entities engaged in data processing activities shall, in accordance with the laws and regulations, establish a sound whole-process data security management system, organize data security education and training, and take corresponding technical measures and other necessary measures to ensure data security. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the Civil Code of the PRC, personal information of natural persons is protected by law. Any organization or individual that needs to obtain personal information of others shall obtain legally and ensure the information security, and shall not illegally collect, use, process, transmit, trade, provide or disclose personal information of others. The Personal Information Protection Law of the PRC promulgated by the SCNPC on August&#160;20, 2021, and effective from November&#160;1, 2021, further emphasized the duties and responsibilities of the processing personnel for the protection of personal information, and provided stricter protection measures for processing sensitive personal information. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">167</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:36pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;12, 2018, the National Health Commission issued the Administrative Measures on National Health and Medical Care Big Data Standards, Security and Services (Trial), or the Measures on Health and Medical Care Big Data, which became effective therefrom. The Measures on Health and Medical Care Big Data provided the guidelines and principles of health and medical big data standard management, security management and service management. According to the Measures on Health and Medical Care Big Data, the National Health Commission, together with other relevant departments, is responsible for the management of national health and medical care big data, while the authorities of health above the county level, together with other relevant departments, are responsible for the management of health and medical care big data within their respective administrative regions. Medical institutions and relevant enterprises, including those engaged by medical institutions to store or operate health and medical care big data, shall take measures, such as data classification, important data backup and encryption, to ensure the security of health and medical care big data, and provide secured channels for the query and replication of information. Without authorization, no unit or individual shall use or disseminate any health and medical care big data or data beyond the scope of authorization, nor obtain any data in illegal ways. The responsible parties shall abide by the relevant regulations when disclosing health and medical care big data, shall not divulge state secrets, trade secrets or personal privacy, shall not infringe upon the interests of the state or the public, and shall not infringe upon the legitimate rights and interests of citizens, enterprise entities or other organizations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;7, 2022, the CAC promulgated the Measures on Security Assessment of Cross-border Data Transfer which became effective on September&#160;1, 2022. The data export measures require that any data processor who processes or exports personal information exceeding a certain volume threshold pursuant to the measures shall apply for a security assessment by the CAC before transferring any personal information abroad, including the following circumstances: (i)&#160;important data will be provided overseas by any data processor; (ii)&#160;personal information will be provided overseas by any operator of critical information infrastructure or any data processor who processes the personal information of more than 1,000,000 individuals; (iii)&#160;personal information will be provided overseas by any data processor who has provided the personal information of more than 100,000 individuals in aggregate or has provided the sensitive personal information of more than 10,000 individuals in aggregate since January&#160;1 of last year; and (iv)&#160;other circumstances where the security assessment is required as prescribed by the CAC. A data processor shall, before applying for the security assessment of an outbound data transfer, conduct a self-assessment of the risks involved in the outbound data transfer. The security assessment of a cross-border data transfer shall focus on assessing the risks that may be brought about by the cross-border data transfer concerning national security, public interests, or the lawful rights and interests of individuals or organizations.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On February&#160;24, 2023, the CSRC, jointly with other relevant governmental authorities, promulgated the Provisions on Strengthening Confidentiality and Archives Management of Overseas Securities Issuance and Listing by Domestic Enterprises, or the Confidentiality and Archives Management Provisions, which took effect on March&#160;31, 2023. According to the Confidentiality and Archives Management Provisions, mainland China-based companies, whether offering and listing securities overseas directly or indirectly, must strictly abide the applicable laws and regulations when providing or publicly disclosing, either directly or through their overseas listed entities, documents and materials to securities services providers such as securities companies and accounting firms or overseas regulators in the process of their overseas offering and listing. If such documents or materials contain any state secrets or government authorities work secrets, the domestic companies must obtain the approval from competent governmental authorities according to the applicable laws, and file with the secrecy administrative department at the same level with the approving governmental authority. Furthermore, the Confidentiality and Archives Management Provisions provide that securities companies and securities service providers shall fulfill the applicable legal procedures when providing overseas regulatory institutions and other relevant institutions and individuals with documents or materials containing any state secrets or government authorities work secrets or other documents or materials that, if divulged, will jeopardize national security or public interest.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">168</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tMAN">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">MANAGEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Directors and executive officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth information regarding our directors and executive officers as of the date of this prospectus. </font>
        </div>
        <table style="width:456pt;height:155.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:120pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:13.25pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Age </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:298.75pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Positions(s) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">Yang Lu </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:13.25pt;">
              <font style="letter-spacing:0.2pt;">44 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:298.75pt;">
              <font style="letter-spacing:0.2pt;">Chief Executive Officer, Chairman of our Board of Directors </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">Ping Ji</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:13.25pt;">
              <font style="letter-spacing:0.2pt;">59</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.75pt;">
              <font style="letter-spacing:0.2pt;">Director Nominee*</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">Lars Erik Birgerson </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:13.25pt;">
              <font style="letter-spacing:0.2pt;">70 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:298.75pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Director Nominee*, President, Chief Medical Officer, Chief Executive Officer of U.S. Subsidiary </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">Shaorong Liu</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:13.25pt;">
              <font style="letter-spacing:0.2pt;">44</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.75pt;">
              <font style="letter-spacing:0.2pt;">Independent Director Nominee*</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">Ming Lun Alan Tse </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:13.25pt;">
              <font style="letter-spacing:0.2pt;">43 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.75pt;">
              <font style="letter-spacing:0.2pt;">Independent Director Nominee* </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">Cheguo Cai</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:13.25pt;">
              <font style="letter-spacing:0.2pt;">46</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.75pt;">
              <font style="letter-spacing:0.2pt;">Independent Director Nominee*</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">Kaiyang Tang </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:13.25pt;">
              <font style="letter-spacing:0.2pt;">60 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.75pt;">
              <font style="letter-spacing:0.2pt;">Senior Vice President, Global Head of Clinical Operations </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">Wei (Vicky) Zhang </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:13.25pt;">
              <font style="letter-spacing:0.2pt;">32 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.75pt;">
              <font style="letter-spacing:0.2pt;">Chief Financial Officer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:120pt;">
              <font style="letter-spacing:0.2pt;">Victoria Elizabeth Demby </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:13.25pt;">
              <font style="letter-spacing:0.2pt;">54 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:298.75pt;">
              <font style="letter-spacing:0.2pt;">Senior Vice President, Global Head of Regulatory Affairs</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.6pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.1pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Ping Ji, Lars Erik Birgerson, Shaorong Liu, Ming Lun Alan Tse, and Cheguo Cai have accepted appointment as a director, which will be effective upon the completion of this offering. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a biographical summary of the experience of our directors and executive officers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Yang Lu </font><font style="letter-spacing:0.2pt;">co-founded our group and has served as our director since 2006. Currently he also serves as our chief executive officer and the chairman of our board of directors. Mr.&#160;Lu has 20&#160;years of experience in the pharmaceutical industry. Prior to founding our company, Mr.&#160;Lu worked at Hybio Pharmaceutical Co., Ltd from April&#160;2003 to March&#160;2004. Mr.&#160;Lu obtained his bachelor&#8217;s degree in biotechnology from Xiamen University in July&#160;2002, and his EMBA-Executive Master of Business Administration from China Europe International Business School in September&#160;2012.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Ping Ji</font><font style="letter-spacing:0.2pt;"> will serve as our director effective upon the completion of this offering. She has over 25 years of experience in biopharmaceutical drug development. Since July 2017, Dr.&#160;Ji served as the global safety leader at Kyowa Kirin Co., Ltd. in the United States. Before that, from August 2011 to July 2017, she served as the global safety leader at Bayer HealthCare Pharmaceuticals Inc. in the United States. Dr.&#160;Ji has also served as the medical safety lead at Taiho in the United States from December 2006 to July 2011, as a medical reviewer at Bristol-Myers Squibb Company in the United States from June 2004 to December 2006, and as a clinical scientist at Sanofi S.A. in the United States from September 2002 to June 2004. Prior to that, from September 2000 to September 2002, she worked as a clinical scientist at Pfizer Corporation. Dr. Ji obtained her master of medicine from the cell biology program offered jointly by Graduated School-New Brunswick at Rutgers, the state University of New Jersey and the UMDNJ-Graduate School of Biomedical Sciences at Robert Wood Johnson Medical School in the United States in May 1993. She obtained her doctor of medicine from Capital Institute of Medicine in the PRC in August 1986.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Lars Erik Birgerson</font><font style="letter-spacing:0.2pt;"> will serve as our director effective upon the completion of this offering. He has served as the president and chief executive officer of Adlai Nortye USA INC since July&#160;2018 and has served as our chief medical officer since July&#160;2021. Dr.&#160;Birgerson has more than 32&#160;years of experience in the pharmaceutical industry. Prior to joining us, Dr.&#160;Birgerson served as the vice president and head of global and US medical affairs at Roche Pharmaceuticals in Basel, Switzerland; the vice president of medical affairs at Genentech in California, the United States; and the senior vice president of medical affairs at BMS in New Jersey, the United States. From January&#160;2016 to date, Dr.&#160;Birgerson has served as the president and senior advisor of The Birgerson Group in New Jersey, the United States. Since February&#160;2016, Dr.&#160;Birgerson has also served as the global medical consultant of Delcath Systems Inc. Dr.&#160;Birgerson received his Doctor of Medicine and doctorate of philosophy from Uppsala University at Uppsala, Sweden in June&#160;1977 and June&#160;1990 respectively. Dr.&#160;Birgerson has been a specialist of obstetrics and gynecology certified by the National Swedish Board of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">169</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Health and Welfare since December&#160;14, 1984. Further, he was certified as a licensed physician by the National Swedish Board of Health and Welfare in Sweden on February&#160;19, 1980. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shaorong Liu</font><font style="letter-spacing:0.2pt;"> will serve as our independent director effective upon the completion of this offering. Mr.&#160;Liu has approximately 15 years of experience in business management and consulting. Mr. Liu has been serving as the managing partner and senior consultant of Shanghai Zhiyi Enterprise Management Consulting Co., Ltd. since April 2008. Further, Mr. Liu has also been an independent non-executive director of Jiangsu CoCreation Grass Co., Ltd. (Shanghai Stock Exchange stock code: 605099) since April 2018. Mr. Liu obtained his master&#8217;s degree in business administration from the China Europe International Business School in September 2012.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Ming Lun Alan Tse</font><font style="letter-spacing:0.2pt;"> will serve as our independent director effective upon the completion of this offering. Mr.&#160;Tse has more than 20&#160;years of experience in financial management and accounting. Mr.&#160;Tse currently serves as a general manager at Jebsen Capital Ltd. and the independent non-executive director of Tian Ge Interactive Holdings Ltd. (HKEx: 1980). Previously, Mr.&#160;Tse has served as an accountant at KPMG from September&#160;2002 to May&#160;2005, a senior analyst at Techtronic Industries Co., Ltd from May 2005 to May 2007. Mr. Tse has also served as a senior manager of corporate planning and development, a senior manager of corporate planning and development at Next Horizon Company Limited from September 2007 to August 2009, and a project and business development manager of finance and administration department at Richemont Asia Pacific Limited from September&#160;2009 to October&#160;2011. Since November&#160;2011, Mr.&#160;Tse has served as a general manager of Jebsen Automotive Technology Beijing Co., Ltd. Mr.&#160;Tse obtained his bachelor of business administration in accounting and finance from the University of Hong Kong in December&#160;2002. He has been a fellow member of the Association of Chartered Certified Accountants (ACCA) since December&#160;2005. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Cheguo Cai</font><font style="letter-spacing:0.2pt;"> will serve as our independent director effective upon the completion of this offering. He has more than 17 years of experience in the biology and immunology industries. Dr. Cai has served as chief scientist at Shenzhen Beike Biotech Co., Ltd. since May 2021 and as professor at Hangzhou Institute for Advanced Study, UCAS since December 2022. From February 2017 to November 2022, Dr. Cai served as professor at the Medical Research Institute and Frontier Science Center for Immunology and Meta, Wuhan University. Dr. Cai served as associate professor and postdoctoral fellow at Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences since April 2015 to January 2017 and since October 2011 to March 2015, respectively. Before that, from October 2010 to September 2011, he served as postdoctoral fellow at Tulane University in the United States. From August 2005 to August 2007, he served as research assistant at Institut Pasteur of Shanghai, Chinese Academy of Sciences. Dr. Cai obtained his bachelor&#8217;s degree and master&#8217;s degree in biology in Xiamen University in July 2002 and July 2005, respectively. He obtained his doctoral degree in microbiology in Institut Pasteur of Shanghai, Chinese Academy of Sciences in July 2010.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Kaiyang Tang</font><font style="letter-spacing:0.2pt;"> has served as our senior vice president and global head of clinical operations since August&#160;2018. Dr.&#160;Tang has more than 20&#160;years of experience in the pharmaceutical industry. From 1990 to 1997, he served as study coordinator at Elizabeth General Medical Center. From 1997 to 1999, Dr.&#160;Tang served as global site coordinator and clinical research associate at Covance Inc. Dr.&#160;Tang served as senior clinical program manager at Pfizer Corporation from 1999 to 2003. From 2003 to 2007, he served as clinical program leader and medical monitor at Pliva Inc. From 2007 to 2010, he served as vice president and head of clinical and regulatory affairs at Hutchison MediPharma Ltd. From 2010 to date, he has served as chief medical officer, head of clinical and regulatory at Generon Inc. Dr.&#160;Tang obtained his medical doctor degree from Capital Institute of Medicine in the PRC in 1986. He obtained his MBA degree from Rutgers, the State University of New Jersey in 1999. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Wei (Vicky) Zhang</font><font style="letter-spacing:0.2pt;"> joined us in June&#160;2021 as our chief financial officer. From July&#160;2014 to July&#160;2015, Ms.&#160;Zhang served as an analyst at Nomura International Plc. She was in the role of executive director within the Corporate Finance Department of Goldman Sachs (Asia) L.L.C. and was employed by the firm from November&#160;9, 2015 to June&#160;12, 2021. Ms.&#160;Zhang obtained her Bachelor of Arts in accounting and economics from Illinois Wesleyan University in the United States in April&#160;2013. She obtained a Master of Science in financial economics from University of Oxford in the United Kingdom in July&#160;2014. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Victoria Elizabeth Demby</font><font style="letter-spacing:0.2pt;"> has served as our senior vice president and global head of regulatory affairs since March&#160;2022. Dr.&#160;Demby has more than 30&#160;years of pharmaceutical experience in various functional areas. From January&#160;1992 to August&#160;1996, Dr.&#160;Demby served at Wyeth-Ayerst Research as associate scientist. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">170</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">She later served at Dupont Pharmaceuticals as senior research investigator from May&#160;2001 to January&#160;2002, and then at Quest Pharmaceutical Services as senior research investigator from March&#160;2002 to April&#160;2003. From May&#160;2003 to July&#160;2008, she served at GSK, Inc. as section head of transport group in the preclinical department. After that, Dr.&#160;Demby served at BMS as senior research investigator of submission documents group from August&#160;2008 to February&#160;2010, as associate director of global regulatory strategy and safety from March&#160;2010 to September&#160;2012. Later, Dr.&#160;Demby served at MSD as a director from September&#160;2012 to January&#160;2019, as an executive director from January&#160;2019 to May&#160;2019. Then, she worked at Greenwich Biosciences as a senior director from May&#160;2019 to October&#160;2019. Recently, Dr.&#160;Demby has served at GlaxoSmithKline, Inc as executive director and team leader of global regulatory team since November&#160;2019 and has also served as interim vice president of global regulatory affairs since July&#160;2021. Dr.&#160;Demby obtained her bachelor&#8217;s degree in biochemistry in University of Vermont in May&#160;1991 and her doctoral degree in pharmacology and toxicology in University of Kansas in May&#160;2001. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Board of directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors will consist of six directors upon the SEC&#8217;s declaration of effectiveness of our registration statement on Form F-1 of which this prospectus is a part. A director who is in any way, whether directly or indirectly, interested in a contract or transaction or proposed contract or transaction with our company is required to declare the nature of his interest at a meeting of our directors. Subject to the Nasdaq Stock Market rules and disqualification by the chairman of the relevant board meeting, a director may vote in respect of any contract or transaction or proposed contract or transaction notwithstanding that he may be interested therein, and if he does so his vote shall be counted and he shall be counted in the quorum at any meeting of our directors at which any such contract or transaction or proposed contract or transaction is considered, provided (i)&#160;such director, if his or her interest in such contract or arrangement is material, has declared the nature of his or her interest at the earliest meeting of the board at which it is practicable for him or her to do so, either specifically or by way of a general notice and (ii)&#160;if such contract or arrangement is a transaction with a related party, such transaction has been approved by the audit committee. Our directors may exercise all the powers of our company to raise or borrow money and to mortgage or charge its undertaking, property and assets (present and future) and uncalled capital or any part thereof, to issue debentures, debenture stock, bonds and other securities, whether outright or as collateral security for any debt, liability, or obligation of our company or of any third party. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Committees of the board of directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will establish three committees under the board of directors immediately upon the effectiveness of our registration statement on Form F-1, of which this prospectus is a part: an audit committee, a compensation committee, and a nominating and corporate governance committee. We will adopt a charter for each of the three committees. Each committee&#8217;s members and functions are described below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Audit Committee</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our audit committee will consist of Alan Ming Lun Tse, Shaorong Liu and Cheguo Cai. Alan Ming Lun Tse will be the chairman of our audit committee. We have determined that Shaorong Liu and Cheguo Cai satisfy the &#8220;independence&#8221; requirements of </font><font style="font-style:italic;letter-spacing:0.2pt;">Rule&#160;5605(a)(2) of the Listing Rules of the Nasdaq Stock Market</font><font style="letter-spacing:0.2pt;"> and </font><font style="font-style:italic;letter-spacing:0.2pt;">Rule&#160;10A-3 under the Exchange Act</font><font style="letter-spacing:0.2pt;">. We have determined that Alan Ming Lun Tse qualifies as an &#8220;audit committee financial expert.&#8221; The audit committee will oversee our accounting and financial reporting processes and the audits of the financial statements of our company. The audit committee will be responsible for, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">appointing the independent auditors and pre-approving all auditing and non-auditing services permitted to be performed by the independent auditors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing with the independent auditors any audit findings or difficulties and management&#8217;s response; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">discussing the annual audited financial statements with management and the independent auditors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing the adequacy and effectiveness of our accounting and internal control policies and procedures and any steps taken to monitor and control major financial risk exposures; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and approving all proposed related party transactions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">meeting separately and periodically with management and the independent auditors; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">171</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Compensation Committee.</font><font style="letter-spacing:0.2pt;"> Our compensation committee will consist of Yang Lu, Shaorong Liu and Cheguo Cai. Yang Lu will be the chairman of our compensation committee. We have determined that Shaorong Liu and Cheguo Cai satisfy the &#8220;independence&#8221; requirements of </font><font style="font-style:italic;letter-spacing:0.2pt;">Rule&#160;5605(a)(2) of the Listing Rules of the Nasdaq Stock Market</font><font style="letter-spacing:0.2pt;">. The compensation committee will assist the board in reviewing and approving the compensation structure, including all forms of compensation, relating to our directors and executive officers. Our chief executive officer may not be present at any committee meeting during which his compensation is deliberated. The compensation committee will be responsible for, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and approving, or recommending to the board for its approval, the compensation for our chief executive officer and other executive officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing and recommending to the board for determination with respect to the compensation of our non-employee directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing periodically and approving any incentive compensation or equity plans, programs, or similar arrangements; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">selecting compensation consultant, legal counsel, or other adviser only after taking into consideration all factors relevant to that person&#8217;s independence from management. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Nominating and Corporate Governance Committee</font><font style="letter-spacing:0.2pt;">. &nbsp;&nbsp;&nbsp;Our nominating and corporate governance committee will consist of Yang Lu, Shaorong Liu and Cheguo Cai. Yang Lu will be the chairperson of our nominating and corporate governance committee. Shaorong Liu and Cheguo Cai satisfy the &#8220;independence&#8221; requirements of </font><font style="font-style:italic;letter-spacing:0.2pt;">Rule&#160;5605(a)(2) of the Listing Rules of the Nasdaq Stock Market</font><font style="letter-spacing:0.2pt;">. The nominating and corporate governance committee will assist the board of directors in selecting individuals qualified to become our directors and in determining the composition of the board and its committees. The nominating and corporate governance committee will be responsible for, among other things: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">selecting and recommending to the board nominees for election by the shareholders or appointment by the board; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">reviewing annually with the board the current composition of the board with regards to characteristics such as independence, knowledge, skills, experience, and diversity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">making recommendations on the frequency and structure of board meetings and monitoring the functioning of the committees of the board; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">advising the board periodically with regards to significant developments in the law and practice of corporate governance as well as our compliance with applicable laws and regulations, and making recommendations to the board on all matters of corporate governance and on any remedial action to be taken. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Duties of directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under Cayman Islands law, our directors owe fiduciary duties to our company, including a duty of loyalty, a duty to act honestly and a duty to act in what they consider in good faith to be in our best interests. Our directors must also exercise their powers only for a proper purpose. Our directors also owe to our company a duty to act with skill and care. It was previously considered that a director need not exhibit in the performance of his duties a greater degree of skill than may reasonably be expected from a person of his knowledge and experience. However, English and Commonwealth Courts have moved toward an objective standard with regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands. In fulfilling their duty of care to us, our directors must ensure compliance with our memorandum and articles of association, as amended, and restated from time to time. We have the right to seek damages if a duty owed by our directors is breached. In certain limited exceptional circumstances, a shareholder may have the right to seek damages in our name if a duty owed by our directors is breached. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors has all the powers necessary for managing, and for directing and supervising, our business affairs. The functions and powers of our board of directors include, among others: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">172</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">convening shareholders&#8217; annual and extraordinary general meetings and reporting its work to shareholders at such meetings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">declaring dividends and distributions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">appointing officers and determining the term of office of the officers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">exercising the borrowing powers of our company and mortgaging the property of our company; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">approving the transfer of shares in our company, including the registration of such shares in our share register. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Terms of directors and officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our directors may be appointed by an ordinary resolution of our shareholders. Alternatively, our board of directors may, by the affirmative vote of a simple majority of the directors present and voting at a board meeting appoint any person as a director to fill a casual vacancy on our board or as an addition to the existing board. Our directors are not automatically subject to a term of office and hold office until such time as they are removed from office by an ordinary resolution of our shareholders. In addition, a director will cease to be a director if he (i)&#160;becomes bankrupt or makes any arrangement or composition with his creditors; (ii)&#160;dies or is found to be or becomes of unsound mind; (iii)&#160;resigns his office by notice in writing; (iv)&#160;without special leave of absence from our board, is absent from meetings of our board for three consecutive meetings and our board resolves that his office be vacated; or (v)&#160;is removed from office pursuant to any other provision of our articles of association. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our officers are appointed by and serve at the discretion of the board of directors and may be removed by our board of directors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Employment agreements and indemnification agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have entered into employment agreements with each of our executive officers. Under these agreements, each of our executive officers is employed for a specified time period. We may terminate employment for cause, at any time, for certain acts of the executive officer, such as continued failure to satisfactorily perform, willful misconduct or gross negligence in the performance of agreed duties, conviction or entry of a guilty or nolo contendere plea of any felony or any misdemeanor involving moral turpitude, or dishonest act that results in material financial, reputational or other harm to us or material breaches of the employment agreement. We may also terminate an executive officer&#8217;s employment without cause upon 60-day prior written notice. In such case of termination by us, we will provide severance payments to the executive officer as may be agreed between the executive officer and us. The executive officer may terminate the employment at any time with a 60-day prior written notice. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each executive officer has agreed to hold, both during the term of the employment and at all times thereafter, in strict confidence and not to use, except as required in the performance of his or her duties in connection with the employment or pursuant to applicable law, any of our confidential information or trade secrets, any confidential information or trade secrets of our clients or prospective clients, or the confidential or proprietary information of any third party received by us and for which we have confidential obligations. The executive officers have also agreed to disclose in confidence to us all inventions, designs, and trade secrets which they conceive, develop or reduce to practice during the executive officer&#8217;s employment with us and to assign all right, title, and interest in them to us, and assist us in obtaining and enforcing patents, copyrights, and other legal rights for these inventions, designs, and trade secrets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, each executive officer has agreed to be bound by non-competition and non-solicitation restrictions during the term of his or her employment and typically for one year following the last date of employment. Specifically, each executive officer has agreed not to (i)&#160;approach the suppliers, clients, direct or end customers or contacts or other persons or entities introduced to the executive officers in his or her capacity as our representative for the purpose of doing business of the same or of a similar nature to our business or doing business that will harm our business relationships with the foregoing persons or entities; (ii)&#160;assume employment with or provide services to any of our competitors, or engage, whether as principal, partner, licensor or otherwise, any of our competitors, without our express consent; (iii)&#160;seek, directly or indirectly, to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">173</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">solicit the employment or services of, or hire or engage, any person who is known to be employed or engaged by us; or (iv)&#160;otherwise interfere with our business or accounts. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have also entered into indemnification agreements with our directors and executive officers. Under these agreements, we agree to indemnify our directors and executive officers against certain liabilities and expenses incurred by such persons in connection with claims made by reason of their being a director or officer of our company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Compensation of directors and executive officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 2022, we paid an aggregate of approximately US$2.5 million in cash and benefits to our directors and executive officers. For stock option grants to our executive officers and directors, see &#8220;&#8212; Share incentive plans.&#8221; We have not set aside or accrued any amount to provide pension, retirement or other similar benefits to our executive officers and directors. Our operating subsidiary in the PRC is required by law to make contributions equal to certain&#160;percentages of each employee&#8217;s salary for his or her pension insurance, medical insurance, unemployment insurance, and other statutory benefits and a housing provident fund. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Share incentive plans</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2020 Share Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We adopted a share incentive plan in June&#160;2020 and amended it in May&#160;2021. We refer to this share incentive plan as our 2020 Share Incentive Plan in this prospectus. Under such 2020 Share Incentive Plan, we are authorized to issue no more than 15,000,000 ordinary shares. To manage this share incentive plan, we set up two holding vehicles, Nortye Talent Limited and Nortye International Limited, and issued 9,000,000 and 6,000,000 ordinary shares to these two entities respectively in July&#160;2021. Nortye Talent Limited and Nortye International Limited are holding these shares through a trust for the benefit of our existing and future share award grantees, and will transfer these shares upon the vesting and exercise of share awards. As of the date of this prospectus, awards for an aggregate of 9,810,102 ordinary shares have been granted. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following paragraphs describe the principal terms of our 2020 Share Incentive Plan: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Type of awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The 2020 Share Incentive Plan permits awards of options, restricted shares, restricted share&#160;units or other types of awards as the case may require. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Plan administration.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The 2020 Share Incentive Plan is administered by our board of directors or officer as authorized by the board of directors (within its delegated authroity) (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Administrator</font><font style="letter-spacing:0.2pt;">&#8221;). The Administrator determines, among other things, the participant eligible to receive awards, the type and number of the awards to be granted to each eligible participants and the terms and conditions of each award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Eligibility.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Awards may be granted to our employees, directors, or consultants, or trusts or companies established in connection with any of our employee benefit plans. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Award agreement.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Awards granted will be evidenced by an award agreement in the forms approved by the Administrator. The award agreement contains the terms established by the Administrator for that award, as well as any other additional terms, provisions, or restrictions that the Administrator may impose on the award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Vesting schedule.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In general, the Administrator determines the vesting schedule, which is specified in the relevant award agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Rights on death or termination of employment.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If the participant&#8217;s employment is terminated for cause other than death, all of the options and awards granted shall be terminated on the date of the termination of employment for cause, regardless of whether they are vested and/or exercisable or not. If the participant&#8217;s employment is terminated by reason of disability, the participant may exercise any options or awards granted that are exercisable at the time of the termination within 12&#160;months of such date of termination of employment. If the participant&#8217;s employment is terminated as a result of death, the participant&#8217;s executors or administrators of estate may exercise any options or awards granted that are exercisable at the time of the termination of employment within 6&#160;months of such date of termination of employment. If the participant&#8217;s </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">174</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">employment is terminated for any reason other than those referred to above, the participant may exercise any options or awards granted that are exercisable at the time of the termination within 3&#160;months of such date of termination of employment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transfer restriction.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Awards may not be transferred in any manner by the participant other than in accordance with the exceptions provided in the 2020 Share Incentive Plan or the relevant award agreement, such as transfers by will or the laws of descent and distribution or by trusts or companies established in connection with any employee benefit plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acceleration of Awards upon Change in Control.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event of any change in control event as defined in the plan, unless otherwise provided under the award agreement, each outstanding award shall be assumed or substituted by the successor corporation and our right to repurchase upon termination of an awardee&#39;s relationship as a service provider shall be assigned to the successor corporation, and if the award is not assumed or substituted or our right is not assigned, shall become fully vested and exercisable and be released from any of our repurchase or similar rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Amendment, termination and suspension.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Unless terminated earlier, the 2020 Share Incentive Plan shall continue in effect for a term of ten years. Our board of the directors may at any time amend, alter, suspend, or terminate the 2020 Share Incentive Plan, subject to applicable laws and our articles of association. Termination shall not affect the Administrator&#8217;s ability to exercise the powers granted to it under the 2020 Share Incentive Plan prior to such termination. No ordinary shares shall be delivered or sold under the plan after the termination thereof, except upon exercise of an award granted prior to the termination of the plan. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2023 Share Incentive Plan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In April&#160;2023, we adopted our 2023 share incentive plan, which is effective upon the completion of this offering. The maximum aggregate number of ordinary shares that may be issued under this 2023 Share Incentive Plan is 15,000,000, including any reserved and issued share under the 2020 Share Incentive Plan held by Nortye Talent Limited and Nortye International Limited. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following paragraphs describe the principal terms of our 2023 Share Incentive Plan: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Type of awards.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The 2023 Share Incentive Plan permits awards of options, restricted shares, restricted share&#160;units and other types of awards as the case may require. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Plan administration.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The 2023 Share Incentive Plan is administered by our board of directors or committee or officer as authorized by the board of directors (within its delegated authroity) (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Administrator</font><font style="letter-spacing:0.2pt;">&#8221;). The Administrator determines, among other things, the participants eligible to receive awards, the type and number of the awards to be granted to each eligible participant and the terms and conditions of each award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Eligibility.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Awards may be granted to our employees, directors, consultants, or trusts or companies established in connection with any of our employee benefit plans. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Award agreement.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Awards granted will be evidenced by an award agreement in the forms approved by the Administrator. The award agreement contains the terms established by the Administrator for that award, as well as any other additional terms, provisions, or restrictions that the Administrator may impose on the award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Vesting schedule.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In general, the Administrator determines the vesting schedule, which is specified in the relevant award agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Rights on death or termination of employment.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If the participant&#8217;s employment is terminated for cause other than death, all of the options and awards granted shall be terminated on the severance date, regardless of whether they are vested and/or exercisable or not. If the participant&#8217;s employment is terminated by reason of disability, the participant may exercise any options or awards granted that are exercisable at the time of the termination within 12&#160;months of such date of termination of employment. If the participant&#8217;s employment is terminated as a result of death, the participant&#8217;s executors or administrators of estate may exercise any options or awards granted that are exercisable at the time of the termination of employment within 6&#160;months of such date of termination of employment. If the participant&#8217;s employment is terminated for any reason other than </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">175</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:157.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">those referred to above, the participant may exercise any options or awards granted that are exercisable at the time of the termination within 3&#160;months of such date of termination of employment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Acceleration of Awards upon Change in Control.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event of any change in control event as defined in the plan, unless otherwise provided under the award agreement, each outstanding award shall be assumed or substituted by the successor corporation and our right to repurchase upon termination of an awardee&#8217;s relationship as a service provider shall be assigned to the successor corporation, and if the award is not assumed or substituted or right is not assigned, shall become fully vested and exercisable and be released from any of our repurchase or similar rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Transfer restriction.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Awards may not be transferred in any manner by the participant other than in accordance with the exceptions provided in the 2023 Share Incentive Plan or the relevant award agreement, such as transfers by will or the laws of descent and distribution or by trusts or companies established in connection with any employee benefit plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Amendment and termination.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Unless terminated earlier, the 2023 Share Incentive Plan shall continue in effect for a term of ten years. Our board of the directors may at any time amend, alter, suspend, or terminate the 2023 Share Incentive Plan, subject to applicable laws and our articles of association. Termination shall not affect the Administrator&#8217;s ability to exercise the powers granted to it under the 2023 Share Incentive Plan prior to such termination. No ordinary shares shall be delivered or sold under the plan after the termination thereof, except upon exercise of an award granted prior to the termination of the plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table summarizes, as of the date of this prospectus, the number of ordinary shares underlying outstanding options that we granted to our directors and executive officers: </font>
        </div>
        <table style="width:456pt;height:161.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:206.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary Shares</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Underlying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Options </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exercise Price</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(US$/Share) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date of Grant </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date of Expiration </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:206.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Yang Lu </font>
              </div>
            </td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,200,000</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.0</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">31/05/2021</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">31/05/2031</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:206.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lars Erik Birgerson </font>
              </div>
            </td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">1.1</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">08/09/2020</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">08/09/2030</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:206.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.2</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/04/2022</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/04/2032</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:206.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Kaiyang Tang </font>
              </div>
            </td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">1.1</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">08/09/2020</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">08/09/2030</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:206.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">1.8</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/11/2020</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/11/2030</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:206.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.2</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/04/2022</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/04/2032</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:206.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wei (Vicky) Zhang </font>
              </div>
            </td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.0</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/10/2021</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/10/2031</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:206.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Victoria Elizabeth Demby </font>
              </div>
            </td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">2.2</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/07/2022</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">01/07/2032</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:206.7pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">All directors and executive officers as a group</font>
              </div>
            </td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,350,000</td>
            <td style="padding:0pt;padding-left:7.33pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.505pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.84pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt; width:4.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.8pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Less than 1% of our total outstanding shares on an as-converted basis as of the date of this prospectus. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">176</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRSH">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PRINCIPAL SHAREHOLDERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as specifically noted, the following table sets forth information with respect to the beneficial ownership of our ordinary shares as of the date of this prospectus by: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each of our directors and executive officers; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">each person known to us to own beneficially more than 5% of our ordinary shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The calculations in the table below are based on 97,983,414 ordinary shares on an as-converted basis outstanding as of the date of this prospectus and 93,710,805 Class A ordinary shares and 16,990,000 Class&#160;B ordinary shares outstanding immediately after the completion of this offering and the concurrent private placement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Beneficial ownership is determined in accordance with the rules and regulations of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to such securities. Except as otherwise indicated, all persons listed below have sole voting and investment power with respect to the shares beneficially owned by them. In computing the number of shares beneficially owned by a person and the&#160;percentage ownership of that person, we have included shares that the person has the right to acquire within 60&#160;days, including through the exercise of any option, warrant or other right or the conversion of any other security. These shares, however, are not included in the computation of the&#160;percentage ownership of any other person. </font>
        </div>
        <table style="width:456pt;height:407pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary Shares Beneficially</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned Prior to This Offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt; width:0pt;" colspan="22">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary Shares Beneficially</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned After This Offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% of Beneficial</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ownership </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Class A </font>
                <br >
                <font style="letter-spacing:-0.16pt;">ordinary </font>
                <br >
                <font style="letter-spacing:-0.16pt;">shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Class B </font>
                <br >
                <font style="letter-spacing:-0.16pt;">ordinary </font>
                <br >
                <font style="letter-spacing:-0.16pt;">shares</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% of Beneficial</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Ownership </font>
                <br >
                <font style="letter-spacing:-0.16pt;">(of total Class A </font>
                <br >
                <font style="letter-spacing:-0.16pt;">ordinary shares </font>
                <br >
                <font style="letter-spacing:-0.16pt;">and Class B </font>
                <br >
                <font style="letter-spacing:-0.16pt;">ordinary shares)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">% of aggregate</font>
                <br >
                <font style="letter-spacing:-0.16pt;">voting power </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:126.67pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.2pt;">Directors and Executive Officers**:</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Yang Lu</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">39,130,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">39.9</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">22,140,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">16,990,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">35.3</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">79.5</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Ping Ji</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lars Erik Birgerson </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Shaorong Liu</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Ming Lun Alan Tse </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cheguo Cai</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Kaiyang Tang </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wei (Vicky) Zhang </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Victoria Elizabeth Demby </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:126.67pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">All Directors and Executive Officers as a Group </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">39,980,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">40.8</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">22,990,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">16,990,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">36.1</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">79.7</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:9pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Principal Shareholders</font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Archer Future Limited</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">16,990,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">17.3</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">16,990,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">15.3</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">73.1</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Nortye Talent Limited</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">9,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.2</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">9,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.1</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.6</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">ATCG Holdings Limited</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">6,868,657</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">7.0</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">6,868,657</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.2</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.0</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">JIN YIN (BVI) LIMITED</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">6,060,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.2</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">6,060,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">5.5</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.7</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:126.67pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Nortye International Limited</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">6,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6.1</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">6,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">5.4</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.7</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:126.67pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">UNIQUE MARK </font>
                <br >
                <font style="letter-spacing:0.2pt;">VENTURES LIMITED</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(6)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">5,750,790</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">5.9</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">5,750,790</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">5.2</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.6</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:126.67pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">PECO International Limited</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">5,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">5.1</td>
            <td style="padding:0pt;padding-left:16.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">5,000,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">4.5</td>
            <td style="padding:0pt;padding-left:18.75pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.4</td>
            <td style="padding:0pt;padding-left:16.55pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">177</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6pt; text-align:justify; width:456pt; line-height:10pt;">
          <font style="letter-spacing:0.16pt;">Notes: </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Represents less than 1% of our total outstanding shares on an as converted basis. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="font-style:italic;letter-spacing:0.16pt;">**</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">The business address of Yang Lu and Wei (Vicky) Zhang is c/o&#160;P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands; the business address of Ping Ji is 212&#160;Carnegie Center, Princeton, NJ&#160;08540 U.S.; the business address of Shaorong Liu is Floor 13, No.256, Pudong South Road, Pudong New Area, Shanghai, China; the business address of Ming Lun Alan Tse is 21/F, Hysan Place, 500 Hennessy Road, Causeway Bay, Hong Kong; the business address of Cheguo Cai is No.1&#160;Xiangshan Branch Lane, Xihu District, Hangzhou, China; the business address of Lars Erik Birgerson, Kaiyang Tang, and Victoria Elizabeth Demby is 685&#160;US Hwy 1, 2nd floor, North Brunswick Township, NJ 08902 U.S. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">&#8224;</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">For each person and group included in this column, percentage voting power is calculated by dividing voting power beneficially owned by such person or group by voting power of all of our Class A ordinary shares and Class B ordinary shares as a single class. Each holder of Class A ordinary shares is entitled to one vote per share and each holder of Class B ordinary shares is entitled to fifteen votes per share on all matters subject to vote at our general meeting. Our Class A ordinary shares and Class B ordinary shares vote together as a single class on all matters submitted to a vote of our shareholders, except as may otherwise be required by law or provided for in our post-offering memorandum and articles of association. Each Class B ordinary share is convertible into one Class A ordinary share at the option of the holder thereof at any time upon written notice to our company, while Class A ordinary shares cannot be converted into Class B ordinary shares under any circumstances. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Represents (i)&#160;16,990,000 ordinary shares held by Archer Future Limited, a British Virgin Islands company wholly owned by Sagitta Future Limited, which is in turn wholly owned by Trident Trust Company (HK) Limited. Trident Trust Company (HK) Limited is holding these shares as the trustee for the benefit of Mr.&#160;Yang Lu and his family members. Mr.&#160;Lu is the settlor of the trust. Under the terms of this trust, Mr.&#160;Lu is able to exercise voting rights and dispositive rights attached to the ordinary shares held by Archer Future Limited. The registered address of Archer Future Limited is Trident Chambers, P.O. Box 146, Road Town, Tortola, British Virgin Islands. The registered address of Trident Trust Company (HK) Limited is 14th floor, Golden Centre, 188 des Voeux Road Central, Hong Kong; (ii)&#160;5,000,000 ordinary shares held by PECO International Limited, a British Virgin Islands company wholly owned by PECO Innovation Limited, which is in turn wholly owned by PraxisIFM Fiduciaries (Hong Kong) Limited. PraxisIFM Fiduciaries (Hong Kong) Limited is holding these shares as the trustee for the benefit of Mr.&#160;Lu and certain of our former and existing employees and consultants. Under the terms of this trust, Mr.&#160;Lu has the power to direct the trustee with respect to the retention or disposal of, and the exercise of any voting and other rights attached to the ordinary shares held by PECO International Limited. The registered address of PraxisIFM Fiduciaries (Hong Kong) Limited is 20/F, 88 Gloucester Road, Wan Chai, Hong Kong. The registered address of PECO International Limited is Nerine Chambers, P.O. Box 905, Road Town, Tortola, British Virgin Islands; (iii)&#160;2,550,000 ordinary shares held by DH Future Limited, a British Virgin Islands company wholly owned by DH Accrescent Limited, which is in turn wholly owned by Trident Trust Company (HK) Limited. Trident Trust Company (HK) Limited is holding these shares as the trustee for the benefit of Mr.&#160;Donghui Yang and his family members. Mr.&#160;Yang is the settlor of the trust. Under the terms of this trust, Mr.&#160;Yang is able to exercise voting rights and dispositive rights attached to the ordinary shares held by DH Future Limited. The Registered address of DH Future Limited is P.O. Box 146, Road Town, Tortola, British Virgin Islands. Mr.&#160;Lu and Mr.&#160;Yang entered into an acting-in-concert agreement, pursuant to which Mr.&#160;Lu is able to exercise voting power entrusted from Mr.&#160;Yang; and (iv)&#160;12,990,000 ordinary shares issuable upon the conversion of 6,060,000 Series&#160;A preferred shares held by JIN YIN (BVI) LIMITED, 3,500,000 Series&#160;A preferred shares held by LAI NUO (BVI) LIMITED and 3,430,000 Series&#160;A preferred shares held by LV YI (BVI) LIMITED. Mr.&#160;Lu and these three Series&#160;A preferred investors entered into an acting-in-concert agreement, pursuant to which Mr.&#160;Lu is able to exercise voting rights entrusted from the other signing parties. (a)&#160;For more information regarding JIN YIN (BVI) LIMITED, please see Note (4)&#160;below; (b)&#160;LAI NUO (BVI) LIMITED is a British Virgin Islands company wholly owned by Hangzhou Lainuo Investment Limited Partnership. Shanghai Haomo Investment and Management Co., Ltd. is the general partner of Hangzhou Lainuo Investment Limited Partnership. Mi Yin and Yan Jiang hold 80% and 20% equity interests in Shanghai Haomo Investment and Management Co., Ltd., respectively. The registered address of LAI NUO (BVI) LIMITED is Craigmuir Chambers, Road Town, Tortola, VG 1110, Virgin Islands (British). The registered address of Hangzhou Lainuo Investment Limited Partnership is Room 328, Building 6, No. 88, Jiangling Road, Binjiang District, Hangzhou, China. The registered address of Shanghai Haomo Investment and Management Co., Ltd. is Room 399, 3rd Floor, Building 5, No.2801-2809, Tiancheng Road, Qingpu District, Shanghai, China; and (c)&#160;LV YI (BVI) LIMITED is a British Virgin Islands company wholly owned by Hangzhou Lvyi Investment and Management Limited Partnership. Congcong Wang is the general partner of Hangzhou Lvyi Investment and Management Limited Partnership. The registered address of LV YI (BVI) LIMITED is Craigmuir Chambers, Road Town, Tortola, VG 1110, Virgin Islands (British). The registered address of Hangzhou Lvyi Investment and Management Limited Partnership is Room 102, 2nd Floor, Building 6, No. 202, Zhenzhong Road, Xihu District, Hangzhou, China. All the preferred shares held by JIN YIN (BVI) LIMITED, LAI NUO (BVI) LIMITED and LV YI (BVI) LIMITED will be converted into Class A ordinary shares immediately upon the effective date of our registration statement relating to this offering ; (v) 1,600,000 ordinary shares issuable pursuant to options exercisable within 60 days after the date of this prospectus that are held by Mr. Lu. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Represents 6,868,657 ordinary shares issuable upon the conversion of 4,600,632 Series&#160;C preferred shares and 2,268,025 Series&#160;D preferred shares held by ATCG Holdings Limited, a limited company incorporated in British Virgin Islands. ATCG Holdings Limited is controlled by Mr.&#160;Hui Shao through a trust and of which Mr.&#160;Shao and his family members are the beneficiaries. The registered address of ATGC Holdings Limited is Start Chambers, Wickham&#8217;s Cay II, P.O. Box 2221, Road Town, Tortola, British Virgin Islands. All the preferred shares held by ATCG Holdings Limited will be converted into Class A ordinary shares immediately upon the effective date of our registration statement relating to this offering. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">178</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:212pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:10pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(3)</font>
          <br >
        </div>
        <div style=" line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Represents 9,000,000 ordinary shares held by Nortye Talent Limited, a British Virgin Islands company wholly owned by Trident Trust Company (HK) Limited. Trident Trust Company (HK) Limited is holding these shares as the trustee for the benefit of certain employees of the Company in the trust. We are the settlor of this trust. Under the terms of this trust, the sole member of the advisory committee, Mr.&#160;Jun Zhou, is able to exercise voting rights and dispositive rights attached to the ordinary shares held by Nortye Talent Limited as of the date of this prospectus. The registered address of Nortye Talent Limited is P.O. Box 146, Road Town, Tortola, British Virgin Islands. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Represents 6,060,000 ordinary shares issuable upon the conversion of Series&#160;A preferred shares held by JIN YIN (BVI) LIMITED, a British Virgin Islands company wholly owned by Shanghai Gaopei Duwei Biotechnology Co. Hangzhou Jingyin Investment Partnership (Limited Partnership) and Hangzhou Jingfeng Investment Management Company hold 99.0% and 1.0% equity interests in Shanghai Gaopei Duwei Biotechnology Co., respectively. The general partner of Hangzhou Jingyin Investment Partnership (Limited Partnership) is Hangzhou Jingfeng Investment Management Company. Hangzhou Jingfeng Investment Management Company is wholly-owned by Shijun Feng. The registered address of JIN YIN (BVI) LIMITED is Craigmuir Chambers, Road Town, Tortola, VG 1110, British Virgin Islands. The registered address of Shanghai Gaopei Duwei Biotechnology Co. is Room 2207A, No. 28, Maji Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, China. The registered address of Hangzhou Jinyin Investment Partnership (Limited Partnership) is Room 357, No.88-2, Yuanshuaimiaohou, Shangcheng District, Hangzhou, China. The registered address of Hangzhou Jingfeng Investment Management Company is Room 606-47, Building 1, No. 217, Wujiang Road, Shangcheng District, Hangzhou, China. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Represents 6,000,000 ordinary shares held by Nortye International Limited, a British Virgin Islands company wholly owned by Trident Trust Company (HK) Limited. Trident Trust Company (HK) Limited is holding these shares as the trustee for the benefit of certain employees of the Company in the trust. We are the settlor of this trust. Under the terms of this trust, the sole member of the advisory committee, Mr. Xiao Zhang, is able to exercise voting rights and dispositive rights attached to the ordinary shares held by Nortye International Limited as of the date of this prospectus.. The registered address of Nortye International Limited is P.O. Box 146, Road Town, Tortola, British Virgin Islands. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Represents 5,750,790 ordinary shares issuable upon the conversion of Series&#160;C preferred shares held by UNIQUE MARK VENTURES LIMITED, a British Virgin Islands company wholly owned by RONGXI HONGKONG INVESTMENT MANAGEMENT LIMITED, which is in turn wholly owned by Zhuhai Rongxi Capital Investment LLP. Zhuhai Rongxi Capital Investment LLP is ultimately controlled by the Industrial and Commercial Bank of China Limited, a PRC state-owned bank and a public company, and the voting and/or dispositive power with respect to the shares owned by UNIQUE MARK VENTURES LIMITED is exercised jointly by members of the asset management department of the Industrial and Commercial Bank of China Limited, rather than any specific individuals. The registered address of UNIQUE MARK VENTURES LIMITED is Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands. The registered address of RONGXI HONGKONG INVESTMENT MANAGEMENT LIMITED is Room&#160;1005, 10/F., Champion Tower, 3 Garden Road, Central, Hong Kong. The registered address of Zhuhai Rongxi Capital Investment LLP is Room 105, No. 6, Baohua Road, Hengqin New District, Zhuhai, China. The registered address of the Industrial and Commercial Bank of China Limited is No. 55, Fuxingmennei Street, Xicheng District, Beijing, China. All the preferred shares held by UNIQUE MARK VENTURES LIMITED will be converted into Class A ordinary shares immediately upon the effective date of our registration statement relating to this offering. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, 0.9% of our ordinary shares are held by record holders in the United States. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of our company. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">179</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRPT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:528pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">RELATED PARTY TRANSACTIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Shareholders agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See &#8220;Description of Share Capital&#8201;&#8212;&#8201;Shareholders agreement.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Employment agreements and indemnification agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">See &#8220;Management&#8201;&#8212;&#8201;Employment agreements and indemnification agreements.&#8221;</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">180</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOSC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF SHARE CAPITAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are a Cayman Islands exempted company incorporated with limited liability and our affairs are governed by our memorandum and articles of association, the Companies Act (As Revised) of the Cayman Islands, which we refer to as the Companies Act below, and the common law of the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this prospectus, our authorized share capital is US$50,000 divided into 500,000,000 ordinary shares with a par value of US$0.0001 each. As of the date of this prospectus, (i)&#160;40,440,000 ordinary shares, (ii)&#160;14,560,000 Series&#160;A preferred shares, (iii)&#160;13,607,896 Series&#160;B preferred shares, (iv)&#160;14,653,013 Series&#160;C preferred shares and (v)&#160;14,722,505 Series&#160;D preferred Shares are issued and outstanding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Immediately prior to the completion of this offering and the concurrent private placement, we will have 80,993,414 Class&#160;A ordinary shares and 16,990,000 Class&#160;B ordinary shares issued and outstanding. Following the completion of this offering and the concurrent private placement, we will have 93,710,805 Class A ordinary shares and 16,990,000 Class B ordinary shares outstanding, assuming the underwriters do not exercise the option to purchase additional ADSs. All of our shares issued and outstanding prior to the completion of the offering are and will be fully paid, and all of our shares to be issued in the offering will be issued as fully paid. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Our post-offering memorandum and articles of association</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have adopted a seventh amended and restated memorandum and articles of association, which will become effective and replace our sixth amended and restated memorandum and articles of association in its entirety immediately prior to the completion of this offering. The following are summaries of material provisions of the post-offering memorandum and articles of association that we have adopted and of the Companies Act, insofar as they relate to the material terms of our ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Objects of our company</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under our post-offering memorandum and articles of association, the objects of our company are unrestricted, and we have the full power and authority to carry out any object not prohibited by the laws of the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Ordinary shares.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our ordinary shares are divided into Class A ordinary shares and Class B ordinary shares. Holders of our Class A ordinary shares and Class B ordinary shares will have the same rights except for voting and conversion rights. Each Class A ordinary share shall entitle the holder thereof to one (1) vote on all matters subject to vote at our general meetings, and each Class B ordinary share shall entitle the holder thereof to fifteen (15) votes on all matters subject to vote at our general meetings. Our ordinary shares are issued in registered form and are issued when registered in our register of members. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Conversion.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Each Class B ordinary share is convertible into one (1) Class A ordinary share at the option of the holder thereof at any time upon written notice to our company, while Class A ordinary shares cannot be converted into Class B ordinary shares under any circumstances. Upon any sale, transfer, assignment or disposition of any Class B ordinary share by a shareholder, or any affiliate of the founder to any person who is not the founder, or an affiliate of the founder, or upon a change of ultimate beneficial ownership of any Class B ordinary share to any person who is not the founder, or an affiliate of the founder, such Class B ordinary share shall be automatically and immediately converted into one Class A ordinary share.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our directors may from time to time declare dividends (including interim dividends) and other distributions on our shares in issue and authorize payment of the same out of the funds of our company lawfully available therefor. In addition, our shareholders may declare dividends by ordinary resolution, but no dividend may exceed the amount recommended by our directors. Our post-offering memorandum and articles of association provide that dividends may be declared and paid out of the profits of the Company or, if permitted by the Companies Act, out of capital. Under the laws of the Cayman Islands, our company may declare and pay a dividend out of either profit or share premium account; provided that in no circumstances may a dividend be paid if that would result in our company being unable to pay its debts as they fall due in the ordinary course of business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Voting rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our Class A ordinary shares and Class B ordinary shares vote together as a single class on all matters submitted to a vote of our shareholders, except as may otherwise be required by law or provided for in our post-offering memorandum and articles of association. In respect of matters requiring shareholders&#39; vote, each Class A ordinary share is entitled to one vote, and each Class B ordinary share is entitled to fifteen </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">181</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">votes. At any general meeting a resolution put to the vote of the meeting shall be decided on by way of a poll save that the chairman of the meeting may, in good faith, allow a resolution which relates purely to a procedural or administrative matter to be voted on by a show of hands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An ordinary resolution to be passed at a meeting by the shareholders requires the affirmative vote of a simple majority of the votes attaching to the ordinary shares cast at a meeting, while a special resolution requires the affirmative vote of no less than two-thirds of the votes cast attaching to the issued and outstanding ordinary shares at a meeting. A special resolution will be required for important matters such as a change of name or making changes to our post-offering memorandum and articles of association. Our shareholders may, among other things, divide and combine their shares by ordinary resolution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">General meetings of shareholders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As a Cayman Islands exempted company, we are not obliged by the Companies Act to call shareholders&#8217; annual general meetings. Our post-offering memorandum and articles of association provide that we may (but are not obliged to) in each year hold a general meeting as our annual general meeting in which case we will specify the meeting as such in the notices calling it, and the annual general meeting will be held at such time and place as may be determined by our directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Shareholders&#8217; general meetings may be convened by the chairman or a majority of our board of directors. Advance notice of at least seven (7) calendar days is required for the convening of our annual general shareholders&#8217; meeting (if any) and any other general meeting of our shareholders. A quorum required for any general meeting of shareholders consists of one or more of our shareholders holding shares which carry in aggregate (or representing by proxy) not less than one-third of all votes attaching to the issued and outstanding shares in our company entitled to vote at such general meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act provides shareholders with only limited rights to requisition a general meeting and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided in a company&#8217;s articles of association. Our post-offering memorandum and articles of association provide that upon the requisition of any one or more of our shareholders holding shares which carry in aggregate not less than ten percent (10%) of the votes attaching to the outstanding shares of our company entitled to vote at general meetings, our board will convene an extraordinary general meeting and put the resolutions so requisitioned to a vote at such meeting. However, our post-offering memorandum and articles of association do not provide our shareholders with any right to put any proposals before annual general meetings or extraordinary general meetings not called by such shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Transfer of ordinary shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Subject to the restrictions set out below, any of our shareholders may transfer all or any of his or her ordinary shares by an instrument of transfer in writing and in the usual or common form or any other form approved by our board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our board of directors may, in its absolute discretion, decline to register any transfer of any ordinary share which is not fully paid up or on which we have a lien. Our board of directors may also decline to register any transfer of any ordinary share unless: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the instrument of transfer is lodged with us, accompanied by the certificate for the ordinary shares to which it relates and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the instrument of transfer is in respect of only one class of ordinary shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the instrument of transfer is properly stamped, if required; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in the case of a transfer to joint holders, the number of joint holders to whom the ordinary share is to be transferred does not exceed four; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a fee of such maximum sum as the Nasdaq Stock Market may determine to be payable or such lesser sum as our directors may from time to time require is paid to us in respect thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If our directors refuse to register a transfer they must, within one&#160;calendar month after the date on which the instrument of transfer was lodged, send to each of the transferor and the transferee notice of such refusal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The registration of transfers may, after compliance with any notice required of the Nasdaq Stock Market, be suspended and the register closed at such times and for such periods as our board of directors may from </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">182</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">time to time determine, provided, however, that the registration of transfers may not be suspended nor the register closed for more than 30&#160;calendar days in any year as our board may determine. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Liquidation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;On the winding up of our company, if the assets available for distribution amongst our shareholders will be more than sufficient to repay the whole of the share capital at the commencement of the winding up, the surplus will be distributed amongst our shareholders in proportion to the par value of the shares held by them at the commencement of the winding up, subject to a deduction from those shares in respect of which there are monies due, of all monies payable to our company for unpaid calls or otherwise. If our assets available for distribution are insufficient to repay all of the paid-up capital, such assets will be distributed so that, as nearly as may be, the losses are borne by our shareholders in proportion to the par value of the shares held by them. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Calls on shares and forfeiture of shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our board of directors may from time to time make calls upon shareholders for any amounts unpaid on their shares in a notice served to such shareholders at least 14&#160;days prior to the specified time and place of payment. The shares that have been called upon and remain unpaid are subject to forfeiture. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Redemption, repurchase and surrender of shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We may issue shares on terms that such shares are subject to redemption, at our option or at the option of the holders of these shares, on such terms and in such manner as may be determined, before the issue of such shares, by our board of directors or by the shareholders by ordinary resolution. Our company may also repurchase any of our shares on such terms and in such manner as have been approved by our board of directors or by an ordinary resolution of our shareholders. Under the Companies Act, the redemption or repurchase of any share may be paid out of our company&#8217;s profits or out of the proceeds of a new issue of shares made for the purpose of such redemption or repurchase, or out of capital (including share premium account and capital redemption reserve) if our company can, immediately following such payment, pay its debts as they fall due in the ordinary course of business. In addition, under the Companies Act no such share may be redeemed or repurchased (a)&#160;unless it is fully paid up, (b)&#160;if such redemption or repurchase would result in there being no shares outstanding or (c)&#160;if the company has commenced liquidation. In addition, our company may accept the surrender of any fully paid share for no consideration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Variation of rights of shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Whenever the capital of our company is divided into different classes, the rights attached to any such class may, subject to any rights or restrictions for the time being attached to any class, only be materially adversely varied with the consent in writing of the holders of no less than two-thirds of the issued shares of that class or with the sanction of a resolution passed at a separate meeting of the holders of the shares of the class by a majority of two-thirds of the votes cast at such meeting. The rights conferred upon the holders of the shares of any class issued will not, unless otherwise expressly provided by the terms of issue of the shares of that class, be deemed to be varied by the creation, allotment, or issue of further shares ranking </font><font style="font-style:italic;letter-spacing:0.2pt;">pari&#160;passu</font><font style="letter-spacing:0.2pt;"> with such existing class of shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Issuance of additional shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Our post-offering memorandum and articles of association authorize our board of directors to issue additional ordinary shares from time to time as our board of directors may determine, to the extent of available authorized but unissued shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Inspection of books and records</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Holders of our ordinary shares will have no general right under Cayman Islands law to inspect or obtain copies of our list of shareholders or our corporate records (other than our memorandum and articles of association, special resolutions which have been passed by our shareholders, and our register of mortgages and charges). Under Cayman Islands law, the names of our current directors can be obtained from a search conducted at the Registrar of Companies. However, we intend to provide our shareholders with annual audited financial statements. See &#8220;Where You Can Find Additional Information.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Anti-takeover provisions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Some provisions of our post-offering memorandum and articles of association may discourage, delay, or prevent a change of control of our company or management that shareholders may consider favorable, including provisions that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">authorize our board of directors to issue additional ordinary shares from time to time as our board of directors may determine, to the extent of available authorized but unissued shares; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">limit the ability of shareholders to requisition and convene general meetings of shareholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">183</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">However, under Cayman Islands law, our directors may only exercise the rights and powers granted to them under our post-offering memorandum and articles of association for a proper purpose and for what they believe in good faith to be in the best interests of our company. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Changes in capital.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our shareholders may from time to time by ordinary resolution: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">increase our share capital by such sum, to be divided into shares of such classes and amount, as the resolution shall prescribe; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">consolidate and divide all or any of our share capital into shares of a larger amount than our existing shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sub-divide our existing shares, or any of them into shares of a smaller amount, provided that in the subdivision the proportion between the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in case of the share from which the reduced share is derived; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and diminish the amount of our share capital by the amount of the shares so canceled. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our shareholders may, by special resolution, subject to confirmation by the Grand Court of the Cayman Islands on an application by our company for an order confirming such reduction, reduce our share capital or any capital redemption reserve in any manner permitted by law.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Exempted company</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;We are an exempted company with limited liability under the Companies Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company. The requirements for an exempted company are essentially the same as for an ordinary company except that an exempted company: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">does not have to file an annual return of its shareholders with the Registrar of Companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">is not required to open its register of members for inspection; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">does not have to hold an annual general meeting; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">may issue negotiable or bearer shares or shares with no par value; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20&#160;years in the first instance); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">may register as a limited duration company; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">may register as a segregated portfolio company. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Limited liability&#8221; means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Exclusive forum</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Unless we consent in writing to the selection of an alternative forum, the United States District Court for the Southern District of New York (or, if the United States District Court for the Southern District of New York lacks subject matter jurisdiction over a particular dispute, the state courts in New York County, New York) shall be the exclusive forum within the United States for the resolution of any complaint asserting a cause of action arising under the Securities Act and the Exchange Act. Any person or entity purchasing or otherwise acquiring any of our shares, ADSs or other securities shall be deemed to have notice of and consented to the provisions of our post-offering memorandum and articles of association. See &#8220;Risk Factors&#8201;&#8212;&#8201;Risks relating to the ADSs&#8201;&#8212;&#8201;You may face difficulties in protecting your interests, and your ability to protect your rights through U.S. courts may be limited, because we are incorporated under Cayman Islands law&#8221; and &#8220;Risk Factors&#8201;&#8212;&#8201;Risks relating to the ADSs&#8201;&#8212;&#8201;Forum selection provisions in our post-offering memorandum and articles of association and our deposit agreement with the depositary bank could limit the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">184</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">ability of holders of our ordinary shares, ADSs, or other securities to obtain a favorable judicial forum for disputes with us, our directors and officers, the depositary bank, and potentially others.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Differences in corporate law</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act is derived, to a large extent, from the older Companies Acts of England but does not follow recent English statutory enactments and, accordingly, there are significant differences between the Companies Act and the current Companies Act of England. In addition, the Companies Act differs from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of certain significant differences between the provisions of the Companies Act applicable to us and the laws applicable to companies incorporated in the United States and their shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Mergers and Similar Arrangements.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Companies Act permits mergers and consolidations between Cayman Islands companies and between Cayman Islands companies and non-Cayman Islands companies. For these purposes, (i)&#160;&#8220;merger&#8221; means the merging of two or more constituent companies and the vesting of their undertaking, property and liabilities in one of such companies as the surviving company, and (ii)&#160;a &#8220;consolidation&#8221; means the combination of two or more constituent companies into a consolidated company and the vesting of the undertaking, property and liabilities of such companies to the consolidated company. In order to effect such a merger or consolidation, the directors of each constituent company must approve a written plan of merger or consolidation, which must then be authorized by (a)&#160;a special resolution of the shareholders of each constituent company, and (b)&#160;such other authorization, if any, as may be specified in such constituent company&#8217;s articles of association. The written plan of merger or consolidation must be filed with the Registrar of Companies of the Cayman Islands together with a declaration as to the solvency of the surviving or consolidated company, a list of the assets and liabilities of each constituent company and an undertaking that a copy of the certificate of merger or consolidation will be given to the members and creditors of each constituent company and that notification of the merger or consolidation will be published in the Cayman Islands Gazette. Court approval is not required for a merger or consolidation which is effected in compliance with these statutory procedures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A merger between a Cayman parent company and its Cayman subsidiary or subsidiaries does not require authorization by a resolution of shareholders of that Cayman subsidiary if a copy of the plan of merger is given to every member of that Cayman subsidiary to be merged unless that member agrees otherwise. For this purpose, a subsidiary is a company of which at least ninety&#160;percent (90%) of the issued shares entitled to vote at a general meeting of such subsidiary are owned by the parent company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The consent of each holder of a fixed or floating security interest over a constituent company is required unless this requirement is waived by a court in the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Save in certain circumstances, a dissenting shareholder of a Cayman constituent company is entitled to payment of the fair value of his shares upon dissenting to a merger or consolidation. The exercise of appraisal rights will preclude the exercise of any other rights save for the right to seek relief on the grounds that the merger or consolidation is void or unlawful. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, there are statutory provisions that facilitate the reconstruction and amalgamation of companies, provided that the arrangement is approved by a majority in number of each class of shareholders and creditors with whom the arrangement is to be made, and who must in addition represent three-fourths in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person or by proxy at a meeting, or meetings, convened for that purpose. The convening of the meetings and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder has the right to express to the court the view that the transaction ought not to be approved, the court can be expected to approve the arrangement if it determines that: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the statutory provisions as to the required majority vote have been met; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the shareholders have been fairly represented at the meeting in question and the statutory majority are acting bona fide without coercion of the minority to promote interests adverse to those of the class; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the arrangement is such that may be reasonably approved by an intelligent and honest man of that class acting in respect of his interest; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">185</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">When a takeover offer is made and accepted by holders of 90.0% of the shares within four&#160;months, the offeror may, within a two-month period commencing on the expiration of such four-month period, require the holders of the remaining shares to transfer such shares on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but this is unlikely to succeed in the case of an offer which has been so approved unless there is evidence of fraud, bad faith or collusion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If an arrangement and reconstruction by way of scheme of arrangement is thus approved and sanctioned, or if a tender offer is made and accepted in accordance with the foregoing statutory procedures, a dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of Delaware corporations, providing rights to receive payment in cash for the judicially determined value of the shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shareholders&#8217; Suits.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In principle, we will normally be the proper plaintiff and as a general rule a derivative action may not be brought by a minority shareholder. However, based on English authorities, which would in all likelihood be of persuasive authority in the Cayman Islands, the Cayman Islands court can be expected to follow and apply the common law principles (namely the rule in Foss v. Harbottle and the exceptions thereto) so that a non-controlling shareholder may be permitted to commence a class action against or derivative actions in the name of the company to challenge actions where: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a company acts or proposes to act illegally or ultra vires; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the act complained of, although not ultra vires, could only be effected duly if authorized by more than a simple majority vote that has not been obtained; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">those who control the company are perpetrating a &#8220;fraud on the minority.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Indemnification of directors and executive officers and limitation of liability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Cayman Islands law does not limit the extent to which a company&#8217;s memorandum and articles of association may provide for indemnification of directors and officers, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against the consequences of committing a crime, or against the indemnified person&#8217;s own fraud or dishonesty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This standard of conduct is generally the same as permitted under the Delaware General Corporation Law for a Delaware corporation. In addition, we have entered into indemnification agreements with our directors and executive officers that provide such persons with additional indemnification beyond that provided in our post-offering amended and restated memorandum and articles of association. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Directors&#8217; fiduciary duties</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director acts in a manner he reasonably believes to be in the best interests of the corporation. He must not use his corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer, or controlling shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, the director must prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">186</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As a matter of Cayman Islands law, a director of a Cayman Islands company is in the position of a fiduciary with respect to the company and therefore it is considered that he owes the following duties to the company&#8201;&#8212;&#8201;a duty to act in good faith in the best interests of the company, a duty not to make a personal profit based on his position as director (unless the company permits him to do so), a duty not to put himself in a position where the interests of the company conflict with his personal interest or his duty to a third party, and a duty to exercise powers for the purpose for which such powers were intended. A director of a Cayman Islands company owes to the company a duty to act with skill and care. It was previously considered that a director need not exhibit in the performance of his duties a greater degree of skill than may reasonably be expected from a person of his knowledge and experience. However, English and Commonwealth courts have moved towards an objective standard with regard to the required skill and care and these authorities are likely to be followed in the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shareholder action by written consent</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a corporation may eliminate the right of shareholders to act by written consent by amendment to its certificate of incorporation. The Companies Act and our post-offering memorandum and articles of association provide that shareholders may approve corporate matters by way of a unanimous written resolution signed by or on behalf of each shareholder who would have been entitled to vote on such matter at a general meeting without a meeting being held, and any such resolution in writing shall be as valid and effective as if the same had been passed at a general meeting of our company duly convened and held. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shareholder proposals</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a shareholder has the right to put any proposal before the annual meeting of shareholders; provided that it complies with the notice provisions in the governing documents. A special meeting may be called by the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Companies Act provides shareholders with only limited rights to requisition a general meeting, and does not provide shareholders with any right to put any proposal before a general meeting. However, these rights may be provided in a company&#8217;s articles of association. Our post-offering memorandum and articles of association allow our shareholders holding shares which carry in aggregate not less than ten percent of the total number of votes attaching to all issued and outstanding shares of our company entitled to vote at general meetings to requisition an extraordinary general meeting of our shareholders, in which case our board is obliged to convene an extraordinary general meeting and to put the resolutions so requisitioned to a vote at such meeting. Other than this right to requisition a shareholders&#8217; meeting, our post-offering amended and restated articles of association do not provide our shareholders with any other right to put proposals before annual general meetings or extraordinary general meetings. As an exempted Cayman Islands company, we are not obliged by law to call shareholders&#8217; annual general meetings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Cumulative voting</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation&#8217;s certificate of incorporation specifically provides for it. Cumulative voting potentially facilitates the representation of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder is entitled on a single director, which increases the shareholder&#8217;s voting power with respect to electing such director. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Companies Act of the Cayman Islands, cumulative voting for the election of directors is not permitted unless so provided in the memorandum and articles of association. There are no prohibitions in relation to cumulative voting under the laws of the Cayman Islands, but our post-offering memorandum and articles of association do not provide for cumulative voting. As a result, our shareholders are not afforded any less protections or rights on this issue than shareholders of a Delaware corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Removal of directors</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a director of a corporation with a classified board may be removed only for cause with the approval of a majority of the issued and outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under our post-offering memorandum and articles of association, directors may be removed by an ordinary resolution of our shareholders or by the board of directors. A director will also cease to be a director if he (i)&#160;becomes bankrupt or makes any arrangement or composition with his creditors; (ii)&#160;dies or is found to be or becomes of unsound mind; (iii)&#160;resigns his office by notice in writing; (iv)&#160;is prohibited by any applicable law or designated stock exchange rules from being a director; (v) without special leave of absence from our board, is absent from </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">187</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">meetings of our board for three consecutive meetings and our board resolves that his office be vacated; or (vi)&#160;is removed from office pursuant to any other provision of our articles of association. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Transactions with interested shareholders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Delaware General Corporation Law contains a business combination statute applicable to Delaware corporations whereby, unless the corporation has specifically elected not to be governed by such statute by amendment to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an &#8220;interested shareholder&#8221; for three&#160;years following the date that such person becomes an interested shareholder. An interested shareholder generally is a person or a group who or which owns or owned 15% or more of the target&#8217;s outstanding voting shares within the past three&#160;years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which such shareholder becomes an interested shareholder, the board of directors approves either the business combination or the transaction which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate the terms of any acquisition transaction with the target&#8217;s board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cayman Islands law has no comparable statute. As a result, we cannot avail ourselves of the types of protections afforded by the Delaware business combination statute. However, although Cayman Islands law does not regulate transactions between a company and its significant shareholders, it does provide that such transactions must be entered into bona fide in the best interests of the company and not with the effect of constituting a fraud on the minority shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dissolution; winding up</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, unless the board of directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total voting power of the corporation. Only if the dissolution is initiated by the board of directors may it be approved by a simple majority of the corporation&#8217;s outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by either an order of the courts of the Cayman Islands or by the board of directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under Cayman Islands law, a company may be wound up by either an order of the courts of the Cayman Islands or by a special resolution of its members or, if the company is unable to pay its debts as they fall due, by an ordinary resolution of its members. The court has authority to order winding up in a number of specified circumstances including where it is, in the opinion of the court, just and equitable to do so. Under the Companies Act, our company may be dissolved, liquidated, or wound up by a special resolution of our shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Variation of rights of shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a corporation may vary the rights of a class of shares with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under our post-offering memorandum and articles of association, if our share capital is divided into more than one class of shares, the rights attached to any such class may only be materially adversely varied with the consent in writing of the holders of not less than two-thirds of the issued shares of that class or with the sanction of a resolution passed at a separate meeting of the holders of the shares of that class by a majority of two-thirds of the votes cast at such a meeting. The rights conferred upon the holders of the shares of any class issued with preferred or other rights shall not, subject to any rights or restrictions for the time being attached to the shares of that class, be deemed to be materially adversely varied by the creation, allotment or issue of further shares ranking </font><font style="font-style:italic;letter-spacing:0.2pt;">pari&#160;passu</font><font style="letter-spacing:0.2pt;"> with or subsequent to them or the redemption or purchase of any shares of any class by our company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Amendment of governing documents</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Under the Delaware General Corporation Law, a corporation&#8217;s governing documents may be amended with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise. Under the Companies Act and our post-offering memorandum and articles of association, our memorandum and articles of association may only be amended by a special resolution of our shareholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Rights of non-resident or foreign shareholders</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;There are no limitations imposed by our post-offering memorandum and articles of association on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions in our post-offering memorandum and articles of association that require our company to disclose shareholder ownership above any particular ownership threshold. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">188</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">History of share capital</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of changes in our share capital in the past three&#160;years. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Ordinary shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;28, 2021, Mr. Yang Lu transferred 900,000 ordinary shares through an entity controlled by him to Lucy Zhang for consideration of USD2,833,574 due to debt-to-equity swap for settlement of a convertible loan between Mr.&#160;Yang Lu and Lucy Zhang&#8217;s father, each of Lucy Zhang and her father is an independent third party to Mr.&#160;Lu and us. Such convertible loan was provided by Lucy Zhang&#8217;s father to Mr.&#160;Lu for the purpose of investing on our company. On July&#160;5, 2021, we issued (i)&#160;9,000,000 ordinary shares to Nortye Talent Limited and (ii)&#160;6,000,000 ordinary shares to Nortye International Limited for nominal consideration as reservation for future transfers to employees upon their exercise of share incentive awards. On the same day, we issued (i)&#160;5,000,000 ordinary shares to PECO International Limited for nominal consideration as compensation to certain management personnel and (ii)&#160;16,990,000 ordinary shares to Archer Future Limited and 2,550,000 ordinary shares to DH&#160;Future Limited, for Mr.&#160;Yang Lu and Mr.&#160;Donghui Yang&#8217;s family trust, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred shares</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our ultimate holding company was incorporated in the Cayman Islands on May&#160;9, 2018. Before the completion of the restructuring in 2019, we completed the Series&#160;A investments. From January&#160;2020 to April&#160;2020, Series&#160;A investors exercised the options and converted their equity interests in Adlai Hangzhou to Series&#160;A preferred shares of the Company. As a result, we issued (i)&#160;3,500,000 Series&#160;A preferred shares to LAI NUO (BVI) LIMITED; (ii)&#160;6,060,000 Series&#160;A preferred shares to JIN YIN (BVI) LIMITED; (iii)&#160;3,430,000 Series&#160;A preferred shares to LV YI (BVI) LIMITED; and (iv)&#160;1,570,000 Series&#160;A preferred shares to Yingzhi International Limited. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In parallel with our reorganization, we also completed our series B financing issuing certain convertible loans by Hangzhou Adlai. Meanwhile, we also entered into a forward contract with Series B investors to grant them an option to convert their convertible loans of Hangzhou Adlai to Series B preferred shares of the Company. During April&#160;2020 to May&#160;2020, Series&#160;B investors had exercised the option, and we issued (i)&#160;1,000,000 Series&#160;B preferred shares to BJKR Management Ltd. for consideration of RMB25,000,000; (ii)&#160;960,000 Series&#160;B preferred shares to Ningbo Meishan Bonded Port Area Yahui Xinrun Investment Management Center (Limited Partnership) for consideration of RMB24,000,000; (iii)&#160;640,000 Series&#160;B preferred shares to Beijing Yahui Qianfeng Equity Investment Partnership (Limited Partnership) for consideration of RMB16,000,000; (iv)&#160;2,000,000 Series&#160;B preferred shares to QHYM Investment Ltd. for consideration of RMB50,000,000; and (v)&#160;2,000,000 Series&#160;B preferred shares to Dexuan (Shanghai) Enterprise Management Center (Limited Partnership) for consideration of RMB50,000,000. On May&#160;20, 2019, we entered into a warrant agreement with China Equities HK Limited under the condition of a bank facility agreement. In July&#160;2021, China Equities HK Limited elected to exercise cashless exchange of such warrants, and we issued 100,000 Series&#160;B preferred shares to China Equities HK Limited. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since the end of 2019, we attracted another round of investment and entered into a series of share purchase agreements, by, among others, with six investors pursuant to which the investors agreed to subscribe for a total of 14,653,013 Series&#160;C preferred shares. During December&#160;2019 to August&#160;2020, we issued (i)&#160;1,150,158 Series&#160;C preferred shares to Hongkong Tigermed Co., Limited for consideration of USD5,000,000; (ii)&#160;4,600,632 Series&#160;C preferred shares to ATCG Holdings Limited for consideration of USD20,000,000; (iii)&#160;230,032 Series&#160;C preferred shares to Pingtan Hongtu No. 5 Venture Capital Partnership (Limited Partnership) for consideration of USD1,000,000; (iv)&#160;2,300,316 Series&#160;C preferred shares to Pingtan Yingke Shengxin Chuangye Partnership (Limited Partnership) for consideration of USD10,000,000; (v)&#160;621,085 Series&#160;C preferred shares to Pingtan Puxin Yingke Ruiyuan Venture Capital Partnership (Limited Partnership) for consideration of USD2,700,000; and (vi)&#160;5,750,790 Series&#160;C preferred shares to UNIQUE MARK VENTURES LIMITED for consideration of USD25,000,000. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since early 2021, pursuant to a series of share purchase agreements entered into by, among others, our ultimate holding company, our founders and more than ten investors, the investors agreed to subscribe for 14,722,505 Series&#160;D preferred shares. As a result, from May to July of 2021, we issued (i)&#160;2,268,025 Series&#160;D </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">189</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:224pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">preferred shares to ATCG Holdings Limited for consideration of USD15,000,000; (ii)&#160;756,008 Series&#160;D preferred shares to Hangzhou Tigermed Equity Investment Partnership (Limited Partnership) for consideration of USD5,000,000; (iii)&#160;2,066,927 Series&#160;D preferred shares to Triwise Kangnuo Investment Limited for consideration of USD13,670,000; (iv)&#160;1,239,854 Series&#160;D preferred shares to Qingdao Mukui Equity Investment Partnership (Limited Partnership) for consideration of USD8,200,000; (v)&#160;680,407 Series&#160;D preferred shares to Wuxi Guolian Guokang Health Industry Investment Centre (Limited Partnership) for consideration of USD4,500,000; (vi)&#160;453,605 Series&#160;D preferred shares to Week8 Holdings (HK) Limited for consideration of USD3,000,000; (vii)&#160;302,403 Series&#160;D preferred shares to Ningbo Menovo Ruihe Equity Investment Partnership (Limited Partnership) for consideration of USD2,000,000; (viii)&#160;4,536,050 Series&#160;D preferred shares to Xianjin Zhizao Industry Investment Fund&#160;II (Limited Partnership) for consideration of USD30,000,000; (ix)&#160;226,802 Series&#160;D preferred shares to Adlai Nortye Investment Limited for consideration of USD1,500,000; (x)&#160;453,605 Series&#160;D preferred shares to Legendstar Fund&#160;IV, L.P. for consideration of USD3,000,000; (xi)&#160;1,512,017 Series&#160;D preferred shares to Phantom Capital Fund&#160;L.P. for consideration of USD10,000,000 and (xii)&#160;226,802 Series&#160;D preferred shares to WuXi Biologics Healthcare Venture for consideration of USD1,500,000. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Immediately prior to the completion of this offering, issued and outstanding ordinary shares held by Archer Future Limited will be re-designated as Class&#160;B ordinary shares on a one-for-one basis, and the remaining issued and outstanding ordinary shares will be re-designated as Class A ordinary shares on a one-for-one basis.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Grant of share incentive awards</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have granted options to purchase our ordinary shares to certain of our directors, executive officers, employees, and consultants. See &#8220;Management&#8201;&#8212;&#8201;Share incentive plans.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shareholders agreement</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our currently effective shareholders agreement was entered into on April&#160;15, 2021 by and among us, our shareholders, and certain other parties named therein. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The current shareholders agreement provides for certain special rights, including registration right, right of first refusal and right of co-sale, and contains provisions governing the board of directors and other corporate governance matters. Those special rights as well as the corporate governance provisions will terminate upon the completion of this offering. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">190</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOAD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF AMERICAN DEPOSITARY SHARES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">American Depositary Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Bank of New York Mellon, as depositary, will register and deliver American Depositary Shares, also referred to as ADSs. Each ADS will represent three Class&#160;A ordinary shares (or a right to receive three Class&#160;A ordinary shares) deposited with The Hong Kong and Shanghai Banking Corporation Limited, as custodian for the depositary in Hong Kong. Each ADS will also represent any other securities, cash or other property that may be held by the depositary. The deposited shares, together with any other securities, cash or other property held by the depositary, are referred to as the deposited securities. The depositary&#8217;s office at which the ADSs will be administered and its principal executive office are located at 240&#160;Greenwich Street, New York, New York 10286. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may hold ADSs either (A)&#160;directly (i)&#160;by having an American Depositary Receipt, also referred to as an ADR, which is a certificate evidencing a specific number of ADSs, registered in your name, or (ii)&#160;by having uncertificated ADSs registered in your name, or (B)&#160;indirectly by holding a security entitlement in ADSs through your broker or other financial institution that is a direct or indirect participant in The Depository Trust Company, also called DTC. If you hold ADSs directly, you are a registered ADS holder, also referred to as an ADS holder. This description assumes you are an ADS holder. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADS holders described in this section. You should consult with your broker or financial institution to find out what those procedures are. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Registered holders of uncertificated ADSs will receive statements from the depositary confirming their holdings. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As an ADS holder, we will not treat you as one of our shareholders and you will not have shareholder rights. Cayman Islands law governs shareholder rights. The depositary will be the holder of the Class A ordinary shares underlying your ADSs. As a registered holder of ADSs, you will have ADS holder rights. A deposit agreement among us, the depositary, ADS holders and all other persons indirectly or beneficially holding ADSs sets out ADS holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement and the ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the material provisions of the deposit agreement. For more complete information, you should read the entire deposit agreement and the form of ADR. For directions on how to obtain copies of those documents, see &#8220;Where You Can Find Additional Information.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends and Other Distributions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How will you receive dividends and other distributions on the shares?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary has agreed to pay or distribute to ADS holders the cash dividends or other distributions it or the custodian receives on shares or other deposited securities, upon payment or deduction of its fees and expenses. You will receive these distributions in proportion to the number of Class A ordinary shares your ADSs represent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Cash</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The depositary will convert any cash dividend or other cash distribution we pay on the Class A ordinary shares into U.S. dollars, if it can do so on a reasonable basis and can transfer the U.S. dollars to the United States. If that is not possible or if any government approval is needed and cannot be obtained, the deposit agreement allows the depositary to distribute the foreign currency only to those ADS holders to whom it is possible to do so. It will hold the foreign currency it cannot convert for the account of the ADS holders who have not been paid. It will not invest the foreign currency and it will not be liable for any interest. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before making a distribution, any withholding taxes, or other governmental charges that must be paid will be deducted. See &#8220;Taxation.&#8221; The depositary will distribute only whole U.S. dollars and cents and will round fractional cents to the nearest whole cent. </font><font style="font-style:italic;letter-spacing:0.2pt;">If the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, you may lose some of the value of the distribution.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">191</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The depositary may distribute additional ADSs representing any Class A ordinary shares we distribute as a dividend or free distribution. The depositary will only distribute whole ADSs. It will sell Class&#160;A ordinary shares which would require it to deliver a fraction of an ADS (or ADSs representing those shares) and distribute the net proceeds in the same way as it does with cash. If the depositary does not distribute additional ADSs, the outstanding ADSs will also represent the new Class A ordinary shares. The depositary may sell a portion of the distributed Class A ordinary shares (or ADSs representing those shares) sufficient to pay its fees and expenses in connection with that distribution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Rights to purchase additional shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If we offer holders of our Class A ordinary shares any rights to subscribe for additional shares or any other rights, the depositary may (i)&#160;exercise those rights on behalf of ADS holders, (ii)&#160;distribute those rights to ADS holders or (iii)&#160;sell those rights and distribute the net proceeds to ADS holders, in each case after deduction or upon payment of its fees and expenses. To the extent the depositary does not do any of those things, it will allow the rights to lapse. </font><font style="font-style:italic;letter-spacing:0.2pt;">In that case, you will receive no value for them.</font><font style="letter-spacing:0.2pt;"> The depositary will exercise or distribute rights only if we ask it to and provide satisfactory assurances to the depositary that it is legal to do so. If the depositary will exercise rights, it will purchase the securities to which the rights relate and distribute those securities or, in the case of Class A ordinary shares, new ADSs representing the new Class A ordinary shares, to subscribing ADS holders, but only if ADS holders have paid the exercise price to the depositary. U.S. securities laws may restrict the ability of the depositary to distribute rights or ADSs or other securities issued on exercise of rights to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="font-style:italic;font-weight:bold;letter-spacing:-0.2pt;">Other Distributions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The depositary will send to ADS holders anything else we distribute on deposited securities by any means it thinks is legal, fair and practical. If it cannot make the distribution in that way, the depositary has a choice. It may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with cash. Or, it may decide to hold what we distributed, in which case ADSs will also represent the newly distributed property. However, the depositary is not required to distribute any securities (other than ADSs) to ADS holders unless it receives satisfactory evidence from us that it is legal to make that distribution. The depositary may sell a portion of the distributed securities or property sufficient to pay its fees and expenses in connection with that distribution. U.S. securities laws may restrict the ability of the depositary to distribute securities to all or certain ADS holders, and the securities distributed may be subject to restrictions on transfer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADS holders. We have no obligation to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADSs, shares, rights or anything else to ADS holders. </font><font style="font-style:italic;letter-spacing:0.2pt;">This means that you may not receive the distributions we make on our shares or any value for them if it is illegal or impractical for us to make them available to you</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Deposit, Withdrawal and Cancellation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How are ADSs issued?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary will deliver ADSs if you or your broker deposits Class A ordinary shares or evidence of rights to receive Class A ordinary shares with the custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of ADSs in the names you request and will deliver the ADSs to or upon the order of the person or persons that made the deposit. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How can ADS holders withdraw the deposited securities?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may surrender your ADSs to the depositary for the purpose of withdrawal. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will deliver the Class A ordinary shares and any other deposited securities underlying the ADSs to the ADS holder or a person the ADS holder designates at the office of the custodian. Or, at your request, risk and expense, the depositary will deliver the deposited securities at its office, if feasible. However, the depositary is not required to accept surrender of ADSs to the extent it would require delivery of a fraction of a deposited share or other security. The depositary may charge you a fee and its expenses for instructing the custodian regarding delivery of deposited securities. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">192</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do ADS holders interchange between certificated ADSs and uncertificated ADSs?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may surrender your ADR to the depositary for the purpose of exchanging your ADR for uncertificated ADSs. The depositary will cancel that ADR and will send to the ADS holder a statement confirming that the ADS holder is the registered holder of uncertificated ADSs. Upon receipt by the depositary of a proper instruction from a registered holder of uncertificated ADSs requesting the exchange of uncertificated ADSs for certificated ADSs, the depositary will execute and deliver to the ADS holder an ADR evidencing those ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do you vote?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ADS holders may instruct the depositary how to vote the number of deposited shares their ADSs represent. If we request the depositary to solicit your voting instructions (and we are not required to do so), the depositary will notify you of a shareholders&#8217; meeting and send or make voting materials available to you. Those materials will describe the matters to be voted on and explain how ADS holders may instruct the depositary how to vote. For instructions to be valid, they must reach the depositary by a date set by the depositary. The depositary will try, as far as practical, subject to the laws of the Cayman Islands and the provisions of our memorandum and articles of association or similar documents, to vote or to have its agents vote the Class A ordinary shares or other deposited securities as instructed by ADS holders. If we do not request the depositary to solicit your voting instructions, you can still send voting instructions, and, in that case, the depositary may try to vote as you instruct, but it is not required to do so. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Except by instructing the depositary as described above, you will not be able to exercise voting rights unless you surrender your ADSs and withdraw the Class A ordinary shares. However, you may not know about the meeting enough in advance to withdraw the Class A ordinary shares.</font><font style="font-style:normal;letter-spacing:0.2pt;"> In any event, the depositary will not exercise any discretion in voting deposited securities and it will only vote or attempt to vote as instructed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We cannot assure you that you will receive the voting materials in time to ensure that you can instruct the depositary to vote the Class A ordinary shares represented by your ADSs. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner of carrying out voting instructions. </font><font style="font-style:italic;letter-spacing:0.2pt;">This means that you may not be able to exercise voting rights and there may be nothing you can do if the Class A ordinary shares represented by your ADSs are not voted as you requested.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to give you a reasonable opportunity to instruct the depositary as to the exercise of voting rights relating to depository securities, if we request the Depositary to act, we agree to give the depositary notice of any such meeting and details concerning the matters to be voted upon at least 30&#160;days in advance of the meeting date. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Fees and Expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;min-height:18.25pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:222pt;">
              <font style="letter-spacing:-0.16pt;">Persons depositing or withdrawing shares or ADS holders must </font>
              <br >
              <font style="letter-spacing:-0.16pt;">pay: </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:222pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">For: </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:59.25pt;white-space:normal;text-align:justify;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 3.5pt 0pt; width:222pt;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">$5.00 (or less) per 100 ADSs (or portion of 100 ADSs) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 3.5pt 0pt; width:222pt;text-align:left;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Issuance of ADSs, including issuances resulting from a distribution of shares or rights or other property</font>
              </div>
              <div style="margin-top:6pt; text-align:justify;">
                <font style="letter-spacing:0.2pt;">Cancellation of ADSs for the purpose of withdrawal, including if the deposit agreement terminates </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;min-height:19pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">$.05 (or less) per ADS </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 3.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Any cash distribution to ADS holders </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:43pt;white-space:normal;text-align:justify;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:222pt;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:222pt;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Distribution of securities distributed to holders of deposited securities (including rights) that are distributed by the depositary to ADS holders </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;min-height:21pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:5.5pt 0pt 2.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">$.05 (or less) per ADS per calendar year </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 2.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Depositary services </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">193</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;min-height:18.25pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:222pt;">
              <font style="letter-spacing:-0.16pt;">Persons depositing or withdrawing shares or ADS holders must </font>
              <br >
              <font style="letter-spacing:-0.16pt;">pay: </font>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:222pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">For: </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:53.25pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Registration or transfer fees </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.833pt 0pt; width:222pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Transfer and registration of Class A ordinary shares on our share register to or from the name of the depositary or its agent when you deposit or withdraw Class A ordinary shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:49pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4.167pt 0pt 4.833pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Expenses of the depositary </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 4.833pt 0pt; width:222pt;white-space:normal;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Cable (including SWIFT) and facsimile transmissions (when expressly provided in the deposit agreement) </font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">Converting foreign currency to U.S. dollars </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:55pt;white-space:normal;text-align:justify;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:222pt;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Taxes and other governmental charges the depositary or the custodian has to pay on any ADSs or Class A ordinary shares underlying ADSs, such as stock transfer taxes, stamp duty or withholding taxes </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:222pt;white-space:nowrap;text-align:left;">
              <font style="letter-spacing:0.2pt;">As necessary </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:33pt;white-space:normal;text-align:justify;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:222pt;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Any charges incurred by the depositary or its agents for servicing the deposited securities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 2.833pt 0pt; width:222pt;white-space:nowrap;text-align:left;">
              <font style="letter-spacing:0.2pt;">As necessary</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:16.1pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary collects its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may collect its annual fee for depositary services by deduction from cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them. The depositary may collect any of its fees by deduction from any cash distribution payable (or by selling a portion of securities or other property distributable) to ADS holders that are obligated to pay those fees. The depositary may generally refuse to provide fee-attracting services until its fees for those services are paid. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">From time to time, the depositary may make payments to us to reimburse us for costs and expenses generally arising out of establishment and maintenance of the ADS program, waive fees and expenses for services provided to us by the depositary or share revenue from the fees collected from ADS holders. In performing its duties under the deposit agreement, the depositary may use brokers, dealers, foreign currency dealers or other service providers that are owned by or affiliated with the depositary and that may earn or share fees, spreads or commissions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary may convert currency itself or through any of its affiliates, or the custodian or we may convert currency and pay U.S. dollars to the depositary. Where the depositary converts currency itself or through any of its affiliates, the depositary acts as principal for its own account and not as agent, advisor, broker or fiduciary on behalf of any other person and earns revenue, including, without limitation, transaction spreads, that it will retain for its own account. The revenue is based on, among other things, the difference between the exchange rate assigned to the currency conversion made under the deposit agreement and the rate that the depositary or its affiliate receives when buying or selling foreign currency for its own account. The depositary makes no representation that the exchange rate used or obtained by it or its affiliate in any currency conversion under the deposit agreement will be the most favorable rate that could be obtained at the time or that the method by which that rate will be determined will be the most favorable to ADS holders, subject to the depositary&#8217;s obligation to act without negligence or bad faith. The methodology used to determine exchange rates used in currency conversions made by the depositary is available upon request. Where the custodian converts currency, the custodian has no obligation to obtain the most favorable rate that could be obtained at the time or to ensure that the method by which that rate will be determined will be the most favorable to ADS holders, and the depositary makes no representation that the rate is the most favorable rate and will not be liable for any direct or indirect losses associated with the rate. In certain instances, the depositary may receive dividends or other distributions from us in U.S. dollars that represent the proceeds of a conversion of foreign currency or translation from foreign currency at a rate that was obtained or determined by us and, in such cases, the depositary will not engage in, or be responsible for, any foreign currency transactions and neither it nor we make any representation that the rate obtained or determined by us is the most favorable rate and neither it nor we will be liable for any direct or indirect losses associated with the rate. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">194</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Payment of Taxes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You will be responsible for any taxes or other governmental charges payable on your ADSs or on the deposited securities represented by any of your ADSs. The depositary may refuse to register any transfer of your ADSs or allow you to withdraw the deposited securities represented by your ADSs until those taxes or other charges are paid. It may apply payments owed to you or sell deposited securities represented by your ADSs to pay any taxes owed and you will remain liable for any deficiency. If the depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to ADS holders any proceeds, or send to ADS holders any property, remaining after it has paid the taxes. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Tender and Exchange Offers; Redemption, Replacement or Cancellation of Deposited Securities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary will not tender deposited securities in any voluntary tender or exchange offer unless instructed to do so by an ADS holder surrendering ADSs and subject to any conditions or procedures the depositary may establish. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If deposited securities are redeemed for cash in a transaction that is mandatory for the depositary as a holder of deposited securities, the depositary will call for surrender of a corresponding number of ADSs and distribute the net redemption money to the holders of called ADSs upon surrender of those ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If there is any change in the deposited securities such as a sub-division, combination or other reclassification, or any merger, consolidation, recapitalization or reorganization affecting the issuer of deposited securities in which the depositary receives new securities in exchange for or in lieu of the old deposited securities, the depositary will hold those replacement securities as deposited securities under the deposit agreement. However, if the depositary decides it would not be lawful and practical to hold the replacement securities because those securities could not be distributed to ADS holders or for any other reason, the depositary may instead sell the replacement securities and distribute the net proceeds upon surrender of the ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If there is a replacement of the deposited securities and the depositary will continue to hold the replacement securities, the depositary may distribute new ADSs representing the new deposited securities or ask you to surrender your outstanding ADSs in exchange for new ADSs identifying the new deposited securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If there are no deposited securities underlying ADSs, including if the deposited securities are cancelled, or if the deposited securities underlying ADSs have become apparently worthless, the depositary may call for surrender of those ADSs or cancel those ADSs upon notice to the ADS holders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Amendment and Termination</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How may the deposit agreement be amended?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may agree with the depositary to amend the deposit agreement and the ADRs without your consent for any reason. If an amendment adds or increases fees or charges, except for taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, or prejudices a substantial right of ADS holders, it will not become effective for outstanding ADSs until 30&#160;days after the depositary notifies ADS holders of the amendment. </font><font style="font-style:italic;letter-spacing:0.2pt;">At the time an amendment becomes effective, you are considered, by continuing to hold your ADSs, to agree to the amendment and to be bound by the ADRs and the deposit agreement as amended</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How may the deposit agreement be terminated?</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary will initiate termination of the deposit agreement if we instruct it to do so. The depositary may initiate termination of the deposit agreement if </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">60&#160;days have passed since the depositary told us it wants to resign but a successor depositary has not been appointed and accepted its appointment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">195</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we delist the ADSs from an exchange in the United States on which they were listed and do not list the ADSs on another exchange in the United States or make arrangements for trading of ADSs on the U.S. over-the-counter market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we delist our shares from an exchange outside the United States on which they were listed and do not list the shares on another exchange outside the United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the depositary has reason to believe the ADSs have become, or will become, ineligible for registration on Form F-6 under the Securities Act of 1933; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">we appear to be insolvent or enter insolvency proceedings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all or substantially all the value of the deposited securities has been distributed either in cash or in the form of securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">there are no deposited securities underlying the ADSs or the underlying deposited securities have become apparently worthless; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">there has been a replacement of deposited securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the deposit agreement will terminate, the depositary will notify ADS holders at least 90&#160;days before the termination date. At any time after the termination date, the depositary may sell the deposited securities. After that, the depositary will hold the money it received on the sale, as well as any other cash it is holding under the deposit agreement, unsegregated and without liability for interest, for the </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">pro&#160;rata</font><font style="letter-spacing:0.2pt;"> benefit of the ADS holders that have not surrendered their ADSs. Normally, the depositary will sell as soon as practicable after the termination date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">After the termination date and before the depositary sells, ADS holders can still surrender their ADSs and receive delivery of deposited securities, except that the depositary may refuse to accept a surrender for the purpose of withdrawing deposited securities or reverse previously accepted surrenders of that kind that have not settled if it would interfere with the selling process. The depositary may refuse to accept a surrender for the purpose of withdrawing sale proceeds until all the deposited securities have been sold. The depositary will continue to collect distributions on deposited securities, </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">but</font><font style="letter-spacing:0.2pt;">, after the termination date, the depositary is not required to register any transfer of ADSs or distribute any dividends or other distributions on deposited securities to ADS holders (until they surrender their ADSs) or give any notices or perform any other duties under the deposit agreement except as described in this paragraph. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limitations on Obligations and Liability</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Limits on our Obligations and the Obligations of the Depositary; Limits on Liability to Holders of ADSs</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement expressly limits our obligations and the obligations of the depositary. It also limits our liability and the liability of the depositary. We and the depositary: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">are only obligated to take the actions specifically set forth in the deposit agreement without negligence or bad faith, and the depositary will not be a fiduciary or have any fiduciary duty to holders of ADSs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">are not liable if we are or it is prevented or delayed by law or by events or circumstances beyond our or its ability to prevent or counteract with reasonable care or effort from performing our or its obligations under the deposit agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">are not liable if we or it exercises discretion permitted under the deposit agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">are not liable for the inability of any holder of ADSs to benefit from any distribution on deposited securities that is not made available to holders of ADSs under the terms of the deposit agreement, or for any special, consequential or punitive damages for any breach of the terms of the deposit agreement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">have no obligation to become involved in a lawsuit or other proceeding related to the ADSs or the deposit agreement on your behalf or on behalf of any other person; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">may rely upon any documents we believe or it believes in good faith to be genuine and to have been signed or presented by the proper person; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">196</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">are not liable for the acts or omissions of any securities depository, clearing agency or settlement system; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the depositary has no duty to make any determination or provide any information as to our tax status, or any liability for any tax consequences that may be incurred by ADS holders as a result of owning or holding ADSs or be liable for the inability or failure of an ADS holder to obtain the benefit of a foreign tax credit, reduced rate of withholding or refund of amounts withheld in respect of tax or any other tax benefit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the deposit agreement, we and the depositary agree to indemnify each other under certain circumstances. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Requirements for Depositary Actions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Before the depositary will deliver or register a transfer of ADSs, make a distribution on ADSs, or permit withdrawal of Class A ordinary shares, the depositary may require: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any Class A ordinary shares or other deposited securities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">satisfactory proof of the identity and genuineness of any signature or other information it deems necessary; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">compliance with regulations it may establish, from time to time, consistent with the deposit agreement, including presentation of transfer documents. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary may refuse to deliver ADSs or register transfers of ADSs when the transfer books of the depositary or our transfer books are closed or at any time if the depositary or we think it advisable to do so. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Your Right to Receive the Shares Underlying your ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ADS holders have the right to cancel their ADSs and withdraw the underlying Class A ordinary shares at any time except: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">when temporary delays arise because: (i)&#160;the depositary has closed its transfer books or we have closed our transfer books; (ii)&#160;the transfer of shares is blocked to permit voting at a shareholders&#8217; meeting; or (iii)&#160;we are paying a dividend on our Class A ordinary shares; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.09pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">when you owe money to pay fees, taxes and similar charges; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">when it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADSs or to the withdrawal of Class A ordinary shares or other deposited securities. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This right of withdrawal may not be limited by any other provision of the deposit agreement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Direct Registration System</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the deposit agreement, all parties to the deposit agreement acknowledge that the Direct Registration System, also referred to as DRS, and Profile Modification System, also referred to as Profile, will apply to the ADSs. DRS is a system administered by DTC that facilitates interchange between registered holding of uncertificated ADSs and holding of security entitlements in ADSs through DTC and a DTC participant. Profile is a feature of DRS that allows a DTC participant, claiming to act on behalf of a registered holder of uncertificated ADSs, to direct the depositary to register a transfer of those ADSs to DTC or its nominee and to deliver those ADSs to the DTC account of that DTC participant without receipt by the depositary of prior authorization from the ADS holder to register that transfer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with and in accordance with the arrangements and procedures relating to DRS/Profile, the parties to the deposit agreement understand that the depositary will not determine whether the DTC participant that is claiming to be acting on behalf of an ADS holder in requesting registration of transfer and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">197</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:352pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">delivery as described in the paragraph above has the actual authority to act on behalf of the ADS holder (notwithstanding any requirements under the Uniform Commercial Code). In the deposit agreement, the parties agree that the depositary&#8217;s reliance on and compliance with instructions received by the depositary through the DRS/Profile system and in accordance with the deposit agreement will not constitute negligence or bad faith on the part of the depositary. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Shareholder Communications; Inspection of Register of Holders of ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The depositary will make available for your inspection at its office all communications that it receives from us as a holder of deposited securities that we make generally available to holders of deposited securities. The depositary will send you copies of those communications or otherwise make those communications available to you if we ask it to. You have a right to inspect the register of holders of ADSs, but not for the purpose of contacting those holders about a matter unrelated to our business or the ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Jury Trial Waiver</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The deposit agreement provides that, to the extent permitted by law, ADS holders waive the right to a jury trial of any claim they may have against us or the depositary arising out of or relating to our Class A ordinary shares, the ADSs or the deposit agreement, including any claim under the U.S. federal securities laws. If we or the depositary opposed a jury trial demand based on the waiver, the court would determine whether the waiver was enforceable in the facts and circumstances of that case in accordance with applicable case law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You will not, by agreeing to the terms of the deposit agreement, be deemed to have waived our or the depositary&#8217;s compliance with U.S. federal securities laws or the rules and regulations promulgated thereunder. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">198</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSEFF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SHARES ELIGIBLE FOR FUTURE SALE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon completion of this offering and the concurrent private placement, we will have 93,710,805 Class&#160;A ordinary shares outstanding, or approximately 84.7% of our outstanding ordinary shares, among which, 7,500,000 Class A ordinary shares are represented by 2,500,000 ADSs. All of the ADSs sold in this offering will be freely transferable by persons other than by our &#8220;affiliates&#8221; without restriction or further registration under the Securities Act. Sales of substantial amounts of the ADSs in the public market could adversely affect prevailing market prices of the ADSs. Prior to this offering, there has been no public market for our ordinary shares or the ADSs. We have been approved to list the ADSs on the Nasdaq Global Market under the symbol &#8220;ANL,&#8221; but we cannot assure you that a regular trading market will develop in the ADSs. We do not expect that a trading market will develop for our ordinary shares not represented by the ADSs. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Lock-up agreements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We and each of our officers, directors who beneficially own our shares, holders of share-based awards, approximately 69.4% of our existing shareholders (representing over 85.7% of our total outstanding and issued shares on an as-converted basis prior to this offering) and Nippon Kayaku have agreed, subject to some exceptions, not to transfer or dispose of, directly or indirectly, any ADSs, ordinary shares or any securities convertible into or exchangeable or exercisable for ADSs or ordinary shares, for a period of 180&#160;days after the date of the underwriting agreement. After the expiration of the 180-day period, the ordinary shares or ADSs held by our directors, officers, our existing shareholders, holders of share-based awards and Nippon Kayaku may be sold subject to the restrictions under Rule&#160;144 under the Securities Act or by means of registered public offerings. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Rule&#160;144</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All of our ordinary shares that will be outstanding upon the completion of this offering and the concurrent private placement, other than those ordinary shares sold in this offering, are &#8220;restricted securities&#8221; as that term is defined in Rule&#160;144 under the Securities Act and may be sold publicly in the United States only if they are subject to an effective registration statement under the Securities Act or pursuant to an exemption from the registration requirement such as those provided by Rule&#160;144 and Rule&#160;701 promulgated under the Securities Act. In general, beginning 90&#160;days after the date of this prospectus, a person who at the time of a sale is not, and has not been during the three&#160;months preceding the sale, an affiliate of ours and has beneficially owned our restricted securities for at least six&#160;months will be entitled to sell the restricted securities without registration under the Securities Act, subject only to the availability of current public information about us, and will be entitled to sell restricted securities beneficially owned for at least one year without restriction. Persons who are our affiliates and have beneficially owned our restricted securities for at least six&#160;months may sell a number of restricted securities within any three-month period that (together with any sales aggregated with them) does not exceed the greater of the following: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">1% of the then outstanding ordinary shares of the same class, in the form of ADSs or otherwise, which immediately after this offering and the concurrent private placement will equal 937,108 Class&#160;A ordinary shares; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the average weekly trading volume of our ordinary shares of the same class, in the form of ADSs or otherwise, during the four calendar weeks preceding the date on which notice of the sale is filed with the SEC. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sales by our affiliates under Rule&#160;144 are also subject to certain requirements relating to manner of sale, notice, and the availability of current public information about us. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Rule&#160;701</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In general, under Rule&#160;701 of the Securities Act as currently in effect, each of our employees, consultants or advisors who purchases our ordinary shares from us in connection with a compensatory stock plan or other written agreement executed prior to the completion of this offering is eligible to resell those ordinary shares in reliance on Rule&#160;144, but without compliance with some of the restrictions, including the holding period, contained in Rule&#160;144.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">199</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tTAX">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TAXATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The following summary of Cayman Islands, PRC, and U.S. federal income tax considerations of an investment in the ADSs or ordinary shares is based upon laws and relevant interpretations thereof in effect as of the date of this registration statement, all of which are subject to change. This summary does not deal with all possible tax considerations relating to an investment in the ADSs or ordinary shares, such as the tax considerations under U.S. state and local tax laws or under the tax laws of jurisdictions other than the Cayman Islands, the People&#8217;s Republic of China, and the United States. To the extent that the discussion relates to matters of Cayman Islands tax law, it represents the opinion of Maples and Calder (Hong Kong) LLP, our Cayman Islands legal counsel; to the extent it relates to PRC tax law, it is the opinion of Han Kun Law Offices, our PRC legal counsel. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cayman Islands taxation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Cayman Islands currently levy no taxes on individuals or corporations based upon profits, income, gains, or appreciations, and there is no taxation in the nature of inheritance tax or estate duty. There are no other taxes likely to be material to the Company levied by the Government of the Cayman Islands save certain stamp duties which may be applicable, from time to time, on certain instruments executed in or brought within the jurisdiction of the Cayman Islands. The Cayman Islands is not a party to any double tax treaties that are applicable to any payments made to or by the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, no stamp duty is payable in respect of the issue of our ordinary shares or on an instrument of transfer in respect of our ordinary shares, unless the relevant instruments are executed in, or after execution brought within, the jurisdiction of the Cayman Islands or our company holds interests in land in the Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Payments of dividends and capital in respect of the ADSs will not be subject to taxation in the Cayman Islands and no withholding will be required on the payment of a dividend or capital to any holder of the ADSs, nor will gains derived from the disposal of the ADSs be subject to Cayman Islands income or corporate tax. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">People&#8217;s Republic of China taxation</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the PRC Enterprise Income Tax Law and its implementation rules, an enterprise established outside China with &#8220;de facto management body&#8221; within China is considered a resident enterprise. The implementation rules define the term &#8220;de facto management body&#8221; as the body that exercises full and substantial control and overall management over the business, productions, personnel, accounts, and properties of an enterprise. In April&#160;2009, the SAT issued a circular, known as SAT Circular 82, which provides certain specific criteria for determining whether the &#8220;de facto management body&#8221; of a PRC-controlled enterprise that is incorporated offshore is located in China. Although this circular only applies to offshore enterprises controlled by PRC enterprises or PRC enterprise groups, not those controlled by PRC individuals or foreigners, the criteria set forth in the circular may reflect the SAT&#8217;s general position on how the &#8220;de facto management body&#8221; test should be applied in determining the tax resident status of all offshore enterprises. According to SAT Circular 82, an offshore incorporated enterprise controlled by a PRC enterprise or a PRC enterprise group will be regarded as a PRC tax resident by virtue of having its &#8220;de facto management body&#8221; in China only if all of the following conditions are met: (i)&#160;the primary location of the day-to-day operational management is in China; (ii)&#160;decisions relating to the enterprise&#8217;s financial and human resource matters are made or are subject to approval by organizations or personnel in China; (iii)&#160;the enterprise&#8217;s primary assets, accounting books, and records, company seals, and board and shareholder meeting minutes are located or maintained in China; and (iv)&#160;at least 50% of voting board members or senior executives habitually reside in China. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our company is incorporated outside the PRC. As a holding company, its key assets are its ownership interests in its subsidiaries, and its key assets are located, and its records (including the resolutions of its board of directors and the resolutions of its shareholders) are maintained, outside the PRC. As such, we do not believe that our company meets all of the conditions above or is a PRC resident enterprise for PRC tax purposes. For the same reasons, we believe our other entities outside China are not PRC resident enterprises either. However, the tax resident status of an enterprise is subject to determination by the PRC tax authorities </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">200</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and uncertainties remain with respect to the interpretation of the term &#8220;de facto management body.&#8221; There can be no assurance that the PRC government will ultimately take a view that is consistent with us. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the PRC tax authorities determine that our Cayman Islands holding company is a PRC resident enterprise for PRC enterprise income tax purposes, a 10% withholding tax would be imposed on dividends we pay to our non-PRC enterprise shareholders (including the ADS holders) if such dividends are deemed to be sourced within the PRC. In addition, non-PRC resident enterprise shareholders (including the ADS holders) may be subject to PRC tax on gains realized on the sale or other disposition of ADSs or ordinary shares at a rate of 10% if such income is treated as sourced from within the PRC. Furthermore, if we are deemed a PRC resident enterprise, dividends paid to our non-PRC individual shareholders (including the ADS holders) and any gain realized on the transfer of ADSs or ordinary shares by such shareholders may be subject to PRC tax at a rate of 20% (which, in the case of dividends, may be withheld at source by us) if such dividends or gains are deemed to be sourced within the PRC. These rates may be reduced by an applicable tax treaty, but it is unclear whether non-PRC shareholders of our company would be able to claim the benefits of any tax treaties between their country of tax residence and the PRC in the event that we are treated as a PRC resident enterprise. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the PRC Enterprise Income Tax Law and its implementation rules, if a non-resident enterprise has not set up an organization or establishment in China, or has set up an organization or establishment but the income derived has no actual connection with such organization or establishment, it will be subject to a withholding tax on its PRC-sourced income at a rate of 10%. Pursuant to the Arrangement between Mainland China and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation and Tax Evasion on Income, the tax rate in respect to dividends paid by a PRC enterprise to a Hong Kong enterprise is reduced to 5% from a standard rate of 10% if the Hong Kong enterprise directly holds at least 25% of the PRC enterprise. Pursuant to the Notice of the State Administration of Taxation on the Issues concerning the Application of the Dividend Clauses of Tax Agreements, or SAT Circular 81, a Hong Kong resident enterprise must meet the following conditions, among others, in order to enjoy the reduced tax rate: (i)&#160;it must directly own the required&#160;percentage of equity interests and voting rights in the PRC resident enterprise; and (ii)&#160;it must have directly owned such&#160;percentage in the PRC resident enterprise throughout the 12&#160;months prior to receiving the dividends. Furthermore, in accordance with the Measures for Non-resident Taxpayers&#8217; Enjoyment of Treaty Benefits, which became effective in January&#160;2020, where non-resident enterprises determine through self-assessment that they meet the conditions for entitlement of reduced tax rate according to tax treaties, they may enjoy such entitlement after reporting required information to competent tax authorities provided that they shall collect and retain relevant documents for future reference and inspections. Accordingly, our subsidiary Adlai Nortye (HK) Limited may be able to enjoy the 5% tax rate for the dividends it receives from its PRC incorporated subsidiaries if they satisfy the conditions prescribed under SAT Circular 81 and other relevant tax rules and regulations and complete necessary government formalities. However, according to SAT Circular 81, if the relevant tax authorities determine our transactions or arrangements are for the primary purpose of enjoying a favorable tax treatment, the relevant tax authorities may adjust the favorable tax rate on dividends in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Provided that our Cayman Islands holding company is not deemed to be a PRC resident enterprise, holders of the ADSs and ordinary shares who are not PRC residents will not be subject to PRC income tax on dividends distributed by us or gains realized from the sale or other disposition of our ordinary shares or ADSs. However, under SAT Circular 7 and SAT Circular 37, where a non-resident enterprise conducts an &#8220;indirect transfer&#8221; by transferring taxable assets, including, in particular, equity interests in a PRC resident enterprise, indirectly by disposing of the equity interests of an overseas holding company, the non-resident enterprise, being the transferor, or the transferee or the PRC entity which directly owned such taxable assets may report to the relevant tax authority such indirect transfer. Using a &#8220;substance over form&#8221; principle, the PRC tax authority may disregard the existence of the overseas holding company if it lacks a reasonable commercial purpose and was established for the purpose of reducing, avoiding or deferring PRC tax. As a result, gains derived from such indirect transfer may be subject to PRC enterprise income tax, and the transferee or other person who is obligated to pay for the transfer is obligated to withhold the applicable taxes, currently at a rate of 10% for the transfer of equity interests in a PRC resident enterprise. However, sales of shares and ADSs by investors through a public stock exchange where such shares or ADSs are acquired on a public stock exchange are currently exempt from these indirect transfer rules under SAT Circular 7 and SAT Circular 37. We and our non-PRC resident investors may be at risk of being required to file a return and being </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">201</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">taxed under SAT Circular 7 and SAT Circular 37, and we may be required to expend valuable resources to comply with SAT Circular 7 and SAT Circular 37, or to establish that we should not be taxed under these Circulars. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">United States federal income tax considerations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is a general discussion of certain U.S. federal income tax considerations relating to the ownership and disposition of ADSs or ordinary shares by U.S. Holders (as defined below) that acquire ADSs in this offering and holds ADSs as &#8220;capital assets&#8221; &#8203;(generally, property held for investment) under the U.S. Internal Revenue Code of 1986, as amended, or the Code. This discussion does not address any aspect of U.S. federal gift or estate tax, alternative minimum tax, the Medicare tax on net investment income, or the state, local or non-U.S. tax consequences of an investment in the ADSs or ordinary shares. This discussion is based on the Code, its legislative history, existing, temporary and proposed regulations promulgated thereunder, published rulings, court decisions, and the income tax treaty between the U.S. and the PRC, or the Treaty, all as of the date hereof. These laws are subject to change, possibly on a retroactive basis. No ruling has been obtained and no ruling will be requested from the U.S. Internal Revenue Service, or the IRS, with respect to any of the U.S. federal income tax consequences described below, and as a result, there can be no assurance that the IRS will not disagree with or challenge any of the statements provided below. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This discussion is not a complete description of all tax considerations that may be relevant to particular investors in light of their individual circumstances or investors subject to special tax rules, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">brokers or dealers in securities or currencies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">mutual funds and pension plans; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">traders in securities that elect to use a mark-to-market method of tax accounting for securities holdings; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">banks or certain financial institutions; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">insurance companies; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">tax-exempt organizations, qualified retirement plans, individual retirement accounts or other tax deferred accounts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">S-corporations, partnerships or other entities treated as partnerships or other pass-through entities for U.S. federal income tax purposes or persons holding ADSs or ordinary shares through any such entities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">regulated investment companies or real estate investment trusts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons that hold ADSs or ordinary shares as part of a hedge, straddle, constructive sale, conversion transaction, or other integrated investment; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">corporations that accumulate earnings to avoid U.S. federal income tax; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons whose functional currency for tax purposes is not the U.S. dollar; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons holding ADSs or ordinary shares in connection with a trade or business or permanent establishment outside the United States; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">U.S. expatriates; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">persons that actually or constructively own 10% or more of (i)&#160;the total combined voting power of all classes of our voting stock or (ii)&#160;the total value of all classes of our stock (including ADSs or ordinary shares). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each prospective investor is urged to consult its tax advisor regarding the application of U.S. federal taxation to its particular circumstances, and the state, local, non-U.S., and other tax considerations of the ownership and disposition of ADSs or ordinary shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this discussion, a &#8220;U.S. Holder&#8221; is a beneficial owner of ADSs or ordinary shares that is: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an individual citizen or resident of the United States for U.S. federal income tax purposes; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">202</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a corporation, or other entity classified as a corporation for U.S. federal income tax purposes, that was created or organized in or under the laws of the United States, any state thereof or the District of Columbia; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an estate the income of which is subject to U.S. federal income tax regardless of its source; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a trust if (i)&#160;a court within the United States is able to exercise primary supervision over its administration and one or more U.S. persons have the authority to control all substantial decisions of the trust, or (ii)&#160;the trust has a valid election in effect to be treated as a U.S. person. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For U.S. federal income tax purposes, income earned through an entity or arrangement classified as a partnership for U.S. federal income tax purposes is attributed to its owners. Accordingly, if a partnership (or other entity treated as a partnership for U.S. federal income tax purposes) is a beneficial owner of ADSs or ordinary shares, the tax treatment of a partner in the partnership will generally depend upon the status of the partner and the activities of the partnership. Partnerships holding the ADSs or ordinary shares and their partners are urged to consult their tax advisors regarding an investment in the ADSs or ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For U.S. federal income tax purposes, it is generally expected that a U.S. Holder of ADSs will be treated as the beneficial owner of the underlying shares represented by ADSs. The remainder of this discussion assumes that a U.S. Holder of the ADSs will be treated in this manner. Accordingly, deposits or withdrawals of ordinary shares for ADSs will generally not be subject to U.S. federal income tax. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Recent Treasury regulations may in some circumstances prohibit a U.S. Holder from claiming a foreign tax credit with respect to certain non-U.S. taxes that are not creditable under applicable income tax treaties, or the Foreign Tax Credit Regulations. Accordingly, a U.S. Holder should consult their tax advisor regarding the credibility or deductibility of any PRC taxes imposed on dividends on, or on dispositions of, ADSs, particularly if the U.S. Holder is not eligible to claim Treaty benefits. The discussion below regarding the creditability of PRC taxes does not address the foreign tax credit consequences to the U.S. Holder if such U.S. Holder is not eligible to claim the benefits of the Treaty. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is subject to the discussion under &#8220;Passive Foreign Investment Company&#8221; below. If we make cash distributions and you are a U.S. Holder, the gross amount of any distributions with respect to your ADSs or ordinary shares (including the amount of any taxes withheld therefrom) will be includible in your gross income on the day you actually or constructively receive such income as dividend income if the distributions are made from our current or accumulated earnings and profits, calculated according to U.S. federal income tax principles. We do not intend to calculate our earnings and profits according to U.S. federal income tax principles. Accordingly, you should expect that distributions on ADSs or ordinary shares, if any, will generally be treated as dividend income for U.S. federal income tax purposes. Dividends received on ADSs or ordinary shares will not be eligible for the dividends received deduction generally allowed to U.S. corporations. Dividends received by individuals and certain other non-corporate U.S. Holders may be subject to tax at the lower capital gain tax rate applicable to &#8220;qualified dividend income,&#8221; provided that certain conditions are satisfied, including that (1)&#160;the ADSs or ordinary shares on which the dividends are paid are readily tradeable on an established securities market in the United States, or, in the event that we are deemed to be a PRC resident enterprise under the PRC tax law, we are eligible for the benefits of the Treaty, (2)&#160;we are neither a PFIC nor treated as such with respect to such a U.S. Holder for the taxable year in which the dividend was paid and the preceding taxable year, and (3)&#160;certain holding period requirements are met. We expect ADSs (but not our ordinary shares), which we have been approved to list on the Nasdaq Global Market, will be considered readily tradeable on an established securities market in the United States, although there can be no assurance in this regard. U.S. Holders should consult their own tax advisors regarding the potential availability of the reduced dividend tax rate with respect of the ADSs and our ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As described under &#8220;Taxation &#8212; People&#8217;s Republic of China taxation,&#8221; we may be classified as a &#8220;resident enterprise&#8221; of China. In the event that we are deemed to be a PRC resident enterprise under the PRC Enterprise Income Tax Law and are eligible for the benefits of the Treaty, dividends, if any, we pay on our ordinary shares, regardless of whether such shares are represented by ADSs, would be eligible for the favorable tax rate applicable to long-term capital gains, subject to applicable limitations and provided that we are not (and are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">203</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">not treated with respect to the U.S. Holder as) a PFIC for the taxable year of the distribution or the preceding taxable year. U.S. Holders should consult their tax advisors regarding the availability of this tax rate for dividends paid with respect to our ADSs and our ordinary shares. Dividends paid on ADSs or ordinary shares, if any, will generally be treated as income from foreign sources and will generally constitute passive category income for U.S. foreign tax credit purposes. Any amount withheld in respect of PRC withholding tax will be treated as distributed to you for purposes of determining the amount of any taxable dividend. Depending on the U.S. Holder&#8217;s individual facts and circumstances, a U.S. Holder may be eligible, subject to a number of complex limitations, to claim a foreign tax credit in respect of any nonrefundable PRC withholding taxes imposed on dividends received on ADSs or ordinary shares. For example, under the Foreign Tax Credit Regulations, in absence of a valid election to claim the benefits of an applicable income tax treaty, in order for any such foreign taxes to be creditable, foreign income tax rules of the applicable jurisdiction must be consistent with certain U.S. federal income tax principles. We have not determined whether the PRC income tax system meets these principles. Additionally, a U.S. Holder that is eligible to claim benefits under the Treaty will not be entitled to a foreign tax credit for the amount of any PRC withholding taxes with respect to which the holder is entitled to obtain a refund from the PRC taxing authorities. A U.S. Holder who does not elect to claim a foreign tax credit for foreign taxes withheld may instead claim a deduction, for U.S. federal income tax purposes, in respect of such withholding, but only for a year in which such holder elects to do so for all creditable foreign income taxes. The rules governing the foreign tax credit are complex and their outcome depends in large part on the U.S. Holder&#8217;s individual facts and circumstances. Accordingly, U.S. Holders are urged to consult their tax advisors regarding the availability of, and the various limitations on their ability to, claim the foreign tax credit under their particular circumstances. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Sale or other disposition</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following discussion is subject to the discussion under &#8220;Passive Foreign Investment Company&#8221; below. A U.S. Holder will generally recognize capital gain or loss upon the sale or other disposition of ADSs or ordinary shares in an amount equal to the difference between the amount realized upon the disposition and the holder&#8217;s adjusted tax basis in such ADSs or ordinary shares. The holder&#8217;s adjusted tax basis will generally equal the amount the holder paid (including the offering price for ADS or ordinary shares and trading fee, transaction levy and brokerage fee paid in connection with such purchase). Any gain or loss the U.S. Holder recognizes will generally be long-term capital gain or loss if ADSs or ordinary shares have been held for more than one year and will generally be U.S.-source gain or loss for U.S. foreign tax credit purposes. Long-term capital gain of individuals and certain other non-corporate U.S. Holders will generally be eligible for a more favorable rate of taxation. The deductibility of a capital loss may be subject to limitations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Gains from dispositions of ADSs or ordinary shares may be subject to PRC tax if such gains are deemed as income derived from sources within China for PRC tax purposes or result from an &#8220;indirect transfer&#8221; &#8203;(see &#8220;&#8212; People&#8217;s Republic of China taxation.&#8221;) In that case, the amount realized would include the gross amount of the proceeds of the sale or disposition before deduction of the PRC tax. Any gain generally would constitute U.S.-source income. However, a U.S. Holder that is eligible for the benefits of the Treaty may be able to elect to treat its gain as PRC-source gain for foreign tax credit purposes. If a U.S. Holder is not eligible for the benefits of the Treaty or fails to treat any such gain as PRC-source, then such U.S. Holder would generally not be able to use any foreign tax credit arising from any PRC tax imposed on the disposition of ADSs or ordinary shares unless such credit can be applied (subject to applicable limitations) against U.S. federal income tax due on other income derived from foreign sources in the same income category (generally, the passive category). Recently finalized Treasury regulations may also impose additional limitations on the creditability of any PRC tax on sales or dispositions of ADSs or ordinary shares. For instance, such Treasury regulations generally preclude a U.S. Holder from claiming a foreign tax credit with respect to PRC income taxes on gains on dispositions of ADSs or ordinary shares if the U.S. Holder does not elect to apply the benefits of the Treaty. However, in that case it is possible that any PRC taxes on disposition gains may either be deductible or reduce the amount realized on the disposition. We also note that any PRC VAT will not be creditable for foreign tax credit purposes. U.S. Holders are urged to consult their tax advisors regarding the tax consequences if a foreign tax is imposed on a disposition of the ADSs or ordinary shares, including the availability of the foreign tax credit under their particular circumstances. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">204</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Passive foreign investment company</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we were classified as a PFIC for any taxable year during which a U.S. Holder holds the ADSs or ordinary shares, the U.S. Holder would generally be subject to adverse U.S. tax consequences, in the form of increased tax liabilities (subject to certain elections described below, if timely made) and special U.S. tax reporting requirements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A non-U.S. corporation is a PFIC for U.S. federal income tax purposes for any taxable year in which (i)&#160;at least 75% of its gross income is &#8220;passive&#8221; income, such as interest and income from financial investments (the &#8220;income test&#8221;) or (ii)&#160;at least 50% of the average value of its assets (generally determined on a quarterly basis) consists of assets that produce or are held to produce passive income (the &#8220;asset test&#8221;). For purposes of making a PFIC determination, the non-U.S. corporation will be treated as owning its proportionate share of the assets and earning its proportionate share of the gross income of any other corporation of which it owns, directly or indirectly, 25% or more (by value) of the stock. For purposes of the asset test, any cash and cash invested in short-term, interest bearing, debt instruments, or bank deposits that are readily convertible into cash will generally count as producing passive income or held for the production of passive income, and goodwill should be treated as a non-passive asset to the extent that it is associated with activities that produce or are intended to produce non-passive income. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based on current estimates of our gross income and the value of our gross assets (including goodwill) and the manner in which we conduct our business, we do not expect to be a PFIC for U.S. federal income tax purposes for the 2023 taxable year, but there can be no assurance that we will not be a PFIC for 2023 or any future taxable year as PFIC status is tested for each taxable year and will depend on the composition of our assets and income and the value of our assets (which may fluctuate significantly with our market capitalization) in such taxable year. With certain exceptions, we do not currently generate any income from our primary business, and our gross income is currently comprised primarily of interest and other investment income (which is passive) and governmental grants and the Option Grant Fee (which are both likely to be active income). Therefore, our PFIC status under the income test for any taxable year in which we do not generate significant income from our primary business, including the current taxable year, will likely depend on the relative amounts of government grants and the Option Grant Fee against the amounts of interest and other passive income we earn. The receipt of governmental grants is subject to various conditions and there can be no assurance that we will continue to receive governmental grants in future taxable years or as to the amount of governmental grants that we will receive in any taxable year. Additionally, the Option Grant Fee is not a reoccurring payment in future taxable years and is subject to repayment if certain conditions under the Nippon Kayaku Agreement are not satisfied. We cannot assure you that such conditions under the Nippon Kayaku Agreement will be satisfied and that the option grant fee will not be subject to repayment to Nippon Kayaku. Further, we will hold a substantial amount of cash and cash equivalents following the offering and while we continue to do so, our PFIC status for any taxable year will depend on the value of our goodwill. The value of our goodwill may be determined, in large part, by reference to the market price of the ADSs and ordinary shares, which is likely to be volatile given the nature of our business and the current market conditions. Therefore, we could be a PFIC for any taxable year if our market capitalization were to decrease significantly while we hold substantial cash and cash equivalents, or if the gross income that we and our subsidiaries earn from investing the portion of the cash raised in the offering is substantial in comparison with the gross income from our business operation. Furthermore, the application of the PFIC rules is subject to uncertainty in several respects, and there can be no assurance that the IRS will not challenge our application of the PFIC rules. Accordingly, we cannot assure you that we will not become a PFIC for the current or any future taxable year. </font><font style="font-style:italic;letter-spacing:0.2pt;">Our counsel expresses no opinion with respect to our expectations contained in this paragraph.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we are a PFIC for any taxable year during which a U.S. Holder holds the ADSs or ordinary shares, we generally will continue to be treated as a PFIC with respect to such U.S. Holder for all succeeding&#160;years during which the U.S. Holder holds the ADSs or ordinary shares, unless we cease to be a PFIC and the U.S. Holder makes a &#8220;deemed sale&#8221; election with respect to the ADSs or ordinary shares. If such election is timely made, the U.S. Holder will be deemed to have sold the ADSs and ordinary shares held by the U.S. Holder at their fair market value on the last day of the last taxable year in which we were a PFIC and any gain from such deemed sale would be subject to the consequences described in the following two paragraphs. In addition, a new holding period would be deemed to begin for the ADSs and ordinary shares for purposes of the PFIC rules. After the deemed sale election, the U.S. Holder&#8217;s ADSs or ordinary shares with respect to which the deemed sale election was made will not be treated as shares in a PFIC unless we subsequently become a PFIC. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">205</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If we were a PFIC for any taxable year during which you held the ADSs or ordinary shares, certain adverse U.S. federal income tax rules would apply. You would generally be subject to additional taxes and interest charges on certain &#8220;excess distributions&#8221; we make and on any gain realized on the disposition or deemed disposition of your ADSs or ordinary shares, regardless of whether we continue to be a PFIC in the year in which you receive an &#8220;excess distribution&#8221; or dispose of or are deemed to have disposed of, the ADSs or ordinary shares. Distributions in respect of ADSs or ordinary shares during a taxable year in which we are a PFIC would generally constitute &#8220;excess distributions&#8221; if, in the aggregate, they exceed 125% of the average amount of distributions with respect to your ADSs or ordinary shares over the three preceding taxable&#160;years or, if shorter, the portion of your holding period before such taxable year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To compute the tax on &#8220;excess distributions&#8221; or any gain, (i)&#160;the &#8220;excess distribution&#8221; or the gain would be allocated ratably to each day in your holding period, (ii)&#160;the amount allocated to the current year and any tax year prior to the first taxable year in which we were a PFIC would be taxed as ordinary income in the current year, (iii)&#160;the amount allocated to other taxable&#160;years would be taxable at the highest applicable marginal rate in effect for that year, and (iv)&#160;an interest charge at the rate for underpayment of taxes for any period described under (iii)&#160;above would be imposed on the resulting tax liability on the portion of the &#8220;excess distribution&#8221; or gain that is allocated to such period. In addition, if we were a PFIC (or treated as a PFIC with respect to you) for any taxable year in which we make a distribution or the preceding taxable year, such distribution would not qualify for taxation at the more favorable tax rate if we are deemed to be a PRC resident enterprise under PRC tax law, as discussed in the &#8220;Dividends&#8221; section above. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under certain attribution rules, if we were a PFIC for any taxable year in which you hold the ADSs or ordinary shares, you would be deemed to own your proportionate share of lower-tier PFICs, and would be subject to U.S. federal income tax under the PFIC rules described in the preceding paragraphs on (i)&#160;a distribution on the shares of a lower-tier PFIC and (ii)&#160;a disposition of shares of a lower-tier PFIC, both as if such U.S. Holder directly held the shares of such lower-tier PFIC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You might be able to make a &#8220;mark-to-market&#8221; election with respect to the ADSs, but not our ordinary shares, in order to elect out of the tax treatment discussed above. If you make a valid mark-to-market election, you will include in gross income for each taxable year that we are treated as a PFIC an amount equal to the excess, if any, of the fair market value of your ADSs as of the close of such taxable year over your adjusted basis in such ADSs. You will be permitted a deduction for the excess, if any, of the adjusted basis of your ADSs over their fair market value as of the close of the taxable year. However, deductions are allowable only to the extent of any net mark-to-market gains on ADSs included in your income for prior taxable&#160;years. Amounts included in your income under a mark-to-market election, as well as gain on any sale or other disposition of ADSs, will be treated as ordinary income. Ordinary loss treatment also will apply to the deductible portion of any mark-to-market loss on ADSs, as well as to any loss realized on a sale or disposition of ADSs, to the extent that the amount of such loss does not exceed the net mark-to-market gains previously included for such ADSs. Your basis in your ADSs will be adjusted to reflect any such income or loss amounts. If you make a valid mark-to-market election, the tax rules that apply to distributions by corporations that are not PFICs generally will apply to distributions by us, except that the favorable rate discussed in the &#8220;Dividends&#8221; section above that may apply if we are deemed to be a PRC resident enterprise under PRC tax law will not apply to any distribution if we are a PFIC (or treated as a PFIC with respect to you) in the taxable year of the distribution or the preceding taxable year. If a U.S. Holder makes a mark-to-market election in respect of ADSs and we cease to be classified as a PFIC, the holder will not be required to take into account the gain or loss described above during any period that we are not classified as a PFIC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The mark-to-market election is available only for &#8220;marketable stock,&#8221; which is stock that is traded in other than de minimis quantities on at least 15&#160;days during each calendar quarter, or regularly traded, on a qualified exchange or other market, as defined in applicable U.S. Treasury regulations. For those purposes, we expect that the ADSs will each be treated as marketable stock upon their listing on the Nasdaq Stock Market, which we expect to be a qualified exchange for these purposes. We anticipate that the ADSs should qualify as being regularly traded, although there can be no assurance in this regard. U.S. Holders of ordinary shares are advised to consult their own tax advisor regarding their eligibility to make such election. Because a mark-to-market election cannot technically be made for equity interests in lower-tier PFICs that we own, if we are a PFIC for any taxable year, a U.S. Holder generally will continue to be subject to the general PFIC rules with respect to the holder&#8217;s indirect interest in any investments held by us that are treated as equity interest in a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">206</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:232pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">PFIC for U.S. federal income tax purposes. You should consult your tax advisor as to the availability and desirability of a mark-to-market election if we were a PFIC, as well as the impact of such election on interests in any lower-tier PFICs. The PFIC rules provide for a separate election, referred to as a qualified electing fund election, which, if available, results in a tax treatment different from (and generally less adverse than) the general PFIC tax treatment described above. That election, however, will not be available to you as we do not intend to provide the information you would need to make or maintain that election. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you own the ADSs or ordinary shares during any taxable year that we are a PFIC, you will generally be required to file an annual report containing such information as the United States Treasury Department may require. You should consult your own tax advisor regarding the application of the PFIC rules to your investment in ADSs or ordinary shares and the elections discussed above. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">U.S. information reporting and backup withholding rules</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dividend payments with respect to ADSs or ordinary shares and the proceeds received on the sale or other disposition of ADSs or ordinary shares may be subject to information reporting to the IRS and to backup withholding, unless you are an exempt recipient. Backup withholding will not apply, however, if you provide a taxpayer identification number certifying that you are not subject to backup withholding and make any other required certification or if you are otherwise exempt from backup withholding. Any amounts withheld under the backup withholding rules from a payment to you will be refunded or credited against your U.S. federal income tax liability, provided that you timely file an appropriate claim for refund with the IRS and provide any required information. Backup withholding is not an additional tax. Certain U.S. Holders who hold &#8220;specific foreign financial assets,&#8221; including stock of a non-U.S. corporation that is not held in an account maintained by a U.S. &#8220;financial institution&#8221; may be required to attach to their tax returns for the year certain specified information. A U.S. Holder who fails to timely furnish the required information may be subject to a penalty. You are advised to consult with your tax advisor regarding the application of the U.S. information reporting and backup withholding rules to your particular circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROSPECTIVE INVESTORS IN THE ADSs OR ORDINARY SHARES SHOULD CONSULT WITH THEIR TAX ADVISORS REGARDING THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES RESULTING FROM OWNING OR DISPOSING THE ADSs OR ORDINARY SHARES, INCLUDING THE APPLICABILITY AND EFFECT OF THE TAX LAWS OF ANY STATE, LOCAL, NON-US JURISDICTION, OR ANY INCOME TAX TREATY, AND ESTATE, GIFT AND INHERITANCE LAWS. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">207</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tUND">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">UNDERWRITING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Subject to the terms and conditions set forth in the underwriting agreement, dated September&#160;29, 2023, between us and Cantor Fitzgerald &amp; Co., 110 East 59th Street, New York, New York 10022, as representative of the underwriters named below (the &#8220;Representative&#8221;) and the sole book-running manager of this offering, we have agreed to sell to the underwriters, and each of the underwriters has agreed, severally and not jointly, to purchase from us, the ADSs shown opposite its name below: </font>
        </div>
        <table style="width:416pt;height:37.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:346.03pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Underwriter </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of ADSs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:346.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cantor Fitzgerald &amp; Co. </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,500,000</td>
            <td style="padding:0pt;padding-left:8.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:346.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">2,500,000</td>
            <td style="padding:0pt;padding-left:8.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.2pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriting agreement provides that the obligations of the several underwriters are subject to certain conditions precedent such as the receipt by the underwriters of officers&#8217; certificates and legal opinions and approval of certain legal matters by their counsel. We have agreed to indemnify the underwriters and certain of their controlling persons against certain liabilities, including liabilities under the Securities Act, and to contribute to payments that the underwriters may be required to make in respect of those liabilities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters are offering the ADSs subject to their acceptance of the ADSs from us and subject to prior sale. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. In addition, the underwriters have advised us that they do not intend to confirm sales to any account over which they exercise discretionary authority. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters are expected to make offers and sales both inside and outside the U.S. through their respective selling agents. Any offers or sales in the U.S. will be conducted by broker-dealers registered with the SEC. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Option to purchase additional ADSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We have granted to the underwriters an option, exercisable for 30&#160;days from the date of this prospectus, to purchase, from time to time, in whole or in part, up to an aggregate of 375,000 additional ADSs from us at the public offering price set forth on the cover page of this prospectus, less underwriting discounts and commissions. To the extent the option is exercised, each underwriter will be obligated, subject to certain conditions, to purchase a number of additional ADSs approximately proportionate to that underwriter&#8217;s initial purchase commitment as indicated in the table above. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indication of interest</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">An investor has subscribed for, and has been allocated by the underwriters, an aggregate of 2,173,913 ADSs at the initial public offering price and on the same terms as the other ADSs being offered, representing approximately 87.0% of the total ADSs in this offering, assuming the underwriters do not exercise their option to purchase additional ADSs. The underwriters will receive the same underwriting discounts and commissions on any ADSs purchased by this investor as they will on any other ADSs sold to the public in this offering.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Commission and expenses</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters have advised us that they propose to offer the ADSs to the public at the public offering price set forth on the cover page of this prospectus and to certain dealers. After the initial offering, the Representative may change the offering price and other selling terms. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table shows the public offering price, underwriting discounts and commissions that we are to pay the underwriters and the proceeds, before expenses, to us in connection with this offering. Such amounts are shown assuming both no exercise and full exercise of the underwriters&#8217; option to purchase additional ADSs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">208</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:103pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:237.34pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Per ADS </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:237.34pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Without</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option to</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Purchase</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">ADSs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">With</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option to</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Purchase</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">ADSs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Without</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option to</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Purchase</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">ADSs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">With</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Option to</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Purchase</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">ADSs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:237.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Public offering price </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">23.00</td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">23.00</td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">57,500,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">66,125,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:237.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Underwriting discounts and commissions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.15 </td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1.15 </td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">2,875,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">3,306,250 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:237.34pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Proceeds to us, before expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">21.85 </td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">21.85 </td>
            <td style="padding:0pt;padding-left:3.6pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:37.5pt; text-align:right; white-space:nowrap;">54,625,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">62,818,750</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8.3pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We estimate expenses payable by us in connection with this offering, other than the underwriting discounts and commissions referred to above, will be approximately $4.3 million. We have also agreed to reimburse the underwriters for up to $1,725,000 of certain of their counsels&#8217; fees and expenses. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Listing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have been approved to list the ADSs on the Nasdaq Global Market under the symbol &#8220;ANL.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">No sales of similar securities</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We and each of our officers, directors who beneficially own our shares, holders of share-based awards, approximately 69.4% of our existing shareholders (representing over 85.7% of our total outstanding and issued shares on an as-converted basis prior to this offering) and Nippon Kayaku (collectively, the &#8220;Lock-Up Parties&#8221;) have agreed, subject to certain exceptions, not to, without the prior written consent of the Representative, directly or indirectly, for a period of 180&#160;days after the date of the underwriting agreement: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">sell, offer to sell, contract to sell or lend, effect any short sale or establish or increase a &#8220;put equivalent position&#8221; &#8203;(as defined in Rule&#160;16a-1(h) under the Exchange Act) or liquidate or decrease any &#8220;call equivalent position&#8221; &#8203;(as defined in Rule&#160;16a-1(b) under the Exchange Act), pledge, hypothecate or grant any security interest in, or in any other way transfer or dispose of, any ADSs or any securities convertible into or exchangeable or exercisable for ADSs, in each case whether now owned or hereafter acquired by the Lock-Up Parties or with respect to which the Lock-Up Parties have or hereafter acquire the power of disposition (collectively, the &#8220;Lock-Up Securities&#8221;), </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">make any demand for, or exercise any right with respect to the registration of any of the Lock-Up Securities, or the filing of any registration statement, prospectus or prospectus (or an amendment or supplement thereto) in connection therewith, under the Securities Act of 1933, as amended, </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">enter into any swap, hedge or any other agreement or any transaction that transfers, in whole or in part, the economic consequence of ownership of the Lock-Up Securities, whether any such swap or transaction is to be settled by delivery of ordinary shares, ADSs or other securities, in cash or otherwise, or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">publicly announce the intention to do any of the foregoing. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Lock-Up Parties may transfer the Lock-Up Securities in certain circumstances, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">as a bona fide gift or gifts; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">to any immediate family member in a transaction not involving a disposition for value, or to any trust for the direct or indirect benefit of the Lock-Up Parties or the immediate family of the Lock-Up Parties (for the purposes of the lock-up agreement, &#8220;immediate family&#8221; shall mean any relationship by blood, marriage or adoption, not more remote than first cousin); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.4pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:8.4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by operation of law and/or pursuant to a qualified domestic order or in connection with a divorce settlement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.4pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:8.4pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">by will or intestate succession to the legal representative, heir, beneficiary or immediate family of the Lock-Up Parties upon the death of the Lock-Up Parties; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">209</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(v)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in sales of Lock-Up Securities acquired in open market transactions after the completion of the Offering; provided that no filing under the Exchange Act or other public announcement shall be required or shall be voluntarily made in connection with subsequent sales of Lock-Up Securities acquired in such open market transactions;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(vi)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in transfers or dispositions of Lock-Up Securities to us pursuant to any contractual arrangement in effect on the date of this lock-up agreement that provides for the repurchase of the undersigned&#8217;s Lock-Up Securities by us in connection with the termination of the undersigned&#8217;s employment with us;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(vii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange Act, provided that such plan does not provide for the transfer of Lock-Up Securities during the Lock-Up Period, and provided, further that no filing under the Exchange Act or other public announcement shall be required or shall be voluntarily made in connection with such establishment of a trading plan; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(viii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">if the undersigned is a corporation, partnership or other business entity, the distribution, not involving a disposition for value, of Lock-Up Securities to members, limited partners, shareholders or other equity holders of the undersigned. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">provided that</font><font style="letter-spacing:0.2pt;">, (1)&#160;prior to any such transfer, (other than transfers pursuant to clause (v) above) the Representative receive a signed lock-up agreement, substantially in the form of the lock-up agreement, for the balance of the lock-up period from each donee, trustee, distributee or transferee, as the case may be, (2)&#160;any such transfer shall not involve a disposition for value, (3)&#160;in the case of the first three bullet points above, such transfers are not required to be reported with the SEC under the Exchange Act, and (4)&#160;the Lock-Up Parties do not otherwise voluntarily effect any public filing or report regarding such transfers. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Representative may, in its sole discretion and at any time or from time to time before the termination of the 180-day period release all or any portion of the securities subject to lock-up agreements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Market making, stabilization and other transactions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters may make a market in the ADSs as permitted by applicable laws and regulations. However, the underwriters are not obligated to do so, and the underwriters may discontinue any market-making activities at any time without notice in their sole discretion. Accordingly, no assurance can be given as to the liquidity of the trading market for the ADSs, that you will be able to sell any of the ADSs held by you at a particular time or that the prices that you receive when you sell will be favorable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The underwriters have advised us that they, pursuant to Regulation&#160;M under the Exchange Act, may engage in short sale transactions, stabilizing transactions, syndicate covering transactions or the imposition of penalty bids in connection with this offering. These activities may have the effect of stabilizing or maintaining the market price of the ADSs at a level above that which might otherwise prevail in the open market. Establishing short sales positions may involve either &#8220;covered&#8221; short sales or &#8220;naked&#8221; short sales. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Covered&#8221; short sales are sales made in an amount not greater than the underwriters&#8217; option to purchase additional ADSs in this offering. The underwriters may close out any covered short position by either exercising their option to purchase additional ADSs or purchasing the ADSs in the open market. In determining the source of ADSs to close out the covered short position, the underwriters will consider, among other things, the price of ADSs available for purchase in the open market as compared to the price at which they may purchase ADSs through the option to purchase additional ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Naked&#8221; short sales are sales in excess of the option to purchase additional ADSs. The underwriters must close out any naked short position by purchasing ADSs in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the ADSs in the open market after pricing that could adversely affect investors who purchase in this offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A stabilizing bid is a bid for the purchase of ADSs on behalf of the underwriters for the purpose of fixing or maintaining the price of the ADSs. A syndicate covering transaction is the bid for or the purchase of ADSs on behalf of the underwriters to reduce a short position incurred by the underwriters in connection with the offering. Similar to other purchase transactions, the underwriters&#8217; purchases to cover the syndicate short sales </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">210</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">may have the effect of raising or maintaining the market price of the ADSs or preventing or retarding a decline in the market price of the ADSs. As a result, the price of the ADSs may be higher than the price that might otherwise exist in the open market. A penalty bid is an arrangement permitting the underwriters to reclaim the selling concession otherwise accruing to a syndicate member in connection with the offering if the ADSs originally sold by such syndicate member are purchased in a syndicate covering transaction and therefore have not been effectively placed by such syndicate member. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Neither we, nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of the ADSs. The underwriters are not obligated to engage in these activities and, if commenced, may end any of these activities at any time. These transactions may be effected on the NASDAQ in the over-the-counter market or otherwise. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Passive market making</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The underwriters may also engage in passive market making transactions in the ADSs on the Nasdaq Global Market in accordance with Rule&#160;103 of Regulation&#160;M during a period before the commencement of offers or sales of the ADSs in this offering and extending through the completion of distribution. A passive market maker must display its bid at a price not in excess of the highest independent bid of that security. However, if all independent bids are lowered below the passive market maker&#8217;s bid, that bid must then be lowered when specified purchase limits are exceeded. Passive market making may cause the price of the ADSs to be higher than the price that otherwise would exist in the open market in the absence of those transactions. The underwriters are not required to engage in passive market making and, if commenced, may end passive market making activities at any time. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Electronic distribution</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A prospectus in electronic format may be made available by e-mail or on the websites or through online services maintained by one or more of the underwriters, selling group members (if any) or their affiliates. The underwriters may agree with us to allocate a specific number of ADSs for sale to online brokerage account holders. Any such allocation for online distributions will be made by the underwriters on the same basis as other allocations. Other than the prospectus in electronic format, the information on the underwriters&#8217; websites and any information contained in any other website maintained by any of the underwriters is not part of this prospectus, has not been approved and/or endorsed by us or the underwriters and should not be relied upon by investors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other activities and relationships</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The underwriters and certain of their respective affiliates are full service financial institutions engaged in a wide range of activities for their own accounts and the accounts of customers, which may include, among other things, corporate finance, mergers and acquisitions, merchant banking, equity and fixed income sales, trading and research, derivatives, foreign exchange, futures, asset management, custody, clearance and securities lending. The underwriters and certain of their affiliates have, from time to time, performed, and may in the future perform, various investment banking and financial advisory services for us and our affiliates, for which they received or will receive customary fees and expenses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have engaged Cantor Fitzgerald &amp; Co. as our capital markets advisor in connection with any financing, including this offering and the concurrent private placement. We have also engaged Cantor Fitzgerald &amp; Co. as our placement agent in connection with the concurrent private placement, and will pay a placement agent fee to Cantor Fitzgerald &amp; Co.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have granted Cantor Fitzgerald &amp; Co. a right of first refusal to participate in any public or certain private offerings of our equity securities within a period of three years following the later date of the completion of this offering or the termination of the Cantor Fitzgerald &amp; Co&#8217;s engagement, subject to certain limitations.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, in the ordinary course of their business, the underwriters and their respective affiliates may, directly or indirectly, hold long or short positions, trade and otherwise conduct such activities in or with respect to debt or equity securities and/or bank debt of, and/or derivative products. Such investment and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">211</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">securities activities may involve our securities and instruments. The underwriters and their respective affiliates may also make investment recommendations or publish or express independent research views in respect of such securities or instruments and may at any time hold, or recommend to clients that they acquire, long or short positions in such securities and instruments. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stamp taxes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If you purchase ADSs offered in this prospectus, you may be required to pay stamp taxes and other charges under the laws and practices of the country of purchase, in addition to the offering price listed on the cover page of this prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Selling restrictions</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No action has been taken in any jurisdiction (except in the U.S.) that would permit a public offering of the ADSs, or the possession, circulation or distribution of this prospectus or any other material relating to us or the ADSs in any jurisdiction where action for that purpose is required. Accordingly, the ADSs may not be offered or sold, directly or indirectly, and neither this prospectus nor any other material or advertisements in connection with the ADSs may be distributed or published, in or from any country or jurisdiction except in compliance with any applicable laws, rules and regulations of any such country or jurisdiction. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">United Arab Emirates</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ADSs have not been offered or sold, and will not be offered or sold, directly or indirectly, in the United Arab Emirates, except: (1)&#160;in compliance with all applicable laws and regulations of the United Arab Emirates; and (2)&#160;through persons or corporate entities authorized and licensed to provide investment advice and/or engage in brokerage activity and/or trade in respect of foreign securities in the United Arab Emirates. The information contained in this prospectus does not constitute a public offer of securities in the United Arab Emirates in accordance with the Commercial Companies Law (Federal Law No. 8 of 1984 (as amended)) or otherwise and is not intended to be a public offer and is addressed only to persons who are sophisticated investors. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Canada</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus constitutes an &#8220;exempt offering document&#8221; as defined in and for the purposes of applicable Canadian securities laws. No prospectus has been filed with any securities commission or similar regulatory authority in Canada in connection with the offer and sale of the ADSs. No securities commission or similar regulatory authority in Canada has reviewed or in any way passed upon this prospectus or on the merits of the ADSs and any representation to the contrary is an offence. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Canadian investors are advised that this prospectus has been prepared in reliance on section 3A.3 of National Instrument 33-105 Underwriting Conflicts (&#8220;NI 33-105&#8221;). Pursuant to section 3A.3 of NI 33-105, this prospectus is exempt from the requirement that the issuer and the underwriters provide investors with certain conflicts of interest disclosure pertaining to &#8220;connected issuer&#8221; and/or &#8220;related issuer&#8221; relationships that may exist between the issuer and the underwriters as would otherwise be required pursuant to subsection 2.1(1) of NI 33-105.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Resale restrictions</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The offer and sale of the ADSs in Canada is being made on a private placement basis only and is exempt from the requirement that the issuer prepares and files a prospectus under applicable Canadian securities laws. Any resale of the ADSs acquired by a Canadian investor in this offering must be made in accordance with applicable Canadian securities laws, which may vary depending on the relevant jurisdiction, and which may require resales to be made in accordance with Canadian prospectus requirements, pursuant to a statutory exemption from the prospectus requirements, in a transaction exempt from the prospectus requirements or otherwise under a discretionary exemption from the prospectus requirements granted by the applicable local Canadian securities regulatory authority. These resale restrictions may under certain circumstances apply to resales of the ADSs outside of Canada. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">212</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Representations of purchasers</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each Canadian investor who purchases the ADSs will be deemed to have represented to the issuer and the underwriters that the investor (i)&#160;is purchasing the ADSs as principal, or is deemed to be purchasing as principal in accordance with applicable Canadian securities laws, for investment only and not with a view to resale or redistribution; (ii)&#160;is an &#8220;accredited investor&#8221; as such term is defined in section 1.1 of National Instrument 45-106 </font><font style="font-style:italic;letter-spacing:0.2pt;">Prospectus Exemptions</font><font style="letter-spacing:0.2pt;"> (&#8220;NI 45-106&#8221;) or, in Ontario, as such term is defined in section&#160;73.3(1) of the </font><font style="font-style:italic;letter-spacing:0.2pt;">Securities Act</font><font style="letter-spacing:0.2pt;"> (Ontario); and (iii)&#160;is a &#8220;permitted client&#8221; as such term is defined in section 1.1 of National Instrument 31-103 </font><font style="font-style:italic;letter-spacing:0.2pt;">Registration Requirements, Exemptions and Ongoing Registrant Obligations</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Taxation and eligibility for investment</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Any discussion of taxation and related matters contained in this prospectus does not purport to be a comprehensive description of all of the tax considerations that may be relevant to a Canadian investor when deciding to purchase the ADSs and, in particular, does not address any Canadian tax considerations. No representation or warranty is hereby made as to the tax consequences to a resident, or deemed resident, of Canada of an investment in the ADSs or with respect to the eligibility of the ADSs for investment by such investor under relevant Canadian federal and provincial legislation and regulations. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Rights of action for damages or rescission</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Securities legislation in certain of the Canadian jurisdictions provides certain purchasers of securities pursuant to an offering memorandum (such as this prospectus), including where the distribution involves an &#8220;eligible foreign security&#8221; as such term is defined in Ontario Securities Commission Rule&#160;45-501 </font><font style="font-style:italic;letter-spacing:0.2pt;">Ontario Prospectus and Registration Exemptions</font><font style="letter-spacing:0.2pt;"> and in Multilateral Instrument 45-107 </font><font style="font-style:italic;letter-spacing:0.2pt;">Listing Representation and Statutory Rights of Action Disclosure Exemptions</font><font style="letter-spacing:0.2pt;">, as applicable, with a remedy for damages or rescission, or both, in addition to any other rights they may have at law, where the offering memorandum, or other offering document that constitutes an offering memorandum, and any amendment thereto, contains a &#8220;misrepresentation&#8221; as defined under applicable Canadian securities laws. These remedies, or notice with respect to these remedies, must be exercised or delivered, as the case may be, by the purchaser within the time limits prescribed under, and are subject to limitations and defenses under, applicable Canadian securities legislation. In addition, these remedies are in addition to and without derogation from any other right or remedy available at law to the investor. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Language of documents</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;font-style:italic;">
          <font style="font-style:normal;letter-spacing:0.2pt;">Upon receipt of this document, each Canadian investor hereby confirms that it has expressly requested that all documents evidencing or relating in any way to the sale of the ADSs described herein (including for greater certainty any purchase confirmation or any notice) be drawn up in the English language only. </font><font style="letter-spacing:0.2pt;">Par la r&#233;ception de ce document, chaque investisseur Canadien confirme par les pr&#233;sentes qu&#8217;il a express&#233;ment exig&#233; que tous les documents faisant foi ou se rapportant de quelque mani&#232;re que ce soit &#224; la vente des valeurs mobili&#232;res d&#233;crites aux pr&#233;sentes (incluant, pour plus de certitude, toute confirmation d&#8217;achat ou tout avis) soient r&#233;dig&#233;s en anglais seulement.</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Australia</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This document does not constitute a prospectus, product disclosure statement or other disclosure document under the Australia&#8217;s Corporations Act 2001 (Cth) (the &#8220;Corporations Act&#8221;) of Australia. This document has not been lodged with the Australian Securities &amp; Investments Commission and is only directed to the categories of exempt persons set out below. Accordingly, if you receive this document in Australia: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You confirm and warrant that you are either: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a &#8220;sophisticated investor&#8221; under section 708(8)(a) or (b)&#160;of the Corporations Act; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.3pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.3pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a &#8220;sophisticated investor&#8221; under section 708(8)(c) or (d)&#160;of the Corporations Act and that you have provided an accountant&#8217;s certificate to the company which complies with the requirements of section&#160;708(8)(c)(i) or (ii)&#160;of the Corporations Act and related regulations before the offer has been made; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">213</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a &#8220;professional investor&#8221; within the meaning of section 708(11)(a) or (b)&#160;of the Corporations Act. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the extent that you are unable to confirm or warrant that you are an exempt sophisticated investor or professional investor under the Corporations Act any offer made to you under this document is void and incapable of acceptance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You warrant and agree that you will not offer any of the ADSs issued to you pursuant to this document for resale in Australia within 12&#160;months of those ADSs being issued unless any such resale offer is exempt from the requirement to issue a disclosure document under section 708 of the Corporations Act. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">European Economic Area</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In relation to each member state of the European Economic Area (each a &#8220;Member State&#8221;), no ADSs have been offered or will be offered pursuant to the offer described herein in that Member State prior to the publication of a prospectus in relation to the ADSs which has been approved by the competent authority in that Member State or, where appropriate, approved in another Member State and notified to the competent authority in that Member State, all in accordance with the Prospectus Regulation, except that the ADSs may be offered to the public in that Member State at any time: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;to any legal entity which is a qualified investor as defined under Article&#160;2 of the Prospectus Regulation; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;to fewer than 150 natural or legal persons (other than qualified investors as defined under Article&#160;2 of the Prospectus Regulation), subject to obtaining the prior consent of the underwriters for any such offer; or </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; text-align:justify; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;in any other circumstances falling within Article&#160;1(4) of the Prospectus Regulation, </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">provided that no such offer of ADSs shall require the issuer or any underwriter to publish a prospectus pursuant to Article&#160;3 of the Prospectus Regulation or supplement a prospectus pursuant to Article&#160;23 of the Prospectus Regulation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each person in a Member State who acquires any ADSs in the offer or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with the issuer and the underwriters that it is a qualified investor within the meaning of the Prospectus Regulation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the case of any ADSs being offered to a financial intermediary as that term is used in Article&#160;5(1) of the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed to and with the issuer and the underwriters that the ADSs acquired by it in the offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer to the public other than their offer or resale in a Member State to qualified investors, in circumstances in which the prior consent of the underwriters has been obtained to each such proposed offer or resale. Neither the issuer nor the underwriters have authorised, nor do they authorise, the making of any offer of ADSs through any financial intermediary, other than offers made by the underwriters which constitute the final placement of securities contemplated in this document. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The issuer and the underwriters and their affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to any ADSs in any Member State means the communication in any form and by any means of sufficient information on the terms of the offer and any ADSs to be offered so as to enable an investor to decide to purchase, or subscribe for, any ADSs and the expression &#8220;Prospectus Regulation&#8221; means Regulation (EU) 2017/1129. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In Member States, this document is being distributed only to, and is directed only at, persons who are &#8220;qualified investors&#8221; within the meaning of Article&#160;2(e) of the Prospectus Regulation (&#8220;Qualified Investors&#8221;). This document must not be acted on or relied on in any Member State by persons who are not Qualified Investors. Any investment or investment activity to which this document relates is available in any Member State only to Qualified Investors and will be engaged in only with such persons. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">214</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">France</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The ADSs are being issued and sold outside the Republic of France and that, in connection with their initial distribution, the underwriters have not offered or sold and will not offer or sell, directly or indirectly, any ADSs to the public in the Republic of France, and that they has not distributed and will not distribute or cause to be distributed to the public in the Republic of France this prospectus or any other offering material relating to the ADSs, and that such offers, sales and distributions have been and will be made in the Republic of France only to qualified investors (investisseurs qualifi&#233;s) in accordance with Article&#160;L.411-2 of the Monetary and Financial Code and decr&#233;t no.&#160;98-880 dated October&#160;1, 1998. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Germany</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each person who is in possession of this prospectus is aware that no German sales prospectus (Verkaufsprospekt) within the meaning of the Securities Sales Prospectus Act (Wertpapier-Verkaufsprospektgesetz, the &#8220;Act&#8221;) of the Federal Republic of Germany has been or will be published with respect to the ADSs. In particular, the underwriters have represented that they have not engaged and have agreed that they will not engage in a public offering (offentliches Angebot) within the meaning of the Act with respect to any of the ADSs otherwise then in accordance with the Act and all other applicable legal and regulatory requirements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Peoples&#8217; Republic of China</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus may not be circulated or distributed in the PRC and the ADSs may not be offered or sold, and will not offer or sell to any person for re-offering or resale directly or indirectly to any resident of the PRC except pursuant to applicable laws, rules and regulations of the PRC. For the purpose of this paragraph only, the PRC does not include Taiwan and the special administrative regions of Hong Kong and Macau. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Hong Kong</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No ADSs have been, may be or will be offered or sold in Hong Kong, by means of any document, other than to persons whose ordinary business is to buy or sell ADSs or debentures, whether as principal or agent; or to &#8220;professional investors&#8221; as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong (the &#8220;SFO&#8221;) and any rules made thereunder; or in other circumstances which do not result in the document being a &#8220;prospectus&#8221; as defined in the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32) of Hong Kong (the &#8220;C(WUMP)O&#8221;), or which do not constitute an offer to the public within the meaning of the C(WUMP)O. No document, invitation or advertisement relating to the ADSs has been issued or may be issued or will be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted under the securities laws of Hong Kong) other than with respect to ADSs which are or are intended to be disposed of only to persons outside Hong Kong or only to &#8220;professional investors&#8221; as defined in the SFO and any rules made thereunder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This document has not been and will not be registered with the Registrar of Companies in Hong Kong. Accordingly, this document may not be issued, circulated or distributed in Hong Kong, and the ADSs may not be offered for subscription to members of the public in Hong Kong. Each person acquiring the ADSs will be required, and is deemed by the acquisition of the ADSs, to confirm that he is aware of the restriction on offers of the ADSs described in this document and the relevant offering documents and that he is not acquiring, and has not been offered any ADSs in circumstances that contravene any such restrictions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Japan</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The offering has not been and will not be registered under the Financial Instruments and Exchange Act of Japan (Act No. 25 of 1948 of Japan, as amended) (the &#8220;FIEA&#8221;). The ADS may not be offered or sold, directly or indirectly, in Japan or to, or for the benefit of, any resident of Japan (which term as used herein means, unless otherwise provided herein, any person resident in Japan, including any corporation or other entity organized under the laws of Japan), or to others for re-offering or resale, directly or indirectly, in Japan or to a resident of Japan, except pursuant to an exemption from the registration requirements of, and otherwise in compliance with, the FIEA and any other applicable laws, regulations and ministerial guidelines of Japan. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">215</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Singapore</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This document has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this document and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the ADSs may not be circulated or distributed, nor may the ADSs be offered or sold, or be made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i) to an institutional investor (as defined in Section 4A of the Securities and Futures Act 2001 of Singapore, as modified or amended from time to time (the &#8220;SFA&#8221;)) pursuant to Section 274 of the SFA, (ii) to a relevant person (as defined in Section 275(2) of the SFA) pursuant to Section 275(1) of the SFA, or any person pursuant to Section 275(1A) of the SFA, and in accordance with the conditions specified in Section 275 of the SFA or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Where the ADSs are subscribed or purchased under Section 275 of the SFA by a relevant person which is, amongst others:</font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;a corporation (which is not an accredited investor (as defined in Section 4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or</font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the securities (as defined in Section 2(1) of the SFA) of that corporation or the beneficiaries&#8217; rights and interest (howsoever described) in that trust shall not be transferred within 6 months after that corporation or that trust has acquired the ADSs pursuant to an offer made under Section 275 of the SFA except: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(1) &nbsp;&nbsp;&nbsp;to an institutional investor or to a relevant person, or to any person arising from an offer referred to in Section 275(1A) or Section 276(4)(c)(ii) of the SFA;</font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; text-align:justify; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(2)&nbsp;&nbsp;&nbsp;where no consideration is or will be given for the transfer;</font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; text-align:justify; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(3) &nbsp;&nbsp;&nbsp;where the transfer is by operation of law;</font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; text-align:justify; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(4) &nbsp;&nbsp;&nbsp;as specified in Section 276(7) of the SFA; or</font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(5)&nbsp;&nbsp;&nbsp;as specified in Regulation 37A of the Securities and Futures (Offers of Investments) (Securities and Securities-based Derivatives Contracts) Regulations 2018.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Solely for the purposes of its obligations pursuant to Sections 309B(1)(a) and 309B(1)(c) of the SFA, we have determined, and hereby notify all relevant persons (as defined in Section 309A(1) of the SFA) that the securities are &#8220;prescribed capital markets products&#8221; &#8203;(as defined in the Securities and Futures (Capital Markets Products) Regulations 2018 of Singapore) and &#8220;Excluded Investment Products&#8221; &#8203;(as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products). </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Switzerland</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The ADSs may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or SIX, or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the ADSs or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Neither this document nor any other offering or marketing material relating to the offering, the issuer or the ADSs have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of ADSs will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA, or FINMA, and the offer of ADSs has not been and will not be authorized </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">216</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">under the Swiss Federal Act on Collective Investment Schemes, or CISA. The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to acquirers of securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Israel</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This document does not constitute a prospectus under the Israeli Securities Law, 5728-1968, or the Securities Law, and has not been filed with or approved by the Israel Securities Authority. In the State of Israel, this document is being distributed only to, and is directed only at, and any offer of the ADSs is directed only at, investors listed in the first addendum, or the Addendum, to the Israeli Securities Law, consisting primarily of joint investment in trust funds, provident funds, insurance companies, banks, portfolio managers, investment advisors, members of the Tel Aviv Stock Exchange, underwriters, venture capital funds, entities with equity in excess of NIS 50&#160;million and &#8220;qualified individuals&#8221;, each as defined in the Addendum (as it may be amended from time to time), collectively referred to as qualified investors (in each case purchasing for their own account or, where permitted under the Addendum, for the accounts of their clients who are investors listed in the Addendum). Qualified investors will be required to submit written confirmation that they fall within the scope of the Addendum, are aware of the meaning of same and agree to it. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">United Kingdom</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In relation to the United Kingdom, no ADSs have been offered or will be offered pursuant to the offer described herein to the public in the United Kingdom prior to the publication of a prospectus in relation to the securities which has been approved by the UK Financial Conduct Authority, except that the ADSs may be offered to the public in the United Kingdom at any time: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:5pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;to any legal entity which is a qualified investor as defined under Article&#160;2 of the UK Prospectus Regulation; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:5pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;to fewer than 150 natural or legal persons (other than qualified investors as defined under Article&#160;2 of the UK Prospectus Regulation), subject to obtaining the prior consent of the underwriters for any such offer; or </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:5pt; text-align:justify; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;in any other circumstances falling within Section&#160;86 of the Financial Services and Markets Act&#160;2000 (as amended) (the &#8220;FSMA&#8221;), </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provided that no such offer of the ADSs shall require the issuer or any underwriter to publish a prospectus pursuant to Section&#160;85 of the FSMA or supplement a prospectus pursuant to Article&#160;23 of the UK Prospectus Regulation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each person in the United Kingdom who acquires any ADSs in the offer or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with the issuer and the underwriters that it is a qualified investor within the meaning of the UK Prospectus Regulation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the case of any ADSs being offered to a financial intermediary as that term is used in Article&#160;5(1) of the UK Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed to and with the issuer and the underwriters that the ADSs acquired by it in the offer have not been acquired on a non-discretionary basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer to the public other than their offer or resale in the United Kingdom to qualified investors, in circumstances in which the prior consent of the underwriters has been obtained to each such proposed offer or resale. Neither the issuer nor the underwriters have authorised, nor do they authorise, the making of any offer of ADSs through any financial intermediary, other than offers made by the underwriters which constitute the final placement of ADSs contemplated in this document. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The issuer and the underwriters and their affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to the securities in the United Kingdom means the communication in any form and by any means of sufficient information on the terms of the offer and any securities to be offered so as to enable an investor to decide to purchase or subscribe for any securities and the expression &#8220;UK Prospectus Regulation&#8221; means Regulation (EU)&#160;2017/1129 as it forms part of United Kingdom law by virtue of the European Union (Withdrawal) Act 2018. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">217</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:455pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the United Kingdom, this document is being distributed only to, and is directed only at, persons who are &#8220;qualified investors&#8221; within the meaning of Article&#160;2(e) of the UK Prospectus Regulation who are also: (i)&#160;persons who fall within the definition of &#8220;investment professionals&#8221; in Article&#160;19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the &#8220;Order&#8221;); (ii)&#160;persons falling within Article&#160;49(2) of the Order; or (iii)&#160;persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as &#8220;relevant persons&#8221;). This document must not be acted on or relied on in the United Kingdom by persons who are not relevant persons. Any investment or investment activity to which this document relates is available in the United Kingdom only to relevant persons and will be engaged in only with such persons. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any invitation or inducement to engage in investment activity (within the meaning of Section&#160;21 of the FSMA) may only be communicated or caused to be communicated in connection with the issue or sale of the ADSs in circumstances in which Section&#160;21(1) of the FSMA does not apply. All applicable provisions of the FSMA and the Order must be complied with in respect of anything done by any person in relation to the ADSs in, from or otherwise involving the United Kingdom. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">218</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tERTT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:429.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPENSES RELATED TO THIS OFFERING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Set forth below is an itemization of the total expenses, excluding underwriting discounts and commissions, that we expect to incur in connection with this offering. With the exception of the SEC registration fee, the FINRA filing fee, and the stock exchange market entry and listing fee, all amounts are estimates. </font>
        </div>
        <table style="width:416pt;height:115.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:344pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SEC registration fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">12,673</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:344pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">FINRA filing fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">17,750</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:344pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stock exchange market entry and listing fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">270,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:344pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Printing and engraving expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">50,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:344pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">2,343,733</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:344pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accounting fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,083,653</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:344pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Miscellaneous </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.59pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">500,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt; width:344pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.59pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; ">US$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">4,277,809</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:3pt double #000000;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">219</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLEMA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:512pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">We are being represented by O&#8217;Melveny &amp; Myers LLP with respect to certain legal matters as to United States federal securities and New York State law. The underwriters are being represented by Latham &amp; Watkins LLP with respect to certain legal matters as to United States federal securities and New York State law. The validity of the Class A ordinary shares represented by the ADSs offered in this offering will be passed upon for us by Maples and Calder (Hong Kong) LLP. Certain legal matters as to PRC law will be passed upon for us by Han Kun Law Offices and for the underwriters by Zhong Lun Law Firm. O&#8217;Melveny &amp; Myers LLP may rely upon Maples and Calder (Hong Kong) LLP with respect to matters governed by Cayman Islands law and Han Kun Law Offices with respect to matters governed by PRC law. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">220</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tEXP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:540pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements of Adlai Nortye Ltd. as of and for the&#160;years ended December&#160;31, 2021 and 2022 have been included herein and in the registration statement in reliance upon the report of Mazars USA LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The offices of Mazars USA LLP located at 135 West 50th Street, New York, New York 10020. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">221</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tEOCL">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ENFORCEABILITY OF CIVIL LIABILITIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are incorporated under the laws of the Cayman Islands as an exempted company with limited liability. We are incorporated in the Cayman Islands to take advantage of certain benefits associated with being a Cayman Islands exempted company, such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">political and economic stability; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">an effective judicial system; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a favorable tax system; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the absence of exchange control or currency restrictions; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the availability of professional and support services. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, certain disadvantages accompany incorporation in the Cayman Islands. These disadvantages include but are not limited to: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Cayman Islands has a less developed body of securities laws as compared to the United States and these securities laws provide significantly less protection to investors as compared to those of the United States; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Cayman Islands companies may not have standing to sue before the federal courts of the United States. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our memorandum and articles of association does not contain provisions requiring that disputes, including those arising under the securities laws of the United States, between us, our officers, directors, and shareholders, be arbitrated. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A majority of our directors and officers are nationals or residents of jurisdictions other than the United States and a substantial portion of their assets are located outside the United States. As a result, it may be difficult for a shareholder to effect service of process within the United States upon these individuals, or to bring an action against us or these individuals in the United States, or to enforce against us or them judgments obtained in United States courts, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cogency Global Inc., with the address at 122 East 42nd Street, 18th Floor, New York, NY 10168, acts as our agent upon whom process may be served in any action brought against us under the securities laws of the United States. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Maples and Calder (Hong Kong) LLP, our legal counsel as to Cayman Islands law, and Han Kun Law Offices, our legal counsel as to PRC law, have advised us, respectively, that there is uncertainty as to whether the courts of the Cayman Islands and China, respectively, would: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">recognize or enforce judgments of United States courts obtained against us or our directors or officers predicated upon the civil liability provisions of the federal securities laws of the United States or the securities laws of any state in the United States; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">entertain original actions brought in the Cayman Islands against us or our directors or officers that are predicated upon the federal securities laws of the United States or the securities law of any state in the United States. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have also been advised by Maples and Calder (Hong Kong) LLP that although there is no statutory enforcement in the Cayman Islands of judgments obtained in a U.S. court (and the Cayman Islands are not a party to any treaties for the reciprocal enforcement or recognition of such judgments), the courts of the Cayman Islands will, at common law, recognize and enforce a foreign monetary judgment of a foreign court of competent jurisdiction without any re-examination of the merits of the underlying dispute based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the a liquidated sum for which such judgment has been given, provided such judgment, provided such judgment (i)&#160;is given by a foreign court of competent jurisdiction, (ii)&#160;imposes on the judgment debtor a liability to pay a liquidated sum for which the judgment has been given, (iii)&#160;is final and conclusive, (iv)&#160;is not in respect of taxes, a fine or a penalty, and (v)&#160;was not obtained in a manner and is not of a kind the enforcement of which is contrary to natural justice or the public policy of the Cayman Islands. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">222</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:344pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">However, the Cayman Islands courts are unlikely to enforce a judgment obtained from the United States courts under civil liability provisions of the securities laws if such judgment is determined by the courts of the Cayman Islands to give rise to obligations to make payments that are penal or punitive in nature. A Cayman Islands court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Han Kun Law Offices has further advised us that the recognition and enforcement of foreign judgments are provided for under the PRC Civil Procedures Law. PRC courts may recognize and enforce foreign judgments in accordance with the requirements of the PRC Civil Procedures Law based either on treaties between China and the country where the judgment is made or on principles of reciprocity between jurisdictions. China does not have any treaties or other form of reciprocity with the United States or the Cayman Islands that provide for the reciprocal recognition and enforcement of foreign judgments. In addition, according to the PRC Civil Procedures Law, courts in China will not enforce a foreign judgment against us or our directors and officers if they decide that the judgment violates the basic principles of PRC law or national sovereignty, security, or social public interest. As a result, it is uncertain whether and on what basis a PRC court would enforce a judgment rendered by a court in the United States or in the Cayman Islands. Under the PRC Civil Procedures Law, foreign shareholders may originate actions based on PRC law against a company in China for disputes if they can establish sufficient nexus to the PRC for a PRC court to have jurisdiction, and meet other procedural requirements, including, among others, the plaintiff must have a direct interest in the case, and there must be a concrete claim, a factual basis and a cause for the suit. However, it would be difficult for foreign shareholders to establish sufficient nexus to China by virtue only of holding the ADSs or ordinary shares. In addition, it will be difficult for U.S. shareholders to originate actions against us in China in accordance with PRC laws because we are incorporated under the laws of the Cayman Islands and it will be difficult for U.S. shareholders, by virtue only of holding the ADSs or ordinary shares, to establish a connection to China for a PRC court to have jurisdiction as required under the PRC Civil Procedures Law. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">223</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tWYCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:460pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND ADDITIONAL INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have filed a registration statement, including relevant exhibits, with the SEC on Form F-1 under the Securities Act with respect to the underlying Class A ordinary shares represented by the ADSs to be sold in this offering. We have also filed a related registration statement on Form F-6 with the SEC to register the ADSs. This prospectus, which constitutes a part of the registration statement on Form F-1, does not contain all of the information contained in the registration statement. You should read our registration statements and their exhibits and schedules for further information with respect to us and the ADSs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are subject to periodic reporting and other informational requirements of the Exchange Act as applicable to foreign private issuers. Accordingly, we are required to file reports, including annual reports on Form 20-F, and other information with the SEC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All information filed with the SEC can be obtained over the internet at the SEC&#8217;s website at </font><font style="font-style:italic;letter-spacing:0.2pt;">www.sec.gov</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">224</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC2">&#8203;</a><a name="TOC3">&#8203;</a><a name="tISFS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:258pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:122.5pt;margin-top:-10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:427.33pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tROIR"><font style="letter-spacing:0.2pt;">Report of Independent Registered Public Accounting Firm (PCAOB ID: 339) </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tROIR">F-2</a></font> <a href="#tROIR"></a></td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:427.33pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCSPL"><font style="letter-spacing:0.2pt;">Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December&#160;31, </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">2021 and 2022 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSPL">F-3</a></font> <a href="#tCSPL"></a></td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSFP"><font style="letter-spacing:0.2pt;">Consolidated Statements of Financial Position as of December&#160;31, 2021 and 2022 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSFP">F-4</a></font> <a href="#tCSFP"></a></td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:427.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCSCE"><font style="letter-spacing:0.2pt;">Consolidated Statements of Changes in Shareholders&#8217; Equity for the Years Ended December&#160;31, 2021 and 2022 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSCE">F-5</a></font> <a href="#tCSCE"></a></td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSCF"><font style="letter-spacing:0.2pt;">Consolidated Statements of Cash Flows for the Years Ended December&#160;31, 2021 and 2022 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSCF">F-6</a></font> <a href="#tCSCF"></a></td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:427.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tNOTE"><font style="letter-spacing:0.2pt;">Notes to the Consolidated Financial Statements for the Years Ended December 31, 2021 and 2022</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tNOTE">F-7</a></font>
            </td>
            <td style="padding:0pt;padding-left:0.835000000000001pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:143.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:424pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#fCCSO"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Operations and Comprehensive Loss for the Six Months Ended June&#160;30, 2022 and 2023 (Unaudited) </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCCSO">F-54</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#fCCSF"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Financial Position as of December&#160;31, 2022 and June&#160;30, 2023 (Unaudited) </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCCSF">F-55</a></font> <a href="#fCCSF"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#fCCSE"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Changes in Shareholders&#8217; Equity for the Six Months Ended </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">June&#160;30, 2022 and 2023 (Unaudited) </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCCSE">F-56</a></font> <a href="#fCCSE"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#fCCSC"><font style="letter-spacing:0.2pt;">Condensed Consolidated Statements of Cash Flows for the Six Months Ended June&#160;30, 2022 and 2023 (Unaudited) </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fCCSC">F-57</a></font> <a href="#fCCSC"></a></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:424pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#fNCCF"><font style="letter-spacing:0.2pt;">Notes to the Condensed Consolidated Financial Statements for the Six Months Ended June&#160;30, 2022 and 2023 (Unaudited) </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#fNCCF">F-58</a></font>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tROIR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:120pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the Board of Directors and </font> <br ><font style="letter-spacing:0.2pt;">Shareholders of Adlai Nortye Ltd. </font></div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Opinion on the Consolidated Financial Statements</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have audited the accompanying consolidated statements of financial position of Adlai Nortye Ltd. (the &#8220;Company&#8221;) as of December&#160;31, 2021 and 2022, and the related consolidated statements of operations and comprehensive loss, changes in shareholders&#8217; equity, and cash flows for each of the two&#160;years in the period ended December&#160;31, 2022, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December&#160;31, 2021 and 2022, and the results of its operations and its cash flows for each of the two&#160;years then ended in the period ended December&#160;31, 2022, in conformity with International Financial Reporting Standards (IFRS) and its related interpretations as issued by the International Accounting Standards Board. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Basis for Opinion</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">/s/ Mazars USA LLP </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have served as the Company&#8217;s auditor since 2022. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">New York, New York</font> <br ><font style="letter-spacing:0.2pt;">April 13, 2023</font></div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCSPL">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:137pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE </font>
          <br >
          <font style="letter-spacing:-0.2pt;">LOSS FOR THE YEARS ENDED DECEMBER&#160;31, 2021 AND 2022</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <table style="width:456pt;height:416pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt; width:19.41pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">REVENUE</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">4 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">45,726</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other operating income, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">183</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">259</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Administrative expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(12,450<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(13,039<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(42,105<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(54,490<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total operating loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(8,646<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(67,270<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other income and gains </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">213</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">2,079</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(70<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(1,395<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Investment income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">32</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">550</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.167pt 0pt 0.5pt 0pt; width:309.76pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Fair value gain on financial assets at fair value through profit or loss (&#8220;FVTPL&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">484</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value (loss)/gain on financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">15 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(46,910<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">7,195</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Finance costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(1,337<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(433<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">LOSS BEFORE TAX</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income tax expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">6 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">LOSS FOR THE YEAR</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Attributable to: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Ordinary Equity Holders of the Parent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">OTHER COMPREHENSIVE LOSS</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:1.167pt 0pt 0.833pt 0pt; width:309.76pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Exchange differences on translation of the financial statements of subsidiaries </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.333pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.333pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(94<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.333pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.333pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(3,157<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other comprehensive loss for the year, net of tax </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(94<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(3,157<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 2.25pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">TOTAL COMPREHENSIVE LOSS FOR THE YEAR</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(56,772<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(61,947<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Attributable to: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.25pt 0pt; width:309.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Ordinary Equity Holders of the Parent </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(56,772<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(61,947<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:309.76pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE PARENT </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Basic and diluted </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.25pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss for the year ($ per share) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 2.25pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(2.23<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(2.31<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 2.25pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted average common shares outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 2.25pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">25,440,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">25,440,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the Consolidated Financial Statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCSFP">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:8.00999999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF FINANCIAL POSITION</font>
          <br >
          <font style="letter-spacing:-0.2pt;">AS OF DECEMBER 31, 2021 AND 2022</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:560.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:325.63pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.75pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:325.63pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.75pt 0pt; width:22.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.5pt 0pt 1.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:325.63pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">ASSETS</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Current assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">64,131</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,758</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial assets at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">12</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">53,809</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 1.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Prepayments, other receivables and other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 1.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">11 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">6,604</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">2,258</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total current assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">124,544</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">66,303</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Non-current assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Property, plant and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">9 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,655</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,713</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Right-of-use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">10(a) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,934</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,162</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other intangible assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">97</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">89</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 1.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Prepayments, other receivables and other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 1.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">11 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">455</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">327</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total non-current assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">7,141</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">6,291</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.5pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total assets</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">131,685</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">72,594</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">LIABILITIES</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Current liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Trade payables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,981</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13,098</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other payables and accruals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">13 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,224</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,877</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest-bearing bank borrowings </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">14 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">10,457</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">10(b) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">834</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,001</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 1.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 1.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">15 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total current liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">17,496</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">312,651</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Non-current liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">10(b) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,054</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,236</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 1.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 1.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">15 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total non-current liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">299,617</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,236</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">317,113</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">313,887</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">SHAREHOLDERS&#8217; DEFICIT</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1pt 0pt 0.5pt 0pt; width:325.63pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Ordinary shares (par value of $0.0001 per share; 442,456,586 shares authorized and 40,440,000 shares issued and outstanding as of December&#160;31, 2021 and 2022) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">17 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1pt 0pt 0.5pt 0pt; width:325.63pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series A convertible preferred shares (par value of US$0.0001 per share; </font>
                <br >
                <font style="letter-spacing:0.2pt;">14,560,000 and 14,560,000 shares authorized, issued and outstanding as of </font>
                <br >
                <font style="letter-spacing:0.2pt;">December 31, 2021 and 2022, respectively) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">18 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">6,415</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">6,415</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Share option reserve </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">18 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7,606</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13,688</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange fluctuation reserve </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">18 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(1,002<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(4,159<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 1.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 1.75pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">18 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(209,431<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(268,221<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.75pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total shareholders&#8217; deficit</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(185,428<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(241,293<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.5pt 0pt; width:325.63pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total liabilities and shareholders&#8217; deficit</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">131,685</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">72,594</td>
            <td style="padding:0pt;padding-left:0.0300000000000011pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the Consolidated Financial Statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCSCE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:215.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY </font>
          <br >
          <font style="letter-spacing:-0.2pt;">FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2022</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:337.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:153.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt; width:0pt;text-align:center;" colspan="40">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Attributable to owners of the parent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.583pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.583pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">paid-in </font>
                <br >
                <font style="letter-spacing:-0.16pt;">capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.583pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;A</font>
                <br >
                <font style="letter-spacing:-0.16pt;">convertible </font>
                <br >
                <font style="letter-spacing:-0.16pt;">preferred </font>
                <br >
                <font style="letter-spacing:-0.16pt;">shares</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.583pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Share </font>
                <br >
                <font style="letter-spacing:-0.16pt;">option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">reserve</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.583pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exchange</font>
                <br >
                <font style="letter-spacing:-0.16pt;">fluctuation </font>
                <br >
                <font style="letter-spacing:-0.16pt;">reserve</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.583pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">losses</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.583pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
                <br >
                <font style="letter-spacing:-0.16pt;">deficits</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0.583pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 17) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0.583pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 18) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0.583pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0.583pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 18) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0.583pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 18) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0.583pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0.583pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.25pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">At January 1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6,416</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,220</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(908<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(152,753<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(132,042<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:5.5pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss for the year </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.5pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.167pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Other comprehensive income for the </font>
                <br >
                <font style="letter-spacing:0.2pt;">year: </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.167pt 0pt 0.5pt 0pt; width:153.88pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Exchange differences on translation of the financial statements of subsidiaries </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(94<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(94<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.167pt 0pt 0.5pt 0pt; width:153.88pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of shares for the trust arrangement under the Share Incentive Plan</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(1<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:1.5pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">3,386</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">3,386</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.25pt 0pt 1.25pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">At December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">6,415</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">7,606</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,002<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(209,431<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(185,428<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:4.75pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss for the year </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.75pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.167pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Other comprehensive income for the </font>
                <br >
                <font style="letter-spacing:0.2pt;">year </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.167pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Exchange differences on translation </font>
                <br >
                <font style="letter-spacing:0.2pt;">of the financial statements of </font>
                <br >
                <font style="letter-spacing:0.2pt;">subsidiaries </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(3,157<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(3,157<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.167pt 0pt 0.5pt 0pt; width:153.88pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Issuance of shares for the trust arrangement under the Share Incentive Plan </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.167pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:1.5pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">6,082</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">6,082</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.25pt 0pt 1.25pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">At December&#160;31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">6,415</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">13,688</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(4,159<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(268,221<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">(241,293<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the Consolidated Financial Statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tCSCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:35pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">CONSOLIDATED STATEMENTS OF CASH FLOWS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2022</font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:554pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt; width:21.66pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">CASH FLOWS FROM OPERATING ACTIVITIES</font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss before tax </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Adjustments for: </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Finance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:21.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,337</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">433</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Investment income </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(32<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(550<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value loss/(gain) on financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:21.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">15 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">46,910</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(7,195<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value gain on financial assets at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(40<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(484<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss/(gain) on disposal of items of property, plant and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(7<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation of property, plant and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:21.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">9 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">861</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">931</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Amortization of intangible assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">16</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">20</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation of right-of-use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:21.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">10(a) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">951</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">1,090</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Equity-settled share-based payment expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:21.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">19 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">3,386</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">6,082</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">(Increase)/Decrease in prepayments, other receivables and other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(419<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">4,346</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">(Increase)/Decrease in non-current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(157<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">128</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Increase in current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(390<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Increase in trade payables </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">600</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">10,117</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Increase in other payables and accruals </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">619</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">656</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Decrease in advances from customers </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net cash flows used in operating activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(3,034<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(43,223<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">CASH FLOWS FROM INVESTING ACTIVITIES</font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Purchases of property, plant and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(1,018<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(1,249<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Purchases of intangible assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(102<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(19<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Proceeds from disposal of items of property, plant and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">17</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Purchases of financial assets at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(81,234<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(58,980<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Disposal of financial assets at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">27,465</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">88,057</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Received investment income of financial assets at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">32</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">550</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net cash flows (used in)/provided from investing activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(54,857<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">28,376</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">CASH FLOWS FROM FINANCING ACTIVITIES</font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Proceeds from issuance of financial instruments measured at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">97,370</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Addition of bank borrowings </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">12,411</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">7,897</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Bank borrowings interest paid </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(427<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(292<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Repayment of bank borrowings </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(10,430<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(13,315<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Transaction costs for issuance of convertible redeemable preferred </font>
                <br >
                <font style="letter-spacing:0.2pt;">shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(758<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payment for lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(966<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(1,070<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.25pt 0pt 1.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net cash flows from/(used in) financing activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">97,200</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(6,780<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">NET INCREASE/(DECREASE) IN CASH AND CASH EQUIVALENTS</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">39,309</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(21,627<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents at beginning of year </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">24,261</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">64,131</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effect of foreign exchange rate changes, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">561</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">254</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:336.15pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">CASH AND CASH EQUIVALENTS AT END OF YEAR</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">64,131</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">42,758</td>
            <td style="padding:0pt;padding-left:3.78pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the Consolidated Financial Statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tNOTE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">CORPORATE AND GROUP INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:4pt; text-align:justify; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Adlai Nortye Ltd. (the &#8220;Company&#8221;) is a limited liability company incorporated in the Cayman Islands on 9 May&#160;2018. The registered office of the Company is located at Harneys Fiduciary (Cayman) Limited, 4</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;"> Floor, Harbour&#160;Place, 103 South Church Street, P.O. Box 10240, Grand Cayman, KY1-1002, Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; text-align:justify; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The Company is an investing holding company. The Company&#8217;s subsidiaries were involved in the research and development of pharmaceutical products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:4pt; text-align:justify; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this report, the Company had direct and indirect interests in its subsidiaries, all of which are private limited liability companies, the particulars of which are set out below: </font>
        </div>
      </div>
      <div style="margin-top:12pt;margin-bottom:12pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;margin-bottom:5.44999999999999pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;height:38.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 4.167pt 0pt; width:182.26pt;text-align:left;" rowspan="2">
              <div style="white-space:nowrap; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 4.167pt 0pt; width:36pt;" rowspan="2">
              <div style="white-space:nowrap; text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 4.167pt 0pt; width:96pt;" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Date and place of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">incorporation / registration </font>
                <br >
                <font style="letter-spacing:-0.16pt;">and place of operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 4.167pt 0pt; width:72pt;" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Issued ordinary </font>
                <br >
                <font style="letter-spacing:-0.16pt;">share/ </font>
                <br >
                <font style="letter-spacing:-0.16pt;">registered capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 4.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
                <br >
                <font style="letter-spacing:-0.16pt;">of equity </font>
                <br >
                <font style="letter-spacing:-0.16pt;">attributable to </font>
                <br >
                <font style="letter-spacing:-0.16pt;">the Company </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 4.167pt 0pt; width:72pt;" rowspan="2">
              <div style="white-space:nowrap; text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Principal activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;" rowspan="2">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;min-height:17.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:5.25pt 0pt 4.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Direct </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:5.25pt 0pt 4.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Indirect </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.2pt;min-height:28.39pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:4.117pt 0pt 3.373pt 0pt; width:182.26pt;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt; line-height:10.19pt;">
                <font style="letter-spacing:0.17pt;">Alpine Bioscience Ltd.</font>
                <br >
                <font style="letter-spacing:0.17pt;">(&#8220;Alpine BVI&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.117pt 0pt 3.373pt 0pt; width:96pt;text-align:left;">
              <div style="line-height:10.19pt;">
                <font style="letter-spacing:0.17pt;">British Virgin Islands</font>
                <br >
                <font style="letter-spacing:0.17pt;">8 January&#160;2018 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.117pt 0pt 3.373pt 0pt; width:72pt;white-space:normal;text-align:left;">
              <div style="line-height:10.19pt;">
                <font style="letter-spacing:0.17pt;">One share of par value $1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:4.117pt 0pt 3.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.117pt 0pt 3.373pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:4.117pt 0pt 3.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.117pt 0pt 3.373pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.117pt 0pt 3.373pt 0pt; width:72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.17pt;">Investment holding </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.2pt;min-height:28.14pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:4.367pt 0pt 3.373pt 0pt; width:182.26pt;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt; line-height:10.19pt;">
                <font style="letter-spacing:0.17pt;">Adlai Nortye (BVI) Ltd.</font>
                <br >
                <font style="letter-spacing:0.17pt;">(&#8220;Adlai BVI&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; width:96pt;text-align:left;">
              <div style="line-height:10.19pt;">
                <font style="letter-spacing:0.17pt;">British Virgin Islands</font>
                <br >
                <font style="letter-spacing:0.17pt;">10 May&#160;2018 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; width:72pt;white-space:normal;text-align:left;">
              <div style="line-height:10.19pt;">
                <font style="letter-spacing:0.17pt;">One share of par value $1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; width:72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.17pt;">Investment holding </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.2pt;min-height:58.72pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:4.357pt 0pt 3.363pt 0pt; width:182.26pt;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:0.17pt;">Adlai Nortye USA Inc.</font>
                <br >
                <font style="letter-spacing:0.17pt;">(&#8220;Adlai US&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.363pt 0pt; width:96pt;text-align:left;">
              <font style="letter-spacing:0.17pt;">The United States</font>
              <br >
              <font style="letter-spacing:0.17pt;">30 January&#160;2018 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.363pt 0pt; width:72pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.17pt;">10,000 shares of par value $0.0001 each </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.363pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.363pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.363pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.363pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.363pt 0pt; width:72pt;text-align:left;">
              <font style="letter-spacing:0.17pt;">Clinical studies and </font>
              <br >
              <font style="letter-spacing:0.17pt;">testing, and </font>
              <br >
              <font style="letter-spacing:0.17pt;">technology </font>
              <br >
              <font style="letter-spacing:0.17pt;">development and </font>
              <br >
              <font style="letter-spacing:0.17pt;">transfer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.2pt;min-height:38.33pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:4.357pt 0pt 3.373pt 0pt; width:182.26pt;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:0.17pt;">Adlai Nortye (Switzerland) AG</font>
                <br >
                <font style="letter-spacing:0.17pt;">(&#8220;Adlai Swiss&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.373pt 0pt; width:96pt;text-align:left;">
              <font style="letter-spacing:0.17pt;">Switzerland</font>
              <br >
              <font style="letter-spacing:0.17pt;">21 June&#160;2022 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.373pt 0pt; width:72pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.17pt;">100 shares of par value CHF1&#8217;000 each </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.373pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.373pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.373pt 0pt; width:72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.17pt;">Investment holding </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.2pt;min-height:28.14pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:4.367pt 0pt 3.373pt 0pt; width:182.26pt;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt; line-height:10.19pt;">
                <font style="letter-spacing:0.17pt;">Adlai Nortye PTE.LTD</font>
                <br >
                <font style="letter-spacing:0.17pt;">(&#8220;Adlai SGP&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; width:96pt;text-align:left;">
              <div style="line-height:10.19pt;">
                <font style="letter-spacing:0.17pt;">Singapore</font>
                <br >
                <font style="letter-spacing:0.17pt;">22 April&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; width:72pt;white-space:normal;text-align:left;">
              <div style="line-height:10.19pt;">
                <font style="letter-spacing:0.17pt;">One share of par value $1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.367pt 0pt 3.373pt 0pt; width:72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.17pt;">Investment holding </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10.2pt;min-height:28.14pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:4.357pt 0pt 3.383pt 0pt; width:182.26pt;text-align:left;">
              <div style="margin-left:8.5pt; text-indent:-8.5pt;">
                <font style="letter-spacing:0.17pt;">Adlai Nortye (HK) Limited</font>
                <br >
                <font style="letter-spacing:0.17pt;">(&#8220;Adlai HK&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.383pt 0pt; width:96pt;text-align:left;">
              <font style="letter-spacing:0.17pt;">Hong Kong</font>
              <br >
              <font style="letter-spacing:0.17pt;">24 April&#160;2018 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.383pt 0pt; width:72pt;text-align:left;">
              <font style="letter-spacing:0.17pt;">HKD 0.001 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.383pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.383pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.383pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.383pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:4.357pt 0pt 3.383pt 0pt; width:72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.17pt;">Investment holding </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="height:58.72pt; background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:1px 0pt; width:182.26pt;white-space:normal;text-align:left;vertical-align:middle;">
              <div style="position:relative;margin-left:8.5pt; text-indent:-8.5pt;">
                <img src="txt_adlainorty-bw.jpg" alt="[MISSING IMAGE: txt_adlainorty-bw.jpg]" height="15" width="179" >
              </div>
              <div style="margin-left:8.5pt; margin-top:1.212pt; line-height:10.2pt;">
                <font style="letter-spacing:0.17pt;">Hangzhou Adlai Nortye </font>
                <br >
                <font style="letter-spacing:0.17pt;">Biopharma Co., Ltd*</font>
                <br >
                <font style="letter-spacing:0.17pt;">(&#8220;Adlai Hangzhou&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; width:96pt;text-align:left;">
              <div style="line-height:10.2pt;">
                <font style="letter-spacing:0.17pt;">the People&#8217;s Republic of </font>
                <br >
                <font style="letter-spacing:0.17pt;">China (&#8220;PRC&#8221;)/ Mainland </font>
                <br >
                <font style="letter-spacing:0.17pt;">China</font>
                <br >
                <font style="letter-spacing:0.17pt;">14 September&#160;2004 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; width:72pt;text-align:left;">
              <div style="line-height:10.2pt;">
                <font style="letter-spacing:0.17pt;">RMB 200,000</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; width:72pt;text-align:left;">
              <div style="line-height:10.2pt;">
                <font style="letter-spacing:0.17pt;">Product research </font>
                <br >
                <font style="letter-spacing:0.17pt;">and development, </font>
                <br >
                <font style="letter-spacing:0.17pt;">technology transfer </font>
                <br >
                <font style="letter-spacing:0.17pt;">and consulting </font>
                <br >
                <font style="letter-spacing:0.17pt;">services business </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="min-height:60.72pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:5.99pt 0pt 3.45pt 0pt; width:182.26pt;white-space:normal;text-align:left;">
              <div style="position:relative;margin-left:8.5pt; text-indent:-8.5pt;">
                <img src="txt_shanghi-bw.jpg" alt="[MISSING IMAGE: txt_shanghi-bw.jpg]" height="13" width="217" >
              </div>
              <div style="margin-left:8.5pt; margin-top:11.812pt; line-height:10.2pt;">
                <font style="letter-spacing:0.17pt;">Shanghai Adlai Nortye </font>
                <br >
                <font style="letter-spacing:0.17pt;">Biopharma Co., Ltd*</font>
                <br >
                <font style="letter-spacing:0.17pt;">(&#8220;Adlai Shanghai&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; width:96pt;text-align:left;">
              <div style="line-height:10.2pt;">
                <font style="letter-spacing:0.17pt;">the People&#8217;s Republic of </font>
                <br >
                <font style="letter-spacing:0.17pt;">China (&#8220;PRC&#8221;)/ Mainland </font>
                <br >
                <font style="letter-spacing:0.17pt;">China</font>
                <br >
                <font style="letter-spacing:0.17pt;">22 December&#160;2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; width:72pt;text-align:left;">
              <div style="line-height:10.2pt;">
                <font style="letter-spacing:0.17pt;">RMB 10,000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; width:72pt;text-align:left;">
              <div style="line-height:10.2pt;">
                <font style="letter-spacing:0.17pt;">Product research </font>
                <br >
                <font style="letter-spacing:0.17pt;">and development, </font>
                <br >
                <font style="letter-spacing:0.17pt;">technology transfer </font>
                <br >
                <font style="letter-spacing:0.17pt;">and consulting </font>
                <br >
                <font style="letter-spacing:0.17pt;">services business </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="min-height:60.72pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:5.99pt 0pt 3.45pt 0pt; width:182.26pt;white-space:normal;text-align:left;">
              <div style="position:relative;margin-left:8.5pt; text-indent:-8.5pt;">
                <img src="txt_hangzhou-bw.jpg" alt="[MISSING IMAGE: txt_hangzhou-bw.jpg]" height="13" width="153" >
              </div>
              <div style="margin-left:8.5pt; margin-top:2.812pt; line-height:10.19pt;">
                <font style="letter-spacing:0.17pt;">Hangzhou Changchuang </font>
                <br >
                <font style="letter-spacing:0.17pt;">Weilai Technolegy Co., Ltd </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 0.5pt 0pt; width:36pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; width:96pt;text-align:left;">
              <div style="line-height:10.2pt;">
                <font style="letter-spacing:0.17pt;">the People&#8217;s Republic of </font>
                <br >
                <font style="letter-spacing:0.17pt;">China (&#8220;PRC&#8221;)/ Mainland </font>
                <br >
                <font style="letter-spacing:0.17pt;">China</font>
                <br >
                <font style="letter-spacing:0.17pt;">2 November&#160;2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; width:72pt;text-align:left;">
              <div style="line-height:10.2pt;">
                <font style="letter-spacing:0.17pt;">RMB 10,000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.08pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.54pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:5.99pt 0pt 3.45pt 0pt; width:72pt;text-align:left;">
              <div style="line-height:10.2pt;">
                <font style="letter-spacing:0.17pt;">Product research </font>
                <br >
                <font style="letter-spacing:0.17pt;">and development, </font>
                <br >
                <font style="letter-spacing:0.17pt;">technology transfer </font>
                <br >
                <font style="letter-spacing:0.17pt;">and consulting </font>
                <br >
                <font style="letter-spacing:0.17pt;">services business</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:6.81pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:6.81pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">The English name of the subsidiary registered in the PRC represents the best efforts made by management of the Company to translate its Chinese name as the subsidiary does not have an official English name.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.1</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">BASIS OF PRESENTATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The consolidated financial statements of the Group include the financial statements of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.93pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.2</font>
          <br >
        </div>
        <div style=" margin-top:7.93pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">BASIS OF PREPARATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.11pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding that the Group recorded net liabilities of $241,293 as of December&#160;31, 2022 and continually incurred losses from operations, the Consolidated Financial Statements have been prepared on a going concern basis. The directors of the Company are of the opinion that the Group will have sufficient working capital to meet its financial liabilities and obligations as and when they fall due and to sustain its operations for the next 12&#160;months from December&#160;31, 2022 because the convertible redeemable preferred shares would not be contractually redeemable within the next 12&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Consolidated Financial Statements have been prepared in accordance with International Financial Reporting Standards (&#8220;IFRSs&#8221;), which comprise all standards and interpretations approved by the International Accounting Standards Board (the &#8220;IASB&#8221;). All IFRSs effective for the accounting period commencing from January&#160;1, 2020, together with the relevant transitional provisions, have been early adopted by the Group in the preparation of the Consolidated Financial Statements throughout the Relevant Periods and in the period covered by the Interim Comparative Financial Information. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Recently issued accounting pronouncements:</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In 2016, the IASB issued IFRS 16, which increases lease transparency and comparability among organizations. Under the new standard, lessees will be required to recognize all assets and liabilities arising from leases on the balance sheet, with the exception of leases with a term of 12 months or less, which permits a lessee to make an accounting policy election by class of underlying asset not to recognize lease assets and liabilities. IFRS 16 is effective for fiscal years beginning after January 1, 2019. The Company adopted the new lease accounting standard as of January 1, 2019. Adoption of this update increased the amounts of total assets and total liabilities on the Company&#8217;s consolidated financial position, and did not have a material impact on the Company&#8217;s consolidated results of operations and cash flows.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Consolidated Financial Statements have been prepared under the historical cost convention except for certain financial liabilities which have been measured at fair value at the end of each of the Relevant Periods.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.82pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.3</font>
          <br >
        </div>
        <div style=" margin-top:7.82pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">ISSUED BUT NOT YET EFFECTIVE IFRSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group has not applied the following new and revised IFRSs that have been issued but are not yet effective in the Consolidated Financial Statements. </font>
        </div>
        <table style="width:456pt;height:151pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:157.37pt;">
              <div style="white-space:nowrap;font-style:normal;">
                <font style="letter-spacing:0.2pt;">Amendments to IFRS 10 and IAS 28 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:286.63pt;white-space:normal;">
              <div style="line-height:11.9999999999999pt;">
                <font style="letter-spacing:0.2pt;">Sale or Contribution of Assets between an Investor and its Associate or Joint Venture</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:157.37pt;">
              <font style="letter-spacing:0.2pt;">IFRS 17 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:286.63pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Insurance Contracts</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:157.37pt;">
              <font style="letter-spacing:0.2pt;">Amendments to IFRS 17 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:286.63pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Insurance Contracts</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(1)(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:157.37pt;">
              <font style="letter-spacing:0.2pt;">Amendments to IAS 1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:286.63pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Classification of Liabilities as Current or Non-current</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:157.37pt;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Amendments to IAS 1 and IFRS </font>
                <br >
                <font style="letter-spacing:0.2pt;">Practice Statement 2 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:286.63pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Disclosure of Accounting Policies</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:157.37pt;">
              <font style="letter-spacing:0.2pt;">Amendments to IAS 8 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:286.63pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Definition of Accounting Estimates</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:157.37pt;">
              <div style="font-style:normal;">
                <font style="letter-spacing:0.2pt;">Amendments to IAS 12 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:286.63pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Deferred Tax related to Assets and Liabilities arising from a Single Transaction</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(1)</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:157.37pt;">
              <div style="font-style:normal;">
                <font style="letter-spacing:0.2pt;">Amendments to IFRS 4 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:286.63pt;">
              <font style="letter-spacing:0.2pt;">Extension of the Temporary Exemption from Applying IFRS&#160;9</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(1)</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.3</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">ISSUED BUT NOT YET EFFECTIVE IFRSs&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:18.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Effective for annual periods beginning on or after 1 January&#160;2023 </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:4.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4.2pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">No mandatory effective date yet determined but available for adoption </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:4.2pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4.2pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">As a consequence of the amendments to IFRS 17 issued in October&#160;2020, the effective date of IFRS 17 was deferred to January&#160;1, 2023, and IFRS 4 was amended to extend the temporary exemption that permits insurers to apply IAS 39 rather than IFRS 9 for annual periods beginning before January&#160;1, 2023 </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group is in the process of making an assessment of the impact of these new and revised IFRSs upon initial application. So far, the Group expects that these standards will not have a significant effect on the Group&#8217;s financial performance and financial position.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
          <br >
        </div>
        <div style=" margin-top:12.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Subsidiaries</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A subsidiary is an entity (including a structured entity), directly or indirectly, controlled by the Company. Control is achieved when the Group is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee (i.e., existing rights that give the Group the current ability to direct the relevant activities of the investee). When the Company has, directly or indirectly, less than a majority of the voting or similar rights of an investee, the Group considers all relevant facts and circumstances in assessing whether it has power over an investee, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">contractual arrangements with other vote holders of the investee; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">rights arising from other contractual arrangements; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Group&#8217;s voting rights and potential voting rights. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The financial statements of subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies. The results of subsidiaries are consolidated from the date on which the Group obtains control, and continue to be consolidated until the date that such control ceases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Profit or loss and each component of other comprehensive income are attributed to the owners of the parent of the Group and to the non-controlling interests, even if this results in the non-controlling interests having a deficit balance. All intra-group assets and liabilities, equity, income, expenses and cash flows relating to transactions between members of the Group are eliminated in full on consolidation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fair value measurement</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group measures certain financial instruments at fair value at the end of each of the Relevant Periods. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either in the principal market for the asset or liability, or in the absence of a principal market, in the most advantageous market for the asset or liability. The principal or most advantageous market must be accessible by the Group. The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All assets and liabilities for which fair value is measured or disclosed in the Consolidated Financial Statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Level&#160;1&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">based on quoted prices (unadjusted) in active markets for identical assets or liabilities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:justify; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Level&#160;2&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">based on valuation techniques for which the lowest level input that is significant to the fair value measurement is observable, either directly or indirectly </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:justify; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Level&#160;3&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">based on valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For assets and liabilities that are recognized in the Consolidated Financial Statements on a recurring basis, the Group determines whether transfers have occurred between levels in the hierarchy by reassessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each of the Relevant Periods. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Impairment of non-financial assets</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Where an indication of impairment exists, or when annual impairment testing for an asset is required (other than financial assets), the asset&#8217;s recoverable amount is estimated. An asset&#8217;s recoverable amount is the higher of the asset or cash-generating unit&#8217;s value in use and its fair value less cost of disposal, and is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups of assets, in which case the recoverable amount is determined for the cash-generating unit to which the asset belongs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An impairment loss is recognized only if the carrying amount of an asset exceeds its recoverable amount. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. An impairment loss is charged to profit or loss in the period in which it arises in those expense categories consistent with the function of the impaired asset. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An assessment is made at the end of each of the Relevant Periods as to whether there is an indication that previously recognized impairment losses may no longer exist or may have decreased. If such an indication exists, the recoverable amount is estimated. A previously recognized impairment loss of an asset other than goodwill is reversed only if there has been a change in the estimates used to determine the recoverable amount of that asset, but not to an amount higher than the carrying amount that would have been determined (net of any depreciation/amortization) had no impairment loss been recognized for the asset in prior&#160;years. A reversal of such an impairment loss is credited to profit or loss in the period in which it arises. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Related parties</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A party is considered to be related to the Group if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the party is a person or a close member of that person&#8217;s family and that person </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">has control or joint control over the Group; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">has significant influence over the Group; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">is a member of the key management personnel of the Group or of a parent of the Group; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the party is an entity where any of the following conditions applies: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the entity and the Group are members of the same group; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">one entity is an associate or joint venture of the other entity (or of a parent, subsidiary or fellow subsidiary of the other entity); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the entity and the Group are joint ventures of the same third party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">one entity is a joint venture of a third entity and the other entity is an associate of the third entity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(v)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the entity is a post-employment benefit plan for the benefit of employees of either the Group or an entity related to the Group; and the sponsoring employers of the post-employment benefit plan; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(vi)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the entity is controlled or jointly controlled by a person identified in (a); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(vii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(viii)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the entity, or any member of a group of which it is a part, provides key management personnel services to the Group or to the parent of the Group. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Property, plant and equipment and depreciation</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Property, plant and equipment, other than construction in progress, are stated at cost less accumulated depreciation and any impairment losses. The cost of an item of property, plant and equipment comprises its purchase price and any directly attributable costs of bringing the asset to its working condition and location for its intended use. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Expenditure incurred after items of property, plant and equipment have been put into operation, such as repairs and maintenance, is normally charged to profit or loss in the period in which it is incurred. In situations where the recognition criteria are satisfied, the expenditure for a major inspection is capitalized in the carrying amount of the asset as a replacement. Where significant parts of property, plant and equipment are required to be replaced at intervals, the Group recognizes such parts as individual assets with specific useful lives and depreciates them accordingly. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Depreciation is calculated on the straight-line basis to write off the cost of each item of property, plant and equipment to its residual value over its estimated useful life. The principal annual rates used for this purpose are as follows: </font>
        </div>
        <table style="width:456pt;height:70pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:184.46pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Plant and machinery </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:259.54pt;">
              <font style="letter-spacing:0.2pt;">10% to 19% </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:184.46pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Office equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.54pt;">
              <font style="letter-spacing:0.2pt;">19% to 20% </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:184.46pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Motor vehicles </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.54pt;">
              <font style="letter-spacing:0.2pt;">19% </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:184.46pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Electronic equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.54pt;">
              <font style="letter-spacing:0.2pt;">19% to 20% </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:184.46pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Leasehold improvements </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:259.54pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The shorter of remaining lease terms or estimated useful lives</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.9pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Where parts of an item of property, plant and equipment have different useful lives, the cost of that item is allocated on a reasonable basis among the parts and each part is depreciated separately. Residual values, useful lives and the depreciation method are reviewed, and adjusted if appropriate, at least at the end of each of the Relevant Periods. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An item of property, plant and equipment including any significant part initially recognized is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss on disposal or retirement recognized in the statement of profit or loss and other comprehensive income in the year the asset is derecognized is the difference between the net sales proceeds and the carrying amount of the relevant asset. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Construction in progress is reclassified to the appropriate category of property, plant and equipment when completed and ready for use. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Other intangible assets (other than goodwill)</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Other intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is the fair value at the date of acquisition. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible assets with finite lives are subsequently amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each of the Relevant Periods. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Computer software</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Computer software is stated at cost less any impairment losses and amortized on a straight-line basis over its estimated useful life of 5&#160;years. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The estimated useful life of software is determined by considering the period of the economic benefits to the Group, as well as by referring to industry practice. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Research and development costs</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All research costs are charged to expense as incurred. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Expenditure incurred on projects to develop new products is capitalized and deferred only when the Group can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or sell the asset, how the asset will generate future economic benefits, the availability of resources to complete the project and the Group&#8217;s ability to measure reliably the expenditure during the development. Product development expenditure which does not meet these criteria is expensed when incurred. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Leases</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group assesses at contract inception whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Group as a lessee</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Group recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:11.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Right-of-use assets </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Right-of-use assets are recognized at the commencement date of the lease (the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated on a straight-line basis over the shorter of the lease terms and the estimated useful lives of the assets as follows:</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <table style="width:416pt;height:25pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:355.64pt;">
              <font style="letter-spacing:0.2pt;">Offices </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 1pt 0pt; width:48.36pt;text-align:right;">
              <div style="white-space:nowrap; text-align:right;">
                <font style="letter-spacing:0.2pt;">2 to 5&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1pt 0pt; width:355.64pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Office equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1pt 0pt; width:48.36pt;text-align:right;">
              <div style="white-space:nowrap; text-align:right;">
                <font style="letter-spacing:0.2pt;">2 to 5&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8.1pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If ownership of the leased asset transfers to the Group by the end of the lease term or the cost reflects the exercise of a purchase option, depreciation is calculated using the estimated useful life of the asset. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:12.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Lease liabilities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Lease liabilities are recognized at the commencement date of the lease at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for termination of a lease, if the lease term reflects the Group exercising the option to terminate the lease. Variable lease payments that do not depend on an index or a rate are recognized as an expense in the period in which the event or condition that triggers the payment occurs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In calculating the present value of lease payments, the Group uses its incremental borrowing rate at the lease commencement date because the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in lease payments (e.g., a change to future lease payments resulting from a change in an index or rate) or a change in assessment of an option to purchase the underlying asset. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Short-term leases and leases of low-value assets </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group applies the short-term lease recognition exemption to its short-term leases of office equipment (that is those leases that have a lease term of 12&#160;months or less from the commencement date and do not contain a purchase option). It also applies the recognition exemption for leases of low-value assets to leases of office equipment that are considered to be of low value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Lease payments on short-term leases and leases of low-value assets are recognized as an expense on a straight-line basis over the lease term. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Financial assets</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Initial recognition and measurement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial assets are classified, at initial recognition, as subsequently measured at amortized cost, fair value through other comprehensive income, and fair value through profit or loss. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The classification of financial assets at initial recognition depends on the financial asset&#8217;s contractual cash flow characteristics and the Group&#8217;s business model for managing them. With the exception of trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient of not adjusting the effect of a significant financing component, the Group initially </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit or loss, transaction costs.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order for a financial asset to be classified and measured at amortized cost or fair value through other comprehensive income, it needs to give rise to cash flows that are solely payments of principal and interest (&#8220;SPPI&#8221;) on the principal amount outstanding. Financial assets with cash flows that are not SPPI are classified and measured at fair value through profit or loss, irrespective of the business model. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets classified and measured at amortized cost are held within a business model with the objective to hold financial assets in order to collect contractual cash flows, while financial assets classified and measured at fair value through other comprehensive income are held within a business model with the objective of both holding to collect contractual cash flows and selling. Financial assets which are not held within the aforementioned business models are classified and measured at fair value through profit or loss. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All regular way purchases and sales of financial assets are recognized on the trade date, that is, the date that the Group commits to purchase or sell the asset. Regular way purchases or sales are purchases or sales of financial assets that require delivery of assets within the period generally established by regulation or convention in the marketplace. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Subsequent measurement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The subsequent measurement of financial assets depends on their classification as follows: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Financial assets at amortized cost (debt instruments)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment. Gains and losses are recognized in the statement of profit or loss and other comprehensive income when the asset is derecognized, modified or impaired. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Financial assets at fair value through profit or loss</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial assets at fair value through profit or loss are carried in the statement of financial position at fair value with net changes in fair value recognized in the statement of profit or loss and other comprehensive income. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This category includes derivative instruments and equity investments which the Group has not irrevocably elected to classify at fair value through other comprehensive income. Dividends on equity investments classified as financial assets at fair value through profit or loss are also recognized as other income in the statement of profit or loss and other comprehensive income when the right of payment has been established, it is probable that the economic benefits associated with the dividend will flow to the Group and the amount of the dividend can be measured reliably. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A derivative embedded in a hybrid contract, with a financial liability or non-financial host, is separated from the host and accounted for as a separate derivative if the economic characteristics and risks are not closely related to the host; a separate instrument with the same terms as the embedded derivative would meet the definition of a derivative; and the hybrid contract is not measured at fair value through profit or loss. Embedded derivatives are measured at fair value with changes in fair value recognized in the statement of profit or loss and other comprehensive income. Reassessment only occurs if there is either a change in the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">terms of the contract that significantly modifies the cash flows that would otherwise be required or a reclassification of a financial asset out of the fair value through profit or loss category.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A derivative embedded within a hybrid contract containing a financial asset host is not accounted for separately. The financial asset host together with the embedded derivative is required to be classified in its entirety as a financial asset at fair value through profit or loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Derecognition of financial assets</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Group&#8217;s consolidated statement of financial position) when: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the rights to receive cash flows from the asset have expired; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Group has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material delay to a third party under a &#8220;pass-through&#8221; arrangement; and either (a)&#160;the Group has transferred substantially all the risks and rewards of the asset, or (b)&#160;the Group has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">When the Group has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risk and rewards of ownership of the asset. When it has neither transferred nor retained substantially all the risks and rewards of the asset nor transferred control of the asset, the Group continues to recognize the transferred asset to the extent of the Group&#8217;s continuing involvement. In that case, the Group also recognizes an associated liability. The transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Group has retained. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Continuing involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that the Group could be required to repay. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Impairment of financial assets</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group recognizes an allowance for expected credit losses (&#8220;ECLs&#8221;) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Group expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General approach</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ECLs are recognized in two stages. For credit exposures for which there has not been a significant increase in credit risk since initial recognition, ECLs are provided for credit losses that result from default events that are possible within the next 12&#160;months (a 12-month ECL). For those credit exposures for which there has been a significant increase in credit risk since initial recognition, a loss allowance is required for credit losses expected over the remaining life of the exposure, irrespective of the timing of the default (a lifetime ECL). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the end of each of the Relevant Periods, the Group assesses whether the credit risk on a financial instrument has increased significantly since initial recognition. When making the assessment, the Group compares the risk of a default occurring on the financial instrument as of the reporting date with the risk of a </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">default occurring on the financial instrument as of the date of initial recognition and considers reasonable and supportable information that is available without undue cost or effort, including historical and forward-looking information.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group considers a financial asset in default when contractual payments are 90&#160;days past due. However, in certain cases, the Group may also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Financial assets at amortized cost are subject to impairment under the general approach and they are classified within the following stages for measurement of ECLs except for trade receivables and contract assets which apply the simplified approach as detailed below. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.5pt; margin-bottom:0pt; text-align:justify; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Stage 1&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:8.5pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Financial instruments for which credit risk has not increased significantly since initial recognition and for which the loss allowance is measured at an amount equal to 12-month ECLs </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.5pt; margin-bottom:0pt; text-align:justify; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Stage 2&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:8.5pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Financial instruments for which credit risk has increased significantly since initial recognition but that are not credit-impaired financial assets and for which the loss allowance is measured at an amount equal to lifetime ECLs </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.5pt; margin-bottom:0pt; text-align:justify; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Stage 3&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:8.5pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Financial assets that are credit-impaired at the reporting date (but that are not purchased or originated credit-impaired) and for which the loss allowance is measured at an amount equal to lifetime ECLs </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Simplified approach</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">For trade receivables that do not contain a significant financing component or when the Group applies the practical expedient of not adjusting the effect of a significant financing component, the Group applies the simplified approach in calculating ECLs. Under the simplified approach, the Group does not track changes in credit risk, but instead recognizes a loss allowance based on lifetime ECLs at the end of each of the Relevant Periods. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Financial liabilities</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Initial recognition and measurement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Financial liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans and borrowings, payables, as appropriate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable transaction costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s financial liabilities include trade and other payables, derivative financial instruments, interest-bearing bank and other borrowings and certain financial instruments designated at FVTPL. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Subsequent measurement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The subsequent measurement of financial liabilities depends on their classification as follows: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Financial liabilities at fair value through profit or loss</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value through profit or loss. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. This category also includes derivative financial instruments entered into by the Group that are not designated as hedging instruments in hedge relationships as defined by IFRS 9. Separated embedded derivatives are also classified as held for trading unless they are designated as effective hedging instruments. Gains or losses on liabilities held for trading are recognized in the statement of profit or loss. The net fair value gain or loss recognized in the statement of profit or loss does not include any interest charged on these financial liabilities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Financial liabilities designated upon initial recognition as at fair value through profit or loss are designated at the initial date of recognition, and only if the criteria in IFRS 9 are satisfied. Gains or losses on liabilities designated at fair value through profit or loss are recognized in the statement of profit or loss, except for the gains or losses arising from the Group&#8217;s own credit risk which are presented in other comprehensive income with no subsequent reclassification to the statement of profit or loss. The net fair value gain or loss recognized in the statement of profit or loss does not include any interest charged on these financial liabilities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The company assessed the contract characteristics of each series of convertible redeemable preferred shares to determine whether they should be classified as equity instruments or financial liabilities. The Series&#160;B, C, and D Preferred Shares and Series B Convertible Loans were classified as financial liabilities measured at fair value through profit or loss. The decision was based on the presence of a redemption feature and a conversion option with a price adjustment feature, which are considered financial liabilities under IAS 32. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The company also determined that the Series B Convertible Loans are a hybrid instrument that includes a non-derivative host contract and embedded derivatives, which should be accounted for at fair value through profit or loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Financial liabilities at amortized cost (loans and borrowings)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After initial recognition, interest-bearing loans and borrowings are subsequently measured at amortized cost, using the effective interest rate method unless the effect of discounting would be immaterial, in which case they are stated at cost. Gains and losses are recognized in the statement of profit or loss and other comprehensive income when the liabilities are derecognized as well as through the effective interest rate amortization process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Amortized cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the effective interest rate. The effective interest rate amortization is included in finance costs in the statement of profit or loss and other comprehensive income. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Derecognition of financial liabilities</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A financial liability is derecognized when the obligation under the liability is discharged or cancelled, or expires. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as a derecognition of the original liability and a recognition of a new liability, and the difference between the respective carrying amounts is recognized in the statement of profit or loss and other comprehensive income. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Derivative financial instruments</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Initial recognition and subsequent measurement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group uses derivative financial instruments, such as warrants. Such derivative financial instruments are initially recognized at fair value on the date on which a derivative contract is entered into and are subsequently remeasured at fair value. Derivatives are carried as assets when the fair value is positive and as liabilities when the fair value is negative. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any gains or losses arising from changes in fair value of derivatives are taken directly to profit or loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Current versus non-current classification</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Derivative instruments that are not designated as effective hedging instruments are classified as current or non-current or separated into current and non-current portions based on an assessment of the facts and circumstances (i.e., the underlying contracted cash flows): </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Where the Group expects to hold a derivative as an economic hedge (and does not apply hedge accounting) for a period beyond 12&#160;months after the end of the reporting period, the derivative is classified as non-current (or separated into current and non-current portions) consistently with the classification of the underlying item. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Embedded derivatives that are not closely related to the host contract are classified consistently with the cash flows of the host contract. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Derivative instruments that are designated as, and are effective hedging instruments, are classified consistently with the classification of the underlying hedged item. The derivative instruments are separated into current portions and non-current portions only if a reliable allocation can be made. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Cash and cash equivalents</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the purpose of the consolidated statement of cash flows, cash and cash equivalents comprise cash on hand and demand deposits, and short term highly liquid investments that are readily convertible into known amounts of cash, are subject to an insignificant risk of changes in value, and have a short maturity of generally within three&#160;months when acquired. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the purpose of the consolidated statement of financial position, cash and cash equivalents comprise cash on hand and at banks, including term deposits, and assets similar in nature to cash, which are not restricted as to use. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains its cash and cash equivalents at high-quality and accredited financial institutions in amounts that could exceed the $250,000 maximum amount insured by the Federal Deposit Insurance Corporation (FDIC). The Company does not believe that its cash and cash equivalents are subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Provisions</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A provision is recognized when a present obligation (legal or constructive) has arisen as a result of a past event and it is probable that a future outflow of resources will be required to settle the obligation, provided that a reliable estimate can be made of the amount of the obligation. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">When the effect of discounting is material, the amount recognized for a provision is the present value at the end of the reporting period of the future expenditures expected to be required to settle the obligation. The increase in the discounted present value amount arising from the passage of time is included in finance costs in the statement of profit or loss and other comprehensive income. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Income tax</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Income tax comprises current and deferred tax. Income tax relating to items recognized outside profit or loss is recognized outside profit or loss, either in other comprehensive income or directly in equity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Current tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period, taking into consideration interpretations and practices prevailing in the countries in which the Group operates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax is provided, using the liability method, on all temporary differences at the end of the reporting period between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax liabilities are recognized for all taxable temporary differences, except: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.29pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.29pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">when the deferred tax liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in respect of taxable temporary differences associated with investments in subsidiaries, associates and joint ventures, when the timing of the reversal of the temporary differences can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets are recognized for all deductible temporary differences, the carryforward of unused tax credits and any unused tax losses. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which the deductible temporary differences and the carryforward of unused tax credits and unused tax losses can be utilized, except: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">when the deferred tax asset relating to the deductible temporary differences arises from the initial recognition of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.3pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.3pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in respect of deductible temporary differences associated with investments in subsidiaries, associates and joint ventures, deferred tax assets are only recognized to the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available against which the temporary differences can be utilized. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The carrying amount of deferred tax assets is reviewed at the end of each of the Relevant Periods and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are reassessed at the end of each of the Relevant Periods and are recognized to the extent that it has become probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be recovered. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets and liabilities are measured at the tax rates that are expected to apply to the period when the asset is realised or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets and deferred tax liabilities are offset if and only if the Group has a legally enforceable right to set off current tax assets and current tax liabilities and the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation authority on either the same taxable entity or different taxable entities which intend either to settle current tax liabilities and assets on a net basis, or to realise the assets and settle the liabilities simultaneously, in each future period in which significant amounts of deferred tax liabilities or assets are expected to be settled or recovered. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In compliance with IFRIC 23, accruals for risk on income tax are part of the income tax within the statements of operations and comprehensive loss and income tax payable within the statements of financial position. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Government grants</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Government grants are recognized at their fair value where there is reasonable assurance that the grant will be received and all attaching conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the periods that the costs, for which it is intended to compensate, are expensed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Revenue recognition</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Sales of intellectual property</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Revenue from sales of intellectual property is recognized when control of the intellectual property is transferred to the customers at an amount that reflects the consideration to which the Group expects to be entitled in exchange for the intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">When the consideration of sales of intellectual property includes a variable amount, the amount of consideration is estimated to which the Group will be entitled in exchange for transferring the intellectual property to the customer. The variable consideration is estimated at contract inception and constrained until it is highly probable that a significant revenue reversal in the amount of cumulative revenue recognized will not occur when the associated uncertainty with the variable consideration is subsequently resolved. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Milestone payments and sales-based royalties represent a form of variable consideration which is included in the transaction price to the extent that it is highly probable that a significant reversal of accumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. When the Group cannot conclude that it is highly probable that a significant revenue reversal of cumulative revenue under the contract will not occur, the Group constrains the related variable consideration resulting in its exclusion from the transaction price. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As part of the accounting for this arrangement, the Group must use significant judgement to determine: (a)&#160;the performance obligations; and (b)&#160;the method to estimate variable consideration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At contract inception, the Group assesses the goods or services promised within each contract and determines those that are performance obligations, and assesses whether each promised good or service is distinct. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group uses judgement to determine whether milestones or other variable consideration, except for royalties, should be included in the transaction price. The transaction price is allocated to each performance obligation on a relative stand-alone selling price basis, for which the Group recognizes revenue as or when the performance obligations under the contract are satisfied. If a milestone or other variable consideration relates specifically to the Group&#8217;s efforts to satisfy a single performance obligation or to a specific outcome from </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">satisfying the performance obligation, the Group generally allocates that milestone amount entirely to that performance obligation once it is highly probable that a significant revenue reversal would not occur.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group recognizes revenue only when it satisfies a performance obligation by transferring control of the promised goods or services. The transfer of control can occur over time or at a point in time. A performance obligation is satisfied over time if it meets one of the following criteria: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The counterparty simultaneously receives and consumes the benefits provided by the Group&#8217;s performance as the Group performs; or </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s performance creates or enhances an asset that the counterparty controls as the asset is created or enhanced </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s performance does not create an asset with an alternative use to the Group and the Group has an enforceable right to payment for performance completed to date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The portion of the transaction price that is allocated to performance obligations satisfied at a point in time is recognized as revenue when control of the goods or services is transferred to the counterparty. If the performance obligation is satisfied over time, the portion of the transaction price allocated to that performance obligation is recognized as revenue as the performance obligation is satisfied. The Group adopts an appropriate method of measuring progress for purposes of recognizing revenue. The Group evaluates the measure of progress at the end of each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upfront fees </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upfront payment is allocated to the performance obligations based on the Group&#8217;s best estimate of their relative stand-alone selling prices. The Group recognizes revenues from non-refundable upfront fees at a point in time when the transfer of control of the intellectual property to the counterparty occurs and the counterpary is able to use and benefit from the intellectual property. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Milestone payments </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the inception of each arrangement that includes milestone payments, the Group evaluates whether the milestones are considered highly probable of being achieved and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Group, such as regulatory approvals, are not considered highly probable of being achieved until those approvals are received. The Group evaluates factors such as the scientific, clinical, regulatory, commercial, and other risks that must be overcome to achieve the particular milestone in making this assessment. There is considerable judgement involved in determining whether it is highly probable that a significant reversal of cumulative revenue would not occur. At the end of each subsequent reporting period, the Group re-evaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Milestone payments are allocated to performance obligations based on the Group&#8217;s best estimate of their relative stand-alone selling prices unless the criteria under IFRS 15.85 are met, in which case the milestone payments are allocated entirely to the performance obligation which the milestone payments are specifically related to. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group assessed that achievement of all the remaining contractual milestones is highly uncertain and the related milestone payments are not included in the transaction price. Milestones are achieved when the triggering event described in the related agreement occurs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sales royalties </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group recognizes revenue for a sales-based royalty promised in exchange for the sales of intellectual property only when (or as) the later of the following events occurs: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the subsequent sale occurs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.51pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.51pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Revenue from other sources</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Rental income is recognized on a time proportion basis over the lease terms. Variable lease payments that do not depend on an index or a rate are recognized as income in the accounting period in which they are incurred. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Interest income</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Interest income is recognized on an accrual basis using the effective interest method by applying the rate that exactly discounts the estimated future cash receipts over the expected life of the financial instrument or a shorter period, when appropriate, to the net carrying amount of the financial asset. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Share-based payments</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company operates a share option scheme for the purpose of providing incentives and rewards to eligible participants who contribute to the success of the Group&#8217;s operations. Employees (including directors) of the Group receive remuneration in the form of share-based payments, whereby employees render services as consideration for equity instruments (&#8220;equity-settled transactions&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The cost of equity-settled transactions with employees for grants is measured by reference to the fair value at the date at which they are granted. The fair value is determined by an external valuer using a binomial model, further details of which are given in note 19 to the Consolidated Financial Statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The cost of equity-settled transactions is recognized in employee benefit expense, together with a corresponding increase in equity, over the period in which the performance and/or service conditions are fulfilled. The cumulative expense recognized for equity-settled transactions at the end of each of the Relevant Periods until the vesting date reflects the extent to which the vesting period has expired and the Group&#8217;s best estimate of the number of equity instruments that will ultimately vest. The charge or credit to the statement of profit or loss and other comprehensive income for a period represents the movement in the cumulative expense recognized as of the beginning and end of that period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Service and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Group&#8217;s best estimate of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Other employee benefits</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9.62pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pension schemes</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The employees of the Group&#8217;s subsidiaries who operate in Mainland China are required to participate in a central pension scheme operated by the local municipal government. These subsidiaries are required to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">contribute a certain&#160;percentage of their payroll costs to the central pension scheme. The contributions are charged to profit or loss as they become payable in accordance with the rules of the central pension scheme.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary in the U.S. maintains multiple qualified contributory savings plans as allowed under Section&#160;401(k) of the Internal Revenue Code in the U.S. These plans are defined contribution plans covering substantially all its qualifying employees and provide for voluntary contributions by employees, subject to certain limits. The contributions are made by both the employees and the employer. The employees&#8217; contributions are primarily based on specified dollar amounts or&#160;percentages of employee compensation. The only obligation of the subsidiary in the U.S. with respect to the retirement benefits plans is to make the specified contributions under the plans. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Housing fund&#8201;&#8212;&#8201;Mainland China</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group contributes on a monthly basis to a defined contribution housing fund plan operated by the local municipal government. Contributions to this plan by the Group are expensed as incurred. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Borrowing costs</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets (i.e., assets that necessarily take a substantial period of time to get ready for their intended use or sale) are capitalized as part of the cost of those assets. The capitalization of such borrowing costs ceases when the assets are substantially ready for their intended use or sale. Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs capitalized. All other borrowing costs are expensed in the period in which they are incurred. Borrowing costs consist of interest and other costs that an entity incurs in connection with the borrowing of funds. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Foreign currencies</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">These consolidated financial statements are presented in United States dollars (&#8220;$&#8221;), which is the Company&#8217;s functional currency. Each entity in the Group determines its own functional currency and items included in the financial statements of each entity are measured using that functional currency. Foreign currency transactions recorded by the entities in the Group are initially recorded using their respective functional currency rates prevailing at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies are translated at the functional currency rates of exchange at the end of the reporting period. Differences arising on settlement or translation of monetary items are recognized in the statement of operations and comprehensive loss. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the dates of the initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was measured. The gain or loss arising on translation of a non-monetary item measured at fair value is treated in line with the recognition of the gain or loss on change in fair value of the item (i.e., translation difference on the item whose fair value gain or loss is recognized in other comprehensive income or profit or loss is also recognized in other comprehensive income or profit or loss, respectively). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In determining the exchange rate on initial recognition of the related asset, expense or income on the derecognition of a non-monetary asset or non-monetary liability relating to an advance consideration, the date of the initial transaction is the date on which the Group initially recognizes the non-monetary asset or non-monetary liability arising from the advance consideration. If there are multiple payments or receipts in advance, the Group determines the transaction date for each payment or receipt of the advance consideration. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The functional currencies of certain subsidiaries established in the PRC are currencies other than $. As of the end of the reporting period, the assets and liabilities of these entities are translated into $ at the exchange rates prevailing at the end of the reporting period and their statements of profit or loss and other comprehensive income are translated into $ at the weighted average exchange rates for the year. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The resulting exchange differences are recognized in other comprehensive income and accumulated in the exchange fluctuation reserve. On disposal of a foreign operation, the component of other comprehensive income relating to that particular foreign operation is recognized in the statement of profit or loss and other comprehensive income. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the purpose of the consolidated statement of cash flows, the cash flows of the subsidiaries established in the PRC are translated into $ at the exchange rates at the dates of the cash flows. Frequently recurring cash flows of the subsidiaries established in the PRC which arise throughout the year are translated into $ at the weighted average exchange rates for the year.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:12.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SIGNIFICANT ACCOUNTING JUDGEMENTS AND ESTIMATES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Use of Estimates</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preparation of the Group&#8217;s Consolidated Financial Statements requires management to make judgements, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and their accompanying disclosures, and the disclosure of contingent liabilities. Uncertainty about these assumptions and estimates could result in outcomes that could require a material adjustment to the carrying amounts of the assets or liabilities affected in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Estimation uncertainty</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The key assumptions concerning the future and other key sources of estimation uncertainty at the end of the reporting period that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are described below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Fair value of financial liabilities measured at FVTPL</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the financial liabilities, including convertible redeemable preferred shares, convertible loans, forwards and warrants, are measured at FVTPL and determined using the valuation techniques, including the discounted cash flow method and the back-solve method. Such valuation requires the Group to make estimates of the key assumptions including the risk-free interest rate, discount for lack of marketability (&#8220;DLOM&#8221;) and volatility, which are subject to uncertainty and might materially differ from the actual results. Further details are included in note 15 to the Consolidated Financial Statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Fair value of share-based payment</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the awarded shares is determined at the grant dates by the binomial option-pricing model. Significant estimates on assumptions, including the underlying equity value, discount rate, expected volatility, and dividend yield, are made by management. Further details are included in note 19 to the Consolidated Financial Statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The preparation of the consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reporting amounts of assets and liabilities, and disclosure of contingent assets and liabilities, as of the date of the consolidated financial statements, and the reported </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SIGNIFICANT ACCOUNTING JUDGEMENTS AND ESTIMATES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the valuation and accounting for financial liabilities at FVTPL and equity awards. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Impairment of non-financial assets (other than goodwill)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group assesses whether there are any indicators of impairment for all non-financial assets (including the right-of-use assets) at the end of each of the Relevant Periods. Other non-financial assets are tested for impairment when there are indicators that the carrying amounts may not be recoverable. An impairment exists when the carrying value of an asset or a cash-generating unit exceeds its recoverable amount, which is the higher of its fair value less costs of disposal and its value in use. The calculation of the fair value less costs of disposal is based on available data from binding sales transactions in an arm&#8217;s length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. When value-in-use calculations are undertaken, management must estimate the expected future cash flows from the asset or cash-generating unit and choose a suitable discount rate in order to calculate the present value of those cash flows. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets are recognized for unused tax losses to the extent that it is probable that taxable profit will be available against which the losses can be utilized. Significant management judgement is required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and level of future taxable profits together with future tax planning strategies. Further details are contained in note 6 to the Consolidated Financial Statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Uncertain tax positions</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In assessing any uncertainty over income tax treatments, the Group considers whether it is probable that the relevant tax authority will accept the uncertain tax treatment used, or proposed to be used, by individual group entities in their income tax filings. If it is probable, the current and deferred taxes are determined consistently with the tax treatment in the income tax filings. If it is not probable that the relevant taxation authority will accept an uncertain tax treatment, the effect of each uncertainty is reflected by using either the most likely amount or the expected value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group has evaluated the uncertain tax position of each of the companies within the Group as of December&#160;31, 2021 and 2022, the Group did not have any significant unrecognized uncertain tax positions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Leases&#8201;&#8212;&#8201;Estimating the incremental borrowing rate</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group cannot readily determine the interest rate implicit in a lease, and therefore, it uses an incremental borrowing rate (&#8220;IBR&#8221;) to measure lease liabilities. The IBR is the rate of interest that the Group would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment. The IBR therefore reflects what the Group &#8220;would have to pay&#8221;, which requires estimation when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when it needs to be adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary&#8217;s functional currency). The Group estimates the IBR using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates (such as the subsidiary&#8217;s stand-alone credit rating).</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">REVENUE</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:5pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An analysis of revenue is as follows: </font>
        </div>
        <table style="width:416pt;height:63.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:346.13pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:346.13pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:346.13pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Revenue from contracts with customer</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:346.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Sales of intellectual property</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">45,726</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.085pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.085pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:346.13pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">45,726</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.085pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.085pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.1pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group entered into a collaboration agreement with one customer in the year ended December 31, 2021 for a list of patents and related research material, know-how, and research results generated through studies of the five products. The terms of the arrangement include: non-refundable upfront fees of RMB 295,000 (approximately equivalent to $45,726), milestone payments for the achievement of specified certain development and sales targets and sales-based royalties. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Revenue of $45,726 for the year ended December 31, 2021 was derived from the upfront fee for the sale of intellectual property to a single customer, recognized at a point in time, and there was no further performance obligation to be performed.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCE COSTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An analysis of finance costs is as follows: </font>
        </div>
        <table style="width:416pt;height:94.79pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:319.81pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.4pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:319.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.14pt 0pt 1.4pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.14pt 0pt 1.4pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:319.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.14pt 0pt 1.4pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.14pt 0pt 1.4pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.807pt 0pt 0.5pt 0pt; width:319.81pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Transaction cost for issuance of the Group&#8217;s convertible redeemable preferred shares</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0.807pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.807pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">758</td>
            <td style="padding:0pt;padding-left:7.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0.807pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.807pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.39pt 0pt 0.5pt 0pt; width:319.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expenses on bank and other borrowings </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.83pt;width:0pt;">&#8203;</td>
            <td style="padding:2.39pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.39pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">421</td>
            <td style="padding:0pt;padding-left:7.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.415pt;width:0pt;">&#8203;</td>
            <td style="padding:2.39pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.39pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">295</td>
            <td style="padding:0pt;padding-left:9.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.39pt 0pt 1.4pt 0pt; width:319.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expenses on lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.83pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.39pt 0pt 1.4pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.39pt 0pt 1.4pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">158</td>
            <td style="padding:0pt;padding-left:7.83pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.415pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.39pt 0pt 1.4pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.39pt 0pt 1.4pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">138</td>
            <td style="padding:0pt;padding-left:9.415pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.14pt 0pt 2.15pt 0pt; width:319.81pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.83pt;width:0pt;">&#8203;</td>
            <td style="padding:2.14pt 0pt 1.4pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.14pt 0pt 1.4pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,337</td>
            <td style="padding:0pt;padding-left:7.83pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.415pt;width:0pt;">&#8203;</td>
            <td style="padding:2.14pt 0pt 1.4pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.14pt 0pt 1.4pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">433</td>
            <td style="padding:0pt;padding-left:9.415pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:17pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:17pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">INCOME TAX</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group is subject to income tax on an entity basis on profit arising in or derived from the jurisdictions in which members of the Group are domiciled and operate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Cayman Islands</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the current laws of the Cayman Islands, the Company is not subject to tax on income or capital gains. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">British Virgin Islands</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The subsidiaries incorporated in British Virgin Islands are not subject to income tax under the current laws of British Virgin Islands. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Singapore</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary incorporated in Singapore is subject to Singapore corporate income tax effectively at the rate of 4.25%-17.00% on any estimated assessable profits arising in Singapore during the period presented. In the first three years since the establishment of the Singapore subsidiary, the first SGD100 of assessable profits </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:18.91pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">INCOME TAX&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">of this subsidiary are taxed at an effective tax rate of 4.25% and the next SGD100 of assessable profits are taxed at an effective tax rate of 8.5%, and the remaining assessable profits are taxed at 17%.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Switzerland</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary incorporated in Switzerland is subject to a total corporate income tax rate of 11.9%, including 8.5% federal, and Zug cantonal and communal tax, during the Relevant Periods on the estimated assessable profits of the Swiss subsidiary. If the main business is operated in other cantons, the total corporate income tax, including federal, cantonal, and communal tax, could be up to 21.6%. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">The United States</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary incorporated in the United States (&#8220;U.S.&#8221;) is subject to U.S. federal income tax and New Jersey state income tax at the rates of 21% and 9%, respectively, during the Relevant Periods on the estimated assessable profits arising in the United States. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Hong Kong</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary incorporated in Hong Kong is subject to Hong Kong profits tax at the rate of 16.5% on any estimated assessable profits arising in Hong Kong during the period presented. The first HKD2,000 of assessable profits of this subsidiary are taxed at 8.25% and the remaining assessable profits are taxed at&#160;16.5%. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Mainland China</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The provision for corporate income tax in Mainland China is based on the statutory rate of 25% of the assessable profits as determined in accordance with the PRC Corporate Income Tax Law, which was approved and became effective on January&#160;1, 2008. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the relevant regulations on extension for expiries of unused tax losses of High and New Technology Enterprises and Small and Medium-sized Technological Enterprises issued in August&#160;2018, the accumulated tax losses that did not expire from 2018 will have expiries extending from 5&#160;years to 10&#160;years from then on. Adlai Hangzhou qualified as a High and New Technology Enterprise during the years 2022-2024. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The income tax expense of the Group for the Relevant Periods is analyzed as follows: </font>
        </div>
        <table style="width:416pt;height:76pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:319.81pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:319.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:319.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:319.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Current </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:319.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deferred </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:319.81pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.05pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.2pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">A reconciliation of the tax expense applicable to loss before tax at the statutory rate to the tax expense at the effective tax rate is as follows: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">INCOME TAX&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:174.5pt;margin-left:20pt;margin-top:12pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:325.81pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:325.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:325.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 2pt 0pt; width:325.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss before tax </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(56,678<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(58,790<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:325.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Tax at the statutory tax rate (25%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,169<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,698<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:325.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lower tax rates for specific provinces or enacted by local authority </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">13,240</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,933</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:325.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expenses not deductible for tax </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">603</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">2,171</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:325.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income not subject to tax </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,890<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.667pt 0pt 0.5pt 0pt; width:325.81pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Additional deductible allowance for qualified research and development costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,109<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,681<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:325.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Valuation allowance </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">4,325</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">11,279</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:325.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Current income tax expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.75pt 0pt; width:325.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Tax charge at the Group&#8217;s effective rate </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.5pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group has accumulated tax losses arising in Adlai Hangzhou in Mainland China of $50,612 and $83,103 as of December&#160;31, 2021 and 2022, respectively, that will expire in five to ten&#160;years after the loss incurring year for offsetting against future taxable profits. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group also has accumulated tax losses in the U.S. of $45,980 and $46,201 as of December&#160;31, 2021 and 2022, respectively, that can be carried forward indefinitely to offset against future taxable profits of the companies in which losses were incurred, subject to 80% taxable income limitation annually. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets have not been recognized in respect of these tax losses as they have been incurred in subsidiaries that were loss-making in the past and it is not probable that they will generate sufficient taxable income in the foreseeable future to utilize such tax losses. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the double tax avoidance arrangements and other applicable PRC laws, the 10% withholding tax on the dividends the Hong Kong resident enterprise receives from a PRC resident enterprise may be reduced to 5%. However, if an applicant&#8217;s business activities do not constitute substantive business activities, it could result in the negative determination of the applicant&#8217;s status as a &#8220;beneficial owner&#8221;, and consequently, the applicant could be precluded from enjoying the above-mentioned reduced income tax rate of 5%. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the current laws of the United States of America, dividends payable by a U.S. entity to non-U.S. resident enterprises shall be subject to 30% withholding tax, unless the respective non-U.S. resident enterprise&#8217;s jurisdiction of incorporation has a tax treaty or arrangements with U.S. that provides for a reduced withholding tax rate or an exemption from withholding tax. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to Swiss tax policy, a Swiss entity is subject to a 35% withholding tax when the entity pays dividends to a non-Swiss resident enterprise. However, according to the Agreement for the Avoidance of Double Taxation signed between Switzerland and Singapore, the withholding tax rate will be reduced to 5% if the non-Swiss resident enterprise is a Singapore resident enterprise.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.32pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">7.</font>
          <br >
        </div>
        <div style=" margin-top:8.32pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">DIVIDENDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No dividends have been declared and paid by the Company or the Group during the Relevant Periods.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.32pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">8.</font>
          <br >
        </div>
        <div style=" margin-top:8.32pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE PARENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.31pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The calculation of the basic loss per share amount is based on the loss for the year attributable to ordinary equity holders of the parent, and the weighted average number of ordinary shares of 25,440,000 and 25,440,000 in issue during the&#160;years ended December&#160;31, 2021 and 2022, respectively. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:77.0599999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">8.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE PARENT</font>
          <br >
          <font style="letter-spacing:-0.2pt;">&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The calculation of the basic loss per share amount is based on the loss for the years attributable to ordinary equity holders of the parent, and the weighted average number of ordinary shares in issue or deemed to be in issue during the year ended December&#160;31, 2021 and 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:11.2pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Basic loss per share is computed on the basis of the weighted average number of ordinary shares outstanding during the period of the financial statements.</font>
        </div>
        <div style="text-indent:20pt; margin-top:11.2pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Diluted loss per share of ordinary stock is computed on the basis of the weighted average number of shares of ordinary stock and dilutive securities (such as stock options and convertible securities) outstanding. As of December&#160;31, 2021 the Company had 62,967,406 dilutive shares consisting of 57,543,414 relating to convertible preferred stock and 5,423,992 relating to options. As of December 31, 2022 the Company had 64,300,522 dilutive shares consisting of 57,543,414 relating to convertible preferred stock and 6,757,108 relating to options. Dilutive securities that have an anti-dilutive effect on diluted loss per share are excluded from the calculation.</font>
        </div>
        <div style="text-indent:20pt; margin-top:11.19pt; text-align:justify; width:456pt; line-height:13pt;">
          <font style="letter-spacing:0.2pt;">No adjustment has been made to the basic loss per share amounts presented for the&#160;years ended December&#160;31, 2021 and 2022 in respect of a dilution as the impact of the outstanding share options, restricted stock&#160;units and warrant liability had an anti-dilutive effect on the basic loss per share amounts presented.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">9.</font>
          <br >
        </div>
        <div style=" margin-top:13.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">PROPERTY, PLANT AND EQUIPMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:208pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:185.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Leasehold </font>
                <br >
                <font style="letter-spacing:-0.16pt;">improvements</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Plant and </font>
                <br >
                <font style="letter-spacing:-0.16pt;">machinery</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Office </font>
                <br >
                <font style="letter-spacing:-0.16pt;">equipment</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Motor </font>
                <br >
                <font style="letter-spacing:-0.16pt;">vehicles</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Electronic </font>
                <br >
                <font style="letter-spacing:-0.16pt;">equipment</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:185.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:185.14pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">At January&#160;1, 2021, net of accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,758</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,676</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">98</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">18</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">180</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,730</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">192</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">509</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">23</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">726</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation provided during the year </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(385<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(364<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(34<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(6<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(72<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(861<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Disposals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(3<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(1<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange realignment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">24</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">64</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:185.14pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">At December&#160;31, 2021, net of accumulated </font>
                <br >
                <font style="letter-spacing:0.2pt;">depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,601</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1,842</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">68</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">3,655</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:185.14pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,991</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,217</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">163</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">240</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">287</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">5,898</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:2px solid #CCEEFF;padding:3.5pt 0pt 3pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(390<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,375<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(95<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(228<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(155<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:0.5pt solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,243<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:2px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:2px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net carrying amount </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,601</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1,842</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">68</td>
            <td style="padding:0pt;padding-left:9.5pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:3.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">3,655</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:2.85000000000002pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">9.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">PROPERTY, PLANT AND EQUIPMENT&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:208pt;margin-top:12pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:185.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Lease hold </font>
                <br >
                <font style="letter-spacing:-0.16pt;">improvements </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Plant and </font>
                <br >
                <font style="letter-spacing:-0.16pt;">machinery </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Office </font>
                <br >
                <font style="letter-spacing:-0.16pt;">equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Motor </font>
                <br >
                <font style="letter-spacing:-0.16pt;">vehicles </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Electronic </font>
                <br >
                <font style="letter-spacing:-0.16pt;">equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:185.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:185.14pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">At January&#160;1, 2022, net of accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,601</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,842</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">68</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">12</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">132</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,655</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">710</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">360</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">168</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">11</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,249</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation provided during the year </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(416<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(412<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(31<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(19<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(53<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(931<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Disposals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(10<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(10<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange realignment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(121<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(117<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(8<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(250<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.583pt 0pt; width:185.14pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">At Dec 31, 2022, net of accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,774</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1,673</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">33</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">151</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">82</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">3,713</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of December&#160;31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,532</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,386</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">150</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">199</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">276</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">6,543</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(758<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,713<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(117<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(48<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(194<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,830<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net carrying amount </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,774</td>
            <td style="padding:0pt;padding-left:11.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1,673</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">33</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">151</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">82</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">3,713</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:14.19pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the Relevant Periods, none of the Group&#8217;s property, plant and equipment were pledged. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There was no impairment for the Group&#8217;s property, plant and equipment during the Relevant Periods.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">10.</font>
          <br >
        </div>
        <div style=" margin-top:13.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">LEASES</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group has lease contracts of properties and used in its operation with lease terms between 2 and 5&#160;years. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Right-of-use assets </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The carrying amounts of the Group&#8217;s right-of-use assets and the movements during the Relevant Periods are as follows: </font>
        </div>
        <table style="width:416pt;height:67.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:276.39pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Offices</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Office equipment</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:276.39pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:276.39pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of January&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,497</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">337</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,834</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:276.39pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation provided during the year </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(821<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(130<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(951<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2pt 0pt 1pt 0pt; width:276.39pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange realignment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">49</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">2</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">51</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:276.39pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,725</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">209</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,934</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:416pt;height:79.5pt;margin-left:20pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:273.06pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Offices </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Office equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:273.06pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:273.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of January&#160;1, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">2,725</div>
            </td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">209</div>
            </td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">2,934</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:273.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">463</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">463</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:273.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation provided during the year </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(961<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">(129<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(1,090<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2pt 0pt 1pt 0pt; width:273.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange realignment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">(141<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">(145<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:273.06pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of December&#160;31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">2,086</div>
            </td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">76</div>
            </td>
            <td style="padding:0pt;padding-left:19.29pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">2,162</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:152pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">10.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">LEASES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Lease liabilities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The carrying amount of lease liabilities and the movements during the Relevant Periods are as follows: </font>
        </div>
        <table style="width:416pt;height:154pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:352.33pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Lease liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:352.33pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:352.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of January&#160;1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(3,635<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:352.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accretion of interest recognized during the year</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(160<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:352.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">966</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2pt 0pt 1pt 0pt; width:352.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange realignment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(59<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:352.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,888<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.25pt 0pt 0.5pt 0pt; width:352.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of January&#160;1, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,888<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:352.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(463<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:352.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accretion of interest recognized during the year </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(133<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:352.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,070</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2pt 0pt 1pt 0pt; width:352.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange realignment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">177</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:352.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of December&#160;31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,237<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.815pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:416pt;height:67.5pt;margin-left:20pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:346.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:346.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:346.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Analyzed into: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:346.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">834</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,001</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2pt 0pt 1pt 0pt; width:346.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non-current portion </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,054</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,236</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:346.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,888</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,237</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:13pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:13pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The amounts recognized in profit or loss in relation to leases are as follows: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:63.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:319.81pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:319.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.5pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.5pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:319.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.5pt 0pt 0.5pt 0pt; width:319.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest on lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">158</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">133</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:1.75pt 0pt 0.75pt 0pt; width:319.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation charge of right-of-use assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">951</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,090</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.5pt 0pt 1.5pt 0pt; width:319.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total amount recognized in profit or loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,109</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.5pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,223</td>
            <td style="padding:0pt;padding-left:6.695pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">11.</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">PREPAYMENTS, OTHER RECEIVABLES AND OTHER ASSETS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:187.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:378.35pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:378.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:378.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:378.35pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:378.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Prepayments (Note i) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,673</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,912</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:378.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">VAT deductible tax</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,586</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:378.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deposits and other receivables </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">345</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">246</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:378.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">6,604</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,258</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:378.35pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Non-current: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:378.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deposits and other receivables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">208</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:378.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">247</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">327</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:378.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">455</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">327</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:378.35pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">7,059</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,585</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.2pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5.7pt; text-align:justify; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Note i: </font>
        </div>
        <div style="margin-top:2.3pt; text-align:justify; width:456pt; line-height:9.5pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">The amount represents prepayments for Contract Research Organizations (&#8220;CROs&#8221;) and deposit of property, plant and equipment not yet placed in use. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Other receivables had no historical default. The financial assets included in the above balances relate to receivables which were categorized in stage 1 at the end of each of the Relevant Periods. In calculating the expected credit loss rate, the Group considers the historical loss rate and adjusts for forward-looking factors and information. During the Relevant Periods, the Group estimated that the expected credit loss rate for other receivables and deposits was minimal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group seeks to maintain strict control over its outstanding receivables to minimize credit risk. Long ageing balances are reviewed regularly by senior management. In view of the fact that the Group&#8217;s deposits and other receivables relate to a large number of diversified counterparties, there is no significant concentration of credit risk. The Group does not hold any collateral or other credit enhancements over its deposits and other receivable balances.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">12.</font>
          <br >
        </div>
        <div style=" margin-top:11.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL ASSETS AT FVTPL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:96pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:336.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wealth management product </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">46,269</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dual currency structured deposit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">7,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:336.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">53,809</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.7pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">During the Relevant Periods, the Group used surplus capital to purchase dual currency structured deposit and wealth management product from domestic commercial banks, which preserved capital and liquidity. The dual currency structured deposits held as of December 31, 2021 were compound financial instruments which combined traditional bank deposits with foreign currency derivatives with investment periods from 1 to 3 months. The wealth management product held as of December 31, 2021 was an investment into a mutual fund whose portfolio included a mixture of fixed income assets and asset-backed securities, which were redeemable </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">12.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL ASSETS AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">on any work day. The wealth management product held as of December 31, 2022 was an investment into a mutual fund whose portfolio included a mixture of fixed income assets, preferred shares and repos, which were redeemable every 3 months. The returns on all of these financial products were not guaranteed, hence their contractual cash flows did not qualify solely as payments of principal and interest. Therefore, those products were accounted at fair value through profit or loss. Further details are included in note 20(c) to the Consolidated Financial Statements.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8.72pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">13.</font>
          <br >
        </div>
        <div style=" margin-top:8.72pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">OTHER PAYABLES AND ACCRUALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:416pt;height:81pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.35pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:338.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:338.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other payables and accruals (Note i) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">738</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">255</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:338.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payroll and bonus payables </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,486</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,622</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.35pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,224</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">3,877</td>
            <td style="padding:0pt;padding-left:2.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.01pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4.6pt; text-align:justify; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Note i: </font>
        </div>
        <div style="margin-top:2.5pt; text-align:justify; width:456pt; line-height:9.5pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Other payables and accruals are unsecured, non-interest-bearing and repayable on demand. The fair values of other payables and accruals at the end of each of the Relevant Periods approximated to their corresponding carrying amounts.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.63pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">14.</font>
          <br >
        </div>
        <div style=" margin-top:7.63pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">INTEREST-BEARING BANK BORROWINGS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:136pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:384.35pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:384.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:384.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:384.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Revolving Facility, 5.3% interest, due March&#160;8, 2022, unsecured (Note i) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">784</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:384.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non-Revolving Facility, 4.35% interest, due March&#160;22, 2022, guaranteed (Note ii) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,137</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:384.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non-Revolving Facility, 4.35% interest, due May&#160;1, 2022, guaranteed (Note ii) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,137</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:384.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non-Revolving Facility, LPR+1.73% interest, due March&#160;25, 2022, guaranteed (Note&#160;iii)&#160;</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,569</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:384.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non-Revolving Facility, 4.2% interest, due March&#160;31, 2022 (Note iv) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,830</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:384.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non-Revolving Facility, 5.22% interest, due March 22,2023, guaranteed (Note iii) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,436</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.5pt 0pt 1.5pt 0pt; width:384.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non-Revolving Facility, 4.8% interest, due April 24,2023, guaranteed (Note v) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">2,871</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:384.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,457</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:2.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:162pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:344.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Bank borrowings </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:7.99999999999994pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:344.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:344.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of January 1, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">8,296</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">8,296</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.5pt 0pt; width:344.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">12,411</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">12,411</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:344.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Repayments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(10,430<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(10,430<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:344.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effect of foreign exchange rate changes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">180</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">180</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:344.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">10,457</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">10,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.5pt 0pt; width:344.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">7,897</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">7,897</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:344.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Repayments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(13,316<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(13,316<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:344.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effect of foreign exchange rate changes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(731<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(731<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:344.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of December&#160;31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:12.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-33</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">14.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">INTEREST-BEARING BANK BORROWINGS&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">All of the Group&#8217;s bank borrowings were obtained from third party financial institutions. As of December&#160;31, 2021 and 2022, the Group&#8217;s credit facilities were $10,457 and $4,307, respectively, of which nil and nil was unused by the Group.</font>
        </div>
        <div style="margin-top:8.3pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5.8pt; text-align:justify; width:456pt; line-height:10pt;">
          <font style="letter-spacing:0.16pt;">Notes: </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:3.91pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:3.91pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">In March&#160;2021, Adlai Hangzhou entered into a revolving facility agreement for a facility amount of RMB 5,000 and at an interest rate of 5.3% per annum. The revolving facility agreement was repaid at the maturity date of September&#160;25, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:2.1pt; text-align:justify; width:436pt; line-height:9.5pt;">
          <font style="letter-spacing:0.16pt;">In September&#160;2021, Adlai Hangzhou entered into a revolving facility agreement for a facility amount of RMB 5,000 and at an interest rate of 5.3% per annum. The revolving facility agreement was repaid at the maturity date of March&#160;8, 2022. </font>
        </div>
        <div style="margin-left:20pt; margin-top:2.1pt; text-align:justify; width:436pt; line-height:9.5pt;">
          <font style="letter-spacing:0.16pt;">In March 2022, Adlai Hangzhou entered into a revolving facility agreement for a facility amount of RMB 5,000 and at an interest rate of 5.3% per annum. The revolving facility agreement was repaid at the maturity date of September 3, 2022. </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:3.9pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">In May&#160;2021, Adlai Hangzhou entered into a non-revolving facility agreement for a facility amount of RMB 20,000 and at an interest rate of 4,35% per annum, guaranteed by Mr.&#160;Yang Lu. The non-revolving facility agreement was repaid at the maturity date of May&#160;31, 2022. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:2.1pt; text-align:justify; width:436pt; line-height:9.5pt;">
          <font style="letter-spacing:0.16pt;">In June&#160;2021, Adlai Hangzhou entered into a non-revolving facility agreement for a facility amount of RMB 20,000 and at an interest rate of 4.35% per annum, guaranteed by Mr.&#160;Yang Lu. The non-revolving facility agreement was repaid at the maturity date of December&#160;9, 2021. </font>
        </div>
        <div style="margin-left:20pt; margin-top:2.1pt; text-align:justify; width:436pt; line-height:9.5pt;">
          <font style="letter-spacing:0.16pt;">In December&#160;2021, Adlai Hangzhou entered into a non-revolving facility agreement for a facility amount of RMB 20,000 and at an interest rate of 4.35% per annum, guaranteed by Mr.&#160;Yang Lu. The non-revolving facility agreement was repaid at the maturity date of March&#160;22, 2022. </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:3.9pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">In March&#160;2021, Adlai Hangzhou entered into a non-revolving facility agreement for a facility amount of RMB 10,000 and at a floating interest rate of LPR plus 1.73% per annum, guaranteed by Mr.&#160;Yang Lu. The non-revolving facility agreement was repaid at the maturity date of March&#160;18, 2021. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:2.1pt; text-align:justify; width:436pt; line-height:9.5pt;">
          <font style="letter-spacing:0.16pt;">In March 2022, Adlai Hangzhou entered into a non-revolving facility agreement for a facility amount of RMB 10,000 and at an interest rate of 5.22% per annum, guaranteed by Mr. Yang Lu, the chief executive officer and chairman of our board of directors. The non-revolving facility agreement was repaid at the maturity date of March 22, 2023. </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:3.9pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">In May 2019, the Company entered into a non-revolving facility agreement with SPD Silicon Valley Bank Co., Ltd (&#8220;SPD&#8221;) which was conditional on the Company issuing warrant (the &#8220;CEHKL Warrant&#8221;, further details are included in note 15 to the Consolidated Financial Statements) to China Equities HK Limited (&#8220;CEHKL&#8221;), an affiliate of SPD Bank. The total facility amount is $10,000 at an interest of 8% per annum, with the maturity date on May 31, 2022. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:2.1pt; text-align:justify; width:436pt; line-height:9.5pt;">
          <font style="letter-spacing:0.16pt;">In April&#160;2021, the Company signed an amendment of its previous loan facility agreement. According to the amendment, it changed the interest rate to 4.2% per annum, and changed the facility availability period to December&#160;31, 2021. </font>
        </div>
        <div style="margin-left:20pt; margin-top:2.1pt; text-align:justify; width:436pt; line-height:9.5pt;">
          <font style="letter-spacing:0.16pt;">In April&#160;2021, the Company borrowed $3,000 from SPD. At the end of 2021, The outstanding balance is $1,830 as of December&#160;31, 2021. The facility agreement was repaid at the maturity date of March 31, 2022. </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:3.9pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(v)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">In April 2022, Adlai Hangzhou entered into a non-revolving facility agreement for a facility amount of RMB 10,000 and at an interest rate of 4.80% per annum, guaranteed by Mr. Yang Lu, the chief executive officer and chairman of our board of directors. The non-revolving facility agreement was repaid at the maturity date of October 24, 2022. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:2.1pt; text-align:justify; width:436pt; line-height:9.5pt;">
          <font style="letter-spacing:0.16pt;">In October 2022, Adlai Hangzhou entered into a non-revolving facility agreement for a facility amount of RMB 20,000 and at an interest rate of 4.80% per annum, guaranteed by Mr. Yang Lu, the chief executive officer and chairman of our board of directors. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">15.</font>
          <br >
        </div>
        <div style=" margin-top:11.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;font-size:10pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Preferred shares and convertible loans</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">In late 2015, Adlai Hangzhou raised up to RMB70,000 from the Founders and certain onshore investors (&#8220;Series&#160;A Investors&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2018, the Company was established in the Cayman Island for seeking overseas listing opportunity, and the Company issued ordinary shares to the Founders and an option to the Series&#160;A Investors, which entitled Series&#160;A Investors to convert their equity interests in Adlai Hangzhou to up to 14,560,000 series A convertible preferred shares (&#8220;Series&#160;A Preferred Shares&#8221;) of the Company, at par value of $ 0.0001 per share, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-34</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">upon completion of the Reorganization. From January 2020 to April&#160;2020, Series&#160;A Investors exercised the option and converted their equity interests in Adlai Hangzhou to Series&#160;A Preferred Shares of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2018, to accommodate the Group&#8217;s Reorganization plan, certain onshore investors (&#8220;Series&#160;B Onshore Investors&#8221;) entered into convertible loan subscription agreement (the &#8220;Series&#160;B Loan Agreement&#8221;) with Adlai Hangzhou to issue a loan (the &#8220;Series&#160;B Convertible Loans&#8221;) to Series&#160;B Onshore Investors for a total consideration of RMB165,000. Meanwhile, the Company entered into a forward contract with these Series&#160;B Onshore investors to grant them an option (&#8220;Series&#160;B Preferred Shares Forward&#8221;) to convert Series&#160;B Convertible Loans issued by Adali Hangzhou to 6,600,000 series B convertible redeemable preferred shares (&#8220;Series&#160;B Preferred Shares&#8221;) of the Company, at par value of $ 0.0001 per share, upon completion of the Reorganization. Pursuant to the Series&#160;B Loan Agreement, these loans bore interest at 15% per annum and shall mature upon the exercise of the Series&#160;B Preferred Shares Forward. The Series&#160;B Onshore Investors agreed Adlai Hangzhou&#8217;s obligation of repayment the principal and accrued interests of these loans will be automatically relieved with the exercise of Series&#160;B Share Purchase Forward upon completion of the Reorganization. From April to May&#160;2020, the Series&#160;B Onshore Investors have exercised their Series&#160;B Share Purchase Forward and converted their Series&#160;B Convertible Loans to an aggregate of 6,600,000 Series&#160;B Preferred Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Concurrently, certain offshore investors (&#8220;Series&#160;B Offshore Investors&#8221;) subscribed 6,907,896 Series&#160;B Preferred Shares (&#8220;Series&#160;B Preferred Shares&#8221;) for a total consideration of $27,000. The Series&#160;B Onshore Investors and Series&#160;B Offshore Investors are collectively referred to as &#8220;Series&#160;B Investors&#8221;. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2019, the Company issued 14,653,013 series C convertible redeemable preferred shares (&#8220;Series&#160;C Preferred Shares&#8221;) of the Company for a total consideration of $63,700 to certain investors (&#8220;Series&#160;C Investors&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In April&#160;2021, the Company entered into a Series&#160;D share purchase agreement with certain investors (&#8220;Series&#160;D Investors&#8221;) to issue an aggregate of 14,722,505 series D convertible redeemable preferred shares (&#8220;Series&#160;D Preferred Shares&#8221;) for a total consideration of $97,370 and paid in full as of December&#160;31,&#160;2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the original and amended Memorandum and Articles of Association (&#8220;MOA&#8221;) upon the issuance of each series of convertible redeemable preferred shares, the Group designated Series&#160;B, C and D Preferred Shares and Series&#160;B Convertible Loans as financial liabilities measured at FVTPL and recognized Series&#160;A Preferred Shares as equity in accordance with the relevant IFRS. There is no significant change in the major terms of MOA among of each series except mentioned otherwise in the notes to the Consolidated Financial Statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the MOA of the Company in May&#160;2021, the key terms of the Series&#160;A, B, C and D Preferred Shares (collectively &#8220;Preferred Shares&#8221;) are as follows: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conversion Rights (applicable to all Preferred Shares)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each holder of Preferred Shares may, at the option of the holder thereof, be converted at any time into fully-paid and nonassessable ordinary shares of the Company based on the then-effective applicable conversion price (&#8220;Applicable Conversion Price&#8221;). Each holder of Preferred Shares shall automatically be converted, based on the Applicable Conversion Price, into ordinary shares of the Company upon the closing of a Qualified IPO (as defined below). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Applicable Conversion Price is initially equal to the original issue price for each class of Preferred Shares and shall be subject to adjustment from time to time, including but not limited to share splits, share subdivision, share combination and the like, being no less than par value. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-35</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Company issues any additional ordinary shares at a subscription price less than the corresponding original subscription price of the Series&#160;B, C and D Preferred Shares, the Company shall issue new corresponding Series&#160;B, C and D Preferred Shares to the holders of Series&#160;B, C and D Preferred Shares at the nominal price or the minimum price allowed by applicable laws until the Applicable Conversion Price for each holders of Series&#160;B, C and D Preferred Shares is reduced to such issue price. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Group fails to meet any of the below two committed business objectives (&#8220;Business Objectives&#8221;) within the timelines, the holders of Series&#160;C Preferred Shares are entitled to request the Founders, affiliates of the Founders and the Group (collectively referred to as &#8220;Warrantors&#8221;) to jointly make up the share compensation necessary to make the pre-money valuation of the Company immediately before the investment by the holders of Preferred Shares be adjusted to 70% thereof. The share compensation arrangement shall be made on the basis of a nominal transfer price. The Business Objectives are: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">a)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">promote at least three products (self-developed or by introduction) to the next clinical stage within eighteen&#160;months from the Series&#160;C Preferred Shares closing date, on the basis of existing clinical pipelines; and; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.9pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">b)</font>
          <br >
        </div>
        <div style=" margin-top:7.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtain the approval of one new drug application from the competent authority for drug administration in the US or PRC by the 3rd anniversary of Series&#160;C Preferred Shares closing date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Qualified IPO means an underwritter initial public offering of the Company completed no later than the earlier of (i)&#160;September&#160;7, 2023 and (ii)&#160;two&#160;years after the date of Closing of the Series&#160;D Preferred Shares and which occurs on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Market or such other reputable stock exchange approved by the a majority of all of the investor directors with (i)&#160;the pre-public offering market capitalization of no less than $650,000, unless otherwise agreed by the investor directors; and (ii)&#160;shares held by the investors can be listed for trading or otherwise disposed of without transfer restrictions after any applicable statutory lock-up period. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting Rights (applicable to all Preferred Shares)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise required by law or as set forth herein, the holder of each ordinary share issued and outstanding shall have one vote for each ordinary share held by such holder, and the holder of Preferred Shares shall be entitled to the number of votes equal to the number of ordinary shares into which such Preferred Shares could be converted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidation Preference (applicable to all Preferred Shares)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon any liquidation, closure, dissolution, merger or acquisition of any Group company; or the transfer of a controlling interest (i.e., more than 50% of the equity) by the shareholders of any Group company (excluding the holders of Series&#160;A, B, C and D Preferred Shares); or the sale of the majority of any Group&#8217;s assets to third parties; or the transfer of the majority of any Group&#8217;s intellectual property to third parties; or any event that can be defined as a transfer of control of any Group company; or any transfer of the Shares of any Group company (excluding the shares of the Company held by the holders of Series&#160;A, B, C and D Preferred Shares) or shares held by the Founders or their affiliates without the prior written consent of the Investor Director Majority, Series&#160;C Investors and Series&#160;D Investors; or any breach of the Warrantors under the Series&#160;D Share Purchase Agreements, the Series&#160;C Share Purchase Agreements, the Series&#160;B Share Purchase Agreement, the Shareholders&#8217; Agreement and these Articles, as applicable (&#8220;Transaction Documents&#8221;) which would cause the Series&#160;C Investors and Series&#160;D Investors to claim for termination of any of the Transaction Documents (each a &#8220;Liquidation Event&#8221;), whether voluntary or involuntary, all assets and funds of the Company legally available for distribution to the shareholders is distributed to the shareholders of the Company in the sequence as follows: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-36</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:12pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">a)&nbsp;&nbsp;&nbsp;Series&#160;D Preferred Shares </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">b)&nbsp;&nbsp;&nbsp;Series&#160;C Preferred Shares </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">c)&nbsp;&nbsp;&nbsp;Series&#160;B Preferred Shares </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">d)&nbsp;&nbsp;&nbsp;Series&#160;A Preferred Shares </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If there are any assets or funds remaining after the aggregate Series&#160;A, B, C and D Preferred Shares have been distributed or paid fully, the remaining assets and funds of the Company available for distribution is distributed on a pro&#160;rata basis among all holders of outstanding ordinary shares and Preferred Shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends (applicable to all Preferred Shares)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each holder of the ordinary shares (on as-converted basis) shall be entitled to receive dividends on a pro&#160;rata basis on the number of ordinary shares, out of any funds legally available therefor, pro&#160;rata based on the number of ordinary shares held by each holder. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Redemption Rights (applicable to Series&#160;B, C and D Preferred Shares)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At any time after the earlier of the following, any investors of Preferred Shares shall be entitled to require the Company to redeem all or portion of the outstanding Preferred Shares held by them, and/or require each of the Warrantors to jointly and severally redeem or repurchase all or portion of the outstanding Preferred Shares held by them: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">i.</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Company fails to complete a Qualified IPO at the earlier of (a)&#160;September&#160;7, 2023; and (b)&#160;two&#160;years after the date of Closing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">ii.</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(applicable to Series&#160;C Investors and Series&#160;D Investors only) with respect to any Series&#160;C Investor or Series&#160;D Investor, such Series&#160;C Investor or Series&#160;D Investor fails to achieve the investment return which is 100% of its investment amount and plus an amount that would accrue on its investment amount at a simple interest rate of ten&#160;percent (10%) per annum (if such period is less than a year, such interest amount shall be calculated proportionally) through transfer, dividends of the Preferred Shares, or disposal in any other way approved by such Series&#160;C Investors or Series&#160;D Investors plus the value of the Preferred Shares (if any) still held by such Series&#160;C Investors or Series&#160;D Investors by September&#160;7, 2023 (with respect to Series&#160;C Investors) or by three&#160;years following its closing of Series&#160;D (with respect to Series&#160;D Investors); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">iii.</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(applicable to Series&#160;C Investors only) the applicable Group company fails to meet any of the Committed Business Objectives within the timelines specified under these Articles; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">iv.</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(applicable to Series&#160;C Investors only) the applicable Group company fails to obtain approval of a new medicine application from the competent authority for drug administration of its first medicine in the U.S. or the PRC by December&#160;30, 2022; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">v.</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(applicable to Series&#160;C Investors and Series&#160;D Investors only) the first disapproval or rejection by any competent governmental authority (including, without limitation, the National Medical Products Administration of the PRC or the U.S. Food and Drug Administration) of the application made by any Group company with respect to any of its new drugs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">vi.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in case that the Group companies meet the requirements for a Qualified IPO, any of the Group companies or the management shareholders refuses the Qualified IPO or declines to make necessary </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-37</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:44pt; margin-top:12pt; text-align:justify; width:412pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">cooperation for such Qualified IPO, or the Group companies fail to complete the Qualified IPO due to any reasons attributable to any management shareholder;</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.6pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">vii.</font>
          <br >
        </div>
        <div style=" margin-top:7.6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">without the written consent of the majority of investor directors, Series&#160;C Investors and Series&#160;D Investors, Mr.&#160;Yang Lu and Mr.&#160;Donghui Yang terminate their employment contracts with the applicable Group company or fail to comply their commitment to work full time as per the agreement with certain Series&#160;C Investors or Series&#160;D Investors prior to the latest to occur of the following events: (a)&#160;such Series&#160;C Investors or Series&#160;D Investors&#8217; exit; (b)&#160;the occurrence of a Qualified IPO; (c)&#160;the expiry of the two&#160;years period after the closing of Series&#160;D; and (d) September&#160;7, 2023; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.6pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">viii.</font>
          <br >
        </div>
        <div style=" margin-top:7.6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">material change of principal business or, business scope of the Group companies without the written consent of the majority of investor directors, Series&#160;C Investors and Series&#160;D Investors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.61pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">ix.</font>
          <br >
        </div>
        <div style=" margin-top:7.61pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any significant intellectual property of any Group company becomes invalid, frozen, or is transferred, authorized, pledged, encumbered, hypothecated to any third party without prior written consent of the majority of investor directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.6pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">x.</font>
          <br >
        </div>
        <div style=" margin-top:7.6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the occurrence of a material breach by any Group company or any management shareholders of any of their respective representations, warranties, covenants or undertakings under the Transaction Documents and failure by applicable Group companies or management shareholders to make remedy within thirty days after so required; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.61pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">xi.</font>
          <br >
        </div>
        <div style=" margin-top:7.61pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the occurrence of a material breach by any Group company or any management shareholder of any of mandatory laws or regulations in the applicable jurisdiction; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.6pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">xii.</font>
          <br >
        </div>
        <div style=" margin-top:7.6pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:44pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the occurrence of any material dishonesty problem by any Group company or any management shareholder. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Next Equity Financing Warrant</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2018, in connection with the issuance of the Series&#160;B Preferred shares, the Company irrevocably issued to certain Series&#160;B Investors a warrant (&#8220;Next Equity Financing Warrant&#8221;), by which each of these Series&#160;B Investors shall be entitled but not obligated to purchase a certain number of the Company&#8217;s Preferred Shares with a par value of $0.0001 per share prior to the closing date of the Company&#8217;s next round equity or equity-linked financing (the &#8220;Next Equity Financing&#8221;), at an exercise price per share of ninety-five&#160;percent (95%) of the subscription price per share for the investors in such Next Equity Financing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Next Equity Financing Warrant expired upon the closing date of the Company&#8217;s Series&#160;C financing in August&#160;2019 as none of these Series&#160;B Investors subscribed the Company&#8217;s Series&#160;C Preferred Shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">CEHKL Warrant</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;20, 2019, the Company entered into a warrant agreement with China Equities HK Limited (&#8220;CEHKL&#8221;), under which the Company agreed to issue certain Series&#160;B Preferred Shares to CEHKL with agreed price (&#8220;CEHKL Warrant&#8221;) and the CEHKL Warrant will expire on May&#160;20, 2024. In July&#160;2021, CEHKL elected to exercise the CEHKL Warrant and the Company issued 100,000 Series&#160;B Preferred Shares to CEHKL. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Presentation and classification</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group and the Company have designated the Series&#160;B, C and D Preferred Shares and Series&#160;B Convertible Loans as financial liabilities measured at FVTPL upon initial recognition. The Next Equity </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-38</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Financing Warrant and CEHKL Warrant are initially recognized at fair value on the date on which the contract is entered into and are subsequently remeasured at fair value.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The change in fair value of financial liabilities at FVTPL is charged to profit or loss except for the portion attributable to credit risk change that shall be charged to other comprehensive income. The net gain or loss recognized in profit or loss includes any interest paid on the financial liabilities and is included in the loss on changes in fair value of financial liabilities at FVTPL line item. Management concluded that there is no credit risk of the financial liability that drives the change of the fair value of the financial liability. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The movements of the Group&#8217;s financial liabilities at FVTPL are set out as follows: </font>
        </div>
        <table style="width:456pt;height:143.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:269.01pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;B </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;C</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;D</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">CEHKL </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Warrant</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:269.01pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Note ii) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:269.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">At January 1, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">78,283</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">74,697</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">303</td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">153,283</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:269.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Issuance of Preferred Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">303</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">97,370</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">(303<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">97,370</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:269.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in fair value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">13,601</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">23,029</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">10,280</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">46,910</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:269.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">At December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">92,187</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">97,726</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">107,650</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:269.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in fair value</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(1,803<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(594<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(4,798<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(7,195<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:269.01pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">At December 31, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">90,384</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">97,132</td>
            <td style="padding:0pt;padding-left:1.85pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">102,852</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:96pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:366.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:366.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Analyzed into: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Current portion (Note iii) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:366.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non-current portion (Note iii) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:366.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6pt; text-align:justify; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Notes: </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">In July 2021, CEHKL elected to exercise CEHKL Warrant and the Company issued 100,000 Series B Preferred Shares to CEHKL. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Pursuant to the Company&#8217;s amended and restated MOA upon the Series&#160;C Preferred Shares financing in August&#160;2019: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">&#8212;</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:40pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">the holders of the Series&#160;C Preferred Shares were entitled to an option to require the Company to early redeem the whole preferred shares when the Company or any other group company fails to consummate a Qualified IPO at any time on or before 30 September&#160;2021; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:10pt; margin-top:4pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">&#8212;</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:40pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">the holders of the Series&#160;B Preferred Shares were entitled to an option to require the Company to early redeem the whole preferred shares when the Company or any other group company fails to consummate a Qualified IPO at any time on or before 1 June&#160;2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:6pt; text-align:justify; width:436pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">With the Company entering into a series of Series&#160;D share purchase agreements from April&#160;2021 to July&#160;2021, the Company adopted an amended and restated MOA on May&#160;28, 2021, pursuant to which the required latest completion date of a Qualified IPO by the Company under the Series&#160;C share purchase agreements was modified from September&#160;30, 2021 to June&#160;1, 2023. </font>
        </div>
        <div style="margin-left:20pt; margin-top:6pt; text-align:justify; width:436pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">As such, the Series&#160;C Preferred Shares were presented as a non-current liability as of December&#160;31, 2021. Other financial liabilities measured at FVTPL were presented as a non-current liability as of December&#160;31, 2021. </font>
        </div>
        <div style="margin-left:20pt; margin-top:6pt; text-align:justify; width:436pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Series B, C and D Preferred Shares were reclassified as a current liability as of December 31, 2022 according to the MOA signed on May 28, 2021. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-39</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company has used the discounted cash flow method and back-solve method to determine the underlying share value of the Company and adopted equity allocation model to determine the fair value of each financial liability as of the dates of issuance and at the end of each of the Relevant Periods. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Set out below is a summary of significant unobservable inputs to the valuation of financial instruments together with a quantitative sensitivity analysis as of December&#160;31, 2021 and 2022: </font>
        </div>
        <table style="width:416pt;height:82pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:302.57pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:302.57pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:302.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value of ordinary shares of the Company </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$5.25 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">$6.15</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate (Note i) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">0.47%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">4.68%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">1.29&#8199;years</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:32.25pt; text-align:right; white-space:nowrap;">0.44&#8199;years</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:right;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:302.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Volatility (Note ii) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">49.38%</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0.5pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:right;">
                <font style="letter-spacing:0.2pt;">52.86%</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6pt; text-align:justify; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Notes: </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:5pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">1% increase/decrease in the risk-free interest rate with all other variables held constant would decrease/increase the fair value of convertible redeemable preferred shares by $267/$(698) and $83/84 as of December&#160;31, 2021 and 2022, respectively. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:5pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:5pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">1% increase/decrease in volatility with all other variables held constant would decrease/increase the fair value of convertible redeemable preferred shares by $119/$50 and $(49)/$924 as of December&#160;31, 2021 and 2022, respectively. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group estimated the risk-free interest rate based on the yield of the United States Government Bond with maturity close to the expected exit timing as of the valuation date. Under the option-pricing method, the cost of a put option, which can hedge the price change before the privately held shares can be sold, was considered as a basis to determine the lack of marketability discount. Volatility was estimated based on the annualized standard deviation of the daily stock price return of comparable companies for a period from the valuation date and with a similar time span to expiration.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">16.&nbsp;&nbsp;&nbsp;WARRANTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In connection with issuance of Series&#160;B Preferred shares in August&#160;2019, the Company irrevocably issued to CEHKL 171,559 Private Warrants (&#8220;CEHKL Warrants&#8221;) at a fair value of $486. Please refer to note&#160;15 for details of the CEHKL Warrant. </font>
        </div>
        <div style="margin-left:20pt; margin-top:5pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">None CEHKL Warrants were outstanding as of December 31, 2021 and 2022.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">17.&nbsp;&nbsp;&nbsp;ORDINARY SHARES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:6pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Issued and fully paid:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:416pt;height:50.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.35pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:338.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:338.35pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:338.35pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">25,440,000 shares of $0.0001 each </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:10.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.91pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:10.91pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:10pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The authorized share capital of the Company as of December&#160;31, 2022 is $50 divided into 500,000,000 Shares of par value of $0.0001 each, including 442,456,586 ordinary shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In 2021, the Company issued 9,000,000 ordinary shares to Nortye Talent Limited and 6,000,000 ordinary shares to Nortye International Limited respectively to manage the Share Incentive Plan. All these ordinary shares in 2021 were unpaid shares as of December&#160;31, 2021 and 2022. There was no movement in the Company&#8217;s ordinary shares in 2022.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-40</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">18.&nbsp;&nbsp;&nbsp;DEFICITS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The amounts of the Group&#8217;s deficits and the movement therein for the Relevant Periods are presented in the consolidated statements of changes in equity. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:11.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Additional paid-in capital</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The additional paid-in capital represents the difference between the par value of the shares issued and the consideration received. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:11.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Share option reserve </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The share option reverse of the Group represents the equity-settled share-based payments granted by the Group. Please refer to note 19 for details. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:11.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Exchange fluctuation reserve </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The exchange fluctuation reserve represents exchange differences arising from the translation of the financial statements of Group companies whose functional currencies are different from the Group&#8217;s presentation currency.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">19.&nbsp;&nbsp;&nbsp;SHARE INCENTIVE PLAN</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Adlai Hangzhou Scheme</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Adlai Hangzhou, a subsidiary of the Company, was once listed on the National Equities Exchange and Quotations (&#8220;NEEQ&#8221;) (stock code 870946) and adopted a share incentive scheme (the &#8220;Adlai Hangzhou Scheme&#8221;) for the primary purpose of providing incentives to eligible management and employees who render services to Adlai Hangzhou. On June&#160;15, 2017, awards up to 1,220,000 shares were granted to management and employees at the exercise price of RMB7 per share. Awards granted under the Adlai Hangzhou Scheme shall have a contractual term of five&#160;years and generally vest over a four year period, with 25% of total awards vesting on the anniversary date one year after the vesting commencement date and the remaining 75% vesting subsequently in three equal annual instalments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the awards granted to management and employees were $ 0.083 per share and $ 0.0765 per share, respectively, using the binomial option-pricing model on the grant date. The variables and assumptions used in computing the fair value of the awards are based on the directors&#8217; best estimate. Changes in variables and assumptions may result in changes in the fair value of the awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group recognized $81 of share-based payment expenses prior to 2021, and nil and nil share-based payment expenses for the&#160;years ended December&#160;31, 2021 and 2022, respectively, in relation to the awards granted under the Adlai Hangzhou Scheme. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Adlai Share Incentive Plan</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On June&#160;8, 2020, the Company&#8217;s Board of Directors approved a share incentive scheme (the &#8220;Share Incentive Plan&#8221;) in order to provide additional incentives to employees and to promote the success of the Group&#8217;s business. Unless otherwise cancelled or amended, the Share Incentive Plan will remain in force for 10&#160;years. Under the Share Incentive Plan, the maximum aggregate number of shares shall not exceed 4,000,000 ordinary shares, as appropriately adjusted for subsequent stock splits, stock dividends and the like. On May&#160;28, 2021, the Company&#8217;s Board of Directors approved to further reserve 11,000,000 ordinary shares of the Company for the Share Incentive Plan for a total of 15,000,000 ordinary shares approved for the Share Incentive Plan. The exercise price of share options is determinable by the directors, but shall not be less than 100% of the fair market value on the grant date. Share options do not confer rights on the holders to dividends </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-41</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">19.&nbsp;&nbsp;&nbsp;SHARE INCENTIVE PLAN&#8201;(continued)</font>
        </div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">or to vote at shareholders&#8217; meetings. The awards may be granted but not be exercised prior to the last day of the six-month period following the listing date of the Company.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July 5, 2021, the Company issued 6,000,000 and 9,000,000 ordinary shares reserved under the Share Inventive Plan to Nortye International Limited and Nortye Talent Limited, respectively, which are holding vehicles of two trusts established by the Company in order to facilitate the administration of the Share Incentive Plan. The sole purpose of the two trusts is to facilitate the issuance of ordinary shares under the Share Incentive Plan, and as such the 15,000,000 ordinary shares are not included in the Company&#8217;s calculation of weighted average shares outstanding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;8, 2020 and November&#160;1, 2020, awards for 1,435,000 and 2,560,730 shares, respectively, were granted by the Company to its executives, employees and consultants. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;31, 2021, 3,348,483 awarded shares were granted by the Company to its executives, employees and consultants. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;1, 2021, 412,000 awarded shares were granted by the Company to its executives, employees and consultants. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January 1, 2022, 83,500 options were granted to certain new employees; 376,172 options were granted to certain employees and managers for outstanding performance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On April 1, 2022, 1,077,800 options were granted to certain new employees, promoted employees and senior managers; 33,336 options were granted to three consultants. </font>
        </div>
        <div style="margin-left:20pt; margin-top:5pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July 1, 2022, 207,200 options were granted to five new employees. </font>
        </div>
        <div style="margin-left:20pt; margin-top:5pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October 1, 2022, 179,200 options were granted to five new employees.</font>
        </div>
        <div style="text-indent:20pt; margin-top:5pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, the Group measured the fair value of the awards as of the grant date and recognizes the amount as a compensation expense over the vesting period for each separately vesting portion of the awards. </font>
        </div>
        <table style="width:456pt;height:247pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:209.45pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">awards</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Exercise </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price </font>
                <br >
                <font style="letter-spacing:-0.16pt;">$ per share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Grant Fair </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Value </font>
                <br >
                <font style="letter-spacing:-0.16pt;">$ per share</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Weighted </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Average </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Remaining </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Contractual </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Life </font>
                <br >
                <font style="letter-spacing:-0.16pt;">(in years)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Aggregate </font>
                <br >
                <font style="letter-spacing:-0.16pt;">intrinsic </font>
                <br >
                <font style="letter-spacing:-0.16pt;">value</font>
                <br >
                <font style="letter-spacing:-0.16pt;">$ </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:209.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balances, January 1, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">3,995,730</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">1.45</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">0.76</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">9.78</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">1,464</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:209.45pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Options granted</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,760,483</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.01</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.97</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.45</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:209.45pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Options forfeited/cancelled </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(120,769<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.67</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.69</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.83</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:209.45pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Options exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:209.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balances, December 31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">7,635,444</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">1.72</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">1.36</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">9.11</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">26,950</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.5pt 0pt; width:209.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Options granted </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,957,208</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.20</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">3.56</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">9.26</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:209.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Options forfeited/cancelled </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">(82,550<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.11</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">2.68</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.79</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:209.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Options exercised </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:209.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balances, December 31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">9,510,102</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">1.82</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">1.79</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">8.34</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">41,218</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:209.45pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Vested but not exercisable as of December 31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">3,350,480</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.36</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">0.74</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.46</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:209.45pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Vested but not exercisable as of December 31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,980,069</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.59</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">1.15</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">8.00</td>
            <td style="padding:0pt;padding-left:10.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.31pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-42</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:182.67pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">19.&nbsp;&nbsp;&nbsp;SHARE INCENTIVE PLAN&#8201;(continued)</font>
        </div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As of December 31, 2021 and 2022, there were 15,000,000 and 15,000,000 shares reserved for the option plan and there were 7,364,556 and 5,489,898 shares available for issuance, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:11.19pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the award granted during the&#160;years ended December&#160;31, 2021 and 2022 were $&#160;7,410 and $6,913. The Group recognized share-based payment expenses of $3,386 and $6,082, respectively, during the&#160;years ended December&#160;31, 2021 and 2022. </font>
        </div>
        <div style="text-indent:20pt; margin-top:11.2pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of awards granted during the Relevant Periods was estimated as of the grant date using a binomial option-pricing model, taking into account the terms and conditions upon which the awards were granted. The following table lists the inputs to the model used: </font>
        </div>
        <table style="width:456pt;height:77.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:237.97pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">May&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">October&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">January&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">April&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">July&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">October&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:237.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dividend yield (%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:237.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility (%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">46.13</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">49.00</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">48.73</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">48.78</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">48.88</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">48.82</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:237.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate&#160;(%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.67</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.7</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.66</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.52</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3.03</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3.98</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:237.97pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected life of options (year) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:9.2pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021 and 2022, the Company had 7,635,444 and 9,510,102 awards outstanding under the Share Incentive Plan, respectively. The exercise in full of the outstanding awards would, under the present capital structure of the Company, result in the issue of 7,635,444 and 9,510,102, respectively, additional ordinary shares of the Company and additional share capital of $0.8 and $1.0 (before issue expenses), respectively.</font>
        </div>
        <div style="margin-top:15.19pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">20.&nbsp;&nbsp;&nbsp;NOTES TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:13.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Major non-cash transactions </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:11.19pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">During the year ended December&#160;31, 2021 and 2022, the Group had non-cash additions to right-of-use assets and lease liabilities of nil and nil, respectively, in respect of lease arrangements for offices and equipment. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-43</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">20.&nbsp;&nbsp;&nbsp;NOTES TO THE CONSOLIDATED STATEMENTS OF CASH FLOWS&#8201;(continued)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Changes in liabilities arising from financing activities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:349pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Financial</font>
                <br >
                <font style="letter-spacing:-0.16pt;">instrument </font>
                <br >
                <font style="letter-spacing:-0.16pt;">measured at </font>
                <br >
                <font style="letter-spacing:-0.16pt;">FVTPL</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">New bank </font>
                <br >
                <font style="letter-spacing:-0.16pt;">loans and </font>
                <br >
                <font style="letter-spacing:-0.16pt;">other </font>
                <br >
                <font style="letter-spacing:-0.16pt;">borrowings</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Lease </font>
                <br >
                <font style="letter-spacing:-0.16pt;">liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Payable </font>
                <br >
                <font style="letter-spacing:-0.16pt;">for issue </font>
                <br >
                <font style="letter-spacing:-0.16pt;">costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">At January 1, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">153,283</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">8,309</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">3,635</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">165,227</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">422</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">160</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">582</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.667pt 0pt 0.5pt 0pt; width:229.41pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Transaction costs for the issuance of convertible redeemable preferred shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">758</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">758</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">97,370</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">12,410</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">109,780</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Disposal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Payment </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8201;&#8211;&#8201;financing cash flows </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(10,430<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(966<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(758<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(12,154<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8201;&#8211;&#8201;operating cash flows </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest paid </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(427<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(427<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in fair value </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">46,910</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">46,910</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2pt 0pt 1pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange adjustment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">184</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">59</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">243</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">At December&#160;31, 2021</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">10,468</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,888</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">310,919</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.25pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">295</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">138</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">433</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.667pt 0pt 0.5pt 0pt; width:229.41pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Transaction costs for the issuance of convertible redeemable preferred shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">7,897</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">463</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">8,360</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Disposal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Payment </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8201;&#8211;&#8201;financing cash flows </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(13,316<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(936<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(14,252<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8201;&#8211;&#8201;operating cash flows </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest paid </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(290<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(134<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(424<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in fair value </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(7195<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(7,195<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2pt 0pt 1pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange adjustment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(741<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">(176<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(917<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:229.41pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">At December 31, 2022</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">4,313</td>
            <td style="padding:0pt;padding-left:2.68pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,243</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.535pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">296,924</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:15.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:15.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Investment activities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:137.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:244.72pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Dual currency </font>
                <br >
                <font style="letter-spacing:-0.16pt;">structured </font>
                <br >
                <font style="letter-spacing:-0.16pt;">deposit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Swap deposit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Wealth </font>
                <br >
                <font style="letter-spacing:-0.16pt;">management </font>
                <br >
                <font style="letter-spacing:-0.16pt;">product </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:244.72pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2pt 0pt 1.25pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:244.72pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Year ended December&#160;31, 2021</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:244.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">purchase </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,000<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(17,965<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(46,269<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(81,234<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:244.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">disposal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">9,500</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">17,965</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">27,465</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:244.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">interest received </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">28</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">32</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:244.72pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Year ended December 31, 2022</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:244.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">purchase </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(14,900<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(44,080<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(58,980<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:244.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">disposal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">22,439</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">65,618</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">88,057</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:244.72pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">interest received </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">531</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">550</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10.5pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">21.&nbsp;&nbsp;&nbsp;COMMITMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group did not have capital commitments at the end of each of the Relevant Periods.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-44</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:33pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">22.&nbsp;&nbsp;&nbsp;RELATED PARTY TRANSACTIONS</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Related parties </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Parties are considered to be related if one party has the ability, directly or indirectly, to control or exercise significant influence over the other party. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Parties are also considered to be related if they are subject to common control. Members of key management of the Group and their close family members are also considered as related parties. </font>
        </div>
        <table style="width:416pt;height:47.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:202pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name of related parties </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:202pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nature of relationship </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.5pt 0pt; width:202pt;">
              <font style="letter-spacing:0.2pt;">Mr.&#160;Yang Lu </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.5pt 0pt; width:202pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">The chief executive officer and chairman of our board of directors and ultimate significant shareholder of the Company</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As disclosed in note 14 (ii)&#160;and note 14 (iii)&#160;to the consolidated financial statements, the RMB70,000 and RMB40,000 non-revolving facility agreements provided by three third party banks were guaranteed by the ultimate significant shareholder, Mr. Yang Lu for the years ended December 31, 2021 and 2022, respectively. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">23.&nbsp;&nbsp;&nbsp;FINANCIAL INSTRUMENTS BY CATEGORY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The carrying amounts of each of the categories of financial instruments of the Group as of the end of each of the Relevant Periods are as follows: </font>
        </div>
        <table style="width:416pt;height:253.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial assets:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Financial assets at FVTPL: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dual currency structured deposit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">7,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2pt 0pt 1pt 0pt; width:326.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wealth management product </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">46,269</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">53,809</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.25pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other financial assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0.667pt 0pt 0.5pt 0pt; width:326.59pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Financial assets included in prepayments, other receivables and other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">6,604</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0.667pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,258</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2pt 0pt 1pt 0pt; width:326.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">64,131</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">42,758</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">70,735</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">45,016</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.25pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Trade payables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,981</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">13,098</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Financial liabilities included in other payables and accruals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,224</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,877</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2pt 0pt 1pt 0pt; width:326.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest-bearing bank and other borrowings </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">10,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">16,662</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,282</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.25pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2pt 0pt 1pt 0pt; width:326.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Financial instruments measured at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 1pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.75pt 0pt 1.75pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.75pt 0pt 1pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-45</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:13.2pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">24.&nbsp;&nbsp;&nbsp;FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The carrying amounts and fair values of the Group&#8217;s financial instruments, other than those with carrying amounts that reasonably approximate to fair values, are as follows: </font>
        </div>
        <table style="width:456pt;height:152.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:264.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:264.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carrying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">amount</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carrying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">amount</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:264.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:264.7pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:264.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dual currency structured deposit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">7,540</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">7,540</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:264.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wealth management product </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">46,269</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">46,269</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:264.7pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">53,809</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">53,809</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:264.7pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:264.7pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:264.7pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:2.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0.469999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:14.19pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Management has assessed that the fair values of cash and cash equivalents, interest-bearing bank and other borrowings, trade payables, financial assets included in prepayments, other receivables and other assets, and financial liabilities included in other payables and accruals approximate to their carrying amounts largely due to the short term maturities of these instruments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s finance department headed by the finance manager is responsible for determining the policies and procedures for the fair value measurement of financial instruments. The finance manager reports directly to the chief financial officer and the audit committee. At the end of each of the Relevant Periods, the finance department analyses the movements in the values of financial instruments and determines the major inputs applied in the valuation. The valuation is reviewed and approved by the chief financial officer. The valuation process and results are discussed with the audit committee twice a year for interim and annual financial reporting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The fair values of the financial assets and liabilities are included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. The methods and assumptions used to estimate the fair value, including a summary of significant unobservable inputs together with a quantitative sensitivity analysis, are set out in note 15 to the Consolidated Financial Statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The fair values of the non-current portion of interest-bearing bank and other borrowings have been calculated by discounting the expected future cash flows using rates currently available for instruments with similar terms, credit risk and remaining maturities. The changes in fair value as a result of the Group&#8217;s own non-performance risk for interest-bearing bank and other borrowings as of the end of each of the Relevant Periods were assessed to be insignificant.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Fair value hierarchy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following tables illustrate the fair value measurement hierarchy of the Group&#8217;s financial instruments: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-46</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:38.11pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">24.&nbsp;&nbsp;&nbsp;FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS&#8201;(continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As of December&#160;31, 2021</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:416pt;height:155pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:210.55pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value measurement using </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:210.55pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted prices </font>
                <br >
                <font style="letter-spacing:-0.16pt;">in active </font>
                <br >
                <font style="letter-spacing:-0.16pt;">markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">observable </font>
                <br >
                <font style="letter-spacing:-0.16pt;">inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">unobservable </font>
                <br >
                <font style="letter-spacing:-0.16pt;">inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:210.55pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:210.55pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:210.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dual currency structured deposit</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">7,540</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">7,540</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:210.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wealth management product</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">46,269</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">46,269</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:210.55pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">53,809</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">53,809</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:210.55pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:210.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:12.995pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:18.19pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As of December 31, 2022</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:416pt;height:142pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:210.55pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value measurement using </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:210.55pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted prices</font>
                <br >
                <font style="letter-spacing:-0.16pt;">in active</font>
                <br >
                <font style="letter-spacing:-0.16pt;">markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">observable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unobservable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:210.55pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Financial assets </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:210.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dual currency structured deposit </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:210.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wealth management product </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:210.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 2.5pt 0pt; width:210.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:210.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:14.2pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Changes in Level 3 instruments for the years ended December 31, 2021 and 2022 are as follows: </font>
        </div>
        <table style="width:416pt;height:112.5pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:329.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:329.93pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:329.93pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance as of January&#160;1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">53,809</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Acquisitions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">81,234</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">14,900</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:329.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Disposals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(27,465<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(68,709<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:329.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Amount recognized in profit or loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">40</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:329.93pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance as of December&#160;31 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">53,809</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-47</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">24.&nbsp;&nbsp;&nbsp;FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS&#8201;(continued)</font>
        </div>
        <table style="width:416pt;height:97.5pt;margin-left:20pt;margin-top:12pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:326.59pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance as of January&#160;1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">153,283</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Acquisitions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">97,370</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Amount recognized in profit or loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">46,910</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(7,195<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:326.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance as of December&#160;31 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.2pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the Relevant Periods, there were no transfers of fair value measurements between Level&#160;1 and Level&#160;2 and no transfers into or out of Level&#160;3 for both financial assets and financial liabilities.</font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Information about Level 3 fair value measurements: </font>
        </div>
        <table style="width:456pt;height:52pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:152.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:152.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:126.23pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Valuation techniques </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:152.88pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant unobservable inputs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:152.88pt;">
              <font style="letter-spacing:0.2pt;">Dual currency structured deposit </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:126.23pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Discounted cash flow method </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:152.88pt;">
              <div style="position:static;width:0pt;">
                <font style="letter-spacing:0.2pt;">Forward exchange rate of USD/CNY </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.88pt;">
              <font style="letter-spacing:0.2pt;">Wealth management product </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:126.23pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Discounted cash flow method </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:152.88pt;">
              <font style="letter-spacing:0.2pt;">Expected return rate</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8.2pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fair value of dual currency structured deposit has been estimated using a discounted cash flow valuation model based on assumptions that are not supported by observable market prices or rates. The un-observable inputs are the forward exchange rates of USD/CNY. The expected rate of return is between 1.5%&#8201;&#8211;&#8201;2% and is not guaranteed, it depends on the forward exchange rate of USD/CNY. The valuation requires the managers to make estimates about the expected forward exchange rate of USD/CNY on maturity of the dual currency structured deposit. The term of the structured deposit is from one to three&#160;months. The managers believe that the estimated fair values resulting from the valuation technique are reasonable, and that they were the most appropriate values at the end of reporting periods. The actual return rate of dual currency structured deposits held as at December 31, 2021 was 1.93%. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fair value of wealth management product has been estimated using a discounted cash flow valuation model based on an assumption that is not supported by observable market prices or rates. The un-observable input is expected annual return rate. The expected rate of return is not guaranteed and depends on the market price of underlying financial instruments, including bank deposits, debentures, monetary funds, central bank bills with good liquidity. The wealth management product is open-ended and can be redeemed at any time. The valuation requires the managers to make estimates about the expected future cash flows including expected future return. The managers believe that the estimated fair values resulting from the valuation technique are reasonable, and that they were the most appropriate values at the end of reporting periods. The actual return rate of wealth management products held as at December 31, 2021 was 2.67%. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">25.&nbsp;&nbsp;&nbsp;FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s principal financial instruments comprise interest-bearing bank and other borrowings, convertible redeemable preferred shares and cash and cash equivalents. The main purpose of these financial instruments is to raise finance for the Group&#8217;s operations. The Group has various other financial assets and liabilities such as trade payables, other payables and accruals, which arise directly from its operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The main risks arising from the Group&#8217;s financial instruments are foreign currency risk and liquidity risk. The board of directors reviews and agrees policies for managing each of these risks and they are summarized below. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-48</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12.55pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">25.&nbsp;&nbsp;&nbsp;FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES&#8201;(continued)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Foreign currency risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group has transactional currency exposures. Such exposures arise from purchases by operating&#160;units in currencies other than the&#160;units&#8217; functional currencies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table demonstrates the sensitivity at the end of each of the Relevant Periods to a reasonably possible change in the $ and RMB exchange rate, with all other variables held constant, of the Group&#8217;s profit before tax (due to changes in the fair values of monetary assets and liabilities). </font>
        </div>
        <table style="width:416pt;height:94pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:271.69pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:41.49pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/</font>&#8203;<br ><font style="letter-spacing:-0.16pt;">(decrease) in</font><br ><font style="letter-spacing:-0.16pt;">$/RMB</font><br ><font style="letter-spacing:-0.16pt;">rate% </font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:33.49pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/</font>&#8203;<br ><font style="letter-spacing:-0.16pt;">(decrease)</font><br ><font style="letter-spacing:-0.16pt;">in profit</font><br ><font style="letter-spacing:-0.16pt;">before tax</font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:33.33pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/</font>&#8203;<br ><font style="letter-spacing:-0.16pt;">(decrease)</font><br ><font style="letter-spacing:-0.16pt;">in equity</font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:271.69pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:33.49pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:33.33pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:271.69pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">At December&#160;31, 2021 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:271.69pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">If the $ strengthens against the RMB </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2,398</td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:271.69pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">If the $ weakens against the RMB </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">(5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,651<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:416pt;height:94pt;margin-left:20pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:271.69pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:41.49pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/</font>&#8203;<br ><font style="letter-spacing:-0.16pt;">(decrease) in</font><br ><font style="letter-spacing:-0.16pt;">$/RMB</font><br ><font style="letter-spacing:-0.16pt;">rate% </font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:33.49pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/</font>&#8203;<br ><font style="letter-spacing:-0.16pt;">(decrease)</font><br ><font style="letter-spacing:-0.16pt;">in profit</font><br ><font style="letter-spacing:-0.16pt;">before tax</font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:33.33pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/</font>&#8203;<br ><font style="letter-spacing:-0.16pt;">(decrease)</font><br ><font style="letter-spacing:-0.16pt;">in equity</font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:271.69pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:33.49pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:33.33pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:271.69pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">As of December&#160;31, 2022 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:271.69pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">If the $ strengthens against the RMB </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,939</td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:271.69pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">If the $ weakens against the RMB </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">(5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:16.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.745pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(4,081<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.645pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:13.19pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group monitors and maintains a level of cash and cash equivalents deemed adequate by the management of the Group to finance the operations and mitigate the effects of fluctuations in cash flows. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The maturity profile of the Group&#8217;s financial liabilities as of the end of each Relevant Periods, based on the contractual undiscounted payments, is as follows: </font>
        </div>
        <table style="width:456pt;height:125pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:213.42pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:213.42pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">On demand</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Less than </font>
                <br >
                <font style="letter-spacing:-0.16pt;">1 year</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">1 to 5&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Over 5&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.083pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:213.42pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:213.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.69pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:2.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.58pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8201;&#8212;</td>
            <td style="padding:0pt;padding-left:14.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:213.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Trade and bills payables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,981</td>
            <td style="padding:0pt;padding-left:7.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.69pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,981</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.667pt 0pt 0.5pt 0pt; width:213.42pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Financial liabilities included in other payables and </font>
                <br >
                <font style="letter-spacing:0.2pt;">accruals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.77pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3,224</td>
            <td style="padding:0pt;padding-left:7.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.69pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.58pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,224</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:213.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest-bearing bank borrowings </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.77pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.77pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,457</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.69pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.69pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.58pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.58pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">10,457</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:213.42pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">6,205</td>
            <td style="padding:0pt;padding-left:7.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">10,457</td>
            <td style="padding:0pt;padding-left:1.975pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.69pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:2.69pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.58pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:9pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">314,225</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-49</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">25.&nbsp;&nbsp;&nbsp;FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES&#8201;(continued)</font>
        </div>
        <table style="width:456pt;height:132pt;margin-top:12pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:212.37pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">On demand </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Less than </font>
                <br >
                <font style="letter-spacing:-0.16pt;">1 year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">1 to 5&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Over 5&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:15.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Trade and bills payables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">13,098</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:15.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">13,098</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:212.37pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Financial liabilities included in other payables and </font>
                <br >
                <font style="letter-spacing:0.2pt;">accruals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,877</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.045pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.935pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:15.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,877</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest-bearing bank borrowings </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.045pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.045pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.935pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.935pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">16,975</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">294,675</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.045pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.045pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:15.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">311,650</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.1pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Capital management</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The primary objectives of the Group&#8217;s capital management are to safeguard the Group&#8217;s ability to continue as a going concern and to maintain healthy capital ratios in order to support its business and maximize shareholders&#8217; value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group manages its capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Group may adjust the dividend payment to shareholders, return capital to shareholders or issue new shares. The Group is not subject to any externally imposed capital requirements. No changes were made in the objectives, policies or processes for managing capital during the Relevant Periods. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The asset-liability ratios as of the end of each of the Relevant Periods are as follows: </font>
        </div>
        <table style="width:416pt;height:81pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.59pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:326.59pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">131,685</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">72,594</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:326.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">317,113</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">313,887</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:326.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Asset-liability ratio (Note i) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.42</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.23</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.6pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.1pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Note i: </font>
        </div>
        <div style="margin-top:2pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">The asset-liability ratio is calculated by dividing total assets by total liabilities.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">26.&nbsp;&nbsp;&nbsp;SUBSEQUENT EVENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Cash deposit </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On March 12, 2023, the Federal Deposit Insurance Corporation, or the FDIC, took control and was appointed receiver of Silicon Valley Bank. As of April 7, 2023, the Company had four accounts with Silicon Valley Bank with a total balance of $4 which is below the FDIC limit. The Company does not expect any additional exposure or impact to our operations. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Bank loan </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In March 2023, Adlai Hangzhou repaid a non-revolving facility amount of RMB10,000 at the maturity date. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-50</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:170pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">26.&nbsp;&nbsp;&nbsp;SUBSEQUENT EVENTS&#8201;(continued)</font>
        </div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In March 2023, Adlai Hangzhou entered into a non-revolving facility agreement with a third party financial institution for a facility amount of RMB30,000 at an interest rate of 4.0% per annum, guaranteed by Mr. Yang Lu and Adlai Shanghai. The maturity date is August 31, 2023.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In March 2023, Adlai Hangzhou entered into a non-revolving facility agreement with a third party financial institution for a facility amount of RMB20,000 at an interest rate of 4.2% per annum, guaranteed by Mr. Yang Lu. The maturity date is March&#160;27, 2024.</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">27.&nbsp;&nbsp;&nbsp;CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The business transactions and assets of Adlai Hangzhou and Shanghai Adlai Nortye Biopharma Co., Ltd (&#8220;PRC Subsidiaries&#8221;) are primarily denominated in RMB, which is not freely convertible into foreign currencies. All foreign exchange transactions take place either through the People&#8217;s Bank of China or other banks authorized to buy and sell foreign currencies at the exchange rates quoted by the People&#8217;s Bank of China. Approval of foreign currency payments by the People&#8217;s Bank of China or other regulatory institutions requires submitting a payment application form together with suppliers&#8217; invoices, shipping documents and signed contracts. These currency exchange control measures imposed by the PRC government may restrict the ability of PRC Subsidiaries to transfer their net assets to the Company through loans, advances or cash dividends. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The net assets of PRC Subsidiaries in aggregate exceeded 25% of the Company&#8217;s consolidated net assets. Accordingly, condensed parent company financial statements have been prepared in accordance with Rule&#160;5.04 and Rule 12-04 of SEC Regulation S-X.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The subsidiaries did not pay any dividends to the Company for the periods presented. For the purpose of presenting parent-only financial information, the Company records its investment in its subsidiaries under the cost method of accounting. Such investment is presented on the separate condensed balance sheets of the Company as &#8220;Investment in subsidiaries&#8221;. Certain information and footnote disclosures generally included in financial statements prepared in accordance with IFRSs are not required. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2021 and 2022, there were no material contingencies, significant provisions for long-term obligations, or guarantees of the Company, except for those which have been separately disclosed in the consolidated financial statements, if any. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-51</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:10pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">27.&nbsp;&nbsp;&nbsp;CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY&#8201;(continued)</font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; text-align:center; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">PARENT COMPANY BALANCE SHEETS </font>
        </div>
        <table style="width:456pt;height:514pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:363.26pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:363.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:363.26pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">ASSETS</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Current assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">48,363</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">12,194</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Prepayments, other receivables and other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total current assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">48,364</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">12,230</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Non-current assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Due from related parties </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">104,714</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">115,743</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Investment in subsidiaries </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">64,216</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">94,300</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total non-current assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">168,930</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">210,043</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total assets</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">217,294</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">222,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">LIABILITIES</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Current liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accounts payable </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">761</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">888</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest payables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non-current liabilities due within one year </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total current liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">761</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">291,260</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Non-current liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Long-term loans </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total non-current liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">297,563</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">298,324</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">291,260</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.265pt 0pt 0.985pt 0pt; width:363.26pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Ordinary shares (par value of $0.0001 per share; 442,456,586 shares authorized and 40,440,000 shares issued and outstanding as of December&#160;31, 2021 and 2022) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.265pt 0pt 0.985pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.265pt 0pt 0.985pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.265pt 0pt 0.985pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.265pt 0pt 0.985pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:363.26pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;A convertible preferred shares (par value of US$0.0001 per share; 14,560,000 </font>
                <br >
                <font style="letter-spacing:0.2pt;">and 14,560,000 shares authorized, issued and outstanding as of December&#160;31, 2021 </font>
                <br >
                <font style="letter-spacing:0.2pt;">and 2022, respectively) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">6,415</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">6,415</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Share option reserve </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">5,647</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">11,730</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(104,076<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(98,116<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total shareholders&#8217; deficit</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(81,030<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(68,987<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:363.26pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total liabilities and shareholders&#8217; equity</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">217,294</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">222,273</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-52</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:127.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DECEMBER 31, 2021 AND 2022&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">27.&nbsp;&nbsp;&nbsp;CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY&#8201;(continued)</font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; text-align:center; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">PARENT COMPANY STATEMENTS OF INCOME AND COMPREHENSIVE INCOME </font>
        </div>
        <table style="width:456pt;height:217pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:329.05pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">For the Years Ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:329.05pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:329.05pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:329.05pt;text-align:left;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">REVENUE</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other operating income, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">156</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Administrative expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,376<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(1,390<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total operating loss</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(2,376<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(1,234<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other income and gains </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">173</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Investment income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value loss on financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(46,910<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">7,194</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Finance costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(399<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">LOSS BEFORE TAX</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(49,509<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">5,960</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income tax expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">LOSS FOR THE YEAR</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(49,509<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">5,960</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:329.05pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">TOTAL COMPREHENSIVE (LOSS)/INCOME FOR THE YEAR</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:23.25pt; text-align:right; white-space:nowrap;">(49,509<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">5,960</td>
            <td style="padding:0pt;padding-left:11.465pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:13pt; text-align:center; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">PARENT COMPANY STATEMENTS OF CASH FLOWS </font>
        </div>
        <table style="width:456pt;height:129.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.81pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Year ended December&#160;31, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:359.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:359.81pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:359.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash flows used in operating activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(1,610<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(1,134<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:359.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash flows used in investing activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(65,798<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(35,035<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:359.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net cash flows from financing activities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">96,428</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.667pt 0pt 0.5pt 0pt; width:359.81pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:-0.2pt;">NET INCREASE/(DECREASE) IN CASH AND CASH </font>
                <br >
                <font style="letter-spacing:-0.2pt;">EQUIVALENTS</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">29,020</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.667pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(36,169<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:359.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents at beginning of year </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">19,343</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">48,363</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:359.81pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">CASH AND CASH EQUIVALENTS AT END OF YEAR</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">48,363</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">12,194</td>
            <td style="padding:0pt;padding-left:2.53pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-53</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="fCCSO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:68.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND </font>
          <br >
          <font style="letter-spacing:-0.2pt;">COMPREHENSIVE LOSS FOR THE SIX MONTHS ENDED JUNE 30, </font>
          <br >
          <font style="letter-spacing:-0.2pt;">2022 AND 2023 (UNAUDITED) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:472.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Six Months ended June&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:19.41pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:309.76pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">REVENUE</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">4 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other operating income, net </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">137</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">349</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Administrative expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(7,039<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(5,231<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Research and development expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(21,913<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(27,243<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Total operating loss</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(28,815<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(32,125<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other income and gains </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">447</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">269</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(822<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(488<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Investment income </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">81</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">63</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:309.76pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Fair value gain on financial assets at fair value through profit or loss (&#8220;FVTPL&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">644</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value gain/(loss) on financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">15 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">14,167</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(45,894<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Finance costs </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(262<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(243<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">LOSS BEFORE TAX</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Income tax expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">6 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">LOSS FOR THE PERIOD</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Attributable to: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:309.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Ordinary Equity Holders of the Parent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">OTHER COMPREHENSIVE LOSS</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.167pt 0pt 1.833pt 0pt; width:309.76pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Exchange differences on translation of the financial statements of subsidiaries </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(1,505<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(216<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:309.76pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Other comprehensive loss for the period, net of tax </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(1,505<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(216<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">TOTAL COMPREHENSIVE LOSS FOR THE PERIOD</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(16,065<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(78,634<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Attributable to: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Ordinary Equity Holders of the Parent </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(16,065<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(78,634<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.417pt 0pt 0.833pt 0pt; width:309.76pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE PARENT </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:309.76pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Basic and diluted </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:34.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">For loss for the period ($ per share) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(0.57<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">(3.08<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:309.76pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted average common shares outstanding </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 3.25pt 0pt; width:19.41pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">25,440,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:34.5pt; text-align:right; white-space:nowrap;">25,440,000</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:10pt; margin-top:5pt; text-align:center; width:446pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the Consolidated Financial Statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-54</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="fCCSF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL POSITION </font>
          <br >
          <font style="letter-spacing:-0.2pt;">AS OF DECEMBER 31, 2022 AND JUNE 30, 2023 (UNAUDITED) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:591.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.25pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.333pt 0pt 1.917pt 0pt; width:22.18pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.333pt 0pt 1.917pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.333pt 0pt 1.917pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">ASSETS</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Current assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">42,758</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">60,028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial assets at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">12 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.25pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Prepayments, other receivables and other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.25pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">11 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">2,258</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,492</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2.25pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total current assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">66,303</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">61,527</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Non-current assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Property, plant and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">9 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,713</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,034</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Right-of-use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">10(a) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">2,162</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,599</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other intangible assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">89</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">72</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.25pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Prepayments, other receivables and other assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.25pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">11 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">327</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">264</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2.25pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total non-current assets</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">6,291</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">4,969</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 3pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total assets</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">72,594</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">66,496</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">LIABILITIES</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Current liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Trade payables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13,098</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">16,871</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other payables and accruals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">13 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">3,877</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">9,738</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest-bearing bank borrowings </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">14 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">19,495</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">10(b) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,001</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,001</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.25pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.25pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">15 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2.25pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total current liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">312,651</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">383,367</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Non-current liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">10(b) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">1,236</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">664</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.25pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total non-current liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">1,236</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">664</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2.25pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total liabilities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">313,887</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">384,031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">SHAREHOLDERS&#8217; DEFICIT</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:316.19pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Ordinary shares (par value of $0.0001 per share; 442,456,586 shares authorized and 40,440,000 shares issued and outstanding as of December&#160;31, 2022 and June&#160;30,2023) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">17 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.5pt 0pt; width:316.19pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Series&#160;A convertible preferred shares (par value of US$0.0001 per share; 14,560,000 shares authorized, issued and outstanding as of December&#160;31, 2022 and June&#160;30,2023, respectively) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">18 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">6,415</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">6,415</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Share option reserve </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">18 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">13,688</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">16,080</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange fluctuation reserve </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">18 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(4,159<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:27.75pt; text-align:right; white-space:nowrap;">(4,375<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.25pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accumulated deficit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.25pt 0pt; width:22.18pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">18 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(268,221<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(346,639<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3pt 0pt 2.25pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total shareholders&#8217; deficit</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(241,293<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:1px solid #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">(317,535<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 3pt 0pt; width:316.19pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Total liabilities and shareholders&#8217; deficit</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:22.18pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">72,594</td>
            <td style="padding:0pt;padding-left:4.775pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2.25pt 0pt;border-bottom:3pt double #000000; min-width:27.75pt; text-align:right; white-space:nowrap;">66,496</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the Consolidated Financial Statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-55</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="fCCSE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:142pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS&#8217; EQUITY </font>
          <br >
          <font style="letter-spacing:-0.2pt;">FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:198pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:153.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="40">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Attributable to owners of the parent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:30.74pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:34.91pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">paid-in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:35.75pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;A</font>
                <br >
                <font style="letter-spacing:-0.16pt;">convertible</font>
                <br >
                <font style="letter-spacing:-0.16pt;">preferred</font>
                <br >
                <font style="letter-spacing:-0.16pt;">shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:29.49pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Share</font>
                <br >
                <font style="letter-spacing:-0.16pt;">option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">reserve </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:35.93pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exchange</font>
                <br >
                <font style="letter-spacing:-0.16pt;">fluctuation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">reserve </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:43.26pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">losses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:36.04pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">deficits </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:30.74pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 17) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:34.91pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 18) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:35.75pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:29.49pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 18) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:35.93pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 18) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:43.26pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:36.04pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">At January&#160;1, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">6,415</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">7,606</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,002<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(209,431<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(185,428<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss for the period</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:153.88pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Other comprehensive income for the </font>
                <br >
                <font style="letter-spacing:0.2pt;">period: </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:153.88pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Exchange differences on translation </font>
                <br >
                <font style="letter-spacing:0.2pt;">of the financial statements of </font>
                <br >
                <font style="letter-spacing:0.2pt;">subsidiaries </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,505<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(1,505<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Share-based compensation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">3,249</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">3,249</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">At June&#160;30, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">4</div>
            </td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">6,415</div>
            </td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">10,980</div>
            </td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">10,855</div>
            </td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(2,507<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(223,991<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(198,244<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:198pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:153.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="40">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Attributable to owners of the parent </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:30.74pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Ordinary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:34.91pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Additional</font>
                <br >
                <font style="letter-spacing:-0.16pt;">paid-in</font>
                <br >
                <font style="letter-spacing:-0.16pt;">capital </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:35.75pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Series&#160;A</font>
                <br >
                <font style="letter-spacing:-0.16pt;">convertible</font>
                <br >
                <font style="letter-spacing:-0.16pt;">preferred</font>
                <br >
                <font style="letter-spacing:-0.16pt;">shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:29.49pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Share</font>
                <br >
                <font style="letter-spacing:-0.16pt;">option</font>
                <br >
                <font style="letter-spacing:-0.16pt;">reserve </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:35.93pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Exchange</font>
                <br >
                <font style="letter-spacing:-0.16pt;">fluctuation</font>
                <br >
                <font style="letter-spacing:-0.16pt;">reserve </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:43.26pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Accumulated</font>
                <br >
                <font style="letter-spacing:-0.16pt;">losses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:4pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt; width:36.04pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total</font>
                <br >
                <font style="letter-spacing:-0.16pt;">deficits </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:153.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:30.74pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 17) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:34.91pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 18) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:35.75pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:29.49pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 18) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:35.93pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(note 18) </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:43.26pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:2.583pt 0pt 2.167pt 0pt; width:36.04pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">At January&#160;1, 2023</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">4</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">6,415</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">10,980</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">13,688</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(4,159<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(268,221<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(241,293<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss for the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:153.88pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Other comprehensive income for the </font>
                <br >
                <font style="letter-spacing:0.2pt;">period: </font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:153.88pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Exchange differences on translation </font>
                <br >
                <font style="letter-spacing:0.2pt;">of the financial statements of </font>
                <br >
                <font style="letter-spacing:0.2pt;">subsidiaries</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(216<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:27pt; text-align:right; white-space:nowrap;">(216<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Share-based compensation</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">2,392</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:27pt; text-align:right; white-space:nowrap;">2,392</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:153.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">At June&#160;30, 2023</font>
              </div>
            </td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">4</div>
            </td>
            <td style="padding:0pt;padding-left:10.37pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">6,415</div>
            </td>
            <td style="padding:0pt;padding-left:6.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">10,980</div>
            </td>
            <td style="padding:0pt;padding-left:4.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">16,080</div>
            </td>
            <td style="padding:0pt;padding-left:0.889999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(4,375<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:4.945pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(346,639<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:3.61pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt; width:4pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:27pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(317,535<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the Consolidated Financial Statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-56</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="fCCSC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:19pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:534pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.47pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Six Months ended June&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:336.47pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:21.66pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:336.47pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">CASH FLOWS FROM OPERATING ACTIVITIES</font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Loss before tax </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(14,560<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(78,418<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Adjustments for: </font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Finance costs </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:21.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">5 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">262</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">243</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Investment income </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(81<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(63<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Fair value Loss/(gain) on financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:21.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">15 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(14,167<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">45,894</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Fair value gain on financial assets at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(644<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Depreciation of property, plant and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:21.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">9 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">444</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">657</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Amortization of intangible assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">10</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">14</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Depreciation of right-of-use assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:21.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">10(a) </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">557</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">516</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Equity-settled share-based payment expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:21.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">19 </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">3,249</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,392</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">(Decrease)/Increase in prepayments, other receivables and other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(339<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">794</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Increase in non-current assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">92</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">36</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Increase in trade payables </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">2,889</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">3,774</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">(Decrease)/Increase in other payables and accruals </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(977<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">5,838</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.25pt 0pt 2.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:-0.2pt;">Net cash flows used in operating activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(23,265<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(18,323<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">CASH FLOWS FROM INVESTING ACTIVITIES</font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Purchases of property, plant and equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(671<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(85<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Purchases of intangible assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(19<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Purchases of financial assets at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(61,900<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(7<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Disposal of financial assets at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">68,400</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">21,396</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Received investment income of financial assets at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">120</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">63</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net cash flows provided from investing activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">5,930</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">21,367</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">CASH FLOWS FROM FINANCING ACTIVITIES</font>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Addition of bank and other borrowings </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">5,398</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">20,029</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Bank and other borrowings interest paid </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(186<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(168<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Repayment of bank and other borrowings </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(10,313<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(4,330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payment for lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(624<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(568<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.25pt 0pt 2.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">Net cash flows (used in)/from financing activities</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(5,725<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">14,963</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">NET (DECREASE)/INCREASE IN CASH AND CASH EQUIVALENTS</font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">(23,060<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">18,007</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents at beginning of period </font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">64,131</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24pt; text-align:right; white-space:nowrap;">42,758</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effect of foreign exchange rate changes, net </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">638</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24pt; text-align:right; white-space:nowrap;">(737<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:336.47pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.2pt;">CASH AND CASH EQUIVALENTS AT END OF PERIOD</font>
              </div>
            </td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.75pt 0pt; width:21.66pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">41,709</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt; width:2pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24pt; text-align:right; white-space:nowrap;">60,028</td>
            <td style="padding:0pt;padding-left:5.95pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The accompanying notes are an integral part of the Consolidated Financial Statements </font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-57</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a><a name="fNCCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:12pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">CORPORATE AND GROUP INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Adlai Nortye Ltd. (the &#8220;Company&#8221;) is a limited liability company incorporated in the Cayman Islands on 9 May&#160;2018. The registered office of the Company is located at Harneys Fiduciary (Cayman) Limited, 4</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">&#160;Floor, Harbour Place, 103 South Church Street, P.O. Box 10240, Grand Cayman, KY1-1002, Cayman Islands. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">The Company is an investing holding company. The Company&#8217;s subsidiaries were involved in the research and development of pharmaceutical products. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">As of the date of this report, the Company had direct and indirect interests in its subsidiaries, all of which are private limited liability companies, the particulars of which are set out below: </font>
        </div>
      </div>
      <div style="margin-top:12pt;margin-bottom:12pt;margin-left:27.16pt;width:541pt;">
        <table style="width:541pt;margin-bottom:5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;height:36.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:167.45pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:101.16pt;" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Date and place of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">incorporation / registration</font>
                <br >
                <font style="letter-spacing:-0.16pt;">and place of operations </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:86.24pt;" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Issued ordinary</font>
                <br >
                <font style="letter-spacing:-0.16pt;">share/</font>&#8203;<br ><font style="letter-spacing:-0.16pt;">registered capital </font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage</font>
                <br >
                <font style="letter-spacing:-0.16pt;">of equity </font>
                <br >
                <font style="letter-spacing:-0.16pt;">attributable to</font>
                <br >
                <font style="letter-spacing:-0.16pt;">the Company </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:84pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:167.45pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:19.41pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Notes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Direct </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Indirect </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:84pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Principal activities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:167.45pt;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Alpine Bioscience Ltd. </font>
                <br >
                <font style="letter-spacing:0.18pt;">(&#8220;Alpine BVI&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:101.16pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">British Virgin Islands </font>
              <br >
              <font style="letter-spacing:0.18pt;">8 January&#160;2018 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:86.24pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">One share of par </font>
              <br >
              <font style="letter-spacing:0.18pt;">value $1 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Investment holding </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:167.45pt;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Adlai Nortye (BVI) Ltd. </font>
                <br >
                <font style="letter-spacing:0.18pt;">(&#8220;Adlai BVI&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:101.16pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">British Virgin Islands </font>
              <br >
              <font style="letter-spacing:0.18pt;">10 May&#160;2018 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:86.24pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">One share of par </font>
              <br >
              <font style="letter-spacing:0.18pt;">value $1 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Investment holding </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:167.45pt;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Adlai Nortye USA Inc. </font>
                <br >
                <font style="letter-spacing:0.18pt;">(&#8220;Adlai US&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:101.16pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">The United States </font>
              <br >
              <font style="letter-spacing:0.18pt;">30 January&#160;2018 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:86.24pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">10,000 shares of </font>
              <br >
              <font style="letter-spacing:0.18pt;">par value $0.0001 each </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.18pt;">Clinical studies and testing, and technology development and transfer </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:167.45pt;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Adlai Nortye (Switzerland) AG </font>
                <br >
                <font style="letter-spacing:0.18pt;">(&#8220;Adlai Swiss&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:101.16pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Switzerland </font>
              <br >
              <font style="letter-spacing:0.18pt;">21 June&#160;2022 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:86.24pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">100 shares of par</font>
              <br >
              <font style="letter-spacing:0.18pt;">value CHF1&#8217;000 </font>
              <br >
              <font style="letter-spacing:0.18pt;">each </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Investment holding </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:167.45pt;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Adlai Nortye PTE.LTD </font>
                <br >
                <font style="letter-spacing:0.18pt;">(&#8220;Adlai SGP&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:101.16pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Singapore </font>
              <br >
              <font style="letter-spacing:0.18pt;">22 April&#160;2022 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:86.24pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Two shares of par </font>
              <br >
              <font style="letter-spacing:0.18pt;">value $1 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Investment holding </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:167.45pt;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;">
                <font style="letter-spacing:0.18pt;">Adlai Nortye (HK) Limited </font>
                <br >
                <font style="letter-spacing:0.18pt;">(&#8220;Adlai HK&#8221;) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:101.16pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Hong Kong </font>
              <br >
              <font style="letter-spacing:0.18pt;">24 April&#160;2018 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:86.24pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">HKD 0.001 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Investment holding </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:167.45pt;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;font-family:MSungHK-Light;">&#26477;&#24030;&#38463;&#35582;&#29983;&#29289;&#21307;&#33647;&#31185;&#25216;&#26377;&#38480;&#20844;&#21496; <br >Hangzhou Adlai Nortye<br >Biopharma Co., Ltd*<br >(&#8220;Adlai Hangzhou&#8221;)</div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:101.16pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">the People&#8217;s Republic of</font>
              <br >
              <font style="letter-spacing:0.18pt;">China (&#8220;PRC&#8221;)/ Mainland </font>
              <br >
              <font style="letter-spacing:0.18pt;">China </font>
              <br >
              <font style="letter-spacing:0.18pt;">14 September&#160;2004 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:86.24pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">RMB 200,000 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.18pt;">Product research </font>
              <br >
              <font style="letter-spacing:0.18pt;">and development, technology transfer and consulting services business </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:167.45pt;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;font-family:MSungHK-Light;">&#19978;&#28023;&#38463;&#24503;&#33802;&#35582;&#27888;&#29983;&#29289;&#21307;&#33647;&#31185;&#25216;&#26377;&#38480;&#20844;&#21496; <br >Shanghai Adlai Nortye<br >Biopharma Co., Ltd*<br >(&#8220;Adlai Shanghai&#8221;) </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:101.16pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">the People&#8217;s Republic of</font>
              <br >
              <font style="letter-spacing:0.18pt;">China (&#8220;PRC&#8221;)/ Mainland </font>
              <br >
              <font style="letter-spacing:0.18pt;">China </font>
              <br >
              <font style="letter-spacing:0.18pt;">22 December&#160;2021 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:86.24pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">RMB 10,000 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;white-space:normal;text-align:left;">
              <font style="letter-spacing:0.18pt;">Product research </font>
              <br >
              <font style="letter-spacing:0.18pt;">and development, technology transfer and consulting services business </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:167.45pt;text-align:left;">
              <div style="margin-left:9pt; text-indent:-9pt;font-family:MSungHK-Light;">&#26477;&#24030;&#22616;&#21109;&#26410;&#20358;&#31185;&#25216;&#26377;&#38480;&#20844;&#21496; <br >Hangzhou Tangchuang<br >Weilai Technolegy Co., Ltd </div>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:19.41pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:101.16pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">the People&#8217;s Republic of</font>
              <br >
              <font style="letter-spacing:0.18pt;">China (&#8220;PRC&#8221;)/ Mainland </font>
              <br >
              <font style="letter-spacing:0.18pt;">China </font>
              <br >
              <font style="letter-spacing:0.18pt;">2 November&#160;2022 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:86.24pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">RMB 10,000 </font>
            </td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.705pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">100<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:6.165pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:84pt;text-align:left;">
              <font style="letter-spacing:0.18pt;">Product research and </font>
              <br >
              <font style="letter-spacing:0.18pt;">development, </font>
              <br >
              <font style="letter-spacing:0.18pt;">technology transfer </font>
              <br >
              <font style="letter-spacing:0.18pt;">and consulting </font>
              <br >
              <font style="letter-spacing:0.18pt;">services business</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:12pt;margin-bottom:2.61000000000001pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:9.19pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">The English name of the subsidiary registered in the PRC represents the best efforts made by management of the Company totranslate its Chinese name as the subsidiary does not have an official English name.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-58</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.1</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">BASIS OF PRESENTATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Unaudited Condensed Consolidated financial statements of the Group include the financial statements of the Company and its subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.2</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">BASIS OF PREPARATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding that the Group recorded net liabilities of $317,535 as of June&#160;30, 2023 and continually incurred losses from operations, the Unaudited Condensed Consolidated Financial Statements have been prepared on a going concern basis. The directors of the Company are of the opinion that the Group will have sufficient working capital to meet its financial liabilities and obligations as and when they fall due and to sustain its operations for the next 12&#160;months from June&#160;30, 2023 because the convertible redeemable preferred shares would not be contractually redeemable within the next 12&#160;months. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Statement of financial position as of December&#160;31, 2022, which has been derived from audited financial statements audited by /s/ Mazars USA LLP, as indicated in their report included on F-2, and the Unaudited Condensed Consolidated Financial Statements, which have been reviewed by Mazars USA LLP in accordance with standards established by the Public Company Accounting Oversight Board, have been prepared in accordance with International Financial Reporting Standards (&#8220;IFRSs&#8221;), which comprise all standards and interpretations approved by the International Accounting Standards Board (the &#8220;IASB&#8221;). All IFRSs effective for the accounting period commencing from January&#160;1, 2020, together with the relevant transitional provisions, have been early adopted by the Group in the preparation of the Unaudited Condensed Consolidated Financial Statements throughout the Relevant Periods and in the period covered by the Interim Comparative Financial Information. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Recently issued accounting pronouncements:</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In 2016, the IASB issued IFRS 16, which increases lease transparency and comparability among organizations. Under the new standard, lessees will be required to recognize all assets and liabilities arising from leases on the balance sheet, with the exception of leases with a term of 12&#160;months or less, which permits a lessee to make an accounting policy election by class of underlying asset not to recognize lease assets and liabilities. IFRS 16 is effective for fiscal&#160;years beginning after January&#160;1, 2019. The Company adopted the new lease accounting standard as of January&#160;1, 2019. Adoption of this update increased the amounts of total assets and total liabilities on the Company&#8217;s Unaudited Condensed Consolidated financial position, and did not have a material impact on the Company&#8217;s Unaudited Condensed Consolidated results of operations and cash flows. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Unaudited Condensed Consolidated Financial Statements have been prepared under the historical cost convention except for certain financial liabilities which have been measured at fair value at the end of each of the Relevant Periods.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.3</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">ISSUED BUT NOT YET EFFECTIVE IFRSs</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group has not applied the following new and revised IFRSs that have been issued but are not yet effective in the Unaudited Condensed Consolidated Financial Statements. </font>
        </div>
        <table style="width:456pt;height:61pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:168pt;">
              <div style="font-style:normal;">
                <font style="letter-spacing:0.2pt;">Amendments to IFRS 10 and IAS 28 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:276pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">Sale or Contribution of Assets between an Investor and its Associate or Joint Venture</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:168pt;">
              <font style="letter-spacing:0.2pt;">Amendments to IAS 1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:276pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Classification of Liabilities as Current or Non-current</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:168pt;">
              <font style="letter-spacing:0.2pt;">Amendments to IAS 1 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:276pt;">
              <div style="font-style:italic;">
                <font style="letter-spacing:0.2pt;">Non-Current Liabilities with Covenants</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:italic;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:168pt;">
              <div style="font-style:normal;">
                <font style="letter-spacing:0.2pt;">Amendments to IFRS 16 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:276pt;">
              <font style="letter-spacing:0.2pt;">Lease Liability in a Sale and Leaseback</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">(1)</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-59</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.3</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">ISSUED BUT NOT YET EFFECTIVE IFRSs&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:18.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:7.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:7.2pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">Effective for annual periods beginning on or after 1 January&#160;2024 </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:3.21pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.21pt; margin-bottom:0pt; line-height:10pt; text-align:left; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">No mandatory effective date yet determined but available for adoption </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group is in the process of making an assessment of the impact of these new and revised IFRSs upon initial application. So far, the Group expects that these standards will not have a significant effect on the Group&#8217;s financial performance and financial position.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
          <br >
        </div>
        <div style=" margin-top:9.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.62pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Subsidiaries</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A subsidiary is an entity (including a structured entity), directly or indirectly, controlled by the Company. Control is achieved when the Group is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee (i.e., existing rights that give the Group the current ability to direct the relevant activities of the investee). When the Company has, directly or indirectly, less than a majority of the voting or similar rights of an investee, the Group considers all relevant facts and circumstances in assessing whether it has power over an investee, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.81pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:7.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">contractual arrangements with other vote holders of the investee; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">rights arising from other contractual arrangements; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Group&#8217;s voting rights and potential voting rights. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The financial statements of subsidiaries are prepared for the same reporting period as the Company, using consistent accounting policies. The results of subsidiaries are Unaudited Condensed Consolidated from the date on which the Group obtains control, and continue to be Unaudited Condensed Consolidated until the date that such control ceases. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Profit or loss and each component of other comprehensive income are attributed to the owners of the parent of the Group and to the non-controlling interests, even if this results in the non-controlling interests having a deficit balance. All intra-group assets and liabilities, equity, income, expenses and cash flows relating to transactions between members of the Group are eliminated in full on consolidation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fair value measurement</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group measures certain financial instruments at fair value at the end of each of the Relevant Periods. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either in the principal market for the asset or liability, or in the absence of a principal market, in the most advantageous market for the asset or liability. The principal or most advantageous market must be accessible by the Group. The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">All assets and liabilities for which fair value is measured or disclosed in the Unaudited Condensed Consolidated Financial Statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-60</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Level&#160;1&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">based on quoted prices (unadjusted) in active markets for identical assets or liabilities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:justify; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Level&#160;2&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">based on valuation techniques for which the lowest level input that is significant to the fair value measurement is observable, either directly or indirectly </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:justify; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Level&#160;3&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">based on valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For assets and liabilities that are recognized in the Unaudited Condensed Consolidated Financial Statements on a recurring basis, the Group determines whether transfers have occurred between levels in the hierarchy by reassessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each of the Relevant Periods. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Impairment of non-financial assets</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Where an indication of impairment exists, or when annual impairment testing for an asset is required (other than financial assets), the asset&#8217;s recoverable amount is estimated. An asset&#8217;s recoverable amount is the higher of the asset or cash-generating unit&#8217;s value in use and its fair value less cost of disposal, and is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups of assets, in which case the recoverable amount is determined for the cash-generating unit to which the asset belongs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An impairment loss is recognized only if the carrying amount of an asset exceeds its recoverable amount. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. An impairment loss is charged to profit or loss in the period in which it arises in those expense categories consistent with the function of the impaired asset. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An assessment is made at the end of each of the Relevant Periods as to whether there is an indication that previously recognized impairment losses may no longer exist or may have decreased. If such an indication exists, the recoverable amount is estimated. A previously recognized impairment loss of an asset other than goodwill is reversed only if there has been a change in the estimates used to determine the recoverable amount of that asset, but not to an amount higher than the carrying amount that would have been determined (net of any depreciation/amortization) had no impairment loss been recognized for the asset in prior&#160;years. A reversal of such an impairment loss is credited to profit or loss in the period in which it arises. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Related parties</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A party is considered to be related to the Group if: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the party is a person or a close member of that person&#8217;s family and that person </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">has control or joint control over the Group; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">has significant influence over the Group; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">is a member of the key management personnel of the Group or of a parent of the Group; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">or </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the party is an entity where any of the following conditions applies: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the entity and the Group are members of the same group; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-61</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">one entity is an associate or joint venture of the other entity (or of a parent, subsidiary or fellow subsidiary of the other entity); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the entity and the Group are joint ventures of the same third party; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">one entity is a joint venture of a third entity and the other entity is an associate of the third entity; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(v)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the entity is a post-employment benefit plan for the benefit of employees of either the Group or an entity related to the Group; and the sponsoring employers of the post-employment benefit plan; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(vi)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the entity is controlled or jointly controlled by a person identified in (a); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.71pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(vii)</font>
          <br >
        </div>
        <div style=" margin-top:7.71pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">a person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity); and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:justify; width:24pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(viii)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:64pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the entity, or any member of a group of which it is a part, provides key management personnel services to the Group or to the parent of the Group. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Property, plant and equipment and depreciation</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Property, plant and equipment, other than construction in progress, are stated at cost less accumulated depreciation and any impairment losses. The cost of an item of property, plant and equipment comprises its purchase price and any directly attributable costs of bringing the asset to its working condition and location for its intended use. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Expenditure incurred after items of property, plant and equipment have been put into operation, such as repairs and maintenance, is normally charged to profit or loss in the period in which it is incurred. In situations where the recognition criteria are satisfied, the expenditure for a major inspection is capitalized in the carrying amount of the asset as a replacement. Where significant parts of property, plant and equipment are required to be replaced at intervals, the Group recognizes such parts as individual assets with specific useful lives and depreciates them accordingly. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Depreciation is calculated on the straight-line basis to write off the cost of each item of property, plant and equipment to its residual value over its estimated useful life. The principal annual rates used for this purpose are as follows: </font>
        </div>
        <table style="width:456pt;height:82pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Plant and machinery </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">10% to 19% </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Office equipment </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">19% to 20% </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Motor vehicles </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">19% </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Electronic equipment </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">19% to 20% </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Leasehold improvements </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:222pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">The shorter of remaining lease terms or estimated useful lives</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Where parts of an item of property, plant and equipment have different useful lives, the cost of that item is allocated on a reasonable basis among the parts and each part is depreciated separately. Residual values, useful lives and the depreciation method are reviewed, and adjusted if appropriate, at least at the end of each of the Relevant Periods. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">An item of property, plant and equipment including any significant part initially recognized is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-62</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">gain or loss on disposal or retirement recognized in the statement of profit or loss and other comprehensive income in the year the asset is derecognized is the difference between the net sales proceeds and the carrying amount of the relevant asset.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Construction in progress is reclassified to the appropriate category of property, plant and equipment when completed and ready for use. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Other intangible assets (other than goodwill)</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Other intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is the fair value at the date of acquisition. The useful lives of intangible assets are assessed to be either finite or indefinite. Intangible assets with finite lives are subsequently amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible asset may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each of the Relevant Periods. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Computer software</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Computer software is stated at cost less any impairment losses and amortized on a straight-line basis over its estimated useful life of 5&#160;years. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The estimated useful life of software is determined by considering the period of the economic benefits to the Group, as well as by referring to industry practice. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Research and development costs</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All research costs are charged to expense as incurred. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Expenditure incurred on projects to develop new products is capitalized and deferred only when the Group can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or sell the asset, how the asset will generate future economic benefits, the availability of resources to complete the project and the Group&#8217;s ability to measure reliably the expenditure during the development. Product development expenditure which does not meet these criteria is expensed when incurred. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Leases</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group assesses at contract inception whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Group as a lessee</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group applies a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Group recognizes lease liabilities to make lease payments and right- of-use assets representing the right to use the underlying assets. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Right-of-use assets </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Right-of-use assets are recognized at the commencement date of the lease (the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and any impairment losses, and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-63</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated on a straight-line basis over the shorter of the lease terms and the estimated useful lives of the assets as follows:</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <table style="width:396pt;height:25pt;margin-left:30pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:335.64pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Offices </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:48.36pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">2 to 5&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1pt 0pt; width:335.64pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Office equipment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1pt 0pt; width:48.36pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:0.2pt;">2 to 5&#160;years</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.71pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If ownership of the leased asset transfers to the Group by the end of the lease term or the cost reflects the exercise of a purchase option, depreciation is calculated using the estimated useful life of the asset. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.7pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:7.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Lease liabilities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Lease liabilities are recognized at the commencement date of the lease at the present value of lease payments to be made over the lease term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable lease payments that depend on an index or rate, and amounts expected to be paid under residual value guarantees. The lease payments also include the exercise price of a purchase option reasonably certain to be exercised by the Group and payments of penalties for termination of a lease, if the lease term reflects the Group exercising the option to terminate the lease. Variable lease payments that do not depend on an index or a rate are recognized as an expense in the period in which the event or condition that triggers the payment occurs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In calculating the present value of lease payments, the Group uses its incremental borrowing rate at the lease commencement date because the interest rate implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured if there is a modification, a change in the lease term, a change in lease payments (e.g., a change to future lease payments resulting from a change in an index or rate) or a change in assessment of an option to purchase the underlying asset. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11.71pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:11.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Short-term leases and leases of low-value assets </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group applies the short-term lease recognition exemption to its short-term leases of office equipment (that is those leases that have a lease term of 12&#160;months or less from the commencement date and do not contain a purchase option). It also applies the recognition exemption for leases of low-value assets to leases of office equipment that are considered to be of low value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Lease payments on short-term leases and leases of low-value assets are recognized as an expense on a straight-line basis over the lease term. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Financial assets</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Initial recognition and measurement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Financial assets are classified, at initial recognition, as subsequently measured at amortized cost, fair value through other comprehensive income, and fair value through profit or loss. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The classification of financial assets at initial recognition depends on the financial asset&#8217;s contractual cash flow characteristics and the Group&#8217;s business model for managing them. With the exception of trade receivables that do not contain a significant financing component or for which the Group has applied the practical expedient of not adjusting the effect of a significant financing component, the Group initially measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit or loss, transaction costs. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-64</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order for a financial asset to be classified and measured at amortized cost or fair value through other comprehensive income, it needs to give rise to cash flows that are solely payments of principal and interest (&#8220;SPPI&#8221;) on the principal amount outstanding. Financial assets with cash flows that are not SPPI are classified and measured at fair value through profit or loss, irrespective of the business model. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets classified and measured at amortized cost are held within a business model with the objective to hold financial assets in order to collect contractual cash flows, while financial assets classified and measured at fair value through other comprehensive income are held within a business model with the objective of both holding to collect contractual cash flows and selling. Financial assets which are not held within the aforementioned business models are classified and measured at fair value through profit or loss. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All regular way purchases and sales of financial assets are recognized on the trade date, that is, the date that the Group commits to purchase or sell the asset. Regular way purchases or sales are purchases or sales of financial assets that require delivery of assets within the period generally established by regulation or convention in the marketplace. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Subsequent measurement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The subsequent measurement of financial assets depends on their classification as follows: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Financial assets at amortized cost (debt instruments)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial assets at amortized cost are subsequently measured using the effective interest method and are subject to impairment. Gains and losses are recognized in the statement of profit or loss and other comprehensive income when the asset is derecognized, modified or impaired. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Financial assets at fair value through profit or loss</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial assets at fair value through profit or loss are carried in the statement of financial position at fair value with net changes in fair value recognized in the statement of profit or loss and other comprehensive income. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This category includes derivative instruments and equity investments which the Group has not irrevocably elected to classify at fair value through other comprehensive income. Dividends on equity investments classified as financial assets at fair value through profit or loss are also recognized as other income in the statement of profit or loss and other comprehensive income when the right of payment has been established, it is probable that the economic benefits associated with the dividend will flow to the Group and the amount of the dividend can be measured reliably. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A derivative embedded in a hybrid contract, with a financial liability or non-financial host, is separated from the host and accounted for as a separate derivative if the economic characteristics and risks are not closely related to the host; a separate instrument with the same terms as the embedded derivative would meet the definition of a derivative; and the hybrid contract is not measured at fair value through profit or loss. Embedded derivatives are measured at fair value with changes in fair value recognized in the statement of profit or loss and other comprehensive income. Reassessment only occurs if there is either a change in the terms of the contract that significantly modifies the cash flows that would otherwise be required or a reclassification of a financial asset out of the fair value through profit or loss category. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-65</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A derivative embedded within a hybrid contract containing a financial asset host is not accounted for separately. The financial asset host together with the embedded derivative is required to be classified in its entirety as a financial asset at fair value through profit or loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Derecognition of financial assets</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Group&#8217;s Unaudited Condensed Consolidated statement of financial position) when: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the rights to receive cash flows from the asset have expired; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Group has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material delay to a third party under a &#8220;pass-through&#8221; arrangement; and either (a)&#160;the Group has transferred substantially all the risks and rewards of the asset, or (b)&#160;the Group has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">When the Group has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risk and rewards of ownership of the asset. When it has neither transferred nor retained substantially all the risks and rewards of the asset nor transferred control of the asset, the Group continues to recognize the transferred asset to the extent of the Group&#8217;s continuing involvement. In that case, the Group also recognizes an associated liability. The transferred asset and the associated liability are measured on a basis that reflects the rights and obligations that the Group has retained. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Continuing involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that the Group could be required to repay. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Impairment of financial assets</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group recognizes an allowance for expected credit losses (&#8220;ECLs&#8221;) for all debt instruments not held at fair value through profit or loss. ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Group expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">General approach</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">ECLs are recognized in two stages. For credit exposures for which there has not been a significant increase in credit risk since initial recognition, ECLs are provided for credit losses that result from default events that are possible within the next 12&#160;months (a 12-month ECL). For those credit exposures for which there has been a significant increase in credit risk since initial recognition, a loss allowance is required for credit losses expected over the remaining life of the exposure, irrespective of the timing of the default (a lifetime ECL). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the end of each of the Relevant Periods, the Group assesses whether the credit risk on a financial instrument has increased significantly since initial recognition. When making the assessment, the Group compares the risk of a default occurring on the financial instrument as of the reporting date with the risk of a default occurring on the financial instrument as of the date of initial recognition and considers reasonable and supportable information that is available without undue cost or effort, including historical and forward- looking information. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-66</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group considers a financial asset in default when contractual payments are 90&#160;days past due. However, in certain cases, the Group may also consider a financial asset to be in default when internal or external information indicates that the Group is unlikely to receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Group. A financial asset is written off when there is no reasonable expectation of recovering the contractual cash flows. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial assets at amortized cost are subject to impairment under the general approach and they are classified within the following stages for measurement of ECLs except for trade receivables and contract assets which apply the simplified approach as detailed below. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:justify; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Stage 1&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Financial instruments for which credit risk has not increased significantly since initial recognition and for which the loss allowance is measured at an amount equal to 12-month ECLs </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:justify; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Stage 2&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Financial instruments for which credit risk has increased significantly since initial recognition but that are not credit-impaired financial assets and for which the loss allowance is measured at an amount equal to lifetime ECLs </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.19pt; margin-bottom:0pt; text-align:justify; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Stage 3&#8201;&#8212;&#8201;</font>
          <br >
        </div>
        <div style=" margin-top:8.19pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:68pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Financial assets that are credit-impaired at the reporting date (but that are not purchased or originated credit-impaired) and for which the loss allowance is measured at an amount equal to lifetime ECLs </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Simplified approach</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For trade receivables that do not contain a significant financing component or when the Group applies the practical expedient of not adjusting the effect of a significant financing component, the Group applies the simplified approach in calculating ECLs. Under the simplified approach, the Group does not track changes in credit risk, but instead recognizes a loss allowance based on lifetime ECLs at the end of each of the Relevant Periods. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Financial liabilities</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Initial recognition and measurement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans and borrowings, payables, as appropriate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable transaction costs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s financial liabilities include trade and other payables, derivative financial instruments, interest-bearing bank and other borrowings and certain financial instruments designated at FVTPL. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Subsequent measurement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The subsequent measurement of financial liabilities depends on their classification as follows: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Financial liabilities at fair value through profit or loss</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated upon initial recognition as at fair value through profit or loss. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-67</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Financial liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. This category also includes derivative financial instruments entered into by the Group that are not designated as hedging instruments in hedge relationships as defined by IFRS 9. Separated embedded derivatives are also classified as held for trading unless they are designated as effective hedging instruments. Gains or losses on liabilities held for trading are recognized in the statement of profit or loss. The net fair value gain or loss recognized in the statement of profit or loss does not include any interest charged on these financial liabilities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Financial liabilities designated upon initial recognition as at fair value through profit or loss are designated at the initial date of recognition, and only if the criteria in IFRS 9 are satisfied. Gains or losses on liabilities designated at fair value through profit or loss are recognized in the statement of profit or loss, except for the gains or losses arising from the Group&#8217;s own credit risk which are presented in other comprehensive income with no subsequent reclassification to the statement of profit or loss. The net fair value gain or loss recognized in the statement of profit or loss does not include any interest charged on these financial liabilities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The company assessed the contract characteristics of each series of convertible redeemable preferred shares to determine whether they should be classified as equity instruments or financial liabilities. The Series&#160;B, C, and D Preferred Shares and Series&#160;B Convertible Loans were classified as financial liabilities measured at fair value through profit or loss. The decision was based on the presence of a redemption feature and a conversion option with a price adjustment feature, which are considered financial liabilities under IAS 32. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The company also determined that the Series&#160;B Convertible Loans are a hybrid instrument that includes a non-derivative host contract and embedded derivatives, which should be accounted for at fair value through profit or loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Financial liabilities at amortized cost (loans and borrowings)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After initial recognition, interest-bearing loans and borrowings are subsequently measured at amortized cost, using the effective interest rate method unless the effect of discounting would be immaterial, in which case they are stated at cost. Gains and losses are recognized in the statement of profit or loss and other comprehensive income when the liabilities are derecognized as well as through the effective interest rate amortization process. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Amortized cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the effective interest rate. The effective interest rate amortization is included in finance costs in the statement of profit or loss and other comprehensive income. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Derecognition of financial liabilities</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A financial liability is derecognized when the obligation under the liability is discharged or cancelled, or expires. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as a derecognition of the original liability and a recognition of a new liability, and the difference between the respective carrying amounts is recognized in the statement of profit or loss and other comprehensive income. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Derivative financial instruments</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:9.62pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Initial recognition and subsequent measurement</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group uses derivative financial instruments, such as warrants. Such derivative financial instruments are initially recognized at fair value on the date on which a derivative contract is entered into and are </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-68</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">subsequently remeasured at fair value. Derivatives are carried as assets when the fair value is positive and as liabilities when the fair value is negative.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any gains or losses arising from changes in fair value of derivatives are taken directly to profit or loss. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Current versus non-current classification</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Derivative instruments that are not designated as effective hedging instruments are classified as current or non-current or separated into current and non-current portions based on an assessment of the facts and circumstances (i.e., the underlying contracted cash flows): </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.9pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.9pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Where the Group expects to hold a derivative as an economic hedge (and does not apply hedge accounting) for a period beyond 12&#160;months after the end of the reporting period, the derivative is classified as non-current (or separated into current and non-current portions) consistently with the classification of the underlying item. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Embedded derivatives that are not closely related to the host contract are classified consistently with the cash flows of the host contract. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.99pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.99pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Derivative instruments that are designated as, and are effective hedging instruments, are classified consistently with the classification of the underlying hedged item. The derivative instruments are separated into current portions and non-current portions only if a reliable allocation can be made. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Cash and cash equivalents</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the purpose of the Unaudited Condensed Consolidated statement of cash flows, cash and cash equivalents comprise cash on hand and demand deposits, and short term highly liquid investments that are readily convertible into known amounts of cash, are subject to an insignificant risk of changes in value, and have a short maturity of generally within three&#160;months when acquired. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For the purpose of the Unaudited Condensed Consolidated statement of financial position, cash and cash equivalents comprise cash on hand and at banks, including term deposits, and assets similar in nature to cash, which are not restricted as to use. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains its cash and cash equivalents at high-quality and accredited financial institutions in amounts that could exceed the $250,000 maximum amount insured by the Federal Deposit Insurance Corporation (FDIC). The Company does not believe that its cash and cash equivalents are subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Provisions</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A provision is recognized when a present obligation (legal or constructive) has arisen as a result of a past event and it is probable that a future outflow of resources will be required to settle the obligation, provided that a reliable estimate can be made of the amount of the obligation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">When the effect of discounting is material, the amount recognized for a provision is the present value at the end of the reporting period of the future expenditures expected to be required to settle the obligation. The increase in the discounted present value amount arising from the passage of time is included in finance costs in the statement of profit or loss and other comprehensive income. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-69</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Income tax</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Income tax comprises current and deferred tax. Income tax relating to items recognized outside profit or loss is recognized outside profit or loss, either in other comprehensive income or directly in equity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Current tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period, taking into consideration interpretations and practices prevailing in the countries in which the Group operates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax is provided, using the liability method, on all temporary differences at the end of the reporting period between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax liabilities are recognized for all taxable temporary differences, except: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">when the deferred tax liability arises from the initial recognition of goodwill or an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in respect of taxable temporary differences associated with investments in subsidiaries, associates and joint ventures, when the timing of the reversal of the temporary differences can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets are recognized for all deductible temporary differences, the carryforward of unused tax credits and any unused tax losses. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which the deductible temporary differences and the carryforward of unused tax credits and unused tax losses can be utilized, except: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">when the deferred tax asset relating to the deductible temporary differences arises from the initial recognition of an asset or liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:justify; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in respect of deductible temporary differences associated with investments in subsidiaries, associates and joint ventures, deferred tax assets are only recognized to the extent that it is probable that the temporary differences will reverse in the foreseeable future and taxable profit will be available against which the temporary differences can be utilized. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The carrying amount of deferred tax assets is reviewed at the end of each of the Relevant Periods and reduced to the extent that it is no longer probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be utilized. Unrecognized deferred tax assets are reassessed at the end of each of the Relevant Periods and are recognized to the extent that it has become probable that sufficient taxable profit will be available to allow all or part of the deferred tax asset to be recovered. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets and liabilities are measured at the tax rates that are expected to apply to the period when the asset is realised or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets and deferred tax liabilities are offset if and only if the Group has a legally enforceable right to set off current tax assets and current tax liabilities and the deferred tax assets and deferred tax liabilities relate to income taxes levied by the same taxation authority on either the same taxable entity or different taxable entities which intend either to settle current tax liabilities and assets on a net basis, or to realise the assets and settle the liabilities simultaneously, in each future period in which significant amounts of deferred tax liabilities or assets are expected to be settled or recovered. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-70</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In compliance with IFRIC 23, accruals for risk on income tax are part of the income tax within the statements of operations and comprehensive loss and income tax payable within the statements of financial position. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Government grants</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Government grants are recognized at their fair value where there is reasonable assurance that the grant will be received and all attaching conditions will be complied with. When the grant relates to an expense item, it is recognized as income on a systematic basis over the periods that the costs, for which it is intended to compensate, are expensed. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Revenue recognition</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Sales of intellectual property</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Revenue from sales of intellectual property is recognized when control of the intellectual property is transferred to the customers at an amount that reflects the consideration to which the Group expects to be entitled in exchange for the intellectual property. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">When the consideration of sales of intellectual property includes a variable amount, the amount of consideration is estimated to which the Group will be entitled in exchange for transferring the intellectual property to the customer. The variable consideration is estimated at contract inception and constrained until it is highly probable that a significant revenue reversal in the amount of cumulative revenue recognized will not occur when the associated uncertainty with the variable consideration is subsequently resolved. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Milestone payments and sales-based royalties represent a form of variable consideration which is included in the transaction price to the extent that it is highly probable that a significant reversal of accumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is subsequently resolved. When the Group cannot conclude that it is highly probable that a significant revenue reversal of cumulative revenue under the contract will not occur, the Group constrains the related variable consideration resulting in its exclusion from the transaction price. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As part of the accounting for this arrangement, the Group must use significant judgement to determine: (a) the performance obligations; and (b)&#160;the method to estimate variable consideration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At contract inception, the Group assesses the goods or services promised within each contract and determines those that are performance obligations, and assesses whether each promised good or service is distinct. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group uses judgement to determine whether milestones or other variable consideration, except for royalties, should be included in the transaction price. The transaction price is allocated to each performance obligation on a relative stand-alone selling price basis, for which the Group recognizes revenue as or when the performance obligations under the contract are satisfied. If a milestone or other variable consideration relates specifically to the Group&#8217;s efforts to satisfy a single performance obligation or to a specific outcome from satisfying the performance obligation, the Group generally allocates that milestone amount entirely to that performance obligation once it is highly probable that a significant revenue reversal would not occur. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group recognizes revenue only when it satisfies a performance obligation by transferring control of the promised goods or services. The transfer of control can occur over time or at a point in time. A performance obligation is satisfied over time if it meets one of the following criteria: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The counterparty simultaneously receives and consumes the benefits provided by the Group&#8217;s performance as the Group performs; or </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-71</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s performance creates or enhances an asset that the counterparty controls as the asset is created or enhanced </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s performance does not create an asset with an alternative use to the Group and the Group has an enforceable right to payment for performance completed to date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The portion of the transaction price that is allocated to performance obligations satisfied at a point in time is recognized as revenue when control of the goods or services is transferred to the counterparty. If the performance obligation is satisfied over time, the portion of the transaction price allocated to that performance obligation is recognized as revenue as the performance obligation is satisfied. The Group adopts an appropriate method of measuring progress for purposes of recognizing revenue. The Group evaluates the measure of progress at the end of each reporting period and, if necessary, adjusts the measure of performance and related revenue recognition. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upfront fees </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upfront payment is allocated to the performance obligations based on the Group&#8217;s best estimate of their relative stand-alone selling prices. The Group recognizes revenues from non-refundable upfront fees at a point in time when the transfer of control of the intellectual property to the counterparty occurs and the counterpary is able to use and benefit from the intellectual property. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Milestone payments </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the inception of each arrangement that includes milestone payments, the Group evaluates whether the milestones are considered highly probable of being achieved and estimates the amount to be included in the transaction price using the most likely amount method. If it is highly probable that a significant reversal of cumulative revenue would not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Group, such as regulatory approvals, are not considered highly probable of being achieved until those approvals are received. The Group evaluates factors such as the scientific, clinical, regulatory, commercial, and other risks that must be overcome to achieve the particular milestone in making this assessment. There is considerable judgement involved in determining whether it is highly probable that a significant reversal of cumulative revenue would not occur. At the end of each subsequent reporting period, the Group re-evaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Milestone payments are allocated to performance obligations based on the Group&#8217;s best estimate of their relative stand-alone selling prices unless the criteria under IFRS 15.85 are met, in which case the milestone payments are allocated entirely to the performance obligation which the milestone payments are specifically related to. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group assessed that achievement of all the remaining contractual milestones is highly uncertain and the related milestone payments are not included in the transaction price. Milestones are achieved when the triggering event described in the related agreement occurs. </font>
        </div>
        <div style="margin-left:20pt; margin-top:12pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sales royalties </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group recognizes revenue for a sales-based royalty promised in exchange for the sales of intellectual property only when (or as) the later of the following events occurs: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the subsequent sale occurs; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the performance obligation to which some or all of the sales-based royalty has been allocated has been satisfied. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-72</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Revenue from other sources</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Rental income is recognized on a time proportion basis over the lease terms. Variable lease payments that do not depend on an index or a rate are recognized as income in the accounting period in which they are incurred. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Interest income</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Interest income is recognized on an accrual basis using the effective interest method by applying the rate that exactly discounts the estimated future cash receipts over the expected life of the financial instrument or a shorter period, when appropriate, to the net carrying amount of the financial asset. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Share-based payments</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company operates a share option scheme for the purpose of providing incentives and rewards to eligible participants who contribute to the success of the Group&#8217;s operations. Employees (including directors) of the Group receive remuneration in the form of share-based payments, whereby employees render services as consideration for equity instruments (&#8220;equity-settled transactions&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The cost of equity-settled transactions with employees for grants is measured by reference to the fair value at the date at which they are granted. The fair value is determined by an external valuer using a binomial model, further details of which are given in note 19 to the Unaudited Condensed Consolidated Financial Statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The cost of equity-settled transactions is recognized in employee benefit expense, together with a corresponding increase in equity, over the period in which the performance and/or service conditions are fulfilled. The cumulative expense recognized for equity-settled transactions at the end of each of the Relevant Periods until the vesting date reflects the extent to which the vesting period has expired and the Group&#8217;s best estimate of the number of equity instruments that will ultimately vest. The charge or credit to the statement of profit or loss and other comprehensive income for a period represents the movement in the cumulative expense recognized as of the beginning and end of that period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Service and non-market performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions being met is assessed as part of the Group&#8217;s best estimate of the number of equity instruments that will ultimately vest. Market performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award and lead to an immediate expensing of an award unless there are also service and/or performance conditions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Other employee benefits</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Pension schemes</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The employees of the Group&#8217;s subsidiaries who operate in Mainland China are required to participate in a central pension scheme operated by the local municipal government. These subsidiaries are required to contribute a certain&#160;percentage of their payroll costs to the central pension scheme. The contributions are charged to profit or loss as they become payable in accordance with the rules of the central pension scheme. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary in the U.S. maintains multiple qualified contributory savings plans as allowed under Section&#160;401(k) of the Internal Revenue Code in the U.S. These plans are defined contribution plans covering substantially all its qualifying employees and provide for voluntary contributions by employees, subject to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-73</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">certain limits. The contributions are made by both the employees and the employer. The employees&#8217; contributions are primarily based on specified dollar amounts or&#160;percentages of employee compensation. The only obligation of the subsidiary in the U.S. with respect to the retirement benefits plans is to make the specified contributions under the plans.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Housing fund&#8201;&#8212;&#8201;Mainland China</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group contributes on a monthly basis to a defined contribution housing fund plan operated by the local municipal government. Contributions to this plan by the Group are expensed as incurred. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Borrowing costs</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets (i.e., assets that necessarily take a substantial period of time to get ready for their intended use or sale) are capitalized as part of the cost of those assets. The capitalization of such borrowing costs ceases when the assets are substantially ready for their intended use or sale. Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs capitalized. All other borrowing costs are expensed in the period in which they are incurred. Borrowing costs consist of interest and other costs that an entity incurs in connection with the borrowing of funds. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Foreign currencies</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">These Unaudited Condensed Consolidated financial statements are presented in United States dollars (&#8220;$&#8221;), which is the Company&#8217;s functional currency. Each entity in the Group determines its own functional currency and items included in the financial statements of each entity are measured using that functional currency. Foreign currency transactions recorded by the entities in the Group are initially recorded using their respective functional currency rates prevailing at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies are translated at the functional currency rates of exchange at the end of the reporting period. Differences arising on settlement or translation of monetary items are recognized in the statement of operations and comprehensive loss. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rates at the dates of the initial transactions. Non-monetary items measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was measured. The gain or loss arising on translation of a non-monetary item measured at fair value is treated in line with the recognition of the gain or loss on change in fair value of the item (i.e., translation difference on the item whose fair value gain or loss is recognized in other comprehensive income or profit or loss is also recognized in other comprehensive income or profit or loss, respectively). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In determining the exchange rate on initial recognition of the related asset, expense or income on the derecognition of a non-monetary asset or non-monetary liability relating to an advance consideration, the date of the initial transaction is the date on which the Group initially recognizes the non-monetary asset or non-monetary liability arising from the advance consideration. If there are multiple payments or receipts in advance, the Group determines the transaction date for each payment or receipt of the advance consideration. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The functional currencies of certain subsidiaries established in the PRC are currencies other than $. As of the end of the reporting period, the assets and liabilities of these entities are translated into $ at the exchange rates prevailing at the end of the reporting period and their statements of profit or loss and other comprehensive income are translated into $ at the weighted average exchange rates for the year. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-74</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2.4</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The resulting exchange differences are recognized in other comprehensive income and accumulated in the exchange fluctuation reserve. On disposal of a foreign operation, the component of other comprehensive income relating to that particular foreign operation is recognized in the statement of profit or loss and other comprehensive income. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For the purpose of the Unaudited Condensed Consolidated statement of cash flows, the cash flows of the subsidiaries established in the PRC are translated into $ at the exchange rates at the dates of the cash flows. Frequently recurring cash flows of the subsidiaries established in the PRC which arise throughout the year are translated into $ at the weighted average exchange rates for the year.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.02pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:9.02pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SIGNIFICANT ACCOUNTING JUDGEMENTS AND ESTIMATES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:11.01pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Use of Estimates</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of the Group&#8217;s Unaudited Condensed Consolidated Financial Statements requires management to make judgements, estimates and assumptions that affect the reported amounts of revenues, expenses, assets and liabilities, and their accompanying disclosures, and the disclosure of contingent liabilities. Uncertainty about these assumptions and estimates could result in outcomes that could require a material adjustment to the carrying amounts of the assets or liabilities affected in the future. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Estimation uncertainty</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The key assumptions concerning the future and other key sources of estimation uncertainty at the end of the reporting period that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are described below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Fair value of financial liabilities measured at FVTPL</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the financial liabilities, including convertible redeemable preferred shares, convertible loans, forwards and warrants, are measured at FVTPL and determined using the valuation techniques, including the discounted cash flow method and the back-solve method. Such valuation requires the Group to make estimates of the key assumptions including the risk-free interest rate, discount for lack of marketability (&#8220;DLOM&#8221;) and volatility, which are subject to uncertainty and might materially differ from the actual results. Further details are included in note 15 to the Unaudited Condensed Consolidated Financial Statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Fair value of share-based payment</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the awarded shares is determined at the grant dates by the binomial option-pricing model. Significant estimates on assumptions, including the underlying equity value, discount rate, expected volatility, and dividend yield, are made by management. Further details are included in note 19 to the Unaudited Condensed Consolidated Financial Statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The preparation of the Unaudited Condensed Consolidated financial statements in conformity with IFRS requires management to make estimates and assumptions that affect the reporting amounts of assets and liabilities, and disclosure of contingent assets and liabilities, as of the date of the Unaudited Condensed Consolidated financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the valuation and accounting for financial liabilities at FVTPL and equity awards. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Impairment of non-financial assets (other than goodwill)</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group assesses whether there are any indicators of impairment for all non-financial assets (including the right-of-use assets) at the end of each of the Relevant Periods. Other non-financial assets are tested for </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-75</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:1.63999999999999pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">3.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SIGNIFICANT ACCOUNTING JUDGEMENTS AND ESTIMATES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">impairment when there are indicators that the carrying amounts may not be recoverable. An impairment exists when the carrying value of an asset or a cash-generating unit exceeds its recoverable amount, which is the higher of its fair value less costs of disposal and its value in use. The calculation of the fair value less costs of disposal is based on available data from binding sales transactions in an arm&#8217;s length transaction of similar assets or observable market prices less incremental costs for disposing of the asset. When value-in-use calculations are undertaken, management must estimate the expected future cash flows from the asset or cash-generating unit and choose a suitable discount rate in order to calculate the present value of those cash flows.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Deferred tax assets are recognized for unused tax losses to the extent that it is probable that taxable profit will be available against which the losses can be utilized. Significant management judgement is required to determine the amount of deferred tax assets that can be recognized, based upon the likely timing and level of future taxable profits together with future tax planning strategies. Further details are contained in note 6 to the Unaudited Condensed Consolidated Financial Statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Uncertain tax positions</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">In assessing any uncertainty over income tax treatments, the Group considers whether it is probable that the relevant tax authority will accept the uncertain tax treatment used, or proposed to be used, by individual group entities in their income tax filings. If it is probable, the current and deferred taxes are determined consistently with the tax treatment in the income tax filings. If it is not probable that the relevant taxation authority will accept an uncertain tax treatment, the effect of each uncertainty is reflected by using either the most likely amount or the expected value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group has evaluated the uncertain tax position of each of the companies within the Group as of December&#160;31, 2022, and June&#160;30,2023, the Group did not have any significant unrecognized uncertain tax positions. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">Leases&#8201;&#8212;&#8201;Estimating the incremental borrowing rate</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group cannot readily determine the interest rate implicit in a lease, and therefore, it uses an incremental borrowing rate (&#8220;IBR&#8221;) to measure lease liabilities. The IBR is the rate of interest that the Group would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment. The IBR therefore reflects what the Group &#8220;would have to pay&#8221;, which requires estimation when no observable rates are available (such as for subsidiaries that do not enter into financing transactions) or when it needs to be adjusted to reflect the terms and conditions of the lease (for example, when leases are not in the subsidiary&#8217;s functional currency). The Group estimates the IBR using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates (such as the subsidiary&#8217;s stand-alone credit rating).</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:13.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">REVENUE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There were no revenues occurred in the Relevant Periods.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-76</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCE COSTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An analysis of finance costs is as follows: </font>
        </div>
        <table style="width:416pt;height:81pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:314.13pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Six Months ended June&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:314.13pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:314.13pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:314.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expenses on bank and other borrowings </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">183</td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">191</td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:314.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expenses on lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">79</td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">52</td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:314.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">262</div>
            </td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">243</div>
            </td>
            <td style="padding:0pt;padding-left:11.97pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:16.6pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:16.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">INCOME TAX</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group is subject to income tax on an entity basis on profit arising in or derived from the jurisdictions in which members of the Group are domiciled and operate. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Cayman Islands</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the current laws of the Cayman Islands, the Company is not subject to tax on income or capital gains. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">British Virgin Islands</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiaries incorporated in British Virgin Islands are not subject to income tax under the current laws of British Virgin Islands. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Singapore</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary incorporated in Singapore is subject to Singapore corporate income tax effectively at the rate of 4.25%-17.00% on any estimated assessable profits arising in Singapore during the period presented. In the first three&#160;years since the establishment of the Singapore subsidiary, the first SGD100 of assessable profits of this subsidiary are taxed at an effective tax rate of 4.25% and the next SGD100 of assessable profits are taxed at an effective tax rate of 8.5%, and the remaining assessable profits are taxed at 17%. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Switzerland</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary incorporated in Switzerland is subject to a total corporate income tax rate of 11.9%, including 8.5% federal, and Zug cantonal and communal tax, during the Relevant Periods on the estimated assessable profits of the Swiss subsidiary. If the main business is operated in other cantons, the total corporate income tax, including federal, cantonal, and communal tax, could be up to 21.6%. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">The United States</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary incorporated in the United States (&#8220;U.S.&#8221;) is subject to U.S. federal income tax at the rate of 21%. And it is also subject to New Jersey state income tax, at the rate of 6.5% with net taxable income of $50,000 or less; 7.5% with net taxable income greater than $50,000 and less than or equal to $100,000; and 9% with net taxable income greater than $100,000. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Hong Kong</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The subsidiary incorporated in Hong Kong is subject to Hong Kong profits tax at the rate of 16.5% on any estimated assessable profits arising in Hong Kong during the period presented. The first HKD2,000 of assessable profits of this subsidiary are taxed at 8.25% and the remaining assessable profits are taxed at 16.5%. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-77</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">INCOME TAX&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Mainland China</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The provision for corporate income tax in Mainland China is based on the statutory rate of 25% of the assessable profits as determined in accordance with the PRC Corporate Income Tax Law, which was approved and became effective on January&#160;1, 2008. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the relevant regulations on extension for expiries of unused tax losses of High and New Technology Enterprises and Small and Medium-sized Technological Enterprises issued in July&#160;2018, the accumulated tax losses that did not expire from 2018 will have expiries extending from 5&#160;years to 10&#160;years from then on. Adlai Hangzhou qualified as a High and New Technology Enterprise during the&#160;years 2022&#8201;&#8211;&#8201;2024. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The income tax expense of the Group for the Relevant Periods is analyzed as follows: </font>
        </div>
        <table style="width:416pt;height:81pt;margin-left:20pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:315.88pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Six&#160;months ended June&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:315.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:315.88pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:315.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Current </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:315.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deferred </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:315.88pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:14.03pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.2pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The effective income tax rate used as of June&#160;30 is based on management&#8217;s estimate of the projected effective tax rate for the fiscal year. The Company&#8217;s effective tax rate for the six&#160;months ended June&#160;30, 2023 was 0%, as compared to 0% for the six&#160;months ended June&#160;30, 2022. The Company&#8217;s rate remains to be zero&#160;percent primarily due to the company&#8217;s continued loss position where deferred tax assets were not recognized and it is not probable that it will generate sufficient taxable profit in the foreseeable future to recover the deferred tax assets. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group has accumulated tax losses arising in Adlai Hangzhou in Mainland China of $83,103 and $102,980 as of December&#160;31, 2022 and June&#160;30, 2023, respectively, that will expire in ten&#160;years after the loss incurring year for offsetting against future tax able profits. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group also has accumulated tax losses in the U.S. of $46,201 and $54,168 as of December&#160;31, 2022 and June&#160;30,2023, respectively, that can be carried forward indefinitely to offset against future taxable profits of the companies in which losses were incurred, subject to 80% taxable income limitation annually. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Due to various complexities, including the number of legal entities and jurisdictions involved, the overall legal structure, and varying tax laws in relevant jurisdictions, the Company believes it is not currently practicable to estimate, within a reasonable range, the amount of any unrecognized deferred income taxes relating to investments in subsidiaries and interests in joint ventures. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">According to the double tax avoidance arrangements and other applicable PRC laws, the 10% withholding tax on the dividends the Hong Kong resident enterprise receives from a PRC resident enterprise may be reduced to 5%. However, if an applicant&#8217;s business activities do not constitute substantive business activities, it could result in the negative determination of the applicant&#8217;s status as a &#8220;beneficial owner&#8221;, and consequently, the applicant could be precluded from enjoying the above-mentioned reduced income tax rate of 5%. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the current laws of the United States of America, dividends payable by a U.S. entity to non-U.S. resident enterprises shall be subject to 30% withholding tax, unless the respective non-U.S. resident enterprise&#8217;s jurisdiction of incorporation has a tax treaty or arrangements with U.S. that provides for a reduced withholding tax rate or an exemption from withholding tax. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-78</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">6.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">INCOME TAX&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to Swiss tax policy, a Swiss entity is subject to a 35% withholding tax when the entity pays dividends to a non-Swiss resident enterprise. However, according to the Agreement for the Avoidance of Double Taxation signed between Switzerland and Singapore, the withholding tax rate will be reduced to 5% if the non-Swiss resident enterprise is a Singapore resident enterprise.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.62pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">7.</font>
          <br >
        </div>
        <div style=" margin-top:7.62pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">DIVIDENDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No dividends have been declared and paid by the Company or the Group during the Relevant Periods.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.63pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">8.</font>
          <br >
        </div>
        <div style=" margin-top:7.63pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">LOSS PER SHARE ATTRIBUTABLE TO ORDINARY EQUITY HOLDERS OF THE PARENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.11pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The calculation of the basic loss per share amount is based on the loss for the year attributable to ordinary equity holders of the parent, and the weighted average number of ordinary shares of 25,440,000 in issue during the six&#160;months ended June&#160;30, 2022, and 2023, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.11pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The calculation of the basic loss per share amount is based on the loss for the&#160;years attributable to ordinary equity holders of the parent, and the weighted average number of ordinary shares in issue or deemed to be in issue during the six&#160;months ended June&#160;30, 2022 and 2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Basic loss per share is computed on the basis of the weighted average number of ordinary shares outstanding during the period of the financial statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Diluted loss per share of ordinary stock is computed on the basis of the weighted average number of shares of ordinary stock and dilutive securities (such as stock options and convertible securities) outstanding. As of June&#160;30, 2022, the Company had 63,925,782 dilutive shares consisting of 57,543,414 relating to convertible preferred stock and 6,382,368 relating to options. As of June&#160;30, 2023, the Company had 64,958,693 dilutive shares consisting of 57,543,414 relating to convertible preferred stock and 7,415,279 relating to options. Dilutive securities that have an anti-dilutive effect on diluted loss per share are excluded from the calculation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">No adjustment has been made to the basic loss per share amounts presented for the six&#160;months ended June&#160;30, 2022 and 2023 in respect of a dilution as the impact of the outstanding share options, restricted stock&#160;units and warrant liability had an anti-dilutive effect on the basic loss per share amounts presented.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.63pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">9.</font>
          <br >
        </div>
        <div style=" margin-top:7.63pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">PROPERTY, PLANT AND EQUIPMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:206.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:185.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Lease hold</font>
                <br >
                <font style="letter-spacing:-0.16pt;">improvements </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Plant and</font>
                <br >
                <font style="letter-spacing:-0.16pt;">machinery </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Office</font>
                <br >
                <font style="letter-spacing:-0.16pt;">equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Motor</font>
                <br >
                <font style="letter-spacing:-0.16pt;">vehicles </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Electronic</font>
                <br >
                <font style="letter-spacing:-0.16pt;">equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:185.14pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:185.14pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">At January&#160;1, 2023, net of accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,774</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,673</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">33</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">151</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">82</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,713</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">23</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">51</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">6</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">85</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation provided during the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(377<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(224<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(14<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">(18<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(24<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(657<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Disposals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange realignment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(51<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(51<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(4<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(1<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(107<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:1.917pt 0pt 0.5pt 0pt; width:185.14pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">At June&#160;30, 2023, net of accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1,351</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1,421</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">180</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">63</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">3,034</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of June&#160;30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Cost </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">2,446</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">3,319</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">145</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">244</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">273</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">6,427</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accumulated depreciation </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,095<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,898<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(126<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">(64<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(210<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">(3,393<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:185.14pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Net carrying amount </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1,351</td>
            <td style="padding:0pt;padding-left:9.58pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">1,421</td>
            <td style="padding:0pt;padding-left:4.19pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">19</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">180</td>
            <td style="padding:0pt;padding-left:5.1pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">63</td>
            <td style="padding:0pt;padding-left:7.835pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">3,034</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-79</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">9.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">PROPERTY, PLANT AND EQUIPMENT&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:12pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the Relevant Periods, none of the Group&#8217;s property, plant and equipment were pledged. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There was no impairment for the Group&#8217;s property, plant and equipment during the Relevant Periods.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">10.</font>
          <br >
        </div>
        <div style=" margin-top:13.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">LEASES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group has lease contracts of properties and used in its operation with lease terms between 2 and 5&#160;years. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:13.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Right-of-use assets </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The carrying amounts of the Group&#8217;s right-of-use assets and the movements during the Relevant Periods are as follows: </font>
        </div>
        <table style="width:456pt;height:106.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:339.3pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Offices </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Office</font>
                <br >
                <font style="letter-spacing:-0.16pt;">equipment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:339.3pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:339.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of January&#160;1, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">2,086</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">76</td>
            <td style="padding:0pt;padding-left:10.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,162</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:339.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:339.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation provided during the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">(471<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:10.5pt; text-align:right; white-space:nowrap;">(45<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(516<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:339.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange realignment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">(45<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.335pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">(2<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.335pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(47<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:339.3pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of June&#160;30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">1,570</div>
            </td>
            <td style="padding:0pt;padding-left:0.639999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.335pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:10.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">29</div>
            </td>
            <td style="padding:0pt;padding-left:10.335pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">1,599</div>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:18.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:18.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Lease liabilities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The carrying amount of lease liabilities and the movements during the Relevant Periods are as follows: </font>
        </div>
        <table style="width:456pt;height:121.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:383.92pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Six Months ended </font>
                <br >
                <font style="letter-spacing:-0.16pt;">June&#160;30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:383.92pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:383.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of January&#160;1, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(2,237<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:383.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:383.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accretion of interest recognized during the period </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(52<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:383.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">568</td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:383.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange realignment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">56</td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:383.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of June&#160;30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:19.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(1,665<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:17.02pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:105pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Analyzed into: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Current portion </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,001</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,001</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non-current portion </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">1,236</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">664</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">2,237</div>
            </td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">1,665</div>
            </td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-80</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:21.17pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">10.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">LEASES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The amounts recognized in profit or loss in relation to leases are as follows: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:81pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:354.13pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Six Months ended June&#160;30, </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:354.13pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:354.13pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:354.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest on lease liabilities </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(79<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:13.5pt; text-align:right; white-space:nowrap;">(52<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:354.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Depreciation charge of right-of-use assets </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(557<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">(516<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:354.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total amount recognized in profit or loss </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(636<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:13.5pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">(568<font style="position:absolute;">)</font></div>
            </td>
            <td style="padding:0pt;padding-left:10.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:18.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">11.</font>
          <br >
        </div>
        <div style=" margin-top:18.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">PREPAYMENTS, OTHER RECEIVABLES AND OTHER ASSETS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:181.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.61pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Current: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Prepayments (Note i) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">1,912</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">903</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">VAT deductible tax </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">100</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">422</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Deposits and other receivables </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">246</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">167</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">2,258</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,492</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.61pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Non-current: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Prepaid expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">327</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">264</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">327</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">264</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">2,585</div>
            </td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">1,756</div>
            </td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:6.7pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.19pt; text-align:justify; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Note i: </font>
        </div>
        <div style="margin-top:1.5pt; text-align:justify; width:456pt; line-height:10.5pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">The amount represents prepayments for Contract Research Organizations (&#8220;CROs&#8221;) and deposit of property, plant and equipment not yet placed in use. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Other receivables had no historical default. The financial assets included in the above balances relate to receivables which were categorized in stage 1 at the end of each of the Relevant Periods. In calculating the expected credit loss rate, the Group considers the historical loss rate and adjusts for forward-looking factors and information. During the Relevant Periods, the Group estimated that the expected credit loss rate for other receivables and deposits was minimal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group seeks to maintain strict control over its outstanding receivables to minimize credit risk. Long ageing balances are reviewed regularly by senior management. In view of the fact that the Group&#8217;s deposits and other receivables relate to a large number of diversified counterparties, there is no significant concentration of credit risk. The Group does not hold any collateral or other credit enhancements over its deposits and other receivable balances.</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-81</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">12.</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL ASSETS AT FVTPL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:89.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.61pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial assets:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:358.61pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Financial assets at FVTPL: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wealth management product </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:8.94pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:11.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.3pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the Relevant Periods, the Group used surplus capital to purchase wealth management product from domestic commercial banks, which preserved capital and liquidity. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The wealth management product held as of December&#160;31, 2022 was an investment into a mutual fund whose portfolio included a mixture of fixed income assets, preferred shares and repos, which were redeemable every 3&#160;months. The wealth management product held as of June&#160;30, 2023 was an investment into a money market fund that invests in short-term debt instruments such as treasury bills, certain certificates of deposit, bonds, government gilts and commercial paper, which were redeemable at December&#160;31,2023. The returns on all of the financial product was not guaranteed, hence their contractual cash flows did not qualify solely as payments of principal and interest. Therefore, those products were accounted at fair value through profit or loss. Further details are included in note 20(c) to the Unaudited Condensed Consolidated Financial Statements.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">13.</font>
          <br >
        </div>
        <div style=" margin-top:12.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">OTHER PAYABLES AND ACCRUALS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:90pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Other payables and accruals (Note i) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">255</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5,273</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payroll and bonus payables </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">3,622</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">4,465</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">3,877</div>
            </td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">9,738</div>
            </td>
            <td style="padding:0pt;padding-left:2.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.7pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.2pt; text-align:justify; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Note i: </font>
        </div>
        <div style="margin-top:1.7pt; text-align:justify; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Other payables and accruals are unsecured, non-interest-bearing and repayable on demand. The fair values of other payables and accruals at the end of each of the Relevant Periods approximated to their corresponding carrying amounts.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">14.</font>
          <br >
        </div>
        <div style=" margin-top:12.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">INTEREST-BEARING BANK BORROWINGS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:119.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:368.61pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:368.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:368.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:368.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non Revolving Facility, 5.22% interest, due March&#160;22,2023, guaranteed (Note i)</font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1,436</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:368.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non Revolving Facility, 4.8% interest, due April&#160;24,2023, guaranteed (Note ii) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,871</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:368.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non Revolving Facility, 4.0% interest, due August&#160;31,2023, guaranteed (Note i) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4,151</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:368.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non Revolving Facility, 4.2% interest, due March&#160;26, 2024, guaranteed (Note iii) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,768</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:368.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non Revolving Facility, 4.35% interest, due September&#160;1,2023, guaranteed (Note ii) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,768</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-82</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">14.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">INTEREST-BEARING BANK BORROWINGS&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:129pt;margin-top:12pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:368.61pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:368.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:368.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:368.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Non Revolving Facility, 4.2% interest, due October&#160;25, 2023, guaranteed (Note iv) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,384</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:368.61pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Non Revolving Facility, 4.2% interest, due November&#160;11, 2023, guaranteed </font>
                <br >
                <font style="letter-spacing:0.2pt;">(Note&#160;iv) </font>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">1,384</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.167pt 0pt 1.833pt 0pt; width:368.61pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Non Revolving Facility, 5.5% interest, due November&#160;17, 2023, guaranteed </font>
                <br >
                <font style="letter-spacing:0.2pt;">(Note&#160;v) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.833pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">7,040</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:368.61pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Total</font>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:20.25pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">4,307</div>
            </td>
            <td style="padding:0pt;padding-left:11.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">19,495</div>
            </td>
            <td style="padding:0pt;padding-left:0.0449999999999999pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="height:4pt;line-height:4pt;">
            <td style="padding:0pt;font-size:0pt;line-height:0pt;" colspan="14">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:111pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:383.92pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Six Months ended </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:383.92pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:383.92pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:383.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of January&#160;1, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:16.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:383.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">20,029</td>
            <td style="padding:0pt;padding-left:16.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:383.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Repayments </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(4,330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:16.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:383.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Effect of foreign exchange rate changes </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(511<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:16.185pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:383.92pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">As of June&#160;30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:16.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">
              <div style="font-weight:bold;">&#8203;</div>
            </td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">
              <div style="font-weight:bold;">19,495</div>
            </td>
            <td style="padding:0pt;padding-left:16.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.5pt; text-align:justify; width:456pt; line-height:12.5pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">All of the Group&#8217;s bank borrowings were obtained from third party financial institutions. As of December&#160;31, 2022 and June&#160;30, 2023, the Group&#8217;s credit facilities were $4,307 and $19,495, respectively, of which nil and nil was unused by the Group. </font>
        </div>
        <div style="margin-top:9pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:7.19pt; text-align:justify; width:456pt; line-height:10pt;">
          <font style="letter-spacing:0.16pt;">Notes: </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:5.2pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:5.2pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">In March&#160;2022, Adlai Hangzhou entered into a non-revolving facility agreement for a facility amount of RMB 10,000 at an interest rate of 5.22% per annum, guaranteed by Mr.&#160;Yang Lu, the chief executive officer and chairman of our board of directors. The non-revolving facility agreement was repaid at the maturity date of March&#160;22, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:1.5pt; text-align:justify; width:436pt; line-height:10.5pt;">
          <font style="letter-spacing:0.16pt;">In March&#160;2023, Adlai Hangzhou entered into a non-revolving facility agreement with a third party financial institution for a facility amount of RMB 30,000 at an interest rate of 4.0% per annum, guaranteed by Mr.&#160;Yang Lu. The maturity date is August&#160;31, 2023. </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:5.19pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:5.19pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">In October&#160;2022, Adlai Hangzhou entered into a non-revolving facility agreement for a facility amount of RMB 20,000 and at an interest rate of 4.80% per annum, guaranteed by Mr.&#160;Yang Lu, The maturity date of April&#160;24, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:1.5pt; text-align:justify; width:436pt; line-height:10.5pt;">
          <font style="letter-spacing:0.16pt;">In April 2023, Adlai Hangzhou entered into a non-revolving facility agreement with a third party financial institution for a facility amount of RMB 20,000 at an interest rate of 4.35% per annum, guaranteed by Mr. Yang Lu. The maturity date is September 1, 2023. </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:5.19pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:5.19pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">In March&#160;2023, Adlai Hangzhou entered into a non-revolving facility agreement with a third party financial institution for a facility amount of RMB 20,000 at an interest rate of 4.2% per annum, guaranteed by Mr.&#160;Yang Lu, The maturity date of March&#160;26, 2024. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:5.19pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(iv)</font>
          <br >
        </div>
        <div style=" margin-top:5.19pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">In April&#160;2023, Adlai Hangzhou entered into a non-revolving facility agreement with a third party financial institution for a facility amount of RMB 10,000 at an interest rate of 4.2% per annum, guaranteed by Mr.&#160;Yang Lu. The maturity date is October&#160;25, 2023. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:1.5pt; text-align:justify; width:436pt; line-height:10.5pt;">
          <font style="letter-spacing:0.16pt;">In May&#160;2023, Adlai Hangzhou entered into a non-revolving facility agreement with a third party financial institution for a facility amount of RMB 10,000 at an interest rate of 4.2% per annum, guaranteed by Mr.&#160;Yang Lu. The maturity date is November&#160;11, 2023. </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:5.19pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.16pt;">(v)</font>
          <br >
        </div>
        <div style=" margin-top:5.19pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">In May&#160;2023, Adlai Nortye Ltd. entered into a non-revolving facility agreement with a third party financial institution for a facility amount of USD 7,040 at an interest rate of 5.5% per annum, guaranteed by Adlai Hangzhou. The maturity date is November&#160;17, 2023.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">F-83</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Preferred shares and convertible loans</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In late 2015, Adlai Hangzhou raised up to RMB70,000 from the Founders and certain onshore investors (&#8220;Series&#160;A Investors&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2018, the Company was established in the Cayman Island for seeking overseas listing opportunity, and the Company issued ordinary shares to the Founders and an option to the Series&#160;A Investors, which entitled Series&#160;A Investors to convert their equity interests in Adlai Hangzhou to up to 14,560,000 series A convertible preferred shares (&#8220;Series&#160;A Preferred Shares&#8221;) of the Company, at par value of $ 0.0001 per share, upon completion of the Reorganization. From January&#160;2020 to April&#160;2020, Series&#160;A Investors exercised the option and converted their equity interests in Adlai Hangzhou to Series&#160;A Preferred Shares of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2018, to accommodate the Group&#8217;s Reorganization plan, certain onshore investors (&#8220;Series&#160;B Onshore Investors&#8221;) entered into convertible loan subscription agreement (the &#8220;Series&#160;B Loan Agreement&#8221;) with Adlai Hangzhou to issue a loan (the &#8220;Series&#160;B Convertible Loans&#8221;) to Series&#160;B Onshore Investors for a total consideration of RMB165,000. Meanwhile, the Company entered into a forward contract with these Series&#160;B Onshore investors to grant them an option (&#8220;Series&#160;B Preferred Shares Forward&#8221;) to convert Series&#160;B Convertible Loans issued by Adali Hangzhou to 6,600,000 series B convertible redeemable preferred shares (&#8220;Series&#160;B Preferred Shares&#8221;) of the Company, at par value of $ 0.0001 per share, upon completion of the Reorganization. Pursuant to the Series&#160;B Loan Agreement, these loans bore interest at 15% per annum and shall mature upon the exercise of the Series&#160;B Preferred Shares Forward. The Series&#160;B Onshore Investors agreed Adlai Hangzhou&#8217;s obligation of repayment the principal and accrued interests of these loans will be automatically relieved with the exercise of Series&#160;B Share Purchase Forward upon completion of the Reorganization. From April to May&#160;2020, the Series&#160;B Onshore Investors have exercised their Series&#160;B Share Purchase Forward and converted their Series&#160;B Convertible Loans to an aggregate of 6,600,000 Series&#160;B Preferred Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Concurrently, certain offshore investors (&#8220;Series&#160;B Offshore Investors&#8221;) subscribed 6,907,896 Series&#160;B Preferred Shares (&#8220;Series&#160;B Preferred Shares&#8221;) for a total consideration of $27,000. The Series&#160;B Onshore Investors and Series&#160;B Offshore Investors are collectively referred to as &#8220;Series&#160;B Investors&#8221;. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In December&#160;2019, the Company issued 14,653,013 series C convertible redeemable preferred shares (&#8220;Series&#160;C Preferred Shares&#8221;) of the Company for a total consideration of $63,700 to certain investors (&#8220;Series&#160;C Investors&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In April&#160;2021, the Company entered into a Series&#160;D share purchase agreement with certain investors (&#8220;Series&#160;D Investors&#8221;) to issue an aggregate of 14,722,505 series D convertible redeemable preferred shares (&#8220;Series&#160;D Preferred Shares&#8221;) for a total consideration of $97,370 and paid in full as of December&#160;31, 2021. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the original and amended Memorandum and Articles of Association (&#8220;MOA&#8221;) upon the issuance of each series of convertible redeemable preferred shares, the Group designated Series&#160;B, C and D Preferred Shares and Series&#160;B Convertible Loans as financial liabilities measured at FVTPL and recognized Series&#160;A Preferred Shares as equity in accordance with the relevant IFRS. There is no significant change in the major terms of MOA among of each series except mentioned otherwise in the notes to the Unaudited Condensed Consolidated Financial Statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">According to the MOA of the Company in May&#160;2021, the key terms of the Series&#160;A, B, C and D Preferred Shares (collectively &#8220;Preferred Shares&#8221;) are as follows: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Conversion Rights (applicable to all Preferred Shares)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each holder of Preferred Shares may, at the option of the holder thereof, be converted at any time into fully-paid and nonassessable ordinary shares of the Company based on the then-effective applicable </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-84</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">conversion price (&#8220;Applicable Conversion Price&#8221;). Each holder of Preferred Shares shall automatically be converted, based on the Applicable Conversion Price, into ordinary shares of the Company upon the closing of a Qualified IPO (as defined below).</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Applicable Conversion Price is initially equal to the original issue price for each class of Preferred Shares and shall be subject to adjustment from time to time, including but not limited to share splits, share subdivision, share combination and the like, being no less than par value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Company issues any additional ordinary shares at a subscription price less than the corresponding original subscription price of the Series&#160;B, C and D Preferred Shares, the Company shall issue new corresponding Series&#160;B, C and D Preferred Shares to the holders of Series&#160;B, C and D Preferred Shares at the nominal price or the minimum price allowed by applicable laws until the Applicable Conversion Price for each holders of Series&#160;B, C and D Preferred Shares is reduced to such issue price. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Group fails to meet any of the below two committed business objectives (&#8220;Business Objectives&#8221;) within the timelines, the holders of Series&#160;C Preferred Shares are entitled to request the Founders, affiliates of the Founders and the Group (collectively referred to as &#8220;Warrantors&#8221;) to jointly make up the share compensation necessary to make the pre-money valuation of the Company immediately before the investment by the holders of Preferred Shares be adjusted to 70% thereof. The share compensation arrangement shall be made on the basis of a nominal transfer price. The Business Objectives are: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">a)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">promote at least three products (self-developed or by introduction) to the next clinical stage within eighteen&#160;months from the Series&#160;C Preferred Shares closing date, on the basis of existing clinical pipelines; and; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">b)</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">obtain the approval of one new drug application from the competent authority for drug administration in the US or PRC by the 3rd anniversary of Series&#160;C Preferred Shares closing date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Qualified IPO means an underwriter initial public offering of the Company completed no later than the earlier of (i)&#160;September&#160;7, 2023 and (ii)&#160;two&#160;years after the date of Closing of the Series&#160;D Preferred Shares and which occurs on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Market or such other reputable stock exchange approved by the a majority of all of the investor directors with (i)&#160;the pre-public offering market capitalization of no less than $650,000, unless otherwise agreed by the investor directors; and (ii)&#160;shares held by the investors can be listed for trading or otherwise disposed of without transfer restrictions after any applicable statutory lock-up period. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Voting Rights (applicable to all Preferred Shares)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise required by law or as set forth herein, the holder of each ordinary share issued and outstanding shall have one vote for each ordinary share held by such holder, and the holder of Preferred Shares shall be entitled to the number of votes equal to the number of ordinary shares into which such Preferred Shares could be converted. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidation Preference (applicable to all Preferred Shares)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Upon any liquidation, closure, dissolution, merger or acquisition of any Group company; or the transfer of a controlling interest (i.e., more than 50% of the equity) by the shareholders of any Group company (excluding the holders of Series&#160;A, B, C and D Preferred Shares); or the sale of the majority of any Group&#8217;s assets to third parties; or the transfer of the majority of any Group&#8217;s intellectual property to third parties; or any event that can be defined as a transfer of control of any Group company; or any transfer of the Shares of any Group company (excluding the shares of the Company held by the holders of Series&#160;A, B, C and D Preferred Shares) or shares held by the Founders or their affiliates without the prior written consent of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-85</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Investor Director Majority, Series&#160;C Investors and Series&#160;D Investors; or any breach of the Warrantors under the Series&#160;D Share Purchase Agreements, the Series&#160;C Share Purchase Agreements, the Series&#160;B Share Purchase Agreement, the Shareholders&#8217; Agreement and these Articles, as applicable (&#8220;Transaction Documents&#8221;) which would cause the Series&#160;C Investors and Series&#160;D Investors to claim for termination of any of the Transaction Documents (each a &#8220;Liquidation Event&#8221;), whether voluntary or involuntary, all assets and funds of the Company legally available for distribution to the shareholders is distributed to the shareholders of the Company in the sequence as follows:</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">a)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Series&#160;D Preferred Shares </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">b)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Series&#160;C Preferred Shares </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.09pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">c)</font>
          <br >
        </div>
        <div style=" margin-top:8.09pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Series&#160;B Preferred Shares </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">d)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Series&#160;A Preferred Shares </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If there are any assets or funds remaining after the aggregate Series&#160;A, B, C and D Preferred Shares have been distributed or paid fully, the remaining assets and funds of the Company available for distribution is distributed on a pro&#160;rata basis among all holders of outstanding ordinary shares and Preferred Shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Dividends (applicable to all Preferred Shares)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each holder of the ordinary shares (on as-converted basis) shall be entitled to receive dividends on a pro&#160;rata basis on the number of ordinary shares, out of any funds legally available therefor, pro&#160;rata based on the number of ordinary shares held by each holder. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Redemption Rights (applicable to Series&#160;B, C and D Preferred Shares)</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At any time after the earlier of the following, any investors of Preferred Shares shall be entitled to require the Company to redeem all or portion of the outstanding Preferred Shares held by them, and/or require each of the Warrantors to jointly and severally redeem or repurchase all or portion of the outstanding Preferred Shares held by them: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">i.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the Company fails to complete a Qualified IPO at the earlier of (a)&#160;September&#160;7, 2023; and (b)&#160;two&#160;years after the date of Closing; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">ii.</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(applicable to Series&#160;C Investors and Series&#160;D Investors only) with respect to any Series&#160;C Investor or Series&#160;D Investor, such Series&#160;C Investor or Series&#160;D Investor fails to achieve the investment return which is 100% of its investment amount and plus an amount that would accrue on its investment amount at a simple interest rate of ten&#160;percent (10%) per annum (if such period is less than a year, such interest amount shall be calculated proportionally) through transfer, dividends of the Preferred Shares, or disposal in any other way approved by such Series&#160;C Investors or Series&#160;D Investors plus the value of the Preferred Shares (if any) still held by such Series&#160;C Investors or Series&#160;D Investors by September&#160;7, 2023 (with respect to Series&#160;C Investors) or by three&#160;years following its closing of Series&#160;D (with respect to Series&#160;D Investors); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">iii.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(applicable to Series&#160;C Investors only) the applicable Group company fails to meet any of the Committed Business Objectives within the timelines specified under these Articles; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">iv.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(applicable to Series&#160;C Investors only) the applicable Group company fails to obtain approval of a new medicine application from the competent authority for drug administration of its first medicine in the U.S. or the PRC by December&#160;30, 2022; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-86</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">v.</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">(applicable to Series&#160;C Investors and Series&#160;D Investors only) the first disapproval or rejection by any competent governmental authority (including, without limitation, the National Medical Products Administration of the PRC or the U.S. Food and Drug Administration) of the application made by any Group company with respect to any of its new drugs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.01pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">vi.</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in case that the Group companies meet the requirements for a Qualified IPO, any of the Group companies or the management shareholders refuses the Qualified IPO or declines to make necessary cooperation for such Qualified IPO, or the Group companies fail to complete the Qualified IPO due to any reasons attributable to any management shareholder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.01pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">vii.</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">without the written consent of the majority of investor directors, Series&#160;C Investors and Series&#160;D Investors, Mr.&#160;Yang Lu and Mr.&#160;Donghui Yang terminate their employment contracts with the applicable Group company or fail to comply their commitment to work full time as per the agreement with certain Series&#160;C Investors or Series&#160;D Investors prior to the latest to occur of the following events: (a)&#160;such Series&#160;C Investors or Series&#160;D Investors&#8217; exit; (b)&#160;the occurrence of a Qualified IPO; (c) the expiry of the two&#160;years period after the closing of Series&#160;D; and (d)&#160;September&#160;7, 2023; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.01pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">viii.</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">material change of principal business or, business scope of the Group companies without the written consent of the majority of investor directors, Series&#160;C Investors and Series&#160;D Investors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.01pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">ix.</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">any significant intellectual property of any Group company becomes invalid, frozen, or is transferred, authorized, pledged, encumbered, hypothecated to any third party without prior written consent of the majority of investor directors; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">x.</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the occurrence of a material breach by any Group company or any management shareholders of any of their respective representations, warranties, covenants or undertakings under the Transaction Documents and failure by applicable Group companies or management shareholders to make remedy within thirty days after so required; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">xi.</font>
          <br >
        </div>
        <div style=" margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the occurrence of a material breach by any Group company or any management shareholder of any of mandatory laws or regulations in the applicable jurisdiction; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.01pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">xii.</font>
          <br >
        </div>
        <div style=" margin-top:7.01pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the occurrence of any material dishonesty problem by any Group company or any management shareholder. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September 2023, holders of preferred shares confirmed that they will not declare or exercise their redemption right regarding the Group&#39;s preferred shares before planned IPO completion. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Next Equity Financing Warrant</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In June&#160;2018, in connection with the issuance of the Series&#160;B Preferred shares, the Company irrevocably issued to certain Series&#160;B Investors a warrant (&#8220;Next Equity Financing Warrant&#8221;), by which each of these Series&#160;B Investors shall be entitled but not obligated to purchase a certain number of the Company&#8217;s Preferred&#160;Shares with a par value of $0.0001 per share prior to the closing date of the Company&#8217;s next round equity or&#160;equity-linked financing (the &#8220;Next Equity Financing&#8221;), at an exercise price per share of ninety-five&#160;percent&#160;(95%) of the subscription price per share for the investors in such Next Equity Financing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Next Equity Financing Warrant expired upon the closing date of the Company&#8217;s Series&#160;C financing in August&#160;2019 as none of these Series&#160;B Investors subscribed the Company&#8217;s Series&#160;C Preferred Shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">CEHKL Warrant</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;20, 2019, the Company entered into a warrant agreement with China Equities HK Limited (&#8220;CEHKL&#8221;), under which the Company agreed to issue certain Series&#160;B Preferred Shares to CEHKL with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-87</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">agreed price (&#8220;CEHKL Warrant&#8221;) and the CEHKL Warrant will expire on May&#160;20, 2024. In July&#160;2021, CEHKL elected to exercise the CEHKL Warrant and the Company issued 100,000 Series&#160;B Preferred Shares to CEHKL.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Presentation and classification</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group and the Company have designated the Series&#160;B, C and D Preferred Shares and Series&#160;B Convertible Loans as financial liabilities measured at FVTPL upon initial recognition. The Next Equity Financing Warrant and CEHKL Warrant are initially recognized at fair value on the date on which the contract is entered into and are subsequently remeasured at fair value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The change in fair value of financial liabilities at FVTPL is charged to profit or loss except for the portion attributable to credit risk change that shall be charged to other comprehensive income. The net gain or loss recognized in profit or loss includes any interest paid on the financial liabilities and is included in the loss on changes in fair value of financial liabilities at FVTPL line item. Management concluded that there is no credit risk of the financial liability that drives the change of the fair value of the financial liability. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The categories of the Group&#8217;s financial liabilities at FVTPL are set out as follows: </font>
        </div>
        <table style="width:456pt;height:105pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.7pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:353.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;B Preferred Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">90,384</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">105,823</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;C Preferred Shares </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">97,132</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">113,810</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:3.5pt 0pt 2.5pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Series&#160;D Preferred Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">102,852</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">116,629</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.5pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company has used the discounted cash flow method and back-solve method to determine the underlying share value of the Company and adopted equity allocation model to determine the fair value of each financial liability as of the dates of issuance and at the end of each of the Relevant Periods. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Set out below is a summary of significant unobservable inputs to the valuation of financial instruments together with a quantitative sensitivity analysis as of December&#160;31, 2022, and June&#160;30,2023: </font>
        </div>
        <table style="width:456pt;height:90.9999999999999pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.57pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:337.57pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:337.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Fair value of ordinary shares of the Company </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">6.15</td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">7.37</td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Risk-free interest rate (Note i) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">4.68<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">5.38<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected term </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.44&#160;&#8199;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">0.25&#160;&#8199;years </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:337.57pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Volatility (Note ii) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">52.86<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">43.63<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:9.755pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5.51pt; text-align:justify; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Notes: </font>
        </div>
        <div style=" float:left; line-height:10pt; margin-top:3.5pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:3.5pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">1% increase/decrease in the risk-free interest rate with all other variables held constant would increase/increase the fair value of convertible redeemable preferred shares by $83/84 and decrease/increase $(30)/30 as of December&#160;31, 2022, and June&#160;30, 2023, respectively. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:10pt; margin-top:3.5pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:3.5pt; margin-bottom:0pt; line-height:10pt; text-align:justify; margin-left:20pt;font-size:8pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.16pt;">1% increase/decrease in volatility with all other variables held constant would decrease/increase the fair value of convertible redeemable preferred shares by $(49)/$924 and decrease/decrease $(1,087)/$(15) as of December&#160;31, 2022 and June&#160;30, 2023, respectively. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-88</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">15.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL LIABILITIES AT FVTPL&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Group estimated the risk-free interest rate based on the yield of the United States Government Bond with maturity close to the expected exit timing as of the valuation date. Under the option-pricing method, the cost of a put option, which can hedge the price change before the privately held shares can be sold, was considered as a basis to determine the lack of marketability discount. Volatility was estimated based on the annualized standard deviation of the daily stock price return of comparable companies for a period from the valuation date and with a similar time span to expiration.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.63pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">16.</font>
          <br >
        </div>
        <div style=" margin-top:7.63pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">WARRANTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In connection with issuance of Series&#160;B Preferred shares in August&#160;2019, the Company irrevocably issued to CEHKL 171,559 Private Warrants (&#8220;CEHKL Warrants&#8221;) at a fair value of $486. Please refer to note 15 for details of the CEHKL Warrant. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">None of CEHKL was outstanding as of December&#160;31, 2022 and June&#160;30,2023.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.63pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">17.</font>
          <br >
        </div>
        <div style=" margin-top:7.63pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">ORDINARY SHARES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:9.62pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Issued and fully paid:</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:59.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:358.61pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:358.61pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">25,440,000 shares of $0.0001 each </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:20.295pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:20.295pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.4pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:3.75pt; text-align:right; white-space:nowrap;">3</td>
            <td style="padding:0pt;padding-left:11.4pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:12.51pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The authorized share capital of the Company as of December&#160;31, 2022 is $50 divided into 500,000,000 Shares of par value of $0.0001 each, including 442,456,586 ordinary shares. There was no movement in the Company&#8217;s ordinary shares in the six&#160;months ended June&#160;30, 2023.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.63pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">18.</font>
          <br >
        </div>
        <div style=" margin-top:7.63pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">DEFICITS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:7.11pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The amounts of the Group&#8217;s deficits and the movement therein for the Relevant Periods are presented in the Unaudited Condensed Consolidated statements of changes in equity. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Additional paid-in capital </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The additional paid-in capital represents the difference between the par value of the shares issued and the consideration received. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:7.5pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Share option reserve </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The share option reverse of the Group represents the equity-settled share-based payments granted by the Group. Please refer to note 19 for details. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:7.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Exchange fluctuation reserve </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The exchange fluctuation reserve represents exchange differences arising from the translation of the financial statements of Group companies whose functional currencies are different from the Group&#8217;s presentation currency.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:7.62pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">19.</font>
          <br >
        </div>
        <div style=" margin-top:7.62pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SHARE INCENTIVE PLAN</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:9.63pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Adlai Hangzhou Scheme</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Adlai Hangzhou, a subsidiary of the Company, was once listed on the National Equities Exchange and Quotations (&#8220;NEEQ&#8221;) (stock code 870946) and adopted a share incentive scheme (the &#8220;Adlai Hangzhou </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-89</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">19.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SHARE INCENTIVE PLAN&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Scheme&#8221;) for the primary purpose of providing incentives to eligible management and employees who render services to Adlai Hangzhou. On June&#160;15, 2017, awards up to 1,220,000 shares were granted to management and employees at the exercise price of RMB7 per share. Awards granted under the Adlai Hangzhou Scheme shall have a contractual term of five&#160;years and generally vest over a four year period, with 25% of total awards vesting on the anniversary date one year after the vesting commencement date and the remaining 75% vesting subsequently in three equal annual instalments.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the awards granted to management and employees were $ 0.083 per share and $ 0.0765 per share, respectively, using the binomial option-pricing model on the grant date. The variables and assumptions used in computing the fair value of the awards are based on the directors&#8217; best estimate. Changes in variables and assumptions may result in changes in the fair value of the awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group recognized $81 of share-based payment expenses prior to 2021, and nil and nil share-based payment expenses for the six&#160;months ended June&#160;30, 2022 and 2023, respectively, in relation to the awards granted under the Adlai Hangzhou Scheme. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Adlai Share Incentive Plan</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On June&#160;8, 2020, the Company&#8217;s Board of Directors approved a share incentive scheme (the &#8220;Share Incentive Plan&#8221;) in order to provide additional incentives to employees and to promote the success of the </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Group&#8217;s business. Unless otherwise cancelled or amended, the Share Incentive Plan will remain in force for 10&#160;years. Under the Share Incentive Plan, the maximum aggregate number of shares shall not exceed 4,000,000 ordinary shares, as appropriately adjusted for subsequent stock splits, stock dividends and the like. On May&#160;28, 2021, the Company&#8217;s Board of Directors approved to further reserve 11,000,000 ordinary shares of the Company for the Share Incentive Plan for a total of 15,000,000 ordinary shares approved for the Share Incentive Plan. The exercise price of share options is determinable by the directors, but shall not be less than 100% of the fair market value on the grant date. Share options do not confer rights on the holders to dividends or to vote at shareholders&#8217; meetings. The awards may be granted but not be exercised prior to the last day of the six-month period following the listing date of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;5, 2021, the Company issued 6,000,000 and 9,000,000 ordinary shares reserved under the Share Inventive Plan to Nortye International Limited and Nortye Talent Limited, respectively, which are holding vehicles of two trusts established by the Company in order to facilitate the administration of the Share Incentive Plan. The sole purpose of the two trusts is to facilitate the issuance of ordinary shares under the Share Incentive Plan, and as such the 15,000,000 ordinary shares are not included in the Company&#8217;s calculation of weighted average shares outstanding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On September&#160;8, 2020 and November&#160;1, 2020, awards for 1,435,000 and 2,560,730 shares, respectively, were granted by the Company to its executives, employees and consultants. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On May&#160;31, 2021, 3,348,483 awarded shares were granted by the Company to its executives, employees and consultants. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;1, 2021, 412,000 awarded shares were granted by the Company to its executives, employees and consultants. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;1, 2022, 83,500 options were granted to certain new employees; 376,172 options were granted to certain employees and managers for outstanding performance. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On April&#160;1, 2022, 1,077,800 options were granted to certain new employees, promoted employees and senior managers; 33,336 options were granted to three consultants. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-90</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">19.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SHARE INCENTIVE PLAN&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:12pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On July&#160;1, 2022, 207,200 options were granted to five new employees. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On October&#160;1, 2022, 179,200 options were granted to five new employees. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On April&#160;2023, 352,500 options were granted to the employees with an exercise price of $2.20 under the 2020 Share Incentive Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On April&#160;2023, the Group adopted the 2023 Share Incentive Plan, which is effective upon the completion of this offering. The maximum aggregate number of ordinary shares that may be issued under this 2023 Share Incentive Plan is 15,000,000, including any reserved and issued share under the 2020 Share Incentive Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, the Group measured the fair value of the awards as of the grant date and recognizes the amount as a compensation expense over the vesting period for each separately vesting portion of the awards. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A summary of share option details is set forth below: </font>
        </div>
        <table style="width:456pt;height:106pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:345.99pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:345.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:345.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Number of awards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">9,510,102</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">9,862,602</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:345.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted Average Exercise Price $ per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1.82</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1.83</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:345.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted Average Grant Fair Value $ per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1.79</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1.92</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:345.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Weighted Average Remaining Contractual Life (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8.34</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">7.92</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:345.99pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Aggregate intrinsic value $&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">41,218</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">54,640</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:7.6pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A summary of share option vested but not exercisable is set forth below: </font>
        </div>
        <table style="width:456pt;height:91pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:345.99pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:345.99pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:345.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Number of awards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,980,069</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">6,376,777</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:345.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Weighted Average Exercise Price $ per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1.59</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1.69</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:345.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Weighted Average Grant Fair Value $ per share </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1.15</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1.41</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:345.99pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Weighted Average Remaining Contractual Life (in&#160;years) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">8.00</td>
            <td style="padding:0pt;padding-left:2.59pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">7.65</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.6pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">There were 15,000,000 shares reserved for the option plan and 5,489,898 shares available for issuance as of December&#160;31, 2022 and 5,137,398 shares available for issuance as of June&#160;30,2023. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of the award granted during the six&#160;months ended June&#160;30, 2023 was nil. The Group recognized share-based payment expenses of $3,249 and $2,392 during the six&#160;months ended June&#160;30, 2022 and 2023, respectively. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The fair value of awards granted during the Relevant Periods was estimated as of the grant date using a binomial option-pricing model, taking into account the terms and conditions upon which the awards were granted. The following table lists the inputs to the model used: </font>
        </div>
        <table style="width:456pt;height:47.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:110.2pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;8,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">November&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">May&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">October&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">January&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">April&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">July&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">October&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">April&#160;21,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:110.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dividend yield (%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:10.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.49pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:9.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.225pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.00</td>
            <td style="padding:0pt;padding-left:3.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:110.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Expected volatility (%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.35pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">46.81</td>
            <td style="padding:0pt;padding-left:10.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.49pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">46.81</td>
            <td style="padding:0pt;padding-left:9.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">46.13</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">49.00</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">48.73</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">48.78</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">48.88</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">48.82</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.225pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">49.68</td>
            <td style="padding:0pt;padding-left:3.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-91</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:71.36pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">19.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SHARE INCENTIVE PLAN&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:71.5pt;margin-top:12pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:110.2pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">September&#160;8,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">November&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2020 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">May&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">October&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2021 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">January&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">April&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">July&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">October&#160;1,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:2.75pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">April&#160;21,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:110.2pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Risk-free interest </font>
                <br >
                <font style="letter-spacing:0.2pt;">rate (%) </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.35pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">0.85</td>
            <td style="padding:0pt;padding-left:10.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.49pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.05</td>
            <td style="padding:0pt;padding-left:9.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.67</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.7</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">1.66</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2.52</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3.03</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3.98</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.225pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">3.98</td>
            <td style="padding:0pt;padding-left:3.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:110.2pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Expected life of options (year) </font>
              </div>
            </td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.35pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:10.35pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.49pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:9.49pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:2.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:6.305pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:1.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:6.395pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt; width:2.75pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.225pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">10.00</td>
            <td style="padding:0pt;padding-left:3.225pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:17.19pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">As of December&#160;31, 2022 and June&#160;30, 2023, the Company had 9,510,102 and 9,862,602 awards outstanding under the Share Incentive Plan, respectively. The exercise in full of the outstanding awards would, under the present capital structure of the Company, result in the issue of 9,510,102 and 9,862,602, respectively, additional ordinary shares of the Company and additional share capital of $1.0 and $1.0 (before issue expenses), respectively.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:13.19pt; margin-bottom:0pt; text-align:justify; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">20.</font>
          <br >
        </div>
        <div style=" margin-top:13.19pt; margin-bottom:0pt; line-height:12pt; text-align:justify; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Major non-cash transactions </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">During the six&#160;months ended June&#160;30, 2023, the Group had non-cash additions to right- of-use assets and lease liabilities of nil, in respect of lease arrangements for offices and equipment. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:9.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:9.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Changes in liabilities arising from financing activities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:202.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:272.03pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Financial</font>
                <br >
                <font style="letter-spacing:-0.16pt;">instrument</font>
                <br >
                <font style="letter-spacing:-0.16pt;">measured at</font>
                <br >
                <font style="letter-spacing:-0.16pt;">FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">New bank</font>
                <br >
                <font style="letter-spacing:-0.16pt;">loans </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Lease</font>
                <br >
                <font style="letter-spacing:-0.16pt;">liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:272.03pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:272.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">At January&#160;1, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">4,313</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">2,243</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">296,924</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:272.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest expense </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">191</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">52</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">243</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:272.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Additions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">20,029</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">20,029</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:272.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Disposal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:272.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Payment </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:272.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8211; financing cash flows </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(4,330<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">(568<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(4,898<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:272.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">&#8211; operating cash flows </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:272.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest paid </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">(168<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">(168<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:272.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Change in fair value </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">45,894</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">45,894</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3pt 0pt 2pt 0pt; width:272.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Exchange adjustment </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">(540<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">(62<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 2pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">(602<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 2.75pt 0pt; width:272.03pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">At June&#160;30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:3.56pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">19,495</td>
            <td style="padding:0pt;padding-left:2.74pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:17.25pt; text-align:right; white-space:nowrap;">1,665</td>
            <td style="padding:0pt;padding-left:3.77pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">357,422</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-92</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:77.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">20.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font>
          <br >
          <font style="letter-spacing:-0.2pt;">&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(c)</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Investment activities </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:151pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:300.13pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Dual currency</font>
                <br >
                <font style="letter-spacing:-0.16pt;">structured</font>
                <br >
                <font style="letter-spacing:-0.16pt;">deposit </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Wealth</font>
                <br >
                <font style="letter-spacing:-0.16pt;">management</font>
                <br >
                <font style="letter-spacing:-0.16pt;">product </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.667pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:300.13pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 2pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1pt 0pt; width:300.13pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Six Months ended June&#160;30, 2022</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:300.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">purchase </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(16,400<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(45,500<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(61,900<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:300.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">disposal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">22,900</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">45,500</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">68,400</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:300.13pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">interest received</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">120</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">120</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:300.13pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Six Months ended June&#160;30, 2023</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:300.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">purchase </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(7<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">(7<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:300.13pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">disposal </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">21,396</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">21,396</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3pt 0pt 1pt 0pt; width:300.13pt;text-align:left;">
              <div style="white-space:nowrap;font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">interest received</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:7.9pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">63</td>
            <td style="padding:0pt;padding-left:5.48pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3pt 0pt 1pt 0pt; min-width:23.25pt; text-align:right; white-space:nowrap;">63</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">21.</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">COMMITMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group did not have capital commitments at the end of each of the Relevant Periods.</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">22.</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">RELATED PARTY TRANSACTIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Related parties </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Parties are considered to be related if one party has the ability, directly or indirectly, to control or exercise significant influence over the other party. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Parties are also considered to be related if they are subject to common control. Members of key management of the Group and their close family members are also considered as related parties. </font>
        </div>
        <table style="width:456pt;height:47.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name of related parties </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:222pt;text-align:center;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Nature of relationship </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 2.5pt 0pt; width:222pt;">
              <font style="letter-spacing:0.2pt;">Mr.&#160;Yang Lu </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 2.5pt 0pt; width:222pt;white-space:normal;text-align:justify;">
              <div style="text-align:justify;">
                <font style="letter-spacing:0.2pt;">The chief executive officer and chairman of our board of directors and ultimate significant shareholder of the Company</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As disclosed in note 14 (ii)&#160;to note 14 (v)&#160;to the Unaudited Condensed Consolidated financial statements, RMB40,000 and RMB90,000 non-revolving facility agreements provided by three and four third party banks were guaranteed by the ultimate significant shareholder, Mr.&#160;Yang Lu for the periods ended December&#160;31, 2022 and June&#160;30,2023, respectively.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-93</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">23.</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL INSTRUMENTS BY CATEGORY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The carrying amounts of each of the categories of financial instruments of the Group as of the end of each of the Relevant Periods are as follows: </font>
        </div>
        <table style="width:456pt;height:265.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.7pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.75pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.833pt 0pt 1.417pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.833pt 0pt 1.417pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:353.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.75pt 0pt; width:353.7pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial assets:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:353.7pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Financial assets at FVTPL: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 1.75pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wealth management product </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.5pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.75pt 0pt; width:353.7pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Other financial assets: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:353.7pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Financial assets included in prepayments, other receivables and other assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,258</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,492</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 1.75pt 0pt; width:353.7pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Cash and cash equivalents </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">42,758</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">60,028</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.5pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">45,016</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">61,520</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.75pt 0pt; width:353.7pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial liabilities:</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:353.7pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Trade payables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">13,098</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">16,871</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 0.75pt 0pt; width:353.7pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Financial liabilities included in other payables and accruals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,877</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 0.75pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">9,738</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.75pt 0pt 1.75pt 0pt; width:353.7pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Interest-bearing bank and other borrowings </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">19,495</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.5pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,282</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">46,104</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2pt 0pt 0.75pt 0pt; width:353.7pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #CCEEFF;padding:2.75pt 0pt 1.75pt 0pt; width:353.7pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Financial instruments measured at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.75pt 0pt 1.75pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #CCEEFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #CCEEFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 2.5pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.75pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:17.39pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">24.</font>
          <br >
        </div>
        <div style=" margin-top:17.39pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The carrying amounts and fair values of the Group&#8217;s financial instruments, other than those with carrying amounts that reasonably approximate to fair values, are as follows: </font>
        </div>
        <table style="width:456pt;height:120pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:277.17pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:277.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt; width:0pt;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:277.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carrying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Carrying</font>
                <br >
                <font style="letter-spacing:-0.16pt;">amount </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:277.17pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:277.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:277.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Wealth management product </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:277.17pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:277.17pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:13.3pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Management has assessed that the fair values of cash and cash equivalents, interest-bearing bank and other borrowings, trade payables, financial assets included in prepayments, other receivables and other assets, and financial liabilities included in other payables and accruals approximate to their carrying amounts largely due to the short term maturities of these instruments. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s finance department headed by the finance manager is responsible for determining the policies and procedures for the fair value measurement of financial instruments. The finance manager reports </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-94</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">24.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">directly to the chief financial officer and the audit committee. At the end of each of the Relevant Periods, the finance department analyses the movements in the values of financial instruments and determines the major inputs applied in the valuation. The valuation is reviewed and approved by the chief financial officer. The valuation process and results are discussed with the audit committee twice a year for interim and annual financial reporting.</font><font style="font-weight:bold;letter-spacing:-0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The fair values of the financial assets and liabilities are included at the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. The methods and assumptions used to estimate the fair value, including a summary of significant unobservable inputs together with a quantitative sensitivity analysis, are set out in note 15 to the Unaudited Condensed Consolidated Financial Statements. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The fair values of the non-current portion of interest-bearing bank and other borrowings have been calculated by discounting the expected future cash flows using rates currently available for instruments with similar terms, credit risk and remaining maturities. The changes in fair value as a result of the Group&#8217;s own non-performance risk for interest-bearing bank and other borrowings as of the end of each of the Relevant Periods were assessed to be insignificant. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">Fair value hierarchy</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following tables illustrate the fair value measurement hierarchy of the Group&#8217;s financial instruments: </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As of December&#160;31, 2022</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:111pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:250.55pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value measurement using </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:250.55pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted prices</font>
                <br >
                <font style="letter-spacing:-0.16pt;">in active</font>
                <br >
                <font style="letter-spacing:-0.16pt;">markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">observable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant</font>
                <br >
                <font style="letter-spacing:-0.16pt;">unobservable</font>
                <br >
                <font style="letter-spacing:-0.16pt;">inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:250.55pt;">
              <font style="letter-spacing:0.2pt;">Financial assets</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
            <td colspan="6">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:250.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Wealth management product </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">21,287</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:250.55pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Financial liabilities </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:250.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:9.185pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:18.2pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">As of June&#160;30, 2023</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:111pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:250.55pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:0pt;text-align:center;" colspan="22">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Fair value measurement using </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:250.55pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Quoted prices</font>
                <br >
                <font style="letter-spacing:-0.16pt;">in active</font>
                <br >
                <font style="letter-spacing:-0.16pt;">markets</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Level&#160;1) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">observable </font>
                <br >
                <font style="letter-spacing:-0.16pt;">inputs </font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;2) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Significant </font>
                <br >
                <font style="letter-spacing:-0.16pt;">unobservable </font>
                <br >
                <font style="letter-spacing:-0.16pt;">inputs</font>
                <br >
                <font style="letter-spacing:-0.16pt;">(Level&#160;3) </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:2.583pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:250.55pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Financial assets. </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:250.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Wealth management product </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">7</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.75pt 0pt 1.5pt 0pt; width:250.55pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Financial liabilities </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 3.25pt 0pt; width:250.55pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:18.04pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:10.495pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:4.98pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-left:20pt; margin-top:14.19pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Changes in Level&#160;3 instruments for the six&#160;months ended June&#160;30, 2023 is as follows: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-95</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">24.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FAIR VALUE AND FAIR VALUE HIERARCHY OF FINANCIAL INSTRUMENTS&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:106.5pt;margin-top:12pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:398.2pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">June&#160;30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:398.2pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:398.2pt;text-align:left;">
              <font style="letter-spacing:-0.2pt;">Financial liabilities</font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance as of January&#160;1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:6.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Acquisitions </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:398.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Amount recognized in profit or loss </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">45,894</td>
            <td style="padding:0pt;padding-left:6.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:398.2pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Balance as of June&#160;30 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.545pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:6.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:18.19pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">25.</font>
          <br >
        </div>
        <div style=" margin-top:18.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group&#8217;s principal financial instruments comprise interest-bearing bank and other borrowings, convertible redeemable preferred shares and cash and cash equivalents. The main purpose of these financial instruments is to raise finance for the Group&#8217;s operations. The Group has various other financial assets and liabilities such as trade payables, other payables and accruals, which arise directly from its operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The main risks arising from the Group&#8217;s financial instruments are foreign currency risk and liquidity risk. The board of directors reviews and agrees policies for managing each of these risks and they are summarized below. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Foreign currency risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The Group has transactional currency exposures. Such exposures arise from purchases by operating&#160;units in currencies other than the&#160;units&#8217; functional currencies. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">The following table demonstrates the sensitivity at the end of each of the Relevant Periods to a reasonably possible change in the $ and RMB exchange rate, with all other variables held constant, of the Group&#8217;s profit before tax (due to changes in the fair values of monetary assets and liabilities). </font>
        </div>
        <table style="width:456pt;height:76pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:224.54pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:65.15pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/ (decrease) </font>
                <br >
                <font style="letter-spacing:-0.16pt;">in $/RMB rate% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:65.15pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/ (decrease) </font>
                <br >
                <font style="letter-spacing:-0.16pt;">in profit before tax </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:65.15pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/ (decrease) </font>
                <br >
                <font style="letter-spacing:-0.16pt;">in equity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:224.54pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:65.15pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:65.15pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:224.54pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">At December&#160;31, 2022 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.54pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">If the $ strengthens against the RMB </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,939</td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.54pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">If the $ weakens against the RMB </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">(5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(4,081<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:76pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:224.54pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:65.15pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/ (decrease) </font>
                <br >
                <font style="letter-spacing:-0.16pt;">in $/RMB rate% </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:65.15pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/ (decrease)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">in profit before tax </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:65.15pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Increase/ (decrease)</font>
                <br >
                <font style="letter-spacing:-0.16pt;">in equity </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:224.54pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:65.15pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt; width:65.15pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:224.54pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">At June&#160;30, 2023 </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.54pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">If the $ strengthens against the RMB </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">5</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">1,413</td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:224.54pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">If the $ weakens against the RMB </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap;">(5<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:28.41pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:7.5pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:27.575pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:19.5pt; text-align:right; white-space:nowrap;">(1,563<font style="position:absolute;">)</font></td>
            <td style="padding:0pt;padding-left:19.555pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.49pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Liquidity risk</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group monitors and maintains a level of cash and cash equivalents deemed adequate by the management of the Group to finance the operations and mitigate the effects of fluctuations in cash flows. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-96</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">25.</font>
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES&#8201;(continued)</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:12pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The maturity profile of the Group&#8217;s financial liabilities as of the end of each Relevant Periods, based on the contractual undiscounted payments, is as follows: </font>
        </div>
        <table style="width:456pt;height:118pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:212.37pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of December&#160;31, 2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt; width:38.25pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">On demand </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt; width:32.71pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Less than</font>
                <br >
                <font style="letter-spacing:-0.16pt;">1 year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt; width:38.09pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">1 to 5&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt; width:41.87pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Over 5&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt; width:32.71pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:38.25pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:32.71pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:38.09pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:41.87pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:32.71pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">290,368</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Trade and bills payables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">13,098</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">13,098</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.167pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Financial liabilities included in other payables and </font>
                <br >
                <font style="letter-spacing:0.2pt;">accruals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">3,877</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,877</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest-bearing bank borrowings </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">4,307</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">16,975</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">294,675</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">311,650</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:118pt;margin-top:15pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:212.37pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="28">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of June&#160;30, 2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt; width:38.25pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">On demand </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt; width:32.71pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Less than</font>
                <br >
                <font style="letter-spacing:-0.16pt;">1 year </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt; width:38.09pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">1 to 5&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt; width:41.87pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Over 5&#160;years </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt; width:32.71pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:38.25pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:32.71pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:38.09pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:41.87pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt; width:32.71pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Financial liabilities at FVTPL </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8199;&#8212;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">336,262</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Trade and bills payables </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">16,871</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">16,871</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.167pt 0pt 0.5pt 0pt; width:212.37pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Financial liabilities included in other payables and </font>
                <br >
                <font style="letter-spacing:0.2pt;">accruals </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">9,738</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.167pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">9,738</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Interest-bearing bank borrowings </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">19,495</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">19,495</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:212.37pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:21pt; text-align:right; white-space:nowrap;">26,609</td>
            <td style="padding:0pt;padding-left:5.27pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">355,757</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.545pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:11.25pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:13.435pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">382,366</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:17.3pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Capital management</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The primary objectives of the Group&#8217;s capital management are to safeguard the Group&#8217;s ability to continue as a going concern and to maintain healthy capital ratios in order to support its business and maximize shareholders&#8217; value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Group manages its capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Group may adjust the dividend payment to shareholders, return capital to shareholders or issue new shares. The Group is not subject to any externally imposed capital requirements. No changes were made in the objectives, policies or processes for managing capital during the Relevant Periods. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; text-align:justify; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The asset-liability ratios as of the end of each of the Relevant Periods are as follows: </font>
        </div>
        <table style="width:456pt;height:80pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.7pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 1.5pt 0pt; width:0pt;text-align:center;" colspan="10">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">As of </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:353.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">December&#160;31,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2022 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:1.583pt 0pt 1.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">June&#160;30,</font>
                <br >
                <font style="letter-spacing:-0.16pt;">2023 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt 0pt 0.5pt 0pt; width:353.7pt;text-align:left;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">$&#8217;000 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 0.5pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total assets </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">72,594</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">66,496</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:2.5pt 0pt 1.5pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Total liabilities </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">313,887</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 1.5pt 0pt;border-bottom:1px solid #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">384,031</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.25pt 0pt 2.25pt 0pt; width:353.7pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Asset-liability ratio (Note i) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.23</td>
            <td style="padding:0pt;padding-left:6.44pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.25pt 0pt 1.5pt 0pt;border-bottom:3pt double #000000; min-width:24.75pt; text-align:right; white-space:nowrap;">0.17</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:5.8pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:6.2pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">Note i: </font>
        </div>
        <div style="margin-top:2pt; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">The asset-liability ratio is calculated by dividing total assets by total liabilities</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-97</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC3">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:334pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ADLAI NORTYE LTD.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2022 AND 2023 (UNAUDITED)&#8201;(continued) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(All amounts in thousands, except share and per share data, or as otherwise noted)</font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">26.</font>
          <br >
        </div>
        <div style=" margin-top:10pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;font-weight:bold;">
          <!--blacklining:none;-->
          <font style="letter-spacing:-0.2pt;">SUBSEQUENT EVENTS</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(a)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Bank loans</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In August 2023, Adlai Hangzhou repaid a non-revolving facility amount of RMB30,000 at the maturity date.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In September 2023, Adlai Hangzhou repaid a non-revolving facility amount of RMB20,000 at the maturity date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In September 2023, Adlai Hangzhou entered into a non-revolving facility agreement with a third-party financial institution for a facility amount of RMB10,000 at an interest rate of 4.0% per annum, guaranteed by Mr. Yang Lu. The maturity date is September 17, 2024.</font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In September 2023, Adlai Hangzhou entered into a non-revolving facility agreement with a third-party financial institution for a facility amount of RMB10,000 at an interest rate of 4.0% per annum, guaranteed by Mr. Yang Lu. The maturity date is September 18, 2024.</font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(b)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Preferred shares </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; text-align:justify; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In September 2023, holders of preferred shares confirmed that they will not declare or exercise their redemption right regarding the Group&#39;s preferred shares before planned IPO completion.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-98</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:justify; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.8pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 2.8pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:70.32pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">2,500,000 American Depositary Shares</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="position:relative;margin-top:43.84pt; text-align:center; width:456pt;">
          <img src="lg_adlainortye-4c.jpg" alt="[MISSING IMAGE: lg_adlainortye-4c.jpg]" height="45" width="299" >
        </div>
        <div style="margin-top:50.31pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">Adlai Nortye Ltd.</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Representing 7,500,000 Class&#160;A Ordinary Shares</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:84.327pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 84.3266666666667pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:11.51pt; text-align:center; width:456pt; line-height:14pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
        </div>
        <div style="margin-top:8.633pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 8.63333333333333pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:83.72pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">Cantor</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:54.25pt; text-align:justify; width:456pt; line-height:11.5pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Through and including October&#160;24, 2023 (the 25th day after the date of this prospectus), all dealers that effect transactions in these ADSs, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#8217; obligation to deliver a prospectus when acting as an underwriter and with respect to their unsold allotments or subscriptions. </font>
        </div>
        <div style="margin-top:36pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">September&#160;29, 2023 </font>
        </div>
        <div style="margin-top:70.72pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 70.72pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2.8pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 2.79999999999995pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_adlainortye-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_adlainortye-4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    1@  _^$#_FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-RXP+6,P,# @-SDN9&%B86-B8BP@,C R,2\P-"\Q-"TP,#HS.3HT
M-" @(" @(" @(CX@/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S
M+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX@/')D9CI$97-C<FEP
M=&EO;B!R9&8Z86)O=70](B(@>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]M;2\B('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(B!X;6QN<SIX;7 ]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B('AM;&YS.F1C/2)H='1P
M.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(@>&UP34TZ3W)I9VEN86Q$
M;V-U;65N=$E$/2)U=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S,34P
M.$,X(B!X;7!-33I$;V-U;65N=$E$/2)X;7 N9&ED.C-%-$,Y.31%045!13$Q
M140Y1$8S135"14(V-#-$1C,R(B!X;7!-33I);G-T86YC94E$/2)X;7 N:6ED
M.C-$-S<P0CE%045!13$Q140Y1$8S135"14(V-#-$1C,R(B!X;7 Z0W)E871O
M<E1O;VP](D%D;V)E($EL;'5S=')A=&]R(#(U+C0@*$UA8VEN=&]S:"DB/B \
M>&UP34TZ1&5R:79E9$9R;VT@<W12968Z:6YS=&%N8V5)1#TB>&UP+FEI9#IF
M9# S9C5D-"TT83 U+30W8C M8C,U,"TP,V0R,S0R.64V96$B('-T4F5F.F1O
M8W5M96YT240](GAM<"YD:60Z9F0P,V8U9#0M-&$P-2TT-V(P+6(S-3 M,#-D
M,C,T,CEE-F5A(B\^(#QD8SIT:71L93X@/')D9CI!;'0^(#QR9&8Z;&D@>&UL
M.FQA;F<](G@M9&5F875L="(^4')I;G0\+W)D9CIL:3X@/"]R9&8Z06QT/B \
M+V1C.G1I=&QE/B \+W)D9CI$97-C<FEP=&EO;CX@/"]R9&8Z4D1&/B \+W@Z
M>&UP;65T83X@/#]X<&%C:V5T(&5N9#TB<B(_/O_M $A0:&]T;W-H;W @,RXP
M #A"24T$!       #QP!6@ #&R5'' (   (  @ X0DE-!"4      !#\X1^)
MR+?)>"\T8C0'6'?K_^X #D%D;V)E &3      ?_; (0 ! ,# P,#! ,#! 8$
M P0&!P4$! 4'" 8&!P8&" H("0D)"0@*"@P,# P,"@P,#0T,#!$1$1$1%!04
M%!04%!04% $$!04(!P@/"@H/% X.#A04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@ JP2/ P$1  (1 0,1
M ?_$ ,X  0 # 0$! 0$            &!P@%! ," 0$! 0 # 0$! 0
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M @(" @(" @(" @(" @(" @(" @(" @(" @(" @YM^O=#ERTU-XN+]FFIF[1
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M03M 08OSOUTS'\J5OQAZHX* @V3N\ZC9>\0@\ *"2H" @(" @(" @(" @("
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M&$! 0$'RJ::"LIY:2JC$M-.QT<T3M+7,>,"#V058G!^*Z*:Z9IJC&)T2ROO
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M!Z 0?Q 0:SW,_1M9/VKXW,H)V@(,7YWZZ9C^5*WXP]4<% 0;)W>=1LO>(0>
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M @(-9[F?HVLG[5\;F4$[0$&+\[]=,Q_*E;\8>J."@(-D[O.HV7O$(/ "@DJ
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MAW4L@&H8Z0QN/<M_Q)4$I0$&?M]F[BGM[79QL<(CII'@76F8,&L?(<!,T#0
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M(,@W&W5EIKZBVW"(PUM*]T4T3M8<T_9'$51Y4!!:FYS>)\VKB+!=Y<+#7O\
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M9 0:IW(4C:;=Y0S-&FKFJ9W=ELKHOM1J"Q4! 0$&.-XE-'29YS!#'H9TV:0
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M&:9X&AD;>$_8'"@SO7;\\]SUD\U'414E(]Y,-,(8I.;9CH;MN;BX@<*H\_\
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M5I""M;MYOV5:QQDM5956UQ_Y9+:B(=@/P?Z+T$=?YN54'$1YAC<S@+J1S3Z
ME/VU1Z*/S<F!X=7Y@+H\=,<%-LDC1Z9TAP_!4$WL.YO(UC<V5U$ZY5+=(EKW
M"88^U@-C]%J"/YJW&-S+?ZV]LO@HF5;F%M*VCYP1AD;6 !PG9CWOW(0<;ZM_
M]S?N/\2J'U;_ .YOW'^)06SDS+?S1RU19>Z3TSH?._K/-\UM<[,^7O-I^&&W
MAWR@[R @I>][@?+-ZN-W^</,>4*J>KYGH6WL<_(Z39VND#'#'#' (/!]6_\
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MU-TD&MDCQ#"?6Q8._P Z@LFVVJVV>F;1VJDBHZ5NJ*!C8VX\9#0,3RE!ZT!
M0$%59WW,?/+,51?_ "WT+GV1,Z/T7GL.:8&8[7/,QQPQ[U!'?JW_ -S?N/\
M$JA]6_\ N;]Q_B4%I9$RE\RK RQ],Z=L2R2\_P US./.''#9VWZNRH)*@("
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M@[M\K#*.4Z*VR,#:^4=)KSPF>4 D'U P9VE!+$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$!!5^\+F>DNZ1\U>:TX^5^>Z;VN8[OT%E6OZNI\=QC#>T_;X?QX[W]N
ME3%W\C[3NB^1\<=/0?*V&.(U=)T?]NPLZG'G]3X',>%^'P_Z?%_R1QV&)PPP
MQT88X?97HU4OK3<WSGLO-[.'_.YS9UC\UI27[HPQTX=>/<FEB\B\XS9^;/2,
M='E'ROL]O:]B]%>%6//ZF_RG@X_]&/\ 'XW^U?F2O_:__P!/Z7_V#_RW#K_P
M6ON:^7K=,X9_Q_\ 7_XOI25>3;" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.7F79^
M;]SV^B[/1I<?*&UT/O3^7V=/-_=8<""C?U3_ ..OWI4/U3_XZ_>D'KM71O*=
K%L_[?[7/Q8='Z3SV.V/R>UHVON<>%!?:@(" @(" @(" @(" @(" @(/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2225088d1-tbl_pipelin4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-tbl_pipelin4c.jpg
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M ?_$ .D  0 " @,! 0             %!@0' @,( 0D! 0 !!0$!
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M0JW^QF/Z5*&HW5^E/WOHAUG[G^:I^Y'YJFCAMW)@
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MW7_CK_I]32(W#C@                                !DUW]81/X9O\
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M?[&8_I4H:C=7Z4_>^B'6?N?YJG[D?FJ:.&W<F
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M:G_$*M_L9C^E2AJ-U?I3][Z(=9^Y_FJ?N1^:IHX;=R8
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M^(5;_8S']*E#4;J_2G[WT0ZS]S_-4_<C\U31PV[DP
M                             !=^3W^)V+_RY'[1C#SOZ-7F;G<OSEOS
M_1)SA_Q.RC^7+_:(,E^C3YC?7SESS_1"D#,:8              &\<7_ .V#
M-/[99_VE:-1=^<H^[_N=9EO\1=^_'KH:.&W<F                 -WUO\
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M]C,?TJ4-1NK]*?O?1#K/W/\ -4_<C\U31PV[DP
M                          !=^3W^)V+_ ,N1^T8P\[^C5YFYW+\Y;\_T
M2<X?\3LH_ER_VB#)?HT^8WU\Y<\_T0I S&F              !O'%_\ M@S3
M^V6?]I6C47?G*/N_[G69;_$7?OQZZ&CAMW)@                #=];_P!L
M-Q_;2/W<<:>KYV/-K=C;_P /5][_ %0T@-PXX                   ![,_
M^FO_ /%S_P"".4_^W_5]+U/_ /+_ /B_TMQ#6.B     &H?K*_X82/Y;%_=&
M-GNW];T2YK]Q_)SYX>+QU;R\ 6#!:B'?YE1TEB2C@V$UF-()"MJNK<623T/P
M&+&8KFBW55&F(9^[[--[,445:*I;HOL0^KY098[A5KWQ$M&W&&ERDN$N.E4E
M"'4>5HH]-%EJ>S@-31>S55&W&&#K+V4W7;O=C5%45<'+Q_\ 5KKF)RKM,2S=
M6)T34JZZ^.F= 0PRIZ2J.HU)/<AI)ZFE2%$9D6GAX#/RV;BY;VZL*>'!H-X[
MKJL9CLK<37C&U'!C.'H4^;CE_6UT:WL*N5%JY:MD68\RMMEQ1:GHE:B(C/@?
MO#*INT53A$Q,PUES*W;=$5U4S%,Z)F&6>$9DFL[Z.@L"J=-_;.RO=5L^^W;=
M-O\ G= H[>WCL[48^==^ S&QM]G5L^:457UUA;2VX%7%=FSGCT:C1T*==4?V
M$I(S,7:JHIC&9PAC6[5=RK9HB:I\C;7+WE,Q8U&<.YK6S8%K0P6Y=<RZ2XQ[
MEM2EZFE2?*3JTD:O,YN8FCLYB8JGAZ'3;MW3%5-WMZ)B:(B8TQUN?0U6Y1W;
M54U>NULI%(^HVV;)3#A15K(U)-*733L,]4J+0C\!^X-GVE.ULXQCR.:FQ<BC
M;V9V>7"<.?0^/TMQ%KH]O*KY+-3+,TQ9[C+B([JBUU)MPTDE1EH?0?@"*Z9G
M")C$JL7*:8KFF8IG1.$X3Z6?!PK,+.O5;5U#82ZQ)&?:V(KKC1D729*2DR,B
M\.G0**K]NF<)JC'SK]&1S%=&W315-/FE9N5G*V9S#L)I/&_$JJUE;K\A#"E]
M8\C32.E1Z))P]=>.IZ> 8V;S468C#AF?XQ;'=6ZIS=<[6,4T^33/)YU%L*ZP
MJ9CE?:Q'H,]G;UT64VMEY&])+3N0LB46J3(RU+H&;35%48Q.,-+<MU6ZMFJ)
MIF.*>"6,*EL ;O\ K+_U]C']BL_[5P:?=GLU>=V/[F_4M_=:0&X<<    W_R
M.Y289GF(S+K)$R.ULV3D)M3+_4HZLF6%I+30^)J<,:3/9NY:N133HPUNTW'N
MO+YJQ-=R,9BK#3AQ1K5KEQRM@77,.^QO)S<13XXW+5.<0OJS,V'2:1Y1$?3J
M:^CH(7\SFIIM4U4Z:L&'N[=5%S-W+=R/JV\?7P:W;G_*:+%YJ5V 88A:$6$=
METE25F[L-1N&XXH]-=J4(W?Y R^;F;$W*^*4Y_=5,9RFQ9C#:B)Y>7&>A.W.
M-_5[P>>>+Y ]:VUTSM1/G13T;8</B>J4J21::_!(EF70?'46*+N:NQM4X1#-
MO9;=>5J[*YM55<<\/!S?S4SFKRRB84FLOL=GG:8?>(ZRNEKTZQ!FDEDA9D22
M/5)ZI/:7A(R+09>4S4W<::HPJI:G>N[*<M%-RW.U;KT+7R5Y0XUF%!+O\Q6Z
MU&D2TP*@FGB8-;B4F:SXD>XS,R2G_1,8V=SE=NN*:.3A;'<NZ+68M3<O1IG"
MGAP_C^33^2T4K&;^RH)I?^IKI#D=1_?$@_)47V%)T47[(VEJY%RB*HXW,9K+
MS8NU6Y^S/_1%BZQ0   &[N6O^"',G^)_<D-/FOF;;L=U_P".O^GU-(C<..
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MTQ.C&)C'S-Q8O_VP9I_;+/\ M*T:N[\Y1]W_ '.ERW^(N_?CUT-'#;N3
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M3YX1@N,8     7?D]_B=B_\ +D?M&,/._HU>9N=R_.6_/]$G.'_$[*/Y<O\
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M$</GTK%G-W,UO"+=R<:*:ZL(X,.")P6%OF)S!7]8!6.KE/=SG9*@'4&DC8[
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M (O]+<0UCH@    !J'ZRO^&$C^6Q?W1C9[M_6]$N:_<?R<^>'B\=6\O
M               ;O^LO_7V,?V*S_M7!I]V>S5YW8_N;]2W]UI ;AQP
M             -W<M?\ !#F3_$_N2&GS7S-MV.Z_\=?]/J:1&X<<
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MW^QF/Z5*&HW5^E/WOHAUG[G^:I^Y'YJFCAMW)@
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MW\_OZAY;?V*G_91QI]W>U<\^MV/[A_3L?=G_ $M(#<..
M      !O'ZU/^(5;_8S']*E#4;J_2G[WT0ZS]S_-4_<C\U31PV[DP
M                                         !=^3W^)V+_RY'[1C#SO
MZ-7F;G<OSEOS_1)SA_Q.RC^7+_:(,E^C3YC?7SESS_1"D#,:8
M   &\<7_ .V#-/[99_VE:-1=^<H^[_N=9EO\1=^_'KH:.&W<F
M      -WUO\ VPW']M(_=QQIZOG8\VMV-O\ P]7WO]4-(#<..
M         >S/_IK_ /Q<_P#@CE/_ +?]7TO4_P#\O_XO]+<0UCH@    !J'Z
MRO\ AA(_EL7]T8V>[?UO1+FOW'\G/GAXO'5O+P                   &[_
M *R_]?8Q_8K/^U<&GW9[-7G=C^YOU+?W6D!N''                   W=R
MU_P0YD_Q/[DAI\U\S;=CNO\ QU_T^II$;AQP
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MJ/O4^MLSZR?^*,K^1Q?W U^[/T?3+>_N3YO^F/I:B&T<P
M W?S^_J'EM_8J?\ 91QI]W>U<\^MV/[A_3L?=G_2T@-PXX
M        &\?K4_XA5O\ 8S']*E#4;J_2G[WT0ZS]S_-4_<C\U31PV[DP
M                                            !=^3W^)V+_RY'[1C
M#SOZ-7F;G<OSEOS_ $2<X?\ $[*/Y<O]H@R7Z-/F-]?.7//]$*0,QI@
M         ;QQ?_M@S3^V6?\ :5HU%WYRC[O^YUF6_P 1=^_'KH:.&W<F
M             -WUO_;#<?VTC]W'&GJ^=CS:W8V_\/5][_5#2 W#C@
M             'LS_P"FO_\ %S_X(Y3_ .W_ %?2]3__ "__ (O]+<0UCH@
M   !J'ZRO^&$C^6Q?W1C9[M_6]$N:_<?R<^>'B\=6\O
M   ;O^LO_7V,?V*S_M7!I]V>S5YW8_N;]2W]UI ;AQP
M -W<M?\ !#F3_$_N2&GS7S-MV.Z_\=?]/J:1&X<<
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MI964_6H^]3ZVS/K)_P"*,K^1Q?W U^[/T?3+>_N3YO\ ICZ6HAM',
M         -W\_OZAY;?V*G_91QI]W>U<\^MV/[A_3L?=G_2T@-PXX
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MZ(U'=&[NK^*K6?0GR1]2I_/9_P"7#XS,\O1&H[HW=U?Q5:SZ$^2/J5/Y[/\
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M%_=W^>SOT@.\+_6Z(U'<.1]W^*K6?J_<HO[N_P ]G?I =X7^MT1J.X<C[O\
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MHC4=PY'W?XJM9^K]RB_N[_/9WZ0'>%_K=$:CN'(^[_%5K/U?N47]W?Y[._2
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MF@
M
M
M
M                         /S:L?ZPE_PSG[LQWE.B'AUSVI\[&%2V
M]Q?5^_PBQW_G?Z=('([P_7J]'JAZQN'Y&W_5^:4L-0S0
M  <V?WUO_2+]L$QI2F3?\+_&?ZHV67XU&=^SZ?H5\9;6
M   M./?[@?\ "*_:(8%_VFXR?L>E+"PS0
M
M
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M+R&6TN6UE2]K1'CR'4&3>JTDM:EJ4E*C0C<9:F W2"
M                                              'YM6/]82_X9S]V
M8[RG1#PZY[4^=C"I;    >XOJ_?X18[_ ,[_ $Z0.1WA^O5Z/5#UC</R-O\
MJ_-*6&H9H                  .;/[ZW_I%^V"8TI3)O^%_C/\ 5&RR_&HS
MOV?3]"OC+:P                  %IQ[_<#_A%?M$,"_P"TW&3]CTI86&:
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M @
M     !^;5C_6$O\ AG/W9CO*=$/#KGM3YV,*EL   ![B^K]_A%CO_._TZ0.1
MWA^O5Z/5#UC</R-O^K\TI8:AF@                  YL_OK?\ I%^V"8TI
M3)O^%_C/]4;++\:C._9]/T*^,MK                   6G'O\ <#_A%?M$
M,"_[3<9/V/2EA89H                                 HW.'_#FY_Y7
M^ELC0[_^1N?T_FI=)^VO\C;_ *OR5/*P\D>V
M
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MZ4/LJ4TM+S+B==4GM4E*T*+PD1D S
M                                  'YM6/]82_X9S]V8[RG1#PZY[4^
M=C"I;    >XOJ_?X18[_ ,[_ $Z0.1WA^O5Z/5#UC</R-O\ J_-*6&H9H
M               .;/[ZW_I%^V"8TI3)O^%_C/\ 5&RR_&HSOV?3]"OC+:P
M                 %IQ[_<#_A%?M$,"_P"TW&3]CTI86&:
M                    *-SA_P .;G_E?Z6R-#O_ .1N?T_FI=)^VO\ (V_Z
MOR5/*P\D>V
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MQJY@3[)%U3G)0A90R:(FDLR%J4VI"E*WF:E$I*D[=IDH@&X 0
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M3]M?Y&W_ %?DJ:+'DCVL
M
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MUB<<FWUE1SGJ3'K-<J%C#KTV'"1*=9;;-V4ZE!FZ^>IDV:$[4M\-=3,!Z2!
M
M _-JQ_K"7_#.?NS'>4Z(>'7/:GSL85+8   #W%]7[_"+'?\ G?Z=('([P_7J
M]'JAZQN'Y&W_ %?FE+#4,T                  '-G]];_TB_;!,:4IDW_"
M_P 9_JC99?C49W[/I^A7QEM8                  "TX]_N!_PBOVB&!?\
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MBE[>MN]SUZTQ$I=MS2A;6J%/M.=29J0G>>XU: EG55K:7G.VU9K,PBYCD$O
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MS4ND_;7^0M_U?DJ:S'DCVL
M
M     !OOD519+#8D6TEY4?'IB?Q$)PM3><X:/)(_@D1%IK]U_D(QZ%^VLM?H
MB;DSA;JT1R^7R?2\Q_=N;RU=46Z8QNTZ:N2.KY?H;G';O/0
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MO'<9C*AXW40J>(L]RX]?&:B-J47A-+*4D9@)0
M                                       ?FU8_UA+_ (9S]V8[RG1#
MPZY[4^=C"I;    >XOJ_?X18[_SO].D#D=X?KU>CU0]8W#\C;_J_-*6&H9H
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M89;2:E*)MAA#;2"-1]!JZ5&-#O\ ^1N?T_FI=)^VO\C;_J_)4\_CR1[8
M
M                                      #;/*SE8J]4UD61-&FE29+B
M1%EH<DRZ%*+Y/]U^QT]AN3<G;X7;L?4XHZW\O7YG#?N#]P1EXFQ8G_V<<]7_
M ,O5YWHA*4H2E"$DE"2(DI(M"(BX$1$0](B,."'E,S,SC+Z)0          #
M4?,*RSR9S3Q'!L4R$\?I[:KM9US(;BQI4@DPG8J4*8.0VLDN:N["-6J2)1F:
M5&1 E4K/F?GV!PL]Q"7,:R3*J"311L7NYC#<8GF\H=[.P<U$?8C='6E>Y2$I
MZPMO M3 3=I,YB<KL@PXKW,WLMHLNM48Y8-RX$*(]%GS([KD>3$.*VC1!*9,
MEM.]86G0>O$!JO&\LR;E=@W,&SAWC\^UMN9$_&H3TN$S(;CS)$S:]8G'@L(=
M><6@E*ZAO5&\DDA!:F1DMAX-S R-GF%18TU?7>;8Y>M3$V4^YQN31KJY<9HW
MVEI>.##:4R_M6WU9I4I*MNBM#T!"H0LTYR/<CG^>+N;[I=4J6ZWCY5L%,*5%
M@6+D5Q$E9-=;UBR;/:MI2"26GDZ[E&2M4>NNHWUF,QL47\DV8^*1I9PE,0S:
M6TMV4AJ.I74;]C2_QJ5$K>I7!2E)\D$<2.K^9&0R>5/+.VN\ZAXH5_#?>N;%
MB&U(NY;S?!MNO@MQ'F=NIF;ZR9U26W:7'4!6;G-K_(^5W-O'K:WF7];CTBB.
MEM[:L.FL78T^0PYM>8-F/J25(\APVDFLCW'TEH2]6W<J1!IK&;#<BM2XT5YY
MAVP<-F&EQMM2DJ?<21FAHC+RU$7!.I@I>88_-7(H5OA,VKYCS,PD7%W5U&1P
M&J$F\;)FR?*.X<2>F$QMZM:_Q)G(6I>A;M05+]$G<Q^:-_F[V,Y>O$Z;$K5W
M'JB#&@Q)1R;"%':=>?F+E-N*-HUO$E+;1H\DN)Z\00XIM^9^99L7+IS(6<4D
MXY10;#*["B8:EKEV=@IQ*6XJK!E9-L))KK-3:WZJV]!:@(3-,^YDX:]B/+[)
M\@;AW-P_9OS\QHZE^UEKJ:TT=G-%>W&>2W)?ZQ).Z-K:;T,RUUX!!7N<9!<<
MN.;F*6,RQR"B@8V[-I<IM*>11R'"=:<;>BO(=CQ4.+;,DJ2XVT6J5<>) )?(
M^9]K(SE[!&<DL\1HL;J*M^3+HZ)Z^G39MBT;J4J4B'-;89;0E/!3:5+49Z&9
M$9$&+)YH<U;C#,:B54Y=1DTW.TX@N_EU"HQ3ZER'(>1/*!.;2I!FDD+-);?Q
MC9IU))F0"PYG<9#ATBCQ7)>:YUT=4&0\]/@UK,O*+&2;ZNK(H3,*0VW'::\G
MK6V]ZUEX &LLUR?+,Z^KGG"[F_EO.8UED6J;F/UK-;*L()3*UUCM<9UDC:6A
M4HE_BT-F>Q.[@:B,E><IYBW[7,&;RY?S*WI*[%*VO78755CYW5G:6$]*G24Y
MV6!)CQVTH01FDF4;U&>WR2,B(?8/-;F+>8K38]%<779=<Y6]BL;*9E4Y"ZVL
MC1US>\VX$Q*-KCC*=A-K3LZPE<-"T 2F,TV4T/UC8E?D.0N9+&+"9ZZZQE,,
M1YJ4G:P2<:>[,AMM>TR)25DA)^5H>NFIA9><64S,?>H(OMG%PNGGKDE.E-,=
MOO9*FD)ZIJ!%5'DH4G51F^LVS-);=O3J!#5*.;>?0\!YK'67\JUG8B]3GC%[
M<5**N>MBS6V1H?BO1VDJ(O*2EQ3"341[O<T#84N9S%Y;Y3A;N196O*:7+[(J
M&WA/0HL5,2>_%=?8=A''0A:6B4PI"T/*<\GCNW<0%1I+;G3=<K;GFHG.-D^F
M<NY%51]W0>PRXE/,DH-J89-)<-:R84TA33C>TB2H]RMQF$O)R;F/S&YCU-'A
M^4KQ'%I^%5>6NFB!$G2$RILN0A+9'(0>A*22-^NI:-Z$1;E& ^TL[FQS%QR[
MYC4F9'CT9B59,XOCK<"%(B.,5,AV-K/6\VIY2WUL*W=4MOJR/5(#)P?F_<6V
M28K;9!)1%PO/L6.UK8[B&TMP;JI_&6#*7B02U-K94;I&ZM7[V>FG$!"HYBYC
M,PC'\LR#-XN'5&8VEA/B*7$:DW3-,KA6PZ^*F,\E]2T$EUYUU"E))9:=):!7
M).<7V1<M^>N,V-W.R*FH:*/)I+:XJSIK%;-E%E;T.-&Q&WI2J/JAPV4FK4^D
M$O3++KC&*-OM'HZU7$M!Z$>BDL:EP/4C!2\[XGG/,_+F.4%%!R=-.O+L>LY]
M]8-5\)QWK(3K)H<8;-HFD+T,T?!V:*,S0:B3H2VGRIN<J5=YSA.5V_?\C$K&
M)'@W+C#4:0]%GP&9B$O(82ALUM]9M-:4EN ;.!
M                                          #\VK'^L)?\,Y^[,=Y3
MHAX=<]J?.QA4M@   /<7U?O\(L=_YW^G2!R.\/UZO1ZH>L;A^1M_U?FE+#4,
MT                  '-G]];_TB_;!,:4IDW_"_QG^J-EE^-1G?L^GZ%?&6
MU@                  +3CW^X'_  BOVB&!?]IN,G['I2PL,T
M                       4;G#_ (<W/_*_TMD:'?\ \C<_I_-2Z3]M?Y&W
M_5^2IY6'DCVP
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M!)*.<&"U"))*W'NW$UOZ"TUT!"S@
M                                /S:L?ZPE_P ,Y^[,=Y3HAX=<]J?.
MQA4M@   /<7U?O\ "+'?^=_IT@<CO#]>KT>J'K&X?D;?]7YI2PU#-
M           !S9_?6_\ 2+]L$QI2F3?\+_&?ZHV67XU&=^SZ?H5\9;6
M              M./?[@?\(K]HA@7_:;C)^QZ4L+#-
M               %&YP_X<W/_*_TMD:'?_R-S^G\U+I/VU_D;?\ 5^2IY6'D
MCVP
M                                          !MCE5RM.^4UD>0-Z4B
M#W1(JNF2I)Z:J_\ S9&7_O?L=/8;DW+V^%Z['U.*.M_+UN'_ '!O_P"'QL69
M_P#9QSU?_+U>=Z)2E*$I0A))0DB)*2+0B(N!$1$/2(C#@AY1,S,XR^B4
M                         "'RW(&<2Q6]RJ0RJ1'HJ^79NQVS)*W$0F%O
MJ0DSX$:B1H6H!49 S;8K!RIME3<>=7M6:(ZC(UI0\P3Y(,RX:D1Z *"SSRK9
MF(X=?U=%/LK_ #I#B\?QF(ICM2^SI-;RG'7EM--MMIT-:U*T+4@3@L&#<QFL
MOGVV/V---QO+J$F%VE)8]2XHF99*-EYE^.XXT\TO8I.Y"N"DF1D7#4@S;F,W
MBEG5XW54LS)LPN6WWX%+7J8:44>+MZU]YZ2XTTTV1J2DE*5Q4>A$8".J^<^.
M.X_D]SDD.9C$W"S2G)ZBQ0A<F,;C9.-&VJ.MQ#R7B/\ $J;4>\$X&,\V';7(
MH&,Y/BEIB%C>,O2L<.T5%=;G-1DDXXC6*\[U3Z4'O4RYH9)(S 0DOG\PU$GY
M- PZZLN6U6^_'GYC&[(;!%$<-I]]J*I\I+K#:B5O=2WT)49$>@&#8F19CC^+
MXI+S2UE$F@B1BF&^@MRG$+(C;2VGAN6X:DI0G[I1D0(='+_,8W,##*;,X<9<
M.+<QRE-175$IQM)F9:*-/ SX +*
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MUUXZBW+%E("$ #FS^^M_Z1?M@F-*4R;_ (7^,_U1LLOQJ,[]GT_0KXRVL
M               !:<>_W _X17[1# O^TW&3]CTI86&:
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MFC4M[;;;+:&FD$VTV1)0A)$E*4I+0B(BX$1$-S$1$81H:&JJ:IQGAF7(2@
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MI;DZ:KZV.K4][?E;=W#B1@2W,"
M                                              'YM6/]82_X9S]V
M8[RG1#PZY[4^=C"I;    >XOJ_?X18[_ ,[_ $Z0.1WA^O5Z/5#UC</R-O\
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M "TX]_N!_P (K]HA@7_:;C)^QZ4L+#-
M
M
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MDK,M$F9F6H6H!^;5C_6$O^&<_=F.\IT0\.N>U/G8PJ6P   'N+ZOW^$6._\
M._TZ0.1WA^O5Z/5#UC</R-O^K\TI8:AF@"*8R?&I2(SL:Y@O-S75QH:VY+*T
MO/M*V+;;,E'N6E7DJ2GB1\!."<)2HA       (KVHQKL+EGWS![M9=[.[,[4
MSU"'M"/JU.;MI*T,O),]1."<)2B5)6DEH,E)46J5%Q(R/PD(0Q;"UJZAI#]K
M-CP6'%DRV[*=0RA3BB,R01K,B-1D1Z$"<'UNSK79[M6U,879L()U^$EU!OH;
M5IHI39'N(CU+B9 8$ZSK:M+*[.8Q"1)>1%CJDNH9)R0Z>B&D&LRW+4?P4EQ,
M#!E AS9_?6_](OVP3&E*9-_PO\9_JC99?C49W[/I^A7QEM8 /.GUH6ZIV\Y6
MLWDM<"E=NW&K"6VXIA3<=SJ4N'UB32:"-)F1J(_)+B,:]IC%L,ICA5AIP5]G
MV5Y:<]K:#@SBXN$)P^5:Y7"JWU/(8<B)>7UB"W*)#I(2R:..NJ_\X4\%-?!H
MP7/K5VHVM./ UU;0JZ!6<N\TQ?'X6-L3\ACKKK([9V?D4MMUUPW%/I2VE!-D
M9:+U4:DF:4^%0MSQ3#(B9F:J9G'@Y.!M*%A>.9Q]:#F3693$.QJV:ZM?*"MQ
MQ#"WNQPT)6M#:D[C02E;-WP==2X\1=V8FY.+%VYHL4S'+K8_(JZY@U?)NY9Y
M?U+60VM5E,NO@ULQ]++;<#J675:+==:+R5K,]-WW1A;F=G@Y4YBFB;D;4X1@
MC^9+_,R^SGDZNWC1,3YA/O6J6VRV3HT=25MDVHR0XZE>Y!:F6[PBFO:F8XI5
M6MB*:\.&EM3$N3V3M\P8W,OF3E2<COZV,N)3QHL5,.+&2Z2T*5HD_*,TN+^Y
M+IXF>A:7J;<XXS+&KO4[&S3&$*#]7G-L<P'EED]WE,I4.K<S*9$[0EIQY*77
MHT7;OZM*MJ>'PE:%]GB0MVJHIIX>5>S-N:ZXB.JD<+5&QOZQTJI@7"<P5DM*
MJ;-N9#G:9L!++BC1'2ZVHVTLGM3HC;NXIU/HUFG@KY47/K6<9C9PEHO!.6^<
MVG*ICFE6V*9C6&SE3J#&5MD\TI$9TG9CBT&6AJ,R)1%Q,TI,OO18IHF:<>1F
M7+M,5[$\?&]M\N\YJ>8V(UV65![69B-)$<S(UL24<'6E:>%*O?+0_",VBK:C
M%I[MN:*L)6@5K0 F*^W;KHB6UM+<-:U*(T:<.@O","_[3<Y/V/2RO:>/Z*][
MQ>,6&8G0$*[D;#3JVCC/&:%&DS(BT/0]/= =\"Z:GO\ 4(9<;/::MRR(BX:?
M9^R S)DI,.,N2M*EI1IJE/2>ID7_ -H")]IX_HKWO%XP$I!F)G1RD(0IM)F9
M;5\#X ,>PMVJYU+2V7'#6G=J@B,NG3PF Q$Y-'4HD]F>XGIT%XP$X A%Y(PA
M:D'&>,TF9:D1:</\H#)K[AJP>4RAEQLTI->Y9$1<#(M.!_9 94V6F%'5(6A2
MTI,BVHXGQ/0!%>T\?T5[WB\8"5A2TS8Z9"$*0E1F6U? ^!Z ,6PN&J]Y+*V7
M'#4DE[D$1EQ,RTXG]@!CM9&PZZAHHSQ&M1)(S(M"U/3W0$T @U9-'2HT]F>X
M'IT%XP&976S=BM:$-.-F@B,S61$1Z_L .^=,3!CG(6A3B2,BVHXGQ 1?M/']
M%>]XO& EXDA,N.B0E)H2X6I)5TEH>G$!A3[IJ _U"V7'#VDK<@B,N.OV?L .
MEC(F'WFV2CO)-Q24$HR+0MQZ:GQ 3(""]IX_HKWO%XP&;6VK=D;B4-+;ZLB,
M]^G'77HT_8 =T^:B QUZT*<+<2=J.)\=?$ C/:>/Z*][Q>,!,1GRE1VY"4FE
M+A:DE727[("/FWC,*0J.MAU:DD1[D$6G$M?= <(^0L2'VV$QW4FXHDDI1%H6
MON\0$LM6Q"EF6I)(ST+IX (3VGC^BO>\7C 9]=9MV76]6TMOJMNN\B+7=KT:
M?L .5A8(KFDNK;6X2U;2)!$9]&OA 1WM/']%>]XO& F8[Q2&&WTI-).))1)5
MTEK[H".F7K,.2N,MAU:D::J21:'J1'[OV0'&-D#,J0W'3'=2IP]"4HBT+]GB
M E'7"::6Z9&9(2:C(ND]"U 0OM/'U_W5[WB\8"0KK)NQ2XIMM;?5F1'O(BUU
MUZ-/V "QL45R$+6VMPEF9$2"(S+3]D!'^T\?T5[WB\8"98=)]EMXB-).)2LD
MGTEN+70P$;+OF8DA<=3#JU-F1&I)%H>I:\.(!$OF9<A$=+#J%.&9$I1%H6A:
M\>("2?=)AEQXR-1-I4LTETGM+70@$-[3Q_17O>+Q@)&OL$6+2G4-K;)"MIDL
MB(^C7P /EC9-UR6U.-K<ZPS(MA$>FFG3K^R C_:>/Z*][Q>,!-H5O0E9%H2B
M(]#Z>("*DY S%D.1U1W5*;/0U)(M#_8X@.4*\9FR4QD,.(4HC/<LB(N!:^Z
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M%XP$A76*+%"UH;6V2#(C)9$1GK^P 6-DW7);4XVMSK#,BV$1Z::=.O[("/\
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M(].' O<]P(IB-":[E56F4X*EL 6G'O\ <#_A%?M$,"_[3<9/V/2EA89H
M
M
M
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M4H^DS!+=WU><2S*EYQ.X_D,.#5M8?%?C0B9C*2<B+)=:,UM.);).FK:#T-1
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MF9X5JJ<9Q7!G]];_ -(OVQ"(TI3)O^%_C/\ 5&RR_&HSOV?3]"OC+:P
M             %IQ[_<#_A%?M$,"_P"TW&3]CTI86&:
M
M
M
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ML$VM&Q)I+7K>M\CAQ 6B-GE8\Q&G2*YV/)<M5T75[=RT2&T+6HC4DO@_B_V
M%[   !^;5C_6$O\ AG/W9CO*=$/#KGM3YV,*EMZNY:(R).$\NU8!U?<JK![V
MVZOJNT&KKB^'O\K:2=VNWRMNS3@.:S.SVESM-.'U7I.[HN?#V.PPV,9[3EZ?
M+Z='$K&>5MY2<F["LS5EB,\5ZI>*QSZOM"6775NNJ/J]>"B6X?'RN/'[D7\O
M535F(FCJ_686\;==O(UTWHB)[3ZFC'"9QU_2\\#?.#>XOJ_?X18[_P [_3I
MY'>'Z]7H]4/6-P_(V_ZOS2EAJ&: .B'"A5[!1H$=J+&)2EDRPA+2-RU&I1[4
MD1:F9F9_9 =X  Z#A0U2TSU1VCG(1U2))H2;I-ZF>TEZ:D6IGPU =X
M  #'EP(,\FDSHS4E+#J)#!/-I<)MYOX#B=Q'HI/@47$@&0 YL_OK?^D7[8)C
M2E,F_P"%_C/]4;++\:C._9]/T*^,MK                   6G'O]P/^$5^
MT0P+_M-QD_8]*6%AF@"C<Y<IML)Y7Y1E=$I"+>JA*D1%.H)QLG"4DO*2?27$
M$PUOD-G]8+ L-F\PYV44&0UU5#*RETKE4[ 4['21+<2W(:D*VKVZ[3-!EKX
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MHG0HJIF-,.8E2
M
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MR<*_E]ZV;M?9\-,SRQ@V*AQ1D1F6NOA&LP;;%R,U:_8\(A,N8
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M3T XWM,%( @\T_Z.R'^S)O\ 1UC WC\K=^Y5^66RW7\Y9_Y*/S0\<CQ5[\
M                                       +5@V<V>$V?:8VKU<\9%.@
MF>B7$EX2]Q9> _\ [!M]V[RN9.YC'#3.F.7^;2[VW3;S]O9JX*H]FKD_D]3T
M=Y69'6,VU2\3T1XN!]"D*+I0LO HO"0]9RV9MYBW%RW.,2\4S>4N96Y-NY&%
M4?QC'D2(R6(
M                             "GYQS-Q;EZ]4QLA5+5,NUOMUD6OA2;!
M]Y45!..Z-QD.*\E)[CX=&ON (S'^=W+[(KV)C#,J96Y!8$LZ^!<5LZK7))HM
MRNI5+9;0LR+[DE;OL G!@7_U@^6^-Y#98O/>LGK>H<0S8-PJN=,;;<<;2ZDC
M<8:6GBE1'T@8+!4\V.7=WBUAFE??QSQJI4MNTF/I<BJBN-:;D/-/H;=0OB6B
M5((SU+0CU($.C%.;^"9E;]P5$V0S=+:5*BP;*#,K'I,9!D1O,)F,M=8CC]QJ
M9>$B!."MO?66Y4L3YL!R79F==)?A39#5/92([;T59MNEUC,=9&25)/BG4#!L
MG',DH<NIHN0XU8,V=+-3OC3(RMZ%$1Z&7NDHC+125:&1\#+4$)0!$4634^1O
M7#%2\IURBL'*BR)2%(V3&FFGE(+<1;B)#R#W)X<0$N CJ.^ILEK6[B@FM6-4
MZX\RU,CJWM+7%>7'=VJZ#)+C:DZEP/3AP 2(   (?(<GJ<816KMUN(3;6$:H
MA=4TM[67-4:&B5U9'M29EQ6KR2\)@)@  8-S<U6/54N[NY;4"I@-*?F3'U$A
MMMM!:F9F?_\ !@,)O+*5[)6<3:=<5<2*T[MI)-.=2<(GDL;NMV["5O67D:[M
M..F@";   !#X]D]3DZ+)=0MQ::FPDU$WK6ELZ2X2B0Z2>L(MR2,^"T^2?@,!
M,         &I>Z Z);[3$=QYUQ+;39;EK4>A$1=)F81C.B,43A@T',D6'/C*
M#KH:G(O+.D>TFR$F9=XO(/7:7@-)'X/\HZ:BBG(6L9X;M6CR.8KFO/W<(_2I
MT^5O*OK*VOB-08K#3<9A*6VD$E.A)+H(N YNJ[75,S5.,RZ*BS113$1$8,OJ
M(O3U;>G^BD4[<\JYL4\D'9XWR3?FI#;GE-BGD@[/&+_PF_-2&W/*;%/(=1%^
M3;\U(;<\IL4\CBN+%47%ELR+_-3X@FN3LZ>2&O\ F?RWC9G 8DU;A5N45BCD
M5-BWY"D.HXD2E)T/:9^\-AD<]-JK"J,::N"6LWAD8O48T<%<<,2Q^5G,5S)6
M7\=R!KL.85!FU/BK\G>2/)ZU)'TD?A%S/Y.+?U[<XT3_ !@C=^>F[_Z[D85T
M\#9I*+30QJHC@;;%S$@
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M=]7[_"+'?^=_IT@<YO#]>KT>J'H6X?D;?]7YI2PU#-
M!S9_?6_](OVP3&E*9-_PO\9_JC99?C49W[/I^A7QEM8
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M^Y5^66RW7\Y9_P"2C\T/'(\5>_
M         M6#9S9X39]IC:O5SQD4Z"9Z)<27A+W%EX#_ /L&WW;O*YD[F,<-
M,Z8Y?YM+O;=-O/V]FK@JCV:N3^3U/1WE9D=8S;5+Q/1'BX'T*0HNE"R\"B\)
M#UG+9FWF+<7+<XQ+Q3-Y2YE;DV[D851_&,>1(C)8@
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MK45SP8I6%95]JRF17RFI3)]#K"R<3T> TZD+-5-5$X51A*]1737PTS$NCO\
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MK>9MQ<MSC$]'DEXKG,G=REV;=R,)CI\L>1*#+80
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MPZ7AEZWV=<T8Q.$X8QPQZ&0+BT
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MD+>AU2$K3M-:MBCZ"T%G,YRU;M46[4X[,XRN9#)WJ[MR[=C9VXPB.E5XF/\
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ML,F>Y+BB(_A*(_"0W&<S%&6M=A:_JEI\E8KS%WM[NC[,>1NY.A<"\ T#HGT
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MF/[A_</:8V+$_5^U5R^2/)RSQ^;3N<=N\]
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MCE5$D9_=7TC$V:]4LW*MN?!):Y,HI+23-V*AM'6I-"=RB4DB]T#!F7W-'/\
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M)?N AUYI_P!'9#_9DW^CK&!O'Y6[]RK\LMENOYRS_P E'YH>.1XJ]^
M                                     Z>!=(D;[Y4\J>Q=3D^3L_\
MK>#E?7N%^]>$G'"/[O[U/W/2?E='H.Y-R;&%Z]'#]FGD\L^7DCB\^CS']P_N
M'M,;%B?J_:JY?)'DY9X_-IW..W>>@
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MHFHS"2;:;26A)2DM"(AS]5R:YFJJ>&7244Q13%-,<$,HST%'EE6Y"0
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MD\L^7DCB\^CS']P_N'M,;%B?J_:JY?)'DY9X_-IW..W>>@
M
M                                              #YH73IQ ?="
M    !\T+W 'W0A& :"0
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M8]*6%AF@#&@U\"L9.-6Q68<=3CCZF8[:6D&Z^LW75FE!$6Y:U*6H^DU&9GQ
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M[AP
M
M
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MQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>,
M[BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<5
M3Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1
MD^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GW
MU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ
M@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [
MBJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53
MZ,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D
M^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU
M>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@
M'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [B
MJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z
M,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^
M^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>
M, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'
M<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ
M?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,
MGWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^
MKQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>,
M [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<
M53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?
M1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,G
MWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^K
MQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>, [BJ?1D^^KQ@'<53Z,GWU>,
M[BJ?1D^^KQ@,_JT=7U6GXO;MV_YNFF@#\W+'^L)?\,Y^[,=Y3HAX=<]J?.QA
M4MO0%-35/-WEIC.-0<BC4MYC*I#<JME'M0^EY6Y+I)W$:M"+X1$>AJ41C1UU
MU9:]55-.U%7&[BS9HWCE+=NFYL56],<OEP^GSL;.(E+RXY4O<NU7[-[D%G8H
MFJ9BF2FHC3>TSX;E;=31X=#,U='#456)JOW^TV=F(CG6L]1;R62G+[>W755C
MYM6CGEH@;IQCW%]7[_"+'?\ G?Z=('([P_7J]'JAZQN'Y&W_ %?FE+#4,T
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MC7-JER"\BXW.J+C&;JQ9<DU$7((?8SG-,$2G3CJ2MQ)J;29*6VHTN$GCMTU
MP8^$\YL?Y@7"ZK'*>[<C,JE,RKIZ";=6S)A.J;6PN1O,NL/0EI2DC\E1:F1Z
MD0P;&!
M
M
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M]7[_  BQW_G?Z=('([P_7J]'JAZQN'Y&W_5^:4L-0S0
M <V?WUO_ $B_;!,:4IDW_"_QG^J-EE^-1G?L^GZ%?&6U@
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M5I!?KK%5E=OOQI3:V'M'K>6IM9H<(C(EMFA23TXI,C+I ELP$
M
M
M
M                                      #\VK'^L)?\,Y^[,=Y3HAX=
M<]J?.QA4MO055EE#R[Y48Q;TV,0KR9;.2D7$^4@E]3)866C;BMJC(U)5Y"=2
M+0M=.(T5=FJ]?JIJJFG#0[JUF[>2R5NNBW%>UCM3R3Y?H4C-N;WMG1+I/9FM
MJMSK;O:X:-KI=69GMUT+@>O$9EC)=E5M;4RU&>WU\3:FWV<4X\<?]&M!L7./
M<7U?O\(L=_YW^G2!R.\/UZO1ZH>L;A^1M_U?FE+#4,T
M '-G]];_ -(OVP3&E*9-_P +_&?ZHV67XU&=^SZ?H5\9;6
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MR
M     ^&I*=-3(M3T+7W0'T                                !BSK*O
MK&3?L9341DO_ !'UI;3[ZC(3$8J*JZ:8QF<&-79'C]NLVZNTBS'"^X8>0M7O
M$>HF:9A11?MU^S5$I,4KP
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M_1UC WC\K=^Y5^66RW7\Y9_Y*/S0\<CQ5[\
M                                       WIRIYK=;U&,9._P#C>#==
M8N'\+P$TZ9^'P)4?3T'QZ>_W)OO'"S>G[M7T3]$O-?W#^WL,<QEXX--5,>N/
MIANX=T\Y
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MP9$27#+HW:\%#39BU%%7!H>M;@WG5G+,Q7[=/3Y6X!BNF
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M+C2B4D_\I#0UVZJ)PJC"74V[M%RG:IF)CR.\4+@
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MYG3%'6T+D(Y\DGS)2F>K,TK1J7PC):30G3X1Z:%J>@OQ7&SBPZK4Q7L<:O\
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MRX552Z+#<=I)Y)3.K:R%#E$@]R2=CQT-KT/PEJD^((?<T_Z.R'^S)O\ 1UC
MWC\K=^Y5^66RW7\Y9_Y*/S0\<CQ5[\
M                                   -Z<J>:W6]1C&3O_C>#==8N'\+
MP$TZ9^'P)4?3T'QZ>_W)OO'"S>G[M7T3]$O-?W#^WL,<QEXX--5,>N/IANX=
MT\Y
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M(!1H?*;,&/JPV/*IQJ/[6R6;-MILGB-C=,LWY3>KFFG[VXG7[/ #C;\!
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M4>#4K-)1L$TPV6KKI_OCKGA4H_LCEKER:YQE\Q;RWE>S]Z;MV<9GH6 6VL
M!J/FYRS8N(DC)Z9LF[6,@W9;*2T)]M!:F9$7#>1>^.GW/O.;=46JY^K.CR?R
M<3^X=R4WJ)O6X^O'#/E_FT30Y-=XU**742UL.%IN21ZH41>!23X&.ROY:W?I
MPKC%YQE,[>RM>U;JF)>@\"YPUF2&W6W)%!MST2A1G^)>/[!_<G]@QQ&\-S5V
M?K4?6IZ8>G;I_<=O,X47/JU]$MGCG77@                          _-
MJQ_K"7_#.?NS'>4Z(>'7/:GSK+RUP:1S"RR+CK3W9HZDJD39)%N-N.UIN-)?
M?&9DE.OA,8^9O]C1M,_=N1G-WHMXX1IGS.G/:[%*S+9E=A\Y4S'F3;;:E.:K
M5O2A*73W;4;BWDHR-):&70)R]5RJW$UQPF\+5BC,33:JQHX.'U^=<>8W+3%Z
M_%H6?\O;1RRQB0Z466T_^^,/&7 ^))41&9:&E1:D>G$R/ABY;-5S7-NY&%3:
M;RW99ILQF,O5C1.GR?QR2U,-FYA[B^K]_A%CO_._TZ0.1WA^O5Z/5#UC</R-
MO^K\TI8:AFHR!D--:6=G35\M,BQIE--V;*"49,+?1UB$J5IMW&GCM(]2\(G!
M."3$( $/995CM/;UE#9V+,6XN36FKAN&9.2#;TW$@M..FI:B<$Q$RF!"   0
M^-95CN8UQV^,6+-I6$XIGM4<]R.L01&I.ID7$M2$S&"9B8TI@0@   !P>>9C
M,KD2'$LL-)-;KKBB2A*4EJ9J,]"(B 1B\FH46U=1KG-E:6[#DNK8XZ26&"2;
MBFEZ;5;24E1D2M=#UZ!."<)3+/[ZW_I%^V((TI3)O^%_C/\ 5&RR_&HSOV?3
M]"OC+:P     >3^>,?%)/UC\<:S2X>HJ \9(WK&-(5#<2LI,[8DG4D9EN5PT
M\(Q+F&W&/(VF7FKL9V8QG'4NV#HY25\7)HN!YG*R*UEU,E3T298+G;&64'JM
M"5)+;Q41&8KIV8QPE:K[29C:C",6O.2/*.]S_E!7HD9[:U>*V"Y;,G'H*&D-
MFVF0XE:>M,]='#+51&DR/73306[=$U4Z5^_>BBOV8F>5=^:> YK&CX5A> XB
M60\M<>2B585:["-"[7)CJ/J6WUR%D:D$?XU9$C19GQ%==,\$1' LVKE/#55.
M%4H_ZK%IE;]OGL2QH$PJAZ[L)DV>4IITX]L;C*502;3Y2R2DU*ZXO)X:>$+,
MSC*<W%.%/#PX/2PR6N     %IQ[_ ' _X17[1# O^TW&3]CTI86&:
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M@
M       ;WY2<T79:X^)Y"XIR2K1NMG*U4I>A<&G#]W[U7^0_L^@;BWU-4Q8N
MSP_9GZ)^B7F?[CW!%$3F+,81IJI^F/IANL=R\[
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MSU-:3UV*/[.A:#SG?&3BQ>QI]FI[)^WMXSFLOA5[5'!/T-@#1NF
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M(,SPCF-7X7S!R1%_3WM))FU=V[#CUIE8U3RERFC0QY)$<5QMPS4KI0HRVEP
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M1+GF]F=QS*:I<OCT%?AUM(AU#15D>6X^:(C+Z6I"W>!-),^E">L/>K56B4D
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M
M     .Z)$DSY+4*$TI^6^HFV66RW*4I7 B(B%RW;JKJBFF,9E;N7*;=,U53A
M$:9>FN6G+2-AT8K&Q)+^1OIT<<+RDQTJZ6VS]W[Y7AZ"X=/J6Y]STY2G;KX;
MD]'DCZ9>.[]W[5G:MBC@M1^+RS]$-A#HW*@
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MU$Q/&FF8X:GH]G]];_TB_;%M9C2E,F_X7^,_U1LLOQJ,[]GT_0KXRVL
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M6RW7\Y9_Y*/S0\<CQ5[\
M                        [HD23/DM0H32GY;ZB;99;+<I2E<"(B(7+=NJ
MNJ*:8QF5NY<IMTS55.$1IEZ:Y:<M(V'1BL;$DOY&^G1QPO*3'2KI;;/W?OE>
M'H+AT^I;GW/3E*=NOAN3T>2/IEX[OW?M6=JV*."U'XO+/T0V$.C<J
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MLZ'J8\YWOG8S%W"GV:7LG[>W;.4L8U>U7PS]#8 T;I@
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M@0G@ !"XGE=)FU$QDF.2#E4\EV2S'D&A3>]4.0Y%<,DK(E:;VE::EQ+B F@
M! 6>7UM5EE!ATAI]5GD3%A)A.MI0;"$59,&Z3JC62B,^O3LVI5KQUT\(3X"@
M9/S9HL<NE474G)EM$LY3JY,2#';4TEEQQLG);S6Y:$2&5JVEL22T[U)-1$9+
M/^D:E)RA)YB3'8O9C]1USR$H[':L$>D246XS0MPT.)0HMR%*(M%'O0:B%P
M     !!YI_T=D/\ 9DW^CK&!O'Y6[]RK\LMENOYRS_R4?FAXY'BKWX
M                                                        '=$B
M29\EJ%":4_+?43;++9;E*4K@1$1"Y;MU5U133&,RMW+E-NF:JIPB-,O37+3E
MI&PZ,5C8DE_(WTZ..%Y28Z5=+;9^[]\KP]!<.GU+<^YZ<I3MU\-R>CR1],O'
M=^[]JSM6Q1P6H_%Y9^B&PAT;E0
M
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M^Z_8'9[HW13DZ=JKAN3IGD\D?QPN#WWORO/5[-/U;4:(Y?+.KB7T= Y@
M
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MUSVI\[&%2V    ]Q?5^_PBQW_G?Z=('([P_7J]'JAZQN'Y&W_5^:4L-0S0
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MF?!)@EL,$
M
M
M
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MM& =V7GK+[1@'=EYZR^T8!W9>>LOM&) JN]]9?:, [LO/67VC$!W9>>LOM&
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M?:, [LO/67VC .[+SUE]HP#NR\]9?:, [LO/67VC .[+SUE]HP#NR\]9?:,
M[LO/67VC =Z&+YM!(*2RYI]VM)FH_P!GB)'+J[[Y:/YBO& =7??+1_,5XP#J
M[[Y:/YBO& =7??+1_,5XP#J[[Y:/YBO& =7??+1_,5XP#J[[Y:/YBO& =7??
M+1_,5XP#J[[Y:/YBO& =7??+1_,5XP#J[[Y:/YBO& =7??+1_,5XP#J[[Y:/
MYBO& =7??+1_,5XP#J[[Y:/YBO& =7??+1_,5XP#J[[Y:/YBO& =7??+1_,5
MXP#J[[Y:/YBO& =7??+1_,5XP#J[[Y:/YBO& =7??+1_,5XP#J[[Y:/YBO&
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MFW?_ )VFFOOB1^;UC_6$O^&<_=F.\IT0\.N>U/G8PJ6P   'N+ZOW^$6._\
M._TZ0.1WA^O5Z/5#UC</R-O^K\TI8:AF@                  YL_OK?^D7
M[8)C2E,F_P"%_C/]4;++\:C._9]/T*^,MK                   6G'O]P/
M^$5^T0P+_M-QD_8]*6%AF@
M
M
M
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M   "TX]_N!_PBOVB&!?]IN,G['I2PL,T
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M:HJB)B<8EQ55,TS,3&$PYBI2
M
M
M                             /S:L?ZPE_PSG[LQWE.B'AUSVI\[&%2V
M    ]Q?5^_PBQW_G?Z=('([P_7J]'JAZQN'Y&W_5^:4L-0S0
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M^Y5^66RW7\Y9_P"2C\T/'(\5>_
M      -F\K^:#V+/(I;I:G<==5Y"^*E15*/X2?":#/X2?\I>$CZK<N^IRT]G
M<X;<_A_ERPX[?^X(S<3=M1A=C\7\^2?1/D]),O,R&6Y$=Q+K#J26VX@R4E25
M%J1D9<#(R'IM-451$Q.,2\BJIFF9B8PF',5*0
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M7@41D?$@&0   "-N<@I<?3!5=36X2;*8Q603=,RZV;+5M993H1^4LRT(!)
M#IERXD"*]-G/MQ84="G9$E]:6VFVT%JI2UJ,B21%TF9@,%.1T2[UO&43VE7S
MT([5J"D]7%02<2R;Y:<#1O42==?" E    1M-D%+D"9RJ6:W-36S'ZR<;1F?
M538BMKS*M2+RD&>A@)(
M                               !^;5C_6$O^&<_=F.\IT0\.N>U/G8P
MJ6P   'N+ZOW^$6._P#._P!.D#D=X?KU>CU0]8W#\C;_ *OS2EAJ&:
M            #FS^^M_Z1?M@F-*4R;_A?XS_ %1LLOQJ,[]GT_0KXRVL
M=,N'$GQUQ)S#<F*X6CC#R$N-J+[*5$9&(P3$S&ATUU354[2F*F#'@,*/<IJ*
MTAA!G[ID@B+4(B(3-4SI?2J:HHKD$H,<H+JM[L;JD=4I6I'JI&FAGJ1'T!A!
MM3CCBYKKX#CC#SD5E;T7A&<4VDU-%_F&9:IZ/ &!C+H.BI%29$Q59%.7+3U<
MJ0;#?6.H/[E:MNJB^P880G:GE=J:RM0ZP^B&PE^*CJHSA-();3>AEM0>FJ2T
M,RT(,(1M2YQ84*$2TPX[4<G5&XX3*$MDI9]*CVD6I_9#!$S,Z7>)0    M./
M?[@?\(K]HA@7_:;C)^QZ4L+#-                                 $'
MFG_1V0_V9-_HZQ@;Q^5N_<J_++9;K^<L_P#)1^:'CD>*O?@
M                           !M'E7S.5C+J:*\<4N@>5^)>/51Q5J/B?\
M&9_"+P=)>'7K-R;Y^&GLKL_^N='_ &_R<7^X-P_%1VUJ/_9&F.M_/DYGH]MQ
MMYM#K2R<:<(E(6DR4E25%J1D9<#(R'ID3$QC&AY)53-,X3P3#D)0
M
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M:T="D*TW%T'KTF&UP0
M                            #\VK'^L)?\,Y^[,=Y3HAX=<]J?.QA4M@
M   /<7U?O\(L=_YW^G2!R.\/UZO1ZH>L;A^1M_U?FE+#4,T   !Y0RGGKF=?
MS=D74&69<FL=N8F,724H:4VN0^V[U[QK-&XNJ6E1ZDLB\E'WPN8<#)BB-GRK
M)]9_F;G/+RSP)W"9:DHG.V#UA 0VVZF8W#.(M+:MR%*(MJUEY!D>A_L"*84V
MJ8G'%)Y+S:E7<WDY<879*8H<OM#9M8R2;6:D))LEQW#-*C2IM9J2K:9<0B-*
M(HPQQXF-]9;G+<X-4.8_@SAEE*66K"UGMI0X5;7J?0PA:B62D[WG5H;21D?
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M;Q^5N_<J_++9;K^<L_\ )1^:'CD>*O?@
M              ;3Y6\TG,<<;H;YPW*%P]&'SU4J*I1^^;9GTEX.DAUNY=]3
MEYBU=GZG%/5_DXK?^X(S43>LQA<C3'6_\O6]&MN-O-H=:63C3A$I"TF2DJ2H
MM2,C+@9&0]+B8F,8T/):J9IG">"8<A*
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M7];_ .A_?^&G6_OWV/WL$XKO[&__ -R?I"[;_P#J/N'N[JO_ /+[5UW6[_\
MW=FS[.[P A:@
M                       ?FU8_UA+_ (9S]V8[RG1#PZY[4^=C"I;    >
MXOJ_?X18[_SO].D#D=X?KU>CU0]8W#\C;_J_-*6&H9H  *SS#R"=BV$WE[51
M'I]M$BK.OAQVEONN2G/Q;)$ALE*,B6HC5H7!.IB8CA54QC+S+0_5TYKV7*ER
ME=S!B%79"A-U88W(JF%OJG.$AY*79:OQR7-4(2H]?)Z---2%>,8LB;E.UH?(
MCN8Y=(^K_*N:*R;LL=L9U=?*?B/IZM,=4%#3SIJ06B7&TD>Y7 U$KB>AB>4X
M(VGRYY791@W/?$:ZBB2I7+.1>IOZ\F67'6*Y]\THDM*6DC)"2VI,MW#;M\)&
M&.,$51-,\KES9Y-<U:C%.8%XU=QKYG)YD:7:5T6N6]9R&T3&2CM-N))2B0P6
MU6U!:;4GX!$3!173C"=RG'LZQ.1REYF7T=_)EXN3\:_34Q#)]F%+;(F%%'3H
M9]4A2DK/[XBU/B&*F)B<80A<N,GYEXASDR^-4RZY_,94.1C-9.:ZB4\S4N]>
M:C;49:&\7D(\&[W2$XX*MJ*9B.1,XV_<\U^9O+.>WCMI2U^ 5SIY!)LXJXJ"
MG+92V3#1K^%Y:$^X>W4]. B>"%,_5B?*Z,\N6I-'G?+N5RF>AYE=2W$4SU17
M=?$G+<-/5SU2DMH(E)5JZH_!X3UW"833'#$XO1'+VELL<P3&J"X<)RUK*R)$
MF*2K>GKF64H41*/I(C+0C\(MSI6*IQE9!"D <V?WUO\ TB_;!,:4IDW_  O\
M9_JC99?C49W[/I^A7QEM8 -,_6"I+FZ^CWN>NE6'8LLKY4SLC#C_ %,=O=N=
M<ZM*MJ$^%2N!"Q=B9P\[,RU41M8SQ-35/*S+8O-3.8\BKFKQ"CB9#98LXN.Z
M<=R7>QT()J,O;M<5M5IM1KHI/WPM11.U/)PLJ;U.Q3P\,X8^AEMX7FE-A')?
M-6L>G6+V#+E*NL:2RI%BEJ4^2NL;8<(E&M)(UVZ:GY/@XE.S,13.&A&W3-5=
M./M<:UT,:_YD\Y'>:,;';+'<8J:!ZG:[W8.)+GR5J>,MK.JC-)=9T_YI>'@5
M48U58X<2U,Q;M[&.,S+64/EIG2^16&OE36\>RQC(WK.QJ([*HUOV13FO71FW
MT&9NIVZM^0?3KH>@M[$[,>=D3=I[2>&.&/0M^,8%)SNTS&S@,9@T],QR50PL
M@S-]ADY"YB#+J"C)B-N;$*T/>3NG26@JBG:QTZ.-;KN;$1$[.G1"0P'-LWIL
M6Q3E?&Y:V;N453S<.SD6L;JZ=B.A2B.4B41F1GHHE%H7'RM#/AK--4Q$1@IN
M44S5->UP3SLMA[(>77/W-[I_%;>[@9;%B'1OU4?KF5O1VFTJ;==4I*&M%$HC
M4M7 BU/@8GAIKG@THX*[5,8Q&#5[N 9PU]5U>,GC=FK($9.;QUB(4A4HV4HV
M]:31(W&WK]V1:"ULSL88<;([2GML<8PP77F#C-]C/.G(,QEEER,;R.%&['8X
M2EMV0F1&9;:.-(2IIS1)]6:DGY/273QTKJB8JF>'T+-NJ*K<4QAC'*VQR"Q9
MS%.7S4=ZNLJARPEOV"JVYDLRYC)O;4Z*6Q'C$G=LW[%(W%NXGX"O6HPABYBO
M:KTQ/F;/%UC "TX]_N!_PBOVB&!?]IN,G['I2PL,T   !I'FWC][S*YB8?@4
M"1-IJ&D2YEUI?Q64J),R*LF*]EI;S;C*G$N*6ZI"DJ\DB5IT&"4/)PO+.6'-
MO%,[.]M\PKLE)>)Y,](C,*=C-.:OP7S3"8;22$/$I+CKB?)2K370] %*F7$K
M&OJZ7/(^PQBWE<Q*^NFUA5T.LER8LE"GEK38-2TM*84V:5$]^^;]_DD6X$KE
MSAKLUQJ7CN;\OZZ1,O;VE=P:R:CMJ6ME<UOK:^6LB(]J8SY+WK,N!+_R B'W
M-XL[ENYR]PF!-L<;Y<5U4_!GY;1U:;*Q*4REI+;!K*-+..3YDIQ:R:/>KA[H
M#6-[39#/PSG]%AU>236;:-CC]#*OV7G+6R;;6:'5I;ZI"B))HU)K8E2$&G<E
M/0"7HG/:^9(YH<I)<:*Z[$@V%RJ6^VVI3;"'*62V@W%$6B"4HR26[I/@"&N<
M-RQ[E=@$_E=<XO9WO,"%,MBK*I-=*D1+M,Z<]*8D=L2RN.EI27T]:IUS<@DJ
MW%J6@"'>KG,"SO-)&;6&68XQD4J-:4LC$6'9M=+-41II4,C8AR%)>9<0IM!.
M]6E2-#+0@&734$[ (7*O/7<;N(N,T;F0JO*N4?>MQ7(R(T+;EN-16$*5HIM1
MNH0V:FTN\>A0"Z<M;?VIYSYOE<"GL(./3*6EC5]E80GX!3S8=E[W4(D-MKT+
M<2"WI)6A$>FTT@.[FJN34\WN4N5NP)LFAKSOH%A+@Q7IA1W[2/&:C=:EA*U)
M2M2%>49:%IQ 4=S)9F)XIS<Y>2\>N)&96]ID\V@AQ*Z5)8FPKHW'F)*92&^H
M2VDG='-SI*+:9$1JT2 G^7U-;1N;&$39-?(9B1N5<>"_(<96EMN84V(HV%*,
MB)+A$1GL/RM-> "&9H;LN2O/N!W9**?99%E[U?&ZASKI+<A9=4MI&W<M*R^
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M '-F,K=S/_ICZT>U5&B9_ER\;8HZ5R8
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M;3T=]LS/8XVM)I46IE[AF6A@A8
M                                               'YM6/]82_X9S]
MV8[RG1#PZY[4^=C"I;    >XOJ_?X18[_P [_3I Y'>'Z]7H]4/6-P_(V_ZO
MS2EAJ&:                  #FS^^M_Z1?M@F-*4R;_ (7^,_U1LLOQJ,[]
MGT_0KXRVL                  !:<>_W _X17[1# O^TW&3]CTI86&:
M                             (/-/^CLA_LR;_1UC WC\K=^Y5^66RW7
M\Y9_Y*/S0\<CQ5[\                                          #>
MG*GE3U749/D['XW@Y75SA?!\).ND?A\*4GT=)\>CO]R;DPPO7H^[3],_1#S7
M]P_N'''+Y>>#155'JCZ9;N'=/.0
M                                                      %'YS_X
M/<P?_P &KG^@/ 0U5B^#\[WN6=+*B<V8\:J<HHKK%<>,Q'%-QU0TJ2SUQRB-
M1I3Y._;J?3H"63RMR[%,#^K[R[R6_C%+M^P)@4$2,PF1:2I4M9EV:&G3<:G-
MJ=VAD6A:JX$ O'+#$<F9MKSF3GI-Q\RRE$9GN:.OK6*JMA[SCQ"<+]\<U<4M
M]PO)-?P2T+B$IS"S3&\ *';R:[O3,[0EU>.5<)I"[2>XHR<..TK3<EHE$E;J
MU'L1P4KCH1D-*<Q\+R&AY29?FV;OM.99EEOCUCE,:+JN'"KH-A%;9B-])K2P
MWQ<<^Z/<?1Q,EL7F^3C^=<GF81ZSCR5YY)(^'V5JMDG(,C+[DDF6X!$Y9/<Y
ME]Y<E.5K#=?BK!N5N<9/&:0W"@LN\7Z^$E)$AV4Z2E)=T+:T2CW:J/0@O\UB
MN<1)P;";N+09I75T-+<CLK<Z5%KB7L:,VW322TGU:DEN,R(^.@(5'ZNZWH5'
ME6*3TI?O,;R2PAW-TV:C3:S7]DMR:I*C/8XYUWEMD9I29<#T!,MQ@@
M
M             !^;5C_6$O\ AG/W9CO*=$/#KGM3YV,*EL   ![B^K]_A%CO
M_._TZ0.1WA^O5Z/5#UC</R-O^K\TI8:AF@                  YL_OK?\
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M;Q^5N_<J_++9;K^<L_\ )1^:'CD>*O?@
M            !O3E3RIZKJ,GR=C\;P<KJYPO@^$G72/P^%*3Z.D^/1W^Y-R8
M87KT?=I^F?HAYK^X?W#CCE\O/!HJJCU1],MW#NGG(
M
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M3Z3,!8,3Q''\(IFZ'&HG9*Y"W'E$I:WG77WE;G'7775*6XXLSU4M:C,P0FP
M
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M_++9;K^<L_\ )1^:'CD>*O?@
M   &].5/*GJNHR?)V/QO!RNKG"^#X2==(_#X4I/HZ3X]'?[DW)AA>O1]VGZ9
M^B'FO[A_<...7R\\&BJJ/5'TRW<.Z><@
M
M
M                                    #\VK'^L)?\,Y^[,=Y3HAX=<]
MJ?.QA4M@   /<7U?O\(L=_YW^G2!R.\/UZO1ZH>L;A^1M_U?FE+#4,T
M             '-G]];_ -(OVP3&E*9-_P +_&?ZHV67XU&=^SZ?H5\9;6
M                 M./?[@?\(K]HA@7_:;C)^QZ4L+#-
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MOO4C7SCWY0.Y,E[N.>=9XAS_ +V>:G4?13R^]2-?./?E [DR7NXYYUGB'/\
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MPGS?1"UC;M&
M
M
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MJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_%
M/9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QC
MU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S
M5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9^*
M>RV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'
MJ6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?F
MK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJS\4
M]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/
M4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-
M6?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH!
M[+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >RV,>
MI8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:
ML_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#
MV6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]
M2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U
M9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'
MLMC'J6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZ
ME@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJ
MS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /
M9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU
M+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5
MGXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >
MRV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J
M6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK
M/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]
MEL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4
ML#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6
M?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH![
M+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >RV,>I
M8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L
M_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH![+8QZE@?FK/Q0#V
M6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9^* >RV,>I8'YJS\4 ]EL8]2
MP/S5GXH![+8QZE@?FK/Q0#V6QCU+ _-6?B@'LMC'J6!^:L_% /9;&/4L#\U9
M^* >RV,>I8'YJS\4 ]EL8]2P/S5GXH"4V(V=7M+J]-NS3AIT::>X _-RQ_K"
M7_#.?NS'>4Z(>'7/:GSL85+8   #VA]6K_#"/_+97[HARF\OUO1#U#]N?)QY
MY6@:5M0                  <V?WUO_ $B_;!,:4IDW_"_QG^J-EE^-1G?L
M^GZ%?&6U@   #1?-FC>N>=7*UMR&[(J5-74>P=0A2FT-R(I-Z+41&2=VID6H
MQZXQJAG6:L+=7H: H,&S!6'<RE9#!DOS,2IV\4H34PX2W6CM%R%]4D]35M-/
M T_<J%B*9PG'B9U5=.U3AQSCT-I9MVK%<JY(YY9P):\;J*OLEH_%CN2%QW78
M:4))QM!&HM37[FO ].):"Y5P33+&H^M%=,:<4= 3:7F3\_[MNGL(<6YQEWNQ
MN9%=8>>(Z]24;4*+7<LM%$CX1:Z&1'P".&:I\BJ<(IMQCHE@6<:QH^47(R[F
MULPX>.7T:;<(:CN+>89:E*<,U-D6XM22>FOAT+PB)X*:93&$W*XY87JO8FWW
MUDI5] 9E1*RUPQ'8[)QAQOJER>J6C7=MT<21ZFC4C+05QPU^A:GZMG">*IL#
MEKR]S7#)L^3E6?S,Q8E-(;CQY<<V$L+2HS-:3.0]J:BX=!"Y11,:9Q8UV[35
M'!3@V.+K'    6G'O]P/^$5^T0P+_M-QD_8]*6%AF@
M
M
M
M
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M&$QIAW"M;
M
M
M                                       !^;5C_6$O^&<_=F.\IT0\
M.N>U/G8PJ6P   'M#ZM7^&$?^6ROW1#E-Y?K>B'J'[<^3CSRM TK:@
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MR-C=O3313,1'"]9#+:I:<>_W _X17[1# O\ M-QD_8]*6%AF@
M                     "#S3_H[(?[,F_T=8P-X_*W?N5?EELMU_.6?^2C\
MT/'(\5>_               V%RTYER<.DE76)J?QQ]6KC9>4J.I72XV7N??)
M\/27'IZ3<^^*LI5L5\-N>CRQ],.5W[N*G.T[='!=C\7DGZ)>FHDN-/C-383J
M7XCZ2<9>;/<E25<2,C(>I6[E-=,54SC$O';ENJW5--483&F'<*UL
M
M
M
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M8EX[<MU6ZIIJC"8TP[A6M@
M
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M1>'08-G@@
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M]'9#_9DW^CK&!O'Y6[]RK\LMENOYRS_R4?FAXY'BKWX
M;"Y:<RY.'22KK$U/XX^K5QLO*5'4KI<;+W/OD^'I+CT])N??%64JV*^&W/1Y
M8^F'*[]W%3G:=NC@NQ^+R3]$O3427&G1FID-U+\5]!.,O(/<E2%%J1D8]2HK
MIKIBJF<8EX[<MU6ZIIJC"8TP[A6M@
M
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M5$N=.JX<RS@+JK!]I#DFM=<:?7'<46JFU.,J4A1I/AJA1D"EF@
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MG&7-BB6G<E7 ]%)(^/A(2F)P9$6'%@Q&($-E#$*,VAB/';226T--I)*4)27
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MU/[(#.   !!YI_T=D/\ 9DW^CK&!O'Y6[]RK\LMENOYRS_R4?FAXY'BKWX
M               ;-Y7\KWLI>1=72%-8ZTKR$<4JE*2?P4^$D$?PE?Y"\)EU
M6Y=RSF9[2YP6X_%_+EEQV_\ ?\92)M6IQNS^'^?)'IGR^DF668[+<>.VEIAI
M)(;;01)2E*2T(B(N!$1#TVFF*8B(C"(>15535,S,XS+F*E(
M
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MF;"#UC3_ &>2@G&^M863C:]%<-4J22B/W00SP
M                                             'YM6/\ 6$O^&<_=
MF.\IT0\.N>U/G8PJ6V^.2.)\U'*AR]Q+(8]'2S'U,I8F%UZ)#J"VFI+*D+21
MZEMW$9*/3W"&ESUZSM;-=.U,.SW)E,YV>W;KBBBJ=$\./H2O,RAYGUE,6=9/
MF\*6Y126'*F%#0DFSF&ZA*=J#0A!N(2:G.*5*T2?@Z+>5KLU5=G31/UM/F96
M\[.;MV^WKO1.Q,;,1'!CCA_/C>?;2TL;NPD6MM)7,L92M\B2Z>Y:U::<3^P1
M:$7@(;RBB*(PC@AP]V[7=KFNN<:IXWL7ZM7^&$?^6ROW1#EMY?K>B'I?[<^3
MCSRM TK:@                  YL_OK?^D7[8)C2E,F_P"%_C/]4;++\:C.
M_9]/T*^,MK !%Y+00,JQZSQNS(S@6L9V'(-'!1(>0:=R3\"DZZE]D4S&,8*Z
M*IIF)CB:<QWD_P UZ]&.XU99^E&#8S(;>BIJF78-G+88U)N,^XA9$3>T]IEJ
MK4NG4]#*S%NK1CP,NJ_;G&8IX9<;CD=E\#),GL\!NJJ'69<\J9/:MJ_M<B%*
M=W=:[$7J9:J-1JT46A</<U";<XSAQIIS%.S$51/ G;'DY/E9+RWNT7+;J,&2
M_P!M4ZPEIV:Y().Y:4LDE#>JB,]-/#X>D53;X8\BW%^,*HP]I GR$NR]KXO>
MT5VMS+*HN06#2D.)4FN8F.2UQ^A1*<,S01=">!BGLIX?+*OXB.#@]F,%ES+D
MXUS YDU6498]'GX?3078T3'G$+/?*?UWO.'KH9<4\"^\2*JK>U5C.A;HO[%$
MQ&F>-&W7U?J.'E&*9=RV9AXQ9X_,4_,;0TOJID9PB2MM6T]2,T[DD?N*,1-K
MAB854YF9IF*^'%8>57+6;R\E9?(ESVII9+</6[*6D*0;*'E*,D*W&>IEKTD*
MJ*-G%1>NQ7AY(3G,; :?F7B<W$[I2VH\G:XS):_?&'VCU0XDCX'H?21]):D*
MJZ8JC!;M7)MU8PU/+Y(\U<MC5^+<Q,^9L\&KWFG7&(<3J)\U,?\ >TON\-#X
M?"W*/P\5:&+79U3P3/ RHOVZ>&FGA>@&FFV6D,M))#3:20A!<")*2T(B_8(9
M#!<@0 +3CW^X'_"*_:(8%_VFXR?L>E+"PS0
M       !!YI_T=D/]F3?Z.L8&\?E;OW*ORRV6Z_G+/\ R4?FAXY'BKWX
M           !LWE?RO>REY%U=(4UCK2O(1Q2J4I)_!3X201_"5_D+PF75;EW
M+.9GM+G!;C\7\N67';_W_&4B;5J<;L_A_GR1Z9\OI)EEF.RW'CMI:8:22&VT
M$24I2DM"(B+@1$0]-IIBF(B(PB'D554U3,S.,RYBI2
M
M
M
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MF(QXDH*E    "TX]_N!_PBOVB&!?]IN,G['I2PL,T
M              0>:?\ 1V0_V9-_HZQ@;Q^5N_<J_++9;K^<L_\ )1^:'CD>
M*O?@              ;-Y7\KWLI>1=72%-8ZTKR$<4JE*2?P4^$D$?PE?Y"\
M)EU6Y=RSF9[2YP6X_%_+EEQV_P#?\92)M6IQNS^'^?)'IGR^DF668[+<>.VE
MIAI)(;;01)2E*2T(B(N!$1#TVFF*8B(C"(>15535,S,XS+F*E(
M
M
M
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M[+\JQ_*^75K49/EUW691:PZ^VFY$RF/236I;B6MT".X?6-EM4:R/;H?DF2O
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M9XE2M./?[@?\(K]HA@7_ &FXR?L>E+"PS0
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M>5U535,S,XS+F*E(
M
M
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M_*X:%[HP[T1%7 VF5JFJC&>5G=FC_(H\TO$+++.S1_D4>:7B .S1_D4>:7B
M.S1_D4>:7B .S1_D4>:7B .S1_D4>:7B .S1_D4>:7B .S1_D4>:7B .S1_D
M4>:7B .S1_D4>:7B .S1_D4>:7B .S1_D4>:7B .S1_D4>:7B .S1_D4>:7B
M .S1_D4>:7B .S1_D4>:7B .S1_D4>:7B .S1_D4>:7B .S1_D4>:7B .S1_
MD4>:7B .S1_D4>:7B .S1_D4>:7B .S1_D4>:7B .S1_D4>:7B .S1_D4>:7
MB .S1_D4>:7B .S1_D4>:7B .S1B_P#!1YI>( [-'^11YI>( [-'^11YI>(
M[-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^1
M1YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>(
M [-'^11YI>( [-&^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^
M11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>
M( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-&/\ \%'FEX@#
MLT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%
M'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@
M#LT?Y%'FEX@#LT;Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y
M%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX
M@#LT?Y%'FEX@#LT8O_!1YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-
M'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11Y
MI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-&+_P %'FEX
M@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?
MY%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FE
MX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT?Y%'FEX@#LT
M?Y%'FEX@#LT?Y%'FEX@#LT8O_!1YI>( [-'^11YI>( [-'^11YI>( [-'^11
MYI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>(
M[-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^1
M1YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>(
M [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^
M11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>
M( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'
M^11YI>( [-'^11YI>( [-'^11YI>( [-&^11YI>( [-&^11YI>( [-'^11YI
M>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-
M'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11Y
MI>( [-&^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [
M-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11
MYI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-&Z>I1YI>(
M [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^
M11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>
M( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>( [-'^11YI>(!V:%
MIMT\GHT\&@#\V['^L)?\,Y^[,=Y3HAX=<]J?.S\8QBXS"X9H:%E+]D^E:VFE
MK2T1DTDUJ\I9D700HNW:;=.U5H7\IE+F9N;%&E??U=.:WJIG\[C_ !QA=Y6>
M6>9N?#N<Y(YT5DG)?F#B5+*R"\KVF*N'U?7NIDLN&76N):3Y*%&9ZJ61"Y:S
MMJY5%-,\,L;,[ES.7MS<KB-F/+Y<&OQG-(]H?5J_PPC_ ,ME?NB'*;R_6]$/
M4/VY\G'GE:!I6U                  !S9_?6_](OVP3&E*9-_PO\9_JC99
M?C49W[/I^A7QEM8                  "TX]_N!_P (K]HA@7_:;C)^QZ4L
M+#-                                 &+93V*JNF6DDE'&A,.27B06J
MMC*#6K0C,M3T+@+5Z[%JBJN=%,3/-PKUBS5>N4VZ=-4Q$>F<&N_IWPGY.=\R
MC\H.:\393DJYHUNL\(YWEHYYU'T[X3\G.^91^4$^)LIR5<W\SPCG>6CGG4?3
MOA/R<[YE'Y0/$V4Y*N;^9X1SO+1SSJ/IWPGY.=\RC\H'B;*<E7-_,\(YWEHY
MYU'T[X3\G.^91^4#Q-E.2KF_F>$<[RT<\ZCZ=\)^3G?,H_*!XFRG)5S?S/".
M=Y:.>=1].^$_)SOF4?E \393DJYOYGA'.\M'/.I]3SVPA2DI-,U!&9$:C83H
M6OA/1PS]X@C]S93_ +N;^:)_:6=B/L<_\FQXDN-/C-383J7XCZ2<9>;/<E25
M<2,C(=-;N4UTQ53.,2Y*Y;JMU335&$QIAW"M;
M
M
M
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MTP[A6M@
M
M
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M%,84U1&&,-XB^P@!:<>_W _X17[1# O^TW&3]CTI86&:
M                 (/-/^CLA_LR;_1UC WC\K=^Y5^66RW7\Y9_Y*/S0\<C
MQ5[\          #87+3F7)PZ25=8FI_''U:N-EY2HZE=+C9>Y]\GP])<>GI-
MS[XJRE6Q7PVYZ/+'TPY7?NXJ<[3MT<%V/Q>2?HEZ:B2XT^,U-A.I?B/I)QEY
ML]R5)5Q(R,AZE;N4UTQ53.,2\=N6ZK=4TU1A,:8=PK6P
M
M
M
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MFIL)U+\1]).,O-GN2I*N)&1D/4K=RFNF*J9QB7CMRW5;JFFJ,)C3#N%:V
M
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MV=0&P 0
M                   _-JQ_K"7_  SG[LQWE.B'AUSVI\Z7PO$++.L@CXW4
M.L,SI*7%H<E*6AHB90:SU-M"SZ"X>2+5^]%JG:G0RLEDZ\U<[.B8B?+_ !+<
M_*K ><M1"ESL,OJN) 7+D19,*8MYQM;\-TV%K)'9ED6IHX*(R49::^X-5FLQ
MEZIB*Z9QPCIX>5U6[,CG[5,S:KHV<9C"<=-,X8^SY'#G'A_.5[&9&09O?5LN
MCJS:6=?7J=;+>\ZEA*B0<=LE*(W.E:^!:Z!D[N7BO9HIG&>.?^JG?&6S\V9K
MO5T[%.'!3CRX<GEY7GL;QQ+VA]6K_#"/_+97[HARF\OUO1#U#]N?)QYY6@:5
MM0  5KF%/R"MPF\EXI"=L,E**MNJC,$1K.2[^+0KB:2T0:MY\>@A,:55.&/"
M\_4'U6KY_EFW0V69VD%=G'3-L<<(FE0"L'"2[M<(R,U&E:4$I73JGAX!7M+T
MW8QT,2KQ3FC<+Y%KR#'9C,S";";$NWG=ADW$;5#*,\I1*/4C;1MU+7B@PX.%
M,S3&UAQN[(.2>48]SYQN\Q.&](Y=RKAN]F1VC3U-?-4HDR#V\-J5$25)V^#R
M?N2")X$17$T\.ELOZQ&+Y!E=!B4;'8#MA(@Y376$MMG35N*RU();AZF7!)K3
M[XIITJ+<Q$SCR,/G7BV4(S'!>:6)U+E](Q1^0U9T\=24R78DM!)WM;ST,T>6
M6TN)FHO 1B:9XDT3&$Q*L8K5\S<=JN9O->+BS[.<9E*93CV.+-#K\=EHU(0Z
M^6I%P)S>I*N)[.@B4)X-"9F)PC'@A&<AH_,'$[_3)>65@Y?Y%)4K(\\L+!MQ
MTDJ,U%HR3!FELC(O()SB?$SX$1)3<PF."4MF]ASAM*7,^6TWEVW/E7[[D>EO
MJDFV*HX;Q(2E^2IUQ:DO((M^JC^%PX$1&:,$4[/!.+=^!X\_B6%8]C$EXI$F
MHKXL%Y].I)6MAI*%&G7CMU+A]@42M53C.*PB%( YL_OK?^D7[8)C2E,F_P"%
M_C/]4;++\:C._9]/T*^,MK !Q<<0TA3CJB0VDM5+49$DB+PF9@E1IW,EF+S,
MH.7D>"F4S>UTBS1;HD%M;*/O\@FR;42]VSX76%^P+>W]:(7HM?4FKD77M<4I
M)0S?;[6:=Y1]Z>LV^[MUUT%>*SA.E]?E1HJ4JDO-LI6HD(-Q1((U'T$6IEJ9
MAB1$R'+BI)Q2GVR2R9$Z9K3H@S/0B5QX?Y0Q,)$2HSANDV\VHV.#VU1'L/3=
MY6A\.''B&)A+C%G0IR5+A26I*$'M4IE:7"(_<,TF?$,4S$QI5GF%G4;!,1N\
MG;9;LY-*RA]RL2^3*U$MQ+9;E$EPT?"UUV&*:JMF,5RW;FNJ(Y4S57D:?CU=
MD$HT069\6/+4EUPMK?:&TN;36HDD>F[370M1,3P8J)IPJF$@M]AMHGG'4(9/
M0R<4HB3H?1Q/AQ$J<!M]AY3B&G4.+95L=2A1*-"M-=%$70>A^$#!V"4 "TX]
M_N!_PBOVB&!?]IN,G['I2PL,T   !IOF?@]QS/YC8KCLQ-A78'CL>1D$RX@/
MKAN.W&XH\-EEYO1:'&24X]N3X#TUU!*&F<J[3EUS-P_/L2DWN2LS5NXWER;2
M>_:R6ZJ676L/)6^HUI;COIWK))G\+@6NH"I387,3'N15OR'CX)9VN21($RJ@
MW,1+'<TJ"XM:D24OJ=)1.FTK]YV;S<^P>I!:^<N%YZOV;R3EQ$4YDLVK?PJ]
M))DE3-=:M$;<I1F9%I#?1UG3]T!#LYAX[D.-OX-C-/%R)WE%4USD"QC8:Z;-
MH<MA#3<7M"F5M/FP:$KW=2KBH_+X: -:V7+;-'\.YX5=1AMC61<GCT#V+5\V
M2NRL)/9W%%(-Y]Q]_P#&^2EQ2#=/9NVZGH"7H'.*2VL>9'*ZV@Q%OUU//MG;
M22@BV,-R*B2PVI?V%.+2DOLF"&OL2G<Q>5&'2^5U-A-A=Y-!EV1XM=DEE5%)
M9L)CLMA^8_U[:FNKZ\R>:T)1[=$F>NH"#L<#DXGF^6V>6XEDF51<GD,VM998
M98SXC12E1FVI$:1%C3XO5Z.H-3;SF\C0HB4LC+0!)UV#9-@L#EMF]=AQM*QI
M=U[08=53'K2:RQD.Q1NL.S7E&\\VII"GD$YQW*)&NFH"V<NCR>[YM9AFMKC$
M[':&QJ*B%3G9$VB2^41V6IPW&VUKZM>KGP#/7;M,]#/0@[>9]??Q^:7*[-:Z
MDF75-1JNH5L5:EIQ]@[=B.TRZI#CC>K:3;4;BB/R2+H,]",*2_[?XUCO-+EW
M$PBSM+;)++(K''K>*3'=*X=[O=0IY];I*2XT;BB4SLW*,B)/3J06+!,1R6MY
MGX=<3JUYBL@<M(]),DK(MC=DB9%<..KC\,DH4?\ D 1#6$98GE!SNHCJ7RM\
MAOLJETD30NLE,3UZQUM\>).?<@,ZNBY1ROS \M=QBQR"@R/'*6NFHIFFY5A
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M?]WEY/)Z&YAV[SX
M
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MP*.U+++*/)Y'651;F#**W :>?D+-PGC(U.-*V;$]/'0P]( @
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M*HIB(X&MNW*JYX>)=!<6 !:<>_W _P"$5^T0P+_M-QD_8]*6%AF@
M                        "#S3_H[(?[,F_P!'6,#>/RMW[E7Y9;+=?SEG
M_DH_-#QR/%7OP           #9O*_E>]E+R+JZ0IK'6E>0CBE4I23^"GPD@C
M^$K_ "%X3+JMR[EG,SVES@MQ^+^7++CM_P"_XRD3:M3C=G\/\^2/3/E]),LL
MQV6X\=M+3#220VV@B2E*4EH1$1<"(B'IM-,4Q$1&$0\BJJFJ9F9QF7,5*0
M
M
M  !!Y;A^/9Q3+HLEB=KKU.-R&]CCC#S4AA1+:=9=94AQMQ"BU2I"B/\ R:@(
MK$>66,8;82;J"<ZPR&6RF)(NKF?*M)RHR%;TLD[*<<-+9*\K:C0C/B8"X@
M
M                     _-JQ_K"7_#.?NS'>4Z(>'7/:GSL85+;>F$O<J+K
MEE"QKF!DCT.5&FORXS#)+2[%WF:32E1,N)-+A>69*(S(QIK\7Z;TU6Z<>#G=
MGDIR=W)4VK]S"8F9\M.GR>GAQ0^:8MR-KL9G3<.RF=99&UU78H3YD;;FYY"7
M-=(C70V:E%Y9='^07K%[,U5Q%=,13_'E86=R>[[=FJJU<FJO@PC&.7[L<348
MV;F7M#ZM7^&$?^6ROW1#E-Y?K>B'J'[<^3CSRM TK:@
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M,S,XS+F*E(
M
M
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MS;G@^MLX8<,>3T-/#:N3>T/JU?X81_Y;*_=$.4WE^MZ(>H?MSY.//*T#2MJ
M                 #FS^^M_Z1?M@F-*4R;_ (7^,_U1LLOQJ,[]GT_0KXRV
ML                  !:<>_W _X17[1# O^TW&3]CTI86&:
M                     (/-/^CLA_LR;_1UC WC\K=^Y5^66RW7\Y9_Y*/S
M0\<CQ5[\         -I\K>5KF1N-WU\V;="V>K#!ZI5*4D_?)LCZ3\/00ZW<
MNY9S$Q=NQ]3BCK?R<5O_ '_&5B;-F<;DZ9ZO_EZGHUMMMEM#32";:;(DH0DB
M2E*4EH1$1<"(B'I<1$1A&AY+55-4XSPS+D)0
M
M
M
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M[ V9.RD[CF_YGG?^P-F3LI.XYO\ F>=_[ V9.RD[CF_YGG?^P-F3LI.XYO\
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M![0U'I/X#GQ0#VAJ/2?P'/B@'M#4>D_@.?% /:&H])_ <^* >T-1Z3^ Y\4
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M ]H:CTG\!SXH![0U'I/X#GQ0#VAJ/2?P'/B@'M#4>D_@.?% /:&H])_ <^*
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M&<R=W*79MW(PF.GRQY$H,MA
M
M
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MPBOVB&!?]IN,G['I2PL,T                                 0>:?\
M1V0_V9-_HZQ@;Q^5N_<J_++9;K^<L_\ )1^:'CD>*O?@        !9<*S6TP
MJT*;"/K8;NB9L)1Z(=07[2B^Y5X/V-2&UW=O&YD[FU3PQ.F.7^?)+3[TW7:S
M]K9JX*H]FKD_ERP]4X]D-7D]6S;5+W6QG>"DGP6VLNE"R\"B_P#:7 >LY7-6
M\S;BY;G&)Z/)+Q3.9.[E+LV[D83'3Y8\B4&6P@
M
M
M
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MC"8Z?+'D2@RV$
M
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MI/R5I-/0 E0
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M<I<@DY-A$&TEY%7Y6^:WFN_:I'4LR&T.*)LW&M$]4]LV]:@B(B5T%H"%W
M!!YI_P!'9#_9DW^CK&!O'Y6[]RK\LMENOYRS_P E'YH>.1XJ]^
M  67"LUM,*M"FPCZV&[HF;"4>B'4%^THON5>#]C4AM=W;QN9.YM4\,3ICE_G
MR2T^]-UVL_:V:N"J/9JY/Y<L/5./9#5Y/5LVU2]UL9W@I)\%MK+I0LO HO\
MVEP'K.5S5O,VXN6YQB>CR2\4SF3NY2[-NY&$QT^6/(E!EL(
M
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M,)625)5UC9N.:((S(]2,P'HD$
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M%M   !!YI_T=D/\ 9DW^CK&!O'Y6[]RK\LMENOYRS_R4?FAXY'BKWX
M       >AN2V$W-$P[?6CSL5%@V26:OH(T:ZI==2?0K[TNDB/CTZ#TC]O;NN
MV(F[7,QM1[/TS]#RG]T;ULYBJ+-N(JV)X:_HCR<K;@[%PH
M
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MN)D>@#:8(
M                     ?FU8_UA+_AG/W9CO*=$/#KGM3YV,*EL   ![0^K
M5_AA'_ELK]T0Y3>7ZWHAZA^W/DX\\K0-*VH                  .;/[ZW_
M *1?M@F-*4R;_A?XS_5&RR_&HSOV?3]"OC+:P                  %IQ[_
M ' _X17[1# O^TW&3]CTI86&:                                 (/
M-/\ H[(?[,F_T=8P-X_*W?N5?EELMU_.6?\ DH_-#QR/%7OP          '3
MP+I$C>O*OE.;"F<EREC1XC)=?6NE\$RZ'74GX?O4GT=)\>COMR;CV<+U^.'[
M-/TS]$/-/W!^X=K&QEYX/M51ZH^F6[1W3SH
M
M
M
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MX?W#VF-BQ/U?M5<ODCR<L\?FT[G';O/0
M
M
M
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M;%B?JZ*JN7R1Y.6>/S:=SCMWGH
M
M
M
M #S;)^J=VB0\_P"U^WK5J7M[MUTW&9Z:]K&^C>V$>QT_R<-5^UL9F>U_#_Y.
MK]4G_P#?#_\ 9O\ ^EB>]_\ LZ?Y(\*__P OX?\ R/U2?_WP_P#V;_\ I8=[
M_P#9T_R/"O\ _+^'_P C]4G_ /?#_P#9O_Z6'>__ &=/\CPK_P#R_A_\C]4G
M_P#?#_\ 9O\ ^EAWO_V=/\CPK_\ R_A_\FZ.6N#?1YB[>-]O[RZMYU_M/4]G
MUZTR/39O<Z-/OAJLS?[:O:PP=1N[)?"6>SVMKAF<<,/IE;QBMD
M
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M(G/9B8PFY7A]Z=:4&6P@
M
M
M
M
M
M
M
M
M              8-O=TV/P56=]8Q:NM0I"%S)SS<9A*W%$A"3<=4E)&I1D1%
MKQ,!VRK&O@NQ69LMF,]/>[-!;><2VI]_8IWJVB49&M>Q"U[4ZGM29]!& 3+&
MOKB8.PELQ"E/-Q8QON):ZV0\>C;2-QEN6H^"4EQ/P ,D   &,U8U[\V36L2V
M7;&&AIR7#0XE3[*)&[JE.((]R27L7L-1>5M/3H =SSS,=I3\AQ+3*"U6XXHD
MI(OLF>A$ Z6;&ODRY5?'ELO3X/5]MBMN)4\QUR34WUB",U(WD6J=Q<2Z &2
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MU/RI<EQ+++339;E+<6LR2E*2+4S,]" =Z5)6E*T*)2%$1I41ZD9'T&1@/H
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M8LHCLHWDGM-!-)<->XCX&G34!:    <5K0VA3CBB0V@C4M:CT222XF9F?01
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M\I!NI2M!*:<<2LMR5)4G4N)&1@+,A:'$)<;42VUD2D+2>J32?$C(RZ2,!R
M !P;>9>-9,N)<-I1MN$A1*VK(B,TJTZ#XEP 0&09_@N)RF(.49+5TTV5H<>-
M836(KJR,]-Q)=6D]NO#=T + A:'$)<;42VUD2D+2>J32?$C(RZ2,!R
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M4U*4HR(B(NDS 0N-YQA>8G(3B>0UMXJ(9%**MELRS;U,R(U$TI6A'IP/H/P
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M*C2KCH9>Z K<SFGRQK[%VGGYK0Q;9ATX[\!^TAM24/$>TVU-J=)1*(^&TRU
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M=I*VN[PEK=0AM#*G&U[HIK0A&JT^!6H"TX.O+[CV[H$Y9-D1Z2]CUU1D,R-
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MRFGM;7E]3V>0LXQRYK8$,[FJC4:GW)3D7M1.S%SB993'98-I*4--)W:*WKX
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MR7**^RY>WTBQFUTG-J/&XR[I-=WJ349IFYLF7G*DSC+)+3*B)22U(EZ+XEH
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M W)3PK&#&=:L[-=K(7(?>1(=::8-#+KBEMLDEE*2,FDF2"4?E*TU49F"$@
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M=Q[6WDK26O @$Y!Q^FK)TZR@0T,3+%$=J8XC71;<-!MLHVZ[4I0DS(B21%Q
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MI'DZF71T=(#&+$L;+))&7]VL^T<N"FJDS]#WN0DN&X32DZ[3+<?3MU\&NA$
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MI;3NT/57 G%MFAIHN.T=9C\$UJA545B#'4Z>YPVXS:6TFL]"U49)XG[H(2(
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MS"1:1E5=FW<1G(JG>I42W$-,FVZVHT[T;33Y7DK5Q ;!!
M
M
M
M
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M?3-Q:V)%C.$IQIB)VA;AJ=3O)3CLA7E;5;=$DD!L8$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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ME)N*21G]@@'V=<T]8TI^RL(T-A#1R%NR'FVD$RE24FX9K,B))&M)&KHU,O=
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MAV5>Q+4=8M]VHA29TN3"@N2]Q.JC1GG5--J,EK21I3Y*5*2G0C,@%V
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M(@&%.R[&JY$AR79LI*)-BU4DD&;JFY\];2(["DMDHR<6;[>B=-=%$9\.(":
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MM;CDEMQM:'4DM9J3Y1:)XD0;4!
M
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M_P#>]/NO@\0"X^A7V\A]_>S7TE?B^P]M[#WQNX=3LZS\;N^2^ZTUV\-0%_!
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MUO;.K^X^%OZSR=V[7CN!+-QKZ*>S(]D/9_LG=A;.Z^Q;.YNO>^1X=FZ[K_\
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M7Y>F[=X0%V
M
+           ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>fc_ourcorporate-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fc_ourcorporate-bw.jpg
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M  $  @(# 0$             !@<%" ,$"0(! 0$! 0$
M 0(#$  ! P," 08'" L,!P8$ 0T  0(#! 4&$0<2(1/35@@8,2+2E-15E4%1
MD9(4%1<W83*35'2T=:465QEQT4)2LB.SA=5V.%B!8C,UM38)H;&")"5'<D,T
MQ5-C@\/!<X0FADBB1'>'$0$! 0$! 0              $0%!(3'_V@ , P$
M A$#$0 _ -_@
M
M                                      >06]V3WW*=U,LK;[6RUDM/
M=:VCI6R.560TU/4/BCBC:JZ-:UK4Y$_=7E#>*_"@
M
M         ;1]AG*K_1[JOQ6*NE_1ZY6^JEJ;<Y[G0<]!PO9*UFNC7IRMXD3P
M*J!G7HT&0
M
M
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M,GSW1IQQQM8[18:CDU1$"XUO[$GUZT?Y,K_Y#0UKTR#
M
M
M
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M                           #6;MU?4I3_ERB_H:@+C6;L2?7K1_DRO\
MY#0UKTR#
M
M
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M2S11Z+QR00O9R+R\B@BL^PK]2E1^7*W^AIP:V9"
M      :S=NKZE*?\N47]#4!<:S=B3Z]:/\F5_P#(:&M>F08
M
M
M
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M;HV265]CH&0LT:K)(9*5G*Y$Y%XD75WOZA%+]A7ZE*C\N5O]#3A=;,A
M                      -9NW5]2E/^7*+^AJ N-9NQ)]>M'^3*_P#D-#6O
M3(,
M
M
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MNW5]2E/^7*+^AJ N-9NQ)]>M'^3*_P#D-#6O3(,
M
M
M
M                 'C7N;]9.8_ERY_C<H;>KFS'U/;??W:LWXA"&-3@
M                                           *1PKLV6;%LNERJ[91
M>LGCAK77*SVBZ5+GT5+5NUX9W1ZJDLS.)>;D5$X?#IQ(BA:NX(
M                            &LW;J^I2G_+E%_0U 7&LW8D^O6C_ "97
M_P AH:UZ9!@
M
M
M                                                 \:]S?K)S'\N
M7/\ &Y0V]7-F/J>V^_NU9OQ"$,:G
M   (TS,::OR>?%;% MQJ[8L?S_5(](Z:@YYB/CC<_1ROG>U>)L3$Y&\KW,U;
MQ!PY[N/B6VMKAN>55JP_*Y4IK=0P1NJ*VLJ7:(V*G@C17O<JJB>#1-4U5 ,#
M3;BYU40I<7;6WJ*U.:DK6OK;2EQYM=%U6D=5IH[3EX.<XO<TUY K(;?[K8SN
M37W^@QUE4R3')8*:XMKJ:6CE943M>YT;HIVL>UT:L5CM4\*<G)HJD3D
M      =>NDK(J.>6W0,J:YC'.IZ>:58(Y)$3Q6ND1DBM15_A<"Z>\!A<2S.T
MYA3UBT+9:2Z6N=:.\VBL:D=9152-1W-RL17(J*U4<Q['.8]O*URH!(@
M                             :S=NKZE*?\ +E%_0U 7&LW8D^O6C_)E
M?_(:&M>F08
M
M
M                                                /&O<WZR<Q_+E
MS_&Y0V]7-F/J>V^_NU9OQ"$,:G
M0K=S.$VWVVR3-4:CZBU4BNI&/^T=5SN;!3H[_5661FOV ,%V=;))9]G\:JZR
M1U1>,A@_2*[ULJ\4U15WA?E;I)'>Z[A>UO[C4"ZI+;2XNW<[7>7Y'>?_ #%K
MV_@J;?CM,[ECAEAJ$HTE:U57E?\ S\NO\9R>#A0+QM^&44;8;'B%[RS<*25*
M6GNE#237EJ,\5%L[*E75*JW5SG.BD8Q4T\$:>ZH%7Q;[YK=]M*O>7&\-HZK!
M*9M34Q4E5=)(+Q-0T$SX9Y^;922PQJU8WNX%E=XK==? @6)1?]WKC'M)2[N8
M/C2Y):Y:-+I56R>L6W5<5&C=9'-X:>I:]T6B\;=4\5%5JNY$4,OM%N%6[HX'
M09S);*:V17-)'4='!7.KU1L3W1*DTBTT' ]'L<BM:UVGO^X!'+1N_F%=8LMR
M2HP1)K7C%;76Z'YINT57-6R6MSFU$S&U5/1-2!JL<WB1[I%<BHV-?"",'B._
M6<;B;?TV78%MX^Z7*9]7\HI)KC'24D#*>9S(V)431M6>9[4XN&./A;_"<G(B
MB/K"^T1>-R</^<<#P:KN>:T\TM)=[)/4QT5%0RPHW59:V=C6NXN)."-C%>NC
MM4:B<0(DFS&\DNZ#LCLM[L3\:S/$JMM%?+0^9*EC5D5Z,?'*C6<2*L3T7DY-
M$7545 ;CH67>'*-P:C*7[78[0W&TXK62VR2JN]PEH9:^M@;Q/93114LR-9X$
M:^5[=>).1.4$9;;C>.+<S;9<]Q_'*Z>X12R4=3CD4M,E2VLA5O&QDU5)31.:
MB/:[B<YJZ?P>+Q01!L![1V7;HXO<[K@VW-17WRCN,U$V@FKXZ6DBIHHH'MDG
MJYXV-YU[I7(D$37.3AU<K45%41.=D]WX]W+%<JJJM,EAR2PUTEJOMGED2;F:
MB+W6OX6ZM7E3E:BHY')RHB*HW$$W:OSMK]^]N,RIE6.U9JV7%,GC3Q8WHR2)
M:.9_N<<;YU7CTUX&JWP*!L2$                                  UF
M[=7U*4_Y<HOZ&H"XUF[$GUZT?Y,K_P"0T-:],@P
M
M
M
M                 >->YOUDYC^7+G^-RAMZN;,?4]M]_=JS?B$(8U.
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M-CI&M7QUD=S;&JU$Y>1SF^ &-JP@
M &LW;J^I2G_+E%_0U 7&LW8D^O6C_)E?_(:&M>F08
M
M
M
M                   /&O<WZR<Q_+ES_&Y0V]7-F/J>V^_NU9OQ"$,:G
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M@+C6;L2?7K1_DRO_ )#0UKTR#
M
M
M
M   !XU[F_63F/Y<N?XW*&WJYLQ]3VWW]VK-^(0AC4X
M                !T*RRVNOKJ*YU5,UURMRN6BK&JZ.:-)$1'L1[%1RL?HG
M'&J\+M$U1=$ [X    C6=8#BFY./R8QF5O2XV>1[9DBYR2%S)H]>"1CXG-<U
MR:KX%^PO(!V,0PS%L"LD..8?:X;39H%5[::!%7B>[3B>][U<][UT1%>]RNY$
MY>0#.@       <-5315E-+2S*](IFJQZQ2/A?HOAX7QN:YJ_9:J*!QVZW6^T
M4,%LM5+%16ZF:D=/2T[&Q11L3W&M:B(B =H
M         &LW;J^I2G_+E%_0U 7&LW8D^O6C_)E?_(:&M>F08
M
M
M
M                           /&O<WZR<Q_+ES_&Y0V]7-F/J>V^_NU9OQ
M"$,:G
M                                  UF[=7U*4_Y<HOZ&H"XUF[$GUZT
M?Y,K_P"0T-:],@P
M
M
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M$5R!<Q3O8D^O6C_)E?\ R&A=>F08
M
M
M
M      /,'>'LY;P46Y&25%MQ>NO5JN5QJ[A07&VPNJ8I(*J9TK>+F^)6/1'<
M+FN]U.35-%#=07Z MZ^H-\\QF\D%/H"WKZ@WSS&;R04^@+>OJ#?/,9O)!3Z
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MB,C7QN%K4<KG*FG@1->70FZWK#(
M
M
M
M                                                  -=.VW]157^
M4Z#^6X+B[\+_ .3L>_)E%^+L",X
M
M
M
M
M                                     UT[;?U%5?Y3H/Y;@N+OPO\
MY.Q[\F47XNP(S@
M
M
M
M
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MSG>%5]\(RH
M
M
M
M
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MYK5X).%W"B\O)X>4(LP(
M
M
M
M
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M6VB%+?8LICNM/%1_)8DX(5EA>YKWI&U.%-70KPHFJ:\JCQ9VP&U%QVMQ:O\
MTEK&7'-\DKI;QDE=$JNC6IF7DC8Y4;JC=5<J\/*YSO<T!K$6K$,EW(W?GS[.
M[=+;<0PB9]'@5DJD1'5%8NG.W65B*O(NB<PCN5.1=&N;XP<>X.,YWB^\MLWE
MPBP+E5'/9'XWD%D@J8J2K;'\H^41U$2U"HQWC<#7-1?X/V55 RVQV#Y58:K-
M,VS6DCM60YS=?G%UDAF;5?(J6%JLABDFC\1\FCG<2LY/![NJ(-6\$
M
M
M
M
M                                           "F=W.TKAFR]]I+#EE
MFO<\E=3)5TE;;X*26ED9QJQS4=+51.XV*GC-X>35%]T+&L_:)[5>WF[FVT^'
M8W;+U2W.6LIJELMP@I8X."!RJY%=#52NU77D\4+F+&Q_MT[26FPVNUU%FR-U
M10T=/32NCI:%6*^&)K'*U5KD735.35 1>^T>[UBWFL57D>-VNYT%II:E:-LM
MUB@A6:5K$>_FDAGFU1O$U%5=.7D371="+!"
M
M
M
M
M                                          43VL=JOI+VLJZFWP<[
MDV,<=UM7"FLDD;&_^9@3W?YR-.)$3PO8Q N/+@-LECUAN>4WVVXY985J+M=:
MF*CHXD\"RSO1C=5]Q$UU<ON)R@>PFW>$6S;G";+A5H1%I+13-A=+IPK-.NKY
MIG)[\DCG/7]T.:3@
M
M
M
M
M                        >57:AVJ^BS=.OIJ"#FL9OFMULG"FD;(YG+SL
M":<B<S)Q-1/XG ONAO%P]A+:KYPO%QW8NT&M):N.VV#C3D=62L_\Q,W7_P##
MC<D:+X%XW>ZT)K?0,@
M
M
M
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M!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1
M0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$
M.]]VB>N7YLM7H@(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#
MO?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1 0[
MWW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]
M]VB>N7YLM7H@(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?
M=HGKE^;+5Z("(;N#O1N3NI34-)GMY;=X;:]\M#K145,^)TJ(U^CZ:")VCD:F
MK573D3WD!&8Q/M([SX-C]'BV*9(VVV&@1Z4M(RW6V1&\X]TCE5\M,][E5SE5
M5<Y5!&:[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>^[1/7+\
MV6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B AWONT3UR_-
MEJ]$!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9
M:O1 0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>^[1/7+\V6
MKT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B AWONT3UR_-EJ
M]$!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O
M1 0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>^[1/7+\V6KT
M0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B AWONT3UR_-EJ]$
M!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1
M0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!&P/90[2NXFX><38-GM3%=V5-'-645Q
M;3PTL\4M.K55CDIVQQN8YJK_  .)%TY= FXW-#(
M
M
M
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M#U!4^T:SI04[F6P'J"I]HUG2@IW,M@/4%3[1K.E!3N9; >H*GVC6=*"G<RV
M]05/M&LZ4%.YEL!Z@J?:-9TH*=S+8#U!4^T:SI04[F6P'J"I]HUG2@IW,M@/
M4%3[1K.E!3N9; >H*GVC6=*"G<RV ]05/M&LZ4%.YEL!Z@J?:-9TH*=S+8#U
M!4^T:SI04[F6P'J"I]HUG2@IW,M@/4%3[1K.E!3N9; >H*GVC6=*"G<RV ]0
M5/M&LZ4%.YEL!Z@J?:-9TH*I'M4=GG:S:[;*')<-M<U'=WW2FHW325=14-YF
M6.9SDX97N3E5B<N@7-5QV)/KUH_R97_R&A=>F08
M
M
M
M                 /&O<WZR<Q_+ES_&Y0V]7-F/J>V^_NU9OQ"$,:G
M                     X8JJEGEFA@GCEFIU1M1&Q[7.C<Y-41Z(NK55.7E
M Y@ ' E;1K6+;TJ(EKTCY]:7C;SR1*O#Q\&O%PZ\FNFFH'.         X(ZV
MCFJ9Z*&HBDK*9&+4T['M=+&DB:LXVHNK>).5-?"!S@     541%55T1/"H'!
M25E)<*=E705$=522Z\W/ ]LD;M%5%T<U51=%30#G               X9:JE
MIY(89YXXI:ARLIXWO:UTCT17*UB*NKE1$5=$ Y@
M &LW;J^I2G_+E%_0U 7&LW8D^O6C_)E?_(:&M>F08
M
M
M
M                   /&O<WZR<Q_+ES_&Y0V]7-F/J>V^_NU9OQ"$,:G
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MH_R97_R&AK7ID&
M
M
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MBH9[S3U<MQ9 QL<<LT$%0Q)5:U$3C5JHUR^[PH%XVR#(
M     !K-VZOJ4I_RY1?T-0%QK-V)/KUH_P F5_\ (:&M>F08
M
M
M
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M\DDU9/$BJL2*LTC(V/T?PKJYK=$U(BU#09*WM7UVX,F,W=F&5%E2R0W9:-_
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M1_DRO_D-#6O3(,
M
M
M                                                    'C7N;]9.
M8_ERY_C<H;>KFS'U/;??W:LWXA"&-3@                         <%7/
M+34TDT%-)5RL35M-"L;9'KKIHBRO8U/]+D HG8? \_P;,MQ;SE=E93T><7A]
MXI)*2L@J4IDDFJ95CF158Y=$F1$<Q'<ON(%U?H0
M                                      -9NW5]2E/^7*+^AJ N-9NQ
M)]>M'^3*_P#D-#6O3(,
M
M
M                                                         'C7
MN;]9.8_ERY_C<H;>KFS'U/;??W:LWXA"&-3@
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M*+^AJ N-9NQ)]>M'^3*_^0T-:],@P
M
M
M
M       >->YOUDYC^7+G^-RAMZN;,?4]M]_=JS?B$(8U.
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M_0U 7&LW8D^O6C_)E?\ R&AK7ID&
M
M
M
M      #QKW-^LG,?RY<_QN4-O5S9CZGMOO[M6;\0A#&IP
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MI3_ERB_H:@+C6;L2?7K1_DRO_D-#6O3(,
M
M
M
M           'C7N;]9.8_ERY_C<H;>KFS'U/;??W:LWXA"&-3@
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M-9NQ)]>M'^3*_P#D-#6O3(,
M
M
M
M 'C7N;]9.8_ERY_C<H;>KFS'U/;??W:LWXA"&-3@
M                  P>4XG:,NH8J.YI)'/23,K+;<:9R15E'5Q?:3T\FB\+
MTU5.5%:YJJUR.:JHH9.@BK8**&&X5#:NM8U&S5+(N8;(Y/X7-\3^%5]W1=-?
M>\ '9      !@\IQZ3*;>MEFKYJ*SU2.CND=)K'4U$#M-86SH[6)CTU;(K&\
M:M7Q7,7E R=OM]#:J&FMELIXZ2W4<3(*2E@:D<444;4:QC&MT1$1$T1$ [(
M                                    !K-VZOJ4I_RY1?T-0%QK-V)/
MKUH_R97_ ,AH:UZ9!@
M
M
M                                                        \:]S
M?K)S'\N7/\;E#;U<V8^I[;[^[5F_$(0QJ<
M
M  #6;MU?4I3_ )<HOZ&H"XUF[$GUZT?Y,K_Y#0UKTR#
M
M
M
M                     !XU[F_63F/Y<N?XW*&WJYLQ]3VWW]VK-^(0AC4X
M
M                            &LW;J^I2G_+E%_0U 7&LW8D^O6C_ "97
M_P AH:UZ9!@
M
M
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M*$UZ3A@
M
M
M                                             PMWP_$K_4-J[]8+
M==*MC4C9/74<%3(C$75&HZ5CE1-5\ &/^C+;;J=8_9E)T0#Z,MMNIUC]F4G1
M /HRVVZG6/V92=$ ^C+;;J=8_9E)T0#Z,MMNIUC]F4G1 /HRVVZG6/V92=$
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MZ:1W')#0P1TS'.\&JMB:U%4#(@
M
M
M
M                                                 !KIVV_J*J_R
MG0?RW!<7?A?_ "=CWY,HOQ=@1G
M
M
M
M
M                                    &NG;;^HJK_*=!_+<%Q=^%_\
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M)X/"JKRA&5
M
M
M
M
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MKX4<J>%/"BHAE,P
M
M
M
M
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M/71.IZF6CI&/8E0Z-VCFME5^K4<FO)[VB@U>X0
M
M
M
M
M                            (1EF\&V>"W1++E^2TEGNKHFU#:6J5[7N
MAD5S6O31JHJ*K7)JGNHH&N/:RWEVOS;:"IL6*91176[OKZ.9M)3N<LBQQO57
M.Y6IR(&LQ;>*]HG9&BQBR4=5FUNBJJ>@I89HG/?Q-DCA:US5\7PHJ!(L7#MP
M,-W IJFLPR\07FDHWMAJ9J;B5C)')Q(U5<U$UTY= B2@
M
M
M
M
M                                                   U?[;&U7Z8
M;?1YU:X..^XAQ2U/ GCRVJ54Y]%T\/-*B2IKX&\?OA<><0;<M+35%;4PT=)$
MZ>KJ'MA@AC17/?)(J-:UJ)RJJJNB(!ZZ;'[:4^T^VMFQ%K6K<V,^5WJ9FBI+
M<:A$=,NJ>%&\D3%_B,:&-6($
M
M
M
M
M                               XJJFIZVFFHZN)L])4,=#/#(B.8^.1
M%:YKD7D5%1=%0#R*WPVTJ-I]RKSB+FN6V,?\KLLS]566W5"JZ%=5\*MY8GK_
M !V.#>+=[$^U7Z8;@R9U=(..Q8APRTW&GB2W65%YA$U\/-(BRKIX'<'OA->C
MH9
M
M
M
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MDW&R@0
M
M
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MK_Y#0NO3(,
M
M
M                                                'C7N;]9.8_ER
MY_C<H;>KFS'U/;??W:LWXA"&-3@
M                                                       :S=NK
MZE*?\N47]#4!<:S=B3Z]:/\ )E?_ "&AK7ID&
M
M
M
M               #QKW-^LG,?RY<_P ;E#;U<V8^I[;[^[5F_$(0QJ<
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MA  !%LFSRS8SD&+8Q5.22\Y7624=!2M<B2)'3T\D\LZIHNK&<#6+]EZ 2D
M   ->.UEF&X6VF%4N:X+E-1:YW7*"AGM[Z2W5-,L,T,J\35GI9)$<CHT7ED5
M.5>3P:%Q]Y]3[Z8/M_-N%CFX+LBJ+/1I=+G9+Q:;9'3STT;4EF5DE%#3R,X&
M<3M.)>)$Y%10)SM#O#:-SMLH=Q*IC+/%3)/'?(Y7IS%+-1IQ3.YQVG\WPJDB
M*O@:O+RH")5@V6T>>8G:\OMT3H:"[1+/31R+J_FN-S6JO(FBJB:Z>X$2$
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M5]2E/^7*+^AJ N-9NQ)]>M'^3*_^0T-:],@P
M
M
M
M              >->YOUDYC^7+G^-RAMZN;,?4]M]_=JS?B$(8U.
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MW5]2E/\ ERB_H:@+C6;L2?7K1_DRO_D-#6O3(,
M
M
M
M                'C7N;]9.8_ERY_C<H;>KFS'U/;??W:LWXA"&-3@
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M-#6O3(,
M
M
M                                             'C7N;]9.8_ERY_C
M<H;>KFS'U/;??W:LWXA"&-3@                          .FVTVMD,M.
MRAIVP3O22:)(F(Q[T5'(YR::*J*B+JH'<  <,=+2PQ.@B@CCA?KQQM8UK7<7
M(NJ(FBZ@<K6M8UK&-1K&HB-:B:(B)X$1 /T    ?+&,C:C(VHQB>!K4T1/\
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M3U43)Z>1-'Q2M1[')X>5KM44#D                       :S=NKZE*?\
M+E%_0U 7&LW8D^O6C_)E?_(:&M>F08
M
M
M
M        /&O<WZR<Q_+ES_&Y0V]7-F/J>V^_NU9OQ"$,:G
M                    ?+7L>KD8Y'*Q>%Z(NNCM-=%]Y>4#Z  <$5;1U%1/
M2P5$4M52JU*J!CVNDB61.)O&U%U;Q)RIKX0.<              #X26)95A1
M[5F:U'NCU3B1KE5$54\.BJB@?8                                 :
MS=NKZE*?\N47]#4!<:S=B3Z]:/\ )E?_ "&AK7ID&
M
M
M
M                   #QKW-^LG,?RY<_P ;E#;U<V8^I[;[^[5F_$(0QJ<
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M"V_+:6'Y)5R<5-=;>JJKJ6OIUX9H554151%\9J^ZU4 G
M                 UF[=7U*4_Y<HOZ&H"XUF[$GUZT?Y,K_ .0T-:],@P
M
M
M
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M5^:[?DDU10Q\FC%6LK*>3731-5;%%X$_@A=;4A
M          UF[=7U*4_Y<HOZ&H"XUF[$GUZT?Y,K_P"0T-:],@P
M
M
M
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MPW P>XRV:NL^WN%U+[U4U%YIW4-5<+C_ #:T\$5+-I,V.-6<4KY6-1VO"@&
MW4H,IKNT5M[F-JQ6\7'&L4CJ(+M<*:FU8CJI)8]8D>YKI&LXD<Y6IRI]KQ*!
M8>_FV,V\FV%1C]LD2EOL4D%VL<E2CHD960([A;)R<3%<Q[X]=/%5VON: Q6^
M&[O]I*2DI\)O6TM1+F<+&TK\HJZA:6SJJ:L^4SN;$]CN'AXWM@F7C_@HG$U
M1L38J">QV&BH;G<'W"KI*=J5USJ%T=/,B<4LSM5T:CG<3N%.1J<B<B!%!]DJ
MQ3U$.X6ZM1&Z*//\AJJRW<2*G'0P3SO9(U%TY'25$K?_  A=;(!
M                       UF[=7U*4_Y<HOZ&H"XUF[$GUZT?Y,K_Y#0UKT
MR#
M
M
M                                        !XU[F_63F/Y<N?XW*&WJ
MYLQ]3VWW]VK-^(0AC4X                                $7SG![;G-
MLIZ:JD?176V5,=QL5WIT3Y10U].NL<S->1R?P7L=XKVJK5 R]C=>W6Z-N11T
M[+M'JR>2B<]U/+P\B2L;(B.8C_#S;E=P>#B=IQ*&1     #7JHQ'?W;K/,KR
M?!&VG-L<RVL^<:BW769U#<J5[&\$<,<WVBQ1LTCCXE7D3[5JZJXJ64]FW5W$
M@CM^Y-!:<9Q)TD4U?9K;427.X5J0/;(D$L[HXXHH7.:G.<VCWN1.%'-UU MD
M(^)I'Q0R2LB=.]C7.;#&K4>]435&M5[FMU7P)Q.1/?4"@MN<&W!L&^F<[BWN
MPMAQ_+VP04B05E/-44[:=8V-?,Q7-316MXG<VYRIX$1P5L $      B><X_?
M,OH'8M25:6K'[@SF[Y<H7K\O?2OU22FI41-(W2-\5\SG>(U?%:KEXF!(;5:[
M=9+;26>T4S*.UT$+*:CI84X8XH8FHUC&I[R(@';
M           &LW;J^I2G_+E%_0U 7&LW8D^O6C_)E?\ R&AK7ID&
M
M
M
M                              #QKW-^LG,?RY<_QN4-O5S9CZGMOO[M
M6;\0A#&IP
M                                     -9NW5]2E/\ ERB_H:@+C6;L
M2?7K1_DRO_D-#6O3(,
M
M
M                                                        'C7N
M;]9.8_ERY_C<H;>KFS'U/;??W:LWXA"&-3@
M
M   :S=NKZE*?\N47]#4!<:S=B3Z]:/\ )E?_ "&AK7ID&
M
M
M
M                       #QLW/:YNY69-<BHY+Y<T5%Y%14K)0VF]E[4V_
M&/6>WV"SY9\FM-JIH:&@I_FZV2<W34T;8HV<4E*YSN%K435SE5?=4$=[O?=H
MGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1 0[WW:)
MZY?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>
MN7YLM7H@(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?=HGK
ME^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1 0[WW:)ZY
M?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7
MYLM7H@(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^
M;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1 0[WW:)ZY?F
MRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YL
MM7H@(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+
M5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1 0[WW:)ZY?FRU
M>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7
MH@(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z
M("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B
M AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@
M(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("
M'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1 0[WW:)ZY?FRU>B A
MWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>^[1/7+\V6KT0$.]]VB>N7YLM7H@(=
M[[M$]<OS9:O1 0[WW:)ZY?FRU>B AWONT3UR_-EJ]$!#O?=HGKE^;+5Z("'>
M^[1/7+\V6KT0$.]]VB>N7YLM7H@(=[[M$]<OS9:O1 1&<ZW]W:W+LC<=S;(?
MG2S-G95MIOD5#3:31(YK7<=/!&_D1[N3BT!%A]B)KG;Z4JM:JHRV5ZN5$UT3
MA:FJ_P"E40&O3$,
M
M
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M[U:S5$56MT151%771 58 0
M
M
M
M                                             &NG;;^HJK_*=!_+
M<%Q=^%_\G8]^3*+\78$9P
M
M
M
M
M                              !KIVV_J*J_RG0?RW!<7?A?_)V/?DRB
M_%V!&<
M
M
M
M
M                :Z=MOZBJO\IT'\MP7%WX7_R=CWY,HOQ=@1G
M
M
M
M
M
M &NG;;^HJK_*=!_+<%Q=^%_\G8]^3*+\78$9P
M
M
M
M
M                                              !KIVV_J*J_RG0?
MRW!<7?A?_)V/?DRB_%V!&<
M
M
M
M
M                                :Z=MOZBJO\IT'\MP7%WX7_R=CWY,
MHOQ=@1G
M
M
M
M
M                 &NG;;^HJK_*=!_+<%Q=^%_\G8]^3*+\78$9P
M
M
M
M                                          -+KW:=S]W>TGGV$6;<
MZ]89:L?IJ>II(;?+4NI^!(J9BL2&"JI6HJNE5ZOU55#25=UG>'_,1DOQ:_\
MM8)3NL[P_P"8C)?BU_\ :P*=UG>'_,1DOQ:_^U@4[K.\/^8C)?BU_P#:P*=U
MG>'_ #$9+\6O_M8%.ZSO#_F(R7XM?_:P*=UG>'_,1DOQ:_\ M8%.ZSO#_F(R
M7XM?_:P*=UG>'_,1DOQ:_P#M8%.ZSO#_ )B,E^+7_P!K IW6=X?\Q&2_%K_[
M6!3NL[P_YB,E^+7_ -K IW6=X?\ ,1DOQ:_^U@4[K.\/^8C)?BU_]K IW6=X
M?\Q&2_%K_P"U@4[K.\/^8C)?BU_]K IW6=X?\Q&2_%K_ .U@4[K.\/\ F(R7
MXM?_ &L"G=9WA_S$9+\6O_M8%.ZSO#_F(R7XM?\ VL"G=9WA_P Q&2_%K_[6
M!3NL[P_YB,E^+7_VL"G=9WA_S$9+\6O_ +6!3NL[P_YB,E^+7_VL"G=9WA_S
M$9+\6O\ [6!3NL[P_P"8C)?BU_\ :P*=UG>'_,1DOQ:_^U@4[K.\/^8C)?BU
M_P#:P*=UG>'_ #$9+\6O_M8%.ZSO#_F(R7XM?_:P*=UG>'_,1DOQ:_\ M8%.
MZSO#_F(R7XM?_:P*=UG>'_,1DOQ:_P#M8%.ZSO#_ )B,E^+7_P!K IW6=X?\
MQ&2_%K_[6!3NL[P_YB,E^+7_ -K IW6=X?\ ,1DOQ:_^U@4[K.\/^8C)?BU_
M]K IW6=X?\Q&2_%K_P"U@4[K.\/^8C)?BU_]K IW6=X?\Q&2_%K_ .U@4[K.
M\/\ F(R7XM?_ &L"G=9WA_S$9+\6O_M8%.ZSO#_F(R7XM?\ VL"G=9WA_P Q
M&2_%K_[6!3NL[P_YB,E^+7_VL"G=9WA_S$9+\6O_ +6!3NL[P_YB,E^+7_VL
M"G=9WA_S$9+\6O\ [6!3NL[P_P"8C)?BU_\ :P*=UG>'_,1DOQ:_^U@4[K.\
M/^8C)?BU_P#:P*=UG>'_ #$9+\6O_M8%.ZSO#_F(R7XM?_:P*=UG>'_,1DOQ
M:_\ M8%.ZSO#_F(R7XM?_:P*=UG>'_,1DOQ:_P#M8%.ZSO#_ )B,E^+7_P!K
M IW6=X?\Q&2_%K_[6!3NL[P_YB,E^+7_ -K IW6=X?\ ,1DOQ:_^U@4[K.\/
M^8C)?BU_]K IW6=X?\Q&2_%K_P"U@4[K.\/^8C)?BU_]K IW6=X?\Q&2_%K_
M .U@4[K.\/\ F(R7XM?_ &L"G=9WA_S$9+\6O_M8%.ZSO#_F(R7XM?\ VL"L
M=>^QSN'DU MKR3?2]7BV.<V1U%<*6JJX%>SE:Y8YKHYNJ>XN@6N]#V4MVZ:&
M.GI^T)D<-/"UL<44<=<QC&,31K6M2[(B(B)HB($K[[K.\/\ F(R7XM?_ &L"
MG=9WA_S$9+\6O_M8%.ZSO#_F(R7XM?\ VL"G=9WA_P Q&2_%K_[6!3NL[P_Y
MB,E^+7_VL"G=9WA_S$9+\6O_ +6!3NL[P_YB,E^+7_VL"G=9WA_S$9+\6O\
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M:Y6\7#Q*B ULT$
M
M                                                    !JQM5_C(
MW<_)D'_=0A>-IP@
M
M                                            U8[&'_NE_>63_P#2
M!=;3A
M
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M-4<#$:J2/33^<\9.'QD\+='!900
M
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MD\#E_C(Y%:%[!
M
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MMIL?S"V5^5LD<ZYK\JC=55]UEY9WN=Q+QR.=R(SB5S6HC?<"+F"
M
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M=-422"H8DD;DU]]KD4([@
M
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ML27/Y]6JTJ.'@_G./E=X?X/#]@+UO:&0
M
M                                  U8[&'_ +I?WED__2!=;3A  !66
MXVZ>28/>J>U6;;J^Y=33TK:I]QM#$?3QO=)(Q87*J*O&B,1R_8<@51/9=O>X
M>V./T.W5^VPR+2Y7I99KVM.L5)2PUG,PK)+QM1>&-&J]Z^\%U+MU\7S_  #>
MFW;\;?X_-E-NJK=\SY98Z)=:UT351&R1,1%<_5&Q:(UKM'1\O([5",'F/TA]
MIV\X[B,N"W;"]L;7<(KKD=?D<*T=55+ BM;!#"Y$545KGM\7B35R*[AX>4OQ
M+>T)@>;IE>%;R[:6U+QDN&22PU]E:Y&2U5NF1=6Q^#541TK%:FKOYS5$7312
M8B6XF6;K]H*PQ[7XSMQ?,/MUWFI_TEO^2P.HX(*6&1LKFP\;6K)JYK5U;XRH
MG#P^-JA5_P!YKJ':;;;G+;;:JYTF,VZ&CMMJH8GSU50M.QL$$36QM<OC*C4<
M[A\5-7+R(&45V.V^O-AI+EN!GJI-NAFCVUM\<J>+14Z?_3T$2*J\+(6Z<2?Q
MN35>%%"ZH^UV[</"MH\J[.S,"O=TO];45U#8K_2TS7V2>AN<FJ5$U:KVMC<U
MKG*K7<OVJ+[NA6UV#V"3$\*QO%II$FEL=KH;9),W[5[J.G9"KD\'(JLU#+/
M
M
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M4T;94E?KQ2-T31KW:KJYJ(J@3(
M
M                          !@<QS+',!Q^IRG+*MU#8:-8TJJML$]4D?.
MO2-BN93QR/T5SD37ATY0*N[WW9VZY?FRZ^B!8H'LQ[[[4[>_I[^F%_\ F[YZ
MOCZZV?\ DZVHYVF=QZ/_ )B"3A\*<C]%^P%W&RV*]I39;-K_ $6+XMDKKC?;
MBYS*2C9;KDQ7JQJO=JZ2E:QJ(UJN57.1$1 D6N$
M
M
M              /QS6N:K7(BM5-%1>5%10/)[M(;6.VGW1N=GI(5CQRY+\YV
M%43Q$I*ARZQ)_P#L7HZ/3P\*-5?"&\5(%;3]B+:K]*\[GW!ND''9,3T^1<::
MLENLS5YO37P\RS61?><K%#.O18,@
M
M                                                     8W(;#;,
MIL5RQR]0I46FZTTM'61+X5BG8K':+[BIKJU?<7E \>]Q,(N>W.;7K"KNBK5V
MBI="V73A2:!='PS-3WI(W->G[H=$8 WL[".U7R2W7+=J[0:3UW':\?XT\%/&
M[_S,S=?X[VI$U?"G ]/ H9UNB&0
M
M
M  !KWVP-JOI#VOFO=M@YS)<1YRY4?"FKY*/A3Y7"GN\K&I*B)RJZ-$3PA<>9
MM%1U5QK*>WT,+JBNJY604T$:<3Y)97(QC&I[JJJHB!MZ[[+[;TNU.W%EPZ%&
MNKH(N?NT[/!-<)]'SOU]U$7Q&?ZC6AC4_"
M
M
M -->W;M5\X6>W;L6F#6KM7!;;_P)RNHY7_\ EYG:?_AR.6-5\*\;?<:&L:7X
M#AETW"S*S899T_\ /7>I93I)IQ)%']M+*Y$_@QL1SW?80-/87&<=M>(X];,8
MLL7,VJTTT5'21^[S<+4:BN7W7.TXG+[J\H<V5
M
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MQS22N:]BHG\-4=K[FG*3<;%!
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M7/<BPK(YKFRMT<B:HNH(]  R
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MH 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H
M4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[
M@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.
MVW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW
M6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:
M^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?
M#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2
M= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2=
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MQ3MKUA5&)3-B<U6\U&SP\XNNH7-3;_I^?\XYC^3*?\84)K?L,@
M                                  !2':^_P[9E_5G_ !6D"X\ZMF\(
MM^Y&Y>/X3=:B:DM]WFEBGJ*;AYYB1P22HK>-KF^%B)RH&M;G]P';;K-?/AI.
M@"4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H
M4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[
M@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.
MVW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW
M6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:
M^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?
M#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2
M= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2=
M"G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G
M<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!
MVVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VV
MZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS
M7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7S
MX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:
M3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H
M 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4
M[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@
M.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.V
MW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6:^?#2= "G<!VVZS7SX:3H 4[@.VW6
M:^?#2= "JUWZ[).%[3[:7+-K->[I6W"BFI8HZ>L6GYER5$[(G*O-Q-=R([5.
M4&:U!#3V]#F
M       \L>U]_B)S+^K/^%4@;QNCV,OJ L'X3<?QR4,ZOT(
M
M                                TN_ZA'^Y\#_";E_1TX:Q%?\ I^?\
MXYC^3*?\84&M^PR
M%(=K[_#MF7]6?\5I N-$NRO]?^$_A-1^)SAK7JX&
M
M            "@NV;]0%_P#PFW?CD07'E^&WMZ',
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M5_Z?G_..8_DRG_&%!K?L,@
M      !2':^_P[9E_5G_ !6D"XT2[*_U_P"$_A-1^)SAK7JX&
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MSF3<34Y>#1%4"?X??5RC$K!DRL;&MYMU'<5CC558WY7 R;1JKRJB<7($9H
M            "@NV;]0%_P#PFW?CD07'E^&WMZ',
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MJZT_.U-%0RVVHI:R.&96)PNJJELD4C>/E7A<U43E=Q<A<;EAD
M              &EW_4(_P!SX'^$W+^CIPUB*_\ 3\_YQS'\F4_XPH-;]AD
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M$U%3D F(              %!=LWZ@+_^$V[\<B"X\OPV]O0Y@
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M?*/FVJJ:NT@J%71/=T0)C9MKFO:U['(YCD16N1=45%\"HH1^@
M             #2[_J$?[GP/\)N7]'3AK$5_Z?G_ #CF/Y,I_P 84&M^PR
M                                           %(=K[_#MF7]6?\5I
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M[_$3F7]6?\*I WC='L9?4!8/PFX_CDH9U?H0
M(YFF"8UN#:76++(*BKL\G^VHX*VLH8Y4U1=)4I)H><:BM14:_5$4#LXOBMFP
MVTPV.P-J(K73HUE/!55E77\U&QJ,:R-U7+,YK&M:B(QJHU/> PF?;3X)NA%3
MT^<V^>ZT=*J/AH_G"OI:9)&\:)(L--411J]$>Y.-6\6BZ:Z =[&]O<3Q/'Y,
M4L]'*N-R1?)EM=?65=SITIU:K5B8RNFG1L:HY45C=&K[P$%M?9?V9LU162T%
MDF;2UG$YUMDK:J:@9*]%;SC::21T:O;KXBO:[@5$5NBH@6I%BVRNVV%X_48W
MC%F6V45:SFZVJI:FI@KYT737CK(I6S\NG*C9$3WDT!7/A.T&WVW=#66O$+7+
M0VFX(]M9;9:ZNK*.3G4:UZK!53RQHYS6HU7(W54Y-= 5@\:[.&S>)U-956C&
MF:UB2M=#53U%7#&D[%CDYJ.>1[6*YCE9QM3BX>370%9;%-F-NL(QRNQ;%[7)
M;+9<EUKY*:LJXJR7PZ(M6R9LZ-35=&MD1$U7WUU%=O =JL&VP@GI,&H)[70U
M+EDFHUKZ^JIED=PHLB0U-1*QKU1C45[6H[1--= B75,#*J"2FE5[8Y6JQSHI
M'PR(B\GBOC<US5^RU44"'XUM1A.(WFNO]@@KZ>[725)[G/+=[K5)52M141\S
M*BJD9(J(NB*]J\@$U PF,8EC^&T51;<:HF4%!55<]PDIHM>;2>J=QR*QJKHU
MJKX&MY$]P"+WC93!+IE$F:TD-98LIJ45E?<[#75%KEJV*J*K:A*=[6OUTY7*
MG%]GD30M23',*QG$K5/9\>H?D-)5ODFK)62RNJZB>;[>::I>]9I)7>[*^17_
M &>0(CF.[([;XIDM3F%@M];29)7/62OKUN]UF=4N<_G%^4-EJWME17<JI(UR
M!:R^X&VV&[H61N/YM;4N-MCF;4P)SDD,D4S$5J/9)$YKD71RHO+HJ>$(C]YS
M+9_L_6BQXY=JR+&+37NG9:8.:JJGG'0JQTSWR,9,[765G%)*[55=X0KH;8)0
MYSF61;T4U-PVRXT\&.XG6/B6&6IM%"]TTU5PN1KN&>I>Y&<::\$3%T34"TZR
MCI+A23T%?!'54-5&Z&IIIFI)%)%(BM<Q[7(J*U47144(IZU=E+8FS9%'DM'B
M[5JX)$GIZ2>IJ)Z..5JJ[B2"21S5Y5^U?JU-$T1 M70$0;=_;:@W8P"ZX96O
M2GGJF)-;:U4U^3UT*\4,O)RZ([Q7HG*K%<GN@,#O]3EV,_,F51RV[-;9%'1Y
M1;8YI*:>.I:G#S\,D+F.6"HX%DAEC=HYNK=>)KD0,;8]@MKL;R&HRRQVRNHL
MDK'/=6W*.]7CGJA97I(_GE6L7G$<Y$<Y'ZHJ\H6I1F6"XWG]K?9<IAJ:JTRH
MK)Z."NK:&*5JJB\,K:2:'G$U1.1^H1C<1VHPG!+3-8L2IJZV6>9'(M''=KH^
M*-7N1[G0I)5.YIRJFJNBX5\/+RJ!B;'L%M=C>0U&66.V5U%DE8Y[JVY1WJ\<
M]4+*])'\\JUB\XCG(CG(_5%7E"UF\^VNPC<^CI[?G%!-=+?3/YV*C;75M)!S
MJ(J(]T=+/$USD1RHCG(JIJN@1T<(V=V[VR<^;#**JL]/JZ66F2ZW.6B<Y6*U
M7OIYZI\+EX?X3F:IX?<0+45L=@^DS=Z'=JJC7]#\4HY+9A*O142NJJG7Y7<6
M(O\ \GA7F87>"33G&\G"JA= 1!,\V<V]W-?$N<VZINT,#DDAI77.Y04K)$;P
M<;:>"ICB1W#R<2,UY5]]0M82+LW[101,AAM=QCAC:C(XV7Z^-:UK4T1$1*[1
M$1 5)<-VLP;;ZTW&RX=;7VNANTSJFX+'65DE1),]B,5_RB69\S5T3DX7IHO*
MG*JJ$=+$MF-O,%N-QNV*4%9;Z^[*Y]TE2[729*F1_'K)*V:J>U[TYQZM>Y.)
MJKJBHH6OG'-E=N\2R2KR^P4%;2Y'7N5]PKG7>ZSNJG*[C7GVS5;V2\O+_.-4
M%?+-D=N8\N=GK**O3,'IPON_SS=^?<S1&\VO_G-%CT1$YO3AT]P%?5_V4VZR
M?**;-+W05M1D]$J.H;BV[W6!]-HY7:0-AJV-B;JJ^+&U$Y05]9/LOMYF5\M^
M29)0UE9>[2K7VNK2[76!U*]BM<CX&PU3&QNU8URN8B*JIJO*"N_G.V&%;D8[
M!B^96Y;G:J5\<M-SD\R5$<L358UZ3H])%=PJJ.5SEXM?&U".U1[>X70XB_ Z
M>RT_Z(R1/AFM<J.FCD;(O$Y9'2*Y[WJOC<;G*[7EUU @N)=F#97"LCCRFQX[
MI=::3GJ%:JIJ*N*F?[CHHYGN;Q-7E:YW$YJ\J*@6IUG. 8AN18WX[FEKCNEK
M<])6,>KF212M1422*2-6O8Y$54U:Y.3D7D4(@'=<V9DLT-BK+-/74<$T<K'U
M==53SHR%'(V%DKI.*.%>+QHX58CM&\6NB!:M.R6&RXU;8;/C]!!;;73IPPTE
M+&V*-ON>!J)R\G*J\H1D0                        !I=_P!0C_<^!_A-
MR_HZ<-8BO_3\_P"<<Q_)E/\ C"@UOV&0
M                 I#M??X=LR_JS_BM(%QHEV5_K_PG\)J/Q.<-:]7 P
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M17=UKBJ8:%DZNX8OECH'2/;PJBH__P NSA>BZIRZ>$(CU3L-A5QC90WJNO\
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MK[_$3F7]6?\ "J0-XW1[&7U 6#\)N/XY*&=7Z$
M                       ##9#B.*Y=%3P959*&]PTDG/4L=QIHJIL4G\9B
M2M=HJ^[IX0,O'''#&R*)B1Q1HC6,:B-:UK4T1$1.1$1 /H    <*TE(ZK97N
M@C6NCC=!'4JQJRMBD<USF(_35&N5C55-=%5$]X#F     #AJJ6EKJ=])6P1U
M-+*FDL$S&R1N3PZ.:Y%10.9$1$1$31$\"
M                 -+O^H1_N? _PFY?T=.&L17_ *?G_..8_DRG_&%!K?L,
M@                                            !2':^_P[9E_5G_%
M:0+C1+LK_7_A/X34?B<X:UZN!@
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M8]K[_$3F7]6?\*I WC='L9?4!8/PFX_CDH9U?H0
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M?[GP/\)N7]'3AK$5_P"GY_SCF/Y,I_QA0:W[#(
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MO=HJ&5=KN,$=51U,:ZLDAF:CV.3]U%".Z
M     *"[9OU 7_\ ";=^.1!<>7X;>WH<P
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MTV*W:HH*====*65&SM1%7ET21TNFON:!=;+!
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M5NU104ZZZZ4LJ-G:B*O+HDCI=-?<T"ZV6"
M     !07;-^H"_\ X3;OQR(+CR_#;V]#F
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MB(J^! F(_ME::#<WLF4F#V:Y4\ETJK#+0.;'*QZP5B.>K&S-:JJSQT;Q:IX
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M9C8OM489N?:H+=DM938]G4#$;6453(V"FJG-Y%EI9)':*CO"L2KQMY?MFIQ
MW$,P^L9L+VDLYH,TE2WXAN=-\[62_P!1XE$ZMYZ6HYA\RZ-8K5J)F+Q+[C%\
M#T4*D6Z=!1;S;R;:8_B]1'<[7A57+D&5W*D?SM+3,:^G?3T[IH]6\[,Z%R<V
MCN-&^-R)RA&%W#R*PP]M';)TMSI6,M]HK8*Z1TS&L@FGI[BR..1RKHU[G.:B
M-5=>5/?0''[VE<@L4&]NQ#9KG2QNMEXJ9[CQS1M^3133T",?+JOB-=P.T5VG
M@4&,OVI,@P2BN.W#,KDJ;0Q]QEN-!GM!&^>2U-I&,E_F4C;(DCIW\TG"YCVH
MU%?PKH@,8ZT;K=G7)LTLF4Y5N:N17ZPI)'8([E0S6FVT<U2[QJA&NI(6+*J-
M:U9)9%:W1%1&KHH&STM92PT;[A),U*&.)9W3HO$SFFMXU?JFNJ:<O($:U]B"
MQ5%)MG>,IJ85A3)[U4U5(CM?&I:=K845%\"_SJ2MY$]P+K9L(
M                           &EW_4(_W/@?X3<OZ.G#6(K_T_/^<<Q_)E
M/^,*#6_89                                             "D.U]_
MAVS+^K/^*T@7&B797^O_  G\)J/Q.<-:]7 P
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MJD1VOC4M.UL**B^!?YU)6\B>X%ULV$
M "@NV;]0%_\ PFW?CD07'E^&WMZ',
M                        !Y8]K[_$3F7]6?\ "J0-XW1[&7U 6#\)N/XY
M*&=7Z$                                      "*;CX#:-R\0K\2N[
MG0LJD;)1UT2(LU)60KQPU$2\GC,<FOA35-6^!5 _,1K;W<;8MCSBW(S(K<UD
M5=4)&LENKN'D;54TBMX=)-.)T3M)(G<BIIPN<&?;:+2QS7LH*=KVJBM<D+$5
M%3P*BZ <M104-6Y'U5+#.]J:-=+&UZHGO(KD4!3T-#2.<ZDIHH'.31RQ1M8J
MI]GA1 .G<,;QV[U4-;=;115];3_["HJJ:*:6/P_:/>U53P^X!D9(8I8UAEC:
M^%R:.C<B*U4]Y47D ZS+3:XU58Z&G8KD5JJV)B:M<FBIR)X%3D4#\2U6Z!>=
MI:&F94L15B<D;&:.TY/&:W5/] &KV([E56'-N-FW[VYO-3F%5<:BLJ<AIK6E
MYME4DKEYAL$C>+@;'$C88XX^)$1NJZ.5R!4[L^/V/</*<=R6P;?OP^V8[7+=
M);]<[;#:+E62)!)$RGIX6ISRPO61'ROFX$7A:C6N5=6A>81TELUH555;?3*J
M^%>9C_> YG4-$ZG2D=31+2M^U@5C5C3W>1NF@'!\RV?U?3?<8_) Y+C;+;=Z
M5]#=J."OH9/]I3543)XG?NL>BHOP +?;;=::5E#:Z2&AHH_]G34T;(8FZ^\Q
MB(B? !\OM%JD>Z22AIWR/57/>Z)BN5R\JJJJG*J@)+3:Y7K)+0T[Y'?;/=$Q
M57]U50"A=R\CRS#-UZ2]9%A-PRK:.GM?R2TML4#:]:*OF5&S3STFJ)Q<'\RU
MSM$;&Y48JJY[0K\DR+!-SK;+9\.VEJ+E6UL4D$%POEABMMJI'2)PNDFJIVZZ
M,\/#3M?(JIHB>Z@3"_XO?7X%:]E<5DJ&,^:Z6R7G*IHW1QTMKA@93S/C5=.=
MJIHVJV-D>J,5>)ZMT:C@L7'K!:L6L=OQRQT[:6T6NGCI*.G;X&Q1-1J:K[JK
MX7.7E5>5>4(R0                                       TN_ZA'^Y
M\#_";E_1TX:Q%?\ I^?\XYC^3*?\84&M^PR
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MR(+CR_#;V]#F
M        \L>U]_B)S+^K/^%4@;QNCV,OJ L'X3<?QR4,ZOT(
M
M                                 TN_ZA'^Y\#_  FY?T=.&L17_I^?
M\XYC^3*?\84&M^PR
M %(=K[_#MF7]6?\ %:0+C1+LK_7_ (3^$U'XG.&M>K@8
M
M                *"[9OU 7_P#";=^.1!<>7X;>WH<P
M                                       'ECVOO\1.9?U9_P *I WC
M='L9?4!8/PFX_CDH9U?H0
M
M     !I=_P!0C_<^!_A-R_HZ<-8BO_3\_P"<<Q_)E/\ C"@UOV&0
M                                     I#M??X=LR_JS_BM(%QHEV5_
MK_PG\)J/Q.<-:]7 P
M                                                 4%VS?J O_X3
M;OQR(+CR_#;V]#F
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M@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ
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M@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ
M$.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0
M[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O
M4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1
ML!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $:M]L[=G;O<NV8A!@]]B
MO$MNGKGUK8HYH^;;,R!&*O.QLUU5J^ +CM?]/S_G',?R93_C"@UOV&0
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M $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH
M0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#
MO4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]
M1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&
MP'7:F\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4;
M==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1L!U
MVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:
MF\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;
MS>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-
MZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK
M.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ
M $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH
M0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#
MO4; ==J;S>LZ $.]1L!UVIO-ZSH 0[U&P'7:F\WK.@!#O4; ==J;S>LZ $.]
M1L!UVIO-ZSH 0[U&P'7:F\WK.@!%.]J#?G:3.MG+QC>)Y/!<[W4ST3X*..&I
M8YS8:J-[UUDB:WD:BKX0N8T%#3V]#F
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MG+HFC?#KR KU3#
M
M     &K&U7^,C=S\F0?]U"%XVG"
M
M                                                        #5CL
M8?\ NE_>63_](%UM.$
M
M                                                        !JQM
M5_C(W<_)D'_=0A>-IP@
M
M                                                U8[&'_NE_>63
M_P#2!=;3A
M
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MA1I5E!
M
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M"MRRRL?*L4-JMJZ<"NX6NXII5<G!'R>%JKR.U0+*"
M
M
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MLFJ^,^1NNJKJJ\H18@0
M
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MJDWCR>I2X9A-/5Q<ZZXSZJVGXM41C(D=P1L<J:ZJJ(G%H$7^$
M
M
M            #2#MW[5?[LW;M,'\2U9%P)^[\EG=I_IA<J__ )- UC2$-/23
ML6;5?H5MT[,[G!P7_,."ICXT\>*V1Z_)V\O@YS5TRZ>%',]X,:V9" &K_:^W
M P.Z[-9%C=KRBT5N11UE''):*:OIIJUKZ>LCYUJP,D5Z*SA7C3A\73E"XN?;
M+-L,R/';/:\>R*V7:YT5LI%K**@K:>JGA1L3&*LD<3W.;H[Q5XD\/(!0'9=R
MW'=IZK.-E<WNE/8[O9KY45=L=<Y64D=31RQQQHL3Y5:U=6Q-E1-=5:_B35$7
M0NN]%>+=O/VL;#=<0G;<L2VXM<SKE>*=4?325M4V9C8XI$U1Z:R,T5/#P/TY
M$U"<=7:#)K)L]OGNKM]F]?%98,AN+;_CM97O;3TLT50^:56I-(J,XE;*QK>7
ME<QS?MN0*YMQ,@L^]/:%VQQ'"*N*\6_!ZN7(LBNE&]L])$L,D$L<7.MU:Y>*
M!K'<.OC2(GA1VA%Y[N;E46UV'SWU\*UU[JGMH,>M#-5EKKG4:M@A:UOC*BKR
MOTY>%%TY=$ H'<C;C(\$[,>=7JY3NK=S<K=27/-[FQ55ZMDK(N.FC5O(D,$;
MECT3Q>'C7[541"]9'.(\'DS_ +/OT9_(_ES:Y74_S8L7RCYB2G:LW.\S_ X$
M?KQ?Z^G\((VH"
M
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MZYSYY98[8VX\]KSORE*2))>/7EXN/77[(92H
M
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M "'>HV Z[4WF]9T (=ZC8#KM3>;UG0 AWJ-@.NU-YO6= "'>HV Z[4WF]9T
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M(WHU[=4\'$WE]P(DP
M   X:NKI*"EGKJ^>.EHJ9CIJFIG>V.*.*-.)SWO<J(UK43555>0"II.U+L#%
M(^-V;TBN8JM56PU;VZHNG(YL*HJ?910L?/>HV Z[4WF]9T (=ZC8#KM3>;UG
M0 AWJ-@.NU-YO6= "'>HV Z[4WF]9T (=ZC8#KM3>;UG0 AWJ-@.NU-YO6=
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MT;,V2*.>5D#'\RZ-)'-621C.)K%1%5-019H0
M                               !Y:]L.HGF[0V61RR.?'3LML4#7+JC
M&+;::16M]Y.)[G?NJ&\0C&=EMU,SL\-_Q?%:VZ6:H<]D-93M:L;G1.5CT35R
M>!R*@*R_=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$
M9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@
MIW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=L
MWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J
M+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^
M(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+
M!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[
M9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O
M46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G
M\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>
M6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=
MVS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]
M>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW
M/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,
M\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4
M[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;
MZ]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%
MN?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$
M9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@
MIW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=L
MWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J
M+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!4;S':W<+;^FIJS,\>JK-2UCW
M14LM4UJ-DD:G$K4T5>5$ V*[ %1.W<'*:5LCDII;,V62)%\5SXJJ)K'*GOM1
M[D3]U0FO00,@                                            !2G:
MWJ)Z7L\YG+3R+'(YE!$KFKHJLFN5+&]O[CFN5J_NA<>7^/X_>LJO%+8,>HI+
MA>:USF4E'"B+)(YK5>J-U5/ UJJ&U@]VS?7J+<_B,\L)3NV;Z]1;G\1GE@IW
M;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWU
MZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<
M_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(S
MRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3
MNV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9O
MKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46
MY_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1
MGE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"
MG=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS
M?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>H
MMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/X
MC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L
M%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[M
MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]
M1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?
MQ&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW;-]>HMS^(SRP4[MF^O46Y_$9Y
M8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWUZBW/XC/+!3NV;Z]1;G\1GE@IW
M;-]>HMS^(SRP4[MF^O46Y_$9Y8*=VS?7J+<_B,\L%.[9OKU%N?Q&>6"G=LWU
MZBW/XC/+!3NV;Z]1;G\1GE@K$9-LMNIAEGFO^48K6VNS4[F,FK*AK4C:Z5R,
M8BZ.7PN5$!4'BJ)X631Q2.9'4,2*=K5T1[$>V1&N]].)C7?NH%>W(<P
M                                                  'ECVOO\1.9
M?U9_PJD#>-T>QE]0%@_";C^.2AG5^A
M
M               &GG_4#_Y/P[\IU'XN@:Q778!^LG)OR&OXW #7H0&0
M                                         I#M??X=LR_JS_BM(%QH
MEV5_K_PG\)J/Q.<-:]7 P
M                                                     4%VS?J
MO_X3;OQR(+CR_#;V]#F
M               \L>U]_B)S+^K/^%4@;QNCV,OJ L'X3<?QR4,ZOT(
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M2!& VTSYVY.,T>6TUEJ;39[BQ9:!:V2!TTL:.5O%P0ODX471=.)=?L 3(
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M*Z[ /UDY-^0U_&X :]" R
M      %(=K[_  [9E_5G_%:0+C1+LK_7_A/X34?B<X:UZN!@
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MKRA4_"  #AJZNDH*6:MKIXZ6BIV.EJ*F=[8XHXV)JYSWN5$:B)X550.8
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M5-=/2W"./FHXJ;@X713PODBF9)J[A=&_DX%1VCN0$68$
M      *"[9OU 7_\)MWXY$%QY?AM[>AS
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MRG4?BZ!K%==@'ZR<F_(:_C< ->A 9
M              "D.U]_AVS+^K/^*T@7&B797^O_  G\)J/Q.<-:]7 P
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MUQ2W77([!E+TYN[6!U4V"9J(KGT]; Z*6%R_Q5<D<G[K$]]0,\
M             H+MF_4!?_PFW?CD07'E^&WMZ',
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M;]4Y31,E65Z4U"QJ-<KDIZ&'2-B(NB(]_.2HG(LBZKJ7$E[;RHNVV*:+K_\
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M0;LA*B=G7#55=$3YSU7^M:L+J[8IHIXVS02-EA>FK)&*CFN3WT5.10C[
M              &GG_4#_P"3\._*=1^+H&L5UV ?K)R;\AK^-P UZ$!D
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MLLCU?<[ESKZ>FC3B>D-.WBDF>B?:QM56L5Z\G&]C?"Y ,B
M         H+MF_4!?_PFW?CD07'E^&WMZ',
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MO%RG?5UTZ1Z\#72O^U8SB7@BC1L;=5T:FJZD2
M!07;-^H"_P#X3;OQR(+CR_#;V]#F
M                        \L>U]_B)S+^K/^%4@;QNCV,OJ L'X3<?QR4,
MZOT(                                       "%9?M%MMGUZM^0YCC
MM+=[O:V)%1U%1SFB1-<KT8]C7(R1B.<Y4;(UR<J\G*!,XXXX8V11,2.*-$:Q
MC41K6M:FB(B)R(B(!]          $)RS:3 ,ZN%+=,LMDESK:!_.4#Y*VM8V
MFDU:JNA9'.UD;E5C556-1>1 )?24L5%31TL+I'11)HUT\LE1(O+KXTDSGO=_
MXG*!S@                  !^.:US5:Y$5JIHJ+RHJ*!^@
M               :>?\ 4#_Y/P[\IU'XN@:Q778!^LG)OR&OXW #7H0&0
M                                          I#M??X=LR_JS_BM(%Q
MHEV5_K_PG\)J/Q.<-:]7 P
M     1;.MN,)W+MT%ISBT17>@I9DJ:>.1\L3HY414U:^%['IJBZ*G%HON@9J
MRV2T8Y:Z:R6&AAMUIHV)'2T5*QL44;4]Q&M1$Y5Y57W5Y0.^
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M&L6597/;Y*R_6ZCND5/:Z6:DC@96PI.D;EGJ:E7JB/:G%XO*B\G+R$30
M   "LM^\DS7#ML[WE>$5E%25]HIUJ)EKJ9U4YS.-C?YI4E8QCFHKG:R,D1>1
M-/="XS.T-^NN4;7XCD5]J/E=YNEJI:NNJ>!D7.32QHY[N"-K6-U5? UJ($30
M             $%DMNZ2[JPW2.]4*;3);5CFLBPHM<MQU721).;XM.5%UYWA
MTY.#7Q@)T  U^[0&X6Y>!91@$&.W.AI<:R2^TMLJX4H^<K^;=)#QHLLSY(U:
M]'/3Q(F.;R:.77D+C8$(    #7_M7[A;E;8X13Y-@USH:"FEK(:"H66C^45K
M7S,E?QQOE<^'A3FT16N@5>77B3312XV ",)EV66'!L<N&5Y-5I166VQ\[4SJ
MBN7E5&M:UJ<KG.<J-:U/"J@5AAN2;Q;M6N++[9-08!AU<G.V*GJJ-;O=ZNF7
M[2HFUGAAA8]/&8QK7.T]W315*9=E^\&WE;BU%<H;7DF/WV_VJSU>24D,MNJ:
M**NJXXG)/2.?4,=QHY6-F9*U$7D5B*K54,1N3N%N7BV^VW&'TUTHH\,RJIEY
MZEIZ-$JG,@\5T4TT[YM47B8Y'0MB7PI[FJAL"$0?=6V[GW3&H:;:6\T5CR9*
MV!\]7<8FS0NHD1R2L1'13(CE56.UX/ BHBHJZ@39B/1C4D5'2(B<;FIPM5WN
MJB*JZ)_I ^@  "%[@7?*<4HG9A8X?GBTVN)TE\QQ&L;42T;-725%'+HB\_&W
M5W-2*K)6IPMX'\JA([#?;3DUFH<@L54RML]RA94T55'KPOBD35%T7147W%:J
M:HO(O*!D0                       #3S_ *@?_)^'?E.H_%T#6*Z[ /UD
MY-^0U_&X :]" R                                             %
M(=K[_#MF7]6?\5I N-$NRO\ 7_A/X34?B<X:UZN!@
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MMV5XY4I56:YQ)-32Z:.3E5KF/;_!>QR*Q[?<<BH!F@
M                    !07;-^H"_P#X3;OQR(+CR_#;V]#F
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M[+V;YGG.'Y+59S=OGF[6C):ZSPUGR>GI?_+4M/2N:G!31Q-^V>]VJMUY?#X
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M?AWY3J/Q= UBNNP#]9.3?D-?QN &O0@,@
M                 !2':^_P[9E_5G_%:0+C1+LK_7_A/X34?B<X:UZN!@
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MKD2UVR]S7FRTZ>"&&LF>DK&\O(U$6#1$Y-=5\*A=;,A
M                      H+MF_4!?\ \)MWXY$%QY?AM[>AS
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M.VNK-P]\,VC1WS9=,FJ*6@D7P.YNKJZB3P:HJHV>+P+[H76T@0
M             :>?]0/_ )/P[\IU'XN@:Q778!^LG)OR&OXW #7H0&0
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M]V70H[Y!25GS,V1?M73\^O.M335%5BTW+R\G$GOA=;2!
M                       H+MF_4!?_ ,)MWXY$%QY?AM[>AS
M                                              >6/:^_Q$YE_5G_
M  JD#>-T>QE]0%@_";C^.2AG5^A                       ! ]V]N(MR\
M52V05*6_([94PW;&KLJ<2TETHW<<,BHFNK%Y6/3^*NJ<J(!W+'76_/K&^TYE
M8H8[S1I&R_X[<865,450YJIQQ\XCF2P2:/YF9NJ.35.1S7M:'-:=LMMK!6QW
M*Q8=8[7<8EUBJZ*V4E-,U4_BOCB:Y/A [=_P7",KECGRC&K5>YXDX8I;E0T]
M8]K?>:LS'JB<H'):,.Q''Z&HM=AL%MM5MK$5M71T-'!303-<BHJ21Q,:UR*C
ME3E3W5 Z%HVRV[L%%<;=9,5M5!079CH;I3T]'!&RIB<FBQRHUOC,T7[5>0#D
MDVYV^FLE+C4^*VB?'J%5=1VJ:@II:2)SN57,B>Q6HY5Y5=IJON@&;<;>1VAV
M/LQ*RML+W\\^UMMU*E(LO\=84CX%=]GA @&[=JEVUVNOE1L]AM)!<JM8H:^"
MQ4%/#,RCD7AGG;#%&B2O8Q51J*UVFO$J*C50*K"U9CV'[O114[[);*2N;&VG
M?;:FQU7SBUS&\*L=S-/(Z25-/&<Q[W*[EU50OJQMK-J<.:F65D6'QVS;S)W6
MYUOQ2\T_.M>^WI*KZV2CJ><2!9G2L1L;T1Z)$CG(U5T0B;?0QL]^K[&O8U!T
M(2N\[;';9UK98W8;8W62*5U1';5ME(M*V:1&HZ1(N:X$<Y&MU=IJNB>\!RQ[
M=;?0V>3'HL3LT=@EDY^6U-MU*VC=*B*G&Z%(^!7:*J:\.H';Q_$,2Q-DT6*V
M&W6..H5%G9;*."B;(K? KDA8S73[(&$N&T&UMUO$M_N6(6JINU0[CJJB2DB=
MS[]47BF;IPR+JFNKT505,XXXX8V11,2.*-$:QC41K6M:FB(B)R(B(!%Z/;3;
MVWY+-F5#C%LI\IJ'.DENT=+$VI6237C>CT;R/?JO&]/&=JNJJ!WK1BF+8I15
MD-@LM+04]2LD];'1T[&OJ)'ZN>LG"G%(YVJ_;:K[@$+VRVSM>*9'?LLMF/TN
M*4=UIZ6WT%AHV1,<VGI9)IW5%5S"NCY^62H<U&M<Y&1,8G%KJUI5F3P054$M
M-4Q,FIIF.CFAD:CV/8]-'-<U=45%1=%10B-VG;7;FPU[;K8L0LELNC%565M%
M;:2FJ&JOATDCC:Y-?W0..#:W;*EN#;M2X788;HQ_.LKH[71LJ$D\/$DB1(Y%
M^SJ!^UNV&VMRN,EXN.&V.LN\KUFEKZBV4<M2^55U5[I7Q*Y7:\NJJ!RW?;G
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MZS_)&K)75STTDJJR9>*:=_A75[EY$55T;HFO(!,
M   #3S_J!_\ )^'?E.H_%T#6*Z[ /UDY-^0U_&X :]" R
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MAM[>AS
M  >6/:^_Q$YE_5G_  JD#>-T>QE]0%@_";C^.2AG5^A
M                 ./F($F6I2)GRA6\"S<*<?!KKP\7ATU]P#D
M
M!IY_U _^3\._*=1^+H&L5UV ?K)R;\AK^-P UZ$!D
M                          *0[7W^';,OZL_XK2!<:)=E?Z_\)_":C\3G
M#6O5P,
M                                      %!=LWZ@+_^$V[\<B"X\OPV
M]O0Y@
M/+'M??XB<R_JS_A5(&\;H]C+Z@+!^$W'\<E#.K]"
M
M                         -//^H'_ ,GX=^4ZC\70-8KKL _63DWY#7\;
M@!KT(#(                                             4AVOO\.V
M9?U9_P 5I N-$NRO]?\ A/X34?B<X:UZN!@
M
M       H+MF_4!?_ ,)MWXY$%QY?AM[>AS
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M^O2%&N;)'P(C>:D>NNOOA<Q(>P#]9.3?D-?QN )KT(#(
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M2Z45PK9J66.HK$I^9:E/.R5R+S<KG<J-T3D!F-00T]O0Y@
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M1\K6.>Y[D;_ ;PHWW=>0FZV*"
M          !$]S,$H=S,$O>#7&=U-37B!(TJ6-1[HIHI&S12<*Z<7#(QKE35
M-??3P@:,3=@7=MLKTI[]CDD"+_-ODJ*Z-ZM]]6I1/1%_\2AJOCN#;P^N\:\Z
MK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N
M\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#
M;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P!
M!3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J
M_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO
M&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V
M\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0
M4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\Z
MK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N
M\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#
M;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P!
M!3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J
M_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO
M&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V
M\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0
M4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\Z
MK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N
M\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#
M;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P!
M!3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J
M_P! !3N#;P^N\:\ZK_0 4[@V\/KO&O.J_P! !3N#;P^N\:\ZK_0 4[@V\/KO
M&O.J_P! !3N#;P^N\:\ZK_0 5FK;V!LW;8KR^ZW^SNR-\44=B@@DJEHTD^41
M.EDGF=3M>FD+9&M8V%VKG(JN30%;^!D
M
M                     #5CL\+S/:)WWIY?$GDKXY6,7D58_E-0O%^YH]OP
MA=;3A
M
M
M
M
M               !JQL?_BFWK_\ S7](T+OQM.$
M
M
M
M
M                                                 &K&S>M'VM=Y
M*!WC.GIX:I'IR(B*ZG=PZ?\ YW_L"[\;3A
M
M
M
M
M                                            !JQM5_C(W<_)D'_=
M0A>-IP@
M
M
M
M
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M<*)X-45%4:MD(
M
M
M
M
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MHW->]NB,1%:UR-Y.'3PIJ2+?"
M
M
M
M
M                     #5BQ?XZLG_NU'_0T07C:<(  -..U)OCAF8[?9)M
MO8Z>Z2Y+#7PT[FOH)F0*^@K&K+I(J:*GB+PK[H:S%U;*;R8AN!0TF+V&.O9=
M+-:Z9U;\LHY*:+^:;'"[A>_D<O$O@]X)N*3VWS>A[*F29EMUN1;ZVWX7<+K-
M>,5R"GI9)Z26*9K8TC7FT5>+FXXDT;KPN1R+IR*I?J28'-<M^=_J/>*"U5=N
MVUPVW24&.5-PC6%UPK*A)&OF9&Y5\5$F>NJ:Z<#-?&540C#T&1M[,&].>SYE
M;*QFV>?5++O;<AI*=T]/3U;GRROB>C$Y/&FD8K4\9.%BHWA=JA?KN0WF;M,;
MV89D&-VRLBVIV[DEN2WRMA=3QUMS<Z-\;86N^VX7Q1*FO*B<:KIJW4?%N;W[
MCW/#[308MAL25FYN8RNMN+T:<O-.5/YZLDY%TCIVKQJJIIKIKXO%H3$ W+V1
MJ<=[+M^P#$6RW7(E2"ZW:H:U75-UK8ZN&IJY7(FKG.5&*L;?&71K6\J\H+ZP
M]TS?']\\]V@H]NHIZI^+7%;SDKEI9X(K3#3Q,1:>9\K&M1[GMYM&M<O*B>^@
M&U@0
M
M
M
M
M:L6O_P IVZKUSJ?_ %^-,YC3E^U@IM=?>_V3@O&TX0         <;H('2MJ'
M1,6=B*C)5:BO:B^%$7PIJ!R
M
M
M
M
M                      !JQ_\ UU?_ ,M?_H0O&TX0
M
M
M
M                                                       !B,KO
M3\:Q>]Y%%3)626B@JK@RD63F4F=2POE2-9.%_!Q</#Q<+M/#HH&J&&[L]L#<
MJQQY?A6.X]+C=;-.RC6=S&2(D,KHU:[G*J-55JIIQ<":^'0->,_\^]NKJQC7
MW2'TT)X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;J
MZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?
M/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]
M-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U
M]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;J
MZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?
M/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]
M-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U
M]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;J
MZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?
M/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]
M-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U
M]TA]-!X?/O;JZL8U]TA]-!X?/O;JZL8U]TA]-!X@WZ"=L+Z4/I<_1NR?I5\B
M^;>#Y33_ "3F.'A_V?RKBXM/=XPOB<_/O;JZL8U]TA]-">'S[VZNK&-?=(?3
M0>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?
M=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZN
MK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S
M[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?3
M0>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?
M=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZN
MK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S
M[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?3
M0>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?
M=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZN
MK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S
M[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?3
M0>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?
M=(?30>'S[VZNK&-?=(?30>'S[VZNK&-?=(?30>(KG^\O:]VML<>39I8<=I;,
MZICI.<C1LZK+*CG-;PQ5CG:*C'<H68W)H:AU70TU6YJ-=/%'*K4\"*]J.T_[
M0R[
M
M
M            (ON3&^7;K+XHFJ^1]EN36,3E57.I)$1$_= J?L7RQR;!61K'
M(KHJNXLD1/<<M5([1?\ 0Y%"ZV "
M
M                          :V]N*G2;8]TBNT^37>AE1--==4ECT__OU"
MXOS%ZAU7C-EJW-1KIZ"EE5J>!%?"UVG_ &A&6
M
M
M                                             !@\T_Y.R'\F5OXN
M\"D.Q)]15)^4Z_\ EM"ZV+"
M
M                     :\]M:!\VPURD9IPT]?02/U_BK,D?)_I>@7%RX%4
M,J\%QBJC14CGM-!*Q'<CD:^FC<FNFO+RA$A
M
M
M                                           !T;VB+9KBBIJBTLVJ
M?_FW :Z=A7ZE*C\N5O\ 0TX76S(0
M
M                         "A.V7&]_9^R)S&JYL=1;G/5/X+5KH6ZK_I5
M$"XL_:V6.;;+"YHG(^*2PVM[')X%:ZCB5%")8
M
M
M                                             #XFBCGBD@F;Q12M
M5DC??:Y-%3D^P!J]V"99)-G+NU[E5L61U;(T7W&K14+M$_TN50NMI @
M
M                                                    %(=K[_#M
MF7]6?\5I N)OLQ]3VWW]VK-^(0A-3@
M
M
M                                       #5CL):TVW65VI/&BH\EJ.
M"1?MG:TE,SE]SP1H%UM.$
M
M                   IWM5-:[L_YLCD14^34RZ+R\J5L"H%QG-@OJ4P'\AT
M/]"T&K&"
M
M
M                 -6.Q'K36'<&UR<L]'DLW./;RL7BB:SDUT7PQK[@76TX
M0
M                                                          "J
M.TQ#'/L/G+)6\34M_.(FJIXT<L;VKR>\J(H7'/V<99)MC,$?*[B<EJB8B_ZL
M:N8U/]"(B U: 0
M
M
M                    %9[]5^XEEVVN>0[95B4V16;2OEA=3Q57RBBB1>?8
MC96NT<UJ\XFG*O#P^Z%QH-/VR.T',S@CR6&G=KKQQVV@5W[G\Y ]/^P-1"L/
MWSW4P%EVCQ'(%MK;Y4+6W16TM'*Z6H=KJ]'30O5GA7D9PH"-L>R!G6]&Z>37
M6]YAD]578=8X>:=3/AIHXZBOJ45&,5S(FN5(V(Y[N%?#P:\BA-;DAD
M
M                                                 * [5>7[L;=X
MG0YOMQ<6T]MHYODV04SZ2"JX8ZA42&=%E8Y6HC_YMW+X7M^R%QI%EO:BWJS:
MQ5F,WV_Q262XQ.@KZ6*AHH^=C<J+HKTAXV^#^ Y U'4L/:4WLQC'J'%;#E3Z
M&Q6V-(:*FCHZ%71QM551.==3K(O*O\)Z@C=7L@W_ '4SG%[GG6XF05%TMU9/
M\BL-)+%!$SAIU_GY]8HV*[5Z\VWEY%8X,ZV2"
M
M
M                                          !^.:US5:Y$5JIHJ+RH
MJ*!Y2]I?:9VTNYM=;Z&!8L6N^MRL"I]HVGE=X\"+R\L+]6:+R\/"J^$-XI^*
M*6>5D,+'232.1D<;$5SG.<NB(B)RJJJ%>N.PVVL>U6U]DQ9[$;=EC^77IZ::
MNN%4B.E153D7F_%B:O\ %8@8U900
M
M                       ,;D%AMF46.XXY>H$J+3=:>6CK(5Y.**9JL=HO
MN*B+JB^XO*!Y ;FX%=-L\YO.%W5%6:V3N;3SJFB3TK_'AF;]A[%:[["ZIX4#
M;&8CC%SS3)[1B=G9QW*\545'3\BJC5E<B*]VG@:Q-7.7W$15"O8K$,8MF%8O
M:,3L[.&VV>EBHX-41'.2)J(KW:?PGKJ]R^ZY54.;-
M
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M-?=4"0
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M[Z.8Y44)KUN#
M                                       \0@Z/:^R_[GM_X-#_ $;0
MYN\
M                                                !YF]MOZ]:S\F
M4'\AP;QLSV%?J4J/RY6_T-.&=;,A  !I!_U#?_;C^N__ +>&L='_ *>_^^,\
M_!K;_25 -;VAD
M                                                         !5?
M:3^HK.OR8_\ EL"X\V]@OKKP'\N4/],T-:]> P
M
M    /$(.CVOLO^Y[?^#0_P!&T.;O
M
M              >9O;;^O6L_)E!_(<&\;,]A7ZE*C\N5O]#3AG6S(0  :0?]
M0W_VX_KO_P"WAK'1_P"GO_OC//P:V_TE0#6]H9
M
M                       57VD_J*SK\F/_ ); N/-O8+ZZ\!_+E#_3-#6O
M7@,
M                             #Q"#H]K[+_N>W_@T/\ 1M#F[P
M
M                                       'F;VV_KUK/R90?R'!O&S/
M85^I2H_+E;_0TX9ULR$  &D'_4-_]N/Z[_\ MX:QT?\ I[_[XSS\&MO])4 U
MO:&0
M                                                %5]I/ZBLZ_)C
M_P"6P+CS;V"^NO ?RY0_TS0UKUX#
M                                                       \0@Z/
M:^R_[GM_X-#_ $;0YN\             #KUU=0VRDEK[E4Q4=#3MXYZJHD;%
M%&WWW/>J(B?NJ!RQ2Q3Q,FA>V2&1J/CD8J.:YKDU145.145 /L
M        =66YVV"NI[7/6017.K:]]+1/E8V>5L::O5D:KQ.1J>'1.0#M
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MV!<>;>P7UUX#^7*'^F:&M>O 8
M                                                   'B$'1[7V7
M_<]O_!H?Z-H<W> QE^QVQY/;I;5?Z"&X4$K7-=%.Q'\/$U6\3%7E:Y$7D<U4
M5/<4#5OL(V6VU^ 7K++A RLR!E\EH8*^I1)IX8(:.FD1L3WZN8BNF=Q<*IKR
M:^ -:R7;DM-MIMKZ7):6F93Y R[TM/\ .<*<U4NA?#/K&Z1FCG-\5OBN54Y
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MGAT"\;=AD         57VD_J*SK\F/\ Y; N/-O8+ZZ\!_+E#_3-#6O7@,
M
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MX%Y0N:JGLNUV1UW9>NWS\Z22EIVW>GL4DO$JK;HZ=-$17>%K9EF8WW$1NB>
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M8_\ EL"X\V]@OKKP'\N4/],T-:]> P
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M\*ZZ>%0.KG&W^'[CV9;#F=JBNEN1W.Q))Q,EAE1-$DBE8K7QNT735KDY.3P
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M_+8%QYM[!?77@/Y<H?Z9H:UZ\!@
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M29&_*KK5/N-VB9-2VM'M;'!0TD[VN>R%B:KQO2./G97N<YW#R<+?$0)
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MH!A[%@&"8M4.J\9Q>T66J>FCI[;04U'(J:*G*Z&-J^!5 D0
M                           57VD_J*SK\F/_ ); N/-O8+ZZ\!_+E#_3
M-#6O7@,
M                                 #Q"#H]K[+_N>W_@T/\ 1M#F[P
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MRWRTY#0MN5FJF5=(YSHW.;JUS)8UX7QR,<B/CD8OBOC>U'-7D5$4#(
M                   #S-[;?UZUGY,H/Y#@WC9GL*_4I4?ERM_H:<,ZV9"
M #2#_J&_^W']=_\ V\-8Z/\ T]_]\9Y^#6W^DJ :WM#(
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M_P!,T-:]> P
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M,Y(H8HTT:G_:J-:B>%=$0,H5%OGMY\OM%!7U-=:?TA>D=AK+M:Z^W4E:]VG
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MP[.V:9K5Y1N+M?G-W7(*[":^)EOO4K&LGGI:ETJ(DG!HFJ<VUR>%4XE3541
MFN2R1[B97!FV1;GY%<MN;?0W*IH,:BIYJ6AI*>AA1."KD?*Q>?XW+]M(_@73
MQ41% R/9;W*R'<_;)]URJJAKKY:KE4V>IKX&(QM1\G9%*R14:C6:JV9.5C41
M?#X=0:A^^%VDP7M'[.9=3.2),A^4XQ<EY$22E?40L:CU7^"Q]8DB?9:#&S80
M                        *K[2?U%9U^3'_P M@7'FWL%]=> _ERA_IFAK
M7KP&
M                              !XA!T>U]E_W/;_ ,&A_HVAS=X
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MV"X5\<::>!JS<?\ WN4&L7V,8XX;'N)%$Q(XH\MK6L8U$:UK6QQHB(B<B(B
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M5O\ 0TX9ULR$  &D'_4-_P#;C^N__MX:QT?^GO\ [XSS\&MO])4 UO:&0
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MP'\N4/\ 3-#6O7@,
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MFW.AB@:B0PL56.CXG.D<D2IX9/'05]=IZT5&X?Z#[.6MSEKLDO#;C='1JO\
MY>RVR-WRF9^G@3BE9S?%R.>G"G*#%_PPQ4T,=/ Q(X(FMCBC;R-:QJ:(B?81
M$"/L                        \S>VW]>M9^3*#^0X-XV9["OU*5'Y<K?Z
M&G#.MF0@  T@_P"H;_[<?UW_ /;PUCH_]/?_ 'QGGX-;?Z2H!K>T,@
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MBLZ_)C_Y; N/-O8+ZZ\!_+E#_3-#6O7@,
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M#(
M                                              "J^TG]16=?DQ_\
MM@7'FWL%]=> _ERA_IFAK7KP&
M                                                   !XA!T>U]E
M_P!SV_\ !H?Z-H<W>
M
M   \S>VW]>M9^3*#^0X-XV9["OU*5'Y<K?Z&G#.MF0@  T@_ZAO_ +<?UW_]
MO#6.C_T]_P#?&>?@UM_I*@&M[0R
M
M            JOM)_45G7Y,?_+8%QYM[!?77@/Y<H?Z9H:UZ\!@
M
M                 >(0='M?9?\ <]O_  :'^C:'-W@
M
M                            /,WMM_7K6?DR@_D.#>-F>PK]2E1^7*W^
MAIPSK9D(  -(/^H;_P"W']=__;PUCH_]/?\ WQGGX-;?Z2H!K>T,@
M
M                                     *K[2?U%9U^3'_RV!<>;>P7U
MUX#^7*'^F:&M>O 8
M                                          'B$'1[7V7_ '/;_P &
MA_HVAS=X
M                                                     #S-[;?U
MZUGY,H/Y#@WC9GL*_4I4?ERM_H:<,ZV9"  #2#_J&_\ MQ_7?_V\-8Z/_3W_
M -\9Y^#6W^DJ :WM#(
M
M  "J^TG]16=?DQ_\M@7'FWL%]=> _ERA_IFAK7KP&
M
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M[D1>3W@1"=@D5=Z\!T37_P!<H?\ LF:#7KN&
M
M  !X\[O?(?I$O_R'YHX/EL_._H]\M^;^=YUW'P?+?&UU\/-_S?\ $\70-H0%
M
M                                              /UFG&WBTX=4UXM
M>'3[/#RZ?N >K?9>^1?0MC_S?\T?)/Y_@^8/E?R;7G7<7._+OY[G^+7G>+DU
M^U\3A#&KA"  #5KMS_(?HYM/RSYGX_EK_DOSE\M^<>>YOD^0?)/%UX>+G?E'
M\UIP_P +A"X\YPV
M
M  +]['_R'Z9[)S_S1\LXI?DOSK\M^4Z\Q)Q?(N9_F.>X==/E'_A\;0)KU #
M
6                          __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm2225088d1-pht_head4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-pht_head4clr.jpg
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M ,L  0 !!0$! 0             # 0($!08'" D! 0 # 0$! 0$
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MP4%MK)XLAXHM67S1512A4<%"54! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MC2%958@OCYHE(@LE?"T9I"&T4'BT5[K<N8PVXSM.&"93XL6./4)SG#:#L/\
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M(EM(VAD+*<:#Y$4RR8R *JT<\6YRYU *45FL:G6*.@+3QK]*PW;ZQAPZ?')
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MM;V>Y[$OQ?;5TR08TMXHS_D-#?F7M\/[8^9]J8VKIB*EM. ^A7<WP3(D0$!
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MZW%M+;AKXM,TC0PV\L;5\DC2*TQ&/I<.U5CLY>6H[^ZO':I!J4K'1VL@J(W
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MAS2\"E."UUC'9/F<VE1@K,XIYS*^(CX5.6N%3+ WQ$CX44V8U[J44=M(<F
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M11:)+=]8R%+17,2,O((I4,K0 3W(A'$RN*"4AM"'*!#Y,3SBI2P[B)L;B:8
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M<UM^)O<^OS6!@TNZBG\N:K2*NN+EP! [G!,#0?B+VSN1W5O1M8U;3)=9V@(
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M=5GI(5]6WM;?2^L;=PM=O6(N(S))+$QU.PD#TK=\![5^ML!) ZTACN &Q'D
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M#(T$<D,JO\0H[!13+&($9J%42"0O]*(5(',T*$6^6"471SPEK<S16B"EM*9
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M@?@78\VS"ZT?)GD#_P!G6K.' G@F%9<LQ$B @(" @(" @(" @(" @(" @("
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M^9@?JH+<A+'%^!^J@TVORRO@;9PDMD>:&AIQ!'SH,G1],CTZT$CV"6X<*DN
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M2]7V,5X]I5CJ.BZ@ZTU2 B%AI'*YI;PYU('<L['L[<LV>@0:?9WT =)<,+'
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MQ\3@<."-)LIY;DPOY*!CSQ",/N)&Q<TP?<7>6AYK715/!5JMN5/*[E",JT3
M9:J$Q48*2Q*QPH$PI=4H>$PIXKLX*NU6FB"X(*TJ44O==Y90B-T=>2+35"^#
MN1/CACR1T446!AHJ4RJ&&JH97.BJU:&6%+;5)P08<MH4&&^W()!X!4NOQ5L1
MMF?;.#V<6'-\&*OKOA7Q>A[;U@7%BTR.'G"@I@#Q*Z]-LO)]S3,=C;^3,QD,
MF,<K"'^ES</C6NT?-ZSPV:#85[-M/?-QM>Z\%GJ<C[UCG>$4?F:,74_JEMQM
MN?7RUR]UC9EC/HHNO+RM9XU+"/".SBJ--KE,K*B @(" @(" @(" @(" @("
M@(" @(" @(""P'.W$406-;Y;B.(HI6D1RBM<$7B)HH%2]TY54'DKRK10G)2O
M)$6F0J5%6LQ4"5K.]!7($P95# I,JY4,E BM*!$%$%*(F*Y0BV5A!K@H,F*&
M4;A7E12(RS+CQ062-);4(*0DE@!"I6VO95_910LA<SFB%&#S X$4#>:BIC&<
MUMU%)"1B.!]!55FHT]KXKAT3C0 D!&D;.0>7*.8P2K1!,P.C>:]OR+-.6)9,
M!+ZFG#YU*,LMS !Q1.5N.5Q_1 ^-4K27HT.MYC>64/U32KOXR+9;<,H&OY\
M$,JM J:'Q'DB,JTH:' H964?FJ15H*)RE+FOHP>"O,(C*=C&LJ6\3Q*C*<*.
M;EQI7-@2F1I-;A%I-#=0#+&TATA'<05.415KW/@%XP#*>.*QNJW)>C7:K +P
M"2)OAP+SWE0XIW<_J.H26P-FUGEAIQ!- :8<QW(VPS[>\M[.V$S'@R'@,.W\
MRG&&=TS&;[V)H&WK(W%U?$!4@T)^A&>ELK5ZIIEIN$QPSQ"V(.,@&)K3T=B8
M=VO/AS>J[)N;&0,TN[#FG$8@_%F*CQ>QP^Q-IBM=^Z]VV^#7A[1^@T_,F'1]
MW6?)-'9:]*W^T/:PUIBUK3\@4X5OLS]/^*X[/N[T%TLGF#N'T%1XJ_U4_P 5
ML]&V+86TH=/!B2,:$\UI<,.;W\3I/YNGN(M,TB)L<+V!^!#:@.PH>%>]5DZO
M,G)MR7K*YC7=<N[X^0V3S;8>%L(P Q%,1Z%W<>E3MOKQ3/1B:9ISZEUV3)4U
M8TBF5O(=Z]#3CZ/ ]OW?N;Y_3YL\QYJPC#L=V*-M%^'GRQGPNREM./->=RZO
MI/6Y,L0V[A6J\^SJ][38\A1AKY*BU)!('Q)A'F-LW.'#Q?9HF$_<4]U#@,F+
M^8Y?"IPIE;[L<2,6CC3$IA>*.A I0X'U)A>+?(J:5^=4L5JAAH34T;]HX*,*
MY1>6_,?"?+Y. JF$Y4R%I\;2.S!,)E4<PAM7 ]P8,R86\D3034X@#A44JF \
MPCO[4P!D<UH<*$'M-"@E9-C0TQ&&*"5LO(TKR%4$L;G.>&Y:$?M*\A_ J6]5
M+W9#' U'U1A4X*TIDR "I([E>1/F21 4KPI5QIP4V%WRPG0.D!+0,.(6=1E"
M('-&*I3*X0D4)5#*41\EH94-L#C7XD,L::TI_ AEK9[9QK04[U?X+YZ->Z -
M-'"H/$KDO=$K+T2X=;7X-:0 TIRYKKX:YN?3,>GZ5=LDB<\>(D-,;?C^)>A;
MF/EO<XL6-1U+LKR33[7<.FM(U.U8(7%HQR U!^%Y5H:;9CV?;^X;#7=(AO[2
M0/MWX9FD.Q]2Z-;EYO-IBMU!('-:WF.Q:,(R%"1 0$! 0$! 0$! 0$! 0$!
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M3QY*,)RMB!C!<< [$%5IEK+L-NVR6\[J1.J"3WJF1R\UZ=O71CAC\VTEXX5
MIW>M;>70O5M'R1ZS:@Z4X1R1T,[?9)K2M:TKBJXE4Q(\[ZG:)9W^N:'::K46
M1C:74QK^VY4*8BN79Q[ V>TQMAL(FD,.20L%2,W/P]JG&6>UN5;S8.V71L;-
MID,F/MM8*\?0GBC;;$0'9&S;"'/+IS&@_6+!_-3%6XIY7JC.UNGLT7F.LH7!
MN)!8#\657UG5TWU[MTC&=:;*MV.;;637N HT%GA^-H5K%YZ%[9CG9]FZ-?3>
M\RV<46;AY;0/#W\5;73+O]?T9I<[8J)VV-G0R!PMXFEO$EG'_-7=KP3Y.O><
M>,22-!J>D[<GNFQ6MG%DKB<E.SN7I\?%K/@^,_)^]M,R6]&T@L+?3;4,LFMC
M8X#,Q@H#3^%=^FD^3\\YN?DWWN=JV>E:E-$\1N.'"BUNL:Z:='46]QY[?$<>
M7H6>VL+M=;B5DAN-"N3:1Z'%R;?-4M)7+R\>N.SZ+U.7;/=3R@>(7A\VLC['
MU-ZL,0[%RX>EYC8QCG]EN('>45\F%JF:31[X2_LZC)'R]IO)$9?GCLW2M?T.
M&3J'H9>;>QN R=K'!N:+('$$5!(S 8+LQ*\'CS.KUWJ[N[2^H<W3_7;63,XR
M0QW1 <'QNBO7,YBM*-JGC/DVO+,O3^HVK[[98;>T;:4T5K8OB'O%](\1NRY(
M>!,C#S=R3QU^3HO);.CS:XWAN_I_N[1[:75?WI8ZE(&3M?(9J/ !=2C\!5RQ
MVTC+7GWEQFMIU5ZD[EN.HMGMFQ=^[-)N'.:^[;6, @2$<' \6CDJ_;B^_L;S
M'6NGZ97._P"SW+-HFLWL.J:!Y/GB\9()96.+VLR@^8XX 5]GFG@UX_8VL[UI
M-0DZH[QU^^%YJT.CZ+;L\RV:)VQ/>0& B@E/:[ZJTTTF>K'G]C:?%%TFZA:Y
MKQW)M37;CWIMM"6P2',_,'QN)!-7#'-14ND=%Y[BX3_AMB,FI[GA<W[ME_<B
MAQ%!/=X?$G+K,,O2Y=O+K>CUS?NN_P"$=I:GKS0"VV8T1"E:$R-CP_C+GTF:
M]CGY9->CYWTJ#J]O+1+K?&C7 ;'(^MK;OD .1X8\$ RBF$BW^W'G?>WLZ6NG
MU+=/4MVT+1UO!##N-\ODW$DY;D\O(75S&4#VOTD^W%;R\G_E7"[FU;?^R+*S
MW#/JK+IS7#WV%DP>,278-$AY-[TG'&6W/R3KY5U&Y.H&Y]+US:>M/GIHNH-A
M9<!F8,SRNB:*MS5KB>2S^W,NG?V-IP2YZMMU.ZE7L&Y=LZ#M)Y-[J,44UZ6Y
MFT#VPOXDM'!SUK]O7'9Q^Q[&V=,6_P",(='UW6I>K=YMDQL;,'W;3<-H'N+&
MW.)=F_067BW]J_[\D[8_ZN'Z5[>W)+U?W!!9RANH"6XROS $@2 '',M[K+'-
MZUVG+MU>B](^I6KPZQKN@;TE'O>BP.O"]V9Y>&N@: 2"^O[56\-<=F_%S[9Z
MVLOI+O'6M^;HUN\E>\Z/:R,\H.) +6QLS8$]H=R7#RZR=G=Q\UVVP]D="&2/
MGCIY;Z-#.0Y+*2.[DUO3!D[@JJY5:Q0979>U$90R,X@#!,-9.C#EBS!P/"AJ
MI1B-#=6PBG\QK1E/%%;4-K+[EJ+;MN$=?$1RK4?.M^"XK+;66/5]%O1+9B>$
M>9 [%Q/;0=M%W=WS7/P:S;.&JWYH]QJEI!K^W_\ BVG#SY):AKY#4C(XG+4>
M('BL+F=DZ68Q7>].]YVN[-(9(V0-U>W COF4<US7U-!4C$4 X$KOX]LQY?/I
MC-CN8\^4%[JFJT<^OZF?S"<CB2$*FCS!N)J4J8O!J*J$B @(" @(" @(" @(
M" @(" @(" @(" @(+ #FJI0NYJ$AQ""J @(" @(*.<UHJXT"!F;V\J^I :YK
MQF::@\T%:A!2H04+@< 5% %5%$0(F+47*(+7 G@H%.6*E:+2,#10LH >:"CA
M2E%6D1N;4J%Y6.6UDR@5;]9%LM?.6Q7C&@T:2$JV67,QGF-<#]W3$K/!*LC&
M([,4POEBW8+)01[/:F%Y4MOB#(WQ$<E5%1L&9[Y)!3M:@UEW9O$YN6 L8W$'
MM026M['.PPO(;(,"?A5HM&26%C:#Q-/UDJ5"&,:"\TPYK.I1FXM0,9 H%KIK
M.0BLP![/R""M[),;<"%A<T#V@J5#27+7WL1B!R'@YW9\JHE2&S:"R&0>\Q@4
M-./#U*6=V8%UIT>CWCM1M'&)AJ7PD\<Q/8.5>U6D4NSE]^W@U36]O2V[<\1B
M8 WMPF/;WJV&>7K>E:/)<1,DO/V=#ER\A7AB"NCCUZ,]MF^9;0V\;8X6>'[1
M6W@Y]]G$]0[\L9'8XELE>'H;7Y5/@]GT./+@(]-L+<MJ3GD%221A45[%/VWO
M?;\>L3LB8UIB:&F+CFQJK:Z+Z2SK7/[EU]NGVQMM/>TW1QH:DT->PCL7H<7#
MEX_Y/\C-9B6.)AM]1OR'7<F=IXAM:]G->GIPQ^:<GY/EUV[3^?\ U;^RLG6S
M*.87<@>Y5FO5Q\_-=YGYLQL8-6Y2TG@3P75K'GZZ]4,T+X7![78J:[?.2-GI
M5_(V0-D=AVJGP<UVSL[""5CS7,*=JY-H[^*IFY<U"<2N?DG1[OJ;=62(A1>%
M[#['U=UCHPN%Z'DQKB)QC)9QJ*#MQ4K39BZZWSM)D<QM'T +1VU"+9?-_P"%
M[;1O]MZUI&O6KF6MVU[8XI,"36&APKV%=&7FZZ6QY%N;IUK>P>J%GI-O'//H
M+[FW,>3*:-E=$Y^):SFYW)3Y.7;U]O+L]'ZTW.HMW)MG2M5A>_:#86F7R\'@
M&*U+JEQR\W<E&77-+K)T<'O"PVD-V[=9L2SG; R6.22Y<6.;F.0D5:!W\E'F
MQ\;=GIG5/6=&OMUV.F[]TB6?1Y1CJ+ T-#:/H:N<>) ^KS3SB=]*YSIQ;WNA
M=1;N#IHR7_"[K<$/?1S?-,H#FU9E^J&<E/G$\>MG3'1I=LR:/KFY=0EZQPS&
M\@C\VRLVEK"9VF,-%'Y^(+N:OIMFL>?2UN.A-GDW=NAFFV<MA8305MX)<M0T
M1 'V:\34JGQ=&FML>C?AGTRZMM2W2^\@<R.34+HL>>#@+B[J1\(4[]FG#I=:
M](ZU[7EU[IQJUE8M<2]C'@-^TR:*3L/V5CI&O-M:\*Z?]8Y=E[%_P[>Z6_\
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MZ>"WFM<27 8&)_LT]H\N"CQ6F[7RR-M;FI!\H4.8BG955:1DA_GQB2,5)#B
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MA-/+^-;:53GX\S+VC-DS<Z+J^#S).J<&H!55E4! 0$! 0$! 0$! 0$! 0$!
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M6M[,ZOHRWE;<0QW -6RL:^G<X5"[)>CQL?4R(W.( /%2B]TJ@$! 0$! 0$!
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MV#=NU'9VBW,CW.EN+.V>7N))-8&.-2?2N[3L\+DF-G5M H.VG%69KD! 0$!
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M#B?">([E3:-9LQGZ?#Q<Q<^VK:5 Z"QCP? 75Y]BSNN#:9:^6PLY7.>:M X
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MM4JY*=N)[5(J&4&&!/$J$K?*HQP+JU"A,4#0,!@*4HB^&/Y+F.<72%X?2C2
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MJZ-GFX$GT]I7--NJ^^N8Z%\CX\" 0<3VKHFRG'I96)))YI(:#ZDNS?>9BV*
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M:<JX*/-I-%D]J]CFQM#G-=]8C!3FM)(PIK=S2YA=D=R!PJL]\KS:1B36C7M
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MO4;=T>O?]V?Q>"ZCU*VTW4GO<T9@2/:[SWKUO6V</]QZ_P"]_E&WT[JIM=K
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MJ<1\*+Q86&M:8]JA>1"][V/ I6O%$H+F-DS?$ ">Y18M+6IGM[FVK(PGR^(
MP%/4LZO$EO>PR-RO%)>0[?B4)JX@,.;M^!0KBJO )!<[$C *3%30EP]"&&6
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M2N#\_B!X&E.]$+'W4=6QL=61_LBA^52)HRYP\0H5"5Z @(" @(" @(" @("
M@(" @(" @H[@@Q[W^XS?J%!YOT6_X!=_[R[^6](BO4.02)50$! 0$! 0$! 0
M$! 0$! 01JE7 J4"H(B=P1>(R$7B%[:HLQI&XE12,9T3B252KQ$Z)[<6XD<
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MVLB./&O=/HVFW&L7\8:*LS8C"E">^O8O(YN;Q?J']J?B)MO.?D\=I\)\N[Z
MV[H5MI.FPD- F\MIY<<H[ %XG)R>5?;^YRW;::SI(DG,EW-08-&%/A7.[./7
M737LO:PO/N[1CVI*QWWPF]S9:MSS.S#C3C\RTBDSLY?<6_[#0X7AC0Q[< [*
M>SN(5LR.SA]+RN7C>Y.H-SKD[A$]SP":9:@8GO=W++?:?)[7%Z<GR<PZZUBY
M=XB7 _6J<.[$K@Y.1Z_'Z\GPBU^D2S^*6Y<P]F;\Q7'MR[?-T_;U^2L6EM@'
MA/F^G'Y@LIR[?-IKPSY,:XLR3C&&J\VM=$TD8<T&GQ-RW4IC)[/X"M)%+A@&
M/26@M;=-'/Q!U<?0U3FQ3SD1E]C&?#=L^!_\U7F]5MUOP4_><49JR]:#Z'_0
MM)R5G=-+\&7%N^6THYM^VO#^D]*M]ZQCR<&EG:-_I/52ZL'!SKUI:.5)3SKV
MK77FM<._JZ?*.ZT'KK:![67MX!$"*!K9:<Z\RNK7>5YO)Z>ORCOK#JMM75 &
MW4U8W"F;([F.\%:V:V=GF[^C9FQD2W^S;\ULM4;"?LEKQW\HUR_9>=C:+776
MG6[<C+V)T9P+BV3A_%"PO$TFUCE]5UG;<0=*Z^9YP-!1K_YBRO&M]ZH/WGH<
M-LX0:BP,E&9PRR<AC]3O7/MK95YR9ZH8=P:'*PVS-08 PU<<LG/_ ">Y5Q?F
MO-XH_4]%LK>69NH-+7'L?VC]$=J8J\VC#_?>D31QN.H@-)X4D[/U5/C:MY,F
M?5=$$69M\S,.!+7_ ,U/!:;,6VW!IEP_RY[V,TYY9/G">#2;-W;:KI,0PO8P
M*8'*_P#FI-%O*-C;ZQI09G.HQ_Q9/YJW\5/)B3:UI#Y2XZC'0?HR?S4\5YM$
M+]9T)^+K]I]#7_S4\5YM%EMJVA&=Q][::D9"6OQ_S5G6&?J<EL#5=&LNK+))
M;I@S0N .5Y'&']%=7!W9^S?I?3/^)]")_OC?4U_\U>M.SYW;NJ=T[?&#KQI!
MXT:_^:J1=;_BK;K,([UF8]K)/YJE#2[VWQ:;3VEJ.[BYLUO9Q9QY;78@N Q!
M+3S0?(NS=F=5/Q#7UUN;6M7;:;2D>?<XC-,U^0'*0UKO/;Q:[L04UK3>I'X9
MMU:3K=QJ(OMF75[;6\D9EED($LC6FK081]9W(H/I;</73:6U-J:/N;6)3%;Z
MS%YL3,CW<&Q.?0"M/VHXE$M?M3\0/3W=6BZKK4%TZVT?3Y&M?*Z-]2]SPW
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M+V ]H096U-UZ=O'1;?6M)<3:W?[%Y!;ZJ'$<$'2Q!P;XJ>D()$! 0$! 0$!
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M_JJG)O=6GA(W#>F^FMM!(VY+C7*02.%?U5IQ7RF:RVZ,\],])%LUWFXN[_\
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M<PS3![WFF7P^Q,SZR(?>0+I US?8?PJB&1$T,;E' (E>@(" @(" @(" @("
M@(" @(" @(*'@@Q[_P#NDOZI2#SOHK_P"[_WAW\MZ@>F*15 0$! 0$! 0$!
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MOU9H:Z6>82R$T8*ESI'DX-H@[;HCTMFZ6:5JD$\[Y3J%RZ9L;G^%H,T\GVG
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MK(ZA!#3SHI2X'HY5^@W0/$7+OY;U!7I80506O:'#%!&&N!\*E"CF,=[7M\U
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M:U4RZ-M6XB]T86N8?&1G=&<36M,316C%'+G=FGE/B_HVC\ROAMJKY4[V@N-
M>7Y%5JTVZJQQPL/WAQ]"A?:I9HVW+V01?L^+AWC'YD<=G5RO4*=C--\J0C,U
MP#1SH*K36=7H^IQ^5Z/%;3]FZC"XUPPJO+Y9U?0Z;>#.+9&1,#FY<U:5]*Y[
M77KS2NPV9IS9I2)6U&!!(!YE=_#/IKQO=MKK=5$EKECC;X1V>I4R\C6Y0ON0
MV!A^N>(5Y71-<J0W,9/B-%>53;1R75")E_M:^IXG01N,+N8.1W#X5,VZM[Q_
M[>7I/1[6AJNTK*-K\S[=KFR$U)QEDIQ'8%U:5\YSS&ST:H"U<R@(/ J!52"
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MB3+V@.+O:X+2N5=&UH)H:JFM5J170(" @(" @(" @(" :TPXH*"O-!5 0$!
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MF^;R]G>_J[ZS8&01,/&E5WZ/ F,1FZ75NJ,IW?*%Y_OZ]'VG]G=/<W_^R_\
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M6>V9(8P(<:NBD.)B/U^:);/IMT.ZE:7T>WKM?6M,-KJ^IP%MA!FBDS.\R!U
M6OIP:[FH'T)^'S:6M[)V%!INXH!#?M=*Y[7N:/"9I78T+AP(4H?,/XJMGZ;J
M/5#19ML7C':CJ]S%;:E!9/#R82+6-P?Y;^!:7<0@^T>GVV+?:&S-+T.WC'E0
M0QURC+CY;&G"KNSM0>?_ (E]M;;W5TYEL]<O'6$<4L;[.4->X>:R>%PS97LI
MBT<2H'RQNS<W6FUZ-W.W[J&&?08VNKJ[;^U;(Z,T_H6UD=CRS*4NRT+8^X]Y
M_A7LM&VW9R17^2X+[;B9 77;?K%GV@@W'7+HOOG6='VAJ&BV;M1&DR6S[O1"
MY@8\1!KG@E[R #D+3X#[2#CMX]/^K>^K3;^F:9L&+;MGI;F-G?!<6KQ)XH:D
MAK(?ZL\S[7PAZ'N_H]OC6-=Z9WEI:98=O6<5OJ0:8Z![+*.%WUQ]9IX50;_\
M373'=V^M+VU%MRUSG3#(+D-R.Q<VF(+FH-+UGZ3[SL]XZ#U)Z?6TEQJ4,K9+
M^TC>V(.(,CO$7/(Q\/U% XG5]J]=^J/470-?W+MF33-#TX-9=1"YAE;*!*UV
M<AC8L:5'LE2.SZC;=ZO:!OANM:#ICMS;/F@@AN=!GDAB@+66L,3F9IO-P)#_
M .C1#G>E'1/>NI]3G[[U'16[3TV%P>--@=$Z-_F-EPK$80<I(Q\OF@^U6_>$
MM<*=GH4B;RQ\5% O0$! 0$! 0$! 0$! 0$! 06O):TD<0@@OQ6TF'Z!0>>=&
M,= NJ\KA]/X[T'I1-*40JY 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0#P00O2D[
MK*E9M%KA4XJ4+:!!4!:+KS[)16O,>HS1_B[0O0/DG4,WJ%L!Y+!W'Y5*%3B"
M>Q%]48S97./%HJ$9_%X+U@O_ !2.!!+@6GCRH%;29KU?8OV_5NSQ30HS)<B4
M#@2/B7TO!KC5^ >]R>?-M?U=HUI#F#E2BVXN[GWF,,NRD;#=QS'B7 >JM?F6
M'NZYCZK^UN2:>U;\]<?SU?0NVKCS='MGL^J/G*^9W?J_-KCJS+B-KB7GV>)I
MVE<FR>&H*,H0T<%.K79#7&JFJ7J@E<QV#_B5*OJP9@X^SP6=;ZK&%XP*I6B_
M,>:J*$UX(@4I6N+@KH1NE(X\$2H)T0D9,".*9$[9&]JC(N\P'BF0,<;@<*E3
MD:Z>&X8[,W!G=_"B5C+K**/%?3BB\7^\YL&85[,$7BYK6%U'8HA#-829VR1&
MF/=]*"YWF!P#O$[M.*#96+!0.D)HCCY?W*W4C2<C **GD:L&8Y0 ?"&X88*M
MC:1K+AS<I##C6M2L[LUD:EQD,F/B5>Z\J60EOD!S>VO\95NK?79Q_4/69+#3
M&6T!,4MZXV[)&U:YIDHT$$<",RK)UC;X9=_T=V1%M;1&ZC>L,NI7P!FE?E<Y
M["*C,14GVCQ*]33CP^?]SG\KAZK'"QC"RE&$G(!R;R [ NJ/.SE,65=G#G<*
M9:^'X$0N#0&T(4@YC7"GR(+! SQ<:. %.6&""V.TABS9 ?$:\L*]B"]T#'MR
MNQ'%!8((XO$P8@4_/Z4%S(F%PD(J^E*GC1$*^2S#C05PY8HD="UP J13A1 =
M"QPI2G93"GH01-L[?S/,+<[QP+@#3XD%2)&N#1BWO08NHP>^V-S:N>877$3X
MHY68.!>TM!!'"E4'@VTOPU6FF;[GWGK^I7>IR9F26T5S*V:.,LJ<&OSD5\/"
MG!!] CPM!BH&-P#!AAP0<MU"V)I?4';\V@:@^2)LI:YAA+6N#FO:^M7 BOA0
M> 0_A+DFB9I%_N35Y](CDSFUDO,['"E,I:XEM.[*@^C-L[:T[9VB66A:/'E@
MLPYHP:TD/>YYS90T'%R#?-A;+%E>" :XUJ<4%T-K'"S(RN4]J"X0L%:5%>*"
MOEMH:85QP[4%I@8YM'8BM5*%I8UM W #LP4 ^".9F1XSMXY7^(? 42N%O&&A
MK1E I0-PI3LH@O;&&FN)/>@K1!5 0$! 0$! 0$! 0$! 0$!!9+^S*"&^_NDW
MZA0>>]%_^ 7?^\/_ );U"7I#N#5**O0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M \$$+TI%BS76NXJ11!<T*ZR]P\)4JUYAU&_YNT+T#Y)U"CT^V_9,]!^5$J_5
M<I(B>X^0X_H/^(*$:]X^7NJUT^1LSB>$KV_YX"VX?W1Z'Y6^/X_:_P /]7(;
M6MP;5LIQ))/Q!?4<4^E_/=^K>UTF0R/8!\7!3P]T[Z^6%11CX6'B'#YU7VNK
MUOP^_P!OFUQ_CJ]XZ?W39].=;GZC,/A<OD]^]?M_LSZ-;^CI+B!S6<?"Y<E<
MW!6&V,M#DU=6R \#Z5:LV%,PG%9UKJQ77 9@J5M%!('#,J5H5JJAFR8('F(+
MR<X6B$;X@!4HE9D8@H68^'@J4*."@4$I02LE=6G-3$)_-%*/%0KI6/MX)VYF
MBA/Y=B+QA26OE'!%U'DQMJ>* R:=HSU\)P1#+MY8IQB/$@S(L(RT=Z;=F.VN
M:Q<A\PD^E<LO4FK&O3F- MKV:R,'W-KZEYPY+ESU34L&GM:ZK15;Z1G:ONK0
MXO+?8!/P"JUNJVFSROJW"TV.C7-*".^B<[T"1A^98R?5/XNRW&M_@^@=KW3;
MW0K&=@'E>0QK1Z(PO:L?)<FV:W-NZK07CA@JIUG1E$]G!2K:N"A(@(" @M?[
M* S@B%R)$!!:"*D!!9-@TN<:,'$H(/*+@UM ]@.;'B@M#6,E\[)1IHT-Y=B"
M\QL:_.YQ!-<K>54%LDF2@+:2GZW>@5F&5I>TR5J1C4H)' F5IB%!]9!.VE31
M!<@(!P06X%2CNH7-:X-/-!3(X&H*A*0<$! 0$! 0$! 0$! 0$! 0$! 0$%DO
M[,H(;_\ NDWZA0>>=%O^ 7?^\/\ Y<B#TIW >E!<@(" @(" @(" @(" @("
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M! 062_LR@AO_ .Z3?J%!YYT6_P" W?\ O#OY<B@>E.X#TJ1<@(" @(" @("
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MW@%"U51 @(" @(" @(" @(" @(*4QJ@J@(" @(" @(" @(" @(" @(" @("
M@(" @(""R7]F4$-]_=)OU"@\]Z+?\!N_]X=_+>H'I+N ]*D7(" @(" @(" @
M(" @(" @(" @(" @(" >""-_ J;V1.Z)9-%KN*D6H,B/A\"TC-(>"A+RGJ/_
M ,VZ#Z!\DZ#TMG[*/T?.5.$?%=6A6>QMW>?]3;M\%G#;?UHD/P!OTJWP>OZ&
MN>KYP:[SM2+J5)>YOP$A?)^]R8KQ_P OR>'/_E':6S?+C%L1@1[7H'YEP:[3
M#YF9WWZ3O6HMI!<WDDY-?)>8J>@ _.OH_P ;Q2V/T;3A\/7O1W<UD+BUN#$S
M,^2-PRTJ>Q?6;Z:S5X?X_P!K_?Z_X[/%K,W&U-X/S!S(KV5C2"* 8L'/TKY[
M'5^C\V\Y..3]'UALK76ZGI<<9<#Y3(PTU&-0?H73KV?%^WZ_CMETDV7+55NS
MS];A@2&&2)S'.HXG!96Y=.NV&H? R"-S*9JJM:S=YYU,#FMT%HX&=G']=RSK
M?7=U5B2W3[9I'B+55K-LI709L:T19:&B/PYN] J.U!7!O-996PM,C7"E$R(W
M-!3)A&8(CB[VE:5:1:8HQP)4I7>2YOUJH \T>SQ3(O;<W$?*J&$C;R1V+ACS
M0PD%VZG#!!)%>1D8A;*)(YFR.HTY>]%*S7D>[FDF-$484,CO*<RN..*K5*K"
M"P.S8YL%42LMFM/M503Y&T1,2Q G +2%0W;#C^CB?@39?1QNY0/<[A[?ZJ0'
M^*N6NW1I_P /PD_>VL9O9H,OPR+T/7[/._(3#WJ/,,'+IV[O"C('L$J:OJO;
M[(1-51 @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(""R7]F4$-__ '2;]0H//.BW_ ;O_>'?RWJ!Z4[@/2I%R @(" @(" @(" @(
M" @(" @(" @(" @'@@B>4I.Z-9KK'<0@J&@A$I&DA/*LTI)RJTH\JZD?\W:%
MZ!\DZL/3H6@P,/.A^4J,]4?JLD!'I3:%[9>4]5[]CI+-M12-D]?26Q_0I_[:
M^@_'ZSPM_P ?%X1H['3:A*3B!(YS?\IQ7P_M_7R^-[/C_P GR7DYK:[AU602
M/YM;@N7[>LKB]2W[L<KMJ;S]1GA<:YG%U/TCE"^O_'ZS6='ZUOQR^O?X/6]L
M7(,L4L]"R4B( C"KC^9?2R>>K\PDG'S9CF.K.QY)ISJ=DRDE YA:!04C![1S
M"\;;7%?HGI>SKMI,LKI5J5]#-;Z?/7-'1KZ^AR(]ZZW7H]TD,>1@%?$VKL>=
M$NLKY63-:U[FM<YH'/B<52ZR-MM)&)+1QJX*MBVNL><]5&'-HN/LSQTIA]9Q
M6=C>:QT]G(_W"V%, P4-,56QMK,)#*:4=\2AI*B<&NQ%466%J+85<YRP2C+B
M$#.Y +W'L3)E3,>Y1Y5.5S9.]/*F:D#FNP^13*C-5JP*<IR4!-12BG)E>/+
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MU(B@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M 8+KE>9;FMBI2(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MNTX=_'X.MV!K+O/EM'OI$V@8TG#$G@/6O1]3>^75Y'Y#@F^MKUFQG\J2.>N
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M2,NM7&)SB""?*'$'FHE6[)/+8VA PKPHK+^2=%! 0$! 0$! 0$! 0$! 0$!
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M3J4=3Q\$G\Q%HL._=F5_XDS^))_,4;=EC_'>R_\ \FS^+)_,6)A0[[V8?_\
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MN[X2@^T,<?A:GV'+M[=K;P?AYV &CWVT\]_UB,GSL2<#&^S68SH!TNA-6Z8
M?_A_ZM=&$?U%;:SZ2;#L'!UMI[&FE,6L.'\51@_J*Z>TT+1[&,1VMLQK1PH
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MRMHU$8"#R%0@>+L07XJ4F/-0*H" @(" @(" @(" @(" @(" @(" @(" @("
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M)(W$U!-:<#VH+T! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MKHW!M!A1S&'CW(.ZS-K2HKZ4%4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M.! T<.Q'O$=/A<IU6M>P;)M<FE6[Z4:6@_$NOCCCYMLQU5!AW+=R*H" @("
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M$+OT !Z@NMP-BB1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[=7@V>6]RU6LPLNHOW6Z/-&[Q'CW_2OIOQFNNNMP]#VNG9IK/0M2VM<,U33
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MFW_?;2_=+*YUL\/8'N H6NJ. 71)AQ8S>KU&RMXK2)MO$:M8 !7N"EIC#)1
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(""AX*1"52H1NQX*%HM<!3O1>(G!15XA<UW851=&YIIB,5(@RDNQ&"@8]PP
M@8 T64[UKKU>=[S)>[R0>-*^IU5S>S>C7;;$<\(&R0MMQ@X?6]2\WCUSL\^3
MZLN:EU6VM]P103/88A'0DN J2ZO:OJO1X_H6]GDZO8-!M=-NK5@:T.9)A4FH
MQ-.U>C99'F6RUI=Q](=,G/[QTJ0F^!+LF9QQP. !/9V+GF_7JO=.CC+G_$VW
M'%KX91*S!C_+=EIPYMIP7H:R;:X<N;KMEAR=3-6L?#=UH..9C1\P4?9D7^]:
MLCZRZ>*BYDC:>]T8^5P4^&%;MEJI^J6@-)G>]A[\S/YZE7QRY?5NJ-CJ$S1:
M6P>7$-#F^*O <G%6WUQ,KS9[9TRBDNM&;JTT/E8-+0ZK2<Q=P!XKQ/9W>OZV
MF79OD:1),T 2<!4^I>+M>KVO'$;+;6GS7$QO9@6@'*!3#A7YUKQS+BY=L.W:
MQU#7$#A@NW6//V7$. =3$#@*+12 +\[<*,ICVJ%DBE @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""AX*1 6U5:A4,-
M%5,6%BAK%A:HJ\6.&"JLC+*\D2B=&5*&-="C">P+#XM.-YON./S;K-3"OSE<
M?L7HSY=NK675CY,[2WV7"I^-8^OKG9,G1Y7N7;UY=WLMY:DM,0#< 3RKV]Z^
MQ]3&NN'F<^=JZ786[[W23%!>ATC8W<#A]>O85U;ZRQPYLKW+3-PZ+>Y7LF#9
M" 2TN'$^M>9OKBN_3:6,W4(;"_C)D@;*S[7%6TVNO5.VDV<!KNR-(U'/2$,K
M^B3S](73KSUG>&/,]8Z3:5F<WA45J&GO_271KMEC=,.+DZ?:7;RF.0E[>RA_
MG+HDU8]698[6T5LT,$4(S![>7Z7I5?9N-5^+7-?06W;8:?HUO &4A#&@!?(<
M_)FOIO4TZ,QC#-<-C:/"2L)KEW<MQ'H&EVS+>V:Q@I7Q'TT 75QZXCQ>3?-;
M$"@72P54BBI.XJK@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MY.>NB@%&'O-5JX]4B+" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(""AX)1;X>Q4%IR\PB#P=B&44X:]N(X
M*]G1IQWJUDUOF)#<*KGNB^]8ES8G)E/LGB%T<>N%+>C%AVW;3OS^P>% >/Q%
M;[8CGTF5&[?=93YX'$<,0?S),-,,N.XO8:XF@4X,(+G5" 3*VGZ7/Y4P=FND
MU>V;Q>X? K0MC67NHV$[35Y.'$T6DK.M'J$6ELM6S>8:DXXCO[EI-V=CH-HZ
M;$8CJ)&8 5:3W$T^1<7-LZ>/5M+GS;F?RB/NW.'P KSY.KT=;T=7I\#8+,,:
M,OA&"Z9.CCY;FLR'V/6IC&)%*1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 06.>&H+FG,T'M050$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!1WLFB".A[%
M5"A:[L1!E<AA:]M M%].C&()=2BA.UZK)V5'&JM*B]EL0:T@D5IV*=]ODRXY
MTZLZK)&@</2L\UHL=:9VTJ%/D-=>:/F8XU![L5;3;JIOV:&\V\Z2M /C6_E&
M$FWR::?:DKZMS!@(YU^A4NT7DJQNT0^-L4CVN'.E?H5/)?#M;#38M-TUMFW"
MK>./.I^=9;]73K9%+>V<+AE/$T5X>A8ZZW+;SF&[BKDRD4]*W<^UE21@M:0>
MU1&<7J4B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @H0#Q0 *"B"
MJ @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(""A *"SRF5K12A1T#'*$J-MF-05,
M+>2(2C 41*CFAPH>"")UNQR""73HY,:_E\*"-FDQ-/'Y?I09+[8. '("GP(A
M6.U9&0X<0B4P%$%4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! * @('H0$! 0$! 0"@(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
-" @(" @(" @("#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2225088d1-pht_action4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-pht_action4c.jpg
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M1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4
M9,     !_]L A  $ P,# P,$ P,$!@0#! 8'!00$!0<(!@8'!@8("@@)"0D)
M" H*# P,# P*# P-#0P,$1$1$1$4%!04%!04%!04 00%!0@'" \*"@\4#@X.
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!3_P  1" 66!L,# 1$  A$! Q$!_\0 XP !  (" P$!
M  8'!0@#! D" 0$! 0$  P$!              $" P0%!@<0  $# P("! 4)
M$ X&" 0!#0 ! @,1! 4&!R$2,4$3"%%A<2(4@9&A,G*S=!4VL=%"4F*"LB-S
ME+0U=18W&,&2PC-3D],D--155A<)HM)#@\-48X0EA96U=CCPX41%Q*57\:/D
MQ>5&1V<99J01 0 ! P$$!@<'! $# P4! 0 !$0(#!"$Q405!81(R$Q1Q@9&A
M(E(SL<'1X4(5!O!R4S068H*R\9*BPN(C0V/2<__:  P# 0 "$0,1 #\ W^
M
M                                          !T/CS"<W)\96O/2O+V
M\=:>&G,!WP                            .O=W]C8(UU]=0VS7^T6:1L
M:+2B<.94KTH!R0SP7,:36\K)HEK22-R/:M."\4J@'(
M
M
M
M                   !2/>'[Q&'V1Q,-K;0LRFMLFQS\9C'.I'%&BJWTBXH
MO,D=4HUJ<7JBHBI150L0\ZM:;K[F[IY)SM2YR]R:W+Z08F!SF6C5<O!D5K%1
MGB]JKEZU50TZ\NT6Z\%IZ?-H74$=DC>=;AV)O6QHRB+S*Y8J(G'IZ .70N[F
MY&V=['<:3S]W8QPN3M,:][I;*1$7BV2WDJQ:\4KR\R=2HH'I9L!OAC-[M)/R
MC(6V&I<8YEOG<8QRN9'(]%5DL2K5>REH[EYN**CFK6E5,S"V@@
M   #'9_-V&FL%D]1Y5[H\7B+2?(7KV-5[FV]K&Z614:G%51K5X(!I3<=\?4^
MX>ZVC=*Z+M5T_HV]U#BK6[DF1LF1O+>6]B8]DBIS,B8]JT5D=5^KHM U1O.&
M7E!WCLKE(=\=<10WMQ'$S)/1K&2O:U$Y&="(H;AZ'=W&66;8[0\LSW22OQK%
M<]ZJYRKSOZ54,RM$(   %7=X?<7(;7;3YS56&5K<XWL;/%O>U'M9<74K8^T5
MJ\%Y&JYZ(M4541%2@6'E]B<5KS=_6,6-LENM2:ORKGN1UQ-SROY4=(]SY9G(
MUK6I555SD1 TW%[J/=_W1VQW(O\ -ZYQRX_#_%4T-HZ&\M[B*6\EFAHCF0R/
M7S8T?Q<U/$H29;FAD        TTW[[Y]SIK+9?0NVEARYK&7$^.R6?R#$5D-
MS;O6*1MM!Q1ZM<U4[27S>'M')10U$-GMJ\E?YG;#168RD[KK)Y# XN[O;F3B
M^6>>SBDD>ZG6YSE50REH                                 :O=X?O;
MP;69B^T'I+%^GZTM&1>F7EZBML;7TF%D[.5K51TS^1[5I5K4KTKQ:%B%E=VS
M56?UOLMIO5.J+QV0SN1?D7W=V]K6*Y69*ZC8B-8C6HC6-:UJ(G!$!*UP@
M
M
M                           ?CG-8U7O5&L:BJYRK1$1.E54"!9_=W2F&
M>Z"U>_*73>"MM:=DB^.5U$_:\QZ&+09+]L_#'6XYOB$'O-]\V]R_%^+M8&5X
M).Z2=:>5JQ'?MY99TS+'B2Z<>^.K6.57VMA(U5KRK%*E$\"*DOS:FYY;CXS_
M %ZCQ)9_%[[PN<UF:Q+F-^BFM)$?_P#JY$3[,Z]_+)_3=[5C(LG :LT_J:+M
M,/>LF>U*R6Z^9,SW3'46GCZ#S,N"_'WH<L3$LT<"@        #XFFBMH9+B=
MZ1P1-=)+([@UK&I557Q(B >.NZ>O+_<O7^=UG?N=_P!I7+ULX7+7L;./S+>)
M/<1HU%\*U7K#;T/[KNQF#VTT1C-17]E'-KS.6T=[?7\S$6:UBN6(]EK$JUY$
M8U423E]L^M5HC40S,K^"-7>\UW6Y-TK[':GV_AL<?JQ\SH<X^X<MM;W-NYJN
M;/(L;'JLK'(C:HVKD=Q]J@6)?7=O[L.L-EM47&ILQJ>SN8KVR?97N(L897Q2
M*Y[7L=VTJQT5BMX+V5:*J<*@F5I[Z[N?X*Z)CUA\3_'G:7T-AZ%Z3Z'3MV2/
MY^T[&;H[/HY>OI!"GM"]^+3FH[?4-_JC3BZ<QV"L$O8WQY!+^>\N'S,ACMH8
MEMK?SWJ^M>:B(BJM&HJH6BMV_P"8)JA,KVK]&6"X/F_HB74R7?)7^'Y596G_
M $(*-X[3,,_-^#/YF-,-&MFR]OXKN1C4LT6)))&RR<&IV?%'.Z. 9:K;B]_#
M2N$OI<9M[A7ZC6)58_+7<CK.S54ZXF<CI)&^-W9^*J!JBO\ &?Y@6LXKEKLQ
MI#&75I5.:.TGN+62G71\BSI_H@HVEV;[P>@]Z;:2+!2R6&H[:/M;W WO*VX8
MRJ(LD;FJK98T5:<S>*<.9K:H$F'#O_O7>[&X'%:BCTS^<./O[MUC<.]-]!]'
ME6-9(O\ Z>?FYT9)X*<O74$0P?=\[S%GOKD<WB7X#\WLAB8(;J&'TWT[TB&1
M[F2._H\'+V;NS3KKS]5.(F%C;K[AVFU>@,QKJ\M?3F8MD?96*2]@L\T\S(8X
MT?R2<M7/2J\BT2JT"-<-%=^ZTU5J[!Z9OM$?%5KF+ZWL'Y)<MVZ0+<R)&UZQ
MK91U1%<E?/3@&J-P@RTSU'W^[/#:@RN(Q^A?C*QQ]Y<6EMD/C=(?2(X)',;*
MD:64G*CT3FISK3PAJB2=YGO!7VBM&VVC<GI.N1U_IJZ9=K\8<OQ9-?0+;O91
M;5>V[)9%X_:^:G4$B&@NC-1?FAK#3VK/1O3/B')V>4]#Y^R[;T*X9/V?/ROY
M>;DY>;E6G@4-O27N_=Y?_'7,9C$_FO\ $'Q3;1W7;>G^G=IVDG)R\OHT'+3I
MK50Q,-$N\G^G777Y3?\ 8,#4-G=.]ZC1FSNR>A\!;6[M1:S3%QNEQ5O*D,-L
MU[G*U;F?E?RN5%JD;6N=3BO*BHJDHB-A_F!:P9?-?D]'XR?&<WG06T]Q!/RU
MZI']JVM/^C!1MWM%O#I/>;3;M0:8>^*:V>V#)XRYY4N;6=S>9$<C55',=QY'
MIP=1>A4<B$HL ( >>_>A[R_YZVNIMGOS7]!^)\Y+:_'7I_;=K\57,D7-Z/Z,
MSE[3EK3M5Y?&&HA1^R.ZG^#FNX=:_%/QUV5M/:^@^D>AU](:B<W:=E-T4Z.0
M++T7[OV^W^.N'S&6^(/B#XIN8[7L?3/3NT[2/GYN;L(.6G12BAF85SNYWV-)
MZ&S%UIK1N+75.5LGNAO+Y9_1\?%,Q:.8QS6/=,K514=RHUO@<H**B3O_ .X/
M;\SM+89;;F5>S1UTC^7J3G[54KX^7U M%S[.=\W2FXV;M-*ZHQ;M,9^_>V#'
MS)-Z38W$[UHV/GY&.C>Y>#4<BM5>'-6B*28;.A%,[T]Y70FS"IC+]),SJR6/
MM8L%9N:U[&N2K77$KJI$UW5P<Y4XHU4XA8AK->?Y@.N7W/-8:2Q,%GU13RW,
M\G3_  C71)T?4!:+1VL[\.D]796UP&N<4NE[V[>D,&3;.EQCED=P1)7.:QT*
M*O"J\S4^B<B<0E%T;V[JIL[H276R8GX[2.YM[5++TGT2OI"JG-VG93=%.CDX
M@AY1ZSU%^=^L-0ZL]&]#^/LG>93T/G[7L?3;A\_9\_*SFY>?EYN5*^! VW1V
M"[W/QI=:!V>_,[LN2VL<#\=?&?-7T.V;%VWH_HB>V[.O)VO"OME#,PW(R.1L
M,387.4RES'9XZSC=/=74[DCBBBC3F<][G41$1$XJ&6HVX7?STWB+V7';=X)^
M?;$Y6+E[Z1UG:N5%Z8HD:Z1[5\+UC7Q!JB#XK_,"UA%<H[-Z/QMU:52K+.>>
MUDIU^=)VZ?Z(*-J=GM^]";T64KM.3OM,Y:,22_P=ZC674355$YV\JJV2.JTY
MV+PX<R-540),)YJ?,_FYIO,ZA[#TGXIL;F_]&Y^S[3T6%TO)S\KN7FY:5Y5I
MX C5+1??MMM5:LP^G+W1+,19Y.ZCMKC*RYE'QVL3UHZ9S764:*UB><M7M\H:
MHP&M^_S=VNH+BST#IRUO-/6TBQQ9')OF;+=-;P61D4?)V35^AYE<M.*HB^:@
MHV;V0W.N]WM 6FMKK"NP?I,TUO';K,ERR5+9W9NEC?R,7E5Z/;1S:HK5Z>D)
M*Q@BN=[MU/\ !S0DVM?BGXZ[*Y@M?0?2/0Z^D.5.;M.RFZ*='(%A2VW_ 'XM
M.ZIGSK]4:;_-K%83%2Y5;IN02_EN)67%O;LMHH5MK>KY%G\U>?A3CPJY!17,
MG^8)J?XV66'1EA\1<R\MJ^ZF]+5E>%9T;R(M/^A"T;G_ )[8O'Z%M]>ZLIIW
M&KCX<ED(KMZ.=:]M&UZQ.5J><]%=R(C4JYW!$JH9:D:T[_R17TMKH#2K+BQC
M56QY',3.8Z6BTJEO!16HO566OA1 U1PZ2_S ;A;R*'7.D8TL'K2:\PTSNUC2
MO2D%Q5'\.KMF@HW'TAJ_3NN]/V>J-*WS,CA;YO-#/'5%14X.8]JT<Q[5X.:Y
M*HH996\O+3'VD]_?SQVMC:QNFN;F9R1Q1Q1HKG/>YRHB-1$JJJ!J'N'W\]/8
MC(2XS;S NST<+E8[,7TKK2U>K>%8HFL61[5^F>K/(&J(/C/\P+64=RUV9TAC
M+JSJG/'9SW%K+R]='2+.E?K04;5[-;[Z*WKQDUQIY\EGF;)$7(X2\Y4NH4=P
M21O*JI)&J\$>WZY&JM DPLF\O+3'VD]_?SQVMC:QNFN;F9R1Q1Q1HKG/>YRH
MB-1$JJJ$:>[A]_7"XO(38W;G ?'4,*JSXYR,CK:W>J=<4#&]HYJ_3/<Q?J0U
M1&-/_P"8%GF7;&ZJT?9SV+G4DDQEQ+!*QGA1L_:HY4\',VOA0%&X&VVYVD-U
M].1ZFT=>+<6:N[*YMI42.ZMID2JQ3QU7E=Y%5JIQ:JIQ#+H;S;F?X1;?W^NO
MBOXX]!EMXO0/2/1.?TF9L->U[*:G+S5]IQ"PI+;;ON:?UEE<C;ZHTZS2F$Q>
M.FR=SEGY%;[]YDBC;$V%MI$YSGK*B-Y55:\* H@6J_\ , R7QA)%HC25NW%L
M<J1W.8FD?-*WCYRQ6ZL2/R=H\+1.]HN^YIO6>8MM-Z[Q;=,Y"\>D5IDXIEFQ
M[Y7+1K).=K70U7@BJKF^%6@HV$W)UE_A[H3.ZU]"^,?B6V6Z]![7T?M>5R)R
M]IR2<O3T\BAEY1[O[A_XK;BYG7WQ;\4?&_HO_9_;^E=EZ+:0VO[[V<7-S=ES
M>T2E:>,-K^V&[W/Y@:3TMM7^9WQCZ/<OM?C;XS[#F^,;Z2;F[#T22G)V]*=I
MQIU5X$F'H+++%!$^:9[8X8VJ^21ZHUK6M2JJJKP1$0,M4=S._/HS3-[-B- X
MQVJKN%59)E'R^BXY'IP^U+RODF1%KQ1&-7I:YR!JBLK+_,"UO'<\^1TCBKBS
MKQBMYKBWEI]T>LJ?Z *-F=E^\IH+>=5QN/63#ZLC8LLV"O5:KWL:E7/MY6T;
M*U.O@UZ=*M1.(287*$:7?K^?]L?%/^'O_P!3Z+VWQS_TG)S<OH'JTJ&J.UNW
MWXXM,:FN].;<XBTS=MCGK!=9J]DD6WEG8JH]L#(E:KF-5*))ST=U)RT<X47%
MW=-[\COCIO)YJ_T^F%=B[EEDZ>*?M[>YF='VC^S1S6N8K&N9S-7F]LG'P$F%
MRA
M
M                      '2RV6L,'CYLGDYD@LX$YGO7I5>IK4ZU5>"(;LL
MNON[,;TF:-<=;;BY?5TS[=CG6>$:OVJR8M%>B=#I53VR^+H3V3Z;3Z2W%%=]
MW%U[KJH8=U@   .:UNKFRN([JSF?!<Q+S1S1.5CVJG6BIQ)=;%T4E5[;<;H_
M'DD6"U"YK,LOFVMVE&LN%^E<B<&O\%.#O$O3X&KT78^*S=]CFMOKO6D>2Y0
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M[5;98/:31UOHS 2RW%G!-<7#KJYY>WE?<2*^LG(C6JK6\K*HU.#>@,IJ
M
M
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ML/9W5OC78K,U;16W=U7)(ROBDENND)"*9_=QU_W8=+[8MGKD+;.7C;ME:O\
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MHX=%:;AB:C(H\78L8U.A&MMV(B!QL\
M
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M.T]^3++\'8'&S@
M
M                          .MD(77%A=0-]M+#(Q*)5:N:J=!JV:3$I+3
MH^T=0    $KVUNVV6N<-,Y:(^98./AN(W1)[+CJ:RVN&YNW>NW=I9$T%E.1*
MM5;=)%\#?2(_V:'A:'ZT>O['-?N:SGU#K        $GVZ54UMA%1:+Z0B</
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MI'$U&-2J\5HB!'8
M
M                             U S=FN.S.1L%;R^BW,T/+XHWJU/F'V6
M.[M6Q/&'4G>Z!R(   '-:W,MG=07D"TFMY&2QKX',<CD]E"716*2K9_43(]6
MZ"O'V2<[;^R])MF)Q57M:DS&^7F:B'RN*?"S17HEV9VPU:/JW5        )]
ML]C'W^M+>YY:PX^*6XD7JJK>R:GKOKZAY^OO[.*8XN2R-J_-29=F!P.0R[U1
M%M87/CKT+*J<L;?5<J(?/8<?;OBWBYYFD-1G.<]RN<M7.6JJO2JJ?8NH_
M !GM%6:Y#5N%M:51UW"]Z4KYD;D>[V&J=?47=G'=/4U;O;8'R+M
M
M      J7O)Z%U)N/M)EM)Z3MF7>;NY[.2""25D#5;!<LD?Y\BM:E&M7K"PUS
M[MG=LW;VXW;Q.K-68F"TPEI!>1SSQWEM.Y'3VSXV>9&]SEJYR=069;S!D
M
M
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MXRY,<;6PY\X[
M
M
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MV4EYF=2]A!5C/])7KY#YWF.3M9.S\KL8XV++/+<@
M
M
M
M                        !C\[B8,[A[W$7/[U=Q.CYJ5Y7+Q:ZGA:Y$<A
MR8LDV71='0DQ6&I-]9W&.O+BPNV\ES;2.AE;X'L56K\P^PMNBZ(F.EU77-(
M   #*:?U#E-,Y&/)XJ;LYV^:]B\8Y&+TL>WK1?\ ]'$XLN*W);2YJ)HV!TUK
MK3&O;)<7?QQ1WTK>6?&75'-D7PQ*[@_[)/!UGSN;39,$]J-W&'/%T2P.?V/Q
M5V]T^G[Q]@]5KZ-,BS0^1KJH]OJ\QV,7,KHV715F<?!![W9O6]JY4@@@O6IT
M.@G8VO\ '=F=ZWF&*=\S#'8EU6[3:^<Y$7%(U%^B6YMJ)ZTJJ;\]A^;W2G8E
MG<7L=J"X<CLK>V]C#UMCYKB7UDY6_P"D=>_F5D=V)EJ,<K.TQMQIG2SFW-M
MMUD6]%[<T>]J_4)1&M\J)7QGEYM7DR[)V1P<D6Q#I:TW/PVF&26EFYN0S:5:
MELQ:QQ.\,KDZ*?2IQ\G2;T^CNR;9V6EU\0U[S&9R6?R$N3RLZSW<O2Y>"-:G
M0UJ)P1$\"'T>/';9;2W<Z\S5T#D0    '?PN*N<YE;3$6:5N+N1L;5ZFHO%S
ME\34JY3CR7Q9;-T]"Q%6VV/L;?&6-MCK1O);6L;(8F_4L1$2OCX'Q]UTW3,S
MTNU#LF5
M
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M/>RTMVK6*U95(F>IUKXUXFF6'*   !V+.]N\?<-NK&9\%PSVLC%HOD7PIXE
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M(WBBH95S     !7.YFI'P-;I^S?1TK4?>N3IY%]JSU>E?%3PEA)5<:0
M !--O-2/Q>2;BKA__9]\Y&MKT,F7@U4]U[5?4))"<:\U&[!8I(K5W+D+VL<*
MITL8B>>_U*T3QJ2%E2BJJJJJM57I4TC\      !FM+Z@FT[E([MJJMJ]49=Q
M)]%&J\5IX4Z4(+FSN=M\/A9<NBI(U6)Z*B+PD?(GF4\76OB,M*&N[NXOKF6\
MNGK)<3.5\CUZU4VRX       =K'9"ZQ=[#?V;^2X@=S-7J7PHOA14X*!?-AG
M;*]PC,[S=G:]DLLU>/(K$7G:OC145##2D-09NYS^3ER%PJHUR\L$75'&GM6I
M^SXS3+%E      /ICWQO;)&Y6R,5'-<BT5%3BBHH%YZ,U#^<.(;+,J>GVZ]E
M=(G6Y$X/I]4GLU,RJM==ZD?F\J^V@?7&V;ECA:G0]Z<'/\=>A/%Y2PDHH4
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MCV:HY7T\56,]<@P)0        SVF<[+A/C+D?R^E6DD;.-*3?0.\J54@P)0
M       S.E+]V.U%CKE%HU9FQ2<:)R2^8ZOD1:D$EW4OW2Y6TQZ+]KMH>T5/
MJY5^<U!"R@)4        ,]\>R?FBF!YN/I?:4K_L>7FY:>#G\X@P)0
M  SV!SLF*QN:LVO5OIMNC(DK]'SHQ:>/D>Y?4(,"4 .G?X^.]9Q\V9OM'_L+
MXCMZ;4SBGJ9NMJC,\$MM(L4S>5Z>LJ>%#Z3'DMOBMK@F*.(Y$
M   <UM:S7<B1PMJO6O4B>%5.++EMQQ6Y8BJ6QXVUQDDUO;/[9K7N;Z0J461&
MK1'4XT1>E$/FL^HNRS6=SGB*.0ZS0       !G]3YV3-KC>=ZN]&M(XY*K6L
MR^W=Y5X$& *        &=O,Y)<Z8Q^%5RKZ-<3.<B_2(C5C]E[T(,$4
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M9J2V174@NU]&E2O!>T]KZSJ$DABL]DWYC+W>1>M6S2+V:+U1MX,3U&H@&.*
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ML6:['-;4F*H[>XJXM%5[4[2#Z=.E/*G4?08-79DV;I<,VT= [K
M  ,C98B>YH^2L4/A7VRIXD.AGUMN/9&V6XMJD,%O#;1I'"WE;U^%5\*J?/Y,
MMV2:W2YHBCGD8^)[HY$Y9&*K7-7I146BH<:OD        !]/8]E.=*<R(YM>
MM%Z% ^0        'TL;TC;*J?:W*K6N\*M1%5/4YD ^0        'VD;W,=(
MU*L91'+X.;H^8!\         /N.-\KE;&G,Y&N<J)]*QJN5?41 /@
M !V<?$^:_M88_P!\DFC8RG3S.<B(0==45JJUR45."IXT*/P        !]21O
MB>Z.1O*]O!44#Y         ?;HWL:QSDHV1O,Q?"B.5M?710/@        !9
MNTK'(S+R*GFN6W:B^-O:JOS3,K#$[I.>NHH6NX-;:1\GC17R+7URP2A!4
M     /I'N1BL1?,<J.5.JK:HGS5 ^0        'TU[F\R-6G,G*ZG6@'R
M      ^F/=&]KV+RO:J.:J=**G% /D          ^GO<]RO>M7+Q55 ^0
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M2D+[=]E"]>CM9415<GN:)ZY)6$*GAEMII+>=JLFB<K)&+THYJT5/7*CC
M    E&@,6[):CMI%2L%E_.95\;/:)Y>:A)(27=7%/<EEF8TJUB+;3KX$55>Q
M?75Q(659&D        )Y^:TO^'GIO(OIG:_&'+3SNPY>2GDY?MA%0,J
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M+<N1>E&.1$9_HIS>J9E81O=>P<D^/R;4JQS'6TCO K5YVIZM7""5;FD
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M)UN7]CH,M,F  KW5FWEI.R;)XA[+21C7236[^$*HU*JK53VJ^+H\A:I151I
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M\WR#$I'=L2JT\#TX<R%JBE\QBYL+D9\;</9)- J(YT:JK5YD1R=*)U*5'1*
M  !;.F=M[>Q<R]SBMN;IM',M6\86+]57VR^+H\IFJT3XB@&,SF QVH+3T7(1
MU5*K%,WA)&Y>MJ_L= %+ZHTU-IF]9:R3LGCF:LD+VU:[D1:><U>A?54TRP90
M   +"TKMTM[%;Y3,R(EG*ULT-K&OG/8]$<G.Y.A%1>A./D,U6BT8((;:%D%O
M&V*"-$;'&Q$:UJ)U(B$5R =>^L+/)6LEG?0MGMI$HYCOFHO2BIU*@%/:RT8F
MFT9>6UQVMA/)V<;'_OK'*BNHM$HJ43IX>0U$LHB4   "7:3T-<:A8E]<3);X
MQ'*U5;YTKU;THU.A/*OK$J46]C<998FT998^%(;=G0B=*KUJY>E57PJ9:=L#
MYDCCE8Z*5J/B>BM>QR(K5:O!45%Z44"KM9Z!ML?;3YG%2)%:Q>=-:257EJJ)
M]K=QZUZ%]<L2E%=FD   #.Z8TM>:GN)([>1D-O;\GI$S^*M1]:4:G%57E4@N
M3 Z=QNG;7T>Q961].VN'\9)%3PKU)X$0RTRP ""ZJV]M,DLF1Q3FVEXM7RQ.
M_>9%Z57A[5?)P^:6J45$:0   ,CA,-=9[(,QUFK&RO17*^151J-;Q5>"*I!<
MNFM(8W3<?/$G;W[TI)=O3SJ>!B?0I_\ "D5(2* 1C5&BL?J)%N&KZ+DT2C;A
MJ51]$X)(G7Y>GYA:I13&0LI<;?7%A.K736SW1/<Q55JJU:+2J(5'6*  #FM+
M:6]NH+.!$6:XD9#&BK1.:1R-2J^50+?TMH&RPCF7M^K;O)MXM6GVJ)?J47I7
MZI?4,U6B9$4 P>HM+8S4<*-NF]G=L2D-VQ$YV^)?IF^)?8 IG4&"N=/9!<?=
M/9([E21DD=:*QRJB*J+T+PZ#3+%%    M'2NW4#&PY+-N;.YR-DBLV\8T14J
MBO7Z+W/1Y3-5HL5$1J(B)1$X(B=%"*_0.AE\-C\Y:.L\C$DD2\6.3@]COIFN
MZE IO5FD9],2QN[=L]G<*Y('>UD3EHJHY.CKZ4-,HV4   "<Z/T$F:MXLMD9
MN7'/5W9P1K]LDY'*U:K]"E4\OD),K1;-M;6]G!':VL;8;>)$;'&Q*(B(95R@
M (QJW1UKJ2))HU2#*1I2*>G!R?2OITIX%ZBU13N4P^1PURMKD8'0R?0JO%CT
M\+7="H5'1*   !DL-@<IG;CT?'0*^B_;)E\V)B>%SNA/)TD%RZ7TI9::ME1B
M]M?RHB7%RJ4KU\K4ZF_-(J0$5B=0:>L-162VEXG+(VJP7#4\^-WA3PHO6G6!
M3&>TOE=/3*V\BYK95I%=1HJQ.\''J7Q*:984H   '9L;"]R5PVUL('W%P[H8
MQ*\/"J]")XU MO1^AH<$K<AD%;/E:+R(WC'"BI]#X7>%WK&9E:)F175R&/M,
MI:26-]&DMO*E'-7I1>I47J5.I0*;U-H?)8%[[B!'7>+K5L[4JYB>"1$Z/+T&
MJLT18H   'W%%+/(V&!CI)7K1D;$5SE5>I$3BH%EZ1V[=$^/):@8G,VCX;'I
M1%Z463J^M]?P&9E:+)(KYDCCFC=%*U'Q/16O8Y*M5J\%144"J-5[>7-D^2_P
M;%N+%:N?:IQEBZ_-ZW-]GR])JJ40)45JJBI14X*B]-2H_    !.-*[>WF2>R
M]S+'6N.3SDA6K9I?4Z6M\:\?!X256BVX((;:&.WMV)'!$U&1QM2B-:G!$0RK
MD KS6&WWILDF4P34;<N\Z>SX-:]>MS%Z$5>M.A2Q*45?/!-;2N@N(W13,6CX
MWHK7(OC132.,    2736B\IJ![9E:MKC:^?=/3VR>"-%]MY>@E1<N*Q5EAK*
M.PL(^S@9QX\7.<O2YR]:J9:=T"(ZPT3!J!JWMFK8,LU*<R^TE:G0CZ="IU.]
M3R6)2BH,ACK[%W+K3(0.@G;]"].E/"B]"IXT*CJE    S6!TOE=0S(VSBY;9
M%I+=2(J1-\/'K7Q(07/I_3UAIVR2TLTYI'>=/<.3SY'>%?$G4G49:98
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M?W9/F*21=N:_$V1^#3>]N,M-=C;+(8&X]%S>.N56B1W,+G>Y1Z5]@@V',M
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MGKCTK XV>M5?;1<R_5(Q$=[)AID@  "D]Q?E7=>XA][::AF44*-A-.?)[$_
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MM)*N1S)%8M%3E5*\43@O BJ#-LI;MQ<=CJF".M$N(Y8E]1BO_<DDA=1EH
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M+D5>9C55]45.A>*B"51&D3K:RX[/.W-NO1-;.5/=,>U4]A5)*PMTRH
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MK&ZI^]7"QU^Z,5?W!\W#GE4YI%N;5S*_"7<"_P"RN5<B^)[&\/70S*PG9%
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M-;[J!;:YFMG>VAD=&OE8JI^P;99/24KX=2XM[$556X8Q43CP>O*OL*07\9:
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M2B+QZ.!:I1BDVGQU>.0FI[A@J43RTMHK*T@LX*]C;QLACJM5Y8VHU*KY$(K
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M+SR4DD:U7>&C7(A:I1V[+36 Q[VRVF.@CF8M62\B.>U?"CG55"*RH
M&%RVE,%F[EEWDK;M9V-1G,U[V5:BU1%Y52O2!^6^D-,VM%BQD"JG0LC>U7A]
MT5PJ,VB(B(B)1$Z$        QF8P&*ST<<63@[5(55T2HYS'-5W!>+53IH!T
M[?16EK:G9XR)RI_"JZ7WQ7%JE&<BABMXVPP1MBA8E&1L1&M:G@1$X(17V
M    !'KG0^F;R\EO[BRYYYG+))]LD:U7N6JK1KD3BI:E'=LM.8+'2-EL\?!%
M,SBR7D1ST7Q.=54(,H       !A,KI+ YJ[2]R%KVEPC48KFO>SF:WHKRJE0
M/VVTEIJT5%AQD%6\461O:JBIXW\P&:        Q>9T]B<^V)N3@[7L%58G(Y
MS')S4JE6JG31 .K;Z+TM:T[/&1.I_"\TOOBN+49N**.&-L4+&QQ,1&L8Q$:U
MJ)T(B)P1"#4C4GRBR_PVY]]<?8X>Y;Z(=2=[%G*@   6#LU\MHO@T_S$/.YA
M]+UN2S>V!RF+L<Q:.L<A%VMNY4=RU5JHYO0J*E%13YIV&)M]#:5MJ*S',>J=
M<KGR5]1SE0M4HSEK9VEC"EO901V\"+5(XFHQM5Z5HU$XD5S       XKFW@N
M[>6UN6));S-6.5B]"M<E%3@!'X- Z4@6J6"2.\,DDC_85U/8+5*,U8XO&XQK
MFX^TBMD?3G6)C6JZG1542J^J17;        C:Z"TJZ=\[K#F<]5<K>TD1B*O
M%:-1R(6J492QP6&QKTEL;&""9$5$E8Q.>B]*<W3[)%9        ##7FE-/9"
M\=?WE@R6[?3G>JO1'42B5:CD15]0#LVN#PMBYK[3'V\,C>+9&1,1Z+[JE0,@
M       !B\IIW"YJ6.;)VC9Y8DY6/57-7EZ:+RJE4X]8"WTUI^U_><9;-5.A
MRQ-<[UW(J@91$1$HG0       !T<GB,;F8&VV3MVW$+'<[455:J.3A5%:J*!
MU;?2FF[:G98NWJG0KV)(OKOJ!EHXXX6-BB8V.-J4:QJ(UJ)XD0#Z      !P
M7EG:Y"VDL[R))K:9.62-W0J5K["I4#%6^CM,6U.SQ<#J?PJ+-[XKA49>WM;:
MTC[*UAC@BK7DB:C&U\C40#E      !^.:U[7,>B.8Y%1S5XHJ+THH&"BT5I:
M%RN9C(E55JO.KI$X^)[E0M1E;7'V%BBI96L-LCNE(8VQU\O*B$'9
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MGE5Z4+5*)1IO1..TW<OO(9I;BZ>Q8N:3E1K6JJ*M$1.E:)UBI1)B*
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MG-ZZFJ,U=K1^I,P_4MDR[OYYX+AZPR1S2.>U>=%1.#EHE'4I02+G,M
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M1R)P<O!>'06B58^QW1EN\E;6TF/9%:SR-B<[M5<YJ/=2M>5$X5%"JR"*
M       #BNH$N;::V=[6:-T:^1Z*G[(&MRHK55KDHJ<%3QH;92#0]QZ-JK&O
MKP>]T2^/M&.9\U220O8RTK;<#56:Q67BL,;<>C0I"V1ZM:USG.>YR<5<B\$1
M"PDHE^?.J_[2?^TC_P!4M$JN+3E]/DL'8WUTJ.N)HD=(Y$HBNZ%6B>&AEIE
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MW;4=^R8:1O<#-Y#"8F&7&R)#//,D;I:(Y4;RN<M$<BI5:%A)5K^?.J_[2?\
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MQD:-3Q)YJ\$-49JRVE=9:BN\_96EW>+/;7#^SDC>QG0J+Q16M145!15NF5
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MJUHC(T1/)YIJC-67TKK+45WG[*TO+Q9[:X?V<D;V,I147BBM1%14%%6Z94
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M_P"+\C]V9]@9E86$16HNI/E%E_AMS[ZX^QP]RWT0ZD[V+.5    D&D_Z7>_
MY/LV'GZ_Z7K;LWLN?..=.=J_E#<_ I/?8B2L+>,J  (ON%;]OI2\<GMH712I
MZDC47V%4L)*D#2+$VGN.6]R5K7]\BCEI]S<K?W9F5A9US_1YO<.^8I%:VFV6
M<T=\J,7]V3YBDD7V9:  '2S%OZ7B;^UI59K>6-/*YBH@&NIME*=O+CL-5VC:
MT;,V6)?XM7)[+4))"[C+2@-5?*3*_"9?LE-,L.4;+F&@   K?=FWK%B[I/H7
M2Q.^N1KD^Q4L)*L#2+DVQN.VTTL5>-O<21T\2HU_[HS*P[.XOR4NO=P^^-$$
MJ2-(G.U?RAN?@4GOL1)6%O&5  $1W)M^VTM-)_R\L4OKN[/]V6$E2QI%E;37
M%),I:JO2D,K4\BN:OS4,RL)_FOQ-D?@TWO;B*UV-LLYH[Y48O[LGS%)(OLRT
M  ,;J&W]*P62MZ55]M+R^Z1BJGL@:]&V4OVVN.QU1%'6GI$,L7EHWM/W!)(7
M09::[9K\<Y'X3-[XXTRZ)1LN8:   #7'(V_HF0N[6E.PFDBI[ARM_8-LNUIV
MX]%SV-G5:-9<Q<R_4J]$=["D&PAEI2>XORKNO<0^]M-0S**%%]Z-^2^+^XI\
MU3,M,X0  %&:]M_1]5WZ)[6162I]?&U5]FIJ&91LHV/L+CTNQM;JM>WACEK[
MMJ._9,-*WW9_I&+]Q-\UA825<&D71MK\EX_NTOS4,RL)>10 !5&ZUORY6QNJ
M?OMNL=?N;U7]V:A)5^5%Z:#N/2-*8]RKYT;7Q+XNSD<U/8H9E88[<_Y-L^$Q
M_8O$$J<-(LS:3_[Q_P!6_P"*9E86610   JG=>WY<EC[JG[Y Z*OW-_-^[-0
MDJ^*B\M W'I&E+#C5T7:1.\7+(ZGL4,RL.+<7Y*77NX??&B"5)&D6%M/^,<A
M]Q9]F25A:IE0 !!-U+?M,':W")QAN41?<O8[]E$+"2J,TBU]J+CFQ=_:U_>I
MVR4^Z,1/W!F5A,LU^)LC\&F][<16NQME)MO_ )78[_?>\2$DA>)EH  1_6]O
MZ3I7),I56QI*G^Z>U_[!8%$&F4\VKN.3-7=NO1+;*Y/+&]O[#E)*PMLRK7;-
M?CG(_"9O?'&F7'COQA:?=H_LT*-C3#0  XKJ!+FUFMG=$T;HU\CT5/V0-;E1
M6JK7)14X*GC0VRD&A[CT;56-?6B/D=$OC[5CF?-4DD+V,M*)US\J\E[MGO;3
M4,RCQ1L)ISY/8GX%;^]-,-,F   :_P"J;?T74>4BI1/29'HGBD=SI["FF6.M
M)UMKN"Y3IAD9(GUCD7]@HV014<B*BU1>**G10PTJ?=;\<V7P;_B.-0DH"5%T
M;:_)>/[M+\U#,K"7D4  4UN;;]CJ7M:?TBWCDKXTYF?N34,RAI1L#I>X]*T[
MBYJU5;:-KE^J8U&K[*&&D8W6_$UE\)_X;BPDJE-(LS:3_P"\?]6_XIF5A99%
M        *-U];^CZKOT1*-D6.5OCYXVJOLU-0S*-%&Q^/N/2["UNNGMX8Y:^
M[:COV3#2I-S_ )2,^#1_9/-0DH65%]Z-^2^+^XI\U3,M,X0  %4;KV_+E+"Z
M_A;=8_XMZK^[-0DJ_*B]-!W'I&E,>Y?;1M?$OUDCD3V*&96$;W9_H^+]W-\Q
M@@E5YI%O;5_)ZY^&R>]1&96$Y(H  @>ZMOSX6TN43SHKE&_6R,=7V6H6$E4A
MI%L;4W'/B;ZV5?WJX21/)(Q$_<&96&5W%^2EU[N'WQH@E21I%A;3_C'(?<6?
M9DE86J94  1[7-OZ3I7(L1.+&-E3Q=F]KU]A"PDJ)-(GNU5QR9B\ME6B2VW/
MY5C>U/F.4DK"S,U^)LC\&F][<95KL;92;;_Y78[_ 'WO$A)(7B9:  '#=P)=
M6D]LO1-&^-?KVJG[(&MZHJ*J*E%3I0VRD.A;CT;56.>JT:][HE_WC'-3V50D
MD+U,M-;;G^D3>[=\U3;+EQWXPM/NT?V: ;&F&@   U_U3;^BZCRD5*)Z3(]$
M\4CN=/84TRQUI.MM=P7*=,,C)$^L<B_L%&R"*CD146J+Q14Z*&&E%:Y^5>2]
MVSWMIJ&91XHV$TY\GL3\"M_>FF&F3   *:W-M^QU+VM/Z1;QR5\G,S]R:AF4
M-*-@=,7'I.G<7-TJMM$UR^-C4:OLH8:5YNM^.;+X-_Q'&H24!*BZ-M?DO']V
ME^:AF5A+R*  *UW9M_-Q=TB="S1.7R\CF_,4L)*LC2+GVSN.VTPV.O\ 1YY8
MO7I)^[,RL.ENM^)K+X3_ ,-P@E4II%J[3_B_(_=F?8&96%A$5J+J3Y19?X;<
M^^N/L</<M]$.I.]BSE0   )!I/\ I=[\#D^S8>?K_I>MNS>RY\XYTYVK^4-S
M\"D]]B)*PMXRH  Q>H[?TK 9.!$JYUM+RI]4UBJGLH!KX;92_;6X['5$<=?Z
M1#+%ZR))^X))"X[G^CS>X=\Q3+36TVRSFCOE1B_NR?,4DB^S+0   :X7UOZ+
M>W-K2G82OBI[ARM_8-LN[IJ?T;4&,F7@C;F)'+]2YZ-7V%(-@C+2@-5?*3*_
M"9?LE-,L.4;+F&@   A>Y]OVVG&RHG&WN(WJOB<CF?-<A825.&D6AM-<5@R=
MJJ^T?%*B>[1S5^Q0S*PSNXOR4NO=P^^-$$J2-(G.U?RAN?@4GOL1)6%O&5
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MQZ-J?%R5IS3MB_C?M?[HDB][G^CS>X=\Q3+36TVRSFCOE1B_NR?,4DB^S+0
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MNNE:C*="MC8JK7Q\QF5AB]V?Z1B_<3?-8()5P:1=&VOR7C^[2_-0S*PEY%
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M$HV48JN8USDY7*B*K? J]1AIKOFOQSD?A,WOCC3+CQWXPM/NT?V:%&QIAH
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M.Y>FW5%Y55?J:*GDH9E85OJ7-RY_+SWSU7L*]G;,7Z&%J^:GE7I7QJ5&'*
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MBH[UR#'E        #(1926+#W.)15[.XGBF7P?:VO14]55;ZQ!CR@
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M*^TEO43[3%)'$]?JI4>YOV"@<         #GMK66Z[7LDKV,;IG^X92OS0.
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M:L<J5]@#K@        +*U/82,VZPZJGGVZP2/\396.X+ZKFF55J:0
M [-E937TKX84JYD4LR]?FPQND7U^6@'6         <MM ^YN(;:/V\SVQMZ^
M+U1$^:!^3POMYY+>1*21/<QZ>-JT4#C         =F]LY;"9()DH]8XI?!PF
MC;(GK(X#K         .S-9RP6MK=O3[5=(]8U^YNY5 ZP        #LLLY7V
M,M^B?:898X7+]5*U[D^P ZP        "5[=0.EU7:R-Z(&32.\BQN9\UR$DA
M,MU&O7!6KT7S&W;>9/&L<E%)"RJ(T@       !]-8YW,K4KRIS.IU(!\@
M     /IC'2/:QB<SW*C6HG2JKP0#Y          /I[',<K'I1R<%10/D
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M<KU)"Q:N]?VJ>-2"4[H85T-[#G(6UAN$2&X5$]K*Q/-5?*U*>H(65>E0
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M3$7.*HC&31+''X&N;Q8OJ*B&6FOMS;S6EQ+:W#%CGA<L<C%Z4<U:*AMEQ
M     67MA@E<RZS5U'6*5JVUNCNAS57[8M/!P1OKF96$(U#AY<'E[G'2(O(Q
MRN@>OT43N+'>MT^,J,64       3#;K"OR6<9?/;_-,?]M<Y>A95_>T\M?.]
M0DD/G</"OQF=DO&-I:9!5F8[J27_ &B>6OG>J()1$H       RNG,/+G<O;8
M]B+V;G(ZX<GT,+5JY?6X)XR":[H8-6^C9NV9]J:U+:Y1J<&T_>U]E6^L2%E6
MII       '+;6TUY<16MLQ9)YG)'&Q.E7.6B 6IJW2:-TA:06C>>XP[.?S4]
MLQR?;E3RKY_J&55,:0        MS%Z.>NAIL9,SER-ZBW5'<%;*E%C:JKT<$
M1%\JF:JJ61CXGNCD:K)&*K7M7@J.1:*BH:1\@       6MM=A7VUG<9J=O*Z
M[^U6U>GLF+5R^1SOF&96$CUEBWY;3MY;1)S3L:D\*=:NB7FHGC5*H(50QID
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M/H?7\!F96%FD53^N=&R8F>3*XV/FQ4KN:1C4_>'+TI1/H%ZEZNCP&HEF4(*
M     3?0NC9,K/'E<E&K<7$O-&QR4[=Z='#Z1.M>OH\))E87 9566O\ 1DBR
M29[$Q*]'5=?6[$JJ+UR-1.I?HO7\)8E)5J:0     "0Z5TK=ZDO$1$='C8E3
MTFYI1*?2M5>ER^P07C:VT%G;Q6ELQ([>%J,C8G0C6\$,M(EKK2"YV!,ACVI\
M:P-HK.CMHTX\OND^A]8L)*G)(Y(GNBE:K)6*K7L<BHY')P5%1>A4-(^0
M R&&PU_G;UEE81JYZ\9)%]I&WK<Y>I""]L'AK3 XZ+'6B5:SSI)%]L^1>ER^
M7YAEIT]5:;@U)CEMW*C+R*K[29?H7TZ%^I=UE%'7]A=XRZDLKZ)T-S$M',=\
MU/"B]2H:9=8     .:UM+F^N([2TB=-<2KRQQL2JJH%W:/TO%INPI)1^2N*.
MNI4XHE.AC?$GLJ9E69R./M<I936%XSGMYV\KTZT\"HO4J+Q0BJ,U)IJ^TY>+
M#<-5]J]5]&ND3S'M\'B<G6AIEA2@    /N..2:1L43%?*]4:QC4JY57@B(B
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MVJ(J*BI5%Z4(JGM;Z+EQ$TF4QD:OQ,B\SV-2JP.7J7ZBO0O5T>742S*$E
M   +!T)HJ6YFBS66B5EG&J/M('],CDZ'.3Z5.KP^3IDRL0M8RJNM>Z*DNWOS
MF(CYKA>-Y;,3B_ZMJ>'Z9.OIZ2Q*2JTT@     $HTAI"ZU#<MGG:Z+$1N^W3
M="O5/H&>%?"O429%V0PQ6\3((6)'#$U&1L;P1K6I1$3R(9:?8%-Z]TI)A[U^
M3LHZXJY=S+RIPAD=TM7P-5?:^L:AF4,*      =W%8N\S%]%C[)G/-*O3]"U
MO6YR]2(07UA,1;8/&P8VVXLB3SY%2BO>O%SE\JF6E?;C:4D9,_4./8KH9.-]
M&U.+7)P[2G@7Z+Q\>LL)*N32      <D,,MQ*R"!BR32.1D;&I57.5:(B 7C
MH[33=.8SLY:+D+BC[IZ<41>IB+X&_-J9E6,W TJ_,VK<E8,YLE:M5'1ITRQ=
M-$^J;TI_^@02IY45%5%2BITH:1^       MS;S2C\9 N9R#.6^N64@B=TQQ.
MXU7P.=[">J9E89[5FG8]1XMULE&7D2]I:2KU/IQ:OB<G!?7Z@JB[FVN+.XDM
M;J-T5Q$Y6R1N2BHJ&F7"      "P-N]*/N[EF?OF4LX%K:,=_M)6_1>1J^SY
M"2L++RN,MLQCY\==I6&=O+5.EKNE')XT7B950N:PUY@K^2PO6T>U:QR(GFR,
MZG-\2FF6.*      271VEYM17Z.E:K<7;N1;J3HYNM(V^-?80DB[UAB="MNY
MC5@5O9K'1.7DI2E/!0RTH[5^EY].7[D8U78R=56UFZ:)T\CE^F3V4XFF4<*
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MGKA$8G%;6W6JKXG/7H^M3U256BQK.RM,?;LM+*%L%O&E&QL2B?\ S7QD5S@
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MVUR3JJ]%3[5*OA=3H=XT+5**LRF$RF&E[+)6KX%K1KU2K'>Y<E47URHQY0
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M@
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M:1/KW5=[)%9,
M                                            !7-[LOI:_O;B^FN\
M@V6YE?-(UDD*-1TCE<J)6%5I5?">E;S#);$12-GI_%Q^'#@_P,TE_P [D?XV
M#^0-?N63A'O_ !/#@_P,TE_SN1_C8/Y ?N63A'O_ !/#@_P,TE_SN1_C8/Y
M?N63A'O_ !/#@_P,TE_SN1_C8/Y ?N63A'O_ !/#AF-,[88#2N4;E\=<WDMR
MUCXT;</B<RCTHO!D3%]DX<VLORV]F8A8LB$U.BV
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M2_J.Q)^O'LO_  &;^\X?ZP/*7]1V)/UX]E_X#-_></\ 6!Y2_J.Q)^O'LO\
MP&;^\X?ZP/*7]1V)/UX]E_X#-_></]8'E+^H[$GZ\>R_\!F_O.'^L#RE_4=B
M3]>/9?\ @,W]YP_U@>4OZCL2?KQ[+_P&;^\X?ZP/*7]1V)/UX]E_X#-_></]
M8'E+^H[$GZ\>R_\  9O[SA_K \I?U'8D_7CV7_@,W]YP_P!8'E+^H[$GZ\>R
M_P# 9O[SA_K \I?U'8D_7CV7_@,W]YP_U@>4OZCL2?KQ[+_P&;^\X?ZP/*7]
M1V)/UX]E_P" S?WG#_6!Y2_J.Q)^O'LO_ 9O[SA_K \I?U'8D_7CV7_@,W]Y
MP_U@>4OZCL2?KQ[+_P !F_O.'^L#RE_4=B3]>/9?^ S?WG#_ %@>4OZCL2?K
MQ[+_ ,!F_O.'^L#RE_4=B3]>/9?^ S?WG#_6!Y2_J.Q)^O'LO_ 9O[SA_K \
MI?U'8D_7CV7_ (#-_></]8'E+^H[$GZ\>R_\!F_O.'^L#RE_4=B3]>/9?^ S
M?WG#_6!Y2_J.Q)^O'LO_  &;^\X?ZP/*7]1V)/UX]E_X#-_></\ 6!Y2_J.Q
M)^O'LO\ P&;^\X?ZP/*7]1V)/UX]E_X#-_></]8'E+^H[$GZ\>R_\!F_O.'^
ML#RE_4=B3]>/9?\ @,W]YP_U@>4OZCL2?KQ[+_P&;^\X?ZP/*7]1V)/UX]E_
MX#-_></]8'E+^H[$GZ\>R_\  9O[SA_K \I?U'8D_7CV7_@,W]YP_P!8'E+^
MH[$GZ\>R_P# 9O[SA_K \I?U'8D_7CV7_@,W]YP_U@>4OZCL2?KQ[+_P&;^\
MX?ZP/*7]1V)/UX]E_P" S?WG#_6!Y2_J.Q)^O'LO_ 9O[SA_K \I?U'8D_7C
MV7_@,W]YP_U@>4OZCL2?KQ[+_P !F_O.'^L#RE_4=B3]>/9?^ S?WG#_ %@>
M4OZCL2?KQ[+_ ,!F_O.'^L#RE_4=B3]>/9?^ S?WG#_6!Y2_J.Q)^O'LO_ 9
MO[SA_K \I?U'8D_7CV7_ (#-_></]8'E+^H[$GZ\>R_\!F_O.'^L#RE_4=B3
M]>/9?^ S?WG#_6!Y2_J.Q)^O'LO_  &;^\X?ZP/*7]1V)/UX]E_X#-_></\
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M&L;<MCYU7P1JXX;\%]N^$FV868<+(
M
M              !3W>0^0^/_ "K#^#7))9EJ\1ED,#^/,9\+@]\:!OD:<@
M                                     -(N\CWMK^.^N]![3WJVT5LY
MT&6U/ OVUTK55KXK-WT+6]#IDXJOM%1$YG>G@TWZKG+;9Q:83SSW4TES<R/F
MN)7*^661RO>][EJKG.6JJJKUJ>BY7&
M
M        !LIL)WL-2;>W=MIS75Q/G-#2*V)LTKEFO<>BK3GB>ZKI(FITQ.7@
MGM*4Y7=/-IHNVQLEBZVKT4L+^RRMC;9/&W$=WC[R)D]K=0N1\4L4C4<U[')5
M%146J*>1,4<#L$
M                                                          *>
M[R'R'Q_Y5A_!KDDLRU>(RR&!_'F,^%P>^- WR-.0
M                  *![W.Z5UMUMD['X>=8-1:ID=C;25BJV2*U1G-=2L5.
MA4:K8T7I17HJ=!V]-C[5VW=#=D5EYFGLN<
M
M               -Y^XSNG<Y&QR>U67G[1V,C7)X!7JJN2V<]&W$"5X48][9
M&IT^<[J0\S68Z?%#BOCI;DGG.(
M
M         "GN\A\A\?\ E6'\&N22S+5XC+(8'\>8SX7![XT#?(TY
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M5F+N,3E8N*V]RSEYFKT.8Y*M>U>IS%5%\)VK;HNBL-Q-6%-
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MYK&=G4Z.ZMI8^/D54=Y4.OJ(KCEF[<]3CPW7
M
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MQ_3EH?\ *3/L'G!G^G+-VYZOGA.N
M
M           !3W>0^0^/_*L/X-<DEF6KQ&60P/X\QGPN#WQH&^1IR
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M'(DEO(J419(N9M53VS7-=PK1/7P9O$MZW-;=53YV&@
M          "T>[C^G+0_Y29]@\X,_P!.6;MSU?/"=<
M
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M-C<L]B>FXS,P)#+]$D5S#,R1B>)RHQ5]R=?1S\=.IFS>\[CUW,
M                   6CW<?TY:'_*3/L'G!G^G+-VYZOGA.N
M
M                                !3W>0^0^/_*L/X-<DEF6KQ&60P/X
M\QGPN#WQH&^1IR                                      !YQ]^/\
M31!^1+/WZX/8TG<];GLW-:SN-@                            %V=T;_
M -PNCO\ O/\ \JNSK:GZ<_UTLW[F]G>9_01K;X$S\(B/+P?4APV[WE.>Z["0
MZ2T-JS7.8M,'I?%7&0OKQ[61]G&[LFHY:*^22G*QC>ESW+1#%U\6Q69)FCV
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M]W'].6A_RDS[!YP9_IRS=N>KYX3K@
M
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MG+--+<S27%P]TL\SG22R/6KG/<M5557I554]AS/7?_&3:'_\X&F__&+#^6/
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MGV#S@S_3EF[<]7SPG7
M
M!P7ME:9&TFL;Z%EQ9W#%CG@D1',>QR45%10-4-U=JKO0]V[)XQK[C2]P^D4J
MU<^V>Y>$<B^#Z1_7T+QZ<L3"LPCEM;6XO;B*TM(GSW4[TCAAC17/>]RT1$1.
M*JJ@;5[3[3V^C+=F9S+&3ZHG9XG,M&.3BQB]"O5/;O\ 43A55K<0M(J@
M                                #SC[\?Z:(/R)9^_7![&D[GK<]FYK
M6=QL                                        #>'_ "_?Q?KW[MB_
ML+H\S6[X<61@N_\ ?*/17P*]]]C-Z+=*X]S3L]!R
M                                     %H]W'].6A_RDS[!YP9_IRS=
MN>KYX3K@
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M9^_7![&D[GK<]FYK6=QL
M"P]L]Z]?;1Q9*'15W!;,RSH7WO;V\=QS+;H]&4YT6E.T=T'#DPVW[TF(EUMR
M]W=;;MW6/O-:7,-S/C(Y(;1T$#+=$9*Y'.148B5XM0N/%;9N(BB"G*H
M                                                   !:/=Q_3EH
M?\I,^P><&?Z<LW;GJ^>$ZX
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MRMYF+3Z%[:M<G6BAM[-!Q@
M                         'G'WX_TT0?D2S]^N#V-)W/6Y[-S6L[C8
M
M                                      6CW<?TY:'_ "DS[!YP9_IR
MS=N>KYX3K@
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M:&%[8Y(9VL1J*]O.US7(E53FYN*543#;4,@
M                                   \X^_'^FB#\B6?OUP>QI.YZW/9
MN:UG<;                &V&Q'=0TKNSMU9ZSRN=R%A>7-Q<P/MK5L#HD2W
MD5B*G.U5XHG$Z&;4S9=2(<=UU)65^H-H3^]67_:6W^H</G+N$)XCJ7'<#TLY
MRK::RR$3*>:DMK#*J+X55KV?,+YV>!XBI-T^YGKS06+NM0:<OXM5X6R8LMTR
M&)UKD(XFMYG/[!72->UO7R2*[KY:5IV,>JMNFD[&HOB6M9W&P
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MSPG7
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MNDB:HV;4               M'NX_IRT/^4F?8/.#/].6;MSU?/"=<
M
M #Q0S7XXR'PF;WQP<CV%VR_1MH[\AXS\$B#C2H !!]Y_T/;@_P#IK,_@$P(>
M2NC/EAI[\IV?X0P.1[*9K\3Y#X--[VX.-XH!R/:_"_B?'_!H?>VAQN\  @6\
M.ZF%V>T1>:OR[?2)FJEMB\>UW(^ZO9&N6.)%XT2C5<]U%HU%6BKP4L- -#8F
M[[RVY=YK#=W5EEA\!;/8M\ZYO(;-SH:JL=E81S/3E8B5YG\>6O,O,]W$UN>A
MFB,GMEC\?8Z-T%E<0ZSL(>2RQ6-O+>=[8F<7.Y8WN<Y:KS/>M555JJU4,)@
M                  %2;GZM])E73>/?]HB5%OY&]#I$XI'Y&]+O'Y#XGGG,
M.U/@V3LCO>GAZGF:K-7X88O;G5OQ'?\ Q9?24Q5XY/.<O"*9>".\2+T.]1>H
MZ?)N8>!?V+I^"[W3Q_%QZ;+V9I.Z5WGZ$]<
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M%.Z>.>YEY6MDJK641C$5&MHM.9W%:\.]AP1CF7);;121V6@
M "T>[C^G+0_Y29]@\X,_TY9NW/5\\)UP
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M G!/*YO0OB]4^^Y+S#Q;/"OGXK=W7'Y/5TV7M1V9WPGQ]*[H
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MO\P*/LG)9: <LRHY&NFRJ(UKJ>:JM;:5<E>E*IY2QHNL\-2^Z7>MW.W.QLV
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M3/L'G!G^G+-VYZOGA.N
M
M #IY3)VF'L)\E>OY+>!O,[PJO0C4\:KP0X,^>W#9-]VZ&;[HMBLM=L[FKO/Y
M.?)W:^?(M(XTXMCC3VK$\2?_ #/RW5:F[49)ONZ?='!X>2^;YK+''5<8!V,?
M?W.,O8+^S?V=S;N1\;O&G4OB5."G+ARW8KXOMFDPU;=-LUAL/IO/VNH\5%D;
M>C7KYEQ#6JQRHGG-7YJ>(_4=%J[=3BB^/7'"7MX\D7VUAESNN4
M              *PW:W\V\V>LW?G'?I<YY[.>TT_9*V6^EJGFJYM42)B_3R*
MB?2\R\ M&FK>^YN#?;F8K4=[&RQT%:3K'<Z8M:/1]I-YCWR3.1'23,1>=B^:
MWF:GFI5U2T>A-I=8C4V%AO+5\61P67MFR1/HCX;BUN652J.3BU[7="H&6O\
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MT>[C^G+0_P"4F?8/.#/].6;MSU?/"=<
M
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M,M]-,Z:PFCL#8Z9TY:)8X3&Q]C9VK7/D1C*JY?.D<YRJJJJJKE#++
M >>G?OQDEMNIA<IRKZ/?X.%B.7KEM[JX1Z)Y&OC]<];1S\$QUN:S<U:.\Y
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M881DS,5EKEL]LRY:V.9&I$QGGM:YZ(M6KT.4Y<5LVVQ$K$4A!CE4
M        6YW8,?/DM^-%PVZ*JQ7<MT]:<$CMK:69RKT=3:'!J)ICEF[<]5#P
MG7
M                                           " ;E:M^*K-<)8/ID+
MMGV][5XQ0.X>HYW1Y/4/F>=\P\*SPK)^*[?U1^;I:G+V8[,;Y4P?!/*
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ME&T^DY(Y5^I8X[FER=FZD]+=DTEYQ'L.<
M
M              -TNXIMI<>E9?=3)0JVV;&[$X-7I[=[G(ZYE;7Z5&MB1R>%
MZ=1YVLR;K7%?/0W>/,<0
M
MQ&I<_;:<Q4N1N*.D3S+>'H6254\UO[*^(Z.MU=NFQ3?/JCC+BR9(LMJUXOKZ
MYR5Y-?WCUDN;AROD>OA7P>!$Z$0_+\N6[+?-]TUF7B773=-9=<XF0     /J
M*22&1DT3E9+&Y'L>U:.:YJU147PHI;;IMFL;X6)HO_16J8]38I))%1N2MJ1W
MD:<./4]$\#J>O5#],Y9KHU6*L]Z-_P"/K>S@R]NWK24]9V
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MC%I5]&I57P5JK7-]HG!W!.9?6P:B+MEV]S6W-6CO.0
M
M                     NO8GNXZJW@R4%_=12XK0<4G\^S+V\KIFM7SHK1'
M)1[UIRJ_BUG2M5\U>MFSQ9'6S==1Z9Z?P&)TMA+#3N!MF6>(QL+;>TMH^AL;
M$]E5Z7*O%5XJ>-==,S6779(R
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M5AR
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MO]1WVJ\3B$NLS=74EU9R7RMG9CVR.5R16C.5&L1M:-<O-)3AS4"U6Z$
M
M
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MAK.''XNT8D5K96L;88(F)T-8QB(B)Y$#+M@
M
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M,J(JI5*\C>5B+T-0,)R
M
M                                             #73<;4?YPZBF[%_
M-C[&MM:TZ%Y5\]Z>Z=["(>7FO[5S]6Y+HO+:>*]Z[;/W1ZOMJB)PO=
M                          !:.SVH_1KV?3ER^D-W6:TKT),Q/.:GNFI7
MZWQG;T]])[+XW^2:+M61GMWV[)]'1[)^U=!WWY\              T-SWX\R
M?PN?WQQEQL>!M#W;_D/D/RK-^#6Q8:A<)6@#4;??])62^Y6OO##,L2K8(O'N
MT_CS.?!(O?"PU:V1*T              I;<G5OQO>_$UA)7&V;E[5[5X2S)P
M5?&UO0GCX^ ^ YUS#QK_  [)^&WWS^3RM3E[4]F-T($?-ND
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MVRU=1M:(82
M
M                                      "([C:C_-[3LW8OY<A?5MK6
MG2G,GGO3W+?95#@S7]FU[O)=%YG417NV[9^Z/7]E6NAYC]6
M                     YK.[GL+N"]M7\ES;O;+$].IS%J@B:35QY,=N2V;
M;MTQ1M#@,Q!G\/:9:WX,N6(Y[.GDD3@]OJ.14/7LN[45?C>LTUVGS78[OTS[
MNADC;J             :&Y[\>9/X7/[XXRXV/ VA[M_R'R'Y5F_!K8L-0N$K
M0!J-OO\ I*R7W*U]X89EB5;!%X]VG\>9SX)%[X6&K6R)6@            (-
MN-JWXDL/BNQ?3*7K5JYO3%"O!7>)7=#?54^=YSS#P+/#MGX[O='];G3U.7LQ
M2-\J2/SYY(                 6SMAJWMXTTWD)/MT2*N/>Y?;,3BL?E;TM
M\7D/M>1\P[4>#?.V.[^'X/2TN6OPRLT^N>@  *.[SVR,>\.AG28J)OY[8%'W
M6$DX-69JHBRVKE7JE1J<E>AZ-XHBN"Q+RVFAEMY9()XW13Q.5DL3T5KVO:M%
M:Y%XHJ+TH&WJGW8-?Z3UWM9COS;L+3#7N(1MEF\+8L;#'#=HWC*UB<>2=$[1
MKEKQJU55S5#$KG"
M
M                                           &NFXVH_SAU%-V+^;'
MV-;:UIT+RKY[T]T[V$0\O-?VKGZMR71>6T\5[UVV?NCU?;5$3A>Z
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MP[@
M
M                             (CN-J/\WM.S=B_ER%]6VM:=*<R>>]/<
MM]E4.#-?V;7N\ET7F=1%>[;MG[H]?V5:Z'F/U8
M              YK.[GL+N"]M7\ES;O;+$].IS%J@B:35QY,=N2V;;MTQ1M#
M@,Q!G\/:9:WX,N6(Y[.GDD3@]OJ.14/7LN[45?C>LTUVGS78[OTS[NADC;J
M           T-SWX\R?PN?WQQEQL>!M#W;_D/D/RK-^#6Q8:A<)6@#4;??\
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MAD
M
M                           #73<;4?YPZBF[%_-C[&MM:TZ%Y5\]Z>Z=
M["(>7FO[5S]6Y+HO+:>*]Z[;/W1ZOMJB)PO=       6#IK:VXU'A+7,QY)E
MNRY[2D+HE>K>SD='THY.GEJ=BS!-T5J^7UW/[=-FNQ39,]FFVO&(GAULK_@E
M=_VQ'_$._P!<WY:>+H_\IL_QS[?R<+ME,M1>7)VRKU(K'I\\GEKN+DC^48OD
MN]R,:DV_U#IF);J[C9<6*+1UU;*KV-KT<R*C7-]:GC.*_%=;O>SHN<:?53V;
M9I=PG[F+TUA'ZCS=KAHYDMWW/:4F<WG1O9QNDZ$5.GEH8LM[4T=S7:J--ANR
MS%>S39Z9B/O6#_@E=_VQ'_$._P!<[/EIXOEO^4V?XY]OY'^"5W_;$?\ $._U
MQY:>)_RFS_'/M_(_P2N_[8C_ (AW^N/+3Q/^4V?XY]OY.O?[.75A8W5\[+1O
M2VADF5B0N17)&U74KS]="3IYB*U<V'^2VY+[;/#GXIB-_'U(IH[2<FK[Z>QB
MNFVJP0]LKW,5Z*G,C:414\)PX\?;FCVN9<PC1V1?-O:K-$S_ ,$KO^V(_P"(
M=_KG/Y:>+Y__ )39_CGV_D?X)7?]L1_Q#O\ 7'EIXG_*;/\ '/M_(_P2N_[8
MC_B'?ZX\M/$_Y39_CGV_DB.L]&2Z.EM(I;MMVMVU[D5K%CY>S5$ZU6M:G#DQ
M]A[O+.9QK8NF+>SV:=-=[ET9H6;6,=Y)%>MM/1'1M5'1K)S=HCEZG)2G*,>*
M;V.9\VC13;$V]KM5Z:;G9U=MOD-*X]F3]*;>VO.D<ZL8K%CYO:JM5=P5>'EI
MX363#-D5</+N=X]7DFSL]F:;-N]"3@?1,[I+34FJ\JN+CN$M7)$Z;M'-5Z>8
MJ)2B*GA-V6=J:/-YCKHTF+Q)CM;:,SK#;N?2.,BR4M^RZ;+.VW2-L:L5%<Q[
MZU5R_2')DPS9%70Y;SFW69)LBSLTBN_KB/O0DX'T(      "T=GM1^C7L^G+
ME](;NLUI7H29B><U/=-2OUOC.WI[Z3V7QO\ )-%VK(SV[[=D^CH]D_:N@[[\
M^           !H;GOQYD_A<_OCC+C8\#:'NW_(?(?E6;\&MBPU"X2M &HV^_
MZ2LE]RM?>&&98E6P1>/=I_'F<^"1>^%AJULB5H          *QW0U;V4:Z:Q
M\GVV1$7(2-7VK%XI%Y5Z7>+AUJ?(\\YA2/ LG;/>_#\7GZK+^F/6J<^*>:
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MT1%G@=1&N:]%17(WVC^9O4E3$K7"
M
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M/?*UWP27[)AS:?OO&_DG^K_W1]Z:[S_)>T^'Q^\S'8U/=];Y[^,_[-W]D_\
ME:HL\]^D       .:SNY["[@O;5_)<V[VRQ/3J<Q:H(FDU<>3';DMFV[=,4;
M0X#,09_#VF6M^#+EB.>SIY)$X/;ZCD5#U[+NU%7XWK--=I\UV.[],^[H9(VZ
M@          :&Y[\>9/X7/[XXRXV/ VA[M_R'R'Y5F_!K8L-0N$K0!J-OO\
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ML44<;4HUK&,1$:B)T(B!'.
M
M                                              -=-QM1_G#J*;L7
M\V/L:VUK3H7E7SWI[IWL(AY>:_M7/U;DNB\MIXKWKML_='J^VJ(G"]T
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M
M
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M2O9%14146J+Q14/T9[
M
M                                              !"-T-.?'FGGW<#
M.:_QG-<14Z714^VM]9.;RH=?/9VK?0^BY#K? U'9GNW[/7T3]WK:^GFOU$
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M3RL^Q\A]SR/F'B6^#?/Q1NZXX>K['J:7+6.S*QCZIW@
M
M
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M6UQWFP5Z'7+T_<-6OE5#M:>RLUX/DOY'K?#Q1AMWW[_[?SG[UXGH/SD
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MUW<*?02HG'U%Z6GZAH-9;JL471OZ8X2]O%DB^VK-GH.8
M
M
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MU5L%.B1_0Z3]AOB\I^<<WYAYG)V;>Y;NZ^O\'CZC+VYI&Z$0/#=4
M                       ,_I#4LVF<LRZ2KK*6D=Y"GT4=>E$^F;TIZW6>
MGR[6SI<O:_3.^/ZX.;#E[%U>AL';W$-U!'<V[TD@F:CXI&\4<UR514/TVR^+
M[8NMFL2]N)K%8<AM0
M
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MCT+TIX_*?5\F\QBCPLELQ;T3PZG?TW;M^&Z-BP3Z9W0
M
M
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M9>UOKI&K(L-O*V1Z,;1%<J-7HXE;9H
M
M
M                                        J(J47BB]* :V:\TZNF]1
M7%K$WEL9_P"<62]79O5?-^M6K?(>5EL[-S];Y3K?-:>+I[T;+O3^>]&3B>P
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M+$:"Q"6-BB37TR(Z_OW)22:1/F,3Z%O5Y:J:;B$K"@
M
M
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M*U0C%&VN@M!8C06(2QL42:^F1'7]^Y*232)\QB?0MZO+533<0E84
M
M
M
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ML<DZ-1)',8JJUJNI5417+1/&!R@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MKX%144,NV
M
M
M
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MPB57J19G(G@0,RV)"
M
M
M
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M\$^[MK"_MIKB2^BCBO>3L;JSDE\]B-:]KN2B52J*U'45 ]#PR
M
M
M
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M:>F08
M
M
M
M!Y[]_P"_23IG\AI^%SAJ$W_R]_Q/KSX3C?>[@$MT0R  /+'O??\ N)UE_P!V
M?^56@;AN'W)/T%6GY3O_ +-H9EK-WZOTUV_Y#LO?K@-0N_N _HVU-^7%_!(
MDMM0R 8_/9"YQ.#R>5LK)^1O+&TGNK?'QNY'W$L,;GMA:ZCJ*]4Y46B](%!;
M)=[?3>[6HLCI[+8^'25S'%')AVW5^V=;U>=S96HYT4#6O:G9JV-.95\[Z4+,
M-;.^]J'2VI=U,7;Z8FAR&2L,:RTRMS9N;*UT[II'1PJYE4<]C7<:5IS(WI2@
M6'H3I2')V^EL';YIRNS$6/M(\BYW%RW+86)*JKX>>H99<
M
M
M
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M0FU5G[%R2V#KB%EM9P3-XI*VW1TJN>U>+5?(J-7BB<R(H*MD @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                             'Q+-#"B.FD;&U5HBO5&I7U0.+T^Q_YJ
M+^,;\\#];>V;W(UMQ$YSEHUJ/:JJJ]2<0.<
M
M
M
M                                            4MWD_DKB?R@GO$A)
M9EK,1E(-!_+C3/Y5L?PF,$-XC3D
M
M
M
M                                   "EN\G\E<3^4$]XD)+,M9B,I!H
M/Y<:9_*MC^$Q@AO$:<@
M
M
M
M                           4MWD_DKB?R@GO$A)9EK,1E(-!_+C3/Y5L
M?PF,$-XC3D
M
M
M
M                  "EN\G\E<3^4$]XD)+,M9B,I!H/Y<:9_*MC^$Q@AO$:
M<@
M
M
M
M          4MWD_DKB?R@GO$A)9EK,1E(-!_+C3/Y5L?PF,$-XC3D
M
M
M
M
M "EN\G\E<3^4$]XD)+,M9B,I!H/Y<:9_*MC^$Q@AO$:<@
M
M
M
M                                                     4MWD_DK
MB?R@GO$A)9EK,1E(-!_+C3/Y5L?PF,$-XC3D
M
M
M
M                                            "EN\G\E<3^4$]XD)
M+,M9B,I!H/Y<:9_*MC^$Q@AO$:<@
M
M
M
M                                   C&N-*2ZLP[K6RR-QBLK#5]E>6
MTLD2(^GM9$C5.9B]?6G2GC)+4/53=6X_(38+55S=R7-H^JP74TDS*THCV<SE
M145%X.3J,L, !]PS2V\L<\$CHIXG(^*5BJU[7M6J.:J<45%Z% O7:+1VKM42
M1:CU'F,E'IR-W-;V[KN=KKQS5]W5(D7I7Z+H3K4K4-BBM
M
M
M                                        ,!JS6NFM$X_XQU'?QVD3
MJ]C#[:>9R=4<:><Y?)P3KH<V+#?EFEL.'+FLQQ6Z6M6M.\]J7)RR6NC;9F&L
M$JC;N=K;B\>GAHY%C9Y*.7ZH][#RRRW;?MGW/$S<QNG99LA +7>C=&TN?2H]
M37;Y*HY63<DT?#JY)&N;3U#N3H\,Q3LPZD:O-$U[4KNVS[R<&7NH<)KN.*QN
MY52.#+PU9;/>JT1)FJJ]G7Z=%Y?"C4/*U/+9MCM8]O4]33\PBZ:7[.ML*BHJ
M53H/$>P
M             $*W&VYQ>O\ %]E+RVV:MFKZ!?TXM7IY'TXK&J]*=72GCB3#
M4/.8/*:<REQA\Q;NMKZV=RO8[H5.IS5Z%:J<45",+.VBVBDU1)%J/4<3H].1
MNYK>W=5KKQS5]=(D7I7Z+H3K4+$-H(HHX8V0PL;'#&U&1QL1&M:UJ41$1."(
MB&FWV
M
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MM/%EW;C=/VOH>7YYOM[$[X^Q>YX[U@
M                                    C6J=!Z9UE)939VT[::QD1\4C
M5Y'.8BU6)ZIQ6-5Z4]:@2B1111PQLAA8V.&-J,CC8B-:UK4HB(B<$1$"OL
M
M
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MUR7#-T+9L*5CEL[IEQXHT8CD_P!-K3H\RB/!]<.]R^OB^INB?*OI@
M
M
M
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MV.[LW127/CR6WQ6W<RIQN0
M
M
M
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M5\?+)P_;GRW,HIF]4/I>737%ZUPGF/2
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MR.:O4:B^WBYHU.*=UT>U([6]L[Z/M;*XBN8OIX7MD;Z[55.HW5SQ,3N<X4
M                                                   'Q)+'"Q9)
M7MC8G2YRHU./C4),Q&]AKO6FCK'^FZ@QMNO@EO(&+X>"*]#DC%?.Z)=>[58;
M=]]L>N&$N=X=L[2O:ZEM'46GVE7S=*5_V37')&FR3T.M=S+31^N&'N.\%M9
MB]EEI;GA6D5I<IQKT?;(V')&DR\'!=SG2Q^JOJEB[CO+[=P\W9PY*XI2G96\
M:5\G:3,]DW&BR=3AGGNGCYI]7YL=-WH](-YO1\/DI*>T[1((Z^6DKZ>R:C0W
M\8<,\_P]%MWN_%T9>]1B$IV&G+E_3S<]Q&RG@I1CJFO(3Q<<_P @LZ+)]KJR
M]ZR)'4ATHY[*=+[]&+7R);.^::\A_P!7N<<_R&.C'_\ +\G!+WK)U1.PTJQB
M_1<]^KZ^2ENTOD/^KW,S_(9Z,?\ \OR<7ZU60_NS#]]N_DAY"/F3_D%WR1[?
MR/UJLA_=F'[[=_)#R$?,?\@N^2/;^1^M5D/[LP_?;OY(>0CYC_D%WR1[?R<T
M7>LE1M)M*->^O2R_5B4\BVSOFD\A_P!7N:C^0STX_P#Y?DYXN]9 JKV^E7L3
MZ'DOT?7RUMVD\A_U>YJ/Y#'3C_\ E^3M1=ZC#*U5FT[=,?7@C+B-Z4\JM:3R
M$\6X_D%G39/M9"'O1:+<[[?B<HQM.EC+=ZU\BS-,^1OXPY8Y_AZ;;O=^+(P=
MY3;F:G:-R-O5*_;+=BT7P?:Y'\3$Z+)U.6.>:>?FCU?FREMO]M7<*B/S+[=R
MT1$EM+GI=XVQN1*==5,3I,O!SV\XTL_JIZI_!F+7=O;6\IV6IK)M?X9ZP==/
M]JC3$Z?)'1+L6\QTUVZ^/L9RTU9I;(4] SF/NN;VO87<,M>-.'*]>LXIQW1O
MB78MU&*[==;/KAEV/;(U'L<CF.2K7-6J*GB5##L/T
M
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MZZD6XD[5ZROC9&JUHG2D;>"(>?GSW9;NU<[V'#;BMI:DIP.<
M                                   # 9W7&C]-<R9W-V=E*WBL$DS5
MG]2)JJ]?4:9FZ(WN&_-99WIB%<9GO,;?X_F9BXKW+2?0OBB2")?*Z=6/3]H<
M4YK71OYEBC=64 R_>HU!,KVX/!6EFU>#7W<DETZGAHSL4KZ_JG'.>>B'3OYG
M=/=B(0?)[\;HY/F:N;6SB7_9V<,,-/(]&*__ $CCG+=+JW:[-=TH?D=6:HS"
MJN5S5]>\U:I<7,LK>/4B.<J(GB,3=,NK=EONWS,L.9<8
MY(9Y[>1);>1T4K?:OC<K7)Y%2BE(FB2XS<K7^(Y4L-29!C&TY8GW#YHTIT49
M*KF^P:B^Z.EV+=3EMW72F>*[R&Y>/Y4NY[3*-3I]+MFL54\MNL)N,USLV\QR
MQOI*=X?O5P+1F?TZ]GTT]C.C^'72.5K??#DC/QAW+.:1^JWV+!PN_NV.9Y&.
MRKL;._HAR$+X:>61O/&G[<Y8RVR[EFNPW=-/2L+'Y3&Y:!+K%7D%]:KT36TK
M)HUK]4Q50Y(FKNVW1=%8FKME:
M      Z61S.(P\?;9;(6UA%T]I=31P-]=ZHAJVV;MT.._+99MNF(],H1E-\M
ML,75K\XR[E3HCLXI9ZT^J:WD_P!([%NER3T/-R<VTUGZJ^C:A>3[TFF(*IB,
M)>WCDK1;A\5JU5ZJ*U9EIZAV+=#=TS#S\G/\4=VV9].S\40R/>CU3-S)BL+8
M6C5Z%N'2W+D2GA:Z)*^H<\:&WIF70OY_EGNVQ'MG\$4R&_NZ-]5&9=EG&O2R
MVMH&_P"D]CW)^V.:-)CCH=&_G&JN_53T1",7VX>N\E5+W4F2D8[IC2ZE9&OU
MC'(WV#FC#9&Z(=._6Y[M]]WME'[BZNKM_:W<\D\GT\KW/=Z[E4Y(B(=6ZZ;M
M\U<160                    '8M,A?V#N>QNIK9U:\T,CHUK]:J$F(G>W;
M?=;NFB16.YNX6.IZ+J;(\K?:LEN))V)];*KD]@XIP8YZ(=NS7ZBW=?=[4GQ_
M>$W/L:)-D8+]J=#;JVBZ/+$V-5]<X9T>.>AW+.<ZFW?,3Z8C[J)9CN]-GXJ?
M&^ L[I.OT666U]\[<X;M!;T2[UG\@R1WK(GT;/Q3#&=Y_1UPK693%W]BY:5=
M&D5Q&GE7G8[UF'!=H;XW3#OX^?89[ULQ[TUQ6\^V>7HD&H;>W>O!67J/M*+X
MW3M8WUE.O=ILD=#T<?---?NOB/3L^U-+._L,C%V^/NH;N'^$@D;*WCXVJJ'7
MF)C>]"V^VZ*VS5V"-@
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M<24^GE?5Z^2M/ AXV7/?DGXIJ]C%@LQQ\,)&<#F
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M:ODD<KG.7PJJ\5.Q$4>?,S,UE\!
M  '-:WEY83)<6-Q);3M]K+"]T;T\BM5%),1.]JVZ;9K$T3C#;T[EX3E;#GIK
MN%.F*_1MW5/ KY4<]/4<AU[M-CNZ'I8N::G'NOF?3M6-@^]+DHU;'J3!0W#>
MAT]A(Z%R>/LY>T15^O0ZMV@C],O6Q<_NCOVQ/H6=@-^MMLZK8Y,B[%7+O]ED
MHUA3Q_;6J^-/5>=._29+>BKV</-]-DZ>S/7^.Y8MI>6=_ VZL+B.ZM7\630/
M;)&[R.:JHIU9B8WO6MNBZ*Q-8<Y&@
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M\2YL=C,;A[1ECB;.&QLH_:6]M&V&-/(UB(AY5UTW369K+T[;8MBD11VS+0
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M>W3^+I[F1TTBU\+GJJG<BV(W/%OR77S6Z9F>MU2L
M                        #(XC/YS 3^DX/(W..G6G,^UE?%S4ZG<JI5/$
MIFZRV[?%7+CS7XYK9,V^A;.F>\KK'%<D&H+:#.6K:(LB_P UNJ)P]NQ%8OJQ
MU7PG1OT5D[MCW<'/,UFR^(OCV3_7J79I3?+;_5*LM_3EQ.0?P]%R*)"BKX&R
MU6-?$G,BKX#H9-+DLZ*OHM/S;3YME>S/7^.Y8Z*BHBHM47BBH=1Z[]
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M[*?]HW?\XN:IUH]_!BK_ -&C3R,NKR9-\[.#U<6EQX]T;4U.H[0
M                                             $3UUN-IG;ZP2[SE
MQ6ZE15M,=#1US,J</-:JI1J=;G43U>!BZ^+=[K9]19BBMS4O<'>;5NO7R6LD
MJXS .JC<5:N5&N;_ -,_@LB^6C? U#IWY)N?.Y]9?EV;HX*Z.)T@
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M\:I7QGJ8\5MFZ'RFHUF7//QW5ZNCV(V<KI@
M                         "9Z.W4UKHAS(\1D'2XYO3C;NL]K3ZEJJBL_
MW:M.ODP67[X>AIN89L'=G9PG=_7H;':$[P&E-4K%89JF"S3Z-Y9W(MI(]>'F
M2K2BKX'HGB53R\NDNLVQMA]=I.<8LVR_X+O=[5NHM>*=!T7N@
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M'HN         DVW/Z0M)_EG'?A49UM5]&_\ MG['-@^I;Z8^UZ$'Y\^L
M                 ?B*BU1%JJ<%\2]('Z
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M<'D&1)6LCK29K>'3Q5E#'B6<8<\Z7-'Z+O9+$*BM56N14<BT5%X*BH<CKS%
M( $17*C6HJN5:(B<555"Q%7+):7435?+!(QB=+G,<B<?&J$K#4X[HVS$N(K
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M+3NN<C>2++<3/Z5<O4G@1$X-1.")P0\^9J^1OOFZ9F=\ND1D
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M.$<4:>UCC;QY6MKP3U5JJJI]!CQQ9%(?G&HU%^>^;[YVL,<CK@
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M./TS&]?1,5;)/*Q%X+<W2UXIXHVLIY5.GFG;1\[S+)6^+>"B3KO)
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M5JO!\KNCMI:?1*GM6]#4\=57I9,G:]#YO5ZN<LTCNPK,XG0 -DNZ=_\ S?\
M]V__ (L[6#I>YRO]7J^]D.]7^)=.?"KCWMI<_0Y.9]R/2U=.H^?
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MJ=CV[=?COS1BLGM3MKPABN\-^B_(_=[3WYIO1_5AU^<_ZMWJ^V&FA[S\]
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M.FNM3)<\9_C6^YU2M%7TA_17J\!]+A[EOHA^7ZROCWU^:[[4=.5U
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M]185CG-:WVT]HE721T3I<WV[/53Z(UELK%7-KM/XEE8WPTZ.D^8 -DNZ=_\
MS?\ ]V__ (L[6#I>YRO]7J^]D.]7^)=.?"KCWMI<_0Y.9]R/2U=.H^?
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MVG+'];YWA<IX.?69,NR=D<'NX-)CQ;8VSQ6(=%W
M                    (UKW1UCKO3%[IV]5(W3)VEI<4JL-S'QCD3R+P=X6
MJJ=9FZWM11P9\,9;)MEHAGL%D]-9>[PF8@=;Y"S>L<L;NA:=#FKUM<G%KDZ4
M/.F)B:2^1OLFRZ;9WPQQ&             +'V-TI^=6X6/;-'SX_%+\97B*E
M6JD"IV;51>"\TBL14\%3EQVUN=_0XNWECA&UMAN=JC\S]#Y?-L?R7C(5@L5Z
M_29_M<:I[E5YO4.Y?=2*OH=1E\/'-S0_TZ]7BMS+7W;OGGGOD>W=Q/3;W_F9
M?V[OG@[=W%N'W=]6+J+0;,;<R=ID,%(MI(KEJ]8'U?"Y:^*K$]R=W#=6'TV@
MR]O'2=\;%8]Y_2?H.>Q^K[9G\WRL?HMZY*\+FV:G(J^ZCHB>X4X<UNVKH<SQ
M4NB^.G8V,T3\C-.?DNR_!V':MW0]O%W(]$-'-Q/T@:K_ "QD/PJ0Z%_>E\EJ
M/JW>F?M8W3V=R&F<U99[%2=E?6,J2Q+U+3@YKO"UR*K7)X%,Q-)JQCR3CNBZ
M.AOSI34N/U?I^QU%C'5M;V-'\BJBNCD3@^-U/HF.16J>C;=6*OL,>2,EL71T
MM4]_-MET?J'X_P 7%RZ=S+W/:UJ4;;W:^<^+AP1'<7L]5/H3IY;*35\]K]/V
M+NU&Z?M4^<+S&R7=._\ YO\ ^[?_ ,6=K!TO<Y7^KU?>R'>K_$NG/A5Q[VTN
M?H<G,^Y'I:NG4?/@              %M[%;8S:SS[,YDX5_-C$R-DE5R>;<W
M+:.9"E>E$X.D\7#Z(YL5E9KT/1T6F\2[M3W8;E'>?3@           K'5^UK
M=;;@V6;R[D33ECCX8I(6NI)<3MGG>L?#BUB(YJN=UUHG6J1*+*@@AMH8[:VC
M;#;PM2.**-$:QK&I1&M1."(B%5R    "/:VT=B]<Z?N<!E6T9+Y]M<-1%?!.
MU%Y)&UZTK1?"BJG6<N+)..ZL.IJM-;J,<V7?^DM']7Z0S>B<U-A,Y!V<\?G0
MS-JL4T2KYLD;EI5J^NG0O$^AQY(OBL/SC4Z:_!?-E\?FP1R.L          &
MW?=H_1W-^4KCWN$\/6_4]3[WD?\ K>N52=Y3](S?R?;_ &4AWM%]/UO"Y[_L
M1_;'VR[?=?\ E]D?R//^%6IG7=R/3^+7(?KS_;/VVK([T'R!QWY8@_!;HZNA
M[\^C\'K\^^A']T?9<UDTE\J\%^4+3W]AZV3N3Z'Q^E^M9_='VMZM9_(_4/Y-
MO/>'GSN/O1Z7Z7J/IW>B?L>?I],_*P#T"T9\C]/?DVS]X8?,Y.]/I?JFG^G;
MZ(^QI1N?^D35'Y2NO?%/?P?3M]#\[YC_ +-_I10YWGKFV-W;@T7._3>H7JW3
MM[)VD-UT^BSNHBJY$X]F^B<U/:KQZU.AJM/V_BMWOHN4\RC#/AW]V=T\/R;.
M9W3^FM<89+++00Y/%7"))!*QR.I5/-DBD8M46G0YJ^P>1;?=9-8V2^QRX<>>
MRET=J)59)W8-$.NNU9DLFRU5:K;\\"KY$>L71ZAW//7TW0\6>0X*UK=3U?@L
MW2NC-,:#QK[/ VK+2#]\NKF1>:616I[:21W%43P>U3J1#J9,EV2:R]C3Z;'@
MM[-D4AK_ +\;OV>>B=HO2\_;8QKT=E+^-?M<[HUJV*-4Z6-<G,YWT2HE."<?
M2TFGFWXKGS'-^91?'A8YV=,_<J;;WY?:5_+&/_"HSO9NY=Z)>!HOKX_[K?M;
MSZE^3F7^!7/O3CYRSO0_3,O<GT2\]3ZA^4)CMEKNYV_U3;Y=G,_'2_S?)VZ<
M>TMWJE51/IF*G,WUNA5.OGQ>);3I>CR_63ILL7=$[)]#=_\ [*U'A_\ 9WV&
MR=OY8Y;>=OS%:I\_MMGKA^C_  Y+>,3'N:.;D:(NM ZJNL)+S/LG?;\;<._V
MEJ]5Y55?IFT5KO&A]#@R^);5^;Z_23ILLV]&^/0LS87=NST\W\S=3W"08F5Z
MOQE[)^]P22+5T;UZF.7SD=]"ZM>"U3J:O3S=\5N][/)^8QCCPLD[.B?N7[J_
M0>E-P+&*'.VR3\B<UI?0.Y)XT=QJR1*U1? M6^(\W'ENQSL?3ZG28M1;2^*H
M'BN[3H''WK;N[GO\E"QW,RTN)8VQ*B="/[*-CG>HY/(=B[6Y)CHAY>/D>GLN
MK-;NJ?RA9.<SVGM#8%V0R<L=AB;)B1P0L1&UY4HR*%B4JY42C6I\PZMMEU]U
M(WO8RY<>"SM7;(AH_KO5]YKG4][J*\3LTG<C+6WK5(K>/A&SUN+O"Y54^AQ8
MXQVT?G&LU4ZC+-\^KT(X<KI+/[OGZ4L5]RN_P=YT]9].7M\E_P!F/1*_.\-^
MB_(_=[3WYIYNC^K#Z?G/^K=ZOMAIH>\_/0           3/;C;C,;B9EEE:-
M=!B851<EDE;6.%G31*T17NZ&M]5>%3KYLT8XK.]Z&AT5^IOI&[IG@W<PF%QV
MG<3:87$PI!C[*-(H(TXK1.E57K<J\7+UJ?/W73=-9?HV+%;BLBRV*1#OF7*
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MQ3&Z>Q\./LTI5D+:*]4X<SW+5SW?5.55/$R9+LDUNFKV+,=MD4MBC*G&Y
M                  &KW>S_ !CI;[C>?9PGU')>[?ZOO>)S+?;ZVN1]$\@
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MKZEQ<(Y.MJJB-8OW-K3Q\VLRY=\[.$/6Q:3'CW1MXIX=-VP
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MTMRC%<Z+E1RQ-=2M%I4^CY1FLLB[M71&[?+R.88[KIMI$RH/_#G<+^Z>9_\
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MS28K=UOWIO%%%!&V&%C8XF)RLC8B-:U$ZD1."'4F:NW$4?9
M                                   "-:ST'IK7F.^+]06J2*Q%]&NX
MZ,N8'.ZXWT6GC:M6KUH9NMB[>X,V"S+%+H:H;A;&:LT0LM]:1NS.GVU=Z=;,
M59(FIQ^W1)56T^F2K?"J=!T[\4VOG=1HK\>V-L*N.%T
M                       =K'8S(9B\BQV*M9;R^F7EBMX&+)(Y?$C452Q%
M6K;9NFD166Q>V_=M2-T.8W!<CG-H^/!PN16UZ4[>1JT7W#.'U74=FS#Q>UI^
M7=.3V-B[:VM[.WCM;2)D%K"U&0PQ-1C&,:E$1K4HB(AVGMQ$1%(<H4
M                ^7L9(QT<C4?&]%:]CDJBHO!45%Z44),54WKGN[:7U"LE
M]IMZ8'*.JO91MYK)[O'$E%97PL6B?2J=_%K+K=EVV'@:ODN++ML^"?<UTU=M
MGK/1,CUS>-?Z$U:-R-O6:T=X%[1J>;7J1Z-7Q'J8\]E^Z7R>IT&;!WXV<>A$
MCG=                                                    3W1NS
MNN=:+'/9V*V.*?1?C*^K#$K5XU8U4YWU3H5C53QH=;)J;+-\[7J:7EF?/MB*
M1QG^MK9#0FQ6D-&K%?7C/CO.,HY+N[8G91N3KBAJK4\2N5SDZE0\K+JK[]D;
M(?6Z3E.'!MGXKN,_="T3IO:                    I#*]V[3^<USD-27]Z
M^+!7LB7/Q3;-Y'K._C+65:\K'.JZC6UX]*4/6LYC=;CBV(VQTO+NY?;=DFZ9
MV3T+:T_IG :5L4QNGL?#C[-*59"VBO5.',]RU<]WU3E53S<F2[)-;IJ]"S';
M9%+8HRIQN0
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MHY$26=$YYY:?PDKJN=QZE6B=1V;;8C<]K%ALQQ2V*,^:<P
M            'X]C9&N8]J.8Y%:YKDJBHO!45% K356Q&W^IU?/%9+A\@_CZ
M1CE2)JK]5"J+'Y:-15\)V\>JR6]-7CZCE&GR[:=F>K\-RE=3=VO6F)5\V G@
MSEJE51C52UN:)X62.Y%]215\1Z%FMLG?L?.Y^1YK-MDQ?'LG^O6J?+8+-8&X
M6US>/N,?<)_L[F)\2KXTYD2J>-#NVWQ=NFKP\F&_'-+XF)ZV/-.(
M                                    9C!:3U-J:3L\!B;K(<>5SX(G
M.C:OU4E.5OURH<=^2VW?-'8Q:?)E[ELRMW3'=CU)?<D^J;^'$P+Q=;04NKGR
M*J*D;?*CG>0Z5^NMCNQ5[N#D.2[;DF+??/X+MTILYH'2"QS66-2\R$=%2_OZ
M7$R.3K:BHC&+XV,0\_)J;[]\OH]/RS!AVQ;6>,[4\.L],
M
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M5:G'^FOHV_F@]Y87V.E]'R%K+:3ITQ3QNB?ZSD13L1,3N>;=9=;-+HHZY6
M                                 '=QV'R^7D['$V%S?S5IV=K#).ZO
MD8BJ9FZ(WRY+,5]^RV)GT0GF&V&W,S'*Y<4W'0NI]MOY60TKX6(KI/\ 0.M=
MJ\=O35Z>+E&IO_3V?3_55CX/NLIYLFI<^JI]';XZ*GK2S5]Z.K?K_EAZ^+^/
M_P"2_P!GXS^"SL!LIMOI_D?#A8[ZY9_]1D56Z55\/(_[6B^Y8AT[]3DNZ7LX
M>5Z;'NMK/7M_)/8HHH(VPPL;'$Q*,C8B-:B>!$3@AUGIQ$1LA]A0
M
M
M        Q.9TQIS43.SSN*M,BE*-6YA9(YON7.2K?44S-L3O<=^*R_O1$J[S
M/=RVURG,ZTM[K$RKQK9SJK:^YG25*>)*''.&V72OY?BNW5A ,MW5+QM7X+4<
M<J_0PWMNZ*GEDC<^O[0XYP<)=._E<_IN0?*=WC<_'<RPX^#(L:O%]G<QK5/"
MC9EB<O[4XYQ70ZEW+\T=%4.R.W^N<4J_&&G,C"U.F1;65T?33V[6JWV3$V3'
M0ZMV#);OMGV(\^.2)ZQRM5CV]+7(J*GJ*8<+Y                =JRQF2R
M3^SQUG/=OZ.6WB?*M?(Q%\)8BK46S.Z$KQNT6Y>5Y?1-,WK$=T+=,2T3U[A8
MS<8[IZ'8MTF6[=;/V)GB^[)K^\5'9"XL,;']$V25TTGJ)$QS5_;FXPW.U;RW
M+.^D)WB.ZMA(5:[.Y^ZN^MT=G%':I7P<TBS*J>HAR1@CIEV[.5V_JNE86$V3
MVSP7*^#!17<[>/:WZNNU54^IE56)ZC3EC';'0[MFCQ6_I]J=VUK;6<+;>TA9
M;V[.#(HFHQB)XFM1$0Y';B(C<Y0H
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MQMBA8E&1QM1K43Q(E$0X9FKO1$1%(<A%
M
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M9&U&1M1C&\&M:E$1/$B&G,^@
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M0LCI3A]"B''-TSOEV;<=ENZ(AW3+D
M
M
M
M
M
M
M
M
M
M
M                                          (+JO=?3&C<_;8',K,C
MYH4GEN86I*R!'.5&H]J+S<:*OFHJ]'#B1*I5B,YA\_:I>X6^AOK5>F2!Z/HJ
M]3D3BU?$O$JL@
M
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M1NIYO2%HO,(
M               <%[>6V.L[C(7DB16EK$^>>5>AL<;5<Y?41 -'-5:@N=4Z
MAR&?NJI)>S.>QBK7DB3S8V?6M1&F7&ZF+S&4PEVV^Q%Y-97;>B6!ZQNI6M%I
MTIXEX 7'I/O%Y6S[.UU=9ID($HBWUJC8KE$\+H^#'KY.0M6JKPTSKG2VKXD?
M@LC%<34J^T<O9W#*=/-$^CJ)X42GC*M4B"@
M
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MMQVSO2K*>V;R]I$UO!TJ*M5Z LRW&#(
M                                  ! =X,=JC,:,GQ>EK;TF>YD8EZQ
MKVLD6V9Y[D9S*E55R-JE>BJ$E):A7EE>8^X?9W]O):W<2TD@G8Z.1J^-KD14
M(PX  'W%-+;RLG@D=%-&J.CD8JM<UR="HJ<44"TM*;]:OP/);YA6YS'MHBI<
M+R7*)XID1:_7M=Y15:KSTGNYHO5O)!;WOH.2?_\ 0WM(9%=X&.JK'^)&NKXB
MU:JG15
M                                                           /
M/?O_ 'Z2=,_D-/PN<-0F_P#E[_B?7GPG&^]W );FW%Q;VD$ES=2L@MHFJ^6:
M5R,8QJ<55SG41$3QAEY6=Z?6NGM>;S9G,:7G;=XF"*WL&WT?&.XDM8T8^1B_
M1-YO-:[Z)&U3A0-PVM[A..NK;:G-7\[%9!?9R9;9514YV0VUNQSD\*<U6^5J
MAF6MG> W4W/PV\VL\7A]:Y['XRUR#X[:RM,I>001,1C5Y61QRM:U/$B!J&%U
MYOKN;NK98#2V-N\FN,PN*L[2>TM9)YKF_O(+:..ZO+MT:J^5SY$<K>>O*B_3
M*Y5%%_\ </AUM?W>JLIE\QD9-,8QD6-M\3=3ROMO3Y7=I(]L<BJC7Q,8C74I
M^^<:]1)=_O,][?*:2S=YMYMA)%'EK%5AS>?>ULRP3_106['(K.=G1(]R.HZK
M42J5!$-3;.'>W=2>XR=@W4NK)(7+Z1=0^FWS8W*E>57-YFM6G0WAXD"LGI3>
MS>K:/-^CQ9G)6\EF]&W>GLVLTUO1%JK'VUPM8U7K5G(_Q@H]&MCMZ<#O7I),
MYC6>AYFR5EOG,2YW,^VN'-JBM7I=%)15C?UT5.EJAF8>>7>)N]RI]P=40ZMG
MSDFE8M0Y5-/1Y1]X['MB2ZE2/T1)U[-&]GR\O9<.6E. :A!]#7>Y5I=W;MM9
M\Y!?.C:E\NG7WC)5BYO-[7T147EKT<W"H'IKW=LEJ"WV(P&5W$NKYF:MX\E/
ME[O.OF],9%#?W2M?.ZY7M*-B1M%=]!3J#,M,M\>]QK?7>8N\7H3(W.G-$1.=
M%;+:.=;WUVQ%IVLTK:/8CNJ-BHB-X.YE#40K]V@>\'B\4NMEQ&IK2P;'Z2_*
M-]*9*V&G-VKJ.21&43FYE2E./0!=O=T[WFI;#/6.C=U,B[*Z?R#V6MGG;I46
M[LYI%Y6+/+P62)RK1SI*N;T\W*E DPW^#+QY_P 9]X?_ ,X.I?\ QF__ )8-
MT>PP8>1&$WPW5L\SCKO(Z\U+/C[>ZAENX/C>]DYX62-<]O*Z:CJM14HO!0W1
M9^JMR^\?WC;^_NM$6&7@T9;2+%%C,)VD-JQO!4;<7#59VTJHJ.<USJ)TM:U
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MZIQ5%\TDPWJ#(
M             ,/J#2NGM4VWHN>QT-ZQ$5&/>VDK*_22-HYOUJ@4GJONY2MY
M[K1U_P!HWBOQ??+1WD9,U*+XD<U/=$HS12N<TYG=-72V>=L)K&X^A25M&N1.
MMCTJUR>-JJ1EBP  "=:3W;UII+LX;>]6^QK.'H%[6:-&^!CJH]GUKJ>(+5>6
MD]^M(YU&6^95<'D%HG\X7GM7+XID1.7Z]&^4M6JK3AFAN(F3V\C989$1T<D:
MHYKFKT*BIP5"J^P
M
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M;XC@?=7>G\A!FY+6).:22W@BF@EY43IY&SK(OB:H9AY_[5[NZSV=SDV=T=-
MDMU$EO?6EY$D]O/$UW,C7HBM>E%XHK'M7QT#3:+"]_/#9BPGPNY.B'28^]A?
M;7\F)N&S,EAF:K)&>C7'9\%:JI^_A*+KV3R_=EU:C%VLQ6%M<W;-29]E)8Q6
M^7B1BIYU96K(]&K3SXWN:BKTU"35>H0
M                                 !U<AC<?EK5]CE+6*\LY/;P3L;(Q
M?'1R*E0*@U9W=\%D>TNM+73L5=+54M)N::U5? BK5[/7=Y"49HHW5.WNK='O
M<N:QSV6B+1M]#]MMG<:)]L;P;7J1]%\1&:(P   2'3.N-4Z1E1^"R,MO$JU?
M:N7M+=_AYHW5;5?"B5\8*KPTIWB\5=]G:ZNLEQ\ZT1U]:(Z6W5?"Z/C(Q/)S
MEJU5<F*S&*SEHV^P]Y#?6CN"30/;(U%\"T7@J=:+Q*T[H
M
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M_D9_Z'Z9[5?;_P #T>W\0<;(@
M                             /E[&2,='(U',<BM<UR5147@J*B@5IJS
M8S1FHD?<8^)<)DG55);-$[!7?50+1M/<<I*)11FK-FM:Z6[2=+7XTQK./I=B
MBR*C?"^*G.WQ\%:GA)1FBO>C@O2$  '?Q&;R^ NTOL+>S6-TG#M('JQ53P.1
M.#D\2\ +FTIWC+^WY+76%BEY%P1;^S1L<R>-T2T8[ZU6^0M6JKOTWK/3.K8>
MVP.1BNG(E9+>O).SW4;J.3RTH5:L\%
M
M               :']^;2.J]0[A:=N<!@LCE;:+#)'+-8VD]RQK_ $J9>5SH
MF.1%HJ+0-0F?<0TWJ+3N)ULS4&(O<2^XN,>L#;^VEM5D1C+CF5J2M;6E4K0$
MMO0R  /+?O"Z UWD]ZM:7^-TOE[RQN,B]\%U;V%S+%(WD;Q:]D:HJ>10W#?#
MNS8[(8G8S1V.RMI-8Y""WG2>TN8W0S,5;N9R(YCT1R5147B@9E; 1I#WE^Z-
MFLKG+W<':NU;=KD'.N,QIQBMCE2X<M7SVW,J-<CU57/CX.1U5;S<W*TU$M7L
M;J[>+:%\^&L<CG-(K*Y5GQLO;V;5?T*[L941.;ZKEJ%=W36V>\>]F?6\M,?D
MLS>7KD6[U!DUE]&:B_12W<U4HB=#4574]JU0/1[8?9+"[):27$6DB7VH,@K)
M\[EN7E[:9J*C6,1>*11U5&(OA5W2Z@9F47[W6V&>W-VN9#I>V=>YW!7T>3AL
M8Z=K<0MBDBECC1:5?21'HWI=RT2JJB AYQ87+:[V_P \]V"N<GIS4G(ZVE;;
MK-9W:L<J*Z-S4Y7*E6IYJITIX@V](^[-%J'5&QK,;N9;Y"[N[^;(6M^F=2X6
MXN[.Z<JU<ZX\]S',D5J.1:43@&):;[T]U7<#;7+W5[IS'W.HM%/>Z6RR%C&Z
M>XMXJU1EU%&BN:K.CM$3D=TU1?-0U$HTG>%W_3$+HM-793T96]AV"LC7(<O+
M3E])6/TJM/\ I:@HEVQG=2UON'F[+):PQES@-"0O;+>S7C'6UU=QM6O96\;T
M1_G]':JB-1.**J\ 3+TPM;:WLK:&SM(FP6ENQL,$,:(UC(XT1K6M1."(B)1$
M##QP_P ,MR?[G9S_ ,,N_P"2#;V4##QK_P ,MR?[G9S_ ,,N_P"2#;V4##2G
MOWZ6U/J++:)?I_"W^69;V^02=UA:S721J]]ORHY8FNI6BTJ&H9GN(:;U%IW$
MZV9J#$7N)?<7&/6!M_;2VJR(QEQS*U)6MK2J5H"6WH9 -,^]5W6<WJO-7.Y>
MV]NEYE+IK5SV":K62RR1M1J7%O6B.<K43M(^E5\YM554#42UFTMNIOIL8V7!
M8V[R.G[19'.EP^5LT="V5U:JV*\B7LW*J57L^6M.-0K\SVI]^>\)>VEM?IE=
M5)"]S[.SLK/DLXE<JM5_);1LB2GM>T?Q1.EP&[O=7[O=UL[A[W/:H6-^M\Y&
MR*>&)R2,LK1J\_8(].#GN=1TJHJM\UJ-Z*J9F6Q(1YJ]]G0+-*;LIJ2S8C,=
MJZV2^HG0E[;TAN$1/']KD7QO4-PQ_<WT#^>>\=CE;J+GQ6E(W9B=7)5JW+%Y
M+5OB<DKDE3[FH)>G08>=/?'T5K+.[U75_A-.Y/)6*XZR8EU9V5Q<1*YK'53G
MC8Y*IU\0U#9CN<8?+X+96UL,W87.-OFY&]>MK>0R6\J-<]M%Y)$:M%ZN 24F
M[S..R&6V,UCCL5:37V0GMX$@M+:-TTSU2[A<J-8Q%<M$15X("&CG=FT'KG$[
MYZ.R.5TSEK''P7$ZSW=S87,,+$6TF:BN>^-&I551.*AJ7HON#IC\]=#:CTDV
M1(9,UCKJQBF=[5DL\3F,>M.IKE15##R-U#I/7.V6H$ML]C[W3^=QTZ/MKA4?
M"J2PNYF2P3-\UR(J<S'QN5.M%#D;G]RK5&Y^IL[JF]US=YO*8R:RMEQ^0RKK
MJ6T;)#*Y'1POEK&CE1]51O%:5#,M?N\+H#7>3WJUI?XW2^7O+&XR+WP75O87
M,L4C>1O%KV1JBIY%"PW\[O5C?8S971=ADK:6SOK?',9/:W$;HI8W<[N#F/1%
M1?*@9E .^IA,SGMGH+'!8ZZR=ZF9M)%MK*&2YEY&Q3HKN2-KEHE4XT!"@>Y7
MHS6&!WAGOL[I_)8RR7#7<:7-[9SVT7.Z6!4;SR,:E5HO"H66WF^NSV,WIT/-
MINYE;9YBV?Z7A,DYJN2"Z:BI1Z)Q6.1JJQZ?7456H$B7F]EM";T[$:E3)OL,
MG@<G8.=Z/G+!'OM9&="\EQ&BQO8Y/;,=U<'-Z@T:BW,WPWN;;:?RV1R>J(XG
MM=#BK"T:C'2I5&N=#90L1[DJM'/:J@;8]T[NQ9?0F13<G<2W;;:B2)\6"PRN
M:]]HV9JLDGF5JJB2N8JL:Q%\UKEYO.6C23*R>\QL#'O7IRVN,1+'::UPB2.Q
M4TWFPW$4M%?;2N1%5$56HYCN/*[Q.4)$M!K2#?/N_9^:^M;7+:3R;46*:X6!
M7V<\;55>*O9);SL14547SD\ :934>_>_N[5A+I6YRUYDL?=HD5QB\191Q+.C
ME7S7^B1)(]'='(KN5:= *+S[JW=:U+CM2V.Y6Y%@_%0XMRSX3"7*<MU)=(E&
M3SQ],;8U7F8UU'J]$541J><29; ]ZS&9+,[!ZMQN(LY\AD9_B[L;2TB?/,_D
MR=J]W*R-%<M&HKEHG0@2&FO=3T+K?#;^:2R67TUE<?CH/C'MKN[L;B"%G/C+
MIC>9\C$:E7*C4JO2H:EO#OML[C=Z=$2Z;N)DLLQ:R>F83(JWF2&Z:U6T>B<5
MC>BJUZ)XG<5:@9B7G)D=";X;#:G3*LQV3P63LG.9;YNP8^6SE8M$5&SL:Z)[
M')3F8_R.;U!IF,GWG>\+K3'OT[^<=Q+'<1K%<1XNRMX+J5CJ-7S[:%LC:U_V
M:MZ043GN[]U#5^I]28_5&X>*FPFCL=-'=+8W['07=^^->=L20O1'MB543M'/
M1M6\&^%I)EZ,!D
M                      "&ZKVNT;K#GFR-BD&1>GXPM*0SU\+E1%:_Z]JA
M**,U7W?]4X?GN=/R-S=BE5[-J)%=-3QL<M'?6NJO@)1FBI[FUN;*=]K>0R6]
MS$O+)#*U8Y&N3J5KD144B.( !RV]Q<6DS+FUE?!<1KS1S1.5CVKX4<U45 +5
MTGO]JO"=G;9UK<Y8-X*Z5>SNFM\4J(J.^O:J^,56J\]*;JZ,U=R0V-\EKD7T
M3XOO*0S*J]3:JK7_ %CE--534*
M
M                                            !1FY_>JV_P!I=5W6
MC]38O,S9.W@ANF2V,-K+!+'<(BM1KI+F-R*G&O,U$X=/0%HT%WXWER.]>MG:
MCGMUL,/:0ML\-C5<CW0V[55SG/<B(BO>]5<Y:<$HWCRU#40W=[E^VEQH?:Y=
M092!8,UJ^5N05CTY7ML(VJVU:J*E?.1SY4\3T#,MD @
M
M                        8/46C]-:K@[#/XZ*[HE&3*G+,SW$C:/3R(M
M*2U9W<KN'M+O1U\ERQ*N3'7JHR7R,E1$:OUR-\I*,T4OF<!FM/7:V.;L9K&Y
MXT9.Q6HY$6E6.Z')XVJJ$98X   GVD]X=:Z4Y(&7?QEC6T3T*^K*B-\#'U1[
M:)T)S<OB%5JO/2F^VC=0]G;Y-ZX/(NHBLNW(MNKE^EG1$:B?=$86K55GQR1S
M1MEB>V2)Z(YCVJCFN:O%%14X*A5?0
M
M                                            !0V]/=9TMO1J:#5F
M1S5]B<G#:16#V6S8I87QPOE>CE;(G,COME.#J43HKQ"Q+!Z'[D>TVE<C#E<U
M-?:HN;=W/':Y!T<=CS(M6JZ&)C5?3Z5\BM7K:"K91K6M:C6HB-1*(B<$1$"/
MT
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MNID-%,>U;"&V[*V?PJZ_MU5\R(O3[55:J>&/QD2NU8Y5
M
M
M
M                                              !\2Q1S1NBF8V2)
MZ*U['HCFN1>E%1>"@5AJO8C1^?[2YQ378/(.JO-;(CK97?50JJ(GUBM)1**,
MU9M!K72G//+9_&&-95?3;&LK4:G6]E$>WQU;3QDHS1 @@  R6%U!F].W27N#
MOYK&X^B="]6HY$ZG-]JY/$Y% ^L/G;[#Y^TU#$]TE]:W+;ISG*M9'([F<CE^
MKXH[R@;RX^^MLG8VV2LW]I:7<3)X'^&.1J.:OK*:<CL@
M
M
M
M                                                 0C5>U&B]7=I
M->6*6>2?5?3[*D,JN7K>B(K7^5S57QA**,U9L'JW!]I<X16YS'MJM(4[.[:G
MCB55YOK'.5? AFC-%5SP3VLS[>YB?#<1*K9(I&JQ[7)THK5HJ*$<8 #:?N_:
MF^-](282=_-=X27LVHO%?1IZOC7U%1[?(B%AJ%ME:
M
M
M
M                                                $0W!P6C;[ WV
M5U9CHKF&P@?+Z1^]W#48BJC62LHY*K1$2M%7I0)+3.WM;F_N6VUA;R3W$JTB
MMX6NED7Q(C455,L+,TUL)K7-\DV3;'A+-W%777GW"HO@A8M?4>YHHM%[:!VM
MP6@'RW5A<7%UD;F+L;BXF<B,5O,CJ-C:B(G%.OF7QE:B$Y*H
M
M
M
M                                                       PNI],
M8[5V-3$9=TWQ<LK)IX(7]FDW9U5&/5$KRUH[S51:HG$#EP>F<!IN#T;!8Z"Q
MC5*.6%B(]WNWK5SOKE4#*@
M
M
M
M
M
M
M
M
M
M
M
M
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M9:
M
M
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MU,=56/\ $C75\1XV;19<6V8K'&'KX=9CR;(FD]:PSI.X
M                #AN;JULXEGO)X[>%%HLDKVL;5?&Y40L1,[DF8C>C]SN+
MH"SJESJC%,<E/,]-@5_'ZE'JOL'/&GRSNMGV.&=1CC]4>UCY-X-L8GJQVJ+%
M53K9)SIZ[45#<:3-\LL>:Q?-#[BW:VTF:KF:IQR(BT\^=L:^L^BDG29H_3*Q
MJL7S0REKKG1-Z[EL]28NX?\ 2Q7UN]>/'H:]3CG!DC?;/L;C-CG=='M9N"X@
MN8TEMI631+T/C<CVKU]*50XIB8WN6)JY"*
M
M
M                           !^.<UK5<Y41J)557@B(@$&U'O'MQICGCR
M&=@FNF*K5M;*MW+S)]"O9<R-7W:H=S'H\M^ZWV['4R:O%9OE5>=[U^/C5\>F
MM/RW"\49<9"5L*>7LXDD5?VZ'H8^53^J[V.A?S./TV^U7.8[Q^Y^45R6MY;8
MJ-W#DLK=BK3W4_:N3U%0[UG+L-N^*NE?S#+=NFB#Y/7^N,Q7XSU%D;AB],3K
MJ5(_VC7(U/6.W;I\=NZV/8ZMV?)=ONE'GO?(Y7R.5SW+5SG+557QJISN%\@
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MDX,?S*C:JBU:^B<.'A.35Z2<%-M8G[7'I=5&:O1,++.@[P
M
M
M         <*W5JEREDL\:7CF+,VWYV]JL:*C5>C:UY45:5+2:52L5HYB*
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MRUG;VZ(GAEA5[$_;'?QZG'D[MT.CDT^2SO1**G8<#]:YS7(YJJCD6J*G!45
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M5[&NT[F+:]E5.9;9'\EPU*5\Z%_+(GJM/+R8,F/O11Z6//9D[LU2,X',
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M_,=SL:ZBMYD1>5W!4KU*?&/KGZ
M
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MX5= K*K[JIV[-7ELW73]KJWZ7%?OMA5^H.ZGA+A'RZ8S=Q92<5;;WS&W,=?
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MF.*6PD9P.8
M
M                                1;7F@<#N%AEQ&<8Y%C59+.[B6DL$
MJI3F;U*GA:O!3L8,]V&ZMK@SX+<MM+FEVX>V.I-N,BMME8^WQDKE2QRL+5["
M9O4B]/(^G2QWJ53B?5:?4V9HK&_@^8SZ:[#.W=Q0M%5JHJ+14XHJ=-3M.LV&
MVF[Q-QC$@T[K^5]SCDI':YM:OGA3H1L]*J]OU?MDZ^;J\35\OB[XL>_@]C2Z
M^;?AOW<6T=K=6U[;Q7=G,RXM)VI)#/$Y'QO8Y*HYKFU147PH?/S$Q-)>]$Q,
M5A76O-\-$Z&62S?<?&N<95/BVR5KU8[P2R>UC\:<7?4G>P:+)EV[HXRZ>?68
M\>S?+6;7.^>N-;=I:>D_%&%?5/B^Q<YG,U>J67V[_&G!OU)[V#0X\6W?/6\/
M-K<F39NCJ5F=]T7>Q6'RN=O&8_#64U_>R>U@MHW2OI6E51J+1$ZU7@9OOMMB
MLS2&K;)NFD15>.C>Z]J#(]G=ZRO68BU6BK8VRMGNU3K17<8V>7S_ "'D9N9V
MQLLBOV/5Q<MNG;?-%^Z1VIT)HI&287$QK?LHOQC=?SBZYDZT>^O)_NT:AXV7
M59,O>G9P>OBTV/'NC:F9U79              =+*8C%YRRDQV8LX;ZQE2C[>
MXC;(Q?'1R+14ZE-VWW6S6)I+-UD7128K"BM;]U_#9#M;[1%XN+NU\YN.NE=+
M:*O@;)QD9ZO/ZAZ^#F=T;+XKU]+R<W+;9VV31KGJK0^J=%7?HFI,;+9JY52*
M=4Y[>6G\'*VK'<.I%JG6A[F+/9EBMLU>-EPWXYI="/',X0"2Z$TSCM6:BM\/
ME,U;8*SDXON[I:<U%1.2.M&\[J\.=S4\O0O!GR3CMK$=ISX<<7W4F:-Y]&:'
MTUH7%MQNG+1L,;D19[IU'SSN3Z*23I=XDZ$ZD0^1S9[\LUNE]5APV8HI;"1G
M Y@              "O=P]G-);AQON+N+XOSW+2++VS42151*(DK>"2M]UYW
M@<AW=/K+\.[;'!T\^DLR[]D\6I&OMK-5[>7/+F+?ML6]W+;96WJ^VD\"*M*L
M=3Z%WJ53B?2X-59FC9OX/GL^FOQ3MW<4).TZJR=%;X:ZT1CY,59W$=_CNS5E
MI;WZ.E2V<O0Z)4<UR(GTBJK?$='-HL>6:SLGJ=W#K,F.*1MCK0_4FK-1:OOW
M9+4>0EO[I:\G:+2.-%ZHXVT:Q/$U$.SCQ68XI;%'6R9;LDUNFK#'*XU@Z)V9
MUUKE([FQL?0<1(J?]IWU885:O7&E%?)]8U4\:'2S:S'BV3-9X0[F'29,FZ*1
MQ;#Z/[MFB,"D=SGUDU!D6T54GK%:([Q0L6KOKW.3Q'BYN99+]EOPP]C%R_';
MWOBE<%G8V6.MF6>/MHK2TB2D=O QL4;4\36(B(>7-TS-9>E$1$4ASD4
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MBOZ:3UO,RZ'+9T5CJ5A+%+!*^"=CHIHW*R2-Z*US7-6BHJ+Q14/0B:NA,4?
M'T^221>:1RO<B(U%<JJM&I1$X^! /D"TMK]E,IN,SXP=DK6PPT;J3.;(RYO.
M"]'8,=5E:=,JM\*(J'GZK6VX=E)F?<[^FT<Y=M8B&U6B-K-&Z!A;\26*/R*)
M23*75);M]>GSZ(C$7Z5B-0^=SZK)E[T[.'0]_#IK,6Z-O%,SJNR
M
M
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M)C]/8Z#'6J(B.;"Q$<^G0KWK5SU\;E53Q<F6[)-;IJ]BS';9%+8HRQQN0
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MX>9O0>5KK<\Q\$_#PC>]/1788GXXV\9W-PVJUS45BHK%1%:J=%.JA\P^D?H
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MXCQ\VBRX]M*QU/6Q:S'DZ:3UK'.B[H
M
M                                                      ,1J+5&
M TGCW9345_%86;>#72KYSW)QY6,2KGN\3453EQXKLDTMBKCR9+;(K=-&LFX?
M>6S&8[;%Z'B=B<:Y%8_(RHBWLB+P7D3BV)%3RNZT5I[VGY;;;MOVSPZ'AY^8
M77;+-D>]0:JKE556JKQ55Z:GLO(?@'ZG3X?$!MELANWH.:PM]+28^TTMF%Y6
M-2).2UO)*41R2O57=HO1RRN55ZG+T'SFMTF2)[59NC['T&CU6.G9I%L_:OP\
M9ZX                  *:W8WZQ.BDFP>G5CR>J4JR147FMK1W1]L5/;/3^
M#1>'T2IT+ZFET%V7XKMEOVO-U6MMQ_#;MN^QJ+FLWEM19*?+YN[DO<C<+S2S
MRK55\"(G0B)U-3@A]+99;9%+8I#YV^^;YK,UE^X/!9?4F3@P^#M)+W)7"TB@
MB2J^-RJO!K4Z5<Y:)UB^^VR*W32"RRZ^:6Q66WNT^Q.)T,V'-9WL\GJNB.8^
MG-;VB^"%'(E7?](J>1$Z_F=5KKLOPV[+?M?1:716X]MVV[[%JY3$XO.64F.S
M%G#?6$O[Y;W#&R,7P+1R+Q3J7I0\ZV^;9K$TEZ%UL7128K#7[7?=>M+E9<AH
M*[2TE6KOBB\<YT/DBFXN;XD?S>Z0]K!S.8V9(];Q\W+8G;9/J:YZATSG]*7[
ML9J''S8^\;6C)FT:]$6G-&]*M>WZIJJA[F/+;DBMLU>-DQW632Z*,2<CC6#H
MG>;76ADCMK&^].Q$:I_V9?5FA1J=4:U1\?UCD3Q*=+-H\>7;,4GC#N8=7DQ[
MIK'!L7HWO'Z'U'R6V;5VG<DZB4NG<]HY?J9VHB)_O&L3QGB9N79+-MOQ1_70
M]G%S#'?LGX96_!<074++BUE9-;R)S1RQN1['-7K1R514/,F)C>]&)KN<A%
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MX'5FF=40]OI[*VV18B5<V"5KI&^[9[9OUR(>7DQ7V=Z)AZ5F6R_NS5F3B<H
M     #CGN(+6%]Q=2LA@C2LDLCD8QJ>%56B(6(F=R3--ZNM2;\;::;YXW99,
MI=M15]'Q;?2E6G5VB*D5?+(=['H<U_13TNGDUN*SIKZ%-ZH[T^?O$?;Z3Q<.
M,B7@V[NU])GIX48B-8U?+SGIXN5VQWYJ\S)S*Z>[%%+ZAU=J;5EQZ3J/*W&1
MD1>9C9GJL;%6OM(THQG3]"U#U<>&S'%+8H\W)EOOGXIJPIRN)E<%IO/ZGNTL
M=/XVXR-SPYF6\:O1J+UO=[5J>-RHAQWY+;(K=-')9CNOFEL57IH[NLY.Z[.[
MUOD6V,*T5V.L%;+.J=:.F6K&K[E'^4\C-S2(V617KEZN+ELSMOFGH; Z4T!I
M#14/9:<Q4-I*J<LETJ=I<O3ZJ5]7JGBK3Q'BY=1DR]Z7KXL%F/NPDCFM<U6N
M1%:J45%XHJ*<#G5IJ[8C;S5G//\ %_Q1D7<?2\;2"J_5146->/2O+7QG?Q:[
M+CZ:QUNCET6*_HI/4H;5W=IUM@NTN=/R1:@L6U5&P_:+M&IX8GJJ+]8]57P'
ML8N98[MEWPS[GDY>7Y+>[\4*>OL??XNZDLLE:RV=Y$M)+>X8Z*1J^-KT14/3
MMNBZ*Q-7FW6S;-)6+L+I#\Z]PK%\\?/C,-_VE=U]JJPJG8M6O!:R*VJ=;44Z
M6OS>'BGC.QW=%B[>6.$;6\)\D^I
M
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M8LGAKR&^L)DK'<6[TD8OBJG0J=:+Q3K/#OLNMFDQ27M6WQ=%8FL.Z8:
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M?.55X])RY]3?FIVNAQX=/9BKV>E,#JNR
M
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M\:R0<[4]53T+-5BOW70Z%^FRV;[91)S7,<K'HK7M54<U4HJ*G2BH=EUWR
M ,WAM':KU"K4PF%O;]KNB2"WD?&E>M7HG*B>-5.*_-99WIB'+9BOOW1,K'P7
M=JW(RJL?D8[7#0+17+=S))+R^)D':<?$YS3HY.98K=U9=VSE^6[?L6IISNLZ
M3L%9-J/)768E;1701(EG;KX45&J^1?*DC3SLG-+Y[L1'O=_'RVR.]-?<MO3V
MBM)Z3C2/3N'ML>M.598HT69R>!TKJO=]<Y3S<F:_)WIF7HX\-EG=BC/'"Y0
M
M
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MALMW1$>IG#A<H
M
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MM[=RM2L?#=9N2TM']-OCT2T;1>E%='214\3GJ=S'HL-FZ*^G:ZF369;]\^Q
M'O?(]TDCE<]RJYSG+555>*JJJ=UTWU#!-<S,M[>-TT\KD9'%&U7O<Y>"(B)5
M5523--Y$57?M_P!VS4>?6+(:P>[!8E:.]$HBW\B>#E6J1>5]7?4GDZCF5EFR
MSXI]SU<'+[KMM^R/>V@TOI#3FC,<W&:<L([*VX+(YJ<TLKD2G-(]:N<OE7R'
M@9<U^2:W35[N/%;CBEL49PX7*
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M^3@C8_K&HM.E5/$SZO)EWSLX/8PZ3'BW1MXIZ=-VP
M
M
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MW\OVZZ<B]-97U5$7K:VC?$>1FU.3+WI>MBT]F/NPE9UG8
M                           8RZTYIZ^577N)LKESEJY9K>*155.M>9JG
M)&2Z-TRQ..V=\0^;;3&FK->:TPUC;NK6L5K"Q:^'S6H)RWSOF?:D8[(W1#*(
MB-1$1*(G!$3HH<;D?H
M
M
M                                    !\2PQ3LY)HVR,Z>5Z(Y*IXE+
M$T28JX/BW'?\I#_%L^<7M3Q3LQP=EC&1M1D;4:QJ4:UJ41$\2(9:?H
M
M
M
M
M
M
M
M                                                      X+B]L[
M/E]+N(H.>O)VKVLK2E:<RI6E0.#XZP_]H6W\='_K /CK#_VA;?QT?^L ^.L/
M_:%M_'1_ZP'+!D<?=/[*UNX9I*5Y(Y&O=1.NB*H'9
M                          /F22.)CI97HR-B5>]RHUJ(G6JKT =5F7Q4
MCVQQWUN^1ZHUC&RL5RN7@B(B+Q50.X
M              X+B\M+1&K=W$<"/KRK*]K*TZ:<RH M[ZRNU<EI<Q3JRG,D
M3VOI7HKRJH'.
M
M                                            &GG?KT9K#5_Y@_FG
MI[)Y[T/XX],^*[.XO>Q[7T'D[3L&/Y>;D=R\W31? &H:>?X,;P__ )OM2_\
M@U__ "(6J%S0S6TTEO<1NAN(7.CEBD:K'L>Q:.:YJT5%14HJ*%2VRVEW5R5G
M;Y'':&U!=X^[B9<6EW;XF]EAEAE:CV21O9$K7-<U45KD6BH$;&]S+;O<#2V[
MT^3U-I3,87'+A[N%+S)8^ZM(%E?+ K6=I-&UO,J(M$KU!)>@ 9
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M%O\ $LN+?'I Z_M9K5)%8^XYD:LK6UI5*T!+=8,@
M
M
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MDHJ55.M%5%10RDP
M
M                                       \7=9_+#4/Y3O/PAX<CUJV
M8_0]M]_Z:PWX!"''*NN^;^@#/_"<=^&1!8:7=T'_ -Q.C?\ O/\ \JNPU+U.
M##R5[R?Z===?E-_V# W#T6[MGZ"M"_DQGV;PS+S;W]_37K[\N7WOS@U#=#NL
M=WS;ZWVSP^L]4X&SSNI=0QK?<^4@9=Q6]NYZ]@R&*5',:JL1'J_EYJNZ:(@9
MF6O??/VWTQH#<3&3Z2Q\6*QN<Q_I4UA:M;%;LN8IGQO6*-J(C&N;R>:WA6M
MU#N]S39C36YFH<WJ+6-JW(X73;;=EOBY5^TSW=WVBHZ5J>V9&V)?,7@Y7)6J
M(J!)E</?'V:V^Q6UJZRTSIZPP68PUW;1NDQ=O%9,FMKE_8.CDCA:UKJ.<QS7
M*E4I1%HJH")4-W*;ZXM-^<9;PNY8[ZPR%O<IQ\Z-L"SHG[>)JA9;0]];<F\T
M5ME!IO$S+!E-83264DK%Y7-Q\#4==<J_5\\<2_4O4,PTZ[MNS,6]&O\ XHR<
MDD&F,5 M_F9851LKXT<C(X6.5%HZ1R]-.#4=UT#4RW^O.Z_L3>85<'^9EG!
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MF5BN(XJ\6K<V[6N7R+V*>LH26WH9
M
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M>?"<;[W< ENB&0
M
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M?\P/Y8Z._)EQ^$("$J_R]_Q/KSX3C?>[@$MT0RTB[[&Q>7R&1;N]I6T?>1+
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M$ELP$
M
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MH7EW8M*9#1NQ^D\1EHG09.6&:_N(7HJ.9Z?<27$;7-7BUR1O8CDZEJ$E;@0
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MAANXKI3(8/:K(9[(1.A3462?<6+7(J*^TMHVPMDHO4Z1)*>%$J"6T00
M
M
M                                          !IKOGW*KG5&H;_ %CM
MA?6MG<Y.5]UD,#?JZ*#MY%5TC[:5C7\O.Y>;LWM1$6M'(E&H:B5 7'<\[PT,
MKHX]*,N&-Z)HLEC48[R))<L=Z[0M4HT?W&MW<U=1?G3)8Z8QU6K<.DG9?72-
M7I[..V5['*GU4K4\8*M]]NMOM.[8:2L=':8A='CK)%<^61>::>=_&2:5W"KW
MKX."<$1$1$0,)4                       K+)[ [99K<K_%7+XI;W4O)
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M06L#&Q001-1D;(V)RM:UK:(B(B41$".0
M
M
M
M
M
M
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MQ!&S@KV\.:H6BR0@
M
M
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MD:K_ -<E"2P??J_0I;_ERR]YN 0UT[BOZ:[C\AWOOUN&I>D@8
M
M
M
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MWE=^M?Y1[;;4=_8+.Y?1\5IWM+)K&IQY6>C_ &YU/"][E\8:HZ]AOQWA=O\
M)M9>:HSD5Y&O,^QU LMYS-7@J.COT>J(OBIXN(*-\>[CW@K'>[!7$-] S'ZT
MQ#6+E;&)5[&6-ZJC;B#F57<BJE'-555CN%51453,PY^\+O\ XK9# 0+% S):
MQRJ.3#XMZJD:-8J(Z>=6JBI&U5HB)Q>[@E/.<T1#0O(;\=X?<;+/;CM29N2\
M?61F.TXLUJC(V_2QV*-<K4\+JKX5#5&5TIWH-^=MLREKF\K=Y:*W<UE]A-2-
M?+*J)U+)*B7$;Z="\_C<C@4>B&U.Y^G=W-'6FK].JZ..15@OK&546:UNXT17
MPOIP6E45KOHFJB^(,)L!'M>9"\Q.AM397'2K!D+'$W]S:3HB*K)H;:1['(CD
M5%HY$7B@'D)K/76K-PLNW/:RR;\KEVPLMFW4C(XW)#&KG-;2)K$X*Y>H.1G]
M&;W[I[>XAV!T;J.;%8ATS[EUK'%;R-6:1&M<ZLL3UXHU.L)1ZS_'-EB]-)G\
MY=LM;"ULDO,A>S*C61QLB1\CW+U(B54,-!-W.^UKC460N,9MDJ:;TW&YS(L@
MZ-DN2N6)5.=5D1S847I1K&\Z?3]2&J*=;N_OU;L;GEUEJ=+-SZ,NI+Z]=9J_
MP4>Y8E\E J]]D^^SJ3'9.UP&[LC<I@9W)$FH8XFQWEIS<$=,R%J-FC3AS4:C
MT2JU>OFA)AOO;7-O>6\-W:2LGM;AC98)XW(]CXWHCFN:Y."HJ+5%0,N4"$[Q
M9K*:<VKUAGL)<+:9?'8F[N;*Z:C7.CFBB5S7(CT5%HOA0$/)/5NK]2:ZSD^I
M-67[\GF[EL;)[R1K&.<V%B,8E(VM;P:B)T!R)MM]OINOHRVQ>E-,ZEFQ^GX[
ME.2Q9#;O:GI$W-)YTD3G><KE7I"4;I]^K]"EO^7++WFX#,-+=A=U[;9K5N1U
MA-8NR5TN)N;+'V;7<C'W4\L*L[1_2UB(QRNHBKU==0U+/:KWF[S.KHI-67.3
MU#B\ Y%FBFPL=WC,9'#QIRR6Z-1S4K[:21R^%042#:#O@;D:-SEG:ZWRDVIM
M'S2,COVWU)KV")RT=+#/^^.<U./)(YR.I1.55Y@4>E,$\-U!%<V[TEMYF-DB
MD:M6N8]*M5%\"HH8:<=Y'O?9'2V;N]!;6/A3)V#G09C4,K&SI%<)P=#;,?5B
MN8O![WHY.:K4;PJ&HAK+!N;WD,Y'+J.QU)JZ[L85<LUW93W_ *$SEXNYDAI"
ME.NJ!5N;+=]35^$R]KA=U;A,WIBX>D3\QV36W]GS<$>[LD:DT:+[='-YZ<45
M:<JDF'H+;W$%W;Q75K(V:VG8V6&:-4<Q\;TYFN:J<%146J*&7F[O%WCMZ].;
MJ:PP.$U=<6F(QV6N[:RM6P6KFQPQ2JUK45\*JM$\*AN(8W=/O9[CZO;C,5I;
M-WF"Q./L;:&\O+*1;2]O[](6)<3R21<KF-61'<C&*B4XKQ6C11?7<CUANCK2
M/4U]J_4=YF-+8ML%K9QY%R7,JWLRK(]R7$B+*J1QM1%:Y]//10DJVWS[Y>L<
MGJ"^T_M9>IAM,V,K[=,O$R.6[OEC6CI&/D:Y(XU5/,Y$YE3BJ\>5!$*C?K7O
M,OM/C]V<UNF,Y$N/3FW&4;9]DB5Y^9%2/DIU] 5,=KN^-NEH[+VS-79"35>E
MGO:R]M;U&.O(XU5$=)!<(B/5Z)]#(YS5Z."KS(*/2JPOK7*6-KDK&1)K*\AC
MN+:5.A\4S4>QR5\**BAAYF:\[S.^>)USJ;%8[6-Q!C['+7]M:0)!:*C(8;F1
MC&HKH55:-1$XJ&Z))N/WL]U]P\K^;VU27F-P\+6QM?C8'2Y6\<VB.F>YC7.B
M:Y>+61HU4^B5>A"45?AN\%OOHO+<[M89B6[MWIV]AFYI;]B]"JQ\5XKU2J>"
MB^!4"T>A'=]WWQ6]^F);OL68_5>*[.+.8MBJK&ND1>2:%7<5BDY741556JBM
M55X.<9F&GF\F]G>#VSW+U%HY=9W;;.QNG.QKG6]HJOL9T26W7F6#BO9N:CE^
MF10U$-UN[_N#-N;M-IW5%],D^96%;/,/HC7+>VCEBD>Y&HB(LG*DM$X>=U!F
M74[Q^XUUMAM)FM18NX]%S\_98["RT:Y6W=TZG,U'(J*K(TDD2J?0@AJ5W>MX
M]^MT=V,#IF^UA=38-CW7^::D%HU%LK1.=['*V"J)([DAJG'S^E.D+,/0P,@
M
M
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M%YYG-\3Y51J^.,$MQ0R
M
M
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M45O-(RO+)<4YYY$K_"2N>_U0PE(
M
M
M              /,WOM_IUO/R98?8.#<-F>XK^A2X_+E[[S;AF6S(1Y[=ZKN
MS:CPNI\EN+H7&RY/2V7E?>Y.RLV++/874B\TKNR;5RPO<JO1S4HSBCJ(C54U
M$JSV^[TN[^VN"9IC#Y&"]PULU8[*VRD'I*VK?I8GHYCT:G4QSG-;U(@6B-6V
M,W5[PFN9[V"WNM1ZGR+V>F7B,1EO Q$1C5D>U&Q0QL:E$Z$\'$#TYV7VMQ^T
M&WV/T;:R-N;MJNNLO>HE$N+Z=$[5Z(M/-1&MC97CR-2O$,RT-[QG=EU-MOJ"
M_P!1:5QTN2V]O97W-O+:1K*[')(JN6"=C:N:QG0R2G*K:(J\W -1+J:'[X^\
M>A\%;:>CDQV<L;*-L%D_,6\LL\4+$1&L22":!SD:B<.TYE\=* HANK];[K]X
MK5=GZ?#-G<Q&U;?&8K&6RI#;QR.J[D8Q%HBKQ?)(Y5HG%U$2@W/0;NS;+3[,
MZ#?8YA[)-59J9+W,K$J.9$K6\L5NUZ>V2-*U=T<SG4X4#,RU3[_/Z8<)_P"F
MK7\/OPL+O[@WZ'LW_P"I;K\ L DJ<[U'=FU)A-3Y/<70V.ERFELO*^]R5E9L
M62XL+J5>:55B95SH7N57HYB49Q1U$1%4L2KW;?O7;N;7X6+3..ELLKAK-.SL
MK/,P23+;,15\QCX98).5%Z&N<J-Z$H@6C!;A;N;J]X'+8['Y=BY"2W<[XKP.
M&M7]FV22B.<V-G:2/<J(B5<YU$Z*54#=[NE[$9+:/3=_F]5,;'K#421=O9HJ
M/]"M(>960JYJJBO<KE=)1:>U3J#,RQW?=V_S>L-ML=FL!9OO[K35ZZYN[>!B
MR3)97$2LED:C45RHQS8U<B?0U<O!H(:%:!W-USM?DKC+:$R[\3?7</H]R](H
M+ADD7,CD1T=Q'(Q:*G!>6J!IO'@<-JCO']T9EEE;Y][KF::ZN;>^NE;&D]W9
MW\LL374:UK6NB5(6K[5O!>H)NEH]A<QKG9O7,.3M(Y\%K#!RN:^WNXE:YO,U
M6/CDCD3SF/:Y47PHM47H4*NR_P"\+WBN\%;NVYTWC[:),DWL,@S 6TL+Y+=_
M!R7$\\TR11+3SU1S$5*M6J+0%% :RTIE-#:IR^D,VC/C3#7,EI<.B5RQ/6->
M#V*Y&JK'I1S55J+1>@*]=<!J6UUEMK8ZJLY$D@S&';>52G!\MOS/:M.A6NJU
MR=2H'&\?<+^.,?\ "8??&AR/:\.-H)_F!_+'1WY,N/PA U"<?Y?GR/UC^4[?
M\'4$IMWKN[Y=[O8:SU'I1K%US@XW116[W(QM]9.57K!S.HC7L<JOB5:)YSD7
MI14)$M!M-ZOW.V3U)=KA+J]TMJ%B=AD+.>%&JYK5JC9K>Y8YCJ+[7F9PZ@T[
MFN-U]U=Z+VQQ^I\G<YR2)],;B;2!D<?;.2E66]LQO.]4JG,J.=3A6@&YG= [
MO.7VZBN=P=;VOHFJ,G!Z+C<7)QEL[-[D<]TJ?0RR*UOF]+&\%XN5J&9E^=[S
MNZ9;<1(-PM"VWI6J;"!+;*8ME$DO;6-5<Q\5:(Z6.JIR]+VT1.+4:XL2U V[
MWEW4V,OK[&X"X?8LDD1<C@<I;J^'MFHB<SH9.5\;Z4158K55*5K1 M'%KG<G
M=+?[45A%F.US.1BYXL3A<7;+R1]JJ*](H8D<Y56B5<Y7.X)QX ;U=U'8.\VA
MT[=YS5,;6ZWS[6)=6[7-D2RM(U5S(.=M45[G+S2JU:51J)[6JF9EL2$ -$._
MKH#-OU%@]Q[*S?/@UQ[<3DKB%BN;;SP3RRQNF5$X)(D_*UR\/,IX*FH:WZ&W
MKW0VUQ%[@M$:AEQ.)R$WI-S;,AMYD6=6-C5['3Q2.8Y6M:BJQ4K1/ @6CTZO
M=+8O>39JQP6J4D=!J/#65Q+/_P#40W,D$<S)FU1//9)1W%./0J454#+S5W*V
M7W,V4SG:9:SN([*UF;)C-3X_M/1'JUU8WLF918I$5*\CU:]%Z.%%4U5EI^]7
MOY<X1<#)K&=+9S.R=<LM[6.]6.E*>DMB25%^K1W/]4"ALUW>=>[T9B*[["?'
M:2?+VF2U-=L=R.;6KT@YZ+-*OU/!%]LJ F7J)IG3F(TAI_':8P-NEKA\5 RU
MM(4XJC(TI5R];G+YSG=:JJAAE0 'GIWZMO\ -V&X-KN!#9OETYEK*"VN+Z-B
MK'%>VRNC[.5S4\U71]FK%=[;BB>U#4*1T9OGNSH+ 2:4T;J2?&X2>5TWHD4-
MO*Y)9:(Y8Y)8GR,K1.#'(%HW8[[=TV^V&QU\QJM9<Y?'S-:O2B26\[D3J\(9
MAKYW%?TUW'Y#O??K<-2]) P\>=Y_TP[@_P#J7,_A\P;AZG;,HB[.[?(J51=-
M8:J?]0A#$M!>\=W9M2[;Z@R&H]*XV7(;=WDC[F"6T8LKL<CU5SH)V-JYK&=#
M)/:\M$5>8-Q+#Z2[W.]>C]/1::L\I;WUG;1I!8W&1MFW-S;Q-2C6MDJWF1J=
M':H^G1T< 4132.@=T-_M9W%S86]QE<GDKCMLSG[EJLM(%D6KI)I4:C&T3VL;
M>*HE&-Z@/4W;K0N)VUT7B-$X55?8XJ'LUG>B-?-,]ROEE<B="R/<YU.JM P\
MK]_?TUZ^_+E][\X-P]).[9^@K0OY,9]F\,RENXND(M?:%U!HV67L/CJQFM(Y
MUJJ1S/;6)ZHG2C7HURIUA'DMFL#KK9_6D=MD[>XP6J\)<LN;.>G#G@?6.:%Z
MHK9&*K:M<E6J&UW.[W'>'W$M&:)TU:6C<U?M]'2ZP=E-\9R(Y.5RHKII61JM
M>+V1MY>E%:$HH_<7;W4VV6I7Z7U;&R/,);V]Y(D3^U9RW<39:<]$1RL55C>J
M53F:M%5.*E>G?=IU+:ZIV.T7=VTB.?88^+$W#$IS,EQB>B\KD3H56QM<GB5%
MZPS+S"W-_23K'\N9/\+E#2R;/+;]]V>.SN\1>36.F=36UOD;*=(VWF)NDN86
M2I1LS'-9.UJHUZ>:_AUMY54;T$UEN%N3O-G[.34M]=:@RZKZ/C,?;PIRM62G
MF06UNQ$YG42O*WF=3C4#>[ND]WV^VKQ-UK#5\*0ZUSD+8&6=4<ZQL.9LG9/5
M.':2.:UTB?0\K4Z>8,S+9@(\N>]UM_\ F+O+E+FUB[/$:F:F;LZ)YJ27#E2Y
M;PZTF:]U.IKD#<.UW.- _GGO)892YBY\3I2-V8N%5/-6Y8J,M6U^F25R2I]S
M4$O3P,
M
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MAN?W*=N9=';6/U+D8.QR^KYTOD1R4>F/A:K+5%]U625OU+T#,ME @
M
M
M
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M1$0,OL
M
M
M
M
M
# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2225088d1-tbl_summary4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-tbl_summary4clr.jpg
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M ,4   $$ P$!              8 ! 4' P@) @$! 0 # 0$!
M   ! @,$!080  $"! ,$! 4)#Q$%!P0" P$" P 1! 4A$@8Q05$'82(3"'$R
M0E(4@9&QP=%B([,5H7*"TC-SD].4M-0U-A<)\.&2LL)#4X,D5'2$Q!96-QCB
M8S1$=?&BH\-D)QFD)44F565&\N,1 0$  @(" P$!  (" @(# 0 !$0(A S$2
M01,$42)A<3(4\(&1L=%"(P7_V@ , P$  A$#$0 _ -_H!0"@% * 4 H!0"@%
M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!'9
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MJ!T[.P>_@^$!.<J^:=)S T.WK9ZE]"I5,A]Y7:*>D@M!TF0:;)P.Y$"JCO\
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M<0,ZAV%4S, -F?P[+7\*F(,+!9D5%8W[>@\(D9X!0"@% * 4 H!0"@% * 4
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M3]E5*;6FF;SU*NLI*@,4!P;1O$!H3RFT#<.>W-I_4"Z?MM/H?4^CKH1E$DN
M_5&%GQ3Y,!LGWI]&\QKG;['I#E]0]K86VT)<3VU(F20^K-C5+"_%4?*@!"Y]
MTSE[I_DU_>*^V?LM7,TRGG%^DU2I.(#B@9-5:FO)'DP$7W4M4ZPO?+[4>E;
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M)* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
MH!0"@% * 4 H!0"@% * 4 H#P -HQ5Q@//60)NKS#A*7L0&6 4 H!0"@% *
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MA+Z  KJ[\28#+ * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M9R$2@/IUKIARX_):ZW-6@Y0GLGAB%9=N26WIB$B%*^T(&7X/:E4]OJ0&: 4
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MI@''D^BI$\JYG%=:M'B\! 6=W1><#VK]*7#2=T5FNU PI)$@,5HJ'CXC*$X
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MYVKE8$=HWE=3E6\VI.U#R9[/-@B*7[Q'+>U<NN<5HM]"O,U6/A]"Y+$LKZ4
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MZ=[;92Y3_#.B;J67#Y#Z$>,!MAD9>[%J>_<N]5UW+O4Z.QL[F>F0F;2\ UD
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M"7ONO:JOW+K6=XY6:K1DL52_4TM)2S:.#E12T2!G82XOQ&U#K.?-Q@A%<Y]
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M4 O]?M9YZ_V#?X% +_7[6><O]@W^!0'S_7Y6><O]@W^!0"_U^UGGK_8-_@4
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MI0/K'W*#?6$NC4CC>8##T5L[0#_#CC&.W7A,$+?Z/M:D9AJA?W(U^$QR[1+
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M(YV9U(X5$RF:5OP?SB,]=!7.M^[FC15>W;GKTIY2UA$PR@;5*3N<5PCJG3F
MTTEW+FM5VUNX-ZA53EU(.44[:CU@#O?3QX1S[]> 2M_H^5$3_O0O[D:_"8QP
M,+O<)#2PTO52@"9'^2M;#A_.8G% 1KSNG4NB;)75[6H%5:Z4.G*&$),VVW%;
MGE>9#UH"M%=V[4>M[8JNMZEK:0Z1VGP0V(0KREI\\16@G_T=:T_A7/\ P/ML
M4R8+_1UK/^%<_P# ^VQ)@O\ 1UK/^&<_\#[9 ?#W.M9R/PSG_@?;(#'_ *.]
M9?PSO_@?;(!?Z.]9?PSO_@?;(#Y_H[UG_#._^!]L@/H[G>LR9=L[_P"!]L@/
M7^CC67\,[_\ 3_;8&"_T<:S&/;.X?T?[9 >O]'FL_P"&=_\  ^VP'S_1YK/<
M\[/^(^V0$5J'NJ:GT[8ZR]5;SA12H=<,PSAV3:G/)</FP%%45,BFOE.R^J:V
M*U#1PVY' -W@@.R/=\ '*?3A D#1467P>@T\H"SC(*!X]7U8#) * 4 H!1%$
M1J7\2U7\7\8F)'"N_?C>I^@^+3 =%OT=WY%WO^J_?%P@-U8!0"@% * 4 H!0
M&KW?=*/S7.S'6ZOW[106CGQR1J7Z37-$6?\ >R^YG_=@WT;/:DH*N[.>FOF3
MB<=WO1T>;%>R\/>FZV^26J:BVL^C5)D@2 _\0[ATQR2N;NUS&S5%6,U].'*=
M4B-WA)X^".S7P\/LUY9VDJEF4X0KP1>L9&9O-GQ&,4RM(';\^IEPJ,@/#X(O
M'5I%>:LO35QMSEO9>FJ6&$MX.\0L;->.WN=DN*V4IS))XCAZO&,_E2Q/5Z;B
M]:G*EIJ23+#,.,M\:=GATZL'+U5V]+2ZEK+EVG,-X5'#AM*NFY5-1BZP)SZ1
MT1TZ13:LE'=7[K1?)E0);MO25<!%G)L"M0\O;G9*Q%ZI7BIN>,@C?)/G'V(Z
M=N_/PYNJ8H@KM+4VMK&A><BK ZTT^^Z2D;$QP=G+V>OOQ/",T'H%&E:LONN3
M5N$AYJAN4>,831';W^T7%:K^7%%@M!0W$F7$\(Z]>(\?LF:@N8EPFWV3P&1/
M3/84G=$^6LF%.O<R4T+WR>TGX,8';X?-Z8OZM(F:._6RKIPX7#FW I/$]$9;
M=65X^6*CH+]?@'5R2DDB8/FSXCA'->E;*_2*:V4 :RI0GH5/?ZO&.F;.3>9#
ME52L7IOLUO%*/G9[Y]'"(VKGUUY VN= VQNC-4VZ<H]X=Y \Z,8]/KO"GK?8
M]/O5^6J?*<?,5P^>CTNM;:KHTW8Z2TTX52/E8/O9<>D\8WK@J8N%,I5/VXQ4
M=GKQS;*"#1=[2BG]$JE?"'_:.X1FK1D.U&$P6]V(BW"JOM::);OKP>6_,[<4
M@>;[X<(MA ;>T@]0]FVTL*2G;L&_YXQC6VM$P32.T1HP<J?5XSB)NZM=E=WZ
MB<MBR&\4'>)='AXQM.QK[H6HTK1ZHIR@U)[7 I!1TS\X<([/L>?=TUI'3==8
MOY&IT]GL&"??'B>,3-V=V"G,SE[4W1U2D&:U>#WOOA'5INPM5';^2-]15*=/
M50?G.$O/CMUW9X6;R^Y?U&GK@IY:@$JW]7S5#SCQCG[HTE'U3HY;%4;JR9S,
MSLWC+YT>1MIRZ=:/[ VT]1I6Z<N7'YIB?7"]H<YR5J'N7-WIVS,(;5\QM<8[
MZLLN3E%^6=/_ $MG]NF,UW9_E5^05D_H_P"[5 "O>/\ \KKM\Z?BW(@<CM"A
M)U91!7BEU /@SIBQ/+IW<44]MT31JL^)4V,Q (WJ\Z<>AUNMFT9;G+U8/Y4N
M3@2)@@<#X(Z-NSUL#05;6F*HL-XYC+8=^'3&F^WM =V9FEJ*9%>M,BH@[XX=
MYFH3URU"BCI4I FD>'W(Q^L,K=?Z6XJD$=8B7E;_ %(CTP0TO.DDW#,^U@O;
M^J9C37:01=JMESM3I"C\&.E.P>O&]VE@E*^^J<96TU]40#AX!X(SUTPQ5E<6
MJ^Z5:GG,,IF-GAZ(]+3B('^A':X-AE\R3ZAW=$>;^GR">ZT2W@M#+Y!(.X;?
M5CCZ]>0!L6.Z6RXFL=7VJ29S)2/8)CT\2JX'U(Z;I1%I;F14M@ZWN1S;SUJ<
M [4**VT452BG3G)29"8&X^&.CKDJ%0V/5-XJ:UVU5M-\$5222H8$##8GICKD
M%F6 5%K*RX"4)Q/J#HG'/=5V6N5:]:Y[8O!Q((/C;L?>\8KCU&:PZ:M^F*1V
MWT[Q*S[PC8".)A[6I8K>I;%U (F"9>O%]]LQ$3^KM--7>C:=G(MR(]0SXB.3
M2\B.L-[=M;B+<\"64=5)\'@$:;ZRF1TW<0^V0-\<V((VNK5T-.MXGJ@$^M&L
MURG*&L^HDW%?4$@?#[D:7KPS/:VQJK' [FD"9G9[L3KV85J!U17O:9I JD!6
M3*>[HX&-NO\ WY1;@%KUVM+3=0MD=J5)G-7$_.QVSHF%,CZBO?\ >>SI97U!
M(;,>/0(\^]?K4Q#-Z85250>ICG$\3@)#U28WUWF#"5N.GD71KLP_-9VB0]T1
MG.S!3S36CF;$>W+O7)!(EME]$>$9;]F4![FK2J[!%53)FHD$R^C.^-_S[<83
ML%[+5O-6L/K!#K:0J72E,XZ[RJG[/JM5P0&'AUQX>CH'&,-NN3E;V$5*UZ<V
MXE8P"2?6$96X0"]3VRE:/;*1]3QW[IGC';TWV9=T8M%ZSIO356Y&&6:1MV@I
M'"+?HZLQCT^5I(O"VV%*<\0 D>MX(\+?I]J]K7PAVM=ML*J$*. 2O+MV@8>3
M$7\N)G+BW_\ )S7[QU?\I<SJVMWJK'C^RJ%GHCG7=#^Z0 >4MJ7O[%CYK*(K
M1?'E16C0K](#+M+;F\7LF9^#M:F*SR*.[K=P5;M4]FP<H<S$#PED;P8Z]-5X
MW9U)S+7IFV*96DNU#V#0,QUU)4!B$G>(]#KZ9M<IR$=..ZGU#5F]50%/3^-F
MSMJVD+WRXQW;^NLP>1_;K==*ZK;J?2BXRT0K (V)(.Z/*[M>2+,M+2GD +_5
MLCCVK8YN%L[6F>IDGZNVMN?SX(XQ&M%:V7EJY8[Y47!3F#RED8#RE [E'A'5
M]DP+)M]&6FRB>!QGZD8;W)3.^.!=(NF>Q:3L)Z 1%NB<Y8JUO1H:FC<H N22
M"F4CP(]N/3UE5J+TG35M+VUMIFITRPI(7,;" G?/=TQG;BJ54G-+EEJJIO*J
MBWB;3BR20IH2!6H[U1ZG5^G_ !C"N.5L<E]*W.R6A(N;Q*Y##J'R$^:3PCR^
M[?+0<:IY?LZII^T<>DE!"E'*,$B9)EF'&.:=F%<(ZQ62EL%&];:*I+J$SVIR
M^*D)WD\(Z+<X7B,I'*5^\FF<J%-+"BF62<SF B>SP96&+"W4T994X5IRR!R]
M'ACBU[,)UV57>.6ES%Z-51OE+:5]H$R1C)<Y8JCL^V6+K2L%KKF+6PFH5UDI
M3YNX=$<NV\RSVBD>>MHU36OA=NFMI..6:!,!3AWQW_FLS'-M UR\UWJK3M.+
M=54@2RR.O\(DX("0=B3PCT?T]&NW.67M5H4G,)C45.^VPSEK4-K&U6*@GB4@
M;3'GZ=4E\K2M=]?:?U!?]54[BV)-I=3/K).QTGHXQ[W5V373A;"]-%Z4K['1
M4=<A4E9$9D]7> 9;3PCQOT]TVS%IJM=-R7\F&HR 5"4^=[V?#C'E::<K794N
MK[[=&DOU(;FI06 H*!E/.9[(];IUF&>557:BK+GI/4EPJ7)3I:Y64Y?X JZ.
M,7[[_E?2KK[HI/YN'&IS[.N/K)I*01\WV_\ DZ<\-AHJS* 4 H#Y.0F8#RE6
M:< E$I& @$"J4R-L!\S*S99;1.<X!$J! 2,,)F<!D@% 5YSQ_P K]2_].KOO
M-^('&E[\K*G_ *JOX^)'8ON^_P"4FF/^G4'WC3P%F[H#[ * 4 H!1%$1J7\2
MU7\7\8F)'"N_?C>I^@^+3 =%OT=WY%WO^J_?%P@-U8!0"@% * 4 H!0&K/?>
M4E?*UY0V]7[]HH)U:"<A6U/:[HFI3([7[V?,'1HV]U59;FZ_*E2H-[P .".,
M<^]=?5V<IBTT#]IM!>*2'@)B>&()C#7R[_)WH#F[J1-W3;:E$VYXC,-R5'<B
M/1TF7G]NC8QC6U)-*:D!#AG.9/N1:Z.3U8[AKANF;44"9W$3]R.?6JS13FI]
M4ZKO54L6\*#?&:=DAYR1PCIUC;68 2O[T)JDO..+6A4]R/!N$1M&HG59J%=,
MBON#<W-IG/C+<8YK3"48J[57MMTE.V@-JVIS&>!GOC?=.1];M*6VGMJETK*4
MK Q,R-YXJCED3[(^W>@)*F7WTX<?5Z8ZI%+LDF--TRVU5].[LQ$AZG&,]F58
M&[HMQXVZX)S,GIX8^2(YI46)-#MKLR"*9(2"-F/MSXQU::Y84,5=X;?JDY,J
M1\]X(G?7$(DFK@6*A.19$P9R$]T>9OV65O(;:@]'NE')]Z2^)'2/!PCU=8*T
M9T!;+A<)=N LGS>CY\1T2&3K5>C18,J*1^:1/8D='OCQB<K9!MLJK_17<+HW
M% XR("?-Z08RVVX3D5U&K-:&H325]:X4SQFEOP[DQX^FS;?5:NG;W1HH6VJJ
MI!?.W]D>$=+DL$.LU-(TYDS!9(&SY\<(C5;79JW>;)5+?])IE%,S,;.@;S'H
M==X6NRXN5[%WJJ -5E0I1X$)XK.Z+VN990M6;X!X9AQV=.XQS[56FM;9Z>A3
MV[!DYNP/@WDQ$5H>NFL[Q9F2X9J0!, 2]I)XQMK%57W?GG=:A]#*6>SG[Z?#
MBW'3=)$"6W:JK:YE-0Z]($3.*3QZ.B.3?5.3:Z:C>KV"+?6974[AEGQWCHC#
MT7FP2;UM5)6:*OJ"7!@)@#&4]R8F=9=T+3WW4E%J-!#RA3$G;D \7P1Z-ZG#
M[+N7J:F%.RX\4*?.T9L=LMT977!["BDHV+DT*AP>N#^MPBVNV%LL5YM2UTA%
M")&6[P])C?7L2J:M%[I:@L#--/@X \(Z]]\LM:)]/72O4P*>I5,;YRW3.X1Q
M[.C6IRXU3C=&/0S('AX>F*^R]H3UVMQKEM>'*F94XTH"?2VL;HQVK//+E_0X
MZSII?SMG]NF.5TNSW*K\@K+_ $?]VJ %N\?_ )77;YT_%N1 Y'Z$3GU;0HXN
MH'KK3%B.LMAM5NI]-4-+4]8*;&T'B1N,=OMETY/VZ&U6)GM0L):4,!([\.)B
MV;1%(LUHU#4AU*@2DSW^'B(M;A&4EJ!?R/:DTU)Y( $O5XSC.;<IR"[)67*[
MU2J.H.8>$>T!'1=HC*P[;9F[*SV[J<3^K<3'+MME*<96Y6L=K3&6$Y8>W&68
M9"VH+E74R5MS(401,2,OF1T:8RBT$Z>;N#UV5V[ZG&U3F"D#=T1V[S$9ONJ;
MTQ:;AZ*FES">*IJW'P&(UO .]'W2A>MG;-4^5TC ];@>(CB[)F@2USJV]68E
M=*"$JX$;S+S3'3U=4LR(^V7&]ZBL[;SM4ME1EY*3MGQ B_$^%!3IZEK:!N;M
M85X3FI*4QEM<ARY?&7JL4E6GM4C G'VA&/CP92#^E-,/MBO9I4I>'6*IN;=N
M]41-]LXJ2;7:PR[3N%/:+2H"<QC*4:7VRLK&V457;-8..4X/8J6K$;)&0Z8V
MV\*Y6)6TKU1<4NIQ2J9CG]L0RF**QT38-2_3A2YB1F=OJ&,KNC*,U@JL:I0N
ME)" 1,"7'IB=#)OIINCN=(E52G^4)ECCMV[I1KM:G(J:8;920G;'/:C(3Y@5
M+E/:SV?E)EZ\Q&_5Y3E"\MZ%QZA34.B6 V^ QT]^^"18R'FD]4G$1P;12HF_
MT=-<J9;;B=HPP)]R->G;%44I?M"/.5,VGE!O-, (!W_/1[FG?)JC"Q=&V=5K
MLKN?X1:4X3ZNQ)Z8\SLWS8F!I>I*YJL>:Q0D$B6W=X(VX1E)Z9NE0JXS<22@
MG]6Z*;S,0L=;B%A3H3Y)*1TQQX6PKW4-_2FJ%'5HS-DRW\2-PCLUF$)>P66U
MW"E6O+))22!)6](Z1%-^RQ,86])TM+7]LTF2)SECQ\,/?,5%E$U3,)( EA([
M8PVRG*(O%IM]R#C"AXX(W[YCB.,;]6]U9=ERK-CETJVZ@-73S".TS;-V<'>H
M\([KWYC+KF*L.HI5.THI]\I'UI1P2XN7IS;A!/Z3#K+BAXP!)/J>&-=N[_-<
MVUY<Y^\%3^B<QJNGX5;H]9]8CQFKHSW2)?FAM7'LJ?XA$5HO?RHK1H5^D!GV
MEMEM[)F7V6IB)Y%/=T6QMWK6(+QD6\TQM\4LGB.,=VFW"\;G<SM&4K]O264Y
MG6U#*9' @+EY4=WY^S*U0MFL-?<-+&U,OJ:>;3CU4F>5N6\CC&^^\ER#SEM:
M:JRV\TM4\IUS89I"?)2-Q,<'=<D6-1) 5)&R//W:)%X)""5[)3/@C*5&4)65
M%,Z4I23-$MQW1T:TR=,+'HREI5*22 ?4B+Y%5<PZZ_/%%);7E95$))DD;2H;
MQ'H=6DG*E16G]#U-4A-1>JPIF,RDE*3,8$B:5#IC3?=G8L*TFRVMD4%,VE22
M)%8*N 3LF8Y++5:#=?WH6H9;:D+6Y@K&1$\PW@\([NG7,Y*\Z%NE;6L 5*3N
M]A/ "*]L6BT*5(72EI")%P93ZHE'!MY3A6-:U56S5Q94X6Z9Q2@1($2+DNG=
M%YV(O"9NM@HJ97RQ3@.*![11,QLFKCT1KKMGAE=@5=^\.G3]3\D-4F9:.J3F
M7N)3_!GA'3?QSRSUV$NA.9"];59;6SV:C,C$[>KQ2GSHYM^N:^'3K5LT[$FB
MEQ4B@>P(XK5JA;G;4UQ6E2<Z)$$$RF,>D1.O;8SL"]9HS3ZF74>A)2\M*LYS
M+.T$'RHZY^C:^67UP&VBRV&V7=RDI6LCI60M4EREF .TD1K[VHQA+ZB_NU:$
M&H>*%O#$3*ACB=Q/"+3:TRRZ.U=;[X30,)1U,$G,<)2 V@<8;]?&2;,>OC>*
M"F6*)PD+!\7*=H5X8:8JNP1T14NUZ:JDOZIME+@ZWT"?)EQ5'1FR<(@!YH4B
MZ.TWY%M410FGJ]@PRY'>,SL BG;MG5>+9[HH Y=G*>MZ5U_N2DG'@]G_ )-8
MV)B5B@%,#:8#X=A\$!\W">R C[O>J&R4JZNN>0S3M)*UK6H 94I*C*>W!)@(
MZPZSL.I%%-JK$5!&T-F<O%V_LA!*5KKA26YAVHKZA#%.VA2U+<4$X)!)VG@#
M!" MG,'2MXK%6ZCN3"WA-*>N 2<P0-IXF )T=F<N0A1D"%#81Q@,T H"O.>/
M^5^I?^G5WWF_$#C2]^5E3_U5?Q\2.Q?=]_RDTQ_TZ@^\:> LW= ?8!0"@% ?
M-X@(G4OXDJ?XOXQ,0EPKOWXWJ?H/BTQ*'1;]'=^1=[_JOWQ<(#=6 4 H!0"@
M% * 4!J]WXE3Y4N#YW[]HH)C1SNLL%[FE;T\>V^\JJ#HU=-JU^S6Y?9N#X8[
M/&X ^W&>^JO5<4*7>U_*_:%.*"#+UO".$<TCU9OPJNV:1JK)>37(<*W$3,B
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M.XD*X3$]O3+A'3JI0[74M:A$_<C6L)35 J4-Y58^M'+OMAOK&"FU([;WTLU
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MO%4L'%KC 6G * KGGI_E?J3_ *=7?>;\!QJ?_*M[_JROCX#L=W?_ /*72_\
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MI9)&,B.@G@/-B+%LLUTKK=33MMX!<:. 3)7A\GI,-=L"#:Y7+K'!5V)L-HX
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M4:AJ CM.TQW##W(Z-7-LR+U-65#620<2.*@.GA&F&>0+K"OKJEC+1J+*L/%
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M.,!7/.]8_-EJ1L'KIMU<K9ME1OB"7&ZIF-7/*GXUV4"/"^8#L;W?O\IM,?\
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MZF;8I^8UPHV&^QIV+N\EM(F?$JU)&WHC/#3+KQW?Q/E/IG_IU#]XT\1(6K+
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M!K=I=FZ56LZBT)!73!Q:,9 2#B4^P>,>MOOA2K;K]!V6QMJKJ]A.=P$A14K
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MQ.93(&#B0GQ&I8<8 3Y,<P[#R_KZNX:CTJB_/.=GV9?=J6)94O)/U <'$^M
M=-N0O-7\[.EW+DFVIM[;&7*TE:U#KO/H/CI2?WJ?JP%ME*53F)I.[C"#67OO
M=HKE8^VCJ@9);/Y[1'? <_>[_2>FZ]HT)P5\+]ZU'N0'3FP6IZEH%IN#I*)8
M @><K@>D1GI,5/H"+[RNMMVJS>&G@D@SRRF<9#>L<.$=FNS2056&N-AIPTW@
M/^WP\8S[-FDB2N-UJ;O3Y4$REB?5\ X1YF_E>*.U927"CNBZBC=)2"<#E3N
MWQT]&^*UWU#AU57$E%2UG(VF<_8$>U.YYV_6---HI[VP7*2:9[1(]/&7"/.[
MM\HTTPEZ?3--1O=NI<UDC >MN,<>'?K,"FG0XAU26W<H\ X=,<TUPIMH&=86
M>KKJ<]I<)MG#*$H.\<#'N?FO#EV@0H-+5%@IS5TSAD?- .V8XGC'3VW+)+:0
MMM=77%52'#.<\0!Y)XRX1R35>5>%!2ERV%MU.=V6V<MA)W1A-C"H]5U50JZB
MWE@]D#TRP"3PB?9"UM)TE-34:7V$XGP\5#?$7E5+7-;F<*(,C^M&-T0#]1:<
M-TI5H4#([#*>\=(X1CA:;JWM%A;TQ<BIP%1)$L"-TMQ/&-)5YLL:^WNJ52,T
MP3U#P,_*!X1%K6!9=SJ;'=VG4GJ*GA,< .!XQ2QIA;-)>*I^B%3/JX8X<9<(
MOUUA@5V>YMUU($E8"AO]4QU*5EN2NSI2HNS!\'&.?>*U2G-&TKJ[0:AAR13U
MB)#<I/$]$-=.6658:,OE-<*<V^K(1.6)G[X\!'=VWA.O*TM,66W6U&=A<PJ1
MQ!&R?$GC'!ET31-ZKN]:;86*9R:0-@EQ!X1W==4WTPH![6%Z9N*J8D@)QQEN
M$_-CI]G%M<4;Z=UV_J*B>MSHFI($C^R5YHX1EI<K;0$HO5;9+LXT <5#V/ >
M,;[:99:WE?&B]0KK*<!?5;(QGAYW0(X-]<._2L>LK;3Z@2::F5([\/ =Y'"(
MEP;15]+RNM%IJ?E3--[:!E/#+YYA=LJ37![57[Y+<"ZA.5B>!/\ V1.FN4[[
M86GINNMFH[5\"XE#A'J[5<9<([?3$<><H96G'K?<U*3423B92&Y/AC+:<NC7
M7@]3IEC5X50UHRIW;_?;BGA$;:HTV-U:)I]$L%NC(5N.[?\ /*\Z.>NS78S2
M$.)[1EL))!W^[$2IO( YLLN_W,KG"C'LU3,Y^0J+^W#GNO+G-;.KJZ@'_JF9
M_9$QFU=HN5)__1;./]P/VRH@"O>1_P L+K\Z?BW(E+DKR^PUK0'_ 'J/C$01
M'9G3*15V*W)41+L=QGO,7NN&J)O6FJ)^KS+$R%3W[CX8G6*5'ZA;M]#:W&GE
M@-J$I"9V@C<8[^G.>%%'N:%MMUK5UE'5Y259@G+O]5<>O.WU5FJS]):=I[?3
M-MUDBZ0,?^PQP=_9[-Z\:AOO]W[FAND$DYI*(GLG+>#''IUY5R*K1=&+\P3+
MV?UHMV:>J?*94_2VJB)6  !,S)&R.+Z,U%G!C:[Q07%2TME"4+F)!4SB(TQ8
MY )KKEO35JU5]*HG,<R@$G9ZJH]3H_1ZSPM'GEY84VMPI0DI2<-AX2XF'Z._
MVC243:_8-/:)M XB9EZL<G5V8J;<@30B[;4*<IEB54H$ D*&,O6CKVVN.$P^
MK=/WB@KU/-$EM2L)9=APXF(O9+$58%AI:AJE;=?$UF4^/S(\[?;E LJZ!BYV
MT-U ZA$B,=F/2(SUVQ4H:W:6MUN3_(&QB)[Q[),:W9FK3F9>KY1+-!;&RD3D
M5 CCT@QU=6/*<HKESJ&_4]:*.L?6<V&*4\);DQ7OY0MNY)0ZCLZQ0*""9JPV
M>"4<FDY%?NVQI%V%30J&2<^KCO'$F/4NV=>5:L&WONEI.83,I&/,[+RAZJJI
MED%*I =,4G*$,Y=J9AU(21-1 &/$QK.O(]7G5+%LIYN@3\)]H&.C7K58-/WR
MDOH,MO#'AX!#;7 DKK445KI@HI2E9PVF>.'3$Z9VJ^< B^:49U-3"L#A$Y&6
M6?3Q$=$W]:K>4&G3-%I6F]/:&:I(PG,;?5,==[;NSNN#_2%XN%SKG%UA^ (5
MO$L1T 1P[>5<)JZ\OK/J57;)2 \ 59AF.(Q\X"$[/5,F0W>+556.V"CIG"$L
MJ&  V)!\,=6NTL3)R+N65U?=;#+\SA+YB1PCS_T1TY6:Y3-*SJ Z\B4[=NZ.
M&;\J6*N?U-4(U!7VE\2;':H3ZBLO"/1Z]98RR!F]*,?WD?N]09I[12TB6_.%
M#88[_?$PS^1NPZY42(!2PWNW2&,<>S3#Y<=*6Z]ANJ0,KP(F<=N)WJ'&)U[,
M)B;T]8U6-05VF"L-@WRZ3PC#LV]EF+6KKU!3KK6WB24*4!(;9*/3PC/6<)GE
MR_Y[U[]PY@U;S^TU;GKE]1X#C&&SJ=&^Z4">45JQ_>J?XA$847SNB(-!_P!(
M'XUM/^Y9^-J8L*][B*YZW>)X/?\ D17*[IB5=<@;3L\,+!BK"!2J#BIJ$Y'U
M#"5"-I4S94K-X/6C2U;X>%H0Z#VF)_5PBDV9HU]EI"IIP&_]1CITN49(*9RA
M25"8Z8M9E&4O0UF9GLRJ:")'P$1RV8J,@;7]74T=(\6$31CD,^A4MQCMZ[A?
MV5]I6OU55*<4MTBD!)")MG  =$]D=?%\HR^7S55\M=Q:;;"@DJ W><1YIX1&
MVL3E;^D:^INUK8>J?&(3O' '<!QCAWDAD5,L_"Y3B!'-E0X6WVAR3P&[P1&4
MX?%TS!04J&/JPM#2GIVF7%E XQ6\H\![66K4:6H%5BDIP& *I;E'@?-C7I_/
MGY5NR$T/S+&KDN@MA 0#URHRP">*1QCKW_/ZS*)LD[AK:U6UY;2G$+J$). 4
M29CP [XG3\^VT3F0(63F3<KUJE= A*O1@L@<,H6!O0-QBO9T357V6E5NJ" I
M)CG2C7$KJ@ K9$P9Z>WR2I(V1;(^UMD;>H7$G:M)'KI/3#7?DP!K+I2ALEY5
M6)P?<423CY2A[X\(Z=^S*E-^<M%55]BST=02XVC.$@)Q*6WL,?#&GY+S_P#:
MFRB-&.7FCOK"74JS%Q )P_A$<!T1ZO9/\U;5MU8$N5%II5.CK9&RH'?U$SCY
M7]-_UATZI!U*0W()D0K #'=&/5MBH[9PU%[SEDNB+HQ=*1:L @IRI!D<]2L1
M]5^7L_P\/LT_T(.[PQ=ZRB0:YU13(3"@D>33\)<3%/U[\->C3E=^JK9DM%0J
MF'PH:7B-LPVK'$QY?5V?[F7KX_Q6E^L+/=[IJTMK6L(2]E\4; ^L='&/I-/T
M?Y\/)V;1\FM&L6:R,5CG6?=0C B6*FV5><=XCQ?V]V;C_P"?+;IU6LM#:6U%
M2)* ,MNX1Y,VS7H:Z<!V[ZD<M382&P0I4IYL<0=TCPC>Z9UM-M,'EHO'RC3]
MHK RGCX > XQR2Y4AXJI 2LE6 !Z!Z\=&NJV0_<*BU52E4[[:%J6"E76/E3!
MV'ICIUEC#:9>+/H_3],[\H4M&GT@J[3-F7@9A<\5<1$[]MDPQG7RQ<P13T6C
M;V^!\(JBJA+'?3N'VHY/;+61R"U6LKYD7!U0P7=7B/":M9BM=6KKIW?C_P"U
M&F/^G4'WC3Q1>K.3Y7A,5RAZBR"@% * ^;Q 1.I?Q)4_Q?QB8A+A7?OQO4_0
M?%IB4.BWZ._\BKW_ %7[XN$!NK * P.=>21B/*]J$%(W3NT\N[S=WKE6- UC
MV7.<KV.1L(&QX#8(A*"N_=XY/V!HOW)2*=L2F0'EG:!L#_OA$H4GJJO[KFDT
M*"RX_4X3(8K9>1YKBMRX"_>[%J?26H].UCVBZ4TMN^"F2'@?JM2-CV/C)7 7
MQE<$L9M[Q#(UI[\2 OE2Y/89??M% :%=VI;HYFT#;8F?AI_<=28#?F]:MU*X
MYZ"JF^#'OT[PE7FQM8[,L%FK+PMWM7F EL;>L-X/1'-M5+1_9;*U?T9-C?\
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MS;HWFO"62B4$YG#L5/YL<^VN%$1J=IURF*FQ/>!ZAC3JVY9U3UVU-7V.JR/
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M+8#Y"CN'3&SFLY6_J_4S]31)9H 2A9 $OGAQ$:Z:M^[;@?<J^75.JW(N=XI
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M=EE\#QJFLN-!:5,VPDN@=8X#9/B#';U:S:\H4]9=?W.UWH-5P4IQ:P@R$]I
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M30ODN.-<1+BK<8X9JFU=:ZZOLUM0VVWF0V)2F!M5X#QCIUBEM5KK;2]5S%I
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MFNV*C(/9T#I_3;JKM<&AF2"H>,<9>]4>$=%[?;B,\']+JNAJ[<^_0.%"6<
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MV:.D4TRR E""J8)\E(Z3'%W]UMP[='-GO-#)S6KT_P#KGS_]2N//K9T,[I(
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MKXJLYB*U9(:.O^'_ ./K/O=<5[)E&''W61_]RKD/_P"X?^_%QA(M(ZZ<@/\
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M'9U;<,ZB;;R_N=55^E]H$B>8SE[L6[-D1<-AH3;*%"%J!,A'G;><.F1,$!P
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MLY1\I5BPO4[YJ L%).S#C.,M-VJ>0IEBG"B.MA/UHC:TJ,7>55E4:=#9R-S
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M\]M^RW?PNCESS!IM1,%"$D*)R@>HWT>^CQ/U_G];E]'^/M]M1=J][+HZ_$X
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M?1I:21M2#OC>[80K[FMINK<1Z0PX]/;E2C#;X(Z>KOQ$(WE5:;E3U"77TN)
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M7%..);1+/Q"64^U'A_\ _0[<W_Y_R]?\_P +Z:IE+8SU0 PVC'='BSL=^\S
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M..8X;_)B*+$8<2^Z%D2/3X8I0]KT]O2N4XV.(4@^!0(BNO%RBM>-4<NZREU
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M:2XK5E.XSELG'2C:BNQ76KI:T5#6#9.WU"(XMYRYJLW5^H15:0=;8!],= V
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ME/<"=_@CIZXC)E0V^ZJ2*AYQ;:$=8E?5! QWQW<3Y6@VTIJ)B]/.VAU*5HQ
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M;H7*ALH0H REM\,)MRE!VJR-TM4Y5/D%:YG=A.4=*I\]54B%EI]YL)GU05#
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M(U+^):K^+^,3$CA7?_QO4_0?%I@.BWZ._P#(N]?U7[XN$!NK * 4 H!0"@%
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M&[I"5CE%:>AJG];L$1R)7TC:KPQHAH1^D$VV[ZVS\=4Q"5?=Q;KZU>'O7O\
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M<IW^"-.SLGKAA-.5F+U7:J6H%"IX*<GEW<9<8X_KMY:GE=6,II/2437-.9)
MGC(D;(IX70]JO-5<'U,F>7$';T>[$V03?9.4R'5<4*/S(Y[>5HY?=Y5>;FE<
M"=IK7R#_ %E<9]K9T([I.=?*2U'<EJGG]@1'(E?:=JO#%T-"/T@FVW?6V?CJ
MF KSN)X:X?X2>_\ (B%W3!]Y+;:USD 22? (M)E"K=8<S[';*]JV//!3A(29
M8F>8IXQU:=5QX3EDH*QFXK:J:0J++H!)(D)*(]J+W7 )*^BIWK,XRVVA;ZDD
M"9QQ01&6FURJKNGT(_4*=76 !!)*0"#+A';.V0%NEK,+5F:09)$_8 ]J,NW>
M6"=J$M.!3;DR#ALXX1RVH>[?:VJ1*JAD2)]2,E3E]9+86O$SBPQM$*ZRL!Q.
M$11AJ[FIA0;1UDG Y<<#ANB,4.T7)LTA0@=?*1TSE&GIBIP Z>VW)_43M:,P
M92I2C/# +"N$:S;"E3MUMMMNSC+CZT)=9*9!1 /5).\],7UMPSM.WF0W2M);
M([- "01LE%;X5EY8O2E)0EE(,C+'=PC'35N\W+5%+INF2[4D2D"HGA(^Y&^O
M5=DG.FM6V[4_PE"\E7%*2#+8>)XQ3LZKK 4JDG KV;9QQ;3D@7OUS+#A0H_
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MCNG ?%&9)S%)WP'R1"<R0#+?. 2QFP2LS._P0#B($1J7\2U7\7\8F)'"N_\
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MT'3Z?K%.N*RLJ)&[8<(O.W,5%U%8J) ])I)%L[92WQR]F]*]KIJ6E*GFQUU
M@RZ8QTO* 5J+3M17GTEC-FV[(]37?@9--T5QI@$U*E)2G9..?LYI1!6W<(3V
M0RK?3M(,_8BW7JI:K^[-T.H+CZ-6*+;LY;-\^F.NSAG5AZ5T^UI^G0&_%5+W
M(\O?69&'F#=ZMBB+%*">J=D^GA&O1Y2UQ<O%YH[JFH#*\N;;)7$=$>W)F#8W
M1=X5>+(V7D2=D!C/;CQCQ^_JYRE,!8I%+2[BK''U(SBDALW=6 LL%X3)\68B
M;KE=&:KH_2+=4%@F:@3@.@QKT:XJFS5ZXJN-HOO;'.$I7MD>(Z(^FZ\>CFVK
M8/1==0:HL?HKRP*B0F,"=AXF/G^S.<G5&.X\N6BH=BI16""))&XQIU_HQ';@
M7Z4HUVZG535HDF6$_!&/;M[7,<]JM.95EN597%5 @EE*IX< 9Q?3;$1$UH9#
M];0"TUHD4   ] /&,->S"<#VCM]+I9A56\H(3*>) W1&VWV7A.,(=S6M%?WU
M6]E;1&(P6-WJQIKT^LRM*':RUI]--.DX*,C+';A&WMGE6T2Z8LPH77&Q@%3'
M#;(1EW;Y1$\NTL-KS.2S$S$<TV;R':;/0O)"W",XQW1G;RC9%WY :HGF:<$D
M-K"2!ORD1T=58J#5:KFYJ,+<2O*7-LCYXZ(]33L_RNNEEEIBRMLNNE*R@#*9
M3GEE'F;3.RM-]/LL4#CK[H.11*LQ&$L/<B_9JI7J]:RH$!RGI2EQ10IL@''&
M8W&,].K_ #37RYC]X5]51S)KG")$UCTO":A<<6SN=%NZ0E2>45I).UFGGX>P
M1&&R5\'VXK!H3^D#Q5;?K3/QM3&D%?=QE?9ZV=0H YDO#U^P$3MKE%;W\P]2
MU-@HG@TD=F4*GB<,%>Y'9^;KF6%RU-1;;IK+62K@M!-*'2H'&4NU"M_08]Z;
M8U3JV/I;FSIG3S24@DM-I) &W*GH\$>/V:^VSIE1%JYFNW!U_+390V%J!ZP\
M4 [XWVZ)%=JS:3Y@5=ZOM5;G&\R I:0<3*12/;C#?K<UBS&%=C]4CGNBVL9R
MMIPA0W8Q6QTR'27P4A C*J/:VDK2DJV83B,"+NE4VB5.@8;/9$;Z)86>R;:F
M1UCL]:-*F&=)4.FY9)=0G]T(Q[=4475"44U _4-C,L,K5+B0DF48]>O+.M3M
M?<PM1T.I%!FF(80LY1U]@</1'T'7I/5CLL3EOK^X:F;%#64Q3)/C$*W!(W^&
M.3NZYA2>5BU3K5$$-O/)3F'P:"1/' 81Q]>N'3E2G,BZ5;EQ5;*^9H:B;;2L
M2!G4I /K1['3B3A6[)7EU;CHRF].I5]HAW#U%!/#YV,?T7VBN5J5NH*UZR^G
M,LIS%,RJ9GXI,X\/?3.R/8$7#7";E;%V\4Q<N#8(S25M2DC;X3'I]'3ZU:[@
M*GL5XNU0IUY@M]; F8WSWCICV)W368<]F4Y0Z<=I*IHO)FH*3USX1'!W=F37
MA=]D2RU:6VW5AQ*D!)&!E-,MT>7OG+IUW,JFT4=.7*ED2)F1A+IBNUM6RC/E
MIMA*DNKDIN93]#LC333,,G-N<-Q)?;5B<?7D?;B-^ODRCKY:[BXI2FU$D E(
MGO&:+::R3*NUX1UKIKDASLJ@&2L/7($6G;?XY]8GQ3"@;6MPR2XDYAT*$_:B
M;V79OK<(BXV5%>P7FR V<=HX$^W&FO=8C;9*Z-M]/0YDAP9C,&1&_)T]$4[.
MR[1G-^1AG0T%*[624@DSD-D<>TRVFR$K]2T@+E.TZA3J0H 9AM$QQXQKT]2-
MZUOYJ<Q;[9K^VJF8!804YC-6(#KL]G0(^BZ?SRZ>7!OY6EREUDK65H;[1A+3
M[93VBIJ!(2VU/QNE<>;^WI]&O7KE:J%-LHRC9'D:S$=NFB/J74K<R 8+ZI]4
MD1TZ-=]>#JCH6&T%TC8)^P8C;=R?7R:+4EVH4A(P)(GZL9S=UZZ\(K6M6U3Z
M,OM.<5&WU8_^G6(MCY*X]ZO5/F3<%)V&\/3^ZUQGLJZ[]W[_ "FTQ_TZ@^\:
M>,Q98\8P&# $MIZI1M(Z<8"JM9]X3E[HBX_)M]J' ^/'2A 4H=1"Q@5C<L0
M\.]KRAGV2ZVI;&\H:20=^]R *= \]-#<Q+B;1IM]Q;^Y+B A7B..; M6YM4!
M:T0(C4OXEJOXOXQ,2.%=_P#QO4_0?%I@.BWZ.[\B[W_5?OBX0&ZL H!0"@%
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M5P]]%=U)4E7:NL+=.&K;6H2D[1F2-_ACEQ6EL9K=5:5=I>W?JF34G>5(GO\
M?1U:>'!OY9WM:Z9I;*];ZBI;>4H 3*DG82=RNF-(U:S76E36W1YVW5"&FBH2
MZZ4X91Q,=$PA;/+9^Q6FE[.[533RI8!2TGS^!Z1#8?=4KI[G4'T"L;13[DA:
M0-W3T1S5/#'IRHH;$M33U<B2L))6@C8>GIB^U=.8&]445-<:]532U+76GB%I
MX <>B.?:U6V"GEE3T-HSFKKFP,-JT<%=/3$299VK;3K+35OM;A3<$!R0ZH4C
MB??1K-%<JB8U3:ZC4*JU56 V"<9IEXDN/1&5C>6)B[\R[&P]VAK20-@&4\.F
M,K*6P7Z(UUIJZTI<?JD!0E(**??<5=$::QR]E%URU!IM]E#*ZYI;!!FC.CZ:
M.K6.+:\M>N9#>EV7DU]L<82E6U*5IGM2-F8PWKT^O6?T!LZRMX>30AX!LG$S
M$L,>,<TS77MKK_5\Z&U_I.T48IGZE)4J4R2-Q5[[ICI](X-_*3U?S,TDY1BC
MI*A&;BDC<H'SHY.S,-9D(,W#3EPIV7:]QA:R#F!6DG;X>B,.ONV_C-\4]HFF
M63-G:)8CZ:.SWMGA:';^H]+LC*BH;#8W33+V8YMLK2AH:JT6]<5(<=&^1D)3
MR_/1$E6R!=5\P*JU5_HE!6E-),^(H2V [O#$YO\ &UD_K!0:]L[JTIJ*E1=)
MQ5('YLX9O\-9/ZLJWWJR.M)=8J4)7PS)GM\,,W^-+9_4D]?J)A3;SE8E4B#+
M,D[_  Q.;_'G=BUJ/6^D+E;4-UE2TI:DF9*DSVGWT=V7- ,S>M/VN\.N4U>E
M+4\.LD#Q9<>F)RC!U?-=VI31--7)!X9DC>.F&48H)&O:!#TWZA*YG&:A[L,F
M%DZ=USI@#*V^TCPJ X\51IDP,&-0Z;?ZSE8T?HT?31&4X1M7J#2RB\!5-3 P
M.=/#YZ(R85K9M6VIV_.4KU4A+,Y E20/$GO/&&48K/KGY"=;';533C!VI"T'
M>G@8:[+:Y4OJ&R:?N:TL6-UMER?65F2G>#O)W1TZ[MJM_1>F=/6ZP-HNU8R]
M5IF2M:T9O&4=RH;;N:Q'<S=8:-H-!72TMJ0JI4A2&RW)1F6U#<KB8Y[ORWUC
MFQ18ZOI2G$>ELXCY],5J[LSRJ(_N'9A_N/W2HS MWC%3Y87<>\5\6N)')#2J
M0O45()[5I'KK3&FM(Z<\K:JS633U-V]2R',@S#.F>_=.+[=UKJS!57:UTS4N
M&E[9L*S"2IC:/5C"[95J9:U%8J:E2/36L^$^NGW8TT40NIM76T4)%+7MYRD@
MY5IGOZ8Z])$*YM.J4IKFTKN?5!QFM/'PQKMIK_1:5QUA:&;4A3=:VI_+XP6F
M<\>F,9K,^4H/3_,&D+J6ZRN24\2M)]N)WFN$+!:U=IQ2$E-P0#\\CZ:/,WO*
M#]&KM.AK&X-]HH'K!:/IHOE51_,6_4IO"%LW!+C)<$\JTG#,.!CT^G>2 UTU
M>[ ND;SUZ$B0ZI4@?,G&/?N@:4FIM-T@!37MRELSH^FCS)O?XEF.KM.&;BZ]
ML ^3G1]-#LG,:7B-?>==4Q>:]"K;5MKI\W62E:?%S8[SNCW/QV37FN'><BGD
M[\A66A#ZGF&S(=4N)!V'<3&?[=IQA&D6?>M4Z>J+>XE5>V"4$!(6C>#[Z/.Z
M=N79&NEWU!:K;>0IFI2H%6)"AQ' QZE[T58U/JW3KEI;4_5-DY02DJ3/?TQS
M??9<Q6U#W2\:>KK:XNVU:&GRG"2D@SD>)CLZ>_-Y8;*BJ=372U.KSW+,B> [
M1/M1[&ETLYL97(AT;K<W&N#=76#LP=I6)?-CG[_23BQ29_B]:345@;H$YZ]O
M,D RSHW>K'A;[<NG4$:IYIVBWU"44]4")XR(X^&-M-HTPGK!S TW=J)#CE4A
M#^&)*0?FF+6_Q2P0OZWT[3T^1=<V?HDGVXXNS.5-(K/6FOK?V9]!KA/@E2?:
M,>E^.2^71LK^AYCMKJ!3U[X<;)D<9CV8];MNFLXL<&^5M:8N^BWV.V?>;S 9
MA,IP(&'E1XG;WV\*ZRY1NI=<T+)4W15X2D;)*3[L;_GTULYK;EDT1K^D<>RU
ME<,3(%2D\/#$_IZ]=9Q3E8]WU%9JZV+I37MJ*A+QT=/3'F=79BY3BU6ELTKI
M55Q54U;["QF"NLM'$'SH]6_JOKA/JM"@OFC[92HH:9]A D 2%IX2\Z/*N_*8
M$=6N6.L<4Y3UC)"@9D.(WD],=W5V21I(%K/<F[96257-FC!Q1VB92F-T^ BW
M9V1%%AOFE*Q:3VK06)3)4D3/[*,M>QE@2T]QTH:(,N5+!#J9$9TX9A+SHY>S
ML_TOA!(.G;=<%+8JV>S42H26CCX>B.K7L_RK93/6M=;JJV@M5S124[ XC@KI
MC7\^\SY4LH.T,;9\H/>DU379 */66F6&7ICL_3OKZ\5.NMRTA[S3M&[S0JTT
M12IKTIZ2TD%) J5[P>$>!L['0?NF2/*.SC;)BGD?XE$847TG:8K!H/\ I YE
M5N ,E%MF7V6IC04CW5-8V?1NJ_2KR]E1D7F492Q+.^8X1&<)C>)WGORMDNI]
M-(<,U2"4G';Y\=&F^6BCN:?/6U5E1.QW%U+:M@3(2F5\">B/4ZKK_7/V W1?
M,Y*+PW57.YK+)6"K,1XN9).TB.SWUFOF.3%RLR_ZGY<7JMIKD]<25)4A13E0
M3XQ5Y_3'#>Z.^+#LW.KEG:*)BD],)2A*4DA*=@$O/CCWWS71+&"_]XC0E.E
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MC4OXEJOXOXQ,2.%=_P#QO4_0?%I@.BWZ.[\B[W_5?OBX0&ZL H!0"@% * 4
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M\04?W0Q]LB48>?SR\N/\0T7W0Q]L@/1YR<MT_P#Y^C^Z&/MD,F'G\\_+;_\
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MC[9#*,%^>3EO_B&B^Z&/MD,F'S\\_+;_ !!1_=#'VR("_//RV_Q!1_=#'VR
M^?GGY;_X@HONAC[9!)?GGY;?X@HONAC[9 ??SS\MO\04?W0Q]L@@OSS\MO\
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M+N+@6Q1N.OO*E)M"<RC+'8 3L@,GH&IIR]#JI\.Q7]+ ??D[5'\RJ_L+GTL
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M3@??0-3#;1U?V%?TL0/?H.HQMHJK["OZ6)RDA0ZC.RBJOL*_I8>T'WT'4O\
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M2D>.A$!N; 1&I?Q+4_0?&)@EPKO_ .-ZGZ#XM,$.BWZ.[\B[W_5?OBX0&ZL
MH!0"@% * 4 H#6#OOY3RG?S;1D^_J* Y]]WRXU5MY@4-4PJ2D]KL..-+4)]N
M Z&V?5SES"TUJ\I V$XXYN/@CN]9_7788I>;7<>T8K0DS$@%)X1GMHSL675V
MT7*A9N+A!<2"=L]JI>U'/MJQN66S5SM8%TKR)H3*6WI,95EACOM2JU,%5*<J
M>&S>/=AKUQH';+JY#[_8O?5#AC/>#&\U@/,C*Z<VU_K(PZ>F)L#*X65BWVTJ
MM("'L,RA@=OJ[HRH Z:BN]14KJ?2UD)\E1 W0=5KY?7GJVW%M=.%.(E-1G/;
M.+R,Z'])VQ;]4BI"U* V@">XQ9C1?S"M:JVUMKHWBA0V[!Y2>,6RH\\K%UEM
M8]%K79@\5#WY]N&VS19"J@K?[(+!'"<<EV0D+JREBD26))2/&QD-L::[!BQ8
M].W9H+<8:<J98J2<QGZAZ(VN]B<F;-@:M#RG&S,(VG"6SH\,8V,V"\:LJV:0
MOTJ@O++Q53VD<(KZTRC+#S&J[@ZJC=HTE)\I.=6XF--=:C,,=5Z?%_;RJ6IO
M$82Z1Q\$=&L,PYT]HIVRT+CJ'#VDALETC=X8MMO*TO@,U5EN#KSCZEKGM (Z
M(I)&>4717.I8KDTE4A0)F,TC+9.-O77^MM-C76>C!=GDE3>=M<\93'DQS[Z:
M_P!=FNRO=1<I6Z.W+13K4A*93&4#>(SZKRC.525?*9BJIE*2XI+R9'-(<?UH
M]#*<9$6B:2ZT#J;6\^XZ!Y2]AEF5[<<?94^J[[:VFH;%NJ)C+OE/B8YY48>;
MCH92*ABMI5S")S2F4\9#9'5W6?USW41U>HZQNW^AHF'!N,P=LXXM,9\L[$+:
M-7UUM?[.IF9^=/@?=CU->OAG:L"B+M>CT] (4K8?#A[4>=W=?+/V-KE07=S*
MEYU2VT[U'#:(Y+'1:@M;OUU%:6S0-24/&6)CRA'7TQS[5653?%55N-*ZN:Y8
MS..V<>WIKPK -;Z(TUS[;-,$X#U)1EV2-9E:E;4W$VE#A2$X;C[Z.73:)VE5
M^Q>ZRLO8I%K5D23.6(P3..C:J:ZW*]-(WJH;6E*59VN"C*/,[:[).!'S/6I[
MEI>7RK)-E?53CM:7&$K/:<N2E+^6S/\ 36/VZ(W4=G.5/Y#VGZR/VRH CO\
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M!MPCGM<FQS>ZZKJK2\E@(SRF$YCQ]6$9VY57H'5M^MUY>HZNG^#F #U_,5Q
MXQT2)D6W?;NAFUOELDN.2]F7&+R8,@+1B%5C;]/5S2E4O&Z KC&LWPK3JQE5
MBO!8:8!8WJ ,O%/NQ-[%<)+F)J,VVB2Y:J8N.G$R!.(4GS9Q7*+KEGY<:HNM
M]MBUU],$+ 'C9I[5\?!&$=#Y6:@98KEL/MD[L/!X8OE>!VI?M#E;FJ"E(W3(
MX#B8PW7B=:2*M(33K_DXV&>''IWQQ;1>5'W:E;K*!UFIEVDMJCZL;]'-;^[6
M35]Z?TI4NH=25TQ( RXC<.C>8][3HS$^YCI[5-/=%)=I)9VMTQOGP)X1AV]&
M/ZM-UY:"7\MI6\H(4\)3!..Q7N1Y^TPM[CND314-2M55F('DR$]G21'!V<N.
M;A*YN4E3=%5C85D'DRQQ '&*=5Q5LY.J33=MU [VQ64!$R.T &[P]$?0=?=P
MY]]<I2PWMVGN_P C94KID3 ,\/%*O9,9=O\ IRW3D?UB&ZE@,D;./AG'%=6E
MU0]ZLJ*NV&G"=B3NZ9QT==PRNC7]&AJM=S=2Z@);4<%"<O%\$=T[<-]-3YOE
MW3T]4'7JH9!/ 2X1R=G>[==4I=/1K38W55BRXTA/P>S>?"-YCDZ?+;"J.7UW
MT[>KG59U=G433+-E!\17%71'K35G5T6NV+I4M.,KSLG$$;-O1''V:5C:G->5
M-0YRWO#3J>H&'"DX[FEQA(R]G*NE_+9G^FL?MT1=+LYRJ_(BT_61^V5 $FH/
MQ%<_Z(_\4J XJ\U?\S[M_3Q[*84=%.[TIMGE7;'U=8AM&SPKAT[MQG5ZP90Z
MXT&C-(,O"!X8]*3@!KFI;Q7W)+3:?@Y\3+;X(QWUR#&INSUOHTYRGM"-D\9Q
MG-!!*O=4X05 RC;[%$JW9F-04X[;!4MI$3.U"'O&C:NTTJG+>L/ C?.?_=!C
MJZ_T1*OAIZL>JPY6-E)4H;$J.T]($=L_3,?"%I6#3)80TXWAEENCR.SLRH,J
MZWMUM.E+VU"?8QCFES0-)J#;7>R0>KLC?"4_;7?2.N@B9VXQR=G6@]>66B!/
M,(PD79EH:?9 +>)PG+C&D#55H;0V (M[)9FJ/LV2GB)>O$^R S=M-LD*=>7U
M/4C;*AE9?DN@J &5S7/H]V.W69B6;5U\>H"A3+$RYM*9G:91S[Z@:&I:MM22
MR@A9Q(QG&_7KP#JPW%-;2)J*OX-6'C8>S'/OTE2U94,.4:BPXE1RG $'<>$5
MTZ\56J?KJBM5=%-J:5V))D9&7L1WZ\1G1?IYRL1E:2"EJ8X[HQ[+PJ-T+43U
M8X=9AIDY2E:B,^S?#;LP/O94G:JZOBS/K1GKV9 #K#4ZJ5]5*V.H,/4G'I=7
M)D--W3M&4J0V>O(>O';ZJ)%=P;TW1BY*IRI:Q/ '?A%;)4@*KU#?=07INJI*
M8H8*IRDO82.@PQB(6S45S]'8VG"@)>R=<8@G QGCE-H&>O!J7NT+)#NV9!XQ
MTZ>&0ET[?74K2U4(*DJ(2-IE.0CB_3%X/6U%QL%K "/+FJT-JMZF*95!FI..
M[=ZL:>G*\>[>]2JZS9"9\9#ATQ;MAE(MK6E1*3,$'9'/I<52T(:DMSBW558!
M4<3@)[R8];J[%*%46A^[.',D@(Q,P=V/#IC?;LX1/+2CO2TJ*/5Z6-A2VKYC
M[HCSMW2OW]'\ ENY=)6?_"9CEV&]QV^I&0H'O??Y357UW^S5$6@YJ<CP$\S+
M05; ^Q/[I:C1,CK>FIIZ>C14M>,&LWJRGQBMU;ZZJ3UW=ZRON2RRM."B?&]\
MJ,-M73K$KH*]7 *%(^)@]4&9]Z(QL:WPLVE25+*'MD;:5Q92S3J6D!E)RIF/
M<B^WA6TYDT4%W//LA/=Y.,82<J9#+NKVQ5OL@34V%A/A&S?'HZ:\*Y!]^U4:
MQ08J4F1PF?"1[<6WLD-?)A:@VEU9ISU7 0H#;)4H\SLO+MTH7U8Q9+4XNH<6
MKTE:BHIDF<R3[[B(SUK7*:Y<ZPLS%2TCM%)<5) )R@ DI'G1U:UEOX65J:_,
MTQ8?;3VQ<R]=/6'6)W@QK'EW5G1=4(H&JY: 0I()&_$3C1&'DWZFN+&5IOK(
MX= \/3&>S?2LM1<GJ"V=NVA690E@#O2?<C#Y=.> O2W*IN=0O$MNI)*BK#9M
M]F-LN:)MBH54M*HSUEI!"E;09"1BM:ZU5^L[>^FL*6T'LP=H!\X]$4K>;(&G
MH7LS63<I,QZL4:>W L9LKE<IE<Y=F4[>@SB&"QK:RJDI6%DS*,NSHB8K4NW?
M%EWL J7:8''CA%U#L.=8MDYIB>&,6PI?!]2TC#R>N,8NYY$C3T[3)"4#H@M#
MD*(5E'@@O&0B<H)(Q QNC8KS<?6B$L3RF@WVA$LPD?5$XUURSV5QK#1-/<RY
M7I>2#)2P,-O75[<=6NSENO+'H)INVK72+<G*8W?[M/M1GV5:3E8"W/Y.ZIHS
M4E"BD<2!A&&MY:7PHG4CM^J[_4)<;7Z*%KE@J4NU5T<#'HZ;<,?49Z!34--.
MJ*"V&PI?6F <H;XQ7MO"=9RC]=:KJ[>5*89[1P3\69\_AX(XXW ]#KBY5SDJ
MRE4EN?6)"IY9B<I^&-=5*F*>NI;I4!FE*DO$2Q &,Y<3O,;ZUG7RF<U/INZN
M5%(@K0N<R,\\I6#N3[V+;\ZTU\P<55]?ON@M0MUZ5,U2;=6F:IC$4I'E=*C'
MF.QR,U>E:.95T0XKM!\LU&7?+^6+E ==N[]_E)IC_IU!]XT\!9NZ \I20)*Z
MWAQ@/1(2-GK0'G-EPQ,!](S)X0'T[1 1.I?Q)4_Q?QB8A+A7?_QO4_0?%IB4
M.BWZ._\ (N]?U7[XN$!NK * 4 H!0"@% * U>[[J@URN<<EAU?OVB$!H?W97
M7:?FI;W6IDI[;Q>FBJ1N\,!T^N=MHKMV:7&D*;7F"A($#9X>$:]>SIRK74F@
MT6RK6_2-I4TK !$CM &Y/3'7]O",ONF+'443"T5!*48=56''B!QCBW[4#?3-
M S29GV9*6?)3(G81L$9?8A/,KJWE*2Z5(2-RICV8SRPP&KOJE5OJ"P<Z0-\B
M.'3TQI$Q];O=)J2A72.E2UB6*I'>3O)X1I$ANVZ(H:6M-74EH))P"RF>R6\"
M+R&5@LVBD#9JJ=86TWO201CX(C75G*@KY>[17I[%M]I%0C#+G0%8R.R9,3O>
M&^H=?L2JJB*'%YE2ZN8[<?!'E=F_+IU@!KM,7QIQ2J5!2/HAM\"8SFS?U6WR
MGI!;*4_*Y23+!3A^?WJEQ$=$W<6RQVWZ:K4OT0M*/FH()V=!,6G+FV@:N51Z
M&HHR$#>F7@W>K&^L9X0%$[9D73MELI"C.<TI\V7&.B+S45N5-@JE*IWZAI*A
ML0I;8)W["8M.64@:N%UM5F+C=( 'MR0$S]8'IC3ZLK2(.QZH2Y6=G6 EP["=
MNP\3%=NO"TU'*:6BKD?RIO.#L24@GUC'/;A/JD:.B;MU,M%"T&$@>2,O'AX8
M@5+>JFI<NZTAY9(GL)/DB&4HA=MN=SJ$Y2L)!Q(S2]@\(SV3E:%H#-#;TTRE
MA;\L2""=I/MQC=4^R'U%Z6JG<13I4I0\M )&[>(O^:8J8USU[1FN:<9K6%*7
ML"B@G'#C'U/5VR:_#213VE;=?M/79]+B7%4A(ZZ<ZD^(=\@-IC#N[)6DU7?H
M/F/;-,5F2H><)7Y*<IV!7OQQCRM],K^JWE:F8N*577.5-*\A)!][LF>$>9='
M)-498KE15US6IYT(IN"BD#Q3Q/1&.TPUFHOK*F@%*&K$[-PX$(*9[?>$],7Z
M^RY5V.M+:0N1J17O@!1Q)<)!V$;TQZNES&%H^N933)#J4')O5+#:!%=HB[,H
M>IWZ .-@+)$CED=IENC*(RK_ %/76RSTI:+2!4R/72!/:-\QQC7UK6;*;_O"
M_4JJ0I]PD2*4I,S@)[)QR;]=RVG9 +=N8/IUN?M-6IQ3C<AF5M/E;U>U';T]
M;LJB7*J[V.Y"\6EQY#(4"XE!4!*03L3+IWQ[77UYCGWK;/E]SQT5=;-3L/NH
M9J)XI>+2%CK'<79QGV]#DVHWU_JNSU_+^Z,T#J5 LKD4E!!^#7P48\S?JPPS
MRY@TOY:L*W&M8(.X]=,<[H=G.57Y#VD[NP'[94 2:@_$5S_HC_Q:H#BKS5E^
M<^[3V>GCV4Q%'0#D3?J&EY86VE4!/LT @RF,5=,1TZ<M<C$T=%<*G,TMM)69
M2)2-OKQZVLQ 1VO2E)1OYU--J.Y4@?FRC+:F6&]6)574$9 E Q&X8>I%?8RC
M%6=IM 2"%*X"1/L1R[1436"D2TUERX\"(PMHG%,LO([!]I 3[P8?-A-[ P-B
MH5N913,J&Y2P)^IA&D[:,S=,BD6IE,D@;)X13WRJ3TTL*WJ(P QC;1"NKO4K
M:K"RI)"I[P9QWZI9:2^NVU24R)F9$8G#UQ%]M)8@;6ZX4=Q9"A(N<,)^R8\V
MZIRE620G*491NF)1C>#+TILR!G,<8ID)P$-C*)^")@A[ZP^[1*;3E*B-Q,XW
MU\JY5)<#6V>I[3*5'-/ $^Y'K]4X,C.QN4VHJ9"JZ:EB4@9$\=\XS[-3+#J.
MT6FS)%<LY!*82K*GW(TZ?.#( K=:.U)]&HG'&&]Q$T#YBC'I7H_JMV9+9J"[
MTSJ$N5+SC2B >LH@CUXYM^N1&5GMMVRIMK=4M@=L9&>43CCVN$6G5"_2DI:;
M2E!Z9".3;;*I]6UXH,4XQ63*V31O5",P#B@@3'C&7LF(W_/G^F1"P_3U3*G6
M9*40?%D=HZ(PG3ZWY%6:OM[JZQ2NR423LRGCX(]#JN#)O;+35+[-OLE! (Q*
M2!M\$=E[$#FML5/<;8U25*!-(&T#<3Q$8>^*DSMFE&+<XE+3+64= ]H16]J$
MK>[<U5TX8;0D*0"2 .$XSG9R55]Z-)0.FG*VVGIRZR@DSF1OE'J=<X99$.B[
M<BJ(<<?:=\H)2L*/DG9'+^F)@_;06PI",!(QP:Q>!"^/.,U*LQ,@3/US&WJM
ME]H*A3Z$]BK+LPG**]FN5<BFC=+;(#K@S$2Q5Q$>=MK949.0EMU);>3G0<,V
MT>O&FF]B&!JTLLN%3( 2O REO]2.J;D\N=_?)I QKZ:3@&U;/Z0]%-KPZ5S_
M */I14BY C":\?XIF.>C?+?ZD0* [WO^4]2/][_9JB)@YF<HW_1M=4+Z4DJ0
MZV1(3V/-F+:DV=+=$:L?OO;6Y]E>"5(3F2J4I 3Q)XQT2-M=T?=]$U]3>?@4
MS0I7DSEBOH3&.\;3L'%CTFQ9$-K?2V:A4L,"H$RZ =HCCVUY:7LX3=<ZBD[(
MB2EJE,#$XF(G#BR]5$U,)?29'+,C?QB5<F])6]I3/MI62X4J&6>/B\(VTU5M
M5S<BY2W/.5R4MV2D$R,BK'".V<17/*:?T\Q<*45.63DIC 3G*? QQ;;NB1BT
M_INL-4N84A*02DJ!2,)=$<6S:57VK]$7J\:BJ0IU2:=!<RS40DR62)321OBL
M7]@;4:2O5@<#M.^HK[4!(2HDRGT)'"-M:7E>VDVUUVF&4W4SJ4I3E6[MF$#>
MKICIE<^VKZNENKX52,O@TXF!)9D!LW"47E86'^FK+54]4I#KR5I,R1GGPZ(I
MM2"FJ71K_P#MSI3A@)D;1AOCG^6OP%;C:BS4J%"L-J),U Y0<>($:Y9IBT4@
MHV MU06\J694Y[0)XQ&5H\W.TT=P#A*4YY&1('3X>,0M-@G3Z9+58HE/P<S+
M##:.B(7]DPNUO,.-!H%*%2F=@Q/@BB<IU#3C2$M$YP$S,CFV1>*4PHZ-ZNN*
MRVO*&R=\MA!Z8UD5M%=%0.H4IQPYY B8Q]J+X5J8I$@IP$N.$0QP>ME*<".M
MN\,%X]SR)6YO )E\V"8&O[P/&ZIHPE64N!!P,@"O+Q@9%"%9DS@0E":2.(BB
MR(OCZJ:B)"9A(G,">Q*O<C36J; 5ZY/UR5-(<5E$PI()V# ^S'1+PY\<H$W5
MFR59<<)F58S^>GQ'FQAM<ML#"FUG0BV"KPDE.8SE(R0%>=%(811U%::]2JDM
M((,R<!OQ\X\8ZM-C"?ME905-(?04I03XX$A,91/83Q$7L,<(RXVVUU+TJM+&
M8[$KRSQ)X^&,\,\H.Z:78"?Y#3- *&&4;9SX#P1:(-Z.T4.EV57:XMI2[(J0
MF0G.06)3RG:DQ;*#JTUM1J1]=32H6EELD@*!"2$D&6_<J&VW%).8(K[0L4NA
M=0.O-R?7;JP=03Q-,H[^D1QNIQ_U@D#F3=% [;R_@=N-6N ZZ=W[_*33'_3J
M#[QIX"S=T!]@% * 4!\.T0$3J7\25/\ %_&)B$N%=^_&]3]!\6F)0Z+_ *.[
M\B[W_5?OBX0&ZD H!0"@% * 4 H#5_OPR/*EX'8<OW[10&AO=B[5?,^@2V)J
M^&GM_F=3 =2T-K8I2I2,OJ$;XC65?V-%4R:]O%6SI_5PBVUN$Y8A;&'D*0KQ
MO4CS][<K(ZTNFV7!2%S"-W[$^#C$:Y2*5U=,LEW-,'P>[&\K+ 6O5IM]Q<+C
MC@3/B4CAQ\$:ZHJ-LMD;MU8LET)841C,#<>@<8Z-54SJ2W4HI6ZBG?2H#;)2
M3M4!NC61%J,L5RK6GOD\N2HU@@Y29;"?!M,3(S@<O^@*MN_&II.U4RHDYD D
M8) W)C#M;:U-+-8TD(=00IOH._&/(WG+IUW3.F[:]>TNK>F);)^ \0>$6UT;
M?8QTUOJ!<C;U)6*9,]QEXL^$HF1S5-LM-V.J+B'%)3LP(&T2Z.,=&L85DKD-
MUR^V6K,#Y6!C;*)$-5Z?I4!52T\E2I$R"DD\-PB/=M(J"_5-RH+B*HJ=(!/6
M5FW@#HC3KWY5]#*YZK=6M%>2EU>\3*CC(<8]?K[)CRCU$FBVDWVN^4E*+;*,
M<JNKM21L,^$.RRQ"Y;-V%R?SL/CJ>3F&\'=CPCR]]>5?9,5SQIF5-3*EJP,L
M?U;8I4 E[2E.Z\JL*PAU6T$@'9+A&5J&6AM;;2"&B#ZW3PB(BUX1:;@BH[1M
MLE).V2O<C217(CIZ%M;KE(L #]:<1)AURJMU[HFF)<RXJW2E[WHBVW?8UU45
M?[<]:K$]V22JIPE(&>WH$]\1IW6UT10UCN5TJ[N35LE(;.U06-J9[X]7KTS&
MF%ZV7F'3TM,BV.N,#-AU5B>!)\_ICEVZ<,,00O7BU4&51JD-Y]ISH X<8X=N
MK*+%D:&6U4K2]0O-OMGRPL*'E#:F<5UZ/^W)NLVFU#<:6O%(A)?:$Q+K*3LG
MN/3'5KPXMK1/4NIJ*55*XK##?TSBFVRDVX-J*G31T*FVE;9;#P)X137;EI%*
M\Q"\+WV;KB_1E$S).&Q/'"/2ZY+"UFM>B=-OL&J8JT]NI)F,S4\9C<)QI>N*
M^URIG5W+EVDN+KM.TM2%["$S'B@;DQ261ZUW5:_IZ])?=H#2.EA6 (;7N$_-
ME'=U]T_X9;555QLE^TU>5H8I*D(0I)"BTX < =R1'1=Y?ESV#?\ .'JX6-^B
M<244Q04*#A=3@4D;S+?'G]V,53U4S9WO2-44"N%4S\8F/);.T/*H_P#Z)9A_
MN/W2H AU#^([G_1'_BU1(XK<UB1S.NY&WTX2]=,1!N9R:<4G05"I;1)4A!\4
MG>J._JUB<K HC7.5S9IFU!(4 <%#?T1VV&5QT+JD4C:7"E3PE,3F8\_M3DYK
M,[S!6$)SY3X<8Y9;E&5;W*OK;;5X-J(GN"OUHZ=HL*M*W!VNFMQ)3@=H(W=,
M<F\!(3F7(",?49'&E!.>?BX^M%O4#MQNR4NDE76_5TQ;310Q;U%)<G");I_]
ML=<UP,57:1=G3<$B>T^WP,7UVP >\U*Z2O6T01*8$=6N_ (]%U:4J&=77\,<
MN\5RL=EY3QDYL.PQQ;1.7I]19;R9@/5B-=,F39%492S@RW3C>=7!E":INM10
M49J66@3T ^T8MIKRSRIVYZGKJUPJ<8$IXS"O=CVNK3@R-M 72F4 DMH*^@3W
M>&.?OX,IWF#:OEBVI.50RREAAM)X&,^G?&Q:I"YVMZV=FHME<Y3D"=_@$>Y]
MN664M:6JJY+::90I(!!.!&P^K')V[)E6T]3FDLS38(+H P&.\QY'9ORLPVBD
M=<<#[YRI&..'LQS^4L^H7V4TY4VO,1T@^Q'3^>9JN5:U5Y<<>#66<E#:#Q\,
M>WKUS"<CRSZH%LI$!>3.93Q_7$</;UPR(&JNV7X!Y2V^UE,B:9\=Y,>?M<(.
MV6*8I2EOJA'@&R,O>K/2ZQ@N]FI8.4'>/=A[49$N!2$NH]6*XH8W6YTUO0I]
MUP(*TJ$R0-HZ2.$6UUN8BJ7U59%ZCKP_15:%*<7FDEP$XJ)W \8^@TF(YQ;H
MK2]TL"VWZE]S($B8"B01U</%'".#]&T76>TKTAL+3AF]3;'G39>4,ZFM+Z9.
MI&8*Q,IG;/HC3[.2^ DNN>MYRMDH5ZHCIUGLRR<T]]?(S5#DSY,R?;,-OSY_
MJTHKL&H$5LJ113G&&WP#CTQQ;=6*D2)5D)0I0ENQB),+QSI[YWY<S_W:OOAZ
M(VKH7'^CY^HW'PK^)9C&C>_CZL2A0'>\ _-14G_>_P!FJ(O(?#FKR7914<R+
M93.*DVMQH2PEC4-"*^%,.KE@T506=I%?3+ 6ZW,RR^5+@!PBWV$E9[A5+M;3
ME6$A:FP2#MV G=+A%;OEI,JTN?,.[/5I<2T A"\3)>P&?G1$UROR=6?5=5=[
MFDU*@AC,,5$@>,.)(WQ&^F$^JSG$-KH@ZA2%-%&*DD':.B,9%; 6^NHI:XFB
M6HA9E.9WGHCJT5L.3I07)UNOJU$.9DJQEMG/>(TVVX5FO(G%M334S:4$*RRV
M8[(X*ZK#6INJ*!2$JZN:2>&TRXQ3U4R&=3^D+';T*\RUB<DF9QGPB/5:; NU
M-UE;=O1[C2J6,WC%"C+K#C%I&N1M>*=VFHFZ:B!2) ;QN(W1K*SM,+:BZ,MN
M!2E3*%2Q5O$:984T;K[Y;'S4)4I;>\36>G=+A&>U3KJ^KU ]4OBI>!;6#,[1
M,SGO,<]O+::O-7J*I><ZA,AX?=B<GJF+)?/22EIUR4B 9GP<3%LJW494]"W4
MM+=:>&\^,.$XF,[&,4B@@@D$@X&<XF^%8].-)<IPDJFM&S'@(SC5$76KJ+31
MJJ@1XIWG@3T<(VUBF0?8^8;%!<%JK5-)0^H@9E2\8@;U".B15;EDOS%RITKI
MG&"TL!6"QP' F+W7",Y2[%0 I0!1M.PQB8.\Z@V5I"?"/!$H>$NK)&>4E"1\
M!B$9-!;*1%6:OJYYE6[;FS1*#Y#R3U499Q%3*R9O.( C*M$?<9/TK[!Q24KR
M_L2(MK5=HKEFF=I*^H&63:BL3QV%7ZT;9X88Y"&LZ13DRT9JG/#Z/A$29;99
MK!;W+E8WZ,N!+P:6$))D<W9I2-W$Q-U,HRW4-30U#M#4JZJ<PVG<0G?+A%M)
MR93=+='[8K+3+DD&9$R!NX'HCMFN=46\,%YNE<X6ZX9592E4@2=F97&,<.;(
MDTEJFGN);IJY:6EIDD%1"3,9!Y2NDQ2K00WS3]/J!H-J=#C2?%,P< % ;CN5
M%+5CO3EE;LC(I6AU#U=W!*=P'FQ3V6D.M:M!O1-_(_\ XZL^]UQ1LXRZQ&;F
M=<^B\O\ WXN ZZ=W_P#RFTQ_T^@^\:> LT>,8#U * 4 H#X=T!$ZE_$E5_%_
M&)B$N%=__&]3]!\6F)0Z+?H[OR+O?]5^^+A ;JP"@/DQLGC (J2-I ]6 4QL
MGC +,G$3$QM@%,<8!3''9M@-7>_"0>5JVY[)??M$8#1SNGJ2CFQ;\Z<#VTYC
M_P!#5P'2+F#J\6:F[)  )V ;=K9\X>=';KI$(_1>IVZ]C/4I*)[U"0\KB>B*
M[Z<+0<-O6Y7PR)&>X2/1QCS=NNY7RCKJBWJDZEHI4?>@;P(F:<+FS[U)1TX;
M6#VG @3VQC*KA%W"A%93)>IED' E*3CMZ)\(WU5L#&H+]Z/EI6RI*]YV'<>,
M=6K*I_1UMJ-26UYEQXE20"G,KAF.\'A&OM(K@(J-TM-Z-N=</P9EG!,O%"MN
M'&+17"X;)>J%RW 5+H>? D""E>TGIC#MUJS!46E-<7'TA*DS'BX^T>$>98M+
M4,WJ:FTS6IHNSRY@1.4MWA'G1U::S"?:B:V.*K3V_8I*U;5@$\1MC":5M6"_
MT<Y-905;R!/9*-Y,,K8CDUE+2T9I'$DN'8X0-QGMGTQ3:IU"E36.VI2GJEZ=
M.>*L!NWR&^.7;=T:ZJ]U?K.P52Q;FB%N*PSC(=DCM"HWQM_&]D1E@L=/Z4E-
M6V'Z59VD!0P!Z);8?;O/AAM@<W-BGTTT:FUI**1?D) !X;$RXF.G3NM<FU>]
M#7VI:K%5:EK33G<HD#Q5#CQCMDS&&5KT>HK6_2&NJ@%^&1VS&\QR;:W^-LP,
MW*[BX.!RA)#<]B>&' GA&%UV_BML3%O<92V#*2N!]6(C.B&EJLS4LJ09;\.,
M=6L0C'VZRG4JK.;PX^"*6+3</5ZTW$%50VHSWE/'PQS;ZM]=U8:]L5)2,J4$
M MD$2($MPX1/5,5U:V_QK7J?2%=3451=;<4MSD<"4F6 .Q,?1=%F,9:^ZJ]-
M>FW.[#,^>J< I7%)\/"->_22,9NMS6.E+Z_IU-93. +$B"%JG+. =B>B/+FN
M5YLQ<K>8]ZTU2BA74.N9)!692BKRSYP\Z.WZ]<>5;KEN)R\U727NQIN$P:PR
MF5RGBI8\XG8(\CON*PO5?^1F^ZLTJJ@.@'=UNF4<V^W\<LZK_*P6NMJ'F"5*
M)&&TGB8SUM_C::(C66E1>F.U0A/:^]V[1T'A'I=78KMK I8M'UUO,W'%901A
M/P^]$=7NPNG(U-KH;@S)UAI2MRB!'G=F]=$V1-=HFV!GTEJE9+J=IRCW(RU[
MKGPLK74>DK5=G7''*!DKS#K)0#N\!CT=.ZX3F*@YFZ&I:&QU+E+3)0$@DJ2D
M#8#P3%=^W*V&H-D26=5T*)?\TS/H^$3',J[3<K/R#LI'\ /VZH0H@U#^([E_
M1'_BU1(XL<U#+FC=NBO&'JIB!T!Y"4%MJ^7%M<=2DK[),TG+/:K='7U6_P 2
M*+G>:"R+>0RT X#),DCVB(]#*&33>J%OYJBJ<,MP4>CI,<V^EH+Z*_L5@P61
MB!+#W8P],"1=MEOK>N^VDD[Y ^S%-K5V=FBH[<@J8"4@#H'L1S;6AN;LRI<@
M0D\-GMQ7%_@<JJ'5HS#%,L98X1>2@7O+++B%/-C*K;E( ,=NDD5P#6&;A5UJ
M4)2I+>83)"@)3\$7VQ@6C1(:HJ1-.%!2B)$ @GA'#MG/A 9U!I)%8^*A(DI7
M@WGP1KIM_3+'9M)5%'4A>>0&Z?ZT=&]B@Y0CLT $R(&TX;(Y+Y ?J6]OTKJ@
M',!/>?=C7KU @WK.J34!.<E,P#(GW8]&:3 .6*FGO]M4RLD*EAFD-QXSCEUD
ME4Q52:EM-;15A98;4IM2I3 )$B9;A'K=>^LGF(&7+^QO4R\[J$IENQX=(C@_
M3M+XJ1S?TU%32=DRLC+M2#N&.R.'2W*+X ]'24=PJU4=>SXLP"I(W>&.[7M8
M8HE8TQ06VF754J!G ,@ )[.@1&_;%Y#>SJ?N%1V52#V:?.G+#'?'F[;<M(?7
M="F@6Z4Y4)GBG]:--4H5BF57(4VL*V;".B.GJVDOE3%#-?IQQJJ/9H)).&'Z
MT>I.^8\PP?'3E4BE0Z^D&<L,2?8CB[.W*$[IRS+95VQ3E3*<B);O!''>02U"
M2FD<<:ZJY8#8=D8R+Y@)]+J6G%N.+,Y["3&^O7:9$EAO;59-@E/1,]'AC;Z[
M$P/\R*"I<HTJ:4<A.(!.R2NB+Z37/E&TX5C;JI=IK65K40E,B?44/!PCUM9F
M.:+6M&K:>YLI;.?X.6P8&0'OCQCR_P!/79.(MD96^I34TX[$90,>&Z/%N8M*
M=915)4U4"82#MQV>&*>URF^%;ZUMH84JH8ZJ1,\!M4=T>W^>SY80 IJ:BH=0
MA*R0E0G(G8#'LR:X\M(*K(1;ZCTUQ:\HQEZQZ.$<'=I_%LC:WZKM=<^EK,KM
M9A/D[9C;UNF//VZ[_&FK1#OG'-K::<06U$$</2'HY-I70N+]'S]0N)Z5S^PL
MQC1OAQ]6)R*![W?^4]3]=_LU1&FMX(YG\HEII^8=J=QS)>9G+@*AHQ3>M9KR
MZN6C5U&NCIV')JDA(,@#L^BCAVVN5_6,6HM26=;!I6YYW!*1"=\QYT:=>?XG
MUBF]2N.4CV=@'L%',J4]DS/9T1WZ69\K>L#;E^?>4EBW%QI84,1-)X;C&O;Z
MX\HPO31M17+TNANN=7VBD 343/% &^.!6P&ZJ&I:9_-:GG.S29S"EC83YHC>
M684L3NC;O?JRG+-S><4XA.'64<0!YWAC';9$G(Q9NK],PKMIKEX3NBLC?8/7
MNI7=&0NGGVB3.0VB4ST\8TFM<UH>IW+LV^.T62A&XE6P&)NJ-:(K5>J5FHSO
M4Z5.G G+,XD=,9V.C/ F?9;NS =IQE($R-G3T\8K&%IE24SK+ZD/@EL3!.T2
MC17+#<K34.L/U-.)4Z,Q ,Q@ 3L X1GM*WTL_H,)8JFG&UME+K1.(3O2.F,;
M+_'3+K_2H*$5"73+8%2/J1'K?XM<&]IME8;DZ$J(0DJ.!.P$=$7FM_C+; VI
M7*VEIUAIU0D#Y1&Z+R5SW!JU?:]I1"UE8"NM(DX;]\39PHFDU1>I34MJD2,V
M78=DXRE6Q0#?;[<:YUZWKS)82%"9S 2$QO,M\=&D5LJO+YIJJN+8>ILR.RD<
MR9@'+,[9&.K652P\L6K[MIUEND+BR&BD'%4Y)D.(X1K9PJN/1VKW;RQVBUJ"
MCCC,;@=Y/&.3%:+$9N;;5$7%N9@V,ZP""9)3,X3ABJ6HM[6=LZP2I4T@R&&T
M?11&%*%G>8C7RDJF5VH1,@3$L,\O.B\TV_BB5M^M:552E!SR) Q'2!YT-M-O
MXF4<T]4Q7,H>0590 HC#'"?MQSV6-YA@KJEGT=SL\%I"L#(; 8B%H4IF'[G4
M/-@9?& )F-X'3QC:,:':JS+<NJZ1XS0"05'8.N4[2(WTP91J[+76VY%5)4!#
M,Y@A<DGK[,!P$:;8$4JFKW+NX:AR:5J,U9B1BYQ,4U\F6>ZM,40:2E:5./%*
M<"#(KGM]:/0UL];RB^$K9[.7F@]5]FNGRA13.>$@=A'".6V,IK6!=EH7[CVE
M#E8#2IJ(RHQ2N9V>I&.UBV*,K3>*2BIUTZUAQQM)QF#XH X]$8U>0VI];M.W
M$T@ZHSY0HX#Q\OG1FO$]JJI])T%?ED@@VZKDK<?Y,L^W%FCC7J\D<SKI/9\L
M5&/]<7 ==N[_ /Y3:8_Z?0?>-/ 68-I@/4 H!0"@%$41&I?Q+5?Q?QB8D<*[
M_P#C>H^@^+3 KHM^CN_(N]_U7[XN$!NK * :I*\9^*/%7O/&<  \QN;>D^7%
M %WBNIQ5K^HT[KK0<,E-A4TJ<0=C@,!6FAN]QHK4M6JFNU33V]6&1:EM-(\5
M9.+E0?-'KP2\Z\[V^A]+U;=):*FGN+BY]JXA;3R,$MJ&+=0/./K00)^2W/1O
MG :PT=.EE#/9R(24CK]M_O'/X& N=:NL,)H5M*<=D!K)WWDMCE<X5"93ES'C
M.MHI0&C7=6"JCFQ0%!R@]MT?\C50&^]]LRM470(N+Y82C'LU*"=J$G8L'S!'
M;%#^KL+E'0)8M 4,L@7$B6U4]J1TQI[&&9JAO5!3I<34.+Z,RCOZ!&.]:2#2
MT?RF@"ZYH+6-ZA,[3QCBVK2&%SM%57*]);22GHGT#AT1RW5;W.J.D8I*!2G<
M')='3&ND5NRO*V@HJ]_M)%;RMQ .Z/0D9VY3FCJBZ6.L4PBF^"(.U*]F4^#C
M'-OY0@^8520Y45E*SV=5PRE)Q"1NQCIZH!?E1?:ZNJ':>Z/]F)IEF41N6?*,
M:]O@;$V1NE9#C7;!:,-B@=QCPM_*05K;37RA4"MI-J)GU\O 'A'1U5";T94U
MM/;EN5(F4 8&>_-QCLSE&U(W]567'5,3*=^4[QX8KLY;0S4WRCK&W&<C:7T>
M*!*?'C'%V:M^NJFU=4:ANE$]34Y=!FF01GX@[IQPW3EZ>FW"A]1:5U72-IN%
M*NN74)(F%!S>0-R9[(^CZ[PK8OCD95W*YT*&KY2+6XF6#J%DXEP^7X!'/^B<
M,-HV+.E[+7498KF 4[CD2=\]XCCZ]>7/M%<:UME-IVA*+6SE;PQ2F7E#S9<8
M]+7;#"Z@NDNMR-H<!6X&NKL*O.,=4JOHF-&UUQ><;0EMQQOCE4>/",NRIQA<
M]%9VU/%2I!L;\.'@C@JT06HKXU157HE"X,R=LB.@[C'1IX+N?Z?O-3<D>CUR
M<R3QF>)WF*1AD_JZ9AM?9AH=GQRQEO75U +F"U2/41[1EKL]V4 [TQR>SU=?
M"E%VFEO*'+:$%+!21, <)](COZNSF.?=4]BY3MVC4[[R"MVD0< 0"/J? ( V
MF/9[=\QBL]PTQMCB*XAND3()2J0VG@K#;')KIFD4/K&GH;,\'+4X4./F9EE3
MXN4>3X8[+U.K2CG16MK[9K!E8?<+B)2 4O>I7 CC'B?HZG9K>%GZ.YQUCEO*
M]1N%#6&+I4 ,5?PBQT1YVDK+9:FC.8E@NS4J*KIG43&UQLR\;@L\(Z<V?#DW
MT6?1WVQJSLN5%,IW=)Q!.P^^C+[+&'KA$K>H7'U .C)/R2F6R.K3NJ,O58_;
MV*:5.I"3[TI&_H,.R.;2&E/<,[);RI<!$L<?;CECJH7J:1MAU>=M);!&P=$=
MD<^ +S(<M53I*Z-AE!6AI9!D)S"%2WQEMIRZM?#G%;_RRI_Z6S^W3&BCL_RH
M_(.S?6!^W5 $5_\ Q+<OZ)4?%J@.*G-<RYH7HC:*^?[6$&V?)Z_7BATK:T,/
M+33K0@*&90&)(W&/3ZQ=UYL7RG;47!LJ+I&9?S>@QKMY2%:&GK OLD!80.@^
MY&FEX0(K2FN35(;0MR04)C'9..?MO(MRG'P GXJ8Y=]TL5<X'V"*<S($L/UH
MYYL@&=C7IKTAS-DGMQXQTS;@&3J5MT0++DEY<1/W(QVWY$!3MNU=0$/];'&>
M/LQ:\M*PZJK*>RL!%$@>D*$LR1B"<-Q$7TU4H3T_?[E\II:JZAQ9)EUE$\.)
MCHL5JX$E+E.AQ829B<S'G[WE5@>J:>F';/.-MSXJ ]DQID,'[Q2O)(14H5(3
MD%I)P]6(D ;=J)V]N$LAPSZ/UC&^MP(=O154VZ"I"]OFGZ6.J=O L/3MG%(Q
M-Y,U2V;=W@CCNRYT_06ZI<)J*8$C8<@./JQE;E6LK35)2#,TD(XX 1?6*4SN
METI6FU+84%.@$J (.SP&.C754(TEYM]76=L[D8<)W23[)B=M$C-A27&$N-++
MK:I R.82/@CEVT#BE:HV7%E* )SW ;HR]4/KR6%!2>S"CND)Q/JEB8IFD-=H
MAJ3AVX12:M*R&FHR X\V.T\ ]N-M=5*P5BZ=392V <O@W>"-IHI4%3:I;8>5
M2+;$DX;.'JQK]?"M*]:@6*/-2M$E7!)]HQ373"GJ!:YV\/L*?#2DS'!8VQZ/
M5<+2(RQ7*XT-0%.J(,]Y5^M'1V66-)%NV]=/J"V!-<,TAM,CN/&<>-V:_P"H
MM8 =9Z3IF6W'J-I9*02))&[,=PCU.OMPPP@="IKE5CE,XTX$"8F4J \D;XU[
M.V;0PNFT,^CL9"N6''H$>+WZ9,))I)F3GF#/"<<'KA%B+O=I9N;"F9;01NX'
MH/&.SK[&>FF%?U&D6[27:C#JA2Y88RQX#A'I=>V6FW +N%TNAJPVPA2:8X2
M4!*?1T1TQS^W)_96JU5<VM@*2HJ!7M&\3AMMPZ>ORU9[VYJ/[XL)>_@,=O\
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MZX:'I#7%=/((4>@;AP$=NO:HGZ_0].Y;4T]-3-K' )GY4]PC/M[KAIK3:T:
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MG::"J4=O\WS<(\YNYHZI2D<PZ\J\<7AX?_5*@.OG=]_RDTQ_TZ@^\:> LW=
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M223C([AT1.4 6NN2D75STRG6MU+A,LA.Q9XQ?3;F)U\EJ&\N5MM124E,XWF
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M/8-H\XGA'5=%==E=>@T[[QJ*1]3A3CE20=W1'%OU\N_7;@3Z(O*W*]5,\D(
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M@"G"<]N$3KLC 5NU/3:>0BFIU^D(<(2H"2MLT^3+A'3KLC!.4M16V] I6#D
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MPQVGHX1Q[.G6IBKJ3::1;M."E0&$L/8EQB-5U+7_ %!J2]OK0W4.(0D^>M/
M\3PCIUG#*T0Z+4]7LNL7!PJ6@8!1GN4?*\$5UTC2O5-45XKE,M!79A0&&;81
M%]_#*[)_4-NJ:*NIWJ *(6%=H #T#R1'F]GE,V2%#3LO5*T.("&9%2U*$A-*
M21MPBFN<M/A!(UZS:Z];30/8G"8'1T*'&/2[>JX<THQL]\564JJIATI2983E
MQ''HCS_1M$-7WVG4\[3U* M)(W3V '>8Z=-%TCIQ%JR^D4K8!2,9)2-L^$:7
MJ5R8ZDU-;&<WP8S^ ='OHKIUHVV ]3?T72F4WV9ENP_7,;[:*Z;<LFF* T["
MJL^*98>N(\[LF*[]=N!SIZVVMZ=0ED!XD8Y1MQ$93"FVP_:])H0$*F5'?C^K
M?&FL94WJD/IJ [4&:3LQ)Z-\7\,JDJ2K:;1))$X:[J9PP5U,BO2K-MD8[-+E
MC09:J&N9N'8EV;0VC,>$^$3V7A76<IS4RU.TGHS (*=I]4'='%([-:H?5&=-
M0222X?UH]+JX4WY0]IM-[JZ@*1G#<_?2]B.KW<5TY719J=^BMZ6*A #8XSXD
M[Y1Y=X>E8<.7-50H4B&06A@,">GC&/VV,[JKKFI:J:FTY7*=IYND$@E'O3'H
M_G[$8:(WD%#3JEMGLP<H$N,?0?9/KO\ TF>0+8TROUL;WIJ6?C$Q\FZ':'E;
MCH>S_6!^V5 3^H?Q'<_Z(_\ %JB1Q8YJ8\T+J/\ UX]E,5'1ON\,,.\KK6AP
M!7P:.!\I<3TQHM<T%'3@K#: H;R (ZJ(6OM-KN)[1/9BH.Z:9^W%]=K YH-,
M)9;2J:9X3$QL]:.3L[+E"60TIG,AI61I/3+9$Y45YS"U$[34O94ZLZMDTF>,
M^@QU=8KVSWNL?);JU%2SQ)/LF.JT6OH]EQ;/:*ZHPD3ANCS>WR">J84ZTXA:
MLV8'IW1GKIZJ*KU/8VFE+)9F29^+^M'H=7?9\*U7#]IN"JO,VA+5,DS$II&'
MJ1ZG7V7;RH:76\WE)31T=2XAM&!RJ4!('HCLGY];SE46<K:^Y.7I25O*6C&?
M6)W1Y7ZM9$ZKW"E=L0H[3MCQLMH\FB4JK*\V9..^<+L5%WFCLY6?2V@HF>)2
MD^S'7U=N&-#S&DK=7NYZ9" UPDD>P#&N^]7$5!I*TTJ@0R@.(QGE3M'J1P[;
M7(GP6E-A*Q&?M1[2VTRC,@1&:A!W.Q4]V4IU0&?;L'N&-[LB5[M="W96#G("
M=TY ;/4BLV2'-44HN135)6DH;!RA@A4L9],=G4RV4]J;5%YHZE5*:ET4H5((
M6I0$I\)RCT^O3+#V3'+V_NOW7L%/?!K/BE71X8?HZ,3Y;>ZWKW9::[THID94
MJ QG(;/4,>?K,(MRBK%HRWV9+M44!3\C(@).)'@$:79& -=VE"\/.U"3E459
M9CCLVQU]>\P35+6*X.6ALN %,_"-WJ0[<5TC.R7SY13\)B9@\?;,>5V:B:N#
M3CS/:-X+E&&NHJF_N75FY#.E1252!DKC'9K(@1Z=I'ZIUMQV<L#C/B#OC/LO
M+%-:A7::?J/MA2PG@DS.,:=,R((ZAI*&C/HC 0N6Y,MW08Z=M4FUIO8N#Q56
M; 9@'U.)AKLB(#5-[?16.4U&"EF9&$QA,C<8[>N3"<A5IMVK?(6DJ6J8&!.)
M,:[[21,69R^M%11O!UQ)'AG[WHCRN[LB\6LT<ZP3NC@VVEB\<Z._#^7K/UG^
MTOQRM5M_H]OJ-S^>7\2Q ;Z'88#7[O>_Y35/UW^S5,*1S%Y2A7]_;<VG^':G
M]G;B!UFTNU3L6ZC+\@"TD8RW@<8($53;*.L8DA,Y[,!$X1E$'3&>;83)(QET
M#U(MA&4E16=JA9S@24GP</!&6[3+)Z4^T%/3^"2"5;92&)C/4R\L:IH73V"
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M+1S6<#:M21XRAZL$MME=X[E*LR3?*7(K:55%+FP_CX!#O&\I4'LT7ZF[$_\
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M9+@W1TW0'FG+@FH;"5']7KQYOZ-6@B)*,41P:Z,J@M44CEXM;K .524G 8;
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MQ2>"K/BM\C[%@H!0"@%$"(U+^):GZ#XQ,2.%=^_&]3]!\6F Z+?H[_R*O?\
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MI*0I<@,0!M68Y]M5*<ZJM[;U./DMQ*VTD?4B%8"?FSBL94/6^DJ2^TSV:TG
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MEQCGOEC=@A:JI]NK;<9<*PL^(3ZFP1OV>%EI7&VNO6Y"B,F8;$X>5X(Y)6F
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M -TFJZTH0^XZ:@ ;0.GB(\_?;EI#6Q: %+7=K4K<*1,HG*4]VU,3KOPL(7;
M@52JITCX*9W;L>$5E9&%TO#-3)E.('4/@/JQI$O;-CLE+2BX/)3F&.Q,;2"
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M _-BGKDR#]9:18U&CTME\K4WB4S2=F96R1XQ?!:C[1;A:*-++:"'#)!,I'$
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MO.D2&&0 CRCQCSK/](]S6LUS0+;[&L Z^&,MX(WJC:Z_Q/MEXH&F*Y::FA*
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MG%YQ509KZT!YX/V9@IK%D%90F1))<)\4$[91V:=H&$6^ZM,(0ZVXBK,AF*5
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MM(HQ5M11U ?HB4#M<Z,W5EUIIVQ>16@/4VD7+0RFNI%A27E!>9)) SA2L2E
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M_P!ZLBZ"I76A1I7 M[#J)42K?/!))V")]]OXM,,5XOE78T&IIF$!]6UQ*%=
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MV*;8P@&>7UH<6W45#1I^P(4GM4MHGD,][<=79OEPR6"5J_VZD2W;T.-)2S)
MFI P3AN4/8C@VTVM\5MK4R[6)>HB^PXE0E/JF8V3W&+=>MEYBZLM1WNN0^>S
M64A"IB14-A/!4>GI.%,\M*N\I7U%PU(TY4.9CV>,U$['G#O)XQY?Z78V-_1^
ME/97*6S,OXIF/-GD;WGQCX(FB@.][ARFJI_PO]FJ(OKX'-?D1CS1L\OX=C[Y
M9B$NS5&1Z!3_ #@]B)0]AA"25K259L)  RG$ :O6GVWZA+S!)S*!*1+"9)Q
M3 .*%BST3B&G4H]*$L9-SG/ID=L:XHDJ^EHJ\!+K86@ID9)2<,9[0>,<V\H"
M[AI"EHZE57;T%*5SP 2-IGY"!PC'76R^!"OV!ME\5CB%E1,U2 EMGC-,>IU;
M2?(!]<:>:>SU-&T5N.35)M()!.8^2F.R]TQYC'T--!Z9MMD0[?KN.RK$YNR;
M=R)7,@*! <2D[1QCGV[9?E/UW^!+F%J%RXW'/1/$D*F4(42?&4=B5&*3:?U'
MUW_DYL%6_=K<NFK4KFVVHC.#,Y4^^)XQI+/Z>AUIRJK[95J11L/)S*DDY%#
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MQ0[9!5VMQ316G%A)RJ +>;Q4>H(Z=.R7Y4NH NS=31-+N986]4(FM*2DK)6
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MMRM%0\PZJXU%P4MM:D4Z"2&TE8&!GL!E'H_FO#@[?)MR_P!8H<O";?5HR@*
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MU,I4A0P$_F3C':@-K[]3MO%EQ!*$G$  X ]*HI\CU24UKO8"FDE$L<J@A/S
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MB\G#6K5NH-2T6J5KIZ0.=<C.VV\H8D;PH1ZG79AY_;Y6YHFI>]"%YO [-QP
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MCUP(MU:XJ^T4:YHN[NWE3F3X/,#-0<EXH]Y'H_9)'+=;GPNZRVAMI#*"C.@
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M*>6>@;I9UFLN3"65SS'MD+0KR3AG;'"/-_3W>UPC7KN9Q5IU;"'F%H(S3!
MQW&.">L^7H;Q6=XTC75-8HTM*Z$K41F#:I8D[P@QVZ]V)\,M=:,M-6I>FK>'
M*]03)/[X9;$CS@GA'%V[7:NC'!A=M:TJG"VP4JE@2C*0-N."X=>GS6-ERT4[
MU-4FNU2R\%!0+6)!G^_NGB8S_19?#=?OZ/L21<?-!<F=WU)F/.GD;Y%21*9&
M.S&)HH#O?_Y3U/U[^S5$6UL2YK<B,>:-GEC*H8G]TLP2[.VU2?0:<SP[,05>
MU5;2%R60E/%4@/9B4!R^7Y3-0TBE6'$E:00@YL,Q\U40A/43J7J=#Y2$K4!/
M"1Q$X<F##4-W<MC*'FTE6PJR@G#&>PCA I634+%U:"CE2Y+ &0,Y#WQXP$Q-
M2L3@-T2/:9':)&%3'Q<Y$#A&=B\L-W&VW6E-NC,$@DG C =,3(6@ZNJZ<5AH
MT)&7-E!D)#&7&-.&?R?_ ":R]1N,U"&GW%)(94D!93U9#$C#'A%6N557RF=L
M=Q* Q-]Q>4*"#.141(8).T0,I%^H8<I*=NY,ELC)+M4A)/[,Q FF6K?6T;;%
M.<JD)!2!E&(&&R<#(5;M@&H%%Q0+B5F6,]BQQ$14C2Y5#*:)%,M04\0$H1,$
MS((&&W;%<UG0\S9[LZX0BEF./9K]H1OI6.TIXQH^Z.O)==:" E05BE:=AGO1
M'3G7'E22Y>JMJ]+J30I0YV#<QFDYEZIEMV?,CB=*!>J*JFN0I0PI:\V4*2A1
MQS2VX1%B1I34I73)?N"99 "<XEL$_*$4L0BJF^TCE:W2TKJ0$*"2$J3N5+<J
M(P#.GKJ5JD2IUU(2D"94H 8#I,7F1FI+[9ZI2F0\TY,%,DJ;5B9#SCQBT =J
M&]5QKU4-)3NM4@)2'@A242"E)\9*I;,=D6$1;KE=*>YH:^$4A2P KKD3*P-L
MXE,8]64=8*]JMJ,Y94$J43FRB:EJ.T2V=,1[59$/W"F;I5EI 6L R*0"0<O0
M8C*M,/EF]O(:#;SB6T%.1K,X"0-DD@^I$85%5(Z]<+> [6)I:M*,.U<+2IA(
MQQF=IA->483%@+-N2M==7I=6L&3B7@H3.7>J7 QIO6F&2X7RP4LTU=>VLU!R
M(2MYHXN3E@I0X1A9:3""K+@W3)[:B"GV%;$M26)&9V)(&P1:=<7RA*Z[.]5P
MH<I@LB?: M[9GC$[:8EPF45:=U)0H913K^&<4 G.,JY3"1MS1R2;?Q>V"RAI
M:5:EU2AVO:))2.JJ15)0W82C76,[4IE84QU&P%-B9RI'DB-]=8RH>N6JZ2F)
MI\LW&MTDD]68\\<(U]=<*8">M'#=])7>J887C0U.8I1@/@%J,Y3XQDNY1ZH2
MM',:M;GLNSLQO_XM0E =>^[\0.4VF9G9;J&?W#3P%F@C*3/" ]0"@% * 4 H
M!0"@% * 4 H!0"@% * U;[[[A3RL7V9*B)9D[=M;12V0',*Q7EVPU35QIUJ[
M9.:<B=Z5(W*2=BN, 15FMKK<',]0I*U#$!96>'%9X1Z=_7;_  &-G[P6KK-:
M?DJF:I0TF4NT2_YQ5NJ -_",=N_/\&:@[T&N;8L%CL%>'TD^Q5#C'-MMD3=1
MWPN8]2UD53TA&R:D59./]<,8W4#:N\-JY3X?4FG4X-DP^?[1%FF132]\?F5;
MV@PW3TA;&R:*P].ZL'&"E/&>^OS-;\6GH$^%%8/[;!2L-3WT>9SVVGH#X$5G
MX9!&#7_6)S'RY.QI/V-7^&07R]TW?&YCTI)#5()X&::O\,$!&5'>GUQ6/J=6
MQ1$C>45/#^E'A /F.]]S IZ?LVF*.0PD$57'HJX![_K%YC!@TRZ>BR'<$5<N
M/\\CH]Q&L=ZW7M&X7F:6A"CP;J>$MU4(>XAKUWCM>WJI](J54S!VS;-2CAQJ
M%<(>XE+#WJ>8UC6!2FF?2/*=]+7QWIJD\8>P)G>_#S3<):[&@(W=6MW8_P ]
MB/:"(J^]]S&N-8FJ?9M^= (F4U?E"6^K,3[!M2=Z[F#;[FJXT[5!VYWA-5/%
M.7=5 _-A[@B_UP\T"V3Z/;^TW]2LG]^P]A]/?IYK]F6S3V^1W9*[\.C+(CSW
MTN9Z5E9IK?,_[NL_#8K0^I._1S48$D,6X?05OM5T4HC[IWR^9=S5-^GMV/!%
M9T<:P\(K81$,]Z+72:IQTT]%,[\E3+9+^=1C.C#;V8U]Z;7-0E;:J>CD?>5/
MX5&VNF&=K);>]3KFWTYIV&*7(>"*F6_A5#C'3KOAEM$=5=XO6+CWI'84F<XX
M(J/PB-ON4]4[2=\+F/1VQ=L33TB&5  Y458WD_SP#?PCD; 5'.[58N+EQ<33
M)6H@@2?!\66]_P!N L"T=]#F59&/16:>A"1N"*OB3NK$\8!V_P!^'FA4I#:F
M*&72BL\/\],!\/?,YGE>?T>VX>\K/PR-<L<'"^^OS0<1V9I[;+H16_AL,F$.
M]WM^8CZ<KB:-7J59]FKB<F&2@[W_ #&MA*FJ>C/T%7T\*L<893@]5WT.9:YK
M6U1IG[VL']LBWNL@'N])KVHJ35+31 DSV5/"6^J,/<P]N=ZO7;E1VRF:$K&_
M+4R^^H>X<W;O<<P+O8GK#5-4GH[J"VH!-5XI!!(G5D;^$1=DX4M9GP_J2@JE
M+*G':I@DSG^^)$8+.T/*X$:#L9000:?K).)!SJ@)W4!)L=S"3CZ*^<PW?!JP
MG <7N:KG9\RKXH?54U962KQ<R0DB>^)EQ1)VKG#J*RV]NCIA2%#4DX!TC#P/
M)CT?_>W_ ./_ )_]B>MG>5UG:W0_3M4A4,#U:@[?!4B(O[=OY!FNO>;UI>%Y
MWZ>D]1%1[=283]NW\G_S_P"Q'#GYJDR :I)C=E>^WQ/_ +N__'_S_P"P46GO
M8Z_L5,&*:FH9 >95>U5IBF_;F!RKOG\R%B7HM&HSW-U9_MD>?O,T?'.^9S(7
MF952T* H$$I;JQM_KD3U\ 7J^\#JZX51J:A%(%DYMC_MU!CT=.[ \CG]JP.=
MH&J*?SK_ -OC6_LS_ X<[R&LRD(#5%(>]J/PF,=OT9$C;.];KZTHE3M4<^A-
M5[54(YMM\AZ>^7S*43F:I9?.UGX9&-@:+[V_,-Q?:=C1_L:K\+B!Z5WNN8;@
M"2S1X>]JOPN :K[UFOU.=JMNC)'15?A4!)L=\SF13H#;3%&0/>5?M5D X_UK
M<S?X"@_85GX; ?/]:W,W^ H/V%9^&P&9OOM<T$[*:W_8ZS\-@/B^^SS04?\
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M7D=P&@0<*]LS_P!\G\ BJE94]P*A2F7I['J/)_ (K5;'@]P.C_\ Y!K[,G\
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M\#R?P"+A?Z *'^?M?9D_@$6R/2.X!0R_&#('UY/X!%1\5^C_ * ;*]K[,G\
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
M4 H!0"@%$9"B0H!0'R*9J7V+(*)"@% * 4 H!0"@% * 4 H!0"@% * 4 H!1
M7(4,A0R% *$@46"@/D5P/L6"B HD*(R%$A0"@% * 4 H!0"BN HG 42% * 4
M H!0"@% ?,HB,!98C ^Q8* 4 H!0"@% * 4 H!0"B,!1(4 H!0"@% * 4 H!
M0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
M* 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 HJ%%@H!0'F)0]1"2@% * 4
MH!0"@% * 4 H!0"@% ?(S2^Q>(*)"@%$!0"B0H!0"@% * 4 H!0"@% * 4 H
M!0"@% * 40% *)"@% * 4 H#Y,Q3-243FH*("B1]BP4 H!0"@% * 4 H!0"@
M% ?(H% * 42/L6"@% * ^14?8!0R%$Y"B0H!0"@% * 4 H!0"@% * 45"@/D
M0%$C[%@H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 45"@% * 46"
,@% * 4 H!0"@/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2225088d1-lc_activity4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_activity4clr.jpg
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M .   0  !P$!               ! @,%!@<(! D! 0$  P$! 0$
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MO!H7=>Q?>Z*R?JVP]/G?87,7E^9U]/\ A$,5:ACN2M!GCG%C0'.XG\:G[B"
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M-MG>KAMV,;YODVHI'U.)\+GN([T&ZVT)!#J4X T[.Y!70$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$ H,'UQF==XB*-^B-,_K%</'\8B]?;6'2>H <;D$'@2>"#7V6UCOY]U
M7K?ZL/(8+>4%_P!_8Q_2TL-74Z.-.Y!\E]87&3NM27]SEXO)R+W,]1'U,?0^
M6T#C'1O*G)!N#VD976N*W6Q\VBL1]]W_ $77\0]3;V?63:R@_:7 +11I<[ZJ
M(KZ*?KKO\":;5U-1U']8,6*#_P# DHVI@;C+WF(MKC.V7W;E) XW-AYL=QY9
M#W!H\R*C344/!15T<XN:06U=VLK2GUJHIO9YD;XJ]49!:1RI440<I:+#MJ_<
MKJ# WPICM=2/OK*3\F+$V#B[@WS7&I=^,6'X%%5]O;*7<OW'Z@UW"/\ ).C)
M3;VC^'VC,K8O96A,;FT+.UCOJ1&JMU-46>6]R,TV>Q7WOC=."\L667J'6O71
MW6QWF1-#A1W&GB^E19>?5N9EU#K[3NJM Z2^[,K9EEK<#[Q%SU1S3@R._C0:
MT>'L#?H52&6[K:.Q^X'NFTMA\MX;1^.O;AP\1\4$HD \#XSQI3F@]'N1T1@M
M':_T=J' 0^CG8(K<Q=4LO">Z =QE>\<@/Q5%A>];N$/NUTY=!O48,'EI.FM/
MDZG<_J5'AV3T-A]S=W=P]<:B9YTF/R;H+.VK(RD5Y$7$=<3XN1;^,PGZ$1L"
M\]OV&T/E-9;@X2_\F*^QF5?-B?)D=5T]F]@/GR7#SX1W,XJ*Y\;J.YTU[89Y
M+/B^^R6/LY&<!6.=LS'<7-<J)\%G=(6>U<6BAHCS[XVCXQD?O6=E9Z/$;_*Z
M2.'4.'70TXHC?WL_.HK/;MV#SMEZ.+%&&"P^UBEZV.#W./V5:4)_&)0;;W#=
MK-NG9'Z&MO4Y]LK.B/KMX_L_%U&MSX.Y!Q'JIV^K]]M-NO\ $=.LG8V[=96_
MJ<:>N#K\9ZF_9"E#P=Q0=@[52;F/M+X;E6'HKGS&>D^VLYO#TGJ_P/AS[T'O
MW?J=M]2.=Q'H+H-/_9Y$5RA[>M3>X.QVSQ-OHW0GWO@&0M;:7WWOB[7K;U/X
M^7<-+QQKS1&>8'9G=#<+<VQW&W5B^Y&XJ*6"##]5G>=0E=Y@^WLIHZ=+AVL-
M:H-<:\TOJG5ONBDQ>D,G]T94QY'IN?(ANJ-9XG#HG<QO$#O03[F;.[R:6@Q^
MM,_E_P!:<+@+F*_O;#TV/QO3%:$W#Y/,BF<\T:QPZ6L)->1H@WQ?ZFV\WCVC
MPUMF;K[GMM3VT1L(/+NKOR;B\B?%$.J-L)=3K_&Z1WT16J<;[9MXMJ93/MSJ
MC[ZM(#U6^)]!86=0RG2SSKNYE/$,:VI[Z]B#:VR>]^9UIF<CH+6V&^Y-;X.2
M:VNK;U,=YYWI.ELLG7;P,A;1Y+>D//PJ$1O:K@0.=34#X(BLBB @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(($ @@\0>!0<K;T^R_3V[.HYM2VN=^XKZ=Q?<M])+>];B&-Y
MNO(@.#.QJ#86Q'M\T_L;C)[.QO/O')7?EF:^\J6WKY7FT^S=<3MY24X(-T("
M @(.>O<YM7J_7F/L,SH6W]5J7%M=;06O7!'U17,C/-=UW,L<8Z6@\""3V(,J
M]OVW>3VXV]QV'SC>G/O8[U[:L/2YLTQ9QCDD8:L>/E*#7FX^V.X^F-TH-WML
M;'[_ +KR[AE]A/-M+'K-T:/?ZB\E<!TM')L7&JBJ#HO<%NKJC&29?3/]7^F[
M&CIW^NQ><\QT;_,;PC\J0=7R\.7-!?,QMCK&\]R&#W AL.K2UIC[Z">\\ZW%
M)9R>@>691)Q^#*(*GN%VQUEN!E]/7>FK'U<6/D@-V[S;>+H$=QYAX32QD^'C
MX:H)=2;8:PR7N(P>O+>PZM+6F-O[2[O/.@'3)<D] Z#*)#7O#$1B;]#[O;-;
MD:CU;H#3GZYX'4UV^]N[3UMAB/(E<TQL9UW3YGOH/%U!K1V45%73>V.[&L=5
M9_<C7%A^KUU/CLC9XG3_ )UC?]7WA;2,#?56TK .EQ J^/C\%%@TY[?-4Y39
M:[T)J)GW5EV7%OD+(5AN>J>S9+T-^RN T5<X<7/I\"JBEA<U[G=,:2BV\BVX
M]?<P0/M(M1_?>'@JU_4#-Z4M<!T]5>@OXT0;FV7TIJO2NDHH=9Y#UF=N U]T
MSR8(O+>WJ%*V[WL=44/!!L:CC4GMX@?#N4E8:ZS>TF.S.Y6(W'FNO*O<7:36
M;+7RWNZFSN+B>L2M I7_ .64&R.'?4U51BVY&(O\]HO-XC&1^;>W=I<0P1]3
M6]4DD+VM%7EH%2>TH0PKVYZ*U-M_M?B--ZFL_29:UA:R:#S(9>3GD^*%\C>W
ML<HK;7S4;S;SZ.[ZT')VL-"[U:<WU=N;HC27ZP8\LO&,9]XX^QJ+H=(-;E[G
M<O\ \FJBMK:U]RF[.)&D,KHC]5,3<2@7N4^]<1DZ0O:Z)[?)88G?+(75:ZO#
MXH,@UI[;ILGLYIG0F&R/1G=(&SO+*Z\D'U4V-CE,;.B2Y#(^M[F\7/<!VU"B
MO#A]=>YK3>'@TQ/M5]ZWMO"((,O^L&'MNLM'0)?(#' <>/27*HO>Q.T6J]/Z
MFSNY&NSZ?56>N;BY?BJ0/],+SH>^/SK:9T<G2\'Q>6*_ (KH&,U>ZG&G!QY4
M/<HBJJ" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(""@^/A0FC1V4JD$A <0*4=VM_XT%=
M0$ \D% -K\".7P_X4J(&M>KDT_./P*+  .K@*NK5H^"J)B'5<1S[$4:#0]IY
MN/)00)J>H\QP!^'%5$>#:T%&G]LH(#F.RG#HY_MI41(!)J>([4$*$DDBH_80
M*D=75X03SYT*!Y;BZK^);P:>\)50EK2214<J_$HE0<.9I3F@JGCR00)Y](X]
MJ"6E.+1XCS* &UY.\0_&H@@XCQ5- #Q/Q44#C7CQ'8$)2DEKJ-^9W%S/PFJ$
M)@T.!#O&/V*!5$I:6]E6#DWN;WH(MY@_,T\6]E$%= 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 02FI^([E%*'ZNY!,J@@IDD"I%>X<D"H\1KQ'[2"#>%211A02M?4@-Y
M"M4JJ4.ZJN/RU\+N\?0E4HG+BUW2#Q=Q ^"(BZHX@5[W?\2CZ0:#2G:>01$.
MGI%'=O-O_&J(UHX-+:&AIQJ@E)> 0T^(\>GN';Q03!W5P8.IK>?8@ATD\7<
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MM>:C\EI"J,0W%VTWFT+N/>Z]V1LO419MTMSFK7S<>SKNI3TAW7D9'D48.4;
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MY?&N8<7/U75MY$EO*R:%W2RZ<U_0YI-'M-:\4&^8F='2SJY &E.[@DBL@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MDAN8'V[7-C )Z3( ">/ !42XK?W;;-:B?IFTR,OWG&]T71+;R11.>UX9X9'
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MU\+DC?W<E[#C9[1T;8*_>$O0YW47R$T:.QBBLCGO!-[K=*Y.7P,O<3DI6!W
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M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M#))8G>9&_KA>QP+2$1G6\FR5QK2;%ZHTE?NPVJ<)$(;.[CC;*YT D,KXOMI
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MCFL]R8*UJ1]:(F500$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%!
MW4SGR/S/[0>S@HK3N_V\=AM9@PR\LWW<F3MIV-<UDKBT.(BY1L?^6JD-"?V>
MUP+R/7]X!TB6?%D-X\*1W0[?H0=OBI)_*[T1511 0$! 0$!!"AKS00X<JH(#
M]@GFH%/K5$3RY(I0_0B'/L0"*C@$ <?B@C]2@BJ(<$5%$#\$! 0!\4! 0$!
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M 36EK5[G22/A=*QE.GJ%2TCY42C3&#]\5M=W%P,SIP6%F ]UK.#<N\R@'1U
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MT#J';C'933^1RCLG@Q?7$F"+FQ-;!C^B"*VA:(W.):QD9H7GJX\41MM 0$!
M0$'$6^NI<[::]OK2"\<V"DK&Q]+" WU4[0*EM>07):[)=&6=OVK+^C/XGH<%
M^@MNFW;LZ_#:UMB]39ZSFC9;WCHVR7 >\!K#5[B*GBT]RU]N2Z)V2Z[4:#!?
M;,W6UI'E?030L\MSHG3<]Q(7SRXRQDD>0!5SK=A/+XE=KIYF<=M>J/4_EOFU
MD6ZW-%L;(R7Q_P"*60#GRXU_:7NU:95\B @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M"#R293&0NZ9KV"-W<^5C3^V4%6"[M+GC;3QS#_\ )O:_\!/<@K(" @(" @("
M @M.J/\ 5S+?R.?]$Y!QS_9__P"$;B_RC%_H;I!VV%!Y,C:W%Y:R06UT;29_
MRSM:'D?4>"^;K:QL?-T3,4B:->C;O6W#_P _70)Y?Q&W-/\ VE@_2Y?]R>YK
M_I<O^Y/=#3N_FV6KH\#%F+K/SZ@MK7PN@D@B@Z?,D8!\CB3RKR7AEQ78Z773
MQ?<T?-M#DG'6;IOIY(\G4U#L[HK/:NU5;QXJXDQKH0_JO&L:\L^S<[E(0#7I
MHOBG'=PPT'*])DR9(F)FUV#_ %<:T_I_=#X^AM_X2ROILO\ N3W.Z^DR_P"Y
M/=#)=+:;SF",IR^H9<T9".CS8(X>F@(/R$UK59&'%=97BNXF5APW6>]=Q>:(
M90LEDAY(.(?<3<ZDW3WAPVV^F7T9C&73;SI+*&2-D=TRIDZ0.#3^,@QW?72.
M]-QB+76>H[A[WX62..*3KM9'!EQ,SK%&&O&GY**R3W ZL9KG;_;[54= W(W-
MC*8P:AI%ZYO,@'\7N09K[C=O[[&1XO>31\CK35.)<R"Z\MH<Z2VE>Z2=W5(X
M@5:WI(#%!@NRNMK7<'W#X_5L+!;NO;+(SW$574B<^(FE7AI[.Y49MO'O=J;,
M:R9M#MM$#?70D9D,U'(&NA\MQ9(P"1IC<"UW5\WT*"]G9G&[;;2:GCMKK[SU
M-D+.>YS.4+?*DN98K>4=;HQ(]C?":>%!<O:9E+4[(:?A,C6R65J&W+2>+"7R
M.X@\N"#!=EKBWN-^-T]0&1HQ]GE;ISYZ^ M?"7=5?H"H\NJ-Q-9;]:WO-K]%
MSG$:4LY9(<EFXRQYFCB'46>7.U@(E82TEC^'TH-L7>UNVNC=L(]%WW1%I_KB
MBN9AYA$DOC#"0)21P<1P<H+-+[>MC(MN;R&RPUO+91V,TMM>BXN0/,CC>62!
MOGD>$]E:*C'_ &:Y"_\ N'4^G9)W3XC!W=M;8AY :!"Z-[G=( [3WDH,M]TN
ML=3Z0VWGFTK ;B^NIXK6X+7!A]/.'MD;Q:[@0H.)<QO5DK/;"/1$6BH[0"XM
M[F\RC;B=TD\L!>&DL<PM'!]/"@ZFV"UY;[B;+W&%UAC&XO"XN-EB9@Z24S,N
M62N<7"C"*5(X%!E.GO;WL1'HMXQ6(@GL)K9[C=B>Y:'.#7 /Z?/-*=R##/:7
M-=8S4NX.C;&7S-*X3)QVN)C:!Y;(&PN(Z3Q)!/>XJHWAO2VFVNH0!Q-G<$GO
M^PD4(:2V&PN,M_:CDI[> ,DO=/7S[MU7'S"VWN&BM3PX<."JI_:KA<7:;4ZL
M-M;-C-R9?/H7'JZ[( CB>U0AIRV,UIMQN+:VE66,FOFVUW&WB/2.M)1(TDU-
M**CJ?36.TJSV]1X^(1-PYT]*TQ=9H1Z1XH3U5'A[*J#1VT>8MM+[+;BQ8RD=
MK=9&?%V#0>#?46#FQT)K6E.U!G<F"CPOM8N9W_X=D<--=W;B*$S&PE:2>)'8
MJ.:="VF=TH_;;6.O0[/:/O;?'6F)M)B(H[-]Q.'0N#K?QGRNE[O'P/:@WK[F
M+FTRFOMO[>=XGTI-+B[J/C]F;CUTH:ZHX_+\4&R_<GC-)W.T=Y;WK87V]JUT
MN/'F.X31VT_E%O2[CS^*@R'V[-']2NBFMX XJV-?AT*B^[C:&DU[A&8:#+/Q
M+FRLE]0R%LY(8U[:=+G-_*[^Q!QEE-CKJW]PV,T:[5$\CI\+/=C*^B:"WIO/
M+\OR_,IQI6O4@[)VSV^FV\Q<^,FS#\P9Y1,)I(&V_2 P,I1KWUY5YH+7OZ -
MI]4_C$XZ^X\J?Q29$<X[%[$:UU/MEI[,8_<Z[P]I>64$L6.CQEO.V)CHQX ]
MTK2:<N(0;NVZ]N>!T/J!VJ\Q?G4>K"U\;<M+";1[62%KG#HCF<PU<WJY(- V
M^VNF]RO<WJ?&:E8V2UC=E2WJZAXH[JH/@>P]O>@OV[GMQT5MYIYVO='7K,3G
M,*[U,3F-,CI?3,DN/*!EF>!UNC:*AI09Q<[QXV^T3MIA->XMMW;;@V6#M<A+
M/)*P";.VYCE+C$UM.!>2:M^I!/F?:'M?=E^5T/)'I>^<#-%D;<2WM'GJ>'@3
MW/2>)8[_ )/Q17E]M&L-71ZQU5M5J7*OU!!IVXR L,O(V.(FWL+BVLHXPR(%
MH%.I_P Y/B1'3Z @(" @(.%=_<??'<2[(@>YDQD$1:":E]W/2E.]<=S#9EG[
M=,OZ4_A^:S^WV[=U/^"UKVTP.8]5;TL9AXV"OENXGJ'P6!&]U6368>&?:C=/
M2^A&@HI(=#:;BE!;(S%6+7M/-KA;1@CZEW&G^5;^F/4_E?F]T3K<TQ_N7_\
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M5OF\02#XF]E/H7UIL?!9Y9VSVRG.M;]3J)I[N/V+?TVS/"QOV[ _<6K"./\
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M-.:>B?B+\>982_>5G&71DEORRAKAQ!YA!T3M\_7$FGX7Z[LVVF>('G1-GBN
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MB<8;R/UHKU,ZA4$'I/;WJ"Y1W4$PD>Q[7"*K7EIKRXGDJCG;)[Q:IGGW#O\
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M_J9&"1UEH+N!/8JC1.$TEJO*8#6N]NKH!8WF;MKU^(LFOCF$=M=VTK)6AS'
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M) UK"!1S>JCJ_2@OV*]O>5R&W;M?WFK)CKVYQTN4=>&TC+Q,(72F.HE$?BD
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M\Q;4?UIX8Z=W'O\ .YEWJO)Q=Q@W644E+*XZJS&5U.EG4_EQI3M0=](@@("
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M?[UN"_ON/_1+LM)^WW>=AW?-AV##^9C_ 'H_ N.G>S$Z@(" @(" @(" @("
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MY/\ *N_7=]S<<[^=9^BW[V8+=M \F3_\/N?[V[\"\<_RY['OI_F6]K&=M_\
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MI(:7U^S>WD6@\45RY_9^11Q/W"BA;TLCGQ88/IBNCVHCMRA):3V<T%1 0$!
M0$! 00'! -"/B@<>Y XHJ%>' HB)KV(("O:.*!QYG@BPC6O(HB/8@D'545%$
M$2>?TH)D!!(2XT *")/&O=P00/54"O% _&J>0X()J! ^':@D Y_'F$$1R-!2
MG"B"G0-<[H\-?$X\ZE%1#22'=O.OP1%:B >2"D:BHIX2.7>HJ !Z>D^$ \.V
MBJ%#\I-*\:CM01J[JZ>WF/H155$$$.!*!PY(%>Y!%! UJ@@:?6@#AS-:]B
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M:3]ON\[#N^;#L&'\S'^]'X%QT[V8G4! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MS9\UM8]FL58;LEK<Y"2]PM[PFDFEO&'G7S7L:!P: M5R#75F['=TS-W?1O\
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M>$&9:BPF);@,K+Z8=1M)SS=S$;N//L18<G>P 4GW$#11OJ,7^AND1VV#Q '
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M\"XZ=[,34[":]Z@B#4\$$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MD< '$T[R%LM'I+=/9PQYVIU^MNU63BGS=B\\:<>%.[N6>UXWZ$24RJ" @("
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ML,_*,6&/:OVTK&YL"W>^2"*604>]C26_$@%=)9,S$3/4Y6^(BZ8CK5#P%2:
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M N.G>S510$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M->_V?<[+ENX-RP$,DGQ9:UP+2*170X@\54=OLK2IX'M03H" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @((4_P"-16)[@:CBT]IZ<A]+
MV^!LK%C.+_.N&/;&Z@XTZAS6)J<O!9/7.R&[Y/HIU.>/#;[5W9$Q7T.>]2Z
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M(YC?'W.0;H6N.N(-':;ZO(-]&^V>?O##RV;J1R '\[!^*>XJCN! 0$! 0$!
M0*H+3J@C]7,M_([C]$Y!QO[ /S^XO\HQ7Z*Y0=NJ*BJ@@(" @(" @(" @("
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MMBVZ8CK9+W5X@\N-%\"90#R02]0Y*B/[:@! XU010$! 0$! 0$! 0$! 0$!
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M..]Q_P#>MP7]]Q_Z)=EI/V^[SL.[YL.P8?S,?[T?@7'3O9B=0$! 0$! 0$!
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M[X<6_J3;@'F Z[_@**S3V_;Y;BZNW>QFELWIN#'VOV_K)BZ=LC?XA<31](D
M!J6 'Z54=Z(" @A4=Z"-1WH%1WH%0@5" @M.J"/U<RW\CG_1N0<<>P'\]N+_
M "C%?H;I!VX.2"* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MB\NZ.IKZ>)Q'S-:?J7MEUN;);2^Z9A\Q9;&YFBPGV(" @(" @(" @(" @("
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ME>7VF;J2"."_:)?#%$.MW3Y<;F<3*ZO%!V=L)M1%MEMM8Z8NOMKF2)S+TR
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MOT'D^#E^BMF_XELW1TS-O]6$:&U'+CLY!E</.V:*"1L5V8GAP$76USZ]->%
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M'/)OLFVV*5>=FFBV:NFX8(X(F0PMZ(HP T#X+EYFNUEJHJ/K*^1,@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M+3JC_5S+?R.?]&Y!QQ[ ?S^XO\HQ7Z*Y0=N]J@*@@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(,%U%NII#2]\^QRUV(IF!W4"Z(#J:2/QI&]RQYSV\7#
M%9GR-W@Y-J,N+XL1'#Y:]O4LT6_VW,T<CX[_ *S&"7M8Z!SC05- )5\Y,_PX
MK?;=$>6*/72\BU&JFF.DS7K_  :4UWN+K'=R_FT_HV4XK2[7.9<WTCY+5[H@
MYS75<'/C(+'U7/:GF$Y;XLLB9F>CK[:3WNNMY7CY3BX\M/B=,^'].[;%-BU8
M#*;2[2C[LG]5F=1N\-Q]W16]Y%-*:,<92U['$N<WCPY+?:3^.:K4V\67V8\.
MWA],.,U7/[..[X,3=?M]N[WN^)\[.;#5^].LX'6N@\!C,)I]P+8I[KU=A=-C
M(H"VCG-J&N'UA;ZWENGT\<-]TVT\%*.<R9=1J-M\[>NNU[++V]ZJU%6?<#6^
M6G=(>I]A%="YM17B6 2LY<7#Z%9S8+-EN.+O+=&UY?2Q,>W,W=JMK'VK:0R.
M M[#3C&V.2A<SS+QK8HI)@UK@2]P8>+B17@LS2<VOQ7;?=ZGK=@LX:1%&-:+
M]I46&U!:Y3.7IFM;1[)61-?')U21O:]M08APX%9NHYYQV3;;&V7Q9IHMFKJ6
M""&UA9#"P1PQ@-CC:*  <N"Y:9F9K+*5NKE4<U%3* @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((5!J*BHYH+5J
M@C]7,L.WT=QP_P"B<@XX]@/Y_<7^48K]#<H.W.U015! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$!! \B@^=_N1R,\NY>0M2"(8WSMZ75XTG>*@'\*Z3D7
M*L4W79[O:G=][?\ ,>>:C%H\>GQUMB8B9G;'D:DM)7Q3QBW:&ESVT X=1)'
M_2NCUW+,&HQ3;?&SU-'ROG6LTN:)Q7S6=F^>FG4[#VOV%O\ -:<Q^=R&H\AC
M+?)PQW7H+"1HA+9&@]#FN96AY4[EPV.S2:.>''CMNNMV<<Q'%/GAF\RUFIU6
M2Z<]TSM]VNROG;AP>R.W&&+)S@K2]R((<Z_N(6&=SQ0]1( XDBJ^\G,,U_YI
MB.IJK<5MNZ(9Y;V5O:0M@M86Q0LH&QM%&BG*@"P)NF9K+U5N@M<'<2#S:.55
M\B-"36E6GO00Z7$U=RKPISHHJH[L-*KZ1+QJ0":UKQY405% 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\P5 ^S<>'["BPY!]@ #9MQ T4:VXQ= .7&&Z51VY1Q  [.TH)T! 0$! 0$!
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MIO)/X*?5:3P>@^FU7C]*'ZI;K_Y[?_.Y?X*OU6C\'H3Z;5^/TGZH[L?Y\?\
MSR7^"I]5H_!Z(7Z;5^/TGZH[L?Y\?_.Y?X*?5:/P>B#Z;5^/TGZH[L?Y\?\
MSR7^"GU6C\'H@^FU?C])^J.['^?'_P \E_@I]5H_!Z(/IM7X_2@=);K_ .?'
MG_M<I_\ A5^JT?@]$)]-J_'Z6SL+!?VV/@AR,GG7C&-$LG47DN#0#Q/QJM'F
MFV;IFW<W6*+HMB+MZX]17C1Z'4E!&OP*@5^!5%%SA3AU<#U'X_!!,P@N!;PK
MS""J@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MNML'>S-' F.Q>\ _5<%!4_V^\'_1W(?Z/D_QA!!WO\P+6ESM/9!K0*DG'R
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M^,()(O[0+3DX+H,%?RM:>EQ98O< X=AI<<T%3_;[P?\ 1[(_Z/D_QA!!WO\
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MTYS9':AV*R,UOHW&F[]/+Y1;;M+C)Y9Z3P[0>2BU<U^S[9?%7$NMF;B:/CD
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M%:4%1V?2JB(#FEQ XFIK\$$&M->H5+CSKW=R*JU'>B)>IK@0UPKQ' \B@HD
MU<'=(8:./*I'?\"BIVAHX\#U<?V?W$1 A_'X'K'_  ()F#X?-XS7O*BJB(@X
M5:1S^!04O$X49X7-X@'@$4:US3Q'"E2/CVJH@&FO;SZD$[6T/*M>-2@J(('D
M4%*@/@'9Q^DH 'T=([N]!"H?P8X$\B:\0I1:@+(N!(:/[HTXJHJB2-QHUP)Y
MT!!035'>@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MAL\[;MN;>WD9.QLC6O\ '">II\0**Y'VM9'![S]56\30R**+*-C8W@ T20\
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M;7-:SCX>%41W8UH+P[DZG$C\"*K*H(" @(" @(" @(" @(" @(" @(" @("
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M/0J@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(*0:>' T'S=Z*!A%.=._M1$I8ZO*I_&!Y((@/ZN
MH\AV=]4%9 0$! 0$! 0$! 0#R040QU34</Q3\$4#7N(!\-.T<U!6500$! 00
MJ.] J.] J.] J.]!&H[T$*CO0*@BH/UH).!Y]G(]J"7YN/ D<C\/@@@:=72>
MZH)YH'B/2UQJ>:#F3W)9MMUFK/$1.JV*%KI #^.R65O?\5Q7.LM<L1T1'WR_
M0OXW@X<<WSU_="Z^VC--'K\&YWC=(^=HKV,9&WO_ '%[<CR1$S9U[6/_ "7!
M[N3S>MT;4+KW"E0@A4=X0*CO0*CO" 2*'Z*T02#B:D=G!16B?<GG6P86TP;"
M/,EFBN" >-!YK#V_N+F.>9/9BSS^MV'\:P5R3DZJQZFM-ALVW#ZV;%(0([F%
M\8!Y=4CXVCM'%:CE67@SQ,]5&_Y]@^)I]G1/]78(^''M"[]^7I3U$GC\*?'N
M*@E:TD\:UK]0^A43%KN-.'=WD_%0&<' 5JZG$]GT!4HJU'>@$BG/L0:>]P^9
M9C]&LLFN^VN[@1$5X]$MO<-[^\+GN=Y>'%$1U^BDNH_CN&;]17HB/5-K06T6
M5^Y]>8IQ( NI;>T<:T%);F&O:.Y<SH<O!FM\MT1Z8=IS;%\337>2)GT2[<9(
MU[0YI%"*@_ K]&B:Q5^23%)35'>%4*CO010$$'<6D#G1!1Z'$MK7@00.S@@G
M+75[D$M'.<>EHZ?E)/-!%K>[A0T/U(*J @(" @(%4! 00<*@@<$%/Q?+2I[:
M\J(("O$@>'D6]BBHT(%!7B>?<JB0->'$\:?E?C?1]"@FZ3QH./?VJH-;XA4<
M1Q^'_K159 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00'!!;
M\WEK;!XF]S%X";:Q@EN9@T NZ(6%[J D<:#O0<VL]\NU<SY&VN'U'=MB/3(Z
MVQ\4S&GGS;<E169;?>Z3:W</)_=-C-=8K(5(\K--M[*K@*T \]QJ>0%.:#==
M2/$ "#S':JB '$D'AV HJ-!0EW'CPIW(( AQ/93D41*7$N\->H<"#R*"?@./
M#X@<D$*\:#GRIV%!!I'$#@YO"G8/H01 !-7$]79]'<@$FCB?FH2 .Y)6')FY
MNC]8Z@UED+VWQ[Y+9LLK('^7*0Z,R.<#4-([>Q<%K<&6_-=/#-*ST2_2^6:S
M3X=/;$W;:17=U+CLYIC5NF-8QW=W8/9:20OB>XQR@#K>SG5H'(+UY;AR8\T7
M3$[J;GASC58,^#AMNVUKT>5U&2ZA((KR^"[A^=,/UGN=I+0<^/LM07S(K_)2
MPV]K9LDB]0YUP]S&O\M\C'%G4T@N%>*#*;>47,#)FU D <SJX'I/8J,'UONO
MC-"9C&86^P^8R,N3=#'%/C+,W4$9GE=$/-?UMZ0"VKN' <5"&=VTS)X6S]):
MUXZ@UPHX5[QV%!4'.H-:\B>P=R T\34GAV'E]2*T)O)MUK+6FH+>ZQ3+;T4$
M/E#S)'M)(E>X$@-<.3ERW,M#ESY>*.B*.SY/S'3Z;%,75K,_<PW3>R^X.&S^
M/R;V6G1!/$^0-ED/V;9&N=^(.- M?BY7FMOB>J8;74\ZTN3%=;MVQ/1Y.UU5
M"^5S&.E:&N<VI#>_ZUV]N[:_.)I78GJ*EW9V@=_Q7T^0GQ _#@#R089N=N7@
M-JM-_K3J1EP_'^<VW#;5C)'^8]CY!P>^,4I&>U!>='ZHQVL]-8G5&*;(W&Y>
MSM[^V$S0R3HNH63,Z@US@/"\5H2@O1';U=M>/;\/H08]K'6VG=!8>3/:GO66
M=@SJ#.N2.-\D@C?*(XQ*]@<]S8W=+:U*#3N]DV)U5HO#:ZB9D[G!7++:YM8,
M;"VXN7-DMYKECC&"X4+'TJ'<Z!:C7:"=1,4G[;6_Y7S2-'$[*U_#^BTZ&V19
ME8,%J^RN;VUB>;3)16UX&P3M!#)PV1G0>EP!HX5X%:RSDUUET37=+<9/Y'&2
MRZWA]Z)CO\[I&UB=;6T%O(2Z1D;&%W.O2 .??P73V12V(<7?=69GRO0VH^BG
M,]_<5]OA $D'JH"#44[D$[7<N[]NJ"H@(" @(" @(" @(!Y().9!/8@B._XH
MJ9$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 02
M]H'P08EN@!_5[J8]OW7>_P#=I$6''?L>T/IK5&G=4RYO'PW<L5U;-C=*QKZ!
M\3^KB1VT08][K-J,+MAK' :TTD/0.GN(//@@#(FDS736D48T$BC?RD1T3KC>
MC<+$Z3TY?Z(P,.4RV;@;++)=PW3[2(.F=&[J? \%I  /%%:TN/=1N;H'7&*T
MON3C]/RVV3\+9<'+<7DC"Z01 .,DX:#4\J<E!G&I/<!JK16]MKHG4MG8PZ-R
MK9Y<=?M\WSBQKQ'%5SY6QU<X]@^A!5WJ]P&IM'[@8';S0UC9Y+(Y!@EOC.)I
M'1".<1R &WD%"&FM'-518MR?<SK/#;BC;+2-CBH,G#YS+B_U&Z:SM7R0.H?+
MG;,T$$$=-6\2HJ^[<[R[O7FMH]*:WP.+EQTK97-RNGVW=W"/+;PK.^0LXG]I
M!TDXT)^ \/=]:J.0-3>YS<VTWAS&VFF,'CKZ:WFG@LW21W;S6-[(VND,4U T
M%XJ0W@@]#?<KNIH#7N,TCO)I_&6EGF7Q,M;S$,NINE]Q.((^J2XF:T"H<3P*
M*R#='W+Y;':QMMO-JL=;9O5,P^U-VR26W8ULSH'^.UFZA1Q8>+>14%CN?<9N
MYMGJ?%X?>73^,M<1E7PPPWV&;=SADEQ-Y3 Z2>5K&_*\GX<4%SW=]S><T[J?
M#Z5T%;8U\V8M8[N+(9TR069;).^'PS13-;QHTCZT$VC=Z=ZFZTL].:OP>%OL
M1>-#_O+3IN[^-A=*V,5E,A8*"KC\*%5'/7O#N==R;\Z7]7#9A\4UK^KS&OEZ
M)(6Y*4VQFK6A+J]71V<E%=Y[9S:QN=*6<NN;>T@S/E1]4=@Z1\0\ )XR\?FJ
MB-/^X3?;/;6Z[TGIS%8JPOK7-R6+)Y;UDSI&>KO)('%ACD8 0&U%0>*HM>_O
MN1U9M9JS2V P6,L[J'.6MK-()V3ND,]S=2P=+1%*RK:,'82HK'=9>X_?3;J3
M%9_5FF\)#H_+SP1QF-M\;MC+J0AH<Q\K6M>&M=P)5&Q]Q?<UA]':%P&H,?!Z
MO/ZFAMYL1CWLZP?6>8R+K8R8/ \Q@:>FJ(P._P!\?<IIG!6NNM2:4P0TG<ED
MMQ%;-R$EY% \&1Q,+I &]+&.^8T!45G>=]U&E,=M#:;DX^-UU<Y%T-K:6!8Q
M[FWEU ^6)LD;9PX-JT!WBKQ51KF7W!>Y#&X+%:]O='8J[TEEY8#'!80Y*XR#
M8+BKZ^0)*-(:T]M*T45F&[/N)U%H[16D-6X/$,AFU%<8^*YLLI%-!+$V]=('
M5C;(TM<.D?,2JC,]=;KYS36R]GN)9VUO+E;F!DSH)1(80YUO++P#7AU*L'XR
M*YZW@W+R^ZWM6M-49NW@M[V;)V;GQ6W7Y0,N/N)#3S'//,]Z(VYIK6VH]!>V
M;0.7TOBOOC,S87#VUO;&*:>)KGX=LC72"!S7!@?&T./8"@UMJ7W.[W;<QX3/
M:YQ6F?N/,W-K%+9V,UW-D(([L.E/V#YV]#F,C>WQ<G4!08][V-3:JU7MKH;/
MV45N-$9IN)RC7/=(+IN1N[2]E$98'.8&"%_>75[:**RK$[J[G[7>V73^I\YB
M<1<0Q06=I@XNJYE#[!N'$UN^4=;*/(B(=TFG<JC:=U[A+32VQ>!W-U#:L;DL
MY96AL<=9L+V&_O,:;R-@C?*UYBZFN;X7%W9S0:^BWO\ <Q=::?N-!I3!?J;'
M&;]L+VY$7QL&P^K#A!YE"\Q&G.G5P45E#/= S/[)9G<73MJQFH,(+FWR.,O&
MNBZ+RSQWJY:1LF=((P]S65<0>P\5481IWW&;^ZXV_N-<Z6TSA&XS$6SYLD^]
M;?PO>ZUM6W,OE!LK@]I:]O3QXH-N^V_?.XWHT]>7&5M8K'/8N[ELKR"V8]D7
M5;16QD(\V1[CXYB*]R@WFJ" @(" @(" @("!P08KI_6-MG,S?8B(M\RRZ^JE
M*_9R"/CXCW]RU^GU<9<DV1T-CJ-'.+';?/YOZ,H!6P:Y,@((5'>@5'>@5'>@
MC4=Z!4((=3>\(%1SKP0*CO0*CO01J.]!#J;WCAS0100J.] J.5>*"-1WH%0@
M5"!4(%0@A4=Z 2!S*!4=Z!4=Z"-0@AU-J145',((U""%1WA!% 0$$*COY\D$
M:CE7B@5""'4.\<>2"* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(""7M%5!BFYS7OT!J6.-I<YV+O:- J2?3R=R
MJPX/]J&^.D]G\1J#':NL,H9[VX@?$+6V8]M(8W U\V6/M=V(BOO3N-D/<MK'
M :=V_P #D&8BTDA?=7=_9RP@>1<B4T?$Z9AJTH,P]P.O=>;<7.FML,''=6>E
M_3F.[SEJV>.0$3EOYQA;'0M<>8[$5SKN5IVRLM=Z9O<)D<WJ*V=<0^HR63C;
M)"V0W#>#)8J@M(XU)YH.J/=_H:?(Z2T[N-BV&:^P4MK#T,'5]B+A\[R>EI/)
MO> @PGVSQY7>W>6_W:RL+X[#&FXB#2UX83>1=;2T2=?#J;^6H,B]P]IL_J?7
MAQVI;?46!S\!D:W.V-A;MM7N:\$N]1,_DXTXTXT5&";>ZVU[H+<>RTSH6_R&
MKM.SEPFN+UTUS$UH<UE?XJ0P'I<7!0?0V3O;PX5<$'ST_76ST%[P=19R^LKF
M[LWRWUN]MI#YSXA+/!XW#J:&M: 2YQ/!473W :MMM[-RM'XK0]C>W0LKC'ON
M[HP%T<?I[YQ>"^$R@4$C3XE!XHK/*;!^Y0:KU3C+V]P.0M[J!E]:P/N(V&[N
MQTE[R(V-H(W./BY<547WW+;@XW>N\TUHS0=A?WUR<C87<UXVW\R"-L4\C']4
MD#I0TCS&NXCXHKT;PX';&WL-(:(W"L\_9:BQF/MK:/46)L8)H&NBEE:.JXG<
MP =9+_EY"J# M.ZMUCMAN'@L#MKELGK'3^0FMX[MUXZ2X;%%+<-B?U"S(8WI
M8T'Q=_<@RCWDVV19NWMWJ.>TG=C[6+&27LT,;W1Q.9D9I'MZJ4%&BO$J#M+0
M>JL3JW3UMD\/(^2V\MK:OZ:U<T.'RN<.151R)[S;>YGW;VY,,$DS&2XCK?&P
MO IDY2:D#N459O=?:W4N\6U3XK>6:-K,.2YC'.# ,I*36@X41&=>^F*XN-M<
M!';PR2EN6QYZ6-+G<!<\2 J-3;IZ-U"W1&S>X=IC[F^Q>$L<,R^MK:*2:=GI
M[F:Y>3&QO !@YEP45N/<SW&:/U-M)/A,18Y*?.9BS?9,Q[+9KYHY;JWEB'7&
MR5SV@.< ?#P51I#*;,ZUPWMSP.3EL9Y;EF5QF2EQ[(Y7S,@M[9[WET0C#FD=
M-./>@WAA/=!I'3&U&G+*/$W]_J*UAMK2;%MM!+*V0L-3Y3)A(*.H#4(K&/=+
MD,UK7:C1FN8<)=0P^MQEW<6#+687$+&>?,_JB\1;TCG4HCQ[B[S:;SWMSQ6F
M\59Y&YR\5K$RYBCMA(8OXK,UW6&/<YO27"O4W@@PZ^M;O_8WL(!;2F7[QL"6
M!CB[AC)AQ%*HK8FLMR-=;=>V[;&UTI83%N0Q.!M,C>1,N!+;Q3XAXE<'1$!I
M9Y;7>+D>:(YRW>Q-OE=,8/4-KF\_J3.W4UI>9."X:VYL;3S89I9F];.I[71O
M-*/Y-=Q0;P]P5E?7_M)VP?86LMUZ3[A?<L@8Z5\;8L'<=9<&@TI45J@;HZIQ
MFK/:!I7$X2.>2^Q-OC[*^A<P=;9[7 RLD'2QSB "\#B 4$=S=%ZAU#[6]K<I
MA;.2[GTZS 9"]L R1[S#8865\E(V-<XDEP;V=R#/\?[DM%-V-9@9+#)1ZD@P
M PCL2ZV8)?6LQHB/3#YWF&/S/ #T]5>%*HK3.E=$:BQ6P&Y6KLG9S6K=17.<
MFLK"2.2.3R;_ !;)XWF-[0X'@6\R.Q$;SV&MY8/:=FHO)>R1V%NBZ,M(>7'"
M0#@.U!BOL3MYX+O6QGA?%U9G*N;YC2RH+K&A%4':J @(" @(" @(!Y()>/(C
M]A0>++WK<;C+J_>0([:-TCB>YHK\%Y9;^"R;NI[8;..^+>N7-VSFJ6'<[,^8
M?!D'S0Q5[Y;MI%.*X[E>7AU5TS^:OIEWG.--_P"SL_RT_P"%TZWG4CC6@7;/
MSU.J('D4%%U:<#4 U=7G1%1J !VM/&O:B('JH.F@%:FO#@@A4UKQH?"!^ZHJ
M@[(63'/C-S'YD3?,EC+V]365I6E>'%!Y</J#"Z@9//A[R&]CMY7VTQ@D9*&R
MQ4ZFGH<ZA%14%5%7+9;'X+'SY'+7,=KC[=AEFN)WMC8QC14U<\M I\2@PZ+>
M;;I[2]F=LW15X2"YMBRG?7S:(K([75^E[W#3Y^RS-E<X:V:Y]Q>17,,D,18
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MO3W= #?H52JAI[1FF=*NN':=Q-KCO5ROGN'6\8C+Y)>GJ<:=IZ&_L(,A0$!
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M#:Q^?(\"%A :T$5J.XH,OTY[@FPY[%Z>U;AKO%C+.CAQES);/@@ZGBOC?-(
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MN8YU%U\6VVQ.R:NP_CD66WW7W3$;.F?+#G:+ ZDAECE9A[\.C<' BUFJ*?\
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M R1KAV=R#SX?2&E-.ESM/X#'XISQ1[K"S@MBX5KQ\IC:\4$6Z4TVVUGL1A+
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MQ6;#EKIK.Q=>IO>%7R5'?SY((H" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M4,73TXC/10X^[D,E2 R SO>X](Z_EY<4(;2C:>!)J[MXH*J @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(+7G,O%
M@\=-D9899XX&ND,<+0]_A%> );^%>^'%.2Z+8FCQRY?AVS=+7PWPPXYX7+\#
M3_!8Z?IUM_[1?XK>_P#!J?[M9X;N[\4?Z\</_F3+_P UC_\ KI_9[_%;W_@O
M]VL\-W=^)_7CA_\ ,F7_ )K'_P#73^SW^*WO_!/[M9X;N[\3^O'#_P"9<O\
MS6/_ .NI_9[_ !6]_P"!_=K/#=W?B@=\<.13[ERX^(M8_P#ZZ?V>_P 5O?\
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M48.^P>H=N]87%R9YGMEL<+*^-PDGDD%#*^(G@X=B#)K/!:SWJW<P^M<K@[_
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MM);:X8VZMNIIF+^JG(=-0.U$9!9ZG=HK7NOX,0([S4S[3%LQV.=]K+,^C7.
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M9J:VT?NWNGFKXL9*_P#5_P!':$@/GI8^7)Y+'.9U]'6"_I/#M4&4Z*QUEI#
MW&XNX,WE:DO.CULU^YK?3>5*^TC\EUT&2,ZXWL#^I_BX4X4"#46E-;[H3YF[
MUEJ30&8NLM/Y?W?&</>2QVG1&^WE\@3/ZH_,;T]?2[Q=J#&/OR?_ &<_4>6?
M5_YMZ37_ ,6I^:ZJ\O'^V@[E0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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I^=WU*H-^5OUITB+?SC_J_ @.Y!3I#L"HB.;OJ14BKY3GM14?Q5%?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm2225088d1-lc_survival4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_survival4clr.jpg
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M .   0  !P$!               ! @,$!@<(!0D! 0$  P$! 0
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M6R[E;C)\%>S2V39'"!\K1* 7,K0D$*#H15! 0$! 0$! 0$! 0$! 0$! 0$!
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MUY "V*<M!D:#X-<14=D%[&QS2:TH>O3VH*J @(" @(" @(" @(" @(" @("
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M:CVH" @(" @(%0@A4>U J/:@C4((5'>O1!&H00J/:@5![%!&H*"%1VJ$$:A
MJ$$*@]0>B"-4"H0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$$KQ5I'B>B"E)T;45.D4(^5!)H<'UH0&]10=Q3K]**KL%&B@(\:%$3H"
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M^5.>N<+GA#C/*R87"8(3,RUY'(YC7.BJV5\N@CH'-TL%>[AU45BO(WIQYPX
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MR5F\1>\5\AR[.L+."6.^MH\EDL>)I7EA:XML@6NH >KO:@TW^ZIZQ_VZ7/\
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MMJY">*S8\DAMN^4O<!7M^4D<BNPF?5_R(B9 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MAQ3Q32'ZEJ-+BS\NQ1XUML4GUMT-YQWMI<1Q=EV$4JW4234^^)2<MT?A]?\
M)SEG(M),;=597]O*]KCGFNYWKN^YV??[7GP-_;0_:'&ZFJ_30_@&-IZT7I9?
M,SM?%K>31I\$Y;<D7VUILCVMPZ@"">B]Z.;JGU ^*"* @(" @(" @(" @("
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M *T[CJ32B]-[BIBB<2N(JVE#V!4$VI^D'QIU^56&,IZG53P49(U1$4! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MU-CMC--UNZZ;I_>Z"BD!8YQZ GI\B]G&VUC;*YCI4U[K%G.]41! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M]U=,^M[Z+!G,*BK$0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MJ%Z5<[?CG'?2YZH["O=$11! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[N],)6D BO7JE#HJG4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M]7%SLN73B .O@AOE4!% 5!% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MGXOG'=66/4KBE/<H(H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MPPT[5PU?PK6$^SKI5M?!KXX<UT>5DSJ =.ZLO@G<J#L$$4! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MLSNENN<8,,X[<^+\5:[_ ".B-=9&MK1OO7I38Y*=\+H=AU6*HH" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MGL7L_.TR((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 00<2!4?/\B"RO,A;V%L^ZOIV6ULP
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M&NHSI\Z]+;H:KF'*-1H[++LM*7339-6Q+4U+P !U'8=%FTONQ.Q=CN3[5!%
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 02R&C#TK[D&@_51]@MN,#D;Z
M.::3%Y"SOK6WAA?<&2XM[ADT<+PP'X7. ;7L*HK%\?ZT./HK"U;=8+.Q3QL:
MU\;<==$!S6@&E(NR#<O%O*>$Y6PMQF\':W=I!;S>0^.^@DMI"X@/Z"1K>G5!
MGL7BB*B @(" @(" @(+',?T5>_R$O\0H.>O1%_@]<?UU?_=8HKI-5! 0$! 0
M$! 0$! 0$! 0$! 0$'@;U;,_:V9CMVN?*^PNVL8RI<YSH'@  =ZE?1IKN'+;
M=U3$_O?!S"SCTV2WM671Z8EI3A;=<>)G;L2]L+FVRL\SYV.F8(VAE&MKU-5N
M>8X_&CQ8W4<IR+76XKHTMUMT3;3?^U6^P ": ZQX^%?&BYZZD;7<VS%9V+UO
M5HKW(14R @(('L4'@9K 8;<%N+',V45]:L/F1PS@.8' %H(K[G%)9VW4N:4X
M@Q]CA^:N1,;C;=EK906]FV*",:6M!CB<:#WDE?/;]_\ ;R.UYK?7E>G_ #7?
MQ=#0TTZ0:T\2OI<-TJJBB @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @E
M>:,)[=$&"\G;IPVRMH7^XL]9MR%K T>5CWM;()[AW2&-H<#U>^@K0T0:%,OJ
M8S-Q#N+$[$VG98<MUPXB[@K<2,?U;YA,[#JH.E&#Y%%;GX@WM!N_!W3'X4;=
MW#B+AUCG\*U@;Y-XSZVGHVK7-H]IIV/<]T&R8G=37Q/15%4((H" @(" @(""
MQS']%7O\A+_$*#GKT1?X/7']=7_W6**Z3500$! 0$! 0$! 0$! 0$! 0$!!0
MN::0"*@U!]G9!SKOUV:VCR<-[Q8XSXB*!L0EH=(<YQ\5T.COMR8)QSO<!S''
METVO\>+?=_\ JWQCKU]_C;7(!M'3P13:!UZR,#J?-5:#/9$3-OE=U@RS?BMO
MI]Z(GTO6:26M-/ +"(>J=4$! 06A \QW3H!T2=Q'WFAN,?\ 'ODD>'E67_LH
M5XV_>_;R.QYE/_Q>G_-=ZY= QMTUIXKW<:G440$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0"0.Z"5SCI) K\B#4//>T,SN_8Q& B%UE\/>VN8MK1[BQL[
ML?,RX\HT#OK:-**PNR]66P+2RBM,OB,YC]P1L$<N*^Q!TCIHP 6L+9"TM!/<
MN'=!D7 F"R]S=;NY-R]@[%2;YR/Z2L<9,0;F&T9"RWC,[6U:V1S8@[2Q[AU[
MH-W1MH2:GKW'@B*B @(($@=T%*:X$#"]]*-!<34 4'4]33P06EGFK'(PMN<=
M*R[MG$M\V%[9&ZFFCFU:2*A15I>;LP.,EAM,KDK2RO9_]%!//'&Y_O8'D$CK
M[%4>HRY+P'- +"*@@C_=105@ZHJJ+/,?T5>_R$O\0H.>O1%_@]<?UU?_ '6*
M*Z3500$! 0$! 0$! 0$! 0$! 0$!!2G%6CQ4E8:RYJ%-D7#ZT8V1HH3TH0?O
M+[M%=,98:'G<<>ENG=2&4[2N&76 QAAD:\,MH(W2,-?B;&&N!^0BB\=5CIFF
M?++[^77\6EL\EMOJAD[10 >"\'W)D! 0$%N&]7'YDEE3:T'QH0WGCDIW=WEV
M70>SR85X6_>_;R.PYA%>5Z>?\5WKEOZWF,NH$ :33H:KZ'&5VRK**(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M<<28R\8S<U@Y[H9  )F]26&BHU1Z(7M=P[.6FK79F_((ZCJ6(KI5$$! 0$!
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M!X(]JHV?"0"ZG6II]"(KH" @(($ ]P@@(V#LT=J?,@:&>P>Q \MAIT[=D$0
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MH;?U5PZ&M;_JSR=#0VNJR:233Q)*^.^?]2/VZW><4W\DOF>BZV/WPZ7:>M/
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M<PD$$=5!GN&Q..PMG%C<7:165C;ZA!! QL;&@FI(#0 *E!Z7S*HB@(" @("
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MW;',2,TRWD,<[FCM5[:_Y5JLMG#=1U>BU<ZG3V9)B8XK8GTO8=;0N=JT O\
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MY\F9+'S8>+?&2_2&+QUR:SQVD<++=CI6] USQ%K %>_=4;OB;0DD]4150$!
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M W%SRK@K?;^<;/IM;2TGBN&F"@(<3%)(*D^%4&QHP!4 :0.P'9!.@(" @("
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M9 0$! 0$! 0$!!8YC^BKW^0E_B%!SUZ(O\'KC^NK_P"ZQ172:J" @(" @("
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MO0#U\F04_P"(0@Y[]$1']S]P*]?TU?FGNJQ17250JB* @(" @(" @(" @("
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MUKT^1>FQSDUG:N5B(H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(%.M4 "@H@(" @(+',?T5>_R$O\0H.>
MO1%_@]<?UU?_ '6**Z3500$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M!+("6. [D$!(%C%;O9UEH?\ @JSO6+KKHVT8=N+BG:^Z,L[,Y%LWVPM$>N.3
MR_AJ3["OLQZRZRWABC3:KD^#/=Q7S-?)-'EG@W9E QKKH@=OR_8?\E6WF.2R
MV8B(VSU/F_M_3]$W]Y3?P=LL,K_K9<32GG=*?\E?7/-LTQ2EOH8_H>"+=]W>
M:^P$^$V#R?FX;B:6' V,,8:][S(0Y[FM:*4'B5]F?-ESX(K%OH:/!.'3<PNM
MK=NCI=%V=_!?6T=S;DNBE:V2,]JM<*@_PKFKHH[VRZ+EV9!T'M4B64[$[>RJ
M(HH@(" @(" @(" @((4\?% H@\3*W ^SWK'@Z6QFE/D6=-SUTLS.6(ZI:2]+
MV5Q]GQ59P7-W#!-]IN?R<LK&._TKJ="5Y6S#?<[TV2[/6(];?%AD+2_.NSE;
M-&WX7/8X.&H=:5!/M6;G[[+\<\-T4>@%&"* @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M)-3?:$*2:F^T(4DU-]H0I)J;[0A24-;*TJ$8U35"*5" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MMQ1R4@K<4<E(*W%')2"MR#>A-6]*]2E6<Q"JU[#T48[$P()Z)5E1,B" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M(Q.6MK^327EMO,R8AHI^(2K5C=I;[(K,3#W8:AQ!.HTZE(?/,]"N%1% 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ML7>GVGR_-?BV=T_5_G#^TN/_ # _FT\;0=B[T^T^7YK\6SNGZO\ .']I<?\
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M;0=B[T^T^7YK\6SNGZO\X?VEQ_Y@?S:>-H.Q=Z?:?+\U^+9W3]7^</[2X_\
M,#^;3QM!V+O3[3Y?FOQ;.Z?J_P X?VEQ_P"8'\VGC:#L7>GVGR_-?BV=T_5_
MG#^TN/\ S _FT\;0=B[T^T^7YK\6SNGZO\X?VEQ_Y@?S:>-H.Q=Z?:?+\U^+
M9W3]7^</[2X_\P/YM/&T'8N]/M/E^:_%L[I^K_.']I<?^8'\VGC:#L7>GVGR
M_-?BV=T_5_G#^TN/_,#^;3QM!V+O3[3Y?FOQ;.ZI_H'FMSB'[CQY(\?(%/X@
M7AER:.Z/=MNC[5RZ7FW#$QEQ]QX6\\-RS!MK)RYG/65QBHX"ZY@BA >Z,$=&
MG0*=?>OHT=VGBZ(B)KUU?#S+!S+Y>8OR63LC\/EAE_ X<WCW&>PNF<T=:@%Y
M[KX=9-;V\Y+9=;IHXIB9]D-HCW+X&\10$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%CF/Z*O?Y"7^(4'/7HB_P 'KC^NK_[K
M%%=)JH(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(*$H=J+AU;2A"QI%5>%DMOX++75O=9&T9-<6CVR6LCR:QO:0010CL5F\,F
M#'=-9WP]:.-L3/@-6> '@/<L9B)E[612-^QY][@,5D;JUOKRW;-<V;A+;2/)
MJQX-010@=UE%'E?AMNFLO3!:!IT]%C=$2]XB.M%IC:-/0>Y84B$K$)@^/VA6
MD%8-<?M"4CJ*P:X_:$I'45@UQ^T)2.HK!KC]H2D=16#7'[0E(ZBL&N/VA*1U
M%8-<?M"4CJ*P:X_:$I'45@UQ^T)2.HK!KC]H2D=16#7'[0E(ZBL&N/VA*1U%
M8-<?M"4CJ*P:X_:$I'45@UQ^T)2.HK"21S".@U%-ALGI4GQ1S1NBD ?&_HYA
MZ@@^!5]WJ+:VSLEX#N.MC $G 6!U&IK;QCQKX-"Q]WJ?;\[FB-ETIAQSL:G3
M;]C^89]Y3W>IG^H:CM2F_NYV+_9^P_,-3W>H_4,_:D_NYV+_ &?L/S#$]WJ/
MU#/VI/[N=B_V?L/S#$]WJ/U#/VI/[N=B_P!G[#\PQ/=ZC]0S]J3^[G8O]G[#
M\PQ/=ZC]0S]J3^[G8O\ 9^P_,,3W>H_4,_:D_NYV+_9^P_,,3W>H_4,_:D_N
MYV+_ &?L/S#$]WJ/U#/VI0=QUL4 G]7[ >_R&I[O4?/Y^U+4'(O"C\YOC:F5
MVUC+2VPN.O+:3)PM:QC7Q0S"1X(%*ZAT5X;>IN]#S>^S!=;==.V);9AX\V06
M!KMOV.H"CJP,K]Q*6]30W:[/Q?>E4''6QC7_ + L#3I7R&=/X$]WJ9?J&?HN
ME,..=B_V?L?S#/O*>[U+^H9^U(>.=BTZ;?L*_P @S[R>[U).OS]J5.3CO9&C
M^@+!KO;Y#/O*^[U)9KLT;[I:\V_QC>X#F>]WGC[2W@VW/8_8XHX*,<)-+ :M
M'3NT^"M+>I]^77^+@X)NV^VK<EL&Q1Z7C222:%6:-%PQ;TJ^N/Q(4I!6#7'[
M0E(ZBL&N/VA*1U%8-<?M"4CJ*P:X_:$I'45@UQ^T)2.HK!KC]H2D=16#7'[0
ME(ZBL&N/VA*1U%8-<?M"4CJ*P:X_:$I'45A OCIT/7P2D%8>?D\/C\S:NL\C
M V>WDIYC'DT=0U':BSB(AY9<=M^]=6\,%K#';PLTQ1-;&Q@/0-8* ?0DQ$O2
MRV+8HJAT8%.C3[#XK"D+LA-KC]H385@UQ^T)2.HK!KC]H2D=16#7'[0E(ZBL
M&N/VA*1U%8-<?M"4CJ*P:X_:$I'45@UQ^T)2.HK!KC]H2D=16#7'[0E(ZBL&
MN/VA*1U%8-<?M"4CJ*P:X_:$I'45@UQ_C!*1U%82.C+B',- >YIW6,VU29JM
M,CCK?*6DUA>Q"6VF;Y<K7= 6UKX47MBNFRC#-AMR6<-R3!XC'X.V;C\=$V&V
M94LC874%?E)5NR3=.UYX,%F*VEKV L7NB@(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @@2&BI[>*"3SXP:$^%?F0!/&145I\B"<.![
M=:(++,?T5>_R$O\ $*#GKT1?X/7']=7_ -UBBNDU4$! 0$! 0$! 0$! 0$!
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M" @(" @(" @(" @(" @(" @(" @((.) Z(,(Y>OLC8<:;FO<5 ;G(Q8^=]O
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MYQWWD$'>M'E%P)/$]S0"M/,=]Y!YF2]=&]\-):0Y/C22TEO'F.TCGG>"]]0
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M?[KVWSWRENW+6/D8'<(LW8FYU ^:(6D/Z#M1170\;M3 1V\"JB= 0$! 0$!
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M6]M)N/)0XYEW-':VIN9&1&6:9P:QC XC423V"H]Z.9DE"WJ"B)ZH(H" @("
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M%9)R>RVY(]0VT^+KV<OP&!LI\_E;!I($DL9ABB#ST#A2X)Z(*7-^/Q?%N_\
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MS7Q0;ZC[?.B)T! 0$!!+(:-)/8=2@\7-87$YZP?C<W:LO+(N#WPRBK7O%:=
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MIHWO;).P@4<"X..IO3J@Z2BH7:CV/U0/ ^*(K"OB@B@(" @(" @P;E:'.3;
MW+'MLN&:?83"T\MKGO)TU<&M;4ZBVH;3Q0:3X6W]Q'8<%VN*W)E<397-O:WD
M.Z,5DIH(;M]QYDOGB:&5S9'.=4]QUJBO:]'4.;BXQN'92.6/'S9.YEPD4PD#
MFV)9&&TU_@EVK3\Z#HKQ1$4! 0$! 0$'B[FS^'VQB[C.9^]AQ^*M='GW5S(V
M&)FM[6-)<XBGQ.'B@XRV9RWQM9>J/>FZ[S<N.@V]>V-M#:7\MS&R&61@E+@Q
MY< ?K#Q45GG(^3Q^QN=-F\R!L<FSL]8S8/)YJ,.EAC=.8IH7.>TEK>EN14]$
M#F;,X/ECD?C?8&T[JRS]M;7XR^=?9SQW4,=I%)'5CWPN(!>(W]*U5'5##\ \
M13P1$X[(" @(" @I3:1I)'S]>E>B#FCU:\B[*M^+=T;*GSME'NB>V8Z+$/GB
M^TD>8#]0NUGL@RC@KE'8.1XQVSBK'<5C<9/;VV<?)FK>*>-\ELVSLHF3&5FH
MENEPZU HBM59/E_CCF3=,3MY;GPV,XNP5P[R<+>WL,-QD+R$U$TX<]KQ$TG2
MQG0&CJZA1!U=MW/X3<^)M\SMZ]AR&*N6@P75N]LL3V@?@N:2$1[$?1M/NH)T
M! 0$!!+( 6D%!:7UW;X^VFO+N5L-K"S7)*XT#0 222?8 @XFW/RYQQ<^KK9F
M\8-SXZ7;5CA;BWN<FVYA=;1R.CN0&ND#M-?C;XH-J<Z9/>/(>V-OVO%.-_6C
M9N6F?/F;NPNH6B:WATAD+)7/_#<YQ.D_@HK1?J)W)R1)B>.\5F./?U:QV(SU
M@S$,9<1RMD?;@,9  Q[@.C0*D40=K<<YC<F=P OMV8([=ROF&,8]TK)CY36M
M+7UC)'4D]%!F"J" @(" @'L@Q/=N^-I;%M8[[>&7M</92.+([B]F9;L<[H?K
M2.:#W17*GI*Y.V#AX]V8W);@L;;(Y7,%V/M7W,+7S!SI"#$-57=_!$9A=WV,
MXG]4>1SN?,..VYO['VT,&6G_ "-N+J"-D>ETCB&-),(ZG\914;V[Q^]_5-M;
M*[+NH;VTP&+O'9_+8]S+B![+GRQ#;NEBU-K5CR.M51U WNT ]!W\>GR^Y$5D
M! 0$! 06\O5X;3J1T[C^$(-">J+D'96)XSW7M3*9RQMMPWUB/LN+FGB;<2.=
M)&[X8RX.- *]D$?3AR%LW-<:[;VC@\]8W6Z+.R<9\?%/'+-&3)([XF!Q<!3J
MBL&],N[MI;:V_N;#<CY*PQF^_P!(W<F;&7DAMKB:!Q^$GSRTN;75T]Z#UO3/
M<39#>/(^7VZTQ\87N1KMW2Q[+22:.*)L[[?P,9D;+71T+JHCJ&,&G7V^_P#R
MH)QV010$! 0$%ID;F*RM)[RXD$5M;QOEFD)#0UC 7.<:^P"J#D3*\O\ &W+F
M[HX]V;IQ&-XQV]</+<+=W3(+O(Y".@$TS2]KQ"P$M:PT:2237I0K;?*5EA^7
M>#MQP;,DM\O:7=GKQQM7B6&5UC(R8,9Y9([Q4%/%!C^P.>MCXOAFSRF9S%C8
M9?;]FZSN\+<7#(;OSK%H8&B![A*:@ B@ZH/2])^TLKM?BN.7-6@M,GF;R;)R
MP$%I:R<-+0=77IU[HC>T?5M?:?%!.@(" @())::37M0H,2W]O3"<?[7O]U9^
M80X^S;JJ:#4\_5 )Z5Z%!SIL'E+C'<>['\I\D;MP46>D#8]K89U]"U^+LG-^
M%CV&0#SZN=J?2M3X"@!6Q^;^<<+QK8XW$6&0LXMS;D#_ -%S7DS66D$0#"ZX
ME<YP 8-;=-30_,5!Y_!N>XILG1XS';NQ6XN2=Q:K[.WUI=0R2WM[H=+*YC(W
M4:T'60QK0 /#H@WU$*/J?#H/;U\**I*Y010$! 0$%-U=5/ _?0?.SU5Y;?)]
M0DV.VKE9[8X_#PY"*UC<0TF*1P(%.VH'^!!OZ'EV+D[TJ[AWICY#:9RUV]>L
MOV,>"^&_MK)_F%M/P0\$M0/3-ONQP?IXQF[=[Y3R;.%\GVG(W!+J-(9WH">A
M/A[45NZ3?>UF;3;OA^28W:KH([L9.KO+\B2FAWU:T=J'AXH/-N>6=A6FT[??
MEQG88]HW3_)@R;M9C=(2X4%&U[L=X>"#$,SZHN','D;7'7>X6O?=-A>R6%I=
M"QMP&EFMYIU(<#T"(K[J]2G$FS[F"QS.>:Z6XA9-6V89&M9+4L))( J/>HK6
MWK5REAGO3O<Y3&SBYL;RYL9+>:,_"YK[J&E#[U1[6PO45Q/M?:6T-LY/.M9E
M/L%M!+H87QQ/+=($CB6^->P0;NRF[=OX/#.W!ELE%;85C6R&]<[\G1W;J 2X
MGPH$1B^S^=.-=]Y=^&VWG8I\D'?D[9S7L=(V@HYFH-J#V'O"*N,WS3QMM[*W
M^"S&X8+3,XRW-Y>6L@>',A!:VO04-2]H KXH,FVUN3&;JP=CG\+.;C%Y%GFV
MLWU2YA<6ZA\XH$&O=W^I'BC8V5EPN<S)_24!+;F"!AD\IP[AY.D#YD1Z?]]O
M'=WL9^_[3.QMVT:Q?;M+G:)]18&N:.H^(?[ZBM ^F3U06F=M,O8<G;LB=FY\
M@(<+!+K<]\1UCX3U 'U>ZHZ[O+^"PMI[RZE\JVMXW32RN^JUK6ZB2?8![E!K
MNTY]XMOY<7;8_<D-[+F+M^.L(XFN<^6YB#2]M'!NG3K;U\:H,5V#@.+</S/O
M?<.!W/)?;QN6W!SN)>XB.S!F:^8U+>NEXIW0>I-ZGN'+?*_HMNX?.<U_ES74
M43W6\;ZENESZ ]QX-51HOU*30W/J4X>NHW_DIHHY6/!JPQODD(IV]H1746=Y
M8V#MG.6VV,QG+>WW!>:76^/=K>]VMQ:T? UP%2/%!FL$NL--:M>T.82>I!]O
MO1%QX]OG010$$I:TFI'O^A!X^XML8'=6.EQ&?L8K_'W#7,E@F;4%KQ0T((([
M]P45Y^T=@;0V/ ^TVIB(,9!)UD$(<7.IV!<\N=\U5!E&EI^FOT*HF0$! 0$!
M 0$%GE,;8Y>RDQ^2MV75G.-,L$HU,<#X$(,:=Q?Q\34[<L?  ^4/H16406T%
MK&R&",,BC:UD;&]FM:* #Y$1<H" @(" @(" @D$; #0(-1;&X=;LOE'>W(S<
MO]K_ %P^SUQQM_+-M]F!'^D\UVNO_ :@V['4L'XWX7AU03H" @(" @(![()"
MQOL\*(,,W9Q?L3>]Q%=;IP=MD;F'_1S2ZFO'L^)A;7YU%93B\988JSCL\?;1
MVMM& UD430QH Z=@JB\#0":#N@B@(" @(" @(*,C6N-' .]@]R#7^6X2XLS6
M7_3F3VO9SY4RLG=<D/:3)&0YKBUK@TD$#I3JHK.[.RM[&%EI;1MBMXA2..,!
MK0![ %47: @(" @(" @L<KB\?F;.3'Y2V9=64VGS()1J:[2X. /S@%!C9XNX
M](/_ ,MV/6M?R0\1U45[.2VW@<OBI,+DK"&YQ4K-!M'M^#2!04]E ?!!XNT^
M-]D[%9(W:V&M\8)S68Q!Q<>FGZSW./8>U!F0[!5$4! 0$! 02N -*H,<RNQ-
MGYNZ=?9;#6MY>. !FFC#G$"M!7YT*F-V)M#$/E=C<-:VIGB=;3>6P#7#)T<Q
MWM!459GB[CVI<=NV/O/E#M6O^5!D6-Q=AB+1EAC+=EM9Q5$<,0TL;7OT51?-
MZCH@B@(" @(($ BA04KBVAN87V\S ^)XTO8X5!!\"H,3_NNX]\=N6/:E/*%4
M5D>/Q>/Q-G%88^W9;64 TQ01C2QK:]@%4:TYJX?;RPS;$/Z6.(_5[*P9?4(/
MM(E\D_Z.GF1Z:_C=?D0;0M"6MT'I0 ::=>G2M?>@ND! 0$! 0$'D9G;N#W#$
MR#.6,-_;QDN8RX;K#7'N0H/*M^-MAVD[+JVV_9PW$;@Z.1L0#FN'B%1=[HV;
MMG>-D,=N7&PY&R':.8'I\A!!'S%!+M;9NV=FV8QVVL=#C[1G0,A::T][G%SC
M]*BRR-5! 0$! 0$$I:TG41U'1!X.7V3M//7/VS,XBVOKD -\V=@<Z@]ZBI<9
MLG:>"N/MN&Q-M8W6DL,T# QVD^%51X>Z.'^-]Y7S<EN7;UKD+UIJV=X?&:^T
M^6YM?G0JRG$X7%8+'P8O#VD=ECK9NF""(48T#V#QJ41ZJ @(" @(""E/%'/$
M^&9H?%(TL>QW4.:X4(/RA!BAXOX]+B3MRQ+R=1/E#OWZ_2@]_&X?&8FT988N
MUCM;*+48X(AI8W7WH/G08AD>'N-,MG/UDO\ ;EI<9JHK<EKA]7J*M#@T]_Q5
M%JSN")D4;61@-8!0- H /D5150$! 0$!! ]D%AD\1C,Q:OL<I:QW=G(:O@E;
MJ:3[P4&/MXOX]86N;MRQ!;0C\D#2G4**]#*[,VKG71OS.)MKQ\#=$1F8'%C/
M8/H510QFP=G86^;D\5AK6TOV5++B*,-<W4TL-/E!(1:LDC:UHHT41$Z @("
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MYT$?NH!_WD#Y4$/ _P " 'L/0'KV^A!#S&=/B!K6GS((M(/8U'N03(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MR @(" @(""4N %2@:VTK[/<@:O$=1[4 /KU J/:@:C2M$$ TUJ?F03 (""*
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M\051[B @((.<&BI[()3*P=":>WW?*@\JRW5MW(W\V+L<E!<9&W!,]M&\.D8
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M]EEGI7;?W$R+ZLC#IDMWD=*O8/.TU]I0='1T# !T]RJ)D! 0$&';^WMAN/\
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MAO$5U+L?FK>O$@9*["SZMR81SB/+ACN2U\L0%>@#Y](H/P51T6B" @())?\
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M.F9I8X CL:%!SYZ3<K#BL)N?C:^C^RY_;F<NG36CB72&VN61/CE(/6A.IO\
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M03Y>VNKFYN/L[ZM<&,-I& 2.OU@@]G/\)74/"D?$&RLI^CX?+M[>YO)]1?-
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M;^Y RF]+/?,UNZ?"7XM;>"T: R,>5&X@/TL+A5WBT(.B)2UL3GO(:QK27$]
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MF-J[<R>]/UUQ-T,/;/R-SAFV5(WQP-URL;*8P?JAVDZ45MWBW>+=_P"PL%O
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M;?NX;W;& GRV/Q-SF[QI#(,=9AGF/>X&A)D?& T4Z]4&A^+^5>5\WSYD./\
M?-O:8VPBQ(R#,5;'S71.E9%*P.D,;#J ?U'4>]!TT6T'7P_RH-(Y;<^<WCS-
M;; VSD'6FW-M1"_W7<0])))P 8K9IIUJY['/K3X0[QZ(JCR;R/O&?D'$<0\9
MO@M]QWUL<AE,S<,\R.RMM;VC\F6D.<1&XT^3J@H[/WUOG:W(T'$7)E];Y:_R
MMG)D,%GK6/RO.,7Q/A=$&@-+6L>[54]D%YM[=6?V=S'<\>;HR#KO!;@MAE-K
M3SD.?'('2,FMR[H208PYO_#"@W=&YNHFM:= %45T! 04Y=/2OB@TKS+R9N#
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M1MD%:NZ4Z(,0Y5RG&6XN/=YW.P..CDXX+7(..\8K0PPQS01R&2X9=R,I*8Y
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MJ['VKK8"(  @ZI9*]051B/J:VC>[HXXCO\8X_I':^1ML_;- U%[;5LD<K2?
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3FCH@25J/X?D00^"O7MX?2@__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm2225088d1-lc_data4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_data4clr.jpg
M_]C_X0 817AI9@  24DJ  @              /_L !%$=6-K>0 !  0   !&
M  #_X0,O:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835 @0V]R92 W+C M8S P," W.2YD86)A8V)B+" R,#(Q+S T+S$T
M+3 P.C,Y.C0T(" @(" @(" B/B \<F1F.E)$1B!X;6QN<SIR9&8](FAT=' Z
M+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B \<F1F
M.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7 ](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"\B('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UP.D-R
M96%T;W)4;V]L/2)!9&]B92!0:&]T;W-H;W @,C(N-2 H36%C:6YT;W-H*2(@
M>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#HT-#E$-38R-$%%044Q,45$.41&
M,T4U0D5"-C0S1$8S,B(@>&UP34TZ1&]C=6UE;G1)1#TB>&UP+F1I9#HT-#E$
M-38R-4%%044Q,45$.41&,T4U0D5"-C0S1$8S,B(^(#QX;7!-33I$97)I=F5D
M1G)O;2!S=%)E9CII;G-T86YC94E$/2)X;7 N:6ED.C0T.40U-C(R045!13$Q
M140Y1$8S135"14(V-#-$1C,R(B!S=%)E9CID;V-U;65N=$E$/2)X;7 N9&ED
M.C0T.40U-C(S045!13$Q140Y1$8S135"14(V-#-$1C,R(B\^(#PO<F1F.D1E
M<V-R:7!T:6]N/B \+W)D9CI21$8^(#PO>#IX;7!M971A/B \/WAP86-K970@
M96YD/2)R(C\^_^X #D%D;V)E &3      ?_; (0 ! ,# P,#! ,#! 8$ P0&
M!P4$! 4'" 8&!P8&" H("0D)"0@*"@P,# P,"@P,#0T,#!$1$1$1%!04%!04
M%!04% $$!04(!P@/"@H/% X.#A04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04_\  $0@#8P4J P$1  (1 0,1 ?_$
M .   0  !P$!               ! @,%!@<(! D! 0$  @,!
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M0M>Z52+JZB.JO#DDQ!%>U7"BHH" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$! 0$! 0$! 0$! 0$! J.] J.] !!Y% 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! J$"H0$! 0$! J$"H0$"H0$"H0$! 0$! 0$! J!S0*H%0@("
M@((%!(Q_4T'TD?405$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M. \&>2*O,\^A!MM 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M5D?50\>Q!VGCK=UI86MK),^YD@B9&^XD #Y',: 7N   +J5( 1'J0$! 0$!
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MTMBZ@]7N[!7LITA:,OVI8;2^9Q6Q+)H.GJ<1W<EQK)]ESKK8B7H'-9(B@("
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MI<&^630W_P#EO_\ <7JJ-!^9.A\XVW%./_<N?_:%17:^X/'0&K 3RP^0)_\
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M6<F.AQEJS'S2NN);41-\)\SW^(YY;2E2[UOE0J]MQC;"\M18W=M%/:"@$$C
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MNOF;8I#T^UQW8\46WSS3':Y:\V-M=WN[>R5I8W3K.[ER.19!=,#7.C>?<P'
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M3-;5]V7-<;@NKQ=45'#FH*>E=D==:-N[>PP>N;AND+:7KCQ\L75((ZBK.H2
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M=_>@O&TVW5CM9HNST=CKA]U:VCG.9-( ''J#1R'^BB,W0$%*'V3\I_A054!
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MWWVYTO?XS:[;F;5^*GN!)<WL6-R5^&2#JHWKLB&CF>!51ND^:OSC4X[%W/\
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M@[$(<U_Y=7^&>>I^7L_]Z@[(?7I/%$<*Y,$_YD&#!_)IODX:9F165?YA@_\
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M;,"8[220AW6\N<2Y_,4Z13T]D5UJ&AOJ"@:!04X #T!5%1G!HJ@GJ@QC<?\
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M$! 0$! 0$! 0$!!*&AO+O_A03(" @(" @(" @(" @(" @(" @(" @(" @("
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MSIQ0.D((T0.?-!#I'-!% 0$! 0$! 0$! 0$! 0$! 0$! (J*()>AM:]J &-
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MH1MDA>TO(]S%:5K2J*R[_+[F=<;5:BN7,\-T^I;QY8>;2;2S-#\E41UN@("
M@(" @D#5B#F5!64$L4U7H;!ZM;"W,Q^(8*^'0#F?EKWKDXMQ?BFMLNMW?3L6
M[MIDBL1JQ9VQ^AFM)]THXTX4'%<VSJVXCM=9/P[M)B?9CP8=MR<-I'7>J\=5
MMO9121MA9(X, K%'Q!XK?N,>;/;%TU==TV_#M<M]E(B*_P!C<^-U'B\E*8;6
M>*:9K2_IC?U'I! Y >E=1DQ3;Q>KP[NR^:1*\N:V1E?9 JN/$ZN9=;713=#4
M- -?2.];*IRS':IO:YKFLXO:>=>5>Q-$K=$][ES6^CLYF/, ;' YR3 Y*ZQ
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MU6A0JN31ZH"J,>U__834W]57WYN]!SCY!?\ #357]Z;[\VM$'6* @(" @("
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M<C%]F'S3J>"[#FNMF.VOK9]&6TH%L=;*<$'D0?D1$4! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M.Y;'D\N*_'=RWQ25RB %0/14^E5I5$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$&.Z_\ ["ZF_JJ^_-WH.</(+_AIJK^]-]^;
M6B#K% 0$! 0$! 0$! 0$! 0$!!!WLGY$'GZ6M+2T ?(%))FFCR7\#I[.YBC_
M *29KF-_Z0(6=DZPQRQ6V:<6%[<:-?@,5>6>7AAGGFO9YFO>ULAZ)'EPJ2#W
MKE;K/==2DSP='TS86XK;^:V/:NF>$=K&M&BWAW:U0QK!%"R&)H#6T9[;^  7
M/R1S;.)[>;Y^#@;;DLZC=$1$1R?O;C:!U L/"O/M72/73-=7I1$4$* \2.*
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M0<X-:7'D$%,3L/?QX(!G:*U'&M!RX\:(#KA@)'$D?P()FR->:-^6O8@G0$!
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M$T8W65E7B-6-(4E:43J @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M6T@NK:&YH6^*QLG3W=30?XUG5X&ZL11[8FT92II19-41RJPX"I19E%I!03*
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M25K Y[6N?2M!U#LXKKLE(FD/6V^9,1-U%W6+-% 0$ \D$G)9,2M$H54R22:
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M34J?DI18S8]!9\2[NRSDMIRQ_=:KWKV?T7H#%XK)Z;MY(+N6\CB<Z20O'07
M'A0+5-M)AZ;H77-QNLW+=3P=;6CXWDF(U'+@:BBY$ZOF4Q=9I+U<:^A3EACS
M2CQ3E.:40Z@HK1E%$]0I1*H@DJI"*BB @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M%_;FOT[2 :5!'!95)P7O9#ZPZNL.!' A2K5RS"JTDDUY*,IHF1! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$$DI#8W./(<4&L,SKO3.K=":GO=.Z@%K:8TOL[[*QQR@VLK.DN-.D.)
M </9JHKG'1>=\I6G+ZUSVH=:2ZOU1"RC\IE+:[EJ]P]=S6/B<6U/+UN"#I[;
M[=#0&Y$%Z[063&0ML7X4=TT1R1-C$W7T "1K>?0[DJ,Z@)ZB./J\./:41Z$!
M 0$! 0$! 08[K_\ L+J;^JK[\W>@YP\@O^&FJO[TWWYM:(.L4! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$$".%%!+T>E*(.CJ.:0RB:)# 2[JZSZ59U8]M4LL+0TG
ML'&G>D:+=67E$;GR#K!8QM0/2%.>8B981;/-K#3UUDK+$[XRRWTS8(CAPQCW
M&@+GS'A\]%W48>;:<U=>;]SQF>^W'UKFG2/)I\_.W2V<MC'2.H<@5T>.RD4>
MVON[83B=Q /3S]*SG18BL53LD+S0BB,8U5$40$!!!S>H4Y(L2ATFE*JI.IT\
M* H1HI>ZMZ^HNX5J6TX%*E9KQ2SVWB"C']'_ )%$NBKFUOE%AAFGELM87-J)
MW=<C8[9H!/&G*7TKC>3-:U_;Q>^R_%EN2:W8+?YO[$_[IUQ_QW>?_+C\:KY4
M]_[>+1^I<?\ X]OC_8C^Z;<?\=WG_P N/QJ>5/?^WB?J7'_X]OC_ &,'W3V(
MOMO=(7FJ+;6%Y>R6KV 0&+PFFM>9\0]W<LJS#L-AU*S?Y_*G%%D4F:UKP=1:
M+N7-TGB9I#U/?;1DDGB26UKPKW+=$O![JZ.::,ALIW3,+WBCCS;6I 64N'9$
MS%9[7JJ5BSHFXH@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @())&AS"T\CP[T&!Y[2UIB]'YRPT=@\<V
MZOPZX^'R1-CM+FY<0#XK6EH)(;VGN17-V)U1MO@+BWQF\NS5II2>5S8G99MB
M/A[GG@7A\C &L)Y>LY!TGH#';;6EC+D-NK/'6^-NRSWF;%QLC8]T0/2)"SA4
M=9I\J@SB(\2*<N=?2@JJH(" @(" @("#'=?_ -A=3?U5??F[T'.'D%_PTU5_
M>F^_-K1!UB@(" @(" @(" @(" @(" @(" @(" @(" @(*5P[HA>[N"),TBKR
MQN! ))]8 _(M-_%MY](:?WTT_BQCK+4 MZY5U[:6OO#7$'PB7DC@5Z#IE\WS
M-D\*3+QGQ)@MMQVYH^USV1\U6W;26&6%C6FI#02!RXA=1?;,2]59=$Q2'J :
M&@!:;9YFV=(HG8*.%.[BLYE8C151! 0$! 0$!!*0:\J_.@ATGLX?+Q01Z7>C
MZB"!:ZG8@UMO%HO*ZWT'?Z>P_2Z^N'M?$)G]+*MKS*QNBKO.B[G'M=QSWS-*
M3ZVJ=(:\W"TOJ+(:+UM'9/&"P4F1CBL@6$^$^)L8+^IPXAQKP6GS)B9CL=WN
M>G;3/LK,V/FYKLG+ZI[&[-M-7NUQHS&ZMEM19OR397NMF'JZ?"E?%S_Z%5NM
MNJ\QU':?AL]V*OV:>N(EF#9 74K7FMCK:JG4L64:ID! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M+SG2IG'N[L7'EC][=[7#IY\1S736Q1[6=9!(/&C:#S%3]0J3]J$NTEZ%FB*
M@(" @(" @(" @\+PZ1_J<'BO%W)9\$B;9G6KFS=_;W<!FJLWK_3=S8Q8^;$&
MPOFW!>93;MZ7R -$9%26"GK+B9+9UE[GI/4-I&WLP71=6+J]E/I8QY?MY8M.
M:4R=KJRY$&E<$(&XX10]4K77<DLC@>D\?6J5CBNGA+L/B7IUDS;FQQK?6O\
MEB(=9XG)6V6L+;(VKNJVNHVRQ.(Z26N%02"N4^=Y+)MF8GL7'J%*U5EKM5%
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 02R&C">=$& ;M8F;,[>9_&6T%S<7=Q;'P8+![X[ESVN! 86$
M$'Y.:*T%HG?K=?3>D\)I^\VBU#D[C&6D%B;XLEZY1:Q",/=6,U+NFI)4&Z=I
M]R-1[@192;4.C<AI!]@8!$S(AS3<";Q*] <UOL] K\JHV? :AP[CR]'9]5$5
MD! 0$! 0$! 08[K_ /L+J;^JK[\W>@YP\@O^&FJO[TWWYM:(.L4! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!!!WLE%A(>Q$GBIR\0?F_C64,;HT:BT=UMW8U
M<6FH,;*M'8.IB[++=/X>V.RKS6RI^8Y=->2&V(R.(+34GB>]=/?=-8>HMTF9
MHA''2Y#FF@%>H?56RD<2^LS$O;P1$4! 0$! 0$! 0$!!2["/2K*VO!D+&WOH
M9[6YC;+!.TL>QXZF.%*$$'AQJBX[N2ZKAK?;;_/Z(R.;NK2UM['16:GM6V<,
M9:?7MH6?:CB*O<\K1DFFKZUT;?6;O'%LS[=G[Y=5;8:EQN3VYQ62@E\*UM;:
M.&>67U6M?&T5YU[UG9,3%7S_ *KM[_Q>6V-;INGZ6<V]W!=P130/$D4K0YDC
M35KFD\PMD2Z>_%,>S=]I=5&M% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!*\T:4&/:KLLQ?Z?O[33UTR
MSS-Q&X6EU*"8V/J.+@ 3]9%<ZC;+S?![9/UCX1Y::#J=>'U@>'4#;4HB,[V>
MW"UED]2:@VXW'CA?J_3L=M<OR%D*VEQ:W9E:QS06QN!K"ZH+.Y16[8P021RX
MU515J@(" @(" @("#'=?_P!A=3?U5??F[T'.'D%_PTU5_>F^_-K1!UB@(" @
M(" @(" @(" @(" @(" @(" @(" @((.Y(L)3Q+?D26,\5)Q'&O)6&=T:-!9A
M^N-+:\SV<P>%]^M;X-8)?$:T=((<30CN"[_'Y63!;9=.L2\)N;]WM][DRX\?
M/;-L:UB&9[5:^RNMK+)S7UD+:7'W#;;I#P[CT]1[ NOWVTMQS;,>EV_2.IY=
MW9=-]O+,4[:]_P!38\+@'M!-'NXD>FE5UT\7HN>L/5_&J(H" @(" @(" @("
M"0AH!J>U4K1(^-KA7@37M1)U:\WATCC=6Z/NK#)LD<+<.NH/!-'^+$/5HI?$
M3#N.C[B_#N+;HFFL.4,/NW%C=H;O;N\P>0%[<QD/O3$WW=K^IAXDN!^UYT6B
M9B+7O\'3HS;R-Q-W&9FGRU;(VM\PF%QUGI?1,^%R#9WN@QL=R]D0A=)([HZQ
M]+7IJ:DT4MR:1#H=_P!"OFZ_-;.D3+J^JWO$(JH(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ED]@U08_J
MMF?DT_D&:6=$S4/A'W%TPZHO$)%.JO"E 45SJ++SG!WTE_AV1U;UN=':&@!%
M'$#D!S*#8VT&UV;TGD\SK;6V5CS.M]0^#'=WD%60,@M^LQQQM :T &5_&G:B
M-PQ^T:'U>STA05500$! 0$! 0$&.Z_\ ["ZF_JJ^_-WH.</(+_AIJK^]-]^;
M6B#K% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0"*BB"'3Q![D$G@M-:D\46
M96S(1R.BNF$ 1>$\=?"O%JMDSSN/EMK9,4[&G?+_ ".$6IV-H0_)]-3S-&E=
M[U6REEE.Z?W/,=!]C)EM[*Q_[F[&%S96BC2VG$]H-."\]$3I5Z^[T<'I#W<P
M/569H=;ZT %$U8IP:BJBHJ@@(" @(" @()7,#NVBL2DQ4Z.%*E*K&BC-:QSE
MOB>L!S! (([BHM9B:QHP_7F@;+4VD<M@<?#;6E[?1!D-R8F-#'=;75]5M>0H
ML9MK#L=MU'-AR1=S3IZ9<T;I8BWV]RNU5CD988_A$D+<C?- CC<(WEQ>YSJ<
M/2L.2(H]KTS<7Y\62*S[4]_HAT1C-[]M\M?0XVPU!97%[<.$=O#%*U[GN()H
M ":\EE5Y&_I&ZLLYIMT^6&P#.[HZ@ MD15TMU8A-'(]S0X@<>Y*%=%4>E11
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M71]J)CY8H][9 XT]%?KT1JG1/U!"$4! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M\NWKS09>.@!J?6'+BMD],SQ&MOKAC=\0[2M(OGPGZF9X++8[,VT%[C91/;3
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MV1/+27L4400K]3O00ZN-!Q01!)YBB"* @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MPNIOZJOOS=Z#G#R"_P"&FJO[TWWYM:(.L4! 0$! 0$! 0$! 0$! 0$! 0$!
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M^E68;IZIN9F*9+M/[TM4:%P^,T]YG=08_%64-ACHL2QD,%M&V**KHH7DM:P
M<>)X+3$>V[G<Y\NXV/-=,W4F.,^ETFV:.H;7B>/);GD>*<S,!H3Q5HDS2:)J
MCFHJ* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @QW7_]A=3?U5??F[T'.'D%_P --5?WIOOS:T0=8H" @(" @(" @("
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M,?2O\1#HVFE/0CCUJJ#@@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(,=U_\ V%U-_55]^;O0<X>07_#357]Z;[\VM$'6
M* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @A0(% I2!#H9W*I0Z&]R%#H;W(L:'AL/"BQFR*46IX;*4IP62)6V\+#5K
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MU>^Z-N=K9S7VTCY;?K;/@DE>]WBMZ"!6@-0LW0Q6FL/2$5% 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M;^JK[\W>@YP\@O\ AIJK^]-]^;6B#K% 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!*8V.-2T$
M]Y 00\*("@8VG=0(M92RL8&$T /?1$B&FF -WW ZB2;*0GAPXQ?^5=GKY$_M
MVO,761;U*R9[KOHEMSQ6M]4GUOG[5U&L3P>GNNME#Z5K^H/-/N:FBRY=6?+%
MVJMXCB*N/33CPJG+)-(18?7:2\FO&G%6(HPI757""*H(" @(""7PV'B6COY!
M! 0PCE&T?(T(1HCT,Y](K\B"/2WG05^1 Z1W!!:+S3.G[_)09B^QEI/E;5H9
M;7LL$4EQ$T.+@&2.:7- ))H#S4I#D6[G+;9-D771;/96:>'!=FQL:*!H^HJX
MZ/2VE*"GR('2WN'U$#I;W!!X^EU>'#Y%EI1C?QI#FK<4?_Q4:&;V^ZQ ??RK
M1/&'N>G1'Y=DF>ZYTW&:=0[C1;*/$1-4_5Z4HM#J]*4DH=7I2DE#J]*4DHAU
MBO%W\*L05HC1Q;0'YU6,Z\$0"&MJ>/:BQHG4! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!3<
M\AW3P''F4$AN*.+2*$<3V\$$OO#BWJ8 1W\^'>@B+AW/A0<_D[T5 W#CQ:!T
M$5!/RTXHBNTDM!/ H,?U_P#V$U/_ %5??F[T'.'D%_PTU5_>F^_-K1!UB@("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(""G."Z)P',I6FI2K1>M,+KNQW"&I-*64-T?=Q$SW@
MDM(>UK7&C7-/ 5[5V^UR;:ZRF2;OF>3ZAMMS&ZLR88B=)K5*S4&_'9B,;7C]
MI-^.7)G#L)G6Z_U?4X%NYZU$Z68I^7F_YE9NH=]PVIQ..[1[$WXU87X=CV77
M^KZFV[>==G7R\%/\_P#S+;F-9;U8O&7.1R.+QS+*W87S/:V8$-'_ +996;;9
MW:<UU?F^IJR;[J>+;Y,F6VSV8KIS?6W!HW)767T]A<G=!@FN[*WN)@P$-#Y8
M6O-*DFE3VKHL^"VS+-)G29H]=T[<^?M<=\\;K+9\8B62CGQ6+FHH" @(" @(
M" @(""! /-!% 0$!!1 '4?D2>!VN8]QCT>:;1$CN'1:Q&E.Y\JU3QA[CI^O3
MLD>BYTI'.RKC45/$U*VO$SCF%03L[VJUA.2X\=G>U*P<EYX[.]J5@Y+T?'9W
MCZRE87DN49+B/JZ:^M2M!W!6IY4SQ5HGEU6UX\_F26NWBJ$D]'I/%(6[BJJ*
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(*;HR[JY<:>C^!!JC7^A=T=29KQ=/:Z=IS",C:(;
M6V@9+(Z2KNHO+F\!3IIZRBL1V6USKANXFK=I-?9)F:R>G8Q=6>79'T.F@D,9
M8)"UC17IE;4'M"H\.7U7N#NMN;FM"[>YG]&M.Z79''E,['$V2:6^DJ\Q-$@X
M@-+.[FH,@VFU]J8:[U!M#KRX;?Y_ PMN+'*!G2;ZRHRCW\ .NCV]7IJJ-XMD
M:P4(/2.9[D18->OKH74W T.*ON/_ .SO17.?D%/_ .[75([?THOJ_P#RUHB.
ML :H(H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MG$=M#2.-GVTLSN#&-X\R2BM<[&;?97%SY[<[5Q<S5NM)3=RV_ -M;2=XE@B
M(+@YK.AKJGL1&*>5HRVV?W3Q.4N8[C-Q:DDFG<.$GAOL[41F@/+A0(JH'2W/
MG+(Q]S&([# /.8A;0OZ9(8VQM/'GUOC</0@O.XVG_,Q?ZJN;G;[,8VUTP:"W
MAN(JRTI0]1\9O;Z$&OM3:8\X$6G,O+E,]B7XQMC=&]C;#Q,'@NZP/]X/&B#W
M_P"7\V5NU>HQ.[JN!JB]$S@* N%I9U-.ZJ(ZV0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$!!0<SZ5Q=R(H/E4F64\&/ZPP7Z2:?O<&9'1,NHS$9&"KA7Y>"WX,D6S$N
MOW^S_$8+\=:<T4:XL]F,I;V\-O%JN]@CB8UD;.EG!H'I;V+FSNK>:LVUAY[!
MT++CQ\MN68I3L>K]3N:_XQOOEZ8_YJV?CL7N_6V_D^Z]_/\ +"/ZG<U_QA??
M>Q_S4_'8O=^L_)]U[^?Y8/U.YK_C"^^]C_FI^.Q>[]9^3[KW\_RP?J=S7_&%
M]]['_-3\=B]WZS\GW7OY_E@_4[FO^,+[[V/^:GX[%[OUGY/NO?S_ "P?J=S7
M_&%]]['_ #4_'8O=^L_)]U[^?Y8/U.YK_C"^^]C_ )J?CL7N_6?D^Z]_/\L'
MZG<U_P 87WWL?\U/QV+W?K/R?=>_G^6#]3N:_P",+[[V/^:GX[%[OUGY/NO?
MS_+#%]?Z)SVB].R9V+5-Y<O@E@ B>& 'JF8T\FCO6_%FQYIY8LIHXFZV>ZVM
ML7SFFZD]T-T:=FGN\+C[J>0NZX(W/KP)JT<5T^2(B:/6;>^ZZR+IE=@USGCH
M=1G:WT+4Y,Q=.M4_1(/MUA4I/>=$OW:%)[TDG4RG4>KN"L>DK-OI31U)X<U:
MPRYZ]BOQ[1\ZPN@5%DQ%00$! 0$'/^Z)'[P&W?\ ]W=_]I(N/?\ ;C]N][#8
M?_5Y?\?[H;W')OS+D0\?=P3\.->5.*3Q*:).ID8+:CUN'U%:L9G2@2PQ4#@:
M\A\B5U6=81:X \. IQ5A*S*?J% X<0>U8MD:HEU','>LJ-<S24ZQ9(H" @("
M @\LS&OE8[L:37ZRRB=&,\8]"(#7O:1[(%*]B%:S5Z !6JQ9(H" @(" @("
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M8H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MT?8VY[IBZ.$-L6<IEB@=7UG-#B!Z>?-5T66VF1=6\A\BC"4R((" @(" @("
M@(" @(" @(" @(" @(" @(" @(""!:#P(!"!TCN"!TM[@@=+>X((H,=U_P#V
M%U-_55]^;O0<X>07_#357]Z;[\VM$'6* @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(%
M @@6M/, _*$ -:.0 ^9 H.Y*"-!W*4"@[DH%!W)0*#N2@4'<E H.Y*!0=R4"
M@[DH/'D+*VOHFPW,39HJ]70]H<VHXBH(/:K$TX,;K(NXZM-;M:(NLA=X*3 8
MV,F.X>ZZ\-@;ZI#0*]("[;:9YMXR\KUCIOG9<<VQI;=6?!Z3HIXW4M;\XR/X
M&VR<USRP>&Z0]'"E*5X+7=N+IQTJW3TZ/QF/)2*1$QXT;/&FL%0'X9;?@F?8
M7"\Z_P"]/B[Z=OC^['@C^C."_P#IEM^"9]A/.O\ O3XGX?']V/!2GT[@F-Z?
MAML [G]$SL^97S;^^?$_#8Z3[,>$-#Z,S(PF[F7Q1LBR+*W<\=J]K#'&UD9+
MN'81P7?9MM7:\U9K$1+Q/3[HV_4KK;N&6Z:?-#H)S6QBCG'PR07'MKZ/0O-5
MY=7O:127I,DQY@#Y/^=358JE/B=E?F/--6=90+I&/H[F?J<%8GO8\T=JHPN)
M]!5F*I$PG[@2L.1EP5:]BS8HH-/[L[076O\ 4&*U!8YF7$WF*B$<+X6@N]MS
MB>(/W2UW65FKT'3NKSM,<X^6+HNFNK%!L/KR@'ZQ,B34D>JRG'_HJ<CG_J"W
MW5G@L>L]E=;8K26<R5UKJ]O;:SL+NXFLWM;2:.*%SW1FC>3@**39HYNRZ[;D
MW&.SR[8YKK8X=\K5MAM)JW46BL3EL;K6^Q=E/%U16,0C#6L)(+>+">86-EFC
MD]6ZM9@W%UL61-)[88IO=MWJ+2#-/')ZDN\W'?7IA89VM/@.'31PZ0./K!+L
M?I<SHG6[,V2;9LBWY(>/:K;_ %%J'6FK,78:CGQ=SCS!X]]&P!TYDZ^=:CAT
M_75BS7BV]1ZOCPV\L61=776/E;I_4+KVGJ;B9$4["V(@\.?!@67(\M^?6U_[
M=G@?J%U_7CN+?@]Q:S^:G(SGK]ON[/!#]0NO_P!HE_\ >L_FIR'ZAM]U9X(_
MJ%U_^T2_^]9_-3D/U#;[JSP/U"Z__:)?_>L_FIR'ZAM]U9X'ZA=?_M$O_O6?
MS4Y#]0V^ZL\#]0NO_P!HE_\ >L_FIR'ZAM]U9X'ZA=?_ +1+_P"]9_-3D/U#
M;[JSP/U"Z_\ VB7_ -ZS^:G(?J&WW5G@UAK_ &SU1A=?:&Q%[JJ\R%WE9[B.
MVO7M9UVSHS%Q80V@KU]M5)L=UM>L8[\%]W)$?-Q;+&Q.OG4#=Q+\F@/%L9<*
MCC6C %>3TNGCK=D1/^W;X)AL/KTG_$2^^7I8/_U4Y&%G7[(MG_:MX]R(V%U_
M^T2_^]9_-3D7]0V^ZL\$?U"Z_P#VB7_WK/YJ<A^H;?=6>!^H77_[1+_[UG\U
M.0_4-ONK/ _4+K_]HE_]ZS^:G(?J&WW5G@?J%U_^T2_^]9_-3D/U#;[JSP/U
M"Z__ &B7_P!ZS^:G(?J&WW5G@?J%U_\ M$O_ +UG\U.0_4-ONK/ _4+K_P#:
M)?\ WK/YJ<A^H;?=6>!^H77_ .T2_P#O6?S4Y#]0V^ZL\#]0NO\ ]HE_]ZS^
M:G(?J&WW5G@?J%U_^T2_^]9_-3D/U#;[JSP/U"Z__:)?_>L_FIR'ZAM]U9X'
MZA=?_M$O_O6?S4Y#]0V^ZL\#]0NO_P!HE_\ >L_FIR'ZAM]U9X)7;$Z\80'[
MBWX![0V.OUVE7EHEW7K+[)CRK?!J[>[:W6&F=-P7%_J6[U$);D,9;2QM>6EU
M!U ,#>]8W6N[Z3UBR9NCEBW3LAUS@;&2SQEA;R2.E=%"UCI7>T:-[0%NE\_W
MU\9,\W1%*S+(6CU1W4".+1.@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(,=U_P#V%U-_55]^;O0<X>07_#357]Z;[\VM$'6* @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(*<O #Y4I4K13H'.(!Y<Z<E2-=$IZ1
M4-^U[%C=%2)5@"15&54>E4JHW#.IO3P%:\UA=;,\"6E=U<M9X#76C,KE)/#L
M;0W?CO#7.H71@--&@DKN-E9-^&^/D>&Z_=&'?;3)/"/,KX0O<F^&WQ:&R9%S
MF@"H;!..7_LUIOZ9DFVL\/E=Q?U_:66Q67I_7GMW_P#47_)X$_/\&LOR_+'8
MV?G>W^\\.3WPT1+9S-LLB?>"US8G>#**.IP^T6W'T[+,\'$S]>V]ML^TQ[0.
M].G[?3\#-4Y%YRP+G/=X4KJ-X#L:>]9;CI>2)AQ=C\1[6_2Z=66,WNT)-,R!
MF0<Z61P:SZ"9H)=P JY@[UHCIN2(=CDZ[M8NI75L.*4W3&&(U:X!X)%.'_(K
MJ;\<Q+T%8FVL/=3M6Q$513>P%W56A0T2B( UJ">\HNB2>VCN()+>:CX96EDC
M#R+7"A'SJK$TFL<5"TM8K2'W>W8(X8A2*-HHT#Y$E(F;KIF5*[QEA?M8Z[A9
M-X1!C#Q7I=SJ*HV8\DVS[*%KBK.TEDNHH61SRD>+(T4<_IY5/;S1C.29C5[6
M.#B0*\1168:HNU3#@:5HI1E-T)N@_=(:'0?N_KHNAT'[OZZ&AT'[OZZ&AT'[
MOZZ&AT'[OZZ&AT'[OZZ&CQSV%I=7$4]Q"V6:W-87N ):3SHE%MOFDQ"JR-HZ
MF.J0XU/%66%MM:HQ1B-W2#0$UYI,EML1"MTDGVOD49:'0?N_KH:'0?N_KH:'
M0?N_KH:'0?N_KH:'0?N_KH:'0?N_KH:'0?N_KH:'0?N_KH:'0?N_KH:'0?N_
MKH:'0?N_KH:'0?N_KH:'0?N_KH:)'Q=0()KWJ),1,)&64;00?9/VHY<42SV4
M1;@.[^0X^A*%=:O2!0 (R11! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$!!CNO_P"PNIOZJOOS=Z#G#R"_X::J_O3??FUH@ZQ0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!)(SK;2M%8D4H[=[*U?4GT*U28]JJ8
M0$$DFM2I58[56G9V*"*"E-$Z3IHZ@'/AS0[5ES>C\)J%T+\O:QW1@!#.L'MY
M\B%MQY;K(I$N'NMGBW$Q-\5HMHVNT-VX: _?_P Y;9W>68IS.+/1]G,UG''K
M^M!NV&A*<<)!_P"?_.6<[_//\3"WHNS]W'K^M;LQMKI%MA<BQPD/O C<8@.H
MDNIP[5LQ[[-$_::<_1-I-DQR1Z_K8SMGMKB3I6!NI\-'\5J0YLC7M=T\#RZ@
MLMQO,MTQ/-6C3LNB;2R*3CCU_6Q;>S2^"P#<$[$6$5J^6Z9U%G5V.%.9*Y&T
MSY<E=70_$6QV^WLMNMMCC],M^6G4RTMBP^N6L!([BT?87273,R^@1$VXX72J
MQJS1JE52N;U)62B'0%*R4@Z E9-$OAGC0\U:RL:2@(:"E>?-*RD12:C@/9)Y
M=B:KI*!Z6\6\"KJQTM!ZU"34\U*RNDJG0%*R4@Z E9*0= 2LE(.@)62D'0$K
M)2#H"5DI!T!*R4A Q\01PIS5K*QHAX7K$D\S4)64C1)T.C:2[UR3PIW*UJQI
M,(E\;?:/2WO*:RLTCBAUMH2T=0[*'FFJTB8K"H&@@$BE>Q2LIHCT!2LK2$KP
MU@J0I-TE(4?>&>+X?3VT)JME)H1$3,QW)P]I<6TX@TYJ:I$Q,T5.D*5E:0CT
M!2LE(.@)62D'0$K)2#H"5DI"F'1GM6=)8UA, #V*+-$6M)/JF@',+*"85**"
M'2:UJBU3(@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(,=U_
M_874W]57WYN]!SAY!?\ #357]Z;[\VM$'6* @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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ML_T_&3X#OY^6VGWX3FV/?=ZCRNL_T_&6%ZHQNY=OJS3<><N;>3//?*,31WJ
M^IU%U.?VJYF*=CR?Q>IU&YP]7\^VO)6FFLLS;@=^RWI;>61:.1!H3PXGBX]J
MXEUVQKQN=U;AZO3_ ./QE'X#OYQI>V=?](?92+MCWW$X>L4T\OQD^ []_EMI
M]^%.;8]]S'RNL_T_&3X#OY^6VGWX3FV/?=ZD\KK/]/QD^ [^?EMI]^$YMCWW
M>H\KK/\ 3\9/@._GY;:??A.;8]]WJ/*ZS_3\9/@._GY;:??A.;8]]WJ/*ZS_
M $_&3X#OY^6VGWX3FV/?=ZCRNL_T_&3X#OY^6VGWX3FV/?=ZCRNL_P!/QD^
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M/Z.M<%J+*YJ"4NERSHWS1D<&F,4X+==?6' QX>6^9[V7%O!__+M6AS[N"N.
M"(B@(" >2#PRQES2WL-#7TT*RMECDU8SI71MKIFZRES;R.D.3N?>Y!R#7'A3
MC\BVWWUAP\.'DF9[V81BG4>TGDN/5SYFJHJ@@(" @(" @(" @(" @(" @("
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M! 0$!!CNO_["ZF_JJ^_-WH.</(+_ (::J_O3??FUH@ZQ0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$&.Z_\ ["ZF_JJ^_-WH.</(+_AIJK^]-]^;6B#K
M% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 08[K_^PNIOZJOOS=Z#G#R"
M_P"&FJO[TWWYM:(.L4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M7TK#H;4S>()Q=\./_8/"#G+R"O VTU3Z=4WX'+LMK1!UEU! J.] J.] J.]
MJ.] J.] J.] Z@@=00*A J.] J.] J.] J.] J.] J.] J$#J"!UM[T"H/:@
M5'>@5'>@5'>@5'>@5'>@%P"!U! J$"H[T"H[T"H[T"H[T"H[T"H[T$4$":=B
M"'6WOH@CU-[P@5'>@5'>@5'>@5'>@5'>@5'>@50 YO?3T(%1WH%1WH%1WH%1
MWH%1WH%1WH!<!QYH(!P/8@C4?501J.]!"H[T"H[T"H[T"H[T"H[T$4$":('4
M.U ZF]Z!4=Z!4=Z!4=Z!4=Z!4=Z!4=Z!U!!#K:@B' ]J!4=Z!4=Z!4=Z!4=Z
M!4=Z!4(%0@=00*CO0*CO0*CO0*CO0*CO0*CO0*CO0*A Z@@=;>] J.] J.]
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MM^RO-?>R?BD#]^;+#C^JO-?>R?BD'FC\_$TUY-CXMM<G)?VP:ZXM6N<Z:,2
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M509'M[YP[76.O,-HC/:0O-+2YIX98W63>&MD>X'PPT/:VO4X4'I0=3-KU\J
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M=FW?;QO@9C<:Z)CFAT8<;.SK1M.'%%=5MQ.,Z1_N5O\ @6?81$WPC&?D5O\
M@6?80/A&,_(K?\"S["!\(QGY%;_@6?80/A&,_(K?\"S["!\(QGY%;_@6?80/
MA&,_(K?\"S[""G-BL6T"ME!0D5I$P'G\BBN,GVEM^_;':.@B$(PK3X72/#XS
M'[6E%1V;\*Q?5_W*W_!,X_60JJ?",9^16_X%GV$0^$8S\BM_P+/L('PC&?D5
MO^!9]A ^$8S\BM_P+/L('PC&?D5O^!9]A ^$8S\BM_P+/L(*;L1BR\@V4'+_
M %+/L(KEC=6SLH_.)M% RWB;!)C\F'Q!@#2?=+TUZ0*'D@ZFCQ6+J.FS@(/
MUB9V?,B*OPG%_D-N/_8Q_80/A&,_(K?\"S["!\(QGY%;_@6?80/A&,_(K?\
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M\"S["!\(QGY%;_@6?80/A&,_(K?\"S["!\(QGY%;_@6?806_+8S&>XWC6V4
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M82^.,>'#.Q[S60M'LCO0;9TW:S6&#QEG<#IG@M88GLJ#1T; ' 4X'BBKRB"
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MV6(MW763N8K2V'.:=[8XP>[J)_B06[$ZUTKGYC;87-661N:=1AM9XY7^KSH
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M[N2"* @(" @(" @(%!W(" @(" @(%!S[4"@0.2 @(" @("!0(% @4'<@<D!
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M1+:7EU:SVL[3ZKF221N8[ZX*#)M*>:3:7!8[3&F+N_N#</MH;>6]9$/<XY7
M ![W.![.QI0;JU)N3I'2.#CU%G\A':8B9H?;W!/5XC2T.'2!4FH(H@Q70_F(
MVUU_EC@<-?/AS)J8+2[9X3Y6MIZS.8IQ0-2>8S:O2F4SV%S&8;%EM/-:;^T
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M$UOI7 Q74GBW4>.M(YI?NW-A;4_.4660(B* @(" @(" @(" @(" @(" @("
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M<201/J:'I$8/!!;]>X;);I[J8/1LMM(S1VE'-R^<N"RK)[UC"^WA J!0ES)
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MT/6'<*(BBR]9)(8V3@RMH9(P07-/IH> 456,[FT<YU&MYDFGRJH-G\1K962
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M=M%0+AD+;1PKRK[2(ZZA[:D5/&@[$%9 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M& T^=!EF'R=EF+*/(8Z>.XLI@'12PNZV$>@\*JH]-U+%!$Z>9P9$P$O>XT
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M+XL(>Z&>-PI)$^/@YCA7V@>:@O\ T-[_ $]O/O\ _(@]BJ" @(" @(" @("
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MS) UP<#WCN4&O/+)J#*7.G\YH/-,(N="Y2XPUO)+)XKW6769[8$]3N#89&,
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MU:6&!P-#W4*(NOFW ;J/:$&G1\7N^IO(4I;<$$NH0QWG5TM&YOJ?![UIJ30
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M@#-*6GJIQX ?\\52V)GVQQ-@[":6S,&5U9D"<AG[EKGNDGO)!URO'6.# >#
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METLC0 7NIS)[RJB7(;3;;YB]DR67TAA+^_FXS7-UC;2>5Y[W/DC<XGTU07/
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M<M$71F<QN+11\8B%6U/JFO8@M^0T[YH)[JXL+35&#@Q4CWQPWG1)[VR(DT(
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M=TFA!H[N^5!(TEL@)%0[U1W<!4DH/27LK[0J$#Q&?=#@@CUM[P@@)&'DX?\
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M+FL:R,D<O645BWF+U]OKIO2NJL]IZV@TYI? .BBCR3Y(I;V[;+=Q6S7QM:9
MT.ZZ^OTD#TJHWEHB:?46WF N<E.YUUD<;!)=W##X;S)+&"YW4RE'?.BL#V5S
M^3Q.;U+M%J?(/OL[IN;WC%SW$IEFFQ#R!"YSW$EQ:"WJJ:\4&ZBUHITDDD5
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MO13O17*8WLU;JG??2%CIZZ?;;9WEW=X]CAP&0=!&2Z4 \2RH!;\J#JW@.!-
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MQ05=H-?6NXNA\;J6W<#,\>!?PCVHKF/A('5[_5=P[T&PF>SW%$4K@'@0>(!
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MT=/A]/$%/?\ QO#KTMY5[?EX*L7LL/#\!E?=:T_^$\3P>1]FB"T9+P?'9_\
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M<@LN:\'A_P#AO)]??_%[^Q0A[\?X/1!3W;JH/^[>-X?+[6O"B#W.\+A[//\
MZVB#73?</UN<?A7OGPCU?"]^^)]'CR5\6GT'AU]FOKUKV*C/'^!X/'HI4<_&
M[^RB(\V=]W^"WGC>#X?N[^KQ_'Z*4/M^%ZU/]'BHK&-H?<OT(Q'NGPGW;POH
MO@OOGNG3V4]Z^EZ_NO$]:O-!GA\.OVG^T01^B_D?[1!(_P +I/L4[?Z3ZZ"C
M)X74ZO17T^+]>B"I'X=7>Q7M]NO(?\N"# MW?<?T-F][^$^[^\V?5\9]]]V_
MIFTZ?=?I?$K['3V\^"J,LP_N_P 'M?#\'P_"93PO'Z*>&W_6>M3Y>Q%E['^#
MU\>FO'GXO>.[@@UYMQ\._2/5WNOP?J^)M\;W#W_WSQ/!B_[S[SPK2E/"^C^?
MJ0;&C\+A[';7^EK7TJ"L?#Z3['^T0>6+P? 93HZ:BG]+W=E>*HA<>#1G5X=*
MC_6U^?I4%4>%7AT5H/\ 6U^NJC7>YWN'A8'WOX1X?Q.WZ?B7OW7U>*VGN_NO
MK>)_I>KW\$6&PH_!]3V/9-*>+RJ.7_E1%*[\'W6[ZNBGAGJZO&IR[>GC]1!A
KNT_N/Z'6GNGPGP*R='P;WWW>G4WVO>OI.O[KJXJ++/OH_P"3R_ZSD@__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm2225088d1-pht_mechani4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-pht_mechani4c.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    1@  _^$#?FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-RXP+6,P,# @-SDN9&%B86-B8BP@,C R,2\P-"\Q-"TP,#HS.3HT
M-" @(" @(" @(CX@/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S
M+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX@/')D9CI$97-C<FEP
M=&EO;B!R9&8Z86)O=70](B(@>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]M;2\B('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(B!X;6QN<SIX;7 ]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\B('AM<$U-.D]R:6=I;F%L
M1&]C=6UE;G1)1#TB=75I9#HX868P,60W8BTP.# Y+30X,F4M83@Y-BTP.60S
M9F(Y,3,X8V,B('AM<$U-.D1O8W5M96YT240](GAM<"YD:60Z-3,Y-D)&-S%!
M14%%,3%%1#E$1C-%-4)%0C8T,T1&,S(B('AM<$U-.DEN<W1A;F-E240](GAM
M<"YI:60Z-3,Y-D)&-S!!14%%,3%%1#E$1C-%-4)%0C8T,T1&,S(B('AM<#I#
M<F5A=&]R5&]O;#TB061O8F4@26QL=7-T<F%T;W(@,C4N-" H36%C:6YT;W-H
M*2(^(#QX;7!-33I$97)I=F5D1G)O;2!S=%)E9CII;G-T86YC94E$/2)X;7 N
M:6ED.C5D,3!D,6-B+3)B9#4M-#!B-"UA-30Q+3<T86,W9F8R,#@S9"(@<W12
M968Z9&]C=6UE;G1)1#TB>&UP+F1I9#HU9#$P9#%C8BTR8F0U+30P8C0M834T
M,2TW-&%C-V9F,C X,V0B+SX@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO<F1F.E)$
M1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4
M9,     !_]L A  $ P,# P,$ P,$!@0#! 8'!00$!0<(!@8'!@8("@@)"0D)
M" H*# P,# P*# P-#0P,$1$1$1$4%!04%!04%!04 00%!0@'" \*"@\4#@X.
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!3_P  1" :$!P<# 1$  A$! Q$!_\0 ZP !  $% 0$!
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M Q$ /P#OX
M
M         !AVY>[';/9\[ZFYMVXK&7H_ITY[<266_+"CE>GZ4#YMKNUVQWA.
MRIMG=V*R5Z3]3I0VXO>7<=.$+G)(OZ4#,@
M   %.>>"K!+9LRLAK0L=)--(Y&,8QB:N<YRZ(B(B:JJ@06/WYL;+7(L=BMS8
MF]D)U5(*E:_6FF>J(KE1K&2*Y=$15X(!(Y?.X3;]9EW/9*KBJ<CTA98O3QUH
MG2N17(Q'2N:BN5&N73U*!2PVY]M[C\_^+V9HY;W;H]Y]PLPVO+\SJZ.ORG.Z
M>KI=IKST4"5
M
M
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MG]LV/WG.&<NM?CY_H>PG_J6K^\+X8PP?_AY?_I'_ /!/_P P"9=OAB
M
M
M
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M)_\ F 3+M\,0
M
M
M                                                     1&Z\?+E
MMKYO%0(JSWJ%JK$B*K55\T+V)HJ<4XKS _([M!E(L%W7V3E;*HRO4SF.?9<_
MDV+WJ-)%YIQ1JJH9OV(#!:97)T<)B[N9RDR5\9CJ\MR[8=JK8X*[%DD>NFJZ
M-:U5 QK9W=7MSO\ 8UVS]S4,K*Y%7W2*9&6T1..KJ\G3*U/E8!:=U]_]O.WF
MV79?N,^%^+E?Y5:A)"VW+:FTUZ(H7(J.73FJZ-3Q5 ERI8^.*CCHV;=[2]MH
MJM3K>M&"5S86J^5ZR.5*5&/3J<Y5<[IEXJJJ$Z.>.^>\>YV^]RT-Q=T<,N$R
M<M)(L956E+CT6BV61S58V=5D<SK>_1SW+XZ*$P_0;X3HY8OA\V6V9_F/6&Z]
M'>AK\A9<UOZ%JHT,9?F]+C8\SW<?AY6))%D-QK4>Q5T1S9[WEJFOAKU!D_89
MC&1L;'&U&1L1&L8U-&HU."(B)R1 P?D/WYBCA[T[^9$U&,_+M]W2U-$U=.YR
MK\ZKJ&<.]OBMRERE\->46%S_ #+[,76GE355\N2Q"Y_4NO)R-Z5].NGB&,.<
M/@)QM.UW6S60L1H^S0P<JU%<B+T/FLP,<Y.&J.Z=6Z^ARA,OT!W!@,/NG"WM
MNY^JV[ALE"ZO=J/5S6R1/YIU,5KD]2M5%3P#% ;2[3]M=B3MM[1VMC<5?:Q8
MVWH*[%M]#OI-\]Z.DT73BG7Q _+[XALE9RO>_?EJTKG2QYBS4:KT5%\NF[W:
M-./@C(VZ>H,X;WPOQY7<#AL?@Z&P*D='&UH:=:-N0>UK8J[$C:B(E?AP:$:.
M=>[O<1G=7?=_?'Y(CPL^29 EFG#*L[5D@B;%YG4K&<7(Q-> 2[[WAE;&<^#)
M^6MJKK=K:-)]AZKJKI4AA1[OT2HJACXN1/@[PE3-=^< ZZQLL>-AN9".-Z:H
MLT,#FQK\K'O1Z>M RE^HH8 &EOBSR5G%_#]O&:HKFRSQTZCGM3@D5F]!%)U:
M*FB.8YS?G"8<C_ EC:=[O3<M68T?-C,#<MTW*B+T3.L5:RN35/\ FYGMX>D)
ME^B6;PN+W'A[^ S59MO$9.O)3O57JYJ203M5CVZM5')JB\VJBIS1=0Q8UM/M
M%VQV+8CN[3VIC<9D(FJR*_%7:ZXUKF]+D2Q)U2HCD71WM\?$#\S_ (F\E9RG
M?C>\]E7*Z&^E2-'HK=(ZL4<+$1%\-&:IZ>?B&<-Q[9^.JYM;;F)VUC]A54I8
MBG!1@Z<@]B*RO&V-%T2NNBKIJH1HT%WD[F-[N;XL;W7#1X2S;@@AM5H9EL))
M)7;Y:2*Y6,XJQ&MTT^U"8?HAM+*V,U\*%?(6U5UAVR[$4CW+JKEKT)(>I5]*
M]&H8^+A'X5_Z?]D_MFQ^\YPREUK\?/\ 0]A/_4M7]X7PQA@__#R__2/_ ."?
M_F 3+M\,0
M
M
M                                                   /R^^*CLIE
M.V._;V>I57.V/N.S);QEN-OXJ">=5DEJ/T^BK%ZECU^DSEJJ.T,XENKM)\<V
M%J;?J83NK1NNR])C($SF/8RPRRQB(U))XW/8YLFGTE9U([BNB<@C1B/Q#?&%
M2[A[7L;&[>T+='$9%&LS&4R"1Q3RPM7J6"*.-\G2URHG6]S]535O3HNH(A1^
M"#M->SN]'=T,G7<S;^WFRPXN5Z>S8R4S%C7IUYI#&]RN7P>K=.2Z"5U_Q 4R
M_P#'O::S*[\@_DB3W)%UZ/>_>7^\Z>&O1[OK\WJ!#./A([J]C]F]K64LQE,?
MM_><$UEV=GNHD-BVUTSGPNCD5%61B1=#$8U=4<U?9XZJ)<\_%1W7P?=SN8W+
M[8=))M_$T(L73LR-='[PL<LLSYFL=HK4<LO2G4B*J-151.03#N?X3K4-KX?=
MF/A75(XKD+TX:H^*]8:J+]35/4&,OSOPO]/./_\ 5T/_ -3:&3]> P?D/W]_
MIKW]_#E[]><&</TD[O[#L]R>QV5VECT1V5LXZO8QS55$ZK5-8[$;-5X)UK'Y
M>OWP8OSR^'WNN[L=W+3-YBE/)BYX9<1G:;6]-F.)\C'*YK'Z?C(I(FKTKIPU
M;JFH92ZS[N_&7VV;L')5.VV7L9#>&3KOJTGQU;5-:+IV]+IW23QQIU1HJJSR
MU=[>GAQ"-&(_!YW$[X=Q-XVH\_N.UD]AX6JY^12Y%#*LEF9.BO$EA8_-ZOI2
M+I)R9QY@EIKXP-@W]G=Y,MEG0N3"[I5,KC[&GL.D>UK;+->74V5'.T^Y<U?$
M)AUAVJ^+GM1E]C8Y^\<W'@-S8ZK'!E:=F*54DEA8C72P+$QR/;)IU(QOM-Y:
M<E4QT:IN?'7NVUONWBMG[6IYK;5FXRK@*\C;$.3L(Y6QMU<U[V]4K_:8WRM6
MZHBZA.CHSXA'W)?A\WC)D(65\@_#HZU7B>LL<<RJQ7L:]6MZD:[5$=TIKZ B
M'%'P2?TZT_X,O_VC0RE^F08 &"=Z-D3=QNUNY]FU53W[)4U6BCET:MNL]MB!
M%5>2+)&U%7P"8?FEV-[EV>Q?=*+.Y>A.ZM"D^(W!CD3R[387O1)$1K]/QD4D
M;7=#M->GIU375#*78/=#XSNU\.Q,DSM]E;&2WA?K25L?$VK:J^YS3,Z4FDDG
MCC;K'KU(D;G:N1/#B&.C7_PA=R.^?</?KJ68W+:R6Q<16?8S278H9U?)(QT=
M:)+#XUE:]SU\S1'IJUCM0F6L_C/V#?VKW@N;C\EWY#W7''>J6-/8]XBC;%8B
M5?ND<U)-/0] F'3'9CXL^UM_M_BZ>],U'M_<N&IQ5,A7LQR]$_NT:,2:!T;'
M(Y)$;KT)[35U33315,9AK/-_'=N1=]7<=LK;=/-;2DLQUL*R9EF')6=4;'KJ
MU[D_&2:K&WR>I$5$7B$Z.L=[S9&SVBW'8R]9E+*R[<O27J<4GG1PV'47K)&V
M3I;U(UVJ([I34,7YL_"O_3_LG]LV/WG.&<NM?CY_H>PG_J6K^\+X8PP?_AY?
M_I'_ /!/_P P"9=OAB
M
M
M
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MY^5):\O3[EYW1Y?D00::^>[JZM?#EXB9;4"
M
M
M
M                           "FYR([0G5C,O2*BHNGSD,H4ETUXAETPIK
MT:^)$PGHAZ1K%3@BC1A-'I6HB<2="+:/L341RJ@93;56#$ ^.Y >$T\0G5[1
M$Y@U?0@
M
M
M
M              4W_2T,99:*3G*WD(:IG102W(CNCRM7*BJBZ>SP]*^DG5CU
MR^R67-5GXI7(YR-U:FNFJ:ZKZ$,HF&7Q)>EFZ55-$1R)U*B\.'I^0:FLRJ.?
MTIJ]%31-?KZ#5,0],<J<."O1/:1.2$,M-'OK?Z @1[D71S>?+0)?%<YR.U31
M$Y:^(0I*]S4T5/QBZJU/#U)\H-%9BKHFO!VG%/6!ZUXDI>B
M
M
M
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M7@J\-/:#?--)3U.>.S7ALPO\R&9B212)R<QZ=35^=%):+0KH[VD#4JD,@
M
M
M
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M."(UCWF>-<CN$<FJ^@W*+VS1$5$331>)"'I7(!]
M
M
M
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M?\HU8J_FHKD:C555^E][\IDE]CD\SJ]E6]+E:FOCIX@>P
M
M
M
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MD7S8_2FB^E%^H;&E)1\'N17*JK[2)X(U0*H
M
M
M
M                        ?%Y*!X]K3@H3+PBOUYKH2U\7MVNGTM V1*V;
MUM31TG5Q(8UK/B]/<G1RZM>'3Z3+1%K:<FH.XLD^WI)ZV3A3)[-S4:1V*TJ*
M]L%EK^I'-:FJHSA'TMZ>#N.IIMK#J[.GQ)_3R:'QU.MA\M>V7DIW)A;?57QV
M0XS1^5"CG-7\6CD1$T16-7312E:\ZR[^/;VPZWM]Z+<H\DWMZ3?NS[L&+33<
M.VY7)!2N2.;UOJQ>RQ5:Z17(O1H[BU/D%;LJ[O#N/NQ7I^=GN_[J0[!L.DTC
M5TM9TZ(Y%=##)(U>&G-6MUY>CD;XXN9?9Y+Y8B)TCJ^MR9N'*;HQNZ/>L3%'
M+3MSU8<$YZ(YLTJJUJ(B=:=+GN5O4KM-%YE;),Q?@]#AV./%FZ;:2ZLVKE-P
M2XZI!GGP6<L[R%B@<W1(>'%%<KU:]VJMZ4:[4LS,Q"-]@K2-:\(T7S<!E?/6
M>RBU,:Q7.DL-EC75%75R(UKE6/Q^DGK-=;<>+C8\E-.-=9:'WWEKF1RF(RE.
MO[ICJ5QL=-[$5RQS]$B];&-T?KP?Q1OB1GX6C18VVWMN/O1.D59OM^]C\I=L
M045G]V>]OF2V>IECKZ&ZNB\QC%T]2-4RK$:.Q7'2D:3I,J_<3<6(V=5F?:GD
MS]]5\I<5+-TPQO5>#%5[7-1K5]KI52.<Z2I3:>=9Z6AF=QNX?\8/)NO1E**=
MU.&3'N]TACG8SK<QT:R/5S.ER*BI[.J\]=39:M8B.#37+FMK'5,PVIC<-@]R
MW7SY#$U+>0=C89++(_*IQ37FN<^7JBGU<QWCUN734PG!C_###9;C/736\M4]
MPW[EW-[Q65B8K:&V70UTI*]L\;9)9?+Z?8<B2N;TM_&1M5J\RCDGIX0ZNWR3
M.769XK6AC*26*BTI4DJUX'2+8E5(WN<R/J>J1OZ7KKI^+1$^J5HIKS=G=[R=
M>F)X>ELRODG0Y7#XVI8\B*U45\VK7NDN12QQ]<3VMT6-=%Z4=(FB]7!."E[#
M&CS^YI\2/I; K9#!92H[#K&Y)J[/\UC<Q_0KFHO4FBL1-6KPYE_JX.%;%>D\
M)3.+VVS;MR',8RE' ZXB-6Q7='$YB)HCE5->I>*%>-.J%FEJ6CITXRR:7=.V
M]OUV6K<GEY!CTCA1J.Z5ZM7Z:-8O-4UZ=>/,LS:(5\N*:RY[V9O:EOGNUG.X
M.^<DD6'P4#H<+5<DDB0N8^![7PQHCGZHKY?H,\5*]LC/%M)MRC5=8'-3YNW=
MMX"TW;FPK]A*D=*O'(KE8V-LOO#7-Z>A_6WR^IT?+AXFF<RW;817P]3-^VE?
M(4=SQ;ESF3;<Q6-C]WQ<,#7-J-8U7.TBCZGK'^J.7J7@O+F88\EIGC*SO=M@
MO73%2(X?(Z!V=O\ P.^&WI]O7ELQ8^PZI8=T2M3S6(U51%>QFO!Z+JW5#I4M
MJ\9GVML<\99>UZJJL\Q55>.O%/FXFY7BT+ENO2FO/0@?0
M
M
M
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MD]?@9M4/02
M
M
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M4T71-43ER+4<G*>B0
M
M
M
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M
M
M
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M!
M
M
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M-<UM?*XJU5U7Z*JJ<_61!"L2D
M
M
M
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MT$Z:(X^*H
M
M
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M(R9(AG]?]20RE5FW5Q52$
M
M
M
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MCCXEN)>=WNUK3S;&IHY*[4=IKZ$\/49ZZN56-(5PR
M
M
M
M                    'QR]+5=STXA$J26$7[54(F=$1.KQ+91B_15=28G5
MNBFOBM[E^6*I8FKP+-+&Q71QM>UJO7I5=$55T3CPXB9TAC,:--Y*_MS,;IJY
M!^,2CG^AR7+#NE9'0QJQJQRN:BZM<B)HFO)"I>_R._LL$SCZ_-SAW)WE=EW1
M+UO91QD3T7(R*R6:%:\:(BQ^7"KGKU-T7DJ%>+<73I2<E9GEIYIKLMEORS+F
M\YE*CF8ML/XN^Y.I$?U1HV.%B=3^I417:HU431=2W3)\BGFF,=M--6RTFG7
MTJ^?ACHY"!ZV;L<;V/=5;JYB(]['/:YRHJ.Z6*JZ+R,JZN76^O@Q+:3J2U-S
MXR&5[:]*G[@]KV/\ITK+$,BO5>E&N=HY$T:NNG'D;X;9I$PTSE(EVHC]Q5ZL
MN4;0N.?%91S)&4O.:R%6QM;H]&*C].'W2\2)ES\D:)7=F'VOW3A7?U.O'#[N
MV5F[9.EK/,<Y$\E8&2-\QTOFO59%]O5--$3BI.G!%=9:]HXG*1U\91P]7RZ]
M2W#)6J-B>C+E'(/CAUEB;H[K6-OX_7IU3P0US9<QQ$-B97M3FUAMUJ%!F,I9
M5Z>\QN5D5=6*Y=6UVJY%CCB1Z_JJK[.G'@HCBUYIB>3%K_:_-9S+3W+--(MK
MX:M#3DO/=&]9FPPI$K8$:JJO5Y*HKNA6\O U9+=+9M=G;-&FJ=V_C-N926AM
M6HYT.'K))9?'&SIEE2-[?,9)[&G4O4J,56HGRG/Z]9>^P;7'M\4\(F=/J;/C
MPVU,;CV1;AN6,#CLD]KE@Q[726)E@UA8U4ABF^DU.*JW1%]!T\,:0\/W"\VR
MSQX</8M<KL#9.1I?DO$XJMD["Z68\;+$V6!KDU:G3TM:UCG(_J<KG<U7Y"U;
M)$^"C>:S,<&![GH;F2["S/8NGMJACW)#1QU#25R-T5_7(L,L[5<JN=Q;IPT3
MF3&6(\$3$+G;^Z:[:^,JY::'(9'&-7\FRY!LDLUB#1R*G3JCD<BN<[VD:G F
M<D*5JVCQ2EO?FZ7Y&K2VO*BX;+M<W)77.>YSZ*H[I=(QCVN\U7-T7J9RT]GQ
M,8GJ6=M$VF8MQT>DV$N(V_9RG:^5%IP6I)(,=D98^NP_V-7Q^7Y#8G:*CE\[
M373I3VM$*.:'6V6\QS>*Q737[%SV]W%G*.1AQF\<;:J7LS<DR,T^BR0.DD1K
ME:JL\S1$5OL]3O$J5B-7J;8YFD3%O!G/=S*X2G(^CD)7M=/8CGQMF&.222G(
MR5KIF:,8]42558W@G#I]I3?DI'2Y^&N2+:Q?1A=[ [4WK9@NNR%JK,R-(K&C
M7*QRHB(CU3R55>2JI7KCB7LMON<F+'/WM>'+5.6>W<VVL')E-LMJYNRVO(_R
MT5L<W4UBJQR];HUZD^U3F)IHX6?=VW&7HF)KKXSR89+O7)MC@V\M5D62R:.A
MO^]:^8L"KH^-Z]:(J+JWI^]])7^-'+1Z3'VO!CTM:*WG3P9CMK<6SMFXJ#%P
M92.''KUI[E%'+UR2R/<]45S&='BY.*$VW%:3YN1N]EBM>9C'&OH; Q6^J&>@
MEVY.EW&R=:.CN,E;-TOZ4T5/*8[1='>)?P[JMXY.%G[9;%>+SI,1X:->;PH.
MVGO=MRM)&M552]'6T5U:>)6+#UKT*B=?4G3HKD71.1S]W29GA+M;:?XC'%*1
MT37FL<I?R&!P=6Q4FUQ\O5!6C>[65E5OM-Z>E4Z6J]7>RJ:\UTXD6R=4<%S#
MAQ6SQ:M8TAKA=UV;K7)6Q5%D=3RX);;4_P XTED2)B+I)JY4<]%]EOK*<ZNS
MEB--==&Z\$FZ<7LG<.,L5EMNGJ5Z]/H<C7RN?+T/ZE<_1-&KU>UH=';UU>-W
M71CSQDF8M$0C^V_;'\APP22R3,9.UOO74^-S6SJW\;"O0WDQ5Z=>2^"J9?PT
M]4SJK[SN7532LS$<?%M#<.QL7F&T;E.%K[F/8Y6Y%G2SRHXD;ULE5Z:N9HW1
M&L\$7U%JE='EZ[J^O.63[%N76R04*,/G8Q-5M6U<U5C<B_WKBFC%X^STJNFA
M9AIW-YM#:E*/R:Z-Z4;Q541O+BNNIG#F1$^*XU)2^*[1=- AZ"0
M
M
M
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M76/5NORKKS-])>;SYK1.C/JVODM\=.'$V*T6F>*KJ@2^.7P"='H(
M
M
M
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MC3Y&Q%F3J1B*J.335>E51?G)<^>"IS1%\0F)>P@
M
M
M
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M%YDM42KD,P
M
M
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M><S9^N6;HWH:B(NNOIYDN=:=7B1T4*-=*NBJJ(B<N*AC%5R$@
M
M
M
M                         /COHJ!3:B:?F"#51FT5Z,:YJ2.Y-5>:)S$L
M-',G<CX1\?NW/6=R;<W%/@%MND][I>7)?9)++IU+U3V%Z$5>I?9;PUX<C5--
M5['GFC#]D=C)^V^;GBM9A,KG?)D@6G#$C6LAF5'(LCVNU35.E?HF,5BKN8M_
M'PHYK7);&R2Y^S1=3>E"PSSG9"NLCHJ[D1J:+ITM5>*KHIMF(F#!>V371#[U
MK5FX&+I]ZP&48](Z-6S%Y=^=BH]5>V)SN+>I.>OH.3N(Z7H>U[:;Y)_9^N&"
MT,Q8RVY*^/H3(D+7IT3^5'P8J>G1?%>>I0PZQ+UVYPX,6&T5CP^7[6^LIBLY
MNW&T<GA9$?4?$D$N-Y/9TJY_F-5J*JZZHW0[U.,/G/1BC-:VC!F=O-W599H[
M,#:%:>))'06(DGG145516Q3L71%5J-U1?24LV'5>CNU9O%9F?HADNT,Q1V=M
M]L=^@U<]:EEM,;%R@K,8URH]>"M7I1_#I,J1TQ$->ZR?$XQR:\WAWLK;WS\4
M%6C#/B<?'*R"!)M5E=HJ(Z56MU8GLM5RHY?$WQ+DX8Z)U:_R^;SMI[6[;Q?G
M.>DWGKCH&2UX&N1/,8V9&=4JM;U)J]->'AJI/3JRW>6+5B(\I4=K+87,V;FY
M:D\+,53?8@A5J^PYL2O:ZP[V%8C^EKD1>I%37T<<>G24=NW/PJQ66Y,!!GLK
M'5]TACQ6WL@QSZ]55T<R5BHU98WJWK=U*Y7_ $M$UX%S'"AW3>1;3YTPWMQA
M)'KE+KXWMZ'-AK+"WW?WAJZ(][NI-556JNBM7F6HARL.6(JU)N/>KJ<UFE9O
M2Y.]%I7Q==*L%.I(YZ))[+8-&ZIQ3Z"Z\5(F&JN7XG)JW*[HSUN[8DMT9+^5
MR&E.O:55;JW1'I$QK6]/!6ZZHG48Z,T]LZ:Y8VU;R<6'DL1PN2!JPSS.E?85
M&NT8U--6(U>K77PY$:LNE<XS#[]J4K&]5;<;-6?TO:D2R1NB]E$=)U)TM15>
MJ)[/,1+&V/5@62RT^\-XQ)-$N-=/,OO-I7:R-3VG*][%1$;KRX*867,-9B69
M[EQ\>V[\6/@R<-]9HM:CXNE6O8]%;UOYZ:IRYE:U8=[#>8A-;39N.S6=A,G6
MAL3R0K%A9VHV*6-D+'))T^7&U9%5O1T]:K\VJE>V.'5V^;2WWN3*\9@M[5*=
MB2'&N;CJ\,B.A6+KDG:UB^\22]4:JC&(B.=Q5$15Y&,4T4I[O6,O3QTUTY1Y
MI3MG4Q^0W-8AHX>O*M:K/8ES%?69E>=D:O5%U;TL<CD73T*G VU;]WFQ6IU3
M#)]V8G-;CQ\F%SV&=E<(Y4GQ&2A62)*DD:*URRN@:S5CG/57.D<[33D;^F-'
M/VV]KDGHC7BAZ6-IU\5EHMCPV8[D=.2*1;LDK87QNZ7/9&KY)D=J_1=>E%3B
MG(I9::NUBPWFW3"I@MQ9"YL6Q:2"&S?Q\_57QSHHVK*UK5149*UG6Y=7>@YD
MP]#.**9:UTXS"5[B9C'[G[:U4VVV6@B2(^Y5=&U)IGHYS=4?JKT;IT\ETU3D
M6:\8-KL[X]WDM?C%H^QI_$4+6,R$.1NPS28_16^5T*SJ:B+HUSD5%:J*NO!2
MC6-?!Z;HOEB9K/R-X]K\3N/)[%S\F7@D@HSVY+59)&:.\IT<"M:WV454X?2U
M.CBK/2\7OKQ7)T_K:M=/PEZSG/R5@;"17LBZ3IT7WI(HHFND5K_-ZO+<K4<C
M>E-5=P-LXW.RTO2.J>22?L#>&/J/K8V_-BVW6/8C,BS2Q=6--94@;-YBHY$7
M5J1N375$X"*:*V/>SKI,\$/9VOE-L8...3)6KW1.V:VGE^7:JRO76+S&HY5<
MFO5[+W:>RO#F5\O!Z_84QY8TF&\/A\G??W%-8P\TONL<<;,O%/$R)76'L5&2
M,:BN1-5ZG*B=)<VG-YG^8L$8Z^7-U5 QJL1ST]M/%%54X'3F'SOJ>YGI%$Z5
MR:HQ-=#$0=BXV_:K,;P9JBJGR*&4,A#$
M
M
M
M        !\7D!2Z7:\N&H8O$OF)(JM17:HG3P31NGKY\1#;&BF^)&M=*YOM(
MU>K35=>'K,H83&LM*[G6[A=RI!CJLJ1JB9"_/THY+#(.E4B:KE54U1^G#I^4
MKY]9Y+D8Z_#TB>+ MS[CSWFKF<<K,;5CB>YZJULC5:U='+^,:_BBIH:\=ICF
M[W;*Q%9BWFTYN=M^7#6\Y>C?>QF4E;!'.J=$;E5JJJQ/;TNZM8U33@G,KYYB
M7J,&>U;3I'#1A\;J^W[M6_CK\-F%K_-F9$JN<R-$5O2[J:GCQYE.M='2G%KA
MM%YZ9=-[:9._!4+=6^RFL<*P3.>FK;$>JN]C5KN*J[U<CH8[1#Y]FVTQGMQG
M1CN=WM4V/MVS7M-?>\^])8J5WZ(M>NYD36H]R.:[7J:[3BXZ-)IXRK;S95B=
M:VUX,"WYN2IG<9BLO#-.K<]B8TKM2.)J>;78Z61VK5^Y<BKZCG9*SUSIR6\'
MW*1U<.#1[MN*M>OE:&&=)'"UDTF9\V9L<DS$1[T1K7]/K1.G[8SI$PJ;S)68
MUK.K,ZN?RUNGCY+TE:.FJ1MCH3:PV9NCIT;#Y+-'*_@GMO3P]9;IHY6#/K?2
MWFC9K\JV,S%MZI*ZSE89*ES&WO8MJU6/C5D;8W2-Z4ZG(KNM'::+SY5,LQUO
M08L$9+_=6[,SG<+@4VF[(.EQ55LL[ZMEK(W5O.17OB;)&U9'=?4NG4[AIPT-
ME<M8YRC-L:ZQ$VXLNQ'>?/024,,D*T8YH/=;;)F1NBDZG(D:M<J/>FL>FJIH
MIOKGI/BSMVSII'-F&"QG;_O3=@K,PD]/>]-?*KMHOEDCKM5?U9[7V-%1=6_2
M:[Z1NBT2\Y&UG%JL-J['VE@_>\9^3K%[/XF19*ES(.?!H]51?-:R&9S58G5T
M>TWGX#5E2O5PA*;(V>VS?1M2";%SO8Z6',L;YM2SIP7RFRN5%:J(O'RT7@IK
MEG;2G/@O-S[FS>S\+7MTUIW\"EU\5U:VLC8WJR-$5OFQMZEU<S@[AIZS"=6R
M)B(UU7^=[>X[N15S.(R+*;-XX2)LU6_&Z6"Q&V*5OF/=#"UL+F/8CV(KFJ[C
MKHFB*83JLTCQASIN?MEDXJD^>E]X?%#*M"O$J(U)$@5-71JFBJQ$>BHJJB^E
M#"=6R+1KQ9%@]VQ[6KXC%9V!US$UZS72.8B->UMR)K=7.1S'>QHBI[7'Q,)G
M3FZ>')IRXM\0OFW1VBFR.WKBL?5=:?'YK6^W5@C1R,541_%6\/7XJ:K6AEM<
M$SEZK1I'5$^MK38]S=V$M8_)16'_ )(DL2P/H^1 BIYTW3-+U(SJ5K%U=Q=R
M\#"-5[NUM<>F/CQAGJY#>\N9J;MQ,WOVWJ3):<M'RHTG7WA[7+'*U&=*(]8G
M]+FR=73Z%-\3+E]OZ:UMU_=GAHH(W:N,NW(*6.2&FKX\CBJ]R>PV9;$4:,>U
MZ,D>FGF/?TIU*BMTUX\#&:K<;S+2\VB(E<[D?'MO;^#7'4);C]P3)#;O-:B3
MHU_G:Q,BZTBUUB:J+P7U\RO>D1#M?Q5LF6,GX>4,4SD&V=I55P-BVR?)8YW1
M%%&][H94=[7XMSE:]43J7Z2)R*-IB)=+MVZS9<UNNG173A/FQY^>EF;%PF3&
M3.61SG1Q(C'*FB)(NNJ+P3Z.I8I6);L'=(PUF.#?NP,7N*+9_E?CYY,DYK?Q
MD<;/(@<V/14Z.;575-5XE^D1$/*]QW7Q+S:/.95<EL]=O6$VQBYXZ<.3:YV:
MO-3SI'NE31&Q^:U>EBN33J;TNT<OJ+58B7#S;S)?A:NCG7N!VVK4,Q-!#G_(
MEQ]B6*"M,^3I7RW],:1.1KG.5-/M]->&NIA:FBWDQ3&.MO.-?4G^V5'</\87
M8+-677<?FJ<D;9W,8V)&UXU1[5<UK7=6DB<CEYJSX+W;]SDK/&.#??9K;]C$
MYNOCL'1DQF$HRRNG9)K)YTBO5R/<^1TCT:JHJMT=R7D;]M$QX-?==U6]9]$N
ME:Z(D2:>E=?E\3IR\7IHJ*B.16N35%YH0A"6:#HIX)H6KP<FJ>K4(3H2
M
M
M
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ME#V0D
M
M
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M5?6IG+&\Q,ZPK$,'S1 /H
M
M
M
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MGAS-\1H\[.N2_P Z7J.1\*.1O1KKP,9;IKT\%8A
M
M
M
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M<)7W3Q#;JJMT1. :]=7T
M
M
M
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M"0
M                        /BN1J:N5$3TKP HNN5&?2G8B^CJ34PF]?-ET
MSY*:Y.BG]^;\VJ_G$?$KYIZ+>1^5*'_/)]1?L#XM?,^';R?4R-%W*=OSZI^:
M/B5\SHMY*K+-9_T)F.^1R&46B?%'3*J9,0
M
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MK$1&]3EYG1IR>5R<THFBIH3)H]M31-"('TD
M                                                      %M/D*E
M?A)(BN^Y;[2_6-=LE89Q291LV>=R@BT^^>OYR?9-$Y_*&V,7FL9<G>EYRJU/
M0SV?S.)JG):?%LBE86SGN>NKW*Y?2JZFO5F\A(    /;)I8N,;W,_!54_,)B
M9CDB8B5W%E[L?-Z2)Z'IK]=-%-D9;0USCK*_ASL3N$\:L7[IOM)]0W5SQXM<
MXI\$E#9KV$UAD1_J3G]1>)OBT3R:IK,<U4R8@
M
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M/'S9/"U6Z(]$3[E$^OJ9-"MHGH ^@
M                                               +&WE:U;5K5\V5
M/M6\D^533?+%6RN.90MG)VK.J*_HC^X9P3Y_%2K;):5BM(A9FML
M    ^HJM5'-545.2IP4(2-;,V8=&S?CF>O@[ZIOKFF.;5;'$\DU6NU[:?BG>
MUXL7@Y/F+5;Q;DKVK,+@S8@
M      #RY[&)J]R-3TJNA$SH:+=^2HQ\YFK^#J[\S4PG)6/%G%+>2@[-TF\N
MMWR-^RJ&'QJLOA2IKG:VO".33YOLD?'A/PI/R]7_ .;?];[(^/!\*7IN<J+S
M9(GS)]D?'J?"E59EZ#O[YTK]\U?L&<9:L?AV7,=FO+^IRL<OH14U^H9Q:)\6
M,UF%4R8@
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M%VOA\@%4
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M4"$Q2S*II';XIX2IS^="S3-X2T6Q>2::YKVH]BHYJ\45.**6HG57?20
M                                 *<LT4#>J5Z,;ZU(F8CFF(F4;/G8
M6ZI78KU^Z=[*?9*]L\>#=&*?%'396[-_?/+;Z&>S]?F:9RVEMC'$+-SG/7J>
MJN=Z57535JS? D      !7BN6H?U*5S4]&NJ?47@91>8Y2QFL2OX<[,WA/&C
MT]+?97[!NKGGQ:IQ1X).ODJEG1&/Z7K]H_@OV"Q7)66F:3"[-C
M
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MKH3K<J\_!/4-&/%]\IJ\UT)1TRKM31J)Z$,6;Z
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M4:_FIZ%-E,DU:[4BS)*]B*S&DL3M6KS3Q1?0I>K:+1K"I,3"J9(
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MCJ^]#===..FGS!!T-7P"=7KEP"
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MS$D6D=G62/DC_MD^R6*9ICFT6QZ\D['(R5B21N1S%Y*A;B=5>8T>B4
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M7.+9;7H5J<61+]SJY/IJ&<0W-_P]_P#4^_/VSC?UNP$2[1#$
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M:KQ-L<&BEM4D0U@
M               YF^.K^A2O_#E+]9L!,-._\/S^6.\?X,K_ +X4)EWV&(!K
MGO[_ $*;^_@.]^LN"8?G;\*>,QN9[^;2QN7IP9#'3_E'SJEN)D\+^C&6GMZF
M2(K5T<B.35.:!E+],&=M>W,;VR1[0PC)&*CF/;C:B.1R<45%2/@J!@R&I3J4
M(&U:->.M69]"&%C8XV_(UJ(B :.^+[![BW'V7NXG;&-NY;(S7Z2NHXV"6U.^
M*.3K<JQPM<Y6HJ(J\-$"8<%[>V1\1VT7SR;4VYO?!26D:VT_%TLM2=*V/56H
M]8&,ZD;JNFO+4,D+W#_WP_\ PW_>Q_&7^_\ Y(_C1[__ -'Y_N_OW^#\SH^]
MU\ ,Q[%_[[?RYMS^)G\:OXB?ERI^4_R/^4?R3^KP^\>=[O\ B?U/3S.O[7GP
M!+]50P   "WNVV4X5D=Q<O!C?2IA>_3#*M>J6+2ROFD=+(O4]RZJISYF9G65
MV(T>"$@ #XYS6-5SE1K43557@B(1,Z<R(F9TA!W<^B*L5!.I>2S.3A\R>)RL
MV^\*?2[&#M_CD^A$+YUA_F3/61Z^+N)S9F;3K,ZNK$5I&E8TA7C@,XJPFRZ9
M!ZC;%6J;J[*_J-L4:INK-K^HSBK7-U1*_J,NACUOON_J)Z#K>5K^HCH3UJ;J
M_J,9JRBZB^#U&N:LXNMWP>HUS5MBZUD@]1IFK=%GB&>S3?UUWJSTMYM7Y4%+
MVQSK62^.F2-+0G*&<@L*D5G2&=>"+]HY?4O@=;#O*WX6X2XVXV-J<:\8]:6.
M@YH   75&X^G,CTXQNX2,]*?90SI?IEA>O5#*(Y&2L;)&O4QR:HIT(G53F-'
MHE                               ALCEM-8*CO4^5/S$^R5<F7PA8IC
M\90G,JK      'B2:*%.J5[6)Z7*B?FF%KQ7G.C*M+6Y1JLY,Q09P1ZO7T,:
MJ_771"M;=XX\=5NNRRSX:+=V>B_O<#E_"5&_F:FF=]'A#?';[>,P\+G9%Y5T
M1/6[7\XP_CI_#ZV?Y?'XO4^?EV7]CI^F7[ _CI_"G\OC\3TW/?=UU3Y':_G(
M91OO.OK8SV_RMZE9F<J.^FU[/6J(J?64V1O:3SUAIML,D<M)7<5^G-PCF:J^
MA5Z5^HNA8KGI;E*M?;Y*\XE<&]H      NJ=Z:F_5BZQK]-B\E_Y3.EYJPM6
M+,DK68K4:21+JGBGBB^A2_6T6C6%2U9A6,F(    -/?%1_0!O;]K5_WY $P_
M/KX=NYV![1]R8-X[DKW+6,BIV:SHL>R*2?KG:B-5&S2Q-T33C[092Z__ *_/
M9[_8FY?W+0_T\,=$A@OCA[3[@S>-P-+#;BCN96U!1KOFK46Q-ELR-B:KU;=<
MJ-17<=&K\@-'1.:_U/D/VM-^MN"'Y!=HK5:EW8V)=NS,K4ZVXL1-8L3.2.*.
M*.]"YSWN<J(UK43557D&;]7+'=;M=5C6:SO; PQ)P5\F4IM37T:K*&#\^OC"
M[J;3[G;^QJ;.G2_C<%2=3ERC45(IYY)72.2+5$5S&)HB/Y*NNG#15,X=/? Q
MAKN+[)RW+;%9%F<U<OTU5-.J%L5>IJGI3KKO#&47\97?3^)6W%[:[;L(W=.X
M8%_*<\;O;IXR35KDX<GS\6)XHSJ7@JM4$0Y1W%V6GV?\/N*[GYZ-T6=W-G*D
M&+K.U18<2ZG<E1[D^ZG<QCT]#&M^Z4,M70__  ]_]3[\_;.-_6[ 1+M$,0
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M'[WUF40RK?56:BJBZN5SD^DB\F^I#8TWA58O#1? 2BLZ+@P9@
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MWHR0  )7#W?*D]UD7\6]?85?!WH^<L8;Z3HT9*Z\4^7%8
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MNZPBMKLF1_5HJ:?30$P_1>O/':KQ68M?*F8V1FO!>EZ:I^:&*H
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M=3M$14Y^E?D(95X/20M1%355U]).K*9U/);Z5&K#I5"&0
M
M  !#YNWTM2HQ>+O:D^3P0K9K^#?BKXH,J+(  I6;,-2!]B=W3&Q./I5?!$^4
MUY,D4KU3R;,6.V2T5KS87<O3Y.?S9?9C;PBB3DU/L^L\UFS6RVUEZK!@KAKI
M'/QE[ABY"M4VLD(8BQ6JM:R^BA]18K57M9?10^HL5JKVLO(X-? WQ5HFRZ97
M]1MBK3-UPV#U&V*-4W5$K^HSZ&'6^^[+Z">A'6^+7]1$T3UJ3H/4:YHV1=;R
M5_4:IJVQ=:20>HU35NBRSEA*]JM];+&:$T6JL5LL)HN97M59K9'S1%:U5FME
MQBLL_&RI#,JNIO7VDYJQ5\4_/0L;;<SBG2?=5MWM(S1K'O>UF#7->U'L5',<
MFK53DJ*>BB8F-8>8F)B=)?24 #EQ3F!E..M^]UD<Y?QK/9D^5/'YSH8[]4*5
MZZ2NS8P                           B\M?\ );[M"OXUR>VJ?:M7\]2O
MER:<(;L=->,L?*:T   %K=R%:@SJF=[:_0C3BY2OFSUQ1Q6,&WOEG2OTL;MY
M.W?56JOEP+_>FKS^5?$XN7<WR_)'D[^':TQ<><^:E%":8JW6LNXX/4;HJTS9
M=,@]1NBK3-U=M?U&R*M<W5FU_49Q1A-WM*_J,NACUGNWJ'0=;XM?U$=">M2=
M7]1A-&4747P>HPFK9%EM)!ZC5-6V+K62#U&F:MT66[735I/-@>L;T\4_/])A
M$VI.M9T;+16\:6C6$W0SS)52&ZB1R<DD3Z"_+Z#JX-[%N%^$N/N-A->-.,>7
MBFN?%#I.2$@  NJ%U].;JYQ.X2-]7I^5#92_3+7>O5#*&/;(U'L7J8Y-45/%
M%+\3JIR]$@  T]\5'] &]OVM7_?D 3#\]?A][GXCM#W&@WEFZ=F]1BJ6:JUZ
M?E^:KIVHB+^,<Q-$TX\0REUM_7^[;?S9SGU*G^7"-#^O]VV_FSG/J5/\N#1T
M7AMT5-Z]NZV[J$,E>EFL4MZO!/T^:QD\*O1K^E535->.BAB_*/LQ_3#V^_\
M4N&_?\(9R_88, #&NX&SJW<#9F9V9<LOIU<S76K+:B:CI(VJJ+JU'<%7@!S#
M_P#T_-G_ ,\<G^YZ_P!D,M6H?B,^%W ]D]D4-U8O/W,K8N96'&.KV8HHV-9+
M7L3J]%9QU1843YP1*(^&OX=L+WSH[BMY;-6L2["RU8HFU8XY$D2RV5RJ[KY:
M>7X!,R_3*I7;4J05&N5S8(V1(Y>:HQJ-U^L&"L
M                                  !\T1? #RL43OI,:ORH@9=4BPPK
MSC;]1 =4^8D,**JI&U%5.E5Z4U5/0#JE]2*-$Z48U&IR31-. 1K+ZB(G) A]
M
M                         \R/;$QTC^#6(KE^1")G2$Q&K$9Y73S/F?\
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MCX6XU]BGNMG&7[U>%O:RJ.1DK&R1N1S')JUR<45%.]6T3&L/.6K-9TGF]&2
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MZ9G<-/0!8=I.R.S>R]?*U=GR77QYA\,EOW^9DZHZNCT;T]$<>GTUU"=6R @
M                                                         :[R
M7>?:&+R-O&667%LTII*TRLA8K>N%ZL=HJR)JFJ'7Q]JS7K%HTTF->;DW[IAI
M::SKK$Z+;_?MLG_F[W^)9_E#9^3Y_D^G^AA^;X/E^C^D_P!^VR?^;O?XEG^4
M'Y/G^3Z?Z#\WP?+]']+9%:=EJO#:BU\N=C9&:\%Z7HCDU^J<:U>F9AUZSK&J
MJ8L@
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M>'@ORVJ #EQ3F!E++2R8];3?II&YR_A-1=?KH="+:UU4IKI;1=FQ@
M                 &-Y:U[Q96-J_BHO93UKXJ4<MM96\==(1YI;0 !%9K+)
MCXO*A5%MR)["<^E/NE_.*&[W/PHTCWI='9[3XLZS[L,58UTCE?(JN>Y=7.7B
MJJIP(UF=9>DG2L:0OH8N1OK56M9(0Q%FM5:UE_%"6*U5K67L4/+@6*U5[67L
M=<WQ5HFRZ9!ZC;%&J;J[:_J-L4:INJ)67T&?0PZWWW9?0.@ZWAU=?01-$Q=1
M?!ZC7-&R+K>2#U&F:MT76<L&G@:;5;JV64L)HM58K98S0E>U5BMEA-$5K56:
MV1\T7,KVA9K9<8C+/QTJ0S*JTWKQ^\5?%/5Z2QM=S.*=)]WV*N[VD98UK[T>
MMF"*CD1S516JFJ*G%%13T43J\Q,:/I( ?6N5KD<U='(NJ*GI0(972LI:KLE^
MVY/3T.3F=&ENJ-5*U=)7!FQ
M                                     !QUO3^6.X?X3N_OAY]$VG[F
MG[-?8\!NOWU_VI]J#+*L =IX7_4V._:T/ZVT^;Y??MZ9?0\7N1Z(7QJ;0
M
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ME?G^UDIV7"  $IA+/EV%@<OL2IP_"3_D-^&VDZ-.6NL:L@+JJ
M
M   #CK>G\L=P_P )W?WP\^B;3]S3]FOL> W7[Z_[4^U!EE6 .T\+_J;'?M:'
M];:?-\OOV],OH>+W(]$+XU-H
M                                       'Q51J*YRZ-3BJKR1 -<[L
M[[]KMG>9%D,]%<O1ZHM'&_YY-U)S:JQZL8OJD>TJY-UCISEZ#9_R_OMSQKCF
ML>=ONQZ^,_-$M';@^+?<N;L_DOMUMKHGF5602VD?=MOUY*RO!HU'>I7/0H7W
M]K<*0]GMOY-PXJ]>YR<(\ONQ_6G^A%IVS^)/NWI)O#(S8S$R\5AR<WND2I^T
MJS>#D_Z2-ORF'P=QE]Z=(_3P6?S7LW;>&"L6M'X8UG^O;ZIEN;M!\/F.[69-
MVX%SEG)9J6NZK*UC&5ZGER*U[D6/VWNT<QJHO6G+D7MOM(Q3KKK+R/>OYDOW
M"GP^B*TB=?.WT\(]3<Q>>1  &'V)/-GDD^Z<J_,JG,M.LZKT1I"F0R (_-V?
M=<79E1='*WH;Z=7^S];74J;O)T8K3^G%<V6/KS5CY_H8+7;R/+U>OO*4KMY%
MJL*EY2D#>1:I"G>4I7;R+=(4[RE*["Y6%.\I6NS70N4A3O*5A9TMU+M8T4K3
MK*H9L  !%9'<F#Q3ECO78XY4YQ-U>]/E:Q%5/G-^/;Y+\H:;YZ4YRCF;_P!K
MN<C5MN:B_;.BDT3ZC5-T[++Y-/\ &8O-.4<E0R4?FT+,=B-.:QN153Y4YI\Y
M5OCM2=+1HLUO6T:Q.JZ,&8  H6&:IJ:[PVTE$SLYE&\+M)1=AG,IWA<I*+L-
MYE2\+E)1<[>93O"Y245.WF5;0MTE'J]T$S)F<'QN1[5];5U0T:S68F/!9Z8M
M$Q/BV/%(V:)DS/H2-1[?D<FJ'L*VZHB8\7A[UFLS$^#V9,0"[HR="V&>$D$B
M?.C=?SC92>?H:[QR]+*3H*8                       @<[/U3,@3DQ.IW
MRN_Y"GGMQT6<4<-425V\  89N.^MN][K&NL%;@OH63Q7YN1YS?9NN_3'*OM>
MH[=@^'CZIYV]BS@9R*E87+RDX&<BU6%6TI*"/D6JPJ6E)P1\BU6JI:R2@BY%
MJM56UDC!#J6ZU5+62,4"(FJEJM%6UU<VM0     'E[$<G'F8S&K*)T6,\&A7
MM58K9'31%2]5NED;/%IJ5;56JV1L\?,JVA;K*-G9S*MH6J2C)V<RK:%NDH]Z
MOAD;+&O3(Q4<UR>"IQ*^LUG6.:SI%HTGE+/,?<9?IQ66\WI[;?0Y."I]4]5@
MRQDI%GCMQAG%>:RNC>T 'J-[HWMD;])BHY/E01.B)C5F$4B2QLD;]%Z(Y/G3
M4Z<3K&JC,:/1*        "(R6Z]KX;J_+&;H8_HX/][M0P:*GI\QZ:<C"<E8
MYS"UBV>?+[E+6]%9GV,1R/?CM#B]?>=V4Y-.?NOFW/WNR0TSNL4?K.KB_E[N
M&3EBM\^E?_M,,AV5OK;?<'$RYO:]EUK&PV'U'2OC?"OFQL8]4Z7HCN3TYH;,
M>6N2-:J&^[?FV62,>6-+3&OGP_2&2&USP
M                                 <=;T_ECN'^$[O[X>?1-I^YI^S7V
M/ ;K]]?]J?:@RRK ':>%_P!38[]K0_K;3YOE]^WIE]#Q>Y'HA?&IM
M
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MMH6ZREMIVU9/-1<OLO3S8T^^;P7ZJ?F'1[=ETM-//BY?=<6M8O'AP98=YYT
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M'S2SJZ9[6L5VLKG:>RQJ>SIR+F/%7'&E7EM_W#/O;Q?-.LQ&G*(X?,R4VN<
M                                                           #
MCK>G\L=P_P )W?WP\^B;3]S3]FOL> W7[Z_[4^U!EE6 .T\+_J;'?M:'];:?
M-\OOV],OH>+W(]$+XU-H
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M3NSMQ/P>XZ%YK](EE;%93P6&54:_7Y$75/6A5W6#XF*86=KG^'DB73YXA[(
M+R C;2%2ZY1$6>2E&Z[1%6$*=UVB*L>)3NN415CQ*EERB+L>)5LN49=M557$
MM3T2/1/JZGH.W?NOGEYGN<?Z[YH31TG+  &:'4<\
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MO5$?8V(B(B:)P1.2%EP
M                           <=;T_ECN'^$[O[X>?1-I^YI^S7V/ ;K]]
M?]J?:@RRK ':>%_U-COVM#^MM/F^7W[>F7T/%[D>B%\:FT
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M\G#R8[8YZ;1-9^7@N"6L
M                    ''6]/Y8[A_A.[^^'GT3:?N:?LU]CP&Z_?7_:GVH,
MLJP!VGA?]38[]K0_K;3YOE]^WIE]#Q>Y'HA?&IM
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M'1HU7)Z>:(O!/2X)O-(Z^;X%W>FWKNKQMYUQZ\/+EQT^37DS(WN2
M                                                   ''6]/Y8[A
M_A.[^^'GT3:?N:?LU]CP&Z_?7_:GVH,LJP!VGA?]38[]K0_K;3YOE]^WIE]#
MQ>Y'HA?&IM
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MT>(F=9UE])0 7N/CZDM2>#()/JJFAMQQS]#7>>7I9.7U,
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M7GX-1/2;8B(Y.??)>\ZVF9]*Y):P
M                            <=;T_ECN'^$[O[X>?1-I^YI^S7V/ ;K]
M]?\ :GVH,LJP!VGA?]38[]K0_K;3YOE]^WIE]#Q>Y'HA?&IM
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MH=5%W4O-RI7<QJJOWS5*U]KBMSAWMM_,&_P<*Y9F/_=][VZM9YKX.=G6E<[
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M;C';E+SFY['OMO[^*VGG'WH_T=6=(J.1'-75J\45.2H6'$?0
M                                                 XZWI_+'</\
M"=W]\//HFT_<T_9K['@-U^^O^U/M0995@#M/"_ZFQW[6A_6VGS?+[]O3+Z'B
M]R/1"^-3:
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MB(GK40AEB5D;3]T1=$\M6:_*FBJ='I^[HI=7'57,V(
M   !\5$5%1>2\% P^5BQ2/C7FQRM7YET.9,:3HOQ.KP0D B=QU?>L7(K4U?
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MO=?-/YNW&QRQ7X4UMEUXS7\.GC,<)G73T<731U7SH
M                                         ''6]/Y8[A_A.[^^'GT3
M:?N:?LU]CP&Z_?7_ &I]J#+*L =IX7_4V._:T/ZVT^;Y??MZ9?0\7N1Z(7QJ
M;0
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M  D\+6\VPL[D]B+E^$O+ZAOPUUG5IRVTC1D)=50
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M]KNF*>/B[1."JJ+S15]'@9Z*VK**EVI?A2>G,V:)?MFKR]2IS1?E(2K@
M                                                       #CK>G
M\L=P_P )W?WP\^B;3]S3]FOL> W7[Z_[4^U!EE6 .T\+_J;'?M:'];:?-\OO
MV],OH>+W(]$+XU-H
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M.KZI:?W3MWX/\6CV_E#29OT8\/;N7U<J)R:_6>/U\7Z%*]-K'C]&KU>TW/\
M,.3]7A_[ZUK_ &9]31.\9>T"=;-C5=P/E7@V;*6*D<*+PXI''"]ZISYO1?DY
M'/R?"_5U^=[791W#_J)Q_P#QBVOTS.GJ7';S:7<23,T<IM^"YBZZO:KLJ[S*
MT"PHJ=:=2Z>8BIP5K>K77CP,L.++,ZTUCY5+O?<MCCPVIFFMYF)^[SG7ZO3P
M=7'J7P9<4[UO'S)/3F=#*GBU>"IZ%3DJ?*0,VQ&^89>F#+,\F3DEAB*K%_";
MS3YOK$:)U9=%+%/&V6%[9(G)JU[516JGJ5"$O8
M                                   #CK>G\L=P_P )W?WP\^B;3]S3
M]FOL> W7[Z_[4^U!EE6 .T\+_J;'?M:'];:?-\OOV],OH>+W(]$+XU-H
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MIWA\_P!4C1.K)D5%1%1=47DI"0
M                     ''6]/Y8[A_A.[^^'GT3:?N:?LU]CP&Z_?7_ &I]
MJ#+*L =IX7_4V._:T/ZVT^;Y??MZ9?0\7N1Z(7QJ;0
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M2Y]:%C)7I]_)IUN_1.4NTQUI[L:/*;G?;C<SKEO:_IGZN2=-BD
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M\Q&@SW$;GQN7TC8_R+:__AY%1%5?O5Y._-(T2FB$@
M                                  XZWI_+'</\)W?WP\^B;3]S3]FO
ML> W7[Z_[4^U!EE6 .T\+_J;'?M:'];:?-\OOV],OH>+W(]$+XU-H
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MGWI5+]PK'NQJDZV,IU51S(^J1/MW^T[["?,7L>WI3E'%SLNZR9.<\%V658
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M5.'M+^,:GJ=X_(I&AJSS&9BAEXEDI2]2MTZXUX/;KZ4_/Y&+)?
M                                          ''6]/Y8[A_A.[^^'GT
M3:?N:?LU]CP&Z_?7_:GVH,LJP!VGA?\ 4V._:T/ZVT^;Y??MZ9?0\7N1Z(7Q
MJ;0
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MBY>+7:>+7)P4E"T) #:FU\/^2<:U)6Z6[&DD_I3[EOS)]<QE,)LA(
M                                            XZWI_+'</\)W?WP\
M^B;3]S3]FOL> W7[Z_[4^U!EE6 .T\+_ *FQW[6A_6VGS?+[]O3+Z'B]R/1"
M^-3:                                                   (S*Y_
M&XAJ^\R]4^FK:[/:D7YO#YP,&R.\\K;F:M5WND#'(YL;.+ET75.IWC\G(RT8
MZM@8O(192C#=BY2)[3?N7IP<GS*8LEX
M      !\<UKVJQZ(YJ\%1>**1,:B%N85>,E/BGC$OYRE:^'R6*Y?-$.8YCE8
M]JM<G-%312K,:-[R$@               "K!7FLOZ(6*Y?'T)\JDUK,\F,S$
M<T[2Q$5?22?227FB?:I]DN4Q1'-6MDF>22-[4
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M\$1.*J$,@QN,2MI/.B+.OT4YHW_E+N/%IQGFK7OKPA)F]I
M       4K%:O;B=!9C;+"[FQZ:H!AF8V*J=4^'?KX^ZR+_:N7_WOJDZHT6&U
MMOSSY97WH71Q451SV2)IK)]JFB^'VW_VDRAL<Q9
M                               !QUO3^6.X?X3N_OAY]$VG[FG[-?8\
M!NOWU_VI]J#+*L =IX7_ %-COVM#^MM/F^7W[>F7T/%[D>B%\:FT
M                                        !:W\E2QD/G79FQ,^U1>+
MG+Z&HG%0,&R^][=KJAQC5JP<O-7197)^8WYOJF6B-6*N<Y[E>]RN>Y=7.5=5
M55]*DH>0,KV1E_=;CL;,[2"TNL>O))4_NDX?4(E,-B&*0
M                     !0L5*]INDS$5?!W)R?(IA:D6YLHM,<D/9PDS-75
MW>8W[E>#OL*5K89CDWURQXHR2.2)W3(U6.]#DT-$Q,<VZ)U>2$@
M  K05;%A=(8U=Z_#ZJ\#*M9GDQFT1S2M;!HFCK3]?^C9R^=2Q7!YM%LODEHX
MHX6(R)J,8G@G LQ$1R:9G5[)0
M >)8HYF+'*U',7FBD3$3S3$Z,?O8J6MK)%K)!_9-^4I7Q37ER6J9(E'&EM
M                  JP5YK+TCA;U.\?0B>M3*M9M/!C,Q'-D5'&Q4TZU]N=
M>;_1ZD+M,<5]*K>\V7IM:P
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M.0P15V)'"U&M3T>/REN*Q')6F9GFJ&2
M     (3-[EJX2>""2-9GR^U(UBHCF1\D71>:JO@3HA(T,E2R</GTIFRL^V1.
M#FKZ'(O%"$KH                                           !QUO3
M^6.X?X3N_OAY]$VG[FG[-?8\!NOWU_VI]J#+*L =IX7_ %-COVM#^MM/F^7W
M[>F7T/%[D>B%\:FT
M ,=S.[\?C>J&NJ6KB<.EB^PU?OG?G(3HC5@.3S.0RTG7<E5S475D3>$;?D;^
M?S)0L"0 ]1QR2O;'$U7R.71K&HJN5?0B(!EV'V/8GZ9\LY8(N:0,T61?E7BC
M?_;D1JG1F].A3Q\*04X6PQ^*-YJOI55XK\YBE<
M                         !\5K5XJB*OR >4BB1=48U%].B$:0G5Z1$3D
MB)\A*'T                                                'E[&2
M-5DC4<U>:*FJ$3&J8G1&6<)#)JZN[RW?<KQ;]E#1;#$\FVN6?%%3XZW7U5\:
MJW[IOM)]8KVQVAOB\2M36S          #W%#+,[IB8KU^]34F(F>2)F(25?!
MS/T=8<D;?N4]IWV#?7!,\VF<L>"7K4:U5/Q3/:^[7B[ZI9K2*\FBUIE<&;$
M                                 !0NW(:%66Y872*)O4[TKZ$3UJO
M#4&0O39&Y+=G7\9*[73P:G@U/4B<#)B\U;=FC,VQ4E=#,WDYJZ?,OI3Y21G.
M%WO!8Z:^61()N26&_J:_A)]K^9\ACHG5ES7->U'L5',<FK7(NJ*B^**0E]
M                                       !QUO3^6.X?X3N_OAY]$VG
M[FG[-?8\!NOWU_VI]J#+*L =IX7_ %-COVM#^MM/F^7W[>F7T/%[D>B%\:FT
M                                           M,ED:V*J/N6NKRFZ)
MHQ.I55>2?_:!KO,[MR&4ZH856K37AY;%]IR??._.0RT8ZL?)  !D.'VCD<GT
MS3)[K47CYCT]MR?>M_/4C4T9[B\'CL0SIJ1?C531TS_:D=\_A\B&+)(@
M
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MAAG(V%WF5==75W\6^O3T+\A V%A]PX_,L1('^791-7UW\'IZ=/2GR$,DL0
M                                      XZWI_+'</\)W?WP\^B;3]S
M3]FOL> W7[Z_[4^U!EE6 .T\+_J;'?M:'];:?-\OOV],OH>+W(]$+XU-H
M                                       !1MU8;M:6I8;U0S-5KD^7
MQ3UH!J')X^;%WIJ4WTHU]EW@YJ\4<GRH9,5H2)'%X3(Y>3IJ1?BT71\SN$;?
ME7\Y"!GV'VECL7TS2I[U<3CYCT]EJ_>MY?.I&J=&0$)
M
M                  !@W<_NSL_M#B*>;WE+8BHWK/N<"U85G<LOENDXHBIH
MFC%X@:N;\;78ISFM]]R3=51.I:#]$U\5XA.CHEKFO:U['(YCD16N1=45%Y*B
MA#7?=/O;L/LZW%KO6Q8B=F%G]R95A6PY4K>7YBN1%31$\QH3HP;#_&/V5SN7
MH82A:R+KV2LPTZJ/I/:U9;$B1LU7JX)JY.(-&_@@
M!$[@W/M[:E)F0W'DJ^,J22LKPR6'HQ9)I5T9'&WF][EY-:BJ!+
M                         C,M@<=F&:6H])D31D[.$B?/XIZE U]F=L9#
M$*Z16^?33E/&G)/OD^U_,,M6*$) #TQ[XW(^-RL>U=6N:NBHJ>**@&8X3>[X
M^FMF$5\?)MIJ>TGX:)S^5./RF.B=6<03PV8FSUY&RPO35KVKJBD)5
M                               #CK>G\L=P_P )W?WP\^B;3]S3]FOL
M> W7[Z_[4^U!EE6 .T\+_J;'?M:'];:?-\OOV],OH>+W(]$+XU-H
M                                    QO=V"?E*K+51G5>@X(U.;XU7
MBGS<T^<F$2C\-L9C.FQF'=;N:56+[*?A.3G\B?5&IHS&***"-L4+&QQ,31K&
MHB-1/4B$)>P
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MT0OC4V@
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MFOL> W7[Z_[4^U!EE6 .T\+_ *FQW[6A_6VGS?+[]O3+Z'B]R/1"^-3:
M                                6%G,XZK<AH33M2U.[I:Q..BKRZO1
MKR0"_                                            :"^,W^@#/\
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M+,+ECEC5R(FJ(Y/9=HG4W1=$UT#!F0
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M=_*U/R)W?Y_71$D]+V<D?^<OK^4QE,,@(2
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M7Z3(I$1\COHZMZ.:KTB9;Z^/G^A["?\ J6K^\+X1#%?^'O\ ZGWY^V<;^MV
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MYHOI1>:*!'X3;M3".GDA<LLDJZ->]$ZFQIR;P]?-?$G5"8(2
M                        <=;T_ECN'^$[O[X>?1-I^YI^S7V/ ;K]]?\
M:GVH,LJP!VGA?]38[]K0_K;3YOE]^WIE]#Q>Y'HA?&IM
M                !9Y+)T\576Q<DZ6\F,3BYZ^AJ>(&M\YN6[F7K'KY-)%]
MF!J\]/%R^*F6C%"$@!*;?3)IDX9,7&LD[%U<WDSH7FCU\$4@;;3EQYF+(
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M>".ZF^I4T\ 0_1CLGG<?N/M)LO)XV5LL"X>E7DZ51W1/6@9#-&NGBQ['-7Y
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M9V$
M               #CK>G\L=P_P )W?WP\^B;3]S3]FOL> W7[Z_[4^U!EE6
M.T\+_J;'?M:'];:?-\OOV],OH>+W(]$+XU-H
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M]J*C);3VM;I&BHBI&QK4:W7UNX*N@8RV>$
M                      :K[Z]D,7WQP&.PN0RDV(EQEI;=>W!$V?57QNC<
MQS'.;JBZHO/P"8EJ?9WP(=NL'DHLCN?,WMR1P/21F/5C*55_3QTF1BR/<GJ;
M(WU@U=4PPPUH8Z]>-L->%K8XHHVHQC&,31K6M31$1$31$0(>P
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M@&=;?V8R+IN9AJ/EYLJ<VM_#]*^KD8ZIT9DB(B(B)HB<$1"$OH
M                                                         U?W
M][FYCM%V^DWKAL=!DY:URO7L5K*R-9Y-A7,ZD='R5']'/AX<] F'YW]Y^_V]
MN^UO&U<M5AHXN@]?R?A\>DCFNL3:-ZWJYSEDD^U;HB:(NB)Q74RB';WPC=H;
MW:[MW)?W!66KNO<\K+M^O(WIEKUHFJVM _Q1R(Y\CD7BU7]*\4#&7000
M
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MZZ.+>K*WT9;":HY_J;XHGYIE$(U8@2@ N\?CK>3L-K4XU?(O%5Y-:GI<O@A
MV3@MMT\*Q).$UY4]N=4Y:^#4\$(U2FR$@
M                                         6>4Q&*SE&7&9NC7R6-F
MT\ZG<B98@?TJCDZHY$<U=%35-4 AL)V[[?[:M>_;<VIA\/=TT]YQ^/JU)=/P
MXHVK]<#)0
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MD6.9BZM<GYB^E% V;M_<5?-P]#M(KT:?C8=>"I]TWU?F&*4V0D
M               &&=P>WU#>U#5.FOFZ[5]SN:?/Y<FG%6*OZ7FGBB]'9;VV
MWMYUGG#G[S9USU\K1RER_D<-D\5DY,->K/BR43TB6OIU.5SOH].FO5U:^SIS
M\#V],M;UZXG@\7?%:ENF8XN@.UW:Z/;D<>>ST:29Z1-8(%T<VJUR?4614YKX
M<D/)]Q[C\7[E/=]O]#U/;^W_  OOW][V?TMIG#=L
M         P/?&1R;9FT%:L..>B.:]J_JRISU7U+]K\_H)A$L,,D $MA,!<S4
MW3$GEU6+I+85/93U)Z5]1 V;C<73Q-=*U-G2WF]Z\7O7TN7Q,62\
M                                   QK>6_=K[#H>_[CNM@ZT7W>JSV
M[,ZIX1QIQ7Y5T:GBJ&_#@OEG2L-&7/3%&MI:)H?%9,[<;UR6#:S:LBHR-L+U
M=>B1%7\8JN5&/U\6:-T^Z]/8MVK[G"?O>IRJ]S^]QC[OK=";;W1@-W8UF6V[
M>CO4G\%=&NCF.TUZ9&+HYCO4Y$.+DQ6QSI:-)=C'DKDC6LZI<U-@
M
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M:]3'MX*BH!LW;FXX<S#Y,VD>0C3\9'R1Z)]LW\]/ QF$IXA(
M             (^Q@\1;R=;,V:<4N4IM<RM:<W5[&OYZ?G:\N.G-3;7->M9I
M$\)\&JV*DVBTQQA(&IM                              %GDL;5RM5]2
MTW5CN+7)])CO!R+Z4 U7EL5:P]MU6RFOVT<B?1>SP5#)BDMN[8GS#TL6-8L<
MU>+_ +:147BUOYZC4T;)K5H*D#*]:-(X8TT:QO(Q9*H
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M%N$^INDY3I@
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M/-6F9/ ]8YHUZF/;P5%0#:&W=P0YNOTOTCO1(GG1>"I]TWU?F&*4V0D
M                                                     6F0QE+*
M1-ANQ)(QCD>WP5%3T*G'CX@7+(V1,;'&U&1M31K6IHB(G@B(!Z
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M4Z6AZ+%FIDC6LLA-#<
M                                      '+/Q*[TR$VZ\9M'#7):_Y/
MB26W[O(Z-76+FBM:[I5/HL1KD_#/1=LP1-)M,<W [CGF+16)Y-4^[;N_V[8_
M=,_V3N_PL>4.)_%3YR>[;N_V[8_=,_V1_"QY0?Q4^<GNV[O]NV/W3/\ 9'\+
M'E!_%3YR>[;N_P!NV/W3/]D?PL>4'\5/G*G-0W18B?!/F9989$Z7QOGF<UR+
MX*B\%)C;1'A")W,SXRNL9@:M#21_XZS_ ,XY.#5^]3\\L5QQ"O;),I4VM0
M   $9DL)4R**]4\JSX2M3G^$GB:[8XLV5R35908[<U2)M>KF)8*[->B*.>9C
M$U75=&MT1.*E:=M$\XA9C<S'+55]VW=_MVQ^Z9_LD?PL>4)_BI\Y/=MW?[=L
M?NF?[(_A8\H/XJ?.3W;=W^W;'[IG^R/X6/*#^*GSD]VW=_MVQ^Z9_LC^%CR@
M_BI\Y;'^'G>>3QG<"?;.:O36(,O$Z"+SY7R-;:KZR1JBO5=.IO6WUJJ'&[EM
MX^'K$<:NOV[//7I,\+.M3S+T8
M  B,]@:^;K]+M([<:+Y$^G+U+Z6J2AJZY3L4+,E6TQ631KHYJ_65/2BDH4"1
M7IV[%&S':JOZ)HUU:[\Y?4H&U<'F8,U32>/1LS=&SP^+7?87P,&23
M                0V3W9MG#*K,GEZE:5O.)\S/-_2(JN^L6,>VRY/=K,_,K
MY-SBI[UHACT_>'M["O2F565?'RZ]A4^JL:)]0N1VO<3^KZX^U4GN>WC];U2\
M,[R]O7NT=DWQI]TZM8T_L6*I,]JW'X?7"([GM_Q>J4M2[B;'R"HVOG:B.=P1
M)G^0JJOA^-1A7OL<]>=)]OL6*;W!;E:/9[620S0V(VS02-EB=Q;(Q4<U4]2I
MP*<Q,3I*W$Q/&'LA(
M                      P_NENE-G;$S.;8_HN-A6O1]/O-C\7&J?@JO6OJ
M0M;7%\3)%5;<Y?AXYEQ1CY=UY&O[S'F;3&*Y6IUV9M5T\>"J>SKMZVC72'D+
M;B:SIK*[]VW=_MVQ^Z9_LF7\+'E#'^*GSD]VW=_MVQ^Z9_LC^%CR@_BI\Y/=
MMW?[=L?NF?[(_A8\H/XJ?.3W;=W^W;'[IG^R/X6/*#^*GSE1CV[8LVEM9BTZ
MT]=.I5<Y[WZ</:>[B;:8(AJMGU3T44<$;8H6(R-O!K6IHB%F(T5YG5["
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M
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MY2Q^#V>*+^<0-L4KM?(58[=9W5#*FJ>E%\47UHIBR7
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M<;3)@G2\?/X/18-UCS1K6?F\4^5%H
M                               !S%\5&Z'3W,-LJJ_7RD7(W&-7G))K
M% B^M$ZU_1(>@[5BX3?YG"[GEXQ3YVM*59M2I#6;_>VHBKZ5\5^=3UE8TC1Y
M:TZSJKDL0                  1^:J>^8Z:-$UD8GF1_A,X_73@89(UALQS
MI+?/PN[J_*6U;VU[$FMG"S^;7:J__A;2J[1-?N9$?K^$AXWN>+IO%O-Z[MN7
M6DU\F^#CNL
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MX:<FR>KDOAZ#R._[;.+[].-?9_0]7L>XQE^Y?WO;_2VF<)VP
M                                                >9)&11NEE<C(
MV(KGO<NB(U$U557U <&9S.2;Z[AY7<LBJZM+.^6NCM?9@B_%UV\?%&HT]UL\
M/16*^3Q6[S==IMYI0Z;F                     *W:'/\ \2.ZU)LC_+QN
M3>N.L?<^7;5/*7]#(C-5]"*</N&'JQS'EQ=O89NG)$^?!VV>.>M
M
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M4C:ODW=/:KN7BNGBU?%"-$IHA(
M     -9=^MU?Q7[<9%(7]%_+Z8RKHO'_ #A%\U>''A$C^/IT+^PQ=>6/*.*C
MO<O1BGSG@Y0VQ4\B@L[DT?8=U?H&\$_/4]QBC2-7B\LZSHFS<T@
M           ,<W36<U*^0B56R1KT.<W@J?;-75.6BZE?-7Q6,-O!VYVZW0W>
M6RL-N'J1UBS7:VXB>%F'\7,FGA[;55/5H>"W&+X>2:O<[?)\3'%F4%=O
M
M      :S[D]Z]K=OV2TFO3*;D1-&8R!R?BW*G!9WIJC$^]^EZM.)?VVROEX\
MJ^:CN-Y3%PYSY.2,&EO)9*[GL@JR6;+WRNE<FG7+,Y7R.^K^:>SP4T]$/(9[
MZ^F61%M4                      ,<W-6E:ZODJW4DL*Z.>SFWI7J:[5.6
MB^)7S5UXK.&VG!U7VP[Z;<WO#6Q64E;B]TJUL;J\ZHD5F1$T5T+^":N7^]KH
M[T:\SQFYV-\7&.-7K]MO:Y.$\+-LG-=
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MC(/RH_KMJFKM4T<C5Y([TJB<S!DD0
M      ",S^XL)M?&RY?/W8J&/B^E+*O-VFJ-:U-7.<NG!K455-F/':\Z5C66
MN^2M(UM.D..^\/<U.ZN;H4\-6F@PN.\QM;S?IROF5J.F>QNJ-1$:B(FJZ)Z-
M=#U.QVDXHX\Y>:WNZC+/#E"RBB9#$R&--&1M1K4]2)H>@B-'!F=7L(
M               6V0JI<IS5EYO:O3^$G%/KF-HUC1E6=)U99V.[Q4>WT=C:
M^Z(IF8BS8\^*XQ%>M65S6M>CX].I6+THOL\47P74\WOME;+/57G#T>RWD8XZ
M;<I=:8[)4,O2AR.+LQ7*%AO7!9@>DD;V^IS=4/-6K-9TGA+T-;1:-8Y+HQ9
M
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M/X.<Q='L=IKTR,71S')Z'(>=R8K8YTM&DO08\E<D:UG5,&IL
M      !I_P")+<&;VWV\BR. R$^-O+D:\2V*LCHI/+='*JMU;HNBJB'.[A>U
M,6M9TG5[G^2MIAW._FF:D7KT6G28UC76KDG_ 'N=S_YW97]U2?9/._Q67\4O
MMW^'NV_W&/\ JP?[W.Y_\[LK^ZI/LC^*R_BD_P /=M_N,?\ 5AT7\*^[MT;J
M_C9_&3+VLK[I^3O=O>Y72^7YOO77T]2KIU=+=?D.UVW+>_5U3,\OK?+/Y][=
MMMI\#X..N/J^)KTQIKIT:>UT6=E\K
M   UAWIV=+G\)'FJ$?7D<2CG2,:FKI*KN+T33FK%3J3U=1V^T[J,>3HMRM[7
M&[IMIR4ZXYU]CFT]D\@          &8=K:TMK?V$9$FJLF=*[T(V*-SU7ZB'
M/[C:(V]M?)?[?69SU]+K$\$]R >7O9&U7O<C6)S<Y=$3YU)B-43.CZUS7M1S
M%1S5XHJ<45"$OH         !9Y3(1XRA/=DX^4WV&_=/7@U/G4#4$TTEB9\\
MSE=+(Y7O<OBYRZJ9L5,#)]FX;W^[[].W6I45%1%Y.EYHGS<U^8B2&R#%D
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MX)(GJT1WWNG$\ON=E?#QYQYO2[?>4R\.4^391070
M                                           #4/<KO[MK97G8O#=&
M:W(U%:L,3M:L#O\ II&\U3[AG'P56G3VVPOEXSPJYVXWU<?".,N9,WE]W=Q\
ME^6-SW7R1\?(:J=,,;%^UAB3@U.'/Q\553T^WVM:1I6-(>:S[JUYUM.LK^EC
MZM"/RZS.G7Z3UXN=\JG1K6(Y.?:TSS7)DQ
M M[=*M>C\JS&CV^"\G(OI1? QM6)YLJVF.2+QEK=.PLFW-[5O2PO9P>L?%',
MY]$L:ZM>WY4]? H9]M6\:6C6%[!N9K.L3I+I/MI\0V W7Y.)W/Y>%W [1C)7
M+I2L/7@G0]RZL<OW+^'H<J\#S&Y[?;'QKQCUO2[??UOPMPGU-U(J*FJ<CE.F
M                 &COBM_HPA_A6M^MS'*[G^Z^=]$_D'_N4_[.WMJXG/,/
MT$ =2?!Q_P"=/_"_^^'>[3^O\WUOCG_DC_I_]Y_PW4IWGQP
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M5XJ^-J<V>*M3Z/R<O5]O[E%HC'DGCX3Y^EY??]NFLS?''#QCR:;/1//@
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MVOK81C-N5ZFDUO2>QS1OVC5]2>/SG=IBB.;AWRS/).&YI
M            ^*B.16N1%:O!47BBH! 9#;B*_P!ZQ;O)G:J.2-%T3J3BBM7[
M52O?%KR6*9=.;:/;OXB\WMR2/!]P(Y<ECF:,9D$36]"G).O73S6^M5Z_'5W(
M\]NNVQ;C3A/EX._MNXS'"_&/-T_@\]AMR8Z+*X*[%?Q\OT)X7=2:^+7)S:Y/
M%KD14\3SU\=J3I:-)=ZEZWC6LZPD3!F
M                               #&.XN)R.<V/G<9B)Y:^3FJO=4?7>L
M<CI(_P 8D:.:J+I)T^6OJ4L;>\5R5F>6K1N*S;',1ST<+;9J4K,LKK#/,FBT
M=&UW%NB^.GCH>[Q1$SQ>(RS,1P9>6E4
M  ,5W14I0>5-$SHLRN7J1O!JM3FJIZ=50K9:Q"SBM,NT>SF)R.&[<8&ME9Y9
M[LL"67).]7K%'.O7'$FJKHC&*U.GP/#[R\6RVF.3VFTK-<41+.BFM@
M         #1WQ6_T80_PK6_6YCE=S_=?.^B?R#_W*?\ 9V]M7$YYA^@@#J3X
M./\ SI_X7_WP[W:?U_F^M\<_\D?]/_O/^&ZE.\^.
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M8_4X!N;X7?Z5ZW[1M_VJ%_M_[^OS^R7@?Y[_ .V3^W5W&>M?G<
M      <7?$/A[N-[G33Y*Q-/CLE'#:IND>K_ "X5]A\;-=4:C7M=HWT*AZKM
MUZVQ1'ES>9[C6T9-?/DB:M6O4B2*LQ&1^KFOK5?$]%$1')YZ9F>:L2@
M                         663J4K-61]QFK8FJ[K3@]J(FO!3"]8F.+.D
MS$\&POA5Q.1GW!F<RV>6+$5*[8)(&O5L4UB=VK.INNCNAK7+RX:H>7[I>(K%
M?%Z;ME9FTSX.K#SKO@
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M^=)XQ^IP#<WPN_TKUOVC;_M4+_;_ -_7Y_9+P/\ /?\ VR?VZNXSUK\[@
M            #2/Q-[53,;*@W%!'U7,#,CI'(FJK5LJD;T^9_EN^34ZW;,O3
MDZ?Q.7W'%U8^K\+GK V_>\;$JKK)%^*?^AY?6T/9XYUJ\?DC24D;&L
M                        0>Z+?DT6UFK[=AVB_@,XK]?0TY9TC1NQ1K.K
MK7L7M7^*O;G&1RLZ+^31<G;U31>JRB+&B_)&C$^4\-OLOQ,L^4<'M=EBZ,4>
M<\6R"BN@
M         <]_%/M7WS!XO=]=FLV-E6G<<G['L\6.=ZFR)TI^&=KM>72TT\W'
M[EBUK%_)I7$V_?<?#.JZOZ>F3\)O!?J\SV%)UAY*\:2O3-@
M                6]^RE.G-97G&U5;^$O!/KF-ITC5E6-9T;3^%7:RK^6MZ
MVF:JY4QE%Z^/T99W<?\ !HB_*AY+NF7E3YWJNV8N=_F=&WLA0Q=9US)VH:5-
MBHC[%F1L,:*Y=$17/5$353S]K16-9X/0XL-\MNFE9M/E$:SZD3_'G9/\Y,5^
M[J_]V:_C8_Q1]*]^5;S^YR?U+?8?QYV3_.3%?NZO_=CXV/\ %'TGY5O/[G)_
M4M]A_'G9/\Y,5^[J_P#=CXV/\4?2?E6\_N<G]2WV'\>=D_SDQ7[NK_W8^-C_
M !1])^5;S^YR?U+?8?QYV3_.3%?NZO\ W8^-C_%'TGY5O/[G)_4M]A_'G9/\
MY,5^[J_]V/C8_P 4?2?E6\_N<G]2WV'\>=D_SDQ7[NK_ -V/C8_Q1])^5;S^
MYR?U+?8?QYV3_.3%?NZO_=CXV/\ %'TGY5O/[G)_4M]A_'G9/\Y,5^[J_P#=
MCXV/\4?2?E6\_N<G]2WV'\>=D_SDQ7[NK_W8^-C_ !1])^5;S^YR?U+?8?QY
MV3_.3%?NZO\ W8^-C_%'TGY5O/[G)_4M]A_'G9/\Y,5^[J_]V/C8_P 4?2?E
M6\_N<G]2WV'\>=D_SDQ7[NK_ -V/C8_Q1])^5;S^YR?U+?8?QYV3_.3%?NZO
M_=CXV/\ %'TGY5O/[G)_4M]A_'G9/\Y,5^[J_P#=CXV/\4?2?E6\_N<G]2WV
M-,_$[N7;F6[;Q5<5F*-ZTF3KO6"K9BFDZ$CF17=+'*NB:\SF]QR5MBTB8GB]
M[_(VQW&'N$VR8[5CHMQFLQ'.OG#CL\V^[ '4GP<?^=/_  O_ +X=[M/Z_P W
MUOCG_DC_ *?_ 'G_  W4IWGQP                4Y9X8$ZII&QM]+W(U/K
M@6+L_A6R-A]]B=(]R,:UCNOVEX(GLZ@20     :][S9Q<1LJ>M$[IL921M-N
MBZ*D;M7R+\BM:K5_".OVK#UYXF>5>/V.5W3+T89CQMP<P'MGC     ;![+Y!
MU'?E.%%TCO0SUI/DZ%E3^RC0Y/=:=6WF?*8GZOK=7M=^G/$>>L.H#Q#V8  C
MLOGL-@8/>,S>AI1+KT^<]&N=ISZ6\W+^"ANQ8;Y)TI$RU9,U,<:VF(:XS/?K
M;E-71X:G/DWIRE=_FT*_(KD<_P"JQ#L8NS9;>_,5]?Z?2Y&7O&.ONQ-O4PC(
M]^-W655*->I1C^U5&.FD3Y5>[I_L#IT[-ACG,RYM^[YIY1$,>L]U=_VE57YJ
M5G'5$BCBB1/TC$+=>V[>/U?:JV[AN)_6]BQ_C_O;_;][_'O^R;?X+!^"/H:O
MXS/^.?I58>XV^8'=3,];5=47\9)YB</4_5")V."?U(91O<\?KRFJ'>G?M-4\
MZW#>:GVEF!FFGH58DC7ZY6OVG;VY1,>B?MU6*=TSUYS$^F/L9GAOB!A<K8\_
MB'1I]M/2?U__ '<FG]N<W+V2?U+?3]O]#H8N\Q^O7Z&T-O;OVYNF-7X2_'8>
MU-9(%U9,Q/OHW:.T]>FAQ,^UR89^_&GL=K#N<>:/N3JG"JLM9=];*P;(9$B\
M+-Z&)?D1DDG_ +AVNSUUS^B)^IQN[VTP>F8<UGLWD     =2=G]P+G=F5HIG
M=5O%N6C*J\U9&B+$OZ14;\J*>'[I@^'GG3E;C]KVG;<WQ,,:\Z\/L9Z<IU
M   8!O\ M==RK31>$4:R+\LBZ?F-,H1+#R4+W$U/?\G5J*FK99&H]/O$75WU
MD4@;BY<$,60              !AG=S^C#=W\%6OUM2MNOW5O0[_\O?\ <L'^
MTK[7YTGC'ZG -S?"[_2O6_:-O^U0O]O_ ']?G]DO _SW_P!LG]NKN,]:_.X
M               LLQBZN<Q-[#7F]5/(0259T3GT3-5BJFOBFO SI::VB8\&
M-ZQ:LQ/BX*Q]2WMW<62VUD$Z;5::6O(GAYM=RM54]2HBJA[W;9(M$3'*8>&W
M&.:S,3SAD)=4@                             !';;P3M]]Q\5MU$5U1
M\[66E3PK0:R3KKX+TM<B>O0Y>\S=%;6\G4V>'KM%?-WBUK6-1C$1K&HB-:B:
M(B)R1$/#/:/H
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M'                    =2?!Q_YT_\ "_\ OAWNT_K_ #?6^.?^2/\ I_\
M>?\ #=2G>?'               #%]\R6(<9!+7E?%^.1C_+<K=4<UR\=/D)A
M$M<N<YZJYZJYR\U5=5,D/L;UCD;(WZ3%1R?*BZ@;L:J.:CDXHJ:HOJ4P9/H
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M_,Z9. [@
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M0Y?_ *^E^^8SG=Q_<S\SW'\D?]UQ^B__ -9<)GE'Z.
M  ZD^#C_ ,Z?^%_]\.]VG]?YOK?'/_)'_3_[S_ANI3O/C@
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M+IHDD+N+'I\J<_0NJ'OMMGC-CB\/"[G!.')-9_2'36(_HSH?P%#^\T/%9?\
MFI_;G_[/98O^6K^Q'L<X]NL<S*[WPE.1O7'[RDSV+Q16UVK,J+ZM&'L=]DZ,
M%I^3V\'D=C3KSUCY?9Q;X[TY":CL6S'"Y6+=FAJO5O!>ARJ]R?(J,T4\MVFD
M6W$:^$3+T_=+S7!.GCP:L[&Y&:IO3W%KE\B_6E9(SP5T2>8U?E3I7ZIW.\8X
MM@U_#+B=IO,9M/.&7?$'C6.Q^&RZ-T?%-)4>_P 525OF-1?D\MVA0[)D^]:O
MR:K_ 'FGW:V^73]/H9+V6QS*.Q*EA$1)<A--9D7QX/6)OUHT*7=LG5N)C\,1
M'UK?:Z=.")\]9:([BY";([XSDTKU<L-N6LS7[5E9WE(B>A/9/4[&D5P4B/+7
MZ>+S.^O-L]I^73Z'2VTK/\8=DXR6_P#CENT616U=]NJL\N15U^ZT4\7N:_"S
MVBOA/![';V^)AK,^,<7,NV\PW9&[6Y*Q3]_DQDD\25UD\G5_2Z+7JZ'\M=?H
MGM<^+^(P],3IU:?:\;@R_P /FZIC7IU^QDW<'NM_'7#P8JM2DQ[&SI-9194D
M;(C6JC4U1K>"*NNFGH*6R[;_  ]YM,]7!=WO<?CTBL1IQ>.R#+SM\Q.JJY*S
M*\ZW=->E8E;HWJ_1JPGN\U^!.O/6-/T]#'M,6^/PY:3JSCX@Y84PV&A=I[P^
MS(^/T]#(]'_7<TYG9(GKM/AHZ7>9CHK'CJLOA[QZ=&<RKDXJL%6)WR=3WI]=
MAL[W?W*^F6OLU.%K>B%?N)L+>V[=V6+N,1D.,@AA@K2S3^6U^C>MW2UO4J:.
M>Y.*(8['>X,&&(MSF9\&>]VF?-EF:\(B/-J[<NTMX[2Z'YJ&6.M(O3':CD\V
M%7>CJ:JZ+ZG:*=S;[G#G]R>/DXN?;YL/O:Z>;6^[))&U(8VI^*>_VW>MJ<$^
M?\XW9IX-&&.+L?LUC\=CNV6VXL8])89JC;,TJ<UL3JLDR+^"]7,^8\+O+3.:
MVOF]MM*Q&*NGDSHIK8
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M>I .I/@X_P#.G_A?_?#O=I_7^;ZWQS_R1_T_^\_X;J4[SXX
M  8QON5&89C/&2=B:>I&N7\XF$2UN9( -UP,\J"*/[AC6\?4FA@R5    !SA
MWZ@='O&K*O%LV/B5%];996JGUCV/9IUPS'_N^J'D>\1IFB?D^UJT[CB@
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M]D1RK^&AY3NF+2\7\WJ.VY=:S7R;^.,ZX
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M[G^Z^=]$_D'_ +E/^SM[:N)SS#]! '4GP<?^=/\ PO\ [X=[M/Z_S?6^.?\
MDC_I_P#>?\-U*=Y\<               ,#[@6T=8J4FK^IM=*]/6]>E/[528
M1+##)"[Q=?WO)5*VFJ22L:[\'J37ZQ W(8L@    :4^(/%.?6PV:8GLQ/EJ3
M._ZQ$DC_ +1YZ7LF3C:GSO.]YQ\*W^9HD]0\R    #I'L;MYV+VO+EYV=-G+
MR=;-4T7W>'5K/JJKW?(J'CN[Y^O+TQRK[7KNTX>C%U3SM[$IWAP\V8V/<]W;
MUS4'LO(Q$U56Q:M>J?(QSG?,:.UY8IGC7QX-_<\4WP3IX<7+1[AXH
M    &3[&V;>WIF64*Z+'1BTDOV]/9BBU\/2YW)J?G(I2WFZKMZ=4\_"%S:;6
MV>^D<O&754^'IOP<N AC2*@^JZBR-/HMB=&L:)\R'A8RVC)USSUU>WG%'1T1
MRTT<96():L\M:=O1-"]T<C5YHYBZ*GU4/HU9B8UA\]F)B=)4R4     [.VX]
MTFWL3(_B]]*LYR^M8FJI\YSQIDMZ9]KZ%@G7'7T1[$F:&X
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MQ41JJO+1DG0Y?P3G=PP]>.T>7&'0V&;IO$^?!V\>->N
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M8ZQ\D)(TMP                       PSNY_1AN[^"K7ZVI6W7[JWH=_\
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M%F6E98
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M9IS1OVZ_4X?.3"):P,D &S=F8_W+$-G>FDUQ?-7T]')B?4X_.8RF&1$)
M  TOW;[83WY9=T[<A\RTY.K)48T]J14_OL:)S=]TWQY\]=?2=L[A%8^'DGAX
M3]3SW<MA-I^)2./C'UM#JBM56N31R<%1>:*>I>8? )C;FV,UNJ^W'X:LLTJZ
M>;*OLQ1-7[:1_)$^NO@BJ5\^XIAKU7EOP8+YK=-8=0[&V5C]DXE*594FO3:/
MO7%31TLB)P1/0UNJ]*?GJ>(WF[MN+ZSR\(>TVFUK@II'/QEE!170 !K_ '1V
M@VIN-[[5>-V*R+]56>JB)&YR^+XE]E?T/2OK.MM^Z9L7"?O1\OVN7N.VXLO&
M/NS\GV-5YGL;O#'JY^-6#*P)Q;Y3TAET];)=$^9'J=W%W?#;WM:_I\CAY>TY
MJ^[I9AM[9^ZL:JI>PMR%$^W6"16?,]J*U?JG1INL5^5H^ES[[;+3G6?H0SXY
M(G=$K%8[[ER*B_7+,3JT3&CR$+NMB\E=5$ITY["KR\J)\FOZ5%,+9*UYS$,Z
MX[6Y1,LBQ_;+?>25$APEB)J\W6D2LB>O296K]8IW[AMZ<[1\W'V+=-AGORK/
MS\/:S;#=@,K,YLF>R<-6+FL-5KII%]2N<C&M7],<S+WJD>Y69]/!TL79[3[]
MHCT-H;;[:;0VPK)J=)+%YG%+EM4FE14\6ZHC6KZVM0XF?N&;-PF=(\H=G!L,
M.+C$:SYRRXYZ^  -8][=L.S.VFYBLSJN89RROT3BM5^B2?I=&O\ D13M]HW'
MP\O3/*WM\'&[K@Z\?5'.OL<V'LGD    N*-22_=K48OU6S*R%GX4CD:GYIC>
MW369GP94KU6B/-VNQC8V-C8FC&(C6IZ$3@A\UF=7T6(T>B$@
M          ##.[G]&&[OX*M?K:E;=?NK>AW_ .7O^Y8/]I7VOSI/&/U. ;F^
M%W^E>M^T;?\ :H7^W_OZ_/[)>!_GO_MD_MU=QGK7YW                ''
M_P 2>Y_R]ORMMN&9$HX2-L,BJ[V$M6='R.]'!O0U?D4]/VS%TX^J?UGG.Y9=
M;]/X6.1,9'&R./A&QJ-8GJ1-$/30\W+T$
M   "VR$,=BC/#*Y&L<Q?:<NB(J<45?D4QM&L,JSI+9_PJ[JZ)<SLRP_@]$R=
M%JK]LW2*9$^5/+7YE/)]TQ<K_,]5VS+SI\[ILX#N
M                                         L\KB<;G,?/BLO5CNXZR
MWHGK3-1S')KJG!?%%35%YHO$RI>:SK$Z2QM6+1I/&',G<7X;\GAWR9SMW));
MJ,UD=B7NUMQ^*^2_AYB?>K[?X2GH-MW*)X7X3YN%N>W3'&G&/)J2CN%\4KJ6
M8C=!8C56/>YJM5'-714>U>**AZ*F;7F\_?#IR9 US7M1[%1S')JCD75%3Y2R
MK/H                           /BJC45SET1.*JO)$ @,CN1K7>[8QOG
M3N7I2335NJ\-&I]LI7OETY+%,6O-L_MW\.V=W-)'G-^R2XW&/T>RARO3)X(_
M5-(FKZ_:]3>9Y_==RBO"G&?/P=[;=NFW&_"/+Q=0X/ X?;6,AP^"IQT<=732
M.")-$U7FYRKJKG+XN<NJGG;Y+7G6TZR[]*5I&E8TA(F#,
M :.^*W^C"'^%:WZW,<KN?[KYWT3^0?\ N4_[.WMJXG/,/T$ =2?!Q_YT_P#"
M_P#OAWNT_K_-];XY_P"2/^G_ -Y_PW4IWGQP             JHB*JKHB<U
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M\$6+A'\_F*U?F.7W3-\/!/G;A^GS.GVW%UYX\J\?T^=U*>&>U
M             ##.[G]&&[OX*M?K:E;=?NK>AW_Y>_[E@_VE?:_.D\8_4X!N
M;X7?Z5ZW[1M_VJ%_M_[^OS^R7@?Y[_[9/[=7<9ZU^=P               !J
MKN5V+VSOU9LI4_\ A&YGIU>_0MUBF>G+SX^&NOW;='?+R.CMM]?%PGC50W&S
MKEX\I<O;@V]O+MED4QFXZ:^ZN54KS-57UIFIXPRZ?V*IJGBB'J-ONZY(UK/S
M/-;C:VI.EH75')5,@SKKOU<GTXUX/;\J'2K:+<G-M6:KLR8@
M               (_(YBICFJDCNN?3V86_2^?T(86O%6RM)LK[1V%O;NK<Z<
M;#[MA8W:3WYNIE2/3FB+IK(_[UOS]*')W6]KC]Z>/DZFVV=LGNQ\[JSMUVBV
MKVYA26A&MW./9T6,M81/-5%YMC:G"-J^A./I53R^XW=\W/A'D]+M]K3%RXSY
ML^*:V
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M1R<%1[=-6J>BIFUYO/WPZ<F0-<U[4<Q4<U4U1R+JBH6%=]
M          /$LL<$;I9GHR-O%SG+HB"9T3$:H"7+Y#+VX\3MVM+9MV'>7$D3
M%DFD<O@QB(JE3)GB(UY0M8\$S/G+>';?X:DUBS7<9_FRNTD9A(GJJ(O/_.)6
MKQ7[UB_HEY'F]SW+PQ_3]CT6W[=XY/H=&U*E2A6BI48(ZU.!J1PUX6I'&QB<
MD:UJ(B(GJ.%,S,ZR[41$1I"L0D
M                               4+M*GD:LM'(01VJ4[59-7F:DD;VKX
M.:Y%14)BTQ.L<T3$3&DN<>Y/PUJUTV<[<O5CVZR/P<CUYIQ7W>5R\/4QZ_([
MDAW=MW+PR?3]KB;CMWCC^AI?;V5GN^;5MKK/"B*URIHY6\EU]:*>IQ7UX2\S
MEIIQA.&YI                      (;<&4EQ\,<==42>95]I>/2U/%$].J
MFK)?3DW8Z:\VU^V?PXV,LVON/N#*YE6=&SQ8B)Z^=*UR(YJSRHOL(J?:-]KU
MM7@>8W7<M)FM.?F])MNWZQ$WY>3IC&XS'8:E#C<55BIT*[>F&O Q(XVIZD3T
M^)P+6FTZS.LNY6L5C2.$+LQ9
M  !!9W;%/,ZSHJP7M-$F3BCM$X(Y"=4-=Y/$7\1-Y5R)6HOT)4XL=IZ%_.YD
MH7&WL0[,9%D*HONT?XRP[[Q%Y:^E>0&V&M:QJ,:B-:U-&HG!$1#%D^@
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MB=+?O6HB?/Q/+Y]S?-/WIX>3TN#;TQ1]WGYLQ*JR
M                                                  XB[LX#^(_=
M6\D;?+QN2?\ E"OPT;Y5Q55Z)ZF2=:)\A['M^;JQQ/EP>2W^'IO,>?%3.XX@
M                     !:[(P'\?>YV+PSF^9CHYDDN>+?=:OXR1%]'6J="
M+Z7(<C?9NBEK?-#K;+#UWK7Z7=9XE[(
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M/;]TQ?I)]0@;>@GBLPQV(7=44K4>QR>**FIBR5
M                 !I?XE]J_EO8K,Y!'U7<!,DZJB:N]UGTCE1/D7H>OJ:I
MU>VY>G)T^%G,[ABZL?5^%SEM^W[UC8T5=9(?Q3OT/+ZVA[3'.L/'9(TE*&QK
M                     0.Z;?E4V56K[<[O:_ 9Q7Z^AIRSPT;\4<=77O9/
M:O\ %+MUB:LL?1?OM_*5U%31WFVD1S4<GI;&C&+\AX7>Y?B99GPC@]KL\71B
MB/&>+8127
M                    #0GQ1[4_*&V*&ZZ[-;&'F\BTY$__  MI4:BJOWLB
M-1/PE.SVS+I>:>;D]RQ:TBWDT5AK?OF.AE5=9&IY<GIZF\./RIQ/8TG6'D+Q
MI*_,V                    %KDK24J,UC7VFMT9^$O!/KF-YTC5E2-9T;=
M^%;:OE4\QO2RS\;9<F.HO<G'RX]))G)KS1SNA/E:IY#NF768I\[UG;,7";_,
MZ..&[0
M #D'?]>2KO;/QRZ]3KT\J:_<S/61OUG(?0=E:)P4T\H>"WE=,U_3+'"XJ
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MJ?;-^=/KDPB6K3) !FVQ\UTJN&L.X+J^JJ^GFYGYZ?.8RF&<D)
M                            "TRF.JYC&W,3>9UT[T,E:PSTQS-5CD^H
MIE6TUF)CP8VK%HF)\7!56C:VSN?)[9O\+%6:6L_AHBR5W*B.3U.3BGS'O=MD
MBT1,<IAX?<XYK,Q/A*?+RB                     LMIX%=^=R\5@5;UT?
M/3WOT>[5M99M?1U(U6HOI5#E;W-T4M;R=79X>NT5=VHB-1$1-$3@B)RT/#O9
MOH
M             "*W+@ZNYMOY+;]S_L^1KR5W.TUZ5>U4:]/6U=')ZT-F.\TM
M%H\&O)2+UFL^+A#!LLXG*W\#?;Y5JO))%+$OVL\#E8]OUOK'OL%XGEREX;/2
M8Y\X9&6U0                   #&]SS2325<9717RRN1W0WBKG.7I8B?*N
MI6S6T6<-?%W'L3;4>S]H8C;K$1'TJ[6V%3DZP_VYG</2]SE/!9\GQ,DV\WN<
M&/X=(KY,B-#<
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M4<QR<T5%U10-LX'+QYG'LLIHD[?8L,^Y>GYR\T,&23
M                     ')/Q,;;?@]ZT-W5&=,&7B;YSDY>]T^EBZ^CJC\O
MY=%/3=KS:TZ?&KSG<L6E^KPLQ&&5D\3)HUU9(U'-7U*FIZ>)U>;F-'L(
M              !;9"TE*E-97FQJ]/X2\&_7,;3I&K*L:SHVM\*VUE1F9WK9
M9J^14QM)[O0G3+.Y/E7RTU]2GDNZ9>5/G>K[9BYW^9TH<%VP
M
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M #=4; B^&OF*Q=/0BG&[CFZ<<^=N#K]OP]62/DXNU3R+U8
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M1/4>%W&7XF2;/;8,?P\<59.5V\
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M>C(8TU<Y?S$]*J!98?.4LU"KZR],S/U2!VG6WU^M/6!)@
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ML]T*F&MN]ERJM1Z^"KQ5GS\T,93#.B$@
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M89$:Y5:]BHYJ\5\%0B=WEF-)M*8VN*)UZ89H55D
M
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MO^9J*>7W/<+9.%?NQZWI-OL:X^-N,^IN8Y;I@
M                   'B66*")\TST9$Q%<][ET1$0#6&Y-P29JQT1:LH1+^
M*C7[9>76[UKX>@RABB:ENQ1G99JR+',Q=6N3\Q?2GJ)&RMO;FKYEB0RZ0Y!J
M>U%X/TYN9]@QT2GB$@                    (_(8+"9;7\J8VK<54TZK$,
M<KM/4KD54-U,UZ>[:8]$M5\-+^]6)^9 S=K]@SN5[\' BK_S:R1IQ]3'(A:C
MN&XC]>56=A@G]6%*+M1V^ATZ,)&NBZ^W+/)Q_1R+]0F>Y;B?UO9]B([=MX_5
M]J:Q^TMKXI4=C\/3KR)RD; SS.'WZHKOKE>^YRW]ZTS\ZQ3;8J>[6(^9,E98
M    !%9?;.W\^WIS&-KW%TT221B+(B?>O31R?,IOQ;C)B]RTPT9<&/)[U8EA
MEWL=L6TJK RW21>25Y^I$_QS9#I4[OGCGI/S?9HY]NTX)Y:Q\_VZHUWP_P"V
M%<O1DKZ-\$58573Y?+0W?G67\-?7]K3^38OQ3ZOL7M;L3LF!W5*^]:377IFF
M8B?)^*C8IJMWC//+2/F_I;*]HP1YS\[)\5V]V7AE1]'"UTE;Q;+,U;#T7THZ
M97JB_(4LF^SY.=I]GL7<>RPTY5CV^UDJ(C41K4T:G!$3DB%)<?0
M       #66[,$N*M^\UVZ4+"JK-.3'\U;^>G_(90QECI(^M<YCD<U5:YJZHJ
M<%14\4 VCMC.MS%/HF<GO\"(DS>74G@]$]?CZS&4ITA(
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M0PIHFOBYRKJKG+XN<JJIYZ^2UYUM.LN_2E:1I6-(21K9@
M
M               (_-X+#[CQTN)SM**_CIOIP3-ZFZIR<B\VN3P<WBAG2]J3
MK6=)87I6\:6C6',/<7X<\UMZ23.=OY)<ACV*KW8U5UNPIS7RU3]5;ZOI>IW,
M]#MNY1;A?A/GX.#N>W3'&G&/):=O?A[W)NV6/-[X?+B<2]4<VJY-+T[?0C7)
MI$W\)-?O?$SW7<JUX5^]/J8[;M]K<;?=CUNH]N[9P6U,:S$[>HQ4:+./1$GM
M.=]T]RZN>Y?NG*JGG,F2V2=;3K+OX\=:1I6-(2QK;
M                        #XYS6-5[U1K&HJN<O!$1.:J!K;=&Y7961:=-
MRMQS%XKR65R>*^I/!/G,HABQHD ,UV?MMSGQYBZU6L:O55B7@JKX/7U>@QF4
MPSHA(
M"VOT8,C4EIV6ZQ2)IKXHO@J>M -2Y/'6,5<DIV$]IG%KTY.8O)R?*9,5F2+K
M'W[&,MQW*RZ21KQ1>3FKS:OJ4@;9QF1KY6G'<K+[+TT<WQ8Y.;5^0Q9+P
M                                           :=[E?#]MS>2S93 ]&
M$W$_5[GL;_FEAZ\?QL;?HJJ\WLX^*HXZ>VW]\?"WWH<W<;&N3C7A+0-/LSW4
MR&;7:<V/EK0P*BRWIW:4&Q*JHCTF35'HNG!K=7>I.)W;;_%%->K7Y/%Q:[')
M-]-/G\'2O;CLIM7M^V.ZK$RNXT3VLI88GXM53BD$>JI&GKXN]>G \]N=[?+P
MY1Y.]M]G3%QYSYMEE!>
M
M                                        /BJC45SET1.*JO)$ UYN
MK<ZY!SL?CWJE%JZ2R)P\U4]'WJ?7,HA$L4)0 93M7;2Y&1+]YJI08OL,7^^N
M3_W4\?3R(F4PV*B(U$:U-$3@B)R1#%+Z                    #E_XP>\W
M<#M%_$S^(M^*C^6/RG[_ .;7AL]?NGN?E:><UW3IYS^7,)B'+_\ 7-[_ /\
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MG\NLWIB;^JSN^@Q/SU]1 V;B,/4PU;W>MJKG>U+*[Z3W>GU?(8LD@
M
M
M
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M5>L*+_VIC$XR:<E1?!?23JC1.5:M>E RM5C2*%B:-8W_ -N9"58
M
M
M
M  541-5X(@&O]T[I6TK\;C7Z54]F>=O]\^];][^;\G.8A$RQ R0 3NV]NRYJ
M;S)=8\?$OXUZ<W+]RWU^GT$2-G0015H600,2.&-$:QC>2(ABR5
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M0
M
M
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M@G-RIU.\$0QF6Y:]NI;:YU2>.=K5T<L3VO1%]?2JA"L
M
M
M
M             !89G'ORF.FI1S+"^1.#TY+IX.]2^(&IKE.Q0L/JVF+'-&NB
MHOUE1?%%,F*@2)S;NW9\U/UOUCH1K^-E\57[EOK_ #"!LZO7@J0,K5F)'#&G
M2QC>2(8LE4                         <L?&5V@[B]UOXE?Q!PWY7_)'Y
M4_*'^=5*OE>]>Y^5_P!JFBZNKRG_ $==-./@$PG_ (0>V6^.UVR,[B-]XO\
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MMY"]#/4C]XK6NN-D/2Y=:TLJ)HOW2H&,ND@@
M
M
M
M       A]P8"#-UM.$=R-%\B;_W7>I?K$H87B-I7[MU\5UCJU:N[IG<O-R\]
M&>"Z^GD3JC1L>O7@J0,K5F)'#&G2QC>2(8LE4
M                                                !#9[<-7"0Z+I
M+=>GXJ!%_LG>A/S24+G#Y>MF:C;,"Z/3A-$J^TQWH7U>A2$I
M
M
M
M
M       &.[CW/#B&K6K:2Y%R<&\VQHOB[U^A"8A&K6T\\UJ9\]AZR32+J][E
MU55,D+O$Y6SA[;;59=?M9(U^B]GBBD#:N-R-7*U&6ZKM8W<'-7Z37)S:J>E#
M%DNP
M
M
M                                          $'N_\ D[<_P7ZZPF$2
MU89( -PX7_4^/_:T/ZVTP9+X                                 ,8W
M5MI,E&M^DW3(1I[;4_OK43E^$GA]0F)0UPJ*U5:Y-%3@J+S13)#X!*8/-6,+
M;2:/5\#^$\.O!S?LIX*0-ITKM?(5H[=5_7#(FJ+XHOBBIX*ABR7
M
M
M
M                             $'N_P#D[<_P7ZZPF$2U89( -PX7_4^/
M_:T/ZVTP9+X                                  &'[LVQ[RC\ICF:V
M4XV(6_;HGVS4^Z]*>/R\YB43# #) !,;?ST^$L]7%].1?Q\*>/WR:^*$#:-6
MU7NUV6JKTD@D35KD_P#;@J&+)6
M
M
M                  $9F<W4PM?S9UZYG?J,"+[3U_.3TJ!KU-SY3\J)E'2:
MO3V?)Y1^6O-FGH,M&+9.,R5;*U&6ZKM6NX/8OTF.\6J8LEX
M                           $'N_^3MS_  7ZZPF$2U89( -PX7_4^/\
MVM#^MM,&2^                                    PC=FU_IY3&Q^EU
MF!OUWM3\U"8E$L',D $YMW<,V%GZ'ZR4)%_&Q>*+]TWU_FD#9U>Q#;@99KO2
M2&1.ICTY*ABR50
M
M            4I;,$/ZK(UJ^A5X_4YF,WB.<LXI,\H6DF8JMX,1S_6B:)]<T
MSGJVQ@M*W?FG_:1(GX2Z_F:&N=Q/DVQMX\945R]M>2,;\B?953#X]F7P*O/Y
M4N_=HGZ%/L$?&LR^#1\3*74_OB+^A;]@?&L?!IY/:9>VG-6K\J?8)^/9'P*J
MK<U*GTXFK\BJGV3*-Q/DPG;QX2KQYF!W"1CF>M-'(;(SQXM<[>?!=Q7*LWT)
M6Z^A>"_44W1DK/BU3CM'.%<S:P
M    @]P;DK86-8F:37W)[$.O!NOVS].2>KQ)T0UG<N6;]A]JW(LDS^;E_,1/
M!#)"@!*X',6L/=;) BR12JC9JZ?;IX:??)X$#;+'=;6NT5O4B+H[@J:^E#%D
M^@                                      "#W?_)VY_@OUUA,(EJPR
M0 ;APO\ J?'_ +6A_6VF#)?
M,!W7M=*_7D\:S\0JZV(&I]#TN:GW/I3P^3E,2B88<9( )[;FXYL--Y,VLF/D
M7\9'S5BK]LW\]/$B8&S8)X;,+)X'I)#(G4Q[>**BF+)4
M
M                                      ?'.:QJN>J-:G-5X(1,Z)B-
M4=/EX6:M@;YCONEX-^R5[9XCDL5P3/-'39"U-P<_I;]RSV4^R5[9;2LUQ5A:
MFIM          "O#;LP?J<BHGW*\4^HIG6]HY2PMCK;G"1@S*+HVPS3[]G+Z
MA9KG\U:VW\DE%-%,WKB<CF^HL1:)Y*TUF.;V9,0
M            ,6W)NR/'==+'JDE[D^3@K(OLN]7AX^@F(1JUY++)-(Z69ZOE
M>NKGN7555?2JF2'@"I!!-9E9! Q9)I%Z6,;Q55 V/MS:T.*:VW;1)<BJ</%L
M>O@WU^LQF4LD(2                                       "#W?_)V
MY_@OUUA,(EJPR0 ;APO^I\?^UH?UMI@R7P
M           J(J:+Q10-?;KVQ[FKLECF?YHO&>%O][7THGW/YGR&42B88B2@
M GMN;CFPTWDS:R8^1?QD?-6*OVS?ST\2)@;-@GALPLG@>DD,B=3'MXHJ*8LE
M0
M                                                    $?:RL4.K
M(=))/3]JGV2O?-$<EFF"9YH>:Q-8=U2O5WH3P3Y$*=K3;FN5I%>2D8L@
M          #W'))$[KC<K7)XH3$S')$Q$\TK5RZ+HRTFB_\ .)R^="W3/YJE
M\'X4HUS7M1S516KR5.*%F)U59C1])0                             %
M5$155=$3FH&#;DWAU==#$/X<6RVT\?2C/[KZGI)B$:L*555=5XJIDA\ N:-"
MUDK#:M2-9)7?41/%57P1"!LW [>JX2+J326Z]-)9U3^Q;Z$_-(2F2$@
M                                   0>[_Y.W/\%^NL)A$M6&2 #<.%
M_P!3X_\ :T/ZVTP9+X                                      ^*B.
M16N35%X*B\E0#7NZ=K+15^1QS-:2\98DYQ+Z4^]_,,HE$PQ,E"YHT;.1LLJ5
M&=<S_J(GBJKX(A VKA,3'AJ+:C'K([7KD>JKHKUYZ)X(8LDB
M
M                                     /$LL<+%DE<C6IXJ1,Q$:RRK
M69G2$'<R4EG5D>K(?1XK\I1R99MRY+V/%%>?-8FAO
M N:MV:J[V5UC7Z3%Y?\ (;*9)JUWQQ9/5K45IG7&O%/I-7FA?I>+1P<^])K/
M%6,V                           %.>>&M$^>P](X8TU>]RZ(B :ZW'NN
M;**ZI25T6/Y.7D^7Y?0WU?5,HACJQDD )'$8:YF;'DUFZ,;IYLSOH,1?3Z_0
MA V=B</3P]=(*K?:7C+*[Z;U]*_8,620
M               @]W_R=N?X+]=83"):L,D &X<+_J?'_M:'];:8,E\
M                                  /BHCD5KDU1>"HO)4 P//;,G2TV
M;#L1T$[M'PZZ)$J^/X/YA.J-&48/!UL)6\N/V[+]%GG5.+E]">A$\$(2E0
M
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ML-!J^W-XNTYM9KS7U^!&HV72I5L?795J1I'"SDB<U7Q55\54Q9+@
M                                   !![O_ ).W/\%^NL)A$M6&2 #<
M.%_U/C_VM#^MM,&2^
M
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MA>V2-='MXHI,3,3K")B)C2614[;+<74G!Z<'M]"_8.C2\6AS<E)K*X-C6
M                    ('=&!3,U4DAX7JZ*L7H<B\VK\O@3"):P>QT;G,>B
MM>U5:YJIHJ*G!45#)#R!E>W-HR7NB[DFK'2X.CBY/D3U^AOYI&J=&PHXHX8V
MQ1-1D3$Z6,:FB(B>"(8I>@
M      "#W?\ R=N?X+]=83"):L,D &X<+_J?'_M:'];:8,E\
M
M
M                  %5$35>")S4#'LA<6U+HU?Q+.#$]/K.?EOU3\CHXL?3
M'RK,TMP  <N*\@E"W\VUFL5/1SN2RKQ1/D])7OE\EBF+S03WOD<KY'*YZ\W*
MNJE:9U68C1Y              151=4X*G)0)BAFWQ:16]7Q\DD^V3Y?2;Z9=
M.;1?%KR3['LD8CXW(YCN*.3BA9B=568T>B4  "M6L/K2I*SPX.3TIZ#.EIK.
MK&](M&C)(I631ME8NK7)JATHF)C6'+M$Q.DO9*
M !A^[]MK:1<I0C5UE/\ M$34U5Z)]LB>E/'TDQ*)>=N;/;!T7LLU'3<'15EX
MM;ZW^E?4)DT9D0D
M %ID\?%E*,M"9SF1R]/4YFG4G2Y'<-=?0!CO\0,;^R9_[#^Y)U1H?Q QO[)G
M_L/[D:FC)ZM=M2K!58JN9!&R)KEYJC&HU%7ZA"58
M
M
M          C,M;Z&>[,7VG\7^IOH^<K9[Z1HM8*:SK*%*2Z  /CG(U%<Y=&I
MQ55Y(@2QO)Y5UE5@KJK:Z<%7DK_^0J9,FO".2WCQZ<9YHLTMP
M      7E#(RT7\/:@5?;C_/3UF=+S5KO2+,IAFCL1MEB=U,=R4NQ,3"G,3$J
MA+$  26*M^5)[N]?Q<B^SZG?\I9PWTG16STUC5-EU1
M
M                                                6.5RE;$5'6K*
M\N$<:?2>[P1 ->Q;MRD>4=D7.1[)-&OK<?+\M%X-3T*G@IEHQ;$QN3J96LVU
M4?U-7@]B_28[T.3TF+)>
M                                                          \R
M2-BC=(_@UJ:J1,Z1JF(UG1B\TKII72O^DY=?^0YEIUG5U:UTC1X,4@ #',QD
MEG<M:!?Q+5]MR?;*GYR%3)?7A"WCIIQE$FEO                    O<=?
M?2EX\8'_ *HW\]/69TOTRUWIU0RMCVR-1[%ZF.35JIR5%+JE,/I*  BJBZIP
M5.2@9+2L>\UVR?;I[+_PD.ECMU1JYF2G3;1<&QK
M
M                                          !3L3>[P23]#I/+:K_+
M8FKG:)KHB>D#4F8R]G,VULV/9:GLQ1)]%C?1\OI4R8H\D7V*RMO$64LU'::Z
M))&OT7M]"H0-HXC,5,S6]XK+HYNB2Q.^DQWH7U>A3%DD
M
M                     B\Q/TQLKHO%_M.^1.7URKGMPT6MO7CJABFN@ "+
MS-Y:T/D1KI-*G%?%&^*_.:<M](T;\5-9U8T5%L
MF\'>Z7>Y2+[*\8E7P7Q0L8K^"OEIXIXLJH  D<1/T3K"J^S(G#\)"Q@MI.BO
MGKK&J<+R@              BLUGZ6%BUF7S++DUCKM7VE]:KX)ZR1=X[(5\G
M4CN5G:QO3BB\VN3FU?6A N@
M
M          #$=S[32WUY#&,1MKBZ:!."2>MOWWYOR\YB43#7ZHK55KDT5."H
MO-%,D/@%UC\A:QEEENH_HE;S3FUR>*.3Q12!L_!YZKFZ_5'[%IB)YT"\VKZ4
M]*$,DL0
M                                         !C>0E\ZW([[5J]+?D;P
M.;EMK:73Q5TK"V-;8 ?'.:QJO<NC6HJJOJ0)8=;L.M6'SN^V7V4]#4Y(4+6U
MG5?K72-% Q9                      'UCG,<U[%T<U45%]"H!F52PVU7C
MG3[9/:3T.3@J%^LZQJH6KI.BL9, #U&]8Y&R-^DU45/F)B=)U1,:QHRIKD>U
MKV_1<B*GR*=2)U<J8T?24            Q7<.[X:'74QJMFN?1?+S9&OYZ_6
M_,)T1JU]-/-9E=/.]9)GKJ][EU55,D)?;6>?A;>DBJZC,J).ST>AZ>M/KH1(
MVE&]DK&R1N1T;T1S7)Q147BBH8LGH
M
M                 QC<VUF9-'7J*(S((FKF<FRZ>GT.]9,2AKJ2.2&1T4K5
M9(Q5:]CDT5%3FBH9(> *U6W8I3LLU9%CFC75KD_,7TH!LW;VY*^:B\M^D608
MFLD7@Y/NF:^'J\#'1*<(2
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MS^36_FKZ$]8&U-OXRQB<<RI9G\YZ*KM$^BS7[5J\U34P9)0
M
M                                    8_N/;,&88MB#2+(M3@_DDFG)
MKOSE)U1HUK8KSU9GU[#%CFC71['<%13)"D![BEE@E9-"]62L5',>U=%14 V/
MMO=,64:VG=5(\@B:(O)LOK3T+Z4^H8S"62D)
M
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MJK/;=IYLSN+WKZU]'J,620
M
M             !#9[;U7-PZKI%=8GXJ=$_L7>E/S"4-8W:-G'67U;<:QS,YI
MX*G@J+XHI*%N2/K7.8Y'-56N:NJ*G!45/% ,^VUNYMGHH95Z-L<&PV%X(_T(
M[[[U^)C,)B68$)
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M:,^1Z;>0ZH:*\6LY22)ZO0GK^IZ2-4Z-A5Z\%2%M>M&V*%B:-8U-$0Q2J@
M                                                      1^<R$N
M+Q<]^%K7R1='2U^O2O4]K>.FGI PW^/^2_8T']G_ '1EHC4_C_DOV-!_9_W0
MT-6=4+#K=&K:>B-?/%'*YJ<D5[4<J)]4Q2N
M                           "-S.%J9JOY-A.F5NJPS)])BK^:GI0#6&4
MQ5O$65K6VZ>,<B?0>WTM4R8K$D>HXWRO;%&U7R/5&L:U-555X(B(!MS!U;U/
M&0P9"99K*)JNO%6HO)NOCIZ3!DD0
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M=%4Z+F41);7!S(.;&+Z_NE^L8ZIT9:0D
M                              0>[_Y.W/\ !?KK"81+5AD@ W#A?]3X
M_P#:T/ZVTP9+X
M      6F2QM3*UG5;;.IB_1<G!S5]+5\% UAFL#<PMCRY4\RN]?Q,[4]EWJ7
MT.]1DQ9AM/;7N#&Y&\S_ #YZ?BHU_O35]/WR_6(F4PRHA(
M
M               %AF$UJ(OH>B_65"OG]U8P>\@2BO@ #$\NSHR$R>"JCD^=
MJ*4LGO2O8_=A9&ML        +"^U>MCO!4T^I_\ :&4+0A(   75%JK*KO!J
M?FDHE(!B        >XF]<K&?=.1/JJ(YD\F;'1<T  2N$;[4SO0C4^KK]@M;
M?Q5-QX)@N*8  U=O&;SL_81%U;$C(T^9J*OUU4RAC*!)    O\5A[V8G\FHS
M5J?JDKN#&)ZU_.(&RL+@*6%BTB3S+3DTDL.3VE]2>A/40R2Q
M                                                $'N_^3MS_!?K
MK"81+5AD@ W#A?\ 4^/_ &M#^MM,&2^
M                         #S)%'*B-E8U[45'(CD141S>*+Q\4 ]
M
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M">LB1LJI4K48&UJD:10LY-;^:OI7UJ8LE<
M                                   (/=_\G;G^"_76$PB6K#) !N'"
M_P"I\?\ M:'];:8,E\
M                                                     /CG-;Q<
MJ(GK70"FMFNBZ+,Q%_"3[).DHUA\2Y45=$L1JOHZV_9&DFL/23P.^C*Q?D<B
MC236%1%1>*<4(2
M#R]B2,<Q>3D5J_/P(F-83$Z3JQ5S5:Y6KS1=%^5#E2ZT/@ ".S5?SJ2O1/:A
M7K3Y.2FK+&L-V*=+,7*:X         *4U>.;Z2:.\')S"=5HZC(B^RY%3U\
MG4;1E5?:<B)]4&JZAK1P\4XN^Z4(U5@@         3NWZ^B2V5\?Q;?S5_.+
M&&/%6S3X)PLJP  R3'Q^54B:O-4ZE_1<3HXHTK#FY9UM*Y-K4 4YY4@@EF7E
M&QSU^1J:@:555<JJO%5XJIFQ?   "ZH7[.-M,N57=,K/3R<B\T5/%%(&U</E
MZV9IMLP+H]/9FB7Z3'^CY/0IBR2
M                             0>[_P"3MS_!?KK"81+5AD@ W#A?]3X_
M]K0_K;3!DO@
M             ?%5$T15T5>">M>8'T                          *4UF
M"NFLTC6>I5XK\B<R8B91,Q"-FS]=FJ01ND7TK[*?GJ;(QRUSDA82YR[)]!6Q
MI]ZFJ_7U,XI#";RM)+MN3Z<[U]74J)]1#+IACU2H*JJNJKJOI)0   'IKWL7
M5CE:OJ70"XCR5Z+Z,[E]3EZO[;4QZ891:5Y%G[+>$T;9$]*>ROYZ&,XX91DE
M(09NE+HCU6)R_=)P^JAA-)9Q>$@Q[)&HYCD<U>2M75/K&ML>@
M                               ,>R</E6W*GT9/;3Y^?USGYJZ6='#;
M6JS-+< ?%1'(K7)JU4T5/4H2P^[66I9?"OT475B^EJ\BA:NDZ+]+:QJMS%D
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MD@ W#A?]3X_]K0_K;3!DO@
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MK-P>&;RQ]?CZ8F+^:A NH*U:LBMK0LA:O-(VHQ%TY<D0"J
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MUA,(EJPR0 ;APO\ J?'_ +6A_6VF#)?
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MSET1/6I,1J3.D:LFKPMKPLB;]JG%?2OBITZUZ8T<N]NJ=54R8
M               U#W*[_;:V5YN+PO1F]QMU:Z&)VM6!W+\=(WFJ+SC9Q]*M
M.GMMA?)QM]VKG;C?5Q\(XRYDS66W?W&R*9C<]Y\D::^0U4Z8HV+]K#$FB-3U
M^/BJJ>HV^UK2-*QI#S6?=6O.MIUE?TL?5H1^769TZ_2>O%SOE4Z%:Q')S[6F
M>:Y,F*VNX^K?C\NRSJT^B].#F_(IC:L3S95M,<EAA<MN_MSD5S&V+SXXUT\]
MJ)U12,3[6:)=4<GK\/!44Y^XVM;QI:-8=#!NK4G6LZ2Z;[:]_MM;U\K%YKHP
MFXW:-;#*[2K.[E^)D=R55Y1OX^A7'E]SL+X^-?O5>EV^^KDX3PEMXYCH@
M                                 "#W?_)VY_@OUUA,(EJPR0 ;APO^
MI\?^UH?UMI@R7P
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M)%YN;]E#7:FK96^C(F/9(Q'QN1S'<4<G)30WO0
M               !8Y*I[Q#UL3\;'Q3UIXH:,M.J/E;\-^F=/! %!T   5$5
M-%XHO- ECV4Q"Q*ZQ536+F^-.;?6GJ*N3'IQA:QY->$H<T-X
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M^I!>J2)+5LQLF@E;R='(U'-<GRHIP)B8G27<B8F-85B$@
M             $'N_P#D[<_P7ZZPF$2U89( -PX7_4^/_:T/ZVTP9+X
M                                                         %&W
M4KWH'UK4:2PO31S7?FIZ%]8&M]P[7L8ASK%?6;'JO"3[9FO@_3\TRU8Z,>)
M !]1%5=$XJH&PMJ;9]R:W)7V?YXY-88G?WM%\5^^7ZQC,IAEA"0
M  6MZ]'1BZW>U([A&STK]@RK75C:VC%9YY;,BRS.ZGK]1$]"%B(T5YG53)0
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M    !?8[(R4G]+M75W?29Z/6AA:NK.MM&41R,E8V2->ICDU:J>@KK#T
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M"OR(U>A/P3Q/<<71EU\+<7L=AEZ\6GX6W3FNB
M      1&YJT]S!VJ]:-99W^7TL;S721JK]9"8&O/XMYW]@R_43[).K$_BWG?
MV#+]1/LC4;/Q44D.+I0RM5LL=>)CVKS1S6(BH8LEV
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M6I)Y4JZUWKQ^]7T_9,+UU9TMHR=%14U3BB\E*ZP
M                /CFM>U6N35JIHJ+Z")C5,3HQ^]2=5?U-XPN^B[T>I2AD
MQ],_(Z&+)U1\JS-+<   %*>O#99T3L1[?#7FGR+X&,UB>;*+3')"VL ]-75'
M]2?\V_@OS+R-%L/DL5S>:)FKSUW=,T;F+ZTX+\BFB8F.;?$Q/)3(2
M >F1R2NZ(VJ]R^#4U7ZPB-29T2E7!6)='6%2%GHYN^PANKBF>;3;+$<DW5HU
MJ::0LT=XO7BY?G+%:17DK6O-N:X,V    5JU:2U*D;.7VSO!$,Z4FTZ,+WBL
M:LC@ACKQI%&FC4\?%5]*G1K6*QI#FVM-IUE4,F(                   ''
M?Q#[A=NCN1%MZL_JIX1C:G#BGGRZ23N^9.EB_@'JNV8>G'KXV>9[EFUOIX50
M+6M8UK&IHUJ(C4]"(>C>=?0                   ^.:U[7,<FK7(J.3THH
M$]\/&X7;7[D2[>LOZ:>;8ZIQX)Y\6LD#OG3J8GX9YSN>'JQZ^-7HNVYM+Z>%
MG8AY5Z8
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MG*OM-36)5\4]'S&F]?%NI;P3)J;0
M    !Y>QDC58]$<Q>"HI$QKS3$S'&$#>Q[ZRJ]GM0+X^*>I2ADQ37T.ACRQ;
MA/-9&EN    !\<UKTZ7HCFKS14U0)6,V'H3<?+\MR^,:Z?6XI]8U3CK+9&6T
M+*3;J<XI_F<W\]%_.-<X?E;(S><+=^ NM^BZ-R>I51?KH8SAEG\:%)<)D/\
MFT7]$A'PK)^+4_(N0_YM/TS?LD?"L?%J]MP-YW-6-^5R_G(I/PK(^-5<1[==
M_?9T3U-;K]=50SC#\K&<WR+V+"48^+D=*OWZ\/J)H;(Q5AKG+:5]'%%"WIB8
MUC?0U$3\PV1$0U3,R]DH    !<5:DMM^C$T8GTGKR0V4I-I:[Y(K#((*\=:-
M(XDT3Q7Q5?2IT*UBL:0Y]K3:=953)@                   !%[DS=;;6 R
M6?N?]GQU>2RYO)7+&U51J>MRZ-3UJ;,=)O:*QXM>2\4K-I\'!^$?9RV6OY^^
M[S+5B62661?MI[#E>]WU_KGOMO2(Y<H>&SWF>?BR,MJ@
M    #',V^SB<M0S]!WEVJ\L<L4B?:SUW(]COK?6*FXI$\^4K>"\QR\'>&V\W
M6W+@,;GZ?_9\C7CLM;S5JR-15:OK:NK5]:'@<E)I::SX/<X[Q>L6CQ2AK;
M
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MC%T>U=6KZT R^I9;;KLG;PZD]I/0Y.:%68TE:B=85R$@
M                    #XJ(J*BIJB\T4")N8KG)5^58_L%3)A\87,>?PLBE
M16JK7)HJ<T7F5%M\                   "0IXN2;22?5D7-$^V7[!8IAF>
M,J^3-$<(YIN.-D3$9&U&L3DB%V(B.$*,S,SK+T2@
M!H+XH=X14-M4]GU9FK=RLR3W8FN17-JUE1[4<B+JG7)TJW7GTJ=GMF'6\WGE
M#D=RRZ4BD>+1F%J>YXZ&-4TD<GF2?A/X_63@>QQQI#R.2=97YFP
M            6&:J>^8Z:-$UD:GF1_A,X_73@89(UAGCG26\_A>WA%?VU<V?
M:F:EW%3+/2B<Y$<ZK957N1J*NJ]$G4KM.74AX[N>'2\7CE+UW;<NM)I/@WZ<
M9UP
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MXM_"3[*&O)'#5LI/'1D1H;P
M  6]FE!:3VTT?X/3G_RFN^.+-E,DUY(:SC;%?5R)YD?W3>?SH4[XK57:9JV6
M9I;@              "XKTK%G]3;HS[MW!ILKCFW)KODK7FF*N-@KZ.=^,E^
MZ7DGR(7*8HJIWS39>FYH                     6]Z_2QE.;(9&Q'4HUVJ
M^>Q,Y(XV-3Q<YRHB&5:S:=(YHM:*QK/)S=W'^)669TF$[<,7VM8WYN5FKU77
M3_-XG)P_#>GZ%.9W=MVWQR?0XFX[CX8_I:6KX:[D;;\KN"Q)9N3.\R597K)*
M]R^,CW*JJ>DQX(B/*'G<F:9GSED):50                      !CUC#7<
M=;9E=OV)*UR%WF1+$]8Y6.3QC>U45"KDP1,><+6/-,3Y2W3VX^)66%T>$[CL
M7V=(V9N)FCT773_.(FIQ_#8GZ%>9YO<]M\<?T/1;?N/AD^ETC1OTLG3AR&.L
M1VZ-AJ/@L0N22-[5\6N:JHIPK5FLZ3S=NMHM&L<EP8I
M"QRV:PV!JI>SF1K8RDKTC2S=FCKQ=;D54;UR.:FJZ+PU,+7K6-;3HL[?;9MQ
M;IQ4M>WE6)M/T0A/]YG;?^>&$_\ F53_ "IJ_B,7XJ_3#H?DG</_ /'R_P#]
M=_L/]YG;?^>&$_\ F53_ "H_B,7XJ_3!^2=P_P#\?+__ %W^Q*8;<VV]Q^?_
M !?S%'+>[='O/N%F&UY?F:]'7Y3G=/5TNTUYZ*;*9*W]V8GT*6YV.XVVGQL=
ML?5RZJS773GIK"5-BF
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M(Q=',5'(OK0#,X9&S1,E;]%[4<GSE68T6HG5[(2
M                   !;3T*UC57LZ7K]NW@IKMCK9MKEM5&S8>9O&%R2)Z%
M]E?L%:V"?!9KN(GFL9()H?U6-S?6J</JFB:S'-OBT3R4S%D        >V1R2
M+I&Q7+Z&IJ3$3/)$S$<UY#B;,G&32)OKXK]1#=7!:>;1;/6.7%(P8RM#HKD\
MQ_I=R^H6:X:PKVS6E>\N"&YH                      -==QN\NU.WD;ZT
M\GY1W J:Q8FLY.M%7DLS^*1I\NKO0U2]M]G?-QY1YJ6XW=,7RSY.5MU[UWMW
M4NI-F+'DXF-RNKTHM65(OD;KJ]^GVSE5?D0]1MMG7''W8^=YO<[NV2?O3\SY
MC\34QS?Q3>J94T=,[BY?D]"'4K2*N7:\V7QFP
M  !8Y#$U,BW\:WIF1-&S-X.3Y?2AA:D69UO-7W:F]=[=J[JS8>QYV)D<CK%*
M75]27Y6ZZL?I]LU47Y4.7N=G7)'WH^=U-MN[8Y^[/S.J>W/>7:G<.-E:"3\G
M;@1-9<39<G6JIS6%_!)$^31WI:AY?<;.^'CSCS>DV^[IE^2?)L4HKH
M          T=\5O]&$/\*UOUN8Y7<_W7SOHG\@_]RG_9V]M7$YYA^@@#J3X.
M/_.G_A?_ 'P[W:?U_F^M\<_\D?\ 3_[S_ANI3O/C@
M
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M0  9+@IO,IK&J\8G*GS+Q0T7CBWTG@DS6V
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ML5RNU<Y=55[N;E5>?YYZBF'3F\S?-KR9 UK6-1K$1K431&HFB(A85WT
M                       #XYK7M5KT1S5316JFJ*@&/W]NJV1+F)>L%B-R
M/8Q'*W1S5U16.YM5%Y%>^'7DL4S:<V\^P_>'=VX,W#LC<$7Y51(Y9&Y9SM+$
M+(&JJ^<NBI(BKTL1W!VJ\54\OO\ 9TI7KKP^1Z;9;N][=%N/RNCSA.T
M          :.^*W^C"'^%:WZW,<KN?[KYWT3^0?^Y3_L[>VKB<\P_00!U)\'
M'_G3_P +_P"^'>[3^O\ -];XY_Y(_P"G_P!Y_P -U*=Y\<
M
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M(Y$<U45JIJBIQ144\"] ^D !+[?DTL2Q>#V=7SM7_E->2.#9CYLA-#>
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MV=%]5?L$Z!_&7!?LZ+ZJ_8&@DHI8YHF31.1T4C4>QR<E:Y-44@>P
M
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M6T O\._IR$7H=U-7]*IA?DSIS925U@
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M.K1ORJ@9OT=^![=OY>[.K@)I%=:VSD)ZB-5=5]VLK[U&OR=4DC4_!#"6L?\
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MFPN/W#A+#;6)R=>.W2L-Y/BF:CFKIS1=%XHO%%X*&"1
M      0.]-N0[NVIE]N3:?\ Q"L^.)SN39D]J)Z_@O1KOF-V')\.\6\FK-C^
M)2:^;AC;<DU2S;Q%IJQSQ.=U1.X*V1B]#VKZT5#WN"VKPV>NC)"TJ@
M                       #&]R236[-3$56K)/*YO3$WBKI'KT,:GK55*N>
MVBU@KJ[HV7MR':.U,3MR#14Q]=D<KF\GS+[4K_T3U<[YSP6;)\2\V\WN<./X
M=(KY)TTMH              !H[XK?Z,(?X5K?K<QRNY_NOG?1/Y!_P"Y3_L[
M>VKB<\P_00!U)\''_G3_ ,+_ .^'>[3^O\WUOCG_ )(_Z?\ WG_#=2G>?'
M!![O_D[<_P %^NL)A$M6&2 #<.%_U/C_ -K0_K;3!DO@
M
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M%2P]7LP^4NT*_4B\(E\NUHBJG%$=.[E\G@$2Z-"
M  !Q?WSV\NSNZ4V3@9T8[,Z9&/I3AU2JK+#>'CUHY_Z)#UO;<W5CCSKP>6[A
MAZ<D^5N*.145-4XHO)3T#@ %6M7FMV(:E=BOL3O;%$Q.;GO5&M1/E52+6BL3
M,\H95K-IB(YRZ5J=D]D1U8([=:6:TR-C9YDGE:CY$:B.=HBHB:KQT/%V[MGF
M9TGAZ'L*]KP1$:QQ],M%[_VRFT]TW<3$BI2U2>DKE556"7BU-5Y]*ZLU]1ZC
M9;CXV*+3S\?2\UO<'P<LUCEX>AC)=4G0.R>U>S,WM3%97(5)'W;4/7,]L\C4
M5W4J<D71.1Y/=]QSX\UJUGA$^3U>U[?AOBK:8XS'G+5/<+9\NS=PS4&(YV,G
MUGQTKN.L+E^BJ^+F+[*_,OB=W8[J,^.+>,<W"WNV^!DT\)Y(+"UH;N9QU.PG
M5!8LPQ2M1=%5DDC6JFJ<N"EK+::TM,>$2K8:Q:]8GE,PW)W+[:;2VUM*UEL3
M5DBNQ20M8]TTCT1'R(U>#E5.2GG=AO\ -ES16T\./@]#OMCAQ89M6./#Q:6Q
MV/MY6_7QM&-9;EJ1L,+$X:N>NB<?!/2IZ2]XI6;3RAYS'2;VBL<Y="8+L?M3
M'5&R;A>_)6T;K.JR/KUVKIQ1J,5KM$]+G<?0G(\EF[OFO/W/NQ],O5X>TXJQ
M]_[T_1"AN;L;@+E*2QM9SZ5]&]<$+Y'2UY/%&JKU<Y-?!W4OR&6W[ODK;3)Q
MCUL<_:<=JZX^$^IS]9KSU+$M2S&L5F![HIHW<'->Q='(OR*AZVMHM&L<I>5M
M6:SI/.&QNVG:Q=X0NS&6F?6PC'K'&R+1)9W-^EHJZHUJ<M=%UY'&W_<?@3TU
MC6WL=?8=O^-'5;A7VMJ/[-]NY(EJ,I/99:FKIF6I5F1%\5:YZM_L#AQW7<Q.
MNO#T0[<]LV^FFGKEI?N+V\M;&N1OBD6UA;:JE6RY$1[7)Q6.1$X=2)R5.#OJ
MHGI-COHW%?*T<WG=[LIV\\.-98_MG;F1W5F(,-C&IY\VKGR/X,CC;])[E]"?
M7Y%K<9ZX:3>RKM\%LUXK5OW&=DMDXVLUV6\W(RM3\;--*ZO%KRX-B<U6I\KE
M^4\KD[OGO/W=*^OVO48^U8*Q][[WJ]BEF^QVTLA5<_!/EQMI6]4#DD=/ JJF
MJ=22*YVB^EKOJDX>[YJS]_[T?1+'+VG#:/N?=GZ7/V8Q-[!9.SB,E'Y5VJ]6
M2MYIZ45%\45%147T'K<66N2L6KREY;+BMCM-;<X;#[4]N<1O.CD;V9=8;%7E
MCAK^[O:S5W2KGZ]37:\VG'[EOK[>U8IIQ\W6[=L:9ZS:VO-L+_<1LK_G;_\
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MGQP  0>[_P"3MS_!?KK"81+5AD@ W#A?]3X_]K0_K;3!DO@
M
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MU_=Q^GBSDYJT 76,_P"WP?A&-N3*O-EQ660
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MAPO^I\?^UH?UMI@R7P
M                                    #Q,WKBD9]TU4^JA,(EA1:50
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M_9L3\$^=?S%BZ*S/A;1]H_\ '&7J[CCC\,7_ /K+G<\ _4(
M      '4GP<?^=/_  O_ +X=[M/Z_P WUOCG_DC_ *?_ 'G_  W4IWGQP  0
M>[_Y.W/\%^NL)A$M6&2 #<.%_P!3X_\ :T/ZVTP9+X
M
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M@OUUA,(EJPR0 ;APO^I\?^UH?UMI@R7P
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MR>J5Q'E_^=C^=J_G*9QE\T]2[BOU9>"/Z7>AW#_D-L7B66L+GGQ3D9I
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M>=)GY)Y-H?[X.W7^V?\ ^%M_Y$X?Y7N?P^N/M=G\RV_XO5/V'^^#MU_MG_\
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MS_ANI3O/C@  @]W_ ,G;G^"_76$PB6K#) !N'"_ZGQ_[6A_6VF#)?
M
M             $7G*_FU4E1/:A77]"[@OYQLI/%KO'!C9O:  !J3OEL]^4Q4
M6Z*$?5>Q;59;:U-7/J*NO5_@W+K\BJO@=SM6YZ+?#GE;EZ?Z5#=XNJ.J.<-
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MJ0@RK5]F=O2OW3>*?4-U<OFRBR08]DC4<QR.:O)4-T3JS>B0
M        !@_<"G[53(-3FBP2+\GM-_\ >)A$L(,D*U6P^I9AM1_3A>V1ORM7
M4#<T4C)HF31KK'(U'L7THY-4,&3V                   '/OQ3;J]SP.,V
MC7?I-DY?>[B(O_X>LNC&KZG2+U?H#M=KQ:VF_DX_<LNE8IYM)XFI[ECX8532
M33JD_"=Q7ZG(]A2-(>2O.LKTS8                              "RRU
M3WW'S0HFLFG5'^$WBGU>1A>-89TG26[/A9W5[Y@<GM&P_6;&2^]TT5?_ ,/9
M71[4]39$ZOT9X_NF+2T7\WK>VY=:S3R=!'%=@               T=\5O]&$
M/\*UOUN8Y7<_W7SOHG\@_P#<I_V=O;5Q.>8?H( ZD^#C_P Z?^%_]\.]VG]?
MYOK?'/\ R1_T_P#O/^&ZE.\^.  "#W?_ "=N?X+]=83"):L,D &X<+_J?'_M
M:'];:8,E\
M                             >7L;(QT;TU:Y%:Y/4H&'68'5IWP/YL7
M37TIX+\Z%J)UA5F-)4B4 'E[&2L='(U'QO16O8Y-6JU>"HJ+S128G1#ECN9L
M6796;66HQ5P%YROHR<52-W-T+E]+?M?2WYSV>QW<9Z<?>CG]KBY\7P[<.4L6
MKS<N)=F&NLI."?EQ-4PW1*3@L<N)JF&R)2<%GEQ-4PSB4E!:TTXFJ:LXE(PV
M^7$U35GJOHKGK-<U9:KIEWUF,U9:J[;WK,>E.K[[\OI(Z3J>'7?63TFJA)=]
M9E%6.JSEN>LV15CJL)K?K-D58ZHZ>UKKQ-D58S*-GL>LVQ#"91D]C77B;8AK
MF49//S-L0U3*+L3<S=$--I;T[*[ =0A;O#+Q=-VRQ4Q<+TXQPO3C*J+R5Z?1
M^]^4\WW3>=4_#KRCG]CH[7#I]Z>;<AP'0  $K@ZOFV%L.3V(>7X2\OJ&N\\&
MRD<61FAO             L+629%JR'1[_%WVJ?9--LFG)C-D5+-),[JE<KE]
M97F9GFUZO!                 /<,\L#NJ)RM7Q3P7Y4,HM,<DQ*7JY&.;1
MDOL2?V*EBN2)YLXLO3:R                    A]T4_?<':8B:R1-\YGRQ
M\5^MJA,(EJ@R0 ;2VA<]\P<"*NLE=5@=^@XM_L50QE,)TA(
M     .9OB![6;US&?EWOB4_*^/9#%%[A Q5LUHX4\(^/F-5RN>O3Q]KZ.B:G
M?[?NL=:]$\)</?;;):W7'&&F<;N2*94@R")!.G#KY,5?7K]%3T],L3S>:OBT
MY)Y%14U3BB\E-[0                             %5$35>")S4"!R6Y(
MH56#'HD\Z\.OFQ%]6GTE-%\L1R;Z8M>;<WP_=K-ZX?/Q;WRR?DC'OAEB]PG8
MJ6;,<R>,?#RVHY&O3JX^S]'1=3S'<-UCM7HCC+TNQVV2MNN>$.F3@.X
M          :.^*W^C"'^%:WZW,<KN?[KYWT3^0?^Y3_L[>VKB<\P_00!U)\'
M'_G3_P +_P"^'>[3^O\ -];XY_Y(_P"G_P!Y_P -U*=Y\<  $'N_^3MS_!?K
MK"81+5AD@ W#A?\ 4^/_ &M#^MM,&2^
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MF,5W0EV!7ZZ=/FLUU]&FIA\2GG#'JA<1S0RZ^5(U^G/I5'::_(9Q,3R9*A(
M       7U/(NBTCF571<D=XH;J9-.;*+)AKFO:CFKJU>**A9;'T
M         ?'-1S5:Y-6N3147Q10--Y&HZC>L4W?WF1S$7THB\%^=#)BM21F.
MP;O1;LT'+[,S$E8GWS%T73Y47ZQ$IAGQBD                   #5G<GL7
MM??B2Y&FC</N5VKO?X&(L<SO1/&FB.U^[31WR\CH[;?7Q<)XU4-QLJ9>,<)<
MN[AVYO/MCD$QNXJ;O<WN5*\[55]:9J>,,NG/Q5J\4\40]1MMW7)&M9^9YK<;
M6U)TM'SKFCDJF19U5W^VGTHW<'M^5#I5O%G.M2:KLR8
M         M+V2J8YG58?[:_1C;Q>[Y$,;7BK.M)LMMO;<WGW.R"XW;M-WN;'
M(EB=RJRM"U?&:73GXHU.*^"*<W<[NN.-;3\SH[?:VO.E8^=U%VV[%[7V&D61
MN(W,;E;H[W^=B)'"[T01KJC=/NUU=\G(\ON=]?+PCA5Z7;[*F+C/&6TSG+X
M               T=\5O]&$/\*UOUN8Y7<_W7SOHG\@_]RG_ &=O;5Q.>8?H
M( ZD^#C_ ,Z?^%_]\.]VG]?YOK?'/_)'_3_[S_ANI3O/C@  @]W_ ,G;G^"_
M76$PB6K#) !N'"_ZGQ_[6A_6VF#)?
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M[CZSNE?:A7Z3?1ZT-E+Z)B=$VQ[9&H]BZM7BBH6HG5M>B0
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M-"+%X:I%1Q\":15X&HQB>E>'-5\57BIP+WM>=9G67>K2*QI$:0O3!D
M           $;F]OX3<E-,=G\?!DJ*/25*]J-LL?F-141VCM4U1%4PO2MXTM
M&L+>UW>;;7Z\-YI;336)TG1CW^Z/MA_-'%?N6/[!I_A<7X8=3_$/<O[_ "?U
MI/\ ='VP_FCBOW+']@?PN+\,'^(>Y?W^3^M*9P&T=K[5]X_BWB*N*][Z/>?=
M(FQ>9Y75T=72B:]/4[3Y393%2GNQ$.?N^X[G=Z?&R6R=.NG5.NFO/V)HVJ
M HVJM>[ ^K:8DD$FG6Q55$7I5')RT\4 C?XJ[?\ V$W],_\ NB=4:'\5=O\
M[";^F?\ W0U-$K#%'!%'!$WIBB:C&-]#6IHB<?40E[
M
M    "A<J1W(%A?P7FUWBCO291.DHF-6)3P25I70RIH]OU%3TH6(G56F-%,E
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M:<^E?9=^;K\Q,(EK,R0 ;<V]=]_P]2=5UD1B1R>GKC]E57Y=-3!DDP
M                '/7Q0[+JSX.IO6C68R]3F;7R<S&HU\D$Z(V-TBISZ'HU
MJ:_=';[9FF+32>4\G'[EAB:Q>.?BTKB+?OF/AF5=9$3HD_";P7ZO,]?2=8>2
MO&DKXS8                     +'+V_<\?-,BZ2*G1'^$[@GU.9A>=(9TC
M66ZOA>V75@P=O>MZLQ]ZY,ZOC)GM1SXX($5LCHU7EUO5S5T^Y/(=SS3-HI'*
M.;UO;<,16;SS\'0IQ'8
M
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M"4FK+9FD8UD3>;I9G(QC?EX_7*F>\1\RU@I,_.[MVK@8-K[;Q>WJVBQ8ZM'
MKD^V>U/;?^B=J[YSP67)-[S:?%[K%2*5BL>"8-38
M
M                                     !:W:$-V/I?[,B?0D3FG_(95
MMHQM75C%JI-3D\N9NGW+DY*GJ+$3JKS&B@2@     "A:IT[T?DW:\=F'_FYF
M-D;]1R*AE6TUXQ.B)B)8]<[<;%OJKI\#4:Y>:PL]W_6E9Z"W7>YZ\K3[?:U3
M@I/A")F[,=O)5168Q\//5([-C1=?PI'?6-\=SW$?K>J&O^%Q^2E_N3[??L&;
M]TS?W1/YIG\X^B$?PN/R74'9[MW!I_\ !_,<G!72V+#]>.O%/,T^L83W+<3^
MMZH^QE&VQQX)NCLG:&-T6G@Z4;TY2+ Q[_TSD5WURO?=9;<[3]+9&*D<HA.M
M:UC48Q$:UJ:-:G!$1/!"LVOI      !(X_%26U2235E?T^+OD^R86OHSK35D
MD44<+$CB:C6-Y(AHF=6^(T>R$@         !;W;'N\*N3Z;N#/E]/S&%[:0B
M9T0"JJKJO,IM0  ^<N*\@-.=PNXCKKI<!M^72HFK+EV-?U7TLC5/M?2[[;Y.
M?FM_O^K[F.>'C+F;C<:_=JUO%"<2(4HA?10>HVQ5LB%[%!ZC=%6<0NXZ_J-T
M59Q"[CK^HV15GHN&5O49Q5EHKMK>HSZ4Z/:5O43TIT>O=?4.E.CRM;U#I1HI
MNK>HCI1HHOK>HPFJ-%M)7]1A-6,PM9*_J-<U83"SE@]1IFK"864L'J-,U83"
MREAT-4PUS#:?;SN(JK%M_<,WM\&4KTB\_!(Y%7Q^Y=\RG?V&_P"6/)/HG[5_
M;[C]6S;)Z%T0  :Y6JCFKHY%U1?6@&0U9TL0MD^VY.3T*A=K;6&V)U5C)(
M              Q'*[,?DLM-<;.V"K+TN<B(KG]>FCN'!..GI)U1HOZ6SL)3
MT<^);,B?;3+JGZ5-$^J@U-$['''"Q(XF-CC;R8U$:B?(B$)>@
M            #C;O_MY=I]S?RY79TT<VUM].G@GG)^+L-^553K7\,]7VS-U8
MXCQJ\OW'#IDGRLAFN1S4<U=6JFJ*GBBGHGGWT                   /CG(
MUJN<NC43557P1 )GL!MY=V=S?RY89U4<(UU]>KBGG+^+KM^5%7K3\ \[W/-T
MXYCQL]!V[#KDCRJ[)/*/4
M
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MOL2</T7@;<=M)95E-%IL
M    &G/B2VK^7=@KF(&=5W 3):14^DM:72.9J?5:]?P#J=NR]&73PLYO<,75
MCU_"YLV];]ZQK&N762#\4[Y$^C]8]IBG6'CLL:2E3:U
M  BMPV_=<:]K5TDG_%-^1?I?6-66=(;<4:RZ3^&W:OY"V"F8G9TW<_,MI57Z
M25HM8X6K]1ST_#/%]QR]>73PJ]CV_%TX]?Q-QG+=(
M
M                                           +*WC*MO5SF]$O_.-X
M+\_I,XM,,)K$H2UA[=?5S6^=&GVS.?SIS-L7B6J:3"/5-."\S-@
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M>5)H62_=)Q^7Q+M9UC5MA4,D@
M       %O?HULG1M8VZSS*=R&2O8C7DZ*5JL<GSHIE6TUF)CP1:(F-)<KO\
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MZHH4:V,HU<;29Y=.G#'7KQIR;%$U&-3YD0\]:TVF9GQ>@K$1&D+@Q2
M
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M:QOB7[5=4^12SBGAHSJD3<S
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M$Y')=0
M
M                       %-T$+_IQM=\K44G5&BFM"DO.O'\S43\PGJE'3
M#Y^3Z/['9^E0=4G3#TVE3;]&O&GKZ4U_,(ZI3TPJMC8SZ#4;\B(A"7H
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M-\'HJ?4X_G&W'/%E7FFRTV
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M*><RY;9)UM.KT&/%7'&E8T31J;0
M     B=RVK%+"6K55ZQSQ^7T/1$54ZI&M7GKX*3 U]_&K<'[-=^E9_<DZ,=3
M^-6X/V:[]*S^Y&AJV9BY9)\92GE=U2RP1/>[TN<Q%5>'K,62[
M
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M:L,D &X<+_J?'_M:'];:8,E\
M
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M45Z5C?D6.)WYKCU':9UPSZ?L=+9S]SYVPCL+H!ZBX2L5/ND_-)CF0R4O-P
M                *5BS7JQK-9E;#$G-[U1J?7 Q;);[IP:QXV);,GA*_5D:
M?-])?K$Z(U9%BK[,GCX+K-$\UJ*]J>#TX.3YE(2O
M                                                    &)W][Q4;
MD]-:3GK ]T:O21$UZ5TUTZ2=$:K?_>%#^P'?XQ/[D:&I_O"A_8#O\8G]R-#5
M89G>,65QL]!M1T2S=&CU>CD3I>UW+I3T$Z&K$R4 &:4=\Q5*5:HM)SU@B9$K
MO,1->AJ-UTZ?48Z)U5_]X4/[ =_C$_N1H:G^\*']@._QB?W(T-4O@=RLSLTT
M3*ZPK$U'ZJY':ZKIZ$&@G2$@
M
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MV:_DQ<_;\GZS">F[1^ZG]KZH='9^Y/I;$.RO 'J/]49^$GYI,<QDI>;@
M             ISME?!(R!_ES.:J1R*B+TN5."Z+ST4#3U^Q>L67_E"5\EB-
MRL=YBZ]*HNBHGHX^@R8K4D9IL/)]$LV*E7V9/QL&OW2)[2?.G'YC&4PSLA(
M
M         !J+/_Z[O_\ 7O\ S3)BC20        S'M__ -LN?]4W^V(E,,^,
M4@
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M;=F;PK0XS?"1NDJ35]6U+[8FZO1C7*KF2HFKE9JJ*B*J*GT0QF'3(0
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MR([R_P#W#UG;*Z8(GSF76VL:8X9N=1: *E9O58B;Z7M_-,J\X3#(RZV@
M              USOC&>ZY!M^-ND-M/;TY)*W@OU4X_5,H1+%B4*U2S+2LQ6
MX5TEA<CV_-X+\H&XJ=N*]5AMP+K%,U'M]6O-%]:<C!DK@
M                                                       :JSF/
MOR9B\^.K,]CIGJUS8W*BHJ\T5$,F*P_)F2_8<_\ BG_8 ?DS)?L.?_%/^P _
M)F2_8<_^*?\ 8 ?DS)?L.?\ Q3_L /R9DOV'/_BG_8 ?DS)?L.?_ !3_ + #
M\F9+]AS_ .*?]@!^3,E^PY_\4_[ &5[%J6J]NVZQ!)$UT;419&.:BKU>&J$2
MF&<D)
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MV&7#WF6\=/5CFO6'>[R=3%?&OD,1'(GM-\Q>"Z*&6KNT,0
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M>OSNU/=8,?P\=:^4.]CKTUB$F;V8!=8YG7;9Z&ZN7YD-F./O,J\TZ6VP
M              $;GL8W+8R:KI^.1.N!5\)&\OJ\@-1JBM56N31R+HJ+Z4,V
M+X!F^Q,MHLF(F7GK+6U_LF_^]]4QE,,X(2
M
M
M                         &GOBH_H WM^UJ_[\@"8<7?!)_3K3_@R_P#V
MC0RE^F08.0/^($L/\2-HHY'>?^59NA4TZ>CW=>K7UZ].GSAE" _X>2KIW'37
MA_\ !.'_ ,P!+E7O%YO^]S?WG(U)OXQYCS$8JJWJ]^FUT5=%TU"8?KGMA:[M
MMX9:B:55HUE@3C^I^2WIY\>08)4                    $1EH])62^#DT7
MY4_^TK98XZM=D>:6(  YKW=A5V]N2[CVMZ:RO\ZKZ%AE]IJ)^#]'YCQ&[P_"
MRS7P\/0X>6G1>86,#^1IK*(E)0/Y%FLML)."3D6:RV1*3@EY&^);8E)UYM-#
M=$MD2E()N7$W5ELB4E#/RXF^MF<2D(;'K-\691+U>J8[+U'4LG79:JOYQR)J
MFOI1>:+ZTXF<Z6C24\)8)D.SF LR+)CKL])J\?*<C9V)ZDUZ7?5<I6G;5GE.
MC5.*%*IV6Q$<J.NY6>>).;(HV0JOSJK_ ,PB-K7QDC%#/L)@\'MJNM?#5&5T
M=IYDO%TKU3[I[M57Y.2>!;I6M(X-L1$<E[)9]9,V3JLIK'/B:9LQF4?//ZS3
M-F,RC9YN?$T6EKF478FUU-,RPF47/)S-%I:YE&SR<S1:6J91D\A7M+7,HR=_
M,K6EJF4UL#"KG=U5(WMUJU%][LKX=,2HK47\)W2GR%K8X?BYH\HXL\%.J\?(
MZ)/9NT  )/$1\9)?D:GYJF_%'BSJN[N0IXZ'S[LS88^2*O-5]"(G%5^0L,T&
MN^<(BZ(DRI]TC$T_MB=$:LD1=41>6O@I"7T                 UMO3$I1R
M/OD3=*]S5RZ<DE3Z2?/S,H8RQDD5JMF6G8BM0.Z98G(]B^M -OXZ]#DJ4-V'
MZ$K=5;XM<G!6K\BF#)=
M
M
M          &GOBH_H WM^UJ_[\@"8<4_!58KU>^-26S*R&),;>3KD<C&ZJQO
MBN@92_2*WN?;>/@=:OYFC5K,15?-/9ACC:B(JKJYSD1."!@_/+XR^\FW^Y6Z
M,/M[:%UF1P&VF3K+D8%U@GNVE8C_ "W<GLC;&U$>G!55VFJ:*&<0Z*^"+85K
M:O:J;<>1B=%=W;:]]@8Y.E?<(&^5 JHOW2^9(B^+7-#&7+?QB]O[FSN\61S2
M1.3"[K1,I1GZ?86=41EF/JY*YLB=:I]R]H90ZT^%7OCMK?6P<+L^_D(:N^,!
M5CQLV.G>C);,%5J1PSP=6GF:QM;YB-]IKD75-%:JF,PVEW.[J;1[4;;M;@W/
M=BCECB<ZAC$D:ENY,B+T10LXJJN7@KM.EO-W! A^?':COAW^SO<G'X/;FZ+4
MT^YLHKIL?;1M^G$RQ*LT[F16$?Y4<;>MZI$K=&HH9S#]/0P
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MNL2KR;+RT_1<OET(E,-B&*0
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M;=U"&2O2S52&]7@GZ?-8R=J/1K^E535->.BA"<
M
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MHI[3OD0SI764Q#("XVM:;PP\U+(R7F,5:=IW7UIQ1LCOI(ORKQ0RAC+&R0
M3&,W-EL7TLCE\ZNG]XFU<U$]2\T^8C0U9IC-YXN]I'97W.=?"1=8U^1_#Z^A
M&B=61-<US4<U4<U4U14XHJ*0E]             !@&^,/Y$[<M W\5.J,L(G
MA)IP=^B3Z_RF4(EAY*'U%5JHYJJCD75%3@J*@&U=M9E,QCVN>O\ GD&C+">E
M?!WZ(QE*9(2
M                 '"7_$(_UQL/]K9+]<KAE#'?AD^&387>C861W3NG(Y>I
MD*F7FQD<>,FK10K#%6K3(YR35IG=75,[5>K333@"9;H_J#=GO]M[E_=5#_0
MC5DNP/@][9]N=X8O>N#RN=L97$/?+6ANV*;Z[G21/B7K;'3C<J:/7D].(-41
M\=7]"E?^'*7ZS8!#E3X7>R6U>]F>S^+W5<R%.OBZ<5FN[&2P1/<^27H5'K/#
M,BIIZ$0,IET9F_@"[>2XZ9NW-R9JKENAWN\F0=5M5^O3V>MD->!VFO/1X1JX
MDIW-S]I>X*S59O<]T[3R4D$CHG*K/>*<KHI6:IIU1OZ7-<G)S5]82_8C%9"/
M+8NEE(6JR*]7BLQL=])&S,1Z(OK1%#!K#XAN\M/LSL*?+QJR3=&25U/;M-^B
M]=E4U=*YO_-PHO6[TKTM^V"8A^4N0NWLG=L93)S26;]Z1]FS:F5722RRN5SW
MN<O-5=KJOI#-^MW8+^A38/\  =']9:&$MC!
M
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M<E13%DJ
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M:-9&[5SEX:N<NKG.\7*J@A^@?8+^A38/\!T?UEH8RV,$
M
M                %I'E,9*FL5V!Z:].K96.XIX<%(U81DK/C"[)9@
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M$,DL0
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M:88@
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M.I.J-&38W%4L3!Y%./I1?IO7B]ZIXN4A*]
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M;W%[ V/OK'[>JU]W6,/7EFR[&N\]TEF!&RN5==-7(Y=> 8RWJ$
M
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M1G:(C41K4T1."(G)$(2^@
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M&+])&Z(J+JB)HIOVFYG)]VW-Q_YC[!79:9<.OP[?/TSZ?*?!O<Z#Q(
M
M                       '*OQ);T;EL]6VC2D1U/#?C;BM75'7)4^C_@V+
MI\KG)X%?)/'1XKO>ZZ\D8XY5Y^G^AHYK5<J-:BJY5T1$XJJJ:7G'>/;?;"[0
MV5B,%(FEJ&'S+G+7WB=5ED35.?2YW2GJ0N5C2'TO98/@X:T\=./I949+H
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M-_0/T9D:RQN_YR'VF_.U>*?54C1.K)*.9Q>1T2G:9(]?[VJ]+_TKM%(2OP
M
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M6FMN$Q.D_,N"6
M                                         89W-WY4[?[8GRCU:_*3
MHL&*K.X^985."JGW+/I.^IS5#&UM(<_?;N-MBFWCX>EPW:LV+MF:Y;D=-:L2
M.FGE>NKGR2*KG.5?2JKJ5'SBUIM,S/.6T>PFQG;KWA'E+D75A<$K;4ZN3V7V
M-=8(_7[2=:^INGB9XZZR[/:-I\;-U3[M./S^#L8M/?
M          /$L4<S%9(W5J_6^0B8B4:(>UCI8-7Q^W%Z4YI\J%:V.88359FI
MB                  "^JXV271\VK(_1]LOV#;7',\V452\<;(F(R-O2U/!
M"S$:-CT2                      &+;YO^[XQE-BZ26WZ.3_HX^*_7Z281
M+7)D@ <N* 2U+<N:H:-BM.?&G][E_&-T]'M<4^92-!DE+?\ &NC<C55J^,D"
MZI^E=_=$:)U9'2S^(R&B5K3%D7^]O]A_U':*OS$)20
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MT\_7$MPEUY,
M                                     1^<S>,VYBK6:S$[:V/J,626
M1W/AR:U/%SEX-:G-2)G1JRY:XJS:TZ1#B+N/OW(=P=Q2Y:SU14(M8L;25=4A
M@U\=.'6[F]?3ZD0JVMK+YUO=W;<Y.J>7A'DQO%XR]F<C6Q6,A=8OW)&PUX6<
MW/<NB?(GI5>")Q,8C54QX[7M%:QK,NZ.WFRZFP]KU,#75)++4\Z_91-/.LR(
MG6[Y$T1K?O40MUC2'TC9[6-OBBD<_'TLI,ET
M      6EC'PSZN3\7(OVR<E^5#7;'$L9A%STK$&JN;U,^Z;Q0KVI,,)A;F"
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MG%%(2
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MJS^FCZ=_.6&N7;XMQ7EKI\UHUCV>MUV=I\J
M
M+++9;'8/'6,MEK#*N/JL62>>1=&M:GUU55X(B<57@A$SHUY,E<=9M:=(AQMW
M6[JY'N)D?(@ZZNV:CU6C25='/<FJ>=+IP5ZIR3DU.">*K6M;5X#N'<+;FVD<
M*1RCZY:Z1%541$U5>"(AK<IUGV*[4.VI23=&X(.G<EUFE:"1/:J5WIR5%Y2/
M3Z7BU/9^Z+-*:<7M^T]O^#'Q+Q]Z?5'VMT&UZ$
M           "WFI5IN+F:.^Z;P4PFD2B8A8RXEZ<8GH[U.X*:IQ>3'I6LE.S
M']*-=/2G%/K&N:3#'25!45%T5-%]!@@      B*JZ(FJ^A *\=*U)RC5$]+O
M9_-,XI,ITE=Q8AR\9I$3U-X_74V1B\V72OH:=>#BQB=7W2\5-L4B&40KF:0
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M9+\
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M[/0S=W/B RF_KK'/QF-EDR<:/3Z*-_$48UY^TQJ-<GX!6V_^MSS>>4?I#O\
M>K1VWM-=O7WK1%?KO/S_ %NS3N/D3E_XSJ"R87:>4TX5K5NLJ_MF.-__ .Y.
M3W&.%9?2/Y'R:9,M/.*S]$S]K;4>]HL%V0I[YD<G77V_6MQHO);3ZS&QL7Y9
M7-87/B=.'J^1Y>=A.;N<[>/'),?-U3K/T<6FO@[VU)*[<F^KB*^65S<76F=Q
M<Y55+%A55>>JK"4NWTYV^9ZW^==U$?#V]?#[T^RO_P"3JLZ[YD <;YI4[<_%
MC7O)^*Q^8NQ2N5>#5CS$?DRN=ZDF>]WS'$M_J]SKY_6^M8/_ .=V&:_K4K/^
MA.L?Z.CL@[;Y*
M                                     A=T;KP>SL3+F<]92O49[+&\
MY)9%35&1MYN<NG+YUT0B9T5]QN*8*=5YTAQSW+[I9KN+D/QVM3 UW*M'&-=J
MC>&G7(J:=;U]/VO)/'6K:VKP.^W]]S;CPK'*&!F#F.ENQ_9AU1:^]-W5D2SH
MDF(QDS>,?)6SRM7[;[AJ\N:\=-+%*>,O7]J[9IIER1Q\(^N70QN>J
M                               #RYC'\'M1WRIJ1H*3J=5W.)OS)I^8
M8]$>2-(>%QU-?[WI\CE^R1\.J.F'S\FU/N%^JH^'4Z8?4QU-/[WK\JK]D?#J
M=,/;:=5O*)OSIK^:3T1Y)TA6:UK>#6HU/4FAGHE]
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M$7VD^5%XI\Y"5T
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MK<0[)=I9[C6ZKB+]2ZO/5&N5U5>7_7E#?5UQ>B7LOY0S?#W\5_'6T?\ Y?\
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M&++:D3KTS,:^B4D9*X
M                                       ->=Q^[NW>W\#ZSG)?W$YN
ML&,B<FK55.#IG)KT-_LE\$\3"UXARM[W''MHTYV\OM<B[NWEG][Y1V5S]E9I
M>+8(6^S#"Q5UZ(V>"?77Q52M,S+PNYW.3/;JO/\ 0@X89;$K(((W2SR.1D<;
M$5SW.<NB(B)Q55(5HB9G2'4'9[L8W".K[IWE$V3,-TEH8QVCF5EYH^7P65/M
M6\F\^+OH[Z4TXR]EVWM/P],F7WO"/+T_+[&^3<],
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M\E>1-KW'P9FNWS+>#OM;#=C9KIUHUKG-D9K]M&YVFJ=6BKH$:-G!
M                          'F2*.9BQRL;)&O-KD1R+\R@4:E&G1:]E.%
ML+)'=;VL31%=HB<OF N  'E[&2,='(U'QN31S7)JBHO@J*!AN;V0U_59PZHQ
MW-:KE]E?P'+R^12=4:,)GKSU97068W13-^DQZ*BI]4R0I  *D,\U:1)J\CHI
M6_1>Q5:Y/G0#*,;OJ]7Z8\C&EJ-.'F-T9)]A?K$:)U9?CMPXG)Z-KV$;,O\
M>9/8?KZ$1>?S:D:)2A
M                 ,4S';/86?ST.Y\S@*ES.P="MN2L55<L::,61J+TOZ41
M$3K:NAIMAI:W5,<73P]UW6'%.*F2:TGP^SR^9E9N<P B-T[>H[LVYD]M9'7W
M/*5Y*TCDXN9UIHU[?6Q=')ZT,+TB]9K/BM;3<VVV:N6O.DZ_IZ7,W;3X5<YA
M=ZU\QO.U3GP6)F2Q5@JN?(ZW+&J.BZFO8U&,1=%>BZJNG3IHO4<K#L9K?6W*
M'T;NG\W8LNVFF"+1>\:3K^K'CZ9\OI^1U@=A\O  'S1%5%5.*<E] 'T
M
M                6U_(4<74EOY*Q'4I0-ZYK$SDCC8WTJYVB!A>]:1K:=(<
MX]R/B+GL^=A]@ZP0<62YJ1NDKD\?(8[Z*??N37T(G,T6R>3R>][U,_=P_P!;
M['/LTTUB9]BQ(Z6>5ROEED57/<YRZJKE75555\32\O,S,ZRDMO;;S>ZLG'B,
M#3DN7I./0Q/98W717O<O!K4UXN<N@B-6W#@OFMTTC676W:[LQA]A,CRE]69+
M=+F^U;5OXJOU)Q; CN*>A7K[2^I%T+-::/<[#ME-O]Z?O7\_+T?:VB;'9
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M-IWK%5]*Q9@BFEIS?JL+Y&(YT;]/MFJO2H8+H
M                 +/(XJAE(O*NPI)I]%_)[?D<G$#!\MLB[4UEQSEMP<_+
M71)43Y.3OF^H9:HT8L]CXW*R1JM>U='-<FBHJ>"HI*'D   R';^:SB7JU&O8
M62.5[6>7+^,:C?%4UXIHG'@I V<8L@
M                           !3EG@@;U3R-C;Z7N1J?7(F8A,1,\D=+N+
M$Q+IYRO7[QKE^OIH:YRU;(Q6EX3<V)5>+WIZU8OYQ'QJI^#959N#$/Y641?O
MFO3\U"?BU\T?"MY+AF4QTGT+<6OH5[47ZBJ9==?-C-+>2X9+')^IO:[\%47\
MPRU8Z/9*
M                              :JW]WVVKL]):&-<F;SK=6^[UWIY$3D
M_P"=E35.'W+=5].AKM>(<7>=VQ8>%?O6]7SRYAWGW"W3ONVEC/7%=78JNKT(
M=8ZL.OW+-5U7[YRJ[UE>;3+QNZWF7<3K>?F\&+&*DV9VX[+;CWV^._9:[%;;
M545;\K?;F;Z(&+IU:_=K[/R\C96DR[&R[7DW'&?NU\_L=8[2V9M[9.-;C-OU
M$@C719YW:.GF>GVTK]$5R_63P1"S$1#V^WVN/!7II'VRGR5H
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M6M B(Q^+CM*C4T3KN.=8>O'7BKI%U#&6T@@
M                    ,6R>R*=V:6S!8DAGE<Z1_4B2,5SEU7AP5./K)U1H
MQJ[LS-5=71,;:C3QB=[6GX+M%^IJ3JC1!SUK%9W19A?"_P"YD:K5X?+H2*0&
M8;"H>9;GR+T]F!OEQK]^_FOS)^:1*89^8I
M                           !%9C-1XM&QM;YMEZ:HS71$3TJ:LF3I;L>
M/J8])NC*/75BQQIX(UNO]MJ5YS66(PU6S\]EG_2M.3\%&M_,1#'XEO-G\*OD
MMY,A>E_5+,KD]"O=I]34QFT^;**1'@MU55755U7TJ8LGP     +^KF<E4T2*
M=RL3[1_MM^OR^8SC):&NV.L^"?H[JAE5([S/)<O]\9JK/G3FGURQ7-'BKVP3
M')D#'LD:CXW(YCDU:YJZHJ>I2PK/0
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MEK6SQ).Q'HR1K7.:CVZZ.1'*FOBH8KT
M                I6*U>U&L5F)DT2\V/:CD^N!C60V+CK&KZ,CJLB_:_JD?
MU%75/JDZHT3&"Q?Y'QT=-51TJ*Y\KVZZ.<Y?7ZM$(2D@      0&XMR?D*6M
M&V%)UE1SI&J[I5&IHB:+HO/B3HA;U-\X>;1+#9*SO%7-ZV_5;JOUAH:IRKE<
M;=T]UM12JOVK7)U?I5XD)78
M   ?'.:U%<Y41J<55>"(!'6<]BZVJ+.DCT^UB]OZZ</KFN<E8;8Q6E%6-W)Q
M2K6^1TJ_G-^R:9S^4-L8/.6.W+<MVP^S-IYC^:)P1-$T1$YE>UM9U6:UBL:0
MH$,@           2>)S,^,?T\9*KE]N+7EZV^A393)-?0U7QQ;TLXKV(;<++
M$#NJ)Z:HOYREZ)B8UA0F)B=)524
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MP5&*A1CY10MTU733J<Y=5<Y=.+G*JJ;HC1ZK%AIBKTTC2$D2W
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M-DQ^P:$C;21W&+')DGQ.ZF11QN35855/QCU316^RWBNJ"9?I(&
M                                              #5V\+?O6=G:BZL
MKHV%OZ%-5_LE4RAC*!) "_JYO+4]$K7)6-3DQ7*YOZ5VJ$":K;[RT6B6(XK#
M?%516.^JU=/[$:&J8K;^H2:):K2PJOBQ4D:G]JOUB-$ZIBMN;!VM$CNL:Y?"
M76/^W1$&B4I')'*WKB>U[%Y.:J*GU4('H
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M0
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M=%31R(DLZ)USR:?=RNU<[CX:Z)X&^*Q#U6#:XL$:4C3VI\E:
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M4 R$
M O!.":KZ -2Y+$9J*>:S<IR(Z1[I'O:G6W5RZK[3=4,F**)      *D4\T#N
MN"1T3_NF.5J_50"4K[ISU;1&W'O:GA*B2:_.Y%7ZY&AJRS:^Y<AF;;ZMJ*-&
M1QK(LK$5JZHJ(B*BJJ>)$PF&5D)                &-;WNK6Q#8&+I)9D:
MWAP7I9[:K]5$)A$L+I[ES=+1(K;WL3[27\8W3T>UJJ?,3HA/T^X$J:-OU&N]
M+X7*U?TKM?S2-$ZLX8[K8U_2K>I$7I=S37P70A+T     'Q51J*JKHB<U4"
MRNY8J^L%#26;DLO-C?D]*_6*]\NG)9IAUXRQBQ?NVU7WB=\B+]JJ^S]1.!6F
MTSS6HK$<EL8L@      &NN^+]SQ]O,@[:RRI:ZXTNK6U\]*2JJ2]'3[7W/5T
M_:Z^!7SZ]/!TNW?#^-'7\WI</KJJJKOI>.O/4Y;W(   >HY)(GMEB>K)&+JU
M[55KD5/%%0$QJZ%[#]X<Y-G:^S-T777J5U%CQMNRY73Q3M35L:R+Q<UZ(K4Z
MM51VB)P+F#+.NDO.]SV%(I.2D:3'-T\=!Y8   *]6W8I2I-6D6-_CIR5/0J<
ME)BTQR8VK$\V68S<E>UI#;T@GY([^]N7Y5Y?.6Z98GFJ7PS').F]7
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MTV[C8:3%3221B=4TGX<CM7N^=3=$1#TV#;8\,:4C1.$K(
M
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M\46]+,*5^K?C\RL]':?2:O!S5]:%RMHMR4K5FO-<F3$
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MQN'J,H8FI#2I1_0KUV-BC3UZ-1$U]9LB'?ICK2-*QI"[)9@
M
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M[["^!?I;JAS[TZ97QFU@
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MYQ8ZD^V1S^#%_P"K1INBL0]#M^WX,/NUX^<\9_3T,T,G0
M
M
M           U3NJQ[QGKCD7V6.2)/\&U&K]=%,H8RAB0    %6"S8JO\RM,^
M%_W4;E:OU@)VGO3-5=&RO9:8GA*WVM/PFZ+]4C0U2L^^H+./L0K6?#;DC<R-
M6JCV(YR::Z^RJ::Z\B-$ZL(,D &S]F4_=<)'(J:/LN=,OR?1;]9-3&4PR A(
M   6&8R"8ZD^5%_'/]B%/OE\?FYFO);IALQUZI:_Y\5YE!T7P
M    !SEWR[),ECGWELRITSMUDRV+@;P>WFZ>)B?;)]NU.?-..NM#-A\8>E[;
MW'_]>2?1/U.9RD],   '=?9W<#-Q]N<%;69)K-:!*-OCJYLM7\7H_P"^5J-=
MQ\%1?$ZN&VM(>#W^+X>>T?/]+.C>H     E,#>]RR#.MW3!+[$OHX\E^939C
MMI+5EKK5GA?<\
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M'6B(B-(>PD
M
M                                      CK6!P]USGV*<;I'JJO>U.A
MRJO-55NBZ@1-C8N'EU6%TL"^"-<CF_V2*OUR=4:(FQV_LMXU+C'^A)6JSZ[>
MH:FB)L[2SU;5?=?-:GVT3FOU^;77ZQ.J-$1/6L5G=%F%\+_N9&JQ?J*B$BD
M    'N&)\\L<,::R2.1C$]*N71 -SUH&5:\5:/\ 4X6-C;\C4T,&2J    -?
M9B>6;(V4D>YS8Y7L8BKP:B.TT1/#D<^\S-I=''$16%@8-@
M   8MG.VVQ-QLE;E<!3DEF1>NS'"V&QJOCYL:-?K\YJMBK/@MX]WFQ^[:7#>
M[,&NVMS9? *]9&XZW-69(O!7LC>J,<J>MNBG*M&DS#W6#)\3'6WG"',6X SG
MMCW+RO;C->]P(MG#6E:S)X_71)&)R>SP21NOLK\RFW'DFDZJ.\V==Q72>$QR
MEVQM[<.(W5B*V<P=EMG'V6ZL>G!S7)S8].;7-7@J*=2MHM&L/#Y<5L5IK:-)
MA*&;4    #.=OY+WZFD<CM;,&C7Z\U;X.+N*^L*&6G3*7-S2
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M_H9Y'&R)C8XFHR-B(UK&HB-1$Y(B(9NE$:/02
M
M
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M
M
M                                            %*S.RM7ELR?0A8Z1
MWR-350-,32OGEDFD7621RO<OK<NJF;%X SS8%/I@MWG)^J.2%B^IB=3OS4,9
M3#,R$@  !\<Y&-5R\FHJK\P&L557*KEYJNJG,=5\                   #
MEGXJJ*Q[CP&2Z>%BE)71VG-:\O7IKIX>=Z3G;F/O1+U?9;?<M'R_I[&@"H]
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M^)"E?ON".46EB61^*>^]%;B=N0PK]J^U9=-]5K&1_P!L8_%4;]_M^K3Z9_\
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M[C9%8AUL6UQ8O=K$?,GB5D
M
M
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M?+IJOBJFB;3+R>XW67/.MYU]CJ/X<_Z-(/VY9_MD+&/D]GV7_EH],MLFQW
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M2O1KQUH&_1BA8V-B?(C41#-?K6*QI$:*X9
M
M
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MDE8
M
M
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M)Z86*['!7E2OT)^ICL?03IHU(:R:::0QMC33A]RB>@RT6JTK7E$0N0S
M
M
M
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MQ6Z;Q,2Z@^&'^0.1_AB?]ZUBQBY/9=A_<3^U/LANHVO0@
M
M
M
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M.VVM-O6:TY3.K(C);
M
M
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M0-CT(%K4J\"_2CC:COPM./USHUC2-',M.LS*X,F(
M
M
M
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M>98IATXRKWS:\(9"6%8
M
M
M
M        ##MRXKW:;WZ!/Q$R_C$3[5Z_G*4\M-)U7<-]8TE &A8
M              $CC</;R3M8TZ($71TSN7S>E393'-FN^2*LJI[>QM5$5T?G
MR)S?+Q3]+R+5<585+9;2DV,9&G3&U&M]#4T3ZQM:=7H
M
M
M
M                                   !3G@BLPO@F;U12)HY")C6-$Q.
MDZL/RFW+%-'3556>NG%4^W:GK1.?S%.^*8Y+M,T3S09I;P
M     +BM1MW%TK0ND\%5$]E/E5>"$Q69Y,9M$<V0XW:^CDER2HJ)R@:O]LJ?
MG%BF'S5KYO)DS&-C:C&-1K&IHUJ)HB(6E5]
M
M
M
M                                !C&X<+&D;K]1BH_76:-B<%1?MM/#
MUE;+C\86L63PEBQ56P               ![CCDE>D<3%>]W)K4557YD$1J3.
MBZCQ5Y]ME-T+F2OT5=4X(U?%?D,XI.NC";QIJSVI5BIUXZT*:,C33UJOBJ_*
M7JQI&CGVMK.JL9,0
M
M
M
M               !!97;D-KJGIZ0V.:LY,<OYRFB^*)Y+%,TQPEB,]>:K*L-
MABQR-YM4J3$QS7(F)Y*1"0            )?%8&SD-)9-8:OW:IQ=^"GYYMI
MCFWH:;Y8KZ67TL?4H1]%:-&Z_2>O%SOE4N5K%>2G:\VYKHR8
M
M
M
M                                                    6M['U<A'
MY=EFJI]%Z<'-^13&U8MS9UO->3%+NV;U=RNK)[Q#X=/!Z)ZT7\XJ6PS');KF
MB>:+?3MQ_JD$C-/NF.3\U#5TRV]4>:BJ*U='(J+Z%(9/@      *T-6S872"
M%\GX#5=^83$3/)$VB.:4K;8R4^BRHVNSTO75WU&Z_7-L8;2TSFK"=I;;H551
M\J+8E3Q?]#7\'[.IOKBB&BV:TIE$1$T3@B&YH
M
M
M
M                                               5$5-%35/0!36O
M Y=71,5?6U%(TA.LJ:T**IHM:)47GK&W[!'3'DGJGS>%Q>-=SJ0_-&U/S$(Z
M*^2>NWF\+AL6[G4C^9-/S!\.ODGXEO-X7 XAVNM5O'T*Y/S%(^'7R3\6WFK0
MXS'0?J5:-%3DY6HJ_57528I6/!C-[3XKM$1$T3@B&;
M
M
M
M
M
M
M
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M3'N?;TVX9=IP9*O+N2"M[]8QD;T?/%6ZFL1\C6Z]"*KTZ>K37PY*!+
M   -6=S_ (@NW7:'+T\)O*>W%>O5O?*Z5:SIVK%YCH^*HJ:+JQ> 3HP?^NWV
M*_9>3_<#_P"Z!H?UV^Q7[+R?[@?_ '0-%2O\:O8ZU8BK16\DLLSVQLUHO1.I
MZZ)]MZP:.AP@         :;[@?$]VK[9[HM;0W18NQYFHR*29M>HZ:/IGC;*
MS1R*FOLN0)T;.VQN+&[NV]C-T89SW8K+UH[E-TK?+>L4S4<WJ:O)=%Y!#3>/
M^,#LSD\]5VW5M9!<G<N1X^%KJ3T9Y\LJ0M17=7!.I>83HWT$
M
M
M
M!KCOIW1A[0]M\GN](VSY1%;3P]:3Z$EZQJD?5HJ:M8B.D<FO%K51.(3#\U=@
M;&WU\1/<>6DEUUG+WE??SF<NJZ1L$".1'2.TXKQ<UD<;=/!$T;Q0RY.N8_@
M[=IB_*EW1FG9KIT]\:E1M7KTY^[K"Y^FOAY_SA&KD'NKVQW7V(WXW"7+:^\P
MI'D,)G*:N@\Z'J7HFC5%ZHWM<U4<WJU:Y."JFBJ2_2GL#W#R7<WM=AMRYNN^
MOGFHZGE>N-86R6*^B><Q-$3IE:K9/931%<J)R#&7YJ=_?Z:]_?PY>_7G!E#J
M7!_ 9M++X/&Y5^[LC%+>J06G1I7@5K731M>J)QU5$50C5J/OG\(VX^T>"?N_
M$99FX]KUU8W(/\A:MNKYCD8U[HT?(UT?4J(KFNU153V=.(3$MD_!#WLR<F3=
MV>W%:?9IRPR6=KRS/5SX75V]<M5NO%6+&CI&)]KTN\%X$3#:?QN;RR^U^T,6
M-Q$KJ[MR9"/&7IF+H[W/R99I&(J<4ZUC:UWI;U)XA$.:_A:^&W ]YZF9W'NW
M(6J^#QD[:->GCW,CFFLN8DCG/DD9(C6-:YNB(W5RKS33B93+&_B9['4NQV[<
M9!M^_8M[?S-=]K'NMN8MJ&:N]&RQN=&UB.1.ICFNZ6\]/M=5$2[X^''=^4WS
MV5VEN+-R.GRTM>6K:L2=2OE=0L2U$D<YWTG/2)'.=]TJAC+:80XFR'QA=S*G
M>JUVXCQ6"7!P;IDV\RPZO<6VM1F06HCU<EQ&>9T)KKY?3U?:Z< RT=LAB  .
M$O\ B$?ZXV'^ULE^N5PRAA?PY_"[@>]FR+^ZLIG[F*L4\K-C&UZT44C',BKU
MYT>JOXZJLRI\P)EM[_\ I^;/_GCD_P!SU_L@U97VU^#7;/;;?&'WO1W->O6L
M/))+'5F@A9&]9(GQ*BJU=4T1^H1JO/C!WE@X>R^Y]NTL[33/RRT(+&+CM1>^
M^6MN&1[5A1WF(BM35W#Z/J!#D/X7-B]K=[;LR[>Z]RO!A<?2;)4J6[WY-CGL
M22HWC*DL3UZ6HOLM=X^H,I=1]SX.TG;'X==[[3[89K'5FY2);,="#)QV[$SK
MLD%>;HZI7R/1T+.GQ]D,7)7PS[,[=;W[B38_NA<@J;9I8V:\D=JXF/BL6&30
M1,A6;S(W)JDKGZ,<CEZ?E#*7Z-]I]@=L]AX6XWM:R'\A96RMJ6:M<=D(G2L1
M(NELSY)55&].FG6NBZ^(8I[<N^]D[-1B[LW%C<(LB:Q,R%N&L]Z<O89(Y'._
M0H$/FV]_[&WBKF[4W)C,U*Q%=)%0N0V)6-1=-7,C<KF_.@&1 >7O9&QTDCD9
M&Q%<][ET:C4XJJJO)$ P:WWK[/T;?N-O?>!BM(J-<Q<E57I<JZ:/5)%1JIX]
M2IH$Z,OQ>7Q6<IQY'"WJ^2Q\OZE;IRLL0NT^Y?&KFK]4(:@^)_N)_$OM+N;^
M+^XH,3OAL5)<?#%8B9D?*GO012.BB<O7QB63VFMX<514TU"8<J_!%NC%8KN5
MN?*;JS5>DMS$/ZKN3M,A6:=]N%[M9)W)U/7BY>.H3+]#:-ZCDZD5_&V8KE&P
MWK@M5Y&RQ2-]+7L545/D4,5IG-Q[>VS52]N3+4L/15>E+.1LQ5(E=Z.N9S4U
M^<#'L+W>[5[BMLQ^$WGA;U^14;%4BOUUF>YW!$8Q7HYWZ% ,T B\SN3;NW6P
MOW!EZ6)985R0.OV8JJ2*S3J1JRN;KIJFN@%I+OG9<&$FW++N+&-V[7?Y4V6]
M\@6HR1-/865']'5Q3V==0&V=\;-WI%)-M+/X_-LA_5_R?:BLNCXZ)UMC<JMU
M\.I )\#1?>_X9<%WOW!CMP97.V\5-CJ?N#(:L4<C7-25\O4JOXZZOT"8ESEW
MK^#W;?:SMEG-^8_<M[(6\3[IY=2>&%D;_>KD-9=7-XIHDJN^8)B6F?A[[38[
MO-OR3:&3R,V,K,Q\]]+-9C)']4+XF(W1_#1?,"9=55/@$VA4MP6V[OR3G02,
ME1JUX-%5CD=IS]01JZ]#$  83E^\7:C VG4<QO7"5+S%5LE:3(5_-8YO-'L1
MZJU?PD0&C(\'N/;VYJJWMMY:EF**+TK9QUF*W$CO1UPN<FOS@28$'N/>FT-G
MPMGW7GL?A(I$58UR%J&JK].?0DCFJ[]"!:;<[C; WA+[OM;=&*S%K17+6HW8
M)YT1O-5C8]7HG#T 9.!^7_QF_P!/^?\ VMCOWG$&<.^NP7]"FP?X#H_K+0QE
M^7^S/Z8=O?\ J6G^_P!@9/V&#
M
M
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MUL=^\X@RAWUV"_H4V#_ =']9:&,OR_V9_3#M[_U+3_?[ R?L,&
M
M
M
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M^P,G[#!@
M
M
M                    &(=S^WV([H['RVR<RY8J^1C3R+341SZ]F-4?#,U.
M&O0]$54U3J35OB!^7^7PG=+X:^XL<JK+B,_CGN7'Y.)JOIW:[N"NC5[>F6)[
M5T<U4X<G(CDX&?-NI?C^[@?DOR$VOB/RQT=/OO79\CKT^EY'7K\WFA&C0]'&
M]ROB"[ARR1,FSNZ\Q*U]VVK>F&"+@Q'R*U$9%#&U$1$Y(B:(FNB!+]3^V.P<
M;VQV+AMDXM?,AQD'3/9TZ5GLR*LDTJIX=<CG*B:\$T3P#!^6O?W^FO?W\.7O
MUYP9PW)BOCN[B8G%TL5#MO"OAHUXJL;WI;ZG-A8C$5=)T3540(T:Y[H?$=W5
M[U5H=N9A\%;$22L<W!X:"2..Q,U4\OKZWRRR*B\6MZ^GJXZ:HFA.CJ;X._A\
MRVPHK/<;?%-U+<N1A6KB,9,FDU6F]4<^25NOLR2JB(C5]IC4X\7*B$3*>^,W
MM)F>XNQ\=N#;-9][.[4EGF6A"Q7SSTK36),D;6ZJY[%B8Y&Z<4ZM./!2(<K?
M#W\3>5['5[^WK^)_+6U[T_O2U6R^[V:UKI2-[XW.:]JHYK&HYCD3BB*BIQU,
MIA$=^.^^?^(#/XF*'$KC\5C>N'#X>!SK4\D]I6(][W-8WK>_H:UK6LX<DU55
M51$.[_A>[6W^U/:JIBLW$D.X\M/)ELM!P5899VL9'"KDUU5D<;.I$X(_JT]*
MF,MSA#E&[\%OOG=6QW-_COT>?N!^X_R7^2M=.NZMSR/.]]3737HZ_+]?3X!E
MJZN#$  <)?\ $(_UQL/]K9+]<KAE#4'9KXG]V]E=L6]K8'#X[(4[E^3)OFO)
M/YJ2RPPPJU/*D8G2B0M7EXJ$S#8G]?[N3_-G!_4M_P"7"-&4]M?C6W[O7N!M
MK:-_;^(KTLUD:]&Q/ EKS6,GD1BN9U3*FJ:\-4!HW%\9O] &?_;.._?D01#0
M/_#\_ECO'^#*_P"^%"9=-?%1_0!O;]K5_P!^0!$.2O@&_IAS?_IJU^_Z 3+J
MCXINT]_NQVQEI8&))MSX6PW)XJ'5&NG5C7,E@1R\$5['*K?2]K4X<PB'$7P_
M=_LQV!S>5QV4Q4M_;^1>UN5Q;G+7M5[5=7-22-'IHCT15:]CD3JT3BG2&4PS
M7O5\9FX][+C*7;3\H;1H495LV+OO#66[4G2K6QO;%JU(FZJJM5SD<NBJB=*!
M$0ZP^&E>[=OM^W-]W<G-;RF4D2;%4;4$$$]:BC?9=*L4<;E?*JJ[2155K>GD
MNJ!$N,/BW[-Y7M]W$R&[J%9[]G;GLOOU[D;56.O=G59)Z[W(FC55ZN?&G#5J
MZ)KTJ&42S_:7Q\9K$[8@QFY]K-S>X:D20MRT=WW5EA6IHU\T:PR*C^&KU:[1
MR\D:$:-&;6PF^OB*[P/GC5ZYC.7%NYC(UVN;#0J*Y$>_75>ED;-&1HKM5]EN
MJJH3R=__ !.[?L6/ARW9A,-$Z7W&E2E8Q55[TK8VW7GD55XJJMBA<Y5]08PX
M&^'[O6O8[==_<+\/^6ZV1H/H2UDG]U>U5D9*U[7]$B<V:*BM\=?#13*8=Q[J
MPZ_%3\.56]5K1XS-Y1GY5PT$DBR107Z<LL*,=)TMU1[4DB5W3PZM=.&@8\G#
M';3N1OSX<-^W)78QT5QJ+2SNW\@U\*2QM=U(BJG%KFK[4<B:IQ\6KQ,N;;W=
M#XXLYO+:MS;.T]NIMU^3A?6OY*6W[W.V&5.E[($;%$C5<FK>M=5T7@B+HH1H
MJ?!GV(S&9W13[L;CJ.K;9Q"NDP;9D5KKMU4Z6RL:NBK%%JKNODKT1$UT=H)E
MFG_$(_U/L/\ ;.2_6ZX(3GP _P!&VYOX<7]Z0 EUJ&(  TA\7W_[.V\O_#/_
M *K4"8<E? K_ $UV/X#N_KU<,I?I(&   X!^-WLWE,?NA>[6$JOL8++1Q0YY
M8F*[W6Y Q(62OZ4]F.5C6)U+]NBZKJY RB4;VD^-C,; V?2VAN;;W\88L3"V
MMBKT5OW29M:).F.&5'12H[H31K7II[*(BHJ\0:-1;JW'OKXD.["7J=!9,_F)
M(JF+QE57.CJ58>#$5ZIJC6)K))(NB:JYW!."$\G>O=#L-+N3X>:O:[%3>^Y_
M;U:K8Q-FP[]7R%)BH_5SU]E9D?*QNJZ-ZTUX(&.KB'LAWEW'\.N\LI%D,3)8
MHV]*6X<%.KJMALE9SNA[>I%Z9(E<Y-'-T5%5.&J.0RF-6R^]7QIY?>>/I8CM
ME#D-JLAG;:MY9T[8[DO2US4A1L*N:V/5W4[5Z]6B<$TXD1#H_P"%2UWCS6RY
M]S]U\M8N5\FL2[<HVX((IV5&-576'NCB9(Y)E<WH\QWT6]7)R*$2X[^,W^G_
M #_[6QW[SB#*'?78+^A38/\  =']9:&,OR_V9_3#M[_U+3_?[ R?L,&
M
M
M
M         (S/;<V_NG'/Q.Y<75R^,D75]2]#'8BZDY.Z9$5$5/!4XH!K1?A<
M[!.F\]=D4^OJZM$EM(S777Z"3=.GJTT"=6Q=M[1VOLZC^3=J8:GAJ*JBN@HP
M1UVN<GVS^A$5R\>;M5"$R!@F4[+=I<UD;66RVR\1=R=V1T]NW/3B?++*]=7/
M>Y4U557FH3JM/]P793^8.#_<,/\ <@U9#MWMYL+:,B3[7VQBL-81.GWBA2@K
MS*BIHNLD;$<O!?%0ADH #76[>P_9_?-R3([FVA0M9&;7S[D+7T[$BNX*Z22J
MZ)SG??.55"=5SLWLMVK[?VDO[1VK1QV1:BM9>Z73VFM7@J-FG=(]NOCH[B#5
MG@0     !C6Z>WNQM[R5I=X;>H9N2DCVU'WX&3K$V145R-ZT737I37Y ,>_W
M!=E/Y@X/]PP_W(3J?[@NRG\P<'^X8?[D&J[Q?9;M+A<C5RV)V7B*63I2-GJ6
MX*<3)8I6+JU['(FJ*B\E!JR?<&W,#NO%RX3<N.KY7$3*QTU*Y&V:%SHW(]JJ
MUVJ+HJ(J!",VOVYV'LFQ8M;0VYC\)9M,2*S+0KL@=(QJ]2-<K$35$7B!,9K"
M8C<>+L83/4H<CB+:(VU2LL26&1K7(]$<UW!=%1% @]L=L>WFR[\F4VEMC'87
M(S0NK2VJ-:."5T#W->K%<Q$7I5S&KIZD RL#!=X=F>UF_K7O^[=JT,CD>".O
M+&L-IR-X(CYH58]R)X(YR@U6&UNP'9O9=Z')[=V?1KY&MHM>W,DER:-S4T1S
M'VGRJUWWR<?6$ZMDA"VOX^AE:<V.RE6&]C[+5CL5+,;9H9&+S:]CT5KD]2H!
MJBU\+/8&W9][EV35;+JKNF&>W!%JY-%_%Q3-9IZ$Z> 3JV+MC9VU=E8_\E;2
MPU/"T%5'/AI0LA1[T33J>K417NT^V<JJ$)IS6O:YCVHYCD5'-5-45%YHJ :F
MO_#'V&R61?E+6R*26I'.>YL#[%:#5RHJ_B(961)R^X_-"=6R<%@,+MC$UL#M
MW'P8O#4T<VK1J1MAAC1[E>[1K41-7.<KG+XJJJO%0A$;O[;["W]$V+>6W:.9
M5B=,4UJ%KIXVZZZ,F321B?@N0#$L/\-78K!76Y#'[(H.LL=UL6VLUUB.YZI'
M:DE9P\/9X!.K:;&,C8V.-J,C8B-8QJ:-1J<$1$3DB!" W3L79N]XZT6\,%2S
M<=)7NJ,OP,G2)TB(CE;UHNFO2FOR 5=K[,VILJI-0VCAJF%I6)//GKT86P,?
M+THWK<C$35=$1-0)P   CL]@,)NC%6,%N*A!E,-;Z/>:-MB2PR>4]LC.ICM4
M7I>UKD]: 06VNUO;G9V17+;5VOC</DW1N@6W2K1PRK$]45S.IJ(NBJU. &7
M  'B6**>)\,S&R0R-5DD;T1S7-<FBHJ+P5%0#5&5^&/L-F;CKUW9%)EA[_,<
ME1]BE'U:JOZG6EC9IQY=.@3JS/9W;G8O;^N^MLS;]+#,E1&SR58D2:5&\422
M9=9'Z>'6Y0ADX&%[S[2=M.X4C;&\=L4<K<:B-2[)'Y=KI;R;Y\2LDZ4^YZM
M(3;OPZ]D]JWHLEA=ET&7H%1\,UGS;JL>FJHYOO3Y41R:\%3B$ZMGA##=P=I>
MV6Z\I+F]R[3Q>5R\R,;-=N58YIG-C:C&HKG(JKHB(B 9/B\7CL+CJN)Q-6.E
MC*4;8*E2!J,BBB8FC6,:G!$1.2 8;7[)=H:E^+*5MDX>+(P3-LPVF4XDE9.Q
MW6UZ.1NJ.1R:ZA.K/0@
M
M
M
M
M
M
M
M
M
9                              ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm2225088d1-lc_summary4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_summary4clr.jpg
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M .<  0 !! ,!               ' 04&" (#! D! 0$  P$! 0$
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M!MY'13ZJP\4K3TN8_(6S7 CL(,E0@N>0U!@<3+%;Y7*6EC//_ Q75Q%"]_\
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M+-/"Q_.2UFDMY1[#XG-</:*"&LGX2=D\SD9LOE<7?WF3N'!\UW-E+Y\KW
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M&[9[#:@.I;#3T<>2,C9N@O>ZVZVN+@>X)[OF?VJM1*C(F1L$<8#&- :QK10
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M=*9C.W.F<7E8KK.6<)N+FTC#R61!S6=75T]/-P'!R#( 7$CR=B#D@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M##!)%'+0%HJ]G8J2R'PL;[W6[6 O<9J-W_2K"F 3R^B!<QSM?1[0T U!B<7
MCA4<2@\?B-WRRFD\Y@MLM%W1M=4YZXMX+F\8&.-O;WDH@:6 U/4274/"E.!0
M>3>.XU1L9IS#[@:>U'E\CW-U;C.X[)W]U?P7,4KVM<UK+J65D50Z@Z&\.:">
M=!ZOL-=:2Q6JL>3ZOD(1(6D@EKP2QP-"1[H%09)WK1Y2?)VH!E;2J"@F830<
MT'8@(*$T05KPJ@50<2]M5**\][?V>/MI;R^F;!:P#JEFD(:UK?*25;;9NFD<
MQ NH/%WMKA,G)865EELY P,?\8XV&W?:R!XK1AFN8GU';5@6ZQ[/J+N<4\K'
MG/9':OF@O$WMSKN\FQP]=P%XUT++9F:C@@]9=,7#ZT89IAZ'2.KK+?=#GQIC
MZC:\^.VM.'R=CU9EMNY2F5CJMKQ]M:NV*11]7*J]!5!5 0$!!Y[B_L;0@75S
M% X\A(]K"?HD(*P7EK=#JM9F3M'-T;@\?2*#B<A8-E$!NHN_/*+O&]9]JM4'
M9)<0PL[R9[8V=KGD-'T2@ZHKZRNCTV]Q%,>T,>U_[!*#7;QFZ;P%SM->9Z;&
MVS\W;W4'<Y$PL]9:WHD;TB6G5TG]K6BHE/9^YM;79[;Y]S+'"#IO#>E(YK ?
MXA#Y5"6>,FBE9WL;P^/L>T@CZ(089F]M]O\ .:UQ>M\MCX)=88L-&/NWN E:
M(W%S/1KZ7222VO*IH@S44'&O!!T29&PB>(Y;J)DA^H=(T'Z!*#C>6=CD[22S
MOX8[RQG [V&5K9(G@$$!S2""*A!J1X><9CL+XG]U,;BK:.TQT%B.YM8&AD3
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M2N*=B"J @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @LNI]2XG2&$O=19N<08VQ8Z29YY^B*T'E)IP
M""$MK-N\KK'6=SOAN);&',2/$.F,5(WK%K81ATD;RY_$.+YGD-#6TH#Q5E$L
MY;(X[6&E-68K$2&Z?%#>X>?HXCUF2T#BUOEX3-16D7@KLCCMZ<_CB*&UM+F
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M("#B\.+:-Y^=!U=RZG*GL'^^@KW1\@X<O:Y(.<;2UM"BN:(* J" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""T:J_JQF_
MN"Z^TN0?-?\ 1Q?EOS_]E+S^D<<@^GZ @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M5D$&<Q\LTK@R.-EU"Y[G.-   ZI)/"@07=KJ\:\$'(<D%4! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$!!:-5?U8S?W!=?:7(/FO\ HXORWY_^REY_2..0?3] 04<Z
M@\YY(.!>?)Q[5%4$A[:>?GSJJ@9J<A[?8@Q_6&ML+HG#2YO./>VTBH.F)H=(
MXDTHT%S1]-?#-FMQVUN;'0:#)K,L8\=*SW_U+5/4'BFUW>WDXT[#;X^P[Z0V
MDDD;9)G6_4>[[UKNMH=TTJ&FE5HLVY3/JUA^O;?_  +';$3GI=PCE==\_9#)
M="^*B]?DHK+75K%'CG,##D+1I=)WG[>1A+0&>7H!/F61AW*RD1=$U_KY6DW7
M^#9\47Y,4V=-M9B*W5I_]>?SMH;*]AOH&7%JX/@D'5&X=H]I;JVZ+HK#\OR6
M39=-L\X=_>5!H*T5>%#-R\OD*%'8TU *J*H" @IU<:((MW^UK<Z1V]OHL0'O
MU)G0[$8:*(5D]:O6&%CQ4@ ,>]A)JK COP;;BSZGT'<Z4S4DCM0Z>NYXG&0]
M1=:N[MX)<237O))$&R<D,4L;X96"2&1I8^-P!:YKA0@@\""H-/?%[M=A\<-*
MZHT#B;?%ZTN\KZN)[%C+4R-@M)KBKNZ#07#N1Q/'L5$B^&K?ANYF%=IS4;C!
MKK$-='=Q/'&:.!S8^\#J\7>DWJK0UKSYH)<UIIO ZCP5]!G,9;9")MK-T"ZA
MCF+?0)X%X-.78@CCPOZ>P6-VATQD['&6UMD;NRB?=7L4,;)Y'2,:YW5( '&I
MXFI084[5<^\N_5YH)]Q([;_2D8EO\>UQ;%>W)JX"9H-)(R&@=+^'/@JCT;U1
M1;$7&GMQ=!0,PNG[>ZBM]38.P:+:RN;9\T;.KU:,-C,G3([TJ \!QX!14B[H
M;O6.BMI9=PK;TY+JVC./:!4]_= ,9P)IZ#G"M?)VH,6VAVRQ&KM 6NJ=QK:/
M46L,Z9[F;)9%HNY[8=Z^.)MM),"Z(-C:RG=]/:B/#L7N!EK77NK=E]37LEY<
M:<E,F%NKASII764SFRQQ.D=5SBUDP ZJT#:515^U5M_FMXM29&TU!E+O&[>8
MJ1T%EC[&>6VEN[J,]U*^;NBRK&EKPVKSP=R1&O\ O-M/F_#=!8[A;39R]LL1
M'/W%Y8.N)3'WDH+F]3"XB1M&NKU>;@BMS-$:C;J_2&$U0QAC;F+.*]:P\"T3
M-#@*<?*H(/W1?I/>#7[MJ=090V6GL+%'<7K \Q^L7MR]S8HP6G_-&*IK0>EV
MJH]NC?"-M1I74.,U3CFRW=SC9V75J)GNEB[Z%P<QU'.<*M< 1P16P08&CI;P
M X #D H.2 @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(+1JK^K&;^X+K[2Y!\U_T
M<7Y;\_\ V4O/Z1QR#Z?H"#A("1P06G/Y>WT_B+W,WW4;2Q@DN96Q@.>61-+S
MT@D5-!PXKQ==$167VQ8YONBV.<H>B\5VV4K:B+* C@>JVCK]*8K67;ECMGE/
MT>=VF'^%Z_+;U6]%/]I\SD[Q4;9.-!%DZ>>VC^%4_=,?V;OH\[Z1_!]PGA6S
M_P"T^9!N^FZ6+W+O<4S!NNH\9CQ*703UC:^1_2&N+ YS:@=0KYUJ=9JO:SPK
M$/T?^)?QV_;XONS4ZII2G'OK_9$O 5(X$<R/*M8_1%*<./#^^J3#8W9WQ 8'
M1VE&8'59NY)+64LL1:0MD#;;I;T@ESV\:]2W>EUUN*SIF)GP\[\8_D'\1U6I
MU=^7%TTOGMG_ (2!+XK-M!01Q9/_ -69\*LV-SQ]UWT>=S?P1KXYS9_]I\SE
M8^*#;K(7]EBH(<GZU?SQVT -O&&A\KPT%Q[WEQ\B]V[CCN[)^CSL35?Q+6Z>
MR;[IMI%9Y]WS)T8X.:"%L8NJXV8<E[00$'$UJ3Y$$,,$VOM[Y ]O5I[0<+3$
M\FH?E+AQZQT\OK8BC=7SJH@:Y \/_BJB=&#!I75T4'1&WT(P;DOMFM(;0&DC
M"_EVHO8W@9(R1K7L/4UP!:1V@\5!#>^?]8=JPX5!U,X?S9><U8$+^(W:7,[;
MZCBWUVP:+.6"5OQS:6OUAH[YK@^0B/I!#G =7E<ZIJ@G?:_=C$[N[;W&>L:1
MW\-F8LK:_P#@;DPGJ \K2X.Z?80<?#;7Y%-'G_Z?!P_\6U!KMX%KY^>UAN#G
M+L%U[)!CW]3G%Y!<Z=I](\34!%E,/C,CC=L'G7.:#(RYQ_02!4=5Y$#0]E5"
M&NV]&?O+KPI;5F0N_P!IRSLGJ\GA!)(YM?+[@<U2.;>G1%O%;:,T_# WIC&/
MM7!O(5?$UQ/T24E&H$N2DQGCYO+&V;T0Y"2SAF#3T"@P<,M2!SJYJ+V-W:&G
ME\JB->_% V;6F-PNT.%<TZCU#=MN0'>YCM;=KFR.<>=*RL[%8$Z8/#VNG\/8
MX2RJ+2PA9;VX(^IB%!P4&O6O?!GH;5UY?YRQRE_99Z\+IG7<\CKLNFZ:-)+W
MM[0.*HPW9C6&XFSVZ=ILGN5=RW^,R8:_"WDLLEP:W!,<?2Z0UZ72,Z:<*<4&
MY2@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @M&JOZL9O[@NOM+D'S7_1Q?EOS
M_P#92\_I''(/I^@(.,@JWR4[5!YWL;*PL> YCA0CF"$>HFCR?$^/ XV[:=M6
M@=BG3#Z^WO[U'8K&LX>K,H1Q]$*=$3-3V]_>UF\4&@Y8V8[5>'L@;-ADBRLD
M;27CK#>[D?04#!T=-2>9 [5H=RQ37J[(?K'\%W>VR^[!?,S=?,=/S1-6M(=P
MJ>SZ/M+0T?M*CW!C2YW)HJ:=BML5E\\N2,=LW3RAN]X?MOOP;T)!-EHB<AE)
M'WLD%Q#W,D'6&L[MP+G5(+*]7#GR76:/!%N.*QQ?S3_)-TG5:R^;9]&)X)6=
MB<<YKJVK.7[4<!YEGTB7+QEOCE+J9B<>'ME; QKP0X/ ',</:Y+U1ZG/?,4J
MNL?N48ZO:515 08SK[5EIH?266U3>-ZX\= ^=L50TR/8TD,:37BZG#@@C;;O
M9SNM-PY/)Z@S^/SF8<[(92+'Y*:SA-Q/3CW8Y'I#>*LRB._$[L<':#DU7B,S
MF,CGL$^.XA.5OIKWHB:^KBSJ]R6@N=6B+"8]A->1;@[8X3,$GUZ*%MK>LJ'%
MLD7HCB.=6AIY)(M.^?\ 6':G^T[OZ,O$@2_=VT%Y;26MRP202M+)&.X@@^50
M:&[GZ0U!X7=>/USHT.N-"9LSQW>/'5$QGK!+A$7>FT4K1AIR;R\E.;:#PV?D
M3T?Y/B^W\W^;:DB%?#EB9=O=_MP=$731$^^AMI;0?MXK?O27-K0D5)09;XTK
M^:3;6TTM:U?>ZAO8(+:$'B^2*X@+0&\2>+D&-;\[97\?ABP..M(C)=:=BANG
MQCJ)#9WA\G"GU(<:H0V$VESL.I=M].9>W<'Q2V;80YM"*VKG0'B//&DC6[;+
M#SZU\6VN-9BKK+"O9$)B2X&:"VAM.CJY5 '+S(-FM>ZYQ^B,9%-*PW66OI/5
M<5CHB.^N+AS7.#6@U)H&DF@*"V;>Z%N,))=ZKU+/Z_K7-=,M[<EAI;,?5_JL
M742>B,NZ:^C6@]$<DE&:6>1L;XSML9XYS:RNM[D1D.Z)F>Z8ZG(CR**]7L]G
M:@@;>3 6FJMW-K,;8BN:Q&4ASE\\#BVPLWNE9U$<:%\;P*\%1/B@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @M&JOZL9O[@NOM+D'S7_1Q?EOS_\ 92\_I''(
M/I^@(%*H.)8T\2$%>AH[$% QH% ."#IN[2WN[:6VG9UP2@MD9Y6NYA>;K8NB
MCW9=-LUA#EWX8=L+FX?<-CO;5DA]&WMYVMB:#Q :#&XT'LK5Y-LQ7S6MT>'F
M=QI?YKN&GQQCMZ*6Q$<;>/#YUUTKX?\ ;K2>3BR]E:W%S?V\D<UK+>2B3NGQ
MGJ#F=+6<:TK7R+WAT&/%-8F9\O\ X8.Y_P HUFX6Q;EZ:17U8IS^>>Y*C0.9
M'%;*')RJ6@\PJBG=LYT05  Y(*H" @AW>#:_<#<DVEEBM5V>'P5I,+HV4EA)
M</EE8X.CZWMN& AM/VO:51)6G;3-V6*@M=07<%]D8@&NN+2%UO$6M  HQSY"
M.7[906O7^G]0:GTUD,!I[)6V+DR4$UI<7%W;NNF]S/&8W]+6214-'&G%40[L
M=X>]>;*W,\%CK.RO\!?2B:_L),=(QSB&AI<Q_K)#20T"I:4)97N-MCN%KC.X
M')V6J<?C[/3M\<C8VS\=+,XR&)\-'N%RP'T)'#D@E/%1Y>&U:S,W$-U>CW4M
MO&8(S[#7.>?IJ#P:OTIB-:Z?O=-9R$3XZ^88Y&'SC@1["#Q[=Z.CT#H_&:3B
MN/6H,7"RWBGITES6-#0>9\B"T:YVQM]3Y?'ZMQ%V<1K;%^A99/I[R-T1-3'+
M&"TN94<@YJM46G%[1Y#)ZKQ^MMR,O%G\[A2WXFCL8'6=E YKB_K[I\DSB_J-
M:]?8."5$H7=I!?6DUC=,$EM<1OAGC/)T<C2UP/L@J*B&SV@U5I.WNM/[=:G@
MQ.C[R220X^^M'7<\)N/3E%O*R6$,!>7.XL=2I5JC-= ;>X3;G!G#X)KC-.Y]
MQ?7DQ#I;BZE<Y[Y'D #W3S04Y(J$=:^'#=35^N;S6\&YD6-N'NFBQ\,..<3;
MVDCVN$749S6@CCZC3B6\@@M[_#+O7(PQR[R/?&[@YGQ=S_\ +)43MH7;JVT?
MH*VT7)<NNY.XZ,C?-'=NFG>QK))0T]73U=-:<4J(HT1X<M<[=7LMOH_<)]II
M.7GB9+8R2!W:YLHD:*T\K4J)GTCHC':4]8NFS37^:O36^REXX/N)J4 !+0T=
M(#1042HRE0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 06C57]6,W]P77VER#YK
M_HXORWY_^REY_2..0?3] 0$! 0$%"*B@X(*=*E%J= IPX)0JJ!3@D"JJ" @(
M" @XEO- Z>%*E!6G&M?:0.D(*%M10H'2?+[*!T_005 H@IT\*505Z>'- I44
MJ@ITFM:^T@J6H %.7-!5!2G"B!3LJ@H&\D') 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'6Z7I)!'+
MMKP_[B!WH/(#Z*!WH/9]'@@=Z/)Y^/!!S:X.%1R050$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0*A 0$! 0$! 0$! 0$! 0$! 0$!!:-5?U8S
M?W!=?:7(/FO^CB_+?G_[*7G](XY!]/T! 0$! 0$! 0$! 0$! 0$! 0$! 0*H
M%0@(" @(" @5"!4(%04! 0*H" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @B_=7<Z]V[FQS;73MYG6W_
M 'Q<;)KG=SW'=^[Z6N]UWG#V%\[[^EL=)I;<W.:(VF\4>2M(77%SH+)PP1BL
MDDK7,8 /JBXL  6'?JXM['08?X_&6[IMOB9^92V\4V0NHFSV^A,G<0/]*.:(
M.>UP\H+6$%2S5Q=V)F_CLXYI-T5\L>=(VV>ZM[N'=W5O/IF]P8MF=X);UK@U
MP-!05:WCQ6;;?U.?U6EC#VU2E&"& 'GYU]&O<D! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$%'4(H>1YH.-17C]#SH/#>9K#X\D9#(6UK2M1-,R/@/
M\9P0==MJ+3]XX-L\K9W+B:-;%<1/)/D]%Q07)IK0]G91!S0$! 0$! 0$! 0$
M! 0$! 0$%HU5_5C-_<%U]I<@^:_Z.+\M^?\ [*7G](XY!]/T! 4!4$! *#I,
ML8)J1PX$^<+S5YJHV0.<0*&E*C^\D3$K+N;RYU\ZJPJE05!205! 0$! 0$'$
MBI\_8@M&IM2XC2>&GSF;F[G'VYC;(^A)+I7MC:&M:"2:N[ @NPKR^B>""*]+
M?+<-U]1C5/JWR5]V?P?Z/5>\Z^MW1_!_7J]/N^]X<NGM5$K-Y*#C,U[XGLC>
M8WN!#9  2TD<" X$5'G0:E;]:\W@T!N7I#36F]<SQ8G4\]K;R,EQ^*D?";FZ
M[@ECG6;C0#CZ5>*I"2=:X;?'2>"N,]IC7$FI)[&(3W&+R]GC(&R-8:R=#K2R
M@/!M7<7CEY:(.[8O>ZUWJTW<M9U8K55B.[R4#(J"-_41UQB3O&D4Z?=>7D@B
M/7NO=[,/O_B=J\/KV:'"YJ:..*63'8ITT0DA$I'4;)U:%U!4%!.<NA]UK>W#
MK'<R]N[WH ?%?6&'9;AYI4@P8]K_ &.*"+;;Q$ZUVSUK;Z*WUQ\$$%\1ZAGL
M<P/B>SJ+'/<(W$@ ])H(^KCR0;00RQS,$D3VR,?Z37,(<TCS$<"H.P\D'1-*
MZ.&1[(S-(QKG,A80USW-%0T%Q !/G-$&MNN=Y]T,'O#I70LEC!A<'FGRRM=2
M&XN988H7.(<>J9K?2_:T5&S#?94%4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0=;XXW\7L#O9 *DP]1=,<
MD:[\6\+-JM1N9&UKA:24<&@$$-*QL\1T2W6T9+OS-O%Y/#];V[MJ-.N?$PO,
M1J]S02:.*N"(Z(>=UR7?F)XRE5D4;/<,#:_M119%&HFZ9YNP*O @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @X2R,BC=)(0UC 7.<>0 XE!K+N5NQ
MNCKG)3:1V%Q4EQ;P$MR>IYV,BMAV!L#I"2X5#JN:VO+RJB%+GPA>(O5AEN<[
MJ;'.DDXOBR&2R$GNN) #;:1M$6L.J#P5;]X)G>XC4V'@>QW4UMCD<C"_J_;"
MEFP=GE46L),T9K#Q$;+.MK+=#$RZ@T7UTFRMD6W<T#7D N)>62N#?=&O8J\M
MLL/E['.XRUR^,E$]A>1B6&0=K3P^B"*%0>] 0$! 0$! 0$! 0$! 0$!!:-5?
MU8S?W!=?:7(/FO\ HXORWY_^REY_2..0?3] 04->Q!2OD*@K4JCB7T-.WSKS
M7C08'N1KO\%,>V&!HEO[HED+.(Z2WB7$\. Y+5;CKHP6TCG+6ZW5^QMX<9E
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M=L$<S./U36N</IJ#VH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @((WWZ_)/J7[D?\ N2L?4>I+<;/^IM>?
MP]?DDTY_H7?NBF#U(3=?U$I060U @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @T[UYXZ\7@LS<8C26F_CFWMWN8_)2WIMVDM=3T8_5GU%.->M
M58AB7ZP#.5 _ J#S 9 _^RJ%&Q'AIW6R^\.C\WJO+V[;1[,W-96UJQYD;'!%
M9VD@ <0*^E(X\@B432@(" @(" @(" @(" @(" @(+1JK^K&;^X+K[2Y!\U_T
M<7Y;\_\ V4O/Z1QR#Z?H" @(""A )JB4<9&->PM>*M/,%>9BO-96*]T9I?(2
M=]>8JVEFXDN=&TDD\>9"Q+M%@NFLVQ7R,:_38[^-UL2]&,TYA<.",;90VX)#
MJ1L#>(Y<O97O'IL>/U8B'K'ALL]6(A=V^3R+*?=5 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0#R*#HX@DUK
M[*@-<2*=G&I\R*[&]IX\?H>TD(Y*CR%P<>/U/!U>//S>?RH.Z'B:]IXG_N*#
MN5! 0$! 0$! 0$! 0$! 0$! 0$! 0$$;[]?DGU-]R/\ W)6/J/4EN-G_ %-K
MS^'K\D>G?]"[]T4P>I";K^HE*"R&H$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$&D^B= ^'S;C,ZCT;NQ%C+G,V]X9\??Y6:%D;K%[GM8UI+H
MZ/!8>L5/-O+MHS?U3P4<_5]+ ^3UNW^'02/L$S;J/!ZE;M>(QID9Z6H@<QT
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M#4506G57]6,W]P77VER#YK_HXORWY_\ LI>?TCCD'T_0$! 0$! YH*40.D(
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M"HY(%16B 2!P0*A J$"H""M04! 0$! 0*A!2H05J$! J$"H0*A!3J"!4! )
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M2XV]FDO^Z:Z5D8G9-=.EG::2^Y:^GH^YYU*E77^YN'T1MU<Z_ED8^T]69-9
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MIP5Y0N-/9<5</J0\[IQSRE19#4" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MP!'*3JJK5$IP6D%M!';6S!%!"QL<4;  UK&"@  Y **Y]T*4K[/G]E!:=5Q
MZ8S52:"PNC0\?\R]%?-K]'(*[WYZO9I6\_I''(CZ?H"#B_D.-$%EU+:Y/(X/
M(6>(F;;9.>VFCLYWN<P,F>PM8XN8"11U#4"J]6TB8J^N*ZV+JW<FN3=G?$?U
M>GK>U/;_ .\LC_[.MS&ITE/4GPCSNEQZW11'&R[Z/.YG9WQ&!P_Z;6I J?\
MWED2 ?.#;J_F=)]B?"/.]?G]!,>I=X1YT5;FZ3USI/+6$>O,LW+7-VR1]I*R
MYGN6M:SIZ^DSL86U)'(+8:?)COMGV<4HWVW9M/DLGV<3%*<__+"@1U$BM":@
M'FLFC.B8F9@J*/'('G3@B6\)E)^UVW^ZVJ<)<7^@\]%AL4RZ?');S7=W;%TH
M:PEP;!$]I!!'&JP=1GP6W4R6UFG=#3:[5Z:R^F2V9GYO.SGY&_$>ZG_3>UX<
MP<ED?_9UC1JM)'^$^$>=KIU^AX4LN^CSO=AMI/$%99K'W=[K2VDQL%Q#+=0#
M(7[R^%CPY[0UUN&FH!YE?')GTMUO"V:^2/.QM3K-'?$]-ET3\WG;+Q!PC <:
MGRK3N<ES1! 06;56HK#2>G\CJ/)$MLL; ^YGH*N+(P7$ 5%3P\J"'ML]OM>O
MPLNJFZSFQ&2U-,_)7UL,?9WCFNDH&M[V=A?0!H-*T"LHC/Q3[3ZQ;IJVW'EU
M+)GLYIR6!T)=96EE)'$R;J:0Z!K2X,+W/H2BPV(V<UM;:_V[P6H8']4\MNV.
MZ:11PEB)8>KSGIZO;21B^^7]8MJNS_I,[^C+Q($IYS"XS4>*NL)F;:.[QMXS
MHGMYFB1A%:BH<".!%5!HGEX=5^$?7UU%#+-?;6ZB%P!;Q/,@:QQ=T#H?T /C
M#@WGY>/EIS;2^&VOR)Z.[?\ 9\'VMM4$'>%7$NT'O+N-HFXA$$KHK001@ #I
MM^^<2T#A3TD&<^-7).BVC?@8JNN,O=VS8HP 2YT%S X ?1[$(YH]WYV\N['P
MLZ1MH[;JETZ([AS6M;5C;V0$D>3@_C1"&TVV>7@SF@=.Y&WXQ/L8HA3D3;CN
M3]-B2-7=$XB36GC-U;JEL?>6^!,+S,0WT70V4-D0.=#Q[$&V&K=6XC1N&ES&
M6D(C;Z$43!UR2RD'I8UO"I-$&':$T3DK[,/W)UTR*?5-XT_%-J?39C+*6CVP
MLJ !)3H$A;7BWW1YHB3!(R3J$;PXM);P-:.'8:**Y 5']_F@UZWNTK:9G>#:
M7(8IC6ZE@R]O+?2L ;+\5V,KKDASJ>X)[SA54;#AH4$->)@?]7D%/_G6$_I2
MU5@3&*]GD4$/[O;F8S3F?TWI#%8NVR^X>9NC'A&7D3#%;$1ESI3*:N815H]!
MIYJP(?\ %]IO/6.SL>5U-GKC*Y,Y>T9W$;C!8QA[)B0(6=#7D4'2][.H<?*4
M(YMHM#_U0P=>VSAX_P"0$D:U>"'_ )%KWSYN;Z/2Q!T;PU_/#T#_ +@M?]?O
MD@GDRWQL"NRMU3MO+3[>Q0CFF?;C\GFDA7C\2XZO_JL:#7+:FOYY^XO'A\27
ME/8^,+)63L2/NO9^)&;4+'[397$V6G>Y;WD>1C#Y>^H*D'U>7A_E(..U%GXE
M;?4[W[M97#WFE?590R''1!DPN^IG0ZHMXO1#>OZI!&?CF:U_R9M< 6G+7 <T
M\10^KU16PN/VOVSDALLA)HW!.OV0Q%MV[%V9F!Z0>#^ZZN9JHC,+>WM[6%EO
M;1L@MXQTLBB:&,:/(&MH$&FWB?\ ^T;MD3P L1_K,ZL'8W/K10:[^,77-MIO
M:R;3S'NDR6IIACH[>.A=W3XI'N<ZI%&AS6#V^2HX^'C0FIM&["MCQ38[/6.6
MC-[;27 #F,,AZXQ)Z+N0<X<B@L)QGCC_ !ATV?\ Q#?_ &)!L1H=FJHM*8F/
M6\T-QJQL &6FM1TPNGJ:E@Z6</\ )"@UE\5_'=7:G_>^+_UUZHV[KQXJ"J @
M(" @(.%!V<U!&^J]N<OG<O)D;3-36T,@;TVPED:QA:T-(:!4<:=7MK4ZK1W9
M9K$T:O4Z._+=6+IM^=KCXFM&9#3.,T:Z[RLUYZUG8861ND>]K'=!],=5*%='
MLN.<5EUL\>U\+-!?9/KS/E3I)M+GI'![-03N!/!SII.HUX\>!7-ZO179<LW1
M-(F9GQE\_P!LR>\N\92/I;!W. Q4=A=WDE]*SB9I7%SA4#T03V!;#!CFRV(G
ML;K%;-ED6S-:0OK10+(?55 0$! 0$! 0$! 0$! 0$! 0$! 0$'GFN60]3I2&
M,;S<XT%%*T6(F9I#7'>W?'1>2T]F]#8TW-YE+J*6V[Z&-HMXY15M'N>]KN?:
MUKEI]9K;(MZ8YOT/^/\ \9U>6^,T3;;$3VUK_P#F7#8K>G1>*T_A-"Y62>RR
ML7=VL<TL0-M+-/)TM:Q['.=S(%7L:!Y5\])K+9X2\_R/^-:K3W>VGINMG[-?
M-#9)ERV0!S*.%*\.T>9;R)J_/IB8YNUCNKBJBI-$'%TC&!SGD-:WB230?30(
MYHYFA\+VR,/$.:0X$>8A!RKQH@ZWW,$0:99&QAYHTN<&U/DXH.P.!XCEV(!-
M/8'-!ULN8)'.9'(U[V>[#7 D>R >'-!SZAP\Z Y[6 N>X-8/JB:#VT'&.>*5
MC9(GA['>Y<TAP/L$50<P:U050$'!S^DT0 ^O)!6IX\$''O#YJ5X'S(.;22*G
MGYD%4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$!!\P]3^*'5]KKO.YW;\QX?%Y*3T[>/J,4QC?(X3
MN8PL'>.$GI.-2:#BK58AYOSOM[0:?&T/#_\ +?\ ")5>EMYX.=9:AUYM]J'4
M6IKMUYDYM17##(YSB QEA8T:T.+J-XDTKS)428;$H@@(" @(" @(" @(" @(
M" @M&JOZL9O[@NOM+D'S7_1Q?EOS_P#92\_I''(/I^@(.+_<F@J@Z^@TI3V!
MV(.0#@.5/,.(04<UQH:<DJ([W:VNL-RL,R)[6PYNQ/7C;[I'4PG@YKCSZ'#F
M*\Z'L65I-7.*[ARGG#:Z#63I[Z]G:TYS&@-;X"XFMLKAYQW$CHO6(V@PR&,E
MI>PDBK32H-.2Z6W48[XX2[C!JL.3C;*^:1V9UWK*\BM76CL7BCTFXO;IM#W+
MS0F,"O60!R)"^&768[(X366/J=TQX;9IS[&ZND],8_2.#L\#C&N%E9,$<76>
MIW2"34GM/%<WDR3?=-T\Y<%J,]V:^;KNU>R#R']Y>&.ITNY 4^DH.8' 5050
M$!!"6^>E=W-=6<&G=)6>)_!TS":_=?7DL4EPV-P+8RQMO( TCJZN)K7DJ)3T
MV,Y\3V[-06EO99&-HC?!9S.N(@UC0 0]S(SQ_P 5067<[%:DSNCLG@M-6%E?
M7N3MI[0MR,SH(HQ/&6=X"V*6KFUJ."HA7PZ[5[X;.LGP6:;B,CIB\F$S^[OY
MG36YZ0UQC:ZWH11H]&K>U"67[J:4W;U;J'2][@,=B/BW3>3.3:;J_ECDFK!+
M;T+1;/#?1E)Y\PB)?Q4F7EM&OS%M#:WI]W%;RNFC]\YK#])16.[E;=X3<W2E
M[IC.1!\5PVL$Y:USXI6@AKFD\0>/,%!U[5:/O=!Z!PFDKZ1DUSB[=EN^6,^B
M[NVAM1R\BHQ_6NUEY/K*RW.T0^&UUI91FWN(9OK5O?6Y->B5[ 2#Q/I=+N:(
MM,FU^K-Q-6X756ZC;.TL]-R-N,9IW'S.OK62X:_O.]E?+'#QJ&<.[/N>?D"6
M<O@\;G,1=8+(V[)<;>0NMY8'-:6!CVEOH@B@(!X>11408#0FZNVF(ET5H9V/
MRVENN4XV^R-S):75DRY>9GM;$V*8/Z7O=T^FWZ2J,MVLVKL-M<7>.9)\8:ER
M\LE[F<I(T-DFN97ND(KZ1Z07!HX\@$5#&XNVGB;U7N =48JXP$.(QLLHT_87
M=U/-'#&7 ,F,9@Z6S=#?=-XMZG"IJ@XR:1\:\C7-.?T^ [A5MS<@^U2-!-^W
MNBLWIK0C,-FLD^;5-\UUQE\HQ[Y7>O3,:)'L>XASAU-J"2"@B[1&B/$YHF]E
MQ<NI;/4FG7\67^8N[BYR#''@3]=;)4 =G6$$MZ4T+)BLG+J?4=[\=:MGC[AV
M1DC#&PP FD4#"7]VT$N)Z2*]1X<41FJBK1J'3>)U19-QV:MFW5HV6*X;$\!S
M1+;R-E8:.!%0YH(074@\/IH-?M]]C-4:WU)@=>[?Y"&QU=@Y'.B%T]T43@6M
M:#UL!<".@#@.U46_='9/=7=G;[XMU1G[8ZFADCN;3'6W5#C6RL8\.[QS?=U)
M;TN,=6CJIS023H[3VXNDM$^K7=Y;9[5;(888+>61]K91LA:0 ' 2FI+CU.Z*
MNX5Y(B.O#EM/NAM-=9VVU';8J;&9N]-ZZ>TO)9)8NO@X=#H&!U*#ZI%>#7NT
MV\.I][\)NC8V6&9882T@QT=K)?S-?)#'/-,YYI;$!WUXBGFYH)+WIVTR.[FV
M-YI5[XK#.RF*>WZ7E\#9H96O#2XM!+7!M*]/:@\6U>D=V-/:>LK76^2M;JZP
MUJ+3&8VQED9;/$9Z8W32](+J1@"A8:'V$1@NBMJMX=.[[:AW6O;'#.QV>M[F
MQ?:1W\SI(X9KF*=KQ6V +OK(!'GYHK9< ]HX?L*"M">/[*#6#Q";2;R[P7N
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M4"E"U?'-@BR*PR]'K9S73$Q2B3XQ1M.T<"L1M7- 0$! 0$! 0$! 0$! 0$!
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M='#%U3M:U[0.L]1ITFM>?!!M%J2VR]W@<C:8"Y;99N>WD987;V]38YRWT7$
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MEQ#@&#K]$5KPHM9ALC/=-_8[[<K[=LTL:6W\2M9GY/F2QOJT?)1J9HX#U1]
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MRCG?K\D^I?N1_P"Y*Q]1ZDMQM'ZFUYO#W^2/3G^B=^Z*8/4A-V_42E%9#4"
M@(" @(" @(" @(" @(" @H[D5824)[/?UZW&_P!\S_ZS,MMJ_P *SR1]3D]G
M_4Y_][OK3:M0ZT0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&DF5VLWO\1L@UM/J*VPVD+MO7@L8
M;JX@<;6;ZXTR100O830M%7.+E1-.W]ABXO#1A[?.SB&VL,+<.=>!Q8^.2 2T
MEC>*.#VD=32*&J(N/AKW%N]R=N/C3(2F>^QM_<8NXN".GO#"V.5KN' ^A*WB
MDJF%0$! 0$! 0$! 0$! 0$! 0$%HU5_5C-_<%U]I<@^:_P"CB_+?G_[*7G](
MXY!]/T! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M6=I-VMRTZHZ:I>BG9-$R:-P='(T.8[L(<*A;R)K%6ZB:NP&H7IZ50$! 0$!
M0$! 0$! 0$! 0$'6YY:37W/8H+-J?4>/TUA+K,Y.01VULPO>3PJ:T:T<1Q<:
M <>:^=]\6VS,LO2Z:[/DBRWG+7S;# Y/=S7-QNQJFR?!A(*QX&VD<2TNB<UC
M7=W4@4:UW4.75QX\UJL..<U\WSR=KN>HLV[!&DQ^O$^E='":3$\*]W%LUW30
M34>Z[%N7 .UH   Y*HCC?K\D^ION23]R5CZCU);C9_U-KS^'O\DFG/\ 0N_=
M%,'J0F[?J)2@LAJ! 0$! 0$! 0$! 0$! 0$! 04=R*L)*$]G?Z];C?[YN/\
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M @(" @(" @(" @(" @(.N45:@P'=W6CMO=O<YJ.%YCOX+66/&/#&R 7TS"R
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MEM-)MMF&D\Y^7L\B1V,:QK6,%& 4 '8 LR(HVCD%Z55 0$! 0$! 0$! 0$!
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M$= 13@K5$]Z9T[C])X&PT[B0\8['QB&W[UW6_I!)])U!7FHJ[H" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M)=V32&BT%DY<MV6>7*$V,%&@#@!R740Z!$>]?\/@_P#3-_9*Y[=O6M:'=?\
M#RI0Q''$V/W/%^X"WF'\.WR1]3=V>K#W+[/8@(" @(" @(" @(" @("#%M?Z
MMQNB=.WF?R<C RVB>^&!SVQOGE:TN$;.KFXT6/J,OL[)GM;';]'=JL]N..V8
MK/=\LH5V.T3D-4YJ\W<UI9PR7F2<R;#1&KA"V,U,C*O< "?<AW$$+7:2V[)=
M-]SJ=ZUL8,4:/'PFRL73'^38OII2O*GTUN'#/0.0500$!21"^]S-X3<8CY+6
MR21?QGXT;%):1EO\#W7_ "ES:U^N<EBYK,DQZ,N@VG-I++I_,6=<?.@O6GYR
M'X-9$:PBG=ISN7'(=<F/+>[ XU$3B[WJP+=/J;[J=3]!T.JV2<L=&&(N[.-W
MG=6ASXBQINP.B(IOP>,?\3+),>UH;4\A*X.^BO=VDU%L^L:_5;+&2EV*)GRW
M>=-VS0WK=F+]^YS9(\<(&^J%\EH^LH>"12W<X\O*LW%;?;/I."W?+HKYC\M9
MT^/]TWQ&H\RR7..Q5! 0$! 0$! 0$! 0$! 0$%'<BK"2A79O^O.Y'^][C_69
MEM=7^%9Y(^IRFS?J,_\ O=]::7'VBM2ZP:/H=B#D@(" @(" @(" @(" @("
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MK6BW7_#RI1P__NJQ_P!!%^X"WF#\.WR1]3=6>K#VK[/8@(" @(" @(" @("
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ML$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M_P#69EMM5^%9Y(^IR>S_ *C/_O=]:;5J'6B @(" @(" @(" @(" @(" @("
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M;W$;HIF&'W3'CI(]UY"@D/\ 1SU^7#/4/#\%KNM1V?&..^@@^GR @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(*<^:\CHNN$9-0UH!J2D+#4GPVZ@Q>DH]X\[EKF*VQMIG9)))IWB-@<
M99FL!<0:=3G!OLE;S6V=7LXCN.R?*O/ANPF3UAJ?4^]NHI)'W.4NI[7"Q/N7
M7!@MI)'220/ZFMJR,=TR,\. Y!9&YW>PLC3V\HXSY6/CGJ])L'JK4%OIG#OR
M=R?1'HL:* EU":<?87(:O/&''U3WO.HS1BMFZ4?;.8"6<R:ONW!US<%\;?,*
M#C[=5I=HQ3/_ &3S:K;,$S_VSSN3#['!=+'!OG!W(T]E417JG7FKL3FIK+&X
MA]Q:1!O1< $MDZF@FGH'D3T\^Q:34:C-;?2UIM5K,N.^EMDW0C[4^=U?J5]J
MZZQ,D9M9!(P-87<O+Z(HM)J;L^68F8:?4ZC-FI6R8I-616>XVN;:V9;LP\CF
M1L#&FA^I%!]0LS'J=1;;2D,N-QSQ%/9S_7S)4TEE<EFL-%>9.S=8W;J!T,E:
MG@/3XM;[I='@NFZV)NYTAT.&^;K(NF*3,,B9[GA^Q19#ZN2 @(" @((PW4T#
MJG6\N._!O5USI86??^L-MF/D%UWO=]/5TS0TZ.@^7W2^-]DW3PEL=)J;,7K1
M5#6M]J]SM':9R>HY=S<A>QXV%T[H.B6(/#!7IZO67T^@L++BOB*U=/H-?ILF
M2+;L?-UZ VPW-USI:PU+#N5D+&*^9UMMNF67I(-/=>LLZO>A3#BOF*S<FOUV
MGQ9.F,:8MLMN]5Z+OKB?46L;G4\5Q&61Q7$;V")P(/4.J:7R46PMMF.<N<UF
MJLS>K;1*<9#F M-1QX^VOHU;IR%U!8V<UY<O$5M TR32'@&L;Q)/L+S=-(J]
M6VS=-(:M32W'B$W3FQ??S.VWTR^2821 ]W/*TMB: YIZ0YY+GQN-?0#EJ?U&
M7Y+7>3;&TZ2)I_V9K8F/)S;26T$<%O'#$VD4;6L8*<FL  'T%MG"W73=,S/:
M]#.7.JL/FY*@@(" @("".M]OR4:G^XY/W)65I?Q;?*V&W_C0\GA^_)/IW_1.
M_97K5_BW+N'XLI06&UP@(" @(" @(" @(" @(" @(*.Y%6$E">SO]>]QO]\7
M'^LS+;:K\*SR1]3D]G_49_\ >[ZTVK4.M$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0*504H/(@TFW
M6WHWSU[F;K&;*8;(MTU8ODMW9.PMW2RSR!WN@X< WI H.D\^:I# =.ZD\8^C
M+MN3GQ&=NK")[99[:^LW&!X:0YU>D,Y@4YHO!O%M7N!;;E:2M]206[[.X[Q]
MM?64GNH;B( N:> ^I<UW+M1&;* @(" @Z9YX[:*2XG>(X8@7/>XT: .TGL0?
M,3PV2QL\2&->7 -?>W;6$]I>YP'T2JL\GTWO[6*_LKFPG_@;J)\$E.UDC2UW
MTBHC238W2=YM!XFLOIS4-(8\K!._%73_ *W'-'*PW(Z":]72*L-.T%4=V^^F
M[C=OQ'833&GZ7!P@B=F)8SUM@9T0S>G3W-11O%!/V^NV#M;[0SZ1Q3>N\Q4<
M4V*8[CU26L#X&<1_@O*".O"3J>PTQL?DK;+.%O=Z;O[LY2"5P8^)SY2.EX/N
M2"P\TH2POP-;7Y.R?DMR,M 8()616V'+VD&2-[)#*\']J0Z.A19>3Q0[=WNF
MMX]+;LLC+].2W^/=D7TH(9+6Z$KWN=R <'"E?(42$B>+[)VV9VJQ.G<7(V[R
M^H;RSBQ=M$X.?*_OHR T#B:D$<$(2?L)H"7;G;'#X.[K\9F/O[T'LDD)-*=E
M&D5\Z2)0#6FA(J>=?:HH+3JEK1IC-\/_ #"Z^TN0?-C]''QWOSU?Q5O#_...
M0?3] 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$%KS66M\)C+[,WI<+/'V\MW<= J_NH&%[J#M-!R5LQ
M3=?$1SNFA7@T'W3WQU5N5DKH6-[<XG23@;>#$Q2^A-$QX(DG]$!SG.;U#@.D
M'IXTJN\T.U688BZ[U_Z_LU.;575F(Y(M,?4R6!LCVMF;T2AIIU,J#0^V 5O)
MBK#B^8;B>&7>!F=Q=OMME+?NLA@[**+&W,7N)K*TC;$ \=CV ,J:^E7D*+A]
MVT$XI]I;ZL_6V^#+%UM)YL@UE>7>O=71Z6L7!]E;?7;H,=TN]'I:[CQXMK]-
M?F.LF=1G]G'*(JT^LF[498Q1RYRG*T@9;QB)@]$<>/$\5U<<'11;$1P=] K,
M*=(2@H6M/,>9284:QK1TM% D11#NV5ZJ<?*G3 =#?)S5H.0%%00$! 0$!!Q+
M&DDD<3S01WOJT#:?5%!SL91_Q2OAF]5M=K_46O'X? ';2Z;+N)[EPKYNHJ8/
M47=/QY2@6-/,<ED-2ZY7.::-KYO(H-?=]=P<C?W$&UNCKEDN>RDC;?*PM89)
M88G,$U!0BCNGI=Q^I6MU.7JNC%WNUV'0=-EVLO\ 5Q?WX),VQT-:[?:3L<%;
MO=+,V)DEW*\BCKEPZI"T4%&]1=0?36;BQQ9;2&@W377:O/=?/*LT\C.6-% 3
MS[%]8AJJN0 ')5%4! 0$! 0$$<[[5^2G4P__ %.7]R5E:3\6WRMAH)IFAY/#
M\:;4:=!_\$:?1355]K<NX?BI16*UP@(" @(" @(" @(" @(" @(*.Y%6$E">
MSO\ 7K<;_?%Q_K,RVVK_  K/)'U.3V?]1G_WN^M-JU#K1 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0:36GB2S'AZ9%MEK#1,MQ\1QBTQ]_')ZJZZMH!W397.>U[9"[I]TS@J1#O
MF\?V,N(^XM-#7#KJ3T8FOO&2-+G< .AL0)X^=1:)_P!A8=0RZ4R&H]48T8C+
M:GR<N6?C QT8@8;:WM6M#'$N;46_5Z7EKR(5E$IJ @(" @LV?TII_5$'JV>L
M67MO0@LD+@*'_%(089:^'O9>RN8[VTT9CX+N)PDCFC:]KP\&H((=7FK42#8X
MVSQELRSQ\8M[6/W$;22!]$E06[4.C]-:KA;!J'&PW\;2"WO00X4Y4<T@_304
MT]HW2^E(G0Z>QD-@Q_N^[!+C[+G$GZ:"]]-10GAR08CD]K=O\Q>NR62P-M/?
M/)<^4AS>IQ-22&N /$]JM1E-K9VUC RUM(FPVT8Z8XF -:T#@  %!UY#&6&6
MM)+')6[+JTE:YDD,K0YKFN%"#[2#',/MAH' 7[<GB,#;6U\TU;, ]Y:?*.MQ
M 5J,K='44!I3DH.0% !Y$%IU5_5?-?<%U]I<@^:_Z.+\M^?_ +*7G](XY!]/
MT! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 00KXI9I(=E-2=T>DODQK7D$@\<G:CZ8X+9;9'_LV_UV2^
M>7U):'1BC*>1?I%'.S+G2O'L07O0N4OL/KC 7U@7M='>1B9L9H7Q$&K2>/ \
M%I=WNMC3S7E/_+YY=1&&WJEO/M!I4VE@_45^Z4Y.^KUMDZ:!H-0:=/54UX\5
M^0[7I.B.N><MAMN"8M]I=7JN2HT4_N+?-TY(" @* J" @(" @(" @((ZWV_)
M/JC[BD_<E?#/ZDMKM?ZBUXO#WPVCTY_H7?NBI@]1=U_'E)W>CC44*^]6JHP?
M=37UGM_I6\S3YH&Y01].,M;AW\-.XAH:UH<USJ5ZG!OU()X#BOAGR>SLFYM]
MIVZ==J+<79-:_-%4=;!Z"R4TMWNAK UU)J F>"%HHR&"1QZ?=%[B"UK2STO<
M\./-8FEQS=/M)[6[WW<(B(TN.(Z;/1GOFB>Q#3_\7G6S<95VM%!1!5 0$! 0
M$!!Q+J&@%2@CC?9]=J=35X?Q.3]R5E:7\6VG>V.W_CP\OA^/_53ITGMA/[HK
MSJ?Q)7<)KEE*/7V4XK':T:[J[%!R5! 0$! 0$! 0$! 0$! 0$%'<BK"2A/9[
M^O6XW^^;C_69EMM7^%9Y(^IR>S_J<_\ O=]:;5J'6B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
MANQN=E/$5@K2[O+>QRDLD8/JDT@9>P]X [I<UCF/-*=HI]-4>S3'AQV?TI?-
MR6,TU;NOXWM?'+*9).DM-1Z+GEIH1VA*B5(VAC0UE P<&M H /8"@[$! 0$!
M 0$! 0$! 0$! 0$!!:-5?U8S?W!=?:7(/FO^CB_+?G_[*7G](XY!]/T! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 08]JO3]AJG 9/ Y5H=8W\#X9'. ):7#T9&U%.ICJ.;7M"^N')..
M^+HYQ*3%8H^:>4L(\;E<M86$DE_CL7>36GQ@V&1L9[N1S '$M #N%//S'!?I
MFGRSDLMNGA,]C1Y\4VW33D\C63RR,AMHI+B>4]$4,+'2/<ZA/!K02> 61==%
ML3,\H?"VV9Y)FV+VPR&5U+!?9>,PR&%LS;0CBV,]+O3ZA5C^(]$T(X@K\YWK
M=\>J_P#7QSW75I,2PL==3G]G3T(XU^7N;U6\,4,+8XFAD8' -% M32)AV$11
MWA>U50$! 0$! 0$! 0$! 0$$=;[_ ))]3_<<G[DKX9_4EM=K_46O%X>Z?)'I
MS_0NK[XJ8/47=?QY2)>74%G#+=74C(H(F.EEED<&L:R,%SG$G@  *DK[3,1%
M6LMB9FD-9L?'E-_-TH<M=0Q-V\TS(^(1AY/?SQ1DL=0.XN[R0._:E@HM/U?F
M,E8]6'Z#J+8VC1^SYY,L1=$]T3W3\S9NRMF6L44$4;8XHFAC&- #0UHH. 6X
MMBD<'Y[?=-TUGG+UKT\JH" @(" @("#'-8:MPVBL1/G<[<BWL(B&EQ'4YSC6
MC6M'%QX<AQ7TQX[LEW3;S9&#!=ENZ8:D:\W_ -3:ZQ=]@CC+>PP=Y5I>"Y]Q
MT&OHD]1::@\2&KH<&AMQS%U:S#M='M6/#=%TS,S#EMOOQFM!V5GIZ\L([W 6
M]:2M);.T&@H./3TBE3Z-5-1H;<DS=$TDU>U6YYK;/%MSI;4N,U=A;;/8B3O;
M"Z#N[<06&K3TN!!H>!7/Y+)LNI+B,V*[%=TSS7Q@(YKYOBYH.N:>"VB?/<2L
MAAC%7R2.#6M'E)- $'"TO;._MV7=A<175K( Z.>![9(W BH(<TD&H0=Z#RWF
M2QV.$;LA>06C9G".$SR,B#WGDUO414GR!!Z0X$ @@@\01Y$%:A!Y+;*8V\FF
MMK.\@N+BV-+B&*5DCXR0#1[6DEO @\4'KJ$'7-/#;Q/FGD;%#&*OD>X-:T#M
M)/ (.%I>V=_;LN["XBNK64!T<\#VR1N!%06N:2#4(.] 0$! 04=[DI"2A+9[
M^O.XW^^9_P#69EM]7^%9Y(^IR>S_ *G/_O=]:;EJ'6B @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@A#4./V#P6C;*\R5U;8_$6EJ#8W]E+<0W9CC:"'%MH1+(1P]VURO%$"V_C0B
MTMJ1N(Q#KO56C&%K(KF[MXHK\>E0MB#!!U"GN>]!=5%I+;S;K7^)W(T\W4>&
MM[FVM3*ZW=#>P26\HD8UKCZ,C144>/2%0H,M0$! 0$! 0$! 0$! 0$! 0$%H
MU5_5C-_<%U]I<@^:_P"CB_+?G_[*7G](XY!]/T! 0$! 0$! 0$! 0$! 0$!
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M.2VC]3GG_P#TN^N4Y-Y+2.N50$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MTM;0F@IQ*HV/')050$! 0$! 0$! 0$! 0$! 0$!!:-5?U8S?W!=?:7(/FO\
MHXORWY_^REY_2..0?3] 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MJ_X=*472;9BF(F9_KD_ _P">:['ESVV637T8_P#U<VGB-6 _]Q;M^7.Q$$!
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MC-_<%U]I<@^:_P"CB_+?G_[*7G](XY!]/T! 0$! 0$! 0$! 0$! 0$! 0$!
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MA]_)-IW_ $1_95U?XMR[A^+*3UB-<(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @((*PWA/V:QF)M;/)8.*^NX(FMN+R4 &5[0 7<N%>:H]4'AE
MV&NFE]MIRTF )!,;FO <.PEM4&:[:;:8':['97#:;9W.*R.1?DX[8#A$9+>"
M M_\A7VU!FR @(" @(" @(" @(" @(" @M&JOZL9O[@NOM+D'S7_ $<7Y;\_
M_92\_I''(/I^@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @Z'<*MY$KS%%E"VK=L=VLUJW)YG ;CRX7!7;H76>'9&]
M[8!';QQ/H0\#TWM<_E]4MQIM7I\=E+\?5/>^-]E\\IHB?=RTWHVGP^)S%SN/
M>9-F7RUOAF11-?"Z-US'+)WA+G.J!W5*>=;/!J=+EF8C#'"*OC[+)]KZ&?\
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M7G](XY!]/T! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M<TKLB8YE:]OD51V(" @CK?;\E&I_N.3]R5E:7\6WRMAM_P"-#R>'[\D^G?\
M1']E75_BW+N/XLI06(UP@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M?,?,LVVZV>4N<SX[K+YZHF.,L6W"W5TOM]9F;-W#C<2 ^K6MNT232$<@ 7-
M_P IP7RRY[<<5EG[=M>;67Q%M(BO.>2#\;I/<??O)8W-Z[[O%Z%M'=\W&0R/
MBEG;-TN'2&-XBC *O>"WLYE:V+;]1-9GT759=5IMJMFS%%<W*;N=M8[>/FXM
MD--Z6PNF;!F-PEG'9V;./1$!0O[2XTJ30#B5M;,=ML1$<H<3J=7DU%\WY)K=
M*]F%I_8Y+ZL-V@4 'D0$! 08=K3<[1VW\EK'JO("Q-[WAM1W<DA?W/3UTZ&F
ME.MO/RKQ==%O-EX-)DS>JB+=C?7;;4^@,Y@\1EQ/D;VU?';PF&5M7D&@)<T
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M>Z[1Z>.FRR9LGASZ9I_;GVMB8X@&!K6T X<@5MG!3,R[6M(=4CRJ#M500$!
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MI[D< O>JU<4Z,?"V/I>]9K^'LL?"V$YQP&,,#64ISI_?6K:*9J]2((" @("
M@(""G&OF7CC50+V*H@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @^=&AO&.-!Y#.'%Z)!T[EKHW\.(&3Z/5KF4N[US9?4S4/'=BG0VG3VUX6J
M]+./UA-*?]7/$?\ UO[WJ+1/'AMW3O=X-*Y_5]Y8-QM<[-:6]FV3O^[BBLK-
M]#)T1]1+GN/N0CS1,Z @(" @(" @(" @(" @(" @M&JOZL9O[@NOM+D'S7_1
MQ?EOS_\ 92\_I''(/I^@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @I7C1>:\:*X2T#>HF@'$^P$IQJ(EW>WOT]M5;MLIV
MG(:IO8'W&,Q4;VL+A4LC>]Q#BUCGM(!#'>Y*VFBT%^HGAPB.U\K\D6Q64;[5
M[4:AU_J"/=S=Y\ES)-2XPFG;ECBVV:QQ,;SUD!K0?38P,I6DE>-%EZO58\=D
MX</+_+ROG&.9NZI2CG\9N?+E978B>R9CS0V[7$]7305K1A^JJN(U-FKF_P!"
M;:-?FLU77/3,40+XDK+7-OI;3)U1+;2VS]3V+;9L+B2+CN;GI)!:.% Y=#LU
MN:VVZ,M.KLIW,/V>LZJUM3*[#[O'JF]:L*-JX#J=Y?)T=BYW4XM9.6Z;)MZ9
MF:>2O![MQZSIYVK5JW+ZMML+;Z8RTD,V4R;GQEL#>H=VSI/'@"#Q%%K-7EU$
M6^ROI6Y\=5ERQCC'=QNN[DL:&T[;:=P%I;0M F?%&ZY>. ?*&T+J>==!HL$8
M<<1VTXMYI<,8\<1'<R8<_.LUEJJ@@(" @(""AY&G-!TUJ2#S\J*T$WV8YN[6
MI200'26I#B*5'J-OR7*[E;3+\S^AOX)=U:.[_;^R/.%%JGZ+%5%7INGX8K._
ML]N0<A%)$^:[EGM1*T@NMWAI8YM>;2#P7::3\*WR1]3^6?Y-?%VX9?DOO_\
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MNCV<.2PXFK72[UZ00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MZ*4[#&3S6BW.STHN^2CD-\MF;HN^3^\MG6 %O+@M,Y5R#6@U XGFI(Y*@J"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M2V$B]S4+5Q#G*N?:J*H@@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MRY*@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M/_;#P>'[\E.G^/'NN(\GI+UJ_P 6Y[W":Y4IK%:T0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?'%EL<(=9K7CR/D7F&;2*,^V7& ^4/%09ZT%U;7+^XM8B&EC;ASFEKG-/ M
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MO$!'%-LWJ^&?C#)9=$@K2K72,!XCS*P(YP/A%V!RF&LLC\33S>LPLD[QF1O
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M7]5\U3_F%U]I<@^:_P"CB_+?G_[*7G](XY!]/T! 0$! 0$! 0$! 0$! 0$!
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M"HY*/"J @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @("#']<:5LM<:3RNDLE(Z*QR\)MIY(_=AKB#PXCR(,8V^VQN]O+:VQV/
MU)>WV&MFB.*PO 96-8/J6%SST@>8*U1(ZBJ$5-.Q!Q;6O%!S0$! 0$! 0$!
M0$! 0$! 0$%HU5_5C-_<%U]I<@^:_P"CB_+?G_[*7G](XY!]/T! 0$! 0$!
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MV?TOMM=W-U@3<]]=,$<HN)>\]&H(IP':%AY,MU_-@YM1.3L23'[D+X,1R5!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$!!:-5?U8S?W!=?:7(/FO\ HXORWY_^REY_
M2..0?3] 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 4%*A2L"J
MH*CI<>/.GDX\_808UKC6^GM X&XU%J*Z$%A;4H 09)).)$;!VO-/1"^^#!?F
MOBVWG*3-&LNGM'ZM\3VI+?7FNF2X?;O&R :?Q !D$[ \R.<USRT5-6M=*(_2
MZ>FGHK?9<F+163CL]+)/.>Y\XK?/R-K,/AL9@<;;XC#V[;3&VS>B"WC:&-;5
MQ<2 .'$FI7.WY+KYZKIK+Z1$0]-]D;+'POFO;AEO"T$E[W=(%!7M\RQLF2VR
M*S*771;'&:(OU#NC=7MQ+A-&VSLA=MI2\@>7-Z7 >D UIJ 33W2T>;<INGHQ
MQU?+$M)FW";KNC%'5/>\V$VSSFH9HLIK;(S2R-ZRVRF:9.GTJ#BY_*G91?/%
MMN3)Z66Z9^2?_+SBT.3+/5FFOR)8L,+B<6P,QMG%;,:.D-B:&CZ2Z#%ALQ^I
M$1Y&ZMQVVQPBCWMY5"^L35]7(<500=1%?..VGE4F$1AN=D-N=#8VXU!J#%6=
MS?R=(@M7,:)[F0T:&M/2X\!Q)H:-!6LU&'3VQU76PV.V[!.XYNFRRLSSFE>Q
MJ)K;<:35]Q"ZQPME@L9!-'=0V<3!+('QM(H^2D?4#U'Z@+GLM^.9]&R+?(_:
MMJ_@6DTUD]=+Z_\ PI3Z9XI-VWWAT;?7MK@M:Z8L())AW9SC UL7>=0 ZXRP
M]((J>KO/V5FZ>_2W12^RV''[Y_\ \^MPQ=FPQU\9GIZ.SRUX^"5M7[P;;[76
MIML,VVN;Z4OZ\;8.:SI?%2G>EH=T5ZC0D+:SDQ8[9C'2OR.7V[^-9;Z3=;['
M'/\ E-O#R]C Y,=OCO-/<V66[W1NBIO6(GQEKW2.CD (9)&YT/?-H  [T>U?
M'IRZB(K6V(^GZG0QFV[:ZVQ;;J;IY7<NFG;RNYU^A*VW>R>C- QMDM;<9#*M
M>7_&5VQCIV]36M+6. !:ST:]/'C7BLW%I;+./:YK6;UJ-1Z/5-MGV:\$GM:U
M@HW@T=@'!9=&CF:NJ5[8P7/X, )<[L ':B1%9HUUW2\1[<1?7NFM(6D=]<0#
MNYLN92Z"*4=/4T,#/3H"6GZX.EWL+;8M!-UG5=-'6[9LDYIMF^>FM.%/E0CM
MENWGM YO(Y""UBOK7*2ONLA:BL+W2.-?1D]/I%3^U*Q\&AMNOF*]G<_0-_\
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M32BVVHSX]%9[+%QOGG/<\6^G-9BC:>&''8>R;!"QEI9VT?3&T$1L9'&*\*\
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MX^NO+0>/37LY>5=/H<-DV1=3B_GO^7[AFMU-V&VZ8LMF>$-D(88P.AHHUAH
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M')4<VM#10>R4%4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%H
MU5_5C-_<%U]I<@^:_P"CB_+?G_[*7G](XY!]/T! 0$! 0$! 0$! 0$! 0$!
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M;!E8;2&2!PDC$W=A_?->64EH>'!W&BWF@MR6V]58Z9[*NPVBS+9%8NMZ>ZJ
MFVM]T-$UG/4"A#8W<_H+<5BO"7377VSVQ5[<+:8]N3AEU+9W[\)'Z<T%I;B2
M:0@BC!WCF  BO&OM+S?,T]&8J^-]WHS%DQ7RMWMKM3X'5&EX+G3>/N,7C+1W
MJ<5G=PQV[F&(4'2R)SVAO_"BY/4676WS%TUE^>ZW%?9EGKF)GY&>Q !@ Y!?
M%@.:((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @M&JOZL9O[@NOM+D'S7_ $<7Y;\__92\_I''(/I^@(" @(" @("
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MDJ*]+?(@IT,K6G$FOMH*T""J @(*=(\B!0>1!6@0$%.EM:TXH :&\ *(*H"
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(.)K7R(%33S^1 J:^9!R04-?[R"E2.'
M8/;0 ZO(U0*D<SR^F@5-?80*UX]G) ->0YH.2 @(" @HXT%0@XAU>1K]- J>
M5?[Z"I)]A J?9!0 3[* 3QIVCC1 KP0 2>%>/E04J0.)0./E^B@K4\3R]E -
M>8_X50.)Y'V_90"XCZ-$!IJ$') 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$!!:-5?U8S?W!=?:7(/FO^CB_+?G_P"REY_2..0?3] 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0>245:]M>GL!\OM) ^5-E:W]G!';9.WFM;^(=
M,\%RQ\4S'^1[) ' ^ROU+!=$V1,-!G]:7HX"M>17W?%TW,+I87QQM<^5[7!D
M; 7.>XC@ !4DD\*!>+II$OICGTHAM]HKPK8'(:4Q-[G\OE!?W-M'.^&)\43(
MQ*.L,Z)87N:6@T-3S7Y7K<=F;4WY>^GT1$?V?JNA_E&;18+<-EF.Z+:\9MFO
M&9G[4=[)+;PE;>13LFDR&6E:P@]W)-;%I\QI;#@EEW1RA]<G\QU=T4Z,<>2+
MOO,IB\.^U4;&L?A634%"Z0^D3Y3TT7TG-?+0W[UJ;YXW?7YUXP>SN@-.7!N\
M1B(H+EP+3)3J):?*#4=B\W9;KHI,L;)N6>_G<RHX'%&G\3@%/)$SC[/!>>J>
M]A3EOGMEWQ8VU@'3#$R-HY!C&M_8"E9>>N9[7:;=AYT  I0#@HG5+A05Z1P;
M3B0B-9-X=H=?ZXUG>9*UNHY,0UL;<9;2/8.Z8(8VR 5D%.I[7./#M7SONRVS
M6RGSOTG^,[SIM!BNB^9K=,=D^9 FK= ZHT1-%%J"S,8G=T130D31.<:T;ULZ
M@'$ GIK58<Z#4:J:Q;%8^6/._4]%_)-%FMFE\^$LJPFP6X.:LXLAZM'9VTT;
M9HN_>QLO2\ @.C<]KFGCQ!"^EGYC%'1$1PX>'DEJ=7_+-#;=2+IGCW2VJV:T
M[G]+:.BPVI+KUF]MWN$#VD.#+< ".-O27"C:+*MK3CS?B.\9[<^JOR6\KKIG
MQE(\-.GA]!5IW8J@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$;3&ZKF 2-!<)&BK>7,+2[CNUMMLV8YK,\)9>#2S;-9;Q1M#(VL#0T-% T<
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M1\+":<#U,C#N'E\J"6E 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M(" @(" @(" @(" @(" @(" @(" @(" @(" @(.+WA@J>/F""@E:?[B#F@("
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MI\X./][<?!('YV/AT^<''^]N/@D#\['PZ?.#C_>W'P2!^=CX=/G!Q_O;CX)
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MI\X./][<?!('YV/AT^<''^]N/@D#\['PZ?.#C_>W'P2!^=CX=/G!Q_O;CX)
M_.Q\.GS@X_WMQ\$@?G8^'3YP<?[VX^"0/SL?#I\X./\ >W'P2!^=CX=/G!Q_
MO;CX) _.Q\.GS@X_WMQ\$@?G8^'3YP<?[VX^"0/SL?#I\X./][<?!*BGYV/A
MT^<''^]N/@D%?SL?#I\X./\ >W'P2#A)XL/#JYM!N#CR?,VX^"14J8K(669Q
MUGEL;,VYQM_#'<VEPRO1)!,T2,>T$#@X$%0795! 0$! 0$! 0$! 0$! 0$!
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MHAEK-UZ+@67J'=]$ICZ2WUBXZN7.H]A!]7]H?R4Z$_L[B?\ 4HD&:(" @("
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M%W?8N]ECFN+.YMK< NCZN3FCJ%>KL5$Q!M#_ '%!5 0$!!2@0.D('3Y^/E0
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M_CL_)?BS_P#4V5/^042.:_>"?(7.0V4C=<FIMLG<VT5:FD<44 :.*@V+0$!
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M90CM(#J(=CZ$L-17_O>TH.2 @(" @(" @(" @(" @(" @(" @(" @(" @("
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MWNBXE]9"^@D=[FA=3LXD8OX9]?ZLTQN'G=CM9W9O1BBZ/%7#O1=P<'L:&C@
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M**!KI"TG^$LY7\.@4]-!GNG,!+IZQ98OR]]EVL%!/DG0/E ]F"&$?\5!>T!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M<T%236@/GJ@JTU050$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M! 0$! 0$! 0$! 0$! 0$! 0>#+RWT&,OIL9$)\DRWE?9P.-&OG:PEC3P/-U
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M $C4A)11X)?R$V7^\K_[8%'J>;8I$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MX>1$?-WQS.:[>J -<'4PEF":UH1-<<"CU#<O5\C!X;]3$N'2=(90 UX$G'S
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M:6]S=$,83)UT ;2-O$TIS19;QZ+W0P>X-_/'I6*6\PULP&3,4I;.E/\ FXG
M.:^@H20Y*(^?N_5I<XGQ0WMWDHG6EF_*XJX9<3-,<;HF0VI<YKG4!:WZH]B+
MV-^M0:OP&I='ZB=A+R.]L[6V'5?6[VRVKG2!KJ-E82TD5H17FD/+2GP%%K=X
M,UUD4.F[H"O#CZ_8*/<KKXW]M,Q8ZOM]Q+.WDFPN4B]5N9(V.>V&6W:T_7"
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MM];/LM'XIF*M)*]44<DKV\7%QH)'OIQ/8H,I0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!Q(J:H.N>06\+YG->
MYK&]3FQ-,CS3L#6@D^T@U&@=GW>+:[U^[2>HF:3N,?'8LR)PN0$7>Q11-/$P
M<JQGCR5.QMS"_OX8YVAS6R-:]K7M+'@.%:.:ZA!\QXJ#M:*(*H""E*\_:04H
M:U[?*@4(/#D@4)X=B!0]OM (%#SI[2"@:>U!6A]OZ2"G24%0U  -./9R0 #R
M^@@JT4050$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M6LZW])+J.!'D"M$9ECM6X6\.-L[B\AAS>2MHKIF,<]O?#O(P\MH">(!160J
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MXCDDC*K;=W:B]N8;*RUUIZYO+A[8;>WARUC)))*\AK6,:V4DN)- !Q*@S(N
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M(=["[[;+KO9=,QRB'7Z#J]E'5%&>L[?96U;)R5! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$%FU%I73^K+06&HK&._LP'#N92[IH\ .'HD
M<Z(+1I?:O;_1DO?:7P%MBY2>HFV#VCJ\M"XA6HS!0$! 0$! 0$! 0$! 0$!
M0$! 0$&H<>M<?JGQ+973^YMTVSPVGG30Z:L9GBVLY0)'ATTCG'TG'HC#?3 X
M'@JBR>(35FEKK>_:.7&7<1Q>)S&,?=WK!TV;61Y!CG$3#ZV0UHJ:.X#FBPDC
MQ:9C'9OPZ9R_QLW?6DMW8-BEH0']-Y%4MKS'G"$)/V2>SY*=-/ZAT"V?5U>'
M":3M24A _A-<T[F;M $$G-Y$CCS'K?-%>?=G(6>$\7FW^6RTS;3&Q13.?=3$
M,C -FYE>IU![H@(-A-5:AQ&=T1J&;%73;JWMHC%)<1$.@+@ZA#)!Z+J4XT*(
MC#P2N:=B[-H(ZADK\D=H!D%%'J67ZF\-6T.K<[?ZDSN$-SE\E*9[N?O7MZI"
M *T'L*HR/;_:;0^US;R/1N/-@V_+3<CK<_J+!0$=7)0:R:3N(#XYM14E8>\E
M<&'J'I%N'=6GEHJ-TN/+L4%:@#CP0:9;*WEG%XQMS9);B)D;[++1M<][6M+_
M (VM/1!)Y\.2+V-NLOJ#"X&V?>9G(6]C P5<^XE9$!['60B-*M9668\6FZ^.
MM<1;S0[9:<JQ^3=&^#O&W+ZRNC?(.EQ<R%E*-X>VJ-KM6[1:(US@\9I[4V/]
M<QN*;2TB#W,Z20T$U'/W(2HQ/&^%G9;$9.SR]A@3%?6,\5U;2=Z\],L#P]CJ
M>9P""9!7SCR^50:A8::+\^75WIM'7;X]K.(XD8JTJ!Y:45);<7T1GLYX1SDC
M>T4_PFD*#4[P=QG :LW6TO.QS;F'-.:WK(!I:RW$9)'"O/F."HV:U;JW!Z(P
M-WJ34,[K?$6;"^XF8QTK@UK2XT:P$G@T\@H+5@-T]O=2X<:@QFH;(XYPZB^:
M>.![0/V[)'-+?;"M!A.E,$[6^[MWN]) ZWQ6,L(L#@7EIB=<-8^YEDF+7U):
MX78:"*>Y1$>^--S6V^VC2X C4;'$5XAM&\2D*V#S3V-VYR#G. ;\2R\2>'&U
M("(A'P1N:=GXV@CJ%Q,"*\1_&)RBSS8QNU(P>+G;0EP'3<GJXCA6WBYH)3\4
MGX&,VHR$^MK:6YL62QBS%M5LHN2UY;0T<!P#O="B0(\MLYC<[M];Z S>YV*=
MIV:T;9Y*\A+8<H^,L#'M8^2L0!'_ .37SJHG;;QVWV%TE!B]#9"TFT_BXG.I
M;W$<[HV-!),A:33@.VBBK%LK'/FK+,[A9%A;?:EOY9;9I'1W=E!'%;M9TGB/
MKD,C^/[9)18_%^YH\.^L6D@.=\6=(KQ-,K:'@H]0A3.;3Y*\V?T3O!M]U0ZW
MP%G$^9L9#FW%LV5\4GHT]T&NX\?<M\O%>D;$[';O8S=K2=OD&RLCS]JSNLI8
MD],C)8Z,<_H)+NDG]D*"*]][[;?,[HX;"Y#(OT[K7 L^,8]0$AD#6EL31#Z;
M'!Q>)&NX<@PJPBX9B?0VYLF+L-S]>8>]Q>.E$UO88N=EI#//Z(#KEUPZ4T%.
M'0YG,^:@;(6<MK+;1264D<EJ6@Q/A<'1EIY%I!((7E6K'C89'E+?0&E@TR7.
M<RKK-C6$=0[V2V:.''GR"HVBQL9AQ]G"1QCAC81YVL 4'L0$! 0$! 0$! 0$
M! 0$! 0$! 7FHZWLZP017S),5%@S^'QQP]X1;1MI$_T@T B@YK!U&&WHFD/A
MELMFV>#6W1\<<FL<5#**Q.O(V=)XU!D XKA,,1&HMC_Y1];C='%<]L3WMI8L
M98QM866T8+>3ND5!7Z+;9;W.UBR(['O H*+ZQ#Z*J@@(" @(" @HX5%$'  F
MM:T4%LS]!A;_ ,O</I7V%\-1'_7=Y'SR^K+5_1 #M8X-I^JO(0??A?GVF_46
M_P"T?6XG1?C6>5MFT< !V<E^CV\G<N0!\GM*CDJH@(" @(" I4=4L+)?=L#A
MYPO,VQ*3"!M\HXX\GC1$ *QNK2@XU*XC>HCVMODGZW.;Q%.FC)]DH8GZ?G<]
MH<\24XBOU3UNMGMB<?@R=IC_ *OG_ND^.(1%Y:*!U%O+;(BM&[=S.2^@Y("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M%8K'8>R988NUCM+2/W,430T5/ D^4FG,H/;0!!5 0$! 0$! 0$! 0$! 0$!
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M1% %!54$! 0$! 0$!!0@H*=)\J(4*BN2H(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @("#B[^\@H*DUX^0>1!6M#0\4%* \N8^CQXT0":=G]]!44X
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MK&U(JY[B&M':X@!06#1.0S^J(VZKR/7C\1>L$F)Q%"V1MN[W,DY</2,@'>-
M:V@<!QI55'9K[(:RQV$N9='64$U['$Z7UBY?Z#>GB6]T*%W#C7J2!&'A2W#U
M3N5H[)Y[5=WZW>F\(C !;'&TND]%@)) %!VHJ<<MEK'"8V[RV2D$%A91/GN9
MW$!K(XQ5Q)) '!005MMF]9[Z6M_K1^;O=,Z3=*;?!6.,>(9W&,!SGSND:\/!
MZFTHUJJ+OM;NCEY=9YO:C7,C':JQ3^K&7K1W?KMETN/7TN))+3')U.::>P@[
M][=VK_1MQAM%:5$<NN-22PPV@D'6VW@GD,1N',:0X@=+Z'@*CFD"VZZM=PMK
MM+#76,U%?9^ZQIA?FL/D'">WDBGD;#)ZNR-K',+>OJ%2[D@EC1>J\=K;2N+U
M7BG!UCDX&S, (?TN!+'L)':U[7-/L**OU4 NH*_\ @X]1[./L?L(*EU#3Z*"
MH-4''J/,<D%2X@TIYT$;:USN9O=>::T/IZ]?9W#FRYG*R1#J)L8&/MRQX'(&
M6:%WM*HB3#;@[G0>)V?;?4>:BN<-:6@NV064+K:%S9W0.8'-?)(26M?3FBMI
M.K_O!0.H^V@IU]GT$'*OT/*@P/6&H,MH:X_"6X<Z]T>]\,.2AZ29K1TTC81.
M'"H[II+2\$>B.IY=0*HS.QOK7(V<%_8RLN+*YC;+!-$X/8^-XJ"US201YPHK
MTBO:@J@(" @(" @(" @(" @(" @(.))!\R"@?517*I\BJ%4%4! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$'"1_0*U'MH.L3/+@*#CV=M/*@[T! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$!!PH*>?L0:]9'35EOSKG5<EZ.O36G;"XTSCIXP3&<E=PS>L2M>3TN+8[
MB BG#@JC!/!WJC(Z8SNI-E=0-$%UC[F6]L(I>$WUR*.L8': R/O/\I%;A5"@
M@;5>C,+K[>+/:9ST7>6-[I9[:@T<QWK5J6N!\H(5[$0?H#5FH/"SN=<;::OE
M=+MQD7S.QF1N&%I:USPZ*5KVU:13T7"GNG=E*(K8#Q-7-O=[#ZCO;25LUK/:
M-E@FB<',?&]O4US7"H((-00@SO=#,OTYMUJ?.1NZ7X_&W%R'T)IW49=R'%00
M3X%\;"W:J\S%:W5UD[B"2O/IA;&YO[LJK/-8_&]=MP&1VRU1$XLNK'*22]?$
M@-M'P3#@./,E"%D\3>:?F=<;,:?G?_%\@<3?R- (J;BY$3CY/:1(;I,LXF6;
M;'_,B(0T'/I#>G]A0::>%++-;O/NEH<^E923Y>\,)!XMBR$5OS%!RD5*-S+2
MTMK"TALK.,16MNQL4,0XAK& -:*\^ ':H-8M_M-LW*WKVWTGC&==UB1D;O.R
MQ5>8+6=MHV-T@;RXM=3CQXJB?M?Z?S>I](97 8#(1XG)9"!]NR_DB,_=B1I:
M7-8'LX^2IHH-/KK3?B?\/,#<IAKS\)M(V+2^ZMFVS)(Q#$3(\NC@>96CIK5W
M4 %1M#LONUBMW](1Z@L0RVR$4K[;(8\/ZGPS1AKN1H:$/::\NQ013OYJ1^I-
MW-O=HH)0<?>7+,EEFL-'/%FY]P(G>05@8[RJC9B"WCMH8[:W:(X(6-CB:./2
MQ@H /8HH/-F13#9"G_-IOM90:R^!6OR9Y'M_CI_=2*D\V7>+[.RX#9?(NC?T
MG(SLQK^!-6W$,P(X>P$%]\,EA#9;'Z0?%_YW:"YDK^W?Z)_<H(0WAOV:6\96
MW-Q;.Z/C2SQ=M,75(+K[*75N:4IS![46G!UW,[-6>.6/&73^J+#6CH(Q0BA@
MMGW;?IRHG8VMUY9Q7VB<_;S5[HX^Y?Z-*UCB<\<P>UJ0-:_!KJW,2;/Y.SQE
MB<O>X"Z=%;6 D%N7&X=)<$&1X+?JZ_20GFR/0/B-UIK34VKM-?@DQN7P,LMI
M;8B R/F%S!-W+Q//5T;6-((+NEHK3B@Z1XA-Q-$[D8_1^[^GL=B\5F2_XNR&
M/,IZ6,(XO=WT[7%H(ZNFG'R(+YKK<S?G$XZ[U/IC1%DW35AU2RQ9,RNOY;9G
MI%[8F30O8>GZET1-4HB0]HMR+'=;0]CK"TB%NZX<Z*XM6O[SNIV %S":#B X
M**Q@[PW^J=RK[;;;V&TN)L- RXS.;NV2W-M Z0.+8Q'%)"7$T;Z0D/NJ=BHQ
M#4/B!W!V^W MMOM4:6M<[D<N.O!W6+>[&13-X\Q<R7/&K7- ZN:"=-*YC+YC
M"1974.&=IZ_?WAFQTT[+AT38WN:"7L#1Q: [EVJ#"-KW_A/J356X,K:LN;I^
M'QKF@A@M[!P@EZ:U)ZI( ZO+R<%91"\W'QQY#_=%G^XM45+>N=>;B2:OLM);
M3LQ.4GB<1J*2^M;FY9CVDL#"^2"Z@8'$]Y];<>KT3Y"E!)%M=Y#$8B:_U9>6
M;C;,,MQ<VD4EO UC15Q+9992*?XR@B[0FY^N-VH<UF-$VN.Q>F\;=28^QN,K
M;7-R^\ECC;(7-Z+BVZ6?7&BO33GQ5&-Z.\2.J]0ZQGV]FT&Z;4^-DC9E98+U
MD$+(I"#WC(I&O<0UAZB.LI03MJ+$QZ@T[D\-<Q@LR-G-;/C)Y&6,MY\.1*@@
MCPHZRN[VPU+MQ?.#GZ+R5Y8V+B:O-LRZD/'R])>&CV%9&QX^D>*@J@(" @("
M @(" @(" @(" @(.#Z]B\W<E:7;H;O[D8+<'4&*Q.H);?'VUR8K>!L<#FL8&
M@TJZ,GM\JY/-J\T7S%9X3+]__C_\;V[4:'%DR8XNNNMK/&[SL1^73=?\9IB?
M]%;_  2^/YS-]J70_">U>YCQN^\?+ONU^,T_V&V^"3\WF^U+W\);3[F/&[[Q
M\N^[7XS3_8;;X)7\YF^U)\);5[B/&[[Q\N^[7XS3_8;;X)/SF;[4GPEM7N(\
M;OO'R[[M?C-/]AMO@D_.9OM2?"6U>XCQN^\?+ONU^,T_V&V^"3\YF^U)\);5
M[B/&[[Q\N^[7XS3_ &&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_8;;X)/SF;[4
MGPEM7N(\;OO'R[[M?C-/]AMO@D_.9OM2?"6U>XCQN^\?+ONU^,T_V&V^"3\Y
MF^U)\);5[B/&[[Q\N^[7XS3_ &&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_8;;
MX)/SF;[4GPEM7N(\;OO'R[[M?C-/]AMO@D_.9OM2?"6U>XCQN^\?+ONU^,T_
MV&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_ &&V^"3\YF^U)\);5[B/&[[Q\N^[
M7XS3_8;;X)/SF;[4GPEM7N(\;OO'R[[M?C-/]AMO@D_.9OM2?"6U>XCQN^\?
M+ONU^,T_V&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_ &&V^"3\YF^U)\);5[B/
M&[[Q\N^[7XS3_8;;X)/SF;[4GPEM7N(\;OO'R[[M?C-/]AMO@D_.9OM2?"6U
M>XCQN^\?+ONU^,T_V&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_ &&V^"3\YF^U
M)\);5[B/&[[Q\N^[7XS3_8;;X)/SF;[4GPEM7N(\;OO'R[[M?C-/]AMO@D_.
M9OM2?"6U>XCQN^\?+ONU^,T_V&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_ &&V
M^"3\YF^U)\);5[B/&[[Q\N^[7XS3_8;;X)/SF;[4GPEM7N(\;OO'R[[M?C-/
M]AMO@D_.9OM2?"6U>XCQN^\?+ONU^,T_V&V^"3\YF^U)\);5[B/&[[Q\N^[7
MXS3_ &&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_8;;X)/SF;[4GPEM7N(\;OO'
MR[[M?C-/]AMO@D_.9OM2?"6U>XCQN^\?+ONU^,T_V&V^"3\YF^U)\);5[B/&
M[[Q\N^[7XS3_ &&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_8;;X)/SF;[4GPEM
M7N(\;OO'R[[M?C-/]AMO@D_.9OM2?"6U>XCQN^\?+ONU^,T_V&V^"3\YF^U)
M\);5[B/&[[Q\N^[7XS3_ &&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_8;;X)/S
MF;[4GPEM7N(\;OO'R[[M?C-/]AMO@D_.9OM2?"6U>XCQN^\?+ONU^,T_V&V^
M"3\YF^U)\);5[B/&[[Q\N^[7XS3_ &&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3
M_8;;X)/SF;[4GPEM7N(\;OO'R[[M?C-/]AMO@D_.9OM2?"6U>XCQN^\?+ONU
M^,T_V&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_ &&V^"3\YF^U)\);5[B/&[[Q
M\N^[7XS3_8;;X)/SF;[4GPEM7N(\;OO'R[[M?C-/]AMO@D_.9OM2?"6U>XCQ
MN^\?+ONU^,T_V&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_ &&V^"3\YF^U)\);
M5[B/&[[Q\N^[7XS3_8;;X)/SF;[4GPEM7N(\;OO'R[[M?C-/]AMO@D_.9OM2
M?"6U>XCQN^\?+ONU^,T_V&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_ &&V^"3\
MYF^U)\);5[B/&[[Q\N^[7XS3_8;;X)/SF;[4GPEM7N(\;OO'R[[M?C-/]AMO
M@D_.9OM2?"6U>XCQN^\?+ONU^,T_V&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_
M &&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_8;;X)/SF;[4GPEM7N(\;OO'R[[M
M?C-/]AMO@D_.9OM2?"6U>XCQN^\?+ONU^,T_V&V^"3\YF^U)\);5[B/&[[Q\
MN^[7XS3_ &&V^"3\YF^U)\);5[B/&[[Q\N^[7XS3_8;;X)/SF;[4GPEM7N(\
M;OO'R[[M?C-/]AMO@D_.9OM2?"6U>XCQN^\?+ONU^,TWV&W^"4_.9OM2?"6U
M>YCQN\Z]Z-WGW-RVL,!C<AJ&::QNLA;0W$1C@:'1R2M:X5;&#Q!6=HM3DNRQ
M%UTS#EOY-_'-OTVBG)BQQ;=6.-9_O+=J)GHLIP'!W_#SKI:OP68>T&O$*H("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(,+W2U<_1.B<IF[4=YE&1.BQ< XNEO'@]U&T>5
MQX<58&"[=Z/WAT=I>WQF/N=-$3DW=Q+=07SKB2:8-!=(8Y@TNH&C@.Q$:_[S
M8O7&T>\6GMXLPZP$&2G@M<E)B(YX[8,ZBR4O$KWNZN[X>3EVHK>#%Y&VRV,M
M<G:/$EM=Q,GB>T]0(> >?FY*"-;,T\0M_P#V9=_K5JKV(]&]NS^&W=TG+B+I
MC8,S 6SXW(- $L<K X4ZO(0X\/*BM*[K=34NE]LM7;&;EMFAR]I$^WQ$UPTN
M)$!,0C#F!P<T@#I?6E!S0HWWW*PS]1: U)@6,,CLCC[BV;& 3U&5A;2@XH(*
M\#-]$=I[S$D%MY;92YFE8>!:V5D0%0?\4H2QSQJP?A'J/;+1D+.]N;S($=VT
M.+BV]EC@XT[/0*$+=XFL#)A];;,Z@GB<(,?+B<?+)0]+1;7+9' GD$(;DOO(
MVXY^0:?K(@,XKQ'3T]?["@T\\(N%??[N;DZY;%_%Y;G)V3)J'I_C-_%<  _^
M+5&TFM]9V6CL6V9P]9R]Z_U?$XV.IFN+AS20UH%> Z>+C0>?B$%BVST#>8*X
MR&L-5%L^NM0=#\C(TAS+=C2]S;>(@N'0SK(YFO#B4E$DJ*ZKB&&YA?;W+&RP
M2M+)(WCJ:YKA0@@\P04&L_AZTJ[2N[^Z6/Q''25M-#!9F/C%ZTZ"WFEH>5:2
M#@K(P^]?<3^.S3T5R"Z"..^%N'M]$-&(N7>C4<?20AN:H/#FO_<^0^YIOM;D
M&LO@4_)EDJ?\]/[J14GFS'Q<Z?EU!LQDXH8G2G'2C)%K 7$"VAEX\/.4%Y\,
MMY!>;'Z.;":FULFV\I''TV'J(_XR"#-SK4ZR\9FAK:WC[X8*WQ\DW2#1IQ^0
MN;HD^P.*%>#NNK1FE?'%;Y6\C,<&:L7SQR$$->Z:VDM&T/+G%1#L;.[EY2/#
M: U%?RD-8RRECJZM/KX[H<O\=($&>![3T^)VMN,Q)$8FYVZ=<,)!'6+>26WK
MQ_Q$)YK3X9VCY>]['4]+XZRHKVT.3=P0ET>+%C';L;3AS00[XR#@0*$5AY^5
M(&S>N TZ/S@(%#9S5!X_4E(1!7@;J=DY*GC\<WM!_P"+@4>I8KMA876S/B)U
M1C]5@V^*U7;0G%Y:6KH7B,%Y)>SJ#*.86GO.F@X\N*J+ENEA[G=G?W0AT>R6
M[Q.FC%<9C-VPI:Q&"26X$8E< V3K]%I$9=[I!/.Z^HQI?0V3OVOZ;NX$-A:,
M )<Z6^F9;#I J26]YU>:E3P2!<]"X!NF=)8G#AO3-!;1F[=PJZY>P&9QIVN>
M22@U!W%BU-/XL]2QZ/E9#J(X&V]2>\ CJ[JUY5(%?9*0=B3O"KN)B\KB;W16
M=A&/W(Q3@<W%<!S;FZ>2YID<YPH7 BI#74'5R"2)MU_IZ?5FB<_IJVD=%<96
MQGLHY&'H<UTS"T$$TI2O-00!X5-1PZ(TSG=O]<@8/-8O*S2P^N$L9-;N@A8T
MMD-6.=6-U6M=7EPXJT%-HM(YG/>(766[<5G/8Z1NW-BQSYV=SZRYMI'"XM8\
M-?TAQX'IH:(-I*>;V?*H-0_#@Z=GB-W9MVMZ;"DTG 4;WQN8:^W14;>M\J@Y
M(" @(" @(" @(" @(" @("#@^O#^XHJ/LOLOMSGLG=9C)X6.?(7K^\N)7/E!
M<_M- \!8-VAPWS68XS\L^=TNG_DFOT^.W'CR3;;;RCAYGC'A_P!JNW 1>;TY
MOWZ\3MV">SZ9\[(N_EVZ>]GPCS.7R [5?B_#]DF^$7G]LP=T^,^=ZC^8;I[Z
M?"/,K\@&U/;IZ+W\W[]3]LP=T^,^=?C#=/>SX1YCY -J/Q?B]_-^_3]LP]T^
M,^<^,=T][/A'F/D VH_%^+W\W[]/VS#W3XSYSXQW3WL^$>8^0#:C\7XO?S?O
MT_;,/=/C/G/C'=/>SX1YCY -J/Q?B]_-^_3]LP]T^,^<^,=T][/A'F/D VI_
M%^+W\W[]/VS#W3XSYSXQW3WL^$>93Y -J?Q>B^R3?OT_;,'=/C/G/C#=/?3X
M1YE?D VI_%^+[)-^_3]LP=WTSYSXQW3WL^$>8^0#:C\7XO?S?OT_;,'=],^<
M^,=T][/A'F/D VH_%^+W\W[]/VS#W3XSYSXQW3WL^$>8_-_VH_%^+W\W[]/V
MS!W?3/G/C'=/>SX1YCY -J?Q>B^R3?OT_;,'=/C/G/C#=/>SX1YCY -J?Q>B
M^R3?OT_;,'=/C/G/C#=/>SX1YC\W_:C\7XO?S?OT_;,'=],^<^,=T][/A'F/
MD VH_%^+W\W[]/VS#W3XSYSXQW3WL^$>8^0#:C\7XO?S?OT_;,'=],^<^,=T
M][/A'F/S?]J/Q?B]_-^_3]LP=WTSYSXQW3WL^$>8_-_VH_%^+W\W[]7]LP]W
MTSYSXQW3WL^$>8_-_P!J/Q?B]_-^_3]LP]WTSYSXQW3WL^$>8_-_VH_%^+W\
MW[]3]LP]T^,^<^,=T][/A'F/D VI_%^+W\W[]/VS#W3XSYSXQW3WL^$>93Y
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M-/\ DDJ*A+Q2:+U7N)M]+I32&FI,UE9);>>VO!<V=M'!W<S72 ^LSQ&I8VG
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M(" @(" @(" @(" @(" @(" @(*$ \"*CSH'2WR#Z""J @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M;V^R3Q)[2HJY@4050$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0"@X-YA!5W_#Z*#D$! 0$! 0$! 0$!!Q=S;[*#BSW7M?W2@Y#W)0<AR" @("
M"@[?90/JO:04=[H>P4#M'L!!R0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
H 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm2225088d1-lc_antitum4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_antitum4clr.jpg
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M1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@ .061O8F4
M9,     !_]L A  $ P,# P,$ P,$!@0#! 8'!00$!0<(!@8'!@8("@@)"0D)
M" H*# P,# P*# P-#0P,$1$1$1$4%!04%!04%!04 00%!0@'" \*"@\4#@X.
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!3_P  1" 1U"C\# 1$  A$! Q$!_\0 ]  !  (# 0$! 0
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M_]H # ,!  (1 Q$ /P"_P
M
M
M
M
M
M
M
M
M
M
M
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M572.ZTHC=A2GW)$99D=:.1Y!K0?T4U HZ/\ 3QO?$WNPYRYO,-PLHM2T1K[
M9-1M)<<29MO-:JF3;I)5I(S,TFE2:G349F82\"   I7O)URQHIOV'9V.F4^6
MIMS)YS9\E)TI6+'61&L_(MXM/#UBB.H-1"WV+2I$[&++-EK-V5)@17GW3[5.
M.,I4I1T\IF#++
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MI^!
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MG#>DJ+TS2!18:U76V7RW1KO9IC-PM<Q!.Q9D5Q+S+J#[%(6@S(R!'L
M         ! >9=7VU&"Y1=,1O3-W5=;0\<:4J/%:<:-9$1^:HWTF9<?("T2M
MM]G5DW+Q"W9MCJ7TV:Z<_P ,F6@FGB\,^Y'7J2E2R+SVU4\[L!&S
M        QU\OUEQJV/WK(;A'MEIBIU/S);B66DEZ*E&7$^XNT^X!ZH<N/<(D
M>?$7S8DIM#[#E#+4VXDE).AD1E4C[P'W
M
M
M                 05U;;D2MN]H)WP6Z;-\R)U-EA/(.BVD/H4N0X789&32
M%I2HO6J4DP6'.#;?![AN3G-DPFV*Y4F[R"94^9&HF6$)-QYTR+MY;:5+IWT!
MIUCV[VOPK:VR,V3#[8U$0A!)DSE)2J9)70M2WWJ$I1J,JT]:78DB*A P_6X>
MV6&;HV-ZQ9?;&IC2T*3&F$E)2XJU%P<8=,C-"B/CY#[%$9< '-A_I9WI=RF[
M8Y9<8ESXMMEO16KPZ2(,*2TTLR2\T[*6VE25)\[S5*\G:#=71;9:PYCCFU]@
MQG<'D.Y#;(YPGC8=\0A49M2DL$I1I(C4EK2A7:1TK7B#,MR^!;/^+XW]"W_%
M!%0NON#!B8AB"HD9IA2KE()1M-I09ER"[=)$#4(3Z*H\>5OC$:DM(>:.VSCT
M.))::DA/<=0672GX%L_XOC?T+?\ %!A&/41B679-M!>L1VWMR'[Q=5QVG(S3
MK$,CC$ZEQ[SG5-H\Y*-!EJXD8+"F.U/2IN4>Z&.0]QL2D1<11*4_=GUN,/QE
M-Q6UNDTM3#CA:75H2UP[25]$&JNC_P %6OX-^!O!1_@CE>&^#^4CPW(IIY?*
MIIT4X::4H##DAOOC%FPS=[+L;QY)-V:%./PC"3U):0\A+W*(ZF=&S6:"J=>'
M$&X=!.CN7*E]/^->*6;G(=GL,*5Q,FD37M)5\A5H7H S*B_4_FLC-]Z\HE+=
M-<&T2562WHKJ0AFW*-I6GT%NDXY_= U"XO1=MA9\9VPAYR_#;7E.3FZ^<QQ)
M&\S!;<4TTTA1UTI42.:K335J*OK2H9EGNHSIOC;W_ T^V2XMER&W.*:E7-UE
M3BWH*R_DU$@TFHT*+4C4?"JO*!$O+T^],DK8R^W&^*RT[TFZ0_!R+>F#X1HE
MI<0XAS6<ATU&FBDEYI<%&!,K"@@ BO>7?S#]CO@3\[(-SF?#WBO!_!;4=W3X
M+DZ^9SWV*5YZ=.FO?V=Y8AR6!MTIV@ZL]N<QN.+;:VRV7MJ^R8[4%$B2Q$3$
M)V+&-2S-2):UZ3)LZ?8_H Q1(V\>^N);(QK3*RN%<9C=Y6^U%*UM,.J2J,2%
M*U\]]BA'K*E*@1#%;0=2F"[U7N=8<6M]VAS+?%\<\NYLQFFC:YB&J)-F2\9J
MJLNU)>F!1,8(K;D_6SM5BF27G%KC9\@=N%DG2;9+<CQH2F5/0WE,K4V:YJ%&
MDU(/29I(Z=Q M$VX!FUJW&P^UYK8V9$>U7="W8S,U*$2$I;=6T>M+:W$D=4'
MV+/@"(GW'ZNMMMK\SN>#7^UWR3=K5R/$/08\1R,KQ,=N2G0IV6THZ)=21U07
M&OI@M&=G]3&UMIV\M&XUWF2(,"_-N.VFSNMH7=7R9=6THDL-.+27G(/SU.$@
MN%5$? "B)$_M ,"\9H5BEW*WZJ<\EQ3>T>7E:R37T.9]$%HL)A&[FW^X.*OY
MECMY9.R0R4=S7*,HRX1H3J44E+AERZ%QU'YIEQ(S(&4(Y9UV;7V2Y.6_'[;<
M<C:95I7<&2;BQE4[>6;Q\Q1>B;:2\E06C:-K>KK;#<V\1\;-,K'LAEJ)N%&N
M:6^1(=/L;:?;4I.L^XG"1J/@FI\ *)]!'CNMUMECMTF[WF8S;[7#0;LJ9*<2
MRRT@NU2UK,B(@%:\KZZ=IK)+7#L$.Y9&;9Z3EQVT18JJ>Q5(4EP_Z*@+1C['
MU[[:SI:8]\L-VM+"Z%XI!,2VT'WFLDK0NG[U*C] %HLIB>8XOG5F9R'$;HQ=
MK.^9I1)CJ,Z++M0M*B)2%E7BA:247D!EG %78O7CM#+DLQ6[+DA./K2T@U18
M!))2S))5I./AQ!:-@W9ZN]O-K;^]BJ(DK(;]$/3<6H)MML1ETKRUNN'Q7QXI
M0DZ=AF1\ *-AV4ZB\1WO>G0;%;KA;KI;&4R)C$UM!LDA:M"=#S2U$=3[E$D^
M!\. $P^6Z?4_M7M1-<LUVF/7;(V2^S6BTH2^\R9E4B>6M;;;9]YI->NG'3V
M41$K]H'AY+HC#KF;?'SCD1R5Z'"A_P!L%HD?;KJ^VAW!N3%D5(E8[>92B;C,
M7A#;3+SJCH2$/M+<14^PB<-%3X%4P2B? 0  $;;P[VXKLG;;;=,JAW"9'NKZ
MXT=-L:8=6E;:-9FLGWF2(J>0S!8AJN$]6&UF;6?);^VFXV2T8JPQ)N<F[,L-
MDI,E2T-I93'??4M9J1I)-*F9E2H%$=IZ_=NSN1L+QF\%:M>E,PCC&\:/9&SS
M"+Z',!:+28]?H.36"VY);B<3;;K%:G1.>@VG.1(03B#4D^*3-)D8,H*W#ZR]
MI,'N#UGMZI6472.HVW_@I+9PVW$G0TG(<6E*C+RM$LO1!:-2M'7WMU*EI9O&
M-W>WQ5'3Q+1QY1)X]JDZVSIY=-3] %HLIAF<XGN%9&LAPZZ,W6U.GIYK1F2V
MUD530ZVLDK;67L5I(P9;"     @K<SJSVEVUGOV1V5(O]_C&:)$&SH0\EEQ/
M#0Z\XM#9&1\%)2I2D]Y M$:L?M L(4\E,K$;JW',_/6V]'<62?*23-!&?]T0
M+1/.UN^6W6\##IX?<C5<HR.9+M$Q'AYS2*D6HVS,R4FID1J;4I)&=#.H)1O%
MZ_ ]P]S/>UJ!'% 'T=3<_P"I?;+:*! M-YE/73)"B,+59K6E+S[9*;3I-Y:U
M(;;KVT4K53CIH#%$=6CK[V[E34,7C&[M;H:SH<MM3$K17O4@E(.GETU/T 6B
MS6)Y=C><V*-DN)W%JZ6661FS*9KVIX*2I*B)2%)/UR5$1EWD#+-F9$1F9T(N
MTP%=<^ZT-HL,N#]HMJI>47&.HVW5VI+9PTN)X&GQ#JTDK]\TE:?1!:-';_:!
M8:;A$[A]S2UJ(C4F1'4K3PJ=#T\?0K]$%HF?:KJ0VPW=D?!F/3G8.0Z365EN
MB$QY2TI*JC:TK6VY0B,S)"S41<3(B!*);!'&O<WY2<Q^/+G[[=!MU.V"^13
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MM952I*DF9&1D=2,@1]0
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M!AG
M
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MU547F\3!I=J+^S_P\L<-J;E5R5EQM'28RAA-N2\9</\ -U-FZI)'_P!NDS]
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M>Q15(%=9VKD_>,+3=I,)ZW29UL\2];Y230_'<=8UJ:<2HB,E(,]*N':0,.,
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M!L.7+'3<.ILK;47B(Z:\=*R5S4I[$FE9_5 DKS R
M
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MS[1=F$R8RSH2DUX*0LB,Z+0HE(67<HC(&&;
M
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M@)1?O:_<S'-VL0BYCC*EE$>6MB3%?TD_&DM4ULNDDU$2B(TJ+CQ2HC[P8;D
M *>?M _T/P[XSD>]R!J$/]"EO:F[U2I+B2-=NL4R4T9UJ2U/QH]2]'2\9 LN
MD8,.:G7',>D[X&RZ=40[1!88+CP0I3KQ]I^R<4#<-"VFWKW/VJM]QA8"VTJ)
M<7D/3%.P_%'S&DZ4D2NZA'V 42)\\+J-_P 5&_)1@45V=M-Y==6Z=MD)-:C4
M:4,+2DJG6A$2>!>@"NM<V[7%S8R1?4NNQ;LO$US2?0M2'VI!VTW=1+3I,EI5
MQJ5#J##EW^N?>'_\(.2_EF?]N!JA^N?>'_\ "#DOY9G_ &X"B=>NB3(>RW"&
MWG%+26.MO><=3YCK[A+49GQ,STE4$AMW[/-AI3^XDE2"-]M%G;0YWDAPYQJ+
MZ)H3]("5XP9?PDI25$D1$781<" >*]?@>X>YGO:U .* /H[68^RU'L-KCL))
M#+4..VV@NPDI:21%] B!\U6>OYM![=8NZ:2-Q-ZTI7WDE41XS+Z.D@:A"70K
M\M<CXCF^W1P65_\ /<]QG;7&9>699+\):8E$^:6MUYU?K&FD<#4M1EP+Z)T(
MC,C"E.:=?663'W6,"QR':X-32W+NIKF2E)[E$VTIIM!_N3YA>B#5&EN9GU@[
MR(\/ ._NVR01D1VV,5G@FA1<4JDMH80I)D?^$=/@"[%<05VOLOX'M_N9GVM(
M/FX\[F_*3F/QY<_?;H-NIVP7R*8#\1P?:4@S+GOU??\ ,3F7^S/]U1 :A</H
MD^0J)\9S_KT@S*AF^<QZ=O-G[SYU6G(+FP1\?61Y3C*.TS^I00-0W/;WJ/WI
MV_Q&WXGB+3'P!!YQQ37;^>L_$/+?69N?5>>M7T. %'ORKJ<WXS+'+GBU\C1W
M;1=HZXLQ"+8:%FVX5#TJXT,NTC[C HC_ &ACWNT;JX1<D09*?#WVVJ6?*6@C
M;.4V2TFHTG0C29D9@.C?51\@&;>YH_OQ@&8<X]BH[4K>? 67TZV_AZW+-)]A
MFW(0LJ_1(@:EU]!ASSZ_&6T[GXY()/V9RPH;6JI\4HF2325.S@:C!J&]_L]_
MP/GGNFV^UR )1/UROR7M[DMOD9-1[-";C&=:&V:WG#I7NUK7V L)B_9]M,EB
MN:/I212%W"(A:_JC0AE9I(_0(U*IZ8)*XX,N3?4XQ%C[\YPW$T\HYZ7%::&7
M-=8:6YV=^M2J^B#<+S]&7R 6#W3<??CH,RYJ9/,>N&2WF?)/5(E3I3[Q\>*W
M7E*5VF9]I@VFO$^J'?;$\:M6-V!F.5EM<9N- U6WF*-EM-$F:_JC,N->\$H\
M>>]1&]NY.*S<.RB*R[9IYLJ?2S;3:=)4=Y#R#2LJFD]2"K3NJ7>!1Y.F!F\V
M??C"YG@I#:%2W8[JE-K0GER8SK*JF::4HL"750&
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MO5?(JG35:\:5\"6]DC,TH.+_ *0=.S4IXW*G3L))=P-0L%T4;)XVK$T;L9#
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M$/E;89DZEM!+J<=%3J15!\U5/VA'X'P/W3<O:XX-0TCH!^4G)OB,_?; $NA
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ME3JM2SU.J6KB?'M!&>
M
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M3*C---$1$I1*9:46M:DH215[?0,"860!
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M0:V5.J^J<(TK0:N\DD9U49F#$K$@@
M
M                                          @'?;I7Q+>%Y>0V]_\
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M:H7$^]/:9U/M/B"POQT<1G&.GS&7%TI(>N+J"*M224]]'&I>5!@S+,[\=/\
MC6]]G:*4Y\%Y7;T*3:KVA!+-*3/4;+R:D:VC/C2M4GQ3VF2A$J.Y%T;[\6.4
MIJ'8V+Y%(Z)F6V9'-"O)YDA;+I?W@-5?O&.C3?2_S$,W&SL8_!-1$Y-N4M@T
MI+O,FXRWG#.G9YI$?E JO?LCLCC6R6-*M-I4<Z]3C0Y>KTXCEN2G&ZZ2)-5:
M&T:CT(J=*F9F9F9@S,I/!
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MPC2ZQ$;1HCH<2?$EG5;AEVD2B(R(R,&96)!
M
M
M
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MYMK
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M-6SFW<UFZV+'D2+U'5S&+E<7%S7FUEV*;)PS;0HNY2$$KT0*I:!
M
M
M
M
M!_%)2I)I41&DRH9'Q(R,!#>4]*NQ>62G)TO%FX$YTS-;UJ=>@),S[3Y+*B9J
M?EY8+5K3?1+L2A9+5"N3B2,C-"I[A),B[CTD1T/TP*I8P3:?;K;1IQO",>BV
MEQY.AZ4@E/2G$%0]*WWE+=--2KI-=*@C<@
M
M
M
M
M
M
M
M
M
M
M
M
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MJ-)&I*5*(C.E:5 9X
M
M
M
M
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MQ3B8\2-,=;;9:29T0A*4EP3Z?:#<.D'39\A6"_%B/KU@S*5 0
M
M
M
M
M
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M.BN&B/9H*^5;F$EQ2EYU:FVWGZ44HU'7V))3P!-R&+S8\TVSR7P%WCS<;RB
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M&Z\G*\-O,'',A>Q@[K;WTW!B%.7 .,F4@UK)U*#;Y9$1U56@(ZQ P
M
M
M
M
M
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M%V+QSANRK*X_9U.&9F9MQ5U9+C[%E;:/H S+GWO[\M>??'D[VY0-0Z+]*_R
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M_B6\^_W@;ATRZ;/D*P7XL1]>L&92H"
M
M
M
M
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M"4MZ#5W*6D%A1'8+Y:\!^/(/MR0:EUX!@  '(??WY:\^^/)WMR@;AT7Z5_D
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M&@?-RCWG^6'<'_B6\^_W@;ATRZ;/D*P7XL1]>L&92H"
M
M
M
M
M
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MJX]I5X'2@%'54&
M
M
M
M
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MT6U)ZDQ(##<9G49$1GH:2DJG3M!&)5MIMRM2EKP^R*6HS-2CML0S,S[3,^6
MV1AAB*PU&C-(9C,H2VRRVDD(0A!42E*2H1$1%0B(!C;SBV,9$IE>066!=EQR
M43"I\5F4;9+IJ))NI52M"K0 LV+8QCJGEX_98%I7())/J@168IN$BNDE&TE-
M:5.E0&2?88E,.QI+2'HSR%-O,N)):%H65%)4DZD9&1T,C :VG;3;E"DK1A]D
M2M)D:5%;8A&1EV&1\L!M #XRHL6=&=AS6&Y,1])H>CO(2XVM!]J5)41D9'Y#
M 1U.Z>MD;C(5*DX):">7Z[DQDQT'QK70SH37CY 6K:\7P7"\*96QB./V^R(<
M*CQP(S3"W._[(M"24O\ NC,$;  PUXQ'%,A?;DW^Q6ZZR6D<MIZ=$8DK2BIG
MI2IU"C(JF9T ?6S8WCN.I>1C]HA6E$@TF^F!&:BDX:*Z34324UI4Z5 90!JZ
MMM-N5J4M>'V12U&9J4=MB&9F?:9GRP&R,,,16&HT9I#,9E"6V66TDA"$(*B4
MI25"(B(J$1 ,-E&%XEFT(K=EUDAWJ&FIMMS6$/&V9]IMJ46I!\.U)D8#6K-L
M3LY8)29UJPBT-3$&2FWG(J'UH478:#>)>D_12"U2$"
M
M
M
M
M
M
M  *O[_=(-NW1O#V98;<&;'E<KC<8\I"C@S'"(B)PS;)2FG*%YRDH42NVE:F9
M8E6.X=%V_D):TQK-#N)(]:N+<(J27QIP\0MD_1XD0-5>^Q]$&]USE(:N;-ML
MD8S^R2)4Q#U"[Z)BD\9GY"X%Z(%5S=A^GW&MC[7(\&^JZY1<DH3=+RZ@FZH0
M9F33+=5<MLC.IEJ,U'Q4?!)),S*8 0
M
M
M&%O.4V:QI95-F,-D\:B1S'FVZZ:5IJ,J]H#^6/*;1D#CS=NDLO*8)*G":>;=
M,B49D5=!G3L 9L
M
M
M
M
M
M
M                          !'NX>Z%KP;X-\2]R_'\_35E;M>1RZ^M[/7
M@.7>X?4WF>:LP&Y)P7#A*=4C1&<;IS221UJOCZT![]I.IS,L E721!5!;7-;
M9;7S(SCI&3:E'PHOAV@.F^W&X\3.*LLNDY):BM/O$32VB(UT(Z:O1,%2 "
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M1RF4DS<)+#:4)J9D24-I3Q,S.E3,SX@LI+!
M
M
M
M
M
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MV!
M
M
M
M
M
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M(/\ R[8;_M/_ 'K+$64W@@
M
M
M
M
M
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M^TPE7$E9&_'E,H8U*?FDETELDBBG%<M*^9QU)$65P00
M
M
M
M
M
M
M
M
M
M
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MU'5*3/Z #80
M
M
M
M
M
M                                            !^5*)!5/L 1#NEOC
M8=O+7>Y<M]]IRTD@W#;CD[36I!<"/M]> AG%^N3"+W?+39%3YRY-RFQX:".W
MH2DSD.I;(C,CX>N[0%JL9R2#DT5Z5!4M3;+G*4:TZ#KI)79]$!G
M !S9ZJ;7?KOU+W2/C"'5WR/ C7"*4<S)\O@VW>,6IO3QUI0RI2=/&I<.(-0N
M+TX[SQMY,"9GREH3EMIT0\AC)H7V;3YDA*2[$/$1J+R*)2?J098/K-^0"_\
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MF/*2FITX%4!ZH,^#=(4>Y6R2U-MTMM+\67&<2\RZTX6I*VUH,TJ2HCJ1D=#
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M%LKMMSN5#-,)F0@I"B3Q,TM*-*U$5>)I(!N@
M
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MQO3C!W^P$J+.BJ2S=[0\HE/1'E$9I(U$1$M"R(S0LB\[CP)1&1$F$C @
M
M
M
M
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M%79$4DF3BB*E%+;6VM7#M,^X1)2^
M
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MOD+C35GN*93CY*4TE*'$ZB16OKTI[*& SX
M
M
M
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MG8I.N3\EQ^Y)<0[XLFF67"3S6F3-)):1Q(C*M>-:D1$O@
M
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M$
M
M
M
M                   !Y+C'*5'Y1E4M1'3M[ '-3J<Z?[Y/SO-<UMMON$A3
MSS3S!(2WX=1\MEOAPK3Z("O%EV9W#N5T@0W<>FIC29+3#KB$H-24.+)*C+B?
M$B,!T&Z5-C%XABUYBW1J9'==N27VTRDMDHR)E":E1/94@5;<$         $&
M2MA[M(ZDX6^17>.FU1639.T\M?B%&=M<@UU^M]<YJ](!.8" ^HSIKA;W%:[M
M:IK%FRNW5CN3WFE.(D0CJHFED@R.J%GJ0?=51=Y4+$MXQ7:R%;]G86TF4+1<
MX*+8JTW!UDC;2XE>HC6WJJ:3*M4GW&501!-AZ<NHG:UR1:-H-S8$7$Y4A3YQ
M[I')3C>HR(U$TY%F-Z])$2C0:-5.X%J]62]']]SJQ7&Y9]GDC(=SI*646ZYR
M$*;MD!M#I+<;:CMJ*I+3J*I$E)&==%>(%4L/[5WR;L 6T$VYQSO";,W9$W1*
M%^'T1Z-M+T'YW\FA-2\HJ,EL9MM-VFVXMV#W"<U<94%V2ZJ6PA3;:BDOK=(B
M2KCP)5!!@>HO8TM\<7MMJB3FK9>K3,\3#G/H4X@F74&AYHR3QHNB%>FD@&S[
M-;;1]IMO+3A33R)4F&3CL^8VDTI?E/K-:UT/C3B24_N2(![-S=M,8W8Q23B6
M4LJ5$=,G8TIDR3(C24$9(>:49&1**IE0R,C(S(RH8"O5KV#ZH<&B(QG;_=>$
M6(-ZFF$7!I1/L,5J1-(7&EZ.T^"'DD7<"MZV5Z:8NV^0S-P,PO;N6[BSN9JN
MCZ5$VQSOY12.8I:UN++S3<49>;YI$7&H3X",3E%H<O\ C-ZL++B67KI E0FW
M5D9I0J2RIHE&1<:$:J@(XZ=-GKCLEA,_%;G<V+K(F75ZYID1D+;0E#L>.P2#
M)9F=2-DS^B"S+$]0NP]VWHN&&3;9=X]K3B[TMY]$EM;AO%*7%41)-'93PYUK
MY01.8""]F=AKMMAN'F^:3KO'GQLK>==8BL-K0XR3LI<@B6:N!T)=. H7W8:[
M7?J(LV]3=WCMVRV,MM+M:FUF^LT1W6:DLO-+BY4!N&\>SF,;T8P6/Y :XTJ,
MLW[5=6"(WHKQE0S(CH2DJ(J+0?;Z!D1E!"$;8WJPM< L2MF[L0L02T4=N2XA
MSX10T1:"2A1QENIHGUNF45.PO**NQ,.R.QV.[*6*1"M\A=TR"YK2[>KZ^@D.
MR%HKI2E-5:&TF:C).I1U,S,S$1'^Y'2Y-GYNO<[9_)UX5F<E2EST$E1Q'W'?
MY1PC14T&O_"(-"T+/C0CK4K6;CTV[_;G>%MN].Y\>3C;#J77;?9FJDYR^P])
M1X;>OR+6A>GMH8"T&*8M9,*QVW8MCD4H=EM;*6(K!'4])<34I1\5*49FI2CX
MF9F8(S
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M\RM+C+B26VX@R4E25%4C(RX&1D"/V
M
M
M
M  PMYQ6QWV/(CW&&E]$FG.)2EI)6DR,O6J+R ,+ VJP6 MIYFSMH?963K:R=
M?.BDF1D?%?<9 -LB08L%"FXC9-H4>I1$9G4^SO,P'H
M
M
M           4RZU\>W1SN^8YC6(8U<[OC5LBKGR9$&,ZZPJ?)6IHDJ-)&1J;
M;;(R\G,,&H5>@;*;^6M_Q-LPW(H4DTF@WHT62RO2=#,M2"(Z'0%JR7ZMNIO\
M19=]*=ZH"\G219LUL6U;T+/8MPB7P[M*<2U=B=*1R%-,D@RYM5::DJ@,R@KJ
MBZ5<EDY-/W&VSMZKK#NSBI5ZL<8M4MF6OBX\RCM=0ZKSE)359+,Z$:3\TL2A
M*Y%U-9W:X6 76%E-TM<13:&+7(ARDH(VRHCG*4VDU$@BX&\H]/H NQ<WI4Z>
MIFS]IFY%E9(_/B]MI9=CM*)Q$*&E1+Y&M)F2EK41*<-)FGS4D5:5,S,I,WHV
MJM>\6!S</N#A191J3+M,_3K\-.9)1-N:>%4F2E(67L5'3C0P(<[T8-U(;"9%
M,58K;>;;)61QW+E9V')L"4T2O-/6A#C:B^J23B26FO8DP:9K;;INW<WCS KW
MG42XVNRR9'B+Y?KREQJ6^DC\Y+*'R)Q:U$6E*M.A/>? DF*NEMMMT*SVZ':;
M:R4>W0&&XL1A/K6V6$$A"2] DD1 PHYU1=*N2R<FG[C;9V]5UAW9Q4J]6.,6
MJ6S+7Q<>91VNH=5YRDIJLEF="-)^::B4)7(NIK.[7"P"ZPLINEKB*;0Q:Y$.
M4E!&V5$<Y2FTFHD$7 WE'I] %V+F]*G3U,V?M,W(LK)'Y\7MM++L=I1.(A0T
MJ)?(UI,R4M:B)3AI,T^:DBK2IF9E8T$53ZM?T)G_ !G'_A@J'^E'Y7\=_F9_
MO1X!T,!                'BG7.) ,BDNMMF:346M:4<"],!@T9]CKE=,^(
M=/)*:/\ Z05[(^76)\E&4^*6FG_I#1]OT01S7ZPK\Y*_,SX.GDG1\*<WE.$O
MM\'2ND_0,!57X:NI?^F._P!\ _AWFZGVRW?[X!>?H.OY,9KDZKM<4DR=I;)O
MQ#J4)U>(1V:C[: +QJSK'R,R\=$X'3_2FO5!7K@91:;BXIJ-*CN+2G49-OH6
M=*T["/T01FDJ)2247$C*I'Z8#^@    *2;R6Y.ZO6-B6VU_4;F,VV.VHX1F9
M-N)1&=N;Y'3O>)M+2C\A$"QN7/5:+4JUG9%08YV8V?"G;N4CPW(-.GE\JFG1
M3AII0$4^Z>I+>V_4SN'M!:5F6)S#?EV^)KUI8>CFAYM*>WUK3JVU=YZ4U[!5
M7-$0 408MZ^JKJ<NC-Z<6[MMA!NMHB$HTH=CQ729)":'4CE/$;BU<#Y::<#)
M(+R+Q6FT6JPV]BTV2$Q;K7%23<:'%;2RRV@N!$E""(B!$;;];-67=[";C;SA
M,?G='84Y8+FI*4O-R6RU(:-W@?+<,M"R,Z<:]I$ ^.S]HSW:_95JW9\VB[WS
M'(TIR-$MSW/><A,)-UF/K=)M/,256TEJTT)/G>0,KLUO/C>]>/S;_CL>1"*!
M+.%)AS>63Z5<M+B5T;4LM*B50N/:1@,[N/GUEVPPVYYM?R<7;K:E!FPQI-YU
MQYQ+2&VR4:2-1J47?V<0'ZV[S5G<3#K7F<6WR+9"NZ%/Q8LTV^?R26I"5J)M
M2TD2R3J3YWK3(!M
M
M
M
M
M                                                       (FWJZ
M@\)V3B,HO7,N.1S4&Y L40TD\MLC,N:ZM7!MO46G4=3,_6I50Z%B%4+KU_;D
M/2#59,9L<.)4Z-3"ES'*=WGMOQBX=_F M%D][NI.V;)9AC=BNUI7<;5=XSLJ
MXOQG"3*C()U+;:VVU>:X1T<JDU)[.!@D0F+'LALV5V2#D>/3&Y]EN+1/PY;1
MU2M"N'?0R,C(TJ29529&1\2!&3
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M#B,EV(9CH)M"?H)21 CV
M
M                                                          #7
M<WSG%MNL>D9/E]P1;K1',D<Q=5+==41FEII!54M:J'1*2[C/L(S 5&R;]H&R
MB4XSAV&&]"2?V*9=9?*<65>]AA"B3P_[8P:HE^7U)M6'8G&MYK_92<7?)2(C
MEJB/:-)K>?09MK<2>HTH84O2JE>RI=H)1*.W>X^)[I8TQE.(3/$V]TS;>9<(
MD2([R?7-/MU/0LJ^6AE0R,R,C!&U@
M
M
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M;,BIP-,=LS67<;H$KC @
M
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M\*BWYZOA[7<FE1'W:%6C9GJ;6JGU*%FKT* 42X"
M        #YOR(\5OFR74,M5IK<42$U/T3H _:5)4DE),C295(RXD9& _H
M
M    /DY*C,N-LO/-MNNG1IM:B2I9_N2,ZG] !]0
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MLTQCD7N>D[K>4*(B64J81*T*I]4VV3;1_O01+8
M
M
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M:R[\]9]]Y<=Z-X"4SH;/GD1:J\Y?$J>0&5@A
M        !@,PPG$\^LSE@S&TL7>TN'JY$@CU(678MMQ)I6VK]TA1'Z("OMRZ
M#]G)DDWX5QOUN;4HC.,S*C.-)17B23>C.+K3@1J6?T06K<<!Z3-F=OY[-VBV
MM^]W:,HEQIE[>*4;:BXDI+2$-,ZB/B2C:,R/L,@*IP!
M                    !5/JU_0F?\9Q_P"&"H?Z4?E?QW^9G^]'@'0P$
M                 ?PT(5VI(_3(!^>4U[!/TB .4U[!/TB ?HD(3Q2DB](J
M /Z                     @>Q=(>SMCS->;>&FW&9XDYS%MGO-N6]E\U&L
MC2TAI!J(E'4DN+47H M4\ @
M
M
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MB:,+R^=I(N==&&=?U1\F.2J'Z!<SAZ8$M?\ VAC:"<VZ=))$XHKTE2^\TI.
M9%]#48$-RZ!)3SFUN01%G5EB_.+;(ZU(W8<;47I>;7Z8$MJW\WC=V[R-FU-R
MEL&Y:DS22EA#Q54Z^BM5$?\ B^P&57%=:L[ZF]N?DYK^( N]M?FZ\L<=0MTW
M31%;>.K:6^*S+CP],!)0       (PWAS*7B>*/7**]R742FF25RTN<%&HJ44
M1EW#BY\G4MJ[SA6DC/FBV8Y%2;SU%9VW=I"(MT048E%H(XC%::2\J/*.JNU%
M]=DO?XN!:?JQ6W;TR\GSC=P?QHC[T8_B#/Q&3G]#[?(M-V?/+=L'WXRVX-'X
M^X$M9R$H+3%93YIDGR)+RC[X]3=RRZK6<$Q6S^&WDYY7:'=/S,         4
M;VU-C,^N7+;I<%>)58G+F4,ED:B2NW$BVH(B52F@C.A^4JEY07D7D!'DNEKM
MM[MTFTWB(U.M<Q!LRX<A!.,NMJ[4K2JI&1^0P&/.S6?'<;F6['[?&M-O9CO&
MS$@,MQ64'RSXI0T24EV=Q *X]"5VNEWV[R1^[3I$]Y%Z-"')3JWU)3X1@Z$:
MS,R*I]@++:.LRX3[7LC,EVV4]#E%<8*2?CN*9<(E.'4M2#(^()#V72?.3T@-
MW),ITKC^845_QA.*)_G':VU&O775JKQU5J K3L_M+N+U*8)#+),RD6C",76_
M;[6WI<FNRY[CRYCCSJ%O-D?+YZ$$M2CX)TII0S!K<EW=;-,BZ:=G<5VWQRZ.
MWO<.\F]"AW>2:WW$))9&XZVV\MRAD;S;3"#JDO1T\:CRV?HH;R&W,WK=3.+Y
M<,\>23[K\20VMF,^OSC22Y+;RW-*J><E2*TX$(5?':?,\^V7WG1T_P"XUX<R
M''KLV3F*WB2I2GD$X2S8\Y9J5H6;:V3;,ST.$6D]/;1ENIW<_.).8X[L+M=*
M5;\DR1+;ESN;2S:=:9D*4A#:7$^<V1)0MUU2?.TTT]ID<(>1KHK788'PYB.X
M=ZA[EM))Y%V4M*(;LA!$9)4AM/.)!F5*J=7P^I/L,5:?T>S\@N6_&X\S+$I1
ME"X;R+RE"20136IS;;W N!>>DZTX>04E>,1$3]3,N5!V*S.7!?<C2FHK)M/L
MK4VXD_%,E5*DF1D KCL_M1F_49M];;EN!F5QMN#6UM5KLEGMR_.E'',TNRI"
MG362U&LU(JM*CX&1:2[:NYJ]P+=+ICW?3M9M[?';Q!RN)'9L$:Y'J:0Y<7%Q
MF7C;+4A#C+R%><E-%)+SBIP(),RWHSN$RQS<JE[AW>Z[EQH[DQ$^2HO#+DH2
M:S;151NMI49:4J)SS>W3W 5;QT;;E7_<+;*3'R>8Y<+OCTTX"9SZC6^]%6TA
MQHW5GQ4M)FM&HSJ9$5>/$X2T?:^\W>1UI9[:W[A)=MC,:<;,);SBF$&2HM#2
MV9Z2I4^PA3D>S?G/]P,_W<MW3OM;=5V4U-$YD]W84:'$I<:YZTFXBBDH;9H9
MDA236M>@Q!\[MT10[1:'[U@V;WUG<5AI;K%P>?;;:??26HD590AYO69$6KG+
MIV\0*M_V,W2S1W:"[Y#O%:I]LN>(MOKDSY\1R&N?"C,FZ3J2=2@EN>:IM1IX
M&HB[S!$,8'ANX'5]*NF=;@Y--L6V[<I<*U8]:G-!+)!$:TI)9*;(DI4DE.N(
M6I:JE0B*@+N?O<3:O,NE&)%W*VDRBX3L1AOM,WW'[LXEUHT/N$E*EI:2VVM"
MUJT&9-I6@U$:3XG0;UP,(RRWYWB-ES"UD:(-YB-2VVE'539N%YS:C*E30JJ#
M]$@1GP'.Z?;-P<@ZL\^Q7;JZ*L=RR!<B!=+TBO,B6LCC2'W$*2:5)55E"$Z3
M(S-6FJ:U*KR)/ROHUEXM9I&5[69K?4[A06_%:Y4A*2F+9+4:$+80VM"CIYFM
M2RKP/AQ$*I#Z>-S7M_MHKG;<G<-.1Q$NV2]28_V);B)#/V*4C130M25'ZVGG
MH,RH5 ):/T<Y;?K9?<[V9S*8]*OU@FN2XJY3JG75):642223<,U:"4EI:>)E
MYYGZ8EM_63N%+PO:LK-9I#D?(<JEMV^(J.HTOICM&3KZT&7'B1(:\WC]D A*
MNTV)R\(VZQ[&[D^Y*N\6(A=TD/K4ZXN:]]E?JM9F9D2U&E/'UI$"-S 5-ZWL
MNFO63&=H;#5V]9?/:<?CI/BMAEU*&&S_ )R0I)E_-@L-NWGV4A2.FD\#L[1/
M3<.@,SK6M)><Y)MS9J?41'QU/(-[A[)0(]G2-N,>?;/VZ+,>YE[Q@_@6=J.J
MU-,)(XSAUXG5HTIKWJ2H%E&O[0+]#,/^,W_>X$;V'ZB\ O>VE[QOJ1VX0;,N
M(40LD8;+['S#;2VEY:2[6WTGR7O1,C[3,Q2%KMML_LFY^&6O,["O_-+@W5Z.
MHR-R/(1P=973ZI"N'HE0RX&(BKO[/C\!9U[KM_M3X++];!&F]]7V[=YDU-ZW
M_"<-E*N-.5<68Q*J5.Q#-"] P%S 13+HA6<#,=V+!&HFV1YD93#/82#:D3&B
MTD5"*J:$?#N(59?WH/--VF[F96]4YMQF0JZNU).*EOJXE0CU&LJ\.X0E:O/8
MK$[!LGA24DN-)M,]EY!D1DI#D9Q*B,CJ7$C!%<.@U]5PVDR*TSDID0&KV^@F
M72UI-N1#CZVS2JI&DZ'PIWF"RLY8L;QW%XKL'&;1"LT)]U4EZ-;HS41I;ZTI
M2IQ2&4I(UF24D:C*M"+R BM'6-NI%3CR=E,6([KF^4/1F9<&*7-=8C<Q+B$&
M2:_97EI0E*.W14^'FU+"3,0LC^Q?3HB!.<25QQ:Q3I\LT*U(*:I+TUQ"%=Y$
MZX:4GW@BI'3)<M^F<-NUFV9QV'RY<\Y-RRNZF26$FAE#:(S*7%)2I2:&M1T7
MZ[B2>TS4I-:ZC=[MFLH@63J&Q]A['KDNC5]MR$$M*"X*<;-A1M.DBI&IHTH<
MIQ\A&2BWJ;K;EVHKXB2A5H5'*:F81U;.,:.83A'['3YP(K?T@17LC3N#O#/2
M92\TOKQ1-?%28<92G$D7<1$IXT?W +*&L[S>Q;<]=%PS+)EN-V2V\GQ2V&S>
M<+Q&-MQT407$_/<2"\B=E=;>Q24FHIER49$9DDH"ZGZ!541 E)0WO/OK/ZDX
M$;:?9O&KE.8ERF'[I.DM$@]+1ZFTF3:UI;:)?G+<=47K>SO W+@[6X66W>WN
M.X6;Q2';/#;8D/IKI7(55QY2:\=)N*5I] $;!>OP/</<SWM:@%/_ -GQ^ LZ
M]UV_VI\%E<X$                                 ','J+WRS;<7<6[8
M]:+C*CXI;)KMKM-I@..(3)4PX;/.<2V9&ZMU1502O6D9)(JU,S<0C9.S>[[B
M2<3@&2K2LM1+*SSS(R/C6O)XU J_OZF-X?\ \'V2_D:?]I JOIT38QDF*;57
MBW939IUDN#N029#<2YQGH;RF50H2"<2AY*%&DU(41*I2I'Y 9E9($
M                             53ZM?T)G_&<?^&"H?Z4?E?QW^9G^]'@
M'0P$
M
M
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MDN-UX%V@LOUO:@]F.I["]W6"-C'<ITP+^M*:-DM))BR%+I0OY%;3I5XFI!F
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MW!\O-89D+,F9;:NY&JJ)#?8E55%V>=57L(R,B,CJ1\2,A$>*]?@>X>YGO:U
M*?\ [/C\!9U[KM_M3X+*YP(                                 .<[U
MIB].G5E'OF9Q5EADJ?-G6RY*0IU"8ER0ZA#J3H9J5&6Z272(M14J1<4U-;X7
MXM6=83?&6I%FR.V3V7DZVE1IC#M4TKV)69^F#+)?#5G_ !A&_IF_XP#TQY4:
M6@W(KR'VR/2:VE$M)*+C2J3/CQ ?4
M     !5/JU_0F?\ &<?^&"H?Z4?E?QW^9G^]'@'0P$
M
M
M
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MX)?N4B&Y"3XF+*YB&4.DLZQG72*AJ+UU 65F@0
M           <J^H+<G+-X]U9]K8\1,MENN#UJQ>QQDK<X-N\DEH:14U//FDE
M*/BKB22X)(@;AAV^G#?-U"7$X+="2HJD2FDH5Q\J5*(R^B!5^OFV;Z_U%N?]
MXC^.!5>+HUPC+,"VPNUGS&TOV>YOWZ1+:C22(EJ87#AMI65#/@:FU%] &96(
M!                                    %4^K7]"9_QG'_A@J'^E'Y7\
M=_F9_O1X!T,!
M
M
M                                         !1#KEW>O"[VWM!:G"8L
MC,>/.OID1&Y(D.'S66C,ZF2&TDE?"FHU<>P@:A5^U[7[H7:*S=+)AE_G0G"2
MY'FP[7,>:41D2DJ0XVT9'P,C(R,%9?\ 5EOS_4[+OR9<_M0"S/13B.Y&/9[D
M$G-+%?+5 =M!MQWKQ$EQF5/>*9/2A4A"4FK21G0N- 25WP9
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M;Q^VXIC]LQJSM\JUVF,U"B([3)MA!((S/O,Z5,^\Q$90
M                                                       '.^YP
M873?U71\LO[1/X1<)LZ7#G,I)WD,W)MUMPB)-3)<5;U%H]<:"J1><0-;X7=M
M^[VU5TBHF0<VL;L=9$9'\)14J(S(CHI*G"4DZ'ZU1$8,O3^LW;;^N-C_ "G$
M^V@,U:+[9,@C+FV&Y1;K#;6;*Y$%]N2TEU)$HT&II2B)1$I)T]$@&0
M                               53ZM?T)G_ !G'_A@J'^E'Y7\=_F9_
MO1X!T,!
M
M
M                                    !0;K7V^GV+<6T;LI@JGXO<"B
M1[J5*H1+A'0FW#XT2\TE)),^]*O0!J%RL/W,P#-;+%N^,7V#(A/M)63!/-(?
M9*A>8ZR:M3:DUH:5$#+8?AJS_C"-_3-_Q@'VCSX,M1HBRF7UI*JDM.)69%Y3
M))F ]                                 "GW6A^&\3]R2_;&P&Y]-OX
M8NGN%KVQ("QP       /XI)**BBJ0+5\%0HJE&M39&H^TZGZHE&NO)X&)_BR
M^F?JA0Z]S](BL(*B$4+TS"B3=,OL*R
M
M                                   .9^Z'39O??=S,SOEIQ"1)M5SO
MMTFP9*7XB4NQY$QUQM9$IXC(E)41\2J#=6I_-7W_ /ZDR?OB']O J?-7W_\
MZDR?OB']O JNUT>X!F&W.V=UL>:VM=HNLB^R)K,9U;3BE1UPX;:5U:6LJ&IM
M9=M> ,RL$"                                    *I]6OZ$S_C./\
MPP5#_2C\K^._S,_WH\ Z& @                     C?<#="!AC4!R2VH_
M&*=2G2\AO^3))GZ[M]< \FTV[$+<>;=(L1I;:K>VTXHUO(>J3BE)X$GL]: E
M,          0OOSU#V39>/#MK$)5]S>[%JMED:4:*-FK03KRDI49)-1:4)26
MI9\"[#,@C$]\NK.Q6T\PRG:> K#6D'(D-1%.,W!N.7G&I:#ER'$:4^N-48J=
MIT!=BP&UFZ6+[NXHSE>+N*Y)J-B;">H4B+)21&IIPB,RK0R-)EP41D8(W8
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MYVY&X_P_^L'!96%_!G@_@[Q<>7'\5XCG\W3XIM%>7RT5TUIJX]P"800
M
M
M4.ZQ-N-T,OW3:F8GCMVN]B.T1&7'(+#KT8WD//*4D]!&G454G](&H5X_4%O7
M_4&^?>+W\4%J?J"WK_J#?/O%[^*!59GHIVUW PK/<@GY=C5QLL*1:#88D3H[
MC"%N^*95H2:R*IT(SH"2N^#(                               "GW6A
M^&\3]R2_;&P&Y]-OX8NGN%KVQ("QP
M
M                                                *VY/UL[58IDE
MYQ:XV?(';A9)TFV2W(\:$IE3T-Y3*U-FN:A1I-2#TF:2.G<0+1BOG\[/?B3)
M?O6!_KX%#Y_.SWXDR7[U@?Z^!1-&T6[N-[T8W*RG%HLZ);XDYRV.-W-MEIXW
MFF67C4DF7GDZ=+R:'JK6O !OX(
M  JGU:_H3/\ C./_  P5#_2C\K^._P S/]Z/ .A@(                T7/
MMP8N%O,M2'2;-UA;]#:4YP09E]3Z0"!(G6=C<@E&<Y/FT[(+Y=H#T?/&QO[N
M3]XO@/VCK$QE5:SB^\7P%5NH?J!?S"'8$VQQAY<-V2;A*CNMD1.I;IZY15]:
M ]/3%OE$VXN613)KZ&CN#$9M/^;N/5-"W%'P2?#M 6=^>-C5"_SXJ^X7P'T8
MZPL;>,R*<7#_ -1? 6=M$Y%TM4&YM'J;FQV9*%4--4O()9'0^SM >P
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M;S:RQ\BQ2Y,W6RRJ\F7'.J=2?7)41D2DJ+O2HB47>0(S(
M
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M;)NW/N.8^8
M
M       J1F'0Q:LNRV_Y6YFDB*Y?;C,NBXJ8"'$M*FOK?-!*-\M1)UTK0J@U
M5A?_ )>]G_KY)_)K?^L 51%O=TD7[9^P_GC#O"<EQ>.\VW<S0P<&5&0\LD(4
M:36^DTFHR1KKP49>;0%B5N^DNRX1:=HV)>!3IDVU7F:]<9;=R-I4F+.-IF.]
M'5RD-E1'((R/3YQ'J[#(&93F"
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MU%_FY\#I46B-]P3=R1OY@6=18F,R[!+C0'H+#$MSFK?<G1GDITERV^PTT^B
MC#]G]=8R\1S"P:B*?%N3,UQLSHOE26":(]/H*84(LK)[IV;-L@P.[6C;JZM6
M3,I'A_@VZ/K6TVURY+3CM5-MO*+4TE:"H@^WN[015/+\"ZR,+Q>[Y;=-T(+U
MNLL5V=*:C2Y*WU-,)-:B02[>A)JH7"JB],%V)BZ1,RRC.=IUWS+KF]=KL5UE
MQRER#(U\IM#)I3P(BH6HP245[5-_J1ZL\GVV49L8OFS2I=G1ZULEJ)<N.1=A
M41_G$8N';3Z-7D>C>4SWGZHL-VG9/G8YB*2N-^2E1&WK,DRGTKIY6T,,EWDI
M9]G$!<81'QEL')BOQB6;9O-K;)PNU.M)E4O2J JI\RZZ_P#X7+__ 'B_]:%J
M(2Z9M@YN[.)W>\QLWN6,(@W$X9Q+>2C;</D-N<Q5'F_.\[3V=PC4KH[,;22=
MI+9<[=)RB;E"KB^B0F1<",ELDA&C0FKCG ^WN%92:((BZF-P2VYV>O\ =&'B
M:N]R;^"+3Q+5XF:1H-2:][;1..%^] 51Z>-_[+LM@SEA<PB\W.ZW"6Y/G7&.
ME*6G-24H:2C4FNE*$E_=&H59:KO?O4WF.X>+;K8MC5RQR^X_RDR7IQ4:>.*^
M3T?B@B+ZIQ"Z^N30NP%AT=Q/);=F.,VG*K0K7;;Q$9FQZ]I)>02M*OW23/2H
MO*0C*I'1;\I>[WNIKWY,%67EZA\0O6P^Z-LZA]OF=-IFR=&1P$U)KQ#W!TED
M78W*37C]2[Q[32!#&=7.863/HNR.78Z_S[3=';D\R?U:%&Y;26VLNY:%$:5%
MY2$(;[U]QG7-K<>EH*K+%^;0X?>1NPY.D_2\T"%D<(=;?PO''VCU-.VN$M"J
M&54JCH,CH?'L!%4?V@"#DVW;Z S14R3,GI89J1&H]$9/"IEPJM)5]$%A_.ME
MM4;.]HKF]PAIF2$+61&>DVI,)9UH7D5P^B*0N:(BF?4@@Y759LQ%8HN0V_:7
MUMU(C)I-W4LU'4^RC:O3H"PN6I24)4M:B2A)&:E&="(B[3,P14'=W?S)MT[Z
MO9;IY2N=-F$;-[REA1H:;8J27.2Z7K&BK1Q_^Y;J9D9U4V;$[)6/9/%/@F&L
MIN03S2]?;MITF^\DCTH01\4M-U,D%Z:CXF(CQY]TW;=[E9Y S_+#G3)L%MIA
M5KYR$V]]EC4I"'$<OF4U*-1DEPJ]A\ &\7;;G [W8UXU<L;MSMC6V;)0TQ6F
MT-H,J?8]"4FV9=QHH9=P"I/3 <S;+J)SS9N-*<DXTHI3D9"S,R2["<0IEPRX
MD2C9<-#AE349%Y"!97=!
M
M                         !6W?7I._75FS>8?G=\!\N"S \%\&^,KR%N+
MU\SQ;/;S.S3W=H+$HR_^7E__ !'_ /@G_P"D 6K4\^Z$\NQBP3;YB^2,9*Y
M:5(=MRHBX$EQMM.I9,ESGTJ61%4DFI->[C0C%6\="&/X6M-ZRNSW.4>6-14V
MR]622EOE-H=<2ZW(96DB-2%FT::&54F1D?U*E"5TP9
M              4^ZT/PWB?N27[8V W/IM_#%T]PM>V) 6.
M      !I&<.7]$R*5G80\URSYAK-)&2M7[I2>X>:XOBRWWV]2*['=\.NQ1;/
M7FFUNX]*Z0
M
M       0C?>K/9#&[W<L>NU[D-76T2GX$YI,"6M*)$5Q33B24ELR,B4DRJ7
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MNW[)7L_N0'1?I)NV0SK_ 'B-=W4.1V;:URDI2A)DHG4EVI(NX!;(
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M9]E#,2MF"
M
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M8G?"Q=,;GT&D
M
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M3J,U>4M%J=N,,B;>8+8,+A&2FK/$;CN.IX$X^?GO.=W\HXI:_H@C:
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M1*YB)"+=&)2%UKJ1YE$JKWIH8#=@
M
M                                   51ZB^EG,-Y-P&LNL5YML"$BW,
M038FF_S=;+CJS5]C:65#YA=X+$HE^8#N3_6:Q_3E_: 6KZQOV?\ GZWDIF95
M9VHY^N6RB4ZLO22IMLC_ +X"JU>QNPF,;'V>5%M;Z[G?KF:#NMY?03:G":KH
M;;;(U$VVDU*/3J,S,^)G0J$F4L @                               "
MGW6A^&\3]R2_;&P&Y]-OX8NGN%KVQ("QP
M
M                                                 #$97>'<=Q:^
M9 RTEYZU6^7/;969DE:HK*W229EQ(C-- %&__F!YC_4ZV??$CU :H?\ S \Q
M_J=;/OB1Z@%#_P"8'F/]3K9]\2/4 H?_ # \Q_J=;/OB1Z@%%G>G/>&Y;V81
M/RJZ6UBUR(=U>MB8\9:W$*0U'CODLS7QJ9O&7T 282\"
M                    *I]6OZ$S_C./_#!4/]*/ROX[_,S_ 'H\ Z& @
M                                           -.QK:C;7#KHY>L6Q6
MV6F[.$I)S(L9MMU*5\%)0HB\Q)]Y(H0#<0
M                                               !^5K)"36?87:
MQ[]\AQEFAPEU(JG0B/\ Z0'P_.:W>Q=_O2]4!^VLB@.K2A).:EF22JDNT^'E
M 9-IU+J34FM".G$!^P
M                                   !23.NN+*L2S?)<5CXI;Y$>Q76
M=;&I#C[Z5N(A2%L)6HB*A&HD5.@-4:__ /,#S'^IUL^^)'J 4/\ Y@>8_P!3
MK9]\2/4 H?\ S \Q_J=;/OB1Z@%$S=.'4U?=[\INN/W6Q1+4S;K><]#T5UQQ
M2E$\VUI,E\*474$F%E00                               !3[K0_#>)
M^Y)?MC8#<^FW\,73W"U[8D!8X
M
M         !^5+0GURB37RG0!^/$QO\<C^^+U0#Q,;_'(_OB]4!]$J2LB4@R4
MD^PR.I /Z                          /%>+5$OMHGV2>2C@W*,]#E$@]
M*C:D-FVNA]QT4?$! /S)-BON2Y_?Z_XH+4^9)L5]R7/[_7_% J^$CHPZ?H>G
MQ:)S&NNCFW(T5I2M-1%6E0*OO\R38K[DN?W^O^*!5*^V.UN)[1V&1C>'-OM6
MR5,7<'4R7C?7SW&FF5&2C(J%I:3P!&Z
M        *I]6OZ$S_C./_#!4/]*/ROX[_,S_ 'H\ Z& @
M
M                                               ,%F;KK.+W-UA.
MMY+-4)[*GJ(!SDWZS/,;=EUP\/:E.0FX;*U/<Q:2+S*GW]P""_UOY E91S@_
M95^M3SW*G4!N^VVX&:SLPQI"+.I41R[PFW7B?49)(Y#9*.E>XC =0-L),J58
M)+DMLVW"F+223,S\WE-'7CZ8#=0
M                                            ! N0='^S.37ZZ9)=
M(MP5<[Q,D7":IN:M"#?ENJ><-*23P+4HZ$"U8[YDFQ7W)<_O]?\ % J?,DV*
M^Y+G]_K_ (H%3YDFQ7W)<_O]?\4"K>-L.GW;K:&[S+WAK$MJ=.C>#D'*DJ?2
M;7,2YP(R*AU07$"J4P0                               !3[K0_#>)^
MY)?MC8#<^FW\,73W"U[8D!8X
M
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MI]6OZ$S_ (SC_P ,%0_TH_*_CO\ ,S_>CP#H8"
M
M                                         ^,J+'FQW(DI',CNEI<0
M9F52^A0P$-;S;1;=2\(R:^R+&VN[-6]TVY)O2",M":)\TG-/#T@',F\8]9V=
MW,>LS45*;;)5%)Z.1JHK6XLE<:UXD7E =!MA=EMLI./-WE_'VUW*)<U+CO\
M.DD:%,DTM!T)TDG17'B0"R%OML&U,JCP&2994HW%)(S.JC(BKYQGW$0#U@
M
M                 @SJ7W^;V4QN,Q:&FY>:WOF)M3#WG-,--T)R2ZDJ&9)-
M1)0FI:E>@DP6(<[[A=MW=X[F_)DKOF83S,E.LQFI$Q#>H^!)882:&TU+@E""
M(&GVLV4[P[+W9AZ%(O.*34&9E!F-/QV722?G)<C2$DAPJ]I*0?TP'1OIVWSA
M;VXDY,?:1"RRT&VQ?8#9GR]3A'RWVJU/ENZ54(^*3(T\>!F9F$Q @
M                        "GW6A^&\3]R2_;&P&Y]-OX8NGN%KVQ("QP
M
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M/B#+(@*J=6I'^9,_XSC_ ,,!#W2C\K^._P S/]Z/ KH8"
M
M                                                 -*W>^3'*OBY
M_P"M <I;[\MV,?OH?MK@#I?T^?H4Y\8O>UM )@
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M?3;^&+I[A:]L2 L<
M
M \LN/'>-)O(UF1'3M_Z# <N>K)EEK'L=Y2=)G->K_1$ MUTZ0(3T''.8T2C5
M88QG4S[>0SZ("R;33;#:6FDZ6T^M3Y._O ?L
M    !S5ZLMIK_MIN=(W"L:'FL;R"9\*0;I&U).'=5*YKK:G$TY:S<(WFCX5(
MZ)J:%4-PRF.==^Z5IMC<&]VJUWR2TC0BX.H=C/K41$1*=)E9-J/RZ$(!*(PW
M2WUW,WWFP+7>='@D/I^#,=M#+A,JE.5;0HD&IQQUTR5I351]IZ2*IU+1T#Z9
MMJY>TVUL*S7=!-Y'<WEW6\ME0^4^^E*4LZBK7EMH0E5#IJU4!F4Q @
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M@
M
M    #2MWODQRKXN?^M <I;[\MV,?OH?MK@#I?T^?H4Y\8O>UM )@
M
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M W/IM_#%T]PM>V) 6.
M
M   ?!_M2+".7'5I^CV.^[7O:B$5<#IO_ -!QOXAC>T,@+'
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M1TK=FQ72^R5X40JO< D+H[85 W(Q6WK+2IF//2:3,C,O\V?/M+@ Z*
M
M                                                           -
M*W>^3'*OBY_ZT!REOORW8Q^^A^VN .E_3Y^A3GQB][6T F
M
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M@
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MXY^9$Y.M6DKG'H53I]6 AWI2,SW?QTS[>3/]Z/ KH8"
M
M                                               -*W>^3'*OBY_Z
MT!REOORW8Q^^A^VN .E_3Y^A3GQB][6T F
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M;+HS*3#8D-N&F)*9TFM:#+@XA->SN 6HZ;FS*Y7!TR]? 9.OIK28"Q0
M
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M:U*53N["X$0,-J 53ZM?T)G_ !G'_A@J'^E'Y7\=_F9_O1X!T,!
M
M                                                       &E;O?
M)CE7Q<_]: Y2WWY;L8_?0_;7 '2_I\_0ISXQ>]K: 3
M
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MO^F]RMQN#-/Y. R5?+1:2 6*
M
M         ?!_M2+".7'5I^CV.^[7O:B$5<#IO_T'&_B&-[0R L<  /RXK0VM
M9]B4F?TB&+YI;,^!JV*S14KJUW/E8M^9_P 'R'VO%_"7,\++4Q7E>$IJT=OK
MCH/)W7W:K=,_A\>__H]7P_'9@ZW7IMIO\:I>W&TU_P!U+[<+7-NSBFH["IJ"
MG-.RFR/FI1YJ5+X'Y_:/T>SA=N.(NV16.:CP.JXA69B)FZD\DIYN'0X\QCT:
M='NMN\2XADSY5M,G?/21G4R57TQYWB&2<$3,<DTV.WT%D99CK<L<J!56W)=I
M=SU6X[C+7$L#QITL*>B,F2V-7FEJ,D\5CM>$<3][U,4\O//W/EQ3A?5QWY;>
M2.2/O7MZ?MQUY)B,-V2MQ3[]P<8J])YJ^*D$7$^)]O8.WU^FB;INCDAYK1ZB
MZV+;+JUF>7I3U)63<=U9G32A1]M.PC'F<ET1$O36QMA17J2RI,_\V.6X:^7X
M^M'M=-7AO)Z0Z+@UO7Z]?!][T6L_RJ<E:M[Z=K&U9KW+NCC"$)E6U)$LVB;K
MK<:7ZXRX]@_0./ZGW6DQ4YXY?X7YYPVN?4Y+=]*^'E0SU)YY<[D[D6.V^=)9
M.-=E$@F92S)*675%0D),J$/ <-P3J=5,3NFL[=K]!SS[C36S&RE/ UG:7ILN
MVYT2RW^?=&S3=E/DX<Z(N2?^;N.LEK6I7G?R?#R#V]^@MPX)W5CP>%XR_6W9
M-1U:SM\/@;YG'1G,Q:UW2\0+M"UVR _.;3$MZFUFY';6X6A25<%53P/RCRN;
M5W8<D;Z127H,&FMRVTF8V[$/8=FN4;;.I@3+A<35<'VW2K)>B^:@R3V*,ZCV
M7!=?9GQWS=%=O+-73<5X7[NZVDQ'B=1L=O[-Y<?0T9'R229T<)SUQGY.SL'7
M:G33BB*\KCZ/5^^F? SXX+L@       '.2^=*^[>Y>[.<72+;467')>179YB
M[W91L-NLN3G5)6TTDE.N$I)ZDJ)&A7L@:JG_ &[Z(MK\5Y,W+G7\ONJ**-$B
ML6WDHN/".THU*])QU23]B"560M=IM=D@LVNS0F+=;8Y:6(<1I##+:?(E""))
M?0($>P                                      53ZM?T)G_&<?^&"H
M?Z4?E?QW^9G^]'@'0P$
M
M                       :5N]\F.5?%S_UH#E+??ENQC]]#]M< =+^GS]"
MG/C%[VMH!,
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MU[8D!8X
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M/^,X_P##!4/]*/ROX[_,S_>CP#H8"
M
M                                 -*W>^3'*OBY_P"M <I;[\MV,?OH
M?MK@#I?T^?H4Y\8O>UM )@
M
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MY#:EI(^/+)LB,^TS35)B97'!D 4^ZT/PWB?N27[8V W/IM_#%T]PM>V) 6.
M
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M_E^]X;CNINCJ?S?<Z'6>R,G8+4PJA<J(PGB@NYI)=@\AQ#'[VZ8_BEW6DO\
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MLEN6]Z--,XJ%R&E:%):==)+:SUD:*)76O=V M$E@@
M                    "J?5K^A,_P",X_\ #!4/]*/ROX[_ #,_WH\ Z& @
M
M
M   #2MWODQRKXN?^M <I;[\MV,?OH?MK@#I?T^?H4Y\8O>UM )@
M
M            :-DF\FV6'Y3'PW*<DBVB_P J.B8TU,-33/)<6IM)K?4GE(,S
M2?FK61TX]@%&YQ946=&:F0GVY,1])+9D,K2XVM!]BDJ29D9'Y2 ?8
M                            %/NM#\-XG[DE^V-@-SZ;?PQ=/<+7MB0%
MC@
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MTEU)$HT&II2B)1$I)T]$@&0
M53ZM?T)G_&<?^&"H?Z4?E?QW^9G^]'@'0P$
M                                 !Y9D]F%HYJ5'KK321'ZVGE,O* C
M^9O;BD+1S8=P/76FEI@_6T\KY>4!\/U\XA]Q7+^B8^W@,A:-X<9O2W418DY!
MLD1JYK;)>NKV:7E>0!OS+J7FFWD$9)<22TD?;115X@/V
M                                          -*W>^3'*OBY_ZT!REO
MORW8Q^^A^VN .E_3Y^A3GQB][6T F
M                                                  !SSZX=MLIA
M;@'N0B,Y*Q.ZQHT=<QLC6B))CHY1M.TKH)9$2T*/@HS,NT@:A:O9O>3::_8%
MCL*S9%;8$B#;XL-VRRGV8<F.Y'92A2.2XI)F1&DZ*15)]Q@DPD7\],._K#;/
MOV/_ !P1Z[??[%=G5,VJYQ)SR$ZUMQ7VWE)36E3)"C,BJ8#(@
M                     *?=:'X;Q/W)+]L; ;GTV_ABZ>X6O;$@+'
M
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M/]*/ROX[_,S_ 'H\ Z& @
M                   -(W#4^GX-Y*357GZJ?^; <E<_NN4,?!W-C+;U<ZGG
M+*M.7^Z :4C+KVZ9I;2:C3VT6O\ C )KV"FY*N9?#>C+_DH^FJE*[5.?N@'5
MG'36>/VDW"HLX<?47D/E)J R0
M                       TK=[Y,<J^+G_K0'*6^_+=C'[Z'[:X Z7]/GZ%
M.?&+WM;0"8
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MDE^V-@-SZ;?PQ=/<+7MB0%C@
M
M       ?ATM3:R\J3+^P JSU.X(637/'7M+!^'8DH^RK<2?G+;/AH(_( Y5
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M"NPV7;X2/%A1825)BMDVE9U41&9U,O3,QQ[[[KM[5F.VSV8>@8?0
M :-NCNWA6T-B3?,PF&WSS-$"WQTD[,E.)H9I:;,TD="/SE*,DIX5/B50J;=_
MV@MU5*45APF.W!29DA4Z:MQU:>XS)IM!)/RE57I@U1(FU_6_@^8W-BQYG;5X
ME/E+2U&G*?*7;E+4=")QW0TIJIT*JD&@OJE$"46G(R,B,CJ1]A@@  *==2N,
M]0&ZNX3NWV$,RD[>QHL9V2YJ*#;G'WDFI?/?/2;VGS?L1:]/ ]->(-0\6%=
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M@J'^E'Y7\=_F9_O1X!T,!
M                    >:7;X4_1XQE+W+KHU5X:J5[/2 5HWUV<VUB_ 'A<
M<BMZ_&:_Y0ZTY%.U1^4!SUV^LMLGW6^M2XK;K;*TDTE1<$EK<+A]($=2]O\
M9?;.T0TR(6.167949@WE)-PS49)KQJL^\P:2XRTVPTVPRDD--))#:"["2DJ$
M7T"!'[
M    &E;O?)CE7Q<_]: Y2WWY;L8_?0_;7 '2_I\_0ISXQ>]K: 3
M
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MZ>X6O;$@+'
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M^+.<.#/6VVN=(A.6J;#YJM"7G&E)2E;52\ZB$F7$R,Z:3%%XP9
M                   %4^K7]"9_QG'_ (8*A_I1^5_'?YF?[T> =# 0
M                                                       !"V_W
M_P"KW_??_9P5S+VT_#.0_P XGVQP&77C#OP;&]S,?6$#3900
M                                              &E;O?)CE7Q<_\
M6@.4M]^6[&/WT/VUP!TOZ?/T*<^,7O:V@$P
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M]UH?AO$_<DOVQL!N?3;^&+I[A:]L2 L<
M
M               #4\^O)6G'+T^A[ENLVR4^BBB2JJ&G#(RKZ) .=6;V:X[U
MOPY;\DG56="VB.21O&12#)7#1V>L =/D,M-F9H223/M ?L
M                 '*N;<YNPW4Q-N\^*X^6/WZ3(6Q4DNO6Z::S)23X%J<C
MOZD]U3X@WR.AV.;];.Y1;&[I;LTM++:D<QR/.ELP9+14(SYC,A2%II6AG2GH
M@S17+J[ZBL$OF"R=L\)N3-^G79Z.JZ3H9D[#8C17DR")+Q>:MQ3C:/65(DUJ
M9'2I8ALW07C<JV;9WK(I+9MMWVZ&4,S*FMB"V3>LC[RYBG$^FDP)6M!D <^^
MD_)K3M1N=D>V&>65[\\+Y,8M$683*7C;=:6XAQMPUT43+NM+FM-4J(B,^%#!
MJ5D-N>FZU[;[P9!N9:[@P[;+TQ+:B6),(F/@]<M]EX^2Z3JDFDB0M!$3:*)5
M0N%:DJKOUA;@VC=/,;#M1AMMD3LJL=SD0)$E;9()4N0IM@H[-:J41J35:CTI
MX%2O:187QM<1R!;(4%YSG.QF&F7'?9J;0235P(NTRKV R]8
M               "J?5K^A,_XSC_ ,,%0_TH_*_CO\S/]Z/ .A@(
M                                                    A;?[_P#5
M[_OO_LX*YE[:?AG(?YQ/MC@,NO&'?@V-[F8^L(&FR@@
M                                         -*W>^3'*OBY_P"M <I;
M[\MV,?OH?MK@#I?T^?H4Y\8O>UM )@
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MDE^V-@-SZ;?PQ=/<+7MB0%C@
M
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M?^&"H?Z4?E?QW^9G^]'@'0P$
M                        0MO]_P#J]_WW_P!G!7,O;3\,Y#_.)]L<!EUX
MP[\&QO<S'UA TV4$
M              !I6[WR8Y5\7/\ UH#E+??ENQC]]#]M< =+^GS]"G/C%[VM
MH!,
M                        "/\ >#:'&=Y<47C60ZH[[2C?M=T9(C?B2:4)
M:2/@I)EP6@_7%WD9$HBJ$9=T7;VX[-<;LMNCY-;24?*FP)++*C17S=;,E;2R
M5Y23K(O9=X-5?3$.BO>O(9C2+["C8Q;5*+FRYTEE]PD5XFAF*MQ1J\B5FBOE
M("J_6T^U6-;/XBQBF-I6XG6<BX3WJ<^7*61$IU=.!<")*4EP2DB+B=3,RWD$
M &N9E@.&;A6Y-IS2RQ;S";,ULIDHJMI2J$:FG$F2VS,BH9H40#8DI2A*4(22
M4)(B2DBH1$781$ BC<6W]/Z<M@93NA,L:,HM3"&+<W>9S:#;:)PW4FF(XZ25
MGJ7JU*;49=U 5DOU^[*?U^L?W\S_ !@*'Z_=E/Z_6/[^9_C 4;_#F1;A$CSX
M+R)$*4VA^-(;,E(<:=22D+29=I*(R,C!'W                      %/NM
M#\-XG[DE^V-@-SZ;?PQ=/<+7MB0%C@
M
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MM9([5JM%[ML^<ZF?$6I$>++;=<424N&9F24F="XF"5=& 9
M            !5/JU_0F?\9Q_P"&"H?Z4?E?QW^9G^]'@'0P$
M                                                 0IU NM-_F[S
M%I17QM-1D5:>'\H#F7MJ\PW><AYCB4D;B::C(O\ ".>4!UWPI]EVW1R:<2LR
MC,5TJ)5/,+R K: 0
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M)29F5%:3,J\.XQVN+)&2R+HY7YYQ#17:/47X+IB9LFDS&YF1]77@
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M(MDRR87CEFN*";N%NM<*'+;)1+)+T>.AM9$I-2.BDGQ(&&>
M         %/NM#\-XG[DE^V-@-SZ;?PQ=/<+7MB0%C@
M
M                       &&RBYIM%G=G*5I)"D)K35ZY1%V$ HCNQG$[,=
M[W=NFW4NP[RJ%$)@F^6M7-CMJH3A]G'O 6KZ?=O#V]PV;9W65,+>NCLPD*=2
M]4EQX[=:IJ7^#[ $N                                  #EGC&VZ=Q
MNIRXX'FLMZ$<V^7=RZNH,DR'5,*?DJ2V:BI5TT<%4[#U%4&^1<U/1CL"E*4G
M8I2S(B(U'<9=3IWG1PB^D0,U?KYF6P'X@D_E&9]M JD[;G;+#]J;)(Q["H:X
M5JDRESWFG7G9"CD.-MM*5J=4HR+2T@J=@(V\   $*]4.TLO=O;)ZWV8DGDMF
M?*Z6E"S2@GE-H4AQ@UJ,B3K0HZ&?#4E-:%4P6$)=,75#M_B. PMNMPI*[%/L
M2WVH<Y3#KT=]EUY;Q$KD(6I#B%+4D]2=)D1'JJ9D"S"P+74OL0ZVEQ.<VXDJ
M*I$LW4*^BE2",OHD"4>VV=0&S-YN4.SVO,[?*N=P?:B0HS:UFMU]]9-MH35/
M:I2B(@*))!                           53ZM?T)G_&<?^&"H?Z4?E?Q
MW^9G^]'@'0P$
M          !\W7D,TUUX]E/0 <U^HKJ*NUW_ #;\/<#/D^.U:XC2?7^'I2B?
M0 5#M]]EVZ1*D,+)*I*M2S-)'7B9]_9V@.C_ $Y[\%>G+K%F3''$1(L4D$49
M"*<5)[2(J]@"XD5XI$5F0GB3K:7"/LX*(C ?4
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M$CU!Z#JQS/QSW^3M3Y9>A#:&D$VVDD(3P2E)$1$7H$0T^4S,S67Z!
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M5L_OU_Q *),@SHES@QKE =3(@S&FY$5]'K7&G4DM"B] R,C!'H
M            %/NM#\-XG[DE^V-@-SZ;?PQ=/<+7MB0%C@
M
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M;NY)O1@5QRG*8L&)<(EW>MC;=L;>:9-EJ-&>)2B>>>5JU/*J>JE*< 24T @
M *Q=<6;7C&-KH-CL[ZXIY-.\'<'FSTJ5"9:4XXUJ(R,N8K02O*G4D^!@L*A[
M:=,.ZVZE@1E&/1(L6POK<;BS+B_R$OFRK0LVTI2XHTDHC3JTTJ1EW U5NOS%
M=Z_NBQ_?KW^K@5;)MWT9;O8MN!BF37-^SG;K+>+?<IA,RW5NFQ$E-O.:$FP1
M&K2DZ%4@2KH #(                          *I]6OZ$S_C./_#!4/]*/
MROX[_,S_ 'H\ Z& @
M               (TW:N;UN^!^2:BYOB=6E1I];RO)Z8#COFDUR9X'F&9Z.;
M2IFKMT>7T@&J )HV!N<F'*OII6L]3<8O7F78IP!V Q99N8Q97#[5P(JC[^)L
MI,!E@
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M.Q>)5>ZK/TCPC_O'MK \]Q7V[/MS/V;_ .O?T^I_E]%RT(]"_&0
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MAFP                     !3[K0_#>)^Y)?MC8#<^FW\,73W"U[8D!8X
M
M                                     &D[D9HC#K(Q<JK2;LM$:J$)
M</SFW%]BC(OJ '/'(L\O^[&\]\P*5()ZRS)3[R(ZVFV#TQV^<BKC9:BI3R@+
MS=/.%Q,4VWMUO)O0ZS)E.$27%++SWE'VJ 2\
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M]"9_QG'_ (8*A_I1^5_'?YF?[T> =# 0
M                              &B;CXX_?\ X,Y!(/P_/U:U&G^4Y=*4
M_>@..6X5H=M7P=S227.Y]-)FKUO+\OI@-) 3]T[8?<;I,OR6N49H:C*\Y9IX
M&ISR$ ZVXVRJ/CMHCKIJ:A1FU4XE5+22_P"@!DP
M                                   &B[R_)ADON4O;$ .1F]/Z7/\
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M>>RY;\M\WWS6ZZ9F9YYG;,ON-/D (YWZ^2/)_P"89]\M#@Z_N+OMRO6_2/\
MNV#IG\MS%=-?R1VG^?F>^5CY\-[B/'Z7,^N/]VR=%GY8;EN%@]MW"Q:9CEQH
MA3I<V%*I54>4@CY;A>E6BB[TF9=XY6HP1FLFV70<&XKDX;JK<]G)LNCM6\L>
MKPTE!?3UF]RQ7()VSN8FIB2R\XFU$Z=2;D(J;C!*/AH<(N8U3@9UI740Z?A^
M><=TX;_$_2?K/A6/5Z>WB>FVQ,1UZ<MO)=TQNN_9*SH] _'%7NJS](\(_P"\
M>VL#SW%?;L^W,_9O_KW]/J?Y?1<M"/0OQD
M                        '-KK*LTY[J#;;N;OAK;=XEM3!EN?R;<<_L#B
MJ\"HEQ+BCX@W"U-KZ-=@($%F+-QUZZ26TI2Y.DW&>VZXHDD1J-,=]ILJF5:)
M00,U>WYH/3M_4W_XG=?]; JVW -CMKMKKE*N^"6'X*N,QCPDE[Q<V5J9UI<T
MZ9+[J2\Y)'4BJ!5(0(  #5MRK;CMXV_R6UY;**#C<JW2&KE.5V1V3;.KWIMG
MYY>D H9TW[XX[L%DF38?E$A-TQ2XR&UQ[_:"\2TEU@E)2Z2?-4IIU"BK3ST&
M5-/%5#4PM6GK Z=U)2H\P-!F1&:3METJ5>XZ1#+Z1@E'Z^=]T[?UR_\ AEU_
MU0"B9;9<H5YML.[VUWGVZX,-2XCVE2-;+Z"<0K2LB454F1T41&"/4
M               *?=:'X;Q/W)+]L; ;GTV_ABZ>X6O;$@+'
M
M                          #XR)<:*23D.I:)5=.HZ5H HUU+;@/7ZR'9
MK(XF7*B7LUK:C.*6X3;3<ELS,DGP*JB 9+IMV6E.7G'-P[E'DH\5'DN.F]&(
MVM3C3C7%Q7$P5="!":M\9,5DB)M)F94(DEQ.O80(](
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M_O1X!T,!
M       :5N#GT#!_@[QRV4>/YW+Y^KCR.76FDC]F0#E#><<R#=+D_ -M>F?!
M.KQ'@TZ]/BJ:=5>RO*50!M./=(>Y4PW53\<O,5&E"FE'&316JM:5 HZ$;3;/
M1<(3)=6I:G)<=A"TNLH1I-NIGV>F F!"20A*"[$D1%] !^@
M                                           &B[R\-L,E]RE[8@!R
M+WH/_P"U[_N5G^T8#1<9_2"W?SR1\\GLR^&?N[NA9K ?PQ:/C"/[:@=1.Z7Y
MSJ_U5G\OI=#-G2(\9E&9<?'N>TLCFZ/V)Z7O.']W/3ZDA#G.Q
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M2H]1$1UXH(<7/I;,TQ-W([_A7'M5PZR^W#,4R;ZQ7=7UMR'*>?
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ML!N?3;^&+I[A:]L2 L<
M                                                         (\W
M5O*K0S:U)4M/.4\7F$D_6DCMU>F I7ME93W&W/R2S*)"^2W.FTDFIM'F3&F^
M!M$9U^R>D OK@EE+'<1M-D(D)*&SRZ-&I2/7*/@:B(^_O ;$
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MOEV@6R0\R4KFH:F26V5*1J>,M1$NI5("B\X,@
M   JGU:_H3/^,X_\,%0_TH_*_CO\S/\ >CP#H8"
M                                    #XRG>1%??X_8FU+X=OFI,P'/
M?JEW@N%X_-3P#LB/R?A'F<Q+1ZM?A:4I7LH8"8.FO:&U6C\Y^?'CKYW@-.A;
MW#1XFM:T\H"UC:";;2V7 DD22+T"*@#]
M                                U[.K,K(<2NME0:$JF,\LC<J2"\Y)
M\=-3[@',OJ'VDDVC*KGJ=C&IB"TLC0;I_P"#KPJ0#0=NMEKM>X*,H9F1$L0Y
M*DK;<-TG#Y24J.E$F78KRCYYIICNGFA\=3LPWSX)2KCEL<LN562WO*2M:YT5
M=45TT6\DN^A]PZ6V^+[9F'YMEGK:BV>CTN@.TB";QN41?=SA_P"1:'8:+V)Z
M7OM!W<]/J;Z.<[$
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M]6;']*7]O HO?B-X?R'%+%?Y+:&I-UMT2<\TW70E<EA#JDIJ9G0C5PJ8,LR
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M!N$236M!D1ZZ=M %D>F]M17.XNF1D2X#1D?=Q6DP%B@
M
M                    !1W?O=%R[QK$4$V'39<DFOE\SAJ)JE:GZ "4^G7;
M%W';JC-'FGR3>K*1U=2CDUEKCR/-,BK]3PKW +'D1$5"*A>0
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M*8GP753Y:THD17$NMJ-*G#(R)22.A\# JFX$
M  !5/JU_0F?\9Q_X8*A_I1^5_'?YF?[T> =# 0
M                                   0MOQN9&P=J+;W'HZ%W.)*TI?;
M=6H])$CS3;,B+UW> HQLIA-QS_X<\?&=1\'>$Y?A%-HKS^=75S-=?Y,J4 =0
MK=:H]LYOAU+5S=.K69'ZVM*4(O* ]P
M                              #\//-L-J>=5I;055*\A?0 <^^IS)%3
MM]7\?B&VZQ,8@,I,DJ)PS=:(CH9F15J?>0":MG+"[9MC,C2XA:5)D37*+-)]
ML=DOJ?2'PU,_Y-W0X^KG_(OZ)5_O*S<W-L"C[?$P"X>Z!T>F[N7YQ/?6],>E
M>/:C]'9/NUSVIH=KH_8GI>^T'=ST^IO0YSL0       'EF.RV]'A6R<K777N
M[*=Y"2W;$3O>E-321GP.G$O1%8?T
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M&T=NKN ="NG%TE3IK5.*+>R1GZ2DD L,
M
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M'?YF?[T> =# 0
M   $?[A;JP-OG'6Y<!R6IJ$JX>8XENJ4FX6GSB/C]C[0$%JZZ\:2=/S2E'_W
MUG[6 _/S[<:J1?FE*X_^NL_:P$N[3[ZVO=:)<)4&U.V\K>\TPM+CR'M1NI-1
M&1I25*4 21>K@W;K;+D*625ML.NH\XDG5"#/A4!S$W+W R/=BYV9\IL@D6_6
MRXE]1/:B?6@Z%I+AZT!>39K:C'L1^&^5 8+QGA:\LEI_DN=VZC_=@)H
M                                                         &I;
MG75=CP*^W9I2DN18Y+2I)D2B,UI+@9^F YW7%U_-=^,>O,A1N)?F6YEPG//,
MR0M*:&:>'8 O4W;&;1M-D<5A!-H-J4NB2,BJ;:2[_2'&U/=7=#BZON;^B5,K
MG\I5@]TP/?!#I=-W<OSJ[OK>F/2O/M1^CLGW:Y[4T.UT?L3TO?:#NYZ?4WH<
MYV(
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MW3PX4!87OZ<,2D85LIB%DFH-N>J(<^6A9:5I<N+JY>A1=QH)TD'Z0,RE,$5
MZSEFF]XI3[EE^V-@-RZ;?PQ=/<+?MB0%C0
M
M         8#+[W%L^.WF2XX27HT"2^E*DK4GS&5J*NDNS@ YR;L76\;FW.WW
M&VQVI"(+"H[ALU8(C4LUE4GUD9]O< N=LULDSMS,NTE7BT^/:9;+Q#T=TOL:
ME'PY*"IV]X":D))"$H+L21$5?0 ?H
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M(4QDS)NM3JZA)=X#-](,CX0W.Q>X$9*2\Q/42B*A?Z*^78?$!T2
M                                          !4_JRAR)%QE+91J26.
M.)K4BXZY?E,!R[E6V;#429+6@S+41:DGP^@9@/S&A29?\@C7Q)/:1<3],R 7
M\Z"+7,MV.Y<<MKEE\(0U^N2KS2:74_-,Q%2%U9;KL8Y<,>MUNE-&BXQ):5DZ
MPZHS/4A!4,B*GKA41KTL[335,Y"JYQ76C;?A*:T/LG7@[6M#5Y" 7_0VENNF
MO'R@/V
M        (/ZGLFCV_:3,K<3J2E>!0I+9H6=:NMGVD5/[("K/35C[V1OXY?U-
MJ5R[NA)K0I*$_8G4GZU1U 7FS.+X3;_(6J&7^9OJXF1]J/0'&U/=7=#BZON;
M^B5#KE\I5@]TP/?!#I=-W<OSJ[OK>F/2O/M1^CLGW:Y[4T.UT?L3TO?:#NYZ
M?4WH<YV(
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M^&+I[A:]L2 L<
M                                               /XI:4)-:U$E)=
MJC.A$ K/O]N0NT7V;C,=M;[,RV$@U-/$2#\0EQ!EI))U^F T/8;;V/EMLO#T
MF,A@XS[2$D\R:S/6@SX=GD 75
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MY3!5(M2S4TDRX]OFFHP:E;SJ^_Y=LR_V9_O6(#,*E="ORUR/B.;[='!J6O\
M60IY74%DI.H)*$LVTF5$==2/ ,&9GY/.-1?0 A?CIX;9:V/P-+"M:#M$91G4
ME>>M.I9</(HS(&9<_>K[_F)S+_9G^ZH@-0Z$;!?(I@/Q'!]I2#,O?NMM_$W+
MQ%S%YJ(ZV''V9!IF,)E-59,S+[&KA7CP,$43WYZ>K1A6.2YL5BWH6W,982N-
M;VV%477L4GNX=@#(=(+'@MSL7A$?!IB>14+27^BOGV KHF"
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M2NVA<>T!N@
M             *1]663K<RB^X:EU7^=P8R":)VJ3-:$K_DN\!L72/C1P<(MR
MW6BUMW9Y9*-K294-!]I]@"RFX?Z#9![A>^M'&U7=7=#BZON;^B5!+E\I5@]T
MP/?!#I=-W<OSJ[OK>F/2O/M1^CLGW:Y[4T.UT?L3TO?:#NYZ?4WH<YV(
M
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M67?<-QV]SS2J=<K9"F2C06E)NR(Z'%T+N*JCX PSH
M   I]UH?AO$_<DOVQL!N?3;^&+I[A:]L2 L<
M
M          -3W-O!8_@=\O)KT%$CDO6:==*K2GL+M[0%$[UDZLUSZT2D.$ZA
MYZ'%,R1RO\-2E#_?=H"\FW>+HQB).92@T>(<0LR4LEUTI,NX!N@
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MX3C_ ,,%0[TI?*_CO\S/]Z/ .A@(
M                    H9UV_IK;?^'C]\21!H_1 I+5@R:0OUC-PBK5Z26C
M,_[0HW'JOW:7-RK'K5:'?\WGP5QG4NLD1FIU\T<#KPX* ;?TM;-*L$?(_&LZ
M.:]"4WI?U^L)ZM?ID N6
M                       #'WNXIM-KD7!9T2P23,R+5VJ)/9]$!SFWMNJL
MKZIH,-L]3$]-O9XEH4?V"G;W=@"Z^RV+(L6(LQ])I-$MYSU^KM-/J -LW#_0
M;(/<+WUHXVJ[J[H<75]S?T2H)<OE*L'NF![X(=+IN[E^=7=];TQZ5Y]J/T=D
M^[7/:FAVNC]B>E[[0=W/3ZF]#G.Q
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ME*2[P1C<;S+%<P*>K%KO&O#5L?\ "37H3A/,H?TDLT<Q-4*,B45=)G0!G
M                  %/NM#\-XG[DE^V-@-SZ;?PQ=/<+7MB0%C@
M
M                        'BNMSC6B&J=+<;:80:4FMU9-(JHZ%YRN "CO
M47O:B[9+E.VMK>):YC<6.PN-<.89J<C,/>;'0GB=3["5Z(#[]-FTEPN=@BWR
MXF\IZ'>*UD0E+5I9Y+GKUJJ1<?H +SI2E/K2(O2*@#^@
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MRU+YE%*IITT5J(DRZ @R *I]6OZ$S_C./_#!4/\ 2C\K^._S,_WH\ Z& @
M                                                /XI24I-2C)*4
ME4S/@1$0"@O75.A+S6V:)+2C/'C(J+2?'Q$GT0$'=.6?6_#\+RZ')=91*G+U
M,$Y*3&<JF.I):2,C-7$^X!D=JL3O>\DUN\RO%).S38[)DXRY</-6HG/7J-&@
MN #I_CMCCV9,A++2&^<:3/0T35=-?)V]H#.
M                                       CG?F[%8MI<ENIJTE':CGJ
MU\KU\IE'K^[M 40P6$YFF\F,92FKC?C8[9J))R4_82,OY7A_Y '1S&(I1+63
M)%3[(HZ:=/;3N >+</\ 0;(/<+WUHXVJ[J[H<75]S?T2H)<OE*L'NF![X(=+
MIN[E^=7=];TQZ5Y]J/T=D^[7/:FAVNC]B>E[[0=W/3ZF]#G.Q
M
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M["[+0]D,/>QUFYN7:=/D^/N,I:"::YYMH;TLH*ID@B07KE&9GQX=A&9E*@(
M                   I]UH?AO$_<DOVQL!N?3;^&+I[A:]L2 L<
M
M                         AWJ.R8K)MC<I,99MR&I,5&K02BXO)(^!@*8
MX-MBK</=.R9K,C)D)N4QGFO<XV5*2P@HWK$F1%0FZ .A6"XG$PRRKM,)HV6E
MOKD&DUF[YRTI36IF?L0&S
M             \5UL]HOL)=MOD"-<[<[_*Q)K+<AE7[Y#A*2?;Y $2WKI0V"
MOCRI#^'LQ'U'4U6^1*AH+T":9=2V7]X"U8F)T9; 1EZWK!)EIU*5H?N,PDT,
MN"?L3K9T+NXU\H%4E8GM)ME@RTO8IBMNMDM'K9C;"5RBX4_EW-3G_6!&Y@
M                         JGU:_H3/^,X_P##!4/]*/ROX[_,S_>CP#H8
M"                                                   T[<?+6,6
MQ/()E7$S(EIF36%H0E9$IIAQ23HHZ'0T]@#D7O!O'<-SKO$NDJ2J0Y'A^#UK
M8;8HGF+614;(B^K/B CFR2WFIL>*DRY#[[:74T*IDI1)/CZ0#I7T@X_985HR
M+PC*DUF13.JU'Q)M5.TP%P
M                           %:NKS+3C[4YICB%*)TX\,R+0DT?Z3'<]=
MV@J'NCO&"N]BLE_D)2IUFZOI-6LTG]CI3S2X=X(OBPREAO0DJ%6OE :]N'^@
MV0>X7OK1QM5W5W0XNK[F_HE02Y?*58/=,#WP0Z73=W+\ZN[ZWICTKS[4?H[)
M]VN>U-#M='[$]+WV@[N>GU-Z'.=B
M                                                        _#S+
M4AI;#[:767"-+C:R)25)/@9&1\#(P$69)TU;&94ZJ1=,*@M2%U-3MNYMM,U'
MVJ,H:V4J.O'SB/T06K54]%^P27C=.R2U(,B(F3N$K05.\C)9*X_O@*MUQCI\
MV6Q!U$BQX7;D26SU-2):%W!U"O*E<Q3RDGZ)&!5)24I2DDI(B214(BX$1$"/
MZ                      *?=:'X;Q/W)+]L; ;GTV_ABZ>X6O;$@+'
M
M                            \TV?"MS1/SWT1V5*)"5N'I(U&1G3CZ!&
M HINEELC-LQR3"H=7657*1R5-.*>U)C.J61DWV=B?H )XV'V\5:\1QN<_K3(
MCN2%J2M@DJX2GJ5.M2X )\
M     !A,JR_&,(M#E^RVZQ[1:6CTG)E+)!*69&9(07KEK,B.B$$:C[B 0#=>
MNK92WR#8B,7R[-$9D4F'"90V=.PZ2I#"^/=YH+1,F7;LX#@>06;&LNO#=IGW
MY#J[>Y)(TQSY*D(,G'::6ZFOS369)X'Q!&ZD9&1&1U(^PP
M                       !5/JU_0F?\9Q_X8*A_I1^5_'?YF?[T> =# 0
M                                                 %/NK^\S(5[>
M@LJ43#^-J-9$I1%Y[DM)U(CH? @',1?:0#^)4I"B6DS)23(R,N!D9 +Y]!=V
MFN6+*><XMXSN4,JK6I5"Y:O*8#H4
M                                9D15/L <_NJ/(%W/=Z_X.E25)E-0
M4DA*C4X?^:,O<$=A]@";.E'&CLN 1&E(6E2;E)<\]!)/CH$5945&L[A_H-D'
MN%[ZT<;5=U=T.+J^YOZ)4$N7RE6#W3 ]\$.ETW=R_.KN^MZ8]*\^U'Z.R?=K
MGM30[71^Q/2]]H.[GI]3>ASG8@
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M[A:]L2 L<
M                                        "'.I/*',3P:WW%I2T*=N
MS,<S;0APZ*C25]CG"GF *Q[2XX_DNZD:]N*;4BY',E'S%*0L^:RXKB2"H1\>
MX!>C%[=\%6.+ +27)YGK3-1><XI7:KCW@,N
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M4/\ 2C\K^._S,_WH\ Z& @
M            ( ZC=ND91;KS?]$<W86/2FT+>6ZE9&RB0Z5"01D?%7> Y)WJ
MR3+(\VQ,6VM;J=:3:-1E2M..I*0'EMT8YMPB0RI60\VT6JI)JXLD\:=W$!TT
MZ0MJY>'6C(FY9Q%<^;%=1X=;JB+0VHCKK0D!<$
M                                         &NYW>58_B=RO"5+2J*A
M"B4T25++4ZA' E&1?5 .=%YE.9WU<6Z6\HW8\]<=MQ,BB%'R[=HX\NM/6]Q@
M.A.W6/1+#CR(;+2$:7W'")"E**JJ>RX@-P :SN'^@V0>X7OK1QM5W5W0XNK[
MF_HE02Y?*58/=,#WP0Z73=W+\ZN[ZWICTKS[4?H[)]VN>U-#M='[$]+WV@[N
M>GU-Z'.=B
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M!N?3;^&+I[A:]L2 L<
M                                            /(_<H,9:FWWTH6FF
MHCKPKQ_Z0'P^'K3]U(_L^H _J;Y:U'1,I!GV=_J /<IUM'KE4J H/NGN3*WC
M9>PF&EAY=LN*IYI@$YSM,8G8]5:U&6G[-QH7;0!8?8S 7+'9\8N3[+R'6H!$
MLW4IH1K:-/$R*O> G0B(N!=@
M        #EN=^N73OU-7*\W""Y)9M-VG&Y&51+DBV7'F$EQ!F5-2F74N)[M7
M ^%0;WPS_5QO#@F[\C#;AA,UV1X"--3<8TB.['=CK?6R:$JUIT*,]"OY-:B]
M$"$F=2G5I@N4X)/P/;AUV[/7LD,S[LXP[%CLQDK2M24)D)0XI:].CB@B(C,Z
MUH"1#<>@S&9MJVSO.1RVS;:O]S/P1F5#<CPFR:UD?>7,4XGTTF!*U@,@
M                               *I]6OZ$S_ (SC_P ,%0_TH_*_CO\
M,S_>CP#H8"
M UO<.2F'@&52UF1(CV>X.J-781(BN*.OT@'+"38U[K7^UR;>2Y$=#K,!QR%0
MR2;CI&===>-%@+2[>]'UNC.',N$ZZ1G8\EIUI"DL442#)7'S/0!5Q8<-$-*D
MH4:M1D9U] $>D
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MM='[$]+WV@[N>GU-Z'.=B
M                                       #G1ULX]>,7WG@9Q'0I,.[
MQ8LF#,--6TS+;1I;?'@9I)+2S+R*!J&8WOZH<*WAV1_-YMB3:\V7*A/2K:XV
M:XYFR9FZIE])F1H\FO2KT.\"(93 NK7#-LMA+'BMI9D7/<&#$D,-Q39-N&P^
M[(=6A;SJS+4E*5DK2V2M1^;YO$R%&"Z#L9N-UW(OV:OMFJWVNW+C+DJ3ZZ;/
M=0I)),^_0VX:J=E2\H$NA ,@                               *?=:'
MX;Q/W)+]L; ;GTXJ0W=[F:UI21P6B*ID7^$+R@JPQ3H)J-!26C67:DEIJ5/0
MJ+$526.R:>N'894R*Z:7$<O0XV95XNI2=#^B.)J[YLQ3,;_VN1IK8OR1$_;8
MKM>]S\FBY]#M+=TEMQ'%QTK:)9$W1RE:D,<.R3DFWK36LOMQ#'&/'?-L4I;*
M=<,OOCH,AR?-2MQ+NE)NK21TTD?#B.]UV.VRZ(MYGGN'9;\MDS=6=K:$28[M
M>6\A=.W2HCI7TC' I+LJP^HBOBY*BM$9NOMH(CH9J6DN/T3$K"TE^$W" HR2
MF4RHS[")Q)G_ &Q4?I]Y/A7G6ED>E"C)23(^)$8^.>Z;<=T\L1/H;QQ$W1'A
M5!ZC=U\UQ+.[#;+%>YL"')A-.OLQUDE"UJDN(,S+RT30<K@-UN?!==?'6F+O
MNAW]F'%%DUMVIONV5W6/R>7*>3JU5H9=U!TWU)FNTWN^I/5ZW6W>#J^MT7T[
M'Q/O.OMZO5W^'K(KV-W3RK*<ZR&U76ZS)<2''>6RT^HC0E29*$$94] Z#] U
MFBQV:;'?$16Z(_*\C@UF6[49;9NFELS'GE:&,^GP;3SRR3J21J4LR+B?ICRM
M](F8>FQS,VQ(=P@$K2<IDE>0W$U_MB1M;F'U1(8=*K;J%E6E4J(^/T!:2E8?
MI3B$<%J))^B9$,U:H^9RXI=K[9>FM/JA5'Y*="49I3):-1=I$M)G_;%)V/LE
M:%D1H42B/L,CJ%$J*6A!&:U$DB[3,Z"5:H^)SH*3)*I+1*/L(W$D?]L6-J2_
M92HRNQYL_247J@/H2DJ]:HC](P2K\.2([1:G74(*M*J41%7Z(E8:I+Y%<("C
MTE*9-7D)Q-?[8L;4G8^Z'&W"U-K2I)]AI,C+^P+1*OT(H
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MG_&<?^&"H?Z4?E?QW^9G^]'@'0P$
M                  ! O4;G)V*R7[&B<=2=QQV91*%))!^(;D,\2,Z_4@*X
M]#F$HN^-7:X3FVW785[94A3A+)1$EEI?"A>4@5T&0VA%205*]H(_0
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MZ73=W+\ZN[ZWICTKS[4?H[)]VN>U-#M='[$]+WV@[N>GU-Z'.=B
M
M         #5-P]N<3W1QM_%\PA%+MSIDXRX@]$B.\DC)+K+E#-"RKZ1EP41I
M,R 4XR/]G[D3<MQ6(Y?"DP55-INZLNQG4^1*E,$\2O1424_O0:J_>,?L_;ZN
M6VO,\NB,04F1NLVAEQ]U9<*I2Y()HD?OC;5Z0%5R<!P#%MM,:BXIB,(H=KC5
M4HS/4\^\JFMYY="-:U4XGZ1%1)$1&6S
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M,4=S%T3N?L1H
M 0]O7MM8;WC>07V;)EMRGT1]:&EMDV6A;394)32C[$^4!S.W4QFVVS=JR6>*
MZ\N(^4 EK<-)N%S9"DG0R01=G9P 6KV3PS!8.+90[=;E-8F(^R0VTT4E:DLK
M/SM+"N%:=Y (&P;'+SO*_,B'&U':4(=(H;C;!_9S-/G'(4HC]9PT@.DFW."Q
M\4@P'T*?YY6YF*XEU;:TEYK9GZQ)<:H\H#?
M                     !SGW*ZL][\;W&R_'K3>X[5JM%[N4""TJ!$6I$>+
M+<:;2:E-F9F24D53XF#5&K_/-W__ !_&_)T/[4"T/GF[_P#X_C?DZ']J H]=
MNZV-]H4E#\J?;[DRDR-4:3 :0VHB[2,X_)7Q]!0%%T^G[?VT;XV"2^F*5KRB
MTFA%WM>OF(H[70\RHR(U-KTGP,JH/@=>"E&9A,0(
M              "J?5K^A,_XSC_PP5#_ $H_*_CO\S/]Z/ .A@(
M                                        /F^ZEAAQ]9T0TA2U'Q.A
M)*I]@#GMUD9>F3OABUBB*;<:N-F@1S,T.$O5(N,QNB3,R(N!\*D LETQ84]A
MV-7B(XAQ)R+@EVCKC;AT)E">!M\.X!/8
M                                #"9-C,+*+4[:IKCK;#RD+4IA24KJ
MA1**AK2HN[R *9]5^P^+XMMU>LPA2[BY/.5#;Y;[L=3%''4(/S4,I5V%[(!4
M+87$8&7[W6#%;@X^W!F'-YCD=2$O%R;?(>+2:TK3VH*M4]@#IUMOLKB>WZK9
MDT:;<%.6[GZ2DN,N-_YQS&3U):82H_Y3A0P%2=_;K^</55-QB+I<C3DP4H4D
ME(=.EM;6=%+HDN*>\@%Q=A,<7C^!6Z$M*TFV_)69+4A1^>ZH^U' !+8  UG<
M/]!L@]PO?6CC:KNKNAQ=7W-_1*@ER^4JP>Z8'O@ATNF[N7YU=WUO3'I7GVH_
M1V3[M<]J:':Z/V)Z7OM!W<]/J;T.<[$
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MYJC6:B5Q[*$5./I#I\UT3.PT]DVVTF:[60'Q<D
M                           :9NNI"=OKVIQ9-H)MJJU'0B^SM]IF Y:[
MQO,%O5C[R74+:05M4I:5$::)E*,^/8 WN7N@WC;J+;$;>?;N'!PXKJ=!5/11
M1%6O: LQT^;6L8_/OKB(S#//9CI,T,FBNE2S[R]$!:9A'+9;;]@E*?I%0!]
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M5/JU_0F?\9Q_X8*A_I1^5_'?YF?[T> =# 0
M                        :[G]Q^"<%R>YI5I7"M,^2DR5H,C9C.+(R/N[
M.T!S*R14K<W=[#LD<6MQ$-^V0E:ZR>#4]3QEK*A$7V7L =1++:XMK9<:BM(:
M2M>HR0G21G2@#)@
M                "M_6O\A=X]W6_P!\) 4,Z5_^97%/3N7^Z)0#ION+>U8Y
MM%<KRE1I5&Y%%)7RS^R3FV_7=WK@%$<;;<S3JJQ_(WC-UF0\TA>NKQ&34%3?
M%?8?8 Z28[!9M]K;C,H2A"5+,B26DN)U[ &6  &L[A_H-D'N%[ZT<;5=U=T.
M+J^YOZ)4$N7RE6#W3 ]\$.ETW=R_.KN^MZ8]*\^U'Z.R?=KGM30[71^Q/2]]
MH.[GI]3>ASG8@
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M[L..E1F2(]P\-(4R2E5/227U-\:\ 7D=.P8
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ME0Z_V!Y^7:VQ,1M?41L
M        5KZJMU+;9MO<SQ9A[_QIAF'I96RM2//>CO\ %94+UAU[0'+7)<BE
MWJ[M7-[1SFD(2G0DTI\Q1J+@9GY0$G;0Q(.1-/R+LI:'6);2&R9\TM)D1\:D
MKO =<,=B1HSCYL&HS4E.K5Z!GZ! -@
M                 !RKW/MV8=/^_P!<+O:C.)-BW%Z\8_+6G6T_!F+6:2.M
M-230M3#I>740-IZM?[0>/X%!7K!5G<DH(EKAW B8<74JF27&#4@CXG34OR5[
MR)1!>_/4ODN^#4.T.6YJQ8K!>\4U;&G3DNN222:"<>>-+9*TI4HD)2A)%J.M
M>%"Q":+7-S;IRZ18]UAG\$Y;EMZYS:7T5>C-SV-*3T+]:X;$0ED5/-KQ*I'0
MF^6N]!6)3KAN#>\T<:5\%6BW+A)D*+S3FS7&S))*/M,FVUFJG94O*!+H0#(
M                                 *I]6OZ$S_C./_#!4/\ 2C\K^._S
M,_WH\ Z& @                                               !V<
M0$'=268L6; <RLQNZ9,O%KFII!MFHC-V+);+SBX%Q(!63HNPE[+<.=R.2R:U
MP,D4UK0XELB)B/#=]:?$_7@.A9$1=@#^@
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MF:-'=9%TTZ]?#NIZUCDJU#@3#[Q+^B*
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MV6^[VIF?&Q;BLMW6Q'B9 ?-]0
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M/]*/ROX[_,S_ 'H\ Z& @
M        #\N*2EM:E&24D1F:CX$1$7: H=UB9@ZG=JQ81%<4['OUDB15FV^9
MHK.G3(QD;)$9+X=U?.[ 1-W2%AK>([;W2WJ;(E.7R1)*L<HY^=$B(];4_8=H
M*L*
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ME9K7P4<''FB[P-\'7.0
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MY)'7B55$F%L@9 %/NM#\-XG[DE^V-@-SZ;?PQ=/<+7MB0%C@
M           ?PR)14/L$F*K$T8:Z8M9KQS?'-*7SB)+FE:DU(N'<?H#Y^ZMK
M5](RW1%&"_5-A.M+GA'=2:&1\]SNX^4?6W\.Y\[IZV]F[9B-CM"7$PF5H)TR
M->IQ2O6UIVGZ(^TYKGQG';+.#XOJ
M                      # 9AD\+$;.=WGJ6F.3J&JMHYBJKK3A] !R9ZL,
MABY-O9E]YA*4J+**W:#6G0K[';HK9U+NXI 0, D#;? Y^6+\=#:0X424TA1K
M<Y9D?!79W@.R^*VY4%V2I22+6E)<#KV&8#9P
M                       <ZNI;J8SZX[AW;$<'ODNPXUC\ARVZ[8ZJ-)E2
MV%&A]Q;S1DO23A*0A*54TEJ[3!J(0FWN/O3'N)1FLMRAJ[2M)DRFXW!,EWF^
M>GS2<U*U5U%Y05^+MN;O(C5;[YF.3)K77%FW.X%Y2.J''?3+L 7WZ*\<R?'=
MIIZLJ@R8,N\7M^ZQ/&$9.OQ9$*&E#U%'JHLT*IJXGV@S*QH(
M                        JGU:_H3/^,X_\,%0_P!*/ROX[_,S_>CP#H8"
M                                                ,!F=R.U8K?K@
M2M/A+=+D:B(E4Y3"UUH?;V .;.:S7MQ>I3;*Z&KG,MS+%!<-1$RJB;NM9D1)
M]!SM =+<<LC-A@N0V$<M"W3=,M1KXFE*>T_WH#,
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MSZUXG2G,(=_Q/769NK2=U?N=5AP7;5@1YQVX
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M),DJ4XV9$?8 E_IN2HKM<UT\U4!HTGW'5:0%C
M
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MA,_XSC_PP5#_ $H_*_CO\S/]Z/ .A@(
M                 #^&9$53[" 0=U#9U%LN$9I9M3?BWL;N)M)-W0X:G8CR
M4T*G;7L 5CZ/,&DYM;H>;R4N$NS9.T@M3//X1$0Y/\HHR-/K_)P[0'0X
M
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M8THE5HDD]G8/*2]!;+Z"-
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M@JPH(
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M^R3N-PB$9*\,G0EMI@U)X&I*4ZET[%*,N-*F9E.@(
M                 JGU:_H3/^,X_P##!4/]*/ROX[_,S_>CP#H8"
M                                        ^4E?+CN.'V)29\ % ^JO
M,9#N[+>%MN.$Q>+=$AJ0:&^6935N,GJ7Q61'JXFGB7< GOH[Q%&([:76W:6R
M-R^R))<I;BT^=#AH[7*'7S %A@
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ML-:3O<;B-D:J;:_NU^VQ+*4I3V%2HXS5']!0
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M?E 4^ZQX4")>L53&B,M)5%EFHFVTH(S)QOMH1 -ZZ;OPQ=/<+7MB0%C0
M
M               8C);["Q^Q76[S7D,L6V'(F/+<KI2VPTIQ2E4XT(D\: .?
MV_W4W=+AD5NCX&S!O5N>@<F0^V;Z30^MUPM/KT\=)I/L ?S8CICRW.?A_P#6
M;$N^,^ \'\%^8DO$<_G\[^5U>LT-]GL@5?#$L&M&)1H[4))+<:BMQ5.+;;2M
M26R255&E)5,]/$$;21$14+@7D
M                   '/#%>H#>I[J#>Q5O(5LVN\Y0NVNVBXM)EQHK*IAL<
MII*R)QOEH+224+34^T&J.AX,@
M    *I]6OZ$S_C./_#!4/]*/ROX[_,S_ 'H\ Z& @
M                           -5W!O:+'B5[GK-)%%AN/'K,R+S2[Z .;N
M5F_N)U+X%>F"-4-=RL,5U;/G((D7 M7KO04 Z98S8FL>@.0F5&I+CRGC,TDG
MBI*4]A?O0&:
M              !$F_NZ%PVOV_N&46^&Q,D19$9E+,@UI09/.D@S,T&1\",!
MSTWBZM\GW)QZ?A=PL4&+"?=8=.3'<>-PC84EPB(EF9<3*@*KDF<I,[QN@C5Q
M\RO#BG2"+K]&O49?G<JPK9+X&B)LQ_"G_B1+=\3P9F7'UM='K_-[.ST0'1AA
MPW6R694,Z]@#Z    UG</]!L@]PO?6CC:KNKNAQ=7W-_1*@ER^4JP>Z8'O@A
MTNF[N7YU=WUO3'I7GVH_1V3[M<]J:':Z/V)Z7OM!W<]/J;T.<[$
M
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ML$ %/NM#\-XG[DE^V-@-SZ;?PQ=/<+7MB0%C@
M                                                      !ALBR*
M/CMJEW20TMUJ(236ANFH]2B3PJ9%W@*1;^[^WB]7^\8/9)$N#!OMN*VH:<2R
M;253V38,UGYRM-5\: /ATS]-4#)<?ND_,$0[M.B7%*8[YKDM&AHFD*TT;T$?
M&I\0%]V(K$;5R$:-5-7$SK3L[?3 ?8
M                         '*/J(S--ZWER.; M,:Q7FQWF;".XVQ3K3DI
M=NE+::DND:S)+]&R,UMZ:GQ,J\0;ALMDZU-]+/$1$D3X%WY:22E^X0TJ>H79
MJ4PIG4?HJX@49/Y]6]?W/8_O)[_6 *+;=+F[&4;Q;?W+)LM1%1<8EX?MK106
ME,M<AJ+%>*J5K6>K4\KC7R S*;@0
M   !5/JU_0F?\9Q_X8*A_I1^5_'?YF?[T> =# 0
M                         $&=2^1':MM\R8:UI>*S/.(6DDF1'I/R^D"J
MM=*V*GF:;#FDLVW9%OR%@DK=-27:176'2H2"T]_"H(Z,
M                                                 *S]9Y$>RUZ]
MW0??"0'*:[E2XOEZ)?6D \0">>B__F6PC_:O^Z)@#K]$_D"],P'W   !K.X?
MZ#9![A>^M'&U7=7=#BZON;^B5!+E\I5@]TP/?!#I=-W<OSJ[OK>F/2O/M1^C
MLGW:Y[4T.UT?L3TO?:#NYZ?4WH<YV(
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MO;$@+'
M                       (3WPWG@[>XM*N128B7HTYN(LI3;ZT$9J4DR/E
MFGCP\H"A]_W?S;=_.96*VNW6^9:;^ZEMAZ$V\V^OEM$YYAO/FDO.;IYR %M.
MGCI[A0L<MU]R@KC;\AMUS.2S#)V/R33'6AQLU$32SH9EQHLOH +2,LI9(R29
MF1G7B ^@
M    "*KOTV;(7VZSKY=L0CR;K<Y#LV=)4_+2IV1(6;CBS)+Q$1J4HSX%0%JU
M:Y[%])]D?\+>;58[=)X_89=U=CN<.WS7)23X5 K+-GTM=/I+)L\+BDXHC4E'
MB9FHTIH1F1<_L*I 5;]A. 8?MS:GK'A5K1:+5(D*FO1FENN)5(6A#:EU=6LZ
MFEM!=M. (V4                                    !5/JU_0F?\9Q_
MX8*A_I1^5_'?YF?[T> =# 0
M        ?":OEQ75^Q*O'TP%%.JG*TR<XD88A31O72UL,(;)*^<9OFXDB2HS
MTD?DJ F+HNQ=W'=II4.2AQIWX;E/)2XI"CH;$8B/S2IW +(
M                                                    *G=:.5V;
M]4M_M*9:#GLSX1.,Z5U+3(37C2G]D%<N[@\E^8ZZ@R-*C*AEV<"(@1Y@$\]%
M_P#S+81_M7_=$P!U^B?R!>F8#[@   UG</\ 0;(/<+WUHXVJ[J[H<75]S?T2
MH)<OE*L'NF![X(=+IN[E^=7=];TQZ5Y]J/T=D^[7/:FAVNC]B>E[[0=W/3ZF
M]#G.Q
M                       !'^9[(;6;A7=-^S+'&;K=TLHC)E..R&U$RV:E
M)31IU!<#4?<"U:5=NGKI?L"4JOM@M-K2HJI.;<7XQ&5:<.;)3W@5EZ8737TV
MW.&Q<;;BUNF6^3_HTN/-DNLN<33YBT2#2KB1EP,"K<L(V;VTVWN$BZX3C[-H
MN$MGPTA]IU]PULZDKTF3KBR]<DCX$!5O0(
M      I]UH?AO$_<DOVQL!N?3;^&+I[A:]L2 L<       ")MZ]TFMM<3>OR
MVW721,:BZ67DLJJX:OJC_>@*_P ?K'B.Z:QIA5\LYOU %EME\_:W)PM.2-)6
MA/BGHU'7">55K2?KD_O@$A@
M                        #XNRXC!D3[[;1J];K6E-:>2I@(6S_J L.-L1
M5QB*4IUU;:RC2VB,M)=ITJ I/?H><;X9E>K%XV8FS7.?,N41B:;TB*AHGENM
MD1)(R.B5429 JWNQ'3GBF(8QC-RN=GMK^4V\GENW-,<TOFM3KI),C41&1DA1
M) 6$C1F8C?*80EMNIGI25"J8(^P
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M2IZ:$9@DPF@$ %4^K7]"9_QG'_A@J'^E'Y7\=_F9_O1X!T,!
M                                 !K&>7INRXO=9BCTG'9UZB42#]<1
M=I^F YTYU-=SCJ@PI234Y$EO6F(YK/FHXR5I/49<*<0'1?!<;9Q:RKMK*6T(
M4^MXR93H3524EV>7S0&S
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M/V)Z7OM!W<]/J;T.<[$
M                                     %6>KWJ$N^V<6%@N%/\ A<LN
M[!RYMR(B-<."I2FT<JO G7%)517U"4\.*DF18A2&^;>;I.XPO=/);7/5C\UQ
MNM^N3A<V0N29\M9$^OG.$OM)9),C[:@TLAF;>2/]$FW[6.P94HF9AS;G(AMN
M.'%B1'YJ^:LV^*")PVSUGP($Y4B]&6^M\W A7';_ #&6NX7^QQTS;;<73-;\
MB!K)IQ+RS]<II:VR)9\5$KCQ*IDF%KP0
M   !3[K0_#>)^Y)?MC8#<^FW\,73W"U[8D!8X       %-NNY)%LY//_ //<
M7Z]T0<SXZ"<>0A78?;3TA1U9Z!VTM;"(0GL*\S^WTF@%H
M                                              '@NUS8MD*5(>4:
M>0PX\9T-7!"3/N](!1+J$ZGYUIG6(K$_&4TZU(-[GQ73/4E3=*><7E 1MLOM
MGF6[UZNL&]0VS9B1TS(_@WFV%?9'-)ZC<4KN,N #H-MYMA:<+MME4T<@KE!M
M[$1UMQQ#B"6EE*%EYJ2K0R[2,%;^"
M                             .8&V=[LN$]5SERW 4AF-#OUW8ERY'\F
MQ,>5(9;>69T+23JB,U'P3Z[N!OD2=^T!?8E7+;^3&=0]'>B7!;3S:B6A:%+C
M&2DJ*I&1EV&0)"<>L#-,2L6SE\QR]/LNWR_(:8M%K-1*?4ZA]#G.T\32EK1K
MUGPJ1)K4R!(:!^S^B2F\(RZ<M)E"?NK++*S+S3<9CDIPB/OH3B*@LK?@R
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MN&C^Y,S3] &&= 53ZM?T)G_&<?\ A@J'^E'Y7\=_F9_O1X!T,!
M                                   ! W4WD";1MOEQDM*7&H*%D2DJ
M5VN(\@BJK]-N-.YOD>,YSRU.(M]\80;K2T--EX5QMSBA?G'35W"HZ0@
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M>Z8'O@ATNF[N7YU=WUO3'I7GVH_1V3[M<]J:':Z/V)Z7OM!W<]/J;T.<[$
M
M                '-7K%2<#J)7,O3*I%I7%M<E$>O\ *0VTDAQ">SURT.EV
M@W"PW5EDF.Y;TVE?<5FL3['*GVY49^,HC02=1^8:2]8I/8I"B(T]AD#,-@V0
MS'%L%Z6L8R',);,6RQX$OFI>TF;]9<C["A!_RBU^M)!%Q G>K/T-1WI>]MQF
MPV3:@L6::XZDO.2VAV0PE"#4=.-3*G>=/3!9=' 9
M            4^ZT/PWB?N27[8V W/IM_#%T]PM>V) 6.       !3?KO^1N
M?\=Q?KW1!S0A_P"DM^F?]HQ1U:Z"_D&3\<S_ .TT LZ
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MJ-VPV>!;9#C267GH,-F*M:4T.BC:21F52K0P&P@
M                                        "H'5!THW/.;N_N)MLVVO
M()*2.]6-:TL^*6@B23["UF2"<-)46E1D2J5(]5=1J)4SNFUFZEJ=*!=<0OC"
MVE<MMM<"4:-2U4^QF2#2>H^S2?$%;E@W3/O3N+<VR58)EH@NJ+Q-YOJ'(;:$
M<"-1)>(G7>'83:5?0+B!5TIVPVYLFU6%6W"[#J<C0DJ5(EN$1.R9+IZG7ET[
MU'V%]2FB>P@8;@                     J!U_726G#,4L$=MQ<:5<7[A*6
MA"E(1X)CE(UJ+@FOB54KVT] &H5AVRVBW[SO'9#F 1)[6)2734^X<TK="DO-
MEHJ27'6R>-/%.I*5$GB52,%?2R[B[X].V9?!5QDSH,J$I"YV-W-Y4B!(97Q]
M;K6V9*(J)=957R*[0-Z\^;[D6C<'I=R?/+'K:AW;'YK:X]24ZP^XA49YE9E2
MNA9J29]Z>/88,\JE/1W&-_J$Q5RI$49NY.F1\:UMTAOA]%=0:E?3J3(CV*SJ
MO'_PU?\ 86@&846Z+W7&]_;(A"J)=B7!#A>5)15KI]-)&#4LOUT2CD;VM,F:
MC\)983)$KL*KK[M$^A]D^G4"%O.DJ,<7I[PQLS(S6W.=J7#^6N,EPOI$J@,R
MIMUMD1;ZS*=]M@5_O% U"ZO2VZX]L%A"W5:E%$>01_N6Y3R$E] B(@9EL^Z^
MXB=K\0=RM5L7=B;?9C^#;=Y"CYQF6K5H<[*>Q!%'-^.I6-G&*R;=^:;MO4N8
MS(-Y4DG?65+33D([:^4!Z.D.25PW0QBX)3RDO,3U$T?$R_S5\NT!T2
M                                    'RDOIC,+?5Q2BE:G3M.G: BO
M,]^+!ADR7#FLL+<B);6O7-:9/[*23*I*2=/7 --/J[Q$FS<*)%.GU/PHQ_$
M5PWYWYA[B2;M8K>T;4:ZQ&HZ6VYR9#52H9^8A)$KL[ $X=#^+1HFU+[SS32I
M#-^E*0XIDB61$Q&,J&?$N("U0
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MEIY3TB2XIYY1ID.I+4M9F9\"IQ'/T]?=Q6:_]7M.'7S?I[+IFLS#?1R'8
M  #6=P_T&R#W"]]:.-JNZNZ'%U?<W]$J"7+Y2K![I@>^"'2Z;NY?G5W?6],>
ME>?:C]'9/NUSVIH=KH_8GI>^T'=ST^IO0YSL0
M                                                       05U*=
M/4;>RR1IMI>:@9Q9TK3;93U28D,+/4J.\:2,R*OG(50])UX448+$N?.1;);Q
MXD^_;[OA]W;;(ZN.18SLN(OEUH9/1B<:53B?KN -5?3&]C]Y<SD,0;3B%V6W
MP2W(FQW(<1M*O._EI)-MD7&M"4!5T,Z;]A(NR.,R"GOMSLRO/+<O,QJILMI:
M(^7'8-1$>A&HS-1D1K4=:4))$9F4U@@
M  "GW6A^&\3]R2_;&P&Y]-OX8NGN%KVQ("QP       *;]=_R-S_ ([B_7NB
M#FA#_P!);],_[1BCJUT%_(,GXYG_ -IH!9T
M                              '$W<V*EBW0E)*E7S+MK]08",P$RX#G
M\/$T6FX1WELW"$TI)+Y7,(C6VIL^"JD?!1@,C>,VR;<K*D6IB0B1#OBFH*D+
M;0P:^8DFS*I$1I],!;3IQZ<VX&,//W2 E,EF\*=0;<M1EH2S',NP_*1@+IDD
MD]@#^@
M         YPW_JCW>VSW;S>V0KJ5WQZ)D5V:9L]W2<EIMA$YXDH:<JEUM*4\
M$)2O214\VA U1/NW?7#MID_*A9I&?Q&Z*HDWW*S+>I1\.#S226BI^S:))>R!
M*+)6>]V;(;>U=;#<(UTMCY59F0GD2&5=_!;9F1]H(]X
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M$EQX -;Z266HFZ^-1(]2CMLSR01\3IX1X^T!T/
M                    &.OJ5+M,E*/7&2:?WQ .=_5/8+R_D&3264M\E4>&
M1&:B(Z\IDNSTP%.)KEQM;O@Y!HUT)7F\2HKT0&=P"'*NV6VA)$DU.OZ"XZ?J
M3 =7.E>U/V?;:3%D$1+5=I#E"/5P-E@NWZ ";P
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M7=];TQZ5Y]J/T=D^[7/:FAVNC]B>E[[0=W/3ZF]#G.Q
M
M !1SJDWLW,VIWMCHPZ^.Q;:Y9X;[UI?(I$%U9O/DI1LN$9)-1)(C6C2KAV\
M:B&:V[Z];#.Y4'<RQN6F2=$JNUIU28AF?:I;"SYJ"+]PIT_0 HM-B&?87GT'
MX1PV^0[S%(B-SPKI*<;U=A.M'1;9^@M)&#+8P
M          !3[K0_#>)^Y)?MC8#<^FW\,73W"U[8D!8X       %-^N_Y&Y_
MQW%^O=$'-"'_ *2WZ9_VC%'5KH+^09/QS/\ [30"SH
M                                     ..&\M_AS[5;4L06&31(69\H
MTU.J.^B2 0BI55&JE*F9T\E0$H;,8G'R3.K%;I$C[#+*2:FE()U/F17EEYIG
M0^*0'339G97"[;C5LGOVJW2[A&DNNIE.VZ/SJH=,T^>9&HJ=W$!.46'#@MFU
M"CMQFE'J-#*$MI-1D15HDB*M" ?<
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MXP_=X%V>M:9,=DF.:TU&C/$MQ*3TZ]3RJZ$I*E. ,RG,$
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M?"GE =9,#O-DOED7,L#4)F$F0MM2+<;:F>8E*3,S-HB+50RJ V<
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M<]J:':Z/V)Z7OM!W<]/J;T.<[$
M                                            &#RC#,3S6 =LRVRP
M[S"XZ6IK*'M!GVFA2BU(5^Z29& K)N%T(X-=B>GX!=W\:E4-:8$S5.@<",Z$
MI:B>;+RJ-;E/(#55,LLQ?(]GLG;9A9+ ?N\<U&S<\8NA/J:4DZ&1J9-#K2O0
M6E)@JX71QOGN-N-?;MB&:7%%VAVRV^-B376DIFDM+[31)6XWI)::+,ZK2:J_
M5 DPN$#(                               "GW6A^&\3]R2_;&P&Y]-O
MX8NGN%KVQ("QP       *;]=_P C<_X[B_7NB#FA#_TEOTS_ +1BCJUT%_(,
MGXYG_P!IH!9T
M   'X==2TA3BJZ4\3H QLB_P8J5*<)RB4FLZ)(^!?1] !$&Z/4!:<*E6UEI<
MQHI;;JS)N.PY7EFDN/,5P[>X!R<RB]KND9AI2U*T+-5#2E/=3N :P G3IP@3
M5[GXNZVI!(4F8::GQH<&1Z #JWMFVZUB49#QD;A./5,NS^4,!MX
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MYSL0
M                      5=ZD^JB][/9&WA6,V*-+NST)J>=TGN+4PVE];B
M"23#>@U&6BNHW2+T#!8A3J];C;[;[W([,[/NN1+>X_ =K;4B(2:\#5'BI2W1
M/LW"/T3!I+VW70EG%\)J?N'<V<9@JHH[=&TSK@9>11I5R6ZEV'K6?E2"57 V
MLV*VYV>;=7AT!PKI):)B9=ICRGY;[9*)6E1^:A)5(CHVVD@2J200
M                       !3[K0_#>)^Y)?MC8#<^FW\,73W"U[8D!8X
M'X><)EEQY7!+:5+,S[*)*H"%]R.H;']O?@SQLJ$CX1Y^CGJ<*OA^76FDO^TX
M@-GPK>'$LUEN0K;<XSS[3'B%H9-RI)U)37SDEPJH!7KKL43FR\UU!U;7>HBD
MJ[C(U.&1B#FC#_TEOTS_ +1BCJMT)OM1>G]4E]9-L,W:XN.K/L2A"6C,S](B
M 25FF_>"X?-9A2KQ#2Z\QSTI=YM3+4I/U*3]B ^NU&]-BW0^%_@Z5%<^"O#<
MSPQN'3Q/-IJUD7^*.@"42,E$2B[#XD _H
M                 #%WW(K)C,1$^_3$08;CA,(=<K0W%)4HD^:1\:),P$,;
ME]4>"X=9)LRR7>WW"ZQ76VTQ'C>0DTK625&9DE/81^4%57S+K*RS,I\K'[!8
M;?.<N2$,QBBO/\Q:])&9)JJE> (UFW8=NMN?(8?NN/W"TI==3;'%1S4XE+2C
M(S<J:NTN:?#T $YX9T2(MK4M$_);FX;BD&V<B.VH^!'6E5@K!;W](RK3;;2K
M&I4R\NNONE(0U&;0;:4H+29T4?:9@BJ4/IWW-F7V9"?QFY-PVUO<I]+23-1(
M71/"O>7$!>GIVV#DXRSB=\N:9$>7$CO$]'?906DULNM$2CK7ZJH"V$2*B&P3
M"#JDC,^RG;Q[@'W                                     #.A5$F:0
M(.WROB;?*3%-9)-ZVN'0S,NU3B>X>&X[DKGLIS??+WWTWINOCF>:_P!2J^V>
M.)R+X4YBUEX;P]*$2OY3F^7]Z/7<$LC\=8[/WO;_ %!K)T_NZ<O6_NKX0,;M
MI1F$^%:,R:01U:1Y"] 37Z>W);$1%-K\7MU5\73-9\JD&[%@<M>29-/;2IMH
M[O,)%")*22N2NA%3N'D]%JIPZJ8INZT/W?AF>,NEQ6\O4M_+":]A<@<.W8O;
M5$1E1U)J,SKVNJ'Z%@N]Y@B_G];\R^H]-U<^6[H^Y8ZXR":M$Z3PHU'>7Z'F
MH,QUVLFF*_\ LSZ'CM+'6R6QSW1Z5/-ZKFNYY+:EM$2B**E!Z3,^UY?E],>7
MT'XXF?"_9>"61APWQ//]R1-OK8]8?A'6E1>(Y%-14_D^9Y/WP]'QW/U.I3^+
M[GB=9DC44IR5\ZM-_?5?+K/B.GH2S*>61I.M:+4GO],=)P/31.6Z>>W[X?J\
M1[G#9='+$>A<#9O$[='QW'9CC:'E*MS>I+C:#(S4V7'B0]=DQV]2E(?B/%]9
M?=JLD5I^*>7POEO1AT&9C.0/M-I9-QMDBY3:"I131<.'H#Q?$L48[KLD<E/N
M=S]/ZVZ,^.V=NV?O5/Q]M>,[AXS#;>6;17*WOJ)1FDN,E-:D7#N';<$U\78N
MK-*S=ZGZ1Q.F;1YKIB*]2_\ +*^^)71-T8DK29?8UI3YIF?:5>\>ASVTF'X#
M./J-B'&0         0?;NE':5K+[WF^0P7,DO-ZN4NZJ9N2B5"87,?6^:$1T
M$E*R3JI]FUU] %JV?--X]HMH(2;??;S"MKD9%(]A@))V4E-*I2F+'(S;(Z\#
M624^B!15;<3KVO<WFP=LK$BV,'5*;O=],B53N4B.V?*0K]^MTO0!:)IZ-LUR
MO/MM[]D&8W5^\7=>126BD2%$>AI,&$HFVT)(DH01J49(0DDU,^'$$E8D$
M                                 53ZM?T)G_&<?^&"H?Z4?E?QW^9G
M^]'@'0P$                                         &,R%+:[-*2Z
MK2@TIJH^[SR <S>K./9D9CE"D36SFE'AZ6*IU&?(9^CV *C -MV\QR5D.4VB
MWQVG7%S)')0EI&M1J,C(B(N\P'6'I6Q";A.VLJT3F7F'G+M(DDB2WREZ5LL)
M(Z>3S $X
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MN>U-#M='[$]+WV@[N>GU-Z'.=B
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M'P\X!;WH&C7-K]8/BY*7:_ VBA4I3Q]>X@%_F*\ENO;I3_: ?0
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M6WA^-M/*?;@)2ZJNI6MSCJ.I_5 ,LQ%CQ6T-,(T-H*B$D9G0OH@/L
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M&E*3<69<5K,DI(UJ,U'0JF#+-
M  *I]6OZ$S_C./\ PP5#_2C\K^._S,_WH\ Z& @
M                    AS??<R+AN(9 1%*3+B-1U$XPAI1%S'6NS6LNY7D
M<^)=FNV^&Y;$YE]I<6]&A@T7$S:49QV-/G\A#A$54<*& VV=TC75B9R2^!B*
MA'0GY=./_F $W[&=+#>/W"R9+/CVQQRVSC?-;#\LW*(/AI2;:4F?'O 7(C18
M\-OE1D$VW75I(S/B?IU ?8
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MNC]B>E[[0=W/3ZF]#G.Q
M                                     $([F=5>TFVDB7:I%P7?,DAK
M6R_:+2DGE-/-J-"D//*-+2#2HC):=9K33UM> +14G</K<W2ROFP\3;8P^U+J
M1'%I*N"DGW*D.I(D^FTTA1>R!JB$CQK<7,H-TSB1 NEXMT1!R+KD4HG7FB2D
MR(S7)>,R4KT-1J] !)72[LGCN]64W:!D\V7&MMFBM2S9@FA#CZG'=&A2UI7I
M3PXT37R&0$RZ*8#M-MYMC'4QA-@C6QUU!-R)A$IV8Z@C(Z./NFIQ15*NG5IK
MV$##<P                                %/NM#\-XG[DE^V-@-SZ;?P
MQ=/<+7MB0%C@   ?Q1$I)I/L,J?3 15NQM]'RGX(J<@_">)_D5MI_E>5VZTG
M[$!R.R_$;SB+KMPF1%LMR9*V4J=4A23,S4NA$@Z]P#R7;/KO=\>9QR2S&3"9
M2RA*VT.$[1@B)-3-PR[N/F@-429I,C+M(!LT#-[I L$C'FFHYPY"'FUK6E9N
MD3Z32JADLB[^'F@-BVQVUO&:(*YVZ&_):B36V5K96TE)*+0NADOCW@.R&)8I
M$QCQGA5/*\5R]?/4A7\EKI32E/L@&R@
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M,VVRTI-5#/Z-"(!]@
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MIQFX8??(=YBE>TFX<-Y+BVZQ'Z$XW76V?H+21@0WWH5^121\>3?:8X)*S((
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M<EFY0I,ISPSQM'P<<52IH+R*\H*GX$
M                       $!;F]4>#X7\%_!5VAR?'>(YWB69?F\GE:=.E*
M>W6=0%"+W?MP-_B8AP+$RZJQZGEE ,TF12J)\[GN'_B^% 5;/8'I18P)VZS9
M<BXMKN<>-5+YQS(E(-:C).A/=J[P1;YELFF6VBXDA))(S] J /V
M /A+_D3],AF[<S=N<^-\/E<R;W0CVAL=5DWR_,N,?JK_ !?EA<78'Y(,7_F7
M_?+HY^G]B/MRO><+_2X^A)(Y#LP    !K.X?Z#9![A>^M'&U7=7=#BZON;^B
M5!+E\I5@]TP/?!#I=-W<OSJ[OK>F/2O/M1^CLGW:Y[4T.UT?L3TO?:#NYZ?4
MWH<YV(
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MQF\1[G#B..NW!+S9\@T4(F4%V*(N\@%H0
M            4DZRF[@K;V 4=3A*_.!GUI*,Z>%F>0!SHNI.IN,HGS,W2<5K
M-7;7T:@/C%:4](;:2DUJ4="215,_H +U=)G3U9<^P5&67.WV]<F#>G6:S8YK
M?TQT,.E15.SS^ "\N,X)8<99D,PK?&92^I*UDPWH(S25.(#:"2E/K2H _H
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M;7O;A[V66RVR+446:Y;9422M#E)#3++RC;6BFI&EY)$9I2=:\ 9E) (
M                               JGU:_H3/^,X_\,%0_TH_*_CO\S/\
M>CP#H8"                                    ,#F$%NXV)Z*Z230I;
M9F2NSS5$8#F!U/8Y;X&197);;:)Y,F.6I-=7%+1>4!6!9$2C(NP!G,2Q]W)+
M[#M3:B0<GFT4I)J27+;6OL+]Z Z)=+.Q<*V6K'<FF(C/28<J49KT.)<,M3B2
MI4Z=X*N4RPU';)IA!(;+B22[.((^@
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MYSL0
M                    !B<BQ?&\NMZK3E%IB7BVKXG&G,H?01TIJ22R/2KR
M*+B K-N%T*8!?>;-P&XR,7GJ(S3">-4^WF?D(G%$\BO>?,41=R06JJ6X73#O
M%MUS9$^Q+N]G;J9W6RZIK!)36JEH2DG6R(N)J<;27H@U5@-I-Y,PV7ODJ\XH
MF*ZN:TF/.B3VC=:=;0K41'H4A:3(^]*R]$"B_P!T]]34+?";-L+UA=LU_MT3
MQLA2'DR(;C9.):/0HR0M*JK(])I/]\#,PGT$
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MGF6R_,O+6W)CI:24*2T[4T'51T+MIV@.D$>,W&2:6ZT4=3KQ ?8
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M9;9Y7ROT.:R*S;YX9YEYJ0V3K*M2#X$=#+L],?2KA3$Q-)?05
M &!NF9XY9Y+L.XS>3)8T\U'*>736DE%Q0@R/@9#YW9+8WN9BT>7)$3;%8GPP
MQWZSL*_&G_T>1]K&/?6<[[_+<_9\\>M^F]RL-=,DHN=3,Z%]@D%Q/_S8OOK>
M=)X=GC]WSQZVTM/M/&9-JU&7;P,O[8^M77S;,;WT%9           ,Z%4^P@
M&,N606BTJ;3<)')4Z1F@M#BZDFE?6I/RC-UT1O??'@OR>S%6#+<_"3[+I_\
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M%_ZS ]\$/):;NY>/N[ZWICTKR[4?H[)]VN>U-#M='[$]+WV@[N>GU-Z'.=B
M
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M^A,_XSC_ ,,%0_TH_*_CO\S/]Z/ .A@(
M        T3>!IM[!IB'5)2@W6*FKLX.%Y0')??:.RUG.1FVI)T?9(M-/\4V
MB0!*.QN.2[IN#87&DKY;OBZ&3:E%YL5\NTO2 =9MC;8Y:=O(4)VNM+\E7%)H
M/SG3/L,!(X                                                #R
MSKA$M[#KTEYMOE-J=TK6E%221GW^D K/O%U)P[&PJW6A&MZ; D<MZ+/0DT.J
M)2$F1)2=3(^) *0P$;D[O26;A/NEU24!Q$92)B7Y1J0X9*,B,S*A=H"_>VG3
M5B6+(GDY;[>Z;SC*TZ89-T-LE>B=>T06 9C,1ZDPVELE>NTE2M!1]0
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MT=D^[7/:FAVNC]B>E[[0=W/3ZF]#G.Q
M
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M[X\N5/-)OE)<01H+26DDH,N!>F W
M                       53ZM?T)G_ !G'_A@J'^E'Y7\=_F9_O1X!T,!
M                                  ?*1(:BM\UXZ(K2I%7B8"GW4IO]
M&C6;(,4MDTO'PIK+9-+C*,B)MU)J\\RH8"H2-FMS]UI1Y3;+:S,AWFKK3I28
M\<U$R7+,]*UI--#0?: \R>ES=%-W^#GK.UK(S)3938U>"-7;S*?V0%R>FGIX
MN.)LXQ>;] 5&DP_'^(TRFG4IYIR6T\$*56I+3V +>0XC,%@H[%>6DS,M1U/B
M=0'W                                         8J_7^WX];95RN#A
MMQXB.8ZI*369)J1=A=O: A?(.K7:?';BFV7"Z2425(2X24P7EEI69D7$D^@
MQY]9FSB2,SNTJA?^H/\ \4!L>(=36V>9S84"S7&0[(G3&K>PE<-YLC>>4A*2
M,U)X%59<0$U ,!E&6VC%8$N9='5-)C179BC2VIRC;25*,Z)(Z^M/@ H;OSU4
M/WJ_0K?@UQ0Y;YD#PKR9$(T*.0ZZXBA&X14+2I/$%1_MST^[@[F2VKI>[4V^
MFU2V$&Y'ELL$AM2B6? UU,^ (Z.8AM9BN$,28]C3()N4M+CO/=YAZD%0J>:7
ME ;J                  /A+_D3],AF[<S=N<^-\/E<R;W0CVAL=5DWR_,N
M,?JK_%^6%Q=@?D@Q?^9?]\NCGZ?V(^W*]YPO]+CZ$DCD.S0[O]<<LM^!Y&_C
MI-&^VU'.-S2095-]HE5U&7<9CH-3&3)G]W^[/J=WH;;*1/*JCMEM9EF>YW9<
MNRV&E2)+JT37X[[37FLM+:3I0E1]Q)[A[318,./A_5V];;Z70\4UF6-7[JVG
M5F(Z=S>]Z>G5$.)=\IQJ&ZY/AQ4*BJ>E-Z.8DR2=4J,J\#'F;=1EQ:VV(IU'
M;Z?W=VDFV[VIJ^73O^L6S1K+;;BRPU'5<]3Z4FTL]"UIK0R4?</<SDLRXKKK
MM[R&HPW8\\19[.Q:S-UNKP'(#>IK\&_V>30/):V(C'=3F<S/,S@OKS2H9<OE
M*L'NF![X(=#IN[E^?W=];TQZ5Y]J/T=D^[7/:FAVNC]B>E[[0=W/3ZF]#G.Q
M
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MT[*Z4\0&SR;/ E06+>\PTN+'T$TTMM*D)Y:305$F5"H1T*@#'Q,/L,*:4^/
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M6T--FHU:6T$A-3H5:)](!Z0
M                !5/JU_0F?\9Q_P"&"H?Z4?E?QW^9G^]'@'0P$
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M]@"ZEFQVTV)MUNW0X\9+JB4LH["&2,TE0C,D%Q 98
M'PE_R)^F0S=N9NW.?&^'RN9-[H1[0V.JR;Y?F7&/U5_B_+"XNP/R08O_ #+_
M +Y='/T_L1]N5[SA?Z7'T))'(=F\5SM<.[1'H<QEMYAXB):'FTNH,DF1E5*N
M!]@QU(K5]+;YMW/+:\;M5H0VW#B1V2;,U(Y+"&B(U=M-)<.T?:+YB*/C?;%U
MW6G>]LZWQ;A&=BR&FW&72TK0XA*TF7HD? Q\9LCK=;E?2+IACH.+6BWF@XT2
M,V;:M:>7';10_*5.P?>,DQ%'SNMB9K+Q[A))."Y 1%0O!/=G[T</53_E7=#C
M:N/\F_HE06Y?*58/=,#WP0Z33=W+\[N[ZWICTKS[4?H[)]VN>U-#M='[$]+W
MV@[N>GU-Z'.=B
M
M   #2-TMJL2W=QE>-97'4IM*N;!GL&2)41^E"<:49&79P4E1&E1=I=@"H<_]
MGWDB9JDVO-(+MN,STN28CS3Y)[JH0MQ)G_=$#55A=BNFC$MD^==6Y*[YE\EO
MDNWA]LF4M-'0U-QVB4O02J%J,U*4?E(N ),IN! !3[K0_#>)^Y)?MC8#<^FW
M\,73W"U[8D!8X
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M<$
M            %4^K7]"9_P 9Q_X8*A_I1^5_'?YF?[T> =# 0
M                      0?U$;KQL&PB1-AON,3F)[$9:^2ETO.U$9$2JEW
M JC6)8Y?=YMTY<B<3<RTWDI$U!&HHSBE)21D9Z"*G$CX CH7M/MO;,,QJQLM
M1C9F08ZFS^S*=(M9JKVF=>!@)*
M            $(=0UQ;BX7DS:C,C*&@^!5[5H$'*;=*2F7DK;J3,R\*V7$J=
MBUBC20&[;?YBO%;A;Y#;QM.QK@S,09-DY13:FS(Z&1U]9V )HN"<]W\RRT3;
M<ZQ-M+SD:Q2B>)N(X>M\U+01)25*I?*BO4 7(V#Z9;1A%JF)R6W&S<"GHEP^
M3,6ZFB$(H9Z5&7KD]@"R4>*S%2:&2,B4=3J=>(#[
M /A+_D3],AF[<S=N<^-\/E<R;W0CVAL=5DWR_,N,?JK_ !?EA<78'Y(,7_F7
M_?+HY^G]B/MRO><+_2X^A)(Y#LP    !K.X?Z#9![A>^M'&U7=7=#BZON;^B
M5!+E\I5@]TP/?!#I=-W<OSJ[OK>F/2O/M1^CLGW:Y[4T.UT?L3TO?:#NYZ?4
MWH<YV(
M
M   I]UH?AO$_<DOVQL!N?3;^&+I[A:]L2 L<
M
M
M                                      *I]6OZ$S_C./\ PP5#_2C\
MK^._S,_WH\ Z& @                             _#CK;*=3JB0DSH1G
MY0&-;R;'WI+D-JY,+E,ZB=9)9&I)H/2=2] ^ #!YSN)8\)LJ+S,EQB96^B.1
MO.\M&I:5*+C0^/F@.?.12KMO1N=D&/14O%:Y\^9.BR(YKE-J;;6I:="#TD9&
M1\#J NILAM7"PS&+ MYM"[A&BK:<6Y%0TZ9K4KUQU,^PP$Q)2E)$E)$22["+
M@0#^@                                             "OO4JA1XCD
MZB(Z>";X_P!V@!ROW"*E]17[G1]<L!J8"0MIL8+(\KQZ,HS),F]0HAT;)PJ.
M/M%V&95]=V .LVRFW%JPW&Y,-R(R_).XKE-/N16VW$'R64EI[3X&BI'4!*I$
M1=A4 ?T                      ?"7_(GZ9#-VYF[<Y\;X?*YDWNA'M#8Z
MK)OE^9<8_57^+\L+B[ _)!B_\R_[Y='/T_L1]N5[SA?Z7'T))'(=F     -9
MW#_0;(/<+WUHXVJ[J[H<75]S?T2H)<OE*L'NF![X(=+IN[E^=7=];TQZ5Y]J
M/T=D^[7/:FAVNC]B>E[[0=W/3ZF]#G.Q?EQ9-MK</L21J^D50$<9MNY:\,<:
M;EJC$;C*WRYSW+X(,R\A\. "+F^L'%UD9DNV</)._P#Z0'T1U>XPI1)UVSB9
M%_IOE_N0$P[>;AP<_:N#D(V#* II*^0[S?Y8EF5>!4]: W4
M
M                                     4^ZT/PWB?N27[8V W/IM_#%
MT]PM>V) 6.
M
M
M            %4^K7]"9_P 9Q_X8*A_I1^5_'?YF?[T> =# 0
M                  5;Z@.IB%M];G6XY7%N5%O"K<ZMF-$=2?+1((Z<YSLJ
MWVTJ"J<VKJURN%E=VO,FY3%VR:J0J,RB#;^:DGGR<1JJ1%P25#\X^((].:=0
MV0;O65&)PYTE+S+R)Q'-BPV6J,DI!^<P2U5^R=E* +6]->S[$&-C69SFX[D^
M5;-;[S;TC6IQYNBCT42@J^@ M?'91'90PV5$(*A%4S_M@/J
M                          #6,IR^)C4)^7(0\I+"D(43*4*/SS(N&M22
M[P&@KWZL:%F@V+A4O^QC_;0'X7O[8D)-1L7#A_V,;[: WW$LTAY3;H5PC(?2
MW+-PD$\AM*OL:U(.I(4HOJ>X!M8##7S(X=CBR9,E#JDQDDM?*2DS,CIV:E%Y
M0%.NI'?2TOP,@L<=J<@WX+6G4S'T5JE7$^89]P#GQDUV3>+BF6C50FDM^>24
MGP-1_4F9=X## )LZ=3IFV)?\36[WQ' =?<?.L-=?\:?UJ0&5
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MI]U&S =+^C>)<XL+,/A)YMXUNP.7R^ZB9%:^:GR@+0@
M
M                                "GW6A^&\3]R2_;&P&Y]-OX8NGN%K
MVQ("QP
M
M
M        JGU:_H3/^,X_\,%0_P!*/ROX[_,S_>CP#H8"
M            -/S[,XF'P(LR0ZTV3[QLD;VJE22:N&GT@''/>>_.WS<G-)/,
MUQI&0W22UI4HT4<EO&1I)1]E%< $>@)?Z;;FW:=PW);K;3B?@Z0C2^6I%5+:
M[@'6W;>XMS\2L3K:&T$[";61-%0B\WN] !N0#\..MLIUN*TH+O,!X';_ &=E
M1H=EH2I/:1UX?V 'X_.6Q?=S?]GU 'Z;R"S/+)MJ8A2U=B2KW%7R ,@TZV^@
MG&E$I!]AEZ #]@                       ^$F0F.E*E&15.G$!!67=2-H
MQ=3R7)=O2;,I44^:3W:C7VZ3[?- :R75]8C(C\=:N/H2/XP#])ZO+$HZ%.M7
MTI'\8!/.%YA$RZS6VZQGFG"GQD22Y.K311$?FZN- &S@ "CW6/E,Q%BRBTM:
M4H9F0M*TFHE\%M'W'3O <]9=WN1RG%>*>+B7FDXNG9Z8#XG=KDHJ>+>_I%^J
M O#TR[S6/$L&Q2'>;K':>A*FF^4DW5++F2Y"TZJ5[E%0%2AN!U<R$,7"#AR;
M5=5&AOP9&F3K<49I4LN#B.SB"*P95==W=W,A?E/8XZS%O"6X[CUNYA)3RFR;
MJ@EN+.OF@/#*Z9,Q599-P=A7MR8VD]+"]*B50RH1U34!$64;8Y?C#KA3K1*C
ML,L\]Y;Y)2:4<:F?$N%" :E'B2);J&(S9N.N'I0DNTU'W + ].V$Y?\ G=BT
MQ%G?5#8R2WJ>>))&E!(?CJ54R/N+B ZQV-EYB(M#Z#;6;AF1'Y-*0&3
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MF1VGC;>MVCF-I72J9-::B.G8"KV1XD2(2BBL-L$JFHFD)16G9721 C[
M         #3=ULMN6"X#=\JM#3#UP@>&Y+4I*ULGSY33*M1-K0KUJSI11<1V
M'#M-;J,]N.ZM)KN\$3+K^(:F[3X+LEM*Q3?TQ"'+#NSU&9/:8]\L.'6F;:I6
MOP\E"'$I7REJ;50ESTGP4DR[!Z#-P[AV*^;+\ET3'V[+H,/$>(Y;(OLQVS$_
M;M/9)W+ZE+6TJ9<L A.1&R-3B8K3SCE"[3HU+=/_ *H^=NAX;?-+<LU\-/\
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MRCJ>(:/!@BWW62+Z[]L;/([7A^KSYYN]YCFRF[9.WRI+'3NX
M                                        4^ZT/PWB?N27[8V W/IM
M_#%T]PM>V) 6.
M
M
M               %4^K7]"9_QG'_ (8*A_I1^5_'?YF?[T> =# 0
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MYY/J?5 >I%_CN=C2R[N[U0'K;N#;E:(45/2 >I*B5V /T
M  ^,HJLF7HD,SN9NW*![U6>5(W9R5U#J$I5(09$=?\0WZ Z;/EBVZ8?FW%K*
MZJ_Q>B%O=AV%QMI<9869*6AEXC,NS_273'9:::XXG[;WN>&1336="11R79
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MB4E1=Z5$1CH\^#)ANZM\4EW>'/9FMZUDUAE1\'W
M                               4^ZT/PWB?N27[8V W/IM_#%T]PM>V
M) 6.
M
M
M      %4^K7]"9_QG'_A@J'^E'Y7\=_F9_O1X!T,!
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MWTVP&8CYCC<HS)B>E9D53HAPN!^FD!EF)<>3_(+)?"O C+@?I@/L
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M[7E.&Q.FUU^")_#-?7'FV+2CQ3V@
M                   "GW6A^&\3]R2_;&P&Y]-OX8NGN%KVQ("QP
M
M
M                                                       JGU:_
MH3/^,X_\,%0_TH_*_CO\S/\ >CP#H8"                    *7=4JOT4_
MVC_[*!+FD  /HUKJ>A1I/OH RT+'9<TU:3.I$2O6*/M 6*P'9ZRW!X_'N6QM
M)Q4N%XE!$6HS3PX]_$!+N6;%;?6*PVR:P=@<D2#;2[R$M:^+6H]7'R@JC>8Q
M&(.4WR)&T>'CW&6RR37K-"'EI3IIW4+@",$ W?:N+%EY,XU+2A37A7%4=IIJ
M2T>4!T6VYVCV_O>*6-V7'LYOOPVW'#>2@U:M->/'M!6:N'3-MO-4M11\?+6K
M5YS:# 1QNKTSX)8L.EW2 Q8424NL)2MAE',HMPB/CZ0(H-GUH8LN57.W1N7R
M8ZT)1R2HWQ;0K@1>F U@![;2W+=N#+<%2D2CU<M2",U%1)F="+CV5 2W9X>Y
MC&-D_%NEQ3:TFJK#:7R;KKH?9P[0$<98]=5W5XKNX\[,-*-:W]6LRTE2NKCV
M -> >RU.)9N,=Q7K4JJ?=W& Z,]'F[>,XKMD_9KF\PU)?O,EY/-E,LF25LQT
M$>E9D=*I/B"K06_=7%;CH./-BJUK)LM,ME7$Z>17H@C:(5[MLY&MF2R?G:"(
MG4*X\/(?H@(*W]WG5MW>RMS"WSU6DIQ>&D$T6HW'T=GE^Q]H"KQ]:MS+ZJ[?
M?Q K^'UKW.A^==_OX@%@.F[?Q_<VW7B1*7,2<*6PPGQDDG3HZ@SX<>S@"+-R
M;K BD1NR&DU(S*KB2[/3,!K,S<S&8.GG3(Q:B,RK*93V>FH!!>^&\.)S?@'P
MDF-(Y?B]?*EL.:=7(I72HZ5H Y=7:0F1R=/U.KOKVT 8T!E+,S<G5/?!RW$F
M1)YG*)1^6E: )JL.V&Z60()/PQ,2RAI#C9.,2#3I47"E"\@"PF"=']SO*G%7
MF3;WBY"'$E+CNG1:J5/SD]H"3?F>8O!9;-4"RFZ9$E:TQ#(S,BXGZWR@*([Q
MX>G'W9S,2*E*6+L[&3R&C26A!O$5.'9YH"(%-K1ZY)D9<#(RIQ >F+$D+61I
M;49&52/2=* .K_3#9+*K;S#G94-@WU61GF+6DB4:M*>VH*GEV%C,=-5LQ4D7
M"AF@J?V01XG+SBL*J35$02/-_E6T_P!LP%%NK6ZVB>UE+<'E*6N5$-"FUH74
MB-JM-)@*,S"I)<+T2_M /PPRN0ZEILC4M5:$1&9\"KV$ D+&FLV1 BP;.].C
MI\\F%,(=TI,UJ4="27EJ FC;/8S.L\NEK>O\];\6:XXW);N+#ZDJ2VE1%KJ5
M*>:5 %M\(Z3L9L;<*1.M]H?DQG5+-Q,8R49&9TI4B\H"2;IL_C:L=F6J-;(+
M9O(,DF3/FD9F1]E/0 5^ROI(C7R[IG-M6M+9-(;TN15J/S34?L3\H#$'T91C
M(R)FT$?N1?\ % ;MMMTR)PZ\VFX(*WI\#<X\_P"P1UH.K+C:N!FDJ'YG: M@
M2:I-*_.(^!^D8#SNVZ __+1T+X4\XJ\ 'B>Q;'7R/FVR.LZ4\Y!'P,!@)^U^
M(S?_ '/!+S33Q9+O^@ U*?T^8A--)G:;9P(RXL>7Z #4I_25B$S32UV<M)&7
MG13/M^@ U:9T36)XT'&C6-DBKJ+PBBK])("&<GZ4,GM_A?@^=%:YG,YG(COE
M73II6B?1.@*B2X;5[L6@FU,WJ:9NU(^4Q(^IIV\/1!'F95NY;*Z[I>%:^!:2
MDI];] "C*QMTMT;69J7-OZM1:?-<D%V ,U&ZH-Q+;4ENY*? D<)#I>M],P&X
MXYUF7TGEHGMWM6AHD_YQ+TD:R,B,_.KQ 3[A7598YII^$6W$D<9"_P#.)K/K
MSTU]=3B DV'U 81*;0KQD1!J02S2J=&J52+@?G>B S,7=_$9=.7.B'5.OA,8
M/AP\BO1 9F+G=@EZ>5+CGJ3J*DAH^'T# 9B/>;=)))MR63U%4J.(/^T8#UI?
M9454N),C[#)1& _9*2?8HC](P&(R6^1L?M3MRE*)++:D),S63956HB+BKAW@
M(WQK=R!?]P(^+QW#4;ZG2120A:?L<9;WK2/CZT!,   _FI)=ID PN612N..W
M""A2=;S6DJ\?JB/L(!S]ZA=CKK,N-ZRA"FO#Q[>E1_8'#5]B;.OG4H IQ)L;
ML6\QK6LR-;^@R/29>N,R[/H )AVMPAB'?[#>Y9L<J!=8LAU3B-)Z&'FW#\X^
M!<"[0%\K9OEB.(XI=F&EL*DDB1*:2S+80LU<@B222K6M4< %>,_ZP+TJX)C6
M9%Y0V[$)/^9R]2.:I3A5/13SNP!%,_=G=#+CU-3,@:(TG&,GG'U<55X\.[S@
M&EY!;]QEI)=PNTXR2VHZ/)>XI[_7=P")W7WGC(W5FLR[#4=: -LP:^R+5)T-
M/.-DX^R9Z%::T,!V4VWS>/F;5Q<8,S\&II*M3B7?Y0EG]3V>M ;T9$9&1E4C
MX&1@(\Q?:>T8;GUSR['S3&MUVAJ8D6LBHAJ0;S;FMJG D*))U1]2?9PX%VNH
MXC?GP6X[]LVSO\%.5UV#0V8<UV2S9UHVQX4ACJG8@          B[J*^1O)/
M^X^_XX[K@OZRS^;\LNFXU^CO_E_-!TZ_(WC?_?O?\@.-?K+_ .7\L'!?T=G\
MWYI;YDN.VS*[%.QZ\-$];Y[1M.EPU),^*5I,^Q2544D^XR'68,UV&^+[=\.R
MSX;<UDV7;I5CVBR&Y;-[CW#:W*W--GN$@D19*JI:3)61$P^BOU#Z=*5>15*T
MTF/9<2PVZ[31J,?M1&WHY8\3QW#<UVBU$Z?)[,SLZ>2?&MB/#/<*N]2_RC8)
M_<>^T#VG OT^7[<CQG'/U&+[<JT0\6]F    CW;+;#]7,G(I'PK\)?#TI,O3
MX?P_)TFX>FO-<U?RG;P[!VNOU_Q461U>KU(IOK7=X(=5H-!\--\];K=>:[J4
MW^&4A#JG:@"L74-/DYQN%BVT]K<.A.MO3]!D9)>EG0E*+_LF24YZ2Q[+@MD:
M?3Y-1=XO%ZYV>)XWC-\ZC46:>WQ^/U1M\:RT*''M\./ B()J)%:0PPV78EMI
M))21>D1#Q]UTW3,SOE["VV+8B(W0P>?8LSFF'7C&72+5/CJ3'4KL1(1Y[*C]
M!+B4F8Y.CU$X,UN3FGS<OF<;6:>,^&['SQY^3SH5Z5<L>5;[QM]<S-$VT.JE
MPVE^N2RXO0^W3NT.T5Z:S'HOJ'3QUK<UNZ[9/W>6/0\]]/ZB>K=ANWV[8^_S
M^EY.F7]-=P_Y]OWQ(&^/=SAZ/NA\^!=]FZ?OE8B^V2VY)9YMBN[)/VV>TIB0
MV?;I5WD?<I)^<D^XRJ/*8<MV*^+[9I,/5Y<5N6R;+ML2H/F6+W[ \M9PFZO+
M=M\":<NUJ45&W&I:FT\Y!=QK2T@EE7@I-.X?J&EU&/48IRV[YBD^*NSSOS'5
M:?)I\L8KMT36/'3;YEU]T\.7G>"7?'(^DI[[:78"E'0BDL*)QLC,^PE&G09]
MQ&/SKA^I^'SVWSNY>B7Z'Q#3?$8+K(W\G3")-G][\<QO&6L)W">=L=\L&J(D
MY+#II<90H]"3)M"C2M!>8:5%Q(B,C.IT[WB7"LF7+[W#^.V_;LF'1\-XKCQ8
M_=9OP76;-L2P]VNI=0NZUBA6!AU>"8NKQ$V<ZA3:7"4M*W.!T-/-Y:&VTGYW
M:JE*T^^/'\MTMTWS_F9-T?;FWSY''R9/F6JMBR/\O'OG[<^Z$H=0&"3,YP%U
MNU-&]>;2Z5PB,I*JW4H2I+K2>\S-"C4DB[5)(ATW!M7&GS_B]F[9/W2[KC&D
MG48/P^U;MC[VOX!U%X.YBT2-F,]=IR*W,IC3F76'G.<MA.CF-FTA7KJ5-)T,
ME5*E.(Y6LX)GC+,XHZUMTUC;#B:/C6"<41EGJW6Q2=DM:PY<O>O>HMQ$1'6,
M,QA"6;>M\M)N.-$HVD\.&OF.*>415TD1)/M*O,U,1H-%[BM<F3?]_FV.)IIG
M7:WWU*66;ON\^U]^I[<Z;:BC[?620<9R<R4B]24&9+*.M1DADC+B6K2:ETXZ
M:%V&8SP'06WUS7Q6GL]//ZFN/:^ZRF&R:5]KHYO6Q^V^\&R.VME3;;1%NCD]
MXDG<KDN*USI+J>\_LWFH*IZ$%P+T3J9_77<-UNJOZUTVTY(KN\SY:'B6BTMG
M5MBZO+--_G27BO4+@689!"QNTMW!-QGJ4A@WV$(;JA"EGJ43JC+@D^X=/J.#
M9\&.;[NK2/#^QW&GXS@SY(LMZU9\'[6E[PS\SVYW+L^Y$:1/G82YRV[A;VWG
M51FE)0;+B#:,^6G6A6MLSX<RI]H[#AEF'5::[!,1&3DFFWGW[^GP.NXE?FTV
MIMSQ,SCY8KLYMV[H\+;YG4GM5'LYW./<W94LT:F[6B.\F2;E/6&:D$A/'M5K
MIY*C@6\#U4W]6;:1SUBCGW<<TL6=:+JSS4FK4MA,;ON19=?=Y<DC*A_"YNMV
MF,LC*J'U)4;B=1$9H0A*6D*^JX^0<_C&?'BPVZ6R:]7?]O/+@\(P7Y<MVJOB
MG6W?;S0L2/)O5@
M     *?=:'X;Q/W)+]L; ;GTV_ABZ>X6O;$@+'
M
M
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M$J4;6M9$DS*0^@ZERR,!8>+%;ALDPU4T$9F6KB?'B ^P
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M^ GQC=))<LEV^135Z/$!'F9=;6:9%C]TQM$BWKMMRC+CN)*"ZA9\PJ'11KX
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M?TDX5N#AT3*T9[ 9@KF.03@$P\T]K)I+_,KRG%TIJ3V@JR0(
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M1%HH1^B0YDZ[43%)R74Z9<.-#IXFL66UZ(;21$14+@1#A.:
M                                        *B=94=3][Q0R,RI%E]A5
M_P (V T'9WJ2QW&+G<3FNVF-6.ADCDW%IBIH652\ZG'AV );5UD8D2C(IEA,
MB/@?PNQZH#^?/(Q+[LL/Y78]4 ^>1B7W98?RNQZH!\\C$ONRP_E=CU0#YY&)
M?=EA_*['J@'SR,2^[+#^5V/5 /GD8E]V6'\KL>J ?/(Q+[LL/Y78]4 ^>1B7
MW98?RNQZH!\\C$ONRP_E=CU0#YY&)?=EA_*['J@'SR,2^[+#^5V/5 /GD8E]
MV6'\KL>J ?/(Q+[LL/Y78]4 ^>1B7W98?RNQZH!\\C$ONRP_E=CU0#YY&)?=
MEA_*['J@'SR,2^[+#^5V/5 /GD8E]V6'\KL>J ?/(Q+[LL/Y78]4 ^>1B7W9
M8?RNQZH!\\C$ONRP_E=CU0#YY&)?=EA_*['J@'SR,2^[+#^5V/5 /GD8E]V6
M'\KL>J ?/(Q+[LL/Y78]4 ^>1B7W98?RNQZH!\\C$ONRP_E=CU0#YY&)?=EA
M_*['J@'SR,2^[+#^5V/5 /GD8E]V6'\KL>J ?/(Q+[LL/Y78]4 ^>1B7W98?
MRNQZH!\\C$ONRP_E=CU0#YY&)?=EA_*['J@'SR,2^[+#^5V/5 /GD8E]V6'\
MKL>J ?/(Q+[LL/Y78]4 ^>1B7W98?RNQZH!\\C$ONRP_E=CU0#YY&)?=EA_*
M['J@'SR,2^[+#^5V/5 /GD8E]V6'\KL>J ?/(Q+[LL/Y78]4 ^>1B7W98?RN
MQZH!\\C$ONRP_E=CU0#YY&)?=EA_*['J@'SR,2^[+#^5V/5 /GD8E]V6'\KL
M>J ?/(Q+[LL/Y78]4 ^>1B7W98?RNQZH!\\C$ONRP_E=CU0#YY&)?=EA_*['
MJ@'SR,2^[+#^5V/5 /GD8E]V6'\KL>J ?/(Q+[LL/Y78]4 ^>1B7W98?RNQZ
MH!\\C$ONRP_E=CU0#YY&)?=EA_*['J@'SR,2^[+#^5V/5 /GD8E]V6'\KL>J
M ?/(Q+[LL/Y78]4 ^>1B7W98?RNQZH!\\C$ONRP_E=CU0#YY&)?=EA_*['J@
M'SR,2^[+#^5V/5 /GD8E]V6'\KL>J ?/(Q+[LL/Y78]4 ^>1B7W98?RNQZH!
M\\C$ONRP_E=CU0#YY&)?=EA_*['J@'SR,2^[+#^5V/5 /GD8E]V6'\KL>J ?
M/(Q+[LL/Y78]4 ^>1B7W98?RNQZH!\\C$ONRP_E=CU0#YY&)?=EA_*['J@'S
MR,2^[+#^5V/5 /GD8E]V6'\KL>J ?/(Q+[LL/Y78]4 ^>1B7W98?RNQZH!\\
MC$ONRP_E=CU0#YY&)?=EA_*['J@'SR,2^[+#^5V/5 /GD8E]V6'\KL>J ?/(
MQ+[LL/Y78]4 ^>1B7W98?RNQZH!\\C$ONRP_E=CU0#YY&)?=EA_*['J@'SR,
M2^[+#^5V/5 /GD8E]V6'\KL>J ?/(Q+[LL/Y78]4 ^>1B7W98?RNQZH!\\C$
MONRP_E=CU0'UA]8.*RY;<4I=C^R'2J;LP9\"KV5 3=MWG,#<&PKOEN=C.L-R
M5Q35#?3);U-I0HR-:.%:++@ VP
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MC^E1ZH!\)VW[L8_I4>J ?"=M^[&/Z5'J@'PG;?NQC^E1ZH!\)VW[L8_I4>J
M?"=M^[&/Z5'J@'PG;?NQC^E1ZH!\)VW[L8_I4>J ?"=M^[&/Z5'J@'PG;?NQ
MC^E1ZH!\)VW[L8_I4>J ?"=M^[&/Z5'J@'PG;?NQC^E1ZH!\)VW[L8_I4>J
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MEV9BI,/Q6B5Z[0MM-:>6A@/2S)CR*\AU#NFFK0HE4KV5H8#Z@
M
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M,D?#LOM\OAHH"R8
M YD=:Z7D[\7(W5DI"K? -E)%32CDT,C\OG$H_H@W"[O3$MA>PN#JCITME!4D
MRI3STONDL_HJ(S!F5&>LWY?[_P"YK=[S:!J%[.FSY"L%^+$?7K!F4J B!^KW
M/\CVUV:E91BSK3-V;N$*.E;[:7D:'EJ)7FJX=P#F;EG4+N1FL)R!?I$1V.ZX
MEY9-QDM'K1V'5)^B Q6);QYKA%YCWZP.QVKE%2XEEQQ@G4D3J#0JJ5'0^"C
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M=-@KBK-)FDH3:3JDZEQ+CV@(GR+++OE$Z5<+JIM4F6I*WC;1H*J2(BH5>'8
MP8#+X_DMSQJXQ[I;#04J+KY1N)UI^R(4A52])1@);LO5MO)8+<BUVR;!;AMF
MI24*A-K.JSU'Q54^T!KV9]0.XV>P9UOR*1$=8N*$-R3:C):4:6S2::&D^'K2
M 1< R5FOL^Q38\^ :"?C+YC6M.HM7HD WMO?G/VXRXJ78G)7747ARKQX'QJ
MQ,S=;+)VKQ"HYZTF@Z-4\TZ^CZ(#79V0W&X5\0:/.0;9Z4T\TZ^CZ(#%
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M,4\5XWF5T]M>4F@"V8
M
M      #^&1'VE4!_-"/8E]( T(]B7T@#0CV)?2 -"/8E]( T(]B7T@#0CV)?
M2 :[F.E,./YI']E[R_<F H+T[K0KK7R-*3*OPED_FEW?97P'1TT),ZFDC/T@
M'\T(]B7T@#0CV)?2 -"/8E]( T(]B7T@#0CV)?2 -"/8E]( T(]B7T@#0CV)
M?2 -"/8E]( T(]B7T@#0CV)?2 -"/8E]( T(]B7T@#0CV)?2 ?TD)+L21?0
M49ZZ%I/:M1$DB,L@C\2[?Y.2"LETB*2<# 4T*O@W_3_T=\$73T(/M27T@#0C
MV)?2 -"/8E]( T(]B7T@#0CV)?2 -"/8E]( T(]B7T@#0CV)?2 -"/8E]( T
M(]B7T@#0CV)?2 -"/8E]( T(]B7T@#0CV)?2 -"/8E](!_20@NQ)?2 4]ZQ5
MH+;3(R,DE2XQN/\ WE(*D[HY-*NF_"Z4-)_"GI?A:8")ST(]B7T@#0CV)?2
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M91*V:G&DZE\/3.SW-% 6:
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MQVVYQ(DJ(^U,-QB1%:?;,T1G5%5"R,CH9 +K.=.FW*UFHK):4D?U)6F)0O[
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ME&?ZRZ__ )B_^L0%[
M
M               !BKY:W;HPTTT:"-"]1ZS,B[#+N(P%<ML>F3)<'WZNFZ\V
M1:5VJ=*NTA#<9Z2N9IN2W%(U(6PA%2U^=1?I5 6B
M 5ZZ@M@LAW;Q+\W[+(MK,@[DW/-5P=D-M<M"'4F56F73U5<+NIZ(#V;*;&7[
M;2/CC5U?M[J[,RZR\<)U]PC-QMQ!:.:TW4O/+MH GD
M  !"&]^RMYW/Q:Z6*V.P&WYTIJ0A4UQ]MO2VZ3AZC::<.M"[B ;;L?@$_:_:
MZPX+<UQG)UJ\7S5PEN.1S\3-?DEH4ZAM1\'2K5)<:@)"
M   !B,CM3MYMIPF302S6E=7#,DT37V)&8"I<_H_S*7O6]N8F79/@MR5X@FU2
M)A2]/AN3324;16O[OL 6GP;')&+6)-JDJ:4Z3KCM6#4I%%T[UI2?=Y &R
M                 Q.1VMV\VIR R:"<6I"B-PS)/FJKVI(S 5T<Z9<D7OI:
M]T_$6KX,@RH<E;9O2O&:8K24'I1R-%:IX56 M"                     A
MO>/9^[[CVJ^P+<[";7=4,):.8X\VDN2;1GKY;:S+^3.E*@/;T][673:#!9&+
M79R([*>N+\\E6]QUUG0ZTRV1&;S;:M56SKYM $K@
M                         #2=U=KL:W=Q&1B62H4EI2B?@SFJ<^)*01DA
MUNO#L,TJ2?!23,O1 42OW0QO';K@MBS/6N\V_51F6B2<5>CN-QIY):3\I)4O
MTS!NJ9=@.C5W",@AYMN3,C3[M;E$_:[+"-3D=F0GBAUYU:4ZU(/BE"4Z250]
M1]@),K? R  #"7S#\6R:.J)D-GB7.*M9.K9E-)=2:T]BC)1'Q*H#P63;3;[&
MI[5TL&-6ZVW%@E$S*BQVVG$$XDTJ(E)(C*I&9& VH
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M242B.M-)4](!\+!M[@V*H8:QO'H%J;C*4N.F(PADD*74U&G214,ZF V4
M                    !AKGB6,WI!HNUIBS4&YSC2^TE9<SB6KB7;YQ@/M;
M,>L5F42K3;V(:DM\DC8;2BC94\WAW>:0#)@                       &5
M>!]@#!WG#,4R%;3E]LT2X+8(TLJDLI<-!*H9D6HN%: /-B6WN#8'XS\R\>@6
M'X0Y?CO@]A$?G<C7R]>@BKIYBZ5\I@-E
M
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MK>/LUF_YELXI\/N(AL2Y$OX1\%RW)!KHUH\*_6B"2K5J^J[.'$L0C7_YAO\
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M%F9:J=NGC0$E<0&0
M   'QD2HL1)+E/ML(4=$J=6E!&?D(U&0#[$9&1&1U(^PP
M
M  !C;[D-AQ>W.7?)+G%M-K:.BYDYY$=HE&1F2=3AD1F=.!=I@(\A]2NQ,^:5
MO8SFW)D&>DE/&['9K6G\LZA#?_6!:)0C28\R.U+B/(D17T)<8?:42VUH654J
M2I)F1D9<2,@1]0&A9=O7M1@DQ5MRK+($"Y(IS(7,-^0BO9K:8)Q::_NB(%HR
M>&[E8#N"TXYAF0PKR;226\Q&=(Y#:3I13C*J.((S.E5)($;4
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MZ4:1:)JTLHR&.TF,]&<6=$JD-MT;4U7UQH2DT]OG=@),+VD9&1&1U(^PP9
M
M                                                  4QZJ.I_-\)
MRFX[7X4PU:WF6&%2<@J;LPRE-)=TQTF1):,B5IU'J5WITF#40ICEV+9;C$J"
M[F,21#N5^B%>F"F&9R78\EYULGG249K)2UM+/S_.,O.[R!ITMZ0?^7;#?]I_
M[UE@Q+)=1VV^9[K;=*PW#)\. _)F,/W$[@MUMIZ+'U+)HE--.F1F[RU\2^I
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M>*5%7O[#(&6P
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M"PO9TY91(S#9+#+U+<-V9X'P4AQ1U6IRW.KAFI1^57)U'Z8,RE$$
M
M                                          !IBMI]OGLWD[C3+''F
MYC))E)7*61R#9*.VEMODH<,T-J(D^O0DE>B HYU\_+#9/^&HOO\ G@U"T_2#
M_P NV&_[3_WK+!)3>"(<ZF+CN1 VX0C:MBXO97,N,:.E=H:4](:CZ'77%JTH
M5I1]C))J.A5415J=#+#G+*B3;-N,R]O];K^\;CB9%Y8>4IJZR6NPC)R5ZY)Z
M=-2452X)47:1IU3VWR+#,HPFSW3;]QH\3\.B/;V&4\LHZ(Y$WR%-]J%-TTFD
M_P"UQ!AR9=2=QW/6B02F#EWXR=2KBILW9G$CKWE4&W9 &'&VQJ4C<NVK0HTK
M3?6#2HCH9&4Q-#(P;=D@8        :9A>T^WVW\B7/Q:QQXEUGN./3;FLC>F
M.K>4:UU><-2B29G70DR3Z #EUO[\M>??'D[VY0-PZU67\#V_W,S[6D&'N 56
MZMI6^<FYV.Q[21[]\&*@R7KR_8VWDH6IQQ)(0IYI)&2R2VJB4KK179QXEA4S
M8JZ;;87N8S-WGMMQYUODI\.A:/L,2<A9U<G,+(G5<M5%43V&7%*NP&I=4TSH
M[]O3<X2BF17&2DQUQS)PGFU)UI-LTU)6HO6T[08<I&=BM\<MS54-[#[I"O%W
MDO2G)L^,[$AH4M9NN.*DN))NB357S5&9]A$9F1 W5MFX?1QNEM[BLG+79-MO
M4&W-F_<V+8X^I]AE)56Z27F6]:$=JC+B1<=-*T%4E=&F_P#?EY!&VBRV8Y<+
M;.;<_-R7(4;CT=YA!NG&-:C,S:4A*M!'ZU1$DN!T(DPO<#(          -,@
M[3[?0,RN&X+=CCO9E<W$O/W:21R'4*;;2VGDDX:DM42DBJV23/O,P% .MOY=
M9GQ9 ^L4#<+O=-GR%8+\6(^O6#,OMOON];=FL#EY$]H>OLFL2P0%?X>:M)T-
M1%_@VR\]P_(6FM5$!$*<])^T=QW;SZ9NOG.N=9+3,5+<>DEJ^$;RM7-HJO T
MM&HG7.ZNA-#(S!90WO[\M>??'D[VY0+#KI(<6S'=>;;-U;:%+2TGURS25227
MHGV PX[[2LIE[K8-'<6:4OY#:6UK[R)<UHC/CZ8-NOUZ_ ]P]S/>UJ!AR)V6
M4I&\6WQH4:3_ #DLY5(Z<%3F2,OHD= ;EV$!@         4@_:&__>X_VW_]
M7@U#>.@;Y'KW_P 2RO>$ $E(G4EO,C9O '+A!,E99>#7"L#2DZDI>TU<?61\
M#2RD]5#[5&DNPS B%/.DZPX'.S23N=NGE=H@JM$@W;7"O-RBL2I5T<^R'*6B
M0Z2S2UJU)49><X=2/S#!J6.ZS<CQ[*=WF+GC-WA7JW%9XC)S+;):EL$ZAU\U
M(YC*E)U$1E4J]X$+B=,^=81(VJP;$V,EM3N5%;^6=C1.CJN!+;YCBT^')?,J
ME"349:>!%7L!F6O[[])Y[T9:>8)RY=IEHB,PF83D$I3*6V-:J$HGVE%J4LU=
MA@1+*8_T;;&6BPMVJZ65V]W$VR3*O$J5):?6Y3BI"&'4(;(C]:24^F:NT"JA
MN\V!R-E-V;CCMEFO<JV/,3['<*Z)"6G4I?9/4FGGMF>@U%2IIKP[ :AU$VNR
MMW.-NL7RV30IEWML:3,)):4E)4V1/$DO)S"53T 8;:          ./.9_+#D
M/_$LSW^L&W88&$!]0/306^EUMEV/*%V-RU1516(W@RF-*4MPW%+/[,R9&?!/
MT 6)>+">C'9K';$U!R:VKRB]K1_GMTDOR(R369<29:CNH2VDOJ:ZE_N@*J7]
M2NTD+9G<H[+87G56&X16KK:>:HU.LH<<6VIHW.&HT+:5I/MTFFM3XF:A:+)<
MQN.XO0Q,R&Y25*O!P8\:X2#KK==MUU:84I1]YNI:)2C+V1^D"<J"^AQYMK?
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M%+@LKDMNEY%$VVXCT2/T"!9=( 8
M             !SZZ_[N^]N%BU@49^&@V94YM/<2YTIUI9]ODBI!J$^=$UN8
MA;$0)+)$3EQN,^5(,BI5Q+OAR,_[EE()*K'6[;8T#?.3)8227+E:X,N29%2K
MB27'J?E/2RD&H75Z8+P]?=A,'FOJ-:VH2X!&KMT6Z0[#07I$EDB(&92V"
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M8/=-Q]^.@DI]!
M
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MC47%)MNAN69Z6[*.Z.OM)4F2EI*='(8?J9:#K6@$2K7\P;>'\=XU]]3_ /4
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M#5OV?V(2%7'+<]>;-,5MAJQPW3+@XMU:9,@B/]P3;%?WP$KT R
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M(?D2*>9SYS+D1IJOE4EQQ?I(,&I=)P8
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M%V.F3''L7V*PRW26S;DOPU7%TE<%?^)/.2TZN!<20ZDN/92@,REH$
M
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MM($5#W6Z&;'DMVDW[;F[MX\]+6IU^RRVE.02=69F9LK;/6TFOU&A9%]3I*A
MU5H%C_9_9@[-062Y;;(EN)1ZU6YJ1+>4@CX$1/)CI(S+T3IZ(%5S-M=L\3VH
MQEG%<0BFS"0HWI,AU6N3)D*(DJ>>70M2C(B+@1$1<"(BX RV\
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M.]%FU]PP3;F7D=\C*B7G+GFY2&'"-+B+='091M:3XD:S<<<_>J3W@S*RP(
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MI#+*$MLMI)#;:")*4I25"(B+@1$0,OV
M
M
M
M
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M),-Q.SX+BUJQ"PMFU:;1'3&CDHZK5IXJ6L^%5+49K4?E,P89P
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MF0$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M            &J;E9S$VVP>\9O.B.3HMG;;=<BLJ2AQ9..H:(B-7 J&NH"L_
M_P P/#_ZG7/[XC^H#5']3^T"PPU))>'W,D5+49/QS,B[Z%PK],"B6MKNJ/:G
M=2<U9;7,?M&1/\&+3=T)8<>5WI9<0MQM9^1.O69?4]M"430"
M                   ^,J5%@QG9DU]N-#80;C\AY:6VVT)*IJ4I1D1$1=IF
M UG!MR</W(1=I&&SRN<"SR_@^3.;291UODVEQ7*4JFM)$HO/(M)_4F9<0&V
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M<N]1+3995I596X[KJI3C;A.%)4XDB3H[*<OO F$T @
M
M
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MJJ&!-&AY1N!U$,[F7J'"O.4HLS=]E-1FFCF>'**F8I*$IH5-&BE.Z@*Z8 P
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M_=<LO.SEGN&;2)LK(7'YI2'KGS#E&E,IQ*-7-\ZA)(J>@"2F($
M
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M)Q1^Q09J] "B4@0
M
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MML#(
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MAU(VBR:5F.U^(Y-/7S+A<K5%=G.\2UR2;)+RJ&1=JR4?J@PW0
M
M
M !R5ZD_EUSKXS7]8@&X=0-LODVP[XCMGO1H&&?NCC#5LFNR4ZXR&'5/(U:=2
M$H,U%J[JEW@./&UZ5+W+PQ"$FI:K[;"2DBJ9F<QJA$0-NJ^Z>UV";HV1F#GS
M3B[9;%KF,O(E.Q$LKT&E3BC0M*#HFO%PCIQ\I@R@[#]QNE+IQ@W*SXKD2KO/
MEOF],D14'=)3FE))2T4IAIMDVT4\Q/,[3,^\P-LJM]3&[V&[R9;;\@Q*S2;:
M<2*J),ES29;>ED2]3:E(9-9%H(U%4UF9D9=E :A<SHN<>?V"M+4A'V%N9<&V
M*D=%-'(4H^VI'YRE$#,J,[L8Q/V2WNN4.T$<<K+<VKOCSG&A1E+3*BT/A71P
M;49?5),&E_MZ-V85LZ=KAN!9WM"\CM;#5E,E$:TO7ALD)H?#SVDK6L_WA^D#
M,*D=$& _G/NH[EDIO7;<1C')29E5)SIA*98(ZE3@GFN%Y%((%EZ>NG%[W;]U
MHV426W%V*\V]AJ#*I5I#T34AUBI$5%%4G*'[/Z0AG-J^N)[$<>M.*97B;<NW
MVF,U"8GVETH[O)822$FJ.XDT*49%YQI<01GW<0*-YQ-_HQWHS21?), XF8WI
MU+AVB\N/VYI<@TDG[&EAXHRUK,JFGF*-2CKIJ8&U;^+%8@Q6(45'+C1FT,LM
MU,]+;:22DJG4^!%W@R^P#2MSMLL*W2L*+/G3#CUIA.G-;4W)=B$TZAM2.:9M
MK2D]*5*]>1D0"!\/SKI/Z;FKK QG(SNMTGO<R4_'2=UDFA"2)+"),=E#)-I,
MM1)-SURCJ?D+ME67J>WFPK>?([3=\1LTJWNV]EZ--GSDLMO2T*4@V:H:4NA-
MT70U+.I*["H#40MCT3ME<=A_!7*.A^"5UG-(9>02VW&CY2SJE=2,M:E=P,RJ
MUUG6^!;-[I<6VQ68<4K=!43,=M+3>HT*J>E!$53!J%X]@<=Q].T6!7--JAE<
MO@:$[XPH[1/\PV2JKF:=5?1J#,JA]=UJM=IW$QMFU0H\%E=E):VXK2&4J5XM
M\JF2"(C.A L+*=(M@L3VPN&75VV1'+H2KBLIJF&U2-2+I+))\PTZJD1$1<02
M5+^K3)IF2;[9*F0X:HUG4S:8+9G4FVHS:361>FZIQ?T0:A9O:;J(Z:=M,!L^
M*0+DY'D,Q6CNSB;9*-<B:I!&^XXHFO/,UFJE3.B:$7 @2BH>^UUV\NVYMPO^
MU+AHQN>EF6EMMAR&EB894>)MM:4&DC4GF%0J$:N'8"POSD>3/YETCW')YB^9
M.N6'K>FN4IJE>$TO'Q\KA*!GE4'Z>\'M^XN\&,8M=V^=9WWW9-P:XD2V(3#D
ME3:C*AT<-LFSI[(&I=1X&VFWEIND"]VG%K5;KM:R<3 FPH;,9UI+S9LK(E-)
M2=#0HTT,&&T@/+/MMNNC'AKG$9FQB42R9DMH>1J*I$>E9&52J Y&[ZQX\3>3
M.HT5I#$9J]34-,M))"$))Y1$24IH1$7H W#K5 QW'[6_XFV6J'"DFDT&]&CM
M,KTG0S+4A)'0Z PY%YG\L.0_\2S/?ZP;=,NI/Y"LZ^+%_7H!F'.[IKP.V;C;
MQ8_CU\9*18T&].N,<ZZ76HC2G4MJI3S5K)"5?N3,&I=/K?MQ@%HNT2^V?&+7
M;;Q!0XU%F08;,5U#;R="TU92FI&7"A@PY<[K6[(]LM]+W*N,<EW6#?7+Y 7,
M;)QB4TN4<MAU2:)2M#A4UD7"NI/:1@VLOCO7MCMSA*MNXV&.DR^@V9B[8XW+
M8=0LM*R./)Y=$F1G5)NJX E&Z[%XCTD9!=8][VT91(RVWN^.9CSY,Q%PC*;5
MJ)2([SA(4E!T\Y"5%W&8)-6Z=5MJM;^QV8W-^%'<N3$2.AB8MI"GT)\8SP2X
M9:B+SC[#[S A4OH6MEMNV[=YCW2&Q.CIQR4XEJ2TAY!+*=!(E$E9&5:&95!9
M=&XD2) CHB06&XT5HC)MAE"6VTD9U.B4D1%Q,&7V 4"Z_LGER,TQ?#DN'\'V
M^V*NBFTGP.1-?<9\XB[THCEIKV$H_*#4)BZ)]O\ 'K/M-!SE,-ES),B?EK<N
M*TDI]N/%D.1$LH4952FK2EF2>TU<>PJ$EL&]'2OB&\61V_)79R[!/9;<:NKD
M&.VIR<1FDVE+4I1$2VZ*+4:5&HC(OJ2 B7\RO&HG3MTUY7:L3N4Z4U B2/ 2
MK@XTM]AZZ.)8,VS:;:2DDN.FXDJ&>H^TP-ZA.PMRVWLNY-NO>Z:JXQ;4.R4L
M*CKEMO3$D1,I<;0E1FDC/7Q*E4D1\ :E;S=OJ(Z:MR]O[SBLVY.2)3T1X[.X
MNV2B5'G);,V'&U&UYE%DFM#*J:D? P2BOG1?E,JP;XVRU(=-,#(XTJWS&^)I
M4;;*Y+1F1=Y+9))'W:C[J@LI,_:$?AC _<UR]LC@D)4Z%?D4D?'DWVF."2IY
MU4?+_FWNF/[S8!J'3+;+Y-L.^([9[T:!AM0"LW75\BD?X\A>TR 6$5_L]_PQ
MGGN:V^V2 66D==7RUQ_B.%[=(!86>Z-,)LF/;,VC(XT5HK_D9R95QG$DC=4V
MW)<99:UF5="4-I/3V:C48,RJ)UD6:W6;?:\_!L=$9$^-$G2&VDDA!R'FB)Q=
M$D156:=:C[U&9GV@U"Y?21@]DQ;9FP7:%$0B]9"RJX72<:"YSIN.*Y2#52NA
M""224]G:?:9@S*C/519[=8M_<SM]JCHBPS>B229;224$[,@QY+ID1$1%J<<4
MKZ(-0Z-[=R'9>QV*2I"M;[^*6YUU?E6NVMJ,_HF8,N6>U&)QLZW)Q?$IRC1
MNUQ88F&DS)7A]6ITDF789H)1$?E!IUR8P[%(V.?F@Q982,7Y7ASM!,-^$-HR
MH:3;II.O>9\>\&')_>'%6]L-WLCQRQ.K8CV:X$]:G$J43K+3A(DQR)9^=J;2
MM):N^E0;7]WSOBLGZ3KIDJZ:[S8[5<5:2,DUEN17CH1\2+S@9C>JST*_+7(^
M(YOMT<&I7)WHV9VDW#9;R7<QU=O3:8YQTW<[@J"RPPI9KX\Q1L$>H_7*14^P
MS.A4,Q*-<?Z@>F'8S%F,.PZZ2+O'@FHW?@Z*I^3)>69FIUV0M$=EQ9]FHETI
M0BX$0%)4GWKSC'=Q]Q[MF6,6ERS6VY<I2HCO+UJ>;;)"W32UYJ3<TZE$1GYU
M3J=0:ATRVI=D/[!XBY*3I=/%H1<:U-*8*4H4=3/UR2(P9<N=L,:B9CN-BN+7
M"OP?=[K#B3-)F2CCNO))PB,N)&:*T,&G7E&*8RUCOYHMVF(G%^1X3X()E'A>
M12FCETTT!AR.L318]NW;6;>HR*U9&PB*I1F:B\-.22#,RIQ\T@;=..H6U6N9
ML]F\V7"COS8MDG'&DNM(6ZT9-*/S%J(S3Q\A@S"BO1C;X%SWNB1;E%9F13MT
MY1LR&TNMZB0FAZ5D95(&I=%LEP'$\LQ.9A%VMZ4XS.))2(,-2X23T.)=*AQC
M;,O/22C+L/OJ0,*[6)GI*Z;,HN-XB9&3V2N-E%3$-P[R["TJ/F):\,RHVEKJ
M1+YJZT30J55J+ME"O5)U$[<;R6.W6/%K--^$K9,3);OLUMEC[#RW$+90E*G%
MFA9J2H]6GBDN +$)!_9[N/.6_<&,XBL-+MJ4@S(S(UN)F$LN/#L2@"4:]=-L
MMMIW;LT>UPV(,=6.17%-1FD,H-9SIQ&HTH(BK0B*H$+7]+%@L2MC\)NJK9$.
MZ>'?7XTV&SD:BEOD1\S3JK3AV@DJT]?WRDXS\1E[[?!86!Z1)S-LZ;[7<I%?
M#PUW60[3B>AF4\M797N($E06RQ[KO3N]"8N\A?PCF-Y04Z2GSE-(E/5<-%2/
M@VW70781$1=@-.K-AVXP7&L>:Q:SX_ 8L3;1,JB*CMN)=214,WC6DS<4KZI2
MZFH^T&'-SJPVPLVU^ZSD'&V"B8_>H;5VAPTUY<=3KCC3K2#.OFDMHUI3]22B
M(N! W"[6T.83<YZ9(E]NCIO70K)<(,QU5=2W(!/1B6HS[5+2VE:C\I@SRN=.
MSV*P,WW1Q/%;J1JM=RN+#4YM)FDUQTJUN((TT,M24FFI=E:@TZW2,3QF5C:\
M/>M,7\UW(YPSM*64)BDP94T);(B21%W4[.T&')/;92[/O!B7A5'KA9);TMJ5
MWDW.;+SJ4[2+B#;L*#
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M^,Y'O<@2#]GX1?F?F)]_PE&X_P#F# EX?VA'X'P/W3<O:XX$-EZ!6$)VFO\
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M\ 8<[NMOY=9GQ9 ^L4#<+O=-GR%8+\6(^O6#,I4!
M
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MN'BZ,7D+M,9WG\Q$9Z.;B"44DS=(Z*XDYYQ=X)RJ2]&7R_V#W-<?>;H-2Z@
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M4*+RD#/*HITK_+_A/NF1[S?!J75P&''G#/EAQ[_B6'[_ $ V[# P
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M^+$?7K!F4J @
M
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MJ4J!,M<ZDNES<#>+<-K+<9N5GB6Y%NCP3:N3\II_FLN.K4=&8KR=-%E3SOH
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M=W $5BVCZ-=S\"W)QO,;Q=K"_;+/,3)DM1)$Q;ZD$E140ER&VDSX]ZB!:KQ
MRH7\R7=7\_?SI^&,?^#_ (7^$^7XF;SN3XGG::>"TZM/=JI7O!JJ\&2V&#E6
M.W;&;H1G;KQ#?@2M--7*DMJ;4:3.M#(E5(_*#+GA?NAK>*WW5R+9'+;>+6:C
MY$\I)13T<3(W&G2(TJX4,DFLJGV@W59K >G*873Y(V;W(DQU2)$E^7%E6U:W
MO!K6M+S*DFZA%5(7JUI21)41FFO$S!FJMTCHNWYQ>]G(Q*X0WR:6I,6[P9ZX
M#Y-J(^*B42%H,RX*2E2O3,N(+5N\?H7RFZXQ>;GEN5-S]RYB&SM1K>?=@-+)
MU"G%2I#C2GG5*;)2"TH(DF=?/[A5(_2]T_[C['WR_NY+/L\RQ7R*RA:+;(E.
M/IE1'%&T9I>BLITZ772,]5:TX DR]/5)TW73>9=KR7$YD>/E%J87"=C334VS
M*BFLW4))Q*5:%H4I=*IHK5VIIQ$2A39_I%WFQ;<?&\KNZ;;;[?9+DQ,E&J8;
MKKD=ETN8EM+"%54M%=)+-)<?.\@+,I9ZG^FO.MZLML]^Q:X6F'#M]N*"\BYO
M26G3=Y[CM4DS&>(TT67:HO2!(E*_3_MS>]J=L+9A60R(LFZPGI;KKT!;CD<T
MR)"W4Z5.MM*J1*XU1V@2TC?[I6Q[>*6>3VB85AS<FTM/2S;YD68ALJ(*0A)D
MHEI(M*74\=/ R41)H(E5>7T/[XQY9QV6K5+9(S(I;,[2T9%V'1UM"^/[P&JI
MSV1Z*8.'W>+E6YDZ->[I#4EZ%98B5+M[;R>*5O+=2E3II/B2-"4U+CJ($F5J
M<@M[UVL-TM<=24R)T.1&:4X9D@EO-*0DU&1&=*GQH0,J;[+='NYFW.Y^.YK?
M+K8I%JM#SKLEF%(F+D*2Y'<:+0ER&VDSJLNU9< :F5V094+Q_HFW5M.>VO*9
M%XQ]5O@W>/<W6VY,TWC99DI>4E)'").K27 C52O>#55] 9
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M3#*$MMH3VT2E)$1%Z0#[ /%<[/:+W'\)>8$:XQ*UY$QEN0W4RIZUPE%V ,/
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MS >AMMMI"6FD$AM!40A)$E)$7<1%V /*FT6I*R<3!CDX1ZB632"42BXUK3M
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M(!YG[;;I3G-DQ&7G3*FMQM"U4+T3(P'W:::9;2TRA+;2"HE"")*2+T"(!^P
M
M
M                    !YKBW)>M\MF$X;,QQEQ$=TJ50ZI)DE1:B,N!\>)
M.7.9Y[U/[CPOS/RQ-^N,1Q:>9:&K1X0W5H,EI)Q$6,TIRAD2B2NO$J@WL62Z
M/^G3(,$FRMQL^A';[X\P<2R6ITR-]AIVANONDDST+41:$I/SB3JU%Q($F5O0
M9
M           !X[LVMVUSFFDFMQ<=U*$%Q,U*09$1>F YM;![-;KV#>/#KS>L
M-N\"U0[@EV5,D1'6VFD$A1:E*,J$7$&YETQ!@
M
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MRG2RTE+;::F=$I*A%4^/8"/V
M
M
M
M
M
M                                   #Q0+Q:KJY,9MLUF6[;WCC34,N
M)<-E])$9H7I,Z**O88Q;?;=6D[G(S:;+ABV;[9MB^*VUBE8YX>T;<<
M
M
M
M
M
M
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M>2;;;HOB)V716D^';M>L:?
M
M
M
M
M
M
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ML'3/Y;E4^G7Y8\;_ ._>\) \YP[]1;X_1+]L^M/]GS?R?^Y8OD/8OYF
M
M
M
M
M
M
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M\;_[][PD#SG#OU%OC]$OVSZT_P!GS?R?^Y8OD/8OYF
M
M
M
M
M
M
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M^6/&_P#OWO"0/.<._46^/T2_;/K3_9\W\G_N6+Y#V+^9@
M
M
M
M
M
M
M                                                    'FN$I4&!
M*FI:4^J,RX\EA!D2G#;2:M)&?"ITH HON'O3>^J]RS[0;;8]-MT"9,9E9!<)
M9H7RV&3[7";,TI:;,^89J5J6I*4I*O S5*+OX]8K=B]AMF.6EOE6RTQ68,1O
MO)J.@FTU/O.A<3[S!ED@$<[]?)'D_P#,,^^6AP=?W%WVY7K?I'_=L'3/Y;E4
M^G7Y8\;_ ._>\) \YP[]1;X_1+]L^M/]GS?R?^Y8OD/8OYF
M
M
M
M
M
M
M                                                        'X;9
M99-9M-I;-Q6MPTI))J4?>=.TP'[  $<[]?)'D_\ ,,^^6AP=?W%WVY7K?I'_
M ';!TS^6Y5/IU^6/&_\ OWO"0/.<._46^/T2_;/K3_9\W\G_ +EB^0]B_F8
M
M
M
M
M
M
M
M            8?*L:MV88_-QN[&XFW3TI0^;"B0Y1"TK+2HR41<4EW#Y9<<9
M+9MG=+G\/UV31:BW/CIUK-U=VZC1,0V P7"<BAY/9G)ZKE!YO(*0^A;7V9I;
M*M22;29^:LZ<>T</#H,>*^+K:UAZ;B7UAKM?I[L&6+.K?2M+9KLF+N?GA*8[
M%XH
M
M
M
M
M
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MR20NK:C2=2(S[R\HZO/@NPW]2[>[+!FMS6=:W<RP^#[@
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M&Q<,&0
M
M
M
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MZ,V+-LRE,&Q:\@FQ6+>G2:4J. 4A3JD5[4$<DD$9=Z3+N!J4>7?=O',7ZO\
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M $\>/TM_'4NT
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M-92?#4II?KDUX:T&I->%:@42 "
M
M
M
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MP<!<S&/T:LWN&-[2D?G.H[V[IGTOT'!W=O1'H94?!]P
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M5$7_ &.I/H@S1*8(H+ULDEK?+!I$HS=@_!L(EQB\B+E(-=#J7KB,B^@#4+]
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M0,O>
M
M
M
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M70+F8Q^C5F]PQO:4C\YU'>W=,^E^@X.[MZ(]#*CX/N
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MP&YS3M4&+!-WV7AF4M:NPNW3Y 994
M
M
M
M                                            'Q7%BK?1*6PVJ2V5
M$/*0DW$EQX$HRJ7:8#[  #XE%BID*EI8;*4LJ*?)"2<,N!4-5*]Q /L
M&1&1D95(^T@'QCQ8L1)HBL-L(4=5):0E!&?E,DD0#[  #5-R\%MNY6#7K"KI
M1+-TCJ;9?,JFS)1Y[+Q>BAQ*5>CV (JZ5<MN:L5G[2Y<DXV<[=/JM<J,X9ZG
M+?J,XSJ*D6I!%]C29%302%?5 LK  @  /XI*5I4A:24A1&2DF52,C[2,@'S8
MC1XJ.5%90RW6NAM)(34^^A$0#Z@/PZTT\VIIY"7&EE12%D2DF7HD8 TRTPVE
MEAM+32?6MH(DI+OX$7 !^P       0IU+N;P6S#X>2[.S)#=VL\@W+K BL-2
MG)$)Q/%2674.$LVUI2>E*:Z34?<8+#1K3UU;6+LZ7LBMMWMV0LH),VUM1FWB
M\07!:6G#=01D1_XS0?H 4:OL_:<OWVW^^<!?+,]8\)LS*F<?9E$9*D&EE;#*
M4&9)UDDW%O+<3YI+\TJ\05<=N+&9<<>990VZZ=77$))*EG^Z,BJ?T09?4
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M@
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M"3*QP(
M
M
M
M                                       /,FW6]$Y=S1$93<G$<IR8
M3:2?4V5#T&Y34:>!<*]P#T@                   QTFP6*9**=+MD21-3Z
MV2ZPVMTJ>1:DF?\ 9 9$       &.DV"Q3)13I=LB2)J?6R76&UNE3R+4DS_
M +(#(@/+(MMNER(\N7$9?E1#-45]UM"W&E'2IH4HC-)G0NP!Z@'AN]GMM]@K
MMMVCE)@N&E2V5&I)&:#)1<4F1\#(?7%ENQW=:V:2^>3%;DMZMT5AKGZJMO\
M\2-?TCWVP<SYEJ.UZ'#^7Z?L^EL=HL]ML4%%MM,<HT%LU*0RDU*(C69J/BHS
M/B9CAY<MV2[K7367,QXK<=O5MBD/</D^@
M                                  \LRVVZXDA-PAL2TMU-LGVT.DDS
M[::R.E:#=F2ZSV9F&+K+;O:B)>3\V,:_$T'[V9_BCZ?$9>U/EE\_<8^S'DAD
MVVT-(2TTDD-H(DH0DB)*4D5"(B+L(A\9FK[1%'Z$4
M          4LZA-N<\R'J8P_)K'CEPN&/P_@7Q5SC1UN1V_#SUN.:EI*A:$G
MJ5Y"!J%TP9
M
M
M
M
M
M
M
M
M
M
I                                                   '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm2225088d1-pht_ration4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-pht_ration4c.jpg
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M @   @ " #A"24T$)0      $/SA'XG(M\EX+S1B- =8=^O_[@ .061O8F4
M9,     !_]L A  $ P,# P,$ P,$!@0#! 8'!00$!0<(!@8'!@8("@@)"0D)
M" H*# P,# P*# P-#0P,$1$1$1$4%!04%!04%!04 00%!0@'" \*"@\4#@X.
M%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!3_P  1" 34!AT# 1$  A$! Q$!_\0 \0 !  (" P$!
M  8'!0@" P0!"0$!  (# 0$               0% @,& 0<0  $# P("! 8'
M#PX("@8 %P$  @,1! 4&!R$2,4$3"%%A<2(R%(&14I)3%1>AL=%"8G(CL]-T
M=18V-QC!@J*R,W,DE*2TU#56=M)#DS15E5<)X<)CPU2%M=66.(.C1(0EMN+$
MQ48G1QGP\45W.>/DI29FAJ9(9&4H$0$  @$" @8'!P,"!00" @,  0(#$00Q
M!2%!46$2$W&!D:'1,A7PL<$B4C,4X4(T<@;Q8H*2([)#4R2BPD06TN+R_]H
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M(" @(" @(" @("#\TMN_ZZG^]7_;(U].EPN?Y?6LQ>((@(" @(" @(" @("
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ML1 0$! 0$! 0$! 0$! 0$'YI;=_UU/\ >K_MD:^G2X7/\OK68O$$0$! 0$!
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MKYME^>WIEW%/ECT,LM3,0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M+;O^NI_O5_VR-?3I<+G^7UK,7B"("#<+_P"LG_JK_P"EU\]_]_\ ZOQ?0/\
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MM:.,1+GMM2+Y:UGA,KKS^Q>&FBLXM.OEMIGW+1>W%Q)VK66O9O+BUG"KN8,
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M/6UKSRGV10KNMO?QXZV[8AQ.XIX,EJ]DRQ2WM"1:!_+7 ??]O]L"B;W]B_\
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M81;?:21VM(XW/)C990\C220WF<\F@ZJJ;R>/_!ZY0N;S_P":/0\^S^LOQ;U
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M\*L_G(77W_8G_3^#E:_Y$?ZOQ;0ZWTZ[56E\AA8W!EQ.P.MWNX-$T3@]E3U
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M9U];G\V:,NZBT</%$+BWI_("^_?K?[:U<[RG_(CT3]R_YI_CSZOO:OKMW%B
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M+N*?+'H99:F8@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MO\^LOWIW[9>PF[?A+]$-+_DSA?O&U^TM7S;+\]O3+N*?+'H99:F8@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M'I?\F<+]XVOVEJ^;9?GMZ9=K3Y8]#++4S$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$!!H]WLG!FZ]LX]#<7:$^Q+,NTY-^QZY_!SW,/W/4B7RB87
MX"Z]Y']T5UHH/(MW'RB87X"Z]Y']T30\BW<?*)A?@+KWD?W1-#R+=Q\HF%^
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M]7NK\&O^%A[/?)^C7LI_9C^7Y'^DI]4W/ZO=7X'\+#V>^3]&O93^S'\OR/\
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M[C6,^8\\O*Y!L*"" 0:@\00@(,'JW1NEM=X2?3FL<1;9K"W(^R6EY&)&AU"
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M[K8XC@:.9&0+FZ;0C@QAH4%\@   "@'  (" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MJK*,M)ZX]KR<=HZI<Q)&XT:X$^ $%91:)ZV$Q,.2R>" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(""N=YMP;_0VFH+/3$#;_</4]PW"Z-QA',),C.TGMI!
M0TAMV!T\SCYH:VA(J$&4VNV^L=LM'6>F;6=]]?E\E]F\O-QN,AE;QW:W5W*3
M4ETDA-*D\K>5M>""9(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M'_R4P<SIX<4$,.X.Z.SY[#=[''5NB(S1NXFG;4^L6\7N\KC(N9S !Q=-:\S
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M^_>GD[O_ .3WR>/;_H]T.7/J3_I_[(_X*]\O>?\ R>_^CS7:_H^WM?1/J9G
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M6S;G:WG;EM53-/,V AO+:X^(_!6<1$3>GSN8U-4%H(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M?%8AQBA-*&4N<UW!!?* @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MC? T4'S%/K2M8TB-$2UIM.LSJY+-B(" @(" @(" @(" @(" @(" @(" @("
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M;'W4-W#P^R02-E;QZ.+"0O=5?>EJ3I:)AZ%ZP$! 0$! 0$! 0$! 0$! 0$!
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M[F+WQV['G\;;QQO[X/7=T[@<T=E%$!U?86]''H?(3Q36YX-I'7/O??6=U?\
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M>"J-.\S3_<R$&"PEM3L,=;1D=;86 ^W2JR\,-,YLD\;3[7O:UK &L :T= '
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M36^8QKFPYO3V2B=9Y;'3N%1'=6TE',K0\KA5CJ'E<:%!-4! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MP74,M_9MC?=VK)&NFA;/S&,R,!YFA_*[EYAQH:(/0@(" @\LN2QT/"6[A8?
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MX?U_<?&60'$V3J=?FN^@G\W/_P#'/LD_C8OU_<?&UT.)LW4Z_2_P5Y_/R?\
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M;ALO* 9(_1D97W33Q'EZ%OBT3P4F7#?'.EH9%9- @(" @(" @(" @(" @("
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M<%U;=;;Z=VSPDF(P8FN;N\F?>YG,WS^WR&1OIC62XNIB 7O<?8:.  ""7H"
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MTI^+)%X<MOME;;7TGIK/"4L6Y7" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(,3D].X_)-<XL$-R>B:, &OU0Z"
MJS=<NQ9NG3PV[8_'M3]OOLF+KUCLE%IFY# RBWOFF2U/".9O$4\1_4*H_'FV
M=O#DZ:]4_;[EU$8]S'BIT6[/M][(12QS,$D3@YAZ"%;TO6\:UG6$"U9K.DN2
MS8" @(" @(" @(" @(" @(" @$AH))H!Q)/11!IWN/JC\;M6WV4C<38L(MK
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M24J62#T7#]7Q+&U=8;\.6<5XM#R[0ZDRN.S-SH#/2\Y@878P.H>7L_/<QKJ
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MJ,X[;3"Z<C=27-Y5LD@KTV]C$Y[A3]\DB*VXHZ43=VTK$/O<1TZ,=MEF=12
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M2!IZ6NZ'-/C:X%JL:V\4:N1SX9PY)I/&&2630(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M96]Q,X,'*T%\C'.- *#BO=98S2L\89J&&*WBC@@C;%!$T,BB8 UC6-% UH'
M #H"\9/)EL)A<_:BQSN.M<I9->)6VU[!'<Q"1H(#@R5KA4 GC1>ZO)B)XL)\
MF6VW]CL'_JRT^Y+WQ2Q\NO9!\F6VW]CL'_JRT^Y)XI/+KV0R6'TGI73TLD^
MP>/Q4\S>2:6QM(;9[V UY7&)C217J*\F9EE%8CA#HM]#:)M,@W+6FF\5!E62
M&9M]%8V[+@2N))>)&L#N8UZ:U367G@KKKHSR\9,%D]$:+S=X_(9G3F+R.0D#
M1)=7EE;W$S@P<K07R,<XT H.*]UEC-*SQAG&,9&QL<;0R-@#6,:*  <  !T
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MO//1GHCGD8YW#JXKS664TK/&'ORN&P^=M/4,WC[;)V)<'FVO88[B+G;T.Y)
MX5%>!HFKV8B>+KP^G\#IZ&2WP&+L\5;RN[26*QMXK9CWTIS.;$UH)H*5*3.I
M%8C@\3M#Z*=D_CIVF\6<SVPNOC$V-N;GU@.YQ+VO)S\X=YW-6M>*:R\\%===
M&>7C(01G<"41:4OA]-(8F#V96D_,!6O)\J=L8US1]NI9&VL'JVA,%'2E;9LG
M^5)D_P",IN&/R0H>8VUW%_2E2VJ\0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M'?#>O&'>I#2(" @J.HS.ZU[,_P Z+&L(8#Q ,36Q?MWDKRG39T'[>TB/U?\
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M4(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M#&RX<-=VEG*8G=0)-/;'%5=^7:3KCMX93Z[S6-+QJX?_ !N#P3-'D/T"L/\
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M;&_27#0!(TCJH>CQ4*GX[^*NKE=WMYP99I/J]'4SJV(@@(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M!W,.D>TM5+3CMW+3-2N\P3.GYZQ]O:V,5FXD0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M%9-(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MW$5B(CPQ]\KL6QRH@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MB1\S[+EO:G+?%6=)C%&D_P#2W/=L_M<YI:=(XNA%#2UC!X^ @5"D^&.Q\O\
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MO6^P7UIRJ8OQ\K_]>AZ^]!%<1[N7[Y@X1RVEF^WKT&,0AIIXN9KO93)Q:_\
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M>FM9_'[T5=J???9RZMF92YR5A;.);!;9%WKEC*&4YF,+S)'Y>S<"L=;56/\
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MQ[H]S:#6NF'':[,Z1TS:<SAB9,?B[)A )Y8>SC8"X@5X#B2M\QT:. V>Y_\
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MH<K$_,SYK'VF3C,MC>V-Q*Z2$>!S6-<&'W+FT(X465>FK5DUKDF9[5EY3?\
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M/>RBR1Q 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M&'K4E'$'7+-% WGF>&-\)/SEA>]:QK,Z,ZTFTZ1#%O==9V9ME81$Q!P+Y7<
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M<\,AJH1@^DV&2XD;X>@]F.E9_P >W7+3/-MO'RX_N_J[V[#7,OG7NJ9I">)
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M\/J^)L;>PM_@K6)D+.'B8 %;1$1P?/<F6^2=;S-I[YU>Q>M0@(" @(" @("
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M<YKR(Q''&SBPN:1YI/ ]:F8*36O2Y7G>[IN,\32=:Q73[UH*0H1 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$!!K!WP>\=KCN_?B9^)N/Q5]^,7QGZ[\;PW,W)Z
MAZGV?9>KW%O2OK#^;FYNJE.L)/G]Z]58KNKQ;X6]GCW:LDPF/RILY(YCCNWO
M)(6/;V8F$O(!(>4=M7QE!JKA._1WH-36\EWIO;_#YBUA?V4L^/PV9NXV24#N
M5SH;YP!H0:%!F\?WON]Y<W]K;W&U=K';RS1QRR#3^=;RL<X!QJ;L@4!ZT%Y=
M[WO"ZTV!QVE+S1UAB[Z7.SWL5V,O#<3-:VU9"YG9^KW%O0GM#7FJ@E'=BW]M
M]_-!.S%[';V6LL5,;74.,M>81,<\ET,T39'O>(I6#AS.-'->VII4A ^][WE]
M=[ Y'2EGH['XB^BSL%[+=G+PW,SFNM7PM9V?J]S;T![0UYJH-E=-9*?,Z<P^
M7NFL9<Y"RMKN9D8(8'SQ-D<&AQ) !/"I*#*(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @("#A+##.WDGC;(SW+P'#VBL+TK>-+1$PRK>:SK$Z,
M/?Z7Q5XQQBC]6FIYKXN#:]56]%%69^5X<D=$>&>[X+##S'+2>F?%'?\ %A_Q
M:S]NVEO=QO8WT6ES@?:<TCYJJ_INZI\MHG[>A8?S]O;YJRXC#:HF=V;W,B:/
M\87- /O03\Q8QL][;HG2._H_!E.ZVM>F-9]OXO;:Z-BYQ+D;E]P[K8WS1[+C
M4GYBEXN35UUR6FR-DYI.FF.OA2.VM;>TB$-M&V*(=#6BGLGPE7N/%7'7PUC2
M%1DR6O.MIUEVK8UB @(" @(" @("#XYK7M+7@.:>!:>((08:ZTAI2])==X2Q
ME>>E[K:+G]]RU6$TK/4E5W>:O"]O;+P.VWT*YQ<<%:U/$T:0/:!HL?*IV-WU
M'<?KE\^370G^@K;VG?17DX:=A]1W/ZY=UOM_HFU_<\!8NK\+"R;[8')7#2O"
M/Q^]C;?[BW&\^W3[GLCTEI6&HBP6/C!Z>2T@;7VF+/P5[(:IW6:>-[>V7H9@
ML)&T,CQEHQ@Z&M@C 'L!J]\,=C"<^2?[I]LO6RVMXG<\4+&.]TUH!^8%[HUS
M:9XR[5ZQ$! 0$! 0$! 0=<\$-U!+;7,;9;>9CHY8G@.:]CQ1S2#T@@T*/:VF
MLZQQAI[NELMFM&7L^2PMO+D-*/)DCGC!DDMFGCR3 5-&]4G0>NA55EP37IC@
M^E<MYQCW%8K>8K?[_1\$9TSNCKO243+;"YB5EBS@VSG#;B!H\#6RAW*/K*+7
M7+:O"4[<<MV^>=;UC7MX3[DXM>\WKV%K67%EB[D#TGNAF8\\/"R8-'O5NC=6
M[E5;_;FVGA-H]<?!WR]Z#6YIV&*Q3!]-SQW#Z^2D[5[_ "K=D,(_VWM^NUO=
M\&'O.\3N9<@B&ZM;,GK@M6.(_P MVBQG<W2:<@VE>,3/IGX:(QD=U=QLKS"[
MU+?!KJ\S;>3U5I!Z12 ,%/$M<Y;SUI^/EFUIPQU]?3]["6V-U)J6X+[2TOLO
M='@7Q1RW3_9(#BL(B;=Z5;)BPQTS6L>J$RQ&Q.YF6Y7?%'J$+O\ &WTL<-*^
M%E3)^P6V,%YZE9EYWM,?]WB]$:_T3O']UG*OBYLKJ*W@GI^Y6MN^=A/U[W1'
M]@MT;6>N53D_W-2)_+29COG3XL-D]GLGH.X&0R>*CSV)80'3,?(YG$\.9K.1
MS3]<US?*M5L-J=,],)6+FU-U'AK;P69_%:^TQB@8(<&[&@>:YEK'$.CPT[,I
M&2(ZD7)LLM^F;^+TZ_U>VXW0L'/;#B\?<7D[^#6.I'4^ !O.3[2]\WL:Z\NM
MQM:(AVP8C=+6I$++,X+%2<))I@ZW):?#S5E=4>Y: >M913)?N86S;/;].OCM
M[?Z+/T1MM@]%QB>(>N9ES>67(2M (!Z1$WCR ^6IZRIF/%%/2H-[S')N9TGH
MKV?'M3-;E6(" @(" @("#\]MW>]#N9L!WF-88B"7\8-!S26%T-.Y!Y#&,N,?
M;R/-I, YT!YR_A0L)J2PDU0;9[-=XC;/?"P[3262[#.Q,Y[[3M]RPY&"G2X,
MJ1(P?"1%S>(K0\$%K(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MW>GN=(Z/U*;7::SO[FZEM(K''RM.%QE(^;MI+=TP%U(&-YNTJWM?-(H$&^*
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M3,.NQQ.*Q8<W&6-O9-=Z0MHF0@UX\>0!(K$<&5\M[_-,SZ9>Q>M0@(" @("
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M&SW^[KVU^)="YO<V_AI?:FN/4,6]PXC'V#B'N:?!).7-/[T$&ZJ @(" @("
M@H[5N@-3;:9^^W2V7M!=-OG&YUKMZ'%EMEZ&K[NQ'HP7X%>@<LW0X<WI!96@
MM?Z8W*T[%J72MT9[)SWV]S;S,,-U:74)I+;W,+O.BEC/!S'>45!!(2= 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!H'WW]GM=;I;U:-M-
M"86;*7UW@O5KB=@+;>WCM[V9W/<3.I'&P=OTDU/0*F@086;NLCNQ6VD-YM3M
MMM=66%OV#7V&-J)[2ULKL")ES:,D'-*ZVD/-S2 <SN4\K0'%!^AN-O['*X^T
MRF+GCNL9>PQW-E<PD.BE@F8'QO81P+7-((/@0>E 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?'B[$.<[E@B/%SAQE?Y[J\$%IH" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MF^+NW]:['LH;R&G:]G%S5[.OH#I0;,=S[_RVZ!^]+G^?7"#2_P#W<7Y[\_\
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M([@(X;B)[^FGHAU?F(,P@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @Q>2U)I[#U&6RMG8N%?-N+B.)QIX YP)08"?=G;FW=R2:@MR:D?8Q)*.
M'C8QP0?8-V-NKEW+'J&V::T^R<\0X^.1K0@D..S^"S']4Y.TOJ]5M/',>'B8
MXH,B@(" @(" @(" @(" @(" @(" @(" @(" @(""C>\;H7/7F/Q.[FWL7_V3
MMNI'Y+'Q,!YLCC"T^NX]X;Q<)(^8L'$UJUO%]4%F;>:[P6YFB\/KG3<O:8G,
MVXGB:X@OBD!+989*$@/C>UT;QX0@DR @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @ZKFZMK*WDN[R9EO:PM+Y9I7!C&-'27.=0 (*
M9UCWA<1CG266DK;XTNFDM-]/S1V@(]RT4?)^Q'@)055D-6;GZY+C->W(L7]$
M4!%G:\IZO-Y><#ZHN*WX\%[\(:,F>E.,O);;=7K_ #KR]CB)XD1M=*?;/(IM
M>7VZY0[;^O5#(,VYL0/LE[,X_4M:WY]5NCE]>V6F=_;LA\DVYLC^Y7LK3]4U
MKOG<J3R^O5+V-_;KACKC;[*6Y[6PNXY7L-6UYH7U'@IS"OLK1;E]XX3$MU=_
M6>,:,GC-Q-S]$/8R>ZFN+-IIV&0!NH'>(25Y@/$QX4')AO3YH3:9:7^65PZ,
MWYTUJ!\=CG6?$F2>0UKY'<]H]QX<)*#D_7BGU16IM=&Z&XF>NLS;[1;3R13;
MDY> 7%_ECRRVFG<4XM#KZY'$.E>'4M8?IW><?-]()KMWM[I[;+3%OI?3K'F)
MCG7%]?W!#[R^O9CS375S)0&261W%SCX@*  ()6@(" @(" @H_O?YW.:9[NVL
MLWIO)W>'S5K\6>K9''SR6EU%VF5M(W\DL+FO;S,<YIH>()'0@KKN ZPU;K+;
M;4U]J_/9'4%];YPP07.6O)[Z6.+U2!W(U\[WD-J2: TJ4&H&WN6[RV\FX>3T
M5HK<S/09*!MW>@7NH<G;P""WF:P@%DC^/GMH.5!<OZ-/?J_VJ7?_ (KS'^"@
MO+<*#<O;/N996#4>H[Q^Y6'L&"[U%:9"YENS+)E&$.9>.+)B>R>&5KT<.A!K
MEW,^]#JBRW#_ !%W/U)D,YAM5NCM\7D,S>37LEGDP2(F"2X>YS8YZ]F6^[Y#
MP\XH-K.^;J'/Z6V S^9TSE;S"YB&YQS8<AC;B6SN6-DO(FN#987-< YI(-#Q
M"#P]R/4NH]6;%6F7U3E[W.99V3OXW7^3N9;RX+&/:&M,DSGNH.H5X(-C$! 0
M$! 0$! 0$!!6.L][]*Z7=+98X_'6695IBMW 6['#J?-Q%1X&!WCH@IC*[I[F
MZSE?#CYY+*S<:=AC6F!K0>ITU>?HZ:O \2V4Q6O\L:M=\E:?-.C#0Z"S5[(;
MC)7;(Y)#5[G.=-*3X3T ^^4ZFPO/&8A"MOJ1PB99&/;BT'[M?2/\/(QK/GER
MD1R^O7+1._GJAR?MSCR/,O)FGPN#7#Y@"]GE]>V7D;^W9#P7.W-TT$V=[')]
M3*PQ_-!>M-N7VZI;:[^.N'=8YW<S0Y:ZROKIME'_ (HN]:M.4?4.YFM\M 5"
MR;?)3C"9CW%+\)6AI#O$V-TZ.SUC:"RE/#XQM Y\'E?%YSV^5I=Y HZ0NRQO
M[+)VL=]CKB.ZLYAS13PN$C'#Q%M0@]" @(" @(" @(" @(/S:[S6YNY.![V#
M=.8+6.<QFGO6<$WXILLG=VUERSQ6YD'81RM91Y<>;S>->*"Z>_UK_6V@=(:0
MO-%9^^P%U>9*XBNIL=.^W?)&V .#7%A%0#Q06]W7,_F]4[":+S^H[^?*9J]M
MKA]W?W;S+/*YMY.P%[W5)HUH""WD'FR.1L<1C[K*Y2XCM,;8PR7-Y=3.#(HH
M86E[WO<> #6@DE!^2^\/>>UMNCNZW+:9SF2P>C;>ZAL,)CK*ZGM ^TCF_=IV
M1.8'23$E[N8>:"&<>6J#]<4! 0$! 0$! 0$'7--#;0ON+B1L,$32^261P:QK
M6\27$T  04[K#O!X3%.DLM+6_P ;WC:M-W(3':-/BIYTG'P<H\#D%39'6>Y^
MN7.YKRX98O/[C:GU2U \!+2WF'USG%;L>"]^$--\U*<9>.VV[OY/.O;R.(GB
M0QKI3[->53J\OM/&=$*V_K'"&09MS8@?9+V5Q^I:UOSZK='+Z]<RTSO[=D/D
MFW-D?W*]E;]<UKOG42>7UZIE[&_MUPQUQM[DH#VEC=QRN;Q;S!T3ZCHI3F%?
M96BW+[1PF);J[^L\8T9'&Z_W0T0]HDNYYK-IIV%_6[MR/ 'DDM'B8\*%DPWI
M\T)M,U+\)6_HW?W3N=?'8ZAB^),@^C6S.=SV;W?7T!CK]7P'NEI;5ML>R1C9
M(W!\;P',>TU:6GB"".D%!R0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:T84?
MH[;XR:8D/8[0;M7;[O N)Y8,5JDBLUJ !RLCNQ0Q#W5&@4:XH-ET! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&!U;J_"Z+Q3\KFIN
M5G%MO;LH9IY/<1M)%3X3T#K0:NZFUEJ_=/)&WXP8F-W-%CXW$6T+>ITKJ#G=
MXS^M 6W%BMDG2K5DRUQQK+*X;1F,Q@;+<M%Y>#B7R#S&GZEO1[)5YAV=*=,]
M,J;+N[WZ(Z(213D(1X(" @XO8R1I9(T.8X4<UPJ"#X05Y,:O8G1$\WH6RO Z
M?%TM;KI[+_$N/D^E]CAXE79ME6W37HGW+##O;5Z+=,,-M!J&XV1R%_C[JVEO
MK;+7 N<W/<\K[^60#D9(V:C>9K& -9'Z :*-Y:DJEO2:3I/%<4O%HUAN!A\S
MC,_CH,KB+EEU8W#>:.5A]L.'2'#K:>(6#-[D! 0$! 0$% =]K_RQ:Y_ZI_[8
MLD%7_P"[<_-9JS^\!_F5N@TRV?W<SNRVZN7UAI["QYV_?'?6!LI3(&B.>X8\
MO^Q NX&,#V4&QO\ ]T+W4_V:6GOKW_!0;+][&X?>=U_6EW(WD?/C[*5S!]*7
MWELXCCX*H/S7Q6S60S?=\O-ZL!VLMYIS4=SB\Y!'4EN/]4L98+A@'1V4LSQ(
M? \'@&%!LGK3?1F]7<BSIRLX=KC3EUA\?J%CCY\Q%Y%V-YY)VM/-_P HU_"E
M$$Y[K^@;3='N7YC0=WRCXYN,I%;2/]&.[CD9+;2'ZR9C'^P@@?\ N[]=76 U
M=J[9W-AUM+=AV3LK:7@8[^P(M[N*GNW,Y"?%$4$=[VF5O]]N]!@=H-/R\UKA
MY;? 1R-'.R.[O'-FOIZ>")G*V0?\B4'Z283#X_3V&Q^ Q$(M\5B[:&RL8&]#
M(+=@CC;[#6@(/<@(" @("#RY+)6&'L9LED[AEK8V[>>:>4\K6CH]LG@!UH-8
M]P-WL[K:Z?@=+MEL\'(3'R1^;<W0ZS(1Z+*?2 ]'I$]65:S:=(XL;6BL:RQ6
M#T';P!MQF")Y^D6S3]C;]<>EQ^9Y5<X=C$=-^GN5&;>S/13H3&***%C8H6-C
MC;P:Q@#6@>(!6<1$=$*V9F>F7->O! 0$!!'\SI#%94.D8P6MX>(FB% 3]4WH
M/SU"S;2E^GA*9BW5Z=\,!@]1ZPVLR@?:R<UA*ZLUJ\EUI<-'3]:ZGTPHX>3I
MI,N&V.=)76+-7)&L-GM$:[PFN\9Z]BW\ES%07MC(?LL#SU'PM-/-<.!\M0-#
M<E" @(" @(" @(" @_+#O8?^<EOWWIW[5;(+P_WE'Y$:'_"MU_-@@O#N??\
MEMT#]Z7/\^N$%WH-&N^9NSG=<:FQ?=@VL<Z[SF8N(6:F?;N(!=)1\5FY[:T8
MUOV>Y/0UH:":<X0:[]YC:G";,[D[<Z%PE)#:Z=QDV3ON7E==W\N4ONVG<.)\
MX@-:"?-8UK>I!^MJ @(" @(" @(,+JC5.'TAB9<QFINRMV>;'&VAEED/0R-M
M15Q^9TG@@U<U9KO5NZ.0-C"UUOAV.YH<;$XB)C0>#YG\.=P\)_6A;,>*V2=*
MM>3)6D:R]^%T3C<<&S7H%Y=CC5X^Q-/B:>GRE7>'94ITVZ94V;>6OT1T0DP
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MSQECO;7Z-U;C=:8*WS>-/*)/,N;<FKX9V@<T;O)6H/6*%14EGT! 0$! 0$!
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M>L@JE7"P4%?[[?F0W+_NIG?^SIT$@T)^0^F?P58_S:-!($! 0$! 0$! 0$!
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M'4-ED%?[[?F0W+_NIG?^SIT$@T)^0^F?P58_S:-!($! 0$! 0$! 0$! 0$!
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M1*QT9_7 A8VC6)AE6=)B7B[MUV8]5Y6Q)HV?'F6E>ET,T8'S)"N2=4V90$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 01W7FBL%N-H_,:)U)#V^'S-NZVG'#F8X
M^='*RO0^-X;(P]3@$%9=W?6V=FL\QL_N#,9-RMNI&6%Y=/J#D\4\?P'(,YB2
M[M(Z-DXDAW%W%U$%WH" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M3%W@# [FK["#+H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$]KH[3UK=1/@N8,991S0R-+'L>RW8US7-=0@@BA!09Q 0$! 0$! 0$! 0$!
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M:2L+V\-9GLAG2OBM$.KNV63I-19G)4\VWLFVY/CN)6O'VE<FZELH@(" @("
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M:;NMZV[P&L?QK^73!2X7U+XO^(.VQ[L=VO;>M>LTKZ?+R0^2OC0;#H" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M'=PFQ#<H^+(Y/)".L>(?C!ZTUQ^D,DKA"./26RD>5!IYM;E\CN]WO,+K;3V
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MF-6(TQGH\W8@O(%]" VY9X^IP\171[;/&6O?'%SVXP3CMW2SBEH@@(" @("
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M@L=%E,K:VEU));XXR,=DKV*%]R;6S#AVUP8XP7%L;*O-/ @_;7:*^VYN=O\
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MS4 O8"PNX-!XN07]ALUA]18RVS6 O[?)XB\8);2^LY63P2L/6Q["04'N0$!
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M1,-1T<0T="#) !H#6BC1P '  !!]0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M38ESBZYQSGNZ9+-Y):.),9KP  0;"(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M @(" @(" @(" @(" @(" @C^N_R'U-^"K[^;2((?W</S";<?W?Q_VAJ"T$!
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M7*6C@:.;-;O\[S3YI<SF97Z9!8: @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(""!;G;.:!W;Q\=IJ_'<U_:^=C,Y9N]6RMC(#S-?;W+
M1S-H[SN4U83TM*"IQJG>SN]?8-P(;G=+::'A'K#'1<VI,;#PXY"VK2XC8/2F
M8>:E7/=6C4%Z:*UWI#<7!0:ET5E[?,X:?@VXMG5+'T!,<K#1\;P"*LD:'#K"
M"0H" @(" @(" @(" @(" @(,%K/2.#U[I7+:-U);BYPF9MGVEW%PY@U_HO83
M6CV. >QWTK@"@K+8#5^<9#F-F]>W';;A[>NCM)+QX+3E<+(/X!D6<Q)=SQT9
M+Q/*\>=Q=1!=2 @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""#[H[F8S;/ Q7TUM)EM
M19.9MAIG3=H1ZYD\C+PCAB'&C17FDD(HQO$]0(87:;;3*:=GR&OMP;F++;M:
ME8SXZOX^-M8VK"718VP! ++>*O'KD?Y[B>% M) 0$! 0$! 0$%/[._E]O3_>
MNW_[$QZ"X$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0>>_NO4K&YO>3M/5
MHI)N2O+S=FTNI6AI6B#6CNX]\']('7&0T;^)GXN^HXJ;+^N_&?K_ #]C<V]O
MV79^IV]*^L<W-S_2TIQX!RU'WQL;I[?B'8U^DI[B[FS.-P8S0O6,C#LHZ "7
ML>Q)HSM_1Y^-.E!LZ@(*XWOWCT]LCH.^UCFW,GO6M,.%Q!D$<M]>N'F1,-"0
MT>E(\-/*P$T)H"$8[LN_=WW@=)Y?4MY@X\$_&9$XYMO%<.N@\"".;G+G1QT_
M=*4H@RF^W>%T1L'A+7(:E$U_F,D7MQ&#L^7UB?LJ<[W.>0V.-I<T.>?#YH<4
M&L>,_P!Y?CY,FUF9VZFML,Y[0Z>TRK;FZC9],1%):PL>>L#M&>"O6@VS_'K3
M.Y.SN5UGI"\%]@LGAK]]O+RECVN9!(Q\<C#Q:]C@6N'A'@XH/%W</S";<?W?
MQ_VAJ"T$! 0$! 0$! 0$! 0$! 0$!!5&Y_=YV]W/NX\_<PSZ?UW:D/Q^L<#)
MZCEH9&"C296"D@'1]D!('!I;TH*[_'S?W8-IAW3Q+]S]M[<'EUOIZ$,S5I"#
MZ5_8U >&MZ7LX <7/<>""\- [EZ%W0PS<]H3.6V9Q_ 2]@XMFA<>(;-"\-DB
M=XGM!02M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M!16L^[E;,SD^X&RF8=MQN-)YUS)8L#L+DZ5/9W]C3LW<Q/[HUM0?.+7.H4'D
MTQWB[O3V;MM!=X7"C06KYSV>/SH<9-,Y5P-.:VNS40N/3V<SO-X5<"0U!?['
MLD8V2-P<QP#FN::@@\000@^H" @(" @(" @(" @(" @H_?W369PT^'WXT/;N
MGUEH)LGQI81>EEM-2'FO;(\#S/8*SP5]%P=0%Q""VM,:DP^L=.XS5.G[D7>%
MR]M'>6-PWAS12M#A4=3AT.:>(/ H,L@(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @((QK_
M %[IW;73%UJK4LKVV4!9#;VUNPS75W=3'EAMK>(<9)97>:QH\IH 2 @FUN@M
M19+.R;R;KQ-;N#DH3#A,"UYEM=-XJ4#^"0UX.N9!YUU/2KG>8VC!Q"XD! 0$
M! 0$! 0$%/[._E]O3_>NW_[$QZ"X$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 08_/?U'D_O2?[6Y!^:'^[B_/?G_[J7G_:..08_<O_ /. V7]]=,_M[!!^
MIZ#S9%]Q'C[N2S!==LAD=  .8F0-);0=?%!^7FXVPN_.J-!:JWYW]S$UO?XF
MTB?B<+<N9)=.[:XBB#>QBI#:0@2%W9M'.7=+6])"_?\ =N?FLU9_> _S*W03
MS?CNBXW?775AK7*ZLN<<VQMK>Q&*%HVXMS;02OE<T.$L3FF0R/J[R>!!CN_#
M+H#3O=WNM/WUG9P7LTMG::-L(XV1NAG@GC<]UNUH^QMC@#P[E %#RGT@@AW<
MKQ.8Q_=6UK>Y$/9CLK<YFZQ+'C@Z%F/BMY)&GW)EB>VGA:?"@V%[N'YA-N/[
MOX_[0U!:" @(" @(" @(" @(" @(" @(""D-?=V32&H\V=;Z#OKK;G<IA<]F
MI-/?86S.=TB[M06QS-=]/Z+G_3.(X((M!OCNGLS*S%]X_3GKFFVN9%#N?I>%
M]QCB''E#\A:M ? X\.8L8 7<&,(XH-@=,ZITYK/#V^H-*92VS&%NA6"^LI6S
M1$CI:2TFCF]#FGB#P(09= 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$&'U1I33>M<+<Z=U9B[;,82[%)[*\C$L9(Z'"O%KF]+7MHYIX
M@@H*!?MQO!L XWVRMY)KC;6+SI]M,Y<'UZTB!%1BKYX)  ]&*3A3J>XH+-VM
MWRT'NPR>SPES+CM5V%6YC2>6C-EF+*1AH]LEN_BX-/ O9S-'02#P062@(" @
M(" @(" @(" @(! (((J#P(*#7G0I.Q6[-SM+=?8=M==RW&:V\F<0(;')DF2_
MQ(/ -:XGM[=O1Q+1S.)H&PR @(" @(" @(" @(" @(" @(" @(" @(" @("
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M> YKFN%""#P((0:^:A[NN5T;E[G6_=NS+-$ZBG)FR.E+AKI=+Y1PZ&R6P/\
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M_NX?F$VX_N_C_M#4%H(" @(" @Z[BX@M();JZE;#;0M=)--(X-8QC15SG./
M #I*]B)F=(XO)G3IE1-[WI--VV0N[:VPUU=64,A9;7C)6-[9K>!?R.%6@GHX
MGATTZ%T5>1Y)K$S:(GL5<\QK$\%@[>[K:8W&CECQ3I+7*6[>>XQMR&B81U [
M1I:2',J:5'$=8%16LW>PR;;YNF)ZX2\&YIEX<4Y5>E" @(" @(" @(" @("
M@(""&;B[4;?[K8HXC7>#M\I$T$6UTYO9WELX_307#*21FO'S74/6"$%+C2W>
M&V"K)H:_DW>VSA)<=,9F41:DLH!U6MX:B<- X,<WZED8Z4%E;7;_ .W.ZSGX
MW#WK\7J^VJW(Z2S##8Y>VD:*O:8)*<X;UNB+@.NAX(+10$! 0$! 0$! 0$!
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M/J9!RNIY"T>VN@YKCTM6_J56SMT3"Q%1K!@]6X;X\P=S:,;6Y8.VMO#VK.(
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MU<I>WCY5:5G^5MIBW'3WQP1)_P##FB8X-YEP+IA 0$! 0$! 0$! 0$! 0$!
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M(,3J]S?.9]3'D6MJ/^5;U-0; H" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @J#='<'4%SG;?9_:J2-V
MY&5B%QE,LYK9K;3N)<YK7WMPPD<TS@ZEK ?3=YSO-'$)IMUM[I[;+2]MI?3L
M;S#&73WU_<'M+R^O9>,UU=2],DTKN+G'R"@ ""5H" @(" @(" @(" @(" @I
M_9W\OMZ?[UV__8F/07 @(" @(" @(" @(" @(" @(" @(" @(" @XR1LE8Z*
M1H?&\%KV.%06D4((\:]B=!H]#9/T)NA>X&6K+>*ZEL6U/%T$QYH'&OA!C<N[
MS3_(VL7CCIK[./XN:I'E9O#ZO@M1<PMA!5&IK;(:)U7::HPCNQK.+JV>/19.
MTU>P@4\UW@ZP2%TVSR5W&&<=^S3U*G/6<5XO5N5H_4MIK#36-U'9#EBOX0]\
M=:]G*TELC"?J7AS5QFXPSAR32>IT&+)&2L6CK9Q1VT0$! 01_7?Y#ZF_!5]_
M-I$$/[N'YA-N/[OX_P"T-06@@(" @(/'E\E;X;%7V7NS2UL();J8]!Y(6%YI
M7Q!;,=)O:*QQF=&-K16)F>II'HB.?4>K[S4&1^RS-?+>S//$&YN'D@\?&7.'
MD7<;^T8L,4KU]'JASFVCQY)M*V5S"V5%NEQU#; <3ZG&*#P]K*NGY5^U/^K\
M(5&\^>/0WL7!NF$! 0$! 0$! 0$! 0$! 0$! 0$!!3NY7=OT'K_)C5F,=<Z-
MW(@<9;366G7^IWXE((K.&4;.#T.Y_/+?-#P$$'&ZF]FQ/+:;Y83\<]!1<K&;
MD:8AK/!&.'/DK#@6TX%TD=&CJ[1R"^-%Z\T=N)A8M0Z)S-MF\1+P[>U?4L=[
MB2-U'QO^HD:UWB02) 0$! 0$! 0$! 0$'Q[V1M+WN#6-%7.<: #QDH(WD-PM
M"XLEM_J/'0R#B8O6HG24^L:XNZO I5-IFOPI/L:;9\=>-H1/*=X/:_&ES8LE
M+D)&\"RSMY7>TZ01L/L.4VG*-S;JT],H]M]BCKU0[(]ZK!QD_%.GKNY'TINI
MX[;KZPP3J=3D5Y^:\1Z(U^"-;F5>JLHQ>=ZC5#Z_%^"L(/!V[II_![AT2EUY
M%CZ[3[OZM$\ROU1#%O[QNZ-V:VT%E&"2ZD%H]XH>KSWOX!;?I&VKQF?:Q_G9
MIX1[G0=\-Z9"7LD<&.XM#<=&6@'P5C*]^G;./_\ K^KS^5N/M!\MN]?PC_\
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MI!Y\KO<QM]&&)OFQMX#C4D)T@(" @(" @(" @(" @(" @I_9W\OMZ?[UV_\
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MV-OTWI.XT "RD! 0$! 0$! 0$! 0$! 0$!!3^SOY?;T_WKM_^Q,>@N! 0$!
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M#(0*GZUU/;*M>5YO#>:3_=]Z'N\>M=>Q>O=_UDW4^A8,=/)S93 \MC.T^D8
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M;<:8DNJ]K\7P-!<""6,;RL/'ZD!<QOXB-Q?3ME<[:9G%77L3!04@0$! 0$!
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MQP!:X&H(/005P;I'U 0$$?UW^0^IOP5??S:1!#^[A^83;C^[^/\ M#4%H("
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M6NF-W=DCS'2./V.)H/TK0!P]R*+L=UDKML,8Z<=-(^*APUG+DFUEL+F%L("
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M/6?JEDTESJ.GF=Z<CP*5/B\ ZES^XW%LUM;+/'CBD:0RJC-@@(" @(" @("
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MM#)<W,C8;>%IDEED(:QK&BI<XG@  @U[W$WXNKJ67":%<8H:F.3+TK+(3PI
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M1]]+UMJ8HJ^1IYOV2KLO,\EOE_*E4VE(X]*6V6,QV.;R6%K%;BE#V3&M)\I
MJ?959?+>_P TS*76L5X0]:ULA 0$!!T75E9WK.SO+>.XC]S*QKQ^R!6=;VK.
MM9T>36)XHME-M\!?!S[0/L)ST&(\T=?&QW_%(5CBYEEIQ_-"+?:TMPZ$6;AM
M=Z!NSE=.WLS WTKBP<X$M'&DL7TP\1#FJTKN=ON8\-X]OX2B3ARXIUK/L6YH
M'O,13.BQFO[<0O-&MS-JT\G@K-"*D>-T?O0JK=\ET_-BGU3^$_;TIF#F'5?V
MMA+&^LLG:0W^.N([JRN&A\%Q"X21O:>MKFU!7,VK-9TF-)7$3$QK#T+%Z("
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M=-#CXBPS.%"^1[C)(^G&G,]SC3J7&[G/.;)-YZU]BQQCI%8ZF<4=M$! 0$!
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MO@<!8:?LA:63*O-#/.X#GD=X2?!X!U*AS[BV:VMEECQQ2-(951FP0$! 0$!
M0$! 0$!!XLIBK',V;['(1"2%_$'H<UW4YIZB%MQ9;8[>*L]+"](M&DJUQN1U
M)L_JN')XV0R6SC1S22(;NVKYT<@XT/[4T(72?^/?8M)X_=*K_/M[ZQP^]N7I
M+56*UG@;74&'DYK6Y;Y\9(YXI6^G&\#H<T_1Z"N)W&"V&\TMQAT.+)&2OBAF
MU';1 0$! 0$! 0$! 0$! 0$! 0$! 0$'7<6\-U!+:W#!);SL=%+&[H<QXY7
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MS%Q]EC+*"RB]Q;1,A;[3 %#MDM;YIF6^M8KPC1ZU@R$! 0$! 0$! 0$&HG>
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M1ZV.TGA6X+"6]HX4N7CMKH^&5X%1^M%&^PH>[S^;DF>KJ;L./P5B&;41N$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&"U%I3%ZBBK<-[&]:*17<8\\>)WNAX
MC[%%,V^[OAGHZ8[&G+AKDCIXH3A,_KG9[+]O825Q\SAVL#N9]E=-'NAPY7TZ
M^#AY%>6K@WU.GC[X5T3DV]NCA[FTVW6[&F]Q+8,LW^I9R-O-<XF9P,C:=+HW
M<!(SQ@5'6 N3WFPR;>>GIKV_;@N\&YKECHZ)[$\5<EB @(" @(" @(" @("
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M6S^ZKSQU[3PSV.^RW'V\R5W#88[5N%N[ZY>(K>UM\C:RS22.- UC&2$N)/0
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MW%S</L=]>06SN(J.$KVGBL9M$<9>Q$R]&(U%I_4$;IL#E;/*1-H726-Q%<M
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M^RUP*AQQ29X/T+W7W8P6TN%@RN8MKB\GO7OAL+2V#09)6-YJ/>XT8WCQ-"?
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M3.;V$3I*<I<VM>6G2JZE?%.B9:=(U7[E^Y/,RT?)@M7-FO6M)C@O;,Q1/=U
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M:E9T^:&-N$M(-JOZYO/O4_;&+M^:_MQZ7.[+YI]"V5S2U$! 0:!__P!V/_\
M-O\ ],J!_P"YZTO^SU-_%/1% ][76PT[MVS3=M+RY+4TPMRT4YA9VY$DYZ>L
M]FSHZ'%1\UM(T;L4:SJA_=]T=I%^S6?M-0Y.QMK_ %L)HI&3W$+)(K: .BMR
M6EP<'-D+Y17PA88XCPSKULKS.JONZYJV;1.Z=QI')2AEGG>?&S!KN:,7]LYQ
M@<".!J>>-I^K6&&VEM&62-87CWP/S3P_A>U^U3K=G^5KQ<6L.J=.GY$- :OA
M:08[W*8NYD'U=PZ> 5ZJ<LRC3'Y8ENB>F83/O"[AOUWIC;/'6KS->7>,;E,@
MP&I=>3$6G+Y1)%,/'59Y+:Q#&E=)E&]T<#'I;>+"Z<B #<7!@+1W+T%\5O;M
M<[]<X$K"\:6T95G6'Z&JQ0T+W=RTN#VPU;DX#RSQ8NY9"X=+9)HS$UWL%P*P
MR3I66=(Z5!]R?'1-L=7Y8@&:26RM6GK:V-LSS3AUEXZ^I:-OUMN7J;8*4CJO
M[Q7YE]6?>\/\ZA6K+\LMF/YFF>/TY\:=WW+YZ-A,V!U+$^1]*@6]W:QP/\E9
M#$H<1^75(U_,F.O-R?C?NU:'T[VO-D9;N2QO034B#"CE8WV6RV[O86=KZTB&
M,5_-*%[LZ<_%? [<8Y[.SN9].MO[D=?:7UW/<>=XP'AOL+"\::>AE6==7Z#:
M1_)3!?@^T^T,4^O"$6W%6>^V^N-VMQCL7BW1WFM[V,FSM#1S+9CN GG'@]PS
MZ8^*JUY,GA]+.E-53]U';+,7V=GW<U&R1L1$[<,^84DN;BYYF3W'$5Y0USF
M_3%Q\''5AIT^)GDMU+![WN/BN]IV7;H^:7'Y.UF9(!4M$C9(3Q'0#S^W3Q+/
M/\K'%Q93NKY:7*;.8N*9W.[&W%U9-=U\C93*T'R"0#R++#/Y7F2.E="W-0@(
M""']WAQMMUI8(C2-]K>1.'U#7-<![;0NAYMT[6)GMA6[+HS3'I;?KB70B @(
M" @(" @(" @(" @(" @("#4_=8F;>6ZBD-6-N,<QHZ*-,$!/S25MPQK>OIAJ
MRSI2WHE*5U3F!!+MN?RA/WO)\]JK]_\ M^M8;']SU/1N;_6]I][#[8Y8<O\
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M+::T'E;"02V-\;JZM91T/BFAMWL=[((*VYYUB&O%UO)NOISXT[K>@\]&PF;
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M-R99 >7CS1NGHX>(]2WQ,THU=%K.&PV_[]UKW*8/4T-CC<S"UDN.M+?G:+F
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M:/'4*<H^JX$4F^YO.2/#BUB.N>M8;;8Q7IOTROA<ZM1 0$! 0$! 0$! 0$!
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M;B1L40Z7R.#6CV2O8K,SI!,Z,#?:YTQ8U#KYL[Q]);@RU_7-\W]DIE-CFO\
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M,FUIM;^(O=3[%(X1R5/5ROH?:7/Y-KEIQK*SKEI;A++J*VB @(" @(" @("
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MNRL;*,,96G,]W2Y[R*5<XU<X^%<=FS6RWF]N,K['CBE8K#*K2V" @(" @("
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MR1A#FN'A!"YZU9K.D\5G$Q/3#L6+T0$! 0$! 0$! 0<7.:QI>\AK&@ESB:
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M36.(Q6,;RXVQM[-O@MXF1#CQ^D 42V2UOFF9;XK$<(>Q8,A 0$! 0$! 0$!
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M6SO^1:X<7#X1PKX U<WON:7S_EK^6OOGT_!;;?9UQ],],K<5*L! 0$! 0$!
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M#YB>:&Y!XV_'H:ZAY1U.X?3+;S;91:OG4]??':PV.XFL^7;U?!L^N27@@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MXT?<ZMGW;=D([:ZQUH;5FF\9"YQR=_;V =S%SO0,_/2G&E$$M^3O?;_;1_\
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M8XK$58F" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(-#/\
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M 04_WG_S,Y3\*Z;_ /F''(+@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$!!C\]_4>3^])_M;D%?]W#\PFW']W\?]H:@M! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%7]X_\ ,)N/_=_(?:'(+ P/]1XS
M[T@^UM09! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$5W!W'T;M;INXU5K?*18
MS$P>:PO\Z:>4@EL4$8\Z21U.#6CQF@!*"@8M.[H]ZB:._P!<Q7FWVPI<V6ST
MFQQASF>B'G-??/:?L,#NGLQTCHKYLB#933NF\#I'"VFG=,XZ#%8.P8(K2QM&
M".)C1Q/ =))XN<>+CQ))091 0$!!\>]D;'/>X-8T%SG.-  .)))0:093).W)
MW3O,L^K["6Y=)&#T"RM:,B!'5S-:VOC<N\T_B[6*]>GOES6OG9M>K\%HKF%L
MK?=;(-[*PQ335Y<ZYD'@ !8SVZN5]RG'TVOZE=O;=$5;1[2X1^G]N=/8V9G)
M/ZL+F9I%'!]VYTY!\8YZ+F]_E\S<6MW_ '="WVM/#BK":* DB @(" @(" @(
M" @(*>[PVAAJ72)S]E%S9C !T]6CSGV9_=F^/EH)!]:?"KSE&Z\K+X)X7^_J
M^"NWV'QT\4<:J8VUSHOL:[$3NK=6/&*O2Z GA[TFGDHK'F>#P7\<<+?>B;3)
MXJ^&>,)RJ=-0#;6X^)=\K$$\L<M]<P4/06W<<C6#B?"]JZ/=1YFQ_P"F/=HK
M,/Y=SZ_O;G+AW1" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M 0$! 0$! 0$! 0$! 0$! 0==Q<6]I;RW=W*R"U@8Z6>>5P9''&P<SG.<Z@
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MN/@CMXR!3FY&@%Q\;C5Q\97!9LDY+S:>,RZ6E(I6*QU,DM3,0$! 0$! 0$!
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M>_J/)_>D_P!K<@K_ +N'YA-N/[OX_P"T-06@@(" @(" @(" @(" @(" @("
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MZSKX>+=R_#:NMIZ^#8-<TMQ 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!! ]TMI-);M8:+
M'Z@CDMLK8/%S@M06+NPR>-NVD.;-;3#BTAS6DM]%U.(X @*UTKNWJW:S/V.V
M/>%?'6\?ZOI7<R)O98K+#CR0WGTMM=T'$./*[VG/#88$$ @U!X@A 0$! 0$!
M 0$! 0$! 0$! 0$!!3_>?_,SE/PKIO\ ^8<<@N! 0$! 0$! 0$! 0$! 0$!
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M @(" @(" @(*?[S_ .9G*?A73?\ \PXY!<" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(,?GOZCR?WI/]K<@K_NX?F$VX_N
M_C_M#4%H(" @(" @(" @(" @(" @(" @(" @(" @(" @J_O'_F$W'_N_D/M#
MD%@8'^H\9]Z0?:VH,@@(" @(" @(" @(" @(" @A.YV[.A]H< =0:UR(MHGD
MQV-A"!+?7DW5%;0U!>XU'@:WZ8@(*2LMOMR^\M>P:AWIBN-'[1Q2-GPVV<$C
MHKV_#3S,FRTK>5P!H"(>!'@8?.<&R^)Q&+P.-M<-A+.''XFRC$-I96L;888H
MV]#6,8  $'L0$! 0$! 0$! 01G<1UT-"ZACL8WS7MQ83VMM%$"Z1TMRPPL#0
MWCS5>**7L]/.IKPB8GV=+1GU\NVG8AFS6T%MH*Q;F,S&R;5UTW[(\4>VTC</
MW*,]',?IWCR#ATSN8\PG/;PU^2/?WHVTVL8HUGYON6RJ98" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @X30Q7$4D$\;98)6EDL3P',<QPH6N!X$$=(0:WYK;G7&
MP&6N];[$V;\WM_=R.N=3[4\Q C+O.?=88\>SD\-N!RNZ&@^8&!<>VVY^C=V-
M-PZGT9?B[LW49=VL@$=Y9W%/.@N8JDQR-\'0>EI+:%!,$! 0$! 0$! 0$! 0
M$! 0$%/]Y_\ ,SE/PKIO_P"8<<@N! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$&/SW]1Y/[TG^UN05_P!W#\PFW']W\?\
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M!<" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MZ4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!
M$]Q=M=&[JZ9N-*:VQK,AC)O/A?Z%Q;3@$-GMY1YT<C:\'#I%6N!:2"%'XK<#
M77=NR-MI#>N[GU'M5<RMM=-;G\CGW%IS<([7,!O,:CH;/U])KQY V7M;JUOK
M:&]LIH[FSN&-E@N(7"2*2-XJUS'-)!!!J"$':@(" @(" @(" @(""G^\_P#F
M9RGX5TW_ /,..07 @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M 04_WG_S,Y3\*Z;_ /F''(+@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M3;C^[^/^T-06@@(" @(" @(" @(" @(" @(" @(" @(" @(""K^\?^83<?\
MN_D/M#D%@8'^H\9]Z0?:VH,@@(" @(" @(*\W8WHT/L[B8K[5%T^7*WQ[+"Z
M?L6]OD\A.3RMC@A'$U<0"]U&@D"M2 0J7#;2[@;^92TUMWBFG$:-MY!=:=VE
MM)7=@RG[G-EI&\IEEI_B^KH/("^,ALO9V=IC[2"PL+>.UL;6-L-M;0,;%%%%
M& UK&,: &M:!0 "@0=R @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MT @A$1YW2<IJ037@J7FNPQ;>M9IKTRMN5[[+GM:+Z=$+V7.N@$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!6^]VL\WH31L>;P#XV7SK
MV&W)F8)6]G(R0G@>NK0K7EFVIGR^&_#16<RW%\&+Q4XZM=_TE-T3T3V?\5;]
M%=/]%VW9/M<Y'-MS/9[#])3=+X>S_BK?HI]%VW?[3ZMN>[V'Z2FZ7P]G_%6_
M13Z+MN_VGU;<]WL/TE-TOA[/^*M^BGT7;=_M/JVY[O8?I*;I?#V?\5;]%/HN
MV[_:?5MSW>P_24W2^'L_XJWZ*?1=MW^T^K;GN]A^DINE\/9_Q5OT4^B[;O\
M:?5MSW>P_24W2^'L_P"*M^BGT7;=_M/JVY[O8?I*;I?#V?\ %6_13Z+MN_VG
MU;<]WL/TE-TOA[/^*M^BGT7;=_M/JVY[O8?I*;I?#V?\5;]%/HNV[_:?5MSW
M>P_24W2^'L_XJWZ*?1=MW^T^K;GN]A^DINE\/9_Q5OT4^B[;O]I]6W/=[#])
M3=+X>S_BK?HI]%VW?[3ZMN>[V('NAK3-;N8RVL=60VOKN.E;<X?,V< MLC8S
MM(<'V\["'-X@5;Z)H#2H!&-N2[>8Z-8GTLJ\VW,3TQ$^IG=']X/?+$8:/%:B
MRMEE+FR/86^2=:@SW$#  R2?H':'H=X>DDGBH^VY+2(F,O3.O1I/4D;CFV29
MB<?#3IUCK9_])3=+X>S_ (JWZ*E?1=MW^U%^K;GN]A^DINE\/9_Q5OT4^B[;
MO]I]6W/=[#])3=+X>S_BK?HI]%VW?[3ZMN>[V'Z2FZ7P]G_%6_13Z+MN_P!I
M]6W/=[#])3=+X>S_ (JWZ*?1=MW^T^K;GN]A^DINE\/9_P 5;]%/HNV[_:?5
MMSW>P_24W2^'L_XJWZ*?1=MW^T^K;GN]A^DINE\/9_Q5OT4^B[;O]I]6W/=[
M&-SV^FN-3XR3#9^''W^+ED@FDM9K0%ADM9F7$+C1PXLDC8\>,)]%VW?[3ZMN
M>[V,E^DINE\/9_Q5OT4^B[;O]I]6W/=[#])3=+X>S_BK?HI]%VW?[3ZMN>[V
M'Z2FZ7P]G_%6_13Z+MN_VGU;<]WL/TE-TOA[/^*M^BGT7;=_M/JVY[O8?I*;
MI?#V?\5;]%/HNV[_ &GU;<]WL/TE-TOA[/\ BK?HI]%VW?[3ZMN>[V'Z2FZ7
MP]G_ !5OT4^B[;O]I]6W/=[#])3=+X>S_BK?HI]%VW?[3ZMN>[V'Z2FZ7P]G
M_%6_13Z+MN_VGU;<]WL/TE-TOA[/^*M^BGT7;=_M/JVY[O8?I*;I?#V?\5;]
M%/HNV[_:?5MSW>P_24W2^'L_XJWZ*?1=MW^T^K;GN]A^DINE\/9_Q5OT4^B[
M;O\ :?5MSW>P_24W2^'L_P"*M^BGT7;=_M/JVY[O8?I*;I?#V?\ %6_13Z+M
MN_VGU;<]WL/TE-TOA[/^*M^BGT7;=_M/JVY[O8?I*;I?#V?\5;]%/HNV[_:?
M5MSW>P_24W2^'L_XJWZ*?1=MW^T^K;GN]A^DINE\/9_Q5OT4^B[;O]I]6W/=
M[#])3=+X>S_BK?HI]%VW?[3ZMN>[V'Z2FZ7P]G_%6_13Z+MN_P!I]6W/=[#]
M)3=+X>S_ (JWZ*?1=MW^T^K;GN]A^DINE\/9_P 5;]%/HNV[_:?5MSW>P_24
MW2^'L_XJWZ*?1=MW^T^K;GN]B9[3;X:\UAN#B-.9J:V=C;SUGMVQ6[8W_8;6
M65M' \/.8% W_+,&'!:]==8TZ^^$S8\RS9<]:6TTG7J[I;.KDG5" @(" @("
M @(->N]C^3VGOOV;[4NGY!^Y?T.;YY\E?2U>C]!OD76RJL/R0Y(W" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#X>@HQM
MP7UW3ORAU#]Y0_;5SO/_ -NGI;^1_/;T-JUQKKA 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 04OWH/S;1?A.V^US*^Y'_D?],_@H^=?L
M?]4?BU B_<PNWES^W^2'->)(@(" @(" @(" @(" @(" @(" @(" @(" @("
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M@HQMP7UW3ORAU#]Y0_;5SO/_ -NGI;^1_/;T-JUQKKA 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 04OWH/S;1?A.V^US*^Y'_D?],_@H
M^=?L?]4?BU B_<PNWES^W^2'->)(@]%C_GMM^^L_;!86X2RI\T-\MR[NZL-
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M1T):;CZ2DL8',^,H1ZWAKL$%O:\O!O,/I)!YI]AW4N.V.ZG;9=9X<)^W<O\
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M+>#.V;0WUN>R%] XCZ:(MCD>PDU);RT'A*PS<KW&*9\F9\,]6NC+'O<5X_\
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M" @(" @(" @^'H*,;<%]=T[\H=0_>4/VU<[S_P#;IZ6_D?SV]#:M<:ZX0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%+]Z#\VT7X3MOM
M<RON1_Y'_3/X*/G7['_5'XM0(OW,+MY<_M_DAS7B2(" @(" @(" @(" @("
M@(-S<-K;1D6T^/QTNHL6S(,T[#;OM'7MN)FS"Q##&6%_,'!WF\M*U7"9-MEG
M=3;P6T\?9/ZG2X\U/*B/%&OA[>YIDN[<T(" @(" @(" @(" @(" @(" @("
M@(" @(" @(""PM@/SP:?\M]_,;A5G-O\2WJ_]4-/+O\ ,CTV^Z6\2^?.Y$!
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=O_BW]7_JA:<J_P FOK_],MY%\]=Z(" @(" @_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tm2225088d1-lc_triple4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_triple4c.jpg
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M .T  0 !! ,!               ' 04&" (#! D! 0$  P$! 0$
M   ! P0% @8'"!   0,# P,!! 0%"@\+!0<5 0 " P0%!A$2!R$Q"!-!42(4
M87$R%8%"(Q<)D;%2TW65%E8W&?"A8G(SLR0TE+15I=7E5\&"LD-S=,0E-388
MT9+24SCA\:)C@Y-4A-1E)G8GHT1DA;5&I$5F1R@YPL/%$0$  0,! P<(!P<"
M!00#     1$" P0A,1)!47&1,A,%88&AL=$B,Q3PP4)2<A4&X6*2LB-S-(*B
MTN)#4Q:3) <7\6,U_]H # ,!  (1 Q$ /P#?Y 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$!!IGY?\ DMR3PCF5BL6%BWBAN-M-=4"NIC._U?F)
M(OA(>S1NC1TT45$%-Y;>8-;3PU='BD5123L;)#/%8JI\;V.&H<UP>00?H5&R
MEDY>Y0;XMW7E3)Z&*W<A4$59**6>DDIXF^C5^E$70/<'=6?3U0:KXOY^<Q39
M#:8,D%I^X)*J%ER^7H7-F-.7 /V'U3H=$'TNH*R&X4=/744@DI*F)DT,K"'-
M<UX!!!!TZ_0H-*?*#RYY"XQY.J,"X_@HGQ6NE@FN<E93/J7&6HB;, W:]NC0
MQ[>JJ)+\4^;L\YEXWRK)LJ;2OO-HKI::A%# Z)A:RDCF:',WOW$O=[%%:Z5W
MECY?4'S<\N)LAH*;U9)*B6QU;6,BBU)>YQ>  &C4E466R^;WD[DLLE/CMJMU
MUGB&^6.CM,U0YK3T!(9*2 @VO\6.4N8N2Z7(9N6;0+3-020-MH%OEM^]LC7;
MCI*3NT(]B"*^:?-7)(,U=QOP?:8[Q=F3"D=<I(Y*ETU3JYKXH*=NTD #[>[W
M]-%!9>)LZ\T[3GMEI\_M-TJ,2NUP@IKE/<J!I93PR.^(QNBV;/K=J@W_ /8J
MC77RHY+Y=XRM&-U?$]H^]JNX5-3%<F?(RU^R..-KHSI$1MU)/4]U%:EWKS:\
MH,:?%'D=IH+3),"Z%E;:9Z9SP.FK1)*-0%1<:/RY\OKG1PU]!BT-705+!+3U
M,%CJI(Y&.&H<US7D$'V$()U\CO(+DOB?B_CW*++%1P9#D3 +U#74KW-9(*>.
M4M;'O:6$.<>A*@\'BIY=W7EF^5>&\A-HJ7("PU%KJZ8&GCJ " 81&XN^, ZZ
M[D$U>1?(&0<8<2WO-,8$'WU0& 0_-1^M#^5E:UVYH<TGO[T& >'O..<<XX[D
MUSS;Y/YJU5L%-3?(P&!OIRPEYW O?J01T5$(<R>7W-N'\Q7[CS$8;9/2TMP;
M;[73S4;I9Y'/<&,:7>JW5Q<1[%!;,I\H_,3 8H+EF^(T]KMCI #+4VJ6*-VA
MZM]02N#2?I5&V/CGSW0<^8A47QM#]U7JVS_*72@]3U6M>6->U\;B&DL<">X0
M85Y'^7F/\,51Q7'Z:._9K)&YTT(D#:>A)!#?6VAQ+M>IC]R@U7?Y!^9>>F*_
MX[37&"V0,$VEHMCFTDT>NH),C7[P=/Q'*C;[Q*Y4Y(Y0Q_(I.3J1E#?K)7PT
MD=/\I)0S"&6G;*#+'(2=7$Z@]%!L:2!U/95%-S>VHU0-P]X0-1[T#</>$#<T
M]B$#<WWA U'O0-1[T$0>2=WNUCX;R:Z66NJ+;=*:#=3UU%*^GGC=N'5DD9:Y
MI^HHJ _T?F;YKF=)FC\OR.Z9 ZEFHA3NNU;45QB#FR;MAG>_;KIUT0;M[FGL
M0B.,G5ATZH--O/S-,PPS&,,J,0R"YX_/5UM9'4S6JMJ*!\C611%H>8'L+@">
M@**D_P -[_?LFX+LUXR2Z5=XNLL]4V6NN$\M74.#9=&ATLSG..GLU*(GU 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0=4\D4
M<+Y)7M9$P%SWN(#6M;U))/0: :H-$.;//"OH,AEQ+A:AI[F^!X@=?)VNJ8YI
MP[1S*>%FF\'3H_=]01484W-7F[:9#F-107>IM,SB6T=3:G/I 7:]!$QC9 !]
M+D$HYIY(^3-%8\*NF&X['<#>K-'6W>2.TU%0QE:9',<T;'_!IM^R>H4$67?S
MC\E\?KONN^6^UVZY;6N-'5VN6*;;)]D['R@]?8J,OLOE!Y@UUUMU/5X@T6^I
MJ(63R-L=4!Z4CP"X.WD#H==5!]$XM=O7];15'-!I%S-Y!^1%9R;DW&O#&*FJ
MIL<D%+5W&GIY*V9SIH(YFO!.UD3F[B-OQ:]T5#=H\M_(_AO(66;E:@DNFNL]
M1;KQ"*2L,3P6M,<L;0 T$:_8.NFFJ#Z+XMF-FRS#[=FUNF:++<:-M=ZNNK6-
MVGU 7:#4L(<T_2$&DG)7FAR/F6:SX%X^V<U,8=+20UX@=55E6]FH=)#&-HC:
MTZ[2[74=2@RSQPS+RRBY+M&.<OVRXG$+HVL]:XW.B#'LEAI9)HVMEC#6L!<T
M#XAU[(-V41:<ER"RXO9*N_Y!6Q4%GH6&6JJIW!K&M;])]I/0#WH/GQR#YV<D
MY3D<V/<,65D="#/%!,*>2X5]4QG:9D<8&S0-+M-'=#U[**QZV\Z>:&"R1W/)
M**Y5=LK"PE]WMAE@BB<X:NUB;'L 'M>51LYY@<Z9SPA9L<K\)^3]>Z54D%3\
M] 9V[&1%PV@/;H=1W00#:_)_S,O6,_PQL^*TM?C&CGBY4UIEEA+8SM=ILF)Z
M'OH%!)?C7YFWKDC+J;CKD.U14]_K2]M%<Z$.C8Z9FI,4L+M2S0#H=QZJC9;E
M3E#&^(L0J\PR>0FFA&VGIF:"6><C5L;=?:3^H@T)R/S2YZY.NU39^)[*;=2/
M:WTH*"F?<+@P!Y'J.E VM!W-'5FFOMZH,CXIYQ\K;#R)B>'<D4-6ZRWJ\T%!
M7U]WMKFR,AK)VQ%K)V!D;2=?AZ=T'T21%-1[T#4>] W-/8CIW0-1[T#4>] W
M-]X0-0>Q0-1[QU[(+5?GNCLUSEB<62LI9WQO:2"US8W$$$=B"BOG#X4<G\E9
M9SG16G*,SOEZM;[=72OH+E<ZRLIR^-@+7&.:1[=1[.G1$?3/4>] U'O00SY5
MWR[X]P3E=WQ^Y5-JNU-#&ZGKJ"9]-41DR-&K)(G-<W\!140?H_LSS#,L7S"I
MR_(;GD%135E(RGENU9/7/C:]DI<&.G>\M!T&NGN1&XR @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @("#YI?I(?Y3,1_<$_XY,@D'CCSSXBQ# L;Q6YV7)):^SV^G
MHJF6FI:%T+I(8PUQ87US"6ZCIN:$5-?-.5V[._%;(<RM$4\%KOEAAN%)%5-8
MR=L4\D;VB1K'2-! /7:\A0?-BT8#57W@&]YW0ZG^"F0PQ7"-L8)^5N-,Q@D=
M)N&UL<C&M VG4R>SVT?0_P 4.5:6\>/%->[Y,\OQ"GJ*>Z/+&-/H4 <]FQK'
M$G2(  D N</PJ#YZW(73D.FY+YGNC8HWRUS#MA,L;14W6=[P(V.W_DVL8X:.
MD)'14;I?HW2#QCEVG^7A_B<"(V<YB_DCS[_[G+Q_B,R#0;]'-_*-DG[F#^V!
M16^7,5\KL9XRRW(+9L^?M]KJ9H/4&K-X80"0"">_O5'R_P#&SE'%^'JZ^<CW
M>UG)<O>!18_8X7^E/OE(=43NFVR&-A8XC<(GDN&GT@-K^,_/[&LQRZDQ3+L4
MEQ+YZ1M-37'Y\5\8J9'!K63-=34Q8"3]KXNOL0;EL>R1H<QP<" 01](U_P!U
M$<D'SD_22?\ >W"OW-F_M[D&XWC3_(#QU^X5%_:PBM<OTDNG\#L&U_RE5_VF
M-$:HU7'V2X!QUQ_S_B4KX8ZB:2*JGA$FZGKJ>>0,+W!Y^"1C--!M]H16X?,/
M+=GYH\-KQF%M#8*UXI(;O;P\R.I:R.9HDC)+6DC7JTZ=6E!:?T:__<S.OW3I
M/\7>B-9>?;K36#RNOM^K&/DI+5D5/73QP@&1T=-.R5X:'%H+B&]-2$5+7D9Y
M>8)S=@;>/<.L]SHJROJX99:^^&DH:>)L(=IUBJ)]==>[BP!$3GX;<:?FNXEN
M^1ON5MO-UO;WW RVN85-/'!!"/3A,K- 22"YVT=->Y45IAPI8F<\^2%*[-2*
M^FK:V:ZW>FJ722-J(:=^XP%P<':'4#OVZ%4?6^DM]-;Z:&CH(&4]' QL<,$3
M0QC&M&@#0.@ "#NBIV13/F9"UDDQ:9G@:%VT!H)([Z#IU4'H?]D]-?H51\Y>
M?O)_G' N>+MB.+Y"X8Y0U=*RGLK*&W2/E8\,<Z(2RTLDFKR=-=Q(U16/<U9[
MYH8=);N0LPN]7C-CN$^MGH;9/2_*0M<1,R&:&'7=HUP']U-<YVFA[: ,@LW.
M_EEY#XQ%9>+:1MOJ;)3;<HOM"ZFI9JV=QU;Z;Y@!"X-T^"G.\]3KM.T!P\8?
M)CE2@Y4IN,>4;Q5W6BK)9J 0W*,35M-7M.H!F($I'PD$/>0%!/\ Y9^3-3P=
M;:/'L6@CFSJ]0?,4L\[6R04E*'NC,Q9N!>XECFL:1MU[]M#1K;!1>>^16B+E
M"EO5V=;)H!<X8XJREIVNA WM+;<PM:1IU#/1^+W%!-'B3Y77KE"XR<=<D S9
MI$R2:BN\444#:F.,_&R6*-K&LD;KW8P J#'?+CRKSK#LT/%7%D[:&YT[(OO6
M[1QLJ:MTU5&'M@A$C'L;H'C5P!=N]HT5$49C_P",#!>,KK5\I/J[SQY>HVP5
MD5RJX*ZI@DJ0#%*UP<^HA#=NA:XB/4Z.;NT*(DO]&O\ WAGWT2T/_!D15LY4
M\G>7N4^4*CB7@&I%NMXJ)+<VYTWINGK',?L?.VH+7^C"--6NCT?IU)]B@M%P
MY4\I/%3,;51<JWHY7B5V_*&29[KC3S-^ 2B"JF9#.R6('^QEP9UUVN!!5&4?
MI [W0Y)QQQM?[8\R6^Y5%54TSW#1Q9)!"X:C\*";?!K_ -GBQ?\ .:S^VE!L
M<B" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M*(]_DA0UE3X9\.U-/3RRTU$^@DK)HV.?'"R2AGC:Z1S00T%[FM!/<D!14U>
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M:_"=IZ%![4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M4T\C3*0#J&DCN0$'@\EL.Q_@?G?";SQS;/N>E<:>J--"^1L#I8IV@M!U+@'
M_$-5!]')<CM5KLU->;]<*2U4M0R+?45<T=/"))6;@W?(6C4^P(+;^<_CH ?_
M &Y63Z_O*D_;52B^6/(K#D<,L]ANM)=8(7".66AJ(ZEC'$:Z.,;G '1$75 0
M$!!J)S[YP6+C"^5&'X301Y'D=&[;7U,TA;002-<-T6L9W/>!KKH=&GWHJQ\,
M^?=JS'(*;'.1[5#CLM=)Z5'=*61SJ)KST:R82DN;N/XW8(-T(WN<X'7HB.]
M0$&+<BVZ\W;#;Q08_<)[7>I::3Y&NII/1DCF:W5I#P"1U^A%A%'B7R;?N2.,
M7.RJIEJ\FL%;-:KG5S !TKX=K@[=KJ[4'N0$'A\J.1<MQR@Q7!<$JZBAR_,[
ME'14U;3:M=#"QS!([>W5S?M=]I4$UTU73XGC5,_([NV."WTT;*ZZW.=K 7M
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M;W#:X:&LNCZVDBL]P9<XH7RCXX2]LDCAMT&F]VY4;+H@@(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MR2*H;3UD,YEBW/B+P6N[.V.!&OX%1[?X1>8[\,CQ&' K53Y6(6T/\-WWR"6
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M]-DTLE);ZB=D8D;NVO<QA#7@=VGJ$5?N2.<L4M?"57R7CUTD=0W:A>,?N-+
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M<TJHL7^<@=?[#7/+3+1^L'2L:]@#2-C1T<W4^]!MW&PLUU/=5'- 0$! 0$!
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ML).L8V,VDZZ.]ZKRRV-I:T ]T') 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MYM]%A)BC<8V%S6:]FZ]E!/\ XT8Y9*7Q9M,E/;Z=GWM:JVJN?P BHFW31[I
M==QVL 5$8>-1DD\/^1=[RYD-5D,<;220U@HXB&@>P:D] @OEI/\ _0+<>O\
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M0=,D D#FNT<Q^NYKAJ"#[.J"D=,R)C8XVM9&WH&L&T ?4$'>@(" @(" @("
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M=O0::A%6'R)X1GYHQBAHK37Q6K)K/5QUUIN4["X1R,()!<P%[6G0:[4%@L/
MV84W/-EYEOMZH*D4-@CLU?24[)FR2U3('Q.D9O! 82X'J=5!)_*7&MCY7PBZ
MX1D+7&AN,8].1CMCXJB,[XI6G0]6O /4%5$/8#X[YU@7C_?.);;D%"W([K/4
M.AO#&U#((X:G8UWV0'AVUIT(45'6'^+/E%@-F;C^'\MVVT6=DCYA2T]*X RR
M:;WN<ZG+G..G4N)5$W\2\9\NV:BR"V<T9M#FM!=X?EJ:*%CH?2BD8Z.8$B.,
M_$UVB# :3QXYNP>W7;".*,^M]MXXKI'OHJ6Z4TM1<*-E1UE9%*UNW3J0W<"H
M,V?X\C%^"+CP_P 8W7[KKZ^-WJWNNUD=-43N9Z\L@:UVF]K=H:T=!]/4T0MA
M_BMY/\?V@6+#>6;99K4'F0T]-2$;GN[N>YU.7./TN)03OQSQ;R$S"<AQ#G+*
M8LW;>]86S0M=!Z=*]A:YFH9$=22"@CBU^/W/V(8_4\<83R3;Z;C@N,-N=5T;
MW7>EHY'.>]C)&-]/4E[NX.OT*":^'^([#PSA<.'8_-+51>L^MK*VI.LE15S!
MHDD<!T;J&-&@]@51E]9C]FKZZCNE=;J2IN=NW?=];-!&^>G,GVO2D<TN9KH-
M=IZH,>Y/XYMO*.#W;"+M.^GI+I$8_F(NKXWCJUX!/70CL@A>Q<'<_P!)C='Q
MO<>1;=3\?T43J-E5;:%PO3Z0$[8W22_DNK3M)#>@45QPKQ;O6&<+\A\34]\I
MJEV625)M5?(V3\C'/&UC?7Z:DC;\6Q!*_%G'%PP'AVT\:UU9#5W&W6^>ADK8
M X0N?.^5P< X!V@]1489PWX_W/CWAK).++_=J>KFO]5<IS74+7[(XKC!'"!I
M*&DN;L)]R##\.\:^4\?XPS7B>[9I1W7&KU;);=C+'QR T+Y':[I-& EI!.[0
MGJ@V$P/&*G$L,L>,U4[*BIM5'%22SQ ACW1MT)&[KH?I1&/<W\<7#E/B^_8'
M:ZR&AKKM'''%55(>8F%DC7_$& N]GL15[XQQ.JP7C[&\/K:B.JJ[);X*&:HA
M#A&]\+=I<T.T.A^E$964&H>6>,?-[N7LOY/XSY!H,7_A0]@?&89))_09'&-C
MR8GM^U'K\**]M-XH<@YRVE9SSRC7Y-0T4YE99[:UE/22M;M<PR.=&TDAXU(,
M;NG;0H-HZ&V4UMHJ>W4,;8:*DCCIZ6!NNV.&)H8UHUZ]&C1$=_H'W]"=2@B?
MR1XANW-G&DN#V:X4]LK)*VEK!55C7NBVT[G$MTC!.IUZ()+QVV2V6P6JSRO;
M++;Z.GI))&@AKG01-C)&O70EJ"YH" @(" @(" @(" @(" @(" @(" @(" @(
M""'O*/(KKBW!F77:RROIZ]M(863QZAS!,0QQ!!!!T)T(17QG>\O<7R%SB\ES
MG$DDN)ZG4HC8GPAR>ZV3GZPVNCDD^[;W'54EQI6%VQ[&TTDC7EH.GP.:':Z=
MM4'UMBZ-/UH.: @(" @(" @(" @(" @(" @(" @(+1D]@ILHQR[8W6R/CI+M
M1ST,\D1#9&LJ8S&XM+@X @.Z:@_4@TE\<.,^>>".:G8'74U54<47CUZJLKHH
M_FK8Y[(WMAE$NW2&9VQK7-.USF[=S?LZ16Y5BP?"L7JZNOQC'+99:ZO_ +^J
M[=14]'-.02X>J^%C2[J2?BU0:'P\9<W>0GD+'E&=44]%A&-71S:.LE@-)2BA
MH*DED5,V1KMY>6_$?BZGJ0%1]#Z9@C:&-&@: T#Z!T[#Z-$1Z$! 0$! 0$!
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M_P"X+:6U6$6:0N:&./5M?.SH#*X;71 Z[!U[J*E]K&MUT]O=5') 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$%#V*#7SS$QRMR?@:_VZWOACJ8I::L:)I&PAX@D
MW%C2X@%SO8/:BHI\7H/%"Y\:6RBNMKQBIRRG87WTY'2TL]7Z[W$?V6M81MT
MT;&=H]R"=J/'/%QE93/M=DP*.YME8ZC?34EH;,)PX;#&6,#@[=IMV]=4$O0Z
M'MIIITT]R(Y3$@#1!IUY3^3]VQBO/#W$C'U>?7(-IZNN@87R4AG.@B@'MF</
MQOQ =1U[161^*/C&.)*!^;9EMK.2+U&'2_$7LH(IAO=$.P,I)_*/Z_L6]-=:
M(3X"N5OLGG+GEOK9]LUSDO5!1:@G?.VH9/IT['9"\H,;\FZ.JN/F79*6AB?/
M4.GLCA'&-SMK#&YQ_  24'MY,IJBD_2 T%35,,4%7<K1-3R/^%KXQ0PL+A]
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M14>'?(4<\SY(Z.HR"GI&/<YS8H6T<3A'&"=&M#G..T=-24%\M('_ ( ;B?\
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M(]JSV9.*-TQTN?GT_=4]Z)KS35DD3@&Z+,U=CL!U&J@J@(" @(" @(" @("
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MU[201](06:+.\)J*UMM@R.UR5[GF)M*RMIW2F0'3:&!^N[7V:(+^YS6MW.(
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M>7SAFWRYO9([AG.1T;J^MO=6_P!:J9-5ZR1.CE: YK=KF.TZE!T<%WGDK/\
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MJ"/>@PBX<9V>Y<BV?DRHFG;?++1ST%/"QS?0='4Z;BX$;M1ITZHM6;@:(BJ
M@XN>&G0H,6SW-+/@>/U&0W9SGAI;#144(+ZBKJY?AAIX6#4ODD=\+0 BK%Q]
MC=WN$K>1,WI/E\RN4)936Y[Q(VU4+R"VGCZ=)' !TSN^[X>P02.!H /<B*H"
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(*$@ GW(.LSL'4]O?]*"HF
M:?H059()!J.B#F@(" @(" @(" @ZJG^]YOZQWZQ0?-O]'A_*QF'[G?\ 245]
M*&]OZ/<B*H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @("#%N2_Y.LN_<2Y_P"*2(''DH;@&*-(/2S6
M[4__ %+&@\N>9O28=;F.C@=<,AN#C!8K)!UJ*RI.FC6M'4,;J'2//1K>I458
M^/.,:JTW"ISS-YX[KR5=V;:RK9N^6HJ<G5E'2,)(:Q@ #G=WNZH52>J@@("
M@H[L@CFVD?GBO9/^1Z/^VR+6_P"K/0ZM_P#B6_BE(K"""1[ULN4Y(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""CG!HW'L@X>LQ
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M/>HF;KMU'Y-AT&A+B0E9C2UH!.I]I51R0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M ""7L.PVOCKY,TR][*G,:Z,1B-NCH+=3'K\M3=]!_P"L?KJ\C50EG@Z#15!
M0$%"=!J@IN^A!PD?H 0.OL2H@.EY+LT?/UPM0FB;!-31VM\[W ?W9!(X[ 7%
MNAU.W30DGLN3&ICYB;:>1]QD\$R_E%NIKLK6GD3Y$1M( ]O9=9\.["=$%4!
M0#T&J#CN^A!3?[QH@>IWU'U'5 ;('$C30A!S0$! 0$! 0$! 0$! 0$! 0$!
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MZ-S^3S,/W7A_Q<(-UT! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0<7MW#1!B-[X_P (GI+C6U&-VJ:KDBEE
MDJ)*&G=*Z0M)+G/+"2=?:>JBU8'P=@.$7'BO'JNNQNU5-5(RH]6:>AII'NTJ
MI0-SG1DGH-$)2Y,ZBL]"9'F*DMU%"23H&110PM]PZ!K0%411C?WER_=VY9>K
M?+0\:6^5LV)T-7\$EU?&XZ7&>(_$V$D:T\;]-XTD(VD**F2+[ ]JJ.: @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @H=-#KT&G4H(2\I./KWRAPS>
M\9QL-?>-\5930/.GJ_*.WF-O]4[30**^<V9<ZY'=>(*#@[+;,:6XXS<89H:M
MP=',&4XD#HIF//VOCZ$*HD6X\AYYY@<KX=:[989*3#;#6P221M:Z2**)CVOE
MEJ)=  XM;IHUW;V(KZ<44$=-#'3Q-VQQQM8P#70!@ ]J#ODD],:Z:CJ3^!$?
M/;R>\K+]FM)E'&O&MIG98+;&^'*+X\/CFC;%.(WAI:X!K''1O4_%KI]"*D7]
M'2XMX;O_ +?_ +8JCI_]14B"(O,^HJ>0O(?'L LMQ?0RT=%!27">>1T5)2B=
MQJ9*EYU #(X7;Y'>P-*#V\7>'-_=E5KR2R\HV#(J&RUL-16Q6NIEK" QV[:3
M&7-!('3<@N'EUE^1\C\X6'@"Q79]OM+G4T-S9#(^,25-:T2;9AT#@V,M+1VZ
MJ##<@QG)O"3F'%:G'KU5W?%K^S2X0RM;%#5,WB.:%S XMWLW-<U_=NH^D*B6
MO.CE?+[9#C'%N&R34<^71^M724[M)IXY'MBBIV.!!;JXG=IW00ERQPEDWB1#
MB'(F+95437"MG9!<8V?W.T3M8)G1:-)]2([7#XQ[NB#Z28)E-'F6)V;*Z![9
M*6Z4D52U[-0W61H)TW#73507V><NAE;IT+'=?P%4?.+]'CTY7R\__8[_ *2@
M^D[>R(J@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @LF6U=5;\<N]PH6&6MHZ&JGIHF]'/ECA<]C1]
M)< $5\,,BN=?=[]<KI<Y'37"KJ99:F1^FXR.>===.FJ(]>&W>YV/*K->+14O
MI+C3UD#H9XS\329 .FNOO0?=&RS25%GM\\SBZ:6FADD<>Y<Z,$GI])0>Y 0$
M!!Q?]E!U%X9\6G^XF\1MRWRG:L%Q^M]"LB=DTD);;Z-IWO$C^C7O:-=K1W^+
MNM#5:N,-NS?S/I_ ? \GB.HMMI/!7WI\C1:*Y5T%SCO$<G_6$<WS;9-2/RP=
MOU.A!T)7R$74FK^E<FELOT\X9C9-O#Z*/H#QAFL.<8;;K[&1\Q(PQUK "/3J
M(SH]O7]5?:Z;+&3'%S^6O%]!=HM5?AN^S.QF;-7'4K:<C<[1T4! 0#V06R\B
MZ/M=4VSNC;<_3/RKI1K&)/9NZCHK;OV[GC)-W#/#O1K\KSSH/[LLVOT1GO\
M^>M[_P!OSRX5?$>:SK6G(+YS+BE'!=+O56M] ZKIZ640Q$O_ +HD#.GQ_2LV
M+#@RW4MF:TF>IJZK5Z_3VQ??%M.*V/XKHCZTW1MVN/U::+E/JW:B" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(.+_LE!KYY<\7Y)RIQ/46O%FB6\6R
M=MQAI=='S"%NI8SW.]R*^>^:<]Y?D&*8EQWEMICIY<%KF3,G_*1U<GH$:QRM
MD<="-O=0JEC%,EY-\O.;<8O]PM,5'B&-3M?-Z+'FBA9$3(X/D<23(_4#354A
M],*=K6,V,&C&Z-:/< --$1VH" @(" @(" @((XY^_D7S?]RJC]9!K?\ HW/Y
M/,P_=>'_ !<(-UT! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0<7NVM+AUT0>"Z2[K76#336"7_@E188%P')
MMXCQO0#[%3[?_P KF5)6'[UNG,^3RT%-3>GP_9Y3'75<FYCKQ7PNZPQ]033Q
MNTWN[/(+>HU"@F2"GC9$V.-H8R,;&,: &M:W30 #MH%4=[6[1H@J@(" @("
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MT+=T^GMP1,6UV\[Y/QGQS-XI?%^6VRV;8I[L3'7699VUFT::_A6Y$OGW,("
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MUO\ T;G\GF8?NO#_ (N$&ZZ @(" @(" @(" @(" @(" @(" @(" @(" @("
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MR2:AHX:>1S>^CGQM#B/H)51D#6M;]D:(*H" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(*'L?J00[Y'8SR)F/%5RL/%U144^65,U.89*6L^[I#
M'_EFF;?& '-Z%N[J.B*T/QWQ)\O<1FFJ,3;4V&HJ1MJ);7?X*)\@'4![H*EA
M=^%$9QBO!_G'0Y19*V]Y%?)+-3U]++<(Y,J=,QU,R9KI Z/YP[@6@ZMTZH/H
MG3:CH>X UZZ]?>@]" @(" @(" @("#JJ?[WF_K'?K%!\V_T>'\K&8?N=_P!)
M17TH;V_H]R(J@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M ',I_P!U;=_;VKJ>'?%G\-WJ?/>._P"-']S'_/:DD+E/H5500$! 0$! 0$!
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M?/>._P"-']S'_/:DD+E/H5500$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MD0> ):@G[=0YC3[&@!!*&@'8(BJ @(" @(" @(" @(" @(" @(" @(" @("
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MRL9A^YW_ $E%?2AO;^CW(BJ @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @XND:SO]:"PY3FV,85;FW3)KC'04LLC8*9K@
MZ2>HG?T;%!#&'22R.]C(VN<?<@TF\R<#Y(Y?M5'R'8<-K:2Q8W3O<8ZR6-MR
MGHG$O=.;>T&6,-UU<Q[A(UO5S&Z'0KY^;'$].NO;3JB/ICX%\.WS!L6N^;Y-
M1S6ZZ9-Z,=#23D-?]WP_&R1\9ZM+WN.FNG3N$6C<M$4=]DZ]D'27M!_7'UJ#
M$,CS*6GN#<6QJD^],IFC]0Q$[:2DB/02U4@(V#VM8/B?[-.ZP7Y=O#;MGT1T
MNE@TD3;WF2>&R.N[\,<O3R.>-8>+:_[TO50;OD\H_*7*=H&QI_XN%H&C(Q[!
MW4Q8>&MTS6Z4U.K[R."R.&R.2.7RSY66L:6D@GW?4L\N>LF:U-11X?D%=22.
MAJZ6V5LT$K#HYDD5.]S7#Z01JMC3VQ=DMB>68];S=NE\_)N7N3:^@DHZS**^
M>EJHG15$+Y=6OCD:6N:1IV(.B_1?R_3Q-8LC8X7S&3G>BV<N<F4IH:.GR:O;
M20&*"*G9( !$PAH8T'3IH- O%_A^GI,\$5>K=1DF8VMR+;%RCF-/$+D^/$+$
MZ)@VT[V5=WG#F ;G3#6*'7OHQKG#]DOAKNYQSL]^[JM]LNW%65X[@>/XR'36
M^F]2Y3:FIN=2[UZR8NZDOE=UZ^YN@^A:N3/?DV3NYN1ZHR1L3@!K]9"P3 [5
M4%00$! 0$!!3WJ20ME__ .P[E_S:7_@%>[.TQY>Q+"^$7 <<6O\ KI_[<];&
MI^)+2\/^!'G2'ZK->_ZO1:CHN>\$Z?3HJ.1[((UYN_[F4_[JV[^WM74\.^+/
MX;O4^>\=_P :/[F/^>UE.;8W%F&*77&)JR>WQ72%U,ZMI2&SQ!Q^TPD'KT7*
M?0M!KEXZ\BU_)^018_#=\D_@92V]UEGS.E,5OO)IY7"2!LVD<4C&=X7AW3KK
MW17T Q..OAQZW1W6@I[7<FP1BJMU$0::"33XF1D=-H]FBI*](@@(" @(" @(
M" @(" @(" @(" @(" @(" @(" @XOTV'7L@U:\[\BN]@X2DAM<Y@9=:R*AJR
MWNZG=J2W4'IU45CGCUXD\-UG&]ERG*+6;_=KW2-J)?G9'>G"7D@"-D>T@]/>
M?J00KF^ VKQV\I,'H^.*BM90W(P3RTKI/5EVU$KXWQ-T:W5I'8%!]+J?4LW%
MI:7 .VGN-0JCN0$! 0$! 0$! 01QS]_(OF_[E5'ZR#6_]&Y_)YF'[KP_XN$&
MZZ @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(*%P:0#W*#R5U=245+-75<S(*2FC=-43R$-9&R,;G.<X] &@:E!$+9,MY?N[
MV[);/PV8VNAJQK#<;V21U .CHJ5WL.T&0:$?"5%2U;[516RB@M]JIXJ*AIV[
M*>G@8V.-C>^C6M  5'O:-&@>X(BJ @(" @(" @(" @(" @(" @ZYF[V@>S7K
M]2#!N1V.;28V>G_>&V?J^J5K:C[/XH=3P_?DI_V[F:!CM.HUU_6"V*0YG2Y,
MU:#UU]RL\R.YIZ(*H" @(" @(" @(" @(" @(" @(""A[%!'?,7&E#RYQ[=<
M&N$YIFUS ZFJ0W<(JB([HGEH+=='>S5%?/RQY/Y>^-TE1@]OM%;<[+"Y[:&*
M:@FNE$(PXZOIW1=0UWN)T^A09)Q7Q#SOY!<FV;DGF+YZDL%GJ8ZF!U<PTSMD
M$OK-AIH'@%K-_<Z:^]!]'XHO2Z ]  !^!5'-[PS0GVH-)?)[S&H+=07CC[BJ
M2IJ,C;&Z.OR*B>Z(6]T4NV0,(;NWC33>--->A]J*RWP+R[*<MXHOMQRZ^7"_
MW&*_3015ETJYJZ=L3:2F<&"2=[W;0YQ(&NG5$17S9S'RIRYSW3\$<3W^IQ6D
MH:F:@J+A2S2T4TM3 POGDEEA+7AD?IN#&L=\7X=%%<>+>3>6N$?(&'AOEG+Y
M\HLEP:V*.MKJF2H#)JIK98I6S5),H!.K-A=[>@5&0^67,G(\_)UBX+XKNTUD
MN5<(1<*ZAF]&I,M7UCC$D9#X]K?B.T@G4=4&$-SCG'Q2Y<Q^R<FYG6YMBF0Q
ML?6BKJ*NN8(7O](NA=5.<]LL;M#M!T([]P0$N>9_D!DO&UJLF&8!(^CR?)V.
MF?<HP?F(*;<UC1!H#^4>XD:]V^SN@@S-:CR?\8I,6S;)N0+CD=KO$C&5EMJZ
MZJKZ=CMHE= ]E6][=Q /Q1Z=N^B#Z+8O?Z3);%;;_0O;)27&GCJ8W,<)!I(T
M'35O0Z*"YSS-=#*T#NQP!_ 54?.#]'CTY7R\^S[N_P"DHKZ3M[?T>Y$50$!
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M7G'.,<6LE=]^N9->,I>W949#=I#5UTHUU'71C(Q[F01L8/8T(,R]'Z?U1JB
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MGAWQ9_#=ZGSWCO\ C1_<Q_SVI)"Y3Z%54$! 0$! 0$! 0$! 0$! 0$! 0$!
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M9[#'N=0V5CF_"P:G\O5 '\K.\::_#&UK1JX)-8S8-$1R0$! 0$! 0$! 0$!
M0$! 0$! 0$'%QT&J# >3ZJ.*EQPSEL;!D-L.YS@!TE)/?Z%IZF=EOXH=;PZV
M9G)2*_T[F>1$.!(^I;<.2[%00$! 0$! 0$! 0$! 0$! 0$! 0$!!0]C]2##N
M0.0L3XQQFJR_,ZMU%8J5S8Y)8XI:AYDE.D;0R%KG:N/0$@#WD(-$N7?->V\F
M0_P/P7CN.ZBY-DH:66_4S:RN=)5CTF_*T].Y^V0D_#\;]QTZ(JP<0^&O,N1Y
M1:<XRBBHL,M=#64EP%'5 ,JI6P/;)I'24^[TOLZ$3.8X'\4H/IO3MVM#2.H
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M]RJC]9!K?^C<_D\S#]UX?\7"#== 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M*RT4G9QA@/Q3._\ C*@N/[$-7J=1PQPXO=CGY9^GD*)$9!%$T,C8&M T '0
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M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&%YCR/8\/\
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MRL9A^YW_ $E%?2AO;^CW(BJ @(" @(" @(" @(" @(" @(" @(" @(" @("
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MDCD:.CFGWA$1S^C<_D\S#]UXO\7"#== 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M)K\U\3;$\-L\D;(ZF8>FP#0 +.T!K .F@]_U(*@D:?T%*%79^L@J@(" @("
M@(" @C_ES_L&@_=&F_X172T';GHES]=V(Z89\S[#?J"YK?AR11 0$! 0$! 0
M$! 0$%#V/U(,1S[.;-QOB5TS+('EMLM<+I7L:6"1[@#MC9O<T%SCT U45\[;
MYY=>3/)E555''5!46ZQQRC;':* U;X]GQ;7SEC^K@1JW]142?P-YGYG6YI2<
M=\TV_P!&NN<[::DN/RXH)8)Y2 QDT+]@#3^R[]4&]D1U).NNHUU1'<@(" @(
M" @("#C)KM.AT0:V^1W._)O$]VM=MP?"W931W"E=-5SB"LG])^][=NM,"!T
M/Q**UH_1V/=)RCE<CAM>^V-<YON)J-2%1]*F]D15 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!!:<BR"S8Q;9+O?J^&W6R'^R5-0\1L!/1H&O4
MN)Z-:.I/0!%1Z[,\\SR)T7'=L=9+.YP RF_QF,R1$_V2DHM"]VHZM,^SZ6^U
M072P<66*VW&/([_--DV71:/%YNI]0PR#J74L']BI_H]-N[V;B@D", L;J.NG
MM51SVM]P04U.J@XDZ'Z4VFQ1SCM)ZA!A5TY+QVDJS:[;+-?;SNV"VVEGS$@<
M-=6O?JV)A !Z22-*P79[8FD;9\CI8_#LLV\=T<%O/=]*]4/%*WDW(G-])]/B
MUL>W1X=I75YU'73H(V_TR%CGOKZ?9CKEFII,-8FN68W3NM]KWVSC?&Z6L9<;
MG')>[Q'U;6W60U98XD'='&_\G&>@ZL8#]*]VX+8W[>EAR>(9;HI;2R/W8IZ=
M[,'-9& UK0!VZ =%G<^9EC5ZS["L:=)#?;]0T=7&T/=223,-46N[%L#29'$^
MP-:=5L8]/DR=FV9>:T6%W+%+72/CQ/'KUD(8UI=44](:.!KWGHUSJYT#_9J2
MR-PT6:-),=NZVWSU]52JM37<PW5^EKMEHL5.8OM7"IEK9C([VM$#&- :/8[7
MJI;&"V=LS=T;%HUM\F[;DUNN6/C)KXV]5,E/*8W,I8Z1L7Q]6@1GXAK[2OJ_
M!+K)MOX(X8KSU<O6\B!5](Y;9CPX ^_\KU_^B4G]MD7R_P"H.Q9TRZ6AWSYF
MWN@[:=%\:ZJNB @(" @Z*@R[#Z1'J:';NUVZ^S73KI[U)K38K#KE6\@V^AJ[
MA)]T.BI8I)RP?-;BV-I=H/9J0%I9.]MB9K&QDBE5;=6<@UU+2UI-I9!4QQS[
M?[IW!DC0[3Z]"O41EF(FL$\+,X@_TV>IIOT&[3MK[5N,3GU4VJIU1'$GH>J#
MPUUSH+7#Z]QK(J2#7;ZM1(V)NI^EQ 7BZ^+8K.QZB*K [/K9/+Z-EIZV\RZ$
MEU% X0Z#IN$TQCC<TGVL<Y8>_B[L[7K@GE5FJ,]N #:2EH[3"YNCGU,CZF8$
M^UK6-#>@]CE)G+=&SW>D]V&.Y5Q4,PH)?OZ\2U=WB:1050BC@BB<>P=&P$D$
M]_B6OJ-%WUE+IVO5N3AFL-<OS=92,K_@<:0_>@?H9 #Z'I:Z>J':?8TZKY6-
M%D[SNZ;70[VWAJVIX^P"UX):FTM(T27&8!U?6'[4KQV[]FCV!?8Z336X+.&-
M_*YN2^;IJRUY(T:T]/9HMQCW,+J>+K-5U,]9-=;RR6=[I'LAN51'&W=[&M:=
M /J6W9JKK(I$6^>V'*R^&8\E\W3=?6>:^Z(ZHFCJ=Q!C[VN8^ZWQS'#1S3=*
MD@@^P]5D^>OYK?X889\&PS]O)_ZM_M9'CF.4&+6B"R6G>*&EW&,2OWO^)Q<=
M2>_4K2R9)ONK.]U<&&W#9%ENZ%[!)/4_6HS;75745+<*62DJXVRTTS2R6-WV
M7-/L*D;'FZV+HI.YBWYL\#[?<E-_YJS_ #&3GEI3X?ION1U.;.-L'B>V2.R4
MPD8X.:X-/0M.H*=_DYY6-#IXW61U,KCZ$A8&\[$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$%'?9*"/>7.4+)Q%A%QS*]:RQ4K2VEI&.:'SSN'P1M
MW$=SW^A%:!TG-7FAS'5U5[X[9<(++&YWI16RFIX:=L>NH'J5#=)"/:02@E+Q
MT\MLUDS"+BOG*&>.]UCQ!;+E/3BFG9, =(YV -W!Y'PO#?Z2#>B'L?;[S]*(
M[4&(Y_QWAO)EJ98,XM;;O:&2"=E-))+$T2-! .L+V'V^]!<\3Q6P87CM!BV,
MT0M]AMK'145$'/D$;'/<X@.D<YQZN/=Q08?G_!7$_)]T@NV=8Q37:Y4T9@AJ
M723T[Q%J.CC3R1[M".F[73V**O>#\=X7QM:ON+"+/!9K8YYD=%#O<7//M<^0
MO>[_ 'SD'@SWB#C;E".%F=8Y2WAU.08IY-\,X ]GJPN8_;_4[MJ#E@'$7''%
MT=1%@6.4UF^:U^8FCWRSO!(^$S3.?)LU .S=MUZZ*CVYSQWAG)=I%BS>S0WF
MUM>)603[V%DC?:U\;F/:??M<-4%FX]X+XGXPN,]UP;&*>T7*IC]&:I:^>>0Q
M]]K3/))M^G;IK[4$D: =@B(YY^_D8S?]RJC]8(-;_P!&Y_)YF'[KP_XN$&ZZ
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#$<ZS_'L!MYN
M%[F?).X.^1M-&WU[C62#IZ=- "'2.U(_J6]W$#JHK"AB&8\F5+ZOD=WW3AN\
MFDPZDDUDJ:=[06_>4K=/B'9T43MG<$GVE2U06^@M=%3VZW4T5)04K&Q4U- Q
ML<4;&#0-:UH  "KR]&@]R"J @(" @(" @(" @(.!)]B;A0ZC0$J;Q8LPO=#C
MV-7.\7!_IT=-3R.>[0GJ6D = >YZ+#FR199,SR0W-%@NS9K++=]TPPC@;*:;
M)./Z84S'1OMTLM++&X@NW;C(#TZ=0]:NAS1DQTCD=O\ 4GAN31:R;;_M;8]2
M^W#DS&H:EUNM,LU^NP)9]WVIGS#]PUU#I-6Q,(TZA\@*V;L]L;(]Z>:'+L\/
MR\/%?'!;SW>S?Z'CE?R=D#A\O\KBUM>&D&8?/7#J"3\( B;[!IJ=/>5XKEOI
M]GTRR4TF&L37+/)39'M>FDXVL#ZF.OR!T^0W%GQ"2Z2&> .V[=64Y_)#Z#LU
M'O7J,$;[MO2QW^(9-D64LB/N[)Z][-Z6&&&%L<,;8V  !C0&M 'L '1;$1$;
MG.NNFZ:S-7=M;[@J\FUON""J!H$#0>Y 04/9!P/?OV4%1K[5%<D%0O2" @("
M @C_ )<_[!H/W1IO^$5TM!VYZ)<_7=B.F&?,^PWZ@N:WX<D40$! 0$! 0$!
M0$! /9!K;YNV^LK_ !\OT=%"^8P5%)42AHW;88I=7N^@-'4HK'_#WE;BJ+AZ
MSXQ%>;=:+_:XW&[TE4Z*B<^:1Y_*ES]K7EP &[77H@@/RFSC$.2>?L!@X\K8
M[E<J"HI*2KN%(PO8VH%;J!KM^/9WU[:*#Z16YDD=-$R9_J3-C8'OTTU=H 3I
M])"H]B((" @(" @(" @ZJG^]YOZQWZQ0?-O]'A_*QF'[G?\ 245]*&]OZ/<B
M*H" @(" @(" @(" @(" @(" @(" @(" @(" @(""CNC23VT*",>6;S>L4LDV
M6Q9E18GCMKA=)<)*ZV"Y/E>3\(C/S,!!/V0S0J*T[_\ '-=?X3&W#*C_  8V
M#;>OX,Q^KZVIU!I_O+7;IIUWZ_1HJC;'C_.S)BPY!R7D&UWK#JZ!KZ*>.W-M
M;XY0"]S#_=507R%K2T1-&[4=-5%>IN9YSG40_-W:Q:+0]Q_^VF_Q$-?$/^,I
M:-IWRZ^SU'1MT]NO1!?+)QK9+?=XLGO4D^29E"W2*^W8ME?3[AM<*.!C64](
M"/A=\M$PO']D+W:DAG$1T!U&G7L54=FH04U'O0-1[T&.7W+,<QMA?=[A#3$_
M8BUW2OUU^S&W5Q[>QJPW9+;=\MK%ILN2?=B?IY6,MRS+<C!_@E8G4M*[H+G>
MR:1NUP^W'"P/>_3N-0!]*Q3DONCW8V>5O3I,.&9[V_;');M]+JN6*4$T$<W)
MV4.N5."YK:265EGM;G.(.UT,+V&8#3[,\DC>_P (U*R6Z>^^*36_HCV//S_=
MS7!;&.>?M3_NW>:(=-)R?QO9X8['B4<EP=%(8(+58:-TK=PU+M@:UD1:-.I#
MUTK-%DINBV(YY<O)DF^>*Z:S+VMR[/+U#ZN/8;+3-?)MCGOU0RB:&#[3I(H_
M5E&OLT84C#CMGWK^J*_L>9<*>Q\N7-SY[ME%!8H7R]*"T4#:U[(6Z?9JJW:"
MYWMW4Y ^E(R8;=ULW=,T]$>U*5=\_%-BNSI'Y5<+OD9G<TRQ5]PJ(J-X81HQ
M]%1NIZ1S.G5KH#K[=4C5WV]B(MZ(BO7-9])PPR?'L4QO%HI8,;LU%9X)G!TL
M5OIXZ9CG#VEL36@GZ5@ORWY)]Z9GI6D0O6NGL6+I%#J[77L>P08Y?\(P_*)H
MYLFL%OO,M.TM@DN%)#5%C3U(:96.T"RX\M^/LW3;T&R5J;P[Q-MU."V'\-KI
M/VI9_G,_W[NN7GACF7:P85A^*S33XO8+?99:AH94/M])#2ND:TD@.,36D@'V
M%8<F:_)3CF9ISR]1$0R98@0$! 04*DAJ%!@_)^6V?%L:K3<9-9ZV"2GI:9FA
MD>Z5I9J ?8->I6AK,]F+'-=\LV.V9E3C?,+1EN-4;[:\B:BACI:JG?H)8Y(F
M!O8$_"=.A632Y[,MD3:E\3$LPFK*.BA]:LGCIX6]"^5[6-!/TN("VIOB(VL=
M)EC-1GM@$[J>W?,76J#CK!;X73D!O<Z]&D?45@NS6QSO<6J2W'-J^-IMEH@H
M&/;J9;G/\0U[:,@:_J![':)Q9)W1Z2EL<KD,=O\ 5-<R\Y%4R12;=8;=%'0-
M+1U(]0"28$_LHY6)W=T[[MG0<4<D/7;,-QFUUGS]);(S<M277"HW55821UUJ
M)W/E/X7KU;@LMVQ&U)OF60G0@=.JSO 1TU3:;#4]>B*:^W1$H=^I]B]1)0_!
MU0Y%1KIV4%?P(.)U['JJ*!NNGN42CGV[(JG4GKV0JJ0?9T4VBC0=>J#DJ" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(*.^R=>R#4[SZM=QN/";9J.G
M?-'07"&HK'M'PQQ#5N\Z^S5%/&OR0X?/%=FQ^XWN&R7BQ4OHUU'7#TW.$7Q.
ME86AP<#K[]3IV00)RKGN/\V^5>"5''%3+7P4+J:E?7PL(U=%*Z5TD8<>K6M.
MO4*#Z3TP+8PTN+BT!I<>Y([_ *O=5'<@(" @(" @(" @CCG[^1?-_P!RJC]9
M!K?^C<_D\S#]UX?\7"#== 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! U [H//.YK?RA.C0-2=>F@_I((NNG)ETR:X5>*<34<=WN]*(C6Y#4'2
MR4;97$'\LS<9I0!KZ<;3])[J+1?,2XXH,;KI<BNE3+D.;U3/3JLCKV@SB,G=
MZ%,P:MIX->T473]D7'JJ,\;]EOU!$50$! 0$! 0$! 0$! U""A(]Z#I>6AI)
M/0=4&*WW/<9L,HIJRL]:X.)8RAI :BH+OV.QFI:3KH-VBP7Y[;>5OX=%ER[H
MI'/.R&MGD'RM6W^.GPRGM]3::<%M77,K6QB65A/Y%KF#<Z,@M+M-0=-.X*X/
MB.IXO<H_6OT-X)P7W:JZZLV[(INVUKMY4><05M@AS2BMN5TXJ\=NCFTU53RS
M21TOJ=XGS1-<V.5H=[)06CNM'27VQDB+MTR^N_5>ERWZ2[+AV9,<3-:17AY8
MCFGHVM][=1T=OHXZ2WPQTU'"T,A@A:UD;&CL&M:  %]A$1;%(W/YKONFZ9FZ
M:R]@'7IW]Z]/(01U]B)#FWL@JJ" @(" @ME^I[I56Z2"S5L=ON+_ .PU<T'S
M3&'VDQ;X]W3^J5B8B:S%?0L(NRN3E;&8+7,S+Z"I^\;I16H@V4,#!6R;"_\
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ML=^L4'S;_1X?RL9A^YW_ $E%?2AO;^CW(BJ @(" @(" @(" @(" @(" @("
M@(" @(" @(""FYO;4(.+G-((#NI'1!\^/TC617(5N(XI%./NET$M?+3 -W>O
MO+ YQ UTVM&@[(K1)O35P&OTGWGW*HW7_1X4M+=\LRBGN5OAJX[9115-OJ)X
MQ(Z&:28-<(W$:#H-?K45]&(P6$ZCHH2YEPZG5(2BFH(&X^U"'GJ[A14$1GK)
MXZ> =/4E<&-_5.BKU%MUVZ$69)Y"\=V>1U/;:PWRO.NUE$8Q3C0:DNGF?''T
M/0AA>_W-*R3I\U:19=/JZW0LT6RN2ZW'3GG;YHBLK+4Y3R#F#(S!;KPRD>QT
MORN-TAH6F,ENP/N%^=;B[=_^30ZCOJ5X^4ON[>2RS;NB:SZ*_4R?,:;#/].R
M<FS[<12O1'US*[8KAN<6[T9:.P8]C4DC?6GJZF>JR"X/F/\ ZPB.@:'?LG-F
MD66,.EQQLXKI\T>G;ZH:F;69LNRZ[9S<G4N_YN<GN+HCDF>7:LC9N)AMPCL\
M9<?<:0"3:/Q0^1RSQJ;+8]W''GV^MIT7"S\38'998JNGLL-1<H]VZX5>M35/
M<_75SY)=Q<3KW*\7ZK+=]JD<W(;(9A14D%&UD%-"R"!FNV.-H8T:]^@ "U:S
M.]Z>Y$$! 0$! 0$! 0$!!0J2*;V^]04+FGVKU4HL]\R"U6:!TUPKH*7LUGJO
MTU>[[(T;J>OU+#?EBW?+U%M6G?(=;DUQR.:LR=LC9Y1K2;F2Q1FFU.PQ-E:U
MVP_4OB-;=DNOGC=/'$4V*\=0954Y-3P8HZ2.LEU94/C>Z)@@/VR]S>P [']3
MJKHK<MU],<S"Y>&(VML:# \?II8J^JI/GKFW1QK*Q[ZJ7=I['RZG0>Q?9QAM
MG?MES>)D<<#((_3BB$<8'PL8  /U.BSQ%(H\5>I>D$! 0$! 0$! 0$! 0$!
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MUC)!,X.G3W+OXO!L]T1=6&M=J;+9I.]C&!^36"8KB5ML%?;KM+5T39!++#!
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M)*DSU]6(]=0Q]/3"G8"X^T5;@/<?9AR9\^6:SZ5BS1612Z;[I_=X8MZYK/\
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M?-_W*J/UD&M_Z-S^3S,/W7A_Q<(-UT! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MS<ZDG[JJ/UA[D&N/Z-S^3S,/W7B_Q<(-UT! 0$! 0$! 0$! 0$! 0$! 0$!
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MX-P@;3B-E$:,,#7AVNIJ)]W;Z%R/$/$9U5/=X:>=M8<,8XF(32#U7)AF55!
M0$! 0$! 0$! 0$! 0$! 0$! 0<7DC31218[_ )99,9CIY+U6Q4HJY6P0;SH2
MYW373W#VGV+#DRV8^U-'NVV97F"43,#VD.80"US>H((UU"S6TF'F7:JCB[N$
M'"7[#_ZT_K(DL"XI:#:;O^ZM5^N%T-?VK?PPT=%V;NEGHB;[-1H=1V7.;[M5
M!!'_ "Y_V#0?NC3?\(KI:#MST2Y^N[$=,,^9]AOU!<UOPY(H@(" @(" @("
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M3U1KM+NV\L^SO_JM%J_*8N/CIM9.\NI1DPC8#J!U6V\*Z!1#0*AM""N@0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!&'D9_(7GW[C57_!0:G>'ODAP
MOQ9Q",8SS)?NJ^?>E95&E^1N%5^1F;&&.WTU/*SKM/3=J@G\^;'C$>^<?YJO
M'_UD@]UD\N_';)KO0X_8\Q^:N]QE;34<'W9=8]\LAT:W=)2-:-?>7!!-\?M]
M_P#[I0=B @(.!C83J1U0/39[D#TF:::=$%?39KKIU04]-@ZZ=4%?39WT0 QH
M)([GN@CKG[^1?-_W*J/UD&M_Z-S^3S,/W7A_Q<(-UT! 0$! 0$! 0$! 0$!
M0$! 0$!!PE?L;NUTT[H(_P CYAQ6R5HLML^:RG*']&V'&H#<ZIIW!NL[V$04
MS=3]JJFB;]**M==8^5LWDC-[O$>$X[(UKW6FR/%5=7;F@F.HKGL#&GKHYM,W
MX3T$CQ\2@RG#>.\/PJ![<>MC(:J8N^9KY7.J*V7=M)WSRESR"0#MW;=>NB#*
MO2:1I^ H*@[=&CH$10O(ZZ]%0+S[^H4(=$M4V)A=*]K&@:DN( T^G731%B*H
M3\A<UQ)_'&08^R]T3[[-"P16Z.=CZ@[G#0[&DNTZ=UU/"XF=3;#UFP9(Q3?P
MS2F]H_I[5^COEEPL,<LN162*G(;4/N%*V+5[HAO=*T#XV->YO7\8-)'N6EK8
MB<-U=D4;>DNFW+$PW-I.'\TGJHJVYW*T4U4]Q?4U45/472J&X:%C77*66%WN
MW_+@^X!?F]N+2V3,\$W3^]+ZR_Q#/?%*\,?NQ$>IF5'Q;+-%/%?\IN]R,NC=
MD,S;; V(#;L$-&V)FG^]66-1%M."VV/3ZVA=,W;Y>ZV\/\<VRH%3#889IVM+
M&NJW25@ /?X9W/;KT[Z*7ZK+=ONZMGJ>=C+J*TVRVP-I;=20TE*S79#!&V*,
M:G4Z-8 %@NNF[;,U(>CT8]==.J\BOI,]W]- ])GN0<MH4H*Z*CB6-*#CZ3==
M5Y%=C7=U8541M!U ZJHKH$%4! 0$! 0$%-0E!0N^E!US2B*,R%P:UHU<X]@
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M'(53H)'VJC#OMOC;/+(UOM #B&D_A5B<L[XB">'D1%S#P_<[EZV84\K+O<&
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M/,]3=,[Y7O:T=@%F>54! T" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(+5DV/6?++!<<;O]-\W9;G ^FKJ;>^+U(7C1S=\
M3F.;K[VN!063COCC#>+;$,7P6V_=-B$TE7\IZ\]5^6FT#G;ZF25_7:.F[1%9
M@B! /?J@  =AH@(" @(" @(" @((XY^_D7S?]RJC]9!K?^C<_D\S#]UX?\7"
M#== 0$! 0$! 0$! 0$!!YZB=D#7R2R".*-NY[W$-:UH&I))Z#I[4&'W+ECCF
MT4TE96Y7;3#$0'L@JHZF;77L(J<OD/X&E1:+/!SK@UQJ!2V!UROU2!N?':[9
M63%C1[7!T;$J4=5=R9FE3%5S8]QU>JBBBC>(ZZLEHK6=X:3N^7K9XY"T=]=N
MA]BH^0/(%1=:[-+Y7WP:W2JK)IJDM#0-[W:]-GP_J=%DR8[L=W#=&U*U8XR/
MUG!L;27O^%C?ZI>;;>*:0/MWQ'24U)QCAT4$#('.LEM?,&-# ^5U'$7.=IIJ
MXGN?:O,Q,325EF;]&M]Q*53<Q*_<FX#C(=]]Y'14;V2>B^+U0^1KQW:YD>YP
MT^E;%FFRW[K9>K;9NFD15BC>=K=>"^/";#><FF8_:_Y6E=3PAG82"2I]-I83
MVT*]68(F9BZ^V)9[]-?9%;HH[[;=>=[\6NFM5CQ6G]5[9!723W2J,.GPN:RF
MDBB!^@RJS\O$3$\4SYHCZY8[K8CEKT/3!QA=+E'&[-<YO]]>ULC'TM)4-L5&
M[U>GV+8V"5V@Z#U)WA6-5%L>[9;'EI6?36.J'C95D]DX\P2QP1QVK';=3[&-
MB]44T;IGM9V]25X=(\^]SW$D]2L5VHR7[[I>:49,V*)C0QC&M8.@:  !^!8!
MRV,_8C]1 +6]>@0=9:W0] O,+O>>:>"G8PS/8P2/$;-Q U<\Z  G3J=>B5B%
M=D>CB/P]3I_N)".YH:.P2!RU5134^U"AU]A255'TI"*I4<#J3WT5@5[>]1 N
M ]J*\M77T=$SU*RHCIX_8Z5X8/U20O$WQ&]4?<A<L6;$K69+?4PW&[U (HX(
M7MD8'#NZ0L)T:/=JN;J]?;BM]W;<SX\4W2UGH<^RJ@R9V6PW"1UWD=K4%Q)C
MECU_L3VZ]6:#0#V=QUZKY6W59+;^.NWSMZ<43%&SF)\M6?)Z".:GIZQ]P#=*
MJCIX))O3?_7-'8^SJOKL&NMRVUB)JY]^.DL@DRUP:?1M%UED]C/E'L!/UNT
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MVBQ;:DZ=VA]PKZV/3WGT=546YO%-YN%0^IR?D7)+F=H;3MHJH6-C-.Y+;8V
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M5MU+[(NAZOB:;)H^J'"V8/O/#N/YCE5TC?)4T\TU;=*N2.%GY.HE9N<[X6
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M_P @95_@=N_TB@?SC?"/^0,J_P #MW^D4#^<;X1_R!E7^!V[_2*!_.-\(_Y
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MM0/YS)O^R_\ S[_JU _G,F_[+_\ /O\ JU _G,F_[+_\^_ZM0/YS)O\ LO\
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M&^BYI9M'L&U%?1IG$/%+F@_P&Q[K_P#8BA/_ /J1'/\ -!Q1_$7'OWHH?VI
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MN@K*2VTL$S"9F#X'QQAS>ATZ%%8-^CA.G&F4#WWEO^+M5&Z2((" @(" @("
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MBM,KYZ!KI9H?3DE #B/2>S74-'=!E])2Q4<$=- T,AB8V.-HU.C&#:T:GKT
M0=Z @(" @("#JJ:>*KIY::9NZ&9CHY&GVM<-"/U$$><>\#\7\6W6KO6#V)MK
MN-='Z-5,V>>7>S<7:$2R/'<H)(0$! 0$! 0$$?<A<*\<\J2V^;.[.VZR6O?\
MBXRS0^F9""[^Q/9KV'=%9O1T,-!3P4E,T,@IF-AB:-3I&QH:T=>O0!$>I 0$
M! 0$!!XZVWPW"FJ*2J:'TU5&^&9G;='(TM<"1UZ@E!A_'W#N <6MKVX):6VD
M7.1LU=MEFE]1[>Q/JO?I^!%9XB" @(" @(" @(" @(" @(" @(" @(" @("
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M" @(" @(+-E.+63,[%7XQDE**ZQ72+T*ZC<Y[!)'J#M+HW-<.H]A06/C[B?
M^+**KMV!6AEFHJZ1LU3#'+/*'R,! =K-(\CH?85%9HT;6@>X:*HJ@(" @("
M@(" @C_D3A7C3E>>@J>0+#'>I;8V5E"99JB'TVSEA>!Z$D>NNQO?5!FMLMM'
M9[;1VBW1""W4$$=+20 EP9! P1L;JXDG1H ZE!ZT! 0$! 0$! 0$!!&UIX%X
MIL6<OY)M..Q4V:RS5-3)=A/5.>9:QKF3.V/E='\0>X?8Z>S1!)* @(" @("
M@(" @L64XA8LUL=;C63TC;A8K@P15E&YSXQ(P$. +HW-<.H!Z%!:>/\ BK!.
M+;?46K K0RS6^KF%34P1RSS!\P;MW:SR2$=!IT*#,T! 0$! 0$! 0$! 0$!
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MY5<*<EW9MBQN_AEWD(;3TM?$^B?,X_BQ^L&[C]2"962;CIIT]Z#F@(" @("
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M@IWDR!NC0&R2]7>S4=45]".,;M#8?'VR7ZH?Z4-JQ]]=)*1N#&TT#I2[;W(
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M&^2((" @(" @(""'?(>^<M67$:6+AFU&YY?<ZZ.B#A&)!3T[XWN?,7/<V.,
MM#=\ATZ^_116@^'8/E^!>7F#6S/Z]MPR^ON$%TNT[7F8-FJ_5);ZA^T0!W_
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M)D\CP]TT43G,9(=.VH&@'T()G1! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^>LWXALUU?<L"H_FWT;9G>IHZDE#6O800UI(=H_0==%1] D00$! 0$! 0$'
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M 0$! 04V-)U(Z^]!38WMH@Y(" @(" @(" @(*;6DZD=4%-C3W 0-C?<@Y("
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M04U!]J"NH]Z"FH]Z!J/>@\-QOEFM$E-#=;C34,M:_P!*CCJ9HX732=/AC#W
MN/4=&H/<""@J@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M31$?46Q8EBN,,FCQJQV^S,J2#4-MM+#2A[AT&X0M:"1]*BK_ !C1@51R0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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ML+CKW5'T)Y/9&[Q0OKG,:Y[<*<6NTU(/R#>Q0:K?HY(8I<QS)LK&O'W9#IN
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MO$-%"=()YV,>6ENOP]== @V*\>,?O>/^/%CQ^]4,U%>HK=-'+13-VRM>YK]
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M#M&_ >XZ(,Z\XN'^3^0.5+;>,+Q6X7NV0VB&"6JHXC)&V5LTI+2??H0J-XL
MI*FVX%B]NKHG4]=26>@IZB!XT<R6&EC8]I^EI!!1&I/G'P'F6?76PYWQ_9W7
M6Y4<+J"[4U+J^K> ]KX)&L/0M9J_70ZHK,/%#)/)&MO<F-\OV*>UXC:;)Z=K
MJJBB;3/EJHIX(XP^4$[B(M^@&@4&UKVEPT"J-#O*WQ8SRXY^_F/BJ'Y^MJ#%
M57.W,<'U3:ZG :V6&.3<UX+6LU9]'916$YC?/.CE3&QQ[?<:K:6V5[HZ>Y5=
M/0MH7U##T+:B5CM&Q./60,:T$#0_#J%1M%XL^.C>#<7FEO#H:G-[OH;E4P.+
MXXXFG5L+"0-=#]H^_L@UU\C>'>4<H\G:?+<?Q6X7'&VOM1=<X(B^ >B&^IJ[
M7\7VJ#Z(,^PWZ@JCD@T(\U?'//,SS&EY*P.W2WR2>"&AN%!2CU)XW4X(CD:S
M3JSON**DW@V]<^Y;QOFMEY>L4E!6T=OAHL:#J,4DU6'03MDU#26N<"V/[(;W
M^E01/X.<0\FX#R%=KCF>+U]DH9[>Z**HK(O38YY</A!U[H-J/(+AR'FKCNMQ
M1U2*.Y-<*JUU#M?2%7$#L$F@U+#KH?=[BJC2O QYL<"T-7@>+8M-=+%!4F6#
MU*05]*V25K2\TTS'L.UW0EI):':Z $G4K:3QOR+R(RBIOUQYNMC;-;VMAAM%
MN%+'2.]0$F633XI"""WJY^G3H H-2*OB+R6X2YGNV9\>8W+>9)JBKFI:^GIA
M6TDL%<YQ+'@[2'#=V!!U5'GYMXC\J.2[ECV9YI8JN\W>LIRT6RUP#Y:UTS'-
M+(RQI^"1Y<YSP[5WO/0 !] ;AA<N4<*OP.O:^EJ;GCK+34-)V/BEDI!"0>AT
MT=W0?/CC? O+#QZS"Z'"L0GK'5310U=2*05M%/"U[7B2-VK7=-/8?K02IYM\
M7\I<E7/ ;CC&,5UZGI;,]EV=11;Q#52/8]S'#7H==4&S/'V/WNV^.%FQ:NH9
M8,A@QMM'-;GMTF;4>@6^F1^RU.B#5OP<XAY-X_Y,N=US3%J^R6Z:V20Q5-9%
MZ;'2&1A#0=>_106OS.X9Y4SKFO[^P_$[C>+/\A1Q?.TD)?&'Q@APU![A!L_S
MQPA-S3PY0XE%(RBR6VMI:VURU!>&-JH(#&Z-^TZ:.#BTD@Z=^Z#4G #YJ<$V
M^IP;%\/DK[-%4/?$V2@;60"9^@>8IHWQES7:#N3]"HVA\<;YY*9-<[S>^;*.
M.T6!T#(K1:A30TKVU3'@ODV@.E(+#W=(6^[1!K#;N$^68_+:#-'XA<ABC,N%
M>Z[&'^YQ2?,;_5W:_9V]=5!L]YI8?D^><-.L>'6JHO-W^\:684=(SU)/38XE
MSM/<$'5X38/EF"<.36/,;1466[NO-74"CK&>G)Z,D4(:_3W$M(_ J-;>?_'W
MF/$.>9N3>+;'/=J.KK8[W;9Z!GS3J6KB$;I&SLD'3=)JYO<%I[]"H-N?';).
M8<HQ>Y7+FBU&T7\5>RCHW4PI&BF#!U:W5Q.IZZDE!-K=-!IVT515 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!P>PN.NO3]1!01D?JZE!
MQ]%VIZC^F@J(G#J2"?8@IZ+O81]'O]Z"GI.:TZD:@'LBOFUS+SIY%\GW3*.#
M*#%*<4#ZZ6ETMMOK/GYJ.FG.PO?+/*P Z->YS(V_@"#:SQ-X-GX5X^;2WZ&)
MF;7AYJKV87ME;&-SO0A#VM&NQA^+JX;R='$:(B?GMWC3Z?J0=?HD ::$@ZC5
M!RBC],$:Z_\ N(*21N>=1[D%/1/M(^D]=4%?2?H!J$%/1<#WZ:^_3\/9!7TW
M$:'3WH.(@=KUT(_W$%?1.FGO'4:_K=$4]'MVZ#3]5$5])WO^GO\ ^X@X^B_3
MN-?U$5V1LV:Z]RB.:#KDC<\Z@C1!P$!^A!7T3[#^ITZ('I.]A""OIOTZ'K]*
M"@A=[P/J0/2=IIJ .VGU?@0<F1N:[4D>WM]*#D]N\:(.KT7=R03^%!S9&6ZZ
MG4% =&7.!^A!Q]'KKT]X^M0#">VH(^E4!"[74D'^C_WD#TG:GMH?Z/<@>DX^
MT?T?@05])P&@(^E!5D9:[=K[]1_0$'8@X2-+QH-/PH.'HNTT)'TZ(.36.&NI
M!11T;B?9I]?;^DB.3&[6AI]B#D@Z71.))!'4Z^Y ]%VNNH_I_3_Y455L;@=3
MII^'5$=CAN:1[T'48==#T.GL/_O('HGWZ>_3O^J@>CIT&FB (G :'3ZM4#TG
M$=PBAA=[QKII[40])X]H0/1.NNO]'M0/1=KKJ@&)QTZ_6@J8G>PC]9!00N]I
M!T[?^Z@")S?LZ?JZ?[B"OINTTZ$_J(*>D_KJ1H1H?I17.-A8"#I^!$4>PN.H
MT^HH*>D2-':'WD^U!V-!#0#W050$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!U/B+G[@?P=4%/1)Z$A
M!VZ=-$'7Z3OH^CZ$%/2=IH- /Z/J0=-8R:.DG?#UE;&XQD=3N )&@^M%?-_E
M*H\QN<71<<W;#ZRAQV.MD:VK;;Y[=3U;6RD12UD\CC'HUO4;0UOMTU4&Z7CS
MPO;^#\!IL8BF;67R?2IOEP8W:V:K(&H9J [TV$EK-W7N>FN@J)7D87Z:::CW
M]D' 1.Z]1WUZ(.QC=HT0<CV0=1BU[G]3ZT%/1<3J3U_I(*^D[KU'T=T%!$[7
MJ>GZO]'5!R]/4^S3^F@XF)Q[$#\&J"K8BTC30:?A_ @J6$Z:Z:#L@X^B?8=/
M=_1H@[&-+1UZD]24')!UN8YQ/;3V(./HZ=M/I]@_W4#T7="3U!U^G]5 ]$CV
MC0=NZ*"%PU.HU]_?_P B(JV(CJ=-?H0<MKO>@,9L)[:>Q!5["[L=$'7Z)[=-
M-=3KU[(.Q@+6Z'N@XOC+G:]-/PH./I/U[C0]^ZBGI'Z.IU*J'HNZ:'^C]1 $
M!UU)'^Z@IZ+P=00#[T'+TG>\:_5[T%61N:[4D::?A0=B#KDC+]-"!IW04]$D
M $CII[.B"K8R 0?U4%'1.)Z'\*#L T ![A!5!T^D\'4'Z3K[T 0GZ/\ W$%6
MQN#@21H/8$5S>"X:#37Z>R(X>B=3H>_]'N04])^NNX#W]T PN]A"*&)QT['W
MH*^D[3\77W]^GN1%!"[=KJ /9WU11T+B._7V%$4$#O:5%5]%WO&BHJ8G'VA$
M4])VNO33W:_T^R!Z+M"-1U151$\#0D?0B.)@).NO3^@HJOHN]NFGUZ_[B([&
M-VCKWU0<'QEQU&B"A@U/?H@[1T ""J @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(*$:@@="@ZC!KW/X=$')D6P[M=2@[$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?A51,*::ML]4R>5CW: $OBJZMK?>&O:-W8%!+O+?D=8>-L*L.36VE%_N>6"
M8W:X9XF&?YE@<U[G N^!NX:EHTUZ:CN@BN\>1'E'QW0OS'E#B>W4_'],6BMJ
M;;7P/JHVS';&YWIUE46C<0"71::Z#H2$&SN&9I9\\QBUY;C\S9K7=H&5$!#F
M.+=PZL<6%PWL(+7C7H0A1SR_,;/@N-7/+,BF=!9;3"ZHJY&1NE>&C0 !K 22
MXD >SJB-8:'R+\G.0*8Y3Q/Q'2U.".U--57:I9'55$;.\D37U5*7AP&K=D;O
M=J4$D\?^46'9=Q]D.:WN"HQZKP\&/*K34QO,M-4 EK6,<YK XO<-K0=-'=':
M=T5&]K\A/*GD>W4^7<3<1VZ;":X.%#/=;A VID,3BQ[OCK*,[2X';^2^HGNB
M)%\>O(6IYCFO^,Y/8)<9SO%7LBO%M?J&.<XN82UDGY1A:]KFN8[73I\75!%/
M@HXMO'+I'?[]9_PIE%ED=]\H>1<TRVZ8EXV8739HW'GF.\WRNJ(HK>Y^YS (
M)#44[""6G8[U#O'4#3JJB_\ #ODM>,KS6X<2\IXXS#^3[9&Z1]*V9CJ6I('J
M;80Y[R?R9:YI9)('C5P("*OOC]SE=N9/X6BXVV"W''+F^VP_+%Y]5K6ZASM[
MG=?J05Y)YRNN#\PX%QI36V"IHLP#S/62%XEAV%X&P @?B>T((.B /Z1&Z@^V
MBH__ -#PH),S_P DLREY NO$O!>&#,,ULD0FNU56SLI*"G+2-\9]62G#B-S0
M'>LW4ZZ-=W08I'Y0\W<>Y/9+/S]QM3V*TY%.RDH+C:)V3L9(]P9\;F5%4PD$
MCX"YCM.O9!''G3>\_GR;&Z2?'H8\.IJZEFQR[BHA]6MJ'LB=)$^/UBYFV35@
M+F-'37710;(CFF\\<\/?G!YIL3,=N=/(VDI;)1U$%7)4.D.V!L;HYI6[G-!>
M1NU#0XZ=-%1&M%Y!^5UZM[,XLG#E+-QW,WYJG:ZI:;M)1@Z:LB-4R1Q=W:X4
MO4=0"$1.G%?->+\KX$<]M)?0T=+ZS;M25(_*T<M,"Z5K].X &X'3J/8#T14%
M4WD[SGRE<JZIX!XRI[UAMLF=2RW:\U$=,:B1KC\43I*FE8-6Z:L:9"WVGJ$&
M"\:YU6<@^:D-UN]EGQV_4MEFM]XM%20YT%72MCC>&O'1S21JT^[W]U!ORP:-
MT'L51"65\WW?'O(7%^&H;;3RVN_V\U\UP>7B>-P,PVM .TC\E[D&4<V\C5W%
M7%N0Y_04L5=6V6."2.DG+A&_UZF* Z[2#T]37H4&&Y7Y*6W".(<8Y$O5NDJ[
M_E=- ;/C]$UY,]9.QKO3#]K]H!</M=3V&J*CBJ\@?*W$:$YER!Q#0P\?4[1/
M7R6^KC=7Q4K^SS&VLG>W:.K]8.GMT09)S=Y!X_;N";%RU8;%1958KS<::""@
MO5.71,,D507.,;P-'L,1:#]:@OGD!Y!5?!^-XED$-J@K::]U#(:R-^X&& 1Q
MO<8@US=7 ..@)T01[DGDAY-6NU'D6FXBIJ7BH10U@EK:MDET^4D _*.BCJ62
M,WZ[ANIOA!&NO<T3?@_/.%9IQ8_EB.H=0X_1T\L]V$[7!U-)3#\K$-6M]0@C
M:W8/C.@'4H(2M_DEY'\@LFRWB3BBFN?&D<CQ3UEQJ615U3%3N(D=$Q]5 7%P
M!VAD3_BZ?$4&0\*^5M?S!RI<,&_@V;#04-O^:FCK-XKX*R(1MG@DUV@ALCG-
M!V-)'L"(V<8XN!)0:#<M]?/_  4'MZML_M)14Y\T^34'"N>VC&;K;A4V.OHY
M*@S1-EDJWU(!]*&-K-1J]VC=2WH@P#*?)CR5X^I8\XSOB6DM_&<D[&%T57'+
M<HXYVET?J^E4S&,].KWTX;KT.A(03U<>=<#M7%;.7ZVX,;BLM.V>$-?&^>29
MX^&GC:':.E)U&T'WGL"@@NV>2?DE=[<.2:3B2!W#I::XU+:ECKM]V,.KI61&
MJ:^31GQAS*;:X=1TZH,*\!+O15&1<JWIL@BMTCZ:K,TQ$89$73/+GEW1H ZG
M502+=O*3DK/,DN-A\:,'@S.AL;METOUQF%-12//3;"99J5NH(Z?E'%PZ[0J,
MIXK\CK_><X_-)R]BSL-Y+,)J*6&(F>AJXP"XF)['2M #1W]5S20>H/1!CW(W
ME=E&&<TW;B&RX@,AN+*:E^X(:4O;45%=601RALI+MK8V;R2=!V[CN@\<GDIS
MEQG<[;/Y!\<TMCPR[U,=##?+).VJ^5GDU(,[8ZBIUZ#HSX"="6EVFU$2[S-S
MQC?#6(4647*":Z37:1D%CMM*US9*N1[0_P"V6D,&T^UI.I  ]Q4+3>0OE79J
M!N<Y#P_2Q\<$-JI?EZ@&Z1T4NFQSHA522-< 07;J;I[0$1+%T\@[15\$W/FC
M"XX[A%0TS9105!T<R<S,B?%,&.!:YNXZC5!%=I\G^;N4;525O!7&]/?V4L,/
MW_=+G.RCH6UDD8=)!3"IJ*4N]-W37>Y%9[X^>2,G+E5=L1RNS?P8Y'QW5EWM
M+W%K7N8[9(8XI3ZK=CNCFG=I^RZH,7RWRBSK(\ZN''?CCB%/F]UL8<^]7:KG
M9';6!KMA9'*9J>/[7V7&;X^H:TZ$H-=>6N0\OS?G3BJV\AXP_%,XL%?#372@
M:1)32":J8^.6"0/D:YI'[%[A])0;A\Y>0UJXB=;<;M- [).1[\X167'*=WQE
MSSL9)+H"6M+B-!TW=>HTU01E7>1GDGQK3,RCFOBJCH<#,D=-4UUFK(9JBG?,
M=6OD9'5U9V[0?M,:-=!N&HU(DKF_G\\<</4?*V)TL%YIKA44D5''5"2)KHJL
M.=N+?@<"-O9%1K6>1?DOD5H_AOQQQ)3R<>QP&H^=N]0QE9/%$-SYHH#54\FP
MM^R&Q/\ H<41E-LY_KN8N!<CRO +#\SE]OAFH+UCM4\0-IWOC/JELTSHF/ B
M/J-T=K^*1JBH7\'\CY:I;?'9[+B%/6<?55VG-[R*2K@9-2GXG.#834-D=HX!
MOPQ.1&_,;M[=2@T3Y:OV/<6>9C,^Y8MTSL(KK73-L-R?$:N"*:.G;$^1L<>\
M@LD:_5FW=UW =025M)19GQ-S1C]?C^/W^SY+2W*A?Z]NCGBGG9#,PM#YJ8D2
MQZ$_CL:0?<4&&^/W#EYX QZ^VR^9+37+''RR5],V.!].VDC;J^0N<][_ (0W
MZAT4$?4_D_SARC4U]5X]\:TM[QFV5#Z6:Z7FL@@]9P^RZ-KJNF#=0-=H=)]:
MHR7ASR8RW).1JGAWEW$VXER!#%)40>@_6DF$8W;&[Y)-=6_$Q\<CP_V=.J@L
MV1>7&46GEG)N)[+APR"_4;Q2XW34CGL?45+NFZH>]VQD;.A<3M_KAW5%G_\
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MT?D'RW0O=Z=IO$<%BK*&03PU$%HE>'&(LW.!($<F\'30G1!FMYR7_P 0&><
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M..@C<':A^[X=VUHV:>SNBKKY&\*9]EN5XORUQ96T[,XP\%E):ZP,$-0USR2
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MNV/T<WXAU]J!Q-S]D' >+_F>Y3P:ZFY8LV2&T5]JIY*B&MIWR/>P$Z.&I<2
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MB=MC#SVT:''7Z- @O/.MWO?%GEC8^8JK&+G>L4AM/R39;9"9"^=T,T3FAQZ
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M*H*:#W(*Z#W(" @(*:#W(&@]R!H/<@KH/<@:! T'N0-![D! 0$! 0$! 0$!
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M/P/8X**UPIKE37_](*9;5OGBL5B=071X80V&H;2RNVG4#I^4;H51N3ZT?O\
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MX,N43H(FS>JYA:=AW.&@^'NBI.I(#30LA)U$;6L!]^T::HCO0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 015S[<.7K=AL
M<_#%-'592:AK9(I8XI1Z&TZG2;1O?1%A'7D^^\R^*5PFR-@CR*2WV]]VC #0
MVL<UAF :WH-'[NR@B+B.\>4?%G'%BMV&8E29_BMUIVW&U5KIC'-1,F#=T,C7
M2,T^(ZMZN[>Q!,OCWP?FF/9/?>7.5ZZ&KY R-HC;2TQW14E-]K9OZ:GL- .F
MB#8PQ.UZ'VZG]7JJBT9%B5@RRWOM.2VNDN]LDZNI:Z%D\>OL(#P='#V.'5!9
MZ[C#%ZKC^LXSIJ-M%BE91RV_Y2$G2.&4::-W$GH>O4HK5?%H/+/@&W2<;XOB
M5-GV+TLCS8;TZ01FGIY#T8YGJ,TT.KBWXE!*?CEPEDN#5^1\E<CW!MPY+S5P
MDN;(?[%2P!Y>(6O'VST;KT ;M 0>W.[OY"TW-6,V_#***;B262C_ (15+X8'
MR-8Z4BHT>\[QHSW(*^2'!URY:LULN^+7 VS.L8F%98:AYTB=("#M?IV)TZ.]
MBHB"\W3S&Y0L!XONV%TF+TE=&RDNN7NGU]2&+1LCP ]W64-) #!W]B@V4P;B
M>QX=Q;2<7P/]2W0T3J.LG8/3=,^9NDLFA)VEQ).BHUJQ[#_)3QDJ+CBO&F/P
M<@\?5E0ZIM,4D@BFI'2?$X.!?&>O8_$=>Z#*.->'^5.2.4Z/G3G%D-EGM4;6
MXWB-([?\NYO0F5VKM!JW=IJ=VHZH-LF-+6Z%$<D! 0$! 0$!!U3?BA!#O%-R
MYKK,VS>FY(I(Z?$*>J(Q"5D4,9DIA(\#<8R7.^#;]I16L><47(LOFGD5?Q?/
M"S*+59Z>M%#5DB"M@CCB;)3O<.VX.U!T[A!DN1XUY.^2IH\2S[&J7CW":6=E
M3<W-E,KZH,.FQK6R/)Z$]-P"HW*QRQT&-6"V8_:XQ%;K9314E-&!II'"P-'0
M>_35$>]T;BXD$:%!B5'Q9@5MRK^&]MQZ@HLKV31FZ4L+8)7"I.LI>(]H<YY^
MTYPU14$<\\/<B4?(UIYXX4CAFR^W4_RMXLKM(C7P-U+2"-&N<03&X.[C3KT4
M&&7S%?);R6KK3C')&,TV 8#05D-7>&LF]2:K8T]6L:'OW=-1HX@==51M?E5'
M=['@-SI<%IHV7FWVV2''J-C&^DV:&+;3L#':-VC1H /106/B^/-\CXIMU/S!
M21LS&X054%^I1'&R,MDGECC&R/5FAAV=D&MEFP[R-\:+M>+/Q=CE/GV!7BJ?
M6T%,^7T9*)YTW-<PO9M[=-KNNG9!F7!_#O(]]Y+JN>>;((*/)'PFGL5A8[U3
M0L.YI+N[6D G3;UZZZJC:B-I:W0]>J(URR;CS+ZSS!PSD>FMKWX;;++5TE;<
MPYNR.>6FJF-:1KNZN>T=O:BMCFD$:CLB*H" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@("#SUU)'7T=10S:^C4QNADTZ':\%IT/U%!A?%7$F*\/6&;',2^9-NGJ9*Q_
MSDHGD]67[6C@UN@^A%9XB" @(" @(" @(" @(" @(" @(" @(.+V[FZ!!'W(
M'#F*\E7K%;[D9J/G</K'7"T"FE$3/6D=$YWJ@L=N'Y%GM14@,9M)1'- 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MR"&.;/)#%.&)*.T5%+49!F%Q:)*#'K=I\R]A.@>XZ.V-.ATU;U145S>:.:V
M17+/.$+]CN,2D?\ 6[IWS ,/4.V/HH!IIUZ2(-E</SO'\]QBDRW%:UE=:*N/
MU8WL(W-.FI8\=VN'8@H4:OV3S3Y.RJ*HK,1X%NM^MM-/)2NK;?<I9XC)$XM(
M)9;' 'Z-4&78!Y?T][S*FP3DS"KAQOD%=J*%MTE]6"63701[WP4[FN)[:MT4
M&RX?NT(=J#]2J.Q 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M80005!L!:,-P7CL7V^V>W4MDCKG27&^5VXM#S$PN?+(Y[CH&M;J51KKQ)_\
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M;Z-E7YQ0TE:#*S'</A90A^A >X$.>-1W.J#T^8D3;7=^)<NH@([W09-#%3U
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M:W?(^-CG'0= XN.J@V:H:_F7'^ \IJN2:^D?F5MHJN:V7RT2[A+ &ET4I.T
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M;7P&3%J:G?=I:)V@CFG,CFZ.]_PQ[?PJ*V]@AC@A9! QL<48#8V, #6@#0
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MGZ54:F<'_P#M:<P?\VI_UXD63#/_ &[,[_<&F_M4*@XW ;O/VD;[#B8'3O\
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MT#4]?:@[R 001J#T(^M!X#8K&89*8VRD^7E?ZDL/H1['/'XSF[="?I0>\
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M:T?4!H$'FK+-:+B\27"WTU7(WH'SPQRN ^MP*#ULCCB8V.-@9&T:-8T  #W
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M9UTU]OM5&(8?X@\S6>P5%J/,E7BS#75%PBHL8$[(999SJ7SS!]+*X]--K@X
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M?(FLHG#I)M>&%X'T:M:BPVXHR]T$3I#^4,;2_P"L@?[J(]* @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MB'@NT(^E!C^+!T_FHR2L&Z:'!Z,4KG=P',&NGUDG5!<O,T"/\UE9!\-?%E$
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M!SD$[\/NL-U\7\EP[#++<J3(;?9Z^W7>UUM,]M9+=I:61K@T@:2%[^C=O7Z
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MQ7CCLN@J*04-]L4#M)W ,],$!H<\_#V+6NT]R@MF.VGF7R"YCQ;.>0L'FP#
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M(" @(" @(" @(" @(" @(" @("#K,>NO7VD_JH.8&@T0<!%[ST0/2/OT)[E
M]+3L4 Q="-?J0!&??T^KL@&/J#KV04$6G0'^D@YAF@TU^OZ4%#&2>_1!0Q:@
MC7ZB@KL.O=!S0=9CU]J!Z7TH'I=]2@&,ZZZH*^G]/5!3T^O= ](_LNO?\* (
M^G?7ZT$+<\^/D?,1LUWM=_FQG+\>D=+:[M3M+BTNT.C@'-/0M&A!14:VKQ!S
MC(+Y;*_FKE"LS6SVB9M126DQOCB<YIU^(O>[W#L$&V3(&1QMBC :QH#6M T
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M! 0$!!UNET.FGMT0/5][>FJ!ZG?IV05;)N(&FFJ#F@(" @(.#GAITT04]7Z
M@Y@Z@'WH*H" @HYVUI=WT0<6O+CH0@YH" @("#@Z30D =D#U/H04]3Z/9J@>
MKUTT04]4^Y!42Z^SJ@>J>Q""K7[B01IH@YH" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @ZO5.NFWVZ#]9!VH""CCH-4' R@#4#Z4')KMQ(TT0'O#--4
M'$RZ#7;K[D!TNWV(*MD#AKIV04,H'LU0=@ZC5 0=?JZ^SH@-DW$#W^T(.Q!1
MQT&NFJ"C'[_8@Y(" @X.DVNTT0<@=1J@J@(" @(.+W;!KIJ@X>L/=]?ZFJ"I
MET]FOT(.;7;AJ@J@(" @(*..UI/N0</5)Z@:@CH@Y-?N]FB#D@(" @ZW2;3I
M[NZ#F#J ?>@J@(" @HX[1J!J4'#U1WT0#+H-=.B"GJD#J$%1+J=-.W4_4@&7
M0Z::?6@>J-?H0#*!K]"#L0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 08?REFM+QW@%_S*J( M-'-/"QW9\X:1$WN.[]-4
M6&K/B9ROR&,XK,*Y9NM57SY?;J?)<4DKIGS.9$_U/4@9ZAZ-T'9O8M/O4&VV
M3YGC&%TE/6Y1=::TTE7.RDIYJN01,?42G1D8)[N.G15%A9S9Q3)?QBT>86IV
M0%WIBW"I89MX]FFJ*C#RJYUJ^)+#::;'+K0T>3W:L@WQ5(;),VW.DV23QL+@
M-!H1N<"/H4%QS;)<?SFQ\?7^P<MQ8I;Y+S2_EZ-QDBO<K',#[?JR>$?&X$'[
M8_J4$]M^R/9T[*HU+\NKSG,>5\;8IA667#$G9)6R4=36VZ61G1VFUSF1R1;]
M/8-P45Y;CXT^15JHIKC:?(N\W&Y4K3-3T5;3U,--*YGQ;9'_ 'A/H"!_ZMR#
MV<6<U9EGG 6?5.13_+YWB%-7T51<Z-WI%TT$3PR5I9IH_5AZMT08%P]P[SMR
MOQW9,]_\0F0VC[XC?+]W^E457I;)71Z>K]XQ;M=NNNP*C)\,Y"YEX$Y5LG%W
M-5ZCRW$LL:8L?R;23UV50>&!KWR=3W'J,<7::@AVG<-QF.+M=?8B,)Y5Y0QO
MB7&791DHGE@W^C2TE'&9:B>=X^"-C>VI/M)0:Y^/O+G)7(_D1EE+F<578K1'
M9X*FV8E+(_TZ2&79)"][#H/5>QP<YVT=_<HK<-@VM 51;;Y?[3CEOGNU\KH+
M=;*8;IJJI>(XVCZ24&L?DAS;:[IQS17?B3-&RU$5ZHJ:MJK)5ELC8Y9-"QYC
M<#M=U&BBMBZG+++C>,TU[R>Z06ZA93Q.J*RLD$;-3&"27./4GNJCPXGRKQ[G
M<CXL.R6W7J6/JZ.CG;*\ =^@.J*]>6\AX9@E,VKS&^T-DIY/[')6S-B#M3H-
M->I[HCEBN?8AG-&^NQ"]4=ZI(]/4EHIFRANO;73MJBH]X^JZ"R93R%=[AR@,
MIH*>;UZNS3%S8[!'&W<Z,ET\HTT&O1C/J4&05G/G#MOI*"NK,VM$%)<VB2WR
MOJ6!LS"=NK.OO"J,YM]WH+K11W&W5,5703-WPU,+@^-S=-=0X$@A!B+N:>+&
M9 ,5?E]J&1%XB^[C4L]?>3MV[=>^O3NBT7"W\F8-=K!793;;_0U6.VQSX[A<
MXI0ZG@?%H'A[_9IJB+QCN26/+;/37[&[A!=+/5C=3UM*[?"\#IJTCN@XY)D=
MNQ2QW'([Q)Z-JM<#ZJKE#7.+8HAJ[0-!)/N [H-*:_R/S[D/F_CEEBH[EBW&
M-SKW14(G<^GENS6.8)'RL:=#&-0&MZ_2HK8#R7Y3NO%7'+Z_'6M.4WJICM5E
M<\!T<=34D-#R#W+0=1T/540!E."^5_%>%'F!G*\V07*@B;77G%*ILTE%'3.(
M+A&9)7,DV@_$/2CT&NTJ#<'CW+:;.<*L>8T@VQ7:CBJC%WV/>/B;^!VH5'JO
MN;XIC-;;K=?[Q2VVON\GH6RGJ7ACZB7VMC![E$6JS<M\<9#?JC%[)E%MKLAI
M2X3VVGJ&/G9Z?1VK=?8@XTO,'&=;D;L1ILKMDN2L<8W6ME0PS[AW&FO="C)[
MK>K;8[?-=;S5PT%OIF[ZBIJ'AD;&^\DG1!A%-SWP[66ZKNU+FUHEMU ]D=;4
MMJ6%D3I7;6!W7VGH$%>8,[@P[B/)\XHYPXTUJFFML\#NKIIX]D#V'4?C/:[H
MBM=<8OO)./\ *7"N'Y!D]TJWW*R/K,AIZBKED9454X,Q]5I=H[9NVLW#H HK
M::X<D81:<DI<-N5]HZ;**UK7TEJDE J9&N.@+6#4HCEEO(F%X'3QU697ZALE
M/*=(G5LS8MQ^C4Z_TE4>*V\N<;7BLM5OM>46VLK+VTOM,$,[7OJ&-[F, ]=%
M%9LJCC)]@ZH(G\?86P8?4L;R0[D\?/SG[^?NUBZC^YOCGG/Y/^N_ BI"R;*<
M?PZU/O637*"U6N-S6/JZIXCB#GG:T$GVDG0(C&IN:>+::]4^.5&76J.^U?I_
M+T#JE@E?ZP!9H-?Q@1HBT9U&\2,#VD%KNK2TZ@@]0041S0$&M'FQE&58IQC;
M:W$+W66"Z5-YI*1U=;YGP2^E,'@@ECFDCVZ:HK%__#)Y""W-N-N\C;W45_I-
MF@I*FFJ8X'O(W!CY!<92&^\^F?J1&=^+/*.8\E8!>6YP^.HRC&KE/:JJX0-#
M(ZAL48<U_P /3<-2'$ :^Y%17Q=DO(V;X#SQ3?PINCKW:JJM&/5GS<QGI/EC
M+(V.G=J2P$1AFC5!-?CAR)+EG ]BRN_UDM5<;=1R0WNLJ'&2=\U"#ZLDA)U+
MB!J=4&N_"'+7)M1S79[_ )A?*NLP'DB6[TEBM4]1(:6EGHJ@,88XW$L;T9\.
MT=G();\C<IRFHY*XKXMPV]UEDK[]<35W>HH9GP/=;X3JYKC&0=OY-X([=52&
MRT3=HTUUT&FI.I1'8@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(//55<
M5'!-53N#((&.DE>[L&,&I/ZB#YNGDK,(N7G^3399),'AR@8K)2@GT_NQX="7
MZ$Z#4 ;3[U%?1F6]445H??3('6QE*:XS,!=K V/U=P [_#U'O51!M;YI\!4%
MKM]VJ,@D,-R:Y\%/'23/J6AKBW62(#<P$CIJBKKR!Y!831\*W;DS'+XR:W/C
M-);JZFC=.YE?/\,+7L =MT=WW#H@AOB'F;"^3_'7*K#R)D5TFK[?;:BHS.X4
MS'_.0TU1KJZ"22.1KG#0Z -('N4&S7#\>-1<:XQ'A]755^,,H(Q:JVX?WW+3
M]=KI=&1_$?ZT*HQ_R5D?%PKESXW%CVT,A#VD@CI[PBPUHX?\,>/.0.-,=S.\
MY1E<%SNU**BIBH[A21T[7:N&C&R4<C@.GM<41<N+XLDX \C*;ABER*KR7!+]
M2&:AIZ]^^HI-I.W=M 8'#7J6M&[W!16*<>< 8SSQRQR\_++[?;>+%>8XZ-EF
MJX:=CFU(E+MXG@GUT],:;=$%XY+X/R[Q8MHY:X;S*ZW"TV:1CKYC]]>RI;-3
MR.$;G%T+(6.;\75I8".X*HW-P?+J+.<0LV76YNRDN]+'51QN.I87#1S=1WVN
M!&J"\U]=%;J"IN$[7.BIHWRO;&-SRUC2X@#IJ>B(^?'//+/)_(ESPJ[MLD^+
M<2/RBDH[2VJ<8KA<:J)^XRR,:2!& UVT Z?25'I]#6,:S33V*O+HN%QI+713
MW"OGCIJ.F899YY3MC8QO4EQ/9!KGE'E5PMF-KR7!K#D0DR"6@K(Z5SHI(J>6
M5D3CMBF=\+B=#IH5%A[?$.[T]O\ '6Q76[U;8J6!LTE35U+]&L8W0ESG.]@0
MEZ8?-'Q]J+Y]PQ9-^7+_ $VU;J>5M&XDZ:B;39I^%42IEW).'X-C'\+\FNL%
M%8#M].L+@YLA>"6",-.KBX#H B(]P7RRX3Y$OL.-X[D!%XJ7MAI:>MIY:7UI
M'G0-C,H <2?<HKHS2'C&3R!PV:]WB[4W(;*2866U4VGW9/#N&YT_Y%QW ]OR
MH0=][\L>$\;EOE->;X^EJL>JVV^NIG4TOJNJ"TNVPMTUD #3J6]D*,JXPYNX
M\Y@I*BLP6ZMK12.VU5/(QT%1'J-071O < ?>J+%R+Y/<.\6WEN/Y=??3O! ,
ME+20OJGQAW;U/3UV?A073".?.->1<C?B^(74W&YQT3+FYT<3_0^7EZ#24_"7
M ]'-[A!<L0Y>PK.,LR#"K!52S7_&7!MWAD@DB8PD@#:]PT=W]B#.GDM;J.J(
MTG\K.9.2+_CV9XMQ]8:BW8;C!%/EN65GY#U9=[!Z%%M)W [FZN[D:] .JBIT
MPW)OX)^-UERJ?\HZUXW!5#<=Q<YL T!U]Y^E!K9QIXZ7GR,Q-_,F?YS>:+)+
M^^:>Q4]!(QM+2,9(6Q[Q(QQ>P::;6%FGO03=XBYWE&08A?<*S6L-QRK!+G+:
M*NO>XN?+"'.$)<3J7=&'0G\71433FN:63C_&+GF&2RN@L5IB$];-%&Z9[6%[
M6=&,U)ZN'0(B*KKY?\%6>MME!6Y&6U-UBBGA:VGE>V)DX!9ZY'2(]>H=V17O
MS?RGX6X^NU)9<@R)GSU6R.5K:.)]4UD<P!8Z1T>H:"#J"?8A1)UMRJQW>Q19
M-;JZ&:Q30BICK@\"+T2-=V[Z @AZF\Q^ ZK(3C;,E K YS!4.@E;2%S?8)B-
MA)TZ=4$C8'RABG)>*NS'%:E]186OFB=--$^!P=3@.?JR30] >Z#3+*G5M[X+
MY;Y<DFD;)F>0M;;]'. ;;[4]M-"6'7IJ=P('N45L^[EO">).*<3OV<7!U-3U
M=%0T]-'$Q]34S2OA;T9$P%[NW715&77[E/#\5P^+.<FK39[#-&R6-U=&^"<B
M3[+?1> _<?=HB(RH?-#@.XV^HN-/?Y-E-+'"^G=23-J'&9X8US(RW<YNIZD=
M BIYM];#<J*GN%,=U-51LFA<06DLD:'-)![="B/2@@R"#C/_ ,3U?/#>+L>4
MC8XFU%F=I]T-H=OPR-_(@^H1W_*_@14U/J!!"Z1X^&-I<=/<T:GM_P"1$0?<
M_,'@RT6QUVK[[+' VKFH/0^4F-09:9VV0MC W%H/XVFA14E8!R5B')UCCR+"
MKE%<[8\[7F/5LD3]2-DC#U:[Z"B,O0$%CS(D8E?7 Z.%OJB".X/HO0:&>.WB
MKA/,O'(S?)LDR6DNLUQK:9T%LKJ>&F#('@-(;-2S.UZ]?C16=\662^<&>3%!
MP[8<JKLDP"^VRIN4U)<)&S34,D$4KVEQ8&LW%T31N#6Z@]D%WN$TSO.JVTAD
M?\J['I-T.X[#\$O7;KHH/?XQ2U&'<M<Q\45TDCWT]U-\M?J/)_N2I.OP[NXT
ME9I]2"&O(Z]9+D/,V19O8:R1MLX@^YI711N<(GR2541D+M#UV[W%W;LBMB?)
MSD.&A\=:V_VMY9+E5-24UL#'?'_UB _34>YFO95$F\,XHS$.*,.QXND=-26J
ME-2Z5VYYJ9XQ--J=.WJ/=I]"#/400$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M_!!MAKKW3O8^LJ::,CX90QY<X:#MH.W5!N+BN/6_#\=M>,VEFVWVFFCI*<:
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MZA:#J0YVQNO0?LBJ)+1$<\Z\>U_*?%U]P2V5D-!6W9D<<554ASHF%DC7G<&
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MX]GOV]52'S'H_P V_P#"*/TOS-_>'J=-_P"<+Y'7_P"4_N73W>Q$?4?$]O\
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K15%#]H?9[>U!V(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tm2225088d1-lc_combinat4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_combinat4clr.jpg
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M /(  0 !! ,!               ( 0(&!P,%"00! 0$  P$! 0$
M   ! @0% P8'"!    4# @0# @4+"@P/#@,)  $" P01!082!R$Q$PA!42)A
M%'$RTQ4)@9%"(Y25%E87&!FAL<%2,R2T=5<X\-%B<K+2D[,T="4WX?&"DE-S
M5(34566U1G8HHL)#8X.C1,0U184F-B?#9*359CFEEN3%Y2D1 0 ! P$$!0<*
M! ,' P4!   !$0(#!"$Q$@5!46%Q$Y'!(C)2% ;P@:&QT>%"<C058B,S4Y*B
M%O&"LM)SDR3B0S7"8X.C5!?_V@ , P$  A$#$0 _ )_
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MZWI_4;<&+(2X\HD\5427D"MB @
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M\89O#_>\0$2Q5\4_@ >:_P!([PSW$:?\6O\ ]]0 F%VG$?YNV <J?-ROX0Z
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M9>8O=/GF3[U;]HVPMK[K5LMUX:QRT6QUTBBG<%R/=#D&2:)JM:OC*]24G2M
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M>[O-K2ZRY;Y*VG$'J0I)L*-*B,N!D9<2,%>5O91_.,L9>'3F?V (]<0
M
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MVR?[7,_L 1ZX@
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M"#?^*T7,^%*GR%$7^RGAW&63_:YG]@"/7$
M
M  !BFYF(O9[@5_PZ/*3"?O,545$IQ)N(;-1D=321D9\O,!'SMD[0[SL%GEQS
M&X91&O3,VT/6E,6/%<CJ2IZ3&D$LU+<41D1,&5*>("5M.% $+-I^QJ_;<;LV
M;<B5F$.?%M<Q^6N W#=;<63S;B-)+4X9$9=3G0!O_??8S'=]<-7C5Z?>B7"*
MI<JR7!A9I]WG=-2$*6BAI6V=:+295-/Q32JA@J*5H^CDR&++9;N&X3?S(^XV
MF[QX,5UAYZ+K(W$(-3BT$HTD>DUH4DE4.A\@1]^9?1QL7"^J?PG*VK3CJ66&
MF(EP8<F2C6VTE+KCCJ5MI,UK)2_2A)%6A$ WMW1]O%R[A+/CULMU]8L:[))D
M25N2&%R"<)]M*"(B0M%*:0&5=OFTLS97;2#@4ZYMW:1#D2I"IK+2F$**2Z;A
M$25*4?"M.8#1NZW95?-Q=Z;INK&RV) B7!^(^FVN1'''$%%BLQS(UDX1'4VM
M7+Q 2,WAP&1N?MGD. Q9J+=(O<8HS<UU!NH;,G$+J:$FDS^+Y@--]LW:G/V'
MFY._>[_$R&+D45B&J,W%4TE*6E.&HEDXM9*2HETI0!KW<#Z/QJYYF]DVVN6?
M@O!D&<DX;S2W7&);BUJ7[NXPIHT-4-.E'$RX\:4(@K^CYCW/%[HO*LTF7G<J
M4I*;=?9"G%PF&D*3P6RLU.K49:RXO4^+0BH=0W!L'L#DNS^W>1;=W6_P;M;[
MHMY^W28L1V.\R_+8-A[K&MU9+31+1H)*4F5%5,ZE0K MC.S6][1;N(W*F97%
MND5"9R?F]F(XRY^_4*27K4XHO3J\@1O3?;;*5O!M7?\ ;N%<&[7)O)PS1.>;
M4\AOW2:Q*.J$J29ZB9T\_$!@':WVXW/MZB9-$N-]8OAW]R&XVN.PN.311$O$
M9'K6NNKJ_J -:VSL?OT#>F)NJK+X:X<;(&+\=M]S=)Q3;,I,@VM?4I4R3IK0
M%?!NSV'Y#N1N#?<UC9G"@1[O*>DHAN0G75(2ZXI>DU$Z5::J C"OT:V3\/\
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MJ,3A89A[#C-HAE4UR'%/2'GE?'==6="U+/U&222@OL4I+@ S(!%CN=[3+QW
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ME.*+A\ *F4"
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MV[SC%UC7>V+HDY4)U#R$N&E*^FK29FE9)4DU(41**O$@5W39F9<>=: B\
M                '"XHR,SKP(N0"]M1J34^8 XHRI3@7C]0!:THS-53Y>!\
MP'* H? C,N= '":EE]D1'_1Q!7.".%2UDHR(^7ZP#D0=4D?B?,!< L<49%P/
MB?(!:VI1GQ.I'R+X '*
M
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M,R9G6]]J5'7I.AZ7&5*2?'R,!VP
M
M                           #B=8;>;6TZ6IM9&E23Y&1E0R^J C_ -P^
M$8EA';;N%!Q.SQ;1$<@+=6U$:2T2G%O-FI1T*IF9@K2'T:AUM.XWA^^+3_>Y
M8(P_Z2,J[AX:1<SLSI?_ *I8"6&UZK>GM9LRI=%6S\$UG()5-'0**O76O"FF
MHBHF?1P<-P<R(SY69KCX%^^D"C#NR<Y"NY]@Y9F<DX]WZVH_4;G356M?;S!&
MY/I*"_R3MV?A[S=:T_K(GZP##LL-9_1U85J,S_RNY0U'X%=KC3G[.0*W+]'?
MI+8^\:N?X3S*_#[C!!$7\=5$/O?@JA4]V_"[T:/,E>JE/ZJHBIY]S.5;JX;M
MW'NVSMMD73+%7..P[&AV]=U=*&MIXW%&RVA:B(E)1ZJ</JBB(R=_._8B_P#H
MR\D7_5&33^#@CL]E.ZS?[*M[L9VYSUYB-$G3%QKK;G;8B%+028[CA$9&E*T'
M4B/D"O0]"")5:F? $<@  U+NOE&_-DND!C:3#+7DUK=84J?(N,Y$-;4@EF1(
M2E3K=2TT.M 5K_\ *!WK>&TV.T_CAK_A(")?>5F6^5ZDXW:=W,9AXQ&:;=DP
M(]MD%,9=4I6A2UN(6X1*]---:\*T!$43.G ^(#M,<NETM%_MMTLCJX]UB26G
MH3S2S:6AY*R-!I67%)D?(_ !ZEIS[O43P3M/CQGX_P"6&O'_ 'R(KD3N!WJ:
MBU[38\2*EJ,KPT="^Z11(>S2KK(M%O?O45$.\.QV5W&*TK6VU)4VDW4(41GJ
M)*ZD1D9U($=D  +%-)4K48"%=^1"V&[TK7?5N%$Q+<^#*C3G'5ZS*:XHEU0D
MJ::R&X[::^"C!64=\6:3;?M_:MM;"ME5]S^X1[<AM3W3DH9;?;=);95+TJ<2
MAI2E>FB@&UX5MC;$["S462,3RL-Q^;<6V'U:B=D0XKDHTN+12I&M.DS(^0")
MW;_$V1W#A3MS^X3,;+<,RN4M]MNQY#=H3;<>,DB-"B8D.DNOJ/2?"E '+:,I
MP[8ON-Q2P;-94QDFWN>/1K?<[/!G1[C$AR)LA$5LTJCN&E*DFKJ)X$>GT\CX
MAWG=IB-SSKN-VPPZW37K>J\VUV)+F1S^VMQ'92TOJ(C,JT09^FO$!WV__:GM
M=BFS]VR;$67[/D6)0G+@S=&E$J3+-A-33(71)J-1\37Y@.V/.Y6X/8[=\CF+
M><N;>,.P9LM]9K>>E064LNOJ69F9J<4DUF9\S,08KANYT[:SL*L.4VQ]35]=
M3.@6R10G"1*D7:9I4HC/]JE7'SH*C)]D.U+;Z=M[;<KW)B?A7F&5P47"X3YJ
MSD(;3/4J2TIGJH(T.$VZDG#_ &U:5+B"NSPC8_*=D<;W4MS>1)NFVUQM4U^P
M07UNG,COG#43AN)-/3Y))!&E53))&8@P;L;OI8SVT9U?S-LEVV_724UU5:6U
M.M6J I"3/^J50OJBHPSM]LVR^=L7'=+N#S>R7')[S(=*'CF07F%IC1TJ*CCC
M,A[J:U'Z$DLDF24U*I*$5]SF1[?=OV^6&R=E\QBWW!<Y?5:\GQNUW"+=&HRT
M.LE&<TLK-+1FM]73,RJ2261?&,4>@)'6GE0$5
M
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MDAM%*BP66EM*0\T_$4M"="CHI:STZS07,P$Y4E0B($5
M
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MQ
M
M                  4,!Y>8S_/[B?QZO^ *!7J"GF"+P"I *5+S *EY@!J(
MN9@%2,*A4O, U)/D?+F K4@"I     *&I)'0SH8!J+G4 U)\P"I'P(^7,!4!
M2I>8!J27,P U)+@9E4 U)\R -2:5J5/, -22XF?  U%Y@&HO, U)\RX\@%0%
M-2?,@%0        %#4DN9D0!4O,!4!0S(N9@&HN50#4GG4 J7F :D^9 &M-:
M5*OD J  *&9$=#/B K4O,!0C(^1@*@
M
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M,4]?%DOKORH25*-<<TKT=%5"TF:3-1>KQH5$GD<SY\.'$$7@
M
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M"CD>E)?-#1FI2E&:EK4?J6M:C4H^*C,SJ GD7+ZX(J
M
M   ZN]WNV6"([<;Q-:@P64FMUYY9(224E4_AX>0*C1F_?ILUC*9L7'E2LHN,
M;2<?W9!QX;^M*5>F0M*C*E:'5OF0@UO^DJM9</R=R?A^=4<?9_@@J,^POO\
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M;ZD^HBIZB,@$P6^))^ OZ.(L)*%L,B+Z1V?3_B4O^:&@5-8N7UP14
M
M            '"IQ9&=#X5 00W$[=>X?N W!O4S,LC;M& Q;G<HN/QWTDA:+
M9'G/%%_>S"6DN&MO2:7G#4LTF1F8*V1BG8/L-9&S7?6;ID[[J$$XFX3EL-(<
M(O4IHK>F(NBC\'%JH0#*$]EG;,9&7X#F2O/YUN__  P$=+D?8?V]7N.VQ;+7
M<<<=;6:ER+7<GW7'".A:5?./OB2(J<-*2,!IA_L_WGV9REG+=DLJ5+@,R2=>
M@NGHD^[M&24)=;T*9DJ-+CO-I))YES$5/2TOS7+9 7-+3.6PR<I!D23)TT$:
M^!?U0H[($                4,!Y>8S_/[B?QZO^ *!7J"GF"+P   6F1<Q
MC56(Y9MIA&;RV9V46=JXRXR.DR\XIQ"DMF>K3]K6GA7B-K#JLV&*674JQNLB
M[>Z NW_:'QQ>/_=9'RHVHYIJ?;GZ/L8>%;U+D[!;1-K0XG%X^I)D95<D&52X
MEP-T)YEJ9BDW_4>';$[FQVDI11*>1%0N9\"^$<W:]9<P(    Q7<+')>8X=?
M,3AW!5J=O,5<)<]M#;BT,OD2'2)+J5I];9K1734JU*AD1@KI-E-H[%LO@D?#
M+&M;Z"><ES9;JU*4_*=)*5.4,Z)JE"2HDB+AR!&?NDE-*%SY@-#;<=M-KVRN
M.=_@W>9#>-YK%>C+LJ]+J8[CI*2APG5I-PS02UEQ73U<N0BLSV.VGB[-8:O#
MHDYRXL+G2;C[PZ225JE&DS3Z23P+3Y .XW0VSQG=?#+EA>4LK<MLY!FVZTXI
MMUB0@C-I]!I/BIM5%DE9*0=**2HN J-?[#]OS&Q./7ZR6*].S)5Y<:>1*DH;
M5TELH4A-$I0DC^-QJ"M.VGL(<L/5^8]RK[;.N>I[W)\X^LS\5=-":G\(([:/
MV8Y%'DLR%;N90X32TK-LY[M%$@R.A^PZ K?VZ^T^([PXJYBN6MO(9)27HDZ&
MLF)<5Y!D9+96:5$7*AI4E23\2J1&(- I[1]Q;W$M^&YYNQ/NFU]J6_[K9HC2
M(TY3+[O5T/RS2M3W_E242?L-)<!1OS(]L+1/VKF;5XN9XU9GX96^&NW_ &M<
M=HU$I1I,ZF:E>K6I535J,U&9F9@(X6CL/E6&.N%8=S;]:HBUF\Y'A2#C-J<4
M1)-1I:2DM5$D5:5Y C-]O.U6^8-FMHRV7N;D%ZCVMU3SEKFS''8[Y&VI&E:#
M*AEZJ@K,=\>W?$-ZXT2=)=?L6;6KJ+M&26Q269*5*11+4@]"NJT2B0NG!::>
MA:24O5!K$NTO/,YE6Z'OIN=+RO$K.RE$*SVQANU&XMMQLTE(6A"NJG2E1&I7
MVRM#)9<:T2JM%DM-AMD6SV:&U!M<-LFHL1A)-MMH3X$1?J^?B"/M-M!UJDCK
MSKQ <3A$D^' BXT_H\1%1UW-[9IU[SUO=/:G*W<&SMUQ!W)Y++3\!]*/5J5'
MT$2G%+(E+-TUI5QJ5>(HZFZ]H:]PK5<)>\V:W++<WEM=*%/:4BWVV$X@B0AV
M/"CMH02]"22O7J)7$Z5XB#,<V[?F,ZV0L>S-RNZF(MB;MS$>XL()*ULVIGH-
M:B7J+4I!$:C(B*O(BY"HVEA-@1AV&8[B#+RGVL?MD*TMON4U.)@QT,$LZ$15
M42*\" :[VNV,A;:;C9_N#&N;TR3G<MR9(B.)22(ZG9+TFB:)(Z5=IQ,%8'O;
MVFO[B;@HW.P++).'99+;;9OCZ%NK;DIC(;::4@FU(4A6AM*%IU&A1)2>FNHU
M!E%_[>"R;=;!MV;S?WG;]AUN@6]U"6VT-S'(3CSRGED2/3K6\JI)H1> #?::
MZ2KS\01T>7V%&48Y=<=<=-A%TBN15/%Q4A+J329E4!CNS6VL?:7 +=@D:6N>
MQ;C=-$ITB2M1.N&OCI(BX5\@&?$E)'4BX@,%WEVVC;N[;7K;V9,<@1[Q[KKE
MM$1K1[I+9E%0E$HN)M:>7B C?"['+M:X;4"W;K9)#@1TZ68T>8MII":UHE*$
MD1%\ *R_$>RK:NSY#&RK+9UYSF^QB9<:+(9OO$9+\=:7$+T-MM*61&G3TWEK
M;-)F1I,!)AMEIMM#32";:01)0A!:4DE)4(B(N1%Y B[0CR 6.*-*N!T^#B8#
M3;&Q,-KN!D;]_.;IW!^(4'YK(D]$DE%1%K737DFO,!N9M1JKQJ7@ O
M
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MY& X^BCGQKY@.0  6*;2H]1UKR .F7F?L 52DDU,O$!<
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M/+S&?Y_<3^/5_P  4"O4%/,$7@
M
M                         USNS@V?YO$MT? L_>P&3$=<<F2F(#5Q.4VM
M)$E!I<=:TZ3(SJ1G4%1BWSQ_N-V6PIG,/R[3KWU;C$MGN?S-&AT][-1=3J==
M[XNGXNGCY@-F?D$[C"41J[C9QD7_ .[L;_A@(D/8X,ZW6>W0;G..YW*+%98F
M7)2":5)?;;2AQXT$:B2;BBU::G2O,!V                    .$VE'S,@
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MY,J3$2TY C+C$I3C#KO5)1/$1<4I;41'Z5&2B,B#:
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MK.#1;@]=3@65;LJY22TN2)<FV(>?=TZE:26XM2B2:E&1<#4?,%>AY<OK@BH
M                                                     C-WU?YE
MH?\ UBM7]FL!)D                        !PN4U<?'Q >6O>GN7.W*WB
M7@6/6Y$IK#WU6V"_"9<7/DRU(0J0A5$DHR;=);:$IJ7 U$?J 8K8-O>[@H"'
M+#!O[<)SUD2Y2&U&:B(^*7W247/Q(%9/CV!]X[=_M;EPBWSW%,N.J2:YD<TD
MT3J376CWE40>IK:?57Q\O+V"HY@     !$3OUVKFYE@D'+[2[%:EXXM2IQ39
M;<0G(9H6>AGJZ4*=-9\$FLC5R357 !'"V]Y:(';^K9Q.,FY<E65[&DSS=^T>
MZR(RXYO_ +;J%KU$C3I_J@5O7L"VHDXSC%SW'N+T9Z3DK:&(#,22W(4W$;6:
ME$^39&E"S4DC2G74BJ2B(Q!H/M@?M^X7=[*R*ZPT+^<)]YR!A@ZFEF4;JY;:
MD\2XMJ,J"C:WTDL.*B%M_.2T@I;KMR9=?)):U-M)CJ0@U<Z)-:C+X0'7[A97
M<[Q]'SA=P6X;#JG8ME=)LS(EQ+;)E06TGYU1'09^T!LCZ.N.1;)WQS2DU.Y-
M,]5/50H$ J&?UP1%S"(DBP=ZD.WM/&@U98X3IMFHM2)#RG32JE*EQ+AR!7IC
MN'N3A6U-A;R?/;H=IL;LA$-$KH2)1F^ZE:T)T1FG5\4MJXZ:< &KR[U.V7A_
M\\4_^$WC_@8(A;MKD=FRWO=L^1X])]\LUQO2W8<G0XUK04%::Z'4H67$OLDD
M"O51/,$7GR <9H*E./$*E&N<[V=QG<*Z,76^NSD/1F3CM(B/$RC0:M53(VU<
M?JC1SZ.W+OF8[O\ 8^@Y9SW/H(F,5MDU]JVOG8S^:_MUR]XNU?;+3\D-;]KQ
M^U=]'V.U_K76]%F+_!][#]S-F-L< Q2;?5R+FJ4VG1!:7+(TN2%\$),DM5I4
M^)TX#4U&BQXK)NXKOH^QV^3_ !'KM=JK,/!CI,Q6F/H1;*IU-1U,^9GYGXCA
M2_=+;8B*-C;-8_B>691^#>6O3&2EH_R8J(\AE)/I.II6I=?C%\4DEQ,;FDQV
MY+^&Z9C[7Q/Q7J<^CPQFP66737TN*WBV4^6](Y/;!MRKE(NM.=2EI^2';_:\
M=/6N^C['Y/\ ZUUM?4Q?X/O5/M>V\3Q*3=N'E+37^]#+]KQ[^*[Z/L2?C36S
M%)LQ?X/O;=MMO:MMOB6Z,2NC":;CM=3BK0TDDIJ9$53H0Z=MO#;$1T/B\N6<
ME]U\[[IF=G:[(9O$ <#A>I1_5^H0*\\8^2;I;H=S5^W9VPQ-K.;?@:G;-;&5
M3X]I8;*0A]A#CB)RVU*4:#=J2$_&))F?"AAV/<9:.YC=7$$2<IVCCX^UBRG;
MPB]Q+[;'WF&H[9K=,T)?UJ22",]*#K7B53X )$;6[CIW2[:963K<0JXILMP@
MW-#:7$I;E1HZTF@C<(M7ITGJ*I&9\P&'=E5GMN0=O-VL=YC(EVFY7B\1)L5W
MXCK#Y)0X@Z4.BDF9<# :^VLO-S[4-[W]FLPDML[6Y4^;N*W1YQ3YMJ=6:8_4
M4A)=/4M72>U(2@E'JU:"U"#[?HW2/\#,X294/W^'P/\ VIT4=K]'6XXG;7)X
M+[9M/PKT;3J%D:5$LV$J,E$?$C*M#!'!W_PI=RC[70+>RJ1-D7M]#,=HC4M:
MU(:H1)+C4P53N#A2D=XVR-Q<94BWN-QF$R3+[4IU$R0M2"5RJ25I,_A(02ZR
MA>C&KPM-/3"DF5?/HJ%(1<^CQ-US9?()+K9I*1E4UU*J:256# (S37P(R,@1
MV6[O<Q<)V4JV5V%BGD.Y4PUQIEQ26B!;5%P6?64I!*6A-34HO0DZ%J-=4E%;
M!V&V%MVSMNF7"=+5>\\OA)5?K\\6I:S)1JZ3:E%KT$HZ\?C4+@5"(5'T9=M?
MLGG.Y-KO&1I@2=P;4A#J;>J0R<E^,@E);)^,LS4II)J,TFE)<>9^ *Z[?[9[
M;O)-H\K9E6")">MELDW.#+@,,19#;]N:5(;HM"*Z#-.E:?%)G2AT,H-=]LUI
M?WL[5FL0S*=-CPE2UP$3;>\J/.*/!D,RFC)Y9+XFHJ*.G%/ !H_NX[?,0VEQ
MO%KE8;Q?;B]=+PF$\W=YY2FT-]%2]2")M&E7"FH42<VR[6<(P^XV'-[=?LDD
MW*,VS*3%FW(GX9J6A*C)3?129EQY:A!CFXF\K4?>I>)[/;>L9ON]$C+:N5T6
M]'B,,1T(,UH*4MRB5MF6A9.Z/VA&=:&&H>Y5SNGN&S%TN>ZT?&[3ARY<0WK+
M$6MZ[MKZY='[8R3C!I)5-5'>7M%&2=Q"3+L5VZ-/C;\4*A<J_-R01)O8.'%B
M;([<HAL-QT.XU9Y#B6D$@E//0&5N+422*JEJ,U*/Q,14=NU(J=RO<,1<:7F2
M9_?27Q%%,5H?TC6<^VQL_P#-5L$1\>_)U[[=HC\/FRU\OXRN HS[<?)^]6#F
M]YB[;X7;+C@[3Q%9IS\FW-NNLFA)F:DO36UD>LU%ZD$"LE@W'=ZZ;!9E)WKM
M,:RY>3$]#4.(XPZV<$HZ.DO5&>>14UFX7QJ\.0@BYL1VB7'=#;"SYG'W)NEA
M1/ZJ2M<9A3K372=4GTJ*4WSI7X@HW;B?8EAUOE,S<ZRF[YB[$=)Z+'DJ*/%H
M14-+C:UR#47'[%20&6=Z$=N/VP9I'81TV&$6AMILN24IN\(B(O@(@1D/:?\
MS==OR\?FY?\ ?W05]?<MDUHQ?8S/)5Z>4PQ<++/M,52$*<-4NY17(S"*)(Z$
MI:R(U'P(N8(T9V_6S>3#>TR+)VXLL>X9M<[B=SL\*0]&)IVVRUM5=-3KS2$G
MH)1Z5K)7L!7?85D_?%*S"QQLUP>UP<1<FL(O<QJ3;5N-0E+(GEI)J<XLS)-:
M:4F?L$$KF^!%7A3S%1"R(9?I')YUX?,I?\T- J:Z3(RX>9_K@BH
M                                             C-WU?YEH?\ UBM7
M]FL!)D                        !P.UU'^H \Y=W,NPS8;O$DYY;'2NSC
MW3>RBPM1W&G8#\V(T:U(==3TW3=0I,@E(5P4X:>!I!4F8?>WVTN1VWI&9JC/
M.))3C"K7=E*;495-)FB&:3,N1T.@(^R-WF]M=PE,08>;=27)<0RPV=KNZ=3C
MBB2DJJAD15,_$P&]D)/7J,^?A0P',     ISJ0#SN^D>O]X3DV)8N4I96)R
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M!)5K@1EY<@1R
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M4E%R2I]447@        %"         *$     4
M       *$
M      C+WU?YEH?_ %BM7]FL%28K3G0$5+X %0                     !
MPN'ZZ>?B \N^Y')-R]\^XJX;:8?[Y*8L<IRTV2TM*-E*%QD)1+><-)DDDJ=0
MM1NKIZ--3H1 KHOS,.Z51^FS5+^.(?\ P@$=EC_9UW.V^_6N=-LVF'&F1WGU
M?.\1=&VW4J4="?.O @5ZH((M23!'*      *&1'S( )*2Y%_00!I3Y$ 4+R
M-"2Y$0!I27@ :4^1 !I2? R(!6E.0"A@/+S&?Y_<3^/5_P  4"O4%/,$7@
M I0N=.(!0O( ,B+P&,J</$A80*@HJ
M
M                #B4:B5P/AQ :8[ELNAX'@2\KF9#<;)[FYHCM6JG6ER'4
M&3;2JF5$U3\8^!#3U&GNRTX;IMIU.QRS7X])==-^&S-6-U_1VP\O<[WRW)W
M:]PR/(;A)M:7DR6K>]*<>8)QM1J;7H4=-2:\%4'MBQ\$4F9GO:^LU5NHOXHL
MMQ]ENR&SMJ.YO.7LB@V//\VOK5BE*Z+ET8E+DR&EJ,]*C2XH]15,B.G'R&OJ
M-+=DFL7S;W5^UTN7\VQ:>WAOT^/+^:-KU2M<=Z)#C1'I"Y3D=E#*Y+G%;BD)
M(C6KVJYF-JRV;8B*UI&]P\U\7WW71$6Q,S-(W1V?,^X>CQ
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M7I]1]/FL!Z"[0?YJ\%\3_!VTT/\ WDT",V
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MM1EP4:$7BM#\:5(!M;Z/FA;$RR,J?_,,TE?<\45&#=[-#WLV1X</?$UX<O\
M*$414VKI=K;8[=)N]XE-0K7#;4])EOJ2VTTVCB:E*.E $'<DRS-.]/,"V^PL
MI-DV2MLEI[(+N>MI4IA"R61+(C-#BE+;U,-&5"41+.NDS*B7#FV-D1M5*VEM
MSCD2P/621CS3I&2WFX\F,N,:R-1&1K(EFHJ\*@-%X;V';.V:P-0LM:DWV^+(
M_>9Y2%LI]5/2TE&G21>!TKYB##=K,6G]O_=HYM=C,E_\G67PWI<:'+>4]H*-
M$5((R29TU)<^UDM1&HT^/$!MC(\*[M9=_NDG&-R[';L=?EON6F"_:VW7F(:W
M%&RTXLXYFI2$&E)J,SXES%$7>S;&M^K[AN0O[1YG;,9M3=S2BX1KC!3+6Y(]
MW09+2I33E"TT*@"8&8XF<G8:38.X3*VW'2;>7D60VU7S<PZGWAQQE)(239&1
M-FV@T&FBE)K[0&H\1[J]NL:QZP8!M!@M]R5N!&1%C08T%,!;II*JW20VA25+
M=4:G7#27J6I2CXF ^3M2EE/[@=XIB<7D89[Y&M4AW')R2;DQW'6]:S6DDH_=
M5&I[XO)8"O;I@]@R#N9WERZZ1DR+OBTZ$U9S=2E:&57)$HG'$DHCHLB8225%
MQ(C/S =MWT8G:WK5M]F2VR*\VW(8MM:>21$:F)JTN*)="]6DV?37EJ.G,P'%
M](K3\BEA41<2RJ&2?O=<01W'<@=>R2:1<_F;&:^7^'6[F ^'!=Z(^QG:3MIE
M<FPRK^B8I%K*'"43;B5/>]O=0S-*N!=#3R\05VVTO>=;MUMP;/@+.#7.SN7?
MWC3<93R5LM^ZQ797J23:3]72TEQYF T=O:C<Y_O97^1]UAG.CM,?W!<OH](D
M% 5UJ]<E(_<]5*D S^#:?I"IDIN-<+W9X,)XR;>E].UN=-"N!JTMM:CH7'T\
M1!MCMQ[?']F6+S><GO'X29[D3W4NMY7J<6I!+-1$3KQ=51J.BUZU'ZN(HTKV
MHJT]V._:CYJN-WH7C_[;<!$WZ),Z\?&H*A!B"';_ /2%YE?K,A4RSVR*F)<)
MK):FF'V[1'B*0XHN"3)UI;?'[))D!#(;]W\VRP7VZ6)6W-WD+MDR1"5(1(0E
M#AQW5-ZR(VCX*TU(02,VGW!:W:V^LV?L6UVSLW;WFEME*);S?NLIV,>HR2GX
MW2U%PY&*C0GTA2#;V'AT/GD4&E/\6E@-_P"T"3+:K!5>>.VG^!,@,V
M                  /@50''UD^1@-*;U]P5GVP:CV*P159-N/=E^[6?&X/V
M]U3QJ))&ZAM1*(N-"3S,^' 16 8-V]9'N-E#VZW<IT[I>U.(.R8BE1NVJ!';
M/@A3#FI!I50C-!UKQ-=55,Z)4):J1*Y4Y%Y4$1J;N'0:,#8XU/YT@5_NQ#C<
MW_H_/YI?<_!?Z^?^G?\ \+:Z4D53-0[/8^'V;W*C_2"$E>*
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MDF1?'D]>XNJ4A"'*OO&M:$+-LE&TVI+9*J9)*H*V6E!D9<*EXU <P(
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M \O,9_G]Q/X]7_ % KU!3S!%X
M
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MX H%>H*>8(O
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M_3)X=O4UQLBE""OZ4D1)*21$1<"+F.OS:O%;W.7RW9%W>VXGF.*[&U>
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MP.@(N,!Y>8S_ #^XG\>K_@"@5Z@IY@B\
M
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M$7@
M                                              C+M=_/'WU_Q'&O
M^;& $F@&(Y]N+BFVMCD9%E]S;@6]A"EI2HZO/&DR+0TV536JJDEPX%7C0N(B
MHPE"W.[PKA;9&00G\'V"B.N3&&F'2.Z7LTJ-#2EFHM*$$2>73].I7QZI4FB5
M.$X3B^ X[&QG$K<W;;+%-1M,-F:C-2SJI:EJ,U*49^*C]G(B 9$1$7(J BH
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MD\P%X
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MU 'E_C'#OZB%Y7U?\ 4"O4%/,$7@
M
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M^=L<<IT0   %%?%,6$EJ'9/_ *0?XT7ZQCM<U]:WN<CEWXN]MTN8XD;G8E<
M         .%T^-#]@BO++N:O.X._7</<MML:B.SF[%,7:K%:3-+&E;*4(DNJ
M4XLD$2W$J5K,R+1IJ*CEC_1[[\RF4.N2[ PXHM2V79SYK29^"C;C+37X%& [
M6Q?1^[WVJ^6RYR9^/G'ARV)#Q(FR35H:<2M5".(7&A>8#TR;(M?#ZU# <X
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MZO\ @"@5Z@IY@B\
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MBX$1%X#QK6:LUYBL6O9/^>6+_$7_ *RX.K;^CG\_FASI_51^3SMBCDND
MHKXIBPDM0[)_](/\:+]8QVN:^M;W.1R[\7>VZ7,<2-SL2N          '"XG
MUZJ\2^OQ >:W<3N=:]G^[B9FN'PY"\IMI1$Y+%DJ2F%,Z]OCJ+HK1J6@E,J0
MAPC1\8E*J>K@&T8?TD6 ^ZLG.PZ[E.-"?>4L.1E-$[I+5H-2R,TUY5*M 5V%
ML^D3V\NURA6MG$KTT[-?:CH<4N(:4F\LD$9T<Y$9@)D-D=2U%QYD".8
M             4,!Y>8S_/[B?QZO^ *!7J"GF"+P
M
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M5?TAC%54(C*M2&2*F*C7LG_/+%_B+_UEP=6W]'/Y_-#G3^JC\GG;%')=(
M!17Q3%A):AV3_P"D'^-%^L8[7-?6M[G(Y=^+O;=+F.)&YV)7          #A
M7P49^/A[3H BMN_LOVEY9N+>L@W.S6%:<WEG&^=+>]D,*WN-=**RTS6.\9+1
M5E#:N/.M>1B*PC\W/L._E'M__P#5EM_MA4?7:^WOL<B72%)MNX5O>N+,AIR*
MT64VYPU/(61H(DDJIU41<"!4UD4U</Z"!'*                  *& \O,9
M_G]Q/X]7_ % KU!3S!%X
M                                                       *&9%S
M.@#Y)\F+#8?FS'FXT2.VIU^2\HD-MMH(U*4M1F1)21%4S/D"HIY[OGG6[M^G
M;6]MD5<QMM]$"\[C-FHK5")2=2ULR$&7(B41*1J-5*MZN%8-G;0=NN+[4+G7
MF3)>R;-;F\J3.R6Z(2Y+-9J4KT&>HT\55,ZU,^(HV]I<(SY<:T\@E&M;M:=\
M';A+79K[96;4IU9PV7XSJW4M&?I)2B3SH.5ELU<WSPW6T^7\+Z[1ZCDMN&(S
M8LMU\;YBZ*?-M8':<MWPO&<WW X]XLZ+A8$,*D2%1%DTLI+9.ITT+5P)5#J0
MU8G5S=-O%%8^7LN]EP<CQZ:W/.++PW]'%%6R<6MF[T:\MNY=>+5+LA-K)QB$
MPXV^;E2T&2E)I0BKPJ-[!9J(N_F71,=G^R'S',<W*[K/_&QY++NNZ8F&PTU'
M0J^:[5RCX4K2H5B"CA<-+:#4M1$E/$S,R+]4Q9E8CHAH;-,XR3<J^O;<[9&9
MVELS:R7)&R/H,$9F73;>+AJ.GV-:^%2)5.-GR79[O#Q[NF?E\I?><OY=@Y?B
MC5:WUM^/'NNGMI\OJ;)V_P!N;'@-M5$MC9N37Z+G3G?6ZZLB\5'QI6M!O:?3
M6X8I#YOF?-,NNR<5]*1NB-FQ\&X.[N(;>--L3Y!S;_(<;8A6*%]NFNN.F1)3
MH3714C])N:24?I351D1]C2Z+)FG9LMZ;IW>5P[\D6[_(U7:]O-R-[9$:_;LO
MO6+%4F^J)BS&IA]Q#I41UD\=!D1\U^O[$RXCK9-3@T?HX/2NZ;M\/*+;LGK;
MD@;)CUKQR Q:K+$;B08R$MM--))/I05"Y$7&GF/G\F2[),W7369;$6Q#NB\Q
MY1M5<7(6$!0  %#Y +3%1KV3_GEB_P 1?^LN#JV_HY_/YH<Z?U4?D\[8HY+I
M    **^*8L)+4.R?_2#_ !HOUC':YKZUO<Y'+OQ=[;I<#.HXD;G8E74D^1D
MJ         X'OC?#X& @WW ]EFXV[F[N1;@V*\VB):[O[ET(TQ<@GT>ZP8\5
M6HD,J3Q4T9E17(!JV7]'9O!%CN/-7NQR74I,T1VG7TK6HBJ24FXRE-3Y<5 -
M5XGL5F%LWJLNVN8+9Q?)3D194)%Q)TV):2>+3[NZRAQ+A*-"DDM/IU)45:I,
M%>Q39>LC+D?($<X                  H8#R\QG^?W$_CU?\ 4"O4%/,$7@
M
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M>H*>8(O
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MK>T+:':VZ6_(X<%VY93;2JS<ICBU()TSJ3J634I"%ER(R ;];,]1<>!BHYP
M                !0P'EYC/\_N)_'J_X H%>H*>8(O
M
M             %%5TG3F ZVZ7FWV6V2+Q=I*(=LA-J>ERWU:6FVT?&4I7*@"
M*5PW?W2[C[NK#MBV9&-8(Q,=;O&Y*]1)<:BE7I1E4(TK<4M%$I]?(_B:P5N?
M9O8O#=EK*4.Q,E)OCZ5_.E^>325+4M6L]?$Z)J142 VN@B-)'SJ7,$7$1%P(
MJ$   @XUJTE7]416!77>C:ZS7"3:;KE=NB7&&XIF7&=?)*VW$\#2HO,AN8]%
MFOCBBV9B4XHAI+$-TMO(.^>>Y%-R2 U9+BU!3"FK>233QMQTI5I/V&5#&O;R
MK4QDF[AFD_+<^EU6KQ7<OQ8XGTK=[<S&]FULTY!V_*X$I<5A<IYMEXEK)EJA
M*5I+B=*D,\^#)I[)OR6S;#@Z?#?J,EN/'%;KII#63<>[[^W-=_OJE6O:2T+7
M[E%49I*>Y'-2CD.).ADDDG2I\N7[8<"VW)J[HG=9]?R^72^]R7X>1XO#MB+]
M3=OGV(ZH^?Y;EUXW9E35L[;]O]M*<^R3;*KY'0E4"$6I9J(R6G1]C\8STF=2
MYC[/2\LQX+./-Z-O1'3+\[U&LR:C),W3-U\[YED^VNQ-OQVY_AKF;Q7[<.0;
MCLJY+-:F4K4I))-M"N2R2DBUTKQ,BX#RU/,+K[?#Q^C9U0\K,41-=\MRMDE1
M<2H9<B'*K5[;EZ"(E'3F?.@=*.04         %#Y +3%1KV3_GEB_P 1?^LN
M#JV_HY_/YH<Z?U4?D\[8HY+I    **^*8L)+4.RA$?X0$?$O>B_6,=KFOK6]
MSD<N_%WM@Y?99>0XU=;);KJ_8I\]A;#%XAG23%6LJ$XV=2]2?#B.'T.RU'AG
M:YMY9=N[+MOED9&50;%/>N4*3,;)M9+D/=523))GZ%?%6G[(@&^=*2\"%14
M     <:O&G*O$_UQ%><G<%VM;Z9UO'E>68M;TNX_<Y+3L%PY9-50F.TV?I\/
M4DQ4:U_,P[E.!';$?=Q$8!^9CW)$7&VH^[B,!V./=G7<3"OUKFR[:@HD:7'>
M>,II&1-H=2I7#QX$(KU2;X&5*4.IG[3^$4<P(                 *& \O,
M9_G]Q/X]7_ % KU!3S!%X
M                                            ,<S:;EL/%[I(P2'%
MN&7--UM4*X*-N*X[J(M+BDJ09%IJ?Q@&@9F==[4&(_-DX'AR8\=M;SJBG/'1
M#:34JA%*J? @5C^ ;V=WVYF(V[-\3P?$7[!=.O[HZ]*D,.'[L^Y&75"Y52HM
MI5 $A=J+GNI=,?E/[O6BV6;)$3%HB1;,ZI^.J"331H<4I3CADLW#=295Y$7
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M/\_N)_'J_P" *!7J"GF"+P
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M+_3 7(5K*I<@%3 >7F,_S^XG\>K_ ( H%>H*>8(O
M
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M1;OQ/XNF_P!DR.#SO^A\[?T7K2GEIU)*ACX-UU='*AB46JXBH*@
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MW5W8CR6K3&>*:TBX*/WJ?)22%MJ6EU*ZL&2J<#(ZE0J4 >D"&]"JER!'(
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MX\^8J+C<3PIQ >7V,_S^XA_\NK_@"@5Z@IY@B\
M                                                     %JEDFE:
M\?(!3J(I6H!U4%S "<28#@FW*!;HSDVX2&XL-DC4](?6EII"2YFI:S(B+X3
M8/D>^FT&*1VY=\S.UL,.JT(4U(1),U>TF.H9?5 1]WV[LL OV#9-B6VTJZ7G
M()D+1"O%GB&]"96I:343CAJ):/22B_<P5YCJXF9D7#V BJ2+D8#U(^CZEW>=
ML;.;N+CBV85_E1[83Q42B)[I$<(F^!>GJ+</X:@)7H0:3]GZX#D   !Q\/V
MBIN6*42?C&=/&@5!;Z$H,U'1)<3,_ 8U94ZFG,ZWO9@O/6';V$>3Y6G41-,)
M4]&961TJX:%)U%\"B^$<W)K8XN&S;=]#ZWE_P_-]OBZF[PL?3MI=\T3#6.4M
MP,1G?A-O-=_PKS9MQ$BQ8; <_>I.<D(4WH.I<2XTJ:?C$L;^@Y-DU=_'DV=?
MLO37_$6+3XYP:&R++)_%,?S=O\43Y-FQD.,[09+NA<6,HWF9:BV1AAI-EPVW
M]2&S&-))IK)!ZJ4X&G56OV6FB2^BNU6+2QX>F_Q3$=VSL?#7>)FNF_)-9F>O
MZ^UNXMOL%+GC%HYU_P  C?)CD^]9O;N\LO7@MZH7_D_P-7_1>T_<$;Y,9>]Y
MHCU[O++&;+>ISV_#\6M,HIUJL<"#-21H3)BQ66720JE2U(01T.A#RNS9+XI=
M=,]\RRBV(W.^+D0\U5               !0^0"TQ4:]D_P">6+_$7_K+@ZMO
MZ.?S^:'.G]5'Y/.V*.2Z0   "BOBF+"2U%LI_P!(/\:+]8QVN:^M;W.1R[\7
M>VX7,<2-SL2N          '$LBU&9\"X (*[R=W6X>R6_P!E&*OVV/>\$2[;
MWHT:4AUJ2AERVQ5.HB/I42"(W36HS6VYZC/X 5MW;?O0V8W!=9M[TUW&KRM#
M1'&NQ(0RMYRNIMIY"C)1),N*EI00"0=MGVZXQD7"VRV9D%XOM4J.XEYE=#,C
MTK09D=#(R ?<2DGP(P14    !0U$7,P&GNXO?&U[(X),OI''E90^A3%BM;ZS
M^V25I42%K0@R4IM!^I9$I-2*A*(P5YZW#9NZ-]N^4;[YXV\[DU^G0%61V0OU
M]&1*H](6C21ZG/L3-5#2?*O$!-'L3H?;I9O O?KC7R_PI0")7:=/1FO=L_D-
MXBLOR+F_>[RI"VR6AN6ZI<@EH)>JAH6=4GS(!MKZ29""M6WCA$1+6_=4FHR+
M5I2B*9%4OAY CH<]OUSO'T>F$S9CZBD%,9MM4&::Q;?-F0V4'QXETV4$9 K:
M?T=K=-D;VLN:\GF&?PE!@%^P"(LXE;46CO7@6]"M6G+U+-1>/6=4Z?/QJH%>
MD.[V[N+;*XLUE^7MRW;4[+:MZ46]M#SW5>0M:3-*W&BTT;.O'R :/+Z0C8D_
M_0\A^$H4;_A7L 17VHRNV9OWIV+*[*EU-KNMY6_&)])(=))05I]224HB.I>8
M(]6T\P%X
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M^A9U.99CX9K.V>MN%+:JE7A0<E[=*_2H^)B4E%Q)IX"AQ,^)<!%7#)
M     4J5:>(E1TV099C^+M,O7V>W!;D*-#*G=7J4DJF14(QXYL]F**WS1E%D
MSN=#^5[;K\8(W_G/[4:W[AI_;AZ1AOGH/RO;=?C!&_\ .?VH?N&G]N$\*[J9
MC&EQIT9F7%<)V/(;2ZRXGDI"RJDR^$C&];=%T1,;I><Q,.0QFQ:]D_YY8O\
M$7_K+@ZMOZ.?S^:'.G]5'Y/.V*.2Z0   "BOBF+"2U%LI_[_ /\ &2_6,=KF
MOK6]SD<N_%WMN%S'$C<[$K@         !PN%5? O#B P[-]L]NL]ANISG'X%
MT1TNDJ3*;2E]ME*C7I3(3I<0DC,S]*R!7GEW ;+=L&%O//8IN1+B7S0N5^#[
M$=J^,.)=U&RAEYE45#22-)I5K>=7R.GF1I[:'=3=;%\CM5GPS(;DU!?DQH[M
MO9-4ADHRGR-1)963B4$>HZFDBY\3!7L\U4U<>%/'S!'.     X7249U21\O
M!Y\=XVS6^VY>[:I^,8[,O>(PH,9FV+:7'2RE9HU/)(E+0JNLS,Z_4!6G=U87
M=M;MNWH.Z4>X1-N(ZX[;D9YNWM1$+)PB82E$:AE15*$D@&U^QK\NZ;YCIH]\
M_(2?SF;A%[M[G[STG:5_\+JZ]/J^P!@6R$VR;.]XDZU7=3S%ICWF[X_"?=2E
M!Z7Y#D:.\X:S0DD&5%J7RIR(!LOZ1[([//FX1BL.4A^^6TYLJ;$;]2FFYA,)
M:)5*T4?3,])\:4/D9 CN-SMO;C:NP3%;5!);J[>Q R&X=4NFMINXK=G.I-)\
M:H7+)OSX KOOH\LBLS&T.1VB5/99N$.^R;@_'<42%(AKA0T$Z9JX:=2%_6$$
M;]I(]US;O&8N5L:]^*'DDJXR7FU)4DH4:0I!NUJ54DDT\A1Z:9YMUANYME1C
MN<VI%XLZ'T3$17%O-))]M*D)7J96A7 EJ*E: -<?F?=MY%PP.,1^?O=PY_=
M"$.W-AM.+]\-HQ^Q14PK1 O2VHD1"E*2VCW%9TJLU&?$_$P'JDGF"+P
M                                                   'PWNS6W(K
M-<<?O4<I5GNT5^!<(JC4DG8TIM33J#-!DHB4E1E5)D8#2Z^S[MM2DUE@D8C(
MO]V3_P#A(#17:AV];-[A[82+]F6*L76[(O5PAIDKD2FC)AA22;1I9>0FB:GQ
MI414LMOMJ<!VLBS8&!65%FAW%:'9;3;KSVM;9&E*JON.&5",^0#-T<$^H_/B
M8J+JD 5+S 4J7GRY@,=O&>X38SDLW?([9"DQD&M^._+90\E))U<6S7KXER*E
M3 :>O/>3L!:V'%PLD<O<YI?3^;;9#DKDK56AZ">0R@Z?UXBL8>[PIF0W&):-
MI]J\@RFY.-NNR6;DI%A)I#9IH;:E-RDKKJ.M332GC7A1>SG'>GE3LR18=O<9
MQ.V_$8AY%)DR9Q53Q43T9YMM7'_Q1?  ^9KMY[BLMLZ&\ZWRFV_WY1.7*R6N
MVM*2TDG-?29F)D-+IPX*Z?PD?B'=0.RK;;WV-+RW(,HS6/'2HOFO(;F4B$:U
M(-.O2RTRXDRJ>FCOPU*I&&P<=[==D,40\U9L$M?3?-)N%,9^<#JGE3WPWM//
M[&E01L*V6:V66&FWV>"Q;[>UP9BQ6D,,I]A-MDE)%P\A%?<T1DKEP_HX"HY@
M !8DR,A(B8*U4.A>7U!:E%2XI_I@A4J4/P!54&1UH%"JX!17(21QG0^!'Q_9
M!:.)U]F,VIZ0XEMI)&I;BS)*$D7$S,SY!-T06VS,TC;5IG+=Z9$FZHQ#;&WE
M?<E=D)C/RGTK*WQDJ(U*4I:#+5I(C^R+S(U<CY>365NX,<5GKZ'V>@Y!9;9[
MQK+N#%;^&)CQ)^:8Z776S:^S8XAS<3>>^*O%V@,N27?>SU0(R"3U%I;:HI3A
MEQH1?&\$5'II^73?=6^.*Z>C?#'7_$5+/!TD1BQV_BI2^Z.CBF)W]='0NY%F
MV_MS:L>!'(P_;>'1V9D)(I)E%2B6FT$M%$J(R^*?MU?8C[.W#AT-G%?2_)T6
M]$/AKKK\L]G7TMTX%MQBNW5H:M&-P29)!:7)BR0N2Z=:FIQPDIKQ^Q(B27@1
M#BZC4WY[JW3LZNAZV6Q;%(9DWP,R]@UH9.04                4]HQ'6W*
MSVR[:$7.#'FH;/4VF2TAXDF? S(ED9$/._%;?ZT591,QN:IWLQVP6[#FI-OM
M4.(^=PC(-QB.TTK2I1U+4A)'0_(<?F>''9BK;;$36.AL8;KIG>V.G#<2T\+#
M;J>?N;']H.I&FQ;YMCR0\N.ZN]W$5AN.VEEI!-M-I)#:$D1)2A)4(B(N!%PY
M#8C9LZ'FYS&;%KV3_GEB_P 1?^LN#JV_HY_/YH<Z?U4?D\[8HY+I    **^*
M8L)+4.R?_2#_ !HOUC':YKZUO<Y'+OQ=[;I<QQ(W.Q*X          <#I^H_
M8(KS?[H8F_&Y/<!?]O<,.Z7#'K7[DY:8,<_=X[29-MB.R%$[Z-1&LU*41K/]
M@!E6VGT=A,.IG;KY(A]-5I^:+ E>D_BFVM4R2E)^"B4W[M\"Q42XV_V7VSVQ
MAIB8;CD:"LE]5<M:>O*4Z:$(4OJNZE),R01FE%$UY)*H*S]%-14X5YU!',
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M;:UNJ09G\;[:=>' 0;^;.J> J+C >7F,_P _N)_'J_X H%>H*>8(O
M                                                  ?%>+K;[%:+
MA>[L\4:UVV,],G2%$HR;CQVS<<69)(S,DI29\"J \A]]^YO/MV<@E-,W-^VX
ME$ENN6>WQ3]W6ELC4EM3JFU54K2=#]5/&@*U[@&[&>[9WF+>L1O#T1^.X3IQ
MUF;L9TM9+4EQM1T,ETHNE#,O$$>I>$=U>UV1;:0-Q,FN;&,(D*4Q,M<E[WF0
MR\ASI'I2PE3BFS5\59M)X<3(A%B'27[O;V8MTIJ)CZ;UF1K1U5NX[;R=2U4S
M*BTRW8JR/A7@DRX\P'3Q.Z;=3,FI[^V.Q]VNEF94IB-<KC<6+>\3NG@;D4V'
M"X5(Z)>.OF*+$6+ODR^SQCF9)B>)-34(==*.U+.ZQ"66K0I)L+9-::T,B<,O
M: YY/:;F&5W"/)W2WDO636^(A2&8\"&W9GDFHS.O6;?>(^)\C;,09!9^R[8B
M EX[Q:9N42W55.9>ISSKZ2H1:24P<>I%3AJ(Q1M6R;6[;X]$BP;1BMLCLPB)
M$5:HK3KJ"3R/JN$IPS]JE5 9B24I(B25"+DDBH(CE(4         '%0B*GEX
MB3"]CY)LN+ CN2YCR(\5OBZ\ZHD(27*IJ/@1!,Q"VV3,TC:ZE.=89H*M_@5_
MQAO^V'EXUG7#<]PU'L3Y%CF=88=*7Z!P/_=#?[!A&6SVH3W'43^"?([:S7:V
M7AMV1:I;,R.A1(4['<2ZDETK0S3P(Z&7 >EMT7;IJULF._'-+HH[,9/-:X9$
MA1GR\0&#9SN/C& 0%2;O(ZDM6E+%MCZ52G5.&=-"347#@?,R^OP&KEU-F+UM
M[K\NY3GUMU,5NR-LST1'3/S5:K9M>Y.^B>M>7UXEMQ)3K:@-T=G2B)9&G4=$
M:4F1'4Z\.6E1'4N?%F34[9]&WJZWUGC:#D\4LB-1F]K;;%D]VWBK5E&1Y5MK
ML%C<AFVPVU732DHUEA'KFR75F24:JZC2GU:U&=:)KH2I5$GW]#RWBV612SIG
MZWQ.OYGGU5_B9KN*Z=WFAA]DVMRG=V^%F^[ZG(%I9,BLF*1G%$GH:B<(Y"TT
MJ2JT,B+4?.J*4'<R:S'I;8QZ?;/3?]CE<%U_K^1(FVV^%:X3%NM[*(T*.@FV
M6&DDE"$I*A$1$/GKIXIK.V6R^HBYT,8[C>N3S%B:HN%                %
MO#B),K10R.O $K+5V_)4PAG^,HG]DH<;FU/!^>&SI]MS:!%P'9WM9<$*H8R8
MM>R?\\L7^(O_ %EP=6W]'/Y_-#G3^JC\GG;%')=(   !17Q3%A):AV3_ .D'
M^-%^L8[7-?6M[G(Y=^+O;=+F.)&YV)7          !0O(!:2$$9F22(SXF9%
MSH5 %U" *%Y %"          "A *4+E0 H7ERY *T(!2A>0!0O(!7ER 4,!Y
M>8S_ #^XG\>K_@"@5Z@IY@B\
M                   %JSHDS,!IWN0S3%<9V;SJ#?[S%@SKMCUUAVV$\XDI
M,E^5%7&:2RT1FM=774),TIHFM5&15,0>-1D:#H?P>T46$?UP'H#V3]N>*W["
ME[@[@X_'N<B5,0]CBI"I"'&6XYJ2LW&O0A2%J(E)KK(R^L"IP6G$<4LCAR;-
M8X%NDJ3H4_$BLQW%)\C4VA)T!'=$DB*A%P *%Y *T( H7D I0O(!4
M    '#0Z\/B^(E9.UU606*V9):I5BO#!2K9,22)$<U*1K21D=*I,C+B7,AC=
M;%T4EZX\DX[N*W>U9>^WO:6%9YTV-820^PPXXTHWGCHM*3,JD:Z#1RZ7'%DS
M3Z9?3Z;X@UDY;?2WSU0PO8[9O;G,MLK/D&0V=,J[R5RTO/\ 5=;U$U*<;3Z4
MJ(N1$0\M-I<=]D3._O=7GO/-5AU=UMET1%(V4[&^<,P?&\%M\BU8O$*# ?>]
MY>:):W*O&E*#559F9<$I*@Z-F.VS9:^)U6JR:B[BR367=S9L:!'5)FOHCQT%
M53CJB0DB]IJ,B_5&=UT6Q67ABQ79)X;8F9[-K2>1;R7G*YB\5VAMKMTE*);4
MS('DFU"B&HTI2I-4J-9E51G4DTI4B65:<V_5SD]'%OZ^A]CI.28=/CC/KKN&
MWV+?ZD_--*?+LKVN#;)P;'<591FT_P#"3,.HMU$]TC;892M&C0ELU*(Z:E>H
MRIXZ2,AG@T<6SQ7>E,^1J<QY[=EMC%@CP\5O5ZT]&V8=3G.]RUSD8'M#'+(<
MW<=)M]UM-84%AM1$ZZL_LZ<$T29$5:ZC41(7]3I]!%L>)G]&SJZ9[GQ^3+-:
M6[9^6]]FV^QD>QW-&;9[)3D.XBGE2?G"JRCL+,C21-(,DZJ$?-2>!\2(C*HQ
MUG,)R?R\<<../EM6S'3;.V6ZDTH7 <=[.0B*@L"HJ
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MU'QY CD                  %# >7F,_P _N)_'J_X H%>H*>8(O
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M[#,BMM3&VT+H2T*Z9-N%R,^DM6FI5H WNV9&JOC6GU14<X
M    H8#R\QG^?W$_CU?\ 4"O4%/,$7@
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M/\_N)_'J_P" *!7J"GF"+P
M     4,R253 6=8J\C ?#=[_ &7'[:_>+]/CVNTQ4ZY,Z:\W'CM)K2JW'%)2
MGCPXF C+?>Z6^9Y=)6)]N>-2,KN,=?3EY%(9-NSL44:%$3QF2#572I*E>E23
MJ0BOIQSM2N>671C,NX3)7LOR J*38V7%_-#"4J49-$APO4@R5ZD:222JT,42
M/L^/VG'K<U:K'#8M]N82E#4:,A+2$DA))+@DBY$DB!'9(3I*@"X
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M*AU_HIP <X(                 *& \O,9_G]Q/X]7_  !0*]04\P1>
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M+OKAVMV1,4:W221**W0HK1,+02B/BN.EM95+C4!O-/T;VW*_^E][*GCHB?)
MKZ[9]'5MY:;E#N;66WIQR&^U(0A2(NDU-+)9$=&^1F0"8Z*ZN)\>($N8$
M              %# >7F,_S^XG\>K_@"@5Z@IY@B\
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MI1\4E*(JF2>15/@)PQ6JUEV'(A6*XN0R
M            ' X9:CKX<*^V@#SDSW#,(V\[R7K[NE$CW';S(I3ESC'.44EE
M,J6TEQ7O#*=7I;?4NC:TF1HT\#(P$Y+:QL_[DP=OC8ZW!4A*H[:&H3:";452
MHFA4^"@+1]B6-L"6@V&K"3Q*(VS;3#)>JO#33C4!E;==7*B:\/@!'.
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M,5ED4MB(>,W3+[B2G]J0]45H5:T*HJ%"\@#2GR(!6A
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MTDD(21<B)*:$0Z5MD6Q2'AM<Z4)\2&8O(M/(38*E6OL%@5%0
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ML5FD_,E&A**%0J<R(BY#YMLRY$(33RIX%R$%W3+X!45H)0*"AIJ)05%
M      6FHP#5P$VCC4Z:54*E F:+"G65PH1>T*E#KJ\@J.FR',\?Q=A3]ZG-
M1C(JH:-1&ZNM::4$=>.DR\AX9,]EF^65MDRU\O<'.LX6J+@-H.UVTR,E7RZM
MG6E4?N3?%)*+49T5J(R\AS9U67-LQ1Y:O:<<6[WV639ZV+E(N^:3'\CO5349
MR%FF*A1F1^AE.DB_K3,T^P>N+0Q7BOF;I^A)R3T-EQX$6&RB/$90Q';+2VRT
ME*$)+R)*2(B(=&VV(V1%(>,S5S])//C4>C%4DD14+D(*T *"BH
M                                     .!TR2HZ\*T =+,S?#+1*=M]
MVR&VP)[6DW8LJ8PR\C6DEIU(6LE%5)D9< 5\KFX^WITTY99C\R^<8I</[H \
M]=_<PQ?"^ZW&,EV@D0TN$U!.]?-ZE^YOSWYSY/$YT5(2O6V;1K)"M)G0SXU
M>ES1\2K\8O$$<X    "Q;>HZ_P!'  2WI\:_" &W7QX>! *&U7Q 6/1&9+:V
M)"$O1W$FAQIQ)+0I*N!D9'4C(!\5HQVR8_%*#8;=%M4%)FI,:"PW&:(U'4ST
M-$E-3,_(%?>;-?LN'APX@CK;MC&/WXXZKW;(ER5$7U8AS8[4DV7.'J;ZB5:3
MX%Q3Y .R)DBX$?Z@"]""05*UKQ,P%3 >7F,_S^XG\>K_ ( H%>H*>8(O
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M,>IN]UNB['=,S%*[.S:VPGD1'PJ="&=8<.8<J2H5 B@J*
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MAI!:4(21)(DEP(B(N1$.C&S9#Q<B6R(RXB\*5<AB*J,D
M                                  !::R(Z& XUD2CK^N @%W'=GV[^
MZF\^2YWBQ6L[#=?<2B>]RU-/?O6WQXR]2":53UM*IQY -6E]'[O\5:E9./+]
M_K^1 ;%V9[!<TM^90;[N?-@,66TO,2FX$):IAS%-K-1MJ41L&T14(]1:O@ >
MAB&S2?/AYF Y                  !0P'EYC/\ /[B?QZO^ *!7J"GF"+P
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M[O2X9QXXMGH<F^ZLLK)!D=1M,%U#KQ!%PHH95$I5514
M                                 !QF1U/A4C\0'F=E]^OB._5BV(N<
MI-N/*[0V<0I#I,Z%(C:DZ-6FAU\@5Z9-5TT/F"+P%#,BY\"\P%"6DSH1U 7
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MK*5)(]7U!T(>3E%0
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M$HJW2?F%384,958TE4BX"+!0J<A%5(BI04"Y@BHH
M                                    &(/+G,/_ .(-'_ZWV?\ L(HL
MCU%))$ 4+R #21\R 5*G@                  .%X^/U!%AYW]RO<-N!@VY
M&08_CV1366&7R0U':=4TAA*6F5>GT'6IJ,?0S=@Q::R9LBZZZ):L1DXYV[$2
M(^X>31LU1G[%P>+*D/')*Y$LTO\ 4,M!F2Z<]/IK0<:,D<=:5CJ;$I9=O_=%
M?;EFMM>W&RV1&QR(W,<N7OKJW&5);@ON%6B*J42R1H2DC-2J$53'9R7:?+I;
M[K;(MOCAW=[PB,D7QMV-R9EWT8&PW(A[86N=EUV032HLMUHK=:UZU))PE+DK
M;D)4DC53][T-5.-.(Y>#0YLVVR*^1[W7VVQM:1R'?;N-W*>6W$7*QFVMN*<3
M&QIE<E]+:T&DFWW6S7K37V)'3Q\GNB*Y;HL\GVICRV7S&W9T[)6V?M9W/RIJ
M#<G[.N3[SI6W<KY+9^U)6==:FU.*>05>)I)LU>P:WNNEQ73-V;C_ (>"?M=7
M#K[+(I[O%?:F_P U&X,2[0\F;9>+*;] MKA&GW9-J:7,2HBYFOK(CZ?J:AC?
MDT%8FW#%T]<[/M>_[[S"W9CS78[?9MW?4V!C?:=MS8GXDB?-N-V<9XO1I+J2
MA/+,M)J4RE%2\R^V?5'K?S;+->"(L<;+Q9)_F3Q3VMG6K:S;NRM&U QF E"U
M&XKJ,(>]?L-W69<O,:&369LD^E=+"VR+=D0RE;\*WMU?=;BQTE1.M26T)(N1
M<:$5"&C?=;&]Z1#KSS'$FSH=^MZ?,CELD=?]>/.,]G6O#*GX;8C0_P#+UO\
MNMC^W$]XQQTG!*QS-\.;2:E7^W\/*2TH_K)49C"=7BC?/UKP3U.JF;M[=P>+
M]]9,^7VM#SW]Z;4,)U^&/Q?1/V,O!OZGQ'OAM=S^?2^Y)OR \YYEIX_%]$_8
M>#?U*?ERVOJ7^7>'A^])GR(P_=-/[7T3]C+P+^I\=PW[VVC-]2-.?G+_ -BC
MQG4K\?%\FD_JA^YX>B?K^P]WO<#&^UAEIUQL=O[S?@MN&VM/_<OF+',+)W$X
M9C>Y?RUVWG^"V1\/* CY89>^]B>'VN*1O;&Z:CC8ID"G>:2<@I2FOM,G3/\
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M;L(R>X!\B-T['&,_!TUF9</_ !>L6)U4]'TP>AUOJ*'OX?'W['2+D7"5Q_\
M-C/AU'RE*V'N>_G^[L=^M*^2$X=0E;53A;]?[OQWZTKY(.'4+6T*%OWQ_?\
MCOUI7R0O!J.LK;U/E>L^_;Y?^U[&U7_8U2DG_>3&/A:CVI7BMZF)9KA>]<NP
MS/G.[1KE#:2;DB#!=>ZBVD$9JH3C:"50OL2.I^!'R&KJ=/J)LF>*9\C.R^VK
M0%#+GP_H]H^5FVZ*NA$S1FFVF.YG?+WUL-<*))B%J=G.K4TP@C(Z)6:249ZN
M1)2DS^ N(Z.APY+KJV;'ADNMB-K><:Q[\QC(OGFRO&7 C=7)5P_N)#Z/P=17
MUI:DW6=3[2A;]5],[':^/"47_P"$,IQZBN]C6Q=[GOW3_#L=^M*^2$X=0E;5
M?<]_?]W8[]:5\D%-0M;7&['W^;1J1)Q]XRYH03Y*_P"[0DOU0GWB.CZ5C@ZW
M4KN/<2P[0[-;I353,S:<801_Z]])_J#&;]5['TP4LZW91\EWO;(TOX5&=5PX
ME/C(K_YU0GBZO^W_ )H7AQ]?T.<LKWE*A?@$P?\ \3C?VXOCZO\ M?YH.''[
M7T+OPLWD_$)BO\:1O[<3WC5_VH_Q0G!C]KZ%"RO>2AD> L4_C.-_;A[SJO[4
M?XH7P[/:?)(SG=J,2B>P-NB>>F>TNG^M,PG5:J/_ &H_Q0>'9UH^YYF5^S"]
M/2+TE48F%*::MU5$EC29EIHK[+S.@^:U6HNRWSQ]'0W<=L1&QCD*;*MTMF=!
M>7'F1UI=9>;,TJ2I!U*AD-3'==9=Q6['I,<44E(?'KCO9GUF3-9E0;1;'S(F
MY9I<:D+01\5M$GJ<.'V6FO@/JL4ZC-;$Q-*]+1NBRR:;W?KVAO=S6VG(,XN5
MQAM&9]%"285]1>M1?J#8MT.7\629^9YSEMZ(?; V1PJ,\;TQ$J[FHJ)3<7NJ
ME/M+2E)E]<>ON&.?6BJ>+=&YE%MP3#K0TIF#9(K;2CU*U-$YQ_U>HQ[6Z7#;
MNMAA-]TN\B1HT9*6(K266$UTMMI)"2^ BH1#:B*;F,U?70ADQ5
M
M        'PJLEF7,^<%VZ*J>2B64HV6S>UIY*UZ=52ISJ ^X
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M)(2DJ$DB(B*GD0^JB*;&BO)-/$9I651C,D'P *E6HJ*@H
M
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M%    *$ MT)\@ T(/F0"I)(N1 *@*4( H0"H
M
M                    "Q1$9^V@DJL--*<>0%'F)C-3[]XI>'SXOA[?<%!0
M>G2$F7QB VN0N'P +Q4
M
M
M    '%U3/D1']4!13U./"A +NJ=*TX'2GU1!5)Z_5R\ !2*F1UI0!Y@8PO\
M[?,1%/\ WZOC_O!0JO3XDU56I_ #&%VGV@JX
M
M
M                      :^W@W C[7[<W[-I*#?5;6#5&CDI*%./+/2@DFJ
MI5J9JH?D"O.O#MO]_P#N[8NF<3<F4Y#L,EQ-M]]6HV2GI;;=4Q&0FB6E:3:,
MSHE/$@&U.T'N$SE&X<_:'=2^.W S4[%MCD]U+SC5QC.$RN.ETZJ7JI1""5I*
MAF1<0$_$*TIXU,$5ZI&7#B \O\9X=_457A\^K_@"@5Z?H61JX?!]4$<H
M
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M=S'R0!^DIQ/\0KC]W,?) 'Z2G$_Q"N/W<Q\D ?I*<3_$*X_=S'R0!^DIQ/\
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MJ):VDSXZ)!(4HJ$9I)=#/Q!&0@
M         C;WNXW<<CV!NY6\B4JURHUSD(YF;+*E),DD7$SJX0BM5?1_[@8E
M9MJ<FL%YNT>!<85XD79YN0XAJD)R'%;)9:C(S]3+GUA4:$V.MESW$[NFKW8U
MIFQ(-_E7I^42_0<!B09$M*CK4S2I.DO$17I_D^&XSG%K19\MM$2]6M#I2$Q9
M[+<EHG4$:4J)+B5%4B4HB/V@,-/MSV,IQV^L'WKB?)"H\]<>P[%9'>C%PI^S
MQ',47=UQSLRF&SAFU[DI>@VC3HIJ+5\7F"O0I/;GL::M/Y/K!3^+(GR0(O\
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ML9_)[C_WLB?) 'YN.QG\GN/_ 'LB?) 'YN.QG\GN/_>R)\D ?FX[&?R>X_\
M>R)\D ?FX[&?R>X_][(GR0!^;CL9_)[C_P![(GR0!^;CL9_)[C_WLB?) .,^
MW38XC,OR?6"G@7S9$Y?W(%>:FU.,X]=N[&'BMRMD:7C:\CN<1=J=90N,;#1R
M=#?241ITITE0J<*$ ]+B[<MC#*OY/<?^]D3Y($5_-QV,_D]Q_P"]D3Y( _-Q
MV,_D]Q_[V1/D@#\W'8S^3W'_ +V1/D@#\W'8S^3W'_O9$^2 /S<=C/Y/<?\
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M;K$<YR>4P[=%9C&Z39,Z-730FM-1TJ F_L/7\B6V]?'%;&?U[<P8#80
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M56K@7I0H!@79YM'FNSV#7.P9Q&9BW*5/.2RB.\B0DVC02:FI' N) )'
M         #YUF=3(B.E?@$5 ?;;M4WBQKN3B[E76WPV\59OMPN2WT36EN^[2
M3?T'TR/54^HG@*)_-E1((N             6N%5!D BGWG[&[@[UP,.CX%$8
MDN65Z>N=[Q(;C$E,A$<D:37\:O34"I";>V:=C^"XMC]S22+C:K1;X,Q*3)24
MOQHS;3A$I/,B4DZ'XB#*A4             &M-_<.OF?[199A^-MH>O=WADQ
M":=<)ILUDZA?%:N!<$GS 8)V<;2YGLUMC=<8SF.S&NTN^R+DRW'?1)0<9V'#
M929J1P(]3*^ "0P              HHJI,OU@$&,([9-U[)W2W3=2?!B(PZ5
MD5TNK,A$MI3ONLR6X\THVB/41FE1>GP$5.@5               10[T]BMPM
MZF,1;P.)'E*M"IJIOO,AN,22?)HD4UTK\0^0#?\ M38;CBVV>&XS=T);NUEL
M=LML]M"B6A,B'$;9<)*D\%$2D'Q(!F
M
M
M
M                 U_O!N]B>S&).Y9E;RB:UE'@0FJ&_*DJ2:B;;(S(N234
MHSY)+Q.A&$4X_P!)-8%36FI6!2V8"G22Y)3<FW%I:K0UDV<9.HR+CIU%\("8
M^$9MCVX./PLIQ>:F;9YR"4VM)I-:%&1*-#A),]*DUXI_8 9*
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MD5O:F1X#5_C7!+3+KCR6R<-*#87P;6M2/C'734@5+M"C-5*GS_6!',
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MW1M>(9*VAF]PIEJ=DLH5K)LIJ(\M"3.GQB0\DE>2JD*CV^)*25P(!<
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M8]G]WL6WJQ=W+L/:F-6EJ6Y;U%<&D,O=9E#:U&24..%IHXFGJ!&P0
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M;IF26W'"TZ74T/5SKP ;
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MC,@[E2<R;4B=(>0ZP3;+%"T(:)-%&Z:3+TT)53,@]%"*A$0(J
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MW"]LK.YCN"6I%GL[TA4MR*VX\ZDWUH0VI>IY;BN*6TE2M. (RT
M                                    6K1KI7P <?25Q/A4P%R6S)9*
M.E"+A\(#D            ,JE0!P]'CX&"N8$<2FS-1GPH?UP%Z$Z2H N
M         6K3J30@''TC.NJE3\@%4M&1D9GRX\. #E             <*F3,
MS.I5, Z)^%/@ <B$FDJ>T!<             M6G4G3Y@.,F3]@*$R9'6M01S
M             .,VS,ZU\05:;2C,S*@(&R?(CX '1]/A4!<AO2>HSX@.0
M       6K3J30@''T3(_"GA_I !-*(ZU(^(#F <1LU5JK0P5R)*A$0(J
M      .-39J76O#]4%7(3I*GCX@@M.LJ +":,JT\?, 2T9*(Z\ 5R@@
M
M
M
M
M        I4N/'ES *EY@*@
M         &9%SX *5(^1@!*2?(R,!4
M
M                                =5>+Q:,?@R+K?;A&MEJCD:Y$Z:\W
M&8:27$S6XXI*4T]I@.OQS-,/R]AU_$<@MM_9C&3<AZTS(\U#:U%4DK4PM9),
MRXE4161-?%]E147@           H8#B-UHCIK37R,R <A?#]8!<
M                     .-WXI4X4.H#'<CSC"\/)D\MR.V6!$CA'.Z38\(G
M#(C.B.NM&H^!\@'9VFZVN]PXUTLLUBXVN4DG(TZ&ZB1'=0?)2'6S4E1'YD8#
MLP
M                                       !YH=Y>[^Z>'[Z7.QXKF%W
MLUF;A0'$08,QYAA*G&24LR0A1%4^9@-9VS*>]&]0(]TM,K<2X6J8V3T6;$:N
M[[#K2BX*0XVA25)/S2= '?8OWS;[XM(C1+S(CWF)"(VGHEQ8-+ZS(J%U'OW6
MI'QY@/0?9'?'%]\\;?O^.-OPEQ'?=ID"5IZK3AI)1<4F9&1D9<2,%;2:\>/]
M+Z@(Y                =5=9B[=:YUP(M9Q&'G]!^)M(-5/JTH"O'O)\VS_
M +FMW8D>;/-B7D4UNU6F(:G$PXD9YW0RV:4:O0G5ZS(C-1U4=3,!._M1[:,Q
MV#N>23<FO%ON4>]1XS,5FWJD&:%L+6I1K)YILN)**E*@.FW [],*QV_7+$L6
MLTVZWF'(]P;G2"2Q"]Z0[TG4K2:DNT29**I%Q 2^9,^)'S]O,$<H       .
M%TSJ9$JGPGR 15W([W\/P[,[AM[9K+,N>0V^8=K<EK)#4-$Q+G24@ZJ2LR2K
MQ27'P 2J9K4^-2_5 >+>\=TN:-^=PFD37TM)RR]I2@G5DDDE<7R(B*M* /:H
M           %%?%53B=#X (LXOWI8CG6YMOVYQ6S3%KF7#W,[K+T-LJ92HTF
MM""5K(_$B4D14IQ4     %CGQ>=/;R :;WV[A<6V#@6N7D4&9<9-X<<1$B0B
M2E6EHB-:C4Z:4E34GA7Q!64;/;@ENEM[9L]*+[BU>/>'&(JCU*2TS)<83J.I
M^HR;(U4.E0&?@@     U#W,;G7K:/:*\9ECS3+EX:6S$BJD%J0TY+7TB=TU(
ME&@SU$D^!@/,K:G:?<7N>RV]-1[R@I[2'+K.N5X7(4RMUQU*5$2T(=/J&;FJ
MGE4!Z=]NNV%[V?VOMV"Y#-C7"YPI$EY4B&IQ3)H?=-:4I-U"%<".GQ0&V &B
M-\NY_!MAYD.TY!&FW&]SV4S&($)!$9QUN+;UFXX:4%12#]-:B*S#9C<A6[NW
M-JW!3#^;X]Y>N/NL0SJXB/$N$B*UKXF6LT-)-=#IJK3@*C8J."2XU\:\^8"X
M        !TV0WN#C5DNN179:F[7:8K\^:M"36HH\5M3KADE/%1DE)T(N(BH[
M[==X^+[K[IVK;C$K-+;8EKFKD72;H2A3$2*Z\E32$J-1&I2$U):?BU%$G6JT
M,S/F8(Y             %#XD Z;*<CMV)8W=<IO"U(M5FAR+A-6A!N*2Q%;4
MZLR27$S)*3X$ T9L?W66/?7.9^+8[9I5OA6^WKGNRIJD:UJ2^VT1))M1E0R7
M7B0*D:"
M        #R9[\OYQ5W+P^;[=_>" >A_;,DCV VZ,RX_,D3^Q :V[T]GL:S/:
M^\YNN,TSE6+Q538UP]25JCLT-QE6GXQ*(J)U<C!40^Q#))-FWSCVU,CHP+U"
MD1I:#(OMJDIU,IJ?]70"$LNZ/N$W#VNOEGPC;VU-3+[D<9)PI!-JD2D2G776
MD):9HI"SJ@J$I)U,P1'6];\]]^-VN1><@M]QMEHB)UR9\O'XS#+::TJI:XQ$
M15!4C>U+NJD[VE+Q;+&(\',K:PE]IQA6DIS"$I0MTFC(B)9+U*7H])$HJ$0@
MT1OWW*=RNS6[-VQ!W(6G+,TMF=:E.6R&A#]OE))Q)(6IG4HD*UL&O]LA7&I"
MHG=MMF+.>8!CF8,/MO?/%OCR7E1SJVF2:*/H2?\ 4.$M'PI 0%SWO!WJN>\5
MTQ7:W(4)QAZY)@V=IRV17'4I(DH<,^JR;AZ5DL^/@"I*]R'<=.V Q"PP%(;O
M.X%[CN-)=(B;8;=BM-=:2I!)I12W"T)_4H1@B+UC[A.^7+;>F]XO GW.S/J/
MH2H5AC2&3+GI):8QD=",%3,[7<UW"SK;9^Y[H:DYA#NLNWS&G([<-QLHY-T0
MIIM""(RU<>%01NH!JGN*W4NFS.U\_.[/!8N,V))BL)C2C6EHTR72;49FV9*X
M$=2 0MC[X]^=Z:3=K+9;FY:9:>M#6QC\=]HVU<M+GNQZB\C 9;VV=ZN89'F\
M+ ]U31.=ODA$.VW1AEN.IF4X9I;;6VPA)&E:C2DU>',SH"LW[RMU]XL"N5KM
M.W+YMVFXP%_.;90V)1&:UO(5ZW6U&GTDGXI@/.O!<AR7%,IM]_Q ].0PW4N0
M%$VA\R=0HE)/0LC2?$BYD")M6K?_ +CI/;[D.92I2OPYA9%#MT%7S;%*D!Z/
MK<+I$UH/U?9&FI J"]QN=UF9'*N\XJWV1,<E2"TDFLM;IK7Z2H1>LSX%\ (]
M*^SW=_>C<F\Y5%W4D&Y$M\6([;:PF(=''''$N<66T&?!)<P&+]QO>W/QK('=
MOMG":F7A@SCW"_+03Q,SNJ228CM.)-MPR))DM2B,JJH5#28#5%Z[F>\_ X\/
M(,XBRH%@=?0RA=PLL>&P^XM"G":2Z<=/%24*/TG6A& FWL%OUC^^V**O=JTQ
M;U -#5[M&O4Y&<=)734=2*J'-"S0?L,O !#_ '$[N-Y\5WZNN'-9''B89;K^
MB"MMV%#/IP">03FIU31JX(-55&JH*^*1WP;LY5NU:;=BTMFS87/NL& FW*CQ
MI3BX[DA#*U&\XV:JK(S^*KAX4 >E9<B!&CNZK.L_V^VR7?MMW>ED93([*%E'
M;E?:EJHLM#J5IY>- 'DOD.09+>,TGY1?3-65RYZY\U1MH;K-4YU%?:TD22JK
M[$BH ]&.S[>/>[<K+<@MVZ<@WK;#MR)$$O<8\,NN;Z4&>IEM!GZ3Y&8"!>]#
MB6M^=QG%_%3EE\,_'E<7P$A\X[QNY2Z1'-P,0MCF-[:NR%Q($Q4!F9&4HG%)
M2E4E]E1&[0J+2E5*D="(%;F[2.[._;KW5> 9^;;N5I:<DP+C'9)KWM"%+<<2
MXEM*6VS;11)4(M5/$ZB$-Z;W[X8SLCB9Y!?%'(N4LUM6:TMF9.RWFR+41<#T
MI34M2CX%4B\0$(8/=+WA[F2YUZVVM;R[(AQ+7N5IM#5Q9C+2VC4GJK9<69F9
MZ_4K[+RH*C8G;WWKW^=E*]O]\%ML7%Z4J/'OBVVX?1D(JA4=]IM"4I]2?2=*
MD=2,^0"=C:M2:@*/*41%I\>9@(-=S'>GDF(97-VXVM:;CW>VNE'N5ZD-$\I$
MI"RU,M-/)4A1&7 U&1\^ *UT_OAW[Q+<]=Y=INC5KCLJE/S%X]'2RF.A)K-P
MUG&H2226HU>0#>_='N]O)@>-85<-MI)HEW=@G+JI,-B42C-E*ZT=;42>)_8T
M EYS87E.7XIFL7)<45IRN,^IZ,KHH>H\9U,^FLC2?'P,@1Z9]G^Y^[.Y=CR>
M5NF^;LR#*CMVVL5F']J<;6I="90C5Q(N8".;?=AW:;I/.W/:S'W&[9"TLS6;
M-;$W1I+JBJG4MYIU2341'PJ ^%CO)[EMM,LCQ=V(2GF-&I^PS[>S;7U-K^*L
MC;:;74N9<:&"O0>U9K RO 6<WQN1K@W"V?.,%PRXIZC'502DJ+XR:D2DF7/F
M \ZL.[X=XHVX%N:S?(VG<,9FF5V9;M\1#BXS9J(TDMMDE$9T+BD$=_BG>EO+
MGN\5OM<"4Q:\1NLOI,61N+'?4VREHR(C?<;4X:E&G6?JYF9%P!8:#WCW6WAW
M,:M1;J/&\FWJ=.VF<-B'0W23K+[2A&K@DN8(SO:'?ON*Q>V8QA^*23:PF/(;
M9805NBO?:7Y!J=^VK:4LZFM7'5P >LY<B <*E&1GI,S+C000!WT[];]"ND_%
M]IH[<-4&0MAW(9*425*4PLB,FV74&@DJ(E$>I)F7@8JM>WCNB[R\7M4+),F.
M1;\>G.-IA3I=EB,1I!N)4XE"'3CD1ZT(494/D0(ECVO]T[6_!S[#=K:5KRRU
M1TRW4LFI<=^.:R;4M)F7I-*E)J1GQU<.0*B9W9;M[SWC(,QV]O#RE[;Q;JM$
M5DX;#9)1%DGT/MZ6R6=*)XFKB"-1;.;K;O[:IN);6.]$YIE[\90V)E232G[L
MA=.1<@*O6?9F_P!_R?:[$L@RM?4R2Y6YB1<U]-#-9"TU7Z$$24\? B!6? CQ
M)WAW#W,W)OD&\[I.&]=HL7W2$X<9F'^]2=6Y32RA"3]2U<3*H#:>Q>^7<!C-
MOQK"L6D*;P-E]U##90(SY:'Y#CKOVY;2EG]L6O[+AR 2$[S.XK=C9[/[%8L#
MO+5NMLVSHFR6G8D:4:GSDOMFK4\VLR]*$\*T!6E;OWZ[QN8MC]NL\^.SD;#+
MR\@O2XD=2GWURW^FVEE31M)0ACHT-"2,U5J8(F+C._R,=[;K%N_N5-*3<I;*
MR=Z:$,*E2CD/-MMMH;2224:&Z^E/))F(J*;?=EW6;HWNZS-I+9(.QP5(ZENM
MUK9NBHS;QN=$W7%,K42EDVKF=*I.@HS'9SO2W&M>?,;=;ZVY:I4V4B$J9[LF
M%-AR9!H)E#C#3:4F@]7'TZJJ(ZT(P1*_?K<RY;3;3W_<*SQ&;A/M/N1LPY1J
M2TLI<Z/%5J-!DK@3VHJ>) (4-[Z=^%];*\6&Q715HF?;X9QK Q(9Z2CJDDN'
M&/45.2J@K*>W7O9S*]YU:]O=V$(FNWZ8W;85W89;CN,37U]-EM;3*$I-"EFE
MLSI4C.M:$8(R;OAW0W8Q"9%Q7"GC;Q*^V*8WD2"B,R*MO&XPY]L<0I2/M1_8
MJ*G,! W;++<UP?,(F3[?J-O*HJ'DQ7$LMR:$\TIMS[6ZE2?B*5S(!/?:_?/>
MNZ[ [H9QF$S1E..1C=LDA<*.PEM1-+57IH;2A?$B^,1B*TAMKWW[JP,K:F;E
M7=-WQ9F/+6]:XL&)'>?D$POW=!.M,DI-7=/&M//@*BS.^[ONPQJ[DY>D*Q.-
M<D^^6ZV2K7'(BBN&>DVUR&36M!4-)+,SK3F V!;._;,+]@EIQ['\=5<MY9CI
M0%&PDG&GC01:9#3"$4ZCO'[614)1'PTFFA6LY'>?W/X3E!6W-9"2E6YQ"KC8
M)ULC0W30X@G$H6:&4N))25)5P,CH"/1C:G<2%NCMY8,]MQ:(]XCJ4MO2I))D
ML.*8D(3KXZ4NMK2DSYD50$5NXWO:GXSD#VW^SB69MW8,X]PORT=8F)Q.DDF&
M&EI-#AD25$M2B,O50J&DP&I[MW+=Z.%0XF29G%EPL;<<;23\ZR1HL=\W"-:4
M$][N7QDI,RTG6A"*FUL#OQ8M]L2<OEMTQ+U 4AJ]VG7J7&6YJ-M7*NAS0O0?
M]29> J(<[L=WV].&[VY!BT+(68V(VF\^Z] X$1Q:(2'$ZTZU-&LSTUXUJ"K<
MW[Q.XV]P9.;X!;';-MM;7?<G;S\WM2XRWC-"$FZ\\TI*%J-:?21E\8N #9/:
M9W>Y7N5E[6V^XSC<N\W!N0]:+FQ')E;CL=LY"FEH90EM*4M-N*)1EQ,J>((Q
M_O+W>WHL.5Y#@6.OJ3MY/M'N]R;]RCND;$N+ID?;U-FM-24KB2N *B/M!N%N
M7MM?9MXVO<-J\2(IQ9*_=FI?[W4M*S+2\A:2]24\:5!'J?VR9MG.>;26[(]Q
M'3<RA^3,;?5T&XWVMIY2&_M;24I+TTY$ W.GXI *@
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M0VOBVDDDA1*(CH1%0$>MVZ2U/[$9G(<.KKF)71:S/Q-5L=,Z_5,%>;'8^?\
MVE<;,^1L72OP>XO@D/17N6(CV W%7S/YDE4/Q^( \UNS6R6[(>XK$(ET;-QF
M,N3<&22HTTD08[DAE7#F1+0DZ )I_2!6^"YL0B>]&;<FQ;Q#3&D+0E3C1/$Y
MU-"C*J=>DM5.=!%:/^C>MMNF9GF=QE1&7Y]O@0_<I3K:5O,$^XZESI+,C4C6
M1$2M)E4N8J.Z^DFL<)J3@F1DBESE(G6]QP_]@BFV\@O]<^L!M3M4NL^'V=E,
MC/&S)MT3(3@NH]*T+;>E/),C+Q)2J@/.7#L]F8QN!"W!G08]^G1I;MP>A7$C
M<CR7G274W"XU]2C7\(#>VZ/>_F>Z>!7G +IC-L@V^\MMM.RXSCZG6^B\V^1I
M):C+B:"+B(M67?1P7R7'W#S''$G^\;A96[@]R_=;?+0TW[?BRW!4:1WY@)N?
M<KEMM=4:&YF1'&4LN9)>=0CA]<!ZR6/%K2YMQ!PUQE)VA^SHMLAI"202VGHW
M2<^+R-1*49^TQ%>4W;%(=M7<UAQ03-LBNTB*1%_L+S+["T_50LR%1Z@[^((]
MCMR#(JG^#-WH7/\ ]"= 03^CJ_SM9'0N5@<X?[[C\0'IIH3Y4^#@ NY<"
M                                                          >3
M??@G5W$W<_\ DZW?W@@5]^"]]6XVW^'V7"K5CMED6ZQ1&X,9^2F6;ZT,E0E+
M-M]*:G["("K \[W&WM[G\CA1)423=5)4^JSV.UQG#BL(55:^FV@C-9I27QUZ
MEZ2XJX /0'M6[<4;'8\Y<+XMN3G=Z;0=R<842FH[1DE91T*H6K2HO4?(SY<
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M0_(!KSMO[RV=N<+L^V%ZQYZZ/,SO=K9,8>;:;;C2G$'I6E23-2B<6ZJM?'V
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M21%QI7D V,1U(C\P%0
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MMP+=';B1DK</4HR;:2E)&HSJ? !VQ%0J *@
M                                          HHJI,BY^ "+F['9)AV
M[>X%WW!N^27.!/O'NW6B14QS91[K%:BI-.M!JXI:(SJ?/V -J;-;$X3LACSE
MDQ.-KERUD[=KQ(]4R:MO43?449GI2VE1DA"-*2J9TU*49E;0+D"
M
M
M
M
M                                                           %
M2\P"I %2 *D         5(                               "I>8
M     !4@           4J7F K4O/GR         4J7F J         I4O,!4
M      #,BYF                  *5+S 5       !2I>8"H"E2Y5 *EYD
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MA+M$9Z1)>4:W''%(XJ4H^9F"MG @  *&9%S 5        /V@*5(CT^("H
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M\@$-NWS,,JO/=IN_CMTN\J98[8=R^;[>\ZI3#/3NC*$Z$'P*B3-)>P%3+!
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M!L$X3:74.K-VB5);J:4_%J(K>NM?GQ\_;Y"H^@!%;O\ O\PCM/\ CF!7S_\
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MN\7MS2YF(8G!9R.4E@DM2H1S"CON&^I1F1T6B(FB*_&.A^)0;:[C^Y9C;"?
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MI7TA<Y6.)>^;DR+H>0:2J@G/FV41FX95HGJ]/3[:"H[_ +:3IWG[XGY%=?\
MG9@!I*18-S<I[P\QM^W60L8[FZ;K>/F>?<E.H1[N@WM:&S3'D\.GJI5%*>(*
MWP>SW?J?#\K=E/P,O>'O_P!D@.Q[?>W+>W;C=R=N-FN362ZQ;S[R60G;GY+L
MJ2\ZEPR,TN0F$<'C2I7J+E]0!TV;]FN<6C/;AGW;]FD6Q3)DIR:_:9O48*(M
MTR>-#3K+<@G$FLS-#:V$$A-"U*Y@C%B[B.ZS854)6]&,G?<40^_%.X+)MAV4
MO69I44IHG$I(B5]K);"=2:%SJ"IVX7D]NS7%;-F%GUE:K]"CW*(A[03R&Y3:
M74H<)M2TDM)*TK(E'152J".]452X@(4]C!)/<?N J7*^0Z?5EW8!-;2GR 5
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M$R1>("IM$=./$@#I%XG4 Z1'X@+R*A4 6J1J42J\O !0FB(J$9_"8!TB^$_
MS\@%"9*E#.OM,!7HE2E?@ "9(J<>0"O23S/CX +B*A +5-ZC,Z\^9 (?]SF.
M[Y81N-"WPVF4_<[0U#9B9#98ZD*]$5>AK4P9FMXG#D+_ ')"C3IJ8*^?(^\G
M*I>+HC8AM5D[.=OI-MTYUN6FW1UK0I*7&W$J<4LTJ-)T6VDC\1!E'9UL9D>V
M]NO6=9\AEO-<O-+Y1$>MR'$6KJJ0M:3TZG%&E2D%73H3ZJU(J)1*+45 19TB
M\P%>D5:^/#]0 Z95K4 Z:?Z0"AM$?, -K^JX^)^8"O22 H;5:E7@?@ =(J4K
M]4!0F2(]5:T]@"%O?7CM_ON4;-NV.U3+DU#N%R5+5#CNR":);UL,C<-M*B21
MZ#IJ\C$5-+HD?[)"HKT2\_Z"Y '2(_A+D =(J4,ZES 5Z9<>/, Z9%R.A &C
MA2O'S 4-HC.M:%Y>T -HC/GP\J !M%Y@*],N''B7B ITBX\>8!T4\:^/, )H
MB\:F KTR\#X>0"ALD9E0Z4.H!TB\#I[0#I)I3Q\P%#9(_'ER 5-KR, -E)ES
MX^8"G130RKP_I@*]$N/$^/, Z1<>/$SK404Z!5J2N(HJ31%^N KTBK6H 2/:
M M<,D&7,_(@$"M^,8R6?WH8;?(-FG2;.RQ:R>N#,5YR.@TK?U:G4H-)4KQJ8
M*GDT25'0CX\R/V%\(#DZ1>)\ 0Z1'S, Z1>8 ;)'X@'1214\#Y@*=$C.IF9^
MP!<39%X@*H1IKQK4!52245# 6=%/F ):))U(P'(  +#;(U:@#I^%> "G2+SY
M\_: H3"2*AG4!4VB\Z>T!4V^-2.A@+>@FO/AY !L%6M?: KT4\*F9F5>/P@'
M1\C\/( Z7]4?*@#D
M             6=5-:<:@!N$1TI4!0W4D9\_J<0%Z5$HJER 5       !8;I
M$>FAU 4-Y!<^?D KU4\Z'3^CP 5)1*X$ J9DDJGP(!;U"K2A_P"CY *=9!4(
M^!GX '5+CPX^0 ;J:T*I@+M:?,!QN*(S 6H;2OB5*ES.G&@#E0WH,S^I4!>
M     +361'I,N8"G50 IU4?7 .LG^B@"I.),R(O'D8"\!Q='C7VU_4 <I<"H
M      *&="J8"PWDE_3X4 .N@^!<3 <@  M4LDG3Q 6F\DBK0Z^7B N2HE<2
MY *J5I*M*_  LZJ:5,CH J3J5'0@%X               +%(U'7V4 6DR9>/
M$!<A!I,S\P%X
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M%0
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MTMY5#6IEA))ZCIVR>@W5T(JK42"U&()?[<?YO<1_B:W_ ,%;!&4"@
M
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M(CN,1W'-)>!FLZ_5!7H*T5".G+P!'(               "/W>I_-URSX8O\
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MD+!_UJA_\W7($29VX_S>XC_$UO\ X*V(,H%
M
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M/[)U) -YX1!DVK#\=M<Y'3F0K;"BR$5^*ZS'0A1?4,@5D8(
M
M                                     "AD1\3+B 4(_ @$:>^3#\HS
M79N'9L0L\N]W1-\B/JAV]E<AXF4,24J6:6R,])&I)&?M ;HVMA3+9MMAUMN+
M"XT^)8[:Q*C.I-#C3S41I"T+2?$E)41D9&(K+J%Y$*AI3SH5?@ 5 4TI\BX\
M3 -*?(OK !I2=*D7#EP -*:4H5"Y%0 H7D 4+R *%Y$ :2\B -*>="KRY &E
M/D7D 4+G0 TI\B "(BY%3X %0            #F M-*:<BX<N #1W=E8+]E6
MQ>26+&[=)NUXD^[>[P8;:GWG-+Z%'1"",^!$ ^OM<L5ZQ?83#,?R* _:KS"8
ME)EP)C:F7VE*FON)):%$1E5)DHJB*W,DBTEP(5%W+D  !D1\RJ II3QX%QY@
M&E/D0 :4GS(C -*?(OK &E-:T*OF :4\Z%4 TI\B "(BY%0!4R(^!\2 4H7.
M@!0BY$ J
M
M  **2E7!15 "21<BI3@0"H                                    "W
MIHY4X &A/D N(B(J%R
M
M
M
M
M
M
M                                                     !0S(N)@
M,(O&\.VU@S.%M[=[^S%S&XI)<.UJ;>-;A*)1EZTH-LC/2?!2R 9MK3]<!@M[
MWGVRQS,X6WU[R!F'F%Q4VB';7&WZN*?(C;+J$V;9:JES6 SDG$&1&1U(^1D
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MW!P_<>QHR7"KFB[6-Q:VD3&VW6DFMH]*RTO(0K@9>0#).HD@#60!U$EQ/EX
M!+(SIQ 7 +=::TJ =1("X  44HD\P%-9 *DHC 5  '3Y#E6.XG;G+MDER8ME
MO;(S4_)62"/253))<U'[$D9@-8Q.['MZG7#YKBYQ%7-U&WH./,0G4DZ'ZUL$
MGZM0&VX%S@76(U/MLEN7!?+4S)86EQI95I5*DF9'Q(!A^X6\VVFU1P2W OS=
ME^<M9PNJS(>ZG2IJIT&W*4J7,!A!=XG;:9D19Y&J? OWI/\ ^# -GXEGF'YW
M;CNN(W>/=H*=)+<84=4&LJI):%$E2:ERU$0#(26E7(!<
M
M     H9D1D1GQ/D ^2YSXELMTNY37.E#A,N29+G@EIE)K6?U"(!Y:Y5;\IW-
M:W![F(#CI2L3R""5F0@ST^YI?6A:",SKI;4ML^?Q3,17H]M5G,'<? +'F,!5
M&[E'2IQ%=1I=3Z%$? O$J_5%$#N[7$K]FW=!$Q_&'.CD2K6N=;C0=%&_:[<N
M<E*#*E%*Z&E)^!F E/VL;V?E9P=-OO)DSF^.DF%>(YF>ISI$2">(CX^H^!EX
M<./$0:DW"_GW887#BTU^K'; 9WOEL!FV]VZM@3?IS<79RV-UEQHDC1-=<TDL
MSZ2T*14U^G5X)H=!1BV_G:)LY8MKKODV'P58Q?<=C+G-36'G7NNJ.FNEPGG%
M$6HRYHT@/OL>[626KL=M^=W*0XYD[MKEV^/,=49N&XQ)DQ8[BCYF9M,I/S]H
M@Z;M[[0]KLGVJL^9;A07[[D^6Q$W1Y^0^XWT"E*4XVIKIJ*JE(4E2C=-=3\"
M%1P]MMNF;*]QF;["MW%R9C+D1N[VA$@SJCJ--.J,B(])*HX2%'3U::\!%9#<
M.UN_[K;VW_.=[7FY6&(0RSC-G@2UF@VVDDFCB5)JV1Z36K0JIJ4KB7 !KKNL
MV!P79>QV3=/:@GL8O<"X,PBMT9YQ;<@WB6LEDIU:G$J3HTGZC29*Y%3C1L'O
M!S"6?;;C,24]TKOF;]JBR$<2J;L54ETSY%1+B45(Q!BN-XEV'6Z+9L7R95ME
M9FJ,PF>MQVZD2Y2T$I=7&5$R1$JI<#(N HEWMSAV#8-C+-IV]ALP<9?6<QAN
M.\Y(;6IU*4FLENK<,ZDE)<Z C*E&1D1D8#3&['<_M/L[.3:LHG2)-Y,B-5MM
MC27WT$=.*]2VTESX^NOL!47NZ#>_ -ZL'P"YX3+>6J'E4=,R%,;)F2UK94:3
M4DE+*A^:5& G3EN8XU@EDDY)EMR:MEFBI-;TEZI\B-5$I21J4="Y$0(CRCO^
MV%5</<#.\(:)1I]]5#:]WH7)52?U4_U *D5:\UQ6]8TG,+7=6).,K9.45Q09
MDT3))U&:JD1IH7,C*I B/-X[]]A;5='K<TY=K@AIQ3?OL.&V<=>E1IU)-U]M
M=.%>*/J K=VW.Z&%[KV%.1X1<2GP$JZ3Z5(-MUITJU2M*BX'X\#,@1K38[)=
MD)U[W 7M=89=GNEMGR3RMY\ETD2FW%FXMO7(>(ZJ(S*A(^ 174N][^QL:P2+
MX^_<6W&)SUM*UJBM^^N+C(;6IQ*2=4CI_;*$:G",S(^ HRS:+NDVGWEN;MDQ
M:7*B7MM)K1;[FP3#SR"XFILVUNI/3XD:B/R($9ANCN]@>T-C1>\WN7NC+ZS:
MAQFDF[(?<26HTMH*G(N)FHR3[:F0#3-G[[]B+PF::7;K#=ALJ?;8E1&T+D:*
MF:&=#RTZJ$9^LTE[05N#$=V,8S3;IW<^T(EHQUN+(F&W(:0B5THC9N+HA+BD
MUH7#UB#@VDWBQ;>BQ2<AQ%J8U BR#C.)GM-L.=1-:T2AQTJ<#\12C81I4=#(
MB,O $1 +M@G9INGDNY7<9(BR,72IP[';6IRDQ&HW4U()]:B;-"$(K4D*3X'4
M16JL@Q;;W"^Y7;YCMPEK7*=N<1O(;?"=<DP&HIRDI?(WCXJ0;?QO6KAX@)H9
M[L5M/NA<F+QGN.-7FXQ6O=V'G'Y+)I;K4TT8=;+GYD*B)'='MAL5MU#MN$[=
M8#$D[DY*I+,!)2ISBHS;IFA+A)-\TFHU%Z=7#V"*E3V_;-VS9+ 8>+0WCDW1
MXD2KU+/@3LU:$]321<D),C2CV<^(HVP"/.R<]M!N'W+;EYCO0J*G!;$S$MD1
MF4[(22I++"&C-*8IDZHR4VM1Z2H6KB(K>&U.WG9IE=Y8O6U<"WR[W:7$R&%M
M/W-MYMQ!\%I;E.IU4/\ J3(!*)/Q2%1@V[&Z6-[/8HO,\K;E.VIM]N,:8+:'
MGM;I*,J)6MLJ>DZ^H!JG+N]?9+#;A$MDZ1<)DN4PQ)<*!&;<3'3);0XE#QK=
M06HDJ]6C4"N^RONMV;Q#$+3F4Z[NS(5Z(EVZ%":ZLQ:?LC4VM2$ITTXZE?!4
M!V6S_<=MIO>]+AX;)DM7.$WUG;?<&BCOFU4DFXDD+<29$:DD?JKQ!'=;J;S8
M%LU:47;-K@<;K5*)"CH-Z4^HJ5)M'!/"M3-:B+V@-2VGONV(NL2=)2Y=8KD!
ME<@HLB(VEY]+2=1I:TOJ29T+[-20&\<!SVQ[CXE!S:Q$\S9;@WUF/?$):=2@
MR)55I2M9%P_J@5%G:9+F8X[O=O(^7VO*%RF;4=*Z83"EIT$H^)Z32GR^ 163
M]C%PA6OMTCW"XR&XD&/.GN/R'E$A"4I>49FHS\ 1M+:WN P[>"Z7&#AMONSL
M.VK<;=O$F,VS 6;:M):%]8UGJYE5OX0'Q;M=SNU.S4UJU95-D2;TI)+5;;:T
M4A]M"B(TFYK6V@JD? M5:<:<A1AC7?/L9(LJ+Q'>NKCBWTQEVTHK93&]:M*%
MJ2;Q-Z3/Q2LS\R HDC DIG1H\YHC)B2VAYO5P/2M)**I<>-#\P1]9\@&&[D[
M@63:O#;AG&2MR%V>V]/WA$)"77C)U:6RTI6M!<U%6J@(:<R/O@V/QE%N.6[=
M),F>R4@XD2*VMV.A?Q2>U/)21GSHA2O:"MN[9;M8-NW8SON$W'WR.V9)E,+0
M;3["U%4DN(/QIXI,R]H(S;6GG4!@FY^\. [1VE%VS:YE$;>,TQHS:3=DO**E
M20@O*O-1D0#3V-=]>PV1W5JTJE7*TJ?43;<NY1$(CZEJ)*2-3+KJO'GI!4E(
M4N-.89EQ'DOQGT$XR\V>I*T**I&1ES($?4 IJ+S >>5GL%[[V=W;_=+W=)5M
MV@QR2J-"A1%<'D,+HW0G-24N.H,EK4:54,^!4(A%2!NO9#V^W"R%:HN/O6V8
ME"$%>(LIU4PU(30UF3QN,U4?%5&B]E!4:4V;N>;]M6_K6P^2W-=XPK(#0=AD
MR5JJV3I&;:FTU4E/K,T.%R,TF94J"N[[XK;!O&=[16JY-%)M\N;(9DLJ,R);
M:UM$HJD9&51!N1[LX[<7&EH3@K#2UI-*5HF3C4DS+F6J0HJE[2%1&7,\0G]F
M&\V+WW"9\J7MSEJELS[7+61I2ZTM+:FU=/22M)/-J0LT5^,0BO0J*^B2VT^R
MK6R\A+C:_-*RJ1_6%1](
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MA1VX(
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M4I)UI1)@)SMD52/E[!4<P
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M<6VKS0I9&:?J .P(BYT 5H0!0@"A
M
M                           9$? P%-*?( H7D :4^0"H
M      4KS 4TI/P -*?( H5:T 5  %#(CYD :2\@#27D :2X\.?, TESH 4+
MR -*?(!4      *$     H:2/F0"H
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M4C(!SI,SJ9\O !<
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M*3<(U%IJ?AY<11F6:;J8YMUA1YMG*CLL1+1+5">4A<CK*3J)A)(49+<\*)J
MCY8_I#-H[K>D6V?:KG:H+BR05SD$TIDB,Z:C)"C41?"0#=&R&^-EWSL$[(;#
M;I-NC09:H*FYBFU*6I*25K3TE*+3Q!&TTJU **5I*H"/64=X&WV&YEE>(9%!
MFQ',4;87(G5:4U(7*90\A#*25K-5%TY M&/8!WY;3YOD3&/3(4['G9;A,Q)5
MPZ1L..*41)(U-J/36OV5 $I$O)41*+U)5Q2HN)'X@CX[K>K=9+?)NUVD-Q+;
M#;-Z3)>6EMM""\34HR(@5%"^_2(;2VN[+@6VSW6[PD+T'<8Z6FVCH=#,B=4E
M1E\!<0&^MI=ZL)WGL3E\PV4;GNJDHG0GJ(D1UK*J26BM:'X*Y'Q\@&Q$JU%4
M$5 6J/27#ZP#37<YNS(VCVGNV0VX]-ZE).!:ED1^B3)2:$N$=2_<ZZ_J K2/
M;MVD8I=<9M^X>[3*\CR6]ME-5"GGU66TN&:B)PEE52C+XP@S+=GLKVORVS27
ML&MK6+90RW6W.0*1XINERZJ4IK0_$Z\!1U_9=NS?,TP:[X9ETAR3DF*.+A]9
MTS6XJ,V24)):C,S/0?I$&N>V?;3 -P]U=ZBS?'8-]]RR*=[I[\REWIZYK]=-
M>50&^<[[/]C\JLC]OMF,1,?N!(4<:=:VTL.$X9%IU\#J52%&K.R3-LCMMRRW
M8S*'UOO8E)==MBW3-2B96Z:5(2:CKHJ74(J4]8":"/$$7@
M
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M O.HJ(,=L:TW[NLW6O\ ;?MMK92IE3S?%LUZR:YEP^,V8BIU-UXU.HJ+P
M
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M)XF7 U&?PBHW>DE%6OU %P
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MQ]@"X
M                                "I             %2
M                                                          *@
M
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M#4=JWL.Y;XW/9K\'GVOFVW_./S^;U67/6TCIDWTBH?VVM>IX"*V\*@
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M(+B9']B"LY!
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M^R@FTVZ#'C&@N6IMM*5G7VJJ"2R(
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MT$\:FHJS.G(^HVA0BI[$1%2O/P(5BY
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M?7<[]<ED]>KV^E*'9"TFK0@DD:M*$:E4(U&9F9F9\B(C;6@J4J= %4I)/+Q
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M ]NEAV6QB?"=EJO>37XUJOMX?1TU.DX5.BE.I9Z$\>)J,U*,S]A4:+NW:UW
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MX^8"H
M                        +'/ !86FGZWP^(BG#Q\N/ZHJ*%\;]8%4+34Z
MTK7A^P"*G2IT$54]%"I\7P^#Q%186BG&OMKS]O(!SH^* HY3A7S 4+3X>8"O
MZ]>/P@+S <'I\?/]6H KV<ZG7X>'Z@#F3\4J\P%0 !8Y\4!1NM2\@%Y\C_8
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tm2225088d1-pht_mechan4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-pht_mechan4clr.jpg
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M .,  0  !P$!               ! @,%!@<(! D! 0 " P$! 0
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M-JS7A+8B8GC#V!PW;1T\2J+'A5WCU01IJ/'R*"= 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MINJ3PGFVS;3PW,;)X';HWU+="*T-/&BYLQ,-J)AZ%"1 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M?WMMCK*?(7KO3MX=GJOH74WN#1HT$]3Y+3K6;3I'-GF8B-7.EC]Y=\+X<@Y
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M>;:,4ZUGA/)&#--XTGFV?HUNGU!T"Y[95$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$%)M :.U(ZNZ()@:#WCHDC2?/\ N;F,YFG=N^V?ZSD+
MJ?'9']6WX.D<=W'^JO(FLE]5C9&^Z_W>IUH%UL&VK2GQ,ON]D=_9V<M&EERS
M:>BG-?\ @/;W"]O,8ZRQC?5O)Z?'WE9&^KL?(Z/]6^20-VB0M]WKU*T]SN;9
M[:SX,^'%&.-(92]X8Q\CSM;'3U).M-V@T"U?0S:N><OD;KOIF'V\)]'MO8TJ
M?=?\;ZT8/B()XO2G@_OOWO7=W.ZCRZFD?BS_ /Q^VLZUGZ%=IM9WMM9_#CZ_
MLF-)AM.WAA@A;!;C; S0"I/4U\=5X69F9UGF]I$16-(Y/0T>?0JT0K,JK0K1
M"DJK6JZBJUJO$*3*<!6B%9E4:U7T4F50-5M%=4P8IT1JGV)HC5'8IT1J;$T-
M4"S1-$ZI"Q1HG5(6JNB8E(YJK,+1*F6JDPO$J3PJZ+ZJ5-%686B5-X5)A>)4
MG"JK,+Q*FX+'+)#$^:\0L>78MUI=>Y<Q4?;3>\=A8X/IM:]@-2!U70V&^OM<
MG57E^WHEI[O:5W%.F>;V]HN=WV9CN.(<F=_\488MCG?1OZ\RB2:M(8Q&S:V@
MT<:KUVXQUFL9<?NV_P"G;Q>0I-J6G'?WJMI=/K:4Z%:#. T]KF^*#5G<K@N0
M^-C[A<+?\+RNRW.DT;)ZS) UDA_G#_392,$4V?1JNGM=Q$1\._&L_5X-3-BG
M7KKPEL/MMS^R[@\<@R]L-EV1_.[7WG>D2][6C>8XPZH97W0M;<[><-])9<.6
M,E=89I5:K,(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @IDU!!T
M'FAHU9W:[F7/%FP<<XPSXKF^3W_=\-1'3X?TI9?>FB=#^Q<X^\X>S5=':;:+
M^W?A6.?[<^;5SYIKPKSE+VZ[>6G ,;*Y\GQ/(;S;]Y9"CH_5])\GI?JA)(QN
MUDFWW>O4ZK%NMS.:W^6.4+X<,8X]+-.@+AT/7VK39VG.[_+LI?Y"'MCQ)VS,
MWN[[PNJ,/H>BV&\B]R=@8_>P.'NR:>/DNA@Z,&.<^3E'*._L[.6GJ8+5MFO&
M*G.>?H[5YXSQW'\6P]OA<5'MM(-^T5<?KR.D/UW./5Q\5XG<[F^XR3DOSG^&
MCVF#!7#2*5Y1_P!5[ -*G4+!$,DJK6D'S/@%DA255H5E)5FA7B%)E5 5]%)E
M.UJO$*3*JUJMHI,JC6U5HA5.&*RJ.Q6T5U3!J:&H6IHG5*1JHT1JA15F%XE*
MYJC1;51<%64PIN%%689(E3<VJI,+*+VT5)A>)4B*A4E>%)PHJ2O"D\:+',,D
M2H.%?>I3R"JO$M7<[MK_ (9GK7N1@1MFA<8[^+W3ZAN=L .Z4O#=K2?JQZKU
MGDNZC)6=M?EV?1Q[/XO->;;7I_WJ_3].D-_X[(V>8Q]OE;%VZSN@7,T</JN+
M?M 'J/)9[UFD],\W.K,6C5ZB=0*4'B>JHL>ZYKFGZKP6N'F"*%.2&D97R]DN
M>?>-L?\ X%Y"XOO(=/U+X8_2A;N/KS.J^2M6AOMT7;K/S6+2??K^WHASYCX-
M]?Y9=(#WM5Q6_P TP4)$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M!!C_ "[E.+X7@[KD68?LL+/T]YH]U/6D9$/V;7N^L\?96;#BMEM%:J7O%(UE
MJ#M9QK)\@R,O=3FK*\BR&W[OAJP?#>@R6RE]ZW<V.3U(VL/O1C;X:U*W]YFK
M6/@X_=CGZ>WM:F#',S\2W/\ :&VJDFH-'NZN\J>Q<IO+;R#/6/%<-=Y[)?Z'
M9>GN;[VOK2-B&K&N/5P^RLN+%.2T5CM4O>*5ZI:3[9XJ^R,UUW"Y$/\ IS->
MGM;[OZOX02VIUB(8[<P-^P*>TZKG^=[N+6C!C]VG[])[>//TNQY1M>FOQ;^]
M;]VL-EL'@[K]H^?DO-N\A/=6UI"ZXN7;86$#?0GJ:= "5EK#':='G9R3!^-Y
M5W^:DT_X*R=,L77#U6>7QE[+Z5I/ZSS]C8]E:"O5P"MTRIU0\_(^7\9X9:-O
MN3W_ ,!9?9D]&:?J0WI"QYZGR62E)MR8KWBO-Y^)=QN#<[$KN(9?[R$.WU/Y
MM<V]-VXC]O''^B5EFDUYL=<L6Y*?)^ZO;K@]T+'EF=^[;EW2'X2[N*D4^U!$
M\?:'BKUQS9COEBK(\#G\-R?'1Y;!7?Q6,FUBN/3DBK1Q;]65K7=6D=$FLPF+
M:\5W )UK[Q^L%.B-5<-K2G13HC5,&T&O3P5M%9D( ]I'U6^7X4T1J@&N=0'1
MQU+?H4Z&J!80[WF[F^=:443"=5/;2M!6O5_3\BK,+:H%O32M/'HJS"T2IEO@
M[4*LPM$J3F_HZ#]+JJS"\2I.;KIH?TE287B7F>-"?#Q"I*T2MEWF\7:3.AN;
MC;/'HYNQYI77J&D*O3*_5#ROY)A*;OC-?!OI2?GVJO3*W7"1F=Q$\HACNMTC
MOJM].04I[2U8YK+)%H>]X-#Y#JL4PS0M&;Q=OF<9<8^<5C>VK.OUFZCH6^/M
M63!EG%DB\*9<<9*36>2U=B,U<#&9#A&2.Z\XVZ*&)] *BX]6=VC&T'7Q>Y>\
MWFF2*YHY7_=P>&Q5G',XY_E;=;7HSZGBN<V$=*D(,4[C\.@YMQBYQ,G^D1EE
MQ"=>L#A+31[!]GQ*VMKGG#>+=C%EQ]==%?LUS.3EG%&17^F;Q0;;Y,:&DS]S
MA]5C&=/T*A9-Y@^'?6.4\E,&3JKQYPV+UT\0M%L*B @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @YV[A3S]VNX#>VMF[9QG#U_I"^@/J?%VL=W:Z.
M]*1NV2+_ !4AK]K31=K!_P#&Q?%GWI]WQTG]I<_)_O7Z.R.?VMQM;%&QL4#/
M2A97TV5+MM34ZG4U*XK?T1)IN<?>Z;6]*_A19I;OKD;G-W.*[98TU?F?B/O
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MNV?S4=L^Z_*V<4XM=3/R<K)98B^VGC&R%N]VLC .BD;U#::G7Z?'VHA60$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M-K8[60TT'M\T&CN(\9Q?+OF:RN#S$0FL9IIG.8=P%6M93ZKFG\J#L7N+\D_
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0>:Z>8X)-H^K2GX2%,$M$?+JRO!S/\
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M6%HWNEK42N5J6Z[<47IT5X.,>T_->WG$8+J3EO"H.47DA9\.^>XO;;T@ \/
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M.0(:7VLCG, W5/NF4,KI[%WZWBW*7Q[-@OBM-;1QAL]CF/.X>]7ZI]BNP*Z
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MNZ!XH]E=#^)6B5)JP27LAVEN;XY.?BT3KZM3-\3=@UI3H):=!Y+-&6VG-K_
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M6I?):]NJTZRBM8K&D<GN)HT CIT5%DW1$@U1#5W->YUQ'D3PK@\/WCRN:K7
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MQP12FO>_,OZK\SOO-W:-?9K,Q^^'8+:5H-!Y+HP\>K(@0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M"=71P0DO/3PKYKV&RR=6.'Y@_4^SG;[Z\=DS+K+4GI05T(UT6]J\JJJ00$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MG:6]8I2#I0]%.;S&;5Z:QTP4VL1.LSJWA%$R%H$;:,7'ENZ)_P"Y\?$(E41
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MOH<\_P"$XJ4:+J !TT4)3H" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M<H8)VW:<O\Q=Y<N]X8)\T((UI\38NZ_B7=V<:5=/;5TUGO=85"WVV5" @("
M@H'0.)Z#6JA+G3X!G=CN[R"RY,/BN-</F9;QXMQ)AF^,MS(USB"""Q[ X46.
M\L^*NK=L(^'B;;V[1% W[(Z=:K!JV>F%7U)=Q!-!X%1JGI"^0M+:DUU=[5.J
M.F$C-Y;5P.T]">IIYJ%H>3)XNQS%G)CLG VYLIZ>M ^NUQ;J#I3HIB=$3&K2
MV>PG*^R3#R3M_-)DN,AX:>+R[FVMNV0^G1C6$O=J]TGTK-6S5O1N3@G/,-S?
M$V^3L9VQW4H<;BP<X-GC.YS1NC)+A4-W:^"S-=EH--H^M,WQ*@5JA2" @("
M@(" @HWA(M)R-"(WD'^]*ID]V?4R8_>CUN2<Y%)DN57L+B7RR3[6D_W5 OCN
MYK.3<6COE]JVMHQ[:LQRB&3_ -4&=_1%?#WAT74_(,SD_P!Q8#^J'.?H-_A#
M^PGY!F/[BP=Y_5!G/T&_PA_83\@S']Q8.\_J?SOZ+?X03\@S']Q8#^I_._HM
M_A!/R#,?W%@/ZH,Y^BW^$$_(,Q_<6#O/ZH,Y^BW^$$_(,Q_<6#O/ZH,Y^BW^
M$$_(,Q_<6#O/ZG\Y^BW^$$_(,Q_<6 _J?SOZ(_A!/R#,?W%@0_J?SOZ+?X03
M\@S']Q8#^J#.?HM_A!3^09C^XL'>?U09S]$?P@GY!F/[BP=Y_5!G/T1_""C\
M@S']Q8.\_J@SGZ(_A!/R#,?W%@[S^J#.?HM_A!/R#,?W%@[S^J#.?HM_A!/R
M#,?W%@[T?ZH<Y^BW^$$_(,Q_<6#O/ZH<Y^BW^$/["?D&8_N+!WH?U09S]$?P
M@I_(,Q_<6#O/ZH,Y^BW^$$_(,Q_<6#O'=H<XQCGEK=H!)&X>"K/D&:$Q^H<,
ML5L+>7$\C@M0?3G@N8XW[?:\57*QTG%GB.V)AU\MXR[>;<XFLNO(R71A?9:\
MGQ*W"4_BK*HH@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!!1J0?,CJ$$&UJ-:M=X_0H2\&3S6,PT#KG+7D
M%G T5#[B5D0/L&\BNNB2.4NY7+\CWUSLG!,5;.MN)6DK))\LYCF2.=$&W$>T
M..QU7,+30Z+3W&>*PT\^72-(XS+:/NM)#?JCP\JKS\N?HU;VPY+;\([T\TFY
M#!+':9>Y@?9W@C<Z,-AM'-=5QHT5+@%W]K:.B.+H[>T=/%U589_"Y=I=B\E;
M7GDV&:.1PZ^#''R6\VETCZ4ZM\2>J"(U%*ZH%=0"22?'J@JH""@X5:YGBX'7
M\"A+0':UWPG=;NC82FDDM[CRQITW;+:0FGT56'(VL4\&XJ#J3[OD.BQ,\M>]
MP^ZV-X39!N/ S.;J&BSMZW&PES1^L$1+FZ.J*A6BK':['L-==X.<V3<E=>EQ
MFW?J!;7&TG4C5LNO5OY5F^&UYRS+U7ECW<X[!)?6&2'(&QZMAN;ENHZ'1FOB
MG1!&313X'WL=GKV3#\WQ[./9&(@"4A\=J26N?3U9B!X-'TE8IKHS1DU;=B>U
M\8>QS7MD!&]A#F.'0T(ZJC+PEJWEO:KX>YN.6=OKN3C_ "  RWD=I[HNW-:
M"][R:48"T4'BLE;:,5Z+SV@[NNYS:RV7)8(<-RFVVB>Q+C'ZA?ZCJQ"4[GAK
M&@NH-*K/$M68T;6(-:5HWP4JF^A\2&_6/G5()5T! 0$! 0$%"]_T.X_S3_\
M!*QY/=GU,F/WX];E5W^_#_\ ;&?X35\BG_F3_4^R1_PH_IEUBOL+XNAT01ZA
M!)[":J$HG\BD0IK6NGDH)*@?0I0C0#3S\5"3J/H0.J !UU4H*?@4).G0J4"A
M)UUJ@4--#12(4/G50(Z^55* :]5 B"$$""2""B5.Y_82_O'?F*B_NRFGO0Y5
MRO\ OY<?[?'_ (35\BS_ /,G^I]FV_\ PH_HEU9%^S:OKE>3XU;FJ*Z@@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M7KAJ0?38?-U/H"Z./>5MS;-=UP]J&QN#=Z>$\]E-IBKB6VO6]8;U@MWG1SM
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ME^]^9I,]L<WC?,]A.TR=/.)Y,WU)-=-5U')+G]A+^\=^8JE_=E:GO0Y5RO\
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M@^V\^%1^%4MCK/.&.V*MN<+/>?+VV^MS:7W++V?'/_;6;X8_3DH0YN[WOLN
M<%2,%.Y2-OCCE#$NY&7$;K+L/V:;]U%_J_>5[:.(%C3T\G%Z4A<YOZW]:UV_
MSH%LUKK*^3)TPV3Q;B^'X9@[;CV"A;;XZT#FQA@I7<]S]02?%Q6Y$:./:=5Y
MZU T)\?H5D*FB*H*1)KJT:>0'10LTW\Q>&FDXG!RK& LSN(G@BMIFZ/;%<3L
M$E#[0/)8LD:PV,-IK;5OSAW(8N6<<L.0V_[*\:]PIT]R1T?_ (*U'67TU(/@
M&^7M1"):0/>Z#Q&J)->GGXHA*[=3:#1WVG(.?;3U.9=^[Z_D -MPETEHPC73
M(6A(I^$>"PY)8[SV+ISSMQ=7^0/+N&RFRY2UKQ=,:1&R[$K1&\R/<=*1U;0#
M6JI6R(LTSC/O3&9.Y/%@W#9V-P&4XK>/%E@VN+3L$-U,^LE&'?J?KG:L\2RQ
M.K+6=RVV)]#D6,N8[QGUABX)+N ^.CQH=**R1W=?#2,'W?CLCZ[O]9LY(HZ^
M%7(,2Y1F.09D^CR.X^[L8ZGH6?'WC(_$.J*?$,:XEE'4 ]A)43.B-=&R."=J
M;JX-IE>:6L5G9V(>W%<7MW^O96C92[>V-Q=O +J2:GJ5@M=BFVK<\KZ OD?1
M@U<]QH*#S*PJ-4<Q[@9#.W[N#]MH1D\[>!T<MXX[+1D;6ATFR=I+-8]W7J=%
MFK5>*MF=M.!6W;KBEEQFUE-S):M<V6Z>T,<_=(^05 )&F^BSLK,?3JZK1MI]
MI2*R @I 5%>I\$&.<TYAC.$8.XS^8>66D.UL;&BI<^0[6BE1]HJ$N=.(6N6Y
MYRF?NERB'TVDG[@LWD_J8I8W03M#7>\P5:#KU7:VN'HC6>;C;O/U3TPV7]K3
MH/R+><]%60ED_9R?O'?F6/+[EO5*U/>KZX:H_P#VA_\ '-_.%\"O_P#8S_5'
M[GZ(K_\ 71_1/[VV2OT"_.L+3R#%29K'/Q\<[K8O(_6,H33Q&OFN;O\ :3N<
M7PXM-?4Z?EV\C:YHRS6+:=DL([9W]WVY[M67"[D>M8YFVN+IEP35U(6EC=&Z
M:E>>P>4QL^W69>IWGG=O,=)TZ8AU7<,9+#) \>Y*US'#K4.%"MB:ZQI+G1;2
M=6EW=A8X.6R<DL,K-;M=/ZK86-90-J#MU-:&B\];RCV^JMM.+U<>?:X?AVK$
M\%UYQV:CYCR.US[LC+ ;=X>8FM86FCP_J37P6?<^6_%R=6K6V/G,[?%./IB=
M6T(;=L5N+8^^QHV.)^T"NS6L1&CSUK:VU::YA\OF/Y%FY\O:W\EG\4\RR0QL
M86@D^;C5<#<>3Q>\VB>;U6S_ %!;#CBDUUT;,X=QIG%,!9X**5UQ\*P,]5X#
M2:$GP^E=C:[?X..*:\GG]YN?F,LWF--5^DC+V.8[0N! (\*K8F&I$M0N[(,?
MS>;EAR<P=+*9O2V,IJ0:5K7P7!GRK7+-]>W5Z:/._P#X\8>F.39')N-8[E.-
MEQ65B$EM)[S217:X T-*CI5=;<;>F>G3:.#@[;<WP7ZZ3I+2\_RT0MF<;/-7
M$5LXZL;'&!3\:\_/D4:^]J]77]36T]JD:_2SO@':# \'E^+:XWF3(.VXD8&N
M:"*$#:::KH[/RRF">J>,N/YAYQEW4=/NU[EVYWV]PW.[01Y)OI7,8VQ736[W
MM%2: $@:E;&\V--Q''A/>UMAYCDVMM:\NYJP?+1&7B/[\N#:@U+/3C\/95<6
M/(H^\]'_ '-//HC7Z6UN%=O\-PBQ=:8YFZ>4#U;DMVO<0"*D D="NWM-E3;U
MTCC/>\WO?,,FZMK;P8)RGL';9S-WF<L\M/;7-[(998V1LH"[R).JY>X\FC)D
MF_5S=C:^?VQ8XI-(F*K=COEKQ[;IMQD\M/=!IJYCXV$'V:%8J>15UXVX-C)^
MI;].E:1#=&%PF/P%A%C<7"V"V@&UK&Z"E3[3YKT>+#7'7IKPAY/-GOFM-K3K
M,KD!0]* ZK,P)+G]A+^\=^8JE_=E>GO0Y5RO^_EQ_M\?^$U?(]Q_S)_JA]EV
M_P#PH_HEU9%^S:OKE>3XU;FJ*Z@@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @H[*TJ:-/5@Z*$N4[:.\[
M&]R^17O)K66ZXYR_X+X'*P,]>8?=5F6R;VL-&?K)VL;NZCHLV.VC3W&.;<6[
MK2^L<C$+FPNHKJW=TDMY&RL/4?6:2/!;4.=,:/2-:M!U'BI0FU!]B(.N@_*@
MDU)I6A\7!$L0[GB!_!LF;EP:T[""=!N#M.OM5+<EJO=\M;Y7=D>(^O5L_HW6
MX'_;9_W%I.VVOMIT^J4%9 0>.X<?2F:W0AKB"/'1!H'LX[?S;N9/(:32W>-+
M_81!(M?(Q7;?J=::@=1YK"QL4YYV_P 'W!Q[;',L#)(Z>C=M;OD9[P=H"0-2
M K1;1+%,3P#GW#K46?'>27.4MVZ,CNG,MVTJ3T%?TBLL9%^N4]_PON'R:W-G
MF^0W&*B?]9MH]D[: U\:>2GXA.25[[?=KL!V]:]]BXWF3FIZV0E9Z<CJ!P&@
M)'1U%BFRNK+KZ_L<9"Z\R5S':VX%723/;&WZ 7$"IZ!5YH:GR7,>3]T+NYXQ
MV[LWQ85E&97,76ZUE:7-WL$.XEKVN#7-=Y+-6B\5U;3[:=NL5VSX^S!XM_Q,
MHH+B]D:(WS$/>YI< 2!0/H%G9F=(@0$!!3%*TIJ5"7._S;SE_"[6Q_Q4UQ;O
M=]++F.BR8HULIDG2K)BT,HQGU6KTKS"'F?-2""5_[*3]Z[\RQY?<MZI6I[]?
M7#5'_P"T/_CF_G"^!7_^QG^N/W/T17_ZV/Z)_>VR?)?H!^=84I9HH(I)YWB.
M&)I>][B  UHJ=3[%$I:MXWD;3EG<^3GUS(+?B_$X;BPCF<0TSF9KI(RP.(WU
M(I[B\_YCNZ4C69Y/1^6[+)DX5CC+HK@_+I^96]QE(X/1Q@>!9/(<'R1N!U<T
M]-0N/L]U.?6VG#L=G?;.-M,5F=;=K+14DM.A.NFM?I71<Q. >E::=!T4 =0-
M>G4*4*B @(" @((:J0U4"* @(" @(//<G^;3?O'#\A5+^[+)3WH<K97_ '[N
M*?Z_'_A-7R//_P R?ZGV3;_\*/Z)=6Q?LVKZY7D^-6YJBNH(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M*!):XG7W?#PU0>3+8BPS>/FQ64A;<V-QM]:%]=I]-X>WH1T+05 YSC[?<^[(
MLE=PX,Y#Q/0S07CQ";8-K0111DN=N+W./T++6^C6R8=9UAG?"N?<?YW8&YPT
MDL<\-!/:73!!<L+BZE8R2X:-)^A;46U<ZU)KS957INZ*S&L^3Y3@,47MO,A"
MZX9HZUCD8^8?2P.KXJO5"VDL/NN]/%8)A!#99665U=A;8R.9IYN!5/B1#-&&
MUHX+%R3'=S.[^,''\7BX,9Q2XD9+-DW2&*\;Z+M[1Z4IH0XM+3[%AMDUY-G'
MMY[6_>)\<M^(X&RX_9DOLK%KFQDBA_6/=)T%?%RQ-Z5] U#?LA$*B @\SFDA
MS#]H=/"GB@YTOIKOLYW)SN9R5G)<\3Y?-'<236S'32P_"1>E& QF@!>_7<>B
MQ7KJI>NO%M2UY)QV^B;+;Y:SJ\$N9\1$'"A\1NT6#IECB'H^^\&*%^5LFU\#
M<Q#_ ,).F4:2@W.8%Y+8\O8OD\&BYB/YG)TR=+W]6BAT/CX*J%AY9RW"\/QK
MLCF)BUH($4$(#YY"XAON1U!< 3[Q'16B-4Q#6,G%>9=^3%/G6?<' 0X/LF0G
M=-<!CJUF@D(+2V2.@]AJMBM-&6*=LN@L3B+'!XZ#$XR$6]A;@B")E: .<7GJ
M3XDK(N]U ='#1VI'T(*R @(""F0T$./4:?C0<^_-O9//;<7[!K;7=FP$>4ES
M'_85\<Z65M&L+W;SLN;>.X8:M>":CV&B],\PJ?F0$$K_ -E)^]=^98\ON6]4
MK4]ZOKC[6I7R,ASKY'FC63-<ZGD""OS_ )KQ3?VM/*+/T7BI-]A6L<YK_%L(
M\LPA/[9X!_N5]:_N?9=\^#XW_:WF'W:^+7W<CDN0S4,?&^/- LKD;[V[<2R0
M-:2', .A!:5KY_U1LXK/3,Z^IN;;]*[WJCKB/%B,]O=_=N-XQ8L$>#Q^V*,@
MT+V;]VYS3T(J5\\WGFL;F_5/"'U#R[RN-GCTCC9M#)=TN2\-P>'X]V\QMIDQ
M;0;;V:_D?;GU&O<:-VFA&TKT^Q\TV>+#%+6G6/0\;O\ RG>9LUKQ6.,]ZV-^
M8;O);^_<<6PWIGKMN9G'\CEO_G.S^]/@T/R/>?=CQ9)Q[YD,M<SMAY#AH;0$
MZNMA-)_A%8I\[VD=L^"\>0[N>R/%LZW[M\1GB;)ZLK'G5P,=/W5CGSW:]\^"
M_P"0;ONCQ>G^MGAW^7E_D_[:C\]VO?/@?V_N^Z/$_K9X?_EY?Y/^VGY[MN^?
M _M_=]T>)_6QP_\ R\O\G_;3\]VO?/@?V_N^Z/$_K8X?_EY?Y/\ MI^>[7OG
MP/R#=]T>)_6SP_\ R\O\G_;3\]VW?/@?V_N^Z/$_K9X?_EY?Y/\ MI^>[;OG
MP/[?W?='B?UL\/\ \O+_ "?]M/S[:]\^"?[?W?='B?UL\/\ \O+_ "?]M/S[
M:]\^"/[?W?='B?UL\/\ \O+_ "?]M/SW;=\^!_;^[[H\3^MGA_\ EY?Y/^VG
MY[MN^? _M_=]T>)_6SP__+R_R?\ ;3\]VW?/@?V_N^Z/$_K9X?\ Y>7^3_MI
M^>[;OGP/[?W?='B?UL\/_P O+_)_VT_/=MWSX']O[ONCQ/ZV.'_Y>7^3_MI^
M>[7OGP/[?W?='BI3=U>(OBD:V:7WFD >GXD?2HMYYM9CG/@O7R'=Q,<(\6AK
MNZBO>9/O+<DP37L;V$Z&FYJ^>Y+Q?==4<IM#Z/CI--I%9YQ67647[-J^PUY/
MB]N:HK*" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(*1=[Q#NAZ(.6LQ8CB'S+8T61_5<L9?760 T.^
MTL]K*@5KU67%/%I[KA&O<W-D[DV5A>W(%7002R-KTJUA(6U+GPTM\O7;_%<^
M@N>Z/*FB_O<PYLL-M**MB]/U;=VUP(.NP'5:5IUEV,5(K6-'4-ECK+'Q"*QA
M;!%Y-KX5\_I5&67J^CHI0F0$! 02:BA/0=0$'DO["VR-K)9WD8EMI1M+3THH
M2T5F/E;X]>7,MSA\Q/@Q(0?3M862#H!U<_\ [JIHKI$O-:_*KC(*F]Y3>78'
MZ=O&*_B<HZ4=,)<O\K^&@L)[G&Y^YM;JW8Z9DC((P28QN U=XTHFB>F&2=F^
M49#DO#;8YG7+6HVW3JEU3)+(6ZG^Y 6M:NDL$PQC,8^/F_?3$8Z_][&<?CO(
M9+<ZMD,MN)6D_0X>"S8X9*=KHL.H#70"E*+*R*R @(" @(*9KH:Z^"A+4/S(
MQ0W?:V_BF<&M%U9N:30:MG:?%6KS1+&N$323<0Q4\PI*YDFX'K^U<%Z6LZO,
MWYK^333\2LJB-2I0@X;FN;TJ"*_2JVC6)CO3$Z3$]TL S'$98I+B_,\<=J27
MODF>V,:#V^.B^5[_ /2F?)GM>D^S:>^'UG8?K#;X\-<=XGJK'9$RUD>6XM^2
MGL;;?+%;.+'W&P['$:C8X:.!\UYG?>29-K[TQ,^B=7K?+_.:;SW(G3TQ,*XY
M%9:Z.I^]*Y/RUG:^)"A<<LL+=T3-KW33R,CBC8PN)WNVUH-: E;^R\JS;J_1
M1S=_YGBV=.N[9#."Y4L#R6 GJ-P_L+O?V?N_1XP\Q_>NS]/^F4W]!<K7JS^&
M/["?V=N_1XP?WML_3_ID_H+E>A<S^&/["G^SMWZ/&#^]MGZ?],H'@>4_29_#
M"?V=N_1XPC^]MGZ?],L:Y?C[_B%DW(74!N+8EHD] .F<VI\F#V*L_I#=Q&O#
MQADI^L]G:=(U\)7_ (7Q'^GV*BRO'[R&9LH#GVSY8V7$1-=)(ZES3I6A6G;]
M-;B)[/%NQ^I]M,=O@RC^I/DN@)C'_C&JO]N;CT>*W]S;;T^!_4GR?I^JKX'U
M6I_;FX]'B?W-MO3X(_U)<G_XO^5:G]N;CT>)_<VV]/@?U)<G_P"+_E6I_;FX
M]'B?W-MO3X(?U)<G_P"+_E6I_;FX]'B?W-MO3X']27)_^+_E6I_;FX]'B?W-
MMO3X(_U)<G_XO^5:G]N;CT>)_<VV]/@?U)<G_P"+_E6I_;FX]'B?W-MO3X(?
MU)<G_P"+_E6I_;FX]'C!_<VV]/@?U)<G_P"+_E6I_;FX]'C!_<VV]/@?U)<G
M_P"+_E6I_;FX]'B?W-MO3X']27)_^+_E6I_;FX]'B?W-MO3X']2?)O#T_I]5
MJ?VYN/1XP?W-MO3X/?A^S&;@R5O-?/:R"%[9*L>UQ)801I^!;&W_ $]FKDB;
M<H:VY_4F&V.8ISEOAK=K:+Z%$/G$SK*8*4" @(" @(" @(" @(" @(" @("
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M=!6US:W<3)K65DT#J[)(G![#K30@D+ES$QS=!C?<>X-OQ'(O!()9M']]HJC
M.Q,0@[2<:8=&^E<:?^E2K5MS:\K3\Q-@^[[=S3PMW3PWEGZ;AU:TW#"[\RFB
M:\]6Z>/9.',8BVR-N=\$X)#^M=KRW]Q;3.O*"%16E=4$4!!YG.VCS\W>-4&M
M^ZW=?#]OL6YCI'7&=G:66MI;#UI0YQ#:EK#N%-P/16BLS/ F8B.+3_;GAF9;
M/+S3GQ%YS*[(='*]_JN@T?%(&O!%=[=M:A=O!@Z(X\W"W.XZYTCDN/<_EKN.
MX3X2P<7\@R!:RSBBJZ3T]X9(:-J= [R63-DBL<6/!BZ[-J]F>W/]7O$+>RNX
MV_TBN17+W0(<Z5\<DAC)(-#1CP-%Y^UIF=9>@B-.38FS>345 \/-52B6G=K4
MA2%#]5Q.[P/L034 %?Q!$I3NVZ"I.I!Z(ARB&,N>_N;=<C<^"2\9 3X-VCHN
MELXB8G5S=[:8TT;+U\#4CK5=9R(3*00$#\Z"2A\!1QU*JEC'.^4V?%L#<RS2
M$W]XQUM801^]*9)VN8QVT&M [J5CR7B(U9<5)O;2&4_+OPS(<:X:,KF8O3SF
M=V760?6KS)'N9K](7G[VZK:O0UKTQHW$VKJ%P]U465D! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0:P[Q]Q[[MO@F9+'6C+V[N:^E!(7_XN2%AIL->DA*W]IMXS
M6TM.D-;/F^'&L<6-\2^82#*.$'(<;)C;AU?JQ2B(4WGZSR/ -_&LV78Q'&EH
MGZ6.FZB?>C18_FCY#B<OVCN?NG(6]P]U]CSZ,<T;GT%RVIVM<2N=.*U><2VN
MJ)C@V#Q[T9,+9FU>'0!KMCVFH/OGQ'M6U#BQRA<G$!CB=-K2?9H*JQ#4/R]M
M^.[L=U,HW6%U[C2R0:M<'6LHT/CT6C?WG5VWX<.FE5L""D0-*I B=-2=/;IH
MI&HN['=J7B[(L1Q6-F2SMS[HCC<7^D-S:EQC)+3M=4571VVUBWM7X1#5S9NC
MA'&5BXIV]9;73>2<IN'9?DLM3\3<T+HC0L(:YI%=S:5J%R]YYA;)'13V:^CM
M:]:=MN,L^.IJ5QF31#:"I%KS>"Q/)+)^,R]LVYM74.UX.CFG<#H1T(JLV'-?
M%;JK.DEJQ,<6M[;DG)^S&6M\9)+-E^&W-?3=(''X4-T 8R/0!SY*FI7J,-Z;
MVLSPK>/K8JWMBG3G#;7<#(6>;X#>W6,N675NX-(?"]LF@?37:3Y+FWK-9TET
MJSK#&^RKQ)VKXV10L]*>A_\ 2I5I68)77N);Q7/#\C%+3;[CP/(L=4)5"OV&
MGDN>TW&9GDE[HKC=7QI=3!;3:;(Z:5_#XJ4):M;J[5P\?% J?['FI'FN,ECK
M)I=>W<-N1]J:1D?^$0K169Y0B9T:M[I=YL7P[ W%S@WQY;+.VLBM[=WKL&]P
M:75A<34 U"V,>UO:>/!BOFK5RWQ7E6=_I/!RKE^-=>YB]+C'>78D#K:K3$X1
MG0'>*5W+O;?:8J\(MK9QMQGO?G&D.E[^\@Q]O<7ES(UD,#2XN>0UM0*@5/F5
MCF=(:T1JPSL3QZ3N%R6[[IY^-SHX"!Q^WE!V1QSQR03AM:$"K ?%<3<9>NVG
M8]!M\713TNH%JM@0$! 0#T*#E#D+/NOYC((OJQY*UOKD^%32@_,NALYXZ-'>
MQ[.K8^H)&B[#B(J002DT_=^E0 \R3N/0J$K+R?DMAQ7$W%_=RL^):QQMK8D>
MI*^AV^[6M"1314O:*QQ7I2;3I"R=G.!77<2]C[F\_C>]A][$8:8'TXHY*G2I
M:]NQ[:@%<3-FF\^AWL.&,<>ET\M9G$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M*MN3^H;K-YT>I>W<@ >YUO+-$VI!_1-%V]]K&:T-W![D:-V@FI.E2M)L*JE
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MP/@4$W3[2"!TU'4^*"%?+KXN01:=:5-/SE!40$! 0$! 0$! 0$! 0$! 0$!
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MAVM/MHO1[3)3>UG6.FU><]^G_52<ML4]\+B^/GO<EXR6>OY,+QR9M8<5:O\
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MS=&_==Z-O_HTB#YY_(#_ -K<'^9O?_9B@^HA<*5&J"* @(" @(" @(" @("
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M%?O2JLAY=;_Z-R[+']]=.'Y@LU?UC;MPX_"?XJSL.ZTO?;<G[G8L_P TR0R
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MJYDMHGO?([J7$MJ2@MI^4[L=2@XCCJ_[)%_%0;+XCPGCW",5%A>-6,6.L(@
MV.W8V-M&UIHT >*A+)5*"H0$! 0$! 0*A 0$! 0$! /1!)T\J4J4&-\UYCC.
M&82;*7TC?5#7"T@);NDF+'.8QK2YI)<6TH-5GPXIR6TA3)>*1JT)9XW-=Q;_
M /I7S*23[M>_U<;A'EQA:PN]2-SXI:EKV[G-T.@6/>^81A_VL/TV<N9F_&S8
M,$,4$,<$#!'!&T-9"T48UH\@O,S,S.LLD/0 .G@B4XW#I0@JT0E6: K:"J %
M*51K?Q>?B5:(2G %>FGL5DIMFYCHR ^-X(>'>(.A"M"4T$$<+!'$QK(Q]5C1
M0 ?0K3.IHK!J)3AJD3ABE*(;YIH(;?$  ]*^Q3H :":"E?:HT-$=@*:"0M;Y
MJ$)2T!1H)"T54:(2$*-$)"% D<-%64*)"J)'-\E5"BX!0A3=140ID5KYJ$*3
MZ=.CAXCV*J'F%O V?XL1M%R6[#,![^TG=2OE75.J=-->"'CR^ Q&>A,.6M(K
MIM/==*T/<TT(!%?$;BLN'<9,,ZTF81,1/-B\$O+.U-VW*X"YFRO%-X-]B;A\
MD@M[?=OD^&ABVC<R.)K(]QIK0KT^UW^/=>QE]F_9/?V<9GTSQ*7MCY<F^^'\
MMQ7-,-#F,9*'![6^O;DM]2&8QLD='(UKG;7-W@.:=0F;%..VDNG2\7C6&0 =
M/#V#HL.JZ9 0$! 0>>:&*=IAF:)8W?9=J#35(G0<R38BY[*<A^[;AKY^"9#_
M $2\()=;^A%O?ZE-D<>^:;:W]+Z5N;W!\[3KK^)'9WZ\/7/"'(OCG%/^5L:-
MS'M#XW-?$_ZCV'<--#0CVKR&G>R*K:$T\#U<.J)50I2G:*JXF&M:]/M%WY%*
MSPYCD&&P%NZYRUY%;-TV,DD8R5VH!VM>X5IN%5L8L%\DZ5C7[$3:(YM49?NY
MR+//=:<-QXMK33==9%DMM+X.]US'D=6N!_ IW.ZV6Q_&OUV[J:6C]N*],>3)
MRC2/3P89#PNWFO#D<Q<RY"]=U;<%LC11NS0D5Z4_$O)>8?J[<[BO12(QU_RZ
MQW>EO8MA2LZSQEE,;611B.W:(V^P47B)F9G6>+I1P1-= -4#Z% ?2@(")$0
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M_'8J\ON-2S2!L6,@NKF)UN^9K22(61MW%L1TK2BS:Q,+MX<B^9GFG,V8["\
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M6%G9FMG;QPUT=L%%"-49XV3,,4S!)$[4M<*@^"A#QMQUC%&Z"*VC9!)J]@:
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M MS/?X/EF>_*9Z-/]?$QQU9JQZ_L' U-34>'L7QJ'ID#U1 .J @(" @C0(%
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M(&BA*#VM>TL>*@]0B)9_V;[GWO;_ )'#B\C-/<\>NSLBLXR9/3<[W&4CW-:
M":E<+S+8QEK-HTU=39[B:STSR=L07UG<M:Z.9AWZAA<VM/HJO%367H(F&DN_
MG9]G)[&3D?'HH+7-6H,MQ-41&2-M7R$N#7$D@+L^6[Z<5NFTSHT-WMHR1K'-
MRC;S&3<U_P"VB.V0?9J?)>WB8F-7G)C25;160((?1KYU02O8R5A8\!S"*$(A
MLOLGW3N^#9V/ 9F>>XP-Z\16<+"9/3?(YD48#2]K0T4*X'F>PC)7KK$1+J[/
M<S6>F6X_F!RHNL1QW'0%PAO<G8R.8= 6/=(PU /M7GMI'3%[=U;.CNK:UB/4
M]UM;QV5I#9Q- 9;M$;&@:!K?*B\/>TVM,][!RX(W%Q;VD#KB[F9!"P$F25P8
MT "O5U!X**TFTZ1&LC5',NX=UF=^ X9ZK9]VV;)@%L6T;F.V2Q.<#U#AHNI_
M\?85^+N9B>ZO"9U[-:S]93'?+.E?%:<+Q^''QB\O@+O,/UN+N2CY'.-"[WZ
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MGJK)5!T4I5!X*T):0[@^]W6L(W_4;ZVW\-E&5/G,Z>43I^W^Y#+MO^1^W<]
MU!!\5\E>@$0(" @(" @(" @(D1 @(" @>WS4BR<O . F_P [#_AA=WR*9C>5
MT]/V-;=?ARZ4[:.>[@.$?)]9T<M?P3O7V#??CV_;L<S%^'#)G$5U)U6@ND<H
ME53<JR*3M5565)WGXJLBG74]5 IZ:G\A542HDT!\?8H0\U[=VMA ^[O96PVL
M8J^5[@T ?2X@*J(6+ \UXIRV.X=QO*07[;3:9S!-#-L#@2-WI/=2H:>JF:S'
M-,U4+#GO#,OE_N#&9BVN,SK6UCN('R>ZW>:,8\NT:*]%6:3$:FG!D!6-C47*
MHI.ZJ$)''Q54*3JDDG0'I10A(XZ]*CS5)0\]Q<VUJSU+J:*WCZE\SQ&/PEQ"
M16;3I$:H85R/N'!9-,/&K9V;O": 6C#=1 ]-3"ZM%VMIY5?+.N3V(]/#[88[
M6^[Q5^,\'Y_W!A%]R._N.-V;J%MM8220N+3K1S)FGZ%VOE]MMN%8B\_YM)9L
M>&U_>X-HX'M'P7C<?QD]C#?7D0+GY.]CC];34N<\ #Z2JVW5[<(X1W0VZX*5
M[&BN^7>"^R%^_A/%+ED>(BW,NKRSD/O%A(VAT;RTM<UVM0N_Y9Y?'OWCBYV[
MW4Q[-6D8866[!%&- -2O3N+]JI160((>S\JJE3FE])E0-SSI'&-7.<>@ \=4
MF=(XD1,\FW>WG9G!Y;#1<CY]FG<>NKC;+802R0V[PVIJ=MRT$$.&E%YK=^87
MZNG'7JC]NYV=OM*].MITELJ;AG%8+>6Y/=J^+8FN>6#)VA<=HK1HKJ5S/C9-
M=/A1X2W?AU^_/U.;N49S+97-WMA;<CR>0XW!*6PB\FW-E U:X@$M/X%Z?:[>
ML5BTUB)<7/FG68B=86QC&,:(V-#6@: :!=)I)NGTH(:41(>FGT:J!Y[JY9;,
M!+@)'$-:'&FKM!^!)3$:MT=O>T/"LGA;;/\ *.7P8[,W $D<,-Y:AT.IJ*2@
M.;J 5YG=[[-US6M)F/5+M8-K3IB9GBV3?]L+^'#39SBW<++7\MHTW$=+QCK>
M1D0+RTNB!J#2FBY==U$VZ;XXCZ&W.*8C6+2T]S+OYS'DF*BXS"18736[<G=V
MKIF.+@35@<9#5KFG6H79VOEF.+]4\8['/S;RW3I'-K2*%L(H*N<?KO/5Q\RO
M0Q&CDI_SJ4""/T?A1*E/+Z+/=&Z5WNQ1MU<YYZ #J:E1,Q$:GH= ]ANS$&1B
MBYERZV<Z:K9+*PN6>XUI#)&OVR,#@YI!IJO)^9^8S,]%)X.[L]K$1U6YLT^8
M3%B'%X#+6S"(K3)V,9:T>ZV-KI7DF@T IYKE;2>J+UGMK9L;JOLQ/I>FTNH[
MZV@O(G!T<[0\.8:M.[6H(KHO$WK-;37N8/2UOW=P/(KVRCO\5=SR6<#F_$8V
M-[C'*QN]SJQM!K4>ZNYY7FQQU4F(BTQ.ENV)[./UL5XGA/.&+<6O\6^QCMH(
M66%ZT#U[(@0NW  'W"=VG1?,_/=ENL6>ULLVO77A?C/UZ:/0[7)2U8Z=(]#(
M#U/Z)U/TKS;<04""D14 B1$" @(" @@2(VF1Y#6>+CH&CZ? !6B-9TCF,/RT
M,^?S=G8<5M'393U8P_+6K'/="/4H?UL>[;0D.U^E?5/TGLMUBB<F6UJ8_N3P
MUY=DQQX<'%WMZVF(K&L][K3A>)RF$X]966:OI<C>LB8)9[B0RR;PT ZD#Q7H
M]Q>M[S-8TA..)BL:LE8TT)!Z^?58875 .@.E-2?-62@[KX:]*=:*$/'?W$=E
M97-[*?U5K#)/*?[F)I<?+P"J-3\![[\9[@<TR'#,8UPO[#U]Q<U@J+=S02")
M7G[7Z*34T>>_[^\7M.X/]7AW'*"1T#W-#"T/;/Z!!/JUK4_HJO3P1HVJ\AON
MUJ!H:=:^U8Y4E1)T)%/+VT5)567E&=M>,X#)<AO0?@\9:SW<H%*EMM$Z4Z$M
M'1OFHB-91$,,[6]W,%W6L;VZPV]ALYY87-<&M-(FQ.)]V1_^5"7K,)FNC.W!
MU-P/LV_^$L4J)'.'0ZZ=?[I5E65)Q!\Z=-/-4%%^FG@>OT*$2I.(ZG2@IY#:
M/-4E5Y3+%(2V.9CW@T<V-P<0WVT.E%626 ]SNZ>$[86EI<9C<X7DT<,;6!KG
M#U6RD$ASV:?JBLF/'-YX%:39DN S-OR'!X[/6M?A<A;PW41-*AL\;96]"1T=
MYK!:-)F%;1I*XDNJ*_4/0^.[VJBH?,:'I^%!@_,SOYGP&%NLHSV'D<!J0P7#
MP7?15>G\DCV<D_Y+?N4GWZ^N'37IG]-RMJZZ!H\!PJ/+S4 X.^M34?NJ%E"^
ML+3(PNMKZ!D\#J;V/&X&A!&A]H"O6TUG6%9B)CBUKG>Q7$\@_P!; A_&KC_+
M8ID<+SHT:DM/0 C^^*W(W=IX7B+Q_F:U]M2>7!J_D,/<[MK*V**VDY)BC7]?
M*+B[N1HT](PT?6DI]#?8H_+]MN>,3T3]$0TKTO3_ #0R+!<ZPF6A:;N=N-OQ
M7=:WKF6S^KOLO?N^J*_A"\]N/+\N*>$3:.^-936\3SX2RECFO;NC(<T]"W4?
MD6@R*@(K2JE+3'=J+X'G/',GT;=?&[G^ ]*VB8*G\*V=[3XOE6:/N='UWA.&
MVF>OIU^Q.X4T'4+X]#TB5$" @(" @(" @(")$0(" @((#J/S*1CG.)C%@BQO
MUGS0  =?VK1^ZO6?I7!\7?UCT6^QH[VVF*?H=7<6L?NKCN/QYK^H:\;3X;I'
M.]GFOI6XOUY)EI4C2L0NA/6H'L6NLD<JRJIN*A$J512M>O140MF6SF$P-L;W
M.Y&UQMJ/\=>3QV[-33ZTCFCJFBVC&L;W6[:9FY%CCN3XY]T[ZC#>VNYU!70-
ME)/1)K)-60Y+*XO#P.O<S?6^/M&=9[N5D$>NGUI"!U6/FIHQ"+O!VKN+CX>'
ME6.$IT!-]:!AT\_55NB>Y;I4^Z$\-QVYRL]K*R>![6^G/&X/:X!U#1S:@ZJ*
M<R'*OR(M;]R<X(T<1;&H_P S=+8W'.&2_.&-=@!_^\].?M SZ_\ ZL>IR^XK
M;W7?1ZKF2UE%R@4G'550D(4(6Z^S&(QC7/R5]!:@?59+*R-Q^@.(5Z8<F2?9
MK,_0B9B.;7F7[@\DO[YN,X7AI;V)YV_&R03.AI6E1)"2.A7H=KY-68ZLUM/1
M_P!889M:9]F&983LKE\ZV+)<SS=Y^L]Y^*BE$EIKX%LC*K=^)AP\,=(]>G%M
M4VVO&TMI8#@/$>,-'W+A[:TF HZ:*)K'.^D@+7R;C)?WI;=<=:\H7]VUH+WZ
M "KB[04\RL#*YC[^]Y,G;WO]#>+S.9"]KFWU[;.=N!:XM+ ^-Y&US3T(U7I/
M+-C6WMW^MR=YN9K[-7/$+8X:T:]TCM9)7-]YQ\R5ZR)K';#A3$SV*OJ@_9?_
M  5/5'?!I/<AZS6ZEKFCQ)%%/5'?!I/<F8]DC0YAJT]"-0I50EE;$PN/7HQG
MZ3CT 'M4+:=C9? >)8;#86;N!SQK1+&W=A\+=AH$KW-<6.,4NUQVO:/JE>>W
MNZM>WPZ<NV75V^&*5Z[\ULR&:S7.[J3/<BEDAM_>-KBFE_H0L=KM9'(7%H!Z
M"J^?>;>=6P9/@[:?7:/XPULN:V2=9:YR]Q<SY)T,-K<,LHJM_5Q. ?XZ^!7N
M/)K5KABV;-%K3WVC@P3:48[J2-@CCL)VL T:(7!>A^;V_P#Y*_ZH8M$?C9^O
MP5QK_P 4Y3\W@_\ )7_5!H'(2M!+K.=H'4NB< %,;K!,Z1>O^J$:/7#*V>)L
MK>CA5;!HDN)V01UK60_59XD^&BK:8K&L\B%UP'&67\(R&887/?1T<$@JUM?8
MX5%"OD_Z@_4V6N7X>"=(CMB?X2RQ#(ON*Q(H10?0/["\I_<&]^_/C*^LK1=\
M^YCQ.*YXYA;^\^Z+JN\B24"%@!:61["&AI!-05],\DRTWF&+YIK%H]/&?7JS
M5W%ZUTU8W:-OI8S-:X^\O _5]U' ^7>?,N:""O:=>.O#6(:DUO/9*/Q%WZPM
M38W/QE"?AO1?ZM!U]SKHK?$KSUC1'1;EHK.CR[07.P]^UHU)=:R@ #Q.BCXN
M/[T>)\._=*$,PF;N:"TCJTBA"R*\B:40L)ZO.C&>+GGH /$DI,Z#>G87LVW/
M$<QY;;OV1O:ZQL+AE(R"&2LDVR,KN!J*@KROF?F,Q/12>#M[/:QIU6YNJX86
M6T;(88PR%C=K&M% T> 'L7EIXNQHM?*^/VO*,#>X:[C!;/#(R)Y )9(Z-S&O
M;4&A&[0K+BO-+1,*7K%HT<Z<0REWQG+WO!.1DV\>.EDML5=7-8_6@A(C80Z0
MM!+C6FP4/@L/FNRBVF;'&O5QF([)<KC6>F6Q*>[3Z[3H:Z@@KS"S!N5=ML7F
MC+D\63C<PP.D$]J&QND<*NVO=0FCC2JZ>+>=5?A9HC)2>'M<=/3'J1$3$ZUG
M26N,=FLIC\C)@^36YMG1.,<%V]KVMF+2&M.^0@.+C7H%YGSS].5Q5^-M=;UG
MC,<^GZ*QPB(=7:[WJ]F_"64:$5&H/0KP#JB @(D1 @(" @HW5U;V5N^XN'AD
M;0=7$"I )H*D5)IT6?!@OFO%*1,S/<K:T5C67CXEQSDG<W*/MWBXQ7&87$_%
M,:^%TS&D$"KVN8YKFN\%];\M_3^VV..,N6.O+,>[.DQ'U1,3$PXN3<7RS,1P
MJZ.XGPGC_#K5MIAK2.*6@]:[:QK9974 )>6@5)H*KJ9<]LG/EV1V0FE:UY/?
MR/DV"XGC9<KR"_M["TC!(DN98X0YX:YP8TR.:"XAIH*K'#+#2^)^;CMWD.2N
MPAE?%;&8Q-OYO19;UWA@/JFXVTUJKZ);PO>6<;QV$');S*VK,%)&98;U\\0@
MD&TO&R0N#75#32CD@T:*OOG"[=V^>^[(S)+:B7T#>QMA=!3?MKZ@N*4IJFDC
M:]URK \P[?YO+<=OX+ZSDQ=T7NMY8Y2QSK9SMK_3<X--#T)5>TAQ%\H@'_S*
M\E/CZ.3%?[Z%7MR3V+3FP!\W=YIK][7'_P#DV*/Y1]$9?K.+10UU)T6M+#+%
MN;<WXYP/#RYGD-[#:,8QQABDECC=+((WR-:QLCV;B[TW  '51%9DT<^<S^8_
M@O/>W7-\'%/\'<OP^5CM/B3#")I#:/C8UE9G;BXR>Z -5>*3$PG26(?(-_U3
MR,#6MW>C37398:A3G3>&_P#N+WIX5V[C,>0R$5SDVG:;&WEAEG%!(*.C]5C@
M0Z,M/MT6O&.98HKJL_;[Y@N"\\N38,NH\??2/V06]X^&W=)(XQM:UC3,XN<X
MR4 '6BBV.8)I,,D[F9W%8+C%Q=7V?9@[AK7S6CQ<QVTDSQ#*61MWN!<'%IH&
M]:*VVM%;ZS7JABM69C@Y_P"$_-C:_?G]'.4-;\ R?X6WRS@:O:)&1-D?++,&
M4+=SR0/;T6_NMOBF.K'KKW<$5I>.;;_<WN9B..]M[OE%A<_%6^1MY+>QNK)S
M9O3FN+26:,[F/ !:&@Z'1<BF.9MHO%>+D3LE\PN3PW.,U><LRF1RN,O/BH[*
MUD<Z=L;I;F%T9VND:!1K7#\*W<V&)K&C->G#@R[YRLG#G.+\.S4+=EOD3C+J
M-KA0AD\-Y( 14TT=YK%M8TF85Q<)9QQ?OWPG@_;SAV*EN!>7#,5C(KAMN8IO
M2D%JUCVOI*TM+2S4$:+!?!:UI];'..9F6ZN&\SP7.,3%F,%=QW$3FM$L3'QN
M=&\L9(0X,>ZA&\ UZ+4OCFLZ2PVB89"/>-3I0T_$L:K$.-VW]+>],3?VMA@[
M%L^]OO1MO++(-]TG4!X:_IH5['8T^#M)GMM/U36#%'5D]7\725%K.JB@(" @
MI!N[W7FJD81R#M+PCD3G7$V+@MK\T_GT,3/7TVCJX'[+=OT+:INLE>&NL=S!
M?!2W8U5R[A'+^V5A+G,)GKC,8R#;OCRT[MC=[F1BC8PT:NE/CX!9JXMONIZ;
M5BL_Y8_;N:>3#;'&L2N';WE5WS+ 1YF[LO@I'UV,+'QUI+)&:!Y)^QYKSN_V
MM=ODZ(GJ_P"D*X[=4:K%WLPTE]Q%^5MF.=D,53X;TP2[^<SPL?2@)^J/!;'E
MD5R7G#?W<G/_ +=9^U&69B(M'.&,V%['D+..\B<',EW5<#4>ZXMT()\E\6SX
M+8;S2T3$Q_U>GK;JC6'H6NL(" @(D1 @(" @(" @(" @:&OA3H?%2+/!C_Z5
M<\PW&RTR6FV=]X&#<&OB9ZK-W4#II4+ZA^C]K&/'DW,QQC33Z=8G1R-[;JM%
M(=<.V@[6]%WE92$_B4(2.54*3S50B7GU.C.HZ#PIXJJ7 GS5\GSW+.[%IV]C
MOIK?!VLDC)+6)[FQ2[1!*"]I+FD@DTT6SCC2-66&^KSY1^W,5G:P\??+ALO9
M.%,K9Q0174@,@>0YP9XCW-/!8?B2IU-$?.9S[,LY=B>%QY"XAPUL967T44C@
M)BUT$K2]M=KB*D#19<5>&JU8T8+S&]['2\/./XOA;JSY'"YAAR3+*WBF-)-Q
MJ]CW'IIH%->K7B1JW7V8Y1R#D/R]9NWY#+-/+CF6S8)K@O+W>O+<.=J\^P=%
MBO$1;@3#%_D1_P"I>;C^YM_^1NE.Y[$7YPQOL!_^,Y/],]?_ .VO4Y?PT6]U
MWP_V+F-91<H0HNJUKW=7-!('F0/!0AJ=G+N8<PY?=<+P\$>.,+WL-R[U;>8M
M8*ES#5P.AZ[5ZO;^68*8HRVGJU[.$PP1-KVZ8X-FX7L3A8G-N>5W]UR.8ZF'
M(F.XB:?[DEH/M5YW45X8ZQ3U<&[7;1'/BV9B,+A\) +7#V,-C;MT$<# P#\
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MDL\C)#!>0S0,&RR8U@:V0 4&H43HA8/E&.WYE.2]!2')]>GUH56_(6G.'_\
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M/EO&)#:9VP!?*Z-QC,L-=\@<6#<20*4KJNUY=O>B?AWXUEBM$Q/5'-M3MIW
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MK[N]L]2#N)&BQSHB-(EH3Y7^#\GP/S \CRN4L'PV+V9%C998Y6M+G.B H7-
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M&+8S/&S-6]C^+1-'JWLP/B7B(?\ @KI_DV&(YS]3:^1I':EF[&<:FC=\/?7
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MIEWP2.)&I]'U8_\ NU7K][[/33[NJ=I'LS/>W6W0"G0KF-Y40$! 0$! 0$!
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MQ^#]+#O?<8?V%D8+R]C+AZA=4#V!FJYWDD\9:VPYS#/.\<3Y^%R^FTNI-$:
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M'HNQ\7'MZ?#Q?3/_ $7QX)M/59OEC6M:&,&UK:>SHN<WT_4Z*!% 0$! 0$!
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M=?!!)[W]]X^2"(#J4T'T(!'B0#1!"A.K1UZU\D$16M*>Z/SHE"AJ:_@'@B$
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M5Y>PN;7;[NM%WMEY?_\ DR\*]T\)GQAAM>9]FG-L3MAVOMN$X^*XS0AR?+Y
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M?/MF/XPP8Z3>W5;EV0WHV)K UD3 R%NC6,&VGX!H%QF\K^&JD0UK[$$R@$!
M0$! 0$! 0$! 0$! 0$! 0$$-4#5!% 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 02_2@HW%M!<Q.M[F-LT#Q1S'M#P1Y$$$*8G3DA
MH?N%VZRW#)9.8=LHY@X.'Q7'H&O^"+74CJRULXV5#6ESM7:'5=.E\>XCHS?Z
MNWQEHY<,U]JG@Q6+DG.>Y]_:\>P%C=8G&R!YRN3;%<VKX2P;V-$T3I6MWAI;
M1[=>BIAV&+;Q-\DQ:>R.$_5,->)ODG2.#?\ P[@/&N$V;;;#VP?<']MD9V0F
M\F(+J&66.-A<0';17PT6OFSWR3QY=W8Z5,5:1P_Q9/0.-=:CQ\%KLJHH! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! /1!3UH:GIT/F@\.5Q&/S=G+C\I;QW-G*"'
M12L9)2H(J \.%17316I>:SK'-%JQ,<6B;P\A[(\GB98BZO\ MYD#ND$_JSQ6
M+BXL8R/;Z$$3.KB-?-=F(INJ<=(O'U_;,M&9G#/#W99MSS@/$NZ6 ^]+!\4E
M^UAEL,OC3 Z1Y;N<&^NV.5Q8YWU@TZK0QY)QST7C6L\XM_">UFRXJY8<N>M?
M\>OKG!<M!QUY:O+(I[O=;B=K>KVNGVEXKI4!>2\Z\CG':,FVK-ZV[(C73_3&
MD//9*32=)5OOK!]?O6S]O\XC_C+S?Y?N_P#PW_T6_@HC]]8/_P!ZV?\ ZQ'_
M !D_+MW_ .')_HM_ UA'[ZP?_O6S_P#6(_XR?E^[_P##D_T6_@:H??6"_P#>
MMG_ZQ'_&3\OW?_AR?Z+?P-8/OK!_^];/_P!8C_C)^7[O_P .3_1;^!J??>#_
M />MG_ZQ'_&3\NW?_AR?Z+?P-3[ZP?\ [UL__6(_XR?EV[_\.3_1;^!J??>#
MTKE;.GC_ #B.O^$GY=N__#D_T6_@EZN+<;S'<GD4>(QC9V\:C)-YEK82",EG
MO!OK,;)'1XJ*.&J]QY/Y1CV^/X^>/;[*VC_VS&NL>ML8,,Y+>AT]<R<-[.\5
M?!9-MK-T<9;;1O%O%<7<X#O3W!OH^H2[W=-? +M5C)N+\?\ "/X.Y[.*O!AG
M .)97N+?.YUW(AG +M^,P%RU_P '&Q]35]M=LDVN8X59L?HMO<9JX8^'B^F>
MWQABQ4F_M7\&\XXHXF"*)@9&WH  T?D7(;JH/$UZJ!,@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @()!7R_&@C^-!*]H<"US:M<*$4J"#YI \6/PV,Q8D&-L+:R]:AE^&
MA9#O+:TW; *TKHKVO:W.=416(Y/;MH#U_!^XJZI3 4_L>"@3(" @(" @(" @
M(" @(" @(" @(" @(" >B"2FFH^A UJ:BA\P@\&4Q./S5E/CLK;1W=I,"#'-
M&V4 D$!P#PX BNAHK4O-9UA%HB8TEHFX?R+LERB&"U-U?]NKXDO=<>K/%8N+
MBQC(RWT((F]7.&OFNS$4W5..D7CZ_MEHS,XK?Y?L9OG;GL7RR1MWF,EQF]N&
M#:VXN)\;,^A-3[TA>5ITKN:1I$6T]4LMYPWYS7ZEG_H]\N8U,_%:#0#?B=?^
M"KZ[G[MO"5?AX/\ +]2?^C?RY?ZSQ3^'B?XJ:[G[MO"RO1@_R_4#C?RYDT%Q
MQ4GV/Q/\5-=SW6\)3T8/\OU*G]%_ET_RO%OX6)_BJ.K<]UO"3X>#_+]2']%_
MET_RW%OX6)_BIU;GNMX2?#P?Y?J0/%_EV&IFXM3]]BOXJ=6X[K>$GP\'^7ZD
MIXY\N6O\YXII_=XG^*IUW/W;>$HZ,'^7ZD@XY\N1#JW'%1Y'?B?XJ:[G[MO"
MR>C!_E^I=AS'M/P3 W(XOD,&R?83#98N:Q#II@UWI@QPOC+JG337R5?@Y\MH
MZHM].K)%\=(]F8^IB_ ^)9CN3?.YQW'AN&1!V_%X&Y;(+1C75-7VUVR2CFN%
M6;'Z+8W&6N&.C'],]OC#'BI-_:MX-Y10LB8(X6".-N@8P;6@>P!<?5NZ*X'7
MJ@@:UZ:>2"= 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MC/\ E&K3WGX,MG;?B0^B9ZKYN]6B@(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M1$" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @@[H?H08)EO^L)_WQ6Y7DUYYO#X*TH93Q?\
M92_2/S+!E9:,A6!D$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
3$! 0$! 0$! 0$! 0$! 0$'__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tm2225088d1-lc_model4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_model4clr.jpg
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M .,  0 " 04!               '" 8! @,%"00! 0$  P$! 0$
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MVX]'4ZF]E);*"G46[W(2%$JH/0GP^PG&&#XS,WC27)GKR;VK-R)_M)EIF,I
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M5A*]-QJTW"20!Z]S8]Z#R@WNE3GF'D!TU'-H5IU:0#[2;C4>GIWM14T_F/\
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MYB\1N,N7E2LI(0O"[L?0JV<AC45.:"E!?9*DH< )U'3H4H]U4'6[,X9Y[V#
MCX#$<N0\KB&T(;;_ &Q@2Z]'2@=FPC( JO\ V2Z#(<!X[LR<VC=?*VYI&_\
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MB,^X.X>W!P_MM.U,CNY&Y,1&ZP ,;] \S^'H5_52-2;)[6%!+E H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M<6SA\5K+I89UK45DDDEQU:UDW/343;M09<!8 ?#I0:T"@4"@V.A*FR%=N_\
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MI0T$^]^ E70@(5!V^T,7E(_F/OK//07T8:5M>-'8GJ:<3&6\E^,I2$NE(22
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M>W]O"#Q_L[+[TRRK8S"Q')#H40G6L%*6VP3>WN+*4 ]A>B*V[>S'EMR1M_\
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M5BI1U-.K2P VW=*T62.O6H2GMK^UH_XH[BWI\*J-] H% H% H% H%!4/:_\
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M,C\)_LKUQ=[ZOY^OHQAU:],4Y+&H("$@V[#MV[5X,-N&XI0H=4@@_$58E&H
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MZ6^B%'LLCM_)J*QC\OE2T<69U1U!3F66H7%PL%I))'_:JHL+L7EG;F_\QN3
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MAZDT1DV081.B2(3Z=2)+2V7E>NEU)2H7%CU!]*"G&P=VY+P_SF8XSWQCW_\
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MUN2.9>WLK%RT5*M"GX#[<I"5_P U2FE* /WT'<)(4+CM0;'7T-$!=^O:PO\
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MP!'>@UH%!HK\)J3R6$:;C_VG;1_N<W^\FNROP2\[9\R$DH_ *X_%WQR;ZJE
MH% H% H% H% H% H% H% H% H% H% H% H*L><W&#F^N-X^XXLV/$G;24]+"
M9LAN*T['>2 ZA"G2E!=_5ITI4H7[#K8$,?X,\TN%XO'.'P^^<J[MK,X6-'Q8
MBKB3IJ7VH;#;27T+B1WD@+MU2H@A5_2QH)#>\T_&=20$[Y(-^_[*S(_^XJ"8
M-F;KV_O? 8_=6UIGUN!R;9?A2_;<9]QNY3?VWDH6GJ/Y20:#)*!0*!0*!0*!
M0*!0*!0*#0_B'Z:#S5\1_P#?&W?_ *1?Y<FBO25YHN@ =A?[.OIUK&8R,7W+
M@-W9-3)VYN!&#T ^\50VYI7\!\[B*QZ9;:6K'-CYV;RN.IY :Z?_ *F8_P"_
MTZ9;_-I['S/[;Y,8:6Z_R&T&4)*EDX9D )2+GK[_ ,*PV1B.;/5>E[1$1F5/
MN1]RY7<^Y7TY7)?M5K'*5'C2PPF.EW22%+"$J5:YZV-?)=QNFUG]"_ISTC\M
MIB;5Q,Q$_4ES@C,[UW1 7MS'[O3BE8D-);C+QS<Q2F"HC4'%.(_KUZG9]Q-I
MQE^<?J[TF.VM%ZU_#/C^Y-1V;RIJ!&_FCTO?]CL'^,OB]>[,3,/S^NVD5Q,-
M3LOE5SYD<@-:%$%5\,P=5O3J^--*1,1B6J-E,<(2+BX\J+":8FO?42D !U\)
M"-:OCI!-OX:S:+3$SP?6+W-&+6@XWQ=I8O86ZG[/6@HCREREL#->5V"&],W%
MQNR^+BN2OWVY96_E0V"VA"&V%$+9D:%ZE?(4I/S4'3[@YNXTQ'E%M?D786?9
MR6W,\TQA]VNH]R$RU[S@8+C@>0V5);2??6JUKCO03AYV.MK\=\VE*KJ$[&W'
MJ/\ "DT$1;MV'G-E\=<5>1?'"/;W#@]KX!6[([;H0N5C6<:P%*4E70@('MK
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M/E\<UEL=-Q+ZEH8GQW(KBVCH<2EY!0HI5Z$ ]#6&RG7&#3NG5LBT>$Q*'?\
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M ZVHKN.!N%\Y@>&=TX+=C#.,W%O]O(2YH )=BHGL%MMMP%(LIHK<44^E_C<
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MB,NY.XAVURWMM>U=UI6,<MYN0E^*4(E(6VL+^1QQM=@JUE #J*"&XOAYDLA
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MLH)6H% H% H% H% H% H% H-#^)/Z:#S5\1_]\;=_P#I%_ER:*]*A1&M H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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M!0:'N*#S4\1_]\;=_P#I%_ER:*]*Q1&M H% H% H% H% H% H% H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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MNH=]MV6/97H(.AQ.@ZDGLH>M!9#!XV-BF(\#'QVHF/BMAEF.RG2A"$#2$I
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MIQS2AU5&Q8>!>!^"G)"T?>BB*[[VQ6:\7/(R#NG(0I$_;PF/S\<XHZ!.CO(
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MA_<YO]Y-=E/@EYVSYD))1^ 5Q^+OCDU+;9[I!^\"JI[;=PK0-0[&PN+T&X
M6'0?"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@A7R7X<B\T[%5@6W$QMPP%
M&9A99".C]BDM+4I"R&G!^,)L24I-^EB'GIC=W>47 *YFQL%*RF,CM++OTZ\>
MQDF2 2B["I,=_0A1"B @I!_%IN:*T:VWY%>3.Z(;.YG,AD$)<8CR,C*BIB8Z
M&V4KLXMIEIE%PG4D61J43;51'I[Q;LN-QWLK [*A.J<C8:.(NMSJI:@"M:NG
MQ4HVOV'3J>M%9S1"@4"@4"@4"@4"@4"@4&A[B@\U?$?_ 'Q=W_Z1?Y<FBO2H
M41K0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#'-V[MQ>R\3/W'N"6F'@\<W[TN0I
M-PA MU-NIN5 4'G;RYY8[7WIS#L;>F(PLQ6#V/,2^%R76VG9B%64H!M(<#1!
M) ^9>H6/2]J"V' &X=L\W93+\SK=0[F(BU8'#8IN0LG%XL?K?US0(!D25K4I
MQRVDH;;2D!27"HJP2&D(_ +6O_'_ .Y1&^@4"ID=)(R?T##\K(R68T5L%:I#
MJDMMH:'4J65$!( [DFI2DYS(@QQ[*>0N<4 E['<)XUZYZJ8E;@DLGH0NP*(1
M!M9-E+[DBX">KIC7.?YB>*P$#&P(D%B)$C(C1&4!MB.VGVT-MIZ)0E*; !(Z
M #L*U3>9G,L9K$N?Z*+8I]H6/6W7O6'AA8B(<C;2&A9 L/O)_JUJUZJZXQ6&
M4S,\V^MJ% H% H% H% H%!HK\)J3R6$:;C_VG;0_N<W^\FNRGP2\[9\R$DH_
M *X_%WQR;ZJE H% H% H% H% H% H% H% H% H% H% H% H*I>:/)_(?%G[B
MYS8<A331?GN9AI;*GHCS3"6"VF1H 4$74OLM/?O08#QM^8-@)S*,?RAMTXJ>
M= 5/Q!+T5U:UJZJC/V6R$)"/^>=*K^G:@MAL[D38?(41.0V?G(N7:<0IU+;2
MM#X0A6@J<97H<2 HZ0I2?46H,MC$>]IMUM=1%K7MZGO?]%!]U H% H% H% H
M% H% H%!H>XH/-3Q'_WQMW_Z1?Y<FBO2L41K0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0<>I8O>Q%SU[=+T%9/.EC(O<&9!>,6Z@"=$5.#2K7B_.%ZOF%TW";I]?A
M0>6!9!)2G4VHI'R*ZDJ5W%^E^WPZ=K]*"^OY;C64;5R,M383!)PS:EJ2L:G&
M_KU?*;Z;V6-5OL_2%]TJO:_<];4&Z@VK-DD_"M=I6'52,PF#&>E3BW':CMN/
M/K<7H:0VTDJ4I2U6 2 .JJSK29$$%,OR)R2DN^_"X3@.Z'4_.Q)W$X@_.E=B
M%M1DJ!Z#YECU3?Y>OA2/>)^BXR#&BLQ8K"(T5EM+3$=I*4-MMI2 $)2D6"0!
M8)["N>98ON;2$H"1V'QZUA"MU4*!0*!0*!0*!0*!0*#17X34GDL(TW)_M.VC
M_<YO]Y-=E/@EYVSYD))1^ 5Q^+OCDWU5*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0=5FH<'(,.P\A':E1'4 .L2$!UE8OV6A8*5?8*"H7/W&'B$T)^2W+
MEXVV-T7=)3A7_?DJDED:$O0TAQ* -(L@>T+]U"_0J@LJ9&VSN!ESC;.9.2A.
MCVIC\-.,FJ="PH)]B/+F(6FX!3=SKZI%$>NOCOE-P9GB/:.3W8X^YN63#UY%
M4IOVG5+"UA.I.E-OETT$KT"@4"@4"@4"@4"@4"@4&A_$/TT'FKXC_P"^-N__
M $B_RY-%>E0HC6@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'RF9:]T= +GKWZ7Z7 _C
MM08=O'D[ [40(CNK(;ED(6O%[<AD+GRU=4H"&S8I05 I+J[('\ZBX8-#XWRG
M(\C%;RY>!$IMI3\#8T5PKQV.^I0 42G=+:I;U@DDZ&T(/R@+"=:L.NN<9XK$
M,#D^ O"LJ<Y-CS,S#:=+ONQ&Y+2T@.*"@E"ELDI">O?4?M^*;Q"86#X\X^VO
MQEMN/M3:,3Z7%1@#\RBMQQS2$J=<4?Q+5I%_3X "PIU&&5VMU[UFC1Q?MH*[
M7MU([=*QF<0.NG9F+CX;\Z<I$>''079#[JTH0TTD74MPJZ)2D=23Z5:UF50>
M6)_/V6'OI>@</07@0AU*FY&<4RHJ0M'5);B&POJNM?8I3<Z>VMHU1RX_893N
MQBXL5A,6*A,>,A(2VTRD(2A*>P2!T 'W5R3+'#ZDHLD))O86O6*MXZ"J% H%
M H% H% H% H% H-%?A-2>2PC3<G^T[:/]SF_WDUV4^"7G;/F0DE'X!7'XN^.
M3?54H% H% H% H% H% H% H% H% H% H% H% H%!47SF7RA)Q^S=O\;#)K_;
M3LZ/E8^+"]+B4A@LAY:;)0 2O2I2AZT$)<=^ O(F['T9GD_.1\*TZE+CL5MU
M63R5PLIT.E/Z@:DI[HD+(OU%^E!<'COQ>XBXU3[F&P;60R6E;8R>6")DH-K4
MA=K^VE'0H38AO4/C02[&AHC)2EM*4I3T2$#2 FU@ !TH/IH% H% H% H% H%
M H% H-#^(?IH/-7Q'_WQMW_Z1?Y<FBO2H41K0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#
M0D $GH!U)H.)$EIT7;)5UL;>GQO?X4$0;GY+GYK,Y?C_ (G;9R&\\>FV1RTT
M+:PN-64W*9#R0I2G?Y(;9;60KHO38V*R'9O$V)VQ+5N&>^O.[WDM:)^Y)_62
MX5=2AM/S!IH'HAM).E/RE2NY#EY'RN]\!A#-V#@&]R[BUH2<:Y*:A(*".JM;
MRD@_PUEKUZYMFTX8S,H*S'D-SCMK-XK;.=XUAPLYG%)1BHARS+OO*( L%MJ4
M@&]Q\RA7LZNPTWI-^OA'N3,IKXGW+RCN+]K_ .LG9[.U!&^F_999G1Y_U/N!
MTO7#"UE'MZ6_Q6OJZ=C7F;Z:ZS'1/5^Y82,ZXEI!6H$@>@ZFN:5?#/R4*)#>
MERWVXT9E!<=>D*#;2$(&HJ6I5@E( ZJ5T%8UK,RJ%&(^1YSRK;\CW8G$L1T+
M3'<UQG\ZMLBP=;_$F,A8"K*LI?0]+&N[A2/>B9XF(:@,LQH:$,Q&$I;980-*
M$-IZ!( L.U<MK#M:@4"@4"@4"@4"@4"@4"@4"@T5V-2>2PC3<?\ M.VA_<YO
M]Y-=E/@EYVSYD))1^ 5Q^+OCDWU5*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0?#-4G6$]2H"X 23W)ZW'P]:#DA#Y5F]S>W0ZD]+]1]]Z#ZJ!0*!0*!0*
M!0*!0*!0*!0*#0]Q0>:OB/\ [XV[_P#2+_+DT5Z5#^O1&M H% H% H% H% H
M% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H
M%!M4XVC\2@+=[T&TO-!.I2M*3ZJ!';IZT#WVOYP^(^X>M!K[S=KZNG3X^O:@
M>ZW:Y4!Z=>G>@ZW/;BP>W,1+S6>R,;%XJ(E/U$V:ZAAELNK#: I3A2 5+4E"
M0>ZB .IH(8F?OQS4)N*CIF;*XU1)2U^TUH+66SD-7RNI;:<"%QF'FR;.N#6;
MVT*ZV*E? [5QFV<:SB<'CFX./C(2EMAFQ!#7X05*.HFWJJ@R-M.AM"2+%*0+
M#J!841\4A*B\OV[:_P"5?TZ"U:.%[3$3QAERA63G%13SWP][AT6FD(!Z@ZG;
M "U[=NYKW^WB([:^9_;@F8F86>C%,=-W%?CL$D@DFU_A7@UMQF<\UEQ93)P8
M,!^=+D(8B1D+?DONJ]M#3+2=3CBU*L$I0/F42;"M\1EBAJ/#R_->0US$NPN*
M(B]<>$06G,VXDW;D**M*TQ1^)"5 %P];?+>NJ8C7'O693'#QHA):9CMI;C-6
M2AM-DA*$CH$VOVKEF6+L;&L5;JH4"@4"@4"@4"@4"@4"@4"@T/8U)Y+"--Q_
M[3MH?W.;_>3793X)>=L^9"24?@%<?B[XY-]52@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4%7?,KG'>W"D'9\G9ICA>7DRQ-,EH.ZFX@94$)N.FKW#U]+4$
MS<-[KR^^>.L%NW-QHT3(9>,)3L>$Y[["=;C@2$KNJYT!.H7NE5TGM09V2$@J
M40$CN3T%!HAQMR^A:56-CI(/7]%!NH% H% H% H% H% H% H-#W%!YJ>(_\
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M@AQ*D*N1;Y5)64G[#5@>UO$4''XWCG:L/%QF8D-&)B."/&0EII*WVDNK.E(
MNI:E*/VDUC*RS>L8YHUK(:7K#*M*V,752I4>/[STEQ+3;84I1=4$) 03UZ]
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MDJ[WN\SWZ41\_,^[-Q,^%O&*3-4X-S.(CY92^JW6XKCCZ 3]BV4$6MVHJ<_
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M-"776@0AM 4KHVWK7I[%6HDCT 1?Y#>&DKE+<2-\;&RD7"[J?<_Z61-#HC2
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M H% H% H%!H>XH/-3Q'_ -\;=_\ I%_ER:*]*Q1&M H% H% H% H% H% H%
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M5+99<E,ML1D..(0IQTNH6$(!(*E%(*M(ZVKU?3*6G=7@T;9PH0TV E%NR?\
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M_P (C/'N\>Q KT.U]1V]O$Q7&)]S"^NM_B8JOPUV.4%*MS;ATVMT=Q@[]/\
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MN>/ ;B1IZ9RTHCL9%"I+;;ZE >XVC6D!=@.OP%:M&VU9AL_5O95Z.NL],_\
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MIJ1UMJ-A>AEM#]Q>QM]U,PQRT]UM7HK^(5,PRRWH=01TO;[:9A6I>0GN?O\
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M-N/VKP=H9%;OP>?QJ!_];,53K.IU[63Y%?0EQ.$Q<<J_YJ5->*Q]_L1W4_\
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M H% H% H% H% H-CH!;(/Z/O]*"E7YBR"OCO:GM@I0UFE%U:0=*0N(ZD$V[
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M+=P?Z@=W =+1D&W46ZCMT-!$7Y=+UN.MV)5^$9I*;W)N?I6^@%N@H+L,C]6
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MZ0JQZWZ=+]/O-!R(<2YJ">Z>A_JT&^@4"@4"@^=4QE"E)5<:;W)L.W<]3VH
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M"5 K4@:62M2=?S 6-@M-XG\VR.8N/9DG<+[0W/MU8BY9T:M*F%HU,R%J4E"
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M58 D06:\2^:,QS+LK*.;C259W!R&XLR:$I0V^AYO4A8M;J E6J_>JBS- H%
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M]>:-ZI9Z%&&D]?OR$<&_P HB[7*/)&"XHVCDMY9U2S#@H*&66D:U.OJZH92
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M]>]%>AFT]RX+>&WX>X]M9!G*86<'#&G15AQE9:<4TX$J3T.E:%)/VBB.ZH%
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MR:8Z]0A8T%F,ML$]'/<0%"_H441>7&PHF-QT/'8^.W$@1&&X\6(RVEEIIEI
M0AM#: $I2E( "4BP'2@^J@4"@Q+D[8\'DC8V8V3DGW(T'+MI9>>9TE:0AQ+@
M(U CND4$><#^/6"X"C9J-@,M-R:,VJ.N3]:&4Z#&"PBQ:2G_ +HKO093RAQ?
MM?EC:<S:^Y6-3$A*C%E )+T9T]G6M8(!2>MCT-%5 ?\ R[)*=QI$?=B5;2+B
M4K#K6K)>R3U*+->T#;MTHBVW$G$&V.']MJP&VVU+>D$*GY!^RI$E]%P%K5;[
M3:@DY!NA)^('>@W4'RR^GS:M-QIOWMW]#TH*O\E^&&U>8-Y9'>6XMW9IF;)4
ME"(J%L/,1FT) #+(<2K0B]W-(]5F@Q+_ .IP\;M_,G>&;)[?@B'H>G_<Z"8^
M"?'S!<"1<]&P.7F91O..17'G)OM)4VJ(' DI+:4^CBJ"-^<?"O;7)F4R6[MK
MY X3=>267Y*9/SPGGE+05*6E*5+20D*MHM]O2@Y.#/#K;W%>;@[QW'D%YW<D
M9!$5L(283#_30ZVAQ 5J3UMJZ)[^E!;B@4"@CGFCB^/R]M$[-FY>;B(#S[;\
MI>.<#;CS;:5CV5@]%(45!1!]4B@K8G\N;CF1^/=V:24?*"$1 5"Y-U?JN_6@
M^_"_E]<?;9S>*W!$W5F)$G&3(\QIEU$4(4J,ZET V;O8Z?2@R_F+Q"VCS?O5
M6\<]N+)8^?\ 2M0C'A)8+8;8*U)O[B"?Y7QHK __ *F]QL.HWAF^G7JB)_WN
MB)LX'X#P' 4'+XS 9*;E&LN\U(>=FI;U)4PDH 3[:4^BC0370*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0:%*2;E()'8D4&@;; L$@#KT
M 'KWH-0E*?P@#[J#6@4"@4"@T*4DW(!([&@U  Z#I0:%"%7U)!N+&X]* E*4
MBR0 /@.E!K0*!0*!0*#:4()U%(*AV)'6@W=NU H% H% H-NA'4Z1<]^E!KI3
MUZ#KWH-"V@BQ2+6MV'84&H2E-]( OU-NE!K0*!0*!0;2VA0LI((^T"@:$"]D
MCK8GI\.@H-U H% H% H-NA'\T?#L.U #;8-PD ][V'K0-" 20D7/<VH&A Z!
M(M]U!J  + 6'V4&M H%!IH2#<)%SW-J#0-M@6"0!\ !0-"+WTB_>]J#=VH%
MH% H-" 18BX/<&@TT(O?2+CL;4&Z@VEMM7="3]X'WT H0;72#;MT^%!NL!VH
M% H! /?K0; TT.R$_#L*#7VT?S1_ *!H1WTC^"@U"$@ !(L.PM0:T"@4"@$
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M1>X^ Z=.E!S4"@4"@4'$7K*(T_*.FJ_K0:*?L/E3<GL";#^&QH-S+R7@5)[
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M%!;#KB?Q!?0J!HJHW$.].2\;G,CAN/$S<CNW<T+]D03&<6Y)9'U<>4XM*;D
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M36.P3./#$R0Z^S=<GV([:%K;0E("7%I*;J(2?Q4$X?E_\>[ZV&GD-.]-NY#
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MRZD+0M"QI4E23<$$&Q!H,$C\'\-1IJ9K/'FVVY*#[C;R</!"DN!04%)/L]%
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M9()H/NP^<@Y[&Q<OB74R<=,0EV-(3T2MM74*%!V23=()[D T&M H% H% H%
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MQ#*?<>R#SJ41D-&UEEQ5DZ>H^;M01ID/*3@?%Y8869O6#]>5! ]D/OL%:C8
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M]!)'[0&A"@THE=N@(Z:NUS_5M08!O'R XCV"\J+NG=,&'-0LM.Q6UJDO-N@
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M7'+>OMI5:@ZC9?.O%7(4CZ3:6YH4^85%#<0N%B2X4I4M7MLO!#B]*4E2BE)
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M.KX#YNYJ+# _$_@CB[E_*[QVUR&Z^G.;>+"H3,*:([KK0<>:DK]LI5J0VL-
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M9XM+!L/Y2KBB(OV>SR+XR^0.V.*7MQ_O!M'=<IOVXR7%AM3,]\QD.O(.HAQ
M3?2";'L2.M%9YSVK7YH\). E21'B7404]YTH@V/V&B+K_4,7T^XF]NUQ\+_U
M.M5,*Y.\![M'E+_KU$Z$K;0CB,,?=_ZTJ..^C*M(;*+:_FZK[5%622+)2/@
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M+JE:M&NUD$#Y*#)^"]@9CC+B[ ;#S;K,O)85#S3TF)[A8<+TAUX%!=2A70+
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M_8*(Q?>G(FW=@9':T'/JD!W=>8C8/$F.W[@,V6L(0'""FR;GYCUH,^H% H%
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M]300WS=XS;.YJ89FRY+N%W?# ^@S\1&M2+$$)=:UH]Q([BRTD&QOZ$(BVUX
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MX,X @\(S-U3(>:7EE;IE-3'DN1_I_94T7S8'W7-5_>^SM]M!,E H% H% H%
MH% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H% H%
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tm2225088d1-lc_treat4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_treat4clr.jpg
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M .L  0 " 04!               '" 8! @,$!0D! 0$  P$! 0$
M   ! @,$!08'"!   0(% P(#! 0$#PL&" (; 0(# !$$!08A$@<Q"$$B$U%A
M,A1Q@14)D4(C%J&Q4K+2,W/3E+255A<W&<'18G*")#1UM7880[-T)34V\.&2
M4V-$)CCQPH-4A-15A48YHI.CPT75)RCC9*5FI,1EMD=79Q$!  (! @,%! @$
M! 0$!P    $"$0,$(3$205$R$P5Q@;$S82)"@K(4-0;PD:%2P=%R%?&2(S3A
M8J)3XD.31!8'%__:  P# 0 "$0,1 #\ O] (! (! (! (! (! (! (! (! (
M! (! (! (! (! (! (! (! (! (! (! (! (! (! ;5%(&Y1 'M,!J"" 09@
MZS@-8! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! <>]&_
M8% +&NWQE <@Z" 0" 0" 0" 0'&A:5I2I!"A+XDZB Y!T@$ @$ @$ @$ @$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
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MFY/J,*0J1EJ)R@*!85F'=+R&JJ8PK+<TOM31)2:E%'>;BM325D[21Z^LY=3
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MG,HG$53'LWPB_P"8<ZV[-6:5=+C%D77U=?6,3:90JHIG66F&U$$%16\CR?J
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M':^W, @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
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M0^*^ X9=^0,MM>&X\6Q>[NZMFD]=9:;"TH*]5@$@$)5 2'RGVS<J\.6RDO\
ME--2N6BK>-,JMM[ZJE#*TC> _P"5"DA>NT@'X3J#*8>SVU\=</\ (V94MCY*
MR2LH;K4*6Y;K-3L-,4E4IA3;B4+KW75G\HA+J2T6$D_BNA4DJ#ZJ6*SVO'+6
MU8[-0-4-HHV_1IJ.G^!#8FK;]>O6"OC5S92NT'+N;T3Z_5=I;Q6MN+T)6I+Z
M@3T]HG!'VE8=0N2FUARE('I.)DI)!'4*20)0&RMK&6:=RI?5MIV4*6XHJ*0D
M)!.L@>@'6 \W'<KQ;*:%JOQF[TMU84TAX.,N)<< >2%I*T?$VH@CRJ (Z$"
MR9H[FTF4IB<OI@-5)"M>AEX0'Q^[F:%5U[GLQM*5;7*VZTU(VKVJ=:ITB?\
MY4!]4\,QFV4& V3&GJ.F5;V;53TE30^BCY=S\BD.;FY;2%$JW::SU@LOCKQ[
M;+??.:,4QRZTR*FRW/*+=;JVD5-*7*2HN#;3C4TD$!25$320?88(^M'-EEM+
M/ O(-"W1,_*4&*7@4;*D!:6O0M[Q;*=TY%! *3X'7K ?.;L?<4[W'8RVJ0_S
M>YC>  J2;>_+6 ][OTRNY7;FUW&E@-VS':&D8HVDK7L4JH:%27"DDI"PITH!
M ^$" N?VK<:X[A'#.+7&UTS1O^1VNDO%VNI1)YU=P1\XAM1F?*TEX-H"9#2<
MIS,!"OW@O'&/C&;3RC14K=+D:*]JTUKS3<EUC;[2ULJ=,]LV@R4I.V9!D3)*
M0 \_L9SV\-<5<GVEY"7DXB$WJUJ=6M9"ZNDJ 6M5:-H50A20C;YG%GQ@*K\'
M6BEY&YUQFU7W=\C=[NNIJF&MI2=H74E,G$K04J4A*5 IU3[]8#[$+MM Y;W+
M4JF:^S%LBE51K;1\L6%#86O3((V%/EVG24!\6>8L9M^%<F97BMI=<=MUKN+M
M/3+?(+Q:2=$K+:6TGKX)$!=WOJN%?;N!\$H*2H4W27:JI&J]N22'&VJ/UD))
M(G)*TA76"H*[3><>+^%&[[<,YME?59!7%INWU-$PAY;=.F96@E;K<BI<E3VD
MP1['=3W <0<W6"UO8K1W.ERVTO*6BJJZ.F;2ND>F2VXXAUQ:@DDJ2GH"290$
MW_=XWJMK^-+_ &FLJE.L6NZE%OIE=&6GVP^L(!UD7%J5]<%46OO]>EQ_WL?]
MW_X0,#M?;B"$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
M @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @.O4K5L6@ '0CKK,C324
M!\F^%D__ )XU"G4'\Z;H0KI+6KGIX]("6/O$\*I:2_X=G5*T\:N\-5=NN#Y\
MU.GY'T'*9'30J2X^KW[?= 0OV?XH<X[@<=;N-*JOMML15W:YDJ,THIJ=;;#A
M)(/EJ'&!]<![/?0CU.X6Z)^$FWVT"<]"6 -?PP'T([:%[. N/42F/L2EF??L
M@/F=SUQ-?^"N2ZA5O:=HK$Y4*JL2NZ25M^BDA2$;RD2=:!VK&WX@9::P%R.)
M.^;C?(K(S2\E/.XOD;+ 16U2VU/T%2\B22M@L!3B2L^8H4UM3TW*@(*[L^ZF
MT<LV]&!8$P\,9IJMQRYW.J2$?-NTZRVTIE )4EH@*6E3FU2@N2FT;=0E#L,X
MMR"SV>X<A9 A]JBKPNFQRD>4ZD>BVY^6?2CU @I6J:=4?B[@2# 8'W,<P=PO
M%W+ESH;??ZVV8C6.(K<;86W3JIG*-*4I<"%*0"9+!W)W;M1TTF%@\=[TN$*O
M"**ZWZ_.4F2-427*ZR*I715.5+*#N;3L"V1ZBDS1-X"2AN(U #Y^*H\AY]YI
MJ%VJF(N>771=04M("E,L+.]QSTRX!^3:2I:D[]?T8"YW?9AUY?X>Q=VV4ZZR
MBQNM;5=*E VI994Q\JAY2"2N7J+2/+.4X*CCLU[B\#X]QJ]X9R/=/LFC;J/M
M"TUA86XRK>0EULE@+7O4=I2"C;(&:IZ$C&N]#GK#^5JJQ6#!WC<[/9BNH=NI
M2IMIU]]"9H0AP)<V@#52DI\T_" M!V68+58_P/3)O3"VU9,MRO\ 06?*NAJT
M396DA1,EMJ"N@ZP&3_\ !GVZK\[F()*U:J)JJJ9)U/\ R@@,NP+A#C;B:HN%
M3@-E%J>N3:6JQ7KO.%:6]4@!Q2@)%1@/F-@A7_Q4H ,G!D]P"%'60#U1,2\8
M*^P*70$E0!E[^O66L$?$VQ(__+E;3X?G6P?J^TD_W8+VOIMWING_ (9LY(E/
M_JKH9]+Q13ZB"*H?=T$'E?)09I(L"M3U(^>II3ZP'TOV^^ X32)F"#+VZ#6
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M,@3,X"@7;SS9=^W_ #BI<NUO??L%0?E<CM2$*;JVT)) 6VA[8/4;5(['"@*
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ME%+3 ":2!(*F-9ZP5\M[XD_TXW)?7_VK?5(:Z&XJ@/MHTYZB=TI:D2/N@C?
M(! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M(! (! (! (! (! (! (! (! (! (#@?94Z"$D)W C=X@RD# 5MQ7LSQ/$^4V
M.5:2^U;UT9KZFYBC<;2&BY5>IN&X*G(>H?" D?F[A*S<Y8I28I?JUZWT]%<&
MKJS44H"E^JTR\QL\TO*0\3](@,2X/[5,4X.OUQR.S7*HN5SKZ0T!74A*0EA;
MK;RP )D34RCQ@/+YB[.<1YCS1_-;M>ZN@KZEEIAQIA"5HDPD(3*92>@@)IP/
M"V,"PRR870/%^CLE(W1,/N:+4EH2!4!I =?.N-,5Y'M#MBR^W,W"W+4'&]X
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M4/+.$U^$W&K<HJ.X>F7*AH K26G L2!^B PS@+MOL' +M_<L=T?N1R 4@?\
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M" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0&UQ12VI0Z@$B?2
MZ-3<VZ&G>K*]QNFHZ="G7GG%!+:6T"96I2B E('M@*ZY)WV<&8Y7KH4U-PO"
M4:*JK92A; 4.J9U#C"R1_B2]\!*?&_-F!<LT3]7@UV;KETP2:FE<0ME]KU)R
M"DJZRE(J22F<!(P,P#[8#6 0" 0&'\J7K+,;X\R'(,'8HZG)[52FMHZ>Y(==
MI7$4ZDN/I4AEQI9464N;-JQYY=1I 8?V[<RU',_'5+D]R9IZ;(&GG*2ZTE*E
M333;K1^)+3CKKB$D?#N49D& D^XW:GME&_7UKS5-1TR2NH??5M0VA/52B2-
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MEEO[O>3\&O=HM?<'QXSC%JO+BFV[_1.N!ME*$F:S3%527!N* 4^ND@3(W2E
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M=GRQAJCY"Q>L>H+U2L$J2MM"I(? V (FK<T4[E:HW3\VT$3N:C2802/;T^N
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M;<<4H!.ULN3(F("S;<@VB1)&T2)Z]/& W0" 0" 0" 0" 0" 0" 0" 0" 0"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
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M ;DSVS&[K+QE :P" 0" 0" T) ZD"?M@--Z/U0ZRZ^/L@-0I*I[2#(R,M9&
MU@$ @-N]'ZH?A]D!N!!$QJ# (! (! (! (! (! (! (! (! (! (! (! (!
M(! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
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M-)A+R.NFZ")2YH[C<<X35C:KS:JFLM>0K"364BD(^58!!4YL4/.0D[@D$3E
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MQ.-Q6(X3W1W+/-<:6<S6;C?-Q,R!D%Y'7Z*R/J>Q^/WW$7X8CA]#E:XXLZ'
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M'I)*MA*)[?-N)5YM8#'#SUA [P!S*6;E^:JJ,M);^35\_N3:_E#^0W:#?_\
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MH*-,YE7CNEK(GQGK =D   #H(! (! (! (! (! (! (! (! (! (! (! (!
M(! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
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MIZOJ&J9"E@3*07%)!(@/#/,7$X&N<V"8T(^U:*?_ #NOU0&5T]RHZIAFII7
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M5VIJ=00^]05+-4VVL@*DI32U &1@/:!F >DX#6 0" 0" 0" 0" 0" 0" 0"
M0" 0" 0" 0" 0" 0" 0&U2TH^(R'M@F0+2KH9_5!6A<0!K/\!@KA<J&E)6$K
M\P!\#_=C"T\$K.901G*LLS;)ZBFPJK(IL,0*X^B6I55Y;FMFD*EK2 A0&Q9/
ME2>L<TQ,SP>WH^5I5SJ=OMY)>QG)[3DUFH[[;GMU)5M[T:*"A[E)4 I)]H4
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M;*JX4.Y)2LLU=+ZJ=P\#M5!%;NW?C2R\K=H5JQ&\,I<%8JX*:?4D;F:AJX5
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ME;)23$P)GT_[OC!4JA#F])6@^$Y R!/LTZ>V"*5=J.G=7SV3H/M.\"9_UVN
MY_O"Z:M=IN-JAA"U4;5RK$U2D@[05JI-@5+3J#*<!=-1V) 6J2E*D#TGJ3(0
M%6>!'Z:X\U]RC]H<2IEVILS;'I$%/J(IZ]"I;="0N<Y>,%=SL8=:'&F4,+4/
MF$99<RX#HJ12R!/ZPJ".CW^L5%=Q5B%);U?Y_49G;6J52-5!Q=%7A)$M?BE
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MUD]!45*UTMNO*V:)IQ?PMK:2XL!).DU*4H_3 6^<0YM4MM.^226R.GX!J=!
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M:60J M2W/8)F9UU^N \;*;8F^62YV%;RF$72C>HU.I 4I*7T*:4H Z$@*@/
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M,+GN&V76 GC'++;L:QZTXY:$%NTVBBI[?0()W%-/2M):;$_&24B"/3@$ @$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @-" H%*@"DZ$'4$0&T--A
M6\(2%@2"@!.7LG ;X! (! (! (! (! (#8IEE0(4VDA7Q32#/Z8#7TT?J1UG
MT'4P&X"6@Z0" 0" V!ED2DVD2Z2 \(#7TV]/(-.F@T@&Q'7:)CII ;H! (!
M(! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M(! (! (! (! (! (! (! :*) F.OO@. O*&XST$!Q+J74S4""D:*3X@^V?\
MXH#D#RU"6\#2>X"0G]<X#;\PZ0=0%IF#+5.GC+0B<!I\RHI"MTDD [M!('IU
M@- ^Z$+"E?E!J!(#0Z^P].G2 W?,D@*W  @S!&LQUD?= :)?=5*2AKT&BNHT
M)T&D!O#RC(*5+66HUG*<_H@-4O$N^F5">GE\90'8@$ @$ @$ @-%&229R]\!
MQ[S^K!^J)F%S#<5&6ABY26W?_A_H1D8ER Z=9QKF1J(L!%" 0" 0" 0" 0"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
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MN.DE HF); #,SGH?HA+IT-:9U(PO_0\/X4_2MO/42BZZE*U*54U )*@"29+
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M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$!0S[
MR/\ T'"?W=_]; 6SX)_J0XT_W4L7^SF("0(! (! (! (! (! (! (! (! (!
M (! (! (! (! (! (! (! (#I.,E:5H4F86)*!3/K 0[AG#]YX^Y6RC)L:?I
MT\?9:1<*ZPN^JVY2W5(/J.4Z&T%HI<5JI2U!7@!H"2IL9GZ29@@G61T.NL$;
MX! (! (! ("/^4N,[3RIBESQ"])4FDKE(6U4;0M=.\B6UYJ<I$2/3VF @NU\
M0]WF,V!&'V#D.PN8W1-NT5M?K6JERY)I%%7IA3WRZE!2$F2=JI($@DR @J2^
M ^"VN%K5<_F[BY?,HR-YNNOUV6DS4^VV!Z:%'S*0%K<*5+ )GT$$3(P%"85/
M=H=Q$O; <L!L=!4@@3GH=/<9P$,\\<(-\RXM3V9NL=M-]M3ZKA8;DT2&FZM"
M2$!V0)"3/J!Y>HF=("-*_B;N_OEB3BEYY"L3-D="6:BIH&ZENN]('4A[Y<+)
M/^$=?& FKB;BJT<1X?287C_JNTE+N6]6O!(<J*AW5QQ0'P@F92D3VC2>D!CN
M*<27ZFY=R?E?,JJGN-95J%!B5*P''$VZU--^FF:GDI*'7=5NAN:=Y)GK!4T,
M@I:2")'4D'WF<$<D @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @
M$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @
M$ @$ @$ @$ @*&?>1_Z#A'[N_P#K8"V?!/\ 4AQI_NI8O]G,0$@0" 0" 0"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
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MML3.U/C <^+9%39;CEIR>VE?V9>:.GN-$5^599JV4O(W#P.U0@/>3\(\=!K
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MM=544CA;J&'TD*4PM!*=X2=OP^Z QBD[7>Y1EQBM:[@[T2DI<0V]571]((U
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MB@H[2I1T@/)[)N)L$I..[%RG3VTISJO9K*6IN9J:E06R7=NWT%.ED? -0W.
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M!V^_&I76=N5CK'6OEWJB]VQYQC7\FMRDJ5E.OL)E 67XU_J^Q7_5%O\ XHU
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M@+5MLM&A;24^4MIF$DCJGW=("I?W@=JHZKA^@N+U3Z59;;JTNCII_MY=26E
M@SGM0HJ@)$YKN.!W_@6HK.8!4T5@K:9AVK;HB&ZY%25 H2PE?E+P5\ 6DHG\
M0@*YX5R-W@6CC"GMV+8G1W7$K;1HH[%=*^VU#-U=M2&@FF<;;IJEMHA#(3(J
M23^J*NL%25V25.)JQC(/LVLK*WD:HK55F;.71IIM::QTG1D(_*%H?"LK4"70
MI4@#M!%NF%%325'J9_IP') (! (! (! (! (! (! (#B73H6")E.X241U.DH
M#Y]=T'=KGU+R'7\;<2U8M[%DJ/DJJX4K:GJZHKFE%+[:0X-B4H6"UM]-1.W<
M%2,@&%<==Z/+."*KJ#DQIZ_-5C;KU#\^TNEJVW0C:VE"@E*2T5:JFT3IHK70
M,,1BG=IRL@9_2,7VMM]X6X_35#%9\LP$H6IH^FTIY)0E)1)/EF1+4]8*E[M*
MY[Y L7)0X9Y(J*FO8K5KIJ7Y\K=JZ2MITK44A:E3*%B<RJ?02\8(^A%. Z53
M'ID&9"5;A,'VGZN@@.REL).Z9)G/6 WP" 0" 0" 0" 0" 0'":=LF9)D-0#(
MB<YSU@*(?>0-I10X3+4>L^)&73:=("VO!/\ 4AQK[\5L9_#;F# 2! :%()!]
MG]V V*903/QZ=?[D28,.%QK8"L3T(Z>\RC#I(CBA_)+_ &G%>5::XWM:Z>W?
M8S["7D-/5'Y1=33J DTVH] ?&.>\8ER3&-1[AYFXX" D71[^ UW[S&5+0Z+3
MB&&<C\HX3D>!Y':;56.U5QJZ)UIJG%%6@*4I/0J<80(7Y-=N,)OH&!Z#2IDS
M0DSZ3F!&RD-E8P[:Z=*EE6L9S'%EAO::2T"$]"9_^$HL$0Y(JD48_G5VKK!A
M617VV,HJ+E:[;65U'3N)6M#C],PMUM"DMJ0HA2D@$)4# 47[=<+XAY8LE7GO
M/%]^V<OJZRJI7+5>KI\O2L- I*%-)2IEQ*C)23-TI(TE.4%>97W?B>U=U?'.
M/\7V]FBL5FK&;<_44NYU%75U3X4I0=<*EKV*7L*MZAIY=)0&:=R(/_&/PJE)
M\H-K,B=5'[5>UG*")W[J@TGM\SS9I*WIU2=QDEYH"<_=*"L"[=7B.RFBD E/
MV/DZ"DR.IKKA*1G_ '(([W9)EV.U_!]EQZBN3#E^MCM6S5V]2TIJ$J"PZ9-D
MA13M<1YP)3F/" BCL@L-ORBN[@,>N6_[/NSU#0U1:5)8;J%W9M90HID" =-#
M 2B]V$\&)(<]2\ST"0:FF\I$]1_FL^L!C'?!1HH,7XOME.5>A2Y)3,I)EJAM
MD@ ZI!Z:P5;.RA)LUM;5\)IF/*)2'D3!'IBF:\9GIH3II 5#[Q+I36S->'+M
M=7$TMOH[\'GGE3.QMLI4HJ F=![("8:ONAX+H*;YRIS.D12@RW!BJ601IT2T
M5?H0%9>4<OH>[/FS!\.X\*ZC"L5<%QN&0^@ZT%NN+;6\$>IY5)0E+.T*2E6X
MKZB1@J1/O 5%?!% @R0!D=")@23_ */52\3H!I!&>8/W%\-VO#<>M=9EE*S7
MTELHJ=]E;=02AUJF2E0)2V1^*>A@),PCDW".1/G/S.O#5U%#L^:+*'4!OU)[
M9EQ*>LC 96\X6FRL"9FD '_"4![_ &P%3^PU?I\>Y V="J^5!EU,BI1$!;2
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MS+20M76 S+M(IG;^GD/EVZK5]L9I>@TL(0$TAH[0E3=.ZR#-<U^LX%S61Y=
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MI/O;5;5_E%I54>83\^NLX(N"Q+TDR$AT ]P@.2 0" 0" 0" 0" 0" 0" 0"
M^6#N84?"7>#E&19O8GGK>C(;M6AD>BMP4]TJEO4]4@*TF$+2ZV"I/AT,!<'G
M'M^LW=#8\1R"QY0W9*!EARMHK@+8:Q=91W%#;C/Q/TJT) &]*5?JSH("3':B
MP\,\9T2LDK]UHQ:U4U'5W-+*D^HBD92R%>FE2R@K*1^,9$ZF ^<V,5U+S?WA
M-Y#BZ:VGL5PN7S**C:E-4S3TU-LWJVJ6D!2DR^+4'ZH*^J-*A"3-/0!03+I(
MD$_HP1VH! (! (! (! (! (! ("AGWD?^@X1^[O_ *V MGP3_4AQI_NK8O\
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M (! (! (! (! (! (#8IU"5;2?-[)B<O;U@-BJEM(),Y#K&$R9;#5-DB1_\
M#ZHQSE,N1MT+,HRJ9<L9J0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
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M4SBM\RE: 4D@=(#'>]ZHP;'.'18$L4-'>:ZHIF;53(80EX-MKW.%( !2 A)
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MB9QAO(U*ZW2UEXO5P10%;C#BT5+KE93*WHEY5-N-JD>H,!=-CM1X"+83^8]
MK9Y05(F9#Z3^& ]6P]NW#N'WFCR+'L2H:"\42BNDJVV_.VLI*9B7^"50$I,_
M'J)^7RJZ:::2@.1[=Z2MLPK24OI@(?YYYMLG!^'/W^L0FHNU2%-V6W[E)%14
MD2DHIU"4SW*]P@*)\8\3<A]U^9N9YFU<^WBJ'Q\W<5ZI*4K"A2TZ1*1D9!*!
M)/N@+O\ -]AH[#V\YI8;'2"DM]'8JAFCI&$@!#83HV/I@JIWW;AGGF9-GPM#
M?\9;@C$^]N_HN_<DJUA,C8$6VC6KV^NTS5#_ )Z S?[QO':AC)\/R<JG3UM
MY;6D>*7*)]Q]:OHE5)$!;*Q5%/6=L=&\PL+:_,I+:U#Q6S:]BA]2DF IM]W)
M9*Y[E#*LB;:/V;18^J@J'?!-175M.ZTGZTTKA^J PCM6,N\6QD?_ $1R'_9U
M? 3+]Y%<4I_,FT?CK%34_4@I3_\ &@+4]LW]0''7^I*7]9 4S_LW>1/YY6;_
M .UU?[" AOGGMMOO E-:GK_>Z2[.75:T,"C2\D)](>/J >R ^HW!$_Z$.-0>
MHQ:R#\%O9@)!@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @-/
M$Q)&/9S_ -T+[_JZL_YE4:9Y);DZW'/_ '.LW_0:7_FDQEI\FK2Y,KC:W$ @
M$ @$ @$ @$ @$ @$ @$ @$ @$ @$!#?YL<Z_SLHOX,C]A'9U4[GB^5N?[FTX
MUSJ!_P!ZZ+^#(_80ZJ=QY6Y_N:\?9!F*<QR'$\NN#=PJ;4W2K#S* VD_-(]0
M:) Z RC/4I'1$PQVNM>-6U+3GIQ_5+:%[D@#H)?I1YT\WM9R["?$1DS;H(0"
M 0" 0" 0" 0" 0" Z3J#O5(R45%23,^ Z*_N0'RMYRXQ[@\MY:RNZC',IOMM
MI;U<F\>K/1K*IINVBM>73HI5D$(:2%30$>43T@//^S.^%6J7>2I_C;:R\RGU
M_P#.>R DC@*W]V#7+^*KY!7G2\1%4O[2^VZFZ.4'I^@Y+U4OK+9&Z7Q" ^CM
M-(+(2)"4C+I,>S\,!RU!"6E$]!+QEXCQ@/F+W3X1SQR5RY>*VGPN^7/';8ZJ
MALAIJ.K?HS3MI"?4:GN3-WJHHEKK 8+;L5[R;-1,6JSTO(%MME* U3T=$Y=:
M:F0V.H"&U) $O= 7)[.*/F!FPY4SS"K(%UQJ:8VTY.NJ?>#1:47/2^;*C\4I
MR@JOERX)[A^V[/*Z^\/TU9=;76.5%/0U=K97<'5T*_,ANJIBE:-R!(!2T?&)
MI]L$9)P5V]\KYURFWS)S,R_0/,58KG6+HVXBJK:I +;:"RXF26T)0E 3( (
M">D!9+N8X.:YNPEJWTKH8RJS*54V1UPS!4XD)<:<!!T7L3-7^"("E*K1W;LX
M,[PB<9NRL$*S0NL(M*5,235>O-%6&=X;]22YA<I3\# 7"[4N"ZGA'#*\7I*$
MY;D#R'+QZ3@<:0U2%8I4 RVS3ZKJII\%:](*@SG_ +=.5L;Y+J>:^'TU-PJ7
MG_M!YFW:W.GK7G TI+3+8"G&E)<\XU&S=N@,%I.%>X[N0SZWUW+U-<;9:Z/:
MW6UERIUT#35&"%+31TX0ELN.;=IV)U40I72<$?2.R6MBSVRDMM*-M/1M-L)
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M-*$@^T " U#;:=4I ^@ 0&Z H9]Y'_H.$?NU1^M@+9\$_P!2'&G^ZEB_V<Q
M2! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M(! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! 1=S7-.-)4DR/
MSU+J-.J@/THY=2.+3>,LX-,T$I!0$I0G:@A(\HZ2E[(RBN66&_Y5"P%;9STW
M$"9$B(SB,)-<L)XI;D]FO^#DU>D?0&::,J%:X26.D;);(:Q%(! (! (! (!
M(! (! (! (! (! (#1/2+*0V.]#"$LB3$_ZXL^_<K7_%D1VW^37W_%\]L?U#
M6^Y^%*ROB_R8X*<O>^D^TY&?AC(GFY8B$ @$ @$ @$ @$ @$ @.F]-+BE"1
MF5>)&D!\V\<QK%L;[T\LH^6J.F%LN-UNM?;UW$(^S5FY+764V\.IVKFEU &H
M2%3G. NBQ:NVHM^>@P4$$C5JT*T&DYD#K =ZU6W@9FZTCV,4F)(OK:RJC5:6
MK:FMW;2#Z98DN<B>GA XI(I0E)($YD=3UEX3_# =F 0" 0" 0" 0" 0" 0"
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M^[U'ZV MGP3_ %(<:?[J6+_9S$!($ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
M@$ @$ @$ @$ @$!A')&/-Y/8ZBVJN"[46BBK-<A"7%-AJ9F LA)\9QHU*Y:[
MQF$48M@V8Y15.Y>O,:EHA;M%:7/EVUE5 VK1PI)DE2U[CIU2$QS5I,RX^BTS
MG+,?Z/L[3,JS^J"3/I1,B4Q+21CIB)ALZ+=[*,!PY[$:6O9J;B[=*NXUCMQJ
M*IY"4'U7DMH4 $^'Y,$?7K&VK;2DQS9H!*,F]K (! (! (! (! (! (! (!
M(! (! (#1/2+*0V.](0ED1XI_7%GP_\ 16O^*HCMO\FOO^+Y[8_J&M]S\*5S
M\0_Q8X*<I]KZ3[3D9^&,I2>;EB! (! (! (! (! (! (#HOK"5*T(,R"H=$S
M\5:P'R_R7EK'>&>Z;*<UPRBK+I3MW.X4M_L]P#5(H5RGG&:OY=Y*JC>A3@<>
M0I2&SY]I3Y=Q"Q;?WBG":$)2[8,J4N6I326U0F-.OV@/TH#)<![V>*>3LQM&
M$8_9<@I[O=WE,4[MPIJ%JG20VISS*:K75_B>"# 65IR"L@B2MOMF#]&@@.S
M(! (! (! (! (! (#@^:2)E8V@2))\![X"B/WCZM]!A<QMVO5!D=?Q=.GM@+
M:\$F?"'&ONQ:R#37I;V! 2! (! (! (! (! (! (! (! (! (! (! (! (!
M(! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
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MU  Z_5 8QB^>89G-"FY8E>Z2[T[S:7BBG<274)=2%)2\TJ2VUR(&QQ*5#H1
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M4Z[?EWWI'Z90'UGX($N$.-1_^ZUD_P!GL0$@0" 0" 0" 0" 0" 0" 0" 0"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
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MBN\44;JWFOJ4XA!_0C<X=3ISP>O([O=!I;HH0" 0" 0" 0" 0" 0" 0" 0"
M0" 0&B>D64AL=Z0A+(CQ/^N+/OW*U_Q9$=M_DU]_Q?/;']0UON?A2N?B_P F
M."G*?:^D^TY&?AC*4GFY8@0" 0" 0" 0" 0" 0" ZKB#N42E1!\-2)?0(#I5
M=IH+B$IN=&S4I1^U^NVAR4^NW<"1 =16*XTD$?8M'/0@_+L F0U!\L!VZ*V4
MU&%"WL-4M.=?2IT!M.Z74A  G >@RA25[B))*0/9KXP'/ (! (! (! (! (!
M (! 4,^\C_T'"/W>H_6P%L^"?ZD.-/\ =6Q?[.8@) @$ @$ @$ @$ @$ @$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
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M$ @$ @$ @*&?>1_Z#A/[N_\ K8"V?!/]2'&G^ZEB_P!G,0$@0" 0" 0" 0"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0$/Y'1HSK-*'%ULERRV-3=UO+NQ):=
MJ4G<Q3*,IA4CZBDSU2J.>TY:(XREFG1M;3/4R$_#PC.C?AN=_:U1NA+\F-9?
M_P!S;]_T"J_YA4:]3E+HT_F4]L?%IQK_ -P\?_Z$S^L$*NGU#Y]F5QF\\@$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @-$](LI#8[TA"61'BG]<6??N-K_BJ([;_
M ":^_P"+Y[8_]_K?<_"E<_$/\6."G*?:^D^TY&?AC*4GFY8@0" 0" 0" 0"
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M@GX0&?P" H9]Y'_H.$_N[_ZV MGP3_4AQI_NI8O]G,0$@0" 0" 0" 0" 0"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
M0" 0" 0" 0" 0" 0" 0" 0" 0&U9 29^SI 8CF&44^(8Y69!6-%\4K8*:=O5
MUYTF26T#Q4HZ"-4L)EYV!X]66*R^I>%A_(KHZ:Z]5!\:Q\!2VTJ_\VV?R;7Z
ME  C"L-=*XAGK,O20 )"0D!TZ1O;H;7?VI<907Y,<R[_ +FW[_H%5_S"HUZG
M)OT_F4]L?%MXT_[AV#_H3/ZP0JZO4/GV97&;SR 0" 0" 0" 0" 0" 0" 0"
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M-^4E/XM("3/N^>1+A?,<R;CRXU(<8Q_Y>NLK;CCKCJ6*U3B:A(W*(#3:VVU
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M=?O^@5?_ #"HPU.4NBGS*>V/BV\:_P#</'_^A,?K!"KI]0^?9E<9O/(! (!
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MZQ;F! 2! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
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M !5$=M_DU]_Q?/;']0UON?A2N?B_R8X*<I]KZ3[3D9^&,B>;EB(0" 0" 0"
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M_P FOO\ B^>V/ZAK?<_"E<_%]4<%.4^U])]IR,_#&4I/-RQ @$ @$ @$ @$
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MH/K$W'4_DU EAH+J-JI!6S;N$YQIO];ZK7,YX/8Q/&:;%[-0VFEU;ID(2I9
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M %L!;/@G^I#C3_=6Q?[.8@) @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
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MSWN'\I1E>*M/J=2]5V]1MU8I*@X%.TP3YPL$A6]*DJ^DQLK+CW%8BR0HR<I
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M?>1_Z#A/[N_^M@+9\$_U(<:?[JV+_9S$!($ @$ @$ @$ @$ @$ @$ @$ @$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
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MA@R*:5L_^;;]G12IK,R9QLB&6OJ1/".20T)D-QC;,N"(XN1)FD&,6<M8(0"
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M+SHQ]7G*7DTC 04[?*9$@DGI]<;8>?>>KF[$9,6A2%=8F  "1(=(HU@$ @$
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M?A$B!],XW1'!YT\H;G2FF;WIU/P@J]_AI[XO):QE&-\O5?G.3/<?6NG(QRG
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M\M\XNF8=L_=;?<XJ[:FX4MRN5?=6&P5-HJZ&\+4^XVRX4KDM'JJ:WE$MR3I
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MHF4RI1*B=29DP1Z/R")B2B F6WK,2F/$R\?9 <C%(W3J*D=53)^DRG^E <\
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MG38XSA2*]M5I=<74FX,ML AT:;-CKDY>,Y0'T+X),^$.-/\ =6Q_H6YB D"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
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M3-&X>8=("X_;[05EAX2P2SW=E5+<J&STS553KU*%AN9$Q,'0^!@J*?\ @ X
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MO<+B[+YBNK'E*=J'W2HSW.+6I6ITZ1496R@MMI00 1X#I ;X! (! (! 0YW
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MB_V<Q 2! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M(! (! (! (! (! (! (! (! (#28]L!C5UY PBR5[UMNV2VJ@N#&WUJ2JKJ9
MAY&](6G<AQP*$TJ!$QT,83.&,VB'0'*_'!)'YX6/^4J3QG+_ )7W1AYD,?,C
MO=^U<A8+>JMN@M63VFNKG3M9I:6OIGG5D:D)0APJ) ]@C/+.)R[>2WRVV2TO
MW*XOAJF8*=Q3YEE14$I2E(U)4HA( U,XQGB6G#"K3CUQR>[4^29:TI++*BJT
MV%?G13S.CKX$PIV0F#^+$K7CEJC,RD-IH@MR2H!"I)!T'LU^KI&YMAW2)P5L
M2 !(""XP;T#RE0W=)3\8)*,N9,N8Q+&'UAWT[I<W$VZVD$A7KU"#J"G4$(2H
MI5^J 'C&G4U,3AW[/;S>V>QXW'^"OO4%KN%\2Y\G;$;;/:WT^<%8W+JZI!F?
MF75+4I0_$GKJ5 8].71N=3IG$.;+&G<-S2VYE2-NBUWE2+/D*4E90B2D*I*G
M8V)#:LK:*U?^=D.L6*=+7IYU:XGLY)5I/.=W7RS.FGFE*1/T1MB'!>,.X#X1
MFU9;HBD @$ @$ @$!H2$B:C(>T^^ V%U!2K:H*(F) CJ/" C?.LT%AKJ'#\>
M0Q5YUD*5BSV]X_DFD-:KJ*L)FI##:05%4IJD0F:M(BN]@?'U'A=$]+U*^_7-
MQ55>[W4@&IJJIW5:YC5*)Z(;_$3(>$5&>-IVMH3*4D@2'02$!N@$ @$ @$ @
M(<[@?^Y['^L*7],QU;=Y7J/+WPD=H/*I)4^CR6PILJ)2@J(_&EKX1S7\3T-'
MP*P4'>3:,=;S2V<LVQ5ERK&;A\K;[,PA;;M92NM@T[J$5!2X=X"G"N6S:I!'
MQ"$ME>2S."9(QF&(V?**2G>I:6[4K56S3U""VXA+J J1!\/8>A&HT(B*R(P$
M8<]_U9WG_&I/XVU&_;<W#O/"SC'/^RJ3]P9_6"-6IXG1I>%Z\8MQ :)Z192&
MQWH80ED28G_7%GW[E:_XLB.V_P FOO\ B^>V/ZAK?<_"E4_%]4<%.4^U])]I
MS,](R)YN2(A (! (! (! (! (! (#JNJD3+S*$Y)'4B<!#=D[:.*K/EMWSE^
MRM77*+W<:R[U%76S>2T_5U3M0%-)42$2#FSR]93@)GI=@:D@22"=![]9_7U@
M.> 0" 0" 0" 0" 0" 0" 0" H9]Y'_H.$_N[_P"M@+9\$_U(<:?[J6+_ &<Q
M 2! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M (! (! (! (! (! (! (#A4HZD&2C.0/^">L!@-]Y3XXM=:_;[GD5#37%@A+
M].ZX$N).T$3!]H,XTZDQ'-IO:(YH_H^4^.AR!=[@K(Z%- ]:;73LOEY)076J
MFXK<2/>$N()^D1PQ>.IQQJTZYX]C)[CS5QHW2*<H+]27.K'^C4-*X'GW'C)M
M"$($_,2N4=LS&'1;5BO:YL7LU_O5>QEV8)+=<GS6NSH5-JA2M*FTK6D:./%*
MR)J^!.X#J8M6=)RD:E]-+B=H&Z1 EIH.I'NG&W#HBG:]&*C8I7@(L0QF6NY(
MTAA<L>OUWI+)35%PN3XIJ*G!4XZKRI&\Z 'WS_#I$=&E3J1O4X&OD:KH\FRA
M530-4NX6"BIG5TSS"52!=6M)20XZ$A6T?"G:.L<UJYL]33W,:.:Q#WZ7B^F2
MTD?G'?\ :/*C_K:LT TE^V:RC*')K;B+3RAPW;A^SW6E5076\WRMH'2/4IW[
MG5NH)29I)2I9&ABS.2NOCE#/+10LVRG8HJ8$4S#*6FYJ*IAL!(G/4F0ZQLJX
MKWZIXO5 \8S:VL12 0" 0" 0" XWTA3*TD3!$B!X@^$!'W).;5V'VYBEL-N^
MV\NO2U4>/68'9ZU46U*!<5T#+:05NJ)$D DD=8*\KB?C*KPD7&]Y/<_MWDF^
M%+N1W\)VMKV_M;++9D&VFT@)0@ : :0$M00@$ @$ @$ @$!#G<#_ -SV?]84
MOZ9CJV[RO4>7OAV>5^++/S%A/YIWRM716U%2Q6O/-)2LGY<$ 2)3("9$XYK^
M)Z&AX%&\"X9R6^Y%F7*7$%-3"DPVZBTV&TW,-7%54Y;6F?F"A51O*5KFE;:I
M:;BE)F (2V5Y/I!A59?+ABMJN&2TJ*"_5=,W47"A;"PEAYU(46I.>::)[3/Q
MB*]XP$8<]_U97G_&I/XVU&_;<W#O/"SG'/\ LFC_ '!K]8(U:GB=&EX7K1BW
M$!HGI%E(;'>D(2R),3_KBS[]RM?\61';?Y-??\7SVQ_4-;[GX4J_C?5'!3E[
MWT?VG*S\,9+/-RQ$(! (! (! (! (! (! =1YL+42M,TI.Y,_P!6DZ& P6V<
MK\=Y!D-7B5KR6C=RFDJ'J.JM0>0*M#M*XIIP;.HDI"M(*S^GF4J,YC=IKX
M?5!'- (! (! (! (! (! (! (! 4,^\C_P!!PG]W?_6P%L^"?ZD.-/\ =6Q?
M[.8@) @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
M@$ @$ @$ @$ @$ @$ @$ @-J.D2!P5/3\,8V2R,N(EA(S('^<53_ !6EC526
MFD\V2YOE]JQ"UFX5X4^^LI:I*%F2JBH=62$H;3U,SU]@UC.W)G,H:?QW(W<L
MPO-<T?6J^5E]324=I96KY6W4BZ&J<*$I)/Y1?IH+JO':F?02X\3GBY)K/7$R
ML6R9IT$O+K[?='=IN^W)S!.Y$C&UC$9AN  $A&+*.#56B9"+"2QZY7FCM-#4
M7"Y/(:I6-X6M1T(3[B>OM]\29;J:<Q+#K/::_-+FQEN0H6U969N6"QN3#8"T
M_P"DU;9\JG5?$V#H@:IDHJ)US&73.I%8Q"3Z9(0PA*=1+3Z]8RKR<=IS+EC)
MB0" 0" 0" 0" 0" XGY[1( F8T/3ZX"/>2.3+-QO9A<ZMI=RNE2KY>RV.E(7
M6W"M=(0VPRWJ=Q4H35+1,X#K\<XY>F7U9IF9;=SF\H;;K%A,Q14FBTT-+/5#
M:52+@GYU#<J:A."I/@A (! (! (! (! 0YW _P#=!G_6%+^F8ZM!Y7J/+WPD
MVC!-.E2M)) D?AZ:$1SW\3T-&?J,/PWE?$,WI;X_9ZXMTN-W%ZU71RH*60V[
M3)05'<%?!YP-Q\=/")+9')G=N?;JJ5%4TXEYE_\ *-.H)4A2% %)29G0B(KM
MQ)$8<]_U97KZ:3^--1T;;FX=YX6<8Y_V72?N#/ZR-6IXG1I>%Z\8MQ :)Z19
M2&QWH80ED1XG_7%GW[E:_P"*HCMO\FOO^+Y[8_J&M]S\*5OQOJC@KRGVOI/M
M.5GX8RE)YN6($ @$ @$ @$ @$ @$ @.D\I6Y1$R02) ^ \-?; ?+ZIRO$^&^
M[V_9;>:NFR?'U7JZ/5!HV_471NUM0ZMU!;=22':=U2T=?,4[@9&"KFX]WC\
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M;;0CXB3U@/GQWY<B8AG-#B:<8O--=UT;KYJ#2$D("DG:3/6 N[P3_4CQL)S
MQ:R $>P6]F4!($ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
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MV%)Q/'J%MVGHZ5A\256.LNN.J54NH,DE3A"$$R'FT(GH-H!"I>8=#U,!N@$
M@$!U'WW$K4ALC<.D^@,@=1U,1)LCJN>YN^:J%45=CB+?O7\L':*L4[Z>FW>1
M5 3Z]!&%IF(X-%IU.QX5AR7F^_U=YI*:MQM*K-6F@>4:"L\R_1;=F/\ ._\
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M$.-0#.6+603^BWLP$@P" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
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M[ZEBL+Z2EVK=;U3558T&R8W(:UF?BT$E<^.J79:T:=<1S3*S1ML ): 2D2
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M82"5*WKFI3BI;@E/E3(S*L)3GS]):$ ^) E[/I@.U (! (! (! (! (! (!
M4,^\C_T'"?W=_P#6P%L^"?ZD.-/]U;%_LYB D" 0" 0" 0" 0" 0" 0" 0"
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M:V!;E7<TJ4 $Z$A"03[HY9QEW^=;H][*7K)A6,LJO+ENH;:*1*U&N;8:0IM
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MU945J4\ZKSK)))\QT\)#2"9=^ZXG8K^&1?;717(4P4FG^;8;J/3"Y;BGU4J
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M*5:[(CSL4#$I)W),PIXA1"E> \9]-<5F9S+&*S,Y252TR*=Q(;04I$Q+P$_
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ME_A&&5Q'>WI4D"1U]YC#JXLN3<@CPC.8,Y;AU,80-8R" 0" 0" 0" 0" 0"
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M>K(<J'5"1(F1)#<QHRW)M/1*0(V5HXHJSQ@'TTSZD"?TR]\=,-L.41DI (!
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M]U;%_LYB D" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
M0" 0" 0" 0" 0'26\&T[R3L W%4Y #^]$F291SDN0W_*5OXY@+Z6GDK+%TR&
M>YN@UGM;0K1QPC3_  ??X:ILTYZN3+\0Q2VXK96K91A3CI_*5U:^HNU-74J
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M<ZQ:P'9=KHQ2OD;D4RUI]=8_P&P=RO\ )$3J83J1#%U\I.WGUF\+QZYWA20
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M?1(BXE?JN<J"!KUC'*3+%\GSK$\-IU5N6WBEL]$29/5;B6TD#WG6&4B6(?\
M$IP)+S\A64[M /FTR/T092ZM+W&<97FL<H<8>KLH6T!O3C]#4W1*1K\7RZ%
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MN94B,-JJ5E;@5L *.LA[8G3#7TQ,N97E;F/HA'!G;DWM'1/OBQQ(C@Y8H0"
M0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
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MK$P$4(! (! (! :%*29D:P7+38GV0,RU  Z0,M901IM ,Y:Q,#6*$ @$ @$
M@$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$ @$
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MGYNH4201I/:)>,!M5]Y/F20/_82V3.I_SRH]O3X(#;_:49G_ #$MG\,J/V$
M_M*,S_F);/X94?L(!_:49G_,2V?PRH_80#^THS/^8EL_AE1^P@']I1F?\Q+9
M_#*C]A /[2C,_P"8EL_AE1^P@.1/WDF9*2%?F+;-200*NH)$I:_#[^D!K_:1
MYCHD8+;"23M5\W4= 3KMV3U'O@-B_O)\Q!\N"6V1Z U=1.7_ )'M@-O]I1F?
M\Q+9_#*C]A /[2C,_P"8EL_AE1^P@-?[2C,_YB6S^&5'[" T_M*,S_F);/X9
M4?L(!_:49G_,2V?PRH_80#^THS/^8EL_AE1^P@']I1F?\Q+9_#*C]A ;D_>3
M9D?_ *A+9X@#YRH^G]1 :K^\DS5"4J5@5M&Z?_KC_A+PV:=8#9_:49G_ #$M
MG\,J/V$ _M*,S_F);/X94?L(!_:49G_,2V?PRH_80#^THS/^8EL_AE1^P@']
MI1F?\Q+9_#*C]A /[2C,_P"8EL_AE1^P@']I1F?\Q+9_#*C]A ;Q]Y)FA1O_
M ##MLIRG\X_[O#9[X#17WD^9#48);)?],J/#_(@-O]I1F?\ ,2V?PRH_80#^
MTHS/^8EL_AE1^P@']I1F?\Q+9_#*C]A :_VE&9_S$MO\,J/V, _M*,S_ )B6
MW^&5'[& ?VE&9_S$MO\ #*C]C :?VE&9_P Q+9_#*C]A ;T?>2YFO_ZA;8/#
M_2Z@R/AIMUG :C[R3,E ?^PUL29R/^=U"C.1TEM'4R^B T5]Y-F24S_,2VS)
M(E\Y4:2_R(#9_:49G_,2V?PRH_80#^THS/\ F);/X94?L(!_:49G_,2V?PRH
M_80#^THS/^8EL_AE1^P@']I1F?\ ,2V?PRH_80#^THS/^8EL_AE1^P@-Z?O)
M<S4DJ&"6R8(&WYRHF9@]/)X2@/7QG[PS+K_DMFL+F&6UAJZW"EH34BJ?)2FI
M=0V2$$#4;CK. OXTXM<MP TF9=)_3 <L @$ @$ @$ @$ @$ @$ @$ @$ @$
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M/Z?9X3@-WJHT$]3T'T:P&B7FE+V)4"N4Y>X>,!R0" 0" 0" 0" 0" 0" 0"
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MD%(T3*<!G_ W=]><FRQOC/ENUBR96ZH4M'4^@NE7\RA*G'453+VSTE$;=OE
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M(4W:;C3M^FW4O,-N.NMO)!VMJV(.R0 )&WXB((N1,=)ZP&L @$ @$ @$ @$
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M"9$]>NL!O@$ @$!M]-$YRU_OP&GI-^R7T:0&OIHZ2@-4I2@23T_# " H2/2
MT2A*?A$H#= (! (#:IM"_B$S[?& U2D($D]/P_IP!24JZB V^F@2,M1XS/C
M:A"0K<!KT@-T @$ @-I;0KJ/&>FFO2 (0EM.U.@U/4GKKXP!2$*U4 3(CZCU
M$!M#+225! !,IR'672 -L--G<A,E2EN)),OI,!R0" 0" VJ;0KJ.O4C0_H0&
MTL-%25E/G2"$G6<C*?Z4 ++1F"@2(D?H/A :^DW^I\)2\)#W0&H0E.H$H#=
M(! ;%--KF%#KUU(_2@-R4I0-J $IU,A[]8#12$J()G, @:F6L!L73,.#:M 4
MGV& U#+8\/9XD]( VPTU^UIEUUU)U^F Y(! (! (! (! (! (! (! (! (!
M(! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M(! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M(! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
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MP'<%0V0H_J=2-"9'QD)F ?,(]\I3_"9=.L!H*ID]#,>T:CZI=?J@-P>03_\
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MMN/9#2\WNU;N0MW$?(FMJ6:L_+>@@G:XPMQ) 7/HJ"K"H=2E*4I0K8 !,2(
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M)0%A%?"=)Z=(#YR_>'VFY_G5B-[<:<=M"[<[3IJ0G\D*A#I5LW=)2\WUP&O
MO<_PKC>(VO!<RQ!FUNM,)IZNZL4C=2S4K]-*/4=!W.%;GQ+7+;,P5=+&\5XK
MR#C]JPXK2VFX\<5Z7/0I+8MJHMSJ2Z5.C\F5))#H5NET5/Q@CY>=T6-V'$.X
MC)L;QJVT]ML-(NUIIK=3(":=(>MU(\L!'AN4XHGWF ^DW"_%7'F-XOB^76#&
M*&V9+6V.C555],REIYQ513-+<W$>TP5$'*.6]JW$F?W[)LGI$9#R77O,UE31
M);;KW*6J8:V)1.6VG6I"I[73J /9 5T[@^X'A_F7#V;=8,-JK+EMOJ6GZ&ZN
M-4R4%HDI=96653VJ"MTI?$E,$37]W)<*NHQ_.;<\^XJCHJJ@724Q7N9:4^BI
M]0MB<O-M3N^@0%4^[,RY\R\CJ*U[K^[+@+N<3]G. TN!>AR-9EW3,;RT';K6
M5A;<J*5UR94FG6 K843ENUGU@K&>^'C/ [!Q;7YM;<<H:3*KA>6/F[NVP!5.
M?,EQ3I*R)S4K6 POL5XPX[Y!Q3)JO-<:H+W645P0W2OUC*7G4-J:2N05])@C
MZ!6F@I+5;*2V4#*:>AHVD4],P@ )0TT E"4R\ !I <5TJ$TS;C[IVM,M[S(_
M223]$A ?'HL7_G+N!:H+@]]H7&]WGY=\!7I_YHRLI7(KT$FD'3VP'TI':]P@
MJQKLYPRW!)IC3BO2RE-6%>F4>KOEHX)S"@.L!\U:"KK^ >?6O6JUM_FA>V6;
MFY;5.3>HFG0*E&XA*E!;2E(,QK. ^CG/6!X#EG%.7YY=\=HJ^]TV*7*OM=RJ
M&@NK8<;M[KS*D*Z@I(!GX& H)V=8MCN9<QT&/95:::]6EZGJR[25;:74$MTK
MRT]?\)(@KZH8OB&/X=:V[%BEK9M%E;6HMT%*T&FD%1FI0 ]IU@CVE(=/ED=!
M*8ZR]L!\]N_CC_"\.HL5NF.V.FM5SO-9<7KE5,MA#]2H!A<UJ3KH5GK >_V.
M<3<99YQ3=;SE^-4%YO%/D5524]95LH=>0PBBHG0A*CKM2IQ1^E1@//\ O&:6
MBM])Q;142$LT=.U?6J9E( 0A+7V8$A,N@ @.AV6]O&#\B8W7\B9I0INHIZ]=
MMH+<\HN4P+3(6XIQ"DD*)+C93(^61@,K[P;/1<+<'4N"X#MME@RR]K-VI  $
M[9)J@EH #TT^HPB<O"8\8"#>U_D+@OC(5N0\D,KK<K<FS;&Q2&J:IV%"3AF4
ME.]0\9])P&)=R>5\39MG!R?BEMUANX-J>O"7&54K9JDJEO;;V@)2I W'WS@/
MHQ8_LG*.W2QO\DW,FQ7/$;:_DMPJGPA3B7K>TXZZZ\Y,37,J)/Q3@JORNZSM
M<P+;9\%PA=PM58CU*A]BA8I1ZNK9"A5;2?*D:B IWR+F6,WOEBMS/CZSG'\?
M544=3;K2O8@LKIV64NZ-$I\[J%KT/XVL$?4^[XGBG+/%UAR;/+#17FX_8*;E
M2"I92X6:BNHVWG2UOT$U)3^ 05\U>!K#9LB[A\;QV]T+5?8ZBXU5/64%2CU&
M2RVV\0%).DAI!'U >X[P7C_ \R:PBQ4=D9K[36*JFZ)M+25EJF<"20/9O,%?
M*C@W J7D[G'',(KW5-6^Y5E2NN+9VK72T;#U6\VDR5(N(94WT_&@BXW>'P5Q
M9AO"K^0XSCE)9KO:ZNA;;K*-H,K<2^ZEI0=('FF#T]NL!!?9-QKB_)_(-R8R
MVF3=+;9J#YYRUU2 ]3/.O*]!)(/ZG>%?5!66]]G#N&\>G%,FQ"VT]CIKH7Z!
MZVT3(::*F27O6,M=R@X$GZ((GCLMR9U?;FVAMI)1C:KC\N)JDN;[]4=T_P#"
M61IX05\_J?,+=EW+3.8<J//U5CK[HFJOA2MRH4*1.B64$A1*4)2&T?X(EX01
M9GG#GGMMSGBBX8CBEN]+(6&F48ZZ;=\N*<MN-E0#NT2_)I4D3@./[NG*JIG-
M\RPU?Y6EKK4S>-Q45!I5MJ$L23K^.*W73\6 @7N,8=J.XC-V:?2HJ+X\VQKM
M!6XH)$U>$IP'T*MO:AQ!4\;#'TXS2M76IMJFT7QQE+U<W4/LD"H]0RWK;4O<
MGQT$%4&[9;JO%^X?%!1%*U.W/[((6-Q+=<Y\HM1"9B>UPRG!%_\ N@XZPBY\
M59KFUSL-)5Y1;K/4/4%RJ6$K?9*$#;M)U3*4!2KLEPG%,YY%NENS&S4UZMS%
MO+S=+6-!U(7.0(W0'TZQK&;%B%HIL?QJ@:MMCHROY6A92$,M)=<4\HH ]JED
MP'OMDE )\==/9 ;X! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
M(! (! (! (! (! (! (! (! 0;WBB?;=G8]M/2 ?P^G@/GSVA\L8IP_R-=LD
MS)]VFM=79*BV-EAM3Y]9VKI'9;4@DS#)Z0%EL_\ O!<0MS+U'QW:'KL\I(^6
MN-8#3T[:TR)"FG$A9TGXP553C;C3-NY'DBKN"FW5LW6N749+?&VPIJF%2O>X
MO3:G> 2I(/4P1>3O"MU-B7;/<K'86A;K33/VZ@899.B:93Z4+1+Q!!E 5G[.
M;]P18&KI=.2ZFCH\R9>#UJJKCN]-NF1M5-K=Y"YZ@.@U@K ^[+EZS<P\G*O&
M- .X]:Z1FW6^X%"VU/H ]5;BTK\0ZMQL>U*1!'T[XC2?Z*\'09;56"UJ"= G
MS43,^GO@/GAWFX"[QAS=19C0I(MF3%-ZIEE&UE-92.!#["#J"4@-+5^Z" \C
MA"VWCN&[F&,DOM.EZH;>&27Q*5A@AJB++393JB<G%,^5/4'I* ^F>>9;0X'B
M%RRVYLJ<MUN])=6E!FL(>>0PI8F"#L#A7M\92'6 K;F5][,>;T-Y%DU\M5+<
M7P@.UKSRK;<BVTG8A+PFE>T&4DF"J;<1?)T7<9B+&(5SU;9ADU,W:ZNI0:=Q
M^F54)"2XV=4E8^(01]D(",><ZS(Z'B[+JO$67'\B9HU&C981ZJU*)2E4DR.H
M05?5!7S#[9*_C*V\ILO\M"D7C*Z=YII=>T5TS=:OTRRZHD23HE1W'^[!$C=Z
M',V#\A5>,8EQ]4IK+#B[3_S==3@_)..U7HI;;9$I$(0Q\8T\TOQ8"R?W>LCP
M97K&L\AK!,]9"GI9#]& JW]X)_7\?]26_P#7/0%\.UXA/;S@A/06]4_H^9<@
M*G?>,VFZ'*</O_RZOLD4*Z/YOH@5!?6X&Y^'DU@,K[.>?N-\:X]L/&-VK7F<
MLJ+BZVQ2!AU04NX5)+<G)2_&$!$W?I@]RL_+/YYJ0I5JR:DIA3/A!+(?I6@P
MIG=T*I-ASZ%" D;@[+.S6_8%8[=FEDL=KRVW6ZEI;T]=Z<(%34TZ/14]ZR@$
MK+I1ZDO#=*"I(PM[M!S7D-&%X3B5HNE^HF7:XUS%"0PVFE+9!0\H;52*_ Z$
M2B",?O*4I2UQ;L,T'[>*3X$;;9*7NBHF;L)_J"8_UK5_\VQ 6>@-JR0G34Z?
MIP'SA^\<0H<A88_MFVFTK09G:)FJ7X^$!F_9MSWQSCO'N-<7W"XNG,:RYNL,
MTJ:=Q22]<*HEH>I*750G 1M]X]_6SC'^[J/X[4P%K^R?_P!V7!?INW^V*V H
M3WI?^]#FO^/:/]CT,!;WGS"+AG/:%B]/:4+>KK-9[#>#3M)WN.-L4(:4D2\
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M>2,/N.&9"'%6:YAM-6AIQ32E):<2Z!N3[TB K^.PS@=2B?E;D? [:QV0\?;
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M* ;$@ ;1(=!+32 2'L$!IL0-=HGTZ0&GI-:>1/EG+0:3Z_A@-?3;_4#\ \8
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MJ>TSE_=@-T @-)B P\\J\?)SH<:&^-?GR4[Q9@V\7=OH_,3W!&S]K\WQ>[K
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M,9SAV:VP7G$;W1WNV;MBJB@=2^E#FU*]BPB92L)6DE*@")ZB ]WU$=09_1K
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MU4CH=(#S#R)@KMVN5@;R2V*O5EIW*R\6[YVG-124K02IQZH;W[FFT!:2I:P
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MDJD>L!R5F?8739&C#7LAMS67.I+C=C<JV$UQ0&U/%?RY7ZD@VE3D]OP@JZ"
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M5;A#0!E(>;4Z0$VVZZ6Z[T+-QM=8S76ZJ0EVEK:9Q#S+B%_"I"T$I4#[08#
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M A2EO-_!*8) TG!62\)]L'%5)QQ8ZW(\6I+_ 'V[T;%PN%?<VP^XIRK;2^I
MW$[$IWA.T=5 J\8"L/.7#*N(.>N/V[.'&L$OEZIJJQ4RW0XEBH;JJ45;:4E1
M6 -[.J@)]!T@/J$GQ^N+*-QZ1!\^?N^PI6:\@)3HHM/A)UZ_,->R(,.Y_LE7
MD_>2,29KW[8J_NVBU5573";B&JZCIV%D2(!\JCI.446XN?:IP<<7?LM)AU$*
MAJB53TM>XE1J]Z&MJ%%XG=OF)J,YP$$=C=UO.*W'E/!+JH.4^*/*JWMNU?\
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M^ 7ZO)*[@^V7:EFEFGNU7<O54T=I4I"$EQ:P2 =Q^F"+2TX4$$*\#I[92'6
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M9><8"%)*)CRDI5."/+K.U?MZYHQVDS[&J!W'AD])2UU*Y:%IIJ=A'H(2 *1
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M.7T%L.A1)W2'F)@);[6[S;+QP1A"+;4M5+E#;J:BK$A:5%MYH;5-J3KM,Q*
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M 6AXLXNP_B;$*+$\1H&J>FIT#YRLV)^9K*D?&_4.?$M:C/J9)$DIDD  ,V
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M+1<+2BJ6DK2TJNIG& LI!!(25SE 1CVY<)W#@O$JK&JR\-W==0_ZPJ6&2PD
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M5+S'J9GP@.2 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0" 0"
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MK6U+I*$_MB4S^& D9#;;R?%(292!E*6OL@.5MI#4]F@.LO"?M@-TM9S@-8!
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M;L9;=ZKC*D4G"&>03;V&GTT)_+N-(I#5$D K4M)+\RG52DJF@$?0+&^*<=/
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M') (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (!
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MW [1(]-?PR(#OWS&+3DEFJ\?OM(U7V>O:+%92/IW-N-J,Y$'Q$I@@S!U$CK
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M 0" 0" 0" 0" 0" 0" X7:NF8;6Z^\AMEH%3CJR$H2$_$5*.@EXS@/#Q[/\
M!<N<J&L3R:U7YZD -4W:ZVGK5M!1D"M+"UE()'C 4I[HLQMF#=XO'&6W/\I;
M[;8J+YE"5)0K:]6W1N9*B  DJ"C/P@+H5F48_08^K+JN[4C&.(;^87=5O-BF
M-/X%+F[:9F4I'7H-8"G?:<BKSSN2Y0Y:M=(M&(5;%71MU#BD@_,U593.M)1K
M-0*&'"2D$#2<IB879J[6FN973U*$O4[FCC3P2M"DC43200=1X_3 5[Y,[+N-
ML]747*R^IB62/J+JKC;RI;*G%KW+4MG>B9(,IA:0/9!7F<.<9]R?%G(%KQJ]
M7QO)N'E,OA=9ZK2ET266EBF9V/J0\DJ6$3]%"T^U4!&O=S3.8+S_ ,:<O5%"
M3C%*NB77U+:T375T54IU22)[D@,^G)2D[?89@P1<UW,L58Q0YLY>:,8B*<5I
MO:GT&C] Z!8=!*2"=.NITZP%->VJLN7+/<QGW.#;"VL7+1M-)4AEU-/4K;:8
MIFDH<4A(]0,L-N*;,E@+!(U@+EW_ #O"<):I1F61VS'A6;Q0BZUK%%ZP9VA8
M;]=:-Y3N3/;/J(#Q.5[!1\D<5Y#8:!MN[MWFUOFVM(>;2T_4%OU:106I24[2
MZEL@E4OJ@*V]@67VMC$<BXQKG&Z;*[3<W:Y5"Z^V'7VG4(9<4TWNW*2R6?.I
M,TC<G76 Y^^GD>D_-.FX:QU]NY99E-72-5=CIINUB:=MYJH8)2D&1<=0V$I)
M"E S (G 3';..:I/;>KBEI]"[L]BE3945%0DMMIJJBB6TE2PH>7:I8W>(@J'
M>Q3D"UMX;5\0W52+9EEBJWW$6^J5Z-14(J%K=<VLJ 6%-]%((W#732".#OMS
M>T7''+/P_9UBX9C=KE2U"[?3 O.L-()#16A )F[O,DCS2D92(,!:3C;%ZO#^
M.L3Q&M4A=98[/;[95+:,VUO4=,VRXI),M%*05" RH+0@A),E=9=?B,!2SL=!
M1R+S_N$M]ZH]O\,N_P#>@+JH4E0\OAH="(#= (! (! (! (! (! (! (! (!
M (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! (! 0CRUVT89
MRYG%ISS(*JK:N=GI:>CIFJ<R;*:6I=J4D^,RIT@^Z Z/=XAQ/;EG2E@2^7I$
M@G3_ /"%,=9^$!!?'7:5AO+'#.$993W"LQG)*JB2FOK+: I#R$NO)(4S-.I\
MGGW: =(*F7AWM+P/BN[-9*MVJR/+:?U&V+K=4)_()5T4RWY@%@32%A?0F"+
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MRB -8#,(! (# N0>/K!R7C57B^6V_P"<MU23Z1 D\PX 1ZB%E)V*3/RE,_=
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MCH);(&A,A[="=8"&>?>"J+GFQ6JR7.[NVIJUU9K6UL-)=*U%"D2.Y22-%=1
M2XTG:).)FI4P% :D#Q,!W8! (! (! (! (! (! (! (! (! (! (! (! (!
M(! (! 0YF? UORSF[%N:W;P_3W#%Z)NA9M26DJ9="'*I>\N%0()^:(E+P@)>
A9_&\!I(0'+ (! (! (! (! (! (! (! (! (! (! ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tm2225088d1-lc_activate4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_activate4clr.jpg
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M .$  0 !! ,!               ( 0(&!P,$!0D! 0$  @,! 0
M   !! 4" P8'"!   0,# P(#! ,'# H+#P4   $" Q$$!1(&!R$Q01,(46$B
M%'$R%8&10B.T=3BAP5)R,[/3)!87&!FQT6*"DD,E-E8)\.%3DS1TA-0UE3?Q
MLH.CPT14E$55929&5RC"TF/E)Q$!  $# @,#"00&!P<#!0    $1 @,$!2$Q
M$D%1!F%Q@9&QT2(R$_"A4A3!X4)RDA5B@K(C,S0'\:+2XC46%T,D5%.#DT0V
M_]H # ,!  (1 Q$ /P"?P
M
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MAA:>GU8\S3[%?=??-T\Z\?4EJQ$1J(B40W#VJH
M
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MG&DH_>F]*;ORBM2JI</Z)T_\W4UNB^:WS/+[)_BW>?\ 0E>U:HBF\>R5
M
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MD*U/'V]#6Z3%?;-M8Y0\YM6DRXLETWVTX_H20;32E.QN'J%0
M
M                                  %%[ 6>^E%]@"E$7PKW(,=W!LS;
MFYHECRUA&^OPI(UC&R*E')];2J_A*=63#;?'%T9M/9DBET//P7%VR]O3>;88
MYBR?61UPUDM%JU:I5O2FE#KQZ6RSDZ<6BQ8I^&&71M:Q%8UJ-HGP-1*)]Q#)
MHS>2YM5>U7=Z=?I*.8 !UUJBKHZ)^'7K]!%7(E%7HM$[?=*@K455Z*JKW3P
MK14_NJ^P O5*KUI[" UJ(M**GC4HHM5=6BK[OUP*4I55[*E*>-5("-JB-5%T
MIUK[T**JB4=['>'TD%*(UJ-6J,3LOO*+D2B]D]ZIT Y$[)0"H
M
M                                      410%$]G;L HGL I1.].H%:
M)WH   4HG7HG7N!6B   "B  %$ I1/9[P*T0!1/8!141>BI5 *T0
M
M
M            #B>[P153W^ %NO31J*J^*/[I7V5!557.[=56FJK>U?8!:LCZ
MIJ14]E/]G8BKM3ZJCJ*OX.FM*>\!J>B].J)W7OU*CE3L!4
M
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MMQ[6F<Z*C?F;:58VS0NDU*ULC&22:55&UHJA6P$ZIT"*@
M
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MT1*J160HM4J5%0
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M4J*@
M                                   6=*T(Y-;<S<<W/).!LL5:RK%+
M:77S2+5K=5(WLI5W[8UVMTTYK8B.QZ[PQO=NUY[LET5BZWI^^):/_HJ[A_\
M2$_WV/\ M&I_E>1]'_\ (.G[ONE3^BKN#_TA/]]C_M#^5Y#_ ,@X.[[I;$X=
MX/ON/-ROW#>SJ]SK:6T;&CF.2DKF.K\/7\$S='H;L5_5,O*^)?%=FY::,-L?
MM1=V]E?>WOV_M&Z?,UQ4 /$O-J;<R&09E+O'139&/5IN'UU)J;I6G7Q3H8]V
M&R9K,<6QQ;AJ,>/Z=M\Q;/8]E.O5/'N=[7O'RVUMO9Z6.;,8^*\DB558^6M6
MU1$6E%3P0Z;\-E\UNAL-/K]1IXF,=\VQ/<MCVIMR'))F8\=$F3332YHNM/+3
M2WQ\$)]&R+NJG%9W#478_I3?/1W>=Z5_86F3M)K&^B;/9W#=$T+_ *KF]Z*=
MEUL712>3$PYK\5\7V32Z.4NCA=MX';S7MPEC'9M?76D:*E:TKW5?8AQQXK;/
MEBC(U6NSZF?[VZ;O.ZN2V/M++W27V2Q4%S=]/QKT=JHBJO@OO.-^GQW368XN
M[!NNKPV]%F2;8[GL6=E:X^W9:6438;:)J,BC9V:C41J)]Q$.VVV(BD,#+ENR
M73==-9ET,SM?;^XM/VWCXKW0B(WS:]--53LJ?LE.N_%9?\T596FU^HTW^%?-
MOF=C'X;%XJR7'8^U9;V2MT+ RNFE--._LZ'*W';;%(C@ZLVIRYK^N^Z9N[WA
MW/&NQ;R=]S<X*VEN)%J][D=55_PCIG28IFLPV-F^:ZRV+;<MT1#DLN.MD8^Y
M;=66%MX+EE=,K4=5*]%[J+=+BMFL0XY=ZUN2WINR3,/3S6W,)N&-(<U91WL3
M?JMEJJ)U1?!4\4.V_%;?'Q15AZ76YM--<5TVSY%V'P.'P%M\KAK1EE;KWCBK
M3NKO%5\7*7'CMLBD0FIU>;47=66Z;I\KU#M80!2B 5H@%CXHY&JU[:M<E%3W
M >;CMMX+$7,MWC;&.VN9]2S2,K5WF.1SJU5>ZHB@79;;N$SC6,RUE'=-C<DC
M$?7HYM:+T5/V2@=JSQ]ECX&6UE"V&"-$:R-M:(B=$[@>?DMJ;=R]PRZR6/BN
M;B.FB1^JJ474G94\5 ]2.WABB;#&Q&Q-^JU.R <B@1VY$_2ZX93P^Q]Q]/\
MDJ@2*
M                                      *      IX@  %*)6OB@%:>
M(!41>X"B  %$K7Q 40!1 % %$ 40  H@             **!';D7]+OAG\S[
MC_)5 D4
M
M                 **!';D7]+OAG\S[C_)5 D4
M
M                                                 **!';D7]+OA
MG\S[C_)5 D4
M
M                     **!';D7]+OAG\S[C_)5 D4
M
M                                                     **!';D7
M]+OAG\S[C_)5 D4
M
M             #C1Z_2B]G> %-4B+I5.O[+P JLB5THOQ)W3Q :G=$7NO@!R
M       HH$=N1?TN^&?S/N/\E4"10
M                                     /$")G)7J!Y%VOOK.8#$S6C<
M?87*PVZ26S7O1B-1>KJ]>YY;/K\UN2Z(GA$SV0^Y;'X.V_5Z'%FR1=U7VUFE
MS%$]4'*B_P#G%BG_ "5O]LZ/YCG_ !?='N;O_L+:^Z_^)7^D_P JK2EQ8JOC
M2T;_ &Q_,<_XONCW)_V%M?=?_$E!P[N[*[WV)CL_FG,=DKGS_.6-B1L_%W,T
M3:-3M\+$/1:++=DQ1==-9_7+XUXEV[%H-=?AQ5Z;:4KQYVVS[99Z9SS
M                                      !P(J-?^R5W@WLE .M/D[&T
M>L5U<LBD\&O=1?:!SQRQRHDK%16+^$G?[X%_5$Z]?&ON Y4[(!4     **!'
M;D7]+OAG\S[C_)5 D4
M                           #Y\\UK_\ ZKNG_CKO^\:>&U/^+?\ O3[7
MZF\+?]+P?NL"[=:5,=Z=3I5%3I7P*)T>F[_LKQ'_ "G\MN3UFV_X$?;ME^;/
M&_\ U3)_5_L6-N&T>%
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M!(H
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MX\$^"VOV>7+$YTDK7/55\Z:5[J(B=5H!(;\%*=A COR+^EWPS^9]Q_DJ@2*
M
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MN<KM*M3ZOM ^@+5JE>B_1V"*@
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MRQY+XMB)B9\WO=>X^#]=H<,YLO1TQ3E=QX^AM'HJ_0;1XM5 BI0
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MI>FM<1N-5_\ 5E.*I&M1$:B)V*BH
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MNC'?%U:T\CSFZ^,<^OP3ANLBV+J=L]C<"T^CZ#;O!JIU^GQ"2J5
M                                  #4'J8QT^8X2W1CK.Z6QNI_D-%V
MU6M5FC(VSUZOJG5$TA4.^(N.?3?FMGP3[@N9KS,-FN$N;JYM6(]U)G-1/W1M
M:4IV W+QQQ?Z=<3OG Y3;&G[?MKMDF-_$,8OGMKIZI*M/O$1+BJ.I3P7K4HO
MT(J4\%0 D:(M?=0"NFJHM?"@!&455KW HL:.^LM4]@!(T2B>"> !S.ZHM%7Q
M COR*B?TNN&D_P#@^X_R50)%(E$H@%0
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M54_!(2YT[(5      **!';D7]+OAG\S[C_)5 D4
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MGF9QVS/='L?E36VQ&>^(_%=[7I'>PP
M                      P_=&R]BYFS?/N7',N;1M*JY\[>[FI_BG(O=K0-
M*9_TQ>FK+M5]GA(+"]=U?<JN1G7PI\+IT0@\K9OIUV]L7=^"SVU-\?9^)Q5X
MRZN<''B97-NHFU5T2S27#E9J<NK4C5*52HCE8Y$5BZD>B*QW:M>H'83MU[@
M     HO8"._(B?\ Y=\,_F?<?Y*H$B0
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MO;+U#(80
M:6]5<>WY>!=VLW7/Y&$_R=\S-HE?I_RG:Z/A@^-:OTIT_L"A5$SA_P!"ECO3
M;#=T9W<7R[;V21MO8?).D\ID<CFH[S(KYFK4E%HK>@& Q^F';VWN;9^(MW;A
MT19!UI;;?R_R<J^?=W<;9EB\B"Y=HT-=35)*C5IX 2-]'5SGMI[VW7PYE)//
ML,+:KDK:;3$RKKFY2-/A8CW?5:G>5?H"IFHE$1/8$      HO8"._(GZ7?#/
MYGW)^2J!(D
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MMOWII[K3?X5O[L>Q^0==_F,G[UWMEZAD,(
M                          ,,Y.X_Q')^R,KL;-U7%9;Y?YG2Y[%_BMS%
M<LZL5KD^*).R@0SL.$O5'Q5;K@>/LTE[A-;W1JEA;RJU'N62BNN)7.6BN5"5
M'O\ 'OI6W]%NQ_*._,G\[NZQ2*YQ%LV'R%BNX%T-<K63.C=5G@J%&R_31P3E
M^-\MN'>>YI5?G\XLUK)&Y%:J6R7'G1K1)'M^]U DHG9*=@*@    !1>P$=^1
M%_\ R[X9_,^X_P E4"1(
M         %*^! K_ &@K2_-/-%CLFUDPN-<D^<G:K7-;T6-CVS1JY4>Q472]
MB=E-3KM;]..FWYI_6^@^%_#%^ONC+?PQQ]_RSV3W2T/QGQKN#EK<#L[G'JW%
M)-Y]U<JB*V1R.9(L348]JMUM<M%1.AI--I;L]]>SME]-WW?-/L^G^CBCXZ4B
M.[G%>,<:2F9@]NXK;N/@QF*@2"U@8V-C:JYU&)1*N7JO3VGK,6&W';2V'Y^U
M>MRZG).3)-9F7J4.U@JE%*=:@45$5%1_5".7F85+Q1L>=ZR26"^8O>DKT3I]
M"F'.CQ3V/0V^(=;;%(O^Z$=L_M'!6WJ-L=M0VZIB)'V:/AUN5:26^I?BK7N>
M=RXK8U?1V5M]D/J^CW'/=X=NSS/QTOX^:Y(F'B?8\$K968]R/:M6UE>OZYZ+
M\GBCL?*+O$.MNBDW_=#-(8V0Q,ACZ1QM1C$]B-2B(9D12'GKIFZ9F>U>5Q
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MIJ]!.QVL4   +7?V"+ M>RJ%1<W/5/57C:=O,L*_^JGELW^=_K6^R'V?0?\
M\M?YK_[24?6GO\%/4OC"J=BHJ$
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MM\Q-TTY.4K@
M   $,L%ZQ,4NC9W..TKC%Y"YK\VN4@M[>Q7R]5PS5#/(Y5^'R:53ZRHI%;%L
MN7?23=0(^7*;1MG+U5DL5EK_ %&*4>!NSG_TK[<LIKNPM=NYZ2-M66V/AQ[I
M'+TZ-1[4ZD'?].?)TG(^[,[/BMBIM;:<=DQ;+()CX+19Y4E:CF+/ JH]*+JT
ME$ET[($5     "B@1VY%_2[X9_,^X_R50)%
M                      !:OWR.3R\]G,=MS%7.6R4J1V]K&^5R.<C55&)5
M434J)V.G)DBRV9EF:329-3EMQV16;IIZT%>2MZ9KDK<5[?L\R3&6".2**+5Y
M+((I'Z9G-U.;72[JY#Q^HSW9;IE^E-CVS#M>GMLFD7W]L\YF8CX>5><<FO4Z
M(O95K^I[C%>J4\?N!63<>?Y[X#_C]I^41G;C^>/.T^\_Y++^Y=_9E]'3WC\E
M   !3Q55^^%*>SL0 *?3X 50HJ$
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M$3IU7V)W CQR*O\ ^77#2_\ P?<?Y*H5(H(
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MBOB>UZ53Y9O2K?:=EFUV6S$UG[>AAZWQWJ-1ANQ]%OQ1,<I[8I^-OQ.QNWS
M
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M47'EKS1N.?/W]]89N3%3392YRSHHH[*1)$1USU9J56]&]PCZ#L2C42B)[D[
M7                                       "E4"T*H"@BU"%4 =*TJ1
M7B[IW+CMIX2YS>2?IMK9J.>U*>8Y%<UOPHJMK];VG3FS1BMZI;'0:')K,UN*
MR.-WJ0KA@S/-O(RM>LKK1\J122(Y[UC@17(QRJ[S$;TIWZ'D8Z]3EX]K]"W7
MX=AV[A3JI7LXSPKW)MX##6>!Q5MB[*&.&&"-K7-B8UC5>C41SE1J(E5IU4]?
MBQQ9;%L/SKK-3?J,MV2^9F9GM>GI13M8=2@"B_[912GM)0JN*@
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MM-OTW19U3SEX3Q;O=VMU'1;/P6\H\O*6WJHE$]IM7A%QR<0
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MFKIZU"57%0
M                 $1MK<C<\WO&W(&6RN$\K<V-^Q_Y/6OVBQ_G_,7;F759
M-")'HC1%ZHNKL08'_.[ZH_\ 1KMV_P KLZ?^+*,JXUY-]0^5WY@<?N3;Z08.
MXNXX\C.N39-IA6M5T:$U4]E0J8B*U%1'K5W<41SIVZ=@      44".W(OZ7?
M#/YGW'^2J!(H                                        -">J.O\
M(U*)_C8?WPT6Z_)'G][Z=X!_SGHGV(;K2J_@^X\V^_G7VU52C:_ITD9'RKA9
M97HV/^-:G.6B?\"N$,[;YIGM]/LEXCQK;,[7DB/Z/]NQ9OW=F9YDWPVPQ2.?
M:2O;]F6ROHR-R6S$DIK:VE5C<O4XZC+=J,G#T0NT;=AV31=>3YHCXI[_ (II
MRKWID[%VI9[.VY:82S1$9$CGNTMT)JE<KU2B*OBIZK388Q61;#X!NVX7ZW47
M9;NW]'!DQE-.
M                      USS=OC+<;\99[>F#LV9')XWY/R;.63R&/^8O(+
M=U7Z74HV17=O #"L;ZKN+)-A0[ZR=Y<0X]R/;,C+6>16R02)%(B)H15HY?8!
MKC9WK$N>3^5,+M#9N%BFVW/>0Q7N4?-)#,D$R4<OE2QI72[P12*EW1'+J7HO
M9?>A4<R=DIV J     %% CMR*G_Y=\,_F?<?Y*H$B@
M                      T)ZH_\SF)__)#^^&BW;Y(\[Z=X!_SGHGV(<>*N
M3NAYM]^47NOB[Q4*[>/R5SCI$FLWK'<-_<WI1=-45%[HO=%.43,36'1FP6Y8
MI=%82@],W&L<-E#OS(-25]TCEQRJJ?BG02SP/5-+J]43\)#?;;IO_4GT/C/C
MK?)NOG26<.GYO+6+;H[/8DLOMJ>@?(5Q7$
M                                           !\_?ZRQ'UKQ?6OA]O
M_P#]:2BU1$Y#WQLK>.Y?MW [*_DY8O5%GQGVI<9#S*1HW]VE8QR?%5_1/&A4
M3+X']:&)RVZ-J\8XKCC[)BR]S%CG9+[;?=>6LG>3RGV:*O5*Z?,3Z0)U=*HB
M+U3XD7Z0.=.R 5     "B]@([\B?I=\,_F?<GY*H$B0
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M%(?E7-FNRW3=?-9EV?&GL.3I7%0
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M.B 5*@
M               #3/JE@W'/P7NJ/:4+I]P_Y/\ DXV*U%=_E*U5]-:HG1FK
MNH$>?3-N_P!.N-V$EAN*[@MMTPSW"Y*TGBNKES$?.]6+J2)[>O7LH5AVW<AM
M;.>K+$W_  HU;W;++_'+E[N-SVL^59"U)$T7"1N2DNI.C?U CZ+-:OPN7KUZ
M^Y 4<X       $=>0_TNN&/S/N3\E4"10
M             <4L44S/+F8V1E>K7HCD^\IPFV)YN=MTVS6.#!>3-R838VU[
MK+36<#YJ-9%$D;&JOF.2.M=#DZ:C!U=V/%97IBKTNQ:+/K]3;CBZ:>>>SCWH
MQ<)["EY)W/<YK-1^;C+?X+Q&?BTUR1.2/ZCFJG5G@AH-%@^MDX\HY_>^Q^*=
MWC:]-&+%-+YY=O*8KS\Z:D5K:6ZJZW@CB<OUE8Q&_P!A/>>LMLMCE%'YYNR7
MW<YF78.QU
M                     #".4M\XOC38V4WQG(/F<9B?E_.BU-8COFKF*V;U
M<BIT=(B]@J.UAZ7^&N:[1G(N-9DK!^2<Z.6&.]5K/XO^+2B1QHGA4(RO8]EP
MUZ?MYXWC' >:NX<M-'91_-SI-*U]U2Y;U6-%6NKIU"I',3NJ=4\5#BYD5*!3
M4U?'QH JG;[H#4WV@-3?: U)[0 $=N0_TNN&/S/N3\E4"10
M                           <-Q*RWADGE73'$QTCW+V1K4JOZB'"9I%9
M=EELW71$<Y0JYKWS/R-NZ'!XJLMG82R06[V4T/9*L;M72E:4\3R&LS_6R4CL
M?H;PMM5NV:2<N3A=?$3/DI5*+BO8T>Q-J6N+?\615M+V7JC7.:]ZMHB]4Z./
M2:/3_1QQ$\WQGQ!NT[AJKLD?+^SZH9QU^_XF:\XJ5
M                                                     ! _U9<%
M<JY)FY=Q;9OI,KM:?Y'R]NPQW-Q=R:/E(EI3X%I(CI?VJ>TBL)XY]./J#GVG
M:26&>7#6SGRHVPO[>];<-5'K551%3HO=/<$;/XF])6]\9R;C>1>0<_%DI\1/
M!=V;(DN8J2P?#U26J+\)1,]46E%^)?8WH%5<JMZ]U:E=/B$$JM$?TKU1W9.O
M@!56M:ZM:]/U0*:55:^ZM?!/<!5*4JO_ '?>!3NM:U1>K43N%ERI]5!"([\B
M_I=\,_F?<?Y*H$B@                                        TMZA
M.0&[6VT[$64S6Y>^HZ-NI-7DU5DB::HJ]^YI=RU'19TQ/&?8^A>#=G_-ZGZE
MT?!;[><-;>FKCJ2^R+]YY>!WEVZ)\FD[55LS+B-[5<VM4=143J8.VZ;JNZYY
M1^MZ_P <[U&/'&EQSSYT[.F82R/4/AP
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MQNFKUCN8(
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MKX(;E\Z7%0
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M8ZWLWM:D:P6\"(BH]:U10)PIV J
M    UMS+R';[$VM</CD;]IW;5MX(FN3SFI,R1J2M:DD;D1KD^LG8UNNU,8K*
M=L_KXO7>&=ENW#51$Q\%O&9[.$QPY3''N1XX0X^O>1-RW&ZMPN6:PC>Z2221
M7/F?=HL<K75ECD:K515ZZM1I-%IIS7S==R?5O%6\V;9IHT^'A=,=G+IXQV3'
M'T43,9%'"Q(XF(R-O1K&HB(B>Y$/5Q%'Y^FZ;IK*[[G8KBN*@
M
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MVJK1$3MU4I+T:4:B 1WY%_2[X9_,^X_R50)%
M            6^/<CD\S<.<L=MX:]S60E;';6<$LZHY417K#&Z32U%5*N5&K
M1*G5DR19;-T]C+T>DOU6:W%9%9NF(]<T]7%"S<N7R_-W(D=M9MD?8ME\NW1$
M>JLLEG2KE3\8C5:C_H/(Y+[M3E]GF?H;0Z;%L.WS==3JI6>7S=/H[O.F'LC:
M./V7MZRPMC"R-\4<;;B5B(BRR,:C5>Y41*JM.]#U6GPQBLBV'P3==QR:[479
M;YK69IY([H9*933@
M                                (W<Y>DG:O+>2;N7'W";>W*VOS=W9
MV\2RW=600L\R1SD7\7'$K6^YU"#4CO17R-DF?9F3WWDWX=_PR,=+"]NE.J?
MJ^U$*)%<*^GS9W"V/\O%11WV=E1S;G,OMV0W$K72>8UCE8JU1O9.I%;<^)%1
M%\.JIX%172BNJO?N@!S4545>_M!"BZM5')\.D"BHM4T]$I2OB%56J=NOM"%'
M)UI6OA[ KD_!0(COR+^EWPS^9]Q_DJ@2*
M         XI'LB8Z61R,B8BN>]51$1$2JJJJ27.V)F:1S1(]0/*B[IR*;%VV
MZ1]M;W'EW,L>JLERQ]Q;/C1$JCFN1S5JG<\OK]7]2[HMY1[>/W/NG@[P_P#E
M,?YO/2LQ6/);2VZ)\D\);*]/?&+=JX6/<.1B1,MD(T?$Y[4\UD,S(U5BK1')
M\3?JJ9^W:;HMZYYR\AXRWW\WFG#9/P63Z)F)GC^MO!*_>-R^<KBN(
M
M                     **!'?D3]+OAG\S[D_)5 D2
M               "@6JJ)0CE06O?P"(_\^\QQ;?LKG:.&57Y6]B6*=Z51&07
M$<T3E1R517(Y$^$T>OUO36RWF^H^$/#,ZF^-3E^2V:QY9MFV?9VL1].W%C\M
M?KOO/Q)- Q^NT22BK\TUUO<LF1.BUHKNO8QMOTO7/7=]IX2WOC3Q!&&S\IAF
MDTX_N_';-J5K&HU$:U*(AZ5\2F:KBHJ$
M
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M==,S/GGC+M'-TE5K1""I4                   J@
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MK$1*]7-:C:]57OI/6X\<66Q;')^>M7JLFIRSDOFLR])%_4Z'8Q%2H
M            !QN=1Z?=HGM M1%^)$3IX!36U:4[?@J0%5%;6OTK["HOC6K?
MK:O?V O   ..2J*BHGNK[ +>Z41:N\5(JZBN^J[HG@*HMIJ541=+O9W+4<C.
ME45:JG=0+@
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MK1SD_%PVS43P;W]YWVZF;>%_K;C;]]LS3TW\)[_]D)%LJB4I2AL7J5P
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MZK4-GI_\..-7U3:\UV73VW7<YK[9;",ALP
M                            **!';D7]+OAG\S[C_)5 D4
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M%;7SYY)NSE5>FNG<VN&R;;8B9J^JZ+31IL,8XY17[YJR@[F8
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MSWT_'W"MFD;34GPN5J*E4<M3MLP6V3,QVL_3:+#IXI9#-V+7Z3(9RX
M                                            !Q+5%55ZK7I0%'GY
MG)08?$W^8NW:;3'P2WETZJ)IC@8LC^J]$HB 08W5ZN.<\YN/*W7#VVERNQL)
M/+#D;Y,<Z]1L<+ED5WFQ2Z43RE1:NI[0J2'IUYRL.;-JRY&-B0Y7'K%%DH_@
M:GFS(YR:6L<]6T1.J*H1NJB(VB=@(\<B?I=\,_F?<GY*H$B0 &!<S3S6W&NX
M9[>1T4[88E9(Q5:K5\^/LJ=4,#<)I@NGS>V'I?#-D7[EABZ*Q6?[,H"W>X<T
MCI(_M"Y>]ZJE%FD5K>JHJ5:_OT//8---_&9I#8>-O]0<6DO_ "VALLNN_:NF
MVV;?-$Q,3$Q/-TVYK*M<CDO;A7)U;6:33J_PC-G3Q,4K+XM@\9:W%FG+$63,
M]\33U=3,>/=P9:7>>"9)?SJUU[ US'2R*Q4<_I]9ZF!]&['EMX\*Q[7WWP]X
MRT^[Z++AS66VY8LF:Q;;$3RBD<9FO-]",:JNL+97+5RQ1U7WZ4/86\H?.\WS
MW>>7:.3J  'G9Q[X<3?3QK22*VF>U5]K6*IPR32R9\C(TUL79K(GMNCVOGYN
M??6Y'9B[E3)3-?(Y$;"R61&I1C:U1).E4/(VX[LMTS/)]!\6^*M%LN"W3X++
M;\\UYQ;=TTF*]4<)K,3P8N[<V><J2/R-ST[HD\OT?LC/MT\1%*R_/.H\5:K+
MEC-,6QT]D1-./#E5W[?>NY&(C%REPU/P=,\J-]]5=)T,'/IYLBMLS1]J\$^.
M]/JLWY;7666]7RWQ;;%L4B^Z>JLS/&D1'E3_ .-\C<Y3:EM>W:HZ9TDR*K:_
M@R*B=U4]/I[INLK+6[SAMQ:JZVWE2/8RSM7KU]YD-*\BZW3MVQE6*\R=M#,G
M=CY&M7[RG5.6R.<L_'H-1DBMMETQYGFW')&P;2K;G<=A"J)J77<,2B?=4ZKM
M7BCG=#+LV37W_+AOG^K+',OSIQUC4_$Y>WOZ=:VT\+NO7VN0Z+M?BCE-6VT_
MA/<,O/'=9Y[9]R%?)&X;7<.\,ME;!JK;W=S<RQZU145DL\CTIH=WHY#0]'U\
MLW1RK^EZGQ-XGN\-;;CT]LV_7FVWA/=T76\JQ/S6<V*>?<-1J)+(C$HJ-1[J
M-_5[(;&,-D1RCU/RSJ]_UVHS79;LMT==TW4BZZ(BLUX15>EQ(YZ(]VM57Z[U
M55HZE:=>QBY]+$Q6W@^A>#/'^IV[-&'+=U8[[HK-W&8KTQSF[A;2K;'&W"VY
M>1K)U[:W<5G8Q.:E+GS:.:J5^%6-<ABX=%DR\J13OK[GZ6UWC/1:>RV^R/J1
MDBL3;T^]OS:OIEVGB7,NLO-/<9%G^X3(L/5*+5KXC<8MJLCC=,S]O,^>[AXZ
MU>:)MQQ$6^6./W7-RX["XK$QMCQ]I##IZ:XXV,>M:]U:B>TVUF*VSE$0\!GU
M67--;[IGTR[ZIX>T[)8JO;KV AQZKKB-=QVMNQ51\546BT14D@B4TVIMB[-Q
M[&'XAW')AVZS%9-.N;HN]O!';LGPI]\KY!RY'1M=/7IT3WCF1/3R27])%RY^
MX<I;.57.2P?*J]_\?$GZYPT<4U%T1W?IA]HVG<KL^TV8KYK-N29_W:)=&\<@
M"GO\2#K7-_9V?6[G9"U$U*KU1.B$FZ(YN%U\6\Y:LY<Y3P^W-GWMQA\A;W>1
MN');-@B>CWI',US7.1$<U>GM,+-GCII;,5:O7Z^S%AF;9B902NKVXO;A]U/(
MZ615J]TBJY55?>JJ8<6TBCY==EFZ>J>/?5PI5JN=UJOU43]4J<JS/H;IXJYN
MW'M.REP<5L[*/DT_*L8Q9G)I=+(^NJ1/V?@G@+<EV.O3][T>V[MDQ6]'S=W;
MWSWMA/Y4Y]S"NM\5M61D735))CY743Z6R+XH<OKYJ<8KYHEN?SVOOX6X_N_Y
MG6?L?G;>,KHLC=0XI)*5D='>6[6_>U>PX1BOR3RF'#\KK<W"Z>FODNC]+T,;
MZ8L],K5W+N-URW55Z6]U<5HOL\R-3N_*7S/&8H[;-ER?^I?-WIEF^&]-^P,2
MY7HZ_N9G(FIT\T<K%5.O2L53NG163SJV&+9L&/E7ULVDX\VH_#7.!;CH&6]S
M"L#KEL423HCFHU:/T=^GL.Z=/9-O2V,Z7'-DV4X2A7RGQ'N'9&5GG^5DFPTC
MWR6]W&QZQ-1SY5;&YZM:FM&,U*B>!KKK9Q\)Y=_V[7SG<MLOP7]416.S[VN;
M6TN[VX;;6T:R7,BHQ(F(JN57*B41/;51,Q$-+99===2.<\$I_3OP_D\5?+NO
M<-L^T5C%BM[6X8Z.1R.2-[7HUS**B*BI6IW:?%===U3'![O9MLNQS]2^*<*1
M'J2@6BI3HGZALWL%*(WWJOM*CD;V0"H%CN_]D"Q*HWHGW%(JJ]D1.R]_85!*
MKTI\/M\0.1JHJ=/#H!4   XY'::=._2H%OU5I]\@KTZ)TI[2@M.M%HJ]J]@+
MH^E47P O                                                   <
M+E55JB*GQ:?]L# >;I[FVXFWBMJU7/?A\BQ^E%54C=935=T]GM((\^BVPQLG
M!^Z'2MC=\RUSKUSD:KE5]@W5J54\4[U"PX/1K#:6>\.2[3&Z&8]F5A2%D5$C
MTI;+2B,HGWBH][D'UW[&X[WKG-CY';&7N[[!W3[*>Z@?;)%(^/NYFN1%I]*!
M6C=S^M39><YKV)RA#MW*1XS:=CE;.ZLGNM_/F=DHO+8Z-4?IHU?K54(V?_62
M<<I_]'9O_#M/X4"G]9+QQ_H?F_\ #M/X4#Q-W>NG9/)>WK[9.,VUE;&^R[61
MP75P^V\IBQ2-F77HD5W5&*G0P==;U8;H^W-G:'/?@S6WV5ZHY>IJ&1[EE>]*
M(CW*Y%7M55J8..(Z(\SXKN&2^[59)N[;KO;*U'-IVJGL3O4YT8$3'G>AA<S_
M "=RUEFU5--A*V[7532GE_%\551.E/:==\5BL<X>BV#478-;CFMTVS,5MMYS
M'=Y6[(_6I9P6B6\=YCV3PQ^6W6^#Z[6T[?,(O<R>O/2*1]SZA=O.W]<]6FU/
M.:\(X^;]#J+ZU[Q:(N3PZ435_BOO+_&CJZ]7Y/5/N=O\[VC_ .+J_P#=$];-
MX[I]I8?KV_<O^=%Z]7Y/5/N(WO:)_P#U=7ZK5$];-ZBT^T\/TZ=?*_YT.O5^
M3U3[C^=[/_\ %U?JM=3(>LO*Y&":QBRF%5EVQT#FTC5WXU%;TI=>_P!AU9+M
M7,3RIZ?<RL.][/%\4TNKZJQ2?AI7OGR-/SWDF1F=>R*U9)415<WZJT:B=.J^
MPZ]/%+(?+?%VHNS[GENF)CC'S?NVN.BJFFJ*GM3Q^@R'D)BO!1W2KJ*J)X-)
M,5BDN[%?=9?U6S/#N>Y9\QW.(MVV+MWNLU95WD)>^6B:E5?J^>WO]!J[-/GF
M*VSP\\^Y^J\_CK;\5_3FT.6^_OC'93[W')S/+(Y7.W]<M3Q1,FJ?>_C)R_)Z
MG[3/N+?]1=IB*?R[+_\ BQNA-R?C;B37/O!TK_V<E\QWZJSG'\CJ/M7W,BW_
M %0VZWA&@S1_]NSWNK+OK;4Z*L^XX957HNNYA=5/NS$G;\\_:?<[[?\ 5?1V
MQPT6>/ZEOO>MBM[<0QHQF7OWS55-:V]Y:,2BTK34]:'=9MUW[5?1_L8&H_U9
MNF?[K39H\]G_ #.A=W>)OKN>ZP3G+B5D>^S61[9%6)7*YE7,JBKI5.QW:>R;
M(F)[Y?%O'NXY]?J\>?+$V]6*VZ(F*<[KYB/O<75?I=U6O;KX)[S*?../K^U(
M4JG9$7HG55\*> 2V>-(AN_B?U*[-XKPMQA=QH]T\CHUBI/;Q42-E%Z2R-7Q]
MA=)==;-W"O%]9_/Y,>DP1=CONCHX=-M>#-;GUR<;*U5LVN8]>_F7-FOC[IS.
MNR7=D,&[=KYCAAR_P?K=1/7%LI7+\<34]\]I^I^/.'U,G<X1NN6?_1R?P+)_
M7!M%\+EMI8&S.I37/:JG1?8D_L).3+V0G\TS4K&')7]R7E_TV\91JI=6"(M:
M-62WJGT_CSK^IG[ONET_S35?_2O_ ():OY.YOVUR9<VMVV\LH\A&YRNI- FK
MX&M2B-D<O1&G3-F2;NJZ&MW/5ZK5X;;/I71T3,_)/:PUKVJU%:M57LG=24>1
MXQP[5)'1Q-5\CVL9XZE1-/O6O9 Y1CFZ:6\9GL[7M;*YZ7C*ZNGX+(8M;JXB
M=;S23/CD5&.>URMZ2M5%16(<K,5UMW7$3QA[#09]?AP?2MQQ2M>-EU603^L?
M<['+)]JX]Z.7ZL;T5>O7MYYVTR>5E69-PNNY1$?NW/ R_J\W#>.<V3)T21BM
M1;6564U5]EQW2IPG#?=VS#MG3:Z^M;HC^+WL1R/JBR\C$MWY3++XZ[>Y<G:O
MCYY;-)=$UK/IEU?RO6W1QS4]-WO4M?4EBI-*9BXW-<(C-*K'>HB*O]],O03I
MLLSSBCG;L^>?GRS/]:YV'<S[ W)#]F64&;@RLCFK%/D[J%]M1%HK:(]55RUZ
M$G2S;%>;HUFS3&&9B9F[SS+NM<US4<WNO@IUT>&K'8N2JJU7*C53O7HB!8B9
MF*R]3:',>SN(-RVN=W1BILQ&SS/)LK;R%<M87Q.U-F5$7]V:Y/H.W'BZKXF>
M4<WJO#^DF^_ZDQ\,<N'[T-OQ?ZQCC&W55AV5F(Z]]"V;47[TALZ1#W\1$<G+
M_60\<=EV?FU3]O:?PI5%_P!9#QPJ=-GYM$7NJOM/X0"B?ZR'CFM?Y(9NGLUV
MG\*%5_K(>-U6J[/S?M^O:4_?"#JWW^L.XGRD*6^2V'E;R!%UI'<I8S,K14K1
M[U3LJDFV)YQ5PNLMNYQ5YL?KNX'A>DT/%US',U45LD=MC&N1R+6J*BU[G#Z5
MG='J=?T,?X8]4/:;_K'^-6-:QFS<TUC4HC4=9HB(GL3S#LC@[J0O_K)../\
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M9[@QMGEK>WE5/-CCOH&3M:_2JI5$?1:>(5[C75=3PH$7@
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M7!HB>S_)T'?W ; B1:JJ]5_V=O<!R@
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MAI,N2[)=U73,SY>+LT3V)T[%=11.].H"B=J= %$]@"B=Z >3?;6VSD9%FO\
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MMS:>U=G6,F,VC@\?@,;+*MS+9XJT@L8'SN:UBR.C@8QJO5K&M5RI6B(G@![
M  J(O14J H@"B>P"E$I2G3V 5H@%*)[ *+TI1$H!;I3JO@G7WU$D/)W%M+:V
M\;*/&;NP>/W!C(I6W45GEK2&^A9.UKF-D;'.Q[4<C7N:CD2M%5/$#T;''V&+
ML;;&8RUALL;9PLMK.SMHVPP0P0M1C(XXV(C6L:U$:UK4HB=$ [-$3L@
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MJ:I'(Q.GO54 6MU;7;%DMIF3,1::HW(].GO2H'8
M                           !\[?4QD>0]F\[8K*[6R-PZ_N79*YLH6NT
M>7 U(T>UBM15II<H5)GB7U+[-W[M1V1W!=08/.66AN3L;E[;9J.F?)Y?E).]
M'.^%B*[V5 WG:W$-U"V>WE;- ZNF5BHYJT546BHJIW0KBYB*4  *( 5$4
ML>ZBHWM7Q T1ZHN5,WQMLF)-N=,UE;JWL89E<YGEMNW.A5Z.;V<U514J145]
MR7_.G!F6VINC-;SN<O99CROM2UNKR/X73W"0U:D:5>B-1555 G'MCF#8.[LE
M)BL-EH9;]%^&)9(T<^C5>NA$>JNHB=:%1GC/B157JG@OM OH 1$3H@
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M#/)L/*VRK+<7D?+7\D;77]LD<L;(Y'*ZB,65$54H@&Q6HO3Q<[L)6',$
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M)KX([^!T=TL,M%\Q;>9.B?10BI>1_6HO=.R^U .0J
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M$K7Q :47H!T?L3%_:K<Y\NGVJV%;9MSJ=5(5<KM-*T[K7L!WT1$[
M ..541$5?O>T"URJJ43JJ)6GM3V 16]0'I5EYCY&Q&\63:+5K\?:9-NF-:65
MN]ZR_6F8KDH[LU*KX 2$V#L; <=[7LMK[>A2"SM8HHY%37^-FBACA654>Y^G
M4D;?A1:(!DT2U54KVZ*@'*
M      XI$ZTK7QI[@+%6K=5:HJ_"G;H!555J*VFCV>/0"U$JB>4E6IV9VK]U
M0<W.Q:M146OO[ 7        <<B:EIVZ?6 XZ(WH[JB=E[4$BM4[M6JK]9.Q%
M5<JM6B_5\&_[94<C/'V^*!5P0      !:^NE:+0#C:WJFGHM*K](5:Y7*OQ+
MT3I]T42JB.<Q=*I^U2O9/8!R,IJI2FGZJ=RHY2*       +UZ <-6JKJ_"K%
M7KW^% +6HBO1T251_P 6NOM\**!V           !8M46J+1/92M0"*G=$[]>
MX%X                      "R2B45>R=0..BI1:UJM=7L10*HZM74JJ?K>
M)%%<YR=/JKW7]8"Z-:K1%^%O14IXE1R
M               +=#56M.H#0W5JI\2^(#RV=4IW[@-#42E.@%P        "
MBM1>_P! #2U%1:=NB *(!1&-1:HG4"ZE         !41>B@4TMI2G0"B,:G9
M *HU$1$1.B *)6OB!4        !32VJ+3JG8"GELZ]._50+@          !2
MB5KX]@&E *HB(E$[                       % +?+914IT7N!72WHE.W;
M[@!6-7NGC7[H"B=P*@
M
M
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M(W51 K>%G>0W]K%>VKTDMIVH^)Z=G-=U14".='*O4"X
M
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MDL(YFM][A[6"+HJJCY+F9O2G6O7P RG@7?[MK>GSE_;5S<)]K8E^Y$QRRO\
MB:ZUQ<$,71W6B.;V B\S;-Q9WVU]VY=5?F=PYRPR'F4<QJP7[O/Z-6M?C1?B
M G=ZE]MIG/3C@;J%JK>XV6TOFR,KJ:VVM;A]:IU1$6BD5LSTN;D?N+AK:K9W
MJ^YL\;:1RO5VI5<Z/4M?'[X&Z%35[D*D+D[ 5
M
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MTN(.(<1-(Q6LGL[%T:JBI5/)\ B0ZOHM"BY%14JG8"H
M
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M:(ZK_>H4HR]56GAJ3NJ@<B4IT[>X"H
M
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MY<XCE"1/B_\ ;)^N2"5TG9Q25[/J(2">:XJ
=                                  !__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>tm2225088d1-lc_immunec4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_immunec4clr.jpg
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M /   0 !!0$! 0             ( 0(#!@<%! D! 0$  @,! 0
M   !!08#! <""!   0,# P(#!0(&"P8-#0\%  $" Q$$!1(&!R$Q01,(46$B
M,A1Q%8%"([1U%I&AP5(S)'2V%S<)L='3-!@Y\.%BDM)#4Y.SE-0E5?%R@K)S
M@Z-4A*1E-E:BPF-$9,0U194FAB<H6!GDA=5&5Q$!  $# 00$"@4("0,# P4
M  $1 @,$(3$2!4%1$P9A<8&1H;$B,E(4\,'10A7A<I+2XC-3!_%B@J*RPB,6
M%Y,T-4,D5'.#LV.CP]-$_]H # ,!  (1 Q$ /P"?P
M
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MNGRT=114JBN6KD[J=YF&8
M
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MR1RUJK6M6OU%TB]&HGL&CBE8CP'([YOPUGZ;;G<C(MB
M
M                         !I=[R9LFSNI+:XS%O'<0/<R5BSP(J.:JM5%
M19$7HJ'6G461-*NI=K,5LTF4).7>0[[?^Y7WCY%3'V_P6L"?P<=6L:]6]7?,
MK$5>ICN.;YXI><<TUMVHR^"'/5[ITHY.KG)^T5AYW^%V'@3DVYV9N>&PR%TK
M-OW[T;-"]42-LDKXXTD6KFHFEJ+U52V7]G=$]'3]K8>3:^[#DX;I]F[ZZ)BX
MOD79^8O(\?CLI;SW<JZ8XF30O<Y5]B->JJ9"W/9,TJWZS58[YI$[6T(M:HM/
ML.=VU*HB)3K7L!H')UUR RRBM=C,M?/?\4MQ<OD8YB4<G16(J>Q>J'5SS?NM
MW,;K;L_#3%2OA^DN&6W(_+.SMVXK&;IR%MD(;Z:*.2)DSYD1LDBIU3X**GEN
M_9,=;ENLNI-TRUZW7:K#FMMR3%T3X?R1U/MYWRUI;;HVOF,@B_3*C)Y&,2J?
ME+5>E%5/%?:?6HGBNKX(<G-<EMN2RZ[=^S+T]Y\T\59#:EQB8K.XN;NXC8R*
M-8F.9K:]B_%IFKX53H?5V;'?;2+9JY=3S/278^&E9GP+.),1E,;PKF)<A&Z-
MEU%(^V8]'-<C6,E:ZJ*B>)<5LQ9?/1,KRS'?9I)XM\O9],6/M+G9%TZ:%CY/
MJ&U5:_[A&?6BMB>.O6Y.161.#;'3]4-<Y[V]B]J;DV_NG!P):922[9&][.B=
M(Y7ZO;55./56=G6;=CK\VQ6X<EF2R*75IZ+GS\IS/GWWLN>3XI9HVO55\7.L
M8U6I\99F9KX(^I.83_KX_I]U*6GXJJKO8OM^TS;;FA\I[:W5NO#V^)VU?K8+
M+/']=(U_EJZV5'-E1%TO1:H[L=;4677Q2'0UN')ELX;)IU^+I1XXKV\S:O-%
MYAVS/N%M95BDDDHKG+%>^6J_"B)UTF+Q3_J1;U74:IR[!&+5S;$UI/URF(B(
MBJB=EZT4SLM[AE*@
M
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MGSK3\;_YS=%T?3Y&/Y#-<,S]-]SO)D6R
M
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M;*$
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M\G76UOA(A\:;%-E:]+I\LTEVGLFV?IMET\[C+
M
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M5:5[GQ&.V)K1\=E;%W%3:]5&46M%5?'J<KE90
M
M                         !:]%5M$\0/FGL+:[;Y5U;QSQHE*3,;(E.W9
MR+[3YFV)WI-L3O66N*Q]BO\ $K."VJO7RHV,K_K40D6Q&Z$BVV-T/H2-455;
M\R_C>!R/ID:W2E""X"UR*O;O[2"Q6.ZN3YNU"@K'::43W $C5:*J?@%156+^
M#V 51BIW_ !:K'==-$7VKV(HK'*ZM.OM\ BJ,5%JO@G1"@C7)^'K0!I6O;OT
M(JK$5.B]D*B\
M
M
M
M                                  HJT2H#4@"J)W :DK0!5 &I*5!
MBHH%0
M                                  I5 M%:A%*H!6H     *@4J@"I
MJ4*H!6J$J*5*JM0BE4 50+16H12H%:@          "BJB=P*:TK3Q *]K52J
M]_'P :VTKX %>U$5?8 1[52J 7
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M@E*4[M\ %?=U[(@!.O85*+D_;\0*@
M                                                         !BF
MD;!&Z5]5:SJJ)W4^9FCDMMXIHC3?>JYEK=SV\.*5S(7JS4^/JJM6B]K@U_\
M%NJ/IYWKV+^7LWV1=.3?X?V7S?Y6KE7_ .AT3VUC_P#Z@OXKX/IYW-_QU_\
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MUS%,E=3O+>U[D7Q[*I4?>G9
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MCDJ@%0
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M52GQ)W3V5 O
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M) =SQM]:9:QL\MCY?.L+V&.ZM)M+F:H9V(]CM+D1R5:J+1R50#[V?*G2@%P
M
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M*^AA?'#<R9;%1VV.U([[N=>P?E[)KD7HZ-_P2>Y?%"*G>5
M
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M"%[:RR.1=+5D[(OX -';MKESU-<E[5S&]=O?<N$VXLJON%F;,K5>K9F(C')
MY:NAITKW"IR;\X\V5R=A&;>WWBF9?"1W#+QEI))-$U+B)KF-=JA?&Y:(]WC3
MJ$03]<7!W%/%>QMLY7C_ &Y%A;Z_RKK:ZFCFN9E?"EM(]&JD\LB)\2(O1 J>
M''$:?T>[2<BT5<+CJK_Y+&"6T(B(E$[!%0
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M*5*$H&GV=/[Y2I3MU)0-*?L%*FG]DE"JFE/PBA56@"GC[!1"GMZBBJE0
M     6N;7]W[ .*\V^G+#\VW5E/F<JMI#8I^2@^F\]-5%15JDL:]:@<D_P#X
M]MB]:9WO_P#(%_Y4!V+$^GC 8KFK(\TLOO,RV129)++R%;3SX&P+^5\U:]&U
M^0+5JO)'HTXUY!W-<;IHW&7]])]1DJ12W"W$RN57.577#4;5*)1J4Z!'4N+.
M)-J<1[?3;^U[=L,+G++<2-\Q/,F>QC7OTODDIJ\M%HBT WK15M%4"!]C5?[2
M[)IX_3-Z_P#X7A GF
M                                           I3V+0BU*4[%14"BI4
M*:?],E"JI4 **@"A**40(4\0M2G^F*%2@H5*)^P$-/OZE6I1"4*E/V11"G[(
M"GO"U-/B*%511 H  +7HJM5$6B^U ,3FHB*ZB46FKV].B 5=5.]51?! *-55
MJE*-3NOC0"G5*ZNR=>GL_O@5U>'@G=5[@41&Z*]5]KE[J15RZM2?[G^W4"%W
M]I)_5OL[]-O[_P DD*)8<<?U>;2_0N._-8PC9P
M
M                                              "!MA_G,,E_)F_S
M7A GD
M
M6^6VO[G@ T(BJM5JH#0G]_W_ &@4\MOOI[ 'EM]X%VEM*4Z>P!I3]T"%7]I(
ME.-]G?IQ_P":2 2OXW_J\VE^AL=^:Q@;.
M
M                             *.6B5_N@6*]W=M%1/FI^X!19%3LG7V+
MX?:13S75THB53NO@5%[55R55* 7       @;8_YS#)?R9O\ ->$">0
M                                           %%_; IJ4CZHN#Y **
MOAX@*]:!52H
M                (4_VDO\ 5OL[]-O_ #20"5_&_P#5YM+]#8[\UC V<
M
M                                                     6R5TK0#
M$CD:U7JM&)W=X$'RP9"RNM+[>9'JZNE:*B?#T7NGN*/J1JH[VNIW\ ,K/E^S
MN!<      "!MC_G,<E_)F_S7A GD
M                 !1RT\*KX(25A\>3OXL787-_/UBMHWR.:G==#5=3]HX\
ME\66S,]#L8,,Y<EMD;[IHX._U9[6C<K/N6[=1::DECHO[1A?Q>/A]/Y'I<?R
M[U4Q7M+?-*W_ "M=K?\ 0=W_ +['_>'XO'P^G\B_\=:K^+;YI;/L/U!;=W[N
M.UVW:8^>TN[OS/)?*]KD7RHGRNZ-3V,.SI^8VY;XLI298?F_<[4<NT]V>Z^+
MK;:5I'7,1];KO6O3Q\3*-$7GT^0
M                   BXOKOX;6B)]>E?'Z.[_P !/7?PY5:_7^Y/H[O_  ;
M_P 2>I'8G,F<O<#M3ZE;ZQM%OI6W$$T#?*;(R+HZ6)B*M9$Z =@8YRNJY>_9
MOL_"!D        A3_:2_U;[._3;_ ,TD E?QO_5YM+]#8[\UC V<
M
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M8FJV*ZC;*UKJHJ(Y*]:HB_M&UV7<45>#9\,XLEUD[[9H^L^W
M                                  '%-R\/<";0P=YN#/8"WM,;9L5\
MLCKNY1.B?*W5<(BN=V1*]5(J.TO.?H=@E=$[;6272M/ABNW)^REX4=3].V_^
M'-Z;VRK.(=M7-A808MRW.6NH[MFN5+F/5!6666/Y71OHGQ?@ DU&U4=5%Z!&
M<       "%/]I+_5OL[]-O\ S20"5_&_]7FTOT-COS6,#9P
M
M                                          !9(JT1$2M0.(\\;$X.
MWA:VW]*=YC['(1:ON^>]O&VTB*OEZ]$;IXD?T1M>BT"N ;?X,])6)O$O;_=V
M,RC6N1T<$MW;PHU6UI\4=TB]Z+^ @FGMR[P5_A;&]VW-%<X:9E;.:!Z2PO95
M4JU[7.1>M>RE1[;*TZ@7       @;8_YS')?R9O\UX0)Y
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ML38+=B,B9T:WJOO\3L1$1%&)OOF^:SO9D]B>TKX7%?(
M                            <+]5VW\UN7AO(X[!Q27$[;RQN9XK=LDD
MCK6WN&R3HU(VO7Y$7NE/;0"(6_..MB;>VSL3EC!;0=>[<BM[>RW)B5LV33.<
MZZGFFEN(8T:Q)4AC1J*Z5/AI5/$*ZSZ/<U8Y_DW=N2V!@K[!<4W%E<R6EO<V
MWTUNF2?>0/1K?)?)#J2V=$B)K5]$_>T4(FFRFJC%14\0,H       $*?[27^
MK?9WZ;?^:2 2OXW_ *O-I?H;'?FL8&S@
M
M                           "R1:(B>U: 0=YVV!CN0?4MC\)R/F'8_9,
ML5LW$P_41V[72K:*MQH^JC?&JU:Q5T?A\ -Y3T6>G?0CDO+MR4Z+]1C5K_YH
M!(78NU,)LG:.)VEMYSI,-BH5@LWN5CU5BO<^M8VL:O5R]FH!L251$;7K^V!X
M^X]V[>VAC9,ON7)VV+L(T6LUY/%;,732M'3/8WQ]H&D[.]0?%.^<HS"8/<EB
M[*2ZO(M'WUDLLNAKGN\MD=P]SJ-8KEHG1.H'3%D<VG?K\J?W:@<\WMSGQGL'
M(,Q6X]Q65OD7*B.M?K;..2-%<K55[)9XW)14Z] -KVONW;V],5%FMLY.VR>-
ME1%^HM)XKAC7*UKU8YT+WM1R(Y*I4*]E7JE6U157Y2""5CJ3^TNR5>Z6S?YK
MPE1/,                                         %*(009]1_]9-RG
M_P "G_#3&G\P_?R_27<G_P ='C_RVN1T0Q[>U4[I]J!'Z%\0?U9[:_D;?^V<
M;EH/W%OTZ7Y6[R?^2S?G-W['>:XMJJ*OL]HJHKM**YRHB(E7*O1*!:./\J<S
M;)P&,N\+]4N1OKB)T:LL)+>X\M9&JU/,3SFN;WKV[&*UFKQQ;-M:UCH;YW?[
ML:W49+<O#P6Q/WHNBM.KV4.<+M;<&YKKR=NXJ[R#-:1NDAMY9V1HJHFJ18FN
MHB:DJIK&/%=?/LQ,O?=5S#3Z6VN?);9LZ;HBOBK,.W;7]*N<NXX[C<E]#!#(
MU'I%:RR,G:KD1=+FS6JHBI7JGM,OBY7=.VZ?IYGG.O\ Y@X+)F,%LS,?%$4]
M%[I&S/3=MO:FX;7/37$]\MKYFFUGDCEA?YL3XOB;].Q5IJJGQ=SO8>6V671=
M6M/IU-2YGWWU.LT]V&(BSBIMB)B8I,3OXYZNIVZ.&*%B11,1D:=FIT3KUZ&6
MB*0\ZNNFZ:SO7H?3X5 HO[1%47VH05HGL/I*J@4JO3]LBB5_ !4J
M                                   &N;OW%A-J;=O<YN)\<>)MV*DR
M2I6-VI%30J47YNW8*BK=^L[@]MM+@_U7L[K"ZJ_2JZU6V>M%;7REAT]E5.Q!
MT;T_\Y\:\D9C(;2V!MRUV^EE;.RDT=@VWBB<B210*JL@CC2OQ-Z^Q"B03.CD
M1:5\:$&4J       (4_VDO\ 5OL[]-O_ #20"5_&_P#5YM+]#8[\UC V<
M
M                                                     ?)?W]IC
MXV27DC8XW.THYW:M*@13YW]-LW*'(J[RCW@N*_B]NVRM5GN&+"K(D8Y\:1M5
M&ZT[JG<BRT5/25N>G3E>[;_J?O'(^'X"B7?%NV;C9^P,%MN[R3\O<XZW6%^2
M?(^5TU7N=J5\GQ+WIU(-P2J)T2KO!5ZA$=?4UPQNGF.XV]C;"_?;;<LYGORM
MO"LC'RLD9I5M6U;W1/F0JHZ\M\?['V_S!L;9O$\\OZ],^M^][6W5K)8F_=?F
MQJWR8XE34SS%7XE"/T#SEV['X;(Y%J?E+6UGG1J^'E1N=^X!!/ACB_;W/F^^
M1=W[MDN+BZ==75A9Q.>V2*)EQ;PR(YC962:5:YRJBM W?T>R7FW^0>1>.(IW
M2X' 97-16D;U57(MID(K5GL;\C43HU"*[_O'GKAW8&>DV]O'==GB,[%''+)9
MW"2J]K)6ZF.^"-R=4]Y40^V'NO;N]O[0R;=&T\@S*[?O[9_T=]#JT2>3MUD,
ME-2-7X7L<WMX ?H<                                          00
M8]1W]9-S_P!Q3_AIC3^8?OY?I+N3_P"-M\?^6UR0Q[>A.Z?:@'Z%\/\ ]6>V
MOY&W_MG&Y:#]Q;].E^5N\G_DLWYS=U.]+7'C;AW)A]K6#\GF;EEK:-_'D6B+
MU1/8OM.'+EMQ16[<R&BT6;5Y(QXK>*? BEO[GC<V^[S]6]F026EM.JL:L;E;
M<NTZ'U;)&]O3X'>'9:&M9]??F]FW9'I>V\G[HZ;E]G;ZJ8NF/T>F-L3'ACRO
M<X_]-E]DWQYK?EQ,Q[EU/M'*J7&IO1NIST>BIT_8.73\MNOVW[/7ZF.YQWXL
MQ1.+21'C^[Y*423P>VL)MRUCM</906K6,2-9(XHV2/:B)\[F-;55HE38<>&S
M'%+8B'D6KUV;4W3=ENF[RS3R5>J<KHBU3KW]Q!2O6GL[^XJKT[%?(!:M._L(
ML(X^JW/9K"1;5;A\A<V'U/WAYRVDTD"N\M;73J\MS:TU+3[3 \VOF."D]?U/
M6OY>Z/#GG/VEEM_#V=.*(G?Q]:-7Z[[T_P#:/*?\=N/]F8#M+NN7KWX5H_X.
M/]"W[#]=]Z?^T>4_X]<?[,=I=UROX5H_X./]"W[$N?3/ELGEMBS392\GO;A+
MV9$FN97S/THV.B:GJJT0V3E5TW8YK/3]4/">_6GQ8==$8[8MCAC9;$1'3U.U
M)WK[? S+SR5Q4                                           .#>K
MG&P9;A/+6MQ>K86S;JRGED:DBJYD,[7.B3RU14\Q$TU\*A7(^%M]>DZ?CO#V
M]U!:VV1LHO(OK>YQ]Y>2Q2HY5TNF6U5)%TJBU15]@'>>,,[PEE,S=V_&7TJ9
MEMLK[E;>PGM'+:^8Q%JZ6")%36K>E0CJ[5773OTZ^% K*$       0I_M)?Z
MM]G?IM_YI(!*_CC^KS:7Z%QWYK&!LX
M
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M^BBED?,]/J=OMN)*ODJY?CD=W"/T:
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M3I_\NG_[6,V7E/[N?']4/S__ # _[^/S+?K=X,X\S
M                         '.>9,+L#.;$NL?R5Y;MIOF@=/YRO:SS&2(L
M?\&]B_-[P0C3_1?Z+/WEE]OF7?\ RD#?>*(?3#QAGKC*;&O[+'9+(V_T$TRR
MRM:L+Y&2459IGM3XF-4BI*V=S;WL4=Q:2LN+9Z(^*>-R/:Y')7HJ53LI1]54
M"%0  !5   "%/]I+_5OL[]-O_-) )7\<?U>;2_0N._-8P-G
M
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ME$3K5>B(09%8BOU(E*=E"H)6*N7^TNR=4HY;9O3_ /"\)43S
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M:.1%-EY3^[GQ_5#P?OYFLR:Z)LF+HX8W37K=P,X\X
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M %>;2_0V._-8PC9P
M
M           !RGG;B!W,6"Q>(;F+K#?=UVMVL]FL:.>CHW1Z7>:QZ4ZU CY?
M>BFUL[5\^3Y"R5K9I_"37$ME%&U*HB5<Z!$3JJ :YMST9\?2WDD.U>45NLA-
MUEAL;['7$JZ4<O5K(W+VU+V F;QQM+]0]E8;:3KN6_=B;=T#KR?2LDBJ]SZJ
MK$:VOQ4Z(%;9'\M?;[>X1>      "!MC_G,<E_)F_P UX0)Y
M                               %[ 6]:=>_M(^FL[XWOAMBX2;+Y:9&
M:41(;=%:LKU<Y&5:Q7-54152M.QUM1J+<-M99CE7*LW,,T8\<>.>B/+1$/&6
M.\_4!O%;BZ23[KA?JEEH]+>WA5S-<;'JUZ:U15<UKE-5MLR:K)]-CW?/FT?=
MS1\-M..8\%;IVTF8K&SKF$Q=G[2Q&R\);X3$1>7#"QB2R+\\LK(V1ND?3IJ<
MC$K0VW!AMQ6\,/ N9<QRZ[-.7).V:T\$5F:1XJO?.=BP
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MDE>JX;'?FD8&T(J+U0
M                  *@ %4
M                %DB?#_HI^$"$OJ%S&ZN2>?,3P;BMR7>V,1 R*6ZDL+R>
MR==I?6WG(U_EN>U_ENBJFJ+I4#6^6?37E.#]I+R!L[D7<%KD+.>!MPMQEI&-
MD261K*)]/! Y45KGHM7^/V@3 X8WG<\B\7;9WI>QI#<YBV6XD8U%1$5)7LZ:
MGO7\7Q<H5O[.R_:$7       @;8_YS')?R9O\UX0)Y
M                          /EO[^SQEI)?9"=EO90HBRS2N1K&HJHB55?
M>I\771;%9W.?#AORWQ99%;IW1"$6\=U[EYOWG'C\/%<+CUHEM8Q^8Y48D<:R
M*YC7R-Z*QSDHGVFH9\U^IOI$>*'Z+Y9R[3<AT<WY9CBZ;MG7--M(GIHEOQYL
M#%\?X*'%6,;5N=+?JKE&L1TKV]-2N:QBKT\5-GTVFMPVTC>\,YUSC+S'/.2^
M=G1&W9Z9;>E:K[#M,"J5
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MK\O%&B_$J)T*)V<=]./MIZNC?N7&_FL85MK>R!%0
M                                     &M[_P M=X'96>S5@J-O;&QG
MG@5R:FH^-BN2J>/8ZNJR39BNNC?$,OR?3V:C6XL5_NWWQ$^64,G\_<AOD>Y+
MJ"JJJJGE+[?^N-5^=S=;]!1W/Y?$>[/G6_T^<AI7^-0+3NOE+TK_ -D3YW-U
MK_M#E_PSYW1N$^7=X[GWM#ALK/%)92P32N:V/2[4Q$IU55]IW=%J\M^6+;IV
M-3[T]W-'I-%.7'$Q=$Q&]*U.QM#Q$
M                    8Y55$147LO;V^X+"/OJ!]--GS')#F,3E78'=]LU4
MCR3$?UJC&MU)$YCETM:Y/F\0./V'HQY!W'D;/]?M\_6;?L%55LH8IX5E5:*U
M55;AZ+I5C>Z!$S<'A<?MW$6N#Q$:08VS9Y=O&B(B,;55I1$1.ZBA5ZT7R4K5
M4[_:!>      "!MC_G,<E_)F_P UX0)Y
M              L^WHO="/I7I5*^/B!%'U$\J/R5VFS-ON5;=K5^KG:JIYBN
MTKI1%1JHK59WZFL<QU4WW<%NZ'MW<ON_&*SYK-OZ(ZO#Y:NG\#\6KL7 )?9:
M'3N"]<YT[7HU71>6^5C4145WS,5J]%,EH-)V<<4^]/HWM,[W<_\ Q#/P8Y_T
M[=WAK%L^#=+L)EFA
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M_P ;/YUJ=!N;\V
M     "CJ4Z_@ C#SKZJ5XPWI!QYMC;<FX=S*QDUTGU2V;(&31I+&NIUK.UVI
M$<G=* <[3UB<KIT_HYZ>S[WA_P#\<!+#C'=&0WIL/"[GS%A]V9+)0+-=6'FI
M/Y3D>YM/,:R-'=$K70@66X,<B-3V> 1=5 "N1%1J]W=OP 41[52M>@#6VNFO
M54J 5[4HE>ZT N @;8_YS#)?R9O\UX0)Y
M               M[)T^TBN5\X<C,V-M::.T?3,W_P"0M7)2L3G-5Z.HYCT7
MY53J8S7ZGLK*1[TMV[J<EG7ZJ)N]RS;/AZ.N.MQ[T\<<S;ES$^^MPL\RWBE5
M]IKK625WF-E14:]M/F1>K53V&*Y=IHR7<<QLAOO?/G<:7#&DP[)F-O@C93HG
MUI:M1$[)1#:(>&2N*@
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MI1M&TI^]]A40O_M(J_T;;/K_ -./_-) )8\;_P!7FTOT-COS6,#9P
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M]H)Q1#KGISBF3DJW5T;NMK<=5:OL:=_01_KV^7U-%[ZW1^&SM^]:G*AN3\W
M                                                  "U]:=J@0.]
M1N\,[M?U&8Z[XNQ$]UOF"*!V<\N&:2&Y@6T7Z9CWM;(C="*_Y$1:]R0LOI3U
M$^J=*?\ Y?0U3_47O^"*);<89S/[DV#@L]NVP3';CO+=7WUDU'HD4GF.:B(C
MT1W9$7J@1M[?PHY>E:=@+J_M=%<!:KOCI7IXUZ?L 6JC6HG1="=--/:!5>J(
MVOV?: Z4Z=%[*OC4#,G8"!MA_G,,E_)F_P UX0)Y
M                      \_,92UPN+O<M>O1EM90RW$JJM/@B8KU1.U5HAQ
MWWQ9;,ST.UIM/=GRVX[=]TQ'GFB%EZN2YQY8F@:KW8M)Y((YHVHJLLF32>4Y
M>E$Z.3N:C?74Y]G3/H?H7%V?(.51.SCI$TZ[J17U)F[=P5CMS$6V)L(TCAA:
MB*E56KZ(CG=57O0VO%CC';%L/S]K=7?J<LY+YVR]5.ZK[3F=)4J
M                                                      -)Y0Y*
MV]Q-M.?>.YV7$F(MYH+>5MFD3I==R](V+2:2)M$5>M7 ?=LG=^'W_MK';LP3
M94Q.2C\ZV=-Y>MS4<K>\3Y&KU3P<H&PHB5JE%5%Z?Z?O N:FKNO7Q0"OEK[:
M*O=4]W8!Y:^X!Y:HE&K0"NAU*=%3LJ*!1(U2J*M6KX^(%4CZ4_87Q >7V;W:
MGBO>H$*_[2-%3C?9R+_TX^G_ !20"6'&_P#5YM+]#8[\UC V<
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M'9-;;8B6.U'-M7J+.#+ENNMZIFK8#LL4
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M\/!?$R]'GM542GV%%0@
M                     #B'JIQ6ZLUPWE\7LO!IN+.S36K8\<L"72K&LJ:W
MHQ53JQOQ(O@!$'CO/^MWC';MKM?;6P+E^)LVZ+=EYCY9W-3V)^61$]O1 J2/
MISW[ZEMU[KR=ES;M=,%MZ"P6:PN6V+K/7>I/$U&*]9'U^!7K2G@!)=GPNI[?
M%0C*       !"G^TE_JWV=^FW_FD@$K^-_ZO-I?H;'?FL8&S@
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M-;IK,];+_H1"OE5/90/E4H
M                   6/[)]H$:N>/47N#9&ZH>.^.<([.;ZF8Q[K=C6S+&D
MK&RQKY2JQ5U-1_9P5I>$]2?,*<61[VS.&M[K*V\WE9.WM[=(_+;)>20QUK(J
M)^397OX!$HM@[RL-_P"S\3O#&,T8_+0_40?$CZ-1[F4JB)7JT#8E5:53K[*?
MND'.^1N%]G<I93 97=;9YG;>G6ZM;-CH_IY7N;H5)HY(Y$<U4\.@5%/T<6UO
M9\W;X@M8F6\#+2STLC:C&I\-QX-1$*B==P^2.VE? U9)&,<Z-J?C.1%HB?A
M_._(\,\\[FYKWONG"V$V#;>W%W+;7]W#,K'Q/2-RQQ/B>U4U+\J=JH%=F])?
M+VY=P;EW-Q#N^*%^X=G+>0W%]$U6*]F/N8;'2Y'N<Y7*[4Y550CTN;?69@.%
M=_W.Q+_:M[EKJUM[>Y==P744+%2Y8CT32YCEZ5]H$=^$.2;7E_US0<AV-A)C
M+;,VT_EV4KVR21_28+Z5:N:B(M5A5WX2*_2TJ
M               !:J>">)%:YO?=-GM';MWF;MR,:UJQPJY:(LKVKH_;.MJ<
MT8K)NEEN5<OOUNHMQ6^7Q=*)?%.W\ERKR9^LF815LK>Z^\)G+58O-AFBE\I$
M<KNCD5>G8UG28YSYJSUU^NCW/O#K,?*.6]AB]Z;>".NDVS'%T)J00QV\4<$+
M49%$U(XV-2B-8U*(B(G3HB&W1%'YXONFZ9F=\LI]/@
M                                               :CR'O?%<=[2R.
MZ,K5;>PC56PIKK)*Y/R;-3&/IJ=1*THGB140;7U%^I+?,*;OV+M1T6TW)YK(
MW7>'<[R4^)4K/HD[?ZFI4=U]/7J!M^8K;)8C)8U^'WA@9Y;/*63Y4N-?TC8&
M2SH^*)D2(Z61S=#7+2GL [E&U*UIT\%(592@      "%/]I+_5OL[]-O_-)
M)7\;_P!7FTOT-COS6,#9P
M         4JOL"E47HOB"B"W/N4O9.2LDEO=RMA\FV1&L>YC:^2U%Z(J>PTK
M74G/=Y/5#])]S]/9'+;*VQ6MW1X7*&.DB<CV.5C^Z*B]>GO0Z<[6\3$3O?5]
M[Y1%54OKC_?7]OV2<,.#Y;%\-OFA^A_'#G2\=[2DD<KGOPN.<YRK55<MK&JJ
MJF\Z:/\ 2L_-CU/RGSN*<PU$1_%R?XY;/3L=AAQ$TI1.Q250@
M                                             !:]*MIX>($5^>."
M.0<OOZ'E_B&]BBWE&R**2"9D,FM+>-(8Z?5RLB2C7/7M^X17#<!P7ZP,MC[K
M9NY+.#"[4NY8Y;IZR8BY63RY'S)18+I9&_$Y>W[[W%J43MXXV78<=[(PNR;!
M^JSPT/D1.^):IK<_\97+W=XJ$;0M'+T^;O3VM :J+VZKT;]OL B#Z9^+M\;1
MY;W?G]R8OZ+#7]O:QVMS]1;3:W1I/J33%*]Z4U)W:%=+Q^=YIR?.&8VOE,;Y
M/%/E7+++(^;CUZ_3(L:Z(W?4_P (J_,G[1)(V.);KVMZL^-M\9R7C6&/+;>S
M"S/L)E?BHUBFEI''5+V97JB::]D*CH/I6X,W;L?,;@Y0Y(B2#D'=C[IV4C:^
M%[56^GBO'NI;2R0I^5UI\*)^P!).ZV]A+^?ZF_QUK=7%$199H(Y'JB=D5SD5
M5H!!K#VEK9?VE&0M;2".WMH[9-$,+&QQMU;8A<M&M1$2JK4"?
M                             M7W$?2)/J3WN_/;CMMB8QRHMG*D%XQ4
M^:67RGQ*BN:VE-7@XU?F6?COX(^Z]S[C\JC3Z>[5Y/O16WQ1Q1+N_#^R(=D;
M/L[-6(W(74<=Q?+75^7\MK'==3D_%_%6AF='@[*SPR\S[R\UNU^KNNK[-LS%
MOBJZ!_H0[[5U2H
M                   .0^HWCW(<F<5Y/:V)F\B^26WR%NM$6JV$B3Z?B5/F
M5M!546]E>K+??%^UHM@9O8<USE< U]I%/']5(R=>LB.U,@TI\3M/0#HGI1V7
MO'+[VW5SQNNW3%.W5'<V]OAJZO+AO;B')MJYR,<E/,<RBL\.X1+EG1W;PZ 9
M0       (4_VDO\ 5OL[]-O_ #20"5_&_P#5YM+]#8[\UC V<
M                                     %BHB=_P'R^G/^6N0K?8.V9K
MMC_^=+AKF6+&JE?-:B.Z]%I5/<=#6:F,-GAEM'=WDUW,=3%L^Y'O>) :\N7W
MEQ+=3?&^5ROJO3JJU7M0T_:_3V*R++8MCH8:4JG:G@@<BB]_P!7Z-<:?U<;/
M_0F-_-(S>=-^ZL_-CU/R9SW_ ,CJ/_JY/\<MI.PPH
M                                        624HE>]>GV@0]]0W*O+M
M_P GQ\0<.2NL,\D4+Y+W6R)KEN8DE9598GL33H>G?Q"M$_4/^T3>Q*[H:K%\
M%O<=X?\ >@)C\4V>^,?QWM^QY(N?J][PV^G,SM='(CI_,<J+JB1&K\.GL@);
MDZJ45741%KTZU(BKM*HJTJE*JWLI541=**YRJJ-[]/:1%-*Z$UK5?!/!"@J5
M5$=X]V^%?;4"NI$5$I1:Z45.OX2*SIV*B!MA_G,,E_)F_P UX0)Y
M                               #4>1-ZVNQ-L76=GH^2#R_+@5VES]<
MT<2T3JJTUU6B'4U.>,-DW,[R7E=W,-3;ACIKMZO9F?J1A]/>RKC>6Z+C<^:_
M+VMDC4D<]-*NE<E8W)IT]M'@:[H,/:Y*SNA[)WRYI;H=+&GQ;)N]73ZTRJT_
MNU-LA^?SQJGX0+BH
M                     (E>I?U2XC9>%R6U]M7-YC=^V5S8N<U[60KY$JQ3
M2(U$E\SK%)^\_:"OEV9ZQ^';C:^'GWA<W$VYHX$^LE=]-J\Q'N<GSW+7=J=T
M"/8]/W/F<Y@Y<W98V4$B\>X^SN78NY=&](W3QWS&QM5Z/?&K_(D:JHU?V@42
MB:J53NON3P R@       0I_M)?ZM]G?IM_YI(!*_C?\ J\VE^A<=^:Q@;.
M                                              #Y[NZ@LK>2[N7M
MBMX6J^61ZHUK6M[JJJJ(B'Q,Q$5ERX\=V2Z+;8K,H3<BY[+\N\C?<>)J^S;<
M+:VK&HOE>9$KV:ZMU_,B=S4-1DNU&6D>*'Z)Y+I,7)N7=KD]ZG%/72:33HW/
MEY+XEW-B]TS6>V=LY.[Q3(+=8Y[*RGGA61T35DHZ.-6_-6I,^DR6WS%MLS&S
MHGJ<_(^\6FRZ6+L^:RV^MVRZ^V)I79LF6G_T:\CIT_4_-=/_ $;=_P"#.+Y;
M+\%WFEGOQSEW_P C%_U+/M$XTY&5>NT,TB>U<;=IT_WLGRV7X+O-)^.<N_\
MD8O^I9]J>_'UM<V6PMK65Y"^WN[;$8^&>"5JLDCDCMHVN:YKD14<BI144W'3
MQ,8K8GJCU/S'SG);DU^>ZV8F+LE\Q,;IB;IVPV0[#$
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M
M     '">=^#^)=]8/(YO>-O:XB]U03W6X+>&S@O--MH1&+<2V\KJ.;&UE%_%
MZ=B56C@N&W!Z,,%C+;$RX["Y.2T9Y;K^[@P\T\RU5=3WK"BN7K3L4=EX#W_Q
M+G=SY':G$VV+;'XN"P=D;K-8ZVLH8'S^=' Z!7VB-J_3Y<E%;VIU D+&JHZE
M*I[4_="0S        0I_M)?ZM]G?IM_YI(!*_CC^KS:7Z%QWYK&!LX
M                                          .+>HS?OZK;0?A+"6/[
MVRZI;R1JY4E9:7$4Z+*U&O:J*CXT1'=4]QB.99^"SAC?/J>A=RN4?-ZN,M\3
MP8]O@FZ)MV3LGHG<U?TT<=I;V<N]LM'YMY=JK;9MPU'OC>Q^I)6*YE45R+\R
M.ZG5Y9IZ_P"I,?3K9KOSSKBOC2XYI;;OIT[-T[>CJHD>GV=C8'D@E?%?M"G>
MJ+U0(JG]SH!4J
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MZ/RO7.^?-8T6DMTN*:77QT;)CAFR>BF],2B+U\?%#:7@BXKY
M                                                       !P;U=
M87(Y_A3*6.-21'-O+">Z6%WEO2UAN&OF6J*WIH1:A4/MZ;0V!M':W'7*.%MO
MK-FNAM,5D'.7O)-=S2/<KGLJM(HTZZ%^T(ZUZ.\CBK_E?>EQL:R6UX[N8+NZ
MCF?(DSERDM["JL:Y6QN1OD+&J-T4_N 3<:J*J=*+[ ,@       $*?[27^K?
M9WZ;?^:2 2OXW_J\VE^AL=^:Q@;.
M              *55>W<BL%Y>16-G<7LZTAM8WS2K[&QM5RKTKX(?-UW#$S/
M0Y,6.<E\6QONFD>5"G<-S=<R<R-L(W^9BFSI:1O9T1MFVX=1]%5JK3SOM-1R
M3=J<_EIY*OT1HK+>2<GXYV7TXO[7#N_NIFX/&087$6.)@1$9:01051*:EC8C
M=2_;0VS%CBRV+8Z(?GW5Y[L^6[)/WIF?/+T*')1U!$1.A5JK0(4
M                                                    ")GK^VME
MMQ<58V\QKG-@P=Y-D+_3V6!EK(BHOQ-Z57W@= X Y5V!N;CK#V^%NXHI;"V@
MM;N&-DG\-#$QCWU\MJ5<YJ^T0LN/^N?D'8N3X]BV79W,-QNV[NX%L5\MZ31M
MCFMGR:7.C1/B:YJK1Z=@._\ I[PF6VSPQM'!9MKVY6QLG,N72KJ>KO.D=UZN
M\%3Q!1U*-45B*GCU"+@      0-L/\YADOY,W^:\($\@
M                    %%IW4BH?^HS=USNO=5IM#"N^HM[5-2,8NA5N%62-
M[%5VGMI^PU7F.7M,G#'0]Y[E<MMT>ENU.79-W^'9,3Z4CN,MG6^R-IV>$@HY
MS=4KY*4<JRN62BK556FKIU,]I,/98XAY+SWF5VOU5V6?%YMC<>E*]JG<8!<5
M
M        16G]<O"UQ%)!.R]DAD33(QUE=.:J*E.J+ !Y,OJ^].\^-?AYL;<O
MQ+ZUM%L;M6(JM5M6_D/AZ*O8BN@\#<S<2;[RE]M3C6QELI;2W7(3LDM[B)%C
M1\4"KKG8VJ]6=-0'>F-7HJKU\>A49        (4_VDO]6^SOTV_\TD E?QO_
M %>;2_0V._-8P-G
M %OX*^\BN*>H[?*[:VJW$V$JLRF0=I5$1%K;.;)'(E7-<GBGO,/S+/PV<,;Y
M]6UZ)W)Y3\UJNTOCV+/\6R8Z6N>ES8K+3&W.]KYO\=N5DLK9%155;=[;:=KJ
MZJ?,B_BU]YP\KP1$3DG?N]3+=_N;3?DC2V>[;2Z?SO;MZOK\B1R)UKV,\\E7
M%0
M      Y_RQR'L/86(LH^0/-7%YZX7'0QQ6\ERCY',5ZH_P M%5B:4^8*B]D/
M3;Z?][WRWVR=RMVS!<.6::V>^]D1SY?B5:SY"/3UJM$0(Z5Q?Z4>(]F9"'-S
MW,6Y<W CDM+Y\]TUK4?K:_\ )+>S1K5JM3JW\6H5(YJ(B(UJ(U$^5$[4(,\:
M-1/A\5JOVE1<      "!MA_G,,E_)F_S7A GD
M              TKE3=K=F;+R66231=K&^*Q5$1?XPL;WL2BM<GXB]TH=/5Y
MNSQS/2V'N_R[Y[668Z>S6)N\58B>KK1N]/\ M&?>>];G>F4ZLM+AU[&YWQ:I
MI'JKV_"YB)\_[U4]QK^@P]KDXIW1M\KUSOCS&W0Z.W2X_O6\/DB-G7U=:8?R
MI2GV(;6\$5Z_A4"XKY
M                         !P/E'9G!W%NT+G=V7V='<6EM+#"^*TCN+B5
M5N'HQ%1C9*K2O4*X,[G#TOQHKW<?WJ1M15<YV.O$HB=5_P!M[ =9].')_"V^
MMSY2UXPV])BK^"P=)=WCK>:)CH4FB18T=)(]%74YCJ=P)+M5=24[*E.H1<BN
MT_%W .<K:K3H!8YZK16_*JZ:@5UJJ>*4_94!5Z]4[^Q0+FK1O5:KXD4JJ?97
MN5$*_P"TC6O&^SOTX_\ -) )8<;_ -7FTOT-COS6,#9P
M                             !BN)F6\,DTBHUK&JYRKT2C4J?-TTBK[
MLMFZ8B$)=SY&_P"7^5X;*TK=XVWN6^4WJYK;)TL?F*B(B]$J:?ENNU&;9MBO
MH?HK08,?)>53==[-\V[?SJ31,S 8B# 8:QPUJE+6QA9!&B)3X8THG0VW%CC'
M;%L;H?G[6:F[49KLMV^^:^=Z2'(ZBI4
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M+%$=,[9\SRSO#S*[7:RZ^=T5MCQ1,T;T=]K2E$[ JJ
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M;_U>;2_0V._-8P-G
M  '(?4'OE^T-F_3V4_DYG).I9]:59#)%YO9S7?+)X?A,3S'/V>.D;Y;YW-Y5
M&MUE;XK99[WEB>'HZX:-Z7-B_36]UN_(0JVYF:D5B]4^%UO*B.54JVOS-\'4
M.GRO!OOGR-D[_<VX[K=-9.R-MWCCR^'J25[>W]PV%Y )W]_M\ +BH
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M9(;17/?/(Y[GNDU.<JL;7V)V*B3*=@(&V'^<PR7\F;_->$">0
M                       **I%:MR%N:WVEM/)9>XE\I[89([9U41//>QR1
M]W-_&]BG5U6;LL<ST]'C9KDVANUFJLQQ%=L5\5=OH1?X&VYD=_<BW&]<PQ76
M]M(^]6?KI6^CE@?IJYK^[9%6FJOO-?T.'M<O'/C\M8E[+WNUN/EW+XTN+?=$
M6T_J3%T>#ICJHF0B::(WLG2G@;4\!JN*^0
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MD+E=QSM!/%,V]:>*?Q24"5G'"N7C[:B-6BMPV.I7V_21D5M;*Z4K5%]Y47
M                                         4(JE??7[ (1\F[AN^5^
M2F8S%/\ J,7;N8N/C8JNHQ]O L_=:?-&O9$-0U>6=1EI;NZ/,_1G(M%9R?EO
M:9(I?/O?I7</K3%VS@+7;.#L\'9(B06;$B:Y42KD157K1$]IM.''&.R+8>!:
M_67:K/=ENWW35[)SL>
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MM<SRCCONK?=S;7/WKCTA6V\OR\'Y</Y-7.TZH6QN[]:U"/TR
M                      !:J]:*27U")_J1WI-G<Y:;&PTFMJ2)!>PM<JK]
M2DJ>6E$5$_&\4-7YCGX[^"-T>M[?W(Y7&GP7:O+'16V?ZM-KMO#&S(ME[(LK
M5T:LOKQ&WE\KT34V:2*-CV]NB?DTZ&9T.'L\<1TSM>==Y^9SKM;==7V;?9M\
M43,QZW0Z_LKV.^U1<5
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M)YFIUW<U^6E-*?:!^F_'::N/-I(WK3#8ZK>U?XK'X@EM3?E3I3W=P*@
M                                     44BPYMS7O9FRMFW,L4FC*7C
M5;8515J^-\:N_$<GRN_&H8[79^RQ[-\[O0V[NORJ==K+8F/8M][RQ/ACT.-^
MEC9#[C(7N\KYNEMJV-F/1:.\Q)DN(9:T?5-*M3YF_88SEF"MW'/1N],-_P#Y
M@<UBW';IK/O5XO!3@F.CP]$I6)TZ5^PV1XDN*@
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MG1ZM.I: =+5JT6O10()V25_M+LE[/IF_S7A GF
M            #6=_;JL]F;7O<_??P$2-B7YOFF<D;?E:]>Z^PZNIS1BLF99C
MD_+[]=J;<-F^=OFV]<(H<%;8N-^[]=N7+,66UM9%FED1R)_&8T;)'T1S5\/W
MM#6M%AG+EK.Z-[V_O9K[>7:#L,>R;HI'YLUB>A-)$1$2G1$\#;MS\]*I7MW"
M+BH
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MY4Z?:_P4A"%_]I$JKQML]52B_?CZTZ__ !20HECQO_5YM+]#8[\UC V<
M                                     %CY&1HKGN1B>*N5$3]LDOJ(
MF=S%]7:?[O'3O\[>_P"R?/%#[[._JD6\M$2JW$?VZV_WQ6.L[*_JE##FG<]Y
MR;OR#;V%59;:WJRUC7MY[6JDE*)7\3VFI:S-.?+2WR/T'W7T%G*M#.;+LF=_
MBZ/6ESM#;5GL[;MGMVPZVEEYGE]%:GY:5\J]%5WB]?$VC#BC%9%L;H>%<RUU
M^MU%V:_?=3T1$?4]SQ]QSL:N*@
M                                ?->WEK9L:^ZGCMV.6C72O:Q%6E:)
MJ5 (C^H3T\[DY2Y&9NBQW=#C+&V@A^[K-RVJ^5(L*,D>BR/:JZT]O3V!6I-]
M.G+S6-:WE.-&(E$;IQW2G_9!$NN+L)E-M\?8+"9K(IELI96ZQW.13RT\YRO<
M[52.K>RTZ ;C%\ON\ +P      0-L?\ .8Y+^3-_FO"!/(
M                  44BK:^WQ\ J)?J5WP_/[@MMBXOXV6+]-VK/B;(MS';
M31K5$7Y5KV4UGF>?BNX(^[^1[EW&Y5&GT]VKR??C9X.&;[9\[O'$FRH]D;1M
M+%S4;D)F,=?*VOQ2LJVO=?#V&7T6#LL>W?+S/O%S2=?J[K_NQ,\/B;^9!JX
M
M           Y/R_MW;O+/'N2VRW<\&/M9)K9USD[2ZMU\K1)J:Q7OUL372G5
M/L((RV/H[V9C($M['E.2"'OY;+W'*E>WC&I1V3T_<)XCC+<^3R^/WJ_<TUWC
MW6:VC[BTG2-KIHI/,I;L:J=6::KTZA4B$1?#YO:G90BZE:=.GB@!S55OC7P3
MWD6JU&*E$HM:ZG+X5*BM**O1>G5%IX@6Z'5142BIXH TJK:.:J_ZGPJ@%6H[
M35474O6G@@$+?[2'IQMLZJ47[\?7[?I) )8\;_U>;2_0V._-8P-G
M                                 !QGU&Y_,8#9[+G#W;[2X6:-%?'2
MM%>B+WK[3#\TONMLBDTVO0>Y.CPZC5\.6V+HI/J10_I.WVE4^_+E?>NGO_K3
M7.WR?%/G>W_@.A_A6J+R;OMS%1V<N%:O?Y:U_P!:.WR?%/G(Y%H8G]U:ZEZ7
M]NV^X-V9+<%[J?=XCRKF!ZTHZ2Y\YCU7I_<,ARS%%V2L_=:9W]UMVFTMF&WW
M<E8GQ6\,PF'2GV>PVIX&I1:^X"XJ
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MG%.Z-_FE[5WOYC9R[11AQ>S==NIX)B9_Q)H4I[_>;:_/BY.Q7RJ
M
M   AWN[B6/B#AS=,>X-WYJXM<Q?XE&WJ969;B%T<SF(V.65K%8CUD34B?-0*
M\O;'I4OMUX&QW#C=_9]MCD(_-@UYN[54:CE;15;&J=T\% VST\[6PVR^5MQ[
M<M]WY#/YNSQLT=U97N2DOHX_*O61.<D<B(K51[--:>- DI31NJJ.3LO2G@B@
M9@       (4_VDO]6^SOTV_\TD E?QO_ %>;2_0V._-8P-G
M                            !PCU2_\ J3'_ -VC_P"W0P?-OW<>-Z9W
M _[V?%/J0S7L:T_0)X 2>](7\/N7_N5K_P!O*9WE/OW>)XW_ #(]W#X[O5:E
M*;(\6
M              M?V_<]H$5N;LSS#Q1R)_2;MY]SG-AY"&*#*8.#ZFZ9:MM(
MTC1S(E<R&)TLDJ5=7XJ!:N/X#E#U(^J')97%;(R;=J;<L'P5O(DO+"Y1)6NU
M-=/9R2?CV\C4JGC3VA$V^.=MY+9VR,-MG+Y&3+9''0+#<Y&>:2YEF>KW.15E
ME1'NZ+3XD VZ-45O3\*>Q0+@      0-L?\ .8Y+^3-_FO"!/(
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M<,XIFDTWS7?Q>".IV5:J95H"XKY
M                                     09]5/I[Y0STN8SNU,I)DL#=
MS6"18!&N69JQM@C<_P V29K?A>UTGR^X#P=G^E[GMVVL9HW>F,8L72QEMY9)
M(J*J4<YETB*OCT [;Z;_ $VY7B+<.=WKN;-_?.Y,S'-:R/1CXVI!-+#<41'R
M2?[8UWCXD5)-B=4KX=45.@B1D*@      "%/]I+_ %;[._3;_P TD E?QO\
MU>;2_0V._-8P-G                                         !PWU0
M6T\VQV.B9J:V>)%7IW5Z&$YM$SCCQO2.X5]MNMV]4^I#*6"6+^$;IKV[&LOT
M%;?$[E8[:>5-3&*K>U>@+LEL;TH/23975NNX;B:-6PRQV[8W51:JQ\M>R^%3
M/<IMGBNGP/&?YBY;;NRMB=L3=ZH2>-C>-@
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M_P"=*=/<;"\6E<5\@
M                          .6<_<BWO%_&N2W3CV:LAKAL+'JU-%Q>O2&
M-_QQRM72YR+1S:+XT(J)&^.?^;<1LW9.RTS"1\G[J^ENGY**VQ\['03SRVCF
M.C2V6!M7HU=56JA4=:],')G*U]O3<7$O+=TS([@PUO/D8;^)+*-K;6&XAL6P
M+'90M95'ME=J615ZT[44+5*MBH]R.[HG1ON4@RE0      !"G^TE_JWV=^FW
M_FD@$K^./ZO-I?H7'?FL8&S@
M     P7=S'9V\UW.ZD,+'2/7V-8BJO\ </BZZ(BLN7'9-]T6QOF4*=]Y6YYD
MY7M<79*LF.9<165L]41*6DDS=3U1$C7X5D7HJU]YJ6:Z=1GV;MWDJ_0_*=/;
MR3E5V2_9=,3=/YT6[NGJ_(F%M3 0[8V[C,'!VLK6"W>_K\3XHFQJM%<ZE=/M
M-JQ8XLLBWJAX)S#67:K47Y9^]=,^>9GP/93I[U\3E8]<5
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M3/\ *=\_3J>/?S$]VSQV_P"=*?QZI^'WFPO%5Q4
M                                                 :#R[QW9\H[&
MOMHW,B0LN'1SV\BHBHV>W=YD:]5_?(@$1=L^G]O'N^K:3E#?-K]\NQ\EIMRU
MGNK9)4\Z5/(>UKO*=TE:ZE$7J!(/@W@2VXPSF?WG>Y%<MN?<<MQ)+>/1NI+6
M[DBN/+1S>Z)(USNWB!V]C:.JJ]?8!F        A3_:2_U;[._3;_ ,TD E?Q
MQ_5YM+]"X[\UC V<                                       4KUH
MJ2HC[ZD.2G87'P[4PTR?>5ZY?J'1.1SXT9I30Y$5::T?XH8'F>II'!;/C>I]
MR.1QGR3J,L>S;NKTUKM\E%?39QQ]R8G];LE&U,C?(Y+1:+J;;2-95JU1%1=3
M.Q>6::D=I,;>@[\<[[?+\MCGV;-_YT5^J4@:(9UY;4HO;P**A
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M;I56OT53O_J$.UATUF+W887F/.-1KICMKINI^7[6SHVAV6&JN*@
M
M# M')\251/\ 6JO@!"_U6<0;^WYSGQ_N?;>+EO<1BK>Q;?3Q132-C6')2S.2
ML<;FI1BHO54"IC8V-T6/LX94_*QQ1L<C?F:K6(BUK[PCZX^CZ=W>*K[ ,P
M     $*?[27^K?9WZ;?^:2 2OXX_J\VE^A<=^:Q@;.
M                     +74[KX>)%AKF]]XXO9&!GSF4?1D6A&0II5[U?(R
M-=*.<Q%IKJOQ'!GS6XK>*67Y5RS+K\\8L<;Z[>K9,]4]2(G&VV,SS+ON;.YY
M7R6<+V37MPQ7>6DK&M\MJJ]LOS(SLJ]35M/BNU.2L^5[MSS7X>1Z&,.'9=.R
MV.FG3.R;=U4U[.RM<?;165G$V&V@33%$Q$:QJ=^B(;=;;%L4A^=\F6[)=-UT
MUF=[Z3[<(
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MNEJ_&M%JA!)^J*J+1?<J%$$L?3_^2S(^SZ9O;M_ZL0]@)Z
M              HJ5Z>'C4BPIU_#^T!KV\]V8S9N!N<UD9$CCC160ZE;197(
MNA%U.;TK[SKZC-&*SBEE>6<NR:[/&*R*UW^+IZT1-JXO.\Y\E-S&4:Y<0RX9
M/=5U-@9!')&Z2!FI)J*YKE5&N6GO-8PV7:G-6=SW?F&HP<@Y;V6/W^&D==9B
M:73[O3TIIXO'VN)QMIB[)NBSLH8[:!G1*1PL1C4Z(B=D\$-NLMBVV(C=#\\Z
MC-=FR79+O>NF9GQS-7UGTX
M                                      --Y(WWBN-]HY#=N7>C;.R9
M1C572CY9.C&5HO5SNB$5#7_*5]6F\$CW+QYL-9]DS_E89G6'U+_(1:K^59,U
M.WC0"0'IU]0,7,$63P6;LEQ&^\"^2UR^-?1KZVJ01S2HUM4:GG2.;34JI0J.
M\,[]T6G8#(       !"G^TE_JWV=^FW_ )I(!*_C?^KS:7Z%QWYK&!LX
M                                 JT IJ]O0E5HPW5S!:027-T](K>-
M*R2.[(GM4DS3:Y,=EU]T6VQ690KY3W[FN6]TQ;;V]!(^R8YWTEG&Y5?(YD:.
MDU4<C7(GEJY.G0U#4ZB[47TC=T0_0W=_E&'DVEG/FF.+IF>C;L\/31*GC;8-
MAQ_MZ+%6VF2Z5$^JN&M1/,<USU:O9%6B.IU-ETNFC#93IZ7BG/.<9.8ZB<EV
MR.B.K=]C<:>WN=M@%2H
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M\G[Q\YNYCJ9N^Y&RWQ.A(9%JBH
M                                          .2^HKC[(<G\5Y;;.,E
M\G(M?!?0,TM=JDLWI,UE7R1-^)6TJKOV0J'^UO63O#AC;]CQ9N?CMEYG\:Q;
M-+IN7MX&J]SE1*QPVD[/F=_NJ_:$==])>R-Z7^\=U\X[QM6XA^ZTNH\=BF.M
MYVI97UQ!DHI%E@DZK\;F4=$UW2JT[ 2VC3XD=ITJO?K7H16<J       (4_V
MDO\ 5OL[]-O_ #20"5_&_P#5YM+]#8[\UC V<
M             !1?]"A845>ZTJGBI%15]0?,<EW++LK;;T^G1KF9&YHY%<NI
MS'1HDD;532K:ZFNZFM<QU?%/!;NZ7M?<WNS%D1JL\;?NQZ:[)Z:[IAN_ '$_
MZI6'ZQ9AM,U?(J) NE_EM:LB([4R1[5U,?[$H=OE^DX(X[M[7.^'>'YS)V&+
M]W9T]>[KB)V3#NJ=C-O-0
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MV_MJU^DQUNB)'J<LCW:6-C15<O5>C$[D26TIV*(&V/\ G,<E_)F_S7A GD
M                         "B_MA81P]0_+Z8VW?LO 2HN0ET.OGZ7(K&(
ML4S%37'1:T5/A>8#F&LI_IV^7T3#UKN9W;[6Z-5FCV8KP^'?;.Z?7#-Z<^*&
MX>T;O/,LU7UTREDQ=*I&Q5>QZ?#(Y'=6IU5J#EVDI[=WD]+C[Z]X9SW_ "N+
MW;9]KP[ICHCUI$+W]_[AGGE2Y"OD
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M2M1&L1O9&I2GN\#97B\[V0KX
M                                     #G7-/*V*XAV9<[FR+?-GTRM
ML+95TMEGCC630J]TJB>"*!H/IFY/WEROC,MN;<^*7'8YS_*L&O<JO=H>[\5T
M<:TTJU44#0N7?4IO[AWEJXL<K@_J]@7;H8\=<>:[0BI:6_F:D;"NG\K-TJ_K
M0BI3X'-X[<>(L\WB9/,QMVSS('=*.2JI6J*OBA1ZR)J;1.GL4(>6B(B)V_&]
MX!&>U:^T!H35K5>J=@*Z?&O7V@6^7UK7QZ@9 (&V/7^TPR7\F;_->$">0
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M51*%%0@
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M&QQ$0\6NNFZ9F=LRR43Q*^5R=BOD
M                                         (G>OK9>9W;Q?BKG$VLU
MRS!7TV1O$@8^16Q,M9&U70UU$JOC0#<^"N<.*\OL'$6:[DQ6'R.-MX;&ZQ]Y
M>VEK.DEO"QCGK&^97?$K5ZJG4BN3>M?E#C[=7'<>P]JY>PW#NN^NHGV_W7<V
M]\^V;#-;R/U^1(][$>UU4^#KI7V%1(/T][?S&U>%MH;=W#&^'-6%FL=Y#(CV
MO:_SI'?*]K7=E\4(KJ,:HK$I^WW_  E1>      "!MA_G,,E_)F_S7A GD
M                     HO8#Y[NOTLZ]OR;Z>WY5/B[=+FQ^]'C?G-O9[G[
MIR+W.57N>RKE7_X-IHV;;?+]9<JB(TMD>/URU]=/:O3V?ZK^\<3*O2V_:1W^
M:LK.=/R4K]+D\.R^T^[(K,0Z6MR3CPW71OB'Z18JVM[''6MO:QMB@;&U=+4T
MI54157\*F\X[8MMB(?DC49+LF2Z;IK-7VHE$H<D.O*I4
M
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MBI3Q4#(            %JNHM/=4"B.550!J=5$ *^J5:07E
M                                      !\F3QV/RUC/C<I;17EA<L6
M.>UN(VRQ2,=W:YCT5%1?8J 1HW)Z'>+<GEI,OA+O*82XN%59X,?=164'BJ*U
MD-LGM7N![?''HZXEV)E'9^:"YS^8?1'_ 'XZWR,3=*/8U6)+;HY%TN3Q[HGL
M D+Y;/!$2G1*= *M:C4H@%0      0-L/\YADOY,W^:\($\@
M         *5(HJ_A*/GO7:;.X5WRI$_K[/A4^+_=ERXHK?'CA^;^[YHI]QWT
ML+D?&]S%:].RTC:AHV2:W3,/UMRVV;=/;$[_ ,LO$_8.-DGM[0_]9,=XKYO3
M_6J<F/WH\;&\R_[:_P 3](+2GTD%>R1LK7M\J&\V[H?DG)[\^.7T)[#ZAQ2J
M5
M                   # JHKD2NEZUHB]0#4H[KT^WJ!E1$ZJ@!55$JH&"2/
MS&K&K4?$Y%:YBT5%1>Z+7N@5$'UDXZQQ5EL^RQMK#9VD>5QFB"WC;#&E;Y%6
MC6(B)W"/F]8&*NLKZ7MK+:2.8MED+6\G1OC##C+_ %-7JG1:D*K^9]S8AWH]
MP=G'(U\MSMZRL8Z(J*D]O9VKGIU;X(!R_D-T>ULKQ-N#-/\ (QCW95*OJY&T
MQZ1U^'4O5ST\"C=/7)F8)=\<;X*W@\Z[N)4D\U%1%C2&]MGJG5/%/8H5(OU!
MY/F'#[$@N^$[!,AO!<C R6W6*&:EDL<JR.TSN:WHY(_>1'YZ>I+<7J@S6V\/
M#SOADQN#COE=C)DM[6#5=^2]%;^0>Y5^!7+U*/T\XZ33Q]M-R515PV.JJ]D_
MBL8&UL^5/W.@%P             +'I6B>/@!\5_DK+$6KKO(3);VS?FD<BNI
M_K453XOOBV*R^;K[;(K=N>+A]_[0S]PMIB<JRZN&N\MS6QRM^.J)3XF)XN0X
MK-3CNFD2ZV/58LDTMNJV5=*_#XIU0YX=MD:M6E%0  #"J)JJY**JJ!H^X>7.
M/]KW;\9F,S'#DHZ>9"L<U4U(UZ=6QN3Y7(O<ZTZBR)F*[8=#+K\&.:771$O5
MVOOO:6\8W2[8R3,BR-:/1C)&45>O^V,:<EF6VZL1+FPZG%FBN.[B\39>]%5*
M)5*)[SD=ED**+V IT2J^TBM7WUN/"8#;V1=F+QMJDEK.V/4URU<Z-Z(GPM7O
M0ZV?+;9;/%/0S/*M#FU.HL[*WBI='KA^>^XKB&]SV3O+9^NWGNIY87IV<U\K
MG-7P[HIIE]T3=,^%^I=%9./!9;=OBVV)\D/*26-[D9J1%[+T[$X9@MU6*Z_@
MB:W-@V=1VXK%%2M7]/P%L]YP<SG_ -O=XGZ2,IU3Q3N;Z_(Z[PZI2A%$*BH&
M-U$55_9 Q330P1NFE70Q*JJKU2B)55Z'S,T2=FU9;W<%VQ'6STD3W(J=/PI[
MQ$Q,5@MNB=L,R:4]Z+_=*K,4           !:ZM>B55$K0#!=7,-K MQ<O2*
M-OS.5%6GAX$F8C:^;IB(K+Q[#>.V\E/Y%E?MEG1::$9(G@J^+4]BG#;GLNFD
M2X;-1CNFD3M>XOP]%^%/;WJ<SL,C?E3Q**@
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M:CD]Z(AMUNY^<KYK=,^%F0^W'*H0
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MI,O?Q^5L\I"EQ8SLFB<VJ*UR*J5Z]4_"<]MT7;G8MOBZ*P^QCE5:+[#Z?:\
M  ^+*9"#&64]_=+IM;5BS3/[T:WOT3J?%]T6Q,R^;KHMMF9W0@3S!R?EM];D
MNH%E\O$VDSXK.#3&ZGEJK/,U)&QWQ(B?"M:&)ON[2>*7F7--?=J,LVU]F)V>
M2NW=Z'-H9YH)&R1?#(BUIT7JG;JI\S$2PT776S6-Z8'IRY<N=S1KM+-2K-D8
MT<^T?I:Q/+8BO?\ P<;4[KXJ=K3Y)B>"?(W_ ))S*<T<%T^U'TZDC$[&1;2
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MJ=/#\);+XNW%F2V^-DO0:]RI6M/:?;D5:Y57N!>
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MPO6?P<GZ%WV*_KKLW_VAQG_';?\ V8^;P_';^E!^%ZS^#D_0N^Q1=Z;-HO\
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M)$-F[O8;NWXNBDQZDXT[(95Z(
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M^JR*YZ_"C>R'8Q:BLTN9KE_.+-3/#,<-W]'2[>B^*=44[C/JTZA50*.K3IW
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MW!B+J1:K3PJ=AW&0
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M\JL<][DJB?$R..O1:=CNX<,6-WT>BLTUE+6[:UJM.Z>'@GVG8=Y36J]47[4
M>8JHJ(J*[]H"JO3P=U7W] *.<[NBTIT^+Q^P"M7+147[4\:D%'*]%[K3Q]OX
M"E%:R5I[/%2*(]:_"M?%*A%S%5>_CU7W+["B\
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M9+>9K9(Y&K6K')5JHOL5%Z H^EM:=>X14
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M/B1T?Q)[@+]T>J;UC;+Q>-S.Z[6+$8K+HBXN[NL5;LCN$5B2(L:TZ_"Y'?A
MM;ZK/6'+NA^RF00KNN*'ZJ3%)B[?ZA(/IDN]:M_>^2J2?];U U?_ "\?42G_
M -;8Y%_1MOT_:")O^CCEO>G,O&>6W1OFX@N<M:9VXQL,EM RV9]/%9V<S45K
M$1%75,_J!(<                                             QR)\
M5:5Z4IX 1']8.Q=V/R^U>3-G8]]_?8&=TURVWB1[V-AC5K-2K1$15?TJH5RB
M3,;^]4/)6S;.XVW>XO!87ZU;B\GT/AA62P<RKEB5537)"B)T[J$29M>9KW<G
M-&:X4EV_<18^.&YB3-R/C=;OTVJ2?+371=6D*C1-G>1O3;R-O*RL=N75]@<_
M<7$F-EMV1QL\R9C((I&+(J51/+KT0(Z_Z/MD[F@N-T\G;JL)\9D-T9#(W$=K
M=-I(L5_/#>-F2E6JCJJB*@&\<G^D[BGEO=L^]-X,R+LS<1102NM+OR(O+MVZ
M&4;H=UIWZ@0RW5M#%;"YRW-PSLV*XEQF+99R8J*XD2:;3-CH[^X5SJ-K\4KE
M3IT0Z&HMI[35.>\OG)':6>]'Y(?,K5:O7X:K^-U.K5H'2WOB_C?(<@[@MK);
M>5V'21$O9HJMTPH]B/=5.J41Z=216ZZ+89?ENBNU&6*Q[,;WW>I?TJ9?;.+P
M=YPK9;CS65O+F=,VR.\EN8XHD8US%:Q-&A%<KC+19$1N>E6Z7%$1'#&SP0[-
MB_1/Q5<8RSGR%]N6*^D@B?=1)EY6Z97,17I30M*.J7@MZGWV&+X8\SAW/GI3
MS^V]U;1L^(,?N7,;?O7._6.X^LENO)1)HFI\2:-'P*]1P6]1\OB^&WS0ZYOG
MT7<?X_9&Y<CM.XW-=;KM,5?7&#M/O667S<A%;/?;LT:4U:I$:FFO4<%O4GR^
M+X8\T.-['],.['\$;AW;N3%;BCYAQ]S,F#PC[F1K9X&I!H5;=U===<OXWA[C
MYNQQ.RB7:7%=%.&/-#5[[;&ZMOVUO^M.(N<1>R-37;W;-$J*B(O;WHJ*8R[9
M=PO,.9:*<&6:[IE\;(WR2-:VJO?T5/&O@?,S$0QL1,SMZ7Q;SXJYQS5A:KM#
M:.8N;&X3SFW]DQU%:U:)\;7(O4[>GMBZ.+H;YR3EL6V=I?%9GKZF3TI\4,Y0
MY-W1L3DR[S-K+@+"9\MI!>RVT\-];7D5M(Q_S?+J>U4]IW."WJ;-\OB^&WS0
MF GHBX@\<AN9*=_^>)/]@."WJ/E\7PV^:!/1'P^JU^\=S4_3$G^P'!'4?+XO
MAM\T(^<\^E?<VVM[[7Q_$6.W+F=K7<;'9Z[^KFNO*>MQI<BO33II'U[#@MZC
MY?%\-OFAM?+? &+XUO;*WV0S*7UC/%YUQ-?W2WKFRZGII1S]-$HQ%,/JYFS+
M$Q'LT^MG+N08N8\HR6XYMMRX[^.(I[T6XYV13IFZ8<AEBEAD=%.W3*Q5:]KN
MZ46BI^R(F)C8\&S8K\=\V7Q[4325]G87V1F2"Q@?-<.K2-E%[(J]E]R$NOBU
MW.6\NS:[-&/%;,S-?5,[O(W;>7IIO\[PI+O3;>,R][R8ZXB9;X^SF=Y+H?JG
M0R.2!OLC8BUU=ZJ=O15NQUNC:]NYIRK!R^^-/BF+HLZ8\-+NGQO*W=Z2\]9<
M ;9W-MS!Y^XYAO)X8\[AO/?)Y,+OJ/,=Y'3331%^-XG>X8ZF'X+>J'P9#TF;
MG3??%&-AV]GY=HYG#8*XY"NW2N=]%E+J21N1CUT_)>6U&KIHNGWEX8@BV.IR
M7,>FGGR'+W\..V+G9,='<3,M'I$YR.@:]4C6M>M6TZEI"\,.B^CG@#8_.$V^
M(^1$OUFVV[%MLDM+GR%:Z\6\25'U:^O^+LH"D0ZSRYP-_1@^%VV(+B;:R-HR
M:9RRR1JJTTOD5&U55JO1.QBLT39=MW3N:!SWE]UN2<MNZ=_HAR-6]=-%1R+1
M4\:>T^&J_3R-NV9Q5N'?6=PEE=X#(7>R<C>I9YG)6E&I!;JE7O63KIHBIX'-
M@CCFL-JY%H+KLG:W1LMW>%WA?0'P"J:UBS7F+^+]X)U_\$9)Z"X)@O1DVX]1
M65VOF-MYF'A6%)_N[->9IUJVV8^/^,:5K657)\H&Q^H7T2[8VQL6'(<,X7,Y
MK=KLA!#-:^?]72T='*LCM&AO9S6)6OB5&H<K^C6[PO$FPLWQ]MG,Y'D7)063
M]WX[7YZVTTEBDEPWRD:W1IGJWNM.P53F_P!'>0VSM;8V0XDVUF<EN7(6[Y-T
M0L>MPMM-Y$#D;I1&Z/C?*G=>Q"8;MN3@G>5OR_F=I;8VUDTX_ABBDQ.X)V>=
M;.<E@R>5CI$HKE6=71-Z=%Z'2R8)I[+4M9W?LOF)Q^SX-[EVYMD\RXC$WM\O
M'N9M[>RADN9KR6!$AAAA8KWO<NI*-:B*JDMP2X=/W=B+HF^:Q'0V_P!*OIRX
M[]0.P<SO?D'[PDSL&<N,;#]%=?3Q);Q6EI.U-"L?UUSO\3NQ;%L4AMV+';CM
MBVV-D.Z-] ' /XT>91?Y>G^"*Y55] ' ")_!YK_[03_!%1P3!>C%MSZB\KM;
M,;:S,/"\*3?=^9\S1K5MLQT?\8T]:R*Y/E"N\_Y ?I^U:?+S/LK]X)35[/X(
M(XEQ7Z6-W1<G\A[?OL1D,/L>R?D&;.RE]K6WF;%D&QVZZF_.KH/C[)7N<&;'
MQQLWL9K]!;JL?#._K?;EN#.2\??.LH-OW=[$KE2.XACHQ]/953'6VW],2T+)
MR;4Q-(MF?-%?2U_?7"?,EC98:+"[5R.0?DW.6^6VA5WTC(YVLI(NKHKV5<VA
MSX<,SMNBC8.5<FFRE^7?U,W-7HS=@>1-G8WC+;>9RVS[Y\/ZSWRR+<^2CKI&
M2?E-+=%(OB[>\R+<(HU.#TA[J=O#E6QDVCF?U;PUCF9>/[GLEY=VU_%%8-1]
M/RNNW5[Z=-5*A7&-Q<#<Q[2PUWN+<NR\GC,'8M:^\O[F'1#&U[FL:KG5Z5<Y
M$_"!*STO^DOB7EOB'&[TW:S)+F[FZO()5M+OR(M%O.YC/@T.ZT3KU [&WT!\
M -<U6,S24^)KDR'L_P"]$'C\@^E5N!L+>7CI+B\M;=B1+93O=<W3W-:]R.U4
M:E%1K6_:IC\V*Z)K;MB6F\VY-.2[M,6_JZW,L;PAR;?7;+:;;=Y;L<]4?,^/
MX6)[5HIPS;?T1+7K.3:JZD393;X-CM5OZ+./=P82TCWU-?SY-E7RK873K>+X
MZ*C5:YCNK4HB^\[V#'-L5G>WSEW+[=)CIONG?+@?IK]&,&[;3<3^<MNYG!W5
MM):IA6I)]%YK'ME\[II=JTJUGV5.RRS%S7Z,6X#D39N+XMVUF<KLN^6#]9[W
MS/J?(1UVC)/RB-;HI%\7;W@9>2/1=!B><]F;=V1MW,WW$]_%8+N?+>9YWD/E
MO9X[E/.TIHTP-B=\JTK4#'G_ $9,M?45BMK8C;>9FX7F;#]=F?,U45UL]\G\
M8TI2DB-3Y0K3-H^E;D.#9/(^X+W:&:M=[X27$_J)9HBL^KCN;V2*^_)]Y-%O
MI=W2E:GS,1,/B^R+XI,;&')XKDG96"3-<A;.R6!Q[9&V\N1O8DA@662NAK55
M5ZJB'2OP3&YIFI[NUNF<<TB?*D;Q#Z=K+?NWL9NW.WKOU=S-BR>"*W>^*X_+
M:5JV1$5/EU(GO/FS!=,[=SDT7(."^+KYK1M5QZ">!;J>2XF;FGRO57N<[(5K
MJ6O^Y&0B*-PB(B*0QM] / %:+'F5]M+^E/\ P0?3A/IJ]%\&Z[+<C^<=NYG"
M7%I+:)A$\SZ+S8Y&R^<O5K]6E6L^RI4=7WSZ#>(,=LG<N0VG99F[W3:8J^GP
M5M]:DOG9"*WD=;1Z/+35JD1K=->H&@>G/T3[?W3LF_O^:\'F<+NF+*S6]G:^
M?]'JL6V]NYC]&AU:R.E2M?#W!7A9[T9-M_45BMKXC;>8FX4F2'[PS?F:]"NM
MGOD_C&E*4D1K?E S0>B^W=ZEKG:<NW,RG!38D6#.^92K_NMDRI]3IZ_QI71_
M+[@-9D](&?;RSO3"LVEF7<=6%GEY-KY"J_QBYMK5S[%/-I\?F2HUM*)J[="#
M+QUZ/<QE-F[<OMZ;5S-GN:ZWU;8K-VM?)\K:+[)'RW6BBZ:3JK?-K[J%'">6
MN(=X\89R^7-;?O<3MN?(W=K@KJ];1L\$,CO+5KOQOR>E:@E^S6UVK^K&&5._
MT%KU7M_ M"/;;6B5 J
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MG!7'>Y.2L7RUEK*>3>6)2!+&Y9<RLB:ELKEC58FKI7YU[H!TA7:>R_:_V?@
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M*)K]=K+*Q*OB>E%=7IV[!$D0
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MJO>J(!]C?E3K7W@5
M*I[0,4KDZ)XK\M/:!17=D]O;[?$!IJB-3H15$:Y%33\J=%0J+G-JY%_&3I7W
M -":D5>JIV4 Q'(Y>GQ?C?N 4HBTZ=%ZHI%9/B7IV3VE11=5%Z=$ Q:G4]_[
MW_3 O;VJWP_: L575JB]%7]E +J*J+7JG>OL3V -'7XDJU.P!&HJ4IT]I%--
M5^-*KX*5!4^&J=.M5]_N (CNZ)[T:05=T9XHOM3K0L$RL35VI3VI[!*KE;6E
M%IXK[P3"VG7M1R_Z*A&=.B(@%0,:,1':_$!H1'*Y.E0*-;I553NH!K$15HM
M+_B7OT M<BJE7=*=4 QI1%6JJJ*M:>\"NFJ>[QJ 1/A^-=5.RKT OA6K?W0,
M@&-[45R52OM M1E:IV8 TI5>G?JJD46KFIT^'\7[2HO2J(B*G5$ K5:]NOL
MQ*BT72NFG=._<0"?"FGP\/L(M%6KI553I3JM.M4*A'J6JJG7NGO0@*BI\?L[
M+]I15J/[.3MT5?;4 D5$5$7HO@15%91NFGP]W%1547X6KX_*H%6>*TZKX 75
M7V=?8!8]RU1$Z HM1:NZ^'9WO JM433XKV3^Z!:U7+5-7CT4"Y46M:4=^X%-
M*)1:?$O<(+'1*M3OW0$B-2B43[0HJ+JI2OBGN0(JB*B^[O7WD%CE^+I6G=?=
M[T+0JN15K5?'P^PBBM7XJ]:E1='3P^RH&2J
M                         *H JGM \R;*XFWN$MI;^VBNG]K=\T;9'>/1
MJK4$OM1K:)1._P P5>G7K^P$HJ@%P     45$[^P#$BHU%JNI/&O2@'E2[EV
MRR]3&R9FQ9D'+1+)UU"DZK6GR*_5W6G8BO55&N:B*O1/E*C(Q%1J(JU N
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M)X'(E)(W(]JHO5**BJ@%S65JG9OB09FI1$0HJ
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M57?52U7XEHFEJA$E&*O;Q[I4"Y4KT5:+[@+F57JJ44"X
M                               ,3Z_$J)7HO3WBA5JG(^XKG:&P\_NB
MTA?<W.*L9;N&WB8Z1[I(TKI1C%1RK[D6H5^>F5VKOS(\-9[GO+;]S$&Y;"\G
M2PQ[[S3^2^HAB8UB2-\VK63?$B.Z4 E7QUZL..\K-!M3<=S=X?<,>KS+S,)#
M9VDRO5\K4CEFGJ]6LTM7X>CE1/$(D:BIX?M /&OA[/>!>     %KU[)XKX>T
M#E'J'WIDMA<3YS<&(9-)?+Y=I$^V:]\D?U2^5YB>6J*FBNK5X=R*A8S@O<N2
MX@Q/J"L][9+(;W2!^1NTFNF.C9!!YLLBMD:Q9*JZ!BI5WX2HFUP-O.ZWOQ/M
MG-Y%[I,BN-L([R>15<Z2X^B@DDD<YSG*JN<]55R]P2Z?&NIB+^V!>      "
MB]E U+D6Z7'[&W!>_4+9M@LII%ND<D:QT3YD<JI14 _/[@GF_?O$F;?D-Y17
M\W&&7O[R!MY=,N'0L<Q[I'21.D?'"CU^!*ZEZ+[T _1S$Y?'9O&VV7Q4\=UC
MKMGF03P/;(Q4[*FIBN2J*BHO7NE /MBJBHG7]P@S%       $7_6UOK=&T=A
MXVQVS>76*?E[I&7.6LGR12P,BN+5NGS&*B-1Z2N3XNX'(-R\6<J</6MCR?QC
MN_*;PVW%IN+Z-+I]RV2)CE=(]663$U1HQBZG*ZGM E)P7S1A^9=IQ9.)S;7<
M%K6#+XWX8WQSQQQ/D5L2R2/1B><UM7]:] .I)T;T5>B]_<1:OI3L5
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MV.:;[<$.U[>9++!7++=+Y^A8KA'LUH^/2JK3_KD0(ZXU/BKXJG9.WV@7@
M   I5*JGBG<")G+'IQR7+W,?UVZ(Z[2;B,A%C[F'X?+O'R-6W\QSXY$[U5=*
M5IV"M-XNW]NWTO[L?Q5RK<W5YL>]NU3;F6N9))V6UNZ5EI QCYW(Y((X;5ST
MCCCHE:HG= B;>.R-EE<?:Y/'S-GL+R)D]M,VNE\4K4>UR5IT5%10/K
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M9?6UBQRSW3U<YJTD=\B=Z^T"87@OM[HJD%Z=U**@
M                          !B=\U45:5I3W_W@/GO;&UR5I+C[^".YL[A
M%9-!*QLD;V.Z*US7(J*B^]"*YGG9.#KK;V<VED(<1'@\7'%<9G',LXFPP)<R
MM1KUC\E65>]C45:+V AQSUN[BGEV[VEA.$=O07.])9[B5Z82UMH)HXH9+9[_
M #G1-8YU8XWZ:*O2M0/T3QL%S!90PW3_ #)V-^*2JJJK]J]2H^NBU3V 7
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M\3W-KD&.UN1N,7)/O[.566\4-(VK].K-"::HU%\"*G/I[TZ+[/"A49@
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MX\GR;OB\N+;:.3@DCPN$FEN&L1MQ-!<1RMA<]\5&M22/4U>E:)TJ%2?"
M   ,4J.Z*WOXK[@/%CVMM>UOKK*P8:QCR-^Q[+^^;:PMN)HY7(]Z2R(S4]KG
M-1RHY5JO4")G,N^?2[M7;VZ]IIBL5<YV5);MS+>QM$NG74LU)&Q/=$VCZL6J
MKW]H5TKT;;>W+MSARSMMR6L]C)/=W<\%E=5\QD,EQ(]CJ55$1S7-I0(D.WHU
M*=0*@                                          62+2E?E\5 BQR
MIZG,S8<M83B?C7'ID\JW(VC<_,CF?!&EUY%Q;Z9XVT<K7,5'L>M/ *^OE78/
M/^]\E#)@<_;XK"Y;&1VF0LW6:2OMEEDDD>U9&SLJYB.:U7-3P(.H<+\08KB#
M:J;?L)GW%U<R.NKVY>JJKYYJ.DI6JHFJJHE2HZ<WY4 J      "COE6O0"(^
M4]4.X]R\T8S8?%>,^],%92N;G+I%9^762)^F-J3L8YBL?&Y%5*U YMS?Z;>1
MN2O4WELMA9KC&[8SR6K[C*QK2.%+'%VT*L<C)F/<LBQN:BHG0BID\;\;;6XL
MVW:[9VS;M9;0-;'YRM;Y\NE5HLDB-17+UI52C=8VJBJM>G:GL",@     89'
MHU_3JJ?-[@/BR5];8NQN[^\D\NSL8GW-W+15TLB:KU5:(J]D\ (Q;']36Z^4
M.9KG;NR</]5L#&LEAN;QKHU6=_F1JR=%D9'(QJ,<OP4"NX<E<4[1Y5Q2XG=%
ML]8V(Y&75NYL5PS4US?ADTJJ4U*J4\0-GVU@++:^"QV QBR/L<;;0V=NZ9VM
M_EV\;8VZE7NM&]0CUNB*JUHOO"KP@    +9*T2BT55IU Q4U(ZJ=/D=3^Z!R
M?F/@/:/,6/C^]JVN5M4<EOD+;\D_XU8BH]6HCG41E$^+I4#@V$]&^^;Q<7MK
M?&\_O38^'?-+!:LAFCN'K+)Y[:S.F?73(C>[>W0*F=C[6"RMF6ELFB&%-+&)
M^*GLZ!'U         "]E YCG.$]CYO?N/Y$DMY;?<6.6)['VCVP12+#.Z=%E
M:UM7JKW?$JKU2@5TB)'-HS\5.J.7QKX!&8       "QU*HE>J^ '$?59M/,[
MOX2W/B<!;NO,JZ*'Z>Q9I1\J_50JJ(YRM1*(BNZJ%<H]+GI9GVQ'#O?D])[S
M<43E3'XR]5)8X&JV>%RO8]TK7:VR,5NFE%;4(E_3IH]G94\$(K.RBM2BU2G<
MJ+@      6O^50./\V;>Y5S]A:Q<<YJ#&*Q6/GAFM4N'ND8]5U(Y9(Z)3P(K
M5> O3O?[#W)E^3]\Y5V:Y!SB3PR2,:Z&VBL[F2WN?+2)SI$1R31.6K74HZE
M)$^Y>Z_M($7)W4HJ
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ME[E&ZQ1Q6T3(HF-CAC32QK$1K43M2B(1'TM55:BKW**@
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M\/M -14Z>'@H%P
M 8G,57=$Z5K4BJZ7IXU3P3WE1:K'*BU;W[I4"Y6N5R.K]J$F!D*       +7
MMU)1>J>*>T#'Y;E^;K[O:!=I=32O7W^\ UCD6M?M]X%S45$Z^T"X      !>
MW3N!A6/JOPUKU7KX@7HUR.1:]/8!=UH!4        !8YJNKT^P"U6/6FKJB>
M'8"[3U]WL]X%OEJG9*)W5/:!E        HH%0            QJQRK7M5.J
M51JHM?P?@]@%X       %CT>M-*T3Q3W 6HQR*JM2GA^  Z-52E.B_,GM *U
MZ-1*ZE3\ &1$HE *@
M
M
M
M
M                                          "U7HBJGB@#4GOZ@-;:
MT (]'=D6GM\ *>8U%HO0!YB=:HJ46G4 DJ+2B+U KYC:T_; :VH!6J4KX=P+
M?-;X55.RT\/M JDC52J=4]P#4GBB@%>B)V7[ &KMT5>M 'F(G=%]B>\ Z1K>
M_AW4"BR,1=->OL KK1?!>G=0*>8U:JG5$[J!7S&TJG7V4 :T_![?  CVK[OM
M :V@5U5 J
M                                                  6JY/M^P CT
M7P6OL\0KY6Y2P?<):LG8Z=:_DT5*]$K_ ' CZM:4JO3W>(!9&HE4Z_8 21J]
M@*>8U?L]O@!76E:+5%]@#6U>P!7HG>H#6U$JO1 ,=Q=6]I'YUR](HD5$5[UH
MB*O1/V0,4F2L8DC\V=K%EIY:.5$5:K3H!]*/:K=2+T7LH!'(H!9&H UM_#[
M"/:O;P[^X!K3QZ=:)4!KZHFE>O[0#6B(JNZ(GBH'P_?F*\SR?JHTE5=*,U)5
M57LB ?5+<PP,629WEL:E7.=T1$]X&"#+8ZZK]-<,E5OS(Q46@&:"[M[EGF6\
MB2L[:F+5*H!D\UOO N1:I4"H
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M/H
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M%9VH!+Y%=T14T^VOM RQ]E^T"\
M
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MJKV3N!TD
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MR.2+;ZM;\*].B.4(G1^^7LB]:^VGN OBIIJG9>H%X
M
M              !PCU6\3WO*_&<N-Q$GDY;%7#<O%)1'*]MG!.OE(BJB?$YR
M>U0KA?%OK#CV%LVTV3R)MV_M\YM>./"6S[:":>.>'&P16S9%=Y;$34Z-_1*D
M'J\"<W\N<N\VY2Z=:W-CQ]%&U68ZX;Y<+8&N>U)6.?"USGO^!59JZ :1R3?[
MGX!]5=URA=X>3*[6RZQK;30(]ZTML-'9R:VQL>K:27'P]>M"H^?E3F"Z]1^]
M=J;:V3@KMN-@O;.>XOKN*6!6);W3)%^%6*B]%7\8#9_4O@[K'<H\)8Q(WSI9
M9# 1RN8U51-&0G1554K1 -K]<4$\_%6WXX(W/5&3M1C&JY47R(T\"*\7D[9.
M<W?Z0\=!AH/,N[**W<^!:ZG>9>VG9$15Z:57HA1YFV/6Q;;?XYLL.S;%_)O6
MV8YBV2P3^3629[E_*)'6J-<B_($=HQ?J#N]N\,8GE?D;$7%BW,745O!C[1C[
MF=JRLD<FMFECFI6)W= KC_K;OW<F<';-WA@87LQKKQN5ECF:L;V038]9D56J
MBJBTD1%10B0L=[%D/3[8/M55S8\/C(7-3K5\;+='=@J-_"6S,KN[TX;AP-DQ
MT=ZZX\]K)$TU;#D[^3I6G= CPN$/5*O$.Q%V%NO;-XS*8:+Z?%NABGD9<*C7
M.17KY::*O<C>E0-B](^VL_O'E7DCG"]LI,7CMSLR^,CM9FN8K9KVXL;U%1)$
M:Y6HBJFJE.@&D<8<FR^FWEO>UGO/%W$UKF+FZFM'V4<EPY63WKWHM&-[T9VJ
M!?9[VRG('JXVON:ZLTQUI=I>);V#G+YK%BP<T:JYKFM<B.1NI*^T*_1QRLI7
MNB]D^P(A/N&VF?ZTL-,L3W0M@1?,TKI1?O&)4Z]@KY/6_;SS[KV>Z&)\B-OK
M57*QJNHGES^P)+Y.<K>X?R7Q YD3WM99LUT:M&_\UL3JOAU(KD7K"VAF<#S7
MF4QS95VYNR;')+;QQJ]J_=UE9LZNHY4HZ1R]RH]WU ;,FVCO/@7;5I;/=#B;
M2UB?Y;'*UG_.[G]?FIW]I%E)7U=9*VQOIV>D[M#[UR6L5>E7R65TY&]?^M*C
MI'IRL9[#B#:[)TTK-96UPSWLEMXG-_:"NKA
M
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MZMIEDP&UXK=JL8B.C5U_A;BU7XTI^/$!-=&IU5.J)V1>E$*C*WMWZ?W +@
M
M                               "U4;UJH'.=U8W@^>^<[><FWDR*N<K
MOO*XM8I=6IU:I(]%^;5^&H&W[<@VS#BX8]K.M%Q"(GD+8/C?!2B4TK&JIVH!
MAW/;[1GQKF;O=9)B?Q_O&2..#YV]UD5$^;3^&@'D;+L>++9TG]'[\.KO]M^Z
M)H)5[+W\ISO #/N:SXXGR^,DW:_%IG&2PNQ*9"6&.X65)%6)(4D<CE7773I3
MN!DW=:<>W&.A9O=^,3$I7R/O26&*#LE=*RN:G:G8#V,%%@XL; S;BVZXA&TM
M_HG,?!I_U*L54H!H+<7P#]^>;'+MK]8M:=$N;3ZKS*)3X?,U5I3P VC>=KL.
MXPK(M^OQWW'Y[%8[+2Q16_U.EVBCI7-;KTZJ=>U0-*Y5VYL#</#F6P#<KBL/
MMNZQSX,?DWW,$%A"UT"-8]LSM3$1(Z*BI7X0-=],SKU>*Y,9O)L?T=G=S1P7
M;U=]%-9M5C87))-I1U41'=$T]4H176MH6NQ;:P5FR7XY^.JNM<9)%+%57O7J
ML3E3YE?^&I4:[N?'<(399LF['[>3-([X$O[BUCN-5?!LCT7N!NV,BQ+<9 S#
M.A^Z4B1+9;9S70>53II5JJE* ?G-RGMCD7C[E:[S-WF,1O%;^9\^/QV4N[FZ
MDMHWS2O9'Y;(F*UJ-72B(J@;5PML[(;@]2%MR)RMGL%B=VV=O2WVC]:^+(S,
M?C)[9J_27D;97(V)6RI1WR)J[ 3^<C%I5:>P#4IK/C1=V17$[\3^NJ)^21\L
M"9#3K1>C%=K^?W=P+-WV7&5Q=6KM\28EMVUS?HDRDT$3]:(NG0DKFJJTK2@5
M;F;+BV3(XQ^>?ATRC&I]T?5S0,FT>6B)Y*.<BJFBGR^ 1BWG8<2W-[:.W[)A
M4R#%=]'][3V\4JN5(]6A)7M5>B,[>X"_=ECQ7/F,=+O1^'3/,1OW2F2F@BN/
MX2K?);(YKE^/MI\0.$>K#'6NY\CL;:FX+JQPW'$>7QV2R.;R\B6N-<Y&WL#[
M=D\E85F\I_F)&ZGPHJUH@$E=J6F+L-L82QPD\5SA[:PM8<?<P.9)#);1PL;$
M^-S/A5KF(BM5O14[$5[)4
M
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MU]/)"_-7%G<VMS.Q=4RP-F^F5=/S2(S5[%IX@=65K%IUZ 5:C42C5K[0+@
K                                                      /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>tm2225088d1-pht_dendrit4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-pht_dendrit4clr.jpg
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M ,@   $% 0$!               ! @,$!08'" $  @,! 0$!
M  (! P0%!@<($  ! P($! (&!P,*! 0%  L!  (#$00A,1(%05$3!F$B<8&1
M,A0'H;'!T4)2(V*2%?#A\7*"LC,D%@A#4Y,UHM(T5,)C<T0E%W24&.+R@]-D
M1281  (" 00 ! ,%!@8! @<  P !$0(#(3$2!$%1$P4B% 9A<9$R,X&AL5(C
M%?#!T>%"<F+QTH*2LL+B%@>B4R3_V@ , P$  A$#$0 _ /OY  @ 0 ( $ "
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M " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @
M0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ !R0!&VI&)5:;)0I.D>'@K40R)\K?
M=;4UXC)0V":0T$-:'9$E%;2Q;QN+UM)T.KJX'@BPZJX$$S0:R'2,S7!"V%3<
MP259)2@..14)C-#3B[0WV\%,")C?B TT<308$\ H:98J,<V6KQ0ES2*X44*M
MO$5O4<^0#,$C-,W 3!&VX:YS0UKJ'-,A.4LE+](JH'>B(C+K;Y<SCJX!2+JT
M-$C' =2KAF",E$C5HWN2.Z4>?N\?N0"A(EC+7,!:" <@<U 3(]  @ 0 ( $
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M>4(0/9)YGM->'\JI=6-Q3%,FG@0SER4JI#:1$\5<UYR<<*IMBM5G4G$K0[2
M:J$AN6H5>7$ H+- )>T$NX)762&U C9J'$$"E03D?!.EH522"0$M%""<:'[5
M!9&@@#B],(/801@E':'((!  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ "
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M\RM>/([;G9^G._E[>.ULBC7_ $/;XC6-I^I7'L&/00" !  @ 0 ( $ " !
M@ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $
M" !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( C>?, E9 CCAI J0G1+1P7S
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M  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 (
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M $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !
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M( $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !
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MSYFP?"^9CKR9X:W&C62:B? 47#HYR(^1^U)W]SE;3;]S/;?]Q@__ .+MC_\
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M $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !  @ 0 ( $ " !
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MI.C9[;O_ $ZOGJ=G$M+V=K?>]9_;)VO^U!SA=[[EHT0AIR-?U%T_:=K'&_\
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M1G[@4_W7-YK\!7U:B_ZHWC_F,_<"/[KF\U^!'RU0_P!4;Q_S&?N!']US>:_
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M1N_YV?N!']WS>:_ CY:H?ZIW?\[/W C^[YO-?@3\L@_U3N_YV?N!']WR^:_
M/E4+_J?>/SL_<"/[OE\U^!'RR%'<V[DT+V'^P I_N^7S7X$KK(<.Y=UYL_="
MG^[9?-?@3\M4C?W1NX=0/8/#0"G7NF;S7X"_+5)&]T;P1C(S]P)O[GE\U^ O
MRM20=R[J[#6S]T(_NF7S7X!\M45_<&[!M=;*\*M!3+W/+YK\ ^61!+W)NS(2
M>I&)N T!-_<LGFOP#Y=&=9=^SVCI&=PS,C>3^A^F*G+^=59?>.*U>OW%JZ*>
ML'GW=_SD[YVO<X+;9XHY;65[0YQC:30AU<Q7,+/C][GQ_<6_(U\CN.W?F!NU
MZ(1NSV1/D J T-Q)IP6JONCL]_W"/I+R.IF[C(G$44C 7 $.+=2V7[N1J:E:
MZM%N8[^Z.XSNK;. QB%Q:.H8VY'3]ZYN3W'M)Z03\MC*%]W+WS!N3+:!T1A<
M0">BW(T\?%+7W#N/R_<3\MC.@M]YWYD EN9HBZ@JQL8;B?6M5>]V/^4"OK4\
M!S>XMV<Z@>S]T*Y=[)]@ORJ\B4[SO50=3!'Q.D*+>X9%X_N(^5J4]R[NNHF:
M+*1DD^3Z-'/'[5AR>[W4ZK\"?E49;N\]W9I.IKJN#7 - I4A9^M[I:]HG]Q7
M?!!Z5&=1QQ-*U7LL5^53"QYH0K4)N>9]_P![NEOO,3+"[F@B^':XMC>Y@KU'
MC\)"\K[KGO6\([/3QT==3E77'<9C+9MSO&M=B7,N)0X#PHZJX]>WDAZFO+AQ
M^10DW'NV-VBRW*]>/S232G^\Y5+O9?,6F#'Y%JWWWNB$@WNXS.\&RO'M\Q57
MS^;S)?7H]D;$7<MS&WJSWER6\A*_[U?7O9/,CY6OD/F[KDBCU-N;EU1A^K(H
MM[AD7B'RM?(R#W/N=W.QL5]=1-UM)_6DR!QXA)B]QRNT-D/K57@;[MROF".8
M[A<.:0*CJR<AXK=\[?S$^67D,_C-^^3R7MP!X2O'VJ?G,GF'RU?()-VW%N=[
M<X__ #G_ 'H^;OYA\M7R$_BVX_\ O;C_ *K_ +U7\YD\QOEJ^0?Q7<3_ />W
M'_5?]Z/G,GF'RU?(/XIN/_OKG_JR?>H^<R>8?+5\A?XMN%*?&W'_ %7_ 'IO
MG,GF,\-$M@.[[C_[VY_ZLGWIOF\GF1CP4OX"?Q7<J?\ K;C_ *K_ +U/S63S
M(R=6M7L(=VW("IO;G_JO^]);MY$]Q7UZ^0Z'=MQ>:?&W'_5?]ZTT[&1^)'R]
M?(>^?>+F42LW&X9&W-@F>*T]#E-NU=>)/RU?(2:^OVN:X;E<M+<VF60@^JJJ
M^:N#ZR\A9-ROKECXX[ZX9,6D,>V5[#6F'%4V[F5/<FO7KY''6-SWMMN]SSWV
M\W4FVN<.E$^XD=E6N;SSY*['W[^98^O7R.O9N6ZWI$K;R>.-N)(E?B/40GMV
MKOQ*WUEY#7;S>&0P,W"XUY?XTGWJCYS)YD?+KR'&]W6'%U_<D.R_6?\ >CYS
M)YA\M7R&-W7<]7_K;G_K/^]'SF3S#Y=>0X[MN(_^\N/^J_[T?.9/,GY:OD W
M;<3A\9<?]5_WH^<R>9/RU?(0[IN7_O;G_JO^]1\[D\P^6KY"MW3<C$\.O;@A
MWE%)GM=7TU3KOW2B1+8:+3Q&_P 2W&/J!EW,\TU-#Y'5J/VB5E>9MS)?CZUM
MH%AW;<7X&]N!X=5Y^U;*]^R6Y5DZN/#K86;<]RTN#;VXQ!J.H\U%/2E^<RMR
MF(\6&ZGP(+GN"]VW;W[G/>R.,8+?AS(XN<*'Q/+DM&;-DXSXP,NM6J^'7[SG
M^Y]X[J=:[1?;5=W3+3<9/,QL[ZLQ8,:$8>8K#3M96H;&QTQQ_P"1%-O/=%GW
M1M^R'<[D1SQZI9G7$FD58#^;[44[>2ETO!L;K8,<7];_ .']_P#L7>XMU[CM
MIX;?:]UN'/:2)7?$/(=D/S*_L]Z]+?"S17JX>&VI/:]YW]C;&UW6:[=>%U0_
MJR 4-!XUQ'-8W[G9PK,HQ].6^*-,[ON<L++B*[G< T:F]5[2?225J?8Y4^%D
M9>KQ?Q*".'>-WE+FF[G / 3.;0\L\50N]G6G@6>GB2V)/XIN8(B-_.75.4KV
MX>FJ/G;^+,]J8B,;ON(>0;VYC8/P"60U]8*%W<JV)6'&Q?XQND;JNO[EK'8C
M]61U/4"G7N/82W19\I2RT0IW_<^HQC[NX%,W]1^/JJH??R/5LH?5A[ [<MUI
M47T\;_\ F"5[JCU%)\_D6S+%BTV0@W+="S_U]P *BG5D;4\Z50O<\Z\45_+5
MMI9:".WC<LQN$Q&&JDCP</&JKMWLMGN7OKJ(J@CW;=0:&\N-1YRO.'IJKJ=N
MZW88NE1:W'/WG=6D5O+@^F1Y'UIGWWLF)DPXG9*HZ+<]S <7W\PUD'&1[\C@
M!0X)+>X9Z^1G[&+%2Y6&[[P+MS'7\X8XFK>J\X<#6O%5?/9KO5FG@KT7!(O,
MW/<VZPVZN*'\3IG.^U;\7=O3Q,U</#\Z(6;ON@P-]<&G*5]/K2V[MVYDO6"K
MU2$DWC= *B^N?^K)]Z7YS)YA\O7R ;QNFFOQUS_U9/O4?.9/,/EJ^0^#>=T<
MQP%]<9_\R0GZU97O76[(?6KY%VVOI'8W>YWC?ZMQ*W[4WS]O,/EJ^11C[C,%
MZ(/CKQX)H-4\CN(1\_;S#Y:OD3;Q=;G.T&VW&Z8T>8ADLC#0#F'!9>SW\G'1
M^(?+5\BO;[Q>?#:!?776'XG2R.^U9*][*_$/EUY%"\W?N-A8R/<9_/@S]5X)
MK_:6VG;R/Q#Y:OD:O4WIVQ202;E<,W-X)8X325%:T-0[T*]]F_%D_+5G8XW;
M>Y^Y'7DNWW%_>%D#M+I>O+C0GQ\%A7;R^8_RM?(Z?;]SN[Z_^%=N]RQC0VKG
M7$@S!YN'):J=S)YB6ZJ\C=?N&XV;G0-O99HQ[LIE<[[2M*[=_,1=9/P*,^[W
M[QY+R<.XD2O&/M6=]R\[C?+5\B%NZ[D!1U]<5_\ JO\ O4?.9/,/EJ^0[^+;
MA_[ZY_ZLGWH^<R>8?+5\AK]XW!H_];<5_P#JO^](^YDG<E=>OD/AW'<Y<KVX
M_P"J_P"]7U[>3S#Y>OD2MW+<G2:3?3M],[_O5K[-Q7UEY%3<=YW*V! W"9Q?
MY &S.)%>.#ECS]O)52F37K+R.?M9^[8K]M\_=KN;;Q34TSR$ 85PUGDN=;OY
M?,?Y:OD:UUO6X32L;:[E<,U8&DT@Q-!P<%-?<,OF'RR\BS/?7]IMCHCNMR^[
M-7!W6DJ,S^9:5WLD;C+K5;6ASESWOO5G"8FW%W,\8:^M(?O5K[V58]Q\G5HG
ML;?;&_[YN<UJ]]S/HZL8D;)*\X.(YE6X>W>UZR_%&;+AK6LI'LA#L#7(#->X
M=6SB"T?S"K]-DRB=:$Q"*8$@85J4P]3SO?'..[W#(R-;7#53C@,UXGOTG(=G
MKPT58!4$O'F*Q2EI!HLX8UK2'N))(X*>2\A9'51R7D$A5,K+R%;%4\EY$2".
M2\@D0J59>02)0I^2\@D<VE,4<EY$#L.2.2\@D;I1R7D1(4'%')>02+Y?#V(Y
M+R"1II7 )'9>1,AZD<EY$R".2\@D%#LO()#!1R7D$A0<D<EY!(H JIYKR"1U
M CFO(B0H$<EY!(E CDO()'>7P]BGDO(F1KJ4P1R7D$B D<4<EY$2'IQ5/+XM
MB9$J&C5R6A95Y!(^T>1(7%Q(.0.2T6NG78)*N]V75MW/<?*>'!>4[N/G=1H/
M5D':S(HYWL+&N  S \5T?;\4/<EFG=O;-<N:TX-K1HR"[>:8W$DA:\M<&OQS
MQ.*YZLUOJ+(V2KCADFYKR)D8[RC3Q4\EY!(Z&O'%-R7D$CI6-DP#C7FII%WL
M5ID]C '2".FKCCBNA6BJMATS+WMLL=R8026G)M<%P^YD3\!TR+:(I]LD^*N(
MZ6S<"210Y''--TH23)=M(-G;M^_B%\Z"-WZ7B32E0.-.:]+S5J[E#1*Z*RN9
MI(+@ENK(C'AZ"N3DZ\N9&KH9[.V-KMIG7$9!>2""6BIIZEDRX^,>);RD3<&R
M$M8!IC&&&"2J7D$DC6AK&CD!]2T5:\@D2N.(J$[LHV"1<'9 !5N/()&N&DT2
M./()%"33R"1:)N2\@D#@CDO()(P_%')>02/2NR\@D%$KR"1"$2O()!N-4<EY
M$R.1*\@D0$J)7D1(XF@P4IKR"1-13IKR(Y#V . ( <[D0K5=>1,DCHG$"K:'
MDT@)_4KY$E>X>^.,F('J4P5"NO(KDI=NR[I<7$K=R!$#"3&XFM3RS*=77D$F
MC!')+=RF84A;[KCCR3JZ\@DXCY@V<-W<6YD+FNB]PMPK[V>'BO.=^[5W!LJG
MQ0S;MMEOXA<7<8'1\S2 *U!ICGS6'JMME=K-%#N=U\=NFW';&5FMFG2P88@$
M\QR7I<32$Y6-WY03[CN^Q/O^Y01<,>YK \ZC36[.I<>"T9<\+1P5VDZ&ZW(P
M[DT1 F%CAB:TI@L^/+RMJQ^/VD4?S"V>?=&[-!(UV[O(:UA#JXTIB6@<?S+T
M.'%5K=$</M-B6[BMJ_&O.J3$UJ:'PP/-)F2QJ=Q7731C7[C90L;)$X.)QQK]
MRP6[=5X"\;%2/N5KI9(9C2W-0#C3CX+G9>XGX$<;&+//:0W3Y[5VK4230$9U
M\!S7,ME=GL2JVD?ML5U>W#'PM+HM=7@XCZ:+K='K19$YVH/:V#2T!?0L58J<
M&PZF"L(1Y[WI(UF[QAS0[_+MS%?^(]>5]T4W.IU9,2.Y:7M!C!=6F6-%QZU7
M%FW(F:%YN=I;VV@11EYS\HKQ\%4E7R1..K\SGG[?:SM,^KWL2VBJXU^PO3XE
M=UE;.;I;(?0<E3:">9#&Z)E&R-HVM*N%12OH16DAS'7]M9-AZ\#J/X!HH*^Q
M6VQJBD':26Q?(^SI*30>Z2:\TBN1)/%1H#M5%:K!)>B$4S<2"1S5BL@DCD\I
MHT522A>0RA;1TE0#E1$H.1*2T-JB43R*[IK=AU7,HAB?Y&O+@W'/VJ)19@5L
MEFE5L<US@""P@-.D$N#C7G4*Q,S._IWB!6G#$U5B@?+DY#G,#\"2 ,U7?=$W
M<0 ;#&/B&2'2S-M:#!7>HJHA,AM]ZLY!KL9!+)&3K!KF#CF N9D[BG_<M3(=
MDO(=YW*XCNY3'*!^E&":%V  ]!6KK9E9D9-$:=S9R6$H=<$"0^XVE13U$K7>
MJ\BCF9>\VMQN#(!;@@QNU/<"!6M#0XCDN?=\6.KF)=;UW5:[A#8P6(%@1I<\
M$4(I2M Y-7*7^!)=VF\V#X]RB89&RXEI(-*T_:\4W)%<G0V=Q<7EN'3-TN#0
M?60CDB)&$2-?F:>E3R1,BA^/-1R0O(:[6TZ]1H.%42@Y$C'%XS1R0<AA#FR-
M#B2W.A.%>:5J0XJS%F:7G5PY*8,MO45]+./VD\,<K6:R&@#AA]ZLQ8Y9TNRJ
MWIJRP(7"&2[+J,B8Z1PR!#!4@^&"Z&7"O3T:3,V)5I1)PSRON?>X]QBGNMGE
MZM]#5K;1M0QQ - 0: UHO-/+=VAV<3YFJB]-ZJ4Q>T^[_F%\!=V^[[-'T6QA
MNW-.BFHAXP&LTQT\E.>*QQN_M,^=J>2K'W&IVK:;_P!Q27%EW7 ;'<2[7;3:
MFO>(AJ=1I#G4P PJK<>%WNHN_P!Y&6_*BT@EO-PV*TW3^%=OWK]SW7;R6[A
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MR&2A4J@DA=TI-T@+GES6R,+:X\6US5]802:^\N?\5'+&2QH90%IH#@,U8[*
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M%*#DLCIQ0XFMVNKUD D+VD* $ :>)0 H93% "H("J"0J@!NHJ2!S34XH =1
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MWBGK^]G3-=K:'4TU%:<E!REMH*@!P;A5  PTJXY! $9OX'OT." +(9%F[ (
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MR1TD@<*)0(FQA. D]&- '%  1JC:@"2H&') 3(A.&" Y46[(W5KB% ?"]F#
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M978N(V0Q8G&E2JT05H;</W%I!KI/E^E:*U).BNA5K=68S5T"%,ASG!Y.#4C
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M\UTJVJZ/[BJ7XDL44-R[2QPKXE9L:1$DC; QR4!:?$UHMJI6-@(+JV<*N.D
M<JT26I7R(*TS'PV4EQ$*R-;J:5DO"+JHP-DW^/<9YH+\N9+&2 '4%:<L5Q<E
MV[&A51JV;8_B7OH6QN]TM"[.!/B47T-)[06%E0XD8%V6?%%EJ+CO;9,\Z[O^
M6.S=Q]1UO$VTO7'4+AH.?HQ'T**V@]7U?J'+TJ)-OCY*#P#NSL_=NS;QMENA
MC>7 .9+#K+#6N%7M9R/!:J7Y'U[VSW7%WJ<J*W[8_P FS =Y1Y3X$ID=O<V>
MT^X9NV-\MMXAKHA<!,UM"3'4$BAPQHHM7DH.%[M[;C[F&U;)3&DS_D?6NS;M
M;[QMMMN%JXF&X9K:XTS!HX8$C,%8X@^#Y^BL.6U+K1%QQ?4:/.,2[1C2G-65
M4LYM,=;2WX;$UJQW4U/R=DFR)598MRS#-#%N=JS4*NFC  _K!)3-.6B_\E_%
M%?9_(>KZ@W,$@47TB)/-^(O4;R*GB ]"($=D5)*//]]_[E<>D?W0O&=[]4ZO
M7V*"PLUL%  H "I B<"@"2-GD)0!$X8.27>@%*Y<]K/+BJDP+%M<RMA +</1
MX*^K NPFWE_Q" 5<@+S;"R KUQ3TJYHK&.;M#*@W+6N'$N'WJFP%.2YMF.I#
M*)/00J6P&A_4&KFA +HP3$C*44 *'8T5E"!)!05189#K>?374*C)4NDCHC.V
M1S2.N&X.=4^U)Z4:C$5M9.VV<S-?JU5PSSJ/M1Q(9.YVMQ=Q=BH@1CFY*>(@
MU:.8 E>I(!*Z,@<,EHQ+2!T!R/H29<>LDD5:*S&X0#F2D8C/@K<>1:E=G KW
MLE%)Q4>*QYL7,A,LB=D,($(I0!9J]?BY'1#<3=>'2\XE;%:%!+V*;!H)U8\D
M2%4(3J=5V#4C+8'T:1Y#5))GL)IHS2K/5@?'J*QW3:0E>62VVA$6,>:C I8;
M"A(&:6@<4E\;@6^X@+M0'!9JT<BCUT:Z(!P35U =P4,DCTZGAW$<%2R"O>7P
M9Y&_XN31S2)ZD%*&XN"\OGB(8,C2@3DER*\;.[2,!DH LEI8*MQ0 C7(D!Q.
M"F0$JB0'#) "H $ "9$H%78F!2^M U"80/+M+*G-6R,B,NUHDKN36P8XZ#[P
MQJ@H@CN;^0%UN10 $ T2NS1;7&<<VROCNLDCR7P/U8>FO@N?FR2;.7$H;OL&
MX6CQ<P/(836GK]"STRNK&YJQK6E]N-M!%$UVKJ#SX T^CP72IF=C/=\39%CM
MNS!DKYP'S8T)X^WP5Z7'XF5*TZDEX^"6(N:\$#$*G)E670O10VWMR6]F^*:_
M",AU/0517V]I\M1;EF]GVQE^SJV8?>L #)Z&H.%.-$9<CQM0BI5DS-P=NL6X
M1WC92^-Q;^G09>7P\%;B[EGI!:JG0V9ENXOBI/*6\/1_0NI5\E+$LBV'ES":
M8A2[+9%"4,8!4XK-<=#JZ74 P5$CHD+0<258BPL1M;(&!V8<%HQ+^HC+FV/0
M&'"B]K39'%8].]B#SKO@ [I'7_V[?[[UY/W/<ZO4.7  'C5<);,ZF07B5./<
M6HK1C7DBQ%1LAU8)1@#J48@![6AAH< 4U=Q+[$DT=;5U<<#1-GK\);CV.?L+
MEMO=2V3_ "/NO(PGGB/M7+PV^-(C(:\,=QMA^"N1J;(=37>&?@NRUH)4LAD?
M4JS$\EGL@OY5U&ND(>0[ #)(D/7&HFVA,TMF;09K31%%LKJ_@7(CE;I&GDAU
M+%9V4M0R)N2.)),W0X4.:.))"Z4!V@^I*U!!.S2T:E "AU?+S4$D9;I>?0I(
M&?B4 )*VHJJV20M;BE( G2:)R2=H\M5 #'*0(V/8R;S$EHQ]9P0)F_*H*KK[
M;K>\=92W,<=P1K$3WAI-</3P4I-[&G!T<UJ<G5Q]Q?:Z ,#@?>R+3J'TH::W
M,.7'?';5,BD#VZ7R4J<6/'#[%!HR+E947B<_M'>&S[QN=[LEE.WJ6+@QP<16
M5C@"ZF).;J)N.DG9R>RY,.)7:M^!M/JUA*4Y5;JU6-B!TEQ2LIHFB6,]1I')
M0BT:P'S!6(J9>@>Z.$J;;$&/UGMNY7.%-1/VKGR7$FMG3<2:'AZT]0&V['1S
MLF P)6_&@-6:4O)3M",BX*JQ ;C=BUV\N<:$D45#),_MZV=H=<2C%SZ@^% K
M,>Q#58U>IJW1#S@<1P3-%-,N1:<1'NZ- 0/2,4C17>C;E!35'U#J(Y4"A&OU
M;WKQ:@KOA$N<32PYDM"<+Y+/2K97DVO;IV&,VS'5Q#P*8CT)U4T8\F6M8<E]
ML48ABAC HP4K_5HFC0QMNKD-%%4,NQ9_\0H#6J!Y;\")]1D@B4#3@"4D:@/,
MK=)'%65J0.$+BS6[+@KZT EM&-?42#P!3.@ [9G,!FDBUQ>EWV*N]- .>!?;
M22"WA^'M^+<2?_%5<^-0)KC:K_=(HV6X,4%=1D/$XBF1YK77$[+0>NY*R"?;
M&_#:3*[B?3C]JM]+BM1RE?6]O?PTN6#5#5V9!'%<_*T5L+#:[:2 WS"-+,*U
M.%/Z%77DQ206=T).M;3T;GP^XJ7R1/$6XEW)S=,<_G;X#'Z$OK-!Q%E[CO+.
MR; ^/JS 4=ARIR1ZK8<2;;>XVMMBZYMW#70D$$4KZT]LFA:E")#V_M/<#FW$
M%TRVD=BYI=0\^967'3E8IME@V;;;'6,/0:>J!D_Z/L7JL>&*E+O(RCFU=)@X
M' >"Q7KJ)P=VJ[)^) ^4-.JBHLC6J*JXS*1\L]]WG<'<>\R;C=6,T%L:"VB>
MRE,/;G7BK*NE?$^X^S7ZG3PQZM7)QTT4L!+)VF-[32AYG%7U:>QZ*G>P64JZ
M_$@ZK*8N%#@4W%ER[6&VUDSUSY,=ZMLK\]N7L];>YH+-QTAK'E]*5P)J7UQ5
M62CB3Y[]6>UU[-%DH]=]/)(^B8K;6TRR-,;'9DX TR*RV?%3Y'R'-1<Z\7,&
M5>;P+.5T33K J 118+=GFR];D.S6]W?;S:7>/2;/&X^C6#R6C%C;S8W_ .2_
MBBOL_D/>?PAO@/H7U&8/.#JM\%/) /4H40Y%22CS[>R3N=QZ1]07C.]^H=3K
M[%)8F;&)54N? @;4\T5GQ *E6$BACBG20#GGI,Q/J46T SW3.>_2WW36JH=O
M $3QP-<P]05"B$-"(S<,8#'AI'#!3(094]TX2$,=1/S80ACS>.92)[O54I7F
MMYC5HC DVZ_N)SUIG","N9&/JHD]2S+?3J=+L>U,9YS/KI^'43Q]*F6S/=)'
M1:&YM% K$Q$A#4)B8&4!S30$":0,0K$$#7$N%#DI"")I .D"@40B2XPED=6E
M%MB9('$U*I@)&U400/&"DB!"J4$ KJA <5>@@6I1,; (2:+/?+9^))&[P25O
M8!K:AW@K$X(:3'RU+<%?6S(XH<QQTAO@BS)@'QZ@J(U)9 YKM5'9!.@6@LT8
M?'H;@5-H)EE.,36KL22#X++:12Z :XIW225IL*X"F2E42);;&:&C$!6II$)P
M.(PJ5')MP2W(YK64)(QX*75(@4::>*J5F T<5>M %\QPJH;)0K1YM1X*ECPC
M)N+=TFZ0SN_PF$EW*B0BZTT.MN9MGN=J;&QT;9FL (JVM0!XU6[C1UVU,U5:
M3C;5KNHX#!H>0/4L=7-B](V6AP: "HRRMA^*&EH&02R5BL%30XA$L!SFMI@,
M4:@#<@KZI1J J&D -QS2,!2 I02)I<<BAJ29!NF//-"J@D6H=_547<(E,0@<
M$U6F#4CH!1]>*T4JF5M(K[F1%'U'9\_6%A[*==B59R1[4;:<ZBX:O$C[US:6
M5F6YB]NEI;26Q H:>/\ .M&3%15T15C;.6L[AL=P8BSRC\7!4=?U&]]"Z]4U
MJ5>Y]CN]QE@EVU[IHV>^QFIVG/\ +7FMF:UXB2JJ1N;;LL,[(V37 #LBPNH1
M]*T]##1VU1;;1'76UK;[7& *.U"FH$_>N_DA5,O)LQ9]OAN-R9<$ AOI\.2Y
M%\-+;HN3:+-S;P/D::"K1A]"K77QK9!R8QP;&WIQX-X@*V81$CF4TXJO;4@B
M-=>&25ZA!)J:/2EXHD#J.(*>NY,DMO([6 3^)=7%CKR3*,NQZ0T !>HKL<5B
MIF0>==^-/\5BTX?Y=M?WWKS'NE5)U>F<H*DBAPKBN!'PLZF0ETU2TW%KL'NX
M<U#(0W#DE&$#V"05%4$$SV-<]H<[3Q 5N*)U(:DGN@^*QUC&N#4O:O\ #H6T
M..WZW?9/LMPN'4+':P!AQ:1R7'POXT,TF=-;[@_=[2&\<WR-8UK21PH!F N[
M\312U EU;W,38WV3J?F(&KES!5;%6FQ)%*RXK!*/UVBI<<,?4J7(SL[:,ROC
MY[&\,4SQ&P$Z2Z@J,1A4)?4LO$OQ8JUV1KVL[+^IJ-1SQ^Y;*-NJ95=/DR1T
M(8ZF7BK%]I"0GPQ;)0'/),W4=.H,MK<RTN"&O&532OTA5<EXC15["7!8UW3C
M&'!U:A'PLIMH-CJ#5V:2R\A$QQ(UZGXBE%4Y18,<T5U# )>3 875-#DHD"-[
M@WW<$$$8!<:NQ*<">I  02)F@"*:80POE>1T6UJ' -Q:*X%.DAL''+DX+<^4
M>\^X+K>.Z+S<8KF31JTVY8[32/.GDH#B2M"T6A]_]L]IPXNO57KK][+^R_-3
MN_9=$;;OXFU;G!(V+'^V8W.2^FF9N_\ 374["E4^+[[?ZGH%O\[["YV^;XVV
M?;[CI(M^G^HT&HH<:#GA14<;*VBT/'/Z.SU[%;+CP6^K/&[/>;_;-S.Z;?.Z
M&Z:\O:_ GWM0J' @Y#,+0ZRH/IF7V_#EQ+':LK[V?1_8_?5EWA8:'.$>ZM!Z
MUO5I<*&@+6BA<"*$X<5GLH9\+]Z]DR="[XPJO[9_B=@UI T#.F-,0?7]:A0]
MS@XE:)ML20-;&#49JJV^@G--BM UMH,''%:L=?,T.JB2_H:R%SZ4:$N6$F99
M4F!=SQR3%L= ^OM7,HF]RR2S;VT4D)^(C.H4.9'U45\0$DMOI?6-@P9[O&BT
MX[!(YY>TXGS<58K2P)8&]0C5BHN08^\.?N$[=N@.+<7 "N5>6*QIRR3;MHNC
M&R)N#&BA'BMV-52$=4W(UY:]^D!2TAY@GCL9)1UB]H:W.,G$_:DX 1/U0D"0
M!C7D-;4\_2EMC:V)Y,7]&W<V.<::D%SB2 6G'C3@593&V)5<7*'/MND=452V
M3W0,10K0\1:\EGXB1AS#TA'E4XUS*HM6R*FI!]:4+:.\,55!*T(3E2C@>)HG
M54-R8E >?L3<4(TGN.#&G"CO8I].=B88TVAU @.(Y4*GTK> 0R66Z;:,U7>L
MVX_"&@?3@E?-!#,:S[YV?=WR;;L[##<-=0OD+<^0%7<U6\_%:[D0Y(;GN3N2
MP>^TNO- W'RM;_Y N=?M9&XDUJM(-788SW#:R74)8PMQ<V0@'DNAUZ5M^8QW
ME/0WAU(XXX&T:&FITT(P]7BNK55HM!DV1.+7SXN;TB/,"!]:YF;-9N"'9HJ7
M>SP.@FEA;5T@(H"37 CFEIUZW4M"J_F<]8_$6SSM4I.IYJR/30XXCA7BD>)U
MLDMB[E6#3=!(RD0C(=Q.*7LT:V(K8K/T0R'7_B#W3RYX+G53G4NT8H@CE<)"
M6N<?>K1:8JBNR?@67[="UH>[2(CBYO-/Z,J2MVML8^X[?&)62[<3$!BYNIU#
MZZFBJ5>#E"<4]R6P[W_A,XM=VJ;:3",$- Y>\:'AS70IW+K1O^ WIHW'LENV
MFXMSIMWGR >;#TJJ^2UG*+JU4#71.T:?Q*%;S*[%:3;=OG:3-:Q/<<35@^[!
M/HRVO;RKQ_@0-[;V.9U9MNMW/.1,;<_8K,?P[FBO?S5_Y!)V'VI<_IR;/"79
MES0YH_\ "0F=<G@QE[MVJ_DO^Y?Z%.[[ [$VL-O&[7&+J-P?$Z.:5K@]F(P$
M@XA9+YW72QHK[W[@U#R:?]:_^TR.X.]+NU#8W@FW #1&RE=+0!3  Y+)ZWJ/
MBMF<Y4JDWXLT]HVU]Q9Q;O>N/P=T Z)CA1S:XXY<^:L75K6VB,S<,Z#;]R@L
M=PL[.T%6R2QU<*'\0]/-=#$HRT^]?Q0N9S0]D::@..= ?:OHW%,\Y9PR2C>2
M7TT3(],B!#D5)*//M[_[G<>D?4%XSO?JG4Z^Q1)QS6!O4V,3 @\U?6L@-H>2
M+4@@6A' K/8!IED;DPGU*421Z)IJZFNIZ$M@ PM8#08CBLMG!**LMU)&T@-.
MGG3!5\QBG:MFEGK(US6'\1! 1S EW"SCA\^H <ZA',#.M=U^'<_J,\@_$1A]
M2JK>1UH.L3)O+W-MVEP J2P5P%!P]*W4K)+L=%MVU,L02]QU'@?Z5J5"FVI;
M>X@D &B2RABD9+^1]BA (K$2!HG C(1( :< HD!XP;GZE#>@#7) &J '@BB
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MS-4VU)1BRO;<,$-WMI>V+_#E+2/ITI. Z-;:]TEZ/0='H )T-ID*#P6C'"4
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M!@R5U=B& 0R!_!(R!C^"$2,3 " "E4$H**!@&"D KX((!02"D@$ "J>X H@
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M9%MBW=6++V,&*C2,SDJ\V"$5T6IBM%I%=,@)!DJ/K6?"OB-CV.IDVR)[6N!
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MT[-<EUO,WIO:304%/[I7*O@0RR,S=T[!VK>#'(R[=;NM3J8UI: [+]@_E4+
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M$MJX1IMVN&UM"_>V.FE:::@034$K5@Z_$KNRDS9.V^X)-4T3FNMZF*M*5SX
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M$,K:JI[BL8QM,4R()%:B!"HL2(D $ (@$"!P*D",YJ ':0I "*( 1! ( *(
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MO9=32"7J=S>N89R^(>5^-?H6_,_A)$8^N"Y*W D&29B,"A -3 *F)0*"2-2
M*& J0@*J20J$ (KA!'9( 3!$DBC)(P%4 #4 /" !,@*Y80XGQ5B('M<6XC-1
M;8!7O>][?!5(DOODK$ <Z!6H@SS@24TZ$D0:0N?4<>PD+4@%(JH8#FC!9V]0
M' T6_#8">WH&E_)-GOH!SE]<&>\$8X.'V+F8ES9;39FA?[?+>6L9I[@P70]%
MP9J_F(=M;-9O_4;@TBGJ5F/$79-B7N2.XGL)-QA&I]NPN:SB2!7[.:P]K$TB
M,#BQR_:3;GN8SWE[&8+BU<6L!PJ&DC]KDL./&TY&S.6;6ZW]WTO@0PEY&DFG
M '^969<ZB!,:';+W#_!&"Q/^*[$BE?M')68.VJ::$WI):?>7F[W9E+=%J?Q4
MIAB?'FNG?*F*BI-J9<F 2#X<"H)YY<EBMJ!O1BU9:MZ4P<_B!_0FK4""2M,<
MTED!"!445+) BBNJ Z*?IG5Q%%>!;GNPZWU\538@AM=PDDC<TY**@,)9))I_
M%FKZDB/;I4L!F>*K8!5* NE,G(#F#S*U("S';M8#(XU)X)O550.-[IVZ[O)(
M[B$T9;FI!]?@>:Y787)MER>A7&[0;Y<P@0E[H34O I2E?VO%<STQ6SKH+HV[
MHFZ"&Y'V^E+>FA6S&WW8H);K^)L'4#1C%7$D4^[FN7DHTQJ,XW=M_%\_^$"V
M,-/*,.8I^8\UIQ5T+));#=-XBM1VVVU<8Y3_ (E, ''G7]KDNSA"3K-O=<VL
M#+60U>VE0NE06ST.@MY=4='JPK&2$!Q<W)(P%;)JS2-@3QOK)'_65O6_413E
MV/38_<7OZ_E1Q7N.&29;$'GW>Y<-YAI_[=O]]Z\U[IN=7IG-M+O-Z5P?!G4R
M$;O>24W%J/)R"5B ?+BE 13 "MP*2ZT%9&1YZI:H:I, Y[A0^4<%JH6#Y867
M3=#A4L^Q:5L4/<K3OVRYVJ\VZZ8:.86T',>OP7#[>74OQF'V':Q[07V-NS3"
M7N>*XYC^9=#H7Y(G+L=>R1KY)HV/ >2?K74OCY&&#(WRVF;:=.H=(2" /Z%Q
M\M.+9MI:$99@-O"V2[<&M(Q6"UB^2*/8OXFX4;2*M0\F@P]O-:,6/D4V1UEO
M>VFR6S+"6]8Z24:0P5-!^Z%TJ5]+3S*("[V[;+]C&W+"]L9U5!/IY^*NYH8N
M6(M]4<#L&-&EOHK@LF1R#..W79!%N4TS16)[A7'A05X+GVJ2BK96TL&X->S_
M -*"-7VJ[&,=,9@[_#'Z?!;4P&59F3BD8#2XNP0((TEIIP*""RT",:D$C)@V
MX(+1B!FJV!1?!<PN<[\'%0!:9(7,&I2 .EB<X85I@JK;@130Q2C!I5]$2AC+
M2QA9\2YIJS^7-59=BQ&=$R6ZN7OM7!F.II/AZBN?1?&2QE[(VPMY;J60-:,)
M7'++A@M]*25LS+&&;<[R"\>PFQC<'P/RKB"?J6RF-H1G;7T[9G0S 4>QH:/1
M0!7[(5;E,2:&33D5H21[5DL7%.STWUS_ !"2(EC,*^FOCXJVC T[B]E@C>(O
M()1Y 5FSN0.2NHC#=]>[9K>\5%/&OH6&F.;#\C:[:M=T>V2Y8\1VH)):<R*#
MP//FNSAZXK9:>\SSF-F#AF2K[451((WQ!_EBPI[U>)5#AC5J!D9 W2X5*S6J
MAN)-I'3JH4!Q(;H%VWS ?E/U%/:&@:@K]K/'\,N+4X.<33VO^])1ZBELL+30
MI<P$L+BW$<$^!Z 5-SV>U[ACI> B6'_"-:<C_P#"$9%R LV?;6W2[<;/=&&:
M -T1Q@D$&E >"T8>MIXD.? X:S[/WGM+>+A]W(VYV6Y>]UE"TDF)A+M(-6LR
M!;Q*P]W"TM@+.Y6+ T33.]PZRWF2O/8TZW-&%[HZ_M[>K3NRT=%=5B-GY80[
MRUH!R+N:];U^PN,&2SLKZ(O7=F^-K9'LUAV (Y?0HSOF66M&VY6Z<D(=J<*:
M< .5?0L..G%#7RYK;UT(I&CRQ_\ #9YP?'+[581Z&)?$K:BD@>\W'QRIZE R
MR6OI ]FG!VF@&(#./IKP4IDTL^7 :"6^>'2T,< [34G''BG3$OA]/5Z#QB-.
M//S9X^A/R'IQLI3$+-.:>1+6<CKIOZ /A]BINR";;7 VA'(HH!')Y7DA%P)(
MI%<MD23-FTO!5=@,/<K&6VG&XL&-:_3_ #K.T0:]E=/O[?KR'$>6GHQ^U:\&
ME21]0^,M9@47*F9.Z"&6T%A!,&[B\X@\L? ^"R60]!^SV%A9M$5_,)+D#%H.
M-:^@):LO>Q=G.AY;;&C."&Q2D-S?%+\+*PN#2//3/5CS'-35@7W@3,!8:-.8
M\%IY:$/8CK'$QS4BV*UN7=J#'7%N6\)8Z_O!:L'ZE?O7\2OL_D/5:T<!X#ZE
M] \3SK)*IB15#($.(0@//][%-SN#X_8%Y'N?J'5Z^Q1<\566QM&.-159;"C&
ME*B17'%I3O4"74'-H,TR<$,1D3*ZG5)JK9*V0;G'\7$8=(+"*$);4Y* JX<G
M'S]N2-G,4%0#BT &BXG9Z+?D=/%DE&SL77LY>C<L):,!AQ'I7&^1LGX"Y;(N
M][=O_P"K-N9:-=T6 @DFO"O*O-=/%BB#'5P+8Q-L-OBL#4Z,R,OI7H,*@#28
MT2,QR&7-7Y+2@(B URQ):D$K<0E>XK!V"E$#4Q($T0R4)51)(E$2 41( H 0
MYJ0$Q0 J>11"B0$H%$@+49*0%0 -0 \9)6 (3 0MJK$R!NEU:J6] (72/:ZB
MK))V/<6^;Z%,@-<"<D<@$*IJAQA!"N >Q5MD#Z@X!9WN21O=1:L; D!='"YS
MLCP5?8O" Y2Y<^.];(/=<\>RH63I9/B9;39G>F9@L8"UIQ U+T<KB9:_F*Q>
MRNH-&GC7-5UR(OOL0])MS5@J6N/NJ+55W!35P.NV6^T;?+>,8(A%B[@24F7
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M7FO=/S'5Z9SD;I=6(P<Y<'P.ID'.(U424W$J.<' M=2H\$"BR.:YM X ^*(
M2E B $JELM!6*2/6H51JB-HV342<> 5]2QFA%4-JPC$8USQ5W@46.?W>W^'U
MN<XZ'FM1G[W%><[M')?B(]CBE9>]=E76Q;04SK0K;[>X++K0VH;6)EZZ>9^E
MCC4#BN\\R1DXEEWP<^X5:2YH&3J9X\BL&2+N19:9QF^[IMEM</MM]D,(=_A
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M )X*$VP$=JXE6(",NQIQ3 .&*@!:!5L!-*0!V62:KD (#L^&2T*J 3!Q (J
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MF'^+71X5S]07DN^OZAU>OL5K5MTZ.3IM!<!^ESK_ $K*J:2:V8<,>]7-\_\
MC;'1VS' QES=&5,L L]KI$&_+-:_ O-N:RQ@E@)Q) *57DDQK"]W2[N"R9I;
M&T@-PX5]'@KJ4;%9O2VW1+72@XXXX)G6 $;)9S$QQ.!F&&FN-0J7J$&3<G<8
M[H,8PEE36@QX^"KXM:@ZZ%Z".4M#I00>1P32*/D< *9>E3R)#3J8FYD  $_(
M ( 2MDB5"@!"@@9Q2LD6A2$!Z<%"&08<U)(@1 #PI@ABJ2!IS00!" $3D@@
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MIY  ).!32 %J= )DI)$&8]*K8$B1@-<*T35)0W2$\##@W)1 "T1!#!0*" !
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M]=^@$U&G^9P5?RM:BR4I=AMV2]*"0ACL,*_^98[5D97()>V;6WDU/DK7P/\
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MM%_^/E<&LI1SM1)'#-Q5%L1/KH:[:N]F-9T7%W3^SU%5.C)^81=:_NF.,-O
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M/RIG$;U'UP0G))XG\V=HO]W[BMFVVXOL8V6S*AE34]27&@>SFO">\YN.6/\
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MD)!7<ZVD=TVR"O YU*(D(#X4PBKJ&N.8&".(0&J/\OTI8%$)C<-!&FO'--Q
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M3;S;+R6%P-70B1XB=@1YF @'/BAP]#['VO;L/8?QJ3V3M'YVVTK&6G<C!:O
MTNN(00'.IG1C32I\57:L;:GS+W'Z.=;VR8J^,ZV1ZKM^XV>YVHGLKEMS"^A:
MYIJ1@#B."K9X/)@[..W%I?N+T578!!0Z/Q .Q(3(K=8'$Z5("2*4 ]@JT^ J
MH;@E"S1]2T?"<W--/8?O4WMH,8_:SG6U_=QRY$4:#Z"J*6U T""990>+B1[2
MK[VT)0P"K]*S<V.TBS&S&E*TX*Q6$9;$74;1PZ8YJQ-%3;,Z[W"QVE^J:3K4
M_",_M6:S<EU=CG7;KO\ OUW3:VEED#1['&@/'C3P3(DVK?MRPM7&ZOP3=4Q
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MRU'3.5W.!TM[$U@J \:CZPDZ]?B+4]#OY8XX]NM@#YM(J/8O4JOP&&VY6<W
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M!ZIVQWMV]W'$T[3=:GZ098GM>PM)KAYFM!Q!R5D-:L\E[A[1V.JIR5C]J?\
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M27[%;K5B.K6Y5O8;%T@9MVK]<EKW.P &0S YKB9ZIL>LLI77;P9;OM[HCIR
MD2,()/LJIQ5K75EB3,/8^XKSM'=_X5OKC+M-R\LVUAK(0RITUTZ@,"W@%V\6
M>EMF3>C>YU'=TL$8GLV$5N+9[VM:#CK:[CDE[%&]C1T':N:KKX-'QE?6QM;^
MXM""'12NCTC$U!I3!0DXU/TEC[-7B5V]")S'Q/+)VEKAFUPQ1]Q?6U;J:L]S
M^2_=MH^U=VU.&Q7$;M<#M)_5&AK:$BOY"<5GO7Q/E/U;[3=_U%,?>O,]B87R
M'K5J,L,/H.*5.#YGCKPT&AH=700['\(+?K5JU*ZJRW)-3=.FOFY)H&%JU1#
M UKR %*03!9ACK(2,@,2K+I*HW)&0)Q'?]-SAH+A@0>*QTR5G<;<V+^YVRQL
M1?2$.C;3708@^BE5;DS42W&56SF+GN]FY1.L]C:YET[RL<014G+&@25R*VPS
MQP0V?R[DW<B][K=4>^&AS23JQQ]Y705/0ZVQM=NVBW^$VAC8XV4#6D8F@IF
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M#D,2K^PTRVE81#%<#7H(UCQ7+8Y)N.V6-\POM&B(C@V@^Q,P,!K7PS&VF-&
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M6%I-S"871&HI0SQ@_15/6R5FV>L^D<WI=Y.=T_X,^7AYLO>5Q]]>ATW;/?\
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MM5;R\!WDKVGPHH=-Y-.!CH@92"372 ?=_EBI53+ESVY<:N$6XP8P0QS=3L=
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MMH8J]-C/?-37C4<54SX[>RSW;+G#!*)V,CKHA6YH*:8[)<FQR!A[1@I ",$
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MO[(7C.[^H=O!^4L&XDN[=F@?I\/I5E7\!8]RS;5$>EV87/R[D$B2@"$T5M_
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MO+8FU_PGX _T56%XX,;9SS_X9VX^9^XS!LDN$8J*U./XB.2T8T65,VQE??W
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MJ/$>!K]JQ9'5;#IE-V:QEDCP2 $Z 0DE6(B K1*VQ105$L!5,@!0M0$H$<4
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MFU8QN:#(&>:A(&=*JZ]'1")R20Q;A>2-(U?#\:#"N:KQRV%JG2P11PP!E#J
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M:5?,)MY#G26+V>6XB(\'M/VK16 EBLN[" M9U6&O[0^]1;4A[D+I[-FZ60B
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MP30OZ1IRKGZPHM21G8S7]N[K>DQ&_+&-_%F,/#6%4L?VE)M6$5SM%@;%\PN
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M:'Q_F5E9(E>1,6QZ"U@S3\H8F[)MK<67<$9;G+'C_:4T_5I_V7\4&?2AZLW
M!O@%]%>IYY[CZ>*CB !0@ Y%.0CS[?/^Z7'I'U!>/[WZIUNOL4'KG6W-+W$;
MD4D$"*2 4HD%("%0 G!0P!0 B@ 0 *1Q#DE@@2J1U)'#)1&H K4@&N5-T!&3
M0A+C\0)-7E6JK 7548+56P UKR<%.2_PBL4%SB0XG!9ZY&*(Y^D88^*M>1DB
MODU1Y*BV1D%<&1N9*IMDDL)6TJ"592P!*X:A17O4!X<X'5FT<%3>F@C!QBW
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MMVN,C!CZON28\<%O(C83I]&"V)$\B>.CABH>@<AAR2P01\4<0'M*.($S7 #
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M9*L!6'E[XR'!='"OA12W\0Z]W*)C3;,K\06FGI.2HSWA&FB.4CN[_P"/<RX
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M>96V?N&UO+5[K4.9:5TRM/O5R]"XF1PQBZUMM TW<)<V1^,9-.//#Q25U"#
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M2."16 <M%;@*K>0!2BBA USZ46AJ4 IDP7-S8I 02FBI2A0 K93J"D![I:H
MC#CBKJ.!D*GY$L4C!5O4K8RF*A*"$+DF&$P* "B"18_?;Z6_6C#^HA,VQZW'
M[@7N\?Y4<5CDY!Y=\P[83;K&XBI; T#]]Z\5[K*O)U>K>%!R=CN>Z;;*&O<!
MMQ=^LVF):N=B[,5@Z3IR1UD#[?>CU[)_3-*'5AEZ-2T8FLAFXPRL^(1.,<C3
MAF[@EM@2';D8-=:-(Z2KB"!H#JUE. ."LK<DG%\UK>DUOE.'\L4][Z 5+G:?
MBQU8L'G'^6"RV4@9TK[W8FB2<ZH#G&,30>SGS2*L 7;#<]KW,?Y5ABN3[VK
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M23S@HW6S1=BMEW2Q(+I#K%"78/HWC3DK,2:LB%:6=IM'=5M/M$=Y>0NK(,'
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M$O7RML1FOVYOC.YH)(X,76C3J)I2E3^6O)>BPWBI6T:=B_5*YF1;G7P*F]I
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M!\2LEV2 :X#.BK4D$3FOU88A7U;0$S2 ,<4W(!X(]"4D"13!0 VA0 YK:C%
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M65  %< ]JJL ISPQ5E7H(Q*$H -"B %TT4$!1 ">I0 CJ:4$HCHI''M( S0
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M!HPT<57>O+0^3^_?5+RIX<:B'^96^S[%_F>R6]I!#1D3&LB: (XV-#&MIX#
MI%5KQ/G&:]\KEME@LH/-YO517):%:K"',,8! ;0GQ6>^15\"..I"8ZNTO:2S
MTE+3.K^!9)&^0Q/TQX-Y)[->02/ZG5&F4U9Q;E]*1:DR5I=HV:^.FZM0^GNN
M)/!60+S*<VR&-IAVLB%Q]QP%:?3R2<0YBQ6.]V(#[BZ,K?RAM/M*=:!S-&'>
M( S1-&YA)]\Y?4BV05ZC'F"Z/Z<S:?LT<?H*H=>1,$4PZDH$((</QT2<>),C
MY8Y-.ASM;SFZG!3RY:$R5GQD4C8:GC0453J$EJ'9Y+@A[Y.F!B ?Z0M&/KSX
MD$[]N<*L!& IKYJQXH\18*;K66U>':B\'PI]ZAU@8L02$O((KX<D*P%AX.H?
M4K4Y 4URHH8L"!IKCDH"!"=)YH"!G5.J@;AZ4$H=)#&X5< @D'2"FD-P0!$X
M2.;IB-!R26<("3XR6UAT$5//^00LT> '.[O9[QW!(UMM<F.WB(,L8%:MPKD0
MHMEY> %VRV_9MKC:^*WTW(_Q9"2:D>G)8WCE[@5[J_GDGTVCB #ACJHMV+X0
MT-&T=N#RPW,I<SBUP^]:VTR9-&.YZ;B6@>7()%")Y$+YYY9#)(ZK220V@P!6
M9VU#F1W45E)&99X@[32HIS*EX^0O,@M]C[5OHW.NK!I=XE:<.%5%D<.V^W=O
MLIFV5HV-LCM1'"IH./H6KL.KQ-02G#DYN39X+:-D^WL$<P.):*KR&.D6+[7Y
M(ZW>=HN-[=%+87 9 R@(%",*^(YKNX.L[J>4?X^\HB#F-U[*[C<Z*3;]P#.F
MX%[6\6XU_$B^"U+?F;_Q]Y'*1C]K[NMYF7#=Q/P<?^);9AU,\:_8LN3&_,NH
M)'OS&W<D=YM\DY93SBNFM!D0TK.E!;R19CWZW,S3%9OB<",23_Y0M%<JKK&Q
M4[3H9'=7?._;7T&[6Z0M>XZF@>Z!I.>D\U+[W/3C'[?]A5CU-#9M]FWRYVZ6
M_:XW GMZ$FE"7M)X#DHP-^M3_LOXD]C'%#Z  _$,J !?3_$\Y M$TC$J&("$
M!YKOO_>+K_ZC?[H7D>Y^J=7K[%%<V_YC4]Q"*BB5$#=!HF3 !&RM9#2F2EV@
M9&=<[K%#,(F4_EZEEO<DL0R]<:^>/M5:8%IAJ*G@KDR&#G!758HT8BE,%J2D
M@S-SV]]V-+2:>"'AD#S[<>[]T[1D$;;0]&7 .Q'U-/)<!8'4V)([/8GQS6@W
M"9U7R@MTDUH:_P RSY,BJ#1IFV+K:64,JVAX*<6=28[IGEFYP7%WW):&"VJU
MDC-3FCT>"ZN')J0MCV"_@=%:VCM5?TQJ9RP"[E7*)&P$E@IDN;FM %UA!C\0
MJ,=IDDKDASJ!6 2@8( $ " $=F@!$ .T^" $<*44@-*@ 3H!4K((SFE9(T8N
MHA$#WMHVJNJ D=:$<"DL2&AK:TS5"W 1. <$ *,T (@ * $4$"4J@!*XIT %
M7IDCFJ78!RSVU #B,$D$#>FXG')6)P2.TZ4U7($T30<9/<'UK=2Z1,"S7\L?
MD9#JCX._D$M^-@XE:1@>PRT^A<WTX(,,RR1W!DR92@3K0@V?B-4;7<2K%D >
M8S2JEWDD9T_,"<E4V0*6DNJ,E-7!(XX $*WF0.8ZN"5L"9DQ(+*)) '/HTCF
MIKN25SBY6-D"D &BH9(F%%7! U. ( $ +7!0 TG% #@@!P4@"DD8H($<:! #
M=7BH  25)(J )8_?;Z1]:MP_J(3-L>M,]P>A>[Q_E1Q6.3D'E_?TKH]^@>3I
MC%NT$_VY%XCWC*U:#K]38PNI$"YS3K#S0%>9=VTS=8F9=XAC#I\48K.2WP+U
MR)H[7JP_JNIYL<L_2M%?BW*:5DH[3>7#RZ,0M+#[QJ/N5RHB+.#G-SO>YHMT
M&V[=9M.PS. NY@&X-=34<N <Y6J$5S)U=CO%Q;PQ6,;&O@81I. -3GP*MKDU
M&K2'(R[W*[DNFL<W0SC]"2^4LXE@2Q73>FUU7#,C^7@JZODQ'05C8F>3\06A
M8RMJ!KP6/U?A5=E!"'AK9FNU $.:0UKJ4)IXH_-H6IGG.R7>[]L[G>C=H]%O
M<2.=;%^ H304SY+G9D\>I<F=5?1V&X;:;F\<TG :74(#J\*^E4X\SY2"K+(.
MRK^YOX+K^)NT_"_^D:3@3Y</I*]+U\W)"9*%]UBV4-N[F1[7N-&M%:*,^'FB
MFFC*MU87$5W'TB=!\SZ?;BN/;#Z9J;D?NDGPT?E-2\4"RUOR<",3:-FB:?XI
MU*G/3XCU^"[N'#QK)6S;AN7/<7RXMR:TY*:9)M C()I+ALGD)TG@%1?<$AMQ
M5T <X:9&UJ3XK+EL7HYF0WL=X'.B;-;G$@@'[TV!2Y'DZ3:7G<&.U>5D.#(.
M IAEARY+I6NA.(Z[<:&-[2"?= X+)=R*588R 6.;KKP/\ZRNC8O(@G@NK5VJ
M%E6G$M R\$UM*P:,-)U9CW6SR;I.+LR.:8<2P5QS',<U15:E*S\'!/N/<DG;
M.W3;A>,C^&C96KJ>_P"FAX+;5FWH=7)V<\5V/DK=]SN-YW*XW.Z/Z]R0YPK4
M#2T-P]BU['Z0Z75KU\:I78HY'!3)L531V;=KG8]R@W2TQFMW!S0<L"#]B6),
M'<ZU<^-UMXH^O>S.XK7N?M^TW* D3N81<1OKJ#@YS?Q!I_#R2GYU]U]OMUNU
M:5IX?@C?;FDG4YA/34**Y; 0OC<P%PX8K#F0%"VW5LET^V=34TD>RO@LV+0@
MONCC> [BMCU1)$X,:HKH K7_ )FT;P*>16A2T@&1C\E$D03QGR:Y9-0' _TH
MD(,V>>+<R;6)C&QY.<*5K[ DL,B$]OG;6Z[*1TLG(U^\\DZ0%>:^W.RF#7P5
MM3[TW+Z"DNB339<V\[!\-Y^+G_8J:+4"S;NL<R091P\4\ +<2.?[A(\!5:\;
M@!!72"2[5ZU+U D>YI:T2!+9 5'- FK'QS6<"5_4U#!758$@< ,<^*5O4 #@
M31$@1R9HD@(0,:\T2 VY) P1)(D8U!$@-=(Z-U6"IR27V 9/').S*BJ@#,;-
M<64SVQ5&74/ BE40!)/(^_BT-:&#B[F?H0@+.V[3\..O+B/$*^@&C),P@T %
M, M$@5W-+:.X.2-@*X@@ <,%1XB"LBKB_%G&N2OJ0$H(<&0AH'A1:JL"GO5X
M\;9)$S_U0(H!^7!9^UDBC+*J3GMLDOO@P)&DO\5YFE]2U([+8F7+-KDT8L:3
MB#Z%Z/I9="NX]\DD(:]CG%Q]X:CDKLKFS**[E.Y=).=;#I8/>83G]2QW-52(
M7K 1 RVCTY:M+2<?&BS-#,6YL[>@>YC6N=^R F59*6%_LEK+#;.CC9(3362T
M&F2=8%R&K;4N;=V_81WUL]A:'-DC<&M P+2#P*V8\:66GWK^*#L6^$]5K4 #
M*@HOHD'G9U'4*"9'J&*"$!YKOO\ WBZ_^HW^Z%Y#N?JG5Z^Q0-5ANM34]P%:
MA(0.*60(GQF;RZB/'TI+$HSYNVVODZW5KQS_ )UGLABW#!\-'ISTBE?1@BM0
M'L?J:5HXZ$,6H4IP(*,<L!R6K'<DD "W4:(,SN/MK;>XK2CXXVR1"K3I%2<?
MO67LXDEH)7*SA^W9-Z^)EV^>(MM8&E[3XU;_ .8KPO<5IT;-E;2=9-O=[:;7
M<-MX!-*&FC: \#S!5?65F_$&DS%^5?QF\275SO=L(GQEQ87M%<#AP7J,%#/;
M<[JZ_7)IB&FE/ 8+L*T("$,T8# <A@N?E<L"=F#4N.L (&@&M%: ZB "B !
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M*(D!@%<5# D% ,5$$#:!02(>" $-".100,TFN)0 \ ( =0()$* $K100%?!
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M,N5;!&I;CN=';,DCOHGVA+;37IF8#0 4K6BT]>[3-%FFCNW"&6,%K 8VY"F
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MF.-SG, E+<8W"N-4F:L(HQIT^XB#((Y!*T4+A5K /+GX!8\>P]^M@;Y)N?\
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M@%7<E&H!CR0 N/)  03P0$B4(X503(8_E01(M0HU)@0Z2C4D6H1J1 FJF"D
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ME@$_RE/M*^;%?M%B]H8^!I8,FD"@4_*T#FR,[%M)SM(S_9"/E:D\V#=AV@-
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M3P"C0629,2"@!#@B (S* :42[$2'6'(ID$B]1O(IX(D4/!R1 2&H*()D-01
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M!0T<DZ1 M!R3 *@ K1 "52-@)5I3((%H$ !HI" '@E9, H(!  I0!0)@"@0
M4" %0 ( 0FB"8&ZT$P+7"J2& W51$,F!6$.%4R4"M#J!2+ 4" @*! 0% @("
M@0$!0()@5  @ 0 4" $H$ % @ ("AL($TA1+" H.2)80* C4!5( I :7<$$P
M)I2R+ H")9,"T"B6$!0)TP@*!!$!0(" H$! 4" @*! 0!H,E#DE(2OBEAC0%
M?%$,("M<*HAD0&D*99$!I1+"!-*)(@=0)I" H$! 4" @0N#<$#)":JI&F3
MGFEXV\P@48YXITFB&A:!,+ 4" @"!1 0-!I@EM9(E(=50K$P(0*5*9:D0,\B
%DGB?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tm2225088d1-lc_sensitve4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_sensitve4clr.jpg
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M .H  0  !P$!               ! @,%!@<(! D! 0$  @,! 0
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MJ @<D$*BE4"HYU0"0.:"* @(') K]- J$$*A ) %2>"!4<D$0:\D!!"H0*A
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M-<3T.1=&6>6O5NM]#;EZAV1UYFI\O#9&%^"GOI9Y[D,G=,6LZYGOJP1QMZ0
M%!9]XLQK_>_?.79726;N,#@<'ZV;GM9YX'2B,Q.>TF!XXNCG(]9IY*C'=W]F
M]<>6K&0;F;;:ORLMKC_7REI>WMS/!)U4CI*QAB:YA=("WJKQ"(Z=U)N]'C-D
MH]QK=S73W=J^*W>2>D78;+'7OH)(SVHKG':[R[:LWUTK^D[</6679D]0/-]B
MX+:^N8;>&WG9'(QK&/,M&ASY  UR(RCRWZMUCM[N[GO+YKW.2YJYB;!/@Y;N
M:>><0FWN;Q[09WN- PQ#@!P'N(.M\QE<?@\7=9;)2MM["QC=//,[X+&,YN-
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MTJHNB]$@\:\.7=[ZJ*Z @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MX145G#?ZQ3I__95DJ=G_ 'A_J:J)OG%__E3DOSA_J:!\XO\ _*G)?G#_ %-
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MMST%W2RM._I"#[%#X8_N4$R @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M\(.>\LC<.AL<=.?TD5UX0.'NHCAO^L%X:LV0I^4<I^[XI!W,@(" @(" @("
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MOI01 J".0X<0F@@\$UZ2*@U* :CCPKPKW!!%H]8'B!W(*R"605;2G/A]%!2
MZ>%*AHI4\:D(:E"!T]G8.T(B'0[A0@-YNKSHBHD$D5!X=E>:B@!)-/=IV_15
M14;7ER0*=5.UJ"F6D$F@)J:4_701/#CV]I[D$*\./"G&OZZ"!Z>D@CX7#AR4
M'*&[F@,]M]N_@-W-%VO78WES%8Z@@A+6.<R>YDO)GNJ6@@B%@[2JKJ>PN77U
MA:WG33QXF2&,\:%[0:>]5$>H-/$@BG-WNH($@5X<!R* "2XUXGL*!3B>'$<2
M#VH!JYO+AV4X**"M"" ZOP>' #N1  =/#LY']94<I;P:?U'O)O'@M$-M7QZ+
MP+X<CDY'.;X<C[>X?"]I -36.X[6D<%%=183%VN#Q%CB+-C8[6Q@BMH6L  #
M(6!@Y =@51[_ $#X-.)03CEP0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 04Y.
M8X5[D%IU#C;?,X#*8>^>YEID+.XM+F6,EKFQSQ.C<00*@T/8HKCN;RL;T295
MUGB]=P,T-(]PQT?7>">/']1$$;G@CUVQ]'40VBJ.P].82'3V%L\/!QCM(^CJ
M)KU.<2YYX][B2@]]Q<06QB;*0SQ7B%@(KU%U2!P'H050WCT\Z<1[Z X<00*$
M\J\J]R"4]8!I^V<FGL44+23ZO(FO#@%1-TN!(';VGE10!TDU%>/:.U5(5>QM
M/0@X;_K!?YV;(?PCE/W?%(.YD! 0$! 0$! 0$! 0$! 0$%HU!G\5IO'2Y;-W
M#;:QB)K(0X\FEU/5!/)I75ERUQUUMV/9L]GEW62,>*.:TN*_-+_)GS"?R8Q6
M$U):8:/ RWDLEU?,GE9)[8V$ -$;"X4\+M':L='5,.O;][;[>"NH13FY>/=]
M)=/[$:9&C-H]*:6;D(<M^*[,P^WVK7LBEK*]]6"0-</A4XA9.EXM&L=C3,^W
MR8,DTO'+:.V&QF5$E*<^U<G0K*H(" @(" @(" @(" @(" @(" @(" @(.+\S
MY--7Y'S$LWFBU'C68AFIK34?XO='/[1X-K=1W!BJ&]/60R@XT179'%I';U<Q
MWGT)"2]" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @@?<XH'95R@D(/UO/N/<K(@0.0X"O ]R"H
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MT.,\9 )[?@H.T],Y5N<P=CEV-<QE]!%<!CCU$>,QKZ5]%4%V0$! 0$! 0$!
M04Y">H=H_LYH,?UGD,IA=&Z@RV%:)LQC\9>W.-CD'B!UU# ]\37"HK5X'!!Q
M!!O=Y]KRWAN[;0$<UM.QLL$S<0]P?&\!S7-/C\00:A%2W6\_GW]EG$^@!#$(
MW^),W$R,<QG2>IP<)ZB@XU0=C[.9'/9C:S264U4'#4=WC8'Y-LA<7>T.;5P/
M4YQ^BXJ#.(_A4)J[M[E45D! 0$!!+]L@X;_K!?YV;(?PCE/W?%(.YD! 0$!
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MNC17RDE^*2?ABJ'S=&BOE++\4D_#$#YNC17RDE^*2?AB!\W1HKY22_%9/PQ
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M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""5S^GT^@<T$HD/:/>[4
M2$\>%.\<O>14?$Y"G$HXH=;JTX&G.B*F:XD ^CZ:!U'WCR_900ZP/=/#T544
M\3OIW#W1S51#Q.%:$^D<E \7AU'@WO*JIQ6G'FB(H*?B&E10@=HY((A]33Z*
M"= 0$! 0$! 0$! 0$$KW=(Y>_P!B"3Q7$B@X>G]9!4:214\T$4! 0$! 0$!
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MN[ !2E:=B@J*@@(" @@[L]U!PU_6"<=5[('_ /$<I^[XI!W,@(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MJCLW;?2/\@=":>T>)!-#@[&*S%P.3A$*<JD_34&61_"ZP#ZWI[O0J*J @("
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MQON%B\O-YNM)9".PN9,?':VPDNV0O=$TC(WCCZX'3R(/-"'9,5?#;7N03H"
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M,#8VM#0Q@HP#T#L0#'5I8]H<.WMJ#[J#R6^&QEK(9K:PMX97<WLA8UYXUXD
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MI3MQ@OQ+^.LC>?C+]]WEYXOL<^/\+_.YINGI\:3X-*UXUH%1])T00$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MPU_6"#IU9LC_  CE/W?%(0[G0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MN/2#(Z@XGLX+Q[S#.3',1VMB\/\ 4(V6\IDM\.O'T/GW?V%YC+N:PO87V]Q
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M@((5""* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MVGX;0.RI;]N@JLUWC9&%['-+1V\/MD$!KS'=;6U%">)X<O[Y!/)KG&Q\0X.
MYTZ?MD$8];X]Y;5P;U<JTKQ_X2"_V5_#?1B2$U:>WA]4H/57L0/U4%FR.I+#
M'O\ #D>.KM'#E]$((6^JL1< $3M'HJWG]%!,[4F.8ZGBM(]!'U4$XU%BR>$P
MX^EOU4$WX_QH'K3M]XCZJ"HW-XYPJ)FT]T?50'9K'MX^*TCMXCZJ"=N5LW $
M2"AY5(^J@@[+63>!D%1Z1]5!6;>V[VAS7CCZ4$WM4)?X8>"Y!,96 5ZA[Z"+
M9&R"K'!P[:()Z\:=R @@33N]]!3\>,$@N'#L[4$?&9SZATH'C1]/5U"G:@":
M,BO4*('C1U^$/0@CXC>?4*((>-']D @>-'T]74*(("XB/$.J$$OM< K61M?0
M4%-V0MFGI=*P./$<>Q!)^-K&H'CLX\#Q'-!ZHY62MZXW!S>\(*B @(" @("
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MU]>V=KU6C:D>YWM0:VEU=E(Y"'L<#7G5!5.LK]S *$ <_P"RB#SSZTR,3'
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M=DZ_@^L?^O-K$Y\E[1QK$:?7S1+D_B2.'+C[RU]]P3MD,3NN-Y:_F"VH(KV
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M:(CKG;&TEQNWVFK*<2"6&RAC>R5I9(TAOUS30A49?'S'OUJ@JH" @(""4_\
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MWJ::MZV'I=],+<,.6,M(M#\R]0V5]GGG%>-)C\>Q=IIHK:%\\[^B*,%SWGL
M7=,Z<7AK6;3$1VN8<'J'"?TA8[[VV/V1T+HQ,":=8M[EI'+O(6N8LE?U6NO#
M^#[)N]EF_P!OS3EG77L_YJ.H@0>(Y%;*^,Z,8U_K"WT1IF]ST[?$=;M!B@[9
M"7M:0*\. -5Y=UGC#CFS,]'Z;;?[FN&.'-Y>[@X)U1K[56KKZ6]S&3N) ^E+
M<32^ P  48QSW!H-*^ZM/R9KY)UM,R_3>PZ/M=E2*XJ5C3RZ1K/IG3B]&DMR
M-7:-O8;G%9*<0QD'V.2:8V[@T< Z-KV@A,>?)CG6LNKJ/0]IO:37)2-9_I1$
M<WKT=ZZ)U-;ZRTQC]26K:07K9*"O51T,CX7<1_;,*W';Y?F4BW>_,G5-C;9;
MF^"W;73[8B?NEQ?O[IB]T_N+D[NX%8<O(_(Q. IZLTLC0W_B+5=[BG'EG7^E
M,SZYE^A/!^_IN>GTK7MQQ%/5$>UJ[EW"G;[J\+<VV/+YI2\U!N!8Y&)I;:X=
MS;Y\AX@F&:+U?=H]>_8X9R98_J\?5+1_&74*;;86I/;D]WUQ;V.Z.VGTUN+\
MVIE7$0$! 0$! J.2"%0@B@(%14CM'- J@()75K4<#WE4:/\ -'_LVN3Q^%%7
MXU;K.]%_GQ]/)+R[K^7+ASDM\8$0=8^3>OL&KJ?\[8_\FX6H>(/BI]?X,OLO
MAEU"T=_'MX_K+5613J!5!#J''CRYH(U"!5 J$$*A!% 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&CO,N8KG36)T]=Y>7"8?.WWL>5OHH&S
MAL'AN?5Y<YG0 YH/4'M]U318:)R>H]JMOMC;C2%QG'YN3&2LDQ3[:1SIY+J2
M]DN(R61SN=022-'$N%.RG!!U/LSG\KJC:W26H\\'-S.1QUO/>MD:(W-DD;5P
M+0U@''^U"$LZC=5U.1"J*R @(" @@>Q%<-?U@O\ .S9#^$<I^[XI$=S(" @(
M" @(" >(H4'->^&PUUF[Z;5FDV,]KEK+DK9[W /#6O<Y[>ISN-&M:&M:%KN^
MV$S;GI]<?B^O>%/%U<%(V^XF>6.%9[NSA]\ZRY[M-N=7WE\;!F-E;-U.:'OC
M>V,= )^$6T/)86,5YG2(XOJ>3K>TI3GF\:>F-?O=:[*;-,V[MW97+],FI+AI
MC<6.+F0QN/%C2'=+J]+75+:K9-CLIQ>]?XON?#?%/B:>I6^7CX8H^V>_LUCU
MK/YIL1>Y'1UA=6K2Z+'W$DUSS^"]K6#EZ2NKJU)FM;>2/X/?X W-,6\O6W;>
M(B/O<<4(H3\$?![ZK6WW\^%PY_JU[T[$['>FP>+O,-MCC+'(,,=PR6Y>YKJC
MU7S/<#QIV%;=TZDUPQKWOS+XOW%,_4[WIQC2O_3#07F!W6R^9U#=:2Q\[K7$
MXJ9\%PR,-/B31.D9U]?0'"K7\@ZBPN_W5LEYI'9'WQJ^G^#O#V'!MZ[B\<U\
MD1,>:)TG3373MCNU:+$\K7F5KW"5O%KP3U<>VJQ>CZ3R1IIIP=(^7+=;+299
MFC,Y.9[-[/WE,[H#F/ZV,;'P8"ZI>34NJLUT[<VBWRY[/(^1^-O#V*,4[K%&
MEM?>CCYYF>WS=S8_F3Q%WD]!ON+;JZ;%QEF:T=1<UY8T</=*]_5*S.+6/)_!
MJ7@?<TQ;Z*V_I<(^UQ*:@4)Y<7>[V+5GZ+0'/G0NX]_-!W+L*V/!;684Y>=E
MC)+[2X1W+A$6@7D_V9'.H*VO83%,%9M.G;]\OS=XNF=QU3)\N.:(Y>SC_0KW
M,RU!I[1VX5@ZPR7L^2C:#TNAF)<PD%O.%[3PZN1/:O7?'BSQQTM]/,U_9[S>
M=-R<]-:3YX[?[T-3?T4-+>WF<967V2M?8_"=TT/9U^/U+&_M->;7FX>C^+>?
M_P#0MU\O3DCF[]?PY=&Y=+:0P&C<>,9@+06MN#ZWK/D<XT ^%(YY[!VK*8L-
M,4:5C1\_ZAU+/O<GS,UN:?JC[HA??1S7HAC4RKB(" @(" @D<3V<AS*HTMJ_
MS'Z5TGG;C!7$$TT]M0/<&&G5Q!Y>XLWM^D9,M(M$]KSY-Q2DZ2LG]+71_P#U
M.?\ O'+T?L>7O=?ZO&J6_FQT7),QDUM<,C/PG-C)(X=W!<9Z'EB.V%C=8Y;Z
MMKEEU!#<1UZ)F-D;44]5PJ/U5K\UTG1Z]5<4Y*"902NYBG%4T:/\T <_;6Z<
MUI+6NCJ:=]U;\UG>C?SX^GDEY=S_ "Y<.=)[BM\8+0H[N*+HZR\G+7#'ZN)J
M*S6!J1S ;<<EJ'7_ (J?7^#+;+LEU #Q![^7N+5603J"5_*G8>:HEY_4_903
MM-0H(H)2>-.WL*H5^B$-4R@(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @("#7VZ>4VYCQECIW<CV>3$ZDNOQ;;V]TWKCDFZ#(6T(=V-JHK6N%\
MG6QEAE8-06N/ENF-<)8+>9MHZWZF\B&MMFNX'B/6YJHZ MK6WM(&6MNQL=M"
MT-CB HUC1R  [D%>.CJ$#@.T_K**J*H(" @(('L]U!PU_6"_SLV0_A'*?N^*
M0=S(" @(" @(" @E]SB>2BGT4 =]?=HD#QY7%6&:Q\^,R<+;FQN0&S0O <UP
M#@X @@CF%PO2+QRV['HV^XR8,D9,<\MJ]DN9=5^5*]=D9KC2F3B9C'FK8;XN
M?.*M%0/!A:T#JZJ>BBUW+TJT3[D\//\ \'V+I_\ ["I&.*[BD\W?7L^VTRN>
MW_E;CQ>3BR>LKR*_@A]>&SM^+'.X#IF;-":MI7D1QHNW;]+G77)]G_!X^L>/
MIRXYQ[:LTF>V9_PZ6='^SM$!MV -C#.AH'"@I19_3AH^2<\\W-/:X!WET_D,
M#K_,^V0OB@O+J:>T>_\ PD)D+0_AWT6D;FDTRVB>^9^U^H?#&\Q[C88^6=9K
M6(GS3IV, XD5!-%YVT-L>7O3=YF]P+*ZB:6V^-<RZDD' 5@FB?TG@>860V%)
MMFC3R<6C^,M]3!L+5GMOK'KK:'<5[96F2MI+*^A;<6LH EB> YK@""*@^D+;
MK5BT:2_.&++?%:+4G28<PZK\J-RZ\?-I3*1ML*5$5^XOGJ .7@PM:M=S=*MK
M_ES&GG_X/LG3_P#V%6*:;BD\W?7L^VTRM]KY?K/0>-NM6Z\O([^RL(A<,Q]E
M\*1W"K'MGBH10_9!=7Z#Y5>?+V1Y(_C#U9/&-^H9*[;:5FEKSIS6\GGCEM^#
M4&KMP]2ZNNI/:[MS,<*-M\=$YX@B8P- Z6.<ZE>GJ=Q^$L=DS7R<;3]7D;YT
M[HVVV58Y:^]Y;3VS/ITCOTCS*&E-?:HT;>QW6"OI(V,>'R6O4\0R@$<)&L<T
MD'I%>*F/+?'.M9F';U#H^UWU)KEK$\.WAK'HUU=W;;ZTM]>Z5L\_"TQOD#F3
M1G@0^-Q8X_"=P)::<5N&TS_.QQ;ROS1USI=NG;JV&>.G9Z)XLN 7L8(IV]J"
M*((" @(" @D)X\1P''BJ/G;O5_M%S'?XCO\ EN7TCIW\BK![OXVOUD7DT31?
MMC5)['*L<7U"P[J8G'M/$FVAX?\ DPOE>3XI]+9(>]O)=2ID$KB!^O[B"WYC
M"XC4%A)C,U9Q7]A-3Q+:X:'QNZ7!XJ#W%H*[<>2V.>:LZ2DQ$\&-?H?VM^2>
M-^+M7J_7[C\\NOY5.Z#]#^UWR2QOQ=J?K]Q^>5^53NA?,'I/3>EV2Q:<QEOC
M(YRTRMM6",.+*TK3NJ5Y\F>^7XYF7**Q7LA>>U=+DCU#Z*@A4.][FJ)'FC''
MC2G$CT(.8=:^:+.:8U5E<!8XNTDML?.Z!CYHI'/(;VDMN&CZ2VK;]%IDQQ:9
MGC'T\CP9-W%+3&BP?TP-4?DBP_R,WX4O1^PX_P T_3ZG7^MCN7S1OFGS>H=5
M8? 7^*M&096\MK'K@BD:YIN9F1!U77#APZNY>?<=%ICQVM$S[L3/J^IV4W<6
MF(T[748!_8[%JKWIU 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$&EO,'N5H_;'':;R^K\*,U'<90Q6# '%\,XA>_K:UD,Q<>D$<A[J*YJQ6
M[>]FXN:=/LGHBYTZZ&6(W=UDL@RZ9)"_AZL.0M86M]6.4<.\'N4';^E9-0/T
M[C7ZHC;'J'V9GXQ8UT;F^-3UJ&/U>?V*J+TVGB4 [*GNY(*J @(" @@[L]U!
MPU_6"_SLV0_A'*?N^*0=S(" @(" @(" @EY_V=JCDHW-W;6,+[F[F9#;LIUR
MR.#6MJ0!4F@YFBXVM%8UESICMDF*UC66BM2^:73&(NC;87'.S#1P,AF?:<2*
M\G6[_P!58;)U6D3[L:_9^#Z5L? &YS5YLM_E_5%O\4,FV_WXTKKF5E@X?BS+
M/X>RO>Z1E>FI^Z.CC;V%=^#J%,LZ=DL/UCPCNNGQS_'3O[/LUF6U.H&A''TK
M*-*T3 @\NQ5Q108/N)MAI[<6P=;91G@WK 1:WK0XF-]'@$M:YG4 7D])<O%N
M=I3-''M[VR=%Z]N.F9.;'QKY:]_9YIT[.UREC]EH[S<YF@7YFD/1XOMOLO-H
MCED+?#\8?\U2O7VU6MUV?-F^7K]?U/MN;Q1-.F_K(Q\>SEYO/6-=>7S]SJW3
M>E-%[68J1EJ8[2-PZIKB9_KO+0?@];G'B!R!6Q8\.+;5[=/2^);[J&\ZOEB;
M:VGR1$>Q7L-S=$9&Z=:6V5C$S:@^)]S;P_MG4'8N5=YBF?BAU9NA;W'7FM2=
M/6RYCF/;UL<'L/)S>(7K[6"F)CA+66^^)O<IM_D38]1-O#(]\3&ESGAP   !
MJL;U&LSBG1N/A+<4Q;^G/Y9CZG!S@6N(>#U-X%O(K4GZ9B=4O(HKMCRT8J_Q
M^@6W-V'1,NWN\*)[>DM$<TU30\?6Z@>2VCI=?\K7O?G;QUN,>3?\M>/+'&?3
M%6ZPLR^=B @(" @(" @D-*D@5]WO5'SMWJ/_ ,1,OW>*ZO\ ?N7TCIW\B&#W
M?QM?+(O(GB_;&J2Y5[7TLR#WQ:"NI8B0]F'D<QP-'-(M2:CWU\QK'^=']K\6
MQ^1\Y9M19]TKW'*7=22?V^4?2ZE]*C%33LCU->G);7ME)_*#/?E2\^,2_;*_
M*IW1ZD^9;OEF6V6O]8Z<U(+_ !1N<O<.A,3K1\SG L,L;B?7;(!Q:!7I[5X=
MYM<63'I;2KT[?)>+<.+>0WYW3YC1\O'E]V;^"K _MFW_ #_3UO?\[)^7[7GO
M/,)N58V\EW=Z3DCMX6F21[IF@-:P%Q/^:]@"Y5Z5@M.D7^S^*3GO$:\OV_P4
ML;YCMP\S;>V8W2[[BVZBPR,G81U  TX6OI5OTG!2=)O]G\4KN+VC6*_;_![?
MT\;IGA_(^7W?&;^"KA^V;?\ /]/6Y?.O^7[4DF_VYT5'2:2?'V5=.P5]'&U5
M_:]O/]/[/XGSLGY?M2?TA-R.W2QIV?OF/\&5_:L'Y_L_B?.O^7[?X-H[3[C9
M[64%W)J7',Q7@O<V(OG8\NH(R. CC^R/T%B=]M*8ICDGF^IWX[6M'&-&SW$.
MB<0?5Z32G$<1WK%^5VOG%NS_ +1]2=WMLGZR^E['^13T,!N?YDL-7M>9E>V'
M^TG1W\.8S_2XEX][_(O_ &;?<[L/QQZ8?2GN7S%L2* @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#SWET+2!TW
M27]/UK14\O=""6PO/;;9EQT.C#A\%PH>0/>4'J0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 02EU' 4K7NYH/%E,O98;&7F7R,K8;#'P2W5W.X@-9% PR/))('
M!K24&@=?;K^7G6VFL'K/4U_#DM.XG-OMK&820%GXQBM1(YE?&:/VJ4'@ZO%%
M3-\X6PV/L3%998!MO&XP0LDM3R!/2/WSVJ#<NB=5V6M])8?5U@PBRS-K'>0-
M< '>'**BO2YXK[CB@R".A<".7=W*HK(" @(""!%4'#7]8+_.S9#^$<I^[XI!
MW,@(" @(" @(""7AV\^]17/WFIU+>XO3..PEG)TP9:5[;P$]ENZ&9G_&"P75
M<LUB*QV6U^S1]2_]?[&F;<WRVCCCB.7Z^:)<?CB !2HX5]U:X^]/197EUC[N
M.[LY3#=15#)&_"!H03Q[P58F8XPZLN*N2DUM&L2^A>V.HY=6Z%Q&?N&AL]TR
M9I _Z">2'O/V'>MUVF3YF*MGY5Z]LHV>^R88[*Z?;6+?BRZM!1>M@D0?<HH(
M<^']E$'-N*E;;^8ATSN+8K1[R!W-M+H_K+7J3INYGZ?"^N;BO-X?T[[?XZ-,
M;K[I937N8N(XYI&X".4NL[9U  WL) <X5%3R*Q>ZW%LUN,\/)#Z%X>Z!BZ?A
MB9B/F3'O3]-&MZD.X<">=%Y6W.NO+INQ>ZAZM(YV22XRC Z2TGX$&*,%SNHE
MP-:GL:M@Z;NYF>2W'N?"?&OAZFV__3AB(IY8\\]FG#\70DL44T;H9FAT;_AM
M/(A9[35\KK::SK':YGUWY6KK)9*2_P!&7UM R<]4L%_(^-C'4:/4\&!YX^L3
M4K7\W2IU]R8T\[[!TCQ_7%CBFZK:=/+6(GO[>:T>9Y-(>5/)6V0;/K+(6DME
M$0YD..DDDZR"/5>)K=G"E>17''TFVOOS&GF>CJ7_ +!QVQZ;:EHM/EO$1ZN6
MTNG,?8VN,LH;"U:&6\#&L:T=S10+8*4BM8B/(^.9LMLMYO;ME[%V/.(" @("
M @(""4M!-?I>E!I76?EHTGK//W&?N<G>V<]S3K@MQ$8ZBM3ZS2>-5G-OUC)A
MI%8B)T>7)MZWG65@_H?Z,_+N2^A!]HO3^_9?RQ]KK_1T5;?RBZ*MYF3.S&0F
M:SB8W""AX4XT8N,]=RS&G+'VN4;2D2W/J2W;;:-R]NSX,.,N6-[Z,MW ?2"P
MF&=<M9_K1][USV/F7)^V.KWKZE#6I[4J(W)Y9/\ :7'W>RFGQFW6$ZS_ "/K
M_"7NV7QSZ'=I/$\QZ5H+,L)W@/\ \--4 C_^UWQ'Q65>[I_\^G]J/OAUYO@M
MZ):M\N6K--:3VL]HU+E+;%Q7&6N60/NI!&'EL%N2!7G197JV#)EW&E(FVE8[
M/3+HP7BN.-9T;1_3)M61QU;C#W?OAJQ?[?N/R6]3M^=3\T.:=_\ =B\O-511
MZ)U-X^$;;PN_>4H=%XU9.OE7C2BV?I>QB,?^93CKY7AW.?C[LM1_I&UQ^7+K
M^_\ V%F/TF'\L/)^HR=X-Q]<@\,[= _W8^HGZ3#^6#]1D[W>NUF3O<QH''7V
M0F=/=/B<'2N-7'IX+Y_O:13-,1V,Y6=8<*;L_P"TC4O_ &V3]9;]L?Y%/0P>
MY_F2PU>UYV5[8?[2M'?PYC/]+B7DWO\ (O\ V;?<[</QQZ7TGZO>IPXKYBV)
M.H" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M1P^N4M:WRXC3@Q1>MYA!?\9HC6F:M&7^&TYE,C8R5\.YM+*XGB=TN+31\;'
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MULN6RL=<R- $1(Z1TM/51$==[4Y'$93;73&2P,+(<+=6$$MA#$T,9'"YO"@
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M?*W#?G&U^^('Z2-O/E;AOSC:_?$#])&WGRMPWYQM?OB!^D?;SY6X7\XVOWQ
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M_G&U^^(,G00<0&DDT'>@U1OSNK:[1Z#R&HB!)D'-$-E":G[I,X1-=P<SX+G
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M2ZI??[;;@2NEU9AVE\4UP9'W$D=/%>9'22O)(\5H;0#@@U[YJ''^DAI*AH/
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M//G]5%5G^8G2 > +Z,=7!IHZGZJ"5_F)T;'SR+"_T=7U4$S/,3HV1KC[>PN
M/#C]5$2,\Q&D'GC?-%.SC]5%>H^832E#6^;X?;S^JB(P;_:7E!:V]:65X<_J
MH/4S?720B,KKYM??]SO0(-^=*O;ULO6%OO\ U4%QMMZ]*W3/4OF>[Q^JBKYB
M]S\#>O;;VUVU\C^%!6O$@=_I1&<VF0]HA:]AJ" :^Z@M>H-66> M77%]((XP
M"2XUIP!/?Z$&M'>8'1+KAUM^,&>("0:5Y@^[Z$%ZM]WM,7,'5#>M<0#W^GTH
M)H-V,"7&MTW@:5X_515S;N?@RS_.V$GD17ZJ(C%N!B)*DW+>^O'ZJ"23<?"L
M<&NNA]']E!ZV;A8AW%MR*4YU-/U4 [@XGZZY;3OX_50>>;<+$M%1< @'GV?J
MH#]Q\.6,<+EM.'?W>Z@D?NAA6CPQ<MKWFOU4-%JN=W=/6A)GNFM YGC]5!-C
MMY-*Y&X;#:WS3(?K>/\ 9V(-C6>7AO(V2Q.K&X5ZN\504,MGX,:TOE=T,%/6
M/;4@?KH,(O-W]+Q3^ [(,+Z@$"O:AH]-ON9@9H^N.Y:YG?Q^J@GCW)P\CJ1W
M+''T5^J@]#-?8Y_J^.T./(<?JH*@UWC6FLTX:!RY]OOH)SK>PE<#%."#R/\
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M.G\AB[?VG(P6L#H8 0.HF*X!XEKAR)/)!E=MYDO,7%;0QQZ#)C8QK6'VN'B
M !_]Q16+;H[][[:BT!GL+G]%FSP]Y;]%W=>U1.\-@>UP-!9L)X@?7!!M;^K_
M "Z3;#(/<*.-S5[>XFYNT1URT<2[OY%!.@(" @(.3?./GL_C-#S?B?K:R0-$
MKF<209(P>RO(E!\NY[NZGD,L\SWR.XESG$G]5!*VZN6?!FD'N.(_705&Y+(,
M^#=3#_RCOJH*L>;RT+NN.]F:[O\ $=]5!6.H\Y6OXPGX]OB.^J@JQZLU#$*,
MR,W]^[ZJ",FK=12GU\A,:_V[OJH)F:QU)''X3<A-T]Y>[ZJ"H-;:G;P&0E-.
MWK=]5!'^7&J">HY&4^CK/U4$\>O=5QNZF9&4'^Z/U4%1^X>K9#5V2D]P$_50
M7O36Z^O,?DH'VM[+.6DTB!J3ZI[P[]1!]8-I\WDL[I>TO;]CH[F3JZFNX\GN
M'.@[ @Q_?_(93&:/O[C%!SKID9Z2S@:]0'<45\ELYG<W>92YFO;N?QR\AP+W
M-Y<!PKW!$6\9+( $"[FIS_;'<?IH)QF<JT!K;R8 =GB.^J@G.<R[N=[-P_MW
M?502G,Y4\[V8_P#E'?50&YO+-Y7LW^4=]5!,,[F :B\EK_=N^J@G.HLT1T^V
MRT_NS]5!%FI,VS@V^F _NW?503?RFSW26^WS4/\ ;N^J@@S4N<8.EE_,!VCK
M<?UT%:/5NHV>JR_F]P/=]5!G6V6HMP;C5>,&.EN96NN80\NZBVAE97BZH0?6
MG;@7DFE;*6_K[>;>'Q>K[+H;7T<ZH.?/.,_54.F8W8$R>'U4F,8XT\.6OIY(
M/FW+EM107#WS7-S'-4]74YXXUX\"@]MMK;5=O^U7\W2?2X_KH/7#N)K&*M+V
M4@\>)*"O^E+6P+3[?(.D\&\4%R9O-KA@#?:I.7>/M4%&7>'6LQ!==R5'97_]
MU!Z8M[==11F+VIY!%*U'VJ"7]-NN TL-X\>FH^U0>8[RZZ<TM=D'?2^H@H.W
M<UPX4.1=1!0.Z6M2XG\9//TD'BNM?:JO 1-DI>/<2/UT'ITWJ76!RMO^+;NX
MDGZVU:"YXH>??3@@^MVRYS,NC+"7-!POGQ\>JAXUX<N"#47G UGJ#2.E6R88
M/=,YPZG,X4^[0#[%WV10?."76^J);@W+\C,9:@UZC3AZ*^A!=[3=G6EI#X++
M]Y9Z3]6J"O!O%K:W-8KYP]T@_JA![&;YZ^8\/%^ZH_N?M4%:7?O7TPHZ^/\
MQ?M$%>V\PFO[:@%X7 ?W _\ $*"]1>:/<-D889B0WD.J/[T@N47FUUY&QK:'
MJ^N/7']X05OZ6^M.H'I-1S^Z,^\(+G'YR-8M: 834<ONC/P=!1D\X^MWDD1=
M)[/ND?X.@LE[YK]Q9Y1)#.6'NZHS_P"9"#?OEK\R&IM89K\39VLDH)+7U:01
M]S:.#8F]Y[4'=EE<NELFRO;U.< :5IS^H@TEOEOE8[56?7*>N>0_<V5((JV0
M_P#-O^P0<T'SQ/FF?U6Y:*\'>(3PKW>S(,JPGG)QUZUL<I+7'@?7([?\0$&7
MVGFPP4A:R20- YDOKV?XI!>G^:/2- _VMI';ZU/_ #:#SR>;+1T+ZBXJT=SC
M][0>"X\WND8Y*&0D.Y&KOO2"VW?G"TE9^N)'/KV5?VU_Z$]R"W7?G3TVVV=)
M&USGCD.IX[1_T"#';CSSXQL0\"V=U#A^V.]/_HR#QCSPV<G3UV[A4FI\1WX,
M@]C?/#BK8#PK9QKS^Z._!B@QW5'GEOI8^G"VA#W#B?%]/]M:H-43>;/<>XR3
M+OQBV,/:[PNJ,\!3A7P1W=R#Z"^6K<3);B:*M\KDHR)W$,D)(K3PH7\PQG:]
M!O:,BH:WB!S*"H@(" @(" @(" @(""G)\(4%3]!!C>O9K.TT+J:YR)IC(,5?
MR77#K)@9;2.D%!Q/J@H.:,+YPO+);:*QNE+V^N?98+"VM+JV_%=P^,NAB9&:
M^I1WP5%:BV*W0\IVT./N<O=Y&YS.M[MTLL]U-B[EL5637!@;&U_BM9]SE:QQ
M;W5*H[TT+JNQUYI#"ZRQL9CLLW:QWD#'$DM9**@>LUA/]Z$1D<9X\.7T.2"J
M@(" @(" @(" @(" @(" @(" @(" @(*+JDN!X4XCM]]!KR;9+;^YW5M-YI;2
M<Z[LHC!#>"XE\$,?;26AK#7H/W.1PY>E1=6R54$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 06C4N!QNJL#EM+YECI<1FK.XQU_&QQC>ZVNXG0RM#V\02UYXCD@
MQW;':O1VS^G7Z4T/;2VF'ENI+YT<\S[E_CRL8QQZI"30B-O!!G* @(" @("
M@(" @(" @(" @(""#A4$'D@Y#\\6@,EF=.8S76'@=<S:??&7Q1ASC0W,+R>#
M3P 8:^L$&UO+ANM@=R]M\-/:7;'YJR@CM\E:]32]LS(XW.-&O>>G[HT<>-4%
M]UKL=MAN!E/QSJS V]_D0*>T2EX- UK?K7#L8T**XHW^T-MOH7?+;W&: L[6
MQZKFS?>PV[BXB3VB<.ZNISB.#6*HZ1\R6XK=!;"Q,M7EN9R]G8V^/;P]<MFM
M&RT]9I^!(>545H38SRG:[OM!V&H\=K*ZTZ_+A\UQ8V\OA^M#*^&K@^U>>3.'
MK(C)=?\ DZW!RFG+EM]KR\S)C -O9W$H>PESF@CU;,'EW(+_ .0[<N;.:+N=
M 99[FY+ ._>S'T#GB[FNKIY ZB3TAS?K0@U9IG3F%U+YQM38W/6;+ZR=DK[J
MBEK0DY:<'D0>10=JC8C:4&O\EK7T<9?MT&5X32^!TQ:^R8*R996Q/".*M*D
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M.4M9K*X:/^:N(W1/I[SB@U':>4;R\V]K!!-H:QN9HHV,DN9#,'RN:T O<&R
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M&V,9+>/%D=.''N]"#-L7M[I['-:R&RA8U@ KX;*\!2HH$&36UC:V8 @C# .
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M)3IEZ5K:;<U8MQ\\V]C8H'*O)9!J:8>[55Q10$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M,\5S>0=+> '4+6O&K7<SVK'WQ_(O-;UYO7^#;MOU:>IX:WP[G]//]*)K2?\
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MB+QY&Y>#NKX=K.3;Y>$9O+W<)C\6&P[M;S:UFL,%I_&2:=R$;V"ZR4L+)6S
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M6?P>;QCDPYMSAB;^[R5UFOO:<;L%USK&XS-]<XS*[8E^0!=&R]M[J]:QKW4
M>#%&UII0%8[<;CFUK:D1/UMEZ3TRN"D9,>]]W\LUIZN,S+;OETTYJ+3NC;EN
MHJ^+>W7M%JUSBYS8?"8VA! (-6G@LQTS%:E)U\O8T3QKO=ON=Y7Y/96ND^G6
M6X%EVA" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MPVW-G)C9W6\EQE(K:21A+7&-]K<N(!!!YM"SW1<=;YYU_+^,/+NKS6G!Q?\
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MC769U=&6MO'9V\-I .F"WC;%&W^T8T-;] !:W:=9UGRO8]0Y+@" @(" @("
..@(" @(" @(" @("#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>tm2225088d1-lc_effects4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-lc_effects4clr.jpg
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M .D  0 !!0$! 0             ! @,&!P@%! D! 0$  @,! 0
M   !! 4" P8'"!   0,# P($ P,%"@8,!PD1 0 " Q$$!2$2!C$'05$3"&$B
M%'$R0H%2(],5D:$S4[2E%C<8";%B0R1U%\'1<H+2<S1TE"4U=N&28X.3A%6B
MLJ.SXT14I-1%-F8G\<)D984F5O"5M489.!$!  $# 04""@8$#00" P$   $1
M @,$(3%!$@5187&!D:&QT2(R$P;!X4)2%!7P<I('8H*BLM+B(S-3<S06%_'"
M0R23)8.C1#7_V@ , P$  A$#$0 _ ._D! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M$;0@;0@I( %=45#23K4 'H#U2J(?6H!^\?NGP_*HJ1H-KB"3KHJ@ -Q-?!!4
MTGQZH*D!!\Y<PG:'#;U+2?FJHJJI=4UT\O%5$&1K?O&@'2M$-Z0_U*:U:[I1
M!#G ':=:>2'>KKMU?]X^2"AI/W&/:::D5J:(*SJ *Z((JUNKM /%! +2=S7
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M1)?-V.R5U?\ $[ED[W&6&_DA;4U.QD$%/ >:#9XVD@MT=77[$%] 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M-\*UU0JQGL('OX_?W,?\$,E.WR%3!">GY4&W&_*_I\$@7D! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M[""XPZAY!J[0H+R @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M @(" @(""C7[U-4WHD5 ^*@AOS(%-NG4GHJ(J::Z>9"E1)(IIK]JH4\*J"?
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M$! 0$! 0$%.[S52J37P7&JJ0ZKJ=/M\54JG=KMHE"H.J"I%05)%)J"-=$0)
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MSEOF)X/%9M)CTNLQ6V12MVWR5XNC,^?_ ,6LM?"U@_\ C&+T&3_3>*'T'/\
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MT3A\I%= _P""V&3JEE]O+%LPV^HZUAY*1$U\7K?'V)P^0_:<V<FC=' ]MQ"
M]CFFKC&X=13HN'3,-T9.?A2CJZ%BOVWS%*U;ZJ!6@U 7IGK7-/=\/R//\+9S
MD&W&0 #>AU9$>HU\%Y_57?VDQ^G!\^Z[;.35X+9W<_T1+?W%K*WLL%81Q-(
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MHI4^?Y5ZF)V/H40U5WZA>[BDTC:[&6]R7FFFOI46LUT3,1^G8\U\Q1/X2_\
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MQ');ME:9 YP) +>H.B1J+)NY:[4LUF*Z^;(NB;HWQ7;#( 06U(H%DLL_+_\
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MMF_/NV6RU.ET/+KLF6/M3;7Q0WSIHWPIT7H'KDT"BJE00$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MHB:()11 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" H"H(" @C5!* @(" @(" @("
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M[XJAN/F@G</-15-?BH@3XU56A7XI5*)!UZJ%%51YJ ""*@U'FN0FH/1 0*A
M0*A J$"H\T$5%#0]$$;OB@C=X5U1 N/FHJ-Q/0H ?7H4#=3J4H)ZJT*HJ%!+
M2-371!6J(=J%!;J*TKJ@FFO74^"I0KX54"H\2JBH$*BI11 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$!!0?E%7:_8I5$ "/\NB&Y-!U/5%H:D?#]]5$$'IX(B3
M\FG@5/ J&@4V>(UKX*RD0J(-**0Y*1IH>O@JBH>1\4%2*("!4(" @(" @("
M@(" @(" @(" @(%0@(%0@(%0@(" @(" @(" @(" @(" @(" @(" @(" @("
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MT\0BA+@">I\O-)$#<?@?(HLJ@:ZD4(TU1$:DD$?&O@@EO0$FKDB24A5Q2J"
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MS.2L<W<QLC?#!?VMK; 11AC*-9&3J0"=4'/EU^T.P_<+#.XED?KX;[(11O\
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M/&\-D7"^OPZMN1-4%H_@Q\0? +U%^*V[;+XAIM=FQ>Q9QV>5H;N_S>#,R1<
MP+'/,KI;)SG1_*!<L90[V.-.IUVKSNOU$7S%EO#ZGTSY;Z5=@B=9FG=2[?\
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M:%K?S5M>F89MMYI_3<\+\W]5LU>:EN[V9\TQVMO2:1.V]0#2OFMR\'&]R1F
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MD M)HQQ;^$D>"]3ARQDMJ^-Z[27:7+-ET;E/+M.,Y*FI$)H!UZA7+[DG3O\
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M3R\QD5<''\#C^:K@UUN:ZD0=1Z)ET=EMU\Q[45X_2S5HHMA#SLJE4$! 0$!
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M$MJ[JJ*@ @&GCT011I\$#:T:T0-K3J@G:WR"!0>00*#R00&@()VCR"!M;Y!
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MD.?D=/@K%UV;<ALKF/8PAS@:??</(KLLQW7;(8&KUVGT\4S7<M?#]#-8^/\
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M&]4#<$#>$#<"@C>*T46AOU5HB'/T05"0%!/Q04N?M-//5!4#4502@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""*(JD
MZ*54)'BDCQ,YQ3$<@NK"]OVN]7&RF>#TRT N.W[]6FH^58N73V99B;OLMCI.
MH9=-;?;9NOBD_4]B"%D$3(8A2-@#6CR ^Q9$1$12&!?=-TUG>N#JN3@J51!J
MBPI/@/+JN*L>YQ=36?&;ZZMZ>I'Z5*_XTS&^'VKISS2R9;3I6.+]3;;/&O\
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M*IW.+>J(H)^8 ZE%7F$:*(N5!Z*@@(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(""*54H(H46IMI4CJ>JBU-M!3Q*J5 -
M514B((\?)25A3KU&GFBO/SF+9F,9<8]]*3;*U) ^1[7^&O@NN^WFB896EU$X
M<L7QP]5'(W#\]D>U'.+QN8@F;CI9+JX8X1;!^F<8V_--M_,7DL&6=/D]J-C[
MKU+28^L:*WX4QS1%L;^S;.R*]K-^;]^HL/E'7."FW6;V,C].,6\[ZD$N-2XZ
M:+-S=1FM<<^AYSI7RC.?%RY8]K;/VH:RP63R'=/NA:YA]?1BOL=/M>P,</3=
M%$:^E4?@6#9DG+FB;M\S'T/8ZO!CZ1TR[%&^;,D;^WFGCX6W._G$,A+@<3D,
M;$Z6;%Q7CW-C8^0DO,%*  _FGJMEU/#=RV3;PK7S/"_*'4L<9\EE\TC)-G9'
MWD]JN]V(AXY;8;.A]O?8UD5D\3&&"AMH6,=HYP/4'J*J:?J%MEL6W)\P?*N:
M[43EPTFV^9NV<T^]=,]CS^[G>&PS6'9A^.MDFNW31//I^E.-E'M.C'./B%UZ
MOJ$9+>6UE?+GRU?@S?$S4B*3OK'9VLN]OO$)N/<;AOKJ,QW,S9X7,<'M<!ZY
M<*M<!Y+-Z;AY;.:=[1?./4HU.IFRV:Q'+/#[K!O<*1+RKCD+=7?M!X(^V.):
MWJ5T3?3].#TGR;LTN:?X$>F6^^!QNBXEB&G2EI"-?]RO0:3^YM\#YEU>:ZO)
M^M+(P-:E934*E4$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$%N36@(JP]4&I^ZW?G@7:.6*QY/DX!E[B%MS:XN21T
M+Y('2.CWAP8\4!:[]Q%<F<*]S'<SG7>?Z%E_=8KC?[-<]F(D=!,QTC)F@3!P
MB:?F:ZE$3>[1[H\]M.WG$;[D%U_#LM[EUO%OV.DEA@?*UH):X G;Y*+#@&^[
M[>ZGF$L_.>&,S=MP5G^>.BA;;3016K!L=60Q"@W,=K1!T[[:/<7)W(P>5L>8
M6\EEG>-?26MQ<W<S)'W<TS9"]X;'&P,IL%1KU5HE6A.X/N*[]=S.99+#]E+'
M*V3<5//C#%8.M[OU9;&>0R2@.A!&Z-S--: =4&=^W3W*\SGY5/P#NRRZCS;+
M.2]9>WTD321)<6\44>R*(:T>X@U1:LB]T'N-S?#LN.VO;_UW<YN96XZ-]G(P
MS"YR-K&^U/IR1.!(=,V@KJB-$\<]PGN-[2\@Q,W>YV6?ALO-NLHLBVWM(Y8[
M3_E :YL))_A8Z^6B#]#>&<CMN8<7PW)[1NR/+V%ID&-#O4V-O(6S!NZ@K0.Z
MT0>\/NTZ.K5*E%PU;HT:>2"X@(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M?HXT:JN*X- HJ4! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$>*MMEUVZ)E5^&YM[J/U;69DT5:;XW![:_:"0N,Q,;PWM8TR/<&QM!+GDT:
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M(1O=4(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M(1O=4(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M$!!3^((CEGWU_P!7? S_ /AYB/Y)?(L.J$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M^XT ]\,>" 0<GB*C_P U$NKI7^EGP7?2[<GO-K]_HV1=LK,,:&M-M?\ R@4
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M[Z_ZN^!?]_,1_)+Y%AU14(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M#3_U6^5E(=3MZJ"M4$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MQ^5CGQ[;@3.EA]2 -/K32#:1.X]*U 17ZPL)JB+H0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MKC'6]L+DS7\,4<;@9HXMH+"37YZHCI(AP^Z1M'W4%<5=2>IZH+B @(" @("
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MGC> 2X.(U3\TLS8YMRQ,S2>YRC%RS[+H6''R93 QV.=/K3W$>V[<RL8<:^%
M*+STW\M];7?OWM+\J]K7$LSD9[_$Q"WGN'OEG,]S<&LLCR]Q %: U6ZP]9R6
M6TN]$.B<-L\%_BGM=X7A9Q=Y2'U[MM=KX;JX#=M6D"AIXA<<_6<M\4MW>"%M
MP6Q->+>3GLM;:27[L$+72%A/S4:*GJM'2LNZKC;GU>X_>VQQEDT^AC\K!O<[
M5H;<-A%:Q[OS?%>RTW_KZ69GC:QKIYKMCK[ X\X7#6&)=\PM860@LJ1\@IU.
MJ\?ENY[YN[63&QZ3"#\".E5U2L+J@(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @I.@T062-:G2J*M25) :*_XP\$1^=G=.7M=Q
MOW)64_,8[3-82ZN\W<9:MR^TCMYGFY BED:ZK7"0MZ4UT16UHN4^S<Q,W?L6
MA:"8OVO/5IIY^KX(-B]HLY[>LAR"YC[;.QO[8%N/6^DOY;I_HF5@U:][A3?M
M4*M_MH 6'YBU6816P$5).AZ#R05H" @(" @(" @CQ01^((.6O?;0=N^! ?\
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M" @(" @(" @(" @(" @(" @(" @(" @(""C<4J </$H!> E!!E'F@M'0EHZ
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M'^2R(. /[MO^L3F7^AHOY4Q!^DAZA!* @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MV]P?%Y7$806>9G%U=MDD?ZC6>F-II04H%*#)!N-'-^1QZU\547A6@KJ4$H"
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MQD$ZT%-%5V)VZT(W4Z%!<"((" @(" @(" @("#%NY7]7G+/]#Y'^2R(/S_\
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MX6V/D:9-Q#:B6-X&CFZ_D0=-PM9&P,;7:P!M/#0445]#?CT5$T:-$<50T11
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MK2O7XH<'1O8::YG[;6$MR*O]>ZU=4FHE-.I*%&T8JD5(HX]:*DKB((" @("
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M>-HT;%J*J&YLWN1[P_Z=<>GXMP/CV6AO\JR:QN'F""[;Z5W$Z'4,+R '/%2
MJC8/M"[19#A&!FYAGPV/,<AMXV7,1$T4K76MQ*T;HI&M#:BA%$H58+[N.V'(
M+7D>)[G<3MWW$^(%W<S101374SI+J6-@VL#'-Z..A17V<.][&(P&!L<5RCC>
M7ERMG;PV[W;+>WUAB:Q_R.<T_>!\$1JO.7'.O=/SV&.3&W=EQJ&&.9KK^T?
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M*622X;)QPRBH<7FSE(I3R*46K\LN"\![3\OLCF>Y7=%_%,A<1M?M?C9L@9)
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M$! 0$! 0$! 0$! 0$! 0$! 04/J*ENI\:H/*SUG)E,1=V$;G1RW$3XPZ,[7
MN%*@E%\#D[F=M)A,K<6463NS<0RR1RM=(ZFYCJ=1H4WHQ497) T%Y.?ME?\
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M0= >U[L9R#+RY_G'/_19/G+BWR-J+&4M%)F2F3<R2,D:EM!5!I;/7?>CVO\
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!C/<?\ J\Y;_H7(_P ED0<
M?W;G]8G,O]#1?RIB#])":$()0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M.I02@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @((.H*"P6G<3X!)2$;G Z$;!]\'K
M3X*;G*)<X]W?=WP?MKDY^*LQF:O>2ODEC@=8VUI<PAUK/LE#@ZZ8_HUU/D^V
MB(Y9YASCO/[F[^/C.+MVV&!C N6C+V,EF[UH'/ .^W9/ILG'[ZI1O[VR>U'D
M/9O+W/(>47F.NLA<VKK5YQMQ<RM)%Q'*SY9K>$4VL_=45UPRI#36A_%55%R,
M@EU//5!6@(" @(" @(""#T01^(?8@Y9]]G]7G _^_>(_DE\A&]U0@(" @("
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M8;!:RE&U&UN@^Q$WI9M)/6@*"9"0*G5OD/-187&@T!/55%2 @(" @(" @("
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M>C0.J1!,ON/SEH\C5(6B\:?,?%5%3>@02@(" @(" @(""/'X(%-?B@Y9]]H
M[><"I_\ QWB/Y+?(0ZE:23J@J0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 04NW $A!3N)H0?M"DJM5H=QU;THK!+G?OWR6[?D?Z,B7_-('078CHS[QB>T
MFM-WX_-#8TD-H.YG0]/&B(.!.IU/@4%V"+UI6Q;@S=6I=\!5%=+\%[/<>LK:
MVR&5@9=W,K!,R5DMPRC)(VD"@>!H:E)1MJ*)C8]K6T;KIKXJ"L,H* :*@&
MBFAZJ+O54&@\M$54&@=%7%* @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @@J"-WY?L51.M%%4/) &M/AYHBWNU<2/L"JL&[N]RK?M!VZS?<7(
M6,F3M,-]+NL(7MBDD%W=PV@H]P(&TS!W3P0>#V$[W6O?SAU[RO$XJ;"QV>3E
MQ9AN9&3ESH;>"<NJQH%")P*?!0EF/<)P?V\Y:[:6']C9'Y3U_P"2R*C@C^[;
M_K#YE_H:+^5,0?I'J#]J"I 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 04_A0E0*
MH*)"10@T9^(^"#7[N]';:+EK.%W>>MHN1227$,-BXR>H]UH'F6GR4^4,=751
M:[&=QN;+&V:)_J!X!8X?F$5"J+P<UI#@*5T**N5'6M0Y$5#RIH.B"4! 0$!
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MA5/7_EG_ ,@L+_<<_P"%_*_JNC\UC[OG^I#^_$3M/V$"!T=]9_\ ()'S%/\
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MC2[\XC0ZJ+5LUL9 %?W?+X(*V&C:.T/DB2KJ$$J@@(" @(" @(" @(" @("
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M0W4M:.M$H/7;M>:(;5N6W9-\DT;7L_Q@"=>O5!3%8VUNYI@A8W74AK0=.E*
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MZCMY(832AH/SBK0AZS6.WC:0&NU=7K7X+C+DF@:WY?NUU'C5(1=/77HB!-=
M@ 4Z=2J*D! _PH" @(" @(" @(" @(" @((<@@&BB -594/5(20&@4DA-0BE
M4#<@52@@]41"!IX]%0I05KJI,RKY;Z^MK"V?<W3PQC&N?J6@G8*FE2%UWWVV
M167"ZZ+8K+07<;GTN;N78VS/^:0NE82]C-6OV4HYKG?FKQ'4^H?%GDMW15YK
M6ZR;YY8:X/7XG4K0--+->!\\EXI(8;@.?BW.?(^.)C72^JYK6@@N<W3Y1XK;
M=/ZA.FFD^[YZMGI-9\+9.YLT]\.*-)#K3(%].HB@I_\ 'KT7^X-//V;O)'])
MMIZIBB=T^;UO)NN]U@^X>;."Z;$*;?4BBKT'E*?%=%_7;*[(FG@CUNF>JVS.
MR)\WK>/-WIS!D>;8AL=3LWPLK3PK\Q6!?US+79N\#JGJD\'GN[R\OW$QRPAM
M32L#?]M8WYUJNV/(ZIZGDX+3N[_-)&ECI(2T^4#?]M6>MZF>,>1P_,LT_P#1
MXTO+^37+/2D#';J@AL7GHL:[79;MGT.C\3FF*3Z'GOFS4X])UM(XN^4[8G>/
MY%B76Y+^$^1USDR3LIYE@XK+R'9]%./,F)_^TN'P;XV\L^1Q^'DNX3Y&(9[E
MMCQVZ%C?V]SZQ!<-C&TH'%OXGM/4>2]AH/E'5ZS'\2RZRV/X4W1.ZOW9=.*)
MR5V3%)IMV>3N>1_K.P+NEK>4^,<7ZU;/_86NC[>+]J[^@[HPW3L@'=# 'I:W
MNFHK'%^M4_V#K_OXOVKOZ!;AF6P.T7+L5GN:8J*WCFCD^IB;28,;4O#J4H]W
MDN,?)^LTF2W+?=CFVW;-)NK_ #8;+0:>?B5G@V'[U6AOMDYP&D:?LFO_ /6+
M);AZ9R5[3_==V[[%=O<GQ+EV,S5[D;W-3Y6*7%06DT @FM+6!K7&>Z@=OW0.
MJ-M*4U\@V[RO^\![-YSBV;P=G@^3LN<E875G ^6TQXC$EQ"^-I<6W[B&@NUH
M"@UI_=P;?]8?,2*T.'AV_ _5,ZHK](371QZQ]:>-?)$7@:@'SU02@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MR9LA),K0"*"FB#J<5KN/0= B+P-0#YH)0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M=$%Q4$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M>.8MR66Q')69I$1V.G2];U-^.[%??==%\1&VZZ>WO=QM'XB*;?)>5=,*QJ:
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MC,3C,0SZ;&VL=NUE2?3C8PT<:D5:!XJH]$#?M<-"-5%7&  N(ZGJJBM 0$!
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M%/#HBU1\U3J->B -*@:.\RB/&R'&</E)1/>1.>X-V5:]S>A)\#\5WV9KK8I
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M_+]Y6$?99X3%V$SKBTMQ%,]NUS@7&K:@TU)\E!Z0:US:$*B0 !0= @E 0$!
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M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(""
M04$?+YH*20.A0?+D8GW-H^*$@3.V[2[[NC@36E?!<K)B)K)OV.0,E[3N?WN0
MN[R+)X9K)YI)6AUQ= @/<7"M+4ZZKV-O7,,1$4N\D>MK?PL\U6']V>#\V[/8
M3$9CD5WC[JRS&7ML':LQYEED;=7<<LC'/$T4($8$+JD$GIHM5^(T-?=O\WK9
M-MN2FVC-K_VM]T+V%D5SE<$YC"2W9/=C4_\ JBR=/U'28+IFVV^L^#UN%^+)
M?%*Q1G_9CLES+MQDKN\R=[C9K6Y?;.D;:R3R/VP>K6GJ01C_ "GFNKJ'4<6H
MMB(B=E>SN[UT^&;*N@V= 5YUE+@%%%2J" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(()H@I>[1!;]30_N**@#PJ*IM0J0J*7%S2'C4 ?=\2BPJ:UI;0D:F
MM?+X)O1R][ZZ_P"K[@8KI_3K$?+X_P#);Y174;JUHS0JH$O^4$U)\O!07&4I
MI^545(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MF<.H5%P&H!Z?!!* @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MHKNK*?D8-0YO5WVH+[7U:"-01H456#4(B4! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MV=>[8Z^O_/H_6*"?['7NV_C_ .?1^L5$_P!COW;?Q_\ /H_6((_L=>[?^/\
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M" @I>2&Z(/)Y!A;3D6"RG'\EN.,RUI/87 B=MD]*ZB=$^CJ&AVN-"@UIV?\
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ME_J:3PSRR2,^EM9KHT:Z-H-?2IU5@JZG#CMW5K31 A<Y_P Q&B"Z@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MOGVC/NW]CN*_5$DML(]I=7=4S35K5$XM[L!J"HJ[2JJ)0$! 0$! 0$! 0$!
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MSI:/WP$MM[X-(V4;2G1'%^F%L2ZUA#_O%C2:?[D)N-Z_&T-.AJJJXH" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M1X*H%NT!E*UT)04OW"A#20S\/YR*NMJ:5T!%2$1<0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0634/-14%%4L)=4UH:THB*M14-^[YJ*B@:06-ZZ:>'Q05;CTK4#J
MJE$'K\NG^+YJ2L*75<S;39KU*L"[&-K:(BM 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! (!T/1!&UM0Z@W#0% H/)!- @B@\D$@ =$! .
M@J@MF2G70'H5%07$@C=2O0JB'/>UNZE2--OG\41(?XM.X^220 DOJ'5_Q?)1
M5U5! 0$! 0$!!%4$H(\U0/3JH*';AH#4H(+]G4U)THD$@>:T/CT07*#0D:A
M'6M4"@/@@;6^2"'#3Y1J.@04G=4/)( ZM\ZH*=Y::@[FJ*J<3X=?$?!5$!SB
M-K?FKIN\E0!).W=JW]]07*$CR0#6FB"4!!!Z((VD_B*"=?)!;D<6T=70FB%
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M,'21C:US0X$_/IH?%0A].(Y3@L[)/;8V[CGDMRULFR2-VKZT^ZX_FE<:+5[
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M+LOA/4LI _/W;WVL43HVW#62/MG2Q%[!(QP%0*E4A['M[[L2]R^V/&LOR">
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MZW]GG=S*<OX7?\<Y#=Q7N7@FOW020B&(?2V\4+&4C8 2.IW(KD_D."Y'ROW
M9SB7'I&Q-Y#-B<3?3OA=-&R&^M[: N>6 EC1O)+@A+LWVY^UB^[+9#+Y/*9.
MTOY;]]E);_2>N-IM/7W5$@ -?5%$*.GOF<T-K2@ )\%$?CQ[INU [0]S6X4R
MQW#,Q8C.%T1DH#=WEU'0F36OZ'PT567>O!NPQ[+=L>860NX+@NP>8;^@,I%)
MX?4_RNOX$*N#O;-Q#FO.L]G>+\2OXK&TRUG'8<@,UN;AK\;=R^C*-S6N,8HX
MU>*4\T1Z_?/LQG_:_P BXER#'9.UN+N^FO9L;) R200NL!;@EXG%'5^HT0=I
M\A[VY?C7M4QW<"W?LY-%@N/7$TP;"[U)[UUG',]L;V[ #ZKM*:*%7#/#^,\=
M[O&_Y7SGF6#P5XVYGM8;+*WD=A<.B#6SLD#-[*M+IG-K3J"/!56QO;MW(N.S
MG<L<#;R+'9W 7#;:SL[W'R6[H'S9"YBD<&RG<7%NXM+0>JA#]-G':YSP=Q_,
M'5$:9]SF2Y/C>S_);WBT,LV59!"Z"&& W+]QNX138&NK\I/@JK\[NV?;/A7/
M'9*[Y_S#!\?SDEY*Z6/,7S,<]KG-$CP8W2,I1Y<WIUT4-[M#VV]I<;P#)NEX
MKS; Y["&.X!M<3=-O9/6E]/<[>'.T :*BOBJC1W]X!VM_8F?B[K?412/Y'=6
M^.,#"\RL;:V(:2X'Y0#Z6E-4&?\ LO[$_1\5PW=2&ZA;^W&LG$!,ID!L;J:/
M6ORZENE$5Z/?'V\6/.^3W6<YKSC 8^WCN+F3'07UU]$^*&>0$M=0L#B*-!)1
M''G=+A>$[09^WEX1S'!\BD?;5E.'NF9!L;I)7L,;_G?M>T,!(\BBOT4[WWMS
M?]H;B>Z-9/J)A6@;H+.X\@F^3<X*[%=C>6]^L:./Q7L&/PN)A?>6,MW#,V)S
MI+AT;PV6)IW'<3HB0W5[BO;8>(=D^.2W%];W%YPBPOOJ7Q&;;*Z:2W#=@=3I
M3\2@\?V6]@WYC,VO<V6]@_ZG(<V%WJMDVY*QEC  'RFGJ:U5(?HO;L?;Q1QE
MP^1H:#X4 H@Y6]Y_=?DW#>)6?'N*2BUR.2REM8W4CXHIP^UO;.Z#V!CVD@DA
MNHU\D'/? ?9!R[G?%7<QRF7M+:YR<$_T-G<PW4-Q#/;R20-+V-: :F,. \D5
M7V,YESSL5WH;V?R4OJ8Z_P I;8F>X9;-CBF99>IN+73,WT'K=6FOFH/2]\';
M1T%\WN +J)[);=DS8F[RX?6WLAH3]W3>J,K]F/M^ELW.[EOO8'O:;K%EE)6R
M4<V"6M/N4U^U"'=EQ%ZUM-;.(#I&.;ZA^[\PI_LJ2D;GY?\ N][/RX'N3;YH
M7D)?RV_DCC+1(?3^G@@;5P=I^+\*HWQV4[&.[<]GLCR5][!,[DEK87KFQF3=
MN8XM-0_05]3\*B]SE?M[VYY5W=[@9_@&*N([3$9#+Y&2XN9X9'0MEM=\XW2Q
M@EM0P !5*.PN*=N+GVJ=KKNYO;VWO\G<7L\<%Q:EPC:+N %H(N!0D&$GHHKC
M;B^#Q?>?+7?+NY?-\%C,M=6^TQY&YAQKFNMG"%GRM?&-6"HTZ:JIO9SV9Y++
MV?[TXKC_ !GE&,RW&\O?V]G>OQ\D%S$ZVB:9#^F<7D E[OF!"$.U.^_ +CNO
MQ!M@_.V&*XIDK6VEOA>NV->1<1W$3A,VE!N:SH[7\J&]Q1W"]LG;WCF)<[&=
MR>+/S1?'MLH<HV:Y]-Q(<_T72UVBE":(-U>RF\R?*.V&9XG<SL^BR%IEHPS:
M&[99W10;B6C=0!R*Y+YEV;;QGW$6W9CZB*3ZG*X;%-N&&3T@<O':NW$N^>@^
MHU\?)$=B]U^U;NTOMNY+Q\W45S3%B%Q@+R!Z$S2/X37_ "B+1S+[:.Q?)>]>
M*S=A8Y.VL^+P744>6MKF.4ND>8C+$6RQ"K:.C;XBJ#R;6R[E=A^X_P"P^#WS
M'YHP3WD#X;/ZLMAED?;N'IRM>3I%UHB3V,D]P/MFY+V-XWC.?9+,V.0FFRMO
MC8H[5LP>U[H)[EKB)&ANT>A3\J#K/L=W4RUM[3F<YR;VR9/$V&4O'O:V.-KC
M%D;IK:-(VB@:.J#C.XOK?W <ZR6;YOR[#X+%VM[,ZUM\I/#9.DBO-SSM>UT8
M=M+&U*!:<IB]MW/\=><+Y'C>28^2">Z=-A9H;]D4DX?;B-[WF0!P: 2/*B;S
M<ZS]]M^S*^W+"9)DC9?J<SC)'AA!H]]G<N(.W32J#GCL3[=>7=[.WELV;)VU
MOQ6!UU/C(9X9F%EW',Z)Q,T0^>NYQVU08]V^AY%V,]S5IV\MKR&6./.8VQRK
MXX]S9HPYDE&&4;F_PA%>J#H3WN=LQR#B4'<GUF,;B+26;Z=Q?ZCC=W$#?EI\
MNE=:IN6E=K$_9A[?YKW(Q]RGW\!=C7R0-A/JMD+;NST  ^4T]34E24A^A;:M
MVL+@2UH%!\$A9?2S[H514@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(!04$::^*BM%^\/_\ YOYW_P VM/Y?
M;(CE+V4]\>!=J>%<BQO+<O;X^[OLJ+F"&>1['.B%M&S<-L;]*@JC:_=[WI<)
MM>,S6G!Y(,]?WKA:NM[:]= \,N&2,<[YK9U0#MT\:H/ ]B?:K.<3CR'</(VL
ML;\ECKK'B!\6WYX[N-X_2A[JU$738BM8=T.[N99[G<EQ[G.6F/;VTRD+)L5=
MRGZ2VMG6\;I&T#:T<>M$1CGN&Y#V=R&'D@[3<5LC!<QL?EN16-U*X0W8N6.)
M=')'J9 *:.%-R#O#VSSLG[:6_HOW1MF8U].@<+.VJB.(^[=W?>W#O-R&ZP6,
M><=DL S",?%)]&UK[X1SEVHF)IZ7W=*^816T_8;P?(WE_D^Y^<G??G.V(C@]
M6+;LELKPPAPD#_F($/Y@0=+=[>2]L,/B8,9W7@M7X7),N&,BO7R,9+'$8C+_
M  ;2:#<RJ*XXYU:>T;(8^ZDXK=X7'7A+3;PQ,GE-#*TFCGD=&5"#*_9%RWF&
M4Y!=8E]_<7G%8[W(-C^8?3CTK:'TP&@> VTU4G<0[SU%9 ?4!^6G2GQ0IVN+
M??IW#YGPNWXE!Q[(W6,Q][-?1WC8)-C+R-L5L=CA0Z-+C^ZJC5C.<]BLGVKQ
MUW>8/'\E[L"PA<VV=<RQ7AO'N89Q7TRS<6[B[3P45DGL3NH9.599OHBT?/EK
M^1N/W;O2!M:^GNH*[.E:>"HU_P"^@4]R%A3[W[,Q?R_^>E0EWIRX =C^:@BI
M_8&:U\O\TF4J.#?8IW,XSVZY5R2'/W<4$V>AL;.P9*]T9?(V64D-HQ]:;AY*
MH]?WL\;R#\]Q_G%I [)8&]BOK^60-V11,GEBV@N))=UZ[1]B#$<!Q#V^7V(L
M9\IS;%X_(S6\,EQ;OLI)71RNC#GL+A**EKB15%W.JO;/V^X%B+*]Y5P'/6V=
ML&QWMDZ2TM76[1(YD;GBKI'=!MK\OBA#3':B&*3W4<@+XP\13X%[*^#@VUU"
M(_1)I_$3J?N1_P"PHY2JKK4NVCQ8JXOS(_O%W!_>W  G:W^BMG\?_NCD4':1
M[O<2[G]N^72\6O(;IK,)E)'.@D=)\L4#F.^\QGB\)17(7]W&&N[@\PJVH.'A
M 'YO^=,U1&3_ -Y6P1_ZL16H=^WJ_"G[-4A61<LXCE>5>RRV@PD,EYDFX#B[
M;>PB9N?-22P<X@DBFUH+OR*HY-[4\;[97F.O+;N)GK/!9:"]FB$=[;NGD$4<
M<=/NO;IOWC\B5*-]]KNS_9+D/+L;)Q+F6.R>3Q=S;7YMK?'O:\-AG80=SIP!
M5U!50?H;MVN)!W2>/FBL2[C<AXSQKBV0RG,V1?T:A8QV1?<.<R(-,K&MW%K7
M'[[F]%4AQIR6;V8YVYEN[*;!X^YN'.EFF N9R9'O+W$UV]:H-<>W+D^;L>[[
ML#Q'-R7>"=C[BX]"UHV+U#-&TFAJ:[0/%22&\?[QTT[<<0JW:\YMX=YT^DD5
M'I>UGO-QN#LA@>#X^YBFY/A[69DEJR5S9A+<W<\D;:>F0"=VGS%%:(B[LVEY
MWNY+BN[N1]?B\6:N8A:Y&9QBMK<&0^F QM2 X,Z(C7_N)O\ M9E+J*[[3<;L
M[/"LB;'?Y6QG?*UUWZSR7.$C 07L+= =$'>G>"1LO9B>1CO48;J<5'3_ )'<
M*++7_L*@MV<%M9VQCU'VMR'2:UH,E-_M*I#8WO#C)[)\E<P5C=8S;W^#?TL"
ME5:-]DG>#B6+QMQPK(7<,.:O3;,LK9TKO4F%G:/=(X-$9 H&$ZN0=U1N;+;L
M?]\2 /;_ +DBH5@<8^^?B^>N<7BN48VREO8;3,V$SV, :-MM:73G?.3ITIT1
M%[M+[R^ V?;BTBY!]-C\Y9PWDK<?->N=(^7ZB9\;-PMJ-W#;0_%16BN+9C,=
M[O=!C.58#%R.P=CGFW5[=02?4Q017PJTN=MCT_1.\-:*E6Z_??;_ $G X[8&
MHCM+!A=2FK;RG37R0;;]H%3VIF#C0?M2?7_U>W4.#?.YFWYAN!T!Z*HX*]^=
MS^S,]P;(2C=#!D+V3:3M #8K:NNO^!(&U.WG=?B?,^P\>$Q%W#<Y3$X^QMKV
M".1SG02N>';#5C16C#T*#5OLN@B=W!Y-<4!E9G\J ?$5@=5!TY[B.(7W->W<
MF.L7.9);7+;PAD?JDMAAF!TW-I][JE5H_,GMIQWMY<%V.[B96TX_<QQ.>9KR
M$W#BYT@#6[6O;^ UK7P1&^NV/;/L5?\ -\.WC7-\=D,E'<L]&*"PD8\O=4
MF;2NJ#Z_>CW%YQP3D'$>+X;)W=C@&X@Q36,4FR&[%M,8XY2VCJ?=:0->B4'D
M\KYGV#O>%X^ZX]QC'<I[CB&T;<B*[EAN=FRLX-8W,T>23]J#8']WW-$[#3PU
M'JBWOW;?&GU-N*H0TIW^S-IQSWS.Y!DI!%88C/<6O[J5Y(:V&UM,;*]Q(!(
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M1TS6M<^'UFG:X[17;2M$&L>$>TCMSP_,#,.L[++".3U(X[K&6>T#:YM!5KB
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MVU=N>-Y)N9FEO\K>T$;7Y-UI=4(<U[37Z9IJ-FFJM!N5D38V[&L:V-H.UK0
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MBH-'4:ANNOP00-NKCJ7:T*"ML;!4TK777P^Q :-H_P 7]]19VGRR-J!HJ+9
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MN_[*"E_WC7R2!+:T9L^[^.ODA*MVZFG1.(H.ZHW_ '?@HJMG73I15%Q 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
<0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>lc_antitumor-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lc_antitumor-4clr.jpg
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M -P  0 !!0$! 0             ' 0(#!@@%! D! 0$!  ,! 0$
M   ! @,$!08'"!    0#!@,#!P4+!@H'!@0'  $" Q$$!2$Q$A,&!T$R%%$B
M"&%Q0E(C,Q6!H4-3))&QP=$TA-0EM3<8\.&#1%068G*"HV2DM,1%%_%C<]-T
M50FBTC6%)B>2PL-EE5:3E#:R*!$!  $"! (%" <&!00# 0    $1 B$2 P0Q
M!4%181,&\'&AT5*BXA2!L>$B8M(5D<$R<K(6\4*"4P?",T,7DB-CH__:  P#
M 0 "$0,1 #\ [^
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M$,9 /=IM0EJI*MSLD[G,NXN]A-$<*C3<HB,H&0*] $
M
M                                      8#.V*B@@^;C=<"+BQ6).V-
MQW K*  ,=A7VFF[Y0%#Q0BKNGQ.\!4RX<3Y?P@JD(DJ)85'")W@BJ2Q6IL+C
MQ ,1'RVD5Z0&0  8C@LC*%WS !$1F<+5%<GLB R@         #%$C@E5N/C=
M<(*F9Q,_0.\^R HN,HV*N +3*^!@+8&FT[(\/, $9D>%7HWGYP&0
M
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M79H=3:^'5)[%EEBF9B.!MQP^232GE27'B BK_P!0;O4VD.$<$_:8+[>_3RN
M=7;))_\ ME0HV_E</+]L? B$B@
M
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MJ)0*,"3#NGQ 9
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M*+W?=Y8 .WMDB,MLZ(>'"1]5%48QA./\!%2**@
M
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M8R>IE?;*PXYI:$=]UEDCB3)G80#D;P+-)3N%4S*_V'^RSP#]*(8B(!<
M
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MI\ZC*FF.I[T4JYYIU5R3,KC[0&^@
M
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MA_LD\ _23NPB=P*N!
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M\;R]@"ZXK2L(!0_+R'P 7@
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MF?ZL^<8Q1Z?X2 0M)^';?G:.??E]!3V92IC!E(RJ8GW:3,[9J8>5S/+_ )0
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M@/%+GRL32#]T^X=[B> ([3*\C4K$M-]D+P&4
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MI<>!E<9I](B.\A%?3842A84 %XJ
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MGE.Z\%5**HG&PN1?W[ 11,2Q<4V84]G;;QB NPFJR&)L_D "*\L5]U@*R@@
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MU-<9R@9-D$E^7.S3_H((KB+TC^04ET9$S.ZP^'F 9
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MFUS*)!6I:4=ZNP!O.UF[^GMU*4NH4DLN9;AGR7M58<2W4I]HMEHCB31JL+R
M)%3#D4O%AY[(1C< $J,258DKTW_. ^"KSYTZG.SAH[[>'NQ]99)O@?:!".]C
MMV_^;5!F:T3&0EC![/'CAC=?;ORFOJNP%A*:5X8DHHF5Q]L01J<C5=2.ZC=E
M9B7A1TX<+F-FV+1J.PBQ\X*VV!%!$8'Z/'R@**/"> UP4=QPC$$"41J*";?1
M./W1"<!*R5!:3B5L571^04H$<.6XN7RQO%(#M69)/VG'R#*T421':D[> J/+
MU/65T"AS-7(L9L9?=CAYW$MWP5ZW8 CS8S=S_FU1YBII:R#9P0/%CYW'T?5-
M?5=@"63QG#T4^EQ\P%5IJ45JK"+G/M[ %YF4#,[4'?P 4@9'WK"]$NSM!%IG
M R@?<.\NP%7$9%##9&X@%%JC L6'RPB M*)$@R[IG'"B^';: RF9%&/R@,+\
MPU*LF^^>!E//>J\X%=$[S <MZ9\75/K&XSVE)N3R*3W>EF<Q2X_9%/K[B90E
M%!10M4".I<1&9%>1Q@J[Y@A55+42CLB:?DO#H5$6YF\1:!U/1J%D9OQ+J?:X
M\/Y.RT[=DN?6=I )<2XI:2491)?H]D/+QB(E%Q&DC-P[O6^861=WBM]+@0"T
ME&<(V1C%%\?E!%5&?"TCY2^^"J)M*)VEZ*OY@D(G%11M.&%7W[ %2,B--L4J
MC\P@HE233CCB3ZUT?D% S@H\5B2Y57Q[10QQY.\I/H77^405)1$:$I.)*C9V
MP 441F9D7<4J\[[@@E3$?,DXGZ7E[ %'U&A)F7>/T$W>>T%:MI.I:BG''RKD
MOD)1@PJQM+C$EQL;(NP@1M*G";(U*5A2GF.$8QN"17$1*C'N%RGV=HD+*I*L
M)9VX>4^V-ABHH1F9E$O.?8 NYE&1*[Q7%"[\<1%42J)=F'A?>+5**J)=Y7'<
M?J_CB!@M)9G%9%:?#L 5-6&&*X^/9  ML--B?7_F 5O.P[[@)<^;U^)ZF[,Z
MIDZ)4*=UC#^9B/.6UR,LN%RRSQWO%Q 3+I'54CK"AR]?IG?DW\>67>*&!Q;1
M\Z$'>@_1 >+NMN93MK-*S.J:@SU+,MEQ;Q+;]X^TS>AIT[W2]$%?%L_NE*[L
M::3JB29Z>77&"<1N7//,WJ::.]H_1 2)&*DD7);B+L[ JBD#,SPG#UN,>SS0
M$%36:3+T35<5\8?>@ B;=S=__EM/4V7<E\[K\_#W\$,A+1G<RY]9Y!1*<G,]
M1+H>,L,8Q.,80,R[ &<[E0[UUEPA"-]YMS_^5NF?CYLYS1?X6#Z9EKZIWZWU
M11\.I]V#TUI:G:U>8QTI[/ZLL<(8'DRZ+FE*YE>BC\8"2J94I:K23,])*C*O
M8LE4#MP*-*K%$1E RXD ]$              8H$1Q58DK@$!>,!%37L_5?AW
MO/L^(NY_;Y2'/\H#8_#@6/:.A$1V?:X'V?;ID!Q8C:UK=KQ-U>B3C_3TQ/3=
M4G ;F*-'S$6I=:44%-<# 2'NAH^?\*VL)'<;0$OAT6[F_%9/&D\.&7:E&?:3
M2YITXNS2U=Q'D.R!D'4LYK"CZVVU?U#0UYE/F,&$X.)AESA-'[Q"%<R#]$!R
M)X.MN3U53*Y/'.].W]DQHRLSTYQ)6YB?5[ &+?30%9VMU1(UW5LQ_>#;)_-Z
MF7P-R.7@98;1WF''9A6*8=2=A68?5,!UA4];:5TGM*K5.F/9T)N'2E[=4,4\
M3*_?(6OG6J]/S"#FKPSZ*W,9DZCN#3U1?K61!4).WHU3,K<I<+H^@7RWBJ^3
MQ$T#<?3%8H^[=4+_ .%=3G?DG]9;EY%/(I7K%<T?X01TSJS?/3>D=+4O5%43
MCI%2ZCVD7DQZ=Y#-R&%JYEEZ) KY=2;![1[I--URH4G.<>Q9,SU$\F. TMJ[
MB7VOJB*T@',.L-'5;PH;D4&H:0J?5T.O=7CD,A#4.BE$)+VKZYI?/-*5<79:
M5Q'?DK-+?EDO&6'%&R^XS+L$5RAXY=-3\[I2F:GE&\;=(S\THI+\J?D62YE%
MV>J8)+HG;ZO2.KM&TVJR"\V5F,_OP4GDF'$7*2@[T'P%$7:ZVAF)*BU*LR]8
MRY@LB!=,2H>T0WQ>,KC[ '@>#+55:U1H^HKJ\UU;S.1@F,MMJ&-^<(^ZVA)7
M)(@&3QDD9:4IL;8Y\3[?;R8BIZT79IN04DL4<[$=WTRP$.[\>( M$+;TKHYG
MXIKN=Q=-+8NFR\G(>7WYB76RK$RM1VJLAZPM4HM\/VP4QH)<QK/63O7:\J>#
MJGL),Y?3=1+H[LN^XRK$RX@K$%#_ !@H<$@[U:%EMP="S]%=1BF5Y.1:90PS
M++BKEME<WQ,!S5I+>-ZB;"U.B3CF#4-,R,@H$?Y14UN*Y65(Y%<3/[H";?#?
MH-[1.UTH3Z85J>S.L.)'')G9G!<XM!00OT?EM )Z5WC.;5TRH2YPR[)"SNE&
M\XW@("W\3J!&\&D7*\K')?K'&J#11^P,$5C5M^$!V=JLI=% G4S=DK[*-]OM
M4>K;>".3=N3D5;$ZM73"^P_J[!S6?K)R//;?$%2QX3R)>U%-(R@7M\7E^VS0
M"/M KAXHZLHSQ$?30.$+J,X ^%NI2NQN_%25/)A0:MD8EQ5_5:998DGU\[Y=
MGW+A5ZWAQI#FI];ZCW)>]HT[T71JL3RRTQ*.6$:3O3Z3?F[05'FP;6L'MS-=
M*TRJ$[^J<\H,6_8W\/OK+L5P(W[>G16O-9:89INLIOII%O%[7+EG.9YE=TNM
M!WH1Q >/XA9)RFTK2$@XO/R/B6!<"1'&N74=A&?;V@.D]:*_^WT\?/'*MN_K
M2 $2^"YLO^5K'=@98\*H_P"FSD0$W:[HZZ_I:?I3=IS.3"ZS+>;7Q-/J]H#G
M/P359AO2]4THXO+JU,Z?&B!JAU+TZ^5I%A.*?\(P'5+\Q+RC1ON=UI'I6G><
M+BB=Y@(9I'B"T5K&FUQ^23F2E*Z3J3C,)CU2S)'-+H.]'"(BH?VU=W<WHIR:
MUI2J_P!U-(%'I$=/(U/%%;C:[7\ETH.LJO+TNPA4>-2-+U/3'B7DI2N53XK5
M?:YKO3HEH?J@U)L;4I/*HKNP!N6D5*3XK:L<(&?3]W_Y(L!9XNEJ+56ACG/R
M!/Q;,\D6)2'+WN8!U@O()HXJ]D?*4#LM^[>(KEKQ*3.E9C:>H)TH?LDY.?8_
MQGI;#[\HWXKA41[O<1'LIMX1EW2^-61__<6!!U]5U&6AWUI[JNYB1?\ UDN(
MHX\VJ2^6P&M$REBC^%XKK851V', Z%\*BZ:O9RB)D#B1]5C3WR_K\U"U7RB2
MJ*MVD2+OB5T^S3[:X769BN];^J&C*Q7<Y(_](J*:)*9/>+4R)3\J/H<-W]@7
M'FLN 9O R4PF2U@S.*^V?JWJ4P+UIXT6ILN[ 'H^+U5+^(Z12X4*DKXCEJ[_
M 'H(E(V%W2@D!U)(&?2MJ442[T3[.\8BN7O'.ET]OI,TEW4YN.[C-2,!4?9O
MF9IV(84Y8KO_ "_K)CL 2KL<DRVXI6(NZ?48C_.WQ%0)L"M#NYFXBV[4E\%P
ME=_4Y@CO%2CVO!NVANGU\T)ABZ/$F/-!<Y]R #P-9G__ -44@U%%:>IMNOHJ
M &[>- X;8+2?*J&/RPG). ",:AEM;^:)*J_DA_%>F*W_ ,L+'R6WPO =AZNZ
M=O3TXY.E]F++QE;9[5!%RVG$P67%&T:5%X=M7+0?ZL<^&]*7^+57B7?WN;M!
M'2'ADPEM-2(]UM/4QXQC/3(*F,C-1ECM<+T//Y01R7J<R_BEI>8F"5=1B3'L
MHJ86D"LE-KQ;1[U:JE*ROI]/5#X?T90QPR*>:G/=I=7SNES0\E@(]:5ID\UM
M+7]0UA&*I3G1X'HI*.5/&T?=;/#RP+E 0=JF!>&64.8*-++,ZPO_ )PG+N[W
M-ZOR@.YM JE%Z3D#D$_9E9V4<5=Z#[F+FM*!QO!7'BTJFMZ]5JT?;,?J_&J[
M_AUGOX%<2@1OG@74I.B:JE\_M1=/G^3[1/8;K+NP15OB052BW1T VFRIE\8Q
M)[YPC)2QE;R\HJ-/W%9K+OBG)-'/!/VY7NSA^I6X^\[O+$!+NN*+NW6M-U*F
M5I[!2W<C/5AD3AA>0M-C:DJYDE<8"&M6Z4+1?ASI]$1-]9+)SNG<R\J^K(<5
M9C6=Z^)@.M-L#3_<BF8K/?VW_P!9= <W>&8C5O)K8VO<G\+Q%_\ +YGMMO =
MB$9W*.*N) C*"@                              C7?#69Z"V\JE>;/V
MLOD0*'UDTPUQ0Y]9V"#4O#'I=6G]L96<F"S:E4,SJE\N+(G)E*+"4I)02KA
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M&.'+F'64VY;<8Y?!(*^_<R/]R:H1%WCZ?_:&@1S_ ."!)'HV?A[OV.(OSB=
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M:<G=45)&";KN5C**50Z)Z:9+D6HKE%Z)?*".A4E$C@<4G>5P$,P
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M@1E>8#IC6^K--:4IW6ZF>R94[E87EW+0FYE"SO6D!RM6]5ZRWDW6F-$Z,?\
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M["B1WF(*)MB9=Q:OEN%4*,24?.GF3YQ!4B)*<!'$DWEYQ444E.*-YIYN$8W
M!)589GB--R;K_*"J$1Q@FR-YWQ@"+KR."H$KELNA> IA[QP/#C^6X!=$S*TL
M2#]*[Y@%#Q$28%!5M@ 1*296Q27#S@*70LQ&GE.Z^\ 211))V^3L 5,C@=MA
MW%YA!6)Q_P  KP50S41G$X8;U=L?(*BB48>XGNMEZ-\?E 6P.!JO,O3NC\@$
MKH'B-2CC#CYP"&$B2E,%'<48P@ U'66@:=KDY=BJVR;&/$COVX\!WH<090-!
M -JE9=F29*7ETX&F[FXF<,1F=YF9WF(,IFE1J29139$4HR@
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M)?;>N2ML[VR](!H>C]AZ9([8(VRU*Y\2IK<<#F%<O#%.+G#L9?-7,:?I.'R
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MZ_J'Q!=/S>GE,G(AGLY*N_*S*?50JU)W><%;/N#LQ+:VU=1=2NOY*Z/U666
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MQ&.W"\5SW$0>)X7]O9W0V@V7*JG]:3^+JCBFS(F9HD<CBTG%*RN@*)U
M
M
M                                 %D(=V-O A%AK3.C:0UJ!6H6&\NH
M.PS58G%<K64FPUX>7L2 V@5
M                  68B.TCB1?( ^*I4N2JLFN0GF\V4<AB3B4GE42BM29'
M>1<1%JC(M@]%-XBD6,B0<AB8QS"^7_"4_BYHF*B0-.::I&E9%,A19?IY0HXN
M^XY'O*47O%+.]9\0'N@
M                #7=0:2I>HW9=VJ)S$2N/+M6GWA)(^1:?5(![R4(01)1R
MEREV=H#(
M
M                                              ,9VW%"/$!4[?*D
M[P%X                                                       +
M(F9E;!7%-_S@!0X6?. M@<#-)>U+^7FN 5@9F7 SO^0!D
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MOAV^>(#.
M
M
M
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M2*
M
M
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M6(TF<8<I77A(R@
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MCN06N)><9?9R*M(96>WBQQSS=--I-H24$HX1 2"9DDR3=ZO'S@,P
M
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MC 2199A*)E< R@
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MXE9=R6<RZ74<><U E?D]((D]X\:N9<;( .F#)!0(B[A\WR7"*S"H
M
M                         /"+2.GNI*;Z/[05QYCO9A]>%P#VB21&7DN(
M!>     L,L10O+B0*^23ITC(N*5*-X%.PQ=Y1\I'ZQGVA1'U*02HI46(CYN%
MP#7F-#:5EIXZ@Q(0GOK,Y_U<-QK,KC[!%H]F=ITK4"2F:;QX(X3Q**$81Y3+
ML%168DI299-A]O$R5R8J*\R.\C([R$66)^D2,RTAAYK$VU' 6)1<QQ.XR[!1
M?-TV3G954I-MXY14.YB45RB5>DR.\@1\5&TS1-/(65$E,E*X8DYCB[H_6*5Z
MQ@/LE*7(R;JW)5O M<,1XE'<1EZ1GV@/-JFB]-5F9*;J4EG3*8][->1>1)N0
MM)7)(![+#+4HREII.6RW&"(FKF.-YQ.\P!UEJ80<NX46CYV[2C;$K2 0SHO1
MU>T-JJH2S#6;I^J9.0K$TG!TS"S5>M:SBM?&'W 7%Y&T&U\S*3NH4:OIF-I_
MHNG5GD7(E[%[AT^U-X(GB3D96G,)EI)&5+)C!,5*O,SO49G>8#!(T6F2$RY-
M2K&5,.X<9XUJY2,BYE&5QB*^6LZ3H-?6ARKR74.MQRSS76^:!'[M:?5(5'IM
MRDNRP4HVWAE"CW<1G>>+B<;P&&0I,A3L71-8,<(GB4=T?6,^T JE&IU:ESEJ
MFSU$L<(-XEHXD=Z#2=Z2$'E,:#TK*RZI9FGX&#AW,Y\[CC>;AG>8H^FFZ7HE
M-IZZ7)2V&07#$C&X=RS65JE&KF,^(#S%;9Z(78=,C&_V\S_WH%6P2<C*4^73
M*2*,EA$8(BI=YFJ]1F=YF A_<[2.JMP=0TZFL%T^G9;.ZI?L7,68TTM%AK;6
M4%M\#^8!,LK*LR;*95A,&DQXGQ,U<3/M ?0=L3 7
M
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M>4!F
M                                      %MIE?#YP"%]D/+> N
M6E&\R@9W@%L#MC\P"D;+@%3M(^/D ($1$5Q=@"A'<:2[EMH 10,B(X7Q(0+(
MD9% SX^84"^Z?'@ 1(R(O1,!6)P[#[ 12!WEW>WB"T6K2:RRU<JK_)"T!2*L
M2BN-<,!]L+P%;$J))' DW<;P%3B<3CAA<=X"L8%;=Q,%(VE HD?&X$+RNB &
M9D:COA"RX!4B,X1[W^%=\P*I&)$97>M_, <(G:9<016)W@+#->(DI+"GBJ_Y
M@%J3B90/$DN-T &2)F4(V@*J,[#AW0%P
M
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M3BE97$0"4S,SBHN7@8%60
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M2^[VJO\ F(!E
M
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MOO"+"XXG!-\(Q(5%(F9PC%1>2X!F
M
M                             >94*5(5' <\SGFB. \2D7PCRF7800(9
M\16Z[&D=/N:5I?VO5]3P]'+6M?D[LN^YWUM+:]TLS[RB\EH#2=2Z0J.C?#JC
M3]:/#478]87<..&JI=1[M:T\JRY5 )QVA8:EM!TMAFQE'403;W8S+QWG$SB9
M@KE?;B>?9U#NE*-G!I7P"*[#A!IQ5QD")N\)K3:-H:,Z11=<ZJ"XGWL,_-E=
MP@ C1-6G9?Q*3E,8/#*GE^J?_",?$C.\^T!N?AKDF&:GJ=]GNNO=!BO/D1,D
M5YPN :;O;.3%/\1^BGY<H/'\4BJRV%)8*XR,KC ;_OMXFJ=LC496G3=*Z]V:
MS._U"V89:&%W)EG_ *_MX?<"'U?^HE0$0-S34".[[<[;#S4\!U1M9N!+[E:.
MD-7R4OTS<_G8&<9N1R)AU@^\IMOZN/*0#>P
M
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ML9V61(!E
M
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MX&6$RY2O\X!C/O$5AE#$?9V +B.$$PP^KQCV@+8&9XBM45Z>WY0JM*,X(
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M=IM.J^GYAS,.4Z;)+"2?>KFG571[>*@'2!&9GZJ^/$)&4
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M=UI"U\ZTEWE%Y+ 5-:2@HK<1\570^05&4
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M21[6IY.6<4_U=V::/D5"Z' A1T-QB7.?'S ,H(
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M;L 35X5VUM[.T-L[</56>M&?FC^2 #5_&H:RVO6M/OK,I%G]LDHVW7=H#5]
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M'..50?&%WD =!4Z;.>DFYFXUXHI\RC*^!=@#T
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MY 15"B9P,XK+F3V]EHL)*QR9;9AC."CN3 _OD0#(E>/VB#B@KR[> "A*49%
MHH]>,/F 7%"XC[G8 R@            .<?&Q^Y"L?FW[1DA![7A%_<=IW\]_
M:4V G04
M                               ?"Y/R[*B;6O Z5Z(&KRWPA<"J%490
MN^;D"3S)@HX1NM@(C,R\T^@EMGB1P.!E]\494G%)=O: R
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M:78 T':+:V3VFT\= DYKJFE7*RU-7.O.W*==.]WUA%HD9..$#YBXBHR
M        (]H.V=,I6KIO6<P[U5<F<O"]A6WARV%2_*3IH.*#AR?.(K?(D1$1
MV&=Q^8!F%0                       !\]A%CCB)7,NZZZP*JYRW!W1U]J
MNM+T5M+)QP0SZIFRO=BVW,)]C/-(C' XBQ?E["!$.5/PK>(&LS)SD[JS#,+A
MW/AU+.XB3>F:25R0&RZ=T]XB]CY=,[,S/]Y*,W',9RZ33X8C4DN\2GU\[\?\
MGRV!U'H36LCK>C(K,@G+>5'.8BI6&#CC:>\I"".)(,["!:-J(XJ,H]P$AF
M           <X^-C]R%8_-OVC)"#VO"+^X[3OY[^TIL!.@H
M
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MO_<EJ'\R_:,J(-/\#7[FI/\ I?VA/#0Z=(0
M                    &,\11A::;B\X"V!&<+C1>?G"HS        PX#.*#
M*+7W_P -X 1Q@96]B>SY0*0J9)2E1ILC"WS *$1DJ,,*#O*^(#)89FDKR +;
M#@ L.PR5>9>E=#Y *";#+"<87\ %]L>R(!;"!GWCN,!:K$43(\1\"N 6D18S
MPG_CE\E@#,             PJ,SC&PBYR[8W!$DP)+"<(?XA?? XLP
M                  #X)V5:GY1<NZ<6E0[T#L@HCN(R.\@Z4Z$,T_??9[2N
MHT:%D)W(FUQQIRI]>&#1S)6J841Q)1^G^(%17NAXW:;IK5)Z<T=3_BRV^9[.
M7*XL3+3I=V8DE0AB47-P!:IZVHW;I^Y5,)[IOA]13'-E<:G\,5NDGOY3:3BE
MN-G: W"F:6I=)G7JA3F\MQ_#B+$M7(DTESJ/M/@"/<,[R,_-8 O
M    <X^-C]R%8_-OVC)"#VO"+^X[3OY[^TIL!.@H
M
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M
M                                                      >!JTIM
M6GYPI#\L5EY:N[;!U$;%671 <->%O972&O7=0U?4Y9E=1T4"]NG!$IIOZ%YM
M!Q0VGA\X$)G\/_A:H^V,]4*S5$]74YC)R%1<:P9:9AM5B)IU)Q2Z5Y K8*MK
MK3DANHQINB%"L+QY_ON$D3R?>(-/*9W*$1/,?_Q<116!%!*;"(07B@
M     #G'QL?N0K'YM^T9(0>UX1?W':=_/?VE-@)T%
M
M     'Y ^+N9JS^ZLZJJ6&65E<G&2E,7(7FO 0#&R!W%<0#]-? )-UA[;YYF
M:/\ 5Z,.2<&[8S4^:N4L7-V@CL E&5I%AQ7<8P!6<
M         !;V'< PS2G$,*6T456=G:7: _.G:/9M&^&YVI=1ZGJ&4]3^APM9
M)JAGR;S5[+S!7,)]$_QAO>V7@Y;+7L[6M>JZ^0:RNC3 V,S%+.MKME9S$4%8
M.8N'G 33JEO0^VNK:05%9Z6L3'4X&L4RY'+83&US,24$N& G1!&9%$L!'S)C
M'S6@,P            "AW (3\5_[DM0_F7[1E1!I_@:_<U)_TO[0GAH=.D(
M
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MT *.=/&O'_DE6"/E^S8D]GZQDH6@/;\)%NQ^G2*Q1=;#C_Q&; 3N
M
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MTO[0GAH=.D(
M
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M^J)IHX/O]!FG;Z#<RDKSA=V -0WGGGZ5XDM%S4J<)A?Q3$Y8=U(9(K%$97&
MD/?#Q.4#92>E:?4J=U[DWF05G.L0RDL*N1+/?7%QX .6-_/&)I;=3;VHZ2IM
M*Z29G,CO]0\[[F:8?N7)M%<T?I .K_"41IV/T\F/=^VQ/_YC-@)U
M
M              'G56I2E'DE5"I.8)5B&8Y!1\ZB25B",[S+@"H/ILG4]\*J
MFJU0NGT=*1R&.XYFYJ#0KO(-AU.%U@CM*WS7P3NS*LR\N4HPCV*(P;B?$\5Y
MG&\5&8HF9&=I'S !E;B2J&+C"-P"U*2*!0Q)/G5=YK &8
M                $;[V2E7GMOJM+T9S#-+Z? J#9PA-,F?O#(KB,!S9MEX.
MM!5G2<K4*S-9E3=S,Y67,IPX7W4)L;G"2<4D5Q )'TMX7-N=OJU+ZAEIC%,M
M8\I&";*.)M32K3FG"N<XI =&H63A=T\+:N0[XPO"@S@            *'< A
M/Q7_ +DM0_F7[1E1!I_@:_<U)_TO[0GAH=.D(
M
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M]LA__$9L14["H
M                               #!>I6$X+*&,_O /GG*A+TZ5.:G%94
MNW[Q4#5AQ*))6)(S.)F"H/=^*;V5Q*4%DZ-D(V10O,SV_P"A=3A=9\L?,")R
MD)*4D)9J5E$8)5O%EIBHX8C-1VJ,SO,!]H
M          "/]VZ]5=/:*J$]1V\VHIR<EO$A,(S#256N)4GE4=Y .-M*>'C?
MG4-)1J).H.F7.1@UT=,<AE+6U?U"?5CR@-\T#X<=V*/JN4K.J:_UE)E\S,:Z
M.1:YV'&RM9F#5S&G@ [)(C(C*])7"*R"H            H=P"$_%?^Y+4/YE
M^T940:?X&OW-2?\ 2_M">&ATZ0@
M
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M:=@=A=;'Y:C-@)V
M                                  !\DR^S+(4_,'A8;A$[3AB@7")G
M$S 014:A4]YZXNE4T\G24K#/F.XO%FMDM/=63+I0=9,K#^8!-=&I4E1*>U2Y
M!O+DVL6245*Q8E&M7,:C*!J.\P'IV<+"X$ R
M             (ZWDJDW3-$5#HV<]]W)PMXDHAAF&8VJ(RN,%<<Z2W+\35 I
MA24G1,<D4<HNJHY0BM:CYFU'>H!MFF=U-_:SJJ2D-7T[HJ*YFYCV=3'N5A2B
M[K#1+YR25_S G8[921$<.:'R!0JS             *'< A/Q7_N2U#^9?M&5
M$&G^!K]S4G_2_M">&ATZ0@
M
M               ,)FKB>$BYBOON!47[[ZZJF@-"S-;HK.=4TY?3N8D(PQF6
M&U6.(<2<4N'>0(Y8IFW'BWU!3VJZG4.4B;Q84=%0U8<I1M';F)C'#V )%VEV
MFWYIFK&JIN#5^LI3>*#?34QKF8=1?*NFKF-'#\(#K@               './
MC8_<A6/S;]HR0@]KPB_N.T[^>_M*; 3H*
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MZ7]H3PT.G2$
M
M    !B@? \)EPA$!&F^E;T_0MOZA-Z@;S)1&3A[SJ8QFF$G[I*CO4D!R'IWQ
M4;RR-,:1*:<S)'O91];3TQ[ZC5S2IG>?$!(^TN^&[&XNK&J76Z5T-+3BQKZB
M1>Q18=65C;#:B@ILN(#L4               './C8_<A6/S;]HR0@]KPB_N.
MT[^>_M*; 3H*
M                         #'W2(BA!! 0^&LU:6HE.>J<W^3L8;;?362/
M1)1WJ[ 'Y);]>([5>Y->>88F.FHC6'*8P,.<S3!J[QR[:^=N-OW@&N;:;T:I
MTW,)HLQ/8M/S$<YC*9*&63CB>\3*E\ZHV'\P#]>]$2E&D].R:*"C+IZLWITQ
M<5<ZO%[TS5S&=X#84EAL*TSN 9@
M      :;N3+4:8T?/MUUW*II9.8O"XK#[=LRL;/$<50 AQ[I;QM4?24@G3\O
M1^MDI2.3-=2XSCS5*=5W#DEF4#7"U0#<=)>,E6O]22NFZ/1NC7,YF-[J<WW;
M*WB[KDFW]69<P#KU"568^;@?8 S             *'< A/Q7_N2U#^9?M&5$
M&G^!K]S4G_2_M">&ATZ0@
M
M              ,2<*B,CNX (A\14Q0Y/;V<FZXG$RQEY:(N%''-2Z3M;(SO
M,@$/Z3\:>T3=!DY6<5D/,YD6H3RXXW5JO3)0NM ;OHCQ3:'U_7VJ!I%..87B
MQVS)1@TMTO?RK97-J](!T01K])-GGN 6DDS(TJ.)>M=\P#,
MYQ\;'[D*Q^;?M&2$'M>$7]QVG?SW]I38"=!0
M                                                 8S)?,5O8FZ'
MR@-7U_0U:ATK.TI!P<>RL)=N!]M9^DGU>T.DZ'XD:JICM(KDS(/'%367;9Z3
M:%<#/M[0&32&G*GJJNRU&I3.;./X\*<2$\C2W+UJ05R#X@/VTT!0%Z7TK(TF
M85%UG-B4(<[[B^"E>MV@-H,CY86< %X
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M*_\ <EJ'\R_:,J*-.\#7[FI/^E_:$\*.G2$
M
M                            !\%0.<3+N+E"Q.IPY:>Z6*)D1VJL*! 5
MA#TS7=';L)5I#5I=+4Y:&.2^T.9F9!\O:,):24$M)5S6W /33X<-G\*4(H/=
M.,#ZR?X?G(#SIK:W:+;.81JAMGX2;4<3V*>FN8B9Y3==^MAR\0&X:#UL]KE#
MU5E6,JB%AR58R5B]XA5AH0LH+1Q+Y@&\I5B-23*TH8DQN^4()90
M   './C8_<A6/S;]HR0@]KPB_N.T[^>_M*; 3H*
M                                                    # M223B=
M/"WV7_>!4(:BU15]T:LO2NCUX*(B'73T&SQQ0E]OV;Z6EE!;2D]U7E.P$>EJ
M/PX;;:FIB:=/4^U,<,QG3=L5I6?=3,I]4BO >IMWL;H/;56;IZ0P3B;W<Z9.
M_,*YU]PKG% J3").(U%;B_ "*QAQ[Q@+P
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MA"GBO_<EJ'\R_:,J*-.\#7[FI/\ I?VA/"CITA
M
M                                856W<Z>17GO$5$^[&Q6GMRT)F5+Z
M*LICE3<'7HQRB/N9[:.1N J.7:AX6=_9>:4U2]4YDC9@_5],3Z)&?/-1OB%5
ME(NW_A+J)+1/[E5CXLM,82_3(E8QS$\TI-_]F=W#S@CJVG4Z3I<FB1D494FU
M' B*E<RC4=JC,[S/B ^O&4",[,7X %X            #G'QL?N0K'YM^T9(0
M>UX1?W':=_/?VE-@)T%
M                              8E8KS*_P!'^<!:I:6DXUJP(XE"(BH1
MU-J.J;H596D-)JRJ.B'6SL$*C%"7V_9OI:5S-*3W5>4Q42MIC3=,TM3FZ32F
M\ME&+%:M5ZU+]-2CO4?$17OBH
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M> =-E80"H
M                               PJ-.+O'?^ !\$U6Z;).9$R]E.)N/"
MM5Y$?!)]H#&>HJ.F!JF(I7>K X48>3""/JDY^3GT9DL[F)](\*DPO(KR+L!7
MW@                        ,?>*!1[QWJ_F 6E&SC&\K@1@*>E\\V,<7B
MN*!E>4>R%P*RMN)<2:FCQI*ZR'WQ%95PA$RQ0^05 S.*B)43.&%,+@5>"
M         .<?&Q^Y"L?FW[1DA![7A%_<=IW\]_:4V G04
M                                                       !A6HF
MT&MP^ZF\_/Y@$'ZEU-5=SJJO2ND50I"8=7-P0<8H2\CN/I:5S-*38H14JZ9T
MM3M)TINF4QKN(C%>)?>BM2[EJ7"&,^(J<7MECB>$^Z?+9V7B*S"H
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M>!NW9N3,[_:_[?/ .FTW8C 7
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M3?M&2 >YX1R/_DAIR!W=;9#MJ,V G8
M                                      !C*)'"[%<79 15''$-IBX<
M$?+^ 5E!VH-25?=2JN:4THO*H34/B$_!M4<2$OM>S?2TOG:4GNJ\IV J5M,:
M:I.E:<W2Z4UELIQ1/$M48K4OTU*.]1\1!L H
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MZ0@
M                         #YE&9)-2"PPY#O\X"']\O$!IS9BFDY._:*B
M[[B7]JW#"M@E=Y,N\GE>C: X?V^\83^G-<SNHZG)8Y&?RLQK-(H9,LXT5J)-
M1WJ(^4@'Z/Z%US1]?4%C4%%<QRCV.!87"A@=6U](AL[VS]$!M0
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M&[]8S8"=@
M                 &%Q26TFIRTBN\OW 5!VI=157=2JKTGI9S+H;<.NGH(5
MBQ(2^W[-Y+2R@MI2>ZKRG8():TYIJG:8I35)I;67*MXH*Q+5S+4NY:E'>H^(
MJ/7)!Q-/T7HI^_;?> S
M       \JMT66KM/<D)HL3#F'M+E6E7HJ2=Z>T!QAK/PO[R-5=Q_3&H>HIQ8
M<I'14]O!%M!':]-8CBK$ V;97PM5#1&IRUYN/5?B%7;]TCITL8,3+TLJV4FE
MI.*5MWHX><P'7!&2C)7,:8P7=?Y &8   %"* "A=IW@*WWE8 6Q 4^0!6,+
M",;  [@$)^*_]R6H?S+]HRH@T_P-?N:D_P"E_:$\-#ITA
M
M        &$B/'= SNXP ?DWXTGZDYNBZBH*B:<.%,$61DI*-J?D <VG_ (/&
M\@'Z0?\ I_/55S2<ZASO4XLK*/N%"+\_&[O<P#MP
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MQ 29X3T)+933N2[G$76X7,.",:C-QL,$3BJ\07B@
M                                      +34E-I@$8\H#"G$9'9%2H=
M^Z,/)P@"KC6J"S)/?*$2B HA9&M39'WRA$NSC\L01YM7U!2J'(.U.I/Y,DWA
MS',"UPQ*)!6(2H[U%P 1I49JN;LR9R5'<^%T(^=Z#<SF042B[KA-+3A6T9>6
M/8"I&TMIFF:4I;=-IB<#:8XEQ6>**U+*Q:EPAC/B"/>
M                               \H"GE,!J&XM8J]$TK/3U&3^L4Y736
MH[L7FTK]X2DG%*CO(0<JZ=V=WNUI)IU"K<GIWIF/LO@=.<PY:E-7YR".)(]4
M!M.G/#]N/0]02M:U;N!\2IK.9&3^#RDOBQM*;YV)A2B@I257<!2CJE+F&*3.
M*CY;(1@ RH62K@%X           ,<#-)&5IGP[0$+>*?)7LSJ%I]W)3]BAW3
M7']82I\ &I>"5##6T4FB5>ZA!YL3PFW#[=.^L Z6C%1ES%QX ,@
M
M     Q&9P)16D5YW1 J$J!DT5L8V_.(JUQ:40Q%WSN(5%''T,FG-.!JC\WF
M44O M!*."CCW/6AY>$ &HZOW,TWHR"*E,QGR_JV![O<A\Z&EI*"5D8@U]VLZ
M]U]38:?:_NW+NW5#%+5"&%?U3I-G>VI/^5'@*J+M<>#+3>NJ8LZE4X:H.&*K
MY#UO?1#V")Q#?NT$CY[P1$=/_P#3D,IM)SNL<R5.,$?#,.+NGQ348E P5VEM
M[H"A;<:>E]/4!K PUC])P\6)UQWZ5QPR@;BO2!&Y
M     /E5!,2(L1%RMW0[;0$2^(B9U%);>5!K3R\#[F3[2#2H89J7.YTC*XU
MKFO3G@_UO4Z5+5)6J\J8F\<4?#Y97NEJ1?U9%<78")'VE\,=:T)J$J]J34'6
M(*.!/1MM7M.M':S,N?6)X .K$'F'$!D,_N@,2\.$C.TBO,!B6PV\Y%U&-2+C
MB97EY &3"H\*E\R8Q+MB(,*I26=PH4WC(HP.)E"/RBJJAE+2E$VJ!IAC3#MN
MM,!?AQDDW.^=L57?,0G 8S(\LT(3FF?,W'#QLM,4H/,IF((>/&QP;NQ?*5I0
M,!<2"-Y&-& T1R2C&,2[UWX1*"JR3%1D5APL]:'WH"I1SQXTOW)5E7;TT/\
M^(R0#V?"-;L;IQ/$NMPGYZE-Q 3JJ\07B@
M                                ,3A%@+%> M,E)<)*+OY@$7;F[P2F
MWBDM/4OKDG'"[U"F?JC.PF7/K $=.>+Z@,U)%+FZ)EU%^.2WU3JHX$8U6IE,
M/+VF(K<-*>(*CZB4]\3IOP9+>'&[GN3<,6.'=1+I]4B^7R"IP?%3J;7=WJM\
M0K2.GTLQ^3L1;<QXT&E7>;-EPH.,D=I?, FN0E)2GRC,I)MY3",62SB4J$5&
MI7>49G><;0'U124<*H*5<<.P1645
M               4,H@+%'B[H*T;=C44_IG1=1J5+3&;8R,LHIMQS#2#YTJ*
MY1\ '%>CMJO$=7*-\=8J'3RK_NV\FDKY'%MG:;J3O3V C?-O-E=[Y754C5M7
M5+/I36;U#613D1Q,N(3WF'C5S&D[" =F);PY9FK$3>*)PA'$(K*A31\OX149
M"\@           ,7#$KO)X'< A3Q6D:-D]0I-6(SZ*%D+JC*@-/\#ENSDHD[
M3]IW?S^>X@.FDXX&6##VE$C 9@
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M:=_/?VE-@)S],07"@
M               *0X< &-9-F6-96EYQ!$^]V]%'VATZ[5)P\^HEAZ67]HC%
M%UA"^\EEY)02]&TA5J_-VL>)G655W E]P39]HQCRF<4O;CE2E3[W3%V1Y/Q@
MCKS9K<ESQ-3"_CI=/(T^'4R-CF?GD]@]HTW+&C <L2K(QN\X=;2TLW*M(8:*
M#;4<";?2,S.TS/M Z'U)O$%XH
M             M581GY@ CQ&HO,((XWDK!4G0M2F29QO>P@6*$?M+)=AE<8J
MN/M)^(S>N@TY--9TSUDDU&'VZG-0Q+6OC+J.]7:"-PTIXC-UM4ZMDM/UJB?#
M:4_FYK_524Q# PMU/=;ETJYDD5BN(#L])N$@G%'B5Z5Q>00?1#!=< ON%
M        !!"/BO\ W*ZB_,OVC*BJU#P-?N<D_P"E_P!OG@E'3G$P%0
M
M     449E< %!16@/EFIIAAHW)A>%E/O#@9WF1%<4;P'YH^(;Q<:HKU:FM.:
M;5T%&3EXDP9?O;EW2M>E$KYTJ]+B U+9GQ7:XVQ?:IT^CXG1%XL]N,M+8H$\
MM-J95U906Z5Q\.P!VS0-*5_>,I?4^J:AE456/+IN2TJ[$R?M65LKYV4JY?)<
M G2@Z>I% E3DJ1+Y,N=_?<7'O*5](I1WJ,!ZAH/MPH^Z(J[+(5#+(2BU7BH
M                         #YUJ-M!Y=IHAW;H1/R@J+M\-?/[;Z5^+R4G
MUTR7*UF$S].PV=JFW"N<[ HE7*2/&9N\LR>/2\"..477R!^0_P"IB#;MIO$;
MKC=/7+=!J])Z(VL43ZB6>YI9UWZ.7:^J+TA1VDE& VR/R@,I6$ J M[I +@
M!3S@!>0 @1 *Q  &%?TG^2(KG;QJ_N3K7YK^T9(5'M>$/]QFG?SW]I38"<_3
M$%PH
M  #$ZDU)@F\@!2DDC&JXK_NP$5^=_P#Z@>GJ^]6Z/6E%&EM]3A]T7,W(-^MB
MYO(*CB%)M12\A&$D1S2B9PC87\B =9^ FD55W<]-78;RZ2U'&[B0J&*3GVRL
M,\7-Y 'Z<Q4>(H880PKOCVV"*R)O!%XH
M                    M41F1EVP 6I3!:K>P0:3N=JJFZ,TK-ZBG9?JV9/+
MRY?&MJ.:^TT?>2E9WKCRBCDI'C\E&U&AO1F-OM^)J+R\9 !ZVE/%]+;H:IE-
M$MZ=Z&:?S,N8ZTWN1E<P?=.4:*YJ'/\ B =F-XG$)6\=MN$OF.X17U1QW7 B
M^\4           $$(^*_]RNHOS+]HRHJM0\#7[G)/^E_V^>"4=.<3 5
M
M       ,X ,*3-1V7"",MU-;Z6INGIVGS4Q]N5E86<#W!UI1]Y*#*XXWBG%^
M.^JI)^F5>9EWTX&G,&6N)'RMI,[",^T!\%&H<[7JDBF4M&>\['#:E$<*#6?.
MI)7)/B _:C:>D3E&T-3I6?5A=1G=R"3A&9=5>DU%<H@&^&>)28I[Q1LB(K)
MS,E%?Q(5%P                              Q1PEC3;BYEW776"IP:'N
M;K72>@*&=<U9^1M7G[?TG&F_H$.'>XG@,M2@M/CMV;7',F,MHO='@J"L7;=(
MV0%1X>WV\%/W6WB^*Z)8_5Z.=S$OC(.(*R89:5S-+X?@$'9Q<P"\4
M     85_2?Y(BN=O&K^Y.M?FO[1DA4>UX0_W&:=_/?VE-@)S],07"@
M                                                 "BC@ ).(#"M
M199Q.$+S[(F \BN:CIVFI)VIUA_*D48<"\"U1BI*#L;2H[U%P!4(3&BIO?R7
M?_OFSTVFCP='+8DN9EI8^_+K8<3A<80?>O\ ->1$\Q_Z?FFU3&"7KV7(%S(Z
M1Y4;"A:<_BY@5U+MEM?I[:ZB*HFGV\IM<,T\3JL4''7$^]==A#-5<8%&[H@1
M&L_=GR^3M ?2"
M  "Q9&:3@ H2N\LS.!% #BU?5RJ BD.SE=/#2FL/4^].&)Q"4>Z[W-"X!#LK
MO+X>9=MMJ4GN\F.:SE57B9FGO*9^6P!'E0USM[7MX:#_ ' 3U\RGK,Y49IF,
M9 L-DTA)7)7=V>8!V/%Q2#-PHH5]'$K(>4@&9+24J,R^X R            "
M"$?%?^Y747YE^T9456H>!K]SDG_2_P"WSP2CISB8"H
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M\:O[DZU^:_M&2%1[7A#_ '&:=_/?VE-@)S],07"@
M                                   "AG  (X@-=U)J:GZ5I[U0J[GL
M48<!05W\2TH/W:5&4#47 !$U#T[5]TZLJOZH[NGTPR)7V9XHH4TKOLJ:64%M
M).U/S )O8EY>5::883EH+%E(B:KSB=IQ[1%9C)23)Q-L>8[O(0J"25&!=TSN
MX@<%UIGB[.';$!E
M     %BS,R@02L,#[C#2%FX?9&_\ (YDW3WSV:U-39K2-4JF CR\[[/4%>FT
M^GD83ZI7* 0:6C?!.@R954H/N<Z\C45N&TK,<+@$B;337AFT3J-,EMS,]37Y
MB/2KP5AOW;3JEV39+1R+<O\ OP =EMP,E'BC&'=@(K(DE8SB*C(
M   ((1\5_P"Y747YE^T9456H>!K]SDG_ $O^WSP2CISB8"H
M                                                     QF>%-IX
M#/Y0&)Q*,/MSS.RS#]X%>76ZY2].2:IZJ/=/)RT(JPK<Q9BDIN0E1E U%P 0
MK4-X-1:PF543;*2PF4(SV:T=Y$Y[N<91ZCB;_+V CT]*[$2Z)IJM:VF?B4XG
M%C9P'+PBE;9=Z7?A=@.[AYP$PR=.DZ4RF7DVLA*HP[REP@9GZ1GVA*OLQ>K8
M1WJ\WD!%T8J*%Y>E_, I'&4%%B;.Y=WS *G!91,HH/Y+@&2-D0"-D0%0
M                         !YE8D45*GO2:[4NX<P_\51**XR[ &A,[%[9
M2S2R.C8UG#,>ZF<*-MG=SS[8 (BU'KCPNZ9J2J;.'%UB&<O]<E@QH2M-B4*C
M'%P,0JD70NE]J:VN7U'MZC+<+'F.1G51B2VBLFE)]5?H_@%$QD4%GAXW@,A1
MX@*@ "V!E:16^<!0C-1=],/E 5.)7J^8 4I4.XG%\L %"4DX1O "-9G:GN^<
M!6/>21>4!8LH)697V .=?&K^Y.M?FO[1D@'M>$/]QFG?SW]I38"<_3$%PH
M                                                   +5*))1,06
MXRCWN/$48U+1:2S@DO3[8^0"CQ=2:KIVE*4JJ51R#:801!9QBM*+T(7ZY< $
M3Z<TU7=RZHWJ+49=+1&XY5/]D[G8D*:/VK2FUIPK;2KEMNN 3>Q+M2[26I9/
MLT1RVXG9B.)VF ^C#WX\ 6I \<> "\$
M                       6F1'9P(!\4_*(FI)V5/CAM\RB/M+L$5!3GA%V
MAG%N3U1I75S;V'$[U$^UR=TK$39%<1%<*C5*SLCX7-+3AR=7E^D=]7'678]T
ME7MOJ*Y1"*]_1_A]V95-M:GV_:R9N4Q9;N*H+AFI6R=DU,0NQER_@%1T,A.$
ME(+NFF$5WWVW O!F2K&91\H#("           ""$?%?^Y747YE^T9456H>!K
M]SDG_2_[?/!*.G.)@*@
M                   ,?=(L<>Z5WD >?/UB3IC:53KF!9QLPJ/B7JD?: ^1
MS5-%:5EN3.6?'V;BO+P2(/HEJ_2IV8)B4F,QY4<*,"TQ@1F=JDD5Q"BM4KE-
MHLLN;JSV3+)A%W"M=YDFY"5'>HB$$-5;>^K:CG%4+;&G=?/'"$_G(8A!).>[
MG&$E<EQ-_"/8*%!V.?KL\U5]SJA\:G^]"7R2D_14WS2;Z4\J6SNX>4P$UTZF
M2=*E$2<DWE,M1PHQ*5AQ*-1VJ,S.)F"ONP>41##Y111#9(N 7F
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M1[7A#_<9IW\]_:4V G/TQ!<*
M                 "Q1=PR.T!9F&;>.%WXX M6M:OU?2]'4URIU$X*[N6WW
M[>^A!VH0OURX"(C/3VDZON+62U3K!.724_DLG%M48MJ97WV%MJ*"FTJM2*)I
M982R2$L*PL(C H1A'SVG$P5G2<3M[Q^BJ[SV"#-&R(J$;(@*@
M                                         ,:SPI,HV@"B):#A>"M-
MW%J$Y)4%]VG'@FU8(+[IX8.ME<LC(XD9@CGT_!UHG5$*W7ZAUDW.<,F8:AE>
MS^BG$E<E/ !ZNE-G6MAZXR_0*CU-,<Q8I7)-OE;61=]UY]7,^H_Y6)(ZW327
M261+2=OJ]OR@1#*E. RCY05D!           !!"/BO\ W*ZB_,OVC*BJU#P-
M?N<D_P"E_P!OG@E'3G$P%0
M                      &(XE%7*?IE?Y@'./BFU'HK2^E.JKC^55"]V>"8
M5>_*I/W:5)Y5$ _,A[<'53E36]3ZA SAE%DLG&"('SM^<!UAX<]XY!9MTZF(
MS]9N8H%%2.7J%^FSE>ZCQ^<!TK2]H=4:YF2K.YDW@?+DE\MD\5AMGWI-Y!%
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M26)>-*;K(7@,QH[T01>"@
M                +3."0%#L29E> \34-)IU?IKM+JZ<<M,8?9164,M:5WMF
MDSB:2.\22(<?:E\+F\-'GULZ#U9BD7(8/U=(%API29_E,T9G$S7_ "@+4HD'
M9;P[:ATO6$ZEUY6OBE39CE(Z5J6CB;>9.V6F%)Y5(O3P\X+#I1)J49.&4'%1
M@CS67@C+@@NP!E            $$(^*_]RNHOS+]HRHJM0\#7[G)/^E_V^>"
M4=.<3 5
M     &/O%<6(SO5< J1E'"1P,!C4XJQ,/:+N3'L\H@_/O_U UM/3,D;4QB-&
M;B:P&7,4A#O']T4<,+-)MDE=F+E3ZD#MMXQ =3>!O3%;J6YDM7I=C'2)+'FI
MQME'.DYYHK342N8NP!^HA)<4XZEX\3/=PW%PMNMO 9329P,N8KA!>*
M                                     PJ)7>@=J86P[1%:7N#I9&JI
M5J5;F.G?3B[V#,O4VJXU(*Y J-/K>I/^54C^LJSG2K/.WTN#G4F%J$NG>Z0#
M[-M/$%H+=";53Z%-XJ@W"+>7,ES)<5>Y+M)Y6CX@M4M]^/D"!>8(IZ(*L=5!
MLS_E>$I#2]U#T\O1-3EM4+R:$YD9SL'5\LPT:;&>_P ^$K/O KD+0E>WRI.A
MG)32LAU.GCAT*\ZFMW3+BG+'DFOG-7-\E@(VK9]5!7M%J;(/!JC[!\?8]J?]
M>>Z;O'[/W=OL_P#*M 2?X4,:MF*(\DLQUSJLYOEY:A-$FVZ[L$6$:N/51/B;
MGF$*PRIY6%4$'_P>)V';>*C>?#>TVU4-5(DDP</X?C<B=G=F3*Q0#1M\5N-^
M([1>59A^*0NLC26.T!MWB+W\U+M+.2TE0J1UZ',R)]2RQRIEU?2,._6G]P2%
M<I[U^*#5FYNAIG354H71,367[?JV'L&7,LO<J)5HSB;1%S"H[-\)IFYL9IPH
MX$IZV/&^I38"=$\Q@+P
M          6*B2>Z020L+&E$33'Y8 -4UIK2F:+D%3$VYBF3ADMX5E&"D$JU
M*%E<OB C_2ND*KKBK?WPUF6&43^3R<4'&*%L*]I+K0=Z$*M3Y $S-MQ0D^;#
M'!PA&\%9SB5IV0N.\$7QLB J0
M                     "A'P 6$1I7;< T_7U,J-5I!RU+?Z::<ADKP(<AA
M<;-5BS(CB1'>$*URG/:NT5*9NH9CK:6GTL##,(J,KFL:N9:14>CI#=_1.M)L
MY.F3OVY%[.5,<4K5S+905R#,0;\4347HF?.F^,+K1/,K(:BQV"HOXD J
M       @A'Q7_N5U%^9?M&5%5J'@:_<Y)_TO^WSP2CISB8"H
M                                              QJ(E)P':2OP6@K
MX*A5)2D2QSU2<Z:4:O."G(XC)/H$9WF7 0096=TM2Z\G/@.W;&&67[VH8V3N
M23I>RFVFSO;6F_R]@J-FT_L9IJ4ICLMJ,OB,U-8<USVTO#+6HRL:?,CB1I^X
M AJJ^ W;V>K*9R0<P22HY[6&:.$&R2GO*GB.\C.P!T1MQMUI/;&CMT+2[&6S
M;FN8WU1]HXZFQYQT[W57& W1@R3!DSB1W</* SE; U6* 7
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M_P#$9L$3IZ8@N%
M  &%2UDDSPXEV0:B1?/\XBK26X:2-*.\KT(E9#RBBBS<PJ))X#.$%V*^8)1J
M.M->2&C9 YF93BGWOR>3BHHX%()7M";6DH)7BM\P#2-%:&JNJ9TM7ZY;PXO<
M2N)!Q@E;"N_++3ZJ#M3^$!,IM$HDI.TTQ@KLCY &0VBS,?\ *X!DXD J
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MN<D_Z7_;YX64=.<3 5
M           8C,X%9 O2/L_'$!CS#P00F+JKBC?#YK@65Y&LHXB@7UEEOR "
ME%B),8$7-^ !'FO-U:'I9"J:;/7U9V&5(8G&,>'+6?M,I22@E6*_A (1'\CH
M?6.Z,TFJZZGLJB)CER>5+JO2:#]I++:7SM(5=Y+H@M$Y46A4VAR*:?2V,J4*
M/IK5Z2E^FI1WJ/B"/1PJ@9J/$17%<!"["Y"&/YB 5PN1+O\ S$ )020%X
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M-,X;*UNVPNE^>H20(]KPC%_]BM.VQAUO[2FP$Z^F(+A0
M                               !\$XP^_+N-R[O33"\,582<A R.X[#
MB0#\[][-[]2[?U5=/HNH,U^SN]&RGT&5_2,.%<X?$!J&@O$SJ^N*>E:W5\M]
M6' 73,*C#,4?NY9)7)(!VYM=MW/STNUJ+74S\1GN]TYX$R\+76E?DSA%<2+T
M\/.()F23BG<2T=\KG8EQ+L^84XLY'B,E%=Q(!E(H
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M_I?]OGA91TYQ,!4
M       !@6HR*-ZN'E%'.GB%\2]*VD8^'2'M:J?NT=],8'+K.U4LZGE=/B,K
M5S%H[QZ:R*KI+4+.*25&/>ERN;7]5(1OPBHZ:EMX=1;QR3;>UC.5+N1ZN9Q-
M*AA49H[DZRR9Q-EPK/Q 2D#1.SU"TF1SE0/XC57.:8]HQAPXTEW4/+2<4K(O
MD!4EI0I:2.&!1<Q7@+\1*5[4L)ERE?\ >$&3LB7>.X5%\
M                                  &$XJ,R2<5IYR\]P"'O$BI:]L:@
M;$YT:O8X7<O-_KDMP,!#^Q'B5VRT]HB0HE>K6*J2V=;TLX6+,F'W/HI922@E
M1<0$O:=\1>W^L*P5&TW-];-*_P"KFF80;4Y]-+H*Y"N(BIE1$K#3#Y8BHO\
MF 5  %++@%A,I(X@+4R[24X2+Y;11<MHE% 15'&$.'B.\$5RB,L)W !-$2B,
M <L0KY!!SIXU?W*5K\U_:,D*/9\(?[C=.?GO[2FP$Z>F(+A0
M                                 8XD1&96F=YW !'BNM+@ UW6,U.R
M^G9MR33@G"R\MN*3Q1=01VJ*!0(('XD:HG9NHUF>G)X\<R65%7=*'LTIN21%
M<1 /)0XI*U31*BM$,-E\2PF _:G92;GYS;VEKG.],'GQ5W2_K3W!)$5Q""1D
M(M-?I&*+X$5L+0%0
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M ,FY#M/.L_/YX5'3L"(B3P 7
M         ,1J[IDCO+*XK@%BG";@I=AJYE^:ZP!3,225.1BFS$OMX%8(J])P
M,B),$G&"HQ^85,&-QU"+"5!:;K+X@M%YN$E&-)>S](_O"(U+4VZ&C-)%@K51
MR'N#>1,+]4[VVEE<L@5^2&_5;^/[CSM0F%8I!>5DG"$(2C"57)2KF3Q(5$8(
M4E2S1.*PDGR1O_Q0'Z6^ 23JDOM_..3K<)=67D'B1PFI\E<IQO[0'7C*3)MH
MF;$%BCQX^416; 1G$[1442@R.T!><" 5
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M3,C*IP2S.+"F)JCC4:CM49G>?:!#[DD>,U^B?X@&0B@<0%0
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M4!TSX'S95L[(K+_K87_V^= =-$9$5X"\
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MR@:SXA@K8(04DBL24; 1>5G+< J1D K:
M                      ,*\4#@G$I7",(P^] %1WNQ,5)RAG1J6O*F)V&9
M-00K!DN-.%W%E XE$KP1SVCP(:>JS2)RK5[KIM<<;_2.LXL)X2[J)XB*!$1
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M02%23 XQ 7
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M'\8#)@\H@8/* HI$51%%QI(P%0
M                   !A,S-$"MB(-<U9IF6U91)BA.GDDK!@<M7"#B'#L)2
M/4[15<A5_8/Q"T6;.7T96,=)5>KIJ4F$$I.Z8?4KF4L$3#LWL]6=%J*IZ\J7
M75EWW;>0VS'#G(.V6>6CD6CA\\05/N,C627"P*[(Q^\"0S&1'YP%P
M    ,*_I/\D17.WC5_<G6OS7]HR0J/:\(?[C-._GO[2FP$Y^F(+A0
M                                 O 8EK;3S?A$&)U9-MJ=6O+-,,2X
M8H1.!6"B%]7;MOU"<5I70S?55&R,QB)KT4/<LRT2>4EES?@ >EH?:&7HS[=:
MU<[\3KUL',)RV58MNYAXT*Q(-/"R':!"5,!)3WNXSZE\?EOO$5G*V!MW\?Y&
M*BXXG&!XH>C<(J\5%.("H
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MHA'Q6Q_Y)ZA(RA^1?M&5 :CX&BALW)*_[7]H3P#IR-L.P!<
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M%QEB*VU)W\!%7"H  !P
M              !@6K DU*L3ZO\ . BO??6U7T-H6<J%&:ZBK'EY?>;;P_:6
M$'[Q"TG%*SX .6*%HOQ:5Z39J;58PL/XHIZ:AGR*4B\UI.]/8 WW:7;#?5G5
M"*AN/.9TF48)RJ:CZ%U-\H[&_+X?A =@I)HKOP@,EUP   +%&:2,R3:?E ",
MXX3*SB &I1'R_. J4;S3;YP%,1\JBM$ L1Q)28%YQ02HE6D L65CGR"*YV\:
MO[DZU^:_M&2%1[7A#_<9IW\]_:4V G/TQ!<*
M           I&P!8E2C,!1*R7BP<]D?Y&"AN))PD7J7^ @&-U9DE91P)*&$[
MP1X.JM6T?2$B51K+N0WP:PN+CWDHYFT+]<CN!4-N.ZSWHF2:9_4&F%^]=^SS
MT<)1+NGDN%!QF'R]A GG2YH_1E$TG)=-26,$TKWKN-P\4%+-/=6M9% EF5@B
MMG.621Q3_+YQ49DD:?* J28'$!4
M                                  %I\L3!%A&LSB5WR K4=Q-6?W(T
MS4-0J;SCE<F)8L'O7FVO47Z_JB*XKIN\/BLU.U\7I<EBI2_=(S:(4,)FV=JV
M4J.*DG>0J-JT'7?$KJO6$HQKAC+HBLS&K'2%7,.&5DLE"^="/^B(#M6"U.$1
M=TT<;[R 94]Y6(%7&4#B"*@    *&DC\X"TTGPM$%<'E ,'E 7 (1\5_[E=1
M?F7[1E15:AX&OW.2?]+_ +?/!*.G.)@*@
M    PQ,K8X>U5\0&,GB(B4XG GT51CY["!5ZL=A$F)'S)C#YP152S21F1Q[$
M]GRAQ&-2U+,B)&-1<(P!7R5*MTZB-*?J4SE,IA%>!:KS(KD)4=ZB 1)J#Q#T
MI#RI#2DE\8?5#"[FKE(0)*C[K\O"[$5_ $:TSIW=G<M9JK<YT-)X,Y4B]"SU
MFU-*YFB,!(&D=C](Z9<2I]/Q":M@_%]B%B_1)]17*A\@"2FF$R[*&F#P$F,"
MOO./&/: RJ9B<0%ZD13 0%IQ% 4";(@%T!45$4
M                                     !A/$@B(U0/BJ'X $7;ZUZD:
M<V^GJC6F>I6G*RV\3C=\TP@[6TJ]8N #E&D^*_=9FG]*SI;.IWT'ZPDD^F:E
M7RN+F[0$@;3;^[I;D:J1)5>A]#3DQQ*ZN2>C%EU16-L-JYFR =@H2F\@&0
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MAO!+6X6\1JA;B.V\XF",RR(B@9P+T1%5)1J5W@1E\PHJ
M                                                     M41X3 8
M7#7EQ3^#M$5J>Y"*$O24Z6H"_5IY6.USZ]N'NN]S811R%ISQL:=TM3&:'+T7
M/DV<7M>J=1SK4Y<<DH[U=H(W+27C!E]P=52VFZ'2.E3-YD#ZDW(93*WOI)-O
MZL_2 =:MX\+:'2[RXXRCV77 ,B5&E> 09C[!0     4B1@*@   ""$?%?^Y7
M47YE^T9456H>!K]SDG_2_P"WSP2CISB8"H
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M0 0!0
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MF'N&XM/*O#8!#>5()RQ=Q7& R@,:V\5P@R"@
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M1\MY@+B;0DU99856=Z_YC 9,'E ,'E 6FTDUXP%]X"H
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M",!4
M               %(%:1 +$Q0DS4"M/W&TW(ZHT],4BJ.8)"9P9KL%'#+=;<
M*Q"DJ.*DE<8(YC1X<?#8@B2_.16J\LJKE&'FF 'HT?9/9#1]>E*_I1^-6E,S
M+1@J-F:T;1VOO+3RK5Z(#K:#9M124&S\IVVB$0^@C([A14            00
MCXK_ -RNHOS+]HRHJM0\#7[G)/\ I?\ ;YX)1TYQ,!4
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M$5<*@ MX *V%88"H
M                       ,1D<('8KM X- W0T#3-QZ$BDUM[IY),8N85N1
MBZTNYMQL[VRXA AMOP;;)GE]-*9KQ1[F944X_E.<@4" :AH#:S06TV]JZ;06
M^J)4(%BFFL,*<XOZ5UV,<T^(#M4HQM 7 !W"#$I&)HR_E>*2UG6FAZ#KJEN4
M?43'4R#V'-1C=;CA6APK6EH5S(3Q <Z[L^&';*C: J<Y1J7&?ELC CJ)SO9D
MTTD[7)DTE!)F!27H^&C:RBRNT34FJ6Z:HU#%F%C<<PY$],J+Z4TG%)^0!K^V
M&YDKL=39O16L&\I<KE]"[B4K,S5NS#G=8:?A#/27>7;P["#:MDJ34];:IJ.X
MU;D.D;?R,AK.0[' R]**M;-'J%>C\8#6M/UJH>'O7%:3JAO,H55Z7!,12G!T
MTLJ/=93,+.*YA)</N7!Z&CY5[>G=R2W,;ENGT_1LW#WR7BZN17)\3964%L_5
MG\A6A(Z;G9"7G$EU;>8HN4XFG#='E,HQ@!#GCQF4^2E=EJPMIJ!_9O25_P"8
M2?:9]H#9?"6>;LAIQ:%8#+K>$?\ B,V"IT],1%PH
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M&UD7W %X
M                       +%*,DQ*\!9<1)*X[Q!I.Y6D7]::<FM.LN84S6
M7B5 C]TZV[<:T>IZPHYDE? /1"9P3>HH39\J>B<M@9F=J9^%P#7*-X>Z?M'O
M!07'JEU3#_66Y"V\&"047"8=,XFZ [P2DC26"QL^8K_->"LR5%<J\1%YPXW"
MBH          ""$?%?\ N5U%^9?M&5%5J'@:_<Y)_P!+_M\\$HZ<XF J
M           # 4"/$=R+C\X$J&\A',?>7RGVPO\ - !4UJ,SP6*5R_)> IBB
MHB3<?,7W@%Q.$=D<2DWG"%X!C22H&<#^Z$D+'7$,-*??5A:3#&J$8Q.!7"+Q
M?D9XHM?5/6.XDQ(33N.2E,&6UA0F.;*2JCM2V@[T=HJ('EGW&'B>E$X'D\BH
MD<(D9'8JRX!^A'API6K=Z-(I57ZQTDLQ&'V9AWG?F?JC9.]E(#JK26T6D=*+
M8F9"5PU%K'B?S'SCBQERJ>6GE69 -Z0TA*205D.9-\>RT!D)$"AP JID-D<8
M?? %L-&<5%]\0";-!>S.!?R[15JJA&'S"(R"@
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MO:\(L?\ D9IVVPNML_\ F4V")U],07"@                     L6K"F)
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M+;E6K*Y5U_D 7&4;".TN(#(
M                                        M-1$6*-@"PN7"=YB#0MV
M5U\]*SLKIE[!57,K*+"T?*^TH_?=WEQ"CD:3VT\8$TI<VJH84'# 6303A>D_
MI"[ &V;4;![Q3>N9+56[%0SFY#-P2^3()Q9\LZP?>D7RA"#9\I_?"1V.E;90
M;:O1<BWC;>8"]*D'?>"LAVQ([@14          !!"/BO_<KJ+\R_:,J*K4/
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M(,AWXKC+Y11DL(!;W0%?D #(@ S@ J
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M<+K>( 2C411*TN=/GNM 8GYA$N1N/=QI/I6G"-EQ6WB*T?4V\6A-,(-VJ5+
ME/O2R)D\,<)%R,JC'$5PJ(]G?$(Y6F7F="4GXQ,*PX)CJ"E(0,C/NS,NDCB2
M5E\GF ?F-NI3=2T[64Z_J61Z.=F\J+.:R['*EVBYF3,B@1I,!I60\2291:X[
M'$W9Z-I6@/U?\*NVM.T_H9B:FI2$Z]CMS%G#!,S2?1<45R@'1I-)(RPVMHY$
M^>^T!E-)FJ/ !4T)-.$P%"1AY0 T8N8 0T2#B0"\
M
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M?2?TKSOK?6+5ZQ@K9"B<#C;VB(M-EM1Q_& J;3:BA#[XHQM2R&E&;=GW?PF
MN2U!1J7;$"%6V21: R@
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M82BHVG?$I0)AQV6TNS\6F3PX&\3LK"!$9VO2T+L7W!4EYJ-2;X:U;5*25/\
M[OL/0@]G4Z>Y#Q<JDH.]$/E\@#)+[%ZLK^+^_P!J/J&K()Z)AN/RRKZ3O2C^
M40&Z:8V*T#I91=%3,Y\XX9C/FD888H]U3ZB.)*,@$A2-(D*>F%/9RB]'O*5V
MQYC/M,!&.[VP.BMU6S56V<N</EF<4PJXV8]QN8:*YHB!4;Z!\%6@M'U<ZI..
M=;E7-X9IF&)MQ%Z9U?K]@@Z=E)=F5;3*RB<+#<;(F?,9GZ43O,5'TDF!6'C-
M/"Z\!DM@ '&-X"OF /. 6]H
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M3ZUP"^RTUG$NR (OM +A LO.\60M*ZT!4 C
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MG9LU8,2E0+@< (ACGJ;*5)LV9E$3]$XJ[2/@9=@#[$HPQ2DH)X !-D0"\
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M)*?5'8TM6+X>?N]I=H327O)49*M*T<N7%YU:PRV#2*@
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M)V"Q<C)Y!I   4.X!:9D=PBK5$9D?E_ ,I1A6Q X8K_("9*J-MY2T+CB.V/
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MTS)CW^6QY?M?C?COA=]'_0ZJ2<7$GY_O#Z&)P?C%.EF(B*P550
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M*E?,(!FHTQ.P@F5HLPPMC9YAB+S(N3'@+%R3:K& Y*L"%D9PP_.+,+5E&6@
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MM!50                                     !\SBDI;,W#L5S'YCLN
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M73N+IMC##ZK4Q)U714$1]3C/@>6XG_\ (/3G5B,'Y_9L[YX0O3JZAE'V\/\
M(</_ /(-Q?$PMVSOB<5YZOH?]HC_ )#G_N#58<?R]RA:LHI\LQWC]' YP\N
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M";O 4Q67Q(OP@+$O+4T3A)M5=;? X ,R5)6 N./ !4
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MJ/5 JGE9N'V>0M7*A*;^J+L[!Y6IR^+YFZOH^U^A<O\ &NIM-O;HQIUBVO\
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MSXBX""L2!") $2 (D P+,H*5](F&+Y;@XBXW$$:H'V1(!>2CA$RM$5>0J
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MDKDG>8(Z9;4DR-Q)^R] NS@8++,E*4 BXX\ %0
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M?FH*?Q/;1D9F5;_U6>_1@3 /Q/[21_\ CD/S2>_1@4_B?VC_ /._]5GOT4#
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M@271,._$,;.:^]'#3Y91=YU:SO6HP'Z*91$DVT=UM/*B^^T[0'U$:. "Z\
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MP%;*<9/Y<VH_IX!_ 3LM_8O\[4/T\ _@)V6_L7^=J'Z> ?P$[+?V+_.U#]/
M/X"=EO[%_G:A^G@**\!VR[:3<;E+2N]I4/-QG@&1?@5V=)1+*5MX^TG_ -.
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M@;HM5X$=EUWR,?+FU#]. F,%I> W94R_(?\ .U'].%HPR-^ S9A)XDR>$_\
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MG42[3'-U#97-QY3 3HIN!$V@X0Y4]O$[0*,Q&YQ3\Y""\4
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M-1CE>J8(Z)92;9MLJ5C4G%$X0OM ?1'C'Y *K@
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M]92#=3I3F)A6*)0648*6CTT(.]!\ *-B,XX8E?&!1 90
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M32^=I16+/[@#=_!PVP6ULM@*)'F6Q.W[;.=H#HHDP*%T;R\P#*
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MB@E748#B=L)IZ(#0MY]Y'Z$LM%:&9Z_5\W]%B)C!E9,Q?,LJ:.+2E^GP[8$
M^K8G99G;J376*\_UFK9Z'4S& VL.2I]M'=:><:.+3A%87S@)P2=O>.WB8"_#
M:(+Q10R([P%ALH,!C2AQLB)3EA\(%8 Y$V2)E6_>HL!X)G[%!5I_\,?X'9<
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MJVH9C1OP^:D,JFM\KV<TJ.*8G5GW4D2N8H7@.LB/$HC*U)W*NA\@1BLLP(
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MF]%EM^RC.9I*^GG5\F$NS#> [!0HU*,C/L 9"\P"H
M        +8G9 K3 ?/!1D2T>\*_Y1%0?N#L3,574J-8:.JGP6JVYY].4Y'V+
M;"?RA\D\I*N3Q\@J/2VRV>F-,U=W5>HYGXIJ-6' ]EE+8(-NL'W6GE-G%M22
MY>': F!M>*8<(N$/O K/?&-P(J     ^=:4P.)9BN/H@-(W(VTHVY-(^#U!S
M(?1[M_"XO#%QMP^ZEQLCB39%>"RB1'AWUK-23%#K.K^NH2,?42?PV79C%68G
MOMS!+YR)5A_,%43SIO3M-TW3FJ/3$8926Q6Q6?O%J<]-2CO4?$0>ZTI2BB9"
MB\X0MN 5     ?.X1*2I!HBW9 H\WXH"55S]J#82L2M:?K.A:]\*ZC!F,](W
M-<C:6R[TR^?:L[N/F%1LVVNR,AHNJO:EK$U\1U#,X8S.6J7PY:'&>1M]:#BA
M9%R\.T%A+"58G>6*O/=8!3K?07O#_EP$1>*   QNGA;,SO\ YP%,*E+42N6P
M14<[K;4TK=>AG(S+W13C?Y-.X5O8,3C2E^S)UHCB36&T_**(U3X<ZUJ&<DEZ
MUK_6TR2S<F4Z-MF.<GO=^7F$JYDH.W\8)1T+*23$JVB7EVLF7EXX$8C7SF9G
M:9F=Y@=CZH*,S)5O:8#,     QE:DBO/@8"/=XMN$[G:/F],J=@IS+]&/*^R
M]]8U]5ZP#V],Z87IS2\O09=R"Y?'@7"_&\IT[#4KUNT!SOI_PK5[36K)K5<M
M7,ZK/Y>4[TC2,.!A3!V'-*2<4J]4!*^D]&;B4VM-3VH:[\1E.]FL=)*,8_9K
M2GO-+,R@9I.PN "5&T&EM,#BJWY;1%7M+Q"HR@ ! @&!R)DH\6&Z!PC#\<0$
M/:#V51I+7D]K-;V*8F<GT8>[EG)?ZY97+]0!LFYNUM$W-HW053[%.?0S?M'L
MOVC2E=Q#K1*Q$T2;3L$$5S'A]UCJ)INFZBU9U%#[T)7X=+HQ6X^=J82LH+2D
M[_F%$\Z9H5/TS2I6C4=."0E,SN16?O5J<O<4I7,H^(*]DBL21V$<;+[@1F
M%#LM 6DHCO 1;O%M>G=6ALTXGNF,L47<.9>XRN[-:^JA> W6C45J1HLM2'3Z
MIEO'%VUOF<4Y<2C.\^T!"U8V#U!(5OXEH:N_#9=7OY+I&IB$&R0GVDR^9WFM
M5A<8=@#8-L=E$:+J;^IZW4OB=:<P87\@Y;#A0ZSRMO+0<4+(N7AV@)C(R:5
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MX!7+PI]EW?G^^ R     *0M.-P#%E^Q-/;^,!D2G"1%P(!:31),S+C !:EK
M4$<O\NT!<EM";4%!7: (:2@XD O,H@*@ !?> QY11B KED(&60 2+3B**$V2
M". "I-D0"\   "X!9@.("XR(R@=P"Q+1(5$A!528G$4$I@<0%":20"^X@"$2
M 424!4402B*T155)2HK;@%"2LH][YB 8U-+4W#%:?D\H#(39%Q!5X(  "TTQ
M29 ,9R[:D83+[_XQ%5-J)QB*BXV\10,P%$M$A,$6 "4'&*KP6JXDP.,01<
M                           7D I>0!]X0(Q*(H$ J         I;8 %$
MR\H!&R(!&R("H    ! @%+P%0         CB H4>("H"D0 C 5     +# 4.
MT OO (]@"H       *$ J8"V%I A&)1(%7        I$_,*%UP@J H<> "H
M   "E@"I@   I&^ J!G<(JH      I;& *J"
M                 "D2 + %0%+[KP%0       (@ "D2 5       !2) *^
M4@            %+B 4MN,!<      $1!2-IQ%%0%+^  97P "* "IQX
M *''@8"H  H<>  ?9V@*@    *&<#(!4   %(V1 (V1 ")("H   *$<0%3 4
M/S""EQP(K!1<     M*!%$!6\ N(!2'&($JWD 1[+0%0
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M)I2G$I,()C",?*"+&IEMXO9'$R]"WCY3("C+?W81+@=P#,
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M^<!:TXEQO&D^X?H_* SI5C(!4K@%0
M                      !A@:RPF5URH_@ <U>+W15%J6W=0K3K6*>9R8KQ
M.%SS<HW<2R*XNP!"_@PVPT=K[1%25JZF]:99&%6?,,_UB<C8PZW]6D!I6YK6
MI?"AN@S,:5F__IB8Q86,MGZ.3:(^\_U3GO)I1_S72!W<UN?IQG;YC7NIW^CI
M/?QJP/.P^U=*5C+6+FP^A^,4:&GQ6Z#.;EY2IKZ-,WCR)F$R][I.)7<1*^8K
M0&Z;H;T:?VMI;=6JZ,VGKQ0<BZFY;2+FV75<SI< 'Q;7;[:5W<ZE=#1%N6P8
MK7R]YFP]XPU]48"W1.^^F]:U*J2;;/3,4O(S'<3SGY2A:B[IL(.]$.(#6G/%
M3I5"3?DJ?U,J7-,9S[?D+NJE8WV )NHU6:KM-:JDF6%#^++3:?(LT':HD^KV
M JW4%9IVGJ8Y5JR[D4YC#G'A6N.-:4)]VE2N917$((0G_%IM[2LB8F2PTR8Q
M?;OM1PRX%[LI0U<QX?G%$J3^MY0M('JF07U4LOW)P4U&#Y,JYD1OC>D*I1^;
MV@ZW3MX][YB6UL>7)5'!W>^K\GISAWRZ63O91V?? ;]O%N0]LX]3]IM+KS:<
MQG8YF!)AC)F>+N/-O*.*GE%[S\0#LG;K<*0U!I4ZK.IZ67D^>9BISWK[B"[B
M6TG>F%P#2:?XJ] 3=45)(3AE%0A-1FCN0:N3I2.\H -UW.WBTQM?3):N5T\=
M/F\S _[8O=+:;/NM,NJYG2*X!XB/$7H9[0JM?2[F.C-PB>&9+FF>EXR^/G_P
M/Q@-]T+K&C:\H4MJ&B*^Q36/+3!RW+=6T=KB&SO;/T0$7>)C>-_:;13T_(-Q
MJC^'*/$7H3$LD^9EU/*Z? !HOA7W/<UWI7X57V,Q^=YG<9)PY+TTLK&FFR.)
M-IX@()VBJE-V_P#$54VW7,4I[#*;PK+_ (4\9VD3AWN .QM!>(C0NOJ_,Z?E
MW\BILX,#&"97BQ-..GWCEVTE!+<>8%;AK_<.A;<TE55U#-1-4.G1EN%&"VT*
MM:;<A#,3>0(U30._VD-=U8J4TGHZF7Y*U%]W%%#BUVG+MI*"6XVF"I=@>%*3
M."E1M\P42J-=PMYM*[>NE(U0\R?X2\'T\&U<R&7$\KA'> ^#;C?+3FX50J--
MDV,B<IV1FHQNKCU"7%IM4PV5S? S$5R7.^*%[4F]4NF<D_\ Z?DL?L\TK<ZG
MEQ3*I7SI_D0J.U=3;GZ>T?IM&I=2.=&RY'*;@Z]RO)9.UEI9WK3>D%1S3O%1
MH>;K<K2IAOIG)S,Z=49ES'E-FM5A2I0A#B8(D/<C="A[8T=%<JJ,<DJ-L7"N
M<;;]!IT[W2X"#5Z#XA]&ZCT?-:LDBS)&4R\_\H3[U]3">:72=Z>"11%^\_BG
ME*;MVW6],,Q=G8P/$HO<S3+?TTJ?:K@ ]_PL[GJU7IV7DIYB$Z>.W'_ULTKT
M6D%<@@'2)$>!"<6"^R$1%0_K;Q#:4TG73T\RCK*@GF:B^U>VATK3EUIY5QYA
M4;!MMO!I/<J74YI]R$XF&.4@_P 3<(N^ZRV5S:E .+/&;N_5YG6,MI&71DTQ
MG'U$O%M>/'+R;Z>\;)**"BC8H!/NQ.Q>CJ#-R6OJ-W:BO-QH^T'<E^5*UQ]2
M>51^A^,!O>_^[C>T6E'*R36*<?A!.(RY'Y=OZIXKGNP!"WA$WCF=22$XJL,Q
MG9C*RSQ%]&J;C[ME)7)(!)Z?%+H-.MO[CK+)JQ>E]I7",OU/"5P\O^'^(!L\
MEOII:?W$/;UE<:DKE=@\5TH<T=AL$GE+U_Q //UAX@]'Z/J:J*E?6U-$,=DP
MS"*$.%_5UIY5]H#==#:\T_N'1_B6FWLQI'OFL+J81<6A/>>;;.]M1V$ C^M^
M);;ZDSTW+RJNM5+9?5KA-,X<Q*318<L<8Q]$!N.WVZFG=QJ$[7Z">:AC#FMP
M=3#&ZXTFUUIN,<L[D@.-];>*&J5G>VFR,@QET&GY_5R^-"L6?3D*1WE2J5E!
M:3/NF?W '2VMO$=I+;^ERT_69?!*OX\18WSA@6A)>[EW#O<+@"U>;,>*G;YF
M@EJJZF.1Q._:K,+N05G2XN:SE!'MU7Q'Z)I6C&M9H<ZNG+Q8W,,PU"$P4N5G
M3&KF/U @;;MKN5I3<JDG6]+O9[1<R<+Z(=]QLK7FVSO;5P :]K[?72V@I]-.
MG/MM43&*?;,PBEM=Z6'$\KG: ]C1>[6FM;T:;K%"/&<EEYS4'BAG.+;3WG6D
M>H9V$ T2B>*S0>H:D_2)$X3[&#$W"9MQH4Y>J52GE2?$%>UM[XBM#;BUY_3\
M@O*JLM@PLPF5>\:<=/O*EVT\K9GS B+_ !?;[3>W5#/25+3AJ<Y?,Q2>'*<E
M'^1;#B3BEPRY@5(OAXW'+6&EI.0F&(3S&;FS..,<;TPHNX3:"*!(A> F[$9G
MAQ85'R61NO EE!
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MHR&O-*2RE.XZB>9%&%17/S''*;3RM@0FIM.$H +P
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M5*CA73X677 .I]E9*5E] TI4NSE9G41[QJAAFGNTS[0$AD<4E'O(XJN^8!E
M
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MQ?:IA-RU&DH),^ "9R(E.'_@?A(!=&R/: N
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M[ &0
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MF#AC>F%?1&<8Q2")I*QP_P##_ 0#(4"^0!4
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M!XL4?F ,!XL4?F 4P&HBQG$_Y=@"C;:DPML 7&A1G> $@R.,0%Q% !4
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MA&'S *DF!0(X !I)2<*@%":(DX2,!4T'APH/!\X@H2#PP6>/Y@%31%1G&_\
M *+&V<+6"/\ *,0%ZDXC2<;2C\X"S :R2N/>*(!DD:S6J\!<MI"S(UE'[OX
M%<*C3 S 4-N*<)F N),"@DP&,VE*0:5*^8!D4DS*P!9E$2,!'?Q^<!E
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M;(>0!0X0L*) *_> /O *668KP KK;@ X0L^0"%>'> 5
M                                              !0H< %0%I0A;>
MK;#R@!0C;?V !PC9?V ,:S6FPDXO6.,/, Q-DB*E,G$K.[_.8"J<9XS(\-UE
MA@K) B,R4>)7$[A$7\+15#PP%A)5B?8(*G'@40%MF(^T!3NQL+O<"!%>%EW
M%.)1M4 KV]H"EEG9Q 5./ H@!1XE  LXB*'#B"%D?**%D+;@D4L^4!6R/E$%
M(]A1,45XP(K.)@!PB4;^ "G9&X$#A"\&CNQ%16R-MX@J(+;++>T4+(G#FXA
MK;PN 4(S@1P@?8 ''S@!7^4!4O, 1/B0!QMNX *1/LM\X <.-X"OFO 4.ZVT
MP K?(8 4+(>6  4.[&^V  4(E !1,,!$5W:"KHG$XE9V@@?EN 5 6]T LX7@
C%G&\!6R'D!5+(]B@1<                         __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>tm2225088d1-fc_platform4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-fc_platform4c.jpg
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M 0 "$0,1 #\ W^
M
M
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MFNM^+,6KT6YF;!$^:1R1I54:UD;E5[J-Z*U5$ O(
M
M
M
M                                     -/.S]_S:<Y/_'_^HQ!J=R7.
MU5J]='\C]220.5N0S3&8.R:FQ7.R"]7*B=-4@ZUR4[@2%AUQG)^S?V8;"UQ=
M(=1V-A:8BQ=1'-3*WB<4\M%14\55FF1%14JB(H-\K5V7^0>F<3H[%\R-86$>
M;U[J6),LM[DFI<K:PW?VR)(DEJB2.8J/?)3CJY6UIO$RGC5N@M&ZZQ<F'U;A
M+3*V$C.K1L\2+)&G0L4B4?&Y*['1N14Z C4WDG<97D%VB<MR(O;R6YT7J'BN
ML"LR[&2NB6>"1.XYS&/MY.%$XGM:O0&I;J!EK-VZOW*6_P"G++[S<!82MRWT
MAI.?EWI&:; XZ2:3"XU\DC[2!SG.=:1JJJJLJJJH$<=H7LW:$U;H3*YC3&$L
M\'K'#6LE]876-@9:MN$MFK(Z"9D+6M?QM16L<J<37<.WAJBB)77LE\RLCS)Y
M26LN;G=<Y[ 7#\/>W,BUDF;"QDD,KE7:JK'(UKG+M<YJJN\$G,+M3Z'T7J63
M16#QN2UEJZW56W>/P<23,@>WU\;Y*U5[?9-C8[A78Y6JE 4<\N^U+HC6VI8]
M%9K&Y'1NKYW(RTQN<B2%L[W^LCC?6J/=T-D:WB78WB78"C).8?._3_+36NE=
M'ZAQUYP:MD;!89F+JO(XY5F;"YLO$]'IP+)&YRHU=CD[X*)0"(RT!SLP/,?6
MVJM&Z?QUXK-)2.@O\S)U7D4DR2K"C(E:]7KQ*R16JK:4:O>"T8EKOM6Z(TIJ
M:;1>G,5D];:HM%<V]M,%"DT4#XUH]CI*JKGMKXR1L<C5V*J.14!15\MNU!H?
M7VH_U+R5AD-(ZR<O#!B<Y$D*SN5*HR-]?7TV\#VL5?8\0*(Y[?W[MM,_IQ/Z
M).%AL_J74V!T=@[S4FIKZ+&X2P9UEU=S+1K454:B(B55SG*J-:UJ*JJM$VAE
MKM+VT]/W/E%_IW06I<SIBU<K9LW%;-;"B,7QW;%>U$1-J<;VKW40+1,W*[FY
MHGF_A'YO1MXZ1+=R1WUA<M2*\M9')5J2QHYR(CD]:YKG-6BT78H1A6K.U'RZ
MT/KC4^A]3QW=E=:8LHKZ6[1L3X[M]PRVDCM[9B2<;I52Z38Y$1$:Y55&I4+1
MC$?;(TYC[ZR;K71.I=)X').X;+-Y*S5(',55H]6I1RMHE5ZKK%[R@HV+M,GC
MK_&P9BRNHI\5<PMNH+V-[70/MWMXVR->BT5JM7BKW C7K+=L32#\M=XG0.E\
M]KA;!W#=WV(MN*U3:J(K')Q/<BJFQRQM1>A5"T7SE?VI=#\Q]3_J1<X[(Z8U
M>[BZC&Y:-K$E<QO&L;'M=5).%%=PO8VJ;J@HC?MF7EKC]>\C[^^F9;V5KE[N
M>YN)%1K(XHKK%N>]RKN1J(JJH6&0Y#MHZ6A=<9'#:+U'F-&VKUCEU-!:I':+
MP+1SF<:HE$V4ZQ[%[J($HG+E_P P])\SM.0ZIT=?)>XN5RQ2(K5CF@G8B*^*
M:-=K7MJFS<J*BHJM5%4C >4FM.6VH^8G,?"Z.TO\2:EPF0D@U-E.I@B^,+AM
MW<1NDXHG*YU9&2/J]$7Q@J,.SS_S.<[_ ,IF_IS@L[DGZ2UIRVR//[5VCL/I
M?R+F)C<>L^9U-U,#?*K='6:+'UC7+([;+%L<VGB> (U,R?/*QNNU/AN:Z:7S
M3+6RLWV[L"^W:F4D5V/N;?B9'Q45*R<>_P!:BA:;&V.4[2&G,'EM XS-X/*8
M^+F#!;S8V]N&1,BMI+F1(EAN45_$U\:OCX^%%1$<BU"430$1IR\YTX'F7JW5
MFEM/8^\ZK2,WDM]F)>J2TEFZU\2-BX7J]>)8GJBJU-B=] M$EA
M
M
M
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M8Q%W<++O@[Z-2NY U*N[+W[^>?OZ<G_]3O@2=GG_ )G.=_Y3-_3G G<<K_\
MG@YH_H-WV>)!V*'._P#/]IC]&2?^CWH.QGO;)T))JSE'/G\>U?CO1\[<O;21
MU21+9/$N414W(UBI,OW,)"NN>>L3>S!YWFS-;F9<2ENQ$VTS;E\BIPIMHEQX
M]/H-O?!3:=D303M%<G,;?WK%;F=5/=G+U[]K^KN$1+=%5=M.I:U_A>H)3P$
M
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MJO0
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M06=O#:6L;8;6W8V*"%B<+&1L1&M:U$W(B)1 P]0
M
M                             M>HLNW!X>ZR2HCGQ-I"Q=SI'KPM3P57
M;W@(!N;F>\N)+JYD66XF<KY)';55RFV7D
M           5>,R5UB;Z'(63^">%U4[CDZ6KW45-BD&P6-OH<G86^0M_XJXC
M;(U%WI5-J+WT789:50
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MP,;$Q-B)ZUJ(FY /<"VYK3NG]26[;34.*L\O:-55;!?V\5U&BN2BT;*UR;4
MZX33.F]-0NMM.8>QP]N^G'#C[:&T8O"E&U;$UJ+1-P%T H_BG%ID%RR6-O\
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M3E^9',76':0U)CWV$&:7XMTG:SHJN;9L:QCI&JJ)6C(HXN-J4<Y9 2VH"
M
M                                                8)S5>Y,):,1:
M-==(KD[M(WT^>6$E$9I                                        3
M7RXE=)I:W:[=%)*QO@XU=\]3,K#+"*
M
M                             I[VPL<E!Y-D;6&[MJH[J;B-LK.)NY>%
MZ*E4 ]VM:UJ-:B(U$HB)L1$0#D
M
M                 &!<UOS-9?E/^S<6$E$II         !786WAN\SCK2X;
MQV\]S#%*RJI5CY&M<E4HJ51>@@S_ #-MRXP5\['WN,G6=K6O58Y)G-H[:FU9
MD(JCMH>6>7N&65O'<V,\RHR)[G/1O&NQ$JYTB;>^48OJ?3\VG,FZQ>_K87-2
M2WFI3BC553;WT5**$68HOVG/U:ZO(?K#_&=4GD'\=_&T=[UZ'KMA!82@
M                 !-'+7]EX_NTOST,RL,O(H
M
M               #A%1=RUIL7P@<@
M
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MKFM],@PTH         )HY:_LO']VE^>AF5AEY%
M
M             !:=0ZFP.E,<_*ZBOXL?8LV=9*NUSOH6-2KGN^E:BJ<V'!?E
MNY;(K+CR9+;(K=-(:\Y_G;KKF3D7Z6Y18R>WA=XLN35$\IX%6G&KE^UV[%^B
M55=W%1=A]/BZ9ATUO>:B8GQ=G\7C7ZS)FGEQ1Y_#<M?ZB\\>3R)J; WOQS!,
MG7YFRMW27;%E7:]987HCI/NL?C;]R;5Y?JM'K/<OCEX3N]$^R7'W&HT_O6S7
MBD_EYVA=)ZPZK'9M6X#/N\7J;A_\EE=N^US+1$5?H7T7H17'DZSI&7#MM]^W
M\?0[^GU]F39=[LIA/#>D       *J(E56B=T#QAO+2X<YL%Q'*YBT<C'M<J+
MWZ*![       (M0                   M^6S6.PEOY1D)48BU2.--KWJG0
MUO3\XY<6*[)-+7'?DMLBLL&O>9]RKU3'6+&1IZUUPY7JOA:Q6T]-3U+.GQ_-
M/H=&[63V0H_.9GOQ>T]I+^%.3[?CXSX>9CZN_A!YS,]^+VGM)?PH^WX^,^'F
M/J[^$'G,SWXO:>TE_"C[?CXSX>8^KOX0><S/?B]I[27\*/M^/C/AYCZN_A!Y
MS,]^+VGM)?PH^WX^,^'F/J[^$'G,SWXO:>TE_"C[?CXSX>8^KOX0><S/?B]I
M[27\*/M^/C/AYCZN_A!YS,]^+VGM)?PH^WX^,^'F/J[^$'G,SWXO:>TE_"C[
M?CXSX>8^KOX0><S/?B]I[27\*/M^/C/AYCZN_A!YS,]^+VGM)?PH^WX^,^'F
M/J[^$'G,SWXO:>TE_"C[?CXSX>8^KOX0><S/?B]I[27\*/M^/C/AYCZN_A!Y
MS,]^+VGM)?PH^WX^,^'F/J[^$'G,SWXO:>TE_"C[?CXSX>8^KOX0><S/?B]I
M[27\*/M^/C/AYCZN_A!YS,]^+VGM)?PH^WX^,^'F/J[^$'G,SWXO:>TE_"C[
M?CXSX>8^KOX0><S/?B]I[27\*/M^/C/AYCZN_A!YS,]^+VGM)?PH^WX^,^'F
M/J[^$'G,SWXO:>TE_"C[?CXSX>8^KOX0><S/?B]I[27\*/M^/C/AYCZN_A!Y
MS,]^+VGM)?PH^WX^,^'F/J[^$'G,SWXO:>TE_"C[?CXSX>8^KOX0><S/?B]I
M[27\*/M^/C/AYCZN_A!YS,]^+VGM)?PH^WX^,^'F/J[^$'G,SWXO:>TE_"C[
M?CXSX>8^KOX0><S/?B]I[27\*/M^/C/AYCZN_A!YS,]^+VGM)?PH^WX^,^'F
M/J[^$/>VYG9%KD\KLH)&=*1*^-:?7*\S=T^WLF6HUEW;#-<'J?%Y]BI:/5ER
MU*OMI*)(B=U*514[Z'FYM/?BW[G=QYK;]R\G6<P
M                                  # N:WYFLORG_9N+"2B4T@
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M[M+\]#,K#+R*
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MW4V(D;9Y;@2B/<J59+3<G&B+5 )T     #AN[T5^>!R
M>%[=PV%I->W"TA@8LCUZ:-3<G?4W9;-TQ$=K-UT6Q64&YC+W>:OI+Z[=5SEI
M''7Q6,Z&M[R'TV+%&.VD/#R7S?-94!RN,
M       !ZVUS/9SQW5L]8YXG(Z-[=BHJ$NMBZ*2L3,36$L_KC%^JGQ[PIY7_
M !'4]'E.ZG@]GX#P/I9[[D[/8]?O_P"WS=OM94=%V@
M                                    ,"YK?F:R_*?]FXL)*)32
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M[555-(X          )HY:_LO']VE^>AF5AEY%
M                                                        'S0[
M:=G/K;M2:<T3?7<D.,DL<;90\'C)$EY-*Z1[6KLXE54JO31.X!.S?[NOD<C4
M1V4U&YR)M7RNU2J_\(!KKVNNRUH/D5I?!:AT;?Y.XDR-\ZRN8,E+#,WA2)TB
M.:L<,2HM6TVU L_*3L1ZNYN:$QNO,5J?'8^RR76)':W,4[I6=4]6+56(J;T
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MP\-?2,\L5KVM5FE&P1\F^@
M                 P+FM^9K+\I_V;BPDHE-(
M  "YX*?#6]^CL[;ON<<YKFOCC54<CEI1R4<Q=GA(+MJC4]GD[6VP^%MEL\+:
MKQMC=1'/?MVJB*NZJ].VNT#%B@          31RU_9>/[M+\]#,K#+R*
M
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M-K'I\Y>DRTO(    Q#F1^SS?RF/[%YZ&@_4\SIZOX/.B8]YY(
M                           ;$'R+Z(
M                            # N:WYFLORG_ &;BPDHE-(  .\4,LSN"
M&-TCZ5X6(KEIX$ ZN:K55KD5'(M%1=BHJ <                   !WCCDF
M>D<3'22.]:QJ*Y5\"(!62X3-01+--CKJ.%$JLCX)&MIX5;0@H"@  Y:USW(Q
MB*Y[EHUJ;555W(B =WPS,DZE\;FRK1$C<BH[;NV+M XDBEA=P3,=&_?PO16K
MZ2@=      FCEK^R\?W:7YZ&96&7D4
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M0                                      V(/D7T0
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MW3O\D[Q'U^I5=OUJJ2BU9O!<07+.L@D;(WNM6M/#W"*]0
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M-ZJJ[$0#K;W-O=PMN+29D]N^O!+$Y'L6BT6CFJJ+14H(FH]0
M   &Q!\B^B
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M[QFBU2#!<07+.L@D21G=3H\*=!%>H
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MK<X[H[&9G(XP     -B#Y%]$
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M*D=U3QHW>*]/"W;Z;:IX#-%JS5CV2-1['(YCMJ.1:HI%=@
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MEX$5KGR+XC51E>+;2NP[%ELVQ27!?-9JR(VR    #8@^1?1
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M43KT2KD3Z=NSB\*4=X3-"J<L'J;%9^W9/93L=Q[D1:HJ]Q%[O>7:9:7D
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M..?XMFEA;_G(TXD/G7K-5_[MC--:_7&GGOJ^5MI>1,[C85>QRIZ,J ?0
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M=4Z4O=.73JM=+C7K_)[I$V47<UW<<GS2HQXH
M             ,MT;HZYSMU'=WD;H\/&O$][O%ZVGL&=U%Z5_A),B6,A@L7D
MH70W-NQ6.3A5$:E%3N*BI1?10RTBO5'):)_'=8%_4OW]5171JOU.US?K:^ U
M5*(CR^G\O@Y5CR5LZ)M:-E3QHW+WG)L]#>5%L*   !<<1G,G@[A+G'3K&Y:<
M<:[8WHG0YO3\\@G/1/->SR_5V&3^T7J[$:Y:\2_2.7UW@7QO"9F%JDZ*:*>-
M)87H^-VYR;4(KN
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MD<;&[D:U-B'9B(C9#@F:JH(    #8@^1?1
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MVI].GLD[_KO"28*I[P^<L,W;,N+*5KT>G%1KD<BIW45-Z&&ER
M                          4%IG,)?W+[.QR5K=7<=>LMX)XY)&TWU:UR
MJ@%>!PYS6M5SE1&HE55=B(B >-I>6F0MV7=A<1W5I+7JYX'MDC=151:.:JHM
M%2@'N         BWF=<YJVOHH?*I&XBYCK'"SQ&\;=CVNX:*[>B[>Z6$E'1I
M$@<K\UY/?3X69U(KM.M@KT3,3:B?5-3_  22L)7,JL>J--PZEL&6CY.HEBD;
M)%/P\:MZ')2J;T[^^@'AAM$8##<,C(/*;I/^\7%'N1?I6TX4]!*EJE&1D4
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MK,"*  ,0YD?L\W\IC^Q>>AH/U/,Z>K^#SHF/>>2
M                 &Q!\B^B
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MOK0W$/HQR5YGV'-SE[B]7VJL9?O;Y-F;1G_=\A"B=:RGT*U1[/I'-#,I!"
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MJ*BIL5%0@[@
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MO)XOA,S)1-5AC;/&PMAM(T8B(C:T2JHG1LZ.\9:58
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MYGOU9R^N-"Y6=9,UI![8[9'^N=BYZK#M7?U3D?']*W@0$MH@@
M                                                  %IQ^G<9CLK
MD,W#%Q9/).1T]P_:Y&-:UJ,;W&^+5>ZOH4"[     !B7,9CG:=JB51D\;G=Y
M*.3YZG?T,_W/,ZFJ^#SHD/?>0
M  .W _@ZRB]77AXNBM*T%2C88^1?1
M         P777,&QTU:NBA?UEY(BI&QB^,Y>]W$3I=Z6TL0E6NF8S-_G+QU[
MD)..1=C&)5&,;]"U.A#2+>4  %WP&G,GJ.Z2VQ\2JQ%1)9U1>!E?!O5>A$VD
M&P6C.6^,TY"V69G6WCD^V2/3QW>'N)]*GHU,S*T9VB(U$:U*(FQ$3<17(
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MJ*BAER
M              %#F,<S+8RYQTBT2=BM:Y?8O3:U?05$4Y<63DNB[@QDLYK9
MA!5U:SV5Q+:7+%CGA<K)&+T*A]1;=%T5C<\&8F)I+R*@
M                   B*JHB)55V(B 23^I<OZF>2\'_ +WXO+>#IXZ4ZOVN
MSZH\?ZN.^K_+N>E]/_:IV[V?GDO0
M      ".N87,2VT_;.M+)R2WTJ*C&(N_HJM-S$_PMR=TL0DM><AD+O*7<E[>
MR++<2K5SEW(G0B)T(G0AM%*   9GHOE_D=43,FE:Z'&UKQTHZ1$W\-=R?3>E
M4DR-B<!IO&Z>M([:SB:U6)1%:FQ.[2NWPJNU3#2\@
M      !HCVYN</EV0M>4&#N%\EL%CO\ 4KHUV/N7-XK>W6F](VKUKTVIQ.9T
MM#4-, T  ,\Y.<S<ERDU_B]8V'%);0OZC*V;5HES82JB31]RM/&97<]K5Z C
MZZ8?+XW4&)LLYA[AEWBLC!'=65S&M620S-1[')X44,*T
M         4U[8VU_"L%RQ'-5%1%Z4KW (+U[RJFL'OR."CXHEJY]LU-B]/B=
MQ?I/2[AJ)9HBAS5:JM<BHY%HJ+L5%0T.  '+7*U4<U51R+5%38J*@$R<MN9L
MB2,P^;DXI'>+%,[9UG>7H1_V7AWYF%B4VQ2QSQMEB<CXWI5KD,J[@
M                 #">;G+^VYG\N\]HN?A9-D+=5L)WUI%>PJDEO(M-M$D:
MWBIO;5 -7^PQS NL?=:BY,ZA5]O?V<LN1Q=M/5'QR1N2&]MZ+N5KD:]&I].H
M:ENL&6O?.WLFZ'YII<YS!(S36MY*R.O[=G\DNY%V_P IA;1*K[ZRCMM7<>X+
M$LOY$\I,SR@TNN RVK;S4C7<*PVDS6LLK*B;66R.XY4:JKMK)P]*,:M:B4JA
M'266*"-TTSVQQ,2KY'JC6HG=55V(!AN:YE8;'\4..:N0N$V<3%X(47ZM4JOU
MJ4[Y:)5D^&R<68QEMDH=C;AB.<W?PO38YOH*BH15<!!FN<-\39^=L;:6EU_*
M(*;D1Z^,WT'5]"AJ&98ZQCY'HR-JO>Y:-:U*JJKT(B%$ ]K*SL\2S2]Q=73\
M?KFS<LUE9<,C9W8V5SG)-QHG"SJIXO$17(Y5>Y:;#,MVIZ[.O.;G#SBRB9#-
MZ;M+;EO#9/L9\O ]&2R96)L:N?X\G$Y'>-XL<:(SB2KEIMA,(FY2Y+(\@.U+
MG.7.>NI7:>U9.EM!=73W/659W+-C9W/>JJ]ZJ]UNY:^N>ZNU O8]>T=?.Y==
MJ_17,'+,K@)&8ZX?-151L-O,^WN:(FU71L7K*=] 1N;U12Q3Q,FA>V2&1J/C
MD8J.:YKDJBHJ;%14#+2K^\!P]A!'H?54#D@SR27=CUC%1LK[>-(YF+5/&^U/
M5U*;ED#4),[16@+[FSV?K+,K:JNL<-8VV?MX6M195>MNUUY E/HF*YR-3>]C
M4"0R?LMY75^1Y-X2UUIBKO&93$H['6SK^-T,ES8P(WR:9&/HY&HQR1>,FW@X
MMRH"4A:ET#HO65YC+[5>#L\S<X9TDF-6^B2=D3ID:CU1CZM6O WUR+1414VA
M&1-:UK4:U$1J)1$38B(@'(
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M4:]U$7:J]]?2/,SZR;XI;LAWL6FBS;.V67GGNX
M                $<\P^8=K@+5UG9N26^E148Q%W]%5IN8G^%N3I4L0DRUX
MO;VZR-U)>7DBRW$J\3WN^<G<1.A#:*<   D[0'+&YR\D>1S$:LM$HZ.W>E*I
MT+(G<[C>GIV;\S)1/UC86V.@;;VS$:Q$1%7I6G@,M*D
M         ,"YR\S+#E+R]RNL;S@DNX6>3XFT>M$N,A,BI#'LHM*HKWTV\#7*
M%A\BLKE,AG,I>YG+7#[K*9">2ZO+F1:ODFF<KWN5>ZJJJAM*W(KE#)S"CU9J
MC)PJNEM(X>^OIG+5&S9!MK*ZVA1>GA<WK7]YJ(OK@DH>"ICY?<IG\Q^3NML]
MA;99-4Z.N[:^C:S:^YQ\T,GE$*-3>YB1=:S?6BM1*N"(<"MY.PUSD26&XY.Y
MZX^VQ=9?:7?([US%J^XM6U^AVS,3N*_N(&9ANR&0
M     =9(V2L='(U',<E'-7:BH!$O,/E?%?I)E<0B1WB)5R=#Z)N?W^X_T^Z:
MB4H@RYMI[.>2UNHW17$3E;)&Y**BH:1X@ .0)@Y9<R)(9687,R<2NHV"9R[7
M]"-55]GW%]ENWF9A83C%+'/&V6)R/C>E6N0RKN
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M(@9<@
M
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M$D>L4D7%&L[GNX4196(RK$1WK6^-O0$RV""
M           $-<P>;TME?-Q6DY6.=;2(Z\OE1)&/<Q:K$RNQ6]#G>@G=-1"5
M9]HG6V-UGC?*+>D.0A1$O;)5JZ-R]*=UB]"_PDF%9.0
M
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M)%]EP\2TV(J;PM6ZEM;06=O#:6L;8;6W8V*"%B<+&1L1&M:U$W(B)1 R]0
M                          (^Y@\OK345HZYMFI%>Q(KHY&IM:N]=B;VK
MTIT;T+$HUUR&/N\7=R65[&L5Q$M'-7<J="HO2B]"FT4H #LQ[XWMDC<K7M5'
M-<BT5%3:BHH$]<L.8;<E$F)RKT2\C2O$NQ'I]&G^,GHF9A82SO,J
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M/3I:O2A!L[HG6V-UGC?*+>D.0A1$O;)5JZ-R]*=UB]"_PF9AIDY
M
M                                         %EU+J&TT[CI;RYD1BM:
MKD5=M$W5IT[=B)TJ!J[J745YJ3)/OKE52-%5((E6J,:JUV]UR^R4VRLQ0 Y
MF3EARX>Y\>;S$?"^B.AB<G\6B[45:^S7_!\.[,RL0FZ...&-L434;&U*-:FY
M$,J[                                #'M?6[;O0NI[5ZJUD^)OXG.3
M>B/MI&JJ>F!\8PY&]G]WO^9]>?E.-^]W 9ENB&0
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MC8XHXHTX6L8QJ(C6M1*(B)L"/8
M    A+FCS1ZSKM-::F^U[8\AD(U]=T+%$J='T3NG<AJ(290N:0  7'"9O):>
MR4.5Q4RPW<*[%WM<U=['ITM7I0@V=T3K;&ZSQOE%O2'(0HB7MDJU=&Y>E.ZQ
M>A?X3,PTR<@
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M!8+S&XE,MJ"&CDS66X;JX;(GLHFJU(XE2NQ8V([NJH2J80@
M                          (2YH\T>LZ[36FIOM>V/(9"-?7="Q1*G1]$
M[IW(:B$F4+FD    !<<)F\EI[)0Y7%3+#=PKL7>US5WL>G2U>E"#9W1.ML;K
M/&^46](<A"B)>V2K5T;EZ4[K%Z%_A,S#3)R
M
M                    #ASFL:KW+1K4JJKN1$ @CFSKEUU,[ XZ2C*4N7(N
MYB^P\+M[N]L[IJ(9E$1H  &=\N=#S:EOV7EU'_[MA=5&N39(YN^OTK>GNKL)
M,C9.SM(;&W9;P-HQJ;5Z57NJ8:>X
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M3LN(Q3LFF;=8VZYE(4M4R*Q,\J2W1SG)%UM./@17.7AK2JKW0BL
M                                !"7-'FCUG7::TU-]KVQY#(1KZ[H6
M*)4Z/HG=.Y#40DRA<T@      "XX3-Y+3V2ARN*F6&[A78N]KFKO8].EJ]*$
M&SNB=;8W6>-\HMZ0Y"%$2]LE6KHW+TIW6+T+_"9F&F3D
M
M                            (_YFZTCT]C'6UNY%OIJLC9OJ_O\ >;O7
MT$+$)+6V662>5\TSE?+(Y7R/<M5<YRU557OFT=  %_TGIFZU/E&6<37);,5%
MN9&]#578U/IG='I]!!M'@\-:X2PBL[9C6(QJ-5&[D1$V(G>0PTN8
M                           %CUI^QVH?T9>_T=X'Q>#D;O?W>7_Y'_\
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M$K#+/B;$?)]M\#'ZA%>D&/L+5ZR6UK##(J<*OCC:QU%Z*HB 5(
M
M                                 6W.9:##8Z:]G>C$8U517;DHE55>
M\B :JZGS]QJ/+2W\JNZJJMMXW+ZV.O3WUWJ;968H 5-C97.2NX;&T9QW$[D8
MQOAZ5[B)O50-G- Z0MM,XJ)J-XKAZ<3Y%2BN<Y-KE\/1W$,3*PS B@
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MCVI17.V)1$1.DE4O!
M      &N?/#]LX_R*'[.0U#,HV-    ;3\K_ -@L+]SD^_/,2L,N(H
M
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M;S8YDX273&A-.NA?B,3<-D8Z=MN]9HHHTE:QTC7/7CFG5B-<GBM3Z$;F[ 9
M                                                   #7/GA^V<?
MY%#]G(:AF4;&@   -I^5_P"P6%^YR??GF)6&7$4
M
M                      ##>8NJ8M.865R*BW$B<+&?1.=ZUOHTJO>0L)+6
M">>6YFDN)W*^:5ROD>N]7.6JJ;1Y@ ,SY=:3DU+F&22LXK"V<BOKZU\F]&KW
MD]<[O;.DDC9RUMH[2!EO$GB,2E>E5Z57PF&GL
M               4.:_,^0_)IOO;@/B@'(W>_N\O_P C_P#P3_Y@&9;OAD
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MT#JQW VM4B9C\I)5B[=B):W+>&NU>K:OT0:WPW\#(
M                                  -<^>'[9Q_D4/V<AJ&91L:    V
MGY7_ +!87[G)]^>8E89<10
M
M    >5Q/';0/GD6C(TJOJ>B!K!S&U-)J'/2L8_BM+1SF,HNQTFYR^!*<*=Y.
M^;AEAQ0 J+*SGR%W#96K>.XG<C&-[Z]*]Y.D#:70VFK?3F&@@C;]L5NUZI15
MKM5R_5+M\%$,2K*"*                                      %#FOS
M/D/R:;[VX#XH!R-V_P"[SEC27F) KOMKVX9[6]UK%OD<OH*Y S+>(,@
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MN\J1SXV]?P*]'QU1DB>(E&R-<B=" 9:UK6M1K41&HE$1-B(B <@
M                                           #7/GA^V<?Y%#]G(:A
MF4;&@   -I^5_P"P6%^YR??GF)6&7$4
M
M             $<<V=5_$N(6SMGTO+C[7'1:*CG)Z[ZU%KX50L)+7(VC@ !+
M_)W2'E,JYZ\C\1:M@1R;F(M%7ZY4X?!7NF9DA.QEH
M                    %#FOS/D/R:;[VX#XH!R-T/[O?\\:\_)L;]\N S+>
MT,@                                     !BNI]<V6G)ELDMY+G(<*
M/1G\7&B.W*KUK7ZU%+1*HNSUW-KR"ZM[N../)M3K\=U:<*<3$VQJJJJ^,G?^
M<5$3.:K55KD5'(M%1=BHJ&AP  SW0=Q#EXG:7O9NIH])[*=4XN!%7[:VE4JE
M%XJ>$DB>-/:/Q.G5Z^UXY;US>!]S([:K5VJB-2B(E4,U5D!%
M                                                       !KGSP
M_;./\BA^SD-0S*-C0   &T_*_P#8+"_<Y/OSS$K#+B*
M
M                        'C=7#+6WDN'^MC;6G=7H3T5 U7UYJ!^H,_/,
MC^.VMU6*%4W*M?'<GA7=WJ&X98P4 +II_#S9W+6^.B1>&1U9GIMX8V^N7TMW
M?(-K\'BX<1C8;.%B1HQK45J;DHE$:G@388:7(
M                 *'-?F?(?DTWWMP'Q0#D;H?W>_YXUY^38W[Y<!F6]H9
M                                  4U[D+'&PK<7]Q';PI[.1R-JO<3
MNKWD M>$U;B-07ES9XYSU?;M1_&]O DC56BJU%6M$6E:HF\HOI!@7,_#>58Z
M',0MK-9+P3*F]89%V+]:[YZEA)13#-);RLGB7ADC<CFKWT-(M.ML;&VXASMH
MVEGDJND:GL+EOKT]'>GH@8F4 *BQO)\=>07UL[AG@>DC%Z*IT+WEW*!M?I'-
MPYW"VUW$ZM6-6E:K14V5[Z>M7OH8EI?B
M                                        -<^>'[9Q_D4/V<AJ&91L
M:    VGY7_L%A?N<GWYYB5AEQ%
M
M       ".N;.IOB;"NM8'TNKC[6RF]'/1=OUK:KX:%A):]6&,R&4FZC'V[[B
M7I1B51*]+EW(G?53:*_.Z9R6GFVSK]&*ERU5:L:JY&N;O:JT3;14(+*43ER8
MTMU5N_.W3/MD]%BJFZ-J^)Z:^-Z1F5A,9E0
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M(3X9:
M            !KGSP_;./\BA^SD-0S*-C0   &T_*_\ 8+"_<Y/OSS$K#+B*
M
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M.-I=
M           !KGSP_;./\BA^SD-0S*-C0   &T_*_P#8+"_<Y/OSS$K#+B*
M
M                                     I;O(V=DGV^1$?T1IM<OH(!@
M&IN:N,Q7%!%+6=*IU,%)):_3+ZUGH[2T2J(<[S#SN8<]L,BV5N]=O5N59G)]
M-(NWVM#5$8DYRN57.55<JU55VJJJ4< 7/ 9:3"9:VR+*JV)U)6)[*-VQR>DN
MSOD$Z:&TI90YZ^SMNK9(+OAGBHFQK7T?1/JG^-X$0S*I.(H
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M),-._P >!>%B+] ZKF>DO$WTC,K"83*@
M                                     !KGSP_;./\ (H?LY#4,RC8T
M   !M/RO_8+"_<Y/OSS$K#+B*
M
M   HKK$V-XJNEBX9%WR,\5U?G+Z(&%YWE9ALIQ2-@8LJU7K&?:):^%NQR_5(
M6J40?K'3=MIJ]AMK>Z=/US%D6-Z(CF-1>%*N:M%JJ+T)N-(QLH  )MY/:F1U
MNF,N'^/:KU:U7? ]?$7ZU=G>0S*PF@RH
M              !\0@Y&X7]WY^V.L?T9;_TA0S+?L,@
M  6A^H\:W/1Z>1_%>R1N>JIZUKD3B1B]]6U7_P#4"[@   #!M5<P782[EQ=E
M9J^]BIQ2S[(TXD1R*UK5JY*+W4+1*HTRN?R^;?Q9&Z?*U%JV+UL;? Q*(5$H
M<MLU\889<=*ZMSCU1B5WK"ZJL7T-K?2)*PS0BH[YDZ;N;Z2TRF.@?/<JODT\
M<35<Y4VJQU$[FU%7P%A)6O#<K\A<\,V9F2SA7:L$=))E3OKZUOS? 6I1(F&T
M[B,#&K,;;HQ[T1))G*KI'4[KE^<FPRJZ        ><\++B%\$GK)&JU?1 U9
MYA8-^$U)<MX>&&Y59F4W<2K1Z>VV^!3<,L4* &2Z$S#\-J6TF1W#'.Y()%Z/
M'5.%?0<C22-J[>9MS!'.SULC4=X*]'H&&GJ
M
M
M                            %%EKGR6PFD1:/<G SZIVSYF\#5'5>3^-
ML_>737<4+7]5!W.KC\5%3PTXO1-LK*4 *_%8;(YJ62#&P]=+$SK7MXFM\5%1
M-[E1*[=Q!<L'=7^D\];SW\$ELQ5ZJY9(U6UA?1'*E=]/7)3N ;286^2_L(Y.
M)'2-3A>J+6M-R^BAAI<
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ME 1I #E%5%JFQ4W*!M+RXSB9O3EO,YU9D:G6?5[6OV?5(J^B8E89>10
M
M
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M[G$2.\5RI)&G>DHUWI.1GIF96$[F5
M
M
M                    #A51J*YRT:B55>\@&NO-W-K?9*&P8[Q6JMS*G?=X
ML:+WT:B^F;AF4:E #VMK>6[N8;6%.*:=[8XT[KGK1/G@;6:,Q46+Q$442>(U
MK88U7>K(DX:^BM:F)5D9%
M     'Q0S7YXR'Y3-]\<'(VT_N_/VQUC^C+?^D*&9;]AD
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M>!53:AAIZ@
M                     ,;EU]I*+.Q:=7)Q.R<R\"-:O%&V3H8Z1/%1RKL1
MM:UV=P[<:/+-G/R['7G48XNY:[62'4=AUDDCAC?+*](XHT5SWN5&M:UJ5555
M=B(B%B*[()FC'<#KS2FI;F6RQ.19+=Q.<WJ'HL;WHU?7,1Z)Q-^I.UFTF7%%
M;HV.OCU&/)-+9VLD.H[
M                                                     MF?NVVF
M-D57<*R>)5=E$7:Y?20#4[.9)V7R]WD%KPS2*L:+O2--C$]!J(;96XH 9GRT
MQ#LEJ!+A6\3+-O$WN=;)XC$^>OH$D;/6\+;>".!GK8VHU/0Z3#3T
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M7.1.A7I54]!W$AB5ADQ%
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M4Q-NR9[.Q[^AS7WQ,7;:)7/$>H
M                                                          1?
MS>SOD6)FMHW4EE:ELSZJ9*O])B>F6$EKT;0  3WR<P7DV-CO96T?.JW3JIT+
MXD:>DG&AF5A+1E0                          .KWLC8Z21R,C8BN>]RT
M1$3:JJJ[D0#6WF'VP-+Z=O9L5HK'KJ.YAJU^2?(MO8H]-_!1KGRHFY53A;W'
M*AZN'IUUT5NFCK7YXC=M1W_;8UE_5K&>WN/=':^V6<9<?U/B/[;&LOZM8SV]
MQ[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B
M/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]
MQ[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B
M/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]
MQ[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B
M/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]
MQ[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B
M/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]
MQ[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B
M/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B/[;&LOZM8SV]
MQ[H?;+.,GU/B/[;&LOZM8SV]Q[H?;+.,GU/B$[;&LJ[=-8RG3]LN/=#[99\T
MGU/B2SRQ[5NCM;WL&$U%:NTSFIU1EN^:5)K&:2GK4FX6*QSEW->VG1Q*ITL^
M@OQQ6/>AS69HNV)*Y@.U%<VS,9A[.66TF;Q7<\7C.5*TZNB;43I7N^F>=#FE
M&3],:C93BQ-VM?H8)'?.12H\7X3,QUX\==-X?7<4,B4\-6@>#[*]C2K[:5J+
MNXF.3YZ%'@YKF*K7HK7)O14HH' %^T?F?B//6UT]W#;2+U%SW.KD5$JOU*T=
MZ!)$\F6@                   +1J:PCR.%NK:1*L5B\2?2JBM=_@JH&HUS
M!):W$UK*E)8'NC>GTS%5J_..1EY  )WY'Y7K<=-C7NVP/<UK?I7?;&_-5YF5
MA+QE0
M              $0\^M.>68:TU) W[?CG]1<KTK!.J(U5^I?2GU2GO=(S\M\
MV3_-ZWE=1Q5MB[@U[/J7@@  !M=RKTXFG-&V44C42\OD\NNE^FF1%:WZUB-3
MPU/B.H9N]S3PC8^GTF+DQQQG:S0\]W
M
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M/55DEB8QKX9'*N]58[@5=ZJU57>?,:W#&/)LW3M>EBNYK4SG0<P  *B*E%W
M>#[.TD2DEO&Y-]',:J5]% /%V(Q+UXGV%NYW=6%BK\X"L:UK&HQB(UK4HUJ;
M$1$Z$ Y                   #K(QLL;XW>M>BM7P*E -5>86.=CM57C%3A
M;/PS(G?7Q7?X37&X98L4 )#Y/Y/R+4KK=RT9<,1WA6-U/L7.))#9(PT
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M&-17(K7)55^A/*S=*R8[9NB8F(=_%K[+YB)B8F4H'C/2
M
M              L>JLA'C\5(^5W"Q45TB]R.-.)R_,*-3\A>29&^N+Z;^,N)
M'2.3?3B6M/0W&V5,  SWE=B7764FR+FU;;-2*&OOLVS9X&U3T22-EHHTBC9$
MWUK&HU/ B4,-.P                           -*.VPYRZPTRQ57@3&2*
MC>A%6X=5:=^A[_3/AN\KI:GL:P'KNH     !L)R1Y;Z0L-'Y/G7S/A\ITQBG
M.CQ.*>WB9=S,<D?$YJ['HLBI$QB^*KN+BV(>9JLU\WQBLWR[6*R(CFN>>6[7
M7,:2Z;'IBSQN!PD'B6F.BMDFI$B^*CW/6E439XC6)WA;T_'3WIF9)U$]C.,)
MGM)]J'2F:Q>KK&QP7,G"6WE=IGH$2&)\248USW/57)&CU:R1CW*GC(YM%W=>
MZR[2W1-LS-L]CDB8RQ2=[!>R+$^#G&^&2B21XV]8]$5%2K7QHNU-BG9ZA-<7
MG<6"*7(KFTCJO4N=S+].8+(9AD-Y<),['VD]TC%65U.)8F.IZ)W(R6VVQS3$
M;'%=;,S-(8Y>V-]C;J2RR-M+9WL*\,MO<,=%*Q>XYCT14]$Y8F)BL,3$QO=;
M:VN;R=EK:0ON+F5>&*&)JOD<O<:UJ*JJ69B-Y$57G+:'UK@;1+_.:;RF,L55
M$2ZO;&XMHE5=WCR,:GS3CMRV732)B?.LV71V+'%%+/*R&%CI)I'(R.-B*YSG
M.6B(B)M554Y&5TM]*ZHO,HN$M,)?SYIK4>['16LS[I&JB*BK$UBOI1:[C$Y+
M8BM8HURSNH\LSI_/:<N6V6H,7=XF\<WC;;W]O+:RJU>E&RM:M.^6V^V[;$U2
M8F-ZM=H;6K,5\>OTWE&X16=8F36QN$M.K^BZ[@X*=^IGO;*TK%?*UR7<'EI'
M*W6#U9@LW8VJWU[C<C:7EM9-XJSRV\[)&1)PHJU>K4;L2I<EL76S$]L);-)A
M?N;>K<MK?760U)G,0_!Y*Z9;MEQLB/1T:0PLC:OVQK'>,C4=M0XM/CBRR+8F
ML-Y+IF:S%&.X72^IM2.>S3N%O\N^/^,;C[6:Z5OA2)KJ'+=DMMWS$,1;,[H4
M^4P^7P=TZQS=A<XV^;ZZVO(9+>5.C:R1&K\PMMT716)JDQ,;WA9V5YD+AEI8
M6\MU=R;(X(&.ED<O>:U%52S,1MDB)E?LCR[Y@8BU??9;2F8L+&/^,N;K'W4$
M3>G:]\:(GIG'&;',TBZ/2UR7<'CH?]M=.?I2Q_I#"Y?@GR26?%'E2CVL_P!\
MV1_([+[RAT^G_I1Y9<NH^)"!Z#K@    W-[$?Y@U;^66GWJ0\'J?Q6^1WM/\
M,MJ3QW:                            0)SPQO4Y&UR#4HCU=&Y?JD1Z?
M-XS4,RB4T %ZTE>>0ZCQT]:-69(G+]+-]K7[(@VUM)>OMH9OHV-<OA5-IAI[
M                                                   +1J74^#TA
MB)\WJ&\998^!-KW[7/<NYC&IM<Y>AK=ISX,%^:^++(K+@SY[,-DWWS2$%?K-
MS7YYSO@T8C]'<OT<Z.3-2U2ZN&HO"O"YJHJK]+$J-3:CGGTW<:7I\5R_W,GR
M]D>'C]#YKO\ 5=0FF+^WC^;MGP\7I9AICLY<N<$U)\K:R:ARCEXY;O)/<YCG
MKM54A:J,HJ_1\2]\\_/UO49-EL\D<(_-W\'1=/CVW1SSQG\DCXK3&FL%(LN$
MPUCC958L2OL[:&W=U:JCE;6-K=BJB+0\G)GR9/CNF[RS,O6QX,>/X+8M\D1"
MZG YT4\PN<-OIRX=A].LBOLK&M+FX>JNMX5Z64:J<3^[MHWP[$]O1]-G+'-?
MLC\9>9J=;%D\MNV53R^YNV&IW1XK.)'89UR\,2I5MO<*NY&*Y5X7_2JNWH[A
MC6=-NQ>]9MM_&%TVMC)LNV2DT\=Z34CF9=+>:\SLRK7AN5AK]P:V+O\ T)]U
MH;>7!;'B];Y;537+=Y6*'==4 W*TI>_&6F,-?*O$Z>RMWO5=J\:QMXOFU/@-
M19RY;HX3+Z[#=S61/B4FKM;8/1EEY1E)>*ZD15M;&.BS2JG<3H;W7+L]'8;T
MVEOSW4MW<6,V>W%%915@N?=])FN'4%G#%@YW<*.MT>LMNU5V.555>-$]E1J+
MTIW#V\O2+8L]R9YO6\S'U&>;WHV)ER5Q!=Z?O+JUD;-;36<LD4L:HYCF.C54
M5%3>BGS]ELVY(B=]7KW3$V3,<&F!^@OD "4>0J6ZZSN.NIUR6$OD]?H^MBK3
MO\-?0J>-U>O<Q3C^;TNG4[R?(V1/D7T(!J-S)2V37>>\EIU7E3N*GOE$ZS_#
MXC[K0U[BVO!\KJJ=[=3BQ8[KK+YHO]L=/?I.R_I##K:K]&_^F?4YL'ZEOECU
MMQCX%]:
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ME'EE-1\2$#T'7    !N;V(_S!JW\LM/O4AX/4_BM\CO:?X9;4GCNT
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M'XW-\(_U0'QCD/QN;X1_J@/C'(?C<WPC_5 ?&.0_&YOA'^J ^,<A^-S?"/\
M5 ?&.0_&YOA'^J ^,<A^-S?"/]4 F2R+514O)T5-J*DCZU],#(L+S SV+D:V
MZE7(6?LXIUJ^GTLFU:^&J$H52YA\Q99RQ9?V#^*)^QS5V.8]-[7)T*AEI7@
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MO<?*VCW;-FUWA.E;HL,7<W+%?#L=F=5DFWEKL8NJJY5<Y:N7:JKO53NNLX
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M41RK143V1Y>?JM^2V;8B(B7?Q:"VR8F9F:)1/%>D
M                                              $#ZQS,F:SMS-Q5
MMH'+!;-Z$C8M*I]4OC&H96 H
M    !,7+7,R9'#OL)W<4^/<UC57>L+T7@]*BIX*&96&:D4            #2
M?ML?MEIK]&/_ *0X]_IGP3Y72U/8UA/7=0     #:S0=NSG9V<KSEO821IK/
M2,WE6.MGN1JSL1\DD2I79XS9)8*[D=PJZB*>-EGN-1SS\-SNV^_CIVPU=R6,
MR6&OIL;EK2:QR%NY63VMRQT4K')L5'-<B*A[%MT716'3F)C>GSD)R;P^3QF:
MYA\UL>Z+0%C92.MFW+I;;RAZ*CGS,6-S'JUC6JU%:OC.=1*T5#S-7J9B8LQS
M[U79Q8]E;MSCLI2V4_.Z[GQMNMKCI+&_?:6KG+(Z*%TD:L8KEJKE:VB5Z2Z^
MO<Q7?6#!3GFB#-0_G_*_EEQ]]<>A9\,>1U[_ (I;!ZH_Y--%?IF;^EY(\RS]
MW=Y/9#LS^E#,TUKKFU[,FE=3\K,@ZWO< J6.H8(H+>\D9!!QQN<YLT<E.%W5
M2>*VO _B78AP=W9.HNMR1OW-\T]W$VHKTQS[[16K\]8:<P6HG7.3R$K886-Q
MV.5$XEVO<ODNQC4\9SEW)M.YDTFGLMFZ8V1XY_-PVY+[II$NG,7]?[?G9IG%
M<Q\_9ZAU!C[G&,2XL(V1,AAENDE9$]&6]NG'1_'ZU=CDV]"7#R3ANFR*1-5N
MYN>(F:NO:S_?-D?R.R^\H.G_ *4>64U'Q,FT#_R@<P_TRG_RPX<W[JSR?FW9
M^G*(>3?[V-%?IFQ^_M.]J?TKO(X<7Q0E7F3_ ,XME^G]-?>K Z>']I/DN]KD
MO_5\\+ES&SEIIOM?6>9OY&Q64%UBV7$S_6QQSV<4+GKNV-1]3&&V;M+,1XV[
MIIEAA':CTSDL%S=S&1N87IC<WU5[C[ES?$D1(8V2M1=U6/:J*F^E%Z3L:&^+
ML41VPXL]LQ=59M%<GYM4<O-4\Q<IE%PF(T^Q'63I;99F7\S6NXXF/ZR/A7CZ
MJ-KD1R*Y].@Y,NIY,EMD169_!+<=;9E,N-OK3D1R&TUKW26$M,AK#4KV)=YR
M\A6;R9+B.1_"CFJUS4:C48UJ.1JNJJUW'0NB<^>;+II$=CG^"R)B%BY6<X.=
M_-'F5I[$R9>67#V]W%=Y:WLX(;:!ME"Y'R]<^-B.5KD3A1KGT551-ZG)GT^'
M%CF:;>QG'DONN\2V\\?^:*+\NP?WNV-Z7]MYI3)^I'F6KM9_OFR/Y'9?>4-]
M/_2CRRSJ/B0@>@ZX    -S>Q'^8-6_EEI]ZD/!ZG\5OD=[3_  RVI/'=H
M         ".N:69D@@ML) _A\H3K[JF]8VK1C? KD5?0+"2BTT@
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M\L$\AND3Z*%$1COKF<*^&I\3U#!W6:>$[7T^DR\^..,;&:GG.X
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MO+"7WS=-98L<S     -S>Q'^8-6_EEI]ZD/!ZG\5OD=[3_#+:D\=V@
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M]D3-VR)2P>&]0
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M_;8_;+37Z,?_ $AQ[_3/@GRNEJ>QK">NZ@
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MTHK8HF_7J?4:+_\ /H<F7MO]V/5[9]#Y?6_W]=CQ=EGO3Z_9'I3\?+OJ
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M9ERQ2Z=CKX]-CQS6(VLE.F[
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MQ^+?.Q8UO);F2-[I(T=M6-C8Z<5**KDHJT<&9;VAD    &D_;8_;+37Z,?\
MTAQ[_3/@GRNEJ>QK">NZ@    )?T;V9^:^L[.')08Z+$8ZX1'07.7D6VXVJE
M4<D3622\*HNQ5CHO0=')K<5DTK7R.>W#=*HU=V6^;.DK*3(I9VV<M(6K).[#
MROGD8U-_VJ6.*1U/I&.)CUV*^:;O*3@NA#"I38N\[[@
M    99H#EQJGF9E+G#Z4@BGOK2W6[F;-*V!$B1[8U5%?L5:O38<.;-;BBMSD
MLLF[<Q,YG&   &YO8C_,&K?RRT^]2'@]3^*WR.]I_AEM2>.[0    -7^W'HS
M4&IN6>,RV#MY+R'3]^MWD[:%JO>VVEA=&L_"F](UIQ;-B.5=R*%A\X@VS?EO
MS<U]RHR?QEHS+26D;W(Z[QTE9;&YILI- J\*K39Q)1Z=#D"-]N3G;#T%S$6W
MPNJ^#2FK)%2-C+B3_P!W7,B[$ZFX=3@<J[F2TZ$:YRAF8;((J*B*BU1=RA
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M.*)&U[^R^G?N;/O+20J.2HD+47[ML%]WC^]S$[5- ?L]J7[A_LI1)"/2H
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M+=X
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M:X'?QBI]'+7NHQJAF9;+-:UK4:U$1J)1$38B(@1R     &D_;8_;+37Z,?\
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M*3(8++XJ-LV1LY+>)[N!CGI1%=2M/F 6XH 5V%_/.._*8?OC2#8DRT
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M$^;U/I=#^C'G9\>6[P
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M4.9S$3(,E=NN(HW<;&N1J4=2E?%1.A0+84 *["_GG'?E,/WQI!L29:
M          $"Z1<FF^TGJ[#2KPP:BL67UHN[CE:V.5=G>^W;>]WSZ?4_W>FX
M[ODFD_C_  ?,Z;^UU');\\5C\/XIZ/F'TP   6R_T[@,HKG9+%VEVYVU7SP1
MR.KNK5S56IS69LEGPW3'G<=V*R[?$2Q3-\H=%9&SNDLL8RSR+XGI;3Q22L:R
M56JC%5B.X51%I7Q3O8NI9K9BMU8=7)HL5T32*2U?N()K6>6UN&+'<0/='+&[
M>U[%X7(O@5#[*)B8K#YN8F)I+S*B2N5',5NDKM^)R[U^(+Q_$LE%<MO,J4XZ
M)MX51$1R>CX?(ZAHN^CFM^*/Q>AH]3W<TN^&6RD$\-S"RXMI&S02M1\<L:HY
MCFKM145-BHI\A,3$TE]%$Q.V'H10"*.;',RVPUG/IS!SI)G+A%BNI8UJEK&Y
M*.2J?Y14V(GL=_</;Z=H9OF+[X]V/Q_@\O6:J+8Y;=_J:Z'UCP ":N5_*K"9
M[ -SNI(9977,K_)(&R.B8L#/%XEX:.VN1W3N1#Y[7]0OQY.2SLWO8TFCMOLY
MKDH67+C0V/IY/@K5RMW+.Q;A=FS_ "RO/&OUN>[?=/J]3TK=+BMW6P]-1ZPT
MQHFR:F1F9"K6_P FQUNB+,YJ;$1D:41$[ZT;WS.#39<\^['G7+GLQ1M]"(G\
M_<N_.PSML(HM/-=PRV?KIWL79Q=8M$1R;T1$IT+7>>]]GLY*5][CV/*^XW<U
M:>ZG;&9*RS%A;Y/'3)/973$DAE;N5%[O<5%V*B[EV'S.2RZRZ;;M\/;LNBZ*
MQN6S5VJ\=H_#2Y:_7B<GB6MLBT?-,J;&)OIW57H0YM-I[LU_+'^CBS9HQ6UE
M#VG>?63BO7MU-:,N,?,]7-?:MX)8&JNY$5:/:G?5%[ZGOYND6S;_ &YI/C[7
MDXNHW1/OQL39@]0X;4EFE]A;MEU!LX^%:/8J]#VK16KWE0^=RX;\4TNBCV<>
M6W)%;9JN9PN0
M                   &M!MD
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M,KK^T8Y]O=7<DL;E:Z1%15:Y%HNU U5B_P#8RY__ "!;?^8V?X4+4_L9<_\
MY MO_,;/\*"I_8RY_P#R!;?^8V?X4%3^QES_ /D"V_\ ,;/\*"KPN.QSVA(.
M'JM+Q7/%6O59+')PTIOZRX9O[P*L=U7V<><.AL/-G]78*WQ&)A]=<7.6Q3>)
MU*\#&I=JY[UIL8Q%<O0@*HK"@%?A<'F-1Y.WPN L)\GEKMW!;65I&Z:9[M^Q
MK45=B;57H0#<OD[V&9'^39WG#<]6SQ9&Z7L9*N7IX;JYC79WVPK]>&:IIU7I
M[!Z6R4>#TYCK?%XBUMXFP6=I&V*)NS:M&IM5=[G+M5=J[34,2L14
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M-W%,Q\^]<
M                &M!MD
M  !(7*?\XY#[BS[,DK"53*J:_P ?896RGQN4M8KW'W3%BN;2X8V6&2-V]KV/
M145%[BH!J'SC[#N'R_E&=Y27#,1D75D?IZ[<Y;&1=ZI!*O$Z)5Z&OXF=]B!J
M):1:JT?J?0^7EP.K<5<8C+0[76]TSA5S:T1[')5KV+38]BJU>A0TL\,TUM-'
M<6\CH;B%S9(I8W*Q['L6K7-<E%145*HJ ;4<G.VOJW2*6^#YDQ2ZHT^Q&QLR
M351,M Q%WJYZHVX1$Z)%:_Z?H#-&]FAN8.C^9&%9G]&96'*8Y5X9%CJV6&3Z
M":)Z(^-W><U*[TV!EDP     8=S/Y>8KF?I"[TKE7K LBMGL;QJ<3K>ZBKP2
M(BJE=BJUR=+55-F\Y\&:<5_-#%]L7127SJU]RPUGRVR4F/U/C9(8$<K;?(QM
M5]G.WH='*B4VIMX5HY.E$/J,.>S+%;9>=?CFW>P\YW&   %PQ6>SN"E6?!Y.
M[QDRJCEDLIY+=U6K5%K&YJ[%0S=9;=OBK473&YVR^H<_GY$FSV5O,I,BJJ27
MUQ+<N15WK65SE%MEMNZ*$W3.^5M-,KCB-09[3\RW&!REWB[A:5EL;B6V>M-W
MC1.:IFZRV[?%6HNF-RGO\ED<K<+=Y2[GO;IR46>YD?-(J?5/55+%L1N29F=[
MK;7M[9*];.XEMUD3A>L+W1\3>XO"J503$3O(F8W/ J/>YO;V]5BWEQ+<+&G"
MQ9GNDX6]Q.)5HA(B(W+,S.\@OKZUCDBM;F6"*9*3,C>YC7I14HY&JB+L7I$Q
M$D3,-CNS)^[SG3^AH?Z+DCRM=\>/R_D[6#=* (-4ZGM<<N'MLU?PXEVUUA'=
M3,ME5$5-L:.1NY5Z.D].<=LS6D5=;FGBM)ME[V=]>XZX;=X^YEM+IGK)X'NB
MD3P.:J*A)B)WK$S&Y69?4FHM0.:_/9>]RCV4X77US+<JE$X4HLKG;DV&;;+;
M=T1"S=,[Y6PVRN]GJS5..Q\F)Q^<R%IBI=DMC!=S16[]_KHVO1J[UWH8G';,
MUF(JU%TQVK>V]O&6S[-MQ*VSE=QR6Z/<D;G;-KFUHJ[$](U2*U2LD=[>PV\E
MI#<2QVLNV6!CW-C?]4U%HN[I%(WE9>"*J*BHM%3:BH5'O=7M[?/22]N9;F1J
M<+7S/=(J)OHBN5=A(B(W+,S.]48K.9K W'E>#R5UC+K9]OLIY+>3Q5JGC1N:
MNQ2761=OBI$S&XDSF:EO9,C+DKI^0E3AENW3R+,YM46CGJ[B5-G2HY+:4IL7
MFG?50&F0 !(G++DOK;FAD(8L3926N#XD\KSERQS+2)B*G%PJM.L?MV,9M[M$
MVIU<^ILQ1MG;P<MF*;GT4T9I+$Z%TQCM*X1G!C\=%U;7.IQR/55<^1]/9/<J
MN7PGR^3).2Z;I[7I6Q$12%^.-0    >=Q<6]I!)=74K(+:%JR332N1D;&-2J
MN<YU$1$3>J@:H\XNVWI73"3X3EA%'J3.MXF.R\G$F*@=NJQ45'7"I]+PL[CG
M;@U$-&=;\P-8\QLP_.ZSRT^5OU5W5)*ZD,+7;V0Q-HR-NSUK&IW]H:8TB*JH
MB)55W(!LGR=['&O.8"V^9UAQZ3TJ^CT6XCKDKB-4JG50.IP(OT<M.ZC7!*M\
M^6_*/0/*C&?%NC,3':2/:C;O(R4EOKFFVLTZIQ*E=O"E&)T-0,,W A?F5^U$
MGW&+YRFH9ECF*L?C/)6N/ZSJO*96Q=93BX>-:5I5*^F49G<\O,192K!>:GMK
M>=$15CF9'&^B[EHZ=%)5:/']1]/?UNLO2B_]H%2C#\A;16=]<6L$[;J&&1S&
M7#*<,C6K1')17)1?"5%,       !=;73^0N\3=YMJ-9C[38Y[EVN?5J<+43N
M<2;R"HTOIZ/4=Y-:R7B6211]:DCF(^OC(VE%<SN@6(H        7_3^FOCVS
MREWY5Y/\61)+P=7Q]95LCJ5XFT]9WR"P% #*\%H:^RMK\9WT[,;BZ<23S;W-
M^B1%5J4[ZJ2I1<6:,TM=N\FL-21NO%V,:]&<+G=Q/&2OH*H5C>?TUD].7"17
MS$6*2O4W$>V-Z)W%Z%[RA%G*  "ZOT_D(L(S/S(UEC+(D4**M7O5>+:B)N1.
M%=Y!:B@            %=A?SSCORF'[XT@V),M                #'==:4
MM=;Z3RFF+M4:V^A5L,JI7JYV*CXI/K7HU5[J;#MZ343@RVY([)_#M=35Z>,^
M*['/;'X]B-^SWK&XN<1=\N-0_:=4Z1>^T6!Z^,^SB?P-5.[U3OM:T]CP=T]?
MK.FB+XSV?!DV^?\ CO\ 2\GHVIF;)P7_ !X]GF_AN]":CYU]"   &M?/+X\_
M6YOQCQ?%/4M^*:5ZO@HG6][CXZ\733AZ*'U_2>3NO=W]OL?.]0YN\V[NQ&)[
M#S@        !58SXP^,;7XJZSXSZUGDG4UZSK>).'AITU,9.7EGFW=K5E:Q3
M>W/QWEOQ?:?&7"F1ZF/RM&4X>NX$XZ4Z.*I^?7\O-/+NKL?7VUI%=Z-N?$V*
M;I*""\VY*2Y8['-;2O$Q/MJK]*C'47OJT]?I$7=[,QNIM>=U";>[V[Z[&MY]
M:^?7S#:-U1J&-9\/BY[JW1:=>C49$JIO1'O5K57T3K9=3BQS2ZZ(<UF"^_X8
M4V8T[G-/RMAS5A-9/?ZQ96*C74^A<E6KZ"F\6:S)%;9B6;\5UGQ11;#F<;;G
MEQ<8JXT3AUP^RTB@2)[5]<V=O\;Q=]7\2^C4^%UMMT9KN;?7_1]5I9MG%'*R
MDZ3L@
M            UH-L@             )!YG__ +E^X/\ \0D+*/BHOND\M=X;
M*+>65FZ^F6)S.I9Q5HY4JOBHY=E""UOCN;Z\FZF![YY'O>L+&J]R5555*(E=
MA1VML7DKU7I9V<]PL:TD2&)\G"O<7A1:$'A-!-;2.AN(W13-]='(U6N3PHM%
M*.K(WRO;'$U7R.6C6-1555[R(!5W&'R]I%U]U87,$/ODL,C&^FY$0@HBBLM<
M5E+YG665C<7,:;WPQ/D3TVHI!3SV\]M(L5S$^&5-[)&JQR>@M%*/,
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MP5C.<PMY@,@_'WB(KVHCHY&^M>Q=SDJ$>>%_/.._*8?OC0-B3+0
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M<E9.)4V+L5%/.U6CP]W=/+$3$3.S9V.YI]3DYXBLTF8;1'QCZ4
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MQ)PJJ4]*A%8KG-5QYS!QV.5M7+GK=^R[1K6)2NU%3>E4WI2E2HQ(H
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M)EXL8N+NENI[9KXIY%CD8Y6T9PJJO:VNU%W""6,87\\X[\IA^^- V),M
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M<^GB9R6TXPW!/@GU@
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MA@@MF=5;Q,AC3<R-J-;Z24/,F9G>[L1$;GH10
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M[KXW*BIZ"*TU"2P8J
M      +MIBU?>:AQD#$556XC>ZF_@C=QN7TD4@V!,M
M  8]K'1>!UWC(L-J.*2?&QW#+I8(I7P\;XVN:B.<Q4=P^/6B*FVAVM-JLFGN
MYK-]*.KJ=+9J+>6_=6J@PW*GEQI]&_%>F;!CV^MFFA2YE3P23]8_YIRY>H:C
M)\5\^KU.+%T_3X_ALCU^MES&,C:C(VHUC4HUK4HB(G<1#HS-7?B*.Q
M       #7[GYJ!USE['3D3OM%C'Y3<-3<L\VQJ+]2Q-GU1]3TC#2R;Y[=CPN
MHY*W1;P0\>\\E>]/:0U'JMT[<!8NN_)D:L[N..)K>.M$XI7-2JTW5.OFU./#
M3GFE7-BPWY/ABJESF!RVF[]V,S5LZUO6M;)U;E:Y%:]-BM<Q7-5.C8N_8;Q9
MK,MO-;-89R8[K)I=%)6XY7&V)Y#Z@=?Z?NL%._BFQ4B.@K[Q<5<B)X'H[TT/
ME.KX>7)%\?S>N'O]/R5LFW@ED\-Z@
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MU&Z*XB7ADC>E'(O?0TCR
M        !+/+O2DV.8[-9&-67<S>&VA<GC,C=M5RIT*[YB>$S*PSXB@
M                               # -=<J<-K&23)PR.L,\YJ(MTWQXY>
M!J-:DK.\B4XFT7PTH>II.H7X(Y9VV^&YT=1H[<NW=*$Y.4VM8L[%@WV"KUSE
MX<@RKK/JTWO61$V(B>Q<B.[Q]%'4<,V<]?-VO&^CR\W+3S]C9+2VF<=I+#08
M;'-\2/QIIE2CYIG(G%([OK3T$HG0?(ZC/=FOFZY]#AQ1CMY867F-H2WUMB."
M+ABS5HCGV%PNQ%7IC>OT+OF+M[R]C1:N<%__ $SO<.JT\9;?'&Y!>G.4FK\[
M>O@N;5V*M(7JR>ZNVJU$5JT5(V[W]Y4\7Z8^ES]1PXXK$\T^+PV/%Q:/)?.V
M*)^T9H'!Z)MWMQR/EOIVM;=7LJU?)P[:(U/%:VO0GHJI\OJM9?GGWMW![N#3
MVXHV;V4G2=D
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MM8QL:^FJN^<*E&8XC!8K!PK#C;=L7%3K)/72/I]$Y=JD5<0
M /GAS:_>;JS]*77WQ3]6Z=^VQ_TP_*NH_N<G]4L-/0>>
M),Y.:FT+A[W+87F#CX;G!9R!L"9"2!MQ)9RLXT1[*M<YE4D7QF)5%1J]&SQ^
MIX,]]MMV&:763NK2KV^E:C!CFZS-$<M_;2M&3LY/\IH;EN0N^:EA)I]'(Y;>
M%L7E[F;U9PI*Y6K3V75+]2=*>I:N8Y8P3S?AZO:[L=,TD75G/'+PV5]?L6#G
M7S(P^M;S$832L+X=(Z;M_),:LB*UTJJUC%?PN\9&HV-C6([;LJM*T.UTK0WX
M(NOR?'?-9=7JVOLSS;9C^"S<BL]MX(             "9.S#^]2W_(KO[%#Y
M_KW[6?+#Z#H/[J/)+=T_.7Z*              M&:TSA\^U/C"WK,U*,N&+P
M2M3ZI-_@6J 8E+RGLE>JPY*5D?0U\;7KZ:*WYQ:I1T\TUO\ *C_@4]V*E#S3
M6_RH_P"!3W8J4/--;_*C_@4]V*E#S36_RH_X%/=BI0\TUO\ *C_@4]V*E#S3
M6_RH_P"!3W8J4/--;_*C_@4]V*E#S36_RH_X%/=BI0\TUO\ *C_@4]V*E#S3
M6_RH_P"!3W8J4=7\J+9C'/7*/HU%<OVE.A*_1BI1$&<RGQ3E;K'1L29ENY&=
M8J\*JO"BKLHO2II%O_663\73VR^H$/UED_%T]LOJ 9EH'%KK2XN(I7^1LA5J
M(]J=97B:Y5W\.[A3TR2K/_--;_*C_@4]V2JT/--;_*C_ (%/=BI0\TUO\J/^
M!3W8J4/--;_*C_@4]V*E#S36_P J/^!3W8J4/--;_*C_ (%/=BI0\TUO\J/^
M!3W8J4/--;_*C_@4]V*E#S36_P J/^!3W8J4/--;_*C_ (%/=BI0\TUO\J/^
M!3W8J4/--;_*C_@4]V*E#S36_P J/^!3W8J4/--;_*C_ (%/=BI0\TUO\J/^
M!3W8J4/--;_*C_@4]V*E#S36_P J/^!3W8J4/--;_*C_ (%/=BI0\TUO\J/^
M!3W8J4/--;_*C_@4]V*E#S36_P J/^!3W8J4/--;_*C_ (%/=BI0\TUO\J/^
M!3W8J4/--;_*C_@4]V*E'*<IK:J5RDBITHD*)_CBI1D.$T-@<)(VX9$ZZNV[
M6SW"HY6KW6M1$:GAI7OBI1DI%
M
M                                          !BG,6T\LTK?1HE7=5(
MC?"L;J?-1"PDM53:  #:+E?>>5Z3LJK561QHOUK48OS6&)6&9D4
M                  !\\.;7[S=6?I2Z^^*?JW3OVV/^F'Y5U']SD_JEAIZ#
MSP                                  $R=F']ZEO^17?V*'S_7OVL^6
M'T'0?W4>26[I^<OT4                           !29.3JL?<OZ>K<B?
M7;/X0-1,U<)=YB_N46K9;B5[? KUI\PVRH"@!.?(NTX;&ZNG)M?*^B]YJ,:G
MS>(S*PF(RH
M
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M]2W_ "*[^Q0^?Z]^UGRP^@Z#^ZCR2W=/SE^B@
M    +!K.^^+]/7ES6G QS_@VJ_\ Q2P-2C;+@ !LGR?LO)=*P2*E'2IQU[O&
M]S_G*TQ*PD(B@
M
M
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M<6$EK@;0 Y1%541$JJ[$1 -MM'6*8_3]I;(E.!C6?!M2/_%,2TOQ
M
M
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MN<G_ !^_^WDMC?O_  EC#^T7DHW.8_1&G6O:JM<UUF]%14V*BHKSN1T2V?\
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M+"+J+*"+<K6-KX52J_-,-*@
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MGO6M7KTA93($
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M/0&'U7E<5-A,M>1N;?XV=DD2QSPO6-RL21$=U;^'K(Z^Q<FVH99J
M
M                    ,/YE8OXTTO=Q-;Q2(QW GTR)QM_PFM+"2U:-H  -
MEN4N6^,=,01.=66%J1N3>M8OM>WT$:OHF)6&?D4
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M7SJ\M=UL;H\.+])Z;H(TN*F^Z=_AXDAGE/5
M  MV=NF6>*N9GNX6\"M5R]"+O7T$J!J)D+MU_?W-\_8ZXE?*J=SC<JT] Y&5
M,  F[D;B^&"ZR;F[9'JC5[K8TX4^:]QF5A,YE0
M                                -<>VCKY^E>5'ZL6#U^.M97"8V&-E
M>L\CCI)<N:B;Z_:X53_.!88#H#1/;)Y>:3Q^D]+6VG;3#6:/?#%.Z&2;BGD=
M*]9'KM5W$]?G;D"[$;:U7G/R=YR:6YW\T[2R9<7]VVUR$V'5JQSV\$38)F2-
M9L21UNY497?P5]B!L+VT[F"\Y!37=K(V:UN+_'2P3,7B8^-[E<US53>BHM4"
M0CGM5MO5[,'+%T*.6R:_#+=<.Y'+B)4C5W33UW>KZ 6-[<+3+[233>'DL.%;
M%]C;.M59ZSJ5A:K.&E-G#2@9:MZH?8O[>^BFVE/*&869M_3AKU_Q;DG)6B(M
M>J6/?M]"@:[%+I-:=O35WQLJ>4KC%^+N.GXA9<'!39_$\?S:[0=C<(,M/^Q9
MU3M:\YI,4K4T\N4MO(48BK&K?*,@L?5KNHC*5^M#4O;^[_MH6\O]57C6HEQ+
MF&12/Z59%:QN:GH+([TP2]>W3^9^7WZ<=][:"&5=MO\ <5=_I.P^S<$AF^C/
M^6[3W_V/9_\ I# (V["4,4?)>\D8U$?-GKQ\KNESDM[9J+Z34!+&>VU^V')?
M])W_ /2,8%A5=O"&.YP&@K>9*Q39F2.1*TJU\347:G>4$-N41$1$1*(FY RU
M(["K&-Q',)S6HCES;&JJ)1>%L;Z)X$JH:E1]KO\ ?#R2_2:?T^R!"6>T!R3T
MUSDM\1;3YUNGM:8Q[WX&^:K72.ZRCG1NBXV/>VL:.:YCN)BI5.E%)$H=N+#M
MJ\F[>2^@R=IS"TU8,=+-%,Y+V7J6-5RN=UJ6]VY41-T<C_1"[$^\A^<5ESKT
M.W5$-G\79*UN'V&6L./K&1W,;&/XHW*B*K'M>US:ILVMVTJI)A)X0
M
M                    *7(P>4V,\*)5RM56I],W:GS4 U&S]A\69J^L42C(
MI7=6G^;=XS/\%4-LK:4 )9Y)9CR?(7.+>ZC9%25C?JZ,=\U&&9(3X9:
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MM,Z6[8W++%QZ%TM-I[4VE[9O48;,WSZ26MK_ )-$19(GT:B[&N;,C?6HJM1
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MC:UM=ZU=1.*B"92D$
M                                             !K?S@PZX_4++MC:
M17#58J_31K5/\%S4] W#,HZ* %]T?E%Q.HK&ZXN&-STAE7N-D\6OH+1WH$&V
M5I.EU;17"?Y1J*O>7I3T%,-/8
M        !K3VYY9(^24;&.HV7-63)$[K4CG?3TVHH6'S8#;ZN=E?]P&B?R:X
M_IDX8E,(0                                            :\<YLTE
M]FH<?&ZL<"+(^FZJ^(WYC57ZXU#,HQ- !=],X[XTSUC9JWBC=*CY4_S<?CN3
MT42A!MM8P>2V<,'2QJ<7U2[5^:8:5
M                              P?FYRUQW-K0>3T3D;AUFEXC);6^8U'
MN@N8'(^-_"JIQ)5*.;5*M54JF\""<#B>VGH'#6NBL1!IG46*Q\3+/'9JYD7K
MH;:%J-C;MDME7A:B-\>)Z[-Z[PNQF7)'D/J'2&JLOS4YH9MFH>9N<C6&26W1
M?)K6%W#Q-8JM9Q.5K&,3A8UK&IPMJBU!,I\"
M
M                       ",N<N$\NP*WT;:R6M)?@Z\7^ YR^@6$EKN;0
MY VBY:YU,UIRWD>ZLS6IUG=XT\5_^$E?1,2L,R(H
M                      !K-VZOW*6_Z<LOO-P%A\VPV^KG97_<!HG\FN/Z
M9.&)3"$                                           */*W;;+'SW
M"NX5:U4:[=15V5]#>!J/GLD[+YB\R"KXLTB]7WHV^*Q/:HAME;B@!*/)?"K>
M9>;)2-K'"B1,5=U=CW_.:GHF9(;"&6@
M
M
M                       6[.V3,AB[BV>WC16JO"O2B)M3T4J@&H^5L'XO
M)76/DKQ6\CF(J]+47Q5]%**;9490 E7DOG_(\E-B974CE^VQHN[;1C_\5?04
MS)#8 RT                                           :S=NK]REO^
MG++[S<!8?-L-OJYV5_W :)_)KC^F3AB4PA
M                 "-><&?^+<$ZRB=2>Y^U)3NR(J*OH,1WIH6$EKH;0  ;
M,\JL%\4:<A?(WAGF;QR=WBDH]U?!XK?0,2L,\(H
M
M
M                                &N?.' _%V;9D(FTAN$ZMZINXF[6*
MOA:M/K3<,RC8H 7#"Y)^(RMKD6;>H>BO1.EB[')Z+54@VUPM_'DL;!=1O1Z.
M:B*Y-R[-B^BE%,-+@                                          !
MK-VZOW*6_P"G++[S<!8?-L-OJYV5_P!P&B?R:X_IDX8E,(0
M                            !U>]L;'2/6C&(KG+W$3:H&LG-+/.S.HW
MP-=6&SJVG1UCZ*[TD1K?0-PRP<H 7K2F)7-9ZSLE;Q1<?63)O^UQ^,J>CZWT
M2#;.QMDM+2*W3>QOC?5+M7YIAI4
M                                   !39#(66*LILCD9FV]G;M5\LKU
MHB(GSU7<B)O B;%\\(+C4LD%_;I;Z;F5(K:>E9HE15^V24K5'5VHGK>_MKJB
M53!')'+&V6)R/B>B.8]JHYKFN2J*BIO13*NP
M
M                  P;FCI[X[T]*L3.*YB3BB[O&RKFT\.UOUQ826LAM'
M">N2^I/*L>[#SOK+;4C;7Z#:L:^E5OH(9E82V94
M                    !K-VZOW*6_Z<LOO-P%A\VPV^KG97_<!HG\FN/Z9.
M&)3"$                                          8OKS/1X' 7%PY
M?'X55K>[T-3ZYRHA81JM-+)/+)/,Y7RRN5\CEWJYRU5?3-H\P $R\D]/<;YL
MW,W8Y>&)5^@C7H\+_L3,K"<#*@
M                                 ILAD++%64V1R,S;>SMVJ^65ZT1$
M3YZKN1$W@:T<P.8%[K*]ZF'BM\%;N5;6U5:*]4V=9)3>Y>A/8^FJ[B&6%%$G
M\LN9LFGI(\%G9%?@GK2"=:JZU<J_-C7I3HWH9F");"1R1RQMEB<CXGHCF/:J
M.:YKDJBHJ;T4RT[
M                                                        'E<P
M,NK>2W?ZV1JI7N+T+Z"@:J:ZPC\'J*Z@X.&"=RS1(FY.)5XFIX'5]"AN&6-%
M #(-&9QV S]M=\?!!(J13N[C'*E'?6JB.(-K;*Z9>6L=RS<]-J=QR;T],PTJ
M                                          :S=NK]REO^G++[S<!8
M?-L-OK)V9+=MMR&T/&Q55'6#I:KW99Y)%3T%<&)2R$
M                       *M-J[@->><6IOC')LQ$#ZPP4DE1-U:>(GI*KO
M1-0S*,#0 >]G:S7UU#9VZ<4\[VQQIWW+3;W@-L-(8:'"8.VM(DHB,:B*NQ5:
MU*(J^'UWHF):7X@
M                     %-D,A98JRFR.1F;;V=NU7RRO6B(B?/5=R(F\#6C
MF!S O=97O4P\5O@K=RK:VJK17JFSK)*;W+T)['TU7<0RPHH  )/Y9<S9-/21
MX+.R*_!/6D$ZU5UJY5^;&O2G1O0S,$2V$CDCEC;+$Y'Q/1',>U4<US7)5%14
MWHIEIV
M                                               (IYRZ:\NQB9:W
M96:UK(JHFWA1*/3VJ([ZTU"2@ T@  V%Y/ZH^,\6F-N7UN;:D:U7:M$\1WUS
M4IX6F96$H&5                                         UF[=7[E+
M?].67WFX"P^;8;?6GLV?N*T+^C&?9O#$I4"
M                8]K+/08#"7%W,ZE&+L1:*J;J)WW*J-3PEA&J=[>39"\G
MO;A:S7#W2/7HJY:T3O)T&T4X "2>4.FW93,+DYF_R>VK'&OTZIXZ^@U:?7&9
M(;%HB(B(B41-B(9:<@
M                       %-D,A98JRFR.1F;;V=NU7RRO6B(B?/5=R(F\#
M6CF!S O=97O4P\5O@K=RK:VJK17JFSK)*;W+T)['TU7<0RPHH    "3^67,V
M33TD>"SLBOP3UI!.M5=:N5?FQKTIT;T,S!$MA(Y(Y8VRQ.1\3T1S'M5'-<UR
M5145-Z*9:=@
M                                                  %+DK)E_9RV
MST1>-/%KM3BZ -3M4X63 9NYL'-5L*.5]O7WMRK1/0]:O@-LK*4 +_H[/R:=
MSD%YQJVV>J1W%.AJKL=X6KM(-K<?>1W]I'=1JBH]/&IM1'=)AI4@
M                               !K-VZOW*6_P"G++[S<!8?-L-OK3V;
M/W%:%_1C/LWAB4J!                                        <*J-
M17.6C42JJO0B :\\WM5+E,DF(MW_ ,G@5'S4[OL&^@B\2]]>\:AF48F@ ](8
M9;B:.WA:KYI7(R-B;U<Y:(GI@;3<O].QZ?P4$"(G6N;XS_HEWN=Z+OF4,2L,
MK(H
M        ILAD++%64V1R,S;>SMVJ^65ZT1$3YZKN1$W@:T<P.8%[K*]ZF'BM
M\%;N5;6U5:*]4V=9)3>Y>A/8^FJ[B&6%%       $G\LN9LFGI(\%G9%?@GK
M2"=:JZU<J_-C7I3HWH9F");"1R1RQMEB<CXGHCF/:J.:YKDJBHJ;T4RT[
M
M                                     (EYR:5\ML4S-K'6XMZO=PIM
M5GLT]+Q_04U"2@0T@  G3DYJ[RBV7!WDGVZW1&QJJ[X]S%]#UB_6F96$PF5
M                                      !K-VZOW*6_Z<LOO-P%A\VP
MV^M/9L_<5H7]&,^S>&)2H$
M !B/,'4\.G<)-(JHLSVT8SZ)SMC6^BN_O(I826KMQ/+=3R7,[E?/,Y9)'KO5
MSEJJFT>0 "1>4VEW9C,?&4S?Y-:JK8W?YQ4\9?K6KZ:H22&Q[6M8UK&)1C41
M&HG0B;C#3D
M                ZOC9(W@D:CV+O:Y$5/24#R\CL_Q>/VC?4 >1V?XO'[1O
MJ :?9A$3+7Z)L1+F:B?7J;9410  9;RQ8R37>&8]J.:LDE6N2J+]I?T*22&T
M/D=G^+Q^T;ZAAH\CL_Q>/VC?4 ]FM1J(UJ(C42B(FQ$1 .0
M
M                          %-?V<=_:26TB)1Z>*J[D=T :J:ST])IS-S
M6G K;:15DMZ]#57:WZU=GI&V6/% "OPV5N,+DH,C;[7Q.\9E:(]B['-7PH0;
M6Z8SEOGL5!>02<?$Q%5>E47<J]_H7OF&EY
M             &KG;TGDBY-XJ-E.&?45I')7Z%+.]?L]%J!8?.4-OK3V;/W%
M:%_1C/LWAB4J!                                       \KFXCM8'
MW$JT8Q*^%>A$\(&L/,;5,FH\W(R-_%96KE:SA7Q72;G.3NHE.%O>\)N&6&E
M#WL[2>^NH;.V;QSSO2.-O?<M/2 VHT/IV#3V$M[>-/'5B5?2BNZ5<OU2[?2,
M2K)B*
M               TXS/YWR'Y3-]\4VRH2@  R_E?^WN%^Z2?>7DDAM,8:
M
M                                         CKFKI%,[BG7=JRM[!X\
M=-ZO1*4^O39X:%A):X*BHJHJ45-BHIM'  "2.5.L7X7)-Q-T_P#DEP[[15=B
M/=O9]=T?3>$DP0V+CD9-&V6->)CT16JG<4PT[
M               &K';Y_<]A/_N6U_H%^%A\Z0V^M/9L_<5H7]&,^S>&)2H$
M                                      ")N;FM$Q]I\3V$E+N=%;5J
M[6MW.?\ XK>_5>@U$)* S2  "6N3VD%O+E<[>,^U)5MNB_0;G.^N7Q4[U3,D
M)[1*;$W&6@
M                    #3C,_G?(?E,WWQ3;*A*  #+^5_[>X7[I)]Y>22&T
MQAH
M                                              #I-$R>)\,B5C>B
MM<G>4#6SFCI*3!9=^0A9_([MRK(J)L25=M? ]-OAJ;AE@!0 Y:YS7(YJJUS5
MJBIL5%3I0#8GE9K9N;L$Q]X]/+H*-?7I<NYR=YWV7A,3"PDLB@
M                          #5CM\_N>PG_P!RVO\ 0+\+#YTAM]:>S9^X
MK0OZ,9]F\,2E0(                                     ,?U=J2UTY
MBIKN9_"]&JJ4]=W$IWU78TL#5C+Y2YS.0GR-TOVR9U4;6J,:GK6IWD0TRH2@
M!=]-X.?4.6AQ\*+U:KQ3O:E5;&B[53OKN3OD&UF#Q,&&QT-E"Q&(QK45K=R4
M2B-3O(FPPTN0
M                       #3C,_G?(?E,WWQ3;*A*  #+^5_P"WN%^Z2?>7
MDDAM,8:
M                                                    6#5VGK;4
M6)GM)V<;E:J)3UU-^SOHNUO?+ U6RV,N</D)L?=I26%U$=T.:NYR=Y4-,J(H
M 7+!YFZP.2BR-JOC,6DD=:(^-=[5_@[Y!M-I745KJ/%PW=O)QN<U%7NJF[:G
M=1=CN^9:7T@                                    :L=OG]SV$_P#N
M6U_H%^%A\Z0V^M/9L_<5H7]&,^S>&)2H$
M         /"\NXK&W?<S+1C$W=U>A -9.8>L)=395\<,E<=;N7@IZU[TV<7@
M1-C?3Z3<,L,* '+6N<Y&M17.<M$1-JJJ]" ;%<J]&-PF/2_NV?RZ:CI%7H=T
M-3O,K[:IB96$E$4
M                           :<9G\[Y#\IF^^*;94)0  9?RO_;W"_=)/
MO+R20VF,-
M                                                       $3\V=
M#_&5K\;8^.MY#54:U-KDWN9Z.]O?JG2:B4E 9I'  #,N7^LIM+Y-L<SU3&SN
M3K*[HWKLXJ=Q=SO3Z"2-FK&]@R%LRY@<BL<FU$6M%[AAI4@
M                      :L=OG]SV$_^Y;7^@7X6'SI#;ZT]FS]Q6A?T8S[
M-X8E*@0                                  !PYS6-5[U1K&I5SEV(B
M(!!G-C7JSO?@<;)1%2EP]J^M8OL?JG)O[B;.DU$,RAXT  "2>56C),SD&9>[
M92T@=6WJFQ7-WOV_0[D^F\!)DAL3%&R&-L4:<,;$HU$[B&&G<
M
M  TXS/YWR'Y3-]\4VRH2@  R_E?^WN%^Z2?>7DDAM,8:
M
M                              /.>&.XB?#*G%&]*.0#7+FAHN3!9!^3
MM6?R&=U9N%-C7N78[O([YCO0-Q+,H[*  "5N5FOGXZ>/!Y%ZNA?1EJ]R[T][
M55Z4]AZ7<,S!"?(I8YHVRQ.XHWI5KDZ4,M.X
M          -6.WS^Y["?_<MK_0+\+#YTAM]<.SO;K:\C]!QJ[BXL1;RUI3^.
M19*>AQ4#$I-"                                   (QYG:^CPMHN.Q
M[VOOID5&(FVE-BO7Z5.CNKWD+$)+7N222:1\LKE?*]5<][EJJN5:JJJ;1T
M7S2NG+G4N5CL8D<D"*CKF1J>M97<GTSMR?\ 40;38+#VV$Q\5E;L1B,:UJHW
M<B-2B(G>0PTN8
M                           TXS/YWR'Y3-]\4VRH2@  R_E?^WN%^Z2?
M>7DDAM,8:
M                                                        %LSN
M&MLW82V=RQKT>U6HCMRU3:B]Y0-6]6:9NM,91]I,UWDSU5;:1W2U%VM7Z9O3
MZ?2;96$H <HJHJ*BT5-J*@$Y<KN8GE36X;+2?RIJ>*]W^4:GLD^F3V2=._NF
M9A83"BHY$<U:M5*HJ;E13*N0                                 U8[
M?/[GL)_]RVO] OPL/G2&WUWY!?N4T#^@['[RT,2D8(
M               !A.O];VFF<>]C7<=X^K&1M6CG.IN3P>R7H\)8A):U9#(7
M64O);Z]?UEQ,M7+T(G0B)T(FY#:*4 !465E<Y&[BLK1BR7$SN%C4^>O>3>H&
MS7+_ $;;:9Q<:JU'73TXGR*E%<Y4VN_@:G0AB96&9D4
M                                                         &G&
M9_.^0_*9OOBFV5"4  &7\K_V]POW23[R\DD-IC#0
M
M                            8GKG2%IJ?&2QN92X:G$Q[4JY'-38Y.^G
MS4V%B4:QY3&7>'OI;"]9P31+OZ'-Z'-7I132*(H >D,TMO*R>!ZQS1N1\;V[
M%1S5JBH!/_+7F+#EK=N-R;T9?1IXR;D5/HV]Y?9)T+WC,PL)21:[4W&5
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M61[$XFM<R1&(KD1>)'(B[46B F&RH0
M8KK36-CI>P?)+)_*%3A:UJ^.KE38UJ?1+\S>6(1K-F\U>YZ_DO[UU7NV1QIZ
MUC*U1J?]-II%M* '9K7/<C&(KGN5$:U$JJJNY$0">^5O+]N-@3+9.-%O94VM
M5*\+=_ G^/W]G09F5A+!E0
M                                     -.,S^=\A^4S??%-LJ$H  ,O
MY7_M[A?NDGWEY)(;3&&@
M
M         1SS*T#!G[-U]9M2.^A17,?3<J[51?I7?,7;W2Q*2UUN;>>TGDMK
MF-8KB)RLDC=L5%0VCR  >UM<SV=Q'=6LBQ7$3D='(U:*BH!L'RZYC6V;MVV&
M0<V*^C1$<Q5_PFUWM^Q\!B86)28BHJ53:B[E(H
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MV6U9SFQ68M&JS$Z6KD\G=4\5M6/CAB3Z:1Z[OH4<O0$E]0 P
M                 8SK#6%AIBPDFFD1)D2C6I17<2IL:U.ER_\ 6I8A&L^H
M=0W^H[]U[>N5&HJ]3#55:QJK\U5Z5Z32+04  $O\K>7LEQ+'G<K'PHE'6\;D
M]:U4V.^J7H[B;=]#,R0G2.-D3&QQM1K&)1K4Z$0RT[
M                                                           T
MXS/YWR'Y3-]\4VRH2@  R_E?^WN%^Z2?>7DDAM,8:
M
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M9:>H
M                     &G&9_.^0_*9OOBFV5"4  &7\K_V]POW23[R\DD-
MIC#0
M                                                      '#V->U
M6/1',<E'-7:BHH$.<S>6RW*OS.'9_*43QXTW2(G0OTR>Q7IW*:B4F$(/8Z-S
MF/:K7M56N:Y**BIL5%132.H #O%++!*R:%ZQS1JCF/:M'-<FU%14 FWEWS12
M?J\3FG(VY6C62+1&R+W6[D1WTNY>CN&9A:IBBFBGC;+"Y'QNVHY#*NX
M                     >-W:6M_:3V-["RXLKJ-\%S;RM1\<D4C5:]CFKL5
M'(JHJ ?)?G[RHN>4',;(Z<:QZX&Y5;W 7+JJDEC,Y>%BN6M71*BQ/[JMKN5
MW", H  VQ[$O)S]:-52<S\Y!Q8+34G!B&2-JR?*JU%1Z5WI;M5'_ %:L5%\5
M0S,OH8&0                          &X# M=<Q+#3ELZ&!_6WKT5(V,7
MQG=&Q>A.Z[TBQ"5:[9?,7^;O'WM_)QRNV-:FQC&_0M3H0TB@*  "0^7G+RXU
M#<1Y#(1JW'-5'1QN2B2(GLG?2?9> DR-BK*R@L+=EM;M1K&IW$2J]W88:5
M
M                 "%;WD3>7=Y<729J-J3ROE1OD[EIQN5U*]9WS54H\/,#
M>?+D7_#N_""I0\P-Y\N1?\.[\(*E#S WGRY%_P .[\(*E%XTIR=NM-Z@L<V_
M+1W#+1SG+"V%6*[B8YF]7K3?W!4HEDRH
M
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MK&RQ.1\;T1S'M5%:YJI5%14WHH'8
M                                                          '"
MK0#S2XA5*]8WP<2*!SU\/OC?;(!SUT/OC?;( ZZ'WQOIH ZZ'WQOIH ZZ'WQ
MOIH ZZ'WQOMD XZZ'WQOMD [\2*OS@.0
M
M      !P]C7M5CT1S')1S5VHJ*!%',7EE%DFORN):D=XU*KW'HG0_P#@=Z"F
MHE)A!%S;7%G/):W4;HKB)>&2-R45%0TCQ   ,NT?KW)Z7G9'QNFQR+MBKXS$
M5=O!7H^E79X"4&PVFM7XK4EJR>UF:KW;%1-GC=RB[47O*9HTR$@
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M[=>7S^*14X6,38QC$W-:G0B%%"  W!TS^SF'_(;;[TTXY:70
M
M                  %DU=DTP>E\UF7/X6V%E<7*+W%BB<[^ #YI6.K=32S+
M(N:OEXW*[;<R]*UZ' 9);ZEU$YJ*N7O:[/\ O$ON@*V/4FH-WQK>?\1+[H"L
MBU'J!?\ ]ZWG_$2^Z J6Z@SZI7XUN_\ B)/=!7C)J#/_ "K>?\1)[H(I)-1:
M@^5KS_B)?= 4K]2:C:O$W+WJ.:J.;_*).C;]$!OGR\U.W6&C,-J!'(LMW;M\
MHX=R3QU9(GMFJ!E0
M                                                    %1%2B[47
M>@$=Z\Y;V6H('75FWJ;Z-/$>Q*JG32GLF][HZ.X6)2C7S*XF^PUVZRR$2QS-
MVHN]KF]#FKTHII%"4  %?B<QD,)=)=XZ98I/9MWL>B=#F]*$$ZZ(YK6672.P
MR:]1>[&HURUXE^D5?7>!?&\)F86J3HIHIXTEA>CXW;G-VD5W
M            ,%YP<M<;S8T!E=&Y!&LGN&==C+IR5\GOX45894IMHBKPNIO8
MKDZ0/FSR=Y'YS7_-UO+[-6LMG;86XD=JQ=J.@M[.3@ECXDW.D=2)BI]%Q;40
M-S+ZLV=G:X^TM["QA9;V5K&R"VMXT1K(XHFHUC&HFY&HB(B!A[@
M              !51$JNQ$WJ!AVK>86(TW M94?<N1>K8VCG.7Z5O3X5\4M$
MJU^U/K/+:GG<MS(L=G6K;9JJJ+W%>OLE^8G0AI&.%  !WBBDGD9#"QTDKU1K
M&,17.<Y=R(B;P)FY>\K'(^/+9MJ=:U>*.+8K8U3YCG?,3OJ9F5HC?72N35^9
MC5SG-ANI8H^)5=1C'*C42O0B%A&/%  !N#IG]G,/^0VWWIIQRTN@
M                                                         !Q7
MNT3N@*HH'('%>\ KW=GA 5[FWP .+O* XD\'A <2>'P .+O* KW@"K3H <7>
M4!5.G9X0.:IW0.*IW0..- .46H"J <<:5IL3O5VT [;P(D[2V;^(N3>HY4=P
MR7C(K%E.GRB1K7?X/$!\]<:Y:MKOV(!E=FM8T"*]F\*K8@*EB[ /.0(HI=X5
M2R ;,=E'5?6V>9T7._[;9R)D+-J^\2T;(B>!W"OH@;,
M
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MOLD_Z4)160$4   *+(Y:QQ<3I;N5K$:BN5%5$6B=*UV(G?4"%]9<X)+CK+'
MT5NU%N%_BT\"+Z]>^OB]Y340S5$MU=7-[.^YNY737$BU?(]:JIH>(  !6XO%
M7^9NFV>/A669VU>AK6_1.7H0"?=!\L;/!QLOL@G77SDJKW)1:+T-1?6M^:IB
M96B2FM:QJ-8B-:FQ$38B(16IFN_VSSWY=/\ 9J;AECQ0  ;@Z9_9S#_D-M]Z
M:<<M+H
M           I<C?1XZT?=2M5Z-HB-;O55W(!BTFH<XY[G0Q,;&J^*UVU:?-
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M2W-+!7\C^"QN9'6-WMHBQW+58VO>1_"OH ?0#BW(G2!V
M
M                       M^6PUCF;9]O>1->CVJU5<U';%Z%1=Z=X"!-;<
MK+[#2/N\0QTUHM5\G2KG(F_Q%WN3Z7UWA-1+-$;*BHJHJ45-BHIH<   %9CL
MI?XFX2ZQ\[H)DWJU=CD[CD78J>$"7M(\Y&_:[//-2)VQJ3558E]':K?1JG?0
MS1:I>Q^6L,I$V6SF:]')Q(E4JJ+TI38J=]#*JT#">8NHY<381XVS>K+R]1>.
M1JT<R%-BT7H5R[/3+"2AXT@
M >UI=W%C<Q7EK(L5Q"Y'QO3>BH!/NGLQ'G<1;9)B(U\B4EC3;PR-6CD]/:G>
M,-+H!Y3W,%JSK+B1(V=U>GP)T@1QJ[FUC,/QVF/7RB\2K58Q4547Z9VU&_-7
MO%HE4)9_5>9U'*Y]_.J0*O$VW8JHRO=7I<O?<:18R@   93I30V6U1,QT;'0
MV"KMG5*JZF]&(N_P[D)4;#:6T7BM,VK(K>)O6I17.7:JN^B<OLE^=T&:JR8B
M@&I>N_VSSWY=/]FIN&6/%  !N#IG]G,/^0VWWIIQRTN@
M                                                "S:H_-+_ *MF
M]$7I[X&EG-_M#\Q-%:_R>FL(^R;C+/J^I;+;\;TXFU6J\:)\P##8^U7S77;U
MN/\ 0M:?XX%9'VH^:CDJLMC_ ,,ONP*N/M.<T';5EL?^&7W8%7'VE>9B[5DL
MO^'7W8%5'VC>9#O7262_^'7W8%7'VA.8;M[[/_AU]V!51\_-?N7;):? ?]H"
MJBYZZ\>GC/M/@/\ M 5D?.W7"[WVNW_,_P#: J6<Y-9N3:ZU^!_[0%5'S=U@
MJ;7VVW_,_P#: JH^:NJW;W6_P7_: JV<SM4+1.*"B_YK_K J(^9&I7+2L'P?
M_6!W?S+SD+:S/AKT-2/;\\"F;S0U*]WB=0C%W(L7_: JHN8NHWTJL&WN1K[H
M"LAUYGGT1W4KW^K_ .L"XVFL<Q-+'&]8N!SD141G?3O@9?I%$76V9Z*VD*K3
MNU UB[<F7ZS5FE<(UW^ZV<T[D^FGD:U*^@P#7/&.];MV; ,OQZU0(ND855Q*
M!6, XD**21""C>!:K]SHG-FCV2QJCV.[BM7B3YH'T/Y7:G9K/0>#SS7\<LUN
MR.XK[]&G ^J>%*@9H
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M^0VWWIIQRTN@
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M6UK:R232+1K4:N\#<'LRZ=SNF='7F-SBJURW2RPP5XN!'IM2O<V 3B
M
M                                    ++G=,8K/V[X+V!KN--JJE45>
MZO?[Z;2B"]7<J,IAGON,4UUS:[52%=KT3Z5?9>#8[PFJLT1T]CXWNCD:K7M5
M4<UR45%3>BHI1U    &7X7\V0?7_ &;B"O
M              "U9O*Y&RB;:V=R^""X15F2->%7<.Q*JFVFU=E0,7*.
M!E6F-!9O4DC',B=;V3MO7/:O$YO=8W97PK1.^2HGG2G+S#Z;A14B22X5/MCW
M>,YWU3ME? E$,U6C,41$1$1*(FQ$0BN0   !J7KO]L\]^73_ &:FX98\4  &
MX.F?V<P_Y#;?>FG'+2Z
M                        ++JG\TO^K9\\#YL=H]/_ /+V;\$7V $:Q[D
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MMCJJJJJOB@2
M                                                       '62-D
MK%CD:CV.V*UR510,%U9RQP^H6NFC9U5Y3Q9&>*].]Q=*=YWIH6J40?J306=T
MZ][I85N+1E56:-JU:U.E[=Z>':G?-51BQ0  9?A?S9!]?]FX@KP
M                               Q[4O\9;^!WST"+$50 !=<-IW+YZ9(
ML=;J]M4:^9WBQM5>Z[^!*J03-I'D]9V/5WF9_E%PE'(CT\5J_2L6OIN])"56
MB4[6SM[./JK>-&-Z5Z5\*F5>X      -2]=_MGGORZ?[-3<,L>*  #<'3/[.
M8?\ (;;[TTXY:70
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M!
M                                               \;FUM[MG5W$:/
M;T5WIX%Z (VU5RAQ>5X[K&_R:Z7;6-$2J_3-V-=\Q2U2B',]HG/X![UN;9TM
MNRJK/$BJB(GT24JWT4IWS548X49?A?S9!]?]FX@KP
M                     Q[4O\9;^!WST"+$55RQ6"RN:EZO'6SI4K1TOK8V
M^%R[""6-+<EV>)=9U_6KL7JMK8T]#8YWH\*$JM$MXW"X[%1,BLX6L1B<+5HB
M43N(B41$\!E5P         :G\P(^JUKG6UK6[D=[=>+^$W#+&B@  V^TK(R7
M3&%E8M6/L+547PPM..6EW
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M (LU7BV66K[1&.:^-+AM'1[&JJM[P&[/*?\ ,:K]+']B!((
M
M                                  !X7-G;7;."XC1Z="KO3P+O0"/M
M2\HL+EN.>R;Y-=.JO%'1BJO?3UKO11%[Y:I1&MQA)M.3OPUP_CEM5HKZ<-4?
MXZ;*KT.[II'D       !W2*1S5>UCE8F]R(M-G? Z
M            %/+IC+:DNH8L9&CFQU221RT:U7*E-B55=W0@&?:;Y+6D'!<9
MIZSR;^!R<+$^L1:K]<OH$JM$HX["XW%QLCM(&L1B48M$V(G<1$1$]!#*K@
M         -8^;MFMIKS(NI1ERV&=E>E'1-:O^$UQN&98,4  &RO)[.,RVCX;
M-SJW6+>ZUE;T]6JJZ-?!PKP_6J8E82 10
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MWA+O,64F$5_DB73%9'(O%*B<%%J[IV@;H<I_S'3Z6/[$"00
M
M                                     @[F!^UV1_T/WB,U#,L9*
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MJ=]%[BIN5%W&&E6
M         %%F%5N(R#FK14MIE14WUZM0(OY9<TF9!L.GM2S(W()2.ROI%V3=
M",D7Z/N+[+P[]3"1*73*@     675.W$O^K9\\#YJ=HC;SBU#W$6+[ ".XMR
M 7"+<@%PAW(!6P@7&+<@%>U\<3%?(O"U-[EW 6>^U"Z5706/BQ[469>FG< H
M8'*Y>/>J[U7>H%TM^@"Y1;@BZ0] 5<8=Z 7*#^$"X0[T N,70!<H.@"Y6_0!
M<K?>@%XQ_P#O$/U:?/0"4-(?MOF/R2'YX&0+^=\EX&?.*,'UVO\ ],:@[V/N
MOO+BJT#X$9,^B=**AE%9%5$I5:(E$V]P"NAX5I5 BL8C>X!UDX>D"BFWUZ>Z
M6L*H9W.W56G<\)!681%9D;1$W+*VJ=&WO ?03E1^8U7Z6/[$"00
M
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MN_[W;_ZSW(5;DQDN)S=I;3.:]_7-;Q,KPU1*]* ;Y\J/S$O@C^Q D$
M
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MO\"]\J,HY@_F;2WY*_[W (67MS)8_(6N(SMNG'930JUSV[4:Y]'M1>Y6JIZ
M@EBVFM.W&I+]UG"_J61L622=6JYK>A$6BIO4(RC0\38,=JZ%DB2LCA1C96^M
M<C67"(Y.\HE7ERI5/CJ\3I\E79_I&"2&#W*4N)D7?QN^>I427Y FM\'I^\7Q
MKFUG2TOU3?U2)XZJO=5&M=]<95C',#*)D=0RPQ+_ ":P1+6-$W<3/7[/JE5/
M0+"2Q8H    "4.4W^[Y3ZN'YSS,K"1R*              @WG/H=T,ZZOQD=
M8):-RD;4]9)ZULM.X[8CN_MZ5-1*2APT@
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MG,TCW6$CI,Y:OGLEM)GW;%ZM45G#]KI2B]W>!N+RH_,2^"/[$"00
M
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M?N)9E'90
M         "<>36M,QD)':9OHI+RUMXU?!?;U@8FYDBKO:NYG3T;MV9A83(94
M  6;5'YI=]6SYX'S/[0?[Y=2_50_8 1_%N0"X1*B(VN[TOF@6?+:F2)7VN/6
MLB>*^3Z'O(!8HW/>[C>_B5VU57?4"Y0] %T@Z +I#T 7*'>@%TM^@"YP] 1<
MX>@*N,.] +E!_"!<(=Z 7&+H N4'0!<K?H N5OT 7C'_ .\0_5I\] )0T?\
MMMF/R2'YX'&O<M)@L'JW,1PQW,EE9OG;!,E8WK&Q5X7)TU-07;D 7WE$VH.9
M^0GB2)M_I^QGC1OK41UO2B=[>;AFU"&-U!<8VT?:0QHYKGK(KEWU_P"B''.]
MI5NUE>HE60LKWT(*.37U]&ZDEM&G? X3F%=+NAC ](]<WTOK;=B>@)%T?S#S
MDEHVSD>KK5OK85558GH;C$X[9[!WM>8VH;&+J+.=\$-:\$;U:VO=HBFQ1S:C
MO,_E+22^J^=+AKG2N6KG*B<**JKW@-Y^5'YB7P1_8@2"
M
M                                  $'<P/VNR/^A^\1FH9EC)0
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M'Z^&9JL<GH+T=\TBF
M                ,ATCI#*ZPR3;*P8K+=BHMW>.15BA8O2O=<OL6]/@JI!L
M[IS3>*TMC8\9BHD9&VBRRK3K)7]+WNZ57YFY##2[@  %GU.E<4Y/IV?/ ^9_
M:#14YRZEV5\:'[ ".UEB@8LLTB1Q,2KG+T(G<0#&<IJ6>]58+&L5HJ45:[7I
MW>]X +?!\[I7?4"YP] %SAZ +I!T 72'H N4.] +I;] %RBWH!<X.@"Y0[T
MN4'\(%PAWH!<8N@"Y0= %RM^@"Y6^] +SC_]XA^K3YZ 2?I#]M\Q^20_/$"V
M\V5IHW75/DY_S&*6$E'VH=-Q6VF=0:G6X<Y]_I^WMI+=6HC8VP1>OXNFO$<L
M,VM2]S:N3;W#BG>VI)[E&U(*!TRO4#HW?N K(Y5[@%9'+7>!Z 5V)_.5K]U:
M!O\ \J/S$O@C^Q D$
M
M       (.Y@?M=D?]#]XC-0S+&2@
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ME .J,5F\#V:ZH9MF)WS1<,3^<[7[JT.2L1NVM_\ E/\ F-W@C^Q#*00
M
M                                             A;F3;.@U1+,J4;=
M112M7N\+>K_Q#4,RQ$H                                       "5
M^5-L^/&7UVY*,FF:QG?ZIM57_",RL) (H
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MY3R22T5=J0Q2I\X.TDL
M
M         ,1U]IN3.8UMS9MXLA9<3F,3?)&OKFIW]E4_ZRPDH75%1514HJ;T
M-(X                                      *K'8Z[RMY%86,:R7$JT
M:G0B=*JO0B=*D$_83%0X7%VV-@VM@;1S]W$]=KG>BJF6E>
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M" $5: YUVNO.9.M.746'DL9M'2/BER#YVRMN."98:MC1C59NKZY0M$JA
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M  G2U>GMT])CM=#68OI9V;:MU^5V32WU+!CG^*V\QK71+W5C=5?F'3=9-@
M
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MJPTKV@M$IH^/*NX++/6DW7V#7*M$XU:Z9JM153B<R9>#>YM-J"B1^T%S;O\
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M\"^.=6)O?;N;]M;Z6T.)-F'R=MF<;:96T=Q07<;)6+O5$<B+1>^FX"X@
M
M
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MDMG/=6Z3Q/1'->QN0C<YCD7>CD3A4$-P'-:]KF/:CF.14<U4JBHN]%0,M/\
M^[]>]=&:PC5RK&W*0.:ROBHYUO151.ZM$#4MP0R              X7;0"BE
MQ6,GD62:TBDD7>YS$V^BH'FN%PJ>NL8$\+&@J\W8S3S/76]LWPHQ *=T&D6+
M21+%J]".6-%^:H'5&Z/3HLO]6OS@"MT=2JI94[_5I\\#NVWTH]*QMLG-I6K5
MCV>%4W(!A-_S T1!?SXO!8.[U+D(5X9XL-9I/'&O<=,]8XZITIQU[P'FFO\
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M*1=R(Y?ML*?4*02>0
M
M
M         !$/:-Y.+SHY?OPEA+';ZDQLR7^%GFJD:S-8YCH7JFU&R-=2O0[A
M7H"Q*$=-]IKFYRMQL.EN<?+G*W][C6)!'GH$?&Z>./Q&N>Y8WPRKN;UL<M'=
M**NU2T46M.9G.'M/8OS<Z!T%=:=TIDY(OCC4&55Z1+!'(V5$658XV,:BM1SF
ML61[Z43I11N2[S:Y?+I7LL97EWIBWGR4N-QEI:6\=O$Z2XN)674+Y9$CC1RU
M>[CD5$W5"=JR?$6;_L5_$/Q;=?'OZN]3\6=1)Y7UO75X.IX>/BIT<(.UG_9F
MQV0Q/(S1V.RMI-8Y""WG2>TN8W0S,5;N9R(YCT1R5147:@)1-S<T[J"][87+
M+.6>*O+C"VF.LV762AMY9+6)S;O(.5))6M5C51'-5:KTH%[&1]H_E/K/*:BT
MUSGY5QMN=>Z15K)<:ZE;RSC>Z1J,1RM1RMXY&N96KV/HU>)$120L[NT+SMUA
MCUTQI#D_E\-K>[8MO+D\JDL.-L'O3A6=73P1(O#ZYK7JGU^Y11CW8)M9;.WY
MCVLTJ3R09"RA?<,57,D=&ERU7-5R(JHN_:%ED?91P&>PW,+G;<Y?%W>/MLAF
M;>2PFN[>6!EPQ+K)JKHG2-1'HB/:M6UWIW0DL9N\+S"[+?-C4>L=-::NM6<I
MM82K<W]KC&N?/9/61TK45K&O5BPNE>V-7)P/8ZBN1WK2[U1KGM!<Q><F*;H;
MD7HW46*R>2?&R_U+=L6P=91L>BO2.:%[FQU5.%TKI6JC:HC>)=@HV>T!I_+:
M6T;AL!GLO/GLW96Z-R.7NI'S2W%P]5?([CD57*U'.5K.+:C41 RO>1L+3*X^
M[Q=_&DUC?0R6US$NY\4S58]J^%%5 -,M$Y'F)V0LOF])Y_3&1U9RIO[IU_BL
MWB(NNDA>YK6\3DV-:YS&M;)'(YGC-XF*J;S6]SS"U/S*[62XW0FA-)9'37+Q
M+F*\S.HLW'U"2-97@V(JM<C$7B2.-[W/=PJO"B5!N9QVL]$W5OR PFCM'8RZ
MR$6'OL;:VMI9PR7,Z6UI;31-<YL3578B)Q.IO"0V$TA%+!I/ PS,='-'CK1D
MD;T5KFN; Q%147:BHH1>0(_YS\K,;SAT%?Z.OY4M;IZMNL7?JWC6VO8:]7)3
MI:J*YCT^A<M-H6&MFCN<_.KD!C8=!<U= Y#/87#L\FQ6H,=QO3R6%OB,ZY&/
MBE:UM$;5S'L;L<E0M'76?.CG'V@\5-R_Y5:"O\)ALPSR?+9_(\36^32;)&=:
MK&Q1,<W8_P 9[W-JC4[HHV!Y?<CM/:)Y/S<IYG^66V4M;J+/7S6HQUQ<W\?5
MS2M1:\/"WA;'THUK>D)5K_R]U?S$[)_QCR^U]I/):BT RZDN\)J/"0]<UK):
M*]/&5K*.IQK&][',=Q>N:J*%WNNM+KF3VO<S@M-X;2V0TERFQMTV]RF7R[.I
MDG>B*Q7-14HYS&.>R..)7^,[B>J)ZT;F5]MC2>4R'+#2F%TGA[K(,Q^4C8RT
MQ]O+<NBMXK.:-M6QM<J-38VJA(;5A&K?8^P&>P>6YJ/S6+N\:R\S,4EHZ\MY
M;=)F(^Z\:-9&MXDVIM;W0LJ+MBZ=U!G-6<H9L)BKS)0V61O7WLEG;RW#8&NG
MQRHLBQM<C$5&NIQ=Q>X%AW[:FD]5:MDY;V6D[&ZN;Y,E<L\JMHI9&6KYEMFQ
MRROB:[JVHNWB7N*"%0[M8ZITYCDT[J[E=GUYH0-ZAUE:P5Q]U<,3A66.5O&_
M@>Y45$CCD2B['+LJ2B\=F3E3K#"9+4W-[F;%Y/KO6CW.2P<E);2TDDZYS7MV
M\"O<C*1U\1K&HNVJ()6GD-@,]CNT;SDRF0Q=W:8R^N)5L;VXMY8H)T6\<Y%B
MD>U&OV;?%4$G)[ 9ZQ[5G-?,WN+N[;$7EO(EGD)K>6.VF59[9:1RN:C7;$7U
MJ@G<S_M68S)9GD'JW&XBSGR&1G^+NIM+2)\\S^#)VKW<+(T5RT:BN6B;D!".
M,ORQU;K;L;X'1^*M)8=4V5G:WB8FY:ZWFE=:S.>^!6R(BH]6JJM1V]R(FS>#
MM6_ECVFOU+T3@N7NH>6FJ6:PP-E%C&V&.QW%'/Y(UL39%25\<K7OHBR)U3O&
M7>M0M&&Y3'<X<OVC>7W-?7VE+K%XO)7<$-ECK1DM\[%V$+^J8EV^-BMC573K
M,_B5%2KJM;2B!)7;:T7J?46EM+:CTUC)\L[360EFOK:T8Z:5L-PUBI)U;$5R
MM1T2(Y6^MK5=E50D/#F1S!S'/+LQ:YN;#1^5Q&7BNL=:0X>6*2XN)T9?6,SI
M(D;$QSFI5Z+1NSAJO>':S&QY5OYC]EG <N\JU^,RTN"L/)W74;F/M;^U8R2/
MK&.3B:G$W@D2E>%5Z0=J,^7W/C6_(W3UMRVYP:"SD]Q@F)8X;+XJ!MQ#<VT?
MBPLXG.9&Y&^*QKXWKXM$5O$BU+1SA]-\QNTIS@T]S&U?IRXTIRNTB]L^'Q^1
M167-U)%(DJ48YK7.661C%D=PHQ&-X45R[5&YD//G 9[(]HWDWE,?B[N[QEC<
M1+?7MO;RRP0(EXURK+(QJM9LV^,H2&T@1J=V%-.Z@T[I/5D.H,5>8J:;(V[X
M8[^WEM7/:D"HJM25K55$7N!J6V(9       % Q/F#KW"\NM.RZCSCJ6<;VQT
M1415<[<B;%[@$8)VH=-/Q:YN/#W;L4B*Y;JKDCX>[7@H!9T[7^CIG-;!;I5R
MM1OVQU5XEHB4X-]5 N62[1<]A':R7&)\E;?R^3V#Y8Y5ZR5-JHU:(BJJ;: 4
MUUSZSD63M\1):=3D;UCI+6V\FDZQS(][D3;X0*=><.J;S*2X:-;E,K"QDLEG
M%;HV5C)-C7*U&5HX"QS<[+FZRRX23)7*Y9)?)_(DXVR=;]!P-1-H%3<:QS#,
MI;X:YCN_C.\8Z:UM7LDZV5C-[D1%KL[P"#4&4N\K=8&UM+E^:M8F375FV)ZS
M1LF7Q7.:Y:^-PKO [6.9RV3GR%O864]Q+BYEM\BR*)Z);RM9QJQR(M$HFWT0
M+?A]:MU#>/QV$1][?M:Z1]O U7.3JW(QRT;MHBJE0*RTS^1R%]>XZSM;B>_Q
MSDCO[>.->MA<J51'=*5[X'C8ZKNLG83Y6QCEN+"UZU+BYCC<Z./J/XQ%V[*;
M@/-NM%APJZDC8]N"1J/??<+EAX7K1JJM>Z!Z8GF1=9-D\N)GN+AMDJ,N'1K(
M_JW*WC1JT795JU+"3%7M;<U;ZYQTF5MKJYGQD2NZR=Z.EB18UHY'<:+P\*E3
ME><W-&W2PCRU[:6UQC)J.9<SV43V/1VZB\&VHYJ'*\+;G-IJVEXV8K&HZNYM
MG''3P*UE1SG*OL':)P$&R:Q:YB>P1\C&I];P[!6IN7*W[4&F(6HQV.5K$Z&2
MK3;MZ8Z@547:CT>^5D;K.5B.5&JO6(M.):?0H14WVMW#=V,%[ O%#<QMEC6M
M:MD3B3YY%62M,A?-[B,^<H$6<X8^+0^HOR.;[$W ^>5Q Y)*]\S(]K9TK7(R
MJ(CJ-J[HJN\@EJST-@DM[=TN6OI+N:-'\5O8];!56-6BR<:(B-K1=@&&92/X
MMR$]A'.ERRW<K4F8G"CD3;54[P&1Z>TYBLKB_C+)9&X8YSG,2"QM'74C>!W#
MXWC)0"R:TPEM@9[=EA>27<-TUST9/$L-Q%U;^#QT550#"I$>]P%[TI&YF7M:
M^^M ^@.A+WJ(+2!5V/@:M/0-"\<SVK#B,9JZV\6[T_=Q3*[_ #,CDCD3TE0"
M2[2=MU;17#/62L:]O@<B*9'L
M
M
M                        $!\_\/SJQ^?TUS&Y2W5WD[7"_:L[HR*XDC@O
M84EZQ']0CD9(JHKHWT3K$3A5M=M"PQ/)=I7G!G\=+A=%\EM06.KKABPI<9**
M9+2SED2C7N5]O$CJ;TZQT:=W9L!1('9GY/9'D]H*6PU!,V?56:NG9+,+&_K&
M1/<QK&0H_P!DK$2KG=+G.HJI102F@(
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MF\U!9WZ)#>-MN#JW^R<Y[6M<RO=4DR)%TRU[-/8QDGKVVT2.\/ AAI=0
M
M
M
M                                                  !PY41JJNQ
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ME;=9[(1_Q2-C=5($7<ZKMJD$VV#V26<$C$X6.8U6M[B42@54
M
M
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MZ>8&L]/]I+E=I/#9FXLM.9GR/XTQT2HD,_67TD;N-%15VM1$"PV>"
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M88FPL2C&(C6IWD0#T
M
M
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MTCD4#T_5W$HB-\F21/I_&^>J 54&-L;9/M-M&WHJC:>J!5HB)2FQ$V(G0!R
M
M
M
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MVTJ?6M Z+HS,*FRVE]%&@=5T5FU2J6TE/J6@=%T/G%3_ '9_HM0#HNA<\O\
MW=WHM0#S70>?_%W>U0#HN@\^FU85:G?V?P >3M#9FJU8E?04#UM^7&HKU49;
M6KYG*O"B,8B[T[P&[G*#&YK$<O\ $XS/,<R^MH^!6N2CD;Q+1/2 SL   UI[
M46L<CB;K3^ QW&]EQUUU<01JM7]4K4;6G0E5V&[7%DNV(.NN9N4?%2^MYV(C
M>%53B1BHG0J4W)T'-#K1<R#L\:_N+3FA#C;9[H\1FVOCN;9:I'UR)Q,>U%6B
M+L5%0S=#=E]9;S;%3:<$NW#D
M
M
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M;M;_ &D<XFH=/6&5=XK[B%CI$[CDW_-.M,;7=NM7XRP
M
M
M
M             B72_)+]6^>&J><WQ[Y5^LMBMA\2>2=7U%5M%X_*.O=Q_P"Z
M[NJ;Z[?LVEJEH(
M            /*>+K89(Z^O:K?30#2S"YV]Y:ZVU!A+]%AG\KEF8KMB/CE>K
MFJGH*<T.OS4EX<S=56^;Q\US"].-6JJHBUZ"N.ZZJQ\E;G'8Z*6_NW(B,1SN
M#V3G]"4[IN9,<MT- 8Z3%:1Q5O.Q6W#X&SS-[CYOMBI];7A.O+N<S*S(
M
M
M
M
M                           !&?,[DOIKF4QMS=H^RS4**EOD;?9(B+T/
M3<Y/";B6+K:H(O.R-K5\KH+?4]N^Q<M%62)R/X? BT-<T..,:3N679KP&AI(
M\AEKM^9R43D?&QZ<%NQR=*,1=J]]23<Y+;(A.*LHU$:E*)1$3<B'%+4O0J@
M
M
M
M
M
;                                 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>tm2225088d1-pht_tech4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2225088d1-pht_tech4c.jpg
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M@DS=)-[RG',.IFW,^//M:5]UKVM<&U'#PQM/Z)2:KB'KMN/:#FVO6+9=[@F
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M3.C/_$\G_L&?IUQ^Y^[7UM[9\Y3&N Z8@(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(.5;SUA"UZROV-]#0'8<.99@)MS
M>8_4VX/X)S^7EZ6S ]OXL:D3HZJ1 @(""/\ IWU>VQU/R^Z,;M=EP^WVM<0V
M5U>SL\IDT\IE#O*8?%I;Y5-3P">ZG$DL5!U*WC)URN>FC]KR-V;#9"ZCW1Y=
MQY;IC R7R]>GRO><6^]7@@E5$" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(""$=C=#LKM/KQO#J[<96WN,=N6UGM8,;'&]L\3IY[64%SCX2 +<CAWH
MG5-R(:%UFV7N'J)T\RVR]MY*#$W>8$<%S>W#7O:VU#P^5C0SC5X;H/Z$E$PK
M](^GMMTLZ>839$$K+B7'0DWEU&TL;-=3/,LSP#4T+G$-K]K1$-V00'L'H!F>
MG?6_<747!9BU9L[<GQ!N\#Y<@F:;DB?PGBSP3@Z>YA(]B)U9+K=Z<-M=89[7
M/P7TNW-\X]K6V>>LVZBYL9U,;,P.87:#Q8YKVN;WD<$(E'7]CWK#%J,".KUC
M]!TTF\(D^D:>[^-^#\ZNGC7XGG]5#@D;HAZ<MO='IKO/W-_-N/?>2:YE_GKL
M:2&R.#WLA87/(UN +WO>YSJ<P."$RS76KH;M/K;@X,=G726.6L"Y^*S-L&NG
M@,@&ICFNX/C=0:F5'(4(*$2A:UZ&^K;;4,>(VMU<LY\)$=$3LBZ<SLB% T-$
MMK=D4'VHEH.Q$ZPW#I9Z8Y]N[QCZF]4MSS[WW]"*V4LVLVMJX M#FF5SG2%H
M/X/@QK.QM0""-71"(6>6Q.-SN,O,+F+9EYBK^%]M>6DHU1RPRM+7-<.X@H.4
MY/2?U*Z?Y2[O>@W4>7!XV[<9'8C)F01!]/"'NC9-'+3D'/@U =Z+:OK_ $R]
M<.HDEO9=;NJ'QNVH9&RS8G#ZW-G+'5 .N&UC:[N>Z*0CN0U=-XS9VVL1M.'8
M]CCHF;6@LSC6XUPUQNM7,+',?JJ7:P3K+N+B23Q**N=;/TY=7^EV3R!Z"]0(
M,;M?(RF<[?ST1GA@>XT.AQBN X@ #S QCR  XNI5$ZL[T\]-V=@W]%U6ZR[J
M.\MZV=/HR&*/RK&U>RNA[11@.@DEC&1,8UWBH7<AJV/JWT6RG4;J)TXWK992
MWLK79&0CO[JUF8]\EPV.[M[C2PMX TA(X]Z&K.=:>BNVNM6W(L/F97V&5L7F
M?#YF!H?-:RNH'>$EH>QX ULJ*T!!! *$2B5W2+U;/Q)VF[JSCSMXL^'.2,#S
MEC :M(,IM_,K3CK^(U_HD."6^BW1C;G13;$F"PLK[[(7L@N,OEYVADMU,T4;
MX 7!C& D,94TJ22224)E'&Z?3AN_![YR'47H+NV/:.6S+B_,86\A\W&SR/<7
MO<!IE #G'5H,+M))+'-Y(:O&W?3GOC<N]\7O_K[O"+=5[@GMEP^!Q\/E8V*9
MCFO:YU60@M#F@EHA!>0W6X@:2-6?]0?07+]6;S;>YMI9YNWMX[7D>^QNI&OT
M/#GLD8?,CJ]CHWLU-(:[F>"$2QV]^AW4GJ1T4L.GN\=UV=[O*WR8R%SG71.\
MF2)AFT1Z6,C-6B4-KI[$-4F[FZ7[?WQTXBZ<[M8;G'BTMK<W$!\N:*XM6-:R
M>%S@=+FD5%001P<""00A##]$?4[L3'#:.P^J>.=LZ&L=B[)VFJ\MH37PQ!\%
MS0"M /-H/M0U#6$A=$_3[BNDUSD=S9/*3;FZ@YL$97/W0TFDCQ)(R)I<YP#W
M@%[GN+G$#ER0F7S,]%LID_43M[K5'E+>/%X;'R6$N+<QYN)'/MKN#4UX\(%;
MD'YD-4C[ZV_-NW9&Y=JV\S;>XSN*OL9%<2 N9&^]MWP->X#B0TOJ:(AK'0SI
MM?=)NG&.V1D;Z+(W5E+=2ONK=KF1N%S.^4 !_'@'41,I&1 @(" @(" @(" @
M(" @(" @(" @YMZR>G7?._.JECU.V7NVWVWD,=8PV=K(Z*1\\<D9FU/:YO"A
M;+1$Q+%?V'^J;_ZU_P#WJ3]2AK#/[(Z2>H?![LQ.6W3U7^FMO6DXDR&*\N1O
MQ$0!!94MIS0>^JWIXW)G>H]MU@Z4[H9M??C&1PWHNHS+:W CC$ >2 _CY0$;
MF.C<UP ]T\2-5C+T'ZQ=2(&8[KIU$CO=LLH^3;VW+=MK#<3-\3#-/Y4#G-:Z
MATEAY C2>*&K:.BO17.]+NE^>Z=Y/*VN1?DYKR:SO;>.2-L8O;9D&E[7<3I<
MS54'MIV(3+*^GOI-D>C.PY-H9/(PY.Y?D)[\7-LQ\;-,S(F!M'\:CRT)8_K9
MT6RG53=/3S<&/REOCX=EY"6_NH9V/>ZX;)-9RAK"W@"!;$<>]")3,B'#?IQZ
M9X7(>I3?6Y<'^&V7LJ^OF8=U/P(OKZ22%C(QQ:YL<;9J.'=&[M"+2[D15@=[
M8O-9S:.:PNW+R/'YO(V<UI9W\P<YD#YVF/S*-XDM!+F^VB#1_3]T<9T4V,[;
M4UW%D,O=W<U]D;Z!CF,>]](XVM#JFC8V-Y]M43,I61" \ET S-OZA;3K;M3,
M6N/LYA&,YB98Y"ZXU1&VN-);X?'&&/%1^,%3WHG5A]Q>G#>^WM^93J#T'WE'
MM2\SKS-F,)?0^=822N>7O(\,HTN<YS@QT7@).AP!H!JM[7TY]2]_[DQ&>]0F
M];;<.+P<HN+/;6(@\FR?+X3^$?Y5OX26T=^"+G-X:FA#5OG7+H/8]7XL3EL?
ME9=N;YV])YV%SUNTN<SQ"0,>&N8Z@>T/8YKM3'<1S((B4>Y#I#ZK]T8V7:>Z
M.J>*BVM=1_"WUS8V8^/FMW@M>UVFV@/$<#28:@3J/>.":-D])=G[(Z=,Z96E
MK\;MV2":#)-NJ.?>.NP1.^733B^M.'NB@'(((2QWIVZU=+KR]MNAO46WLMIW
MLKIVX3/0F9MNYY .@^3<-+@T>^UC"Z@#N]#5L73/TX9;%;\_M8ZM[G.\M_1"
MEAHC,5E:G26!S&D-J6@NT-;&QC*DANJA U9;K3Z?G]1<]B=_[-STFTNI&$:(
M[7+1,+XYH6EQ:R4-+2"W6X!XK5I+7-<*:1$M)S'1+U,]0K$[5ZD=3\:S9TQ8
MV_CP]F!=74;"UU'TM[6E2#P\PM[2T\D-4J[CZ#;%W!TF@Z/^3):;>L(F#%7+
M"'W-O=1:G-N:D .>YSWF3@ [6X<*H:HKQ?2'U8[5QD.U=M=5,5-MNV9\/:7-
M_::KZ&W: UC6>9;7!X#@ Z8Z1[I0X)+Z(=#L?T@L\I>W63EW!O/<,OQ.>SUP
MTL=*_4YX:QI<\ANI[G.+G%SW&I[ !,K+HGT6RG2O=/4/<&0REOD(=Z9"*_M8
M8&/8ZW;'->2EKR[@21<@<.Y"9.O'1;*=7;[9=WCLI;XUNU\@^_N&W#'O,S7N
MA=I9HY'\$>?>A$I6SN/?EL)DL5&\1R7UK/:LD<*M:Z:-S 2!V"J(1QZ?NDE]
MT<V#-LW+7\&5FFO[B],\#',C+)XXF:"U_'[0U1,HVNO33U!Z?[FR6XO3SO6'
M;5AEG&2ZVUE(C-8-?Q(#3Y<X+020RL6M@X!Q0U7.WO33O'<>^<=U Z][P9NV
M_P ,]LF*PUE%Y./8^-VMA<-$0TAP#BQL0UD#6YPX$:MQZ\=%LIU=OMEW>.RE
MOC6[7R#[^X;<,>\S->Z%VEFCD?P1Y]Z$2F9$(9Z#]%LITBOMZ7>1REODF[HR
M#+^W;;L>PPM8Z9VE^OF?PHY=R)F6A[N]-G4VTZIYKJ3T@WS#MM^XR7Y.WN8G
M%S72:3*  R5DH<]OF#4UI:32O:AJZA;JTMUTUT&JG*O;1$/J @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.=?6%
M_0?!?SJ/XM*N]V;^K;U?K=#9>]/J<:+UCKB":_2O_>U;?O&[_2A<CNW]"?7#
M3WG]->^LW<G6K8>XK#<.'RUE_9[>%D-N'VC9),;(YL4<AG+8WO=&^0:P\5/B
MT4Y:O/[.]ZQ,QRX/-YJUM,1/-'L&+]3=U!%<VVY]L2V\S&R12L9*6N8\5:X$
M6?$$%=B*YI\8_3Y&AKB\I5/H3U0_UDVU^MR__!ITYO./T^0UQ>4NL.A+;UDE
MRS)/9+D6V4 NY(N$;I@0'EO!O NK3@%I=RUZ*ZLVT]Z4UK@ND(" @(" @("
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M:7TFDE< &,U.)>A**<;ULZ^=;+[(W'0O;^-Q.Q\?,ZVCW!N N,ES(RAHUH)
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M1R:!Q)J2&^H@0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M @(" @(" @(" @(" @(" @Y?Z+=,]^7_ %YWOUGZD8:7$NG#K?;5M<R0RO\
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MTLM;6SA@@:27$1Q$-:*GB> 6EW*-*5AFVDZVE-2X+I" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#5-T=2MD;
M+N8[+<N6997<S/,C@$4T[]%:5(AC>0/E6:N&UHZO#SF8CZV*<E8GIXS/E$3/
MU+_;.\-M[QM)+[;609?VT3M$KFM?&YKN="V1K7#ZBK?':G/Q33)6W)G%C9!
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M50/.C/)P0/-CK34*HG23S8^'B''@/F0T/-CI74*5I\Z(/.CK34*CFB='E]S
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MQO&MOX8X:0Y/=]SBR[SX^'2,=M*^75/'6T.WFN#@'--6D5!'(@K$QOJ @("
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MF5A(;(?"6N -._A19(QS'BU\W<,5HTBJ?H@2:GB * ^R@65P9YJJD$! 0$!
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M (" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M[]O7+V&/W8]3)+$N(" @(" @(" @(" @C;8/].]^_OFU_8BB4DH@0$! 0$!
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M^<IC7 =,0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MTYKCS2)GFRPVC;VYH-R;F;/;P2PB&T<US9FZ#4NKP3IT7;V$0(" @(" @("
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M" @(" @(" @(" @(" @(" @(" @(" @(" @(-7ZBW>2L=D9R[Q <[(Q6DKH
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MS!JVI$B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M:_X%DA&DE\9:]SZ :B6DCBKSF]F:Q$<5IKK"PQFQMY9J*USFW,L;"&.VFQ\
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MZX,$+X0WXD.$,KZ-XAA%=1HLGPY:']TR<M(_3Y2RARN*L[K&1OM'6<TS8()
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MS\&YC[9]N^]\QCHVODGI(X&H^T/(56*MM&]N<G52U8CG#>LWNJ]GD9<7\-K
M_'L#2Z.2X+?PS:?ZOLHLU[1$:O/6[9,],QX_IY-.R6_[_ W$7PMI%?07T$D;
M]4TC=(]AT+M[#9_BJZ1PEYW\R;B.UUB^G5,1R\^7J:K-UEM(0[XG#148UMHT
M/N9#01 \1^"'%=F.R3CM6)G777].3R'_ .MMDO/\O37T?_R9K%;VR-]@Q(Z"
MVM[7(/D$ \V9S]+:<:Z:57Q[O??IVN\R8:5XUT^F/XH?7.R7MGVM<EN7[96L
M.?BNLM9@NB?>NDCCC;KE  #@#S:T=BT=OWS+ES1,QPX?7_$Z^\TZ'5+3( >
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MAM[E;[(3V_8W1"YNHN)Y<^"I\'AK!$L?D-]XW<U[87\)\NTQ>5G@,AX!\43
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M=QF;Q.X,]:9'#W4=[926;S'<1&K322G>JS682VT*H(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @X*ZH_WC
M;H_G*Y_9"OH^Q_T]/X8>4W/]6WK=1^GK^ZS%_P"VN_XP]>/[O_J;?)]3N['^
MC'RI27(;R*_4G_<5OK^;'_IV(F$'=&O5ET@V3TOVOM3.W-^S+XJR;;W;8;-\
MD8D#G'PN!XCBB9AK/J7]2_2_JCTON-J;4N+V3+R7MK<-;<6KH8_+A<2[Q$GC
MQ0B'9.U[NVL-B86^O)6PV=MB+6:XF>:-9'';-<YQ/< *HJY4Z7[!EZ_[7ZR]
M1LU#IN]_S28W:YF]Z"#&%LML:D^Z)66['<1^)*+)8])F_P";>G2:RQ63<1N/
M:$AP.3BDX2:;8#X=Q'/\5IC)/-S'(B4ZH@0<L=#_ /S3=:__ &7[(U$SR='[
MKS\>U=M97<<EK/?-QEK+="RM&.DN)W1M);%&UH)+GFC1P[40@#;L_JRZDX*+
M>5GG,%LBSR3738S;\U@^XG;#4B,W#YHY'-<ZE>'8:Z1[J)X-BZ ]7MW[QO=Y
M;*ZFVEK9[QV-<,@O[VS!CM9X7F1OF4<2!0Q%VH4:YKFD <4):CMWJ)UZZ\Y#
M+YSI1?8O9_3C&W4EAC<ADK;XR[R$D="7ECVO#10M<:!NFNFKR#0/>R^L?61W
M7O#='>H=GCK-\5E=29*?'L+H<@&02S6]U Y_B8UP :YGW33[ON@:.H$0(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("""/4!U"P3<$_:%AE6?
M2EQ<1,R$$))<V &K@7-X#EQ%5VNV[>9R1:T<'([AN(BDUK/%SME\?BF64;XV
MLB=K8&/;0%S7. /'MX<5ZO+6(J\ICF;6TGDS&?P^VL"6Y'I]FCN2U#3'DHYH
MW17$3FFH>&Z02SO(Y+G;;/>.%Z]+?S;3%%=,4\&FS.M\Q*\WMPR.61CBW4UQ
M8:-(;$ !]L>%>2V<M^$SIJQ8J<=.3:8.B5EB,')E<<8;;(/C^(F@AB8QCA35
MQ<!4E?$MO_U(Q3W'\-&&(QS;HZOWM==.7+F^@9?RODG;?$G),VB-=/! 6^=Z
MW-FZRP$F';F+^^&HV4A<^+0#0<!6J^J[C-7'I2*1,V\'E,&&<FMYO,17Q3UT
M Z?[<WK9_16;RD^VLBP1? XD.8XR-?J+XVN<:>&@#6@UHFXO..E9Z(GU^"<%
M8R7M'7,>KQ=M[7VOB-GX:#!X2'R;*"IXFKGO/O.<3S)7G\N6V2W59WL>.*5T
MAF5B9! 0$! 0$! 0$! 00!ZJ?^ ;?_?DW[$O2]B]^WJ<GN7NU];EQ>N<)^B&
MW?Z/XK]YV_[$U?,<WOV]<O88_=CU,DL2X@(" @(" @(" @(/CAJ:6]XIPYH(
MGZ6XBWP^\=^V=JZ:2+XRVD+KF1TS]3XW$\7<:>Q!+* @(" @(" @\R2,B8Z2
M0Z6-!+G'D $".1DK&R1G4QP!:X<B"@](/A('$F@0*H+4W-O(QTT0$QB)X-HX
MZAV#N*MI*-7N"Y$D$4SVF(R 48_@X$]BKI*5E,Z2R>Y[9'7#[F0-9#(_2UH'
M/2LO-#V^V=<B5[+R5C9=)&AS:-+.)#>"C706_G/CBN+N+S+MAD \J6E&Z.#B
MT4[**VFO!+[=Y6V8;-PT.-T[3$9"&N';X:]JB*RA5=>FPMYIKZ4O9'JD%&T=
MH'8 .)HL=?:GA&B9F(YJ\65LYVPECZ.G8)8F.\+BUWL*=,ZIF%E>Y)]G*Z4D
MO!BJRWT<20:'Q+)6NO K&L:K^">.9@FH!)I\1X:FU'+DJ6KHI%HE89*\LK62
M*^G;(\1^ EA):UIXZG )CTM,Q$QJO6-5*"6&W?/-YC!:W-'QNU>/4\<>9H/8
MK6X\-$VK,>#7]S9=^-QLMN[(7 BEB$4-W$ULCFRDD\7=M::3P6WM\?7;DQ9)
MZ*=4O>W<E\98VS(I7B2T@\JZ\W2UL3FMU-ET$<:D55<M>F?6M,3%IC2>#:[:
MSB>^.]<[S9C&!K^T/Z(--:+3MDGEHEZR$5L^.+XQY8T2M,9:XL)?QH#3GPJE
M9G4:=UC_ *&D=OQME_&&*LC?(?Q;?O1]A5@5%<$! 0$! 0$! 0$&/S.+MLO8
M2V=U[CVN ?0$M+FEM17M%5*8G2=6F/Z664Y+[G)SND<UK7.+8_$UO(<AR6*<
M<2Z%>X98A4L.FEKB;V.[L,I-%*&2,.ED8!#Z5KP]BM6L5Y,6;=Y,OO+EW3ZV
MD>V1][(][6M8'N8RM&N#P.1X \5DZFCIQUUE:-Z96[BYKLK<!K91(UH;'0%K
M0T=G<L<UB6[AW=\<:1]*E/TIQ[[=T1RD].):=,=03SI4*D8X;$]RRSY*DG2R
MPN*OGRD[WO:T.);']H !V=E$G'$E>Y9J\M%-G2NRAN&/ARMPP:"PM#8Z$'AW
M*?APK/<,LSJ]NZ48UP .3G(:-+?#'P K[/:H^'"\=SS0\V_2VT9$8/I>X,39
MGRL;ICX.<3[/:GPX8X[AEB=5.?I)C#&ZF3G#CVZ8R0:UJ*A(QQ#)/<\T^*XD
MZ6V,_BFRD[G.H22R/F!0=B3CB45[EFCE*K9=.X\==-EM<K.S\$Z(@,CH6OI4
M'A[%:*1#6W&ZOF]Y7/3RW)!=>O+FM# XL83I'9R5VK$Z+,=,K:2NO+7%!(7L
M:&Q@ GAPX*MJZMW%O<F.-(T6\O27&F(M&2F:1[KM,=6U->%0J3BB6:>Y99K-
M=(X^A7DZ5V$Y<^7*3N>ZA<=,="0.'8HG%$QHF.YY8B(X<&)R'0[!Y)\0FR=R
MQL0)8(PQO%W-=+:;J^VC2CA=WV].YS'Q_#RX,3)Z9MFRDF7(73R7:_%H(J13
MN70GO6XF8GAP]'[7%_\ S^UUUX_.REAT.P=I:16+<G<FW@<YT37-CX:N?&B\
M/W#LFWWNXMGR:Q>^FNG".#U.QSVVF*,>/W8\^*M'T2V];317;+Z=TL#Q(TTC
MK4&O<M?%^7MMCM%HFW#T_L;F7N.7)&DZ)-+2T&C^/#B>ZG_,O13'"(AS8YZH
M5Z[9EM]-@]@,FT1Y27XS+2#[6PMO$ZOWQ%%T]G--OCON+?N1]+7W&3IKZ&*V
MST]SF>RUSGXKZ3%8>Y:(K:%M6S.MHQH8.T"@"\;?;Y-QEM>W[WD\]M]ADRY;
M98MTULWR[Z6;2M+.6ZR4UY<,@8Z65\URZFEK:FO+L"VJ=LIIQFWSNS';,7IG
MURAOH1TVVG?8[<O43-6PBQF:R5P_$:W "*PMSY;:DC[9P=2BSYMMCB(ZIX59
MZ=OQ9)BM8F9;=?8O9DUK=2[=V[=7KF-=HN7T;;>&IKXB*A<#/>MN&*)]<\G:
MP_ES;XKQ;-DK3Y9U^I?>FB^NKW:^2,MO!#%#>&*&2!H:YX]XZJ?+0+I=KO;X
M<ZSKQ_5#>[SCP4R4KAO&2O1'&//6?.(3D%W(< 4C%[BR5QB,/=Y"UB$T\#-3
M(G'2"?:4&"W#<Q9G:KX)W!EQ=P0OFB8:E@EI4@^PE6C6.,#5(>@NS62MNFRW
M#;FE!('BHU  \*=M%FC=VCR4FD2Q."Z7X+=S[R3*S3F3#W<UK9R,(:X#4:R'
MAQ>>1=W*GQYUUA,5A]W#TPP>U;6RAQT\_D7MRV!\;B"!YAXN'(ZO:HMGF>:>
MF&5@Z#;+C<)X)[ACVEQ!:\%H)X.H*4XC@IG<6\2(AA\-TIVYO6UOCFS)*RSN
MYK%D9#=+F0NJ"X$&KB35Q[5,;K3W5IK5\S_2_ [;^!M<?)*V#)7#8)X_"T 4
MTAPT@<0%6VXF?>F5:8]&;BZ";0M)'75M-<QSAA:"UP%&CC0<*#BIC<6TTB43
M366&VYTOP&[K.?(Y2:?S[6YFLX3&X,I'#1M?E=3Q'M41EFG"4S6'K-]+\%@9
M,3B;*>8662F\B1CB/ VE:M]I[5$WM/&#IA?CT\[#M+LY.'S8<C4/9=-+6RB0
M TTFG K/DW5[4Z91TPQFW.DFVM[XIN8S)D-QYCX6AA  9"XL%!Q(K3CQ6/#N
M+4KI!TPN<[TZQ.)O\/A;>YN'V&0E,<C"6^!M.3.5*J+YIGF=,,D_H/M*/R9V
M7-T)K($V3R\?@>_1W5Y*(SSR6Z=6(V]TGVWO#$Q9S+ND?=2R.JP:=#3;O=&P
MM:0:$!6P;B^.TZ3P1T/&7Z9X.PS&.P,$\SK+*O<;@%PJ".9;2E*]JK.6TVUM
MS1TLN>A>TL5#/>V,US%/'&YP>' .\#20!PX#Y%-MS>.6B>F&+PG2+;.],1;9
MW-NE-Y<!P<V,@- :X@ >SV*]=UT\O$T;9L_8^(V-GFX_#OD-K+:N>&/II9XJ
M4:!0+%;)UIT2(.2H/J @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(."NJ/\ >-NC^<KG]D*^C['_ $]/X8>4
MW/\ 5MZW4?IZ_NLQ?^VN_P",/7C^[_ZFWR?4[NQ_HQ\J4ER&\BOU)_W%;Z_F
MQ_Z=B)A:>G'%8N;H=L>6:RMY)7XUA<]\3'.)UOYDA"6D^M7&XZUZ'7<MM:0P
MR_25B-<<;&.H7N[0 A"EZB][W&V?3OA-MXG5)N+>UIC\%8P1#5(Z&:!AN*#M
MU,_ _+($(>]I>G;K/M#;F/V[@>MDN)Q=E&1#CH-OVLL4+I7&61K7ON=3O&]Q
MU'GS0U:+T[L,_P"GKU-?DENK.?3F,ZG6QN'YHVS;".;*22R/C<Z)CY&M?YOF
M14:[CYS30=A/@[1140<L=#__ #3=:_\ V7[(U$SR39UFW_+TNZ9;AWU;VS;R
M[Q4,?PMO)41NN+J>.VB+Z$'2U\K7. () 0A#FS.G/6WJGM?$[TW=UBR&)M=P
MVL.2AP^V[:.R$%M=QB2-@N(W,.H,<*^ Z3]LX\4&B>GC#6UUO#U ;<VKE;G+
MLDM3C<=F;Z<7-S<S4O(!.^8!H>72>+6.!'%$RD[T5Y2RGZ,Q;?#PS,X'(WUM
ME;)_AFADDF=*W6P\0"'4J>T$=B(EALWN#$9GUO[4L,9*R>YPNW[JQR4L9#M%
MPZ*\G\DT[6,D:3QYNIS"'@ZD1 @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @L\L+@XN]%I^ZS!*(*?ZS0=/UU:NFL:JVY3HX6C-K''=,R=!?"
M23XX2_C/,U&M:\5]#PS7HC1X'-%^N=68O-APXS86WMXW%M*!>WDS;Q\A)8V$
M_N?P]@/:N9BW$6W$TF>$.EEV\UV\7B.,K3'9FQPFX\-E86&66SN8Y9F6[=;C
M;<I&D#G5IY%;._MCC%,6F*Z^?!J[&+QDB8B9;#897;6:;NN_OM$<UW<3R-$C
M0R1MN1^"#1V$#N7PK\W5[E'<MK;;]5L<=.FGN]75[6OHTT?2.SVVMMMFC)I%
MN.NO/3P;)M;I?U(W5MVS$V4@LL!>1G0]S7&Z$7$-!' <0O5__G>U8MW^)^'/
MQ===-?9ZO4YE=]O,F'X75'1].B/MR^DG=^-PU[D;&:&[R=O'+':R1.+[@1R'
M42*@<NY>NC=XK\.,3IS\G&G:Y:\><>3E7,Q[EZ*60-Z)9-T9&XDI-,7TABBT
MD4%007:NQ8[6MML>NO5-I^1>*QN+Z:=,5=C>B3K#N3?<-_@\X]\T4$9EB>\E
MP:YA -">-#5:N:8R8_B::3KHVL,3CR=&NL::NR%SF^(" @(" @(" @("" /5
M3_P#;_[\F_8EZ7L7OV]3D]R]VOK<N+USA/T0V[_1_%?O.W_8FKYCF]^WKE[#
M'[L>IDEB7$! 0$! 0$! 0$!!\<"00#0D<#W((JZ76EW9[RWY#>WCKZ;XNW=Y
M\C6L=I,;B&^'L")2LB! 0$! 0$!!Y>QLC2QX#FG@014$?(@,8V-H8P!K1P
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M!Y%:K,(" @(" @(" @(" @L\H*XR^K_J9/K,*"*O3+QZ56M?^NWO[,4$PH"
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MUUA 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MWMA;37<39LA%,+%A<"92V)SCIIW!5C#KX)ZFO].LKCH-N8S%374;,A)%+.R
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MCO;R-U_9QPQ6[]5DY[@'F45'#V4*S1,Q'"35?.@=#)':V\$8LG!WF\=-"1V
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M @(" @(" @(" @(" @(" @(" @(" @(" @(" @((%].]+3<_5?# BEEN.5P
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M:W1LX"I+22""N%>LQ/'CJW8V6:9UT6S[N?>N8&%L(C;;>LI/,N)^;+B?W@P
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M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MG@"L^##;+>*UYRQY,D4KK+@;<>YLUU"W-=;SW$?VQ<'386@),=M;-)T,97L
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MS>W[V._Q=TW5%<0FH]K7 T+7#M:X CM7CLF.V.W3:-)=ZMXM&L<F36-80$!
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MG..KUN??>9+>.GJ:5M[:6^NJ>9=#B(+S.WY(^*R-U(]\40=VRSRD@=]"ZI[
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M&9'10,,DK@.QK1Q)0<S=1^J^_,9E\B;2]BQ&&NK:QN,5-+%IG@CF\PN\X/\
M=>XM#:(ET)L/+7N<VAA<OD!^W;RU9+.:4JXCBZG96B(7NY,U%M[#7.5FAFG9
M .,5M&9I23P%&CB4$,]".HNZ-W;OW7B,Y*9[.S;'<V[!'&QML97O:(O 3S:
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M2[E=/=S8VW;<3R$N?)+$P1O<YQ))<7-))[UK;ND4S6B/-FP6ZL<3Z&Y+59A
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M6_\ C>C6"C)J^SDO+9Y^2ZD>WL')KVA>*[G73<6].GU/0;.=<4)=7,;@@("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @@7K92RZN]',
MEV2Y*XLW$CP@R26K&BH[3YAI\B[.RXX,L>C[7/W'#)2?2GI<9T! 0$! 0$!
M0$! 0$! 0$!!'W4[K#M+I=8Z\O-\5FIFZK+#6Y!N)>P.=S$;*_;N^8./!;NU
MV>3//#EYM?-GKCCCS<4=0^JV\^J%X9,_=&WPS'Z[3"VQ++:,#D7#F]X'V[ZG
MNH."]EM=CCP1PCCY^+@YMQ;)/'DTQK6L%&B@70:R[Q&(R^X\K;8';UG)?YB[
M=H@MHA4UI4DD\  .))- .)6'+EKCK-K3I$+TI-ITAVMT:]/F$Z=QPYS/"++;
MT< [XDC5;V9/-MN' >+OE(KW:16OC-[W&V:>FO"OU^MWMOM8Q\9XRFI<EO"
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ME5):T<:"O?PXI"'T<3P^=-!]4C0.L?\ 0T_OZR_C#$&^0_BF?(/L(/: @("
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M+83_ "Y];H)<1T1 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$!! OJ2_:F0Z:9L5!L-R6]'CBX:G1R< >!_%+L]MXQDKYU<_=\)I/I3
MTN,Z @(" @(" @(" @(" @(""!>MWJ'LMC&;:VT#'D-XD%EQ-PDM[ D?;]CY
M1V,Y-^V^Y/:V/;IS>U?A7Z_V.?N=W%.%>?U.-+Z]R&7R%QE\S=27V5NGF2XN
MIW%[W./>2O8X\=:1I$:0X5K3:=94ED57^!P&:W;FK7;FW+5UYE[QVF.-O)K>
M;GO=R:UHXN<> "P9LU<59M:=(ADI2;SI#O+I#T>P?2O#".(,O=S7;1]*9<M\
M3CS\J*O%L33V?;'B>P#PV\WEMQ;RKX0]%@P1BCTI)6@V1 0$! 0$! 0$! 0$
M! 0$%AFL)B=Q8VXP^<LXK_&73=$]K.T/8X<P?80>((X@\0KTO:D]59TE6U8M
M&DN..KG03,]-WS[DV@)<KLJIDNK0^.YL6UXEU.+XQ_K!Q ]_EJ/KMAW.,GLW
MX6^B?VN'N=G-.->7U(MMKF&[B$L+M33S':#W%>AB=7*F-%92" @MY89X[B#)
M8V=]GEK1[9;2[B<62,D8:M(<WB"#R/8L>3'%XTE:MIK.L.ONA?7.#J#;MVQN
M8LM-]6;#J;P8R^CC%3+$.0> *O8/OF^&H;X??["<$]5?=^IZ/:[F,D:3S^M-
MBY#>$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$$ >JG_@&W_WY-^Q+TO8O?MZ
MG)[E[M?6Y<7KG"?HAMW^C^*_>=O^Q-7S'-[]O7+V&/W8]3)+$N(" @("#DWI
MUZ?Y=V;[S^\]ZP.9M6/,7TN.QL@+3?/%R^CWCLA'_3^]Y^EW/</AXJTI[VD:
MSY</K<C%M>J\VMRU^=UA'''%&V*)H9$P!K&- :UK6B@  Y +S3KO2 @(""E)
MI( =[I!K\BD\4"=.L7B[#JWN/Z$>UM@RXJZ-CR]I>^(U)/R]BV9CV-7/R5_^
M53^&SH#ER6JZ"G/YGDO\FGFT\-> K\RF.8QUB^<7$PNWO#SH #S^"U<?Q:O;
M3P0\PQ7,D]_.R^,EM,-,<);PA>T4)![NU.'!,+JPM3:V38F2>;)Q/F.Y.<?S
M%6TZR+B'S2QOQ%/-XUT\E4>]([J#V>Q1K(PF2N;S&F:2TC==R._"Z9#1C6-Y
M@'G7V+-2L6GBE9VF1.Z-OS7+//Q37DMBF!TS#2?>;6A%:45[8_AY/-"VN,CB
M;>\M&YB5[7OA#(K>9A=4N-"XD</%0'V*\1;2=$6:KO3+X['7KSE+2".&VC<V
MQ9$]AFF!X$!I'"G-;VVI-H]F6&9T1ONB"/,W%W8W^8,=J+)K[!]I(+-LQ:?,
M:RXXD4!J.'-=7!'3$3%?'CKQ^9K9<FB![^XQ.;RVBXB>R\!(=DC,92^2O!ND
M #3V+T..DUCT>3C;C+;35F,9BK>R:Z;*@RVMP\,9Y%3&S3]V.1JF7+\.LVCG
M7P\7DNY;^(B:Q''TQJWR..SCC#;:)K2YK6$M&GP-Y CN'<OA_<.X[ZUYSQEF
ME?+JM'H\]%\&WVVD4Z(FT^.D>L9&QK!4G2VOB[>)[5QJ=.YBOL1_+F-;1'/6
M?WI\6UT_"UXS[7+]BG?&V;$]URT2#LB82TN(Y$$+Z=V6LX\LQ3%3IMQBT5Y?
M*\[O;UZ8FTZVC]V9^F&DW<#\[+,^^NY8K>U\AMS91MHT6VOQ%@^V</#5>[M$
MXXTX:_K>@[+CTI6?O1KZIX<$S=,]G7&2BN<!%=S#;)N(\A9WQ>X2^6!00%IK
M2G<O,;W<Q2>J?>TTT_6^@X::0EO#;<.(W)>7=A/*; QCXQDCM0,U *@4XU"X
M^7/%L<1/-LQS>[DNQ=I%%$WXFPEC?)%=W,CC<B2=_%@U$F@8J8XBW+AZD6CR
M9MMI=VPL,5#+,ZU:S6^[>XF0.::AKG$U->2Q3,3K.A#-QSQ7$#W1D2L +3[2
M!Q"P3&DK+:RNYYO,CFMG6SX3I <:L(/+21S5I@5"W(20.:960W.KPO:W4W37
MN/L5> HY.6\B@8VVFC@<YP;)+)5U-7 4]I=0*]-->*7V^QAR45O'-<R1O@D9
M*YT+G1ZS&0=+J$5:2.(58O$2,@UH;7VJFJ'I2- ZQ_T-/[^LOXPQ!OD/XIGR
M#["#V@(" @(" @A[KATIR75;(;1QL$PM,/8S7<V7OJ@OCB>V$-;&T^\]^DAO
M8.9[CU-CNXV\7GG,Z:-/<X)RS6/!)6V=LX39^$M=O[?M6V>+LVZ8HF\22?>>
M]W-SW'BYQXDK0RY;9+3:TZS+9I2*1I')EUB7$! 0$'EU>0_Y<"@L,*0;,N/O
M&64$]Y#R/S% JWU];V<>J9Y&HT:UO%SB1R 5H@6>*R-DRS,?G.!MQJD$PTOH
M\DUH?:DQHF84,=?V#LA<RB60&YHYHF&EGAIP:2HCBB./)I>2ZT=+[/=\6%N]
MPPQY2+\ 6ZAY0E>:!KG5I4+8C#>8UT;,;;+,:]/!M>>SN#;'#:7%V\.<YD[3
M;5-6^\VI'80L45F6'HMKR5<MNO;]GBFWMW>-;;7#2V,M-7FHXT'/@E:6F=(A
M,8[3RA3V[N3;]SAC<V=[YEO;5$CI321M>\'BHO28YEL=J\X>=OYS#37%U#;7
M;W2W$LDX;/PY<]->Q6FLPK-9A=#+8QV0$X<_7I\L24/E5KWJ.F55AN#,X1EY
M:175U(R6UE$NF&M.(Y/IV*U:S,+Q2T^#*9/(8V?'.;YI?'>,\!@XOTGM%%2.
M$HZ9?(\KC+;$E[[@M@A:&.,GO@T[1WIK,V(K,RQFV,EA=5R+6]?)(\^8]MP2
MT@#[FIY+)DZO):<=HYP\V.?P4V=>^.]D+Y3I8UX(B)Y4!/!5FLQ'%$TF#.YG
M"?2<#)[V2.2W-9&Q#4RM>3BHBLS'!$5F>3,23QW%_CYK=X='('D/;R(X*LPB
M8F.;, 4%%"!!\)H@TK>O46RV5D</97UC<SP9:=ML+N)E88GR$-:''O/8/E08
MP]9-IR;GRFT[J7X%UA'(#D;IS8;5\D;:O8'O(%17B$&']-<L4_3@S0/;)#)D
M\@YCV$%I!N7D$$<PB4PH@0$! 0<V^L[I;#OKI7?;@L;?5N/:S3DK26,4E,$0
MK*T.'&M '#Y$&T^ECJ&>H_1C;^6N91+E+"+Z+R1KJ=Y]J T%WM+:%!-(Y("#
M5]][ZP'3O 2;DW+,^'&Q/9$7Q,,CS)(=+0&CO/!!'O\ B@Z<_P#5<S_X;/\
MG(D_Q0=.O^J9FIY?]VS_ )R!_B@Z<_\ 5<SP_P#Z;/\ )W('^*#IS_U7,_\
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M_J=?MT^U,>AV$O(NX(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M<1-E=&Z)QYL=[PYJLQHA=*H("#0.L?\ 0T_OZR_C#$&^0_BF?(/L(/: @("
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MGGYFK9P[7+E]RLS^GFPWS4I[TZ(VRWJ:V'9.,>,MK[)O!X2,B;!$1\LK@_\
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M\EG[VZSV1=<YB"*06=F]NA@C(H9 >UWL6?=Y+Q'H;>^M>M4VXKIO)'F6.RI
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M+8;LQ+,OCVOCB<]\4D,M/,C?&:%K@TD5(H[GR*8<T9:]4&7%..VDLP2 "2:
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MN7NU];EQ>N<)^B&W?Z/XK]YV_P"Q-7S'-[]O7+V&/W8]3)+$N(" @(" @("
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M)<YC1Q:[4-)")9OTP7L.1Z7QW]OJ\BZR%]-'K&EVF2=SA4'B#Q03.B! 0$!
M04YHFSPR0O%62-+37N<*(.:?3,[\EM[=3>F<CC7&Y4Y&S:XT_ W7C) [JO"#
MIKY>: @(" @(" @(" @(" @(" @(" @(/A(:"YQHT<23P  0<2=?^L$_4;._
MD;M8S7.S\;*//=9M+W7]TPZ=?AYQ-/"/L)\7'PT]?V[9QAKUW]Z?HAPMUGG)
M/37DT.PVMOV_8UN)V7F)X0*,>VSG$=*5'B\LMY>U=>V]PUYVCYX:,;>\^$_,
MV*TZ-=;,@1\/M%T+3S==7%O#05I4B29A^H%K6[K@C][ZV:-EDGP9^S]-'6>]
MH9GXG&U[)[ASJ<*_Z&*9:UN]88Y:S\GVLL=OO/DV&S](^\9R/I3>-K; ^]\+
M;23T%>S4Z#L6K;OD>%9^=FCMT^,PV"T]'N'H/I;=^1NG4XF"&.W%:=@>Z;M6
MM;O5YY5CYV:.WU\9;#8^DOI3:D&Y=E,A0U/Q-VUM>/;Y$42UK=WSSY1\C+&Q
MQQYMFL/3QT<QVDP[7AE>*>.XGN;@D@<Z2RN'U M>W<=Q;][ZF6-KBCP2>N>V
MA 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!Q9U\W+-N#J+D+;
M4?@L-3'VT?&@,8K*ZG>9"X5[@%[WM6&,>")\;<?L>:WN3JRS'EP1@NLT4:;S
M>=R[\V[L^,%]G8N^ELG2A;1E=#7?,*?Y87,W'\S-7'X1QET,'L8K7\^$/&V)
M#M7J1FMJR'3C\T/I3&@T $CJN>UH^9X_R HP_P K/:GA;C!ECXF&M_&O"5]U
MBS%QC-GOMK0D3Y29ED2WWO+>USW@??!NCYUDW^2:X](YVG1794BV36?#BVG;
M6W[';.&ML38QAK8F#SI /%)*0-3W'M)/YRVL.*,=(K#5RY)O:9E2W9M>PW=A
MY,3?'RZN;)#<M:'/B>TUU-KWBK3["HSX8RUZ96PY9QVUAD\=:''V%K8F9]P;
M:)D/GRT,C_+:&ZG$=IIQ66E>FL1Y,=IUF91?BL?%U!W9NS*7-3BH+=^#Q\G
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M!$;GN#JN(^Z[EW=A_P!6<FVQ]%MM%N.O]28_Y)<W<_E.F:W5&28_RZ_KA+&
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M+V/NK*.P^W<Y:Y+(,B-P^&VD#R(P:$\/E0;8@(" @(" @(" @(" @(" @("
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MH%\KR;O-DQUQ6O::4]VLS/377C.D<HU>GKBI6TVB(B;<Y\95%J,H@(" @("
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M $AHHUH)-20%EQ8K9+16O.5+WBE9M/*'%/4K=.*WINZ[S^'L'V%O<M8US)'
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M_>GYSX=?*#\G=O\ \E6?\'B_4I\:_P!Z?G/AU\H9%K6L:&, :QH :T"@ '(
M+$N^H" @(" @(" @(" @(,/E=LX/.OBER^.@O)(6EL3IV!Y:'<Z5[T%N-E;6
MJ7_1%J)/*-N'>4W\26Z"SY-/A0>I=F;8FC\N3%6SF$M>6F,$%S!I:?F'!!:6
M/3G9..W _==C@K.WW(]FAV3CC G((I0N09R^Q5AD_*^/MXYS XNA,@U:'.:6
M$CY02$&-@V7M:V&B##VL<57>%L8 \;0UQ^<"B#Q%L;:4#7B'#6K0\M+@V-HK
MH=J'9V'B@V!H(Y_)_P Z"WO\=99.#X:_@9<0:@[RY1J;5IJ#3O""MY8:T-:
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M+])_D[:S@[7CUYWUM\\\/HT?/.[9(ON;:>'#YOVMA7LG($! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M<ETUVC>--2_$6+9"*4\R.!C'\B?MFE?.]U7IS7CTR]1AG7'7U-N6JS" @("
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M-&IV,NK2\H 2:&40$\.X3$KJ]JOTYXCSB6EO:ZXI]#AIIU-:[O *]T\Z]("
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M (KV&C;NWK72X\B/T+NQ?2>W[^NZQZQPM'./T\':PY8R1Z6P+ILP@(" @("
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M(F+<)3KALG%FL38Y>!CXX;^"*Y9%*TLD8)6!VEP-""*T*X&2DTM-9\)8IC1
MW6;/[PS^\+C:NQ<M=XUVU,/<9K+NL)I(72RT:]D+C&YM3HT%K3]T>"]!V_%B
MIBB^6L3UVBL:_6RTB(C64O\ 3O=<6]MF8C<C"#-=P 7;13P747X.9M.SQM-/
M91<;=X)PY;4\I^CP8[1I+WO??6W^G^&.:W#*]D+W^3;00L,DL\Q:7"-@'"I
M/%Q ]JC;;:^>W31$1,HFZ7[ZWINWK+EH]QQ7.(QWT&ZXL-O2R.$<,;KBV,4C
MX^ ,KFO<2]S0ZAIR78WFVQ8MK7HTM/5QM\D_0RVK$5X.H-CYI^$W':3:M-M<
M.%M=#L,<I J?O31WS+3[7N9P;BL^$\)^7]-4X+]-X21)ULZ0Q9@X&3>^%9E0
M[0Z$WT :)*TT&35H#Z\-.JM>Q?3G<T;TQ[)&-DC<'QO <Q[35I:>(((Y@HAZ
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M0EC<_.R'!Y*74!Y=K,_F.%(W%6QS[<:><*VCA+GCTFB6W@W3:O)\=VVY#3S
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MHN[F* OKI$KVLK3G340B%9KFN:'-(+2*@CB""@I7%U:VC0^ZGC@8XT:Z5[6
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M-0YU(E[Z+=),-ZBL1?\ 6/K2ZXS][FKRY@PV*;=W%O:6%G;O+ V,0/8X4>'
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M+MK.Y<Y[*8JV9:S9=T1A=.(JAA<UTDIJ&:6EQ>2XC4>=$5;(@(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MV?70/.=[/KH'G.]GUT#SG>SZZ!YSO9]= \YWL^N@],E+GAM.""JH2(" @("
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MNW7"UIQ6_P ?"/\ :XU^>8<'/V?/CXQ'5'H^SFDS8WJ\Z8;FNVX7=7Q.QMR
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M-O 7]E:V3/;Y=Q"2/K+UG:N.*\^7V2\'O*].2L>?ZDL9[3;=7-H3TH9L==P
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M>OQ=QCO_ ([1\VK";PLOHB_ML0^@ER^(P-N6GFYT60@X?47H.SQT;SJ\Z_\
M++S_ 'VWQ.WS'E:?^.$@]<]FY3.[VZ:WUA:27%I:9*..^=&TD1PZF/U/[A1J
M[&PW$8\62-><?J>3W-.J]);=OII@ZD]/Y1[KI+N$G[Z.H'UEH[6.K;WCU,F;
MA:JR]48__P!>]_\ MQQ_9HUSJMNTOQ^<WP-J>%/E[2KL3YJ+6.#>P'33L1DE
M^H'HI=(.AEBYQK^W)AI XD#3^>B'04I!)<ZA>>P=@1*D:5'#CWHAX=4CA4HE
M1<]S>''ZJ(4W34!+G.'SH+$Y/3)H;<AM./B=0($V7GA]Z[+&GD=7 _(LD<F.
M>:XQ^;F?<1B2?S8G4 *I*\-RBX/;^B%0JK+E0D0$!!SCUM]1EWA\N[I=T@@;
MG.I=Q6.ZNVZ9+/%C[8R$^%TK1S:[PL^VJ? =3=[O%M<4Y<MHK2O.9_3C/E$<
M99L6&V6T5K&LRT#I_P!)+;;=Y+NS=EX[<G4*_<9[_-79=+HE=S$/F5/ <-9\
M1[-(\*^!_F'\W9NX:XL6N/#_ +UOXO1_ACY=7N=AVNF#VK>U?Z(]7VI+7@7;
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!%6\^D]VW,Q]0.EM\=L=0K-QF;
M+;D1VUX3Q<V5M"W4_M)!:_D\&M1],_+OYSR;68P[J9OB\+<[5_[U?ICPUX5>
M>W_:*Y=;8^%O+PG[)_3TI@Z%^HFUZBW,NQ]Z6@V[U4QH++S%259%=^4T%TMM
MJ)XT\1CJ?#XFES:D?=,.:F6D7I,6K:-8F.4O$WI-)F)C283NLJ@@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(+>_OK7&6-UDKZ0165G%)<7,IY,BB:7O
M<?D )5JUFTQ$<Y1,Z1K+B_#^J#J79YF_R[K>',;9N[N66VQ-PUL<T%N7DMCB
MEB&K@*-\8?RY+UUNSX[4C3A.G/\ 8X4;^\6GQA/&R/4GTVW>8[2]NW;=S#O"
M;3*4BB+OT%P/P9'8-9:X]RX>?MF;'QB.J/1]CHX]WCOZ)2\Q[)&-DC<'QO <
MQ[35I:>(((Y@KEMUZ0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$ F@J@YZZ;VAS.2ZQ7P'F0WM]/9L?S\+(7M(^NH6TUX1XK'T9Q
MOBZ4W@D!K]+7<7'F/*#6_F+6BDQ-I\VMM\4X^J)^]/U0S?ITQC;&SWG,0 9M
MP7<5.TZ"#_Z2Q;.DTB8GS>E[K7H^'6?NUGYX:O@(V2;AQ&#/O6F[,E.6_>1,
M(_3+!6NEX]$RTN_Y*VW&*=?>B(^:KI:-S3J((X]OR+K::0YT3$SJYOWE',?4
M!A\=I(9?BWN_UC4%R+5F<LSYN/EI,[C7PEM^6=;_ .(C"!_XT860M'<1*MKA
M\>/X7M<<].PM,_O7CZFG]7XI7==MHV1;2/+Q68#A]U:7;W_6#EU>W^SER_\
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M-'O!IXB.0#4SYV\VE?H1X.82@B! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M_JEK?#;E>X9JQI$QIZH>ATAV*#7Z.]OXR3]4GPUX[GGCQCYH8=WIZZ4DW/\
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MO.?1IYO6=DV>O\VWA[OZY3&OBSUP@(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @((>R63FZ"=7L=U3Q[7-V/NB08W>EI$TEC'2&HN T<-51Y@//4'C
M[=??/R/WO\5M_P -DGV\4</33P_V>7JZ7B.\[/X=_B5Y6^O]OVNX(I8IXF30
MO;)#(T/CD80YKFN%001P((7TEYQ[0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M#7X<GB> :#"/]F5^JJ7B]8M6=8GB^96K,3I*?E=40$! 0$! 0$! 0$! 0$!
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M:$! 0$! 0$! 0$!!;'(6 OQBC=1?2;H3=-LM;?/,#7!ADT5U: XANJE*H+E
M0$!!J^[NHFR]ARXN#=N6CQDN:F-MBVR,E?YTS2T%H\MCZ<7M]ZG-!M" @("
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M2B-7+7JPZ9[8Z+W>TNJ72Z$;9SHR)ADM;)SF0.DCC,S)61UHP -,<C6^!S7
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M5L-_3/:/\\67\8C6IN_Z5O5/U,^#WX]</T<7S=ZP0$! 0$! 0$! 0$! 0$!
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MQ':B?%T;T5Z>X/IMTZP>#Q%FRWNI+.WN,M<!H\VYO98PZ621PXN\1(;4^%M
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MX$$'F"@U"'I-TLM\B,O!LG Q90.#VW;,9:-E#P2=8<(ZAU3[PXH-Q08[%X#
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M 'VA!1V]LK9^TH'VVU\!CL-#*T,F9C[2&V\P#[ORVMU?Y54%YA\!@MO6[[7
M8RTQ5K(_S9(+&".VC=(0&ZBV)K030 508^XV'L:[SD>YKK;.)GW)"]LL68EL
M+9]\R2,U:YL[HS('-/(AW!!D+? 8&URMQG;7%VD&;NV>7=9.*WB9=RL\/A?,
MUH>X>!O GL'<@J97$8G.V4F-S=A;Y+'3?C;.\A9<0/\ OF2!S3\X08;;_3KI
M_M.Z=?;7VMB<-?/U!UU86-O;3$/));KC8UVGC[M:(,SE</B,[:&PS=A;9*Q+
M@\VMY#'<1%S>1T2!PJ.S@@N8((+6"*VMHF0VT+&QPPQM#&,8P4:UK10  "@
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M[%ETGW?,7:0[&3P5!T\;AOD@5]NNE.WDMS91KGIZVON)TQV]3@[&-TX^W'Z
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MG?GLH^0?A--S^YVNY?Z.DA!Y.>X+]45K%8TCD^9VG64ZJ51 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 00YZH<F,?T=RT%=+\C/9VC"/]NV9PY]K8G!=3M==
M=Q'HU:6\G3%+CRW9Y=O%&?M&-;]047OXY/,RJ(/CG!C2]QHUH))]@0=-^D3
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M^@OR7V.=EM_CY(_F9?\ =KX1\O.?DCG#PO>-[\6_17W:_3+N!K6M:&M #0*
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M(" @(" @(" @(" @(" @(/A(:*DT YDH//G0_P"L;_G! \Z+_6-^J$#SH?\
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M9\73AB?/B\[OKZY-/)'Z[KG"#<>BFU#O?JSBH)8_,Q.WO^];^O%I= 08FFO
MUE,8([M2XW=,_P /%.G.>'Z?(W]EBZKQZ.+O%>%>D$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 06N1_<,_WJ)AJI19]JB2O:@](/A1$OH
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MEHXQ^GT3X2S8<ML5HM6=)AIO37J?BNH-E) Z,X[=./K'F<).',F@E8=#BT.
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%KD?W#/\
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M@8 RVEE(\J9\KJO<=0#7$N#0'$Z0NIN.U5IAGIUFT<6IBWMK9/:Y.NEY=V!
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MF,NVSNB_&-;V(,N@("#QYL1?Y8>WS/N:BO#V(/: @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(""UR/[AG^]1,-41D?0B%G)//=2FWLQX&\)
M9#P'R!!D;/#0L DN/&X\P./V479F-K(VAD3=('R!1*LO57$4))4(4'PQ.?J(
M^7AW*R'GR( /<%>_@B'SR8ON?L(*K?+8V@%/8@:V\D#P@UK15U1H^F0N%*ZN
M\'B%,3J:,;>XBPO6GS(=,OW0 _,4K1+5;W!WF,>9\?+I(]T<:./Z+V=ZC1*K
MA-PP96:>PF!@RUIQFMW<*LK0.;WBO<D0,T[@I2W"U_<T/WC?L!&*55 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!0E_&!7CDQV<[=
M8!JW#E!W0VGV'*\*RBE@_;#?85+'*)/6.^M]M#]YO4RO1&.QKC1MN%G<]Q2$
MW9*XNU*C$7-SX>:#$SS(,1<R<'(,;(5"T+23M599%H[B50?*$*1\*D>NQ!]T
M$L<[VA5E,/@Y2?(H6?I)Z#_[DIOYWN_L,0=-OYA3!+R5*JDXT42M"VD/'@H4
ME;NYE%5N]W$H*#G+)X(>!S_Y=ZI*\)&L?<B^\'V%19?(D0$! 01YU8Z*[%ZQ
MX@8_=5GIR$#2,=F;;2R^M2>-&/(.IA/O1O!:>ZM""=7+V9CZP>G>46N^+67>
MO32-VBUW38M+KJVBY-%PUQ);V"DKJ=C9#R7S[OOY,V^]UR8?Y67_ ';3Z8\)
M],?+$N]LN[WP^S?VJ_3"1MK[PVWO/'C)[;R$5];</,##22)Q%=,D9HYA]C@O
MB/<NT[KM]^C/2:^4_NSZI_2?.'L=ONL>>NM)U^MG%R6T(" @(" @(" @(" @
M(" @(" @(" @(-8WEU!VGL*R^+W+D&6[W@FWLV?A+J:G^KB'$\3[QHT=I"[W
M:NQ;ON-M,->'C:>%8^7]4:SZ&EN=YBV\:WGCY>+2<)L_K%ZCBQ^B7I_TEFH7
MW,P/TCD8'?ZMGA+FN';X8^/.2E%]S['^4]KV[2\_S,OWI\/X8\/7S]/@\9O>
MZ9,_LQ[-?+[75O3OICLCI-@!A-H8]EE:@!][>RD.NKE[!^,N)B 7'F>QK?M0
M!P7M'%F6C[_]373_ &?YUCAI#N7.,JT6]BX?"M>/N[FA;3_9AY^1=;;]LRY.
M,^S'IY_,T<N\I3EQERWOSK3U$ZB.DARF1..PCZ@8?'ET$!:>%)""72<.?F.(
M[@%Z;;=OQ8>,1K/G+DY=S?)SG@T!D3(QX1\_:NE$-1\EC$C"WMYCY4F-1W=Z
M=^IXZ@[+CLLE-KW1@6LM,EK-7S1@$0W''B=311Y^[!/:%X7N.U^#DUCW;<OL
M>CVN;XE./.$P+EMP0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%.>>&U@DN;F1L5
MO"QTDLKR&L8Q@JYSB>   J2IB-9T@F='Y\[]WA)U'Z@9;=Q)^C6.^"PS'5&F
MTAJUAH>1=4O(^Z>5]!V&V^#CBOCX^MY?<Y?B7F6'71:BUO;B2)K(;9AEOKEP
MBMH6#4YTCS04 XGB?JJE[=,:K5C67;W0SI@SIGLZ.VO&M=N7*%MWFIA1Q$A'
M@A#AS;$#3[XN/:OG^_W7Q\FL>[')Z?;8?AU],I.7/;0@(" @(" @(" @(" @
M(" @(" @(" @U/?#0\85I%0<C!P_SD&S-MX-(_!,_P T(/OD0_ZEG^:/SD$?
M=8YK:PV;<3O#8@V6#Q  ?Z4+#DG1BR3HVW$.M;S'VMU"&20OB8\/: :@M'<K
MTG5->*IB,):8JV-M#&W09'R\0.;S4J[(R'P\'^J8?\D?G('P\'^I9_FC\Y ^
M'@_U+/\ -'YR"PGP5C<9"#(R1CSK<.:P  "CD%_\/!_J6?YH0/AX/]2S_-'Y
MR!\/!_J6?YH_.04+RPMKJVFMGQM#)F.B)#16D@H>Q!]M+"UM;>*W9&W1"QL;
M:@<F"B"M\/!_J6?YH_.0/AX/]2S_ #1^<@?#P?ZEG^:$&I8J-D>^<L&MI6"'
M@.'VJ#<D!!3F!,9 -#V$"M#V?700KB^C6X,-FKC.2[FFNF%UW<"326W$;IPX
MAK36G,\?D02#TUO;_([.QUWD[AUU>N:]DMP\ .>8WN:":>P(-M0$! 0$! J$
M'G6RM-0KW51&L/2)$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 06N1_<,_W
MJ)AJJ+J%TZC6Q!VETIT#Y42R]M80P,$+!5C15Q'VSCSXHA=Z0P 531=[X]BB
M5)DXJ$:OA:ZG$\"IU'C2SM34-#"#0T4FAH'8[@H3H\NCKR*DT>'-?3AS4Z0E
M3UO9Q/UE$\#@]B5IYDU4,<J%PP2LH:.!X*[(TC,8MC+VWSUJW3D\5*V.5XYR
MVTU&N:[OXNK\RB1LL4@EB;*.+7BK3[*T4#=+;]S0_>-^P$8E5 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!:W$@CD!=[H%2KPI+G;
MJS+JW3D+?_27$%L]OR-#BKPI*,(K=S[ES6\ WB2I8Y0[ZQO^([1'.EH]3*]$
M/[3N'1X*-OZ-R0FS(7-RZJE1C+F;PH,9+.@QDSR7%!9R.596A1<:@J)9%N>:
MH 0>%(]?:H/8_%.^4*)3"F.4GR*%GZ2>A#^Y&;^=[O[#$'3;^:F"7E2JH/42
MM"W=S4*2H.YE%5K)S*)42LD<D//VW_+O5)6A(UE[D7W@^PJK+Y0D0$! 0$'F
M2..:-\4K!)%("U[' .:YKA0@@\""$'.G4#TD;9R>2=NSI9D9=@[P;5S39 G&
MS.)J0^ $&,.X ^6=%.<;E@S[?'GI-,E8M6><3&L,F/):DZUG244Y'?'5?I%.
MW']:=JR7&(:0QF\,(/.LWBH:'/  :"2>3O+=W1E?,.Z_D#%DUOM+?#G[MN-?
MDGG'^]\CTNU[Y:.&6.KTQS^;E]20=K[XVGO.V^)VUEH+\ !TD+':9XP?NXG4
M>WYVKY3W'LN\V$Z9\<UC[W.L_P":.'R<_0]-@W>+/'L6U]'C\S8%QFV(" @(
M" @(" @(" @(" @(" @U7=W4C9>QXB[<>6AM[BFIEDP^;=/[J1,JZA[R /:O
M0=L_+^^[AQQ8YZ?O3PK\\\_\NLM'<;[#@]ZW'R\?T];3,3G.MO6=PAZ5[<=M
MO:TW_P"V&='EM=$>&J!I:X.[?Q;9?E:OK':OR'ML&E]S/Q;?=Y4^VWRZ1/C5
MYC==[R7X8XZ8^G]GZ<4Q=,_2EL;9U\-S;PGDWSO9Y$DF3RPUV\<G?%;N+Q4=
MCI2\BE6Z5])QXZXZQ6L1$1RB.$/.VO-IUGFGU9%$9=>]FY+>W3;)X_#2S-RE
MG2^M[:![FBY\@'7 ]K2 _4TG2T_;AJZ&PS1BS1-N4\/4U=SCF^.8CF_/RW\L
MQ@L !Y.[ZKWM7FU960("#9.GV^LITUW;9[JQ@,D+#Y.2LZT;<6CR/,8>X\-3
M3V. *TMWMHSTFL_I+/ARSCMK#]$]O9_%;IPMEN#"SBXQF0B;-;RCG0\VN'8Y
MIJUP["*+P.3';'::VYP]-2T6C6&36-80$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M<\^J3J2[#8*+IYA9?^^]PMKD"P^*''5H0:<O.(+?O [O"[O:=KUW^)/*O+U_
ML<W>YNFO3'.?J<O6T#+:!D$?NL%*]Y[3\Z]K$://3+[/-';Q.FE-&,%25,SH
M)X]-'2>7*7K.JFZ+>EO$2-LV<HX%PJ#=$'L;RB_15=V-*\GW;>_^'7Y?L^UV
M]EM_WY^1U<O,.P(" @(" @(" @(" @(" @(" @(" @("#5=Z$5PI[/I&'[#D
M&T,]T?(@](($]4=ZZUVI:1A[@)IZ%C?MB&U 6IN&GN>3?ND-\S([ P5TRI#K
M:,&O/4UH!^NK8/=9<'NM\:>?L*V(9WU2" @(" @(" @(" @U#&$?EUE17CY$
M/#_)"#;T! 06N1<_Z/N3" Z3RGZ0>1.D]H0:GTE,GY!XL2M#):2E[0:@'S7=
MJ#=D! 0$! 0>"?$1PX(:J $?F$_@Z_+Q37P)BORKEONBJ::#Z@(" @(" @("
M @(" @(" @(" @(" @(" @(""UR/[AG^]1,-51D8/<61CL9,:)#I?/.8X7=F
ML-+J?. BGBS]CEXIX6NC=0@Z9VGFUW;7YT)UAD?,8WQS/ '8*J)EL4C4=?QC
MA'Q5-3X?%;R7<KQ1O!-5OAPIF2<@<35%NB'@F8BKG$GN0Z(?")NPD)JGI>/V
MP.&LA-3I#+<M^V*:G3#V+NX:/%4A5ZI5Z7IM_0T>%.NIT0K.N;:0<2&'O62&
MI>-%!Y\D&8FL?:>8'RJZT-$WGO#';2P&1S62<UES>'R\=;.-'224TMHWF17B
MHE+8MNNG?MK$/N06W$MG%)(#S#GC53ZZA"0[;]S0_>-^P$8U5 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!CK^@D =Q#AP%*T5X$,
M]3]CNSY.8Q]PV#*VS=(+CH#P.0K\B>*DH3%]=V=X['WX;#>-\+FN-6NI]R5>
M&*40^L6.5V0VK<!I%J;%_'3PU5[TDA!> N S&,CH2[42T@T%.U()7$]RVOO:
M5="PGG;I]Y!833<>!"HE:/F;V\U!HMGR#L^JJK*1<7>WVA!\HYO'B?D")"'G
MEJK\E4'N.TN7\1$]_< T\U9.KP^.:,D.:6.C]YA%#Q1,2]O8&0DCFYP)1.JG
MV/\ D4)?H_Z$R1T5GI_*]U^E8K0.G7DGFJS"LJ1'R_F*NB-5%_#N^91,&JB]
MP/,5*M$&JV=I^3YJI*-5"4@"H''ZB@U4!J]XUH44TXOA!E(8WF""C)$-SQ$C
M_,@B/8#5&1L"J" @(" @("#Q-#%<1/@GC;+#("V2-X#FN:>!!!X$%!!&^O2/
MTHW9<G+X&WGV9N('7%D, X6\0?WFW_%CG_HM!]JBU8F-)Y+1:81E?],?5!TW
M<3B+NPZF;?B]V.4BTRGE@<21(YI+O_:S'V+Q?</R;VW=<8I\*WG3A_N^[]&O
MI=?!W?/CYSU1Z?MYL'#Z@L-B;L8KJ-M_+;+RX%7PW]K*^/AP):0QLA'M\I?/
MM]_T_P!WCUG!>N2/*?9M^NOTP[V'OF*WOQ-?IC[?H2+@MY;4W,S5@,S9Y ]L
M<$S'2#Y65U#YPO$;SLV]VFOQL5JQ'CIK7_:C6/I=C%N\.7W;1/U_-S9Q<=MB
M @(" @(" @(" @(-<S^_]E;6#AG\[9V4K07&W?*UTY [HF:GGYFKN[/L._W?
M'%AM,><QTQ\]M(^EI9=[@Q>]:/K^B&@?V\C<=T_&=+=I9?>60:0WS+>W?%;-
MJ>;G!KWM Y^-C1[5[G8_]/<]^.XR12/*OM3\_"(_WG&S=]I'N5F?7P_3Z&P6
M'1GU*]1W!V\,]9=/,!*3KQ^,_;.1+#R!=$\@<.!/Q(^\7T+M_P"4^W;/28Q]
M=H_>O[7T>['R0X.?NF?+PZM(\HX?M2ST^]*_2/84K<C)C';DW#J\U^6SI;>/
M\TFI<R(M$337B':"\?=+UD1HY4RFL    4 Y!2@0$!!PCZB^FAV#O5V:QL.C
M:^XWON(-(HR"[)U30\. %3K9^A-![J]IVO=_%Q],^]7]-7G]YAZ+:QRE$:[;
M0$!!\(!%#R*"8>@'65_3;,';NX)B[9.4D!=(ZKO@;AW#S6@?:.X"0?(X<B#P
M^Y;'XL=5?>CZ70VFY^'.D\I=T1R1S1LFA>V2&1H?'(PAS7-<*@@C@00O&S&C
MOO2@$! 0$! 0$! 0$! 0$! 0$! 0$!!KF^MZ8?I_MB^W1FG_ +6M&TB@:0))
MYW<(X65^V<?J"I/ %9\&&V:\5JQY,D8Z]4N ;_,9;=N>R&\<^_S,KE9#)3[6
M.+@&,8#R:UH#6_H0OH>VP5Q4BL<H>6RY)O:9EX>]D;"]Y#6-%7./(!;+"WWH
MOTEN^K&;&7R\;X-@XN4><XU8Z]F;Q\F,TY?ZQPY-X#B:CA=QW\8HZ:^]/T>E
MTMIMNN=9Y.X[>W@M8(K6VC;#;0,;%##& UC&,&EK6@<  !0!>*F9F=9>@B-%
M10D0$! 0$! 0$! 0$! 0$! 0$! 0$! 0?#P"")^I&7SMMO+;F-QL'Q5J^L[H
MW>%GFLE8UOBY5H2@DW&R7<UJR2]A\BX(JZ+5KH?E07B#G?U2/9+;;<L.<D]T
M\ <Z ,*T]PT-U/)N/1#*V+ML6FW[5Q-QC((O/)Y5D%:*^WG@R;:WLZ)4B]TG
MVGG\JV(;4/:E(@(" @(" @(" @\R%P8XL%7@<![4&B;9N,E/O;,?2-L+9S(H
MFQM:\/!;IX'AR0;Z@(*5S*V&+6\$MU-:: GWG <:=B")+3K3;7^5NL!=8J6)
M\?Q45Q.QS9FUBU4T:*ZFD#LY(-HZ1R-GV#B9HZ^7(V1[*BAHZ1Q'#L^1!O"
M@\N>QGO$"O>A/ ,D8:7EP#1Q))H!11,Q'-.CRR>"4!T<C7M=[I:00?D(45M%
MHUA$\'O4WO5DZ+>68BIC&JO:./)*QQE6^L:(J=U6O&]43L3Z%E\@-!^-T'FY
MH-?DXKGSDM\;ITG1[">Q8X[?^*^)77[J7&&K ?8N@\AJ](" @(/FIO?[$'U
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M+Z+HKMV*FFRMP!V4_P"9-4]*[CZ2X2+BRSMQ3E5M4U-%P.F6-TT-K;=WN_\
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M]LMK1I:9E6=9<&R")OF@T[-0%?NE;2.K5AZIZ.G]:^:"&@'B0I3+ZB! 0$!
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MRT&R(" @(" @(" @(" @(""C=W=K86LU[?3QVUG;L,L]Q,X1QQL:*ESG.(
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M" @(" @("#X2!]A!\#FD @UKPX(/2!RXE!IN)D9)OO+F-P<!!"*M-172@W)
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M>W+D7%C<"CV&@EAE &J*5M3I>VO$?.*@@KPF;#;%;IMS>DQY(O&L,^L+(("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @T+J9TCVEU1QX@S<'D9:%I;8YBW %S#V@$\G
MLKS8[AW4/%;NVW>3!/L\O)KYL%<D<>;BGJ-TBWKTON7',VQO< YVFVS=J"ZW
M<"?").V-YK[K^WW2[FO8;7?X\\<.?DX6;;VQ\^7FT9KVO%6FH72:KT@(" @\
M-9Y<C9X'.AGC(='+&2US7#B"".1"K-8E,2E3:7J*ZK;2#(),BS<&.90?#Y8&
M:33[)@YLM>[4]P]BY.;M>')QB.F?1]C<Q[S)7QU]:;ML^K[9M^(X-UXJ\PER
M>#YX:7ML".9JT,D%>X1N^5<;+V?)7W9B?H="F_I/O1HEO =5NF^YPP87<^/G
ME?[EN^9MO<'_ -C-HD_Z*Y>3:9J>]66Y7/2W*8;>"' .::M/$$<005JLSZ@(
M" @(+3(93&8F W.4O(+&V%:S7,K(6<.?B>0%:M9M.D1JB;1'-&^XO45TCVX'
ML?GV9.Y;RM\4QUYJIW2L_ _5D6_C[=GO^[IZ^'[6K?=XZ^.OJ1)G/5SF<Q=-
MQ'3?:KYKZX<66TE[JN9WD\M-K;?;#_:N^1=.G:*UC7);AZ/MEJ6WTSPI"WQ/
MIYZD]4,H-U=8,W)8>;0MLF%LUX(B:Z&-'X&W;QX !Q!YMJK7[CAP5Z,,:_5]
MLHKM<F2>K)+HG9'3/973VU^'VOBHK:=S=,]\_P#"W<O?KF=5U*\=(HT=@"X6
M?<Y,T^W/V.CCPTQ^[#;5K,P@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M("#5=Z>]A/YQA^PY!LW,,1"VRDQMK&XN&@.=%&YX:XT!+17BJVY%IX(GZ)W5
MSN-N3WA)$V)F1EDB#&N) -O(YA/UEAI#6PSK,MXWM/;6K,9<W3@V-MY$&D\P
MYU0*+)R9LG"6UL.IM5>)9'I2" @(" @(/+B.2B>$$.5_6/D)8,=@+.%P!GDE
M:\TKPT5!^J%V^V8/B:N/W'+TPM?1OOJ6[Q5YLFZ8UCK$NGAD)\<I>14_(%&_
MVWPT['<=7#5UB#R'M7%K+KV>U(T_%_TZRQ[X(?TH0;@@(/$@+FT!+34<6TKS
M'>@B^7K+@I;U^*N+*[M [XR.6>5K2(S:R20\6,<YQU>67"C3P(^:)0R_26XB
MNNG^(N8'5@F;(^)_%M6ND=0T(!!^567GAS:SU"Z19K>V[\-G;?.?"8RQ+3=6
M3PY^KRW:OP8%!5W)Q<M#/AG):)CP>P[3WW'LMODQS3JM?32?5KZ?2E7RQ"&A
MM .QIY!;E-8CB\?PM.LKF(N.K4>%>%.2MKJI"HB2J @IEW$T(![BL<SQX:+1
M"C-(&D!QI7O_ #%-HO\ NZ(BVG@N(R"P$5I[>:NC75Z0$! 0>&RL>7-:02TT
M< 0:'VTY?.@]H" @(" @Q&YMS839^$NMP;@NFV>+LVZI97<22?=8QO-SW'@U
MHXDK+BQ6R6BM8UF5+WBD:SR<*=2NI6<ZP9P7MZ'V6T[)[OHG$ZN%.7F24X.D
M<.9[/=;VD^XV.QK@KZ?&7G-SN9R3Z&R>G!H;UJM&M #1C+H #@  U:_>/Z/R
MPR[#^H[>7BGH1 0$! 0$! 0$! 0$%ID_W!/]ZB8:FWCS1D:#U"#2^%\@\,#2
M]I[ XU )^<JEFQCMI#F/<V/=E-T68-6QP$O<!V.KQ7-S3.KWO:>F:3U>7ZFU
MP[5G<67&+NWPSQT=HU4K\AYA9HMJU,M/)4N7YZ(GZ;L8,C!R#IX@'U_VC0"?
MG4WB):TWB/>6DN(VGD2UM[B9+64\7.BJ]GRUYT5(QULV,6^R8_<MI\QC^F.Q
M[Z]TWF3=9V#FD^8PN\QI'+@X46*^RK/)T\??MYCX^S:/6RTG0;8TL)?8;U<7
M'B/.C8P?)5:OX&VO"89?_P!=N(G2^+AZ-96P]-\TXUV.ZL=)'3@72-:?K).R
MOYPV*_F^/&D_-*I'Z:[MG&XW7CXV#GHE:311^!MXK6_.$Z:12?FE?L].^SHH
MZWF^*3#FV!K) .]6C8><_0Y]OS7FUUKBKKZY?;CH=LRS-N;*_?E6<3-/<%T(
M^8-%%NTVF'Q<_=?F7?Y9\*>J=5U;[5Z?X0@2P,DD::>3&*EP'MYK-&VQ5GV7
M)S]QSY8TR9)M\D-DL1D'Q^5M+;T-I&\4-]<-TAGM&KCP6SK&C1MDM%=(C59W
M6 ELWLO\Q?'*Y&-U35H9;L'.C6CG14B6&U9T6^4N?+ ?72\NC<QP[#7@ .P+
M+$M*\)UMGR26EL9_QCHF%_WVD*6+DC+"M9N"[R4=Y$/I''7<YB-?$Z$2'@O2
MSKCI6?.' K'5>WKEC=_;4;B8H<YC!6QF/X>,"FAQ6SM-UKK$M#=;;2=8:A"_
M4!VDKK\W,TF)7C J2RPNXSPXJDBXCYJLIA78526:%U&>05)65VGBJ2RPN&$F
MBJB5Q'2JB4KAA"QRRPN(R%CEDA=L(42K"O&L<LL+EM%196:H2N&JDIA6:>2I
M+)"LP\525H7#55=48H1*LU5(;+8_N2+[U:%_>EOT]V%PJ+B @(" @("#E;KI
MZ@)[R>[V!TYN.'&#,9^%W #D^*W</J.D'R-^Z7INW=MUTODCU1]KD;K=Z>S7
MYW/UG9PV4(BB''F]YYN/>5ZR(T<29U7"E @("#+[$W[G^DV?^GL%6XPUP6MS
M&'<XB*:('F.>ES:G0^GA]K20N;O=E7/72>?A/DV]ON)QR[NV?N_![ZV_:;EV
M]/Y^/NV^Z:"2*1OOQ2-!.E[3S'SBH(*\)FPVQ7FMN;TF/)%ZZPSJPL@@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(""E<VUO>6\MI=PLN+69ICF@E:'QO8X4+7-<""".
M8*F)F)UA$QJYVZC^E# YETV5Z?7+<%E'$O.-FU/Q\A[FD!SXJGNU-[ T+N[;
MNUZ<,GM1Y^/[7.S;&MN->#F'=NQ=Z;"N?A=VX>:R:XEL5V )+:6GW$K"6'OI
M6O>%Z;!N\>6/9G5R,F&].<-?:]CQ5I!6WJPO2 @("#X0#P(J$%-UO$[[6GR<
M%&D)9+&9S<>#I]!YN_QE.7P=U+!3];<U8;X*7]Z(GUPO7):O*6VV76WK#C@T
M6V[[R0-H1\2([D\#7CY[)*_.M2W;L$_NQ]3-&ZR1XLQ%ZDNM<;-+\]!,?NWV
M-H'?]"%H^LL,]IV_E],LGXW+YJG^);K3_+5M_ K;_=I_:<'E],GXW+YK2Y]1
M'6RZU [F$,;J>"&SLV4IW.\C5_TE:.U;>/W?IE6=YEGQ^IKF0ZH]3LFTB_WC
ME?+/O,BNI8&'Y1$Y@/U%L5V.&O[L?,QSN,D^,M<M+#,[IR;;3'6][G<Q-P;'
M$)+F9P';P#G4'>LUK8\<:SI$?,QQ%KSPXRGW8/I'S^4=%?[_ +QN&L#1QQ=D
M6S7KAW/D\4<?S:S[ N%N.[UKPQQK/GX.CBV,SQMP=0[.Z>;-V%:"TVMB8+$E
MNF6Z UW,O?YDSZO=QXTK0=@"\[FW&3+.MYU=7'BK2/9ALZUV40$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0":"J#5=Z<3A>X9&&I^9R#:&C@!W)(U
M_>]X^QVMEKJ/\9#:RO;7CR:J6E2_)'_IJAN6=+;"2[:62S3W4A;2GOSO->/R
MJ,<:,6&LU9KK (SMZU>__1WULYE.\.2T+Y.*1(?Q8!YA6KR9(5%9(@(" @("
M"B\Z 7GW0"3\@59XPCDY']5=]:Y'-X/'1R-?/$'2.BYD!PH#\Z]A^7])U>3[
MQDXQ#5/3A9R8KJKC[0@-=+8S.E [2'<%F[]I%.J/TYL79;:Y.G]/!W'&_4ZG
M=QJO$UC2-?-['7CHK*R6GXOAOK*CM$$-1_DA!N" @IRMD<UHB(:X.:7$_<@C
M4/G"#%7N&QC->0%I"V^CBE#)PP:VB0%SZ.]IXH,%TK8';%QFKB/PM".W\*[B
MIU+<6YAA'R=E%2(2\R0ZS6JLC2'PR"%P80:$5U=B@B-9T>7W  ):PN^1-28F
M&GXC>N7N[N_M[_ 7<$=O)I@F8&N;(RM 1Q6I^(MQ]B>#)-.$3'&'BVWSE9,W
M<6<^W[R+&,8#%=:02YQ-"* J/Q.L\I.B-.;'7?5W!VFXW8.6"=KF%L5R\L\3
M)7-:Y@TCCQ!'):.;N-<66*368FWCP\M71P]MS9,7Q:^[^W1&G63 #>VY,=DO
M)FA99L\F ROFMP^74'<&M(J*!9<G?,VWC^529K,\>'[8;FVV=)X62W8]1=MX
MO#VK<E+);2PL9"YDD;PXN: #2HXCM5<O=\5)CKUK-FG_ &^^6TSB]J/0S<&]
M]L7./&5AR,+K%S#*V76T#2/E-5O_ (BO1U>#1MAM6W3/O>3)X[+V&5LX[ZPE
M;/:RBL<C#4%9:9(O&L,'*=)7+;B-W'DWO[%-;Q,:IX/7F UIQ([%;7BA1AAA
M@>]\,8:Z9VN4MX%Q[RJ]?E"=%RKH$! 0$&(W-N;";/PEUN#<%TVSQ=FW5+*[
MB23[K&-YN>X\&M'$E9<6*V2T5K&LRI>\4C6>3A3J5U)SO6#."^O@^RVG9/=]
M$XG5PIR\R2G!TCAS/8/"WM)]QL=C7!7TSSG]/!YS<[F<D^AKS6AH#6@!H% !
MP  76:3>>A&9P^!ZP6V0SF0ML98-Q]PPW5[-';PASF\ 7R.:VI[!5<3NU+7Q
M:5B9G6.3H;*T5OK,Z.OO[4>F?]=,%_XI9_[U>0_"YON6^:7=^-C^]'SG]J/3
M/^NF"_\ %+/_ 'J?A<WW+?-)\;']Z/G/[4>F?]=,%_XI9_[U/PN;[EOFD^-C
M^]'SG]J/3/\ KI@O_%+/_>I^%S?<M\TGQL?WH^<_M1Z9_P!=,%_XI9_[U/PN
M;[EOFD^-C^]'SG]J/3/^NF"_\4L_]ZGX7-]RWS2?&Q_>CYS^U'IG_73!?^*6
M?^]3\+F^Y;YI/C8_O1\Y_:CTS_KI@O\ Q2S_ -ZGX7-]RWS2?&Q_>CYS^U'I
MG_73!?\ BEG_ +U/PN;[EOFD^-C^]'SG]J/3/^NF"_\ %+/_ 'J?A<WW+?-)
M\;']Z/G/[4>F?]=,%_XI9_[U/PN;[EOFD^-C^]'SM@Q>7Q.<LF9'"W]ODL?(
M7-CN[.9EQ"XL.EP#XRYIH10\5AO2U9TM&DLE;1:-8XKQ466F3_<$_P!ZB8:F
MWVHR-6WOBW96Q M&Z[]@/E1<O,:?>;]3B%6T<-6Q@R5B=)<UY:*6RR3IW@_@
MR6.X<>?NN^1<^\ZR]?M,G#@VW!7L-\UK+-S7O: 96@\6TYA1HW.BVND+O(;H
MM(XY;"V?&]XX/+R-(IS'%8OB1#>Q["UHUT:OD-Y8NTAB;:O;)=C@2T4:*<QP
M6'\1TMBG9\=_ZE?H4\?UER^+#[>#$V=W 7_Z<-)#?G6*=]?7P7C\N;:9UK:T
M>K1D1UXMJ:<CLRPN#3BR.0--3P^Y*V:;F9C68ABO^7[:Z4RV^6>'U*C>MFRV
MC\-L")KNRDYI4]G"-7_%5^[#5M^7-SX9?I5X^M.S=36LV-!%*_W0^YH*_.Q6
M_%<.$,<_ES/XY?I5XNN%M;W4-I:;3LK6:<%\5)!+4,I4\&K%^)MKR+?EZND]
M5_IC[&=9OQNXGQMR=O%!$.3(!0 >U9XSZ^$-2W:,6*O"9GUMFL)\,V2"6UAA
M(,= _2"ZH/M66,CD6VU:S[OT,\^YCEA\T/+X^7AY#ZJ<9:D^Q.O&&NY"/XF7
M3$-?,.KP#0>TU5^,,>7)U1P66'V[^4>>B;&:XVQ>#<RGW26<=(6Q7DYU^"6B
M0>(Y?:_(. ^PIU:\\4-VN5;CMXSW<7@8;B2*0#M!>:D_47K:T^)AC7R>9R9)
MIEG3S2\RPLMPX.^QYTOCF9JB[:&A*XG7;'DATYK&3&YRDM);.[FM)?#)#(YA
M'R%>NP7ZJ1+S.2NEI7L? #C59&*)5V$JLLD0NHR0JR+ABQRRPN6=BJLN&<52
M5]5PSL5357:H1JKL6.6>)7,:QRR1*Y:JH7<:I*T2KM5&178>2K*87#51DT5V
MJIJK,[%25XE<-Y*B^JHQ02K-52&RV/[DA^]6AD]Z6_3W87"HN(""TQN3Q^8L
MX\AB[AEU92ES631&K2Z-Q8X>PM<TM(/(A6M6:SI/-$6B8UA=JJ1 0<I=>>O,
MV4FNNGO3VZ_:_BASN=A=P(Y.@@</M>Q[Q[WNMX5)]/VWMO+)DCU1^N7'W>[_
M ':H#M+2&SA$,(X<W./-Q[RO5Q&CB3.JNI! 0$!!1N;B&UA=+.:,'"G,DGL
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MS ^51-83$R[0]+W]S>'_ -O>_P :D7@^Z?ZB?D^IZ39_TH3&N6W5ID_W!/\
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M?-LE.BTU?0<<]58EGR*BBQ,C3\;_ $YRIH-7D0 GO\(0;?7C2GSH/M4'P_\
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M[<\)_.,/V'(-H! #">X!2A#'63<#';JV-M&VC=->WF6CO)@SCY<%L!5Q]E9
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MG\[&+EQ\1_.4:$C>K&3%7-L8M/+WCS^HFB(AZ/5K*]EC#_G'\Y2E]_M9RO\
MU&+_ #C^<@J#JME*<;*('[X_G(*;NK.7%Q% W',+'BKIM1TCZR#T>K&2:]L9
MM(0YQHT%SJGZR .J^4+FM-E%Q-#1Q[_D02O!(988Y3S>T.(^450<&]9][;LW
MOONYPN[;:7"V&&D<VPV\\\O_ %KW#PR/>WCK'#2?#PJ3[GMNVQTI$UG69\7G
M=WEO:VD\-&I !H  H!P '*B[3G/J @(" @(" @(" @(" @IW'XB7[QWV$GD0
M[#]+W]S>'_V][_&I%X#NG^HGY/J>FV?]*$QKEMU:93_A]Q]ZHE,-/)XT4+HF
MZFW;H=Q6KI1^U6VS]!/82#5)Y,^+F@W)YVYL,C#C86-EL'ZC,#V@GAI^1:-[
M:2]ALMA7)36.;''(W>-D):#;12&C2]IDM)!7@*"M'*+<2M\^'V<T?5^I;9B'
M$9R!OTA&_ 7P/X/(Q1B\L'??!I:6U^5(ADK6L3UX,FEO5,_6U^WVYN*2<VV,
MOL3FL?&:,EL9O*EIWF-_$?(M/)MJV>GV_>NX8*?S<?Q:^CIK]4-HP_27?.X8
M)9,=:0L\LZ!Y\S6:W#F&UYD+!&RS1RC6&['YOQ],5MC^'Z[:_J?+CHEU3@JU
MV DN'#MMZ2#[(46VN:.=9;6+\Q;*_/+6/DG[%K_8YU0_JG?GVB _GJGX;+]V
M63^_;#_S:_-/V/K>C?4]Y_HA?C]&Z,M:JSM\OE)_^B[='.\3/^;[&4MN@W5&
M5HE=BX+.,<2;JX;$0.?:%>-IDGG$M+-^:]C7A%HGY_L6%_TJW]8W[K*+&_'$
M 'XBWD!@#CV%]#R6:NP\VE/YLK6O\G'U?YOMAE,+T=WE*YL^X<AC<%;QNU%L
M?[9NM/L)<T K<Q[.*<GG-]^8MQG]Z8KZ-(^QNUAC-JX%_D;>LY]S;BY?&S#6
M&.Y C@ P#YUOTK$/)9<V.TZY+?6N+FPR,5]9RY_1</DD#O(8=38W$CGWE6B\
M(M$S'#DV_!W3;?<N*BB#M8\PN[@TF@!5Y<ZU=)3"\ J$.?K;=5[MS<V1+2'6
M$MY,+B(\1I\UWB'M%5[B^WC+BI,>$1]3Q],GPLM]?&9^ML/43'?#XBUW/B;;
MS;:9S7ON8_$&L=SU@<5JXLT:32>:<N#C%T.[IRD^UNH6-W2)"[;^:LX8+^.M
M6 >)CG4[P0II32=67XL3'2WT-;$X",^9$X!\<@XAT;N+3]1=.ENJ-7/RUZ;*
MK75X\E9C7#2:!5DA=1*DLD*\?-4EDA=,6.5X56J%EQ&JRE<QE4E:%S&L<LD+
MEBK*RY:2J)A7C)6.6:%W'R6.5U9I*2K"LPJDLJLTJDK0KMY*DLD*S#R515:2
MH0VBP_<</WJY^3WI;^/W87*HN("#\VI2#G,^1Q!R5U^R.7TK;>Y'JAY'+[TO
M3VM>TL> YCA1P/(@K98E.WMH;2/RH&Z6<SVDGVE1$:$SJJJ00$! 04;JZALX
M3-,:-'(=I/<%$SH1&J<.A70:7<LEOO[J%:_]S\),+@IAPG:>+9IVG_1]K6GW
M^9\% [RW<NY::TQSQ\9\O4[.TVFOM6Y.MVM:QH:T!K6BC6C@ !V!>6=I]0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0:=O6Z@^*P=GY@^)-]#+Y1]
M[RP2TN^J0@VM\GEL)/ -'$^Q)$5XW&V^Y.K%QN>+3+!B\=)C]1XZ+F26)QI\
MT:P4]J6I6(O;5*S&@$<5E;8\4-:\N-/:IE.K1>G\\CLANFU> !;Y,M8.YKHV
M.^R5CJQQ.K>P.-#\ZR:,FCV."E @(""D97BO#C4@?(JQ.J8C5''4W=XP5M+B
M'M8T9/&W\AF>: .AB%.WVK8PX_B3HU[Y)K+@O Y_*[I+X,Y,962S17HC'!FJ
M ^4TT^]:O>;#;16O7X_]KQ&]S3>\U;P0 *U73:<<7@1-DC?&[DX$'YPI@O/!
M,OI SV6N8]T;;O)->-P]X&X]E*:&RU+OJD+P_>:?S9GT_:]?VB?Y,>K['4M?
M8N"[;4,?5V^LN.T6\ _Z(4DQP0#EG11YS)0&$/F=<W%2[B*&1_$46Q$:L<PP
MUS([0VC&LT>"H'$@=ZG3BJITCF9&_@".T\E*5F]DT5RV6UE'Q5?"YO$4[E6T
M)B5K?.+)2V2,2.?4R\*$N[:*FB>IB(K@V\I=&P:2:%I%:?.FB=5NX2.F\QHT
MO<[G2H 30U9.X#(+J-GFLFH&O\UP/ TK2BK,0)@].\SKK<F=F>&ASK:*N@4;
MP>[L6*:I=!W;0RRN*<? \_62(B.27.&0B%SYL.LL<)2ZHJ.14BE(X/+6MXZ1
M2OR<"@\-:9'4:Z@'$A![\MU \BK".80>0'#@3P[D2J:'-;RK4CY%.B'JE*5H
M3VT30>B*D'N4#YXJ%FHT*"FZXL"(KJ1Q+XW:&<""#WE!7:PM.MK/,>"',;W@
MH.C[,UM(*BA,;#3_ "0@CCK'T<Q'5/$!["VQW98M/T5E:4Y>+R9M/$QD_.P\
M1VAW1V6]MM[>=9YPU=QMXRQZ7%-W:9? Y>ZVUN6U=8YZQ<8YH9!353B'-(X$
M$<01P(XA>[PYJY*Q,3K$O-9,<TG27I9V,0$! 0$! 0$! 0$! 04[C\1+]X[[
M"3R(=A^E[^YO#_[>]_C4B\!W3_43\GU/3;/^E"8URVZM,I_P^X^]1,-/'.JJ
MNT#JGM]^2Q@R5N"Z:S;^$8!4F(\Z*)G@VL%HF>B.;FO*6 COF3AVN(MTM=]P
M!V'VKF9(G5['99Z1'1IQ92&^QN-@\R_D#8B!J::$/]A'M59O,.CBV][^[/!C
M7[NL;;S+K&69BMXN#F/<3$X.[-!\('R!17<Q7FS9^R?%B->?Z>E92;UZ69)S
M6;CV4ULU=3\ABW_"/U=Y:P %)S8K<X^MKU[-O,']#)T_Y:S]<MJQ&6Z%!D?T
M7N[/[;F< ?)=)/+$T]M-3J*L3@U]UKY</<X]_2_^S&K=,;=X @.PW6-T49'_
M +UX7?86U3+2>$<'/R7OII?#K_G_ &,Q'<70X#K+9N^69PX?,5EU_P 32F8_
M\B?GG[">\L(F$Y#JY;O8>?ER.>:_.52?XF;':W[N'3Y?V,5)G^E5N7&^WQ?9
M"8#BRUC<&N^=M%;A$<VQT[N_*NGRQ]BE;;BVIE[QEI@!=>7(=,<]Y*^1M:<*
MM<4K:&EGVFYU]NVOR0NL?!C[Q^O)N?< $@Q1N,<7 D<0R@*?$F.2D;6L\9CC
M#9H9[""V-ICFQV\/;!$T,!)[2!0$_*IZ]6*]=.#"W]D^\F@<P4$+M1)Y,:#Q
M^9,=)UXL%\G#@R>Q+1^4S]Q>CQ65L\5D(H"!]J#\JVM7.R3JECM)[^*,+F+/
M@G,Y(=GQ<_'_ -HY?1<,?R:Z?=CZGS_-:9S6U^]/UI7Z0YJ+-X>^V?E2'F-I
M,#'<=49J"!7N7 WV/X=XM#M[6W728E$74W9\S+3*;7\O5<8DNOL:7?Z2TEJ)
M6>TM(J MS#:+4:&2O3=8=,\Z_.[9CL[A]<I@Z6UV'>\^WJ=#N/&HY%7PZUG3
MTLV:(O&L>3<02=([UON?RE<Q\N/8J2MS7$9*JE<1DU596B5=A->:I++"Y9V*
MBT+ACJ*DKPKQJLI7D9"QRR0O(VU5)65PU52K,5&1<1$\%25UPWL593"LP@D!
M4E97:!P593"LWG3L5)985F\E1=58H5;38?N.'[U<_)[TM_'[L+E47$!!^:-C
M^.R/[\F^R%]-P^[#Q^3FO%F4$! 0$!!0N[N&SB,LQH.36CF3W!1,Z$1JG+H1
MT(FW'-:]0.H%K3$BDV#P<PX3#FV:9I_T?:UI]_F?!0.\MW+N6FM*3Q\9\O1#
MM;3::^U9UN  *#@!R"\L[(@(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @^.H0:\!VH(MZB;7FRF[]O99UR^WLV?M1WDNTR%\DC7"G,<F]R#=K\#"8"
M=S97/=;P2$3SNJ[PBM7$ #ZRI>=(8[SI"&/2[>9#*8K<.5R3R^XO;XRFI)'!
MT@!%>PK!@G5K;:==70+!I %:_*MENR^R>Z4D:#@F,Q>_=Q6C96CX^.VOV05H
M[4?,8]U/\EJPQS8(G2VC?6\0#S- LS/')[2 4@@((_ZC]4,5TWCL[G+LK:7<
MODF6M P]ZS8MO.371KY]Q&.(<I=8.KUIU/QN)?@0Z*>MY:W$3201&\LH:^T-
M*]-VCM\UM,V_3Z' WV^CA$-)P.#@Q=I"&Q!LH9I+NVFHN]G>O5SI6.F.3S=9
MFTS:W.69=V*JU9>N#7%O?P0YI<])MN;7-;N<75;<31RM:.X%S0O+]]I$:3'C
MI^MZ#LN2>-9\-?U.IW@R!T9<6M<--1P=Q[EY)ZAHNV\:S&[WS,;;B>X\R*%V
MJX<'D5;R&D-X(MX()W)+.,YD+A@,09=3L:YO<)'UXFJVJL<L=$&WD)87'XAE
M7.Y4H>2GQ469<]E( WZO:B5)UO)\0T-'$<30THJR/+K-LUPV)M72/KPKS/RE
M5"2QM7Q1P3ED+(BXN+!XNSF>/<BT,>V"WB$Y=J:T@^2XCF$2M'6SA$V4G@:
M=ZK(F;TX-#<]FN_X:('_ #W*DD.AK_\ <5Q_LW?855G-EW033R2.T1L>XEW<
M:H*,SO)MV/B:97R.%"/N3QJ@JN+6R4<-+7MH:<P4'RVMVPP_#LD,I)+G$\@@
M^D^4?,DB?Y+0':VM);I/+B@^1_2(>)'L;);W-8[>-I\6JO#AV)J+B>U@M;.
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M@_WZ?WNWW?I/[='G]!_@]A_KQ>?P0?[]/[W;[OTG]NCS^@_P>P_UXO/X(/\
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MD\UD1*AHA@D:7@F,<]/,J%7V=D0B;/KJ2> Y$?*HD2MT!G,V;RQ?Q>+:/C[
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MB8YP^>3F5GC'$^$.=&?#6>%LL3_&%W4-QU3;)VU)(/MP0/K"16^%3[L?,O\
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M&;3;0N/ 4XE3%>+%-]%]92ESV]O>L5XTADI;66X6QK!&?8N=;FWJ\E552("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MUXMSM12WC'L7,MS="O)655A 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M:#V+7P5URS*<T^Q"+<Q<-@Q[Z^(R2QQ@=^HMHNO;DT<<<6UM;YN R.GE(X,
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M,[B7/<VI*\;FC2\O=X)UQQ/H;@L3,(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MDN]2/Z#9O][\/\YJ0BO-RVWW6_(N5GCVV]7D2/#6<D\1ALE<B.VDHUHFI1A
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M'72')IQLE?;S/(P./9Q.J4N'^35<K-[5I=C%[/%'O53(3YFZ$37ZGSOBA;[
MT\?L+8QUBF/1@O;KR:M_VQ2&QNLA._3;VT$<9)[1$P T7/B..C?M:)A@=LY*
M*62^MJ'0R=[W2'D0V-I;]>JVOAS#6BZ2ME20LV[+<:M D,A!/?4A<S=<);V.
M=86C;^"&>UQ\\HUR2%S&$\Z]RG!7JJQ9K]*KU"<0S%Q<V^)[A[  MO:1QEI9
M;:Z(JSD\;LY@X7'BTS7%!W1Q.<#]5;>2=%,7-OS\_%@]IP75V ULSN(/#B>*
MX6]O%)U>AVU>J&#CSEA>WT4]I>.M@\C4PFHJ>Y<[\16T,\8>*9<C?VT>%M81
M*'/C:US@WB[P\^"MBMK#4W?"6'W+FK+(8ZU@M)FRO:[5,&FI::5H?:NEM8XM
M*]HF&N->(FZZ^&E:GEP6_:VD,,T7.S[AK[FZE9&X&5Y.K_U;!0_76M-HE68T
MAI'4K'37[XK6UMW4@:ZL^DGEQ!)7;VN2(J\9OZ=5^3=>B.(=B]L0Q/<'R3?A
M'$'M>ZJXG<+1:7JNTSI31NN?!%Z"3X0&M'U%@V\<&[N.:[DJVV:X\M(6*>-M
M%9X5U<G=3;AL^Z9P/M*U7O\ 85TQP^3=VG7+*(]T2?A+>-O)SF@CV$A-W_3E
MN]KQZS#]*]A-#=EX%HX 64 I_D!?,-S_ %;>M]FVG]&OJ;$M=MB @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#3NI#
M@S!1//VMW;GZD@4PB42OW0QT[P&N/B(X*4/9W,QI80QQ)('>@V.1[KB**9GV
MPX \T%>UB<SCPK1!C[L2F=]8]0["@R%JTQVONTKQ047M<:>#M[D&7V[4;DQ7
M9X;G@/O%59)J#X%7Q2YPZW&F]13_ *K#]EZQ9>,,E$7174\LTL<D)B8PCRWU
M]Y88T9=)6V0MOBVA@=1_;W++2T1*)B5GC,*RPFEN7@/ED  <?$0![3R62^6)
M1&K).<WMX46MIU2RZ<%G+#%*2)HVR#N> :?(LD9+5X*KB,4Y"G=3@  HF8GB
MB5EF,1#FH6V]S-(R $.+(SIK3O(6S6=(0^G 8Z>WCMI&2&"(:61ZW<OE!5?C
M"[QVW\;B(978JU;'</!+2YQ=XNSF52NXF9TF!@KNSW]<73=4T8LZ\6Q4'!;U
M;8XCG"4Z^GFSO+/<5XR]G,TWP)-3V#S&\/F6.UXF.##9,74Z41;!STA^TM2:
M?Y352LZJUYN5K.9TMM'*?MFU7-SQ[3>KR5B=3>\%5\31826D4KB7-U ]A[UE
MB]H'V.!K(?+<T<!6G>IK,S/-9C!DK5UT((X@W[OA2A6Q-)4G5ZRUS\%Y-TRI
M:UX:]H^Y*I$3"62,L;-,E ULG @!+1(N8WL=X!XJBI!6MHLK0Q1QZO+:!J\1
MH*<569'V>SM9W1NE8'/8X.#C[#5(RS7DJ]/+N+:>&A->ZBO2>JT3*)Y.J>G_
M /0O"_O9OYJZ#2MS;(BH@(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M/F)[!K-5T]O/\N'#RTTAN.0;827N.AR$CX8'3QO#V-+Z/:X.%:5[EP>_YNC
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M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$&H=12UN&MG.- +RVX_\
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M8=/3796$/;\*S\U;S2MS;,BH@(" @(" @(" @(" @(" @(" @(" @(" @("
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MPMPE]![/32=?0_13%_\ #[?[U>'R^_+Z+A]R%VL3*(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M0D(TCP.X55XB(5ZTT;<Q#\%A;'$EXD^$B;$9!PU44RK,ZLLH5$! 0$! 0$!
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MV&,4C8*-'/@M&9F9UET8B(C2'M0D0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0>)*4'YM:?\ VH'^:@#_ "4#ZB!]
M1 ^H@^_40?/J(/G:.7;\OS(*B @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
3" @(" @(" @(" @(" @("#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>txt_adlainorty-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 txt_adlainorty-bw.jpg
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M )T   (" P$! 0             '!@@$!0D# @$! 0
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M%)IU-P,"%I1,5]4Y 2IR11_&14T&A_TM?'3^OT'_ !4K^)T!_I:^.G]?H/\
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M?O57],0M OOV<7ZD+_\ 2N9_1U=H#]H[^I"@_2N'_1UCH&#X3_ZL>"_O6O\
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MV70?6@H/A]CG'853Y3=E+EMA*ZO2'E%?0U)%[D&88P)"-NB+Z*;*,1AC^C8
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MTWXPXCT=D%AD&)9+DDPK5DF;.NM9D9^%()20Q><;:BLJKH+OP<Y;HA$GP)=
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M-C$L'0G>T,[>*AQ%AI2$VG70WDSB(%0@;ALJ3Q.HA(!<.2<=]!(NH<&QCK7
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MB;J#@[\@)/@OKH,?M_H_RLLY$3KS ^R)EWU1=,O,6DR\<AL6$$%1?<:F2F&
ME2VGD-1#VD+?U!P1!$(@T?E_UY5]4^)>&=?T[QR(-)?0VOJ74XD\^]'L'WW5
M'=>/N.N&?'=>.^WV:"S_ 'QUN?;'5.1X7%(6KF4P,FED%L/MV4(QD1E0U15!
M",$;,Q]4 BT%=NI(+GE[%^M[QOR?+"9*09W5D$#JVAL& ]LI]FB&CKINDAH
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M#33BM$Z(_C-R8[7X/1?@#!Q?J+*HUK69%V#VCD>6W-8NX1(AM8Y2.\2YMJ[
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MR%MMQXGN*HOJBZ"RD>.Q$8:BQ6@8C, +3++0H#8-@G$1$1V1!1$V1$^&@]=
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M0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@-
M: T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H#0&@- : T!H
$#0?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>txt_shanghi-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 txt_shanghi-bw.jpg
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M *,   (" P$! 0            <(!08 ! D# @$! 0
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MQ%IC)K@BWBC/I(!O@X+-L\XTI-M-;U< 6@1T%)13>/IZJ2CV#6\+O]4N2/\
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MGH #S#8M<3<J8?S9()6\5LVOQ)S=Q$U%B-)<61 F$B)V%EY#%TU7Z!(B?8Z
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MI_$WD?:\C\J97QQ88195#5(\JQ;(VR5&&-FK8V*+V8==VD3:(JZ_1T^!34&
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M@JVVT&Y&U'<B?%JNXQ#H)KR-\;+W^3QA>!<:0W;J5A$D7)$1K:C\H9#3JRI
M"1)J9/GZGICKV)=/9T _Q'F_S0PS%J7$*_B(I5?0PHU7#?EX_<$^4>(T++:F
M34EL%5!$470!UZ#WX,\8<UY)I^1K+FV%.I5RHB?J&9OJ-OMW#SQR7+!(SA:B
MH$J!J8H1@9CK[>@)OAKQ)S7Q5#R>GSKT:W$9CKGU9!1\7Y@3V3](I; BAM"R
MZ"?\9J1*(+MV^T!#F_B9Y(<I<J643,<G6SQ6$^JP<MLWD1A8K^CNV+ 95-CB
M(>TP!L&MR*B'IWZ!M.%?''CG@^%NQV*L_)GFT;G9'.03F.:HFX6]$VLMJOW
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MXPV!R:^8V3,AI)%E*?#>!(A"I 8EHJ:]^_0%')J^_LJEV+C-R-#;J0$S8N1
MG@*"NJB3)FVA(7L70Q7["HO0)KRU!\F,ZY0P7B'*ZNJL\<K[BNR8<HH(4IAI
M8T-PV#?F$_(<!H@ G%)H=-Q$B"JZCT#Q=! YO73+C"\CJ:YOUK"?5S8L1K<(
M;WGXY@ [B4134E1-55$Z"E^.6$Y#QUPMBF&Y4P$7(*UJ3\[':<!X6RD3'Y C
MO;5154%Q-=JJFOO7H)[E@N06^/+]WBU8WX\MQ2.K"6"F)$GTQ;[H*.[=?1WH
MH;]$)-JJJ MWCUXD3H.*PI7,]E,LHLI_ZY:X_5YP*MJ4^(_?;!M%3UY&@AN
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8UW+\E\[N_P#AM^W7;Z7P;]--_?Z/0?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>txt_hangzhou-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 txt_hangzhou-bw.jpg
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M )@   (" P$! 0            <(!08 ! D# 0(! 0
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M H^ZR"M-FXB)N( (W%$57N@J9*GV5]O0(SA'.?,&0>7LOB.7EK[6"M9!>L!
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M8DH7/1-%0MJ$J[=5[I[>@O\ Y%17(/CEF\)Z4].=C4)LG-E;%D/DV(BKKOI
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M!4**^AG2S+!%T2'Z[S3H/D.G=M#:07._PBJDFNFU0ZV-.MOM@\R:.,N(AMN
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MKEGH(^+PYA'-/ ''V.YI%,@9H:.1#L8B@U.C&$-A21ITP/07!10<%15%%?\
MG(*H%MML)Q;CSAC)<5PVM:JJ*'26?HQ6MQ:F<5Q2,S-2(S)?I$9*J_9Z"E>)
M5E75'C!AEG;2V8%;&8GN2)DMP&&&P^LY7Q&XXHB*?;73H!-=3,3X"YHC<R%6
M,7W"/(9E(BY%':^;2@N):IZ[\;L2"W*V>H2MZ$8ZH.J-[3!QZ6[J,CJHMY03
MF+*GG!ZL2=%<%UEP-=-1(55%T5%1?L+VZ#?Z"L9[GN-\;XU+RC)Y21X<851B
M..BR)<A47TX\=O75QUQ?A$4_-71-5Z"@\+\?W86=KS+R0SLY.S !%(*]QI*8
M=%C5K7_Q(B";Y:)N<]VJ*1 9>@5;EI_(?&/+@Y;PYER7Q#D4QH.0<49!%;AR
MW5V)8PQU$6B=UT<]@F[HA+\8J ,IC>1TN74-=D^.S GTEJP$J#+:7X3;<35-
M47N))]$A+N):HJ(J=!*]! YN\D?"\CD$)&C57-<4 34B08YKHB>]5T[= MWB
MYQ1>3N",1F2LTRW&G9 3G!I83L2+&9;.PDJV3;<B$ZXB. HNZD:HN[<G9>@+
M_P")ZT_K2S7]65O\7=!6?%KC?-.,<9R^HS*,C#EGE%A;UKCDEJ3)>BR&V6A=
M>5C5L5/T=VB+KW741Z"\\Y?D4Y(_HM>?@Y_H%Q_X=_[Q?Z3Z!R^@YZ>#U3;P
M.?,\D3($B,T=5/1IR0VXT!DMG&5$0B'WZ>[W=!%YQQ#Y%^17/<O&N0F4JJ:@
M/TRM([9K20ZMT]X'"4]JON/HB:(7WQ231S8(:"'03$,4I<&QBJQ#'6/EJ6GC
MA$B-]MRB"=S-41-QFNIF6GQ$JK[^@7'SHXJR_D? **PPRM?N;''I[CLFMB#Z
MLDXTIK83C;2:DXH& ? &JZ$JZ:(N@*P6(^2?,%1Q[P[=X!84N,8LY\O%M)-3
M/K@%EY0 WI;\I?356P1=/30%75=$)=.@:7SBQ3F/*\'KH/'PG88D4AL,CH:]
MLRL9+QN@D8E05576 /3<V"(HEH9;D35L+?XK^/K/!N%FY<"V[GU^C;]Z^"H8
MQP!%5N&V2*J*+6XE,A^F:KW5$'H#YT"H>3'BGE?.'(U1FE'>5];"KJJ/6N1I
M@OJZ3C$N3(4D5L"':J/HG?WI^9T#7]!SIXRQ;)XWGK-NI%+/9IER')W4L7(K
MPQE;>B6" 2.J.S0U(=O?OJFGMZ#HMT$9D2WZ4-DN+!%/)/EG?JD; C"'\VH+
MZ2O*V)'L0M%+:FJIV[>WH$D\3/'KD!GER_Y6YA@R8MS2RI3<5)VBG-MYB$C\
MM"^(7&A!PE!P%VD1HH*NQ>@J'ESA_(EWY/5$K!JR>MH;-,W46T=IP6&9R/JC
M1K(V[&]A[5(R+X>@E/Q5?W@G_JB9_#K'_2Z 7\W<8^5\>FK"Y5=L<DJUE$D!
MAF3];$U(],E4]K"$H(HIIN5/M=!T?X6CR(G#G'D26T;$IC&:9I]AT5!QMP(#
M(D)"6BHJ*FBHO00'/_$=GRWBU5&QNV"AS+&[6-?8[;.@I@W+BH2()***2"NY
M"U05^(1[+T%6BQ_-J+&;CNRN,IK@)M65(&]%UQ=?I$C(-@BZ?\T4Z"FYOPEY
M3<R5R8GR7FV+U6%OR6Y$^-CL>6ZZ8LFAMCI(::4D$OB1"=3N@JNJIT#++CLJ
M)B3&,4-Q*KI,*(Q"@W+B-398I&$ $W$D@8.D2!HXI#JNJJBHNBH"L^0%/Y:3
M*@.+JHJO-,9S$_DG\@@UKM?/BMBC9&$S[^Y&9:+1?ONGQ?$GPJHCT#28)CA8
M?A&-8D;J/G054&J)X=4$U@QP84D1>^B[-4Z"#J.+ZQG+7<^RB6YDN8)Z@5LN
M8 C$JXQDNC-=%3<+.HZ(;JD3I]]3VKMZ"^= )O)JFO,AX*S.DQNM?M[J=&89
MB5\45<><593.[:*:JNT=35/L)T%AX;JKVAXFPFAR:*D&]JJ2! FQ!(3](XD<
M&4%2$B121!3=H2IK[.@O'0:-=35%.LHJFOC0"G/E+FK%9;85^0:(A.N^F*;S
M5$1%(M5[=!5<[X_E<@O,5=M?28>">GI:X_6HL5^R-2[MR9HN*:12#X289!LB
M[[G%'X4"TTE)3XW51**@@L5E/!#TH<&*V+3+0:JN@B*(B:JJJOV5[]!O] M?
MA54W57Q[F!W<&5"=GYG;3(Q3&G&B?9)F(VKH>HB*0JXVX.Y/NA)/:B] RG05
M(.,./6\S7D-O&H 9JK1,K<HP*/JAKJIKI\*N+]'U=/4V_#NV]N@MO0"WR/I[
MW(>$,TI,:AO6%W/@BQ$A105QYU3>;0A$4[K\.[7[706+B>GLL>XLP>@N&%BV
M]5C]3!GQB425J3&A--.@JBJHNTA5-473H+AT$+F 2G<1OVH,<I<TZZ8,:*W]
M-UTF#0 '[9+HB= *?$;&\MQ'@?',=S*L<J+2&Y.)J#('TY 1Y$QV0"N@JJHD
MJN$NA:*B::IT!PZ!>^<>,.9W:2PE\(9I9A.M7"CVF,6C\:9#.+-7TW3BR)X&
M['5M"(E$7?H]F]JHB*&QQS,A\$\<T?#U1%GY_GE"R0S:Z@C$K+<NQ>=F*DB6
M_P"G&BM(;V@K(=$U#0]GNZ#[/XEY!YE?![G"T;J,)!P7F.-\<?<]%Y -' 2T
ML- .0J::*#(@&J(0JB] 8)6'8I-Q@L+DTL-S$C82&M*K )#1@=-H(TB(*(*H
MBCHG9>Z=^@5#+O$+/<"FR<C\8\VFX\KI>J]BLJ4ZW'-4[Z-O:D!HG9!;DMK]
MMSH&$XHH.8*:L;/EC,(62V+S J[&AUC<+Y>0JHJHDAHP%T435/\ NP=_S.X$
M;H!=Y&P;*SX.SBMJ($FSM)M<<:) @M%(DNNO& "@-@BD2ZKKHB>SH)[B&LGT
MO$^!TUM'.):5V.U$.=$=3:XS(CP66W&R3W$)"J+T&]F=5F5K7M!A.1,8[:-&
M1D_+KQLV'AVJB ;:NLD*:Z+N ]>@4^'&\A>1?*/$(')-%71JCC%V5-<O*&/*
M;JS:L8PD!([*><4S=)MH$!.X_%J/PDO0.KT S\@L2OLZX;RW$L7BI-OK6*#,
M**KC;*&:/MFNIO$ )H(JO<DZ"S\=TD_&N/L3QRT0!LZBFKJ^:+9;P1^+%;:<
M02]Z;A71>@H'D["Y4LN)+>NXG:;D7$Y/D[2+L4IKE;)16GTB+KM1W0DUW#]#
M=M5#0=0I7"?B; Q*AHRY6L7,PMJ<5.JQ^0X;N/U1NFKI>A%+X'7=YDI.N#IJ
MOPBFB%T#"Y'CE'EU'.QK)8+5E1632L3H+Z;@< M%]RHJ$BHA"0JA"2(0JBHB
M] L&#^(F:\9\@/SL Y3LJ#C=Y5D_5+(B_+)Y504:<:?$XCB(.JH^;2E[MGM+
MH&K@QWHD-B,_+=G/- @',D(T+SJI[3-&&VFT5??L 4^UT"U<T^)DWE7EBMY(
MILTDXH3$9OYHXPNO2VYL0A1EV(2/-(RJMHB$0JFT@0M"4E40_=?X84 M:WW)
M.<6DIQ5]<@MDCLN(7MU!6G"[]]=7.@L57X@\+P6R:L(UQ="2:+]875CI[57N
M,9Y@5U]BH0JG;H-N[\6.&'<6NJ>CQ&%'LYM?*BP9D@GI1LR'F#:;=$I)NJA
M1;A+VHJ:^U.@U?$;C?.N*^(PQC/VTC6Y64N9'KTD!*^5BO(V@MJ;1&VBJ8N.
MZ-DJ?']G7H#OT&=!G09T$=>5*7E5)JBF2Z])*(/SM<\4:6WM)"U;='5175-%
M^RG;H%>YYXF\E)%.&,\7Y[/R3%,D)VLO:>Z;JVY,>-(:)3<*>,=HR8)$(#$=
L#35!3?N7H"7^(P_]VW\17UF/SWU-]7_6FTO1^>W>OOTTW>EZW_S;/M]!_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
